Psyllid ID: psy2131

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------33
Protein Sequence
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK
Secondary Structure (PSIPRED)
cccEEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEcccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEccccccEEEcccccEEEEEEEHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHcccccccccccccccEEEEEEcccccccccccHHHHHHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
EccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEcccccccEEEccccccEEccccccEHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHHcHHHccccccccccccHHHHHHHHHHHHHHHcccHHHHHEEccHHHccHHHHHcccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccEEEc
Coil and Loop (DISEMBL)
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRklqhpnivrLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNhchsngvvhrdlkpenLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLvgyppfwdedQHRLYAQIKAgaydypspewdtvtpEAKNLINQMltvnpskritasealkhpwicQRERVASIVHRQETVDCLKKFNARRKLKvstrqgfagtpgylspevlkkepygkpvdiwACGVILYILLvgyppfwdedQHRLYAQIKagayddepkhksasvvk
Flexible Loop (DISEMBL)
gafsvvrrcvqkatglefaakiintkklsardFQKLEREARicrklqhpnivRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDClkkfnarrklkvstrqgfagtpgylspevlKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAgayddepkhksasvvk
Low Complexity Region (SEG)
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK
Disordered region (IsUnstruct)
***SVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG***************
Disordered Region (DISOPRED)
GAFSVVRRCVQKATGLEFAAKIINTKKLS*RD*QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH**************RKLKVSTRQGFA*****************KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSA**V*
Disordered Region (DISEMBL)
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY*************
Disordered Region (DISPRO)
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	328	2.2.26 [Sep-21-2011]
Q00168	530	Calcium/calmodulin-depend	yes	N/A	0.850	0.526	0.791	1e-140
Q5ZKI0	479	Calcium/calmodulin-depend	yes	N/A	0.841	0.576	0.756	1e-131
Q2HJF7	488	Calcium/calmodulin-depend	yes	N/A	0.829	0.557	0.76	1e-131
Q95266	499	Calcium/calmodulin-depend	yes	N/A	0.841	0.553	0.753	1e-130
P15791	533	Calcium/calmodulin-depend	yes	N/A	0.853	0.525	0.743	1e-130
Q6PHZ2	499	Calcium/calmodulin-depend	yes	N/A	0.841	0.553	0.753	1e-130
Q13557	499	Calcium/calmodulin-depend	yes	N/A	0.841	0.553	0.753	1e-130
O62305	720	Calcium/calmodulin-depend	no	N/A	0.768	0.35	0.804	1e-129
A8WXF6	533	Calcium/calmodulin-depend	N/A	N/A	0.768	0.472	0.807	1e-129
O77708	533	Calcium/calmodulin-depend	yes	N/A	0.853	0.525	0.737	1e-129

>sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster GN=CaMKII PE=1 SV=1

 Score =  497 bits (1279), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 243/307 (79%), Positives = 257/307 (83%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS+V+RCVQK+TG EFAAKIINTKKL+ARDFQKLEREARICRKL HPNIVRLHDSIQE
Sbjct: 23  GAFSIVKRCVQKSTGFEFAAKIINTKKLTARDFQKLEREARICRKLHHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct: 83  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEVQG+ QAWF                            GV
Sbjct: 143 LLASKAKGAAVKLADFGLAIEVQGDHQAWFGFAGTPGYLSPEVLKKEPYGKSVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY+QIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYSQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPNKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           A+EALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 263 AAEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSMITK 322

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 323 KGEGSQV 329

A key regulator of plasticity in synaptic physiology and behavior, alterations in its activity produce pleiotrophic effects that involve synaptic transmission and development as well as various aspects of behavior. Directly modulates eag potassium channels.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 7

>sp|Q5ZKI0|KCC2D_CHICK Calcium/calmodulin-dependent protein kinase type II delta chain OS=Gallus gallus GN=CAMK2D PE=2 SV=1

 Score =  468 bits (1205), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 230/304 (75%), Positives = 250/304 (82%), Gaps = 28/304 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKITTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYG 276
           +P G
Sbjct: 323 KPDG 326

CaM-kinase II (CAMK2) is a prominent kinase in the central nervous system.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q2HJF7|KCC2D_BOVIN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Bos taurus GN=CAMK2D PE=2 SV=1

 Score =  466 bits (1200), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 228/300 (76%), Positives = 248/300 (82%), Gaps = 28/300 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + +  +LKK
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAKSLLKK 322

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q95266|KCC2D_PIG Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Sus scrofa GN=CAMK2D PE=2 SV=1

 Score =  466 bits (1199), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/304 (75%), Positives = 250/304 (82%), Gaps = 28/304 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYG 276
           +P G
Sbjct: 323 KPDG 326

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|P15791|KCC2D_RAT Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Rattus norvegicus GN=Camk2d PE=1 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/308 (74%), Positives = 252/308 (81%), Gaps = 28/308 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYGKPVD 280
           +P G  ++
Sbjct: 323 KPDGVKIN 330

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q6PHZ2|KCC2D_MOUSE Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Mus musculus GN=Camk2d PE=1 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/304 (75%), Positives = 250/304 (82%), Gaps = 28/304 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYG 276
           +P G
Sbjct: 323 KPDG 326

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens GN=CAMK2D PE=1 SV=3

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/304 (75%), Positives = 250/304 (82%), Gaps = 28/304 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYG 276
           +P G
Sbjct: 323 KPDG 326

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O62305|KCC2D_CAEEL Calcium/calmodulin-dependent protein kinase type II OS=Caenorhabditis elegans GN=unc-43 PE=1 SV=2

 Score =  462 bits (1190), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 226/281 (80%), Positives = 239/281 (85%), Gaps = 29/281 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 21  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 80

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHRDLKPENL
Sbjct: 81  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRDLKPENL 140

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 141 LLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 199

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 200 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 259

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVS 253
           A +ALK PWIC RERVAS +HRQ+TVDCLKKFNARRKLK +
Sbjct: 260 ADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKAA 300

Role in locomotion and neuronal cell fate specification. Required for the regulation of synaptic density, egg laying, defecation, and meiotic maturation. Required for viability under chronic osmotic stress in which it acts downstream of osr-1. Regulates the synaptic trafficking of glr-1. Bidirectional modulator of neurotransmitter release with negative modulatory effects mainly mediated via slo-1 activation. May suppress the functional response to an internal pacemaker, perhaps by modulating the activity of the IP3 receptor.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|A8WXF6|KCC2D_CAEBR Calcium/calmodulin-dependent protein kinase type II OS=Caenorhabditis briggsae GN=unc-43 PE=3 SV=1

 Score =  462 bits (1189), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 227/281 (80%), Positives = 239/281 (85%), Gaps = 29/281 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 21  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 80

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNGVVHRDLKPENL
Sbjct: 81  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGVVHRDLKPENL 140

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 141 LLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 199

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 200 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 259

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVS 253
           A +ALK PWIC RERVAS +HRQ+TVDCLKKFNARRKLK +
Sbjct: 260 ADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKAA 300

Role in locomotion and neuronal cell fate specification. Required for the regulation of synaptic density, egg laying, defecation, and meiotic maturation. Required for viability under chronic osmotic stress in which it acts downstream of osr-1. Regulates the synaptic trafficking of glr-1. Bidirectional modulator of neurotransmitter release with negative modulatory effects mainly mediated via slo-1 activation. May suppress the functional response to an internal pacemaker, perhaps by modulating the activity of the IP3 receptor.

Caenorhabditis briggsae (taxid: 6238)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O77708|KCC2D_RABIT Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Oryctolagus cuniculus GN=CAMK2D PE=2 SV=2

 Score =  460 bits (1183), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 227/308 (73%), Positives = 250/308 (81%), Gaps = 28/308 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 23  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 83  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWI  R  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 263 ASEALKHPWISHRATVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 322

Query: 273 EPYGKPVD 280
           +P G  ++
Sbjct: 323 KPDGVKIN 330

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	328
91079668	525	PREDICTED: similar to Ca2+/calmodulin-de	0.850	0.531	0.817	1e-141
270003360	553	hypothetical protein TcasGA2_TC002587 [T	0.850	0.504	0.817	1e-140
321466397	524	hypothetical protein DAPPUDRAFT_198415 [	0.850	0.532	0.807	1e-140
242022287	500	cAMP-dependent protein kinase catalytic	0.850	0.558	0.807	1e-140
322510318	528	calcium/calmodulin-dependent protein kin	0.765	0.475	0.878	1e-139
322510316	507	calcium/calmodulin-dependent protein kin	0.765	0.495	0.878	1e-139
322510314	507	calcium/calmodulin-dependent protein kin	0.765	0.495	0.878	1e-139
322510312	486	calcium/calmodulin-dependent protein kin	0.765	0.516	0.878	1e-139
380011195	524	PREDICTED: calcium/calmodulin-dependent	0.850	0.532	0.807	1e-139
340713027	525	PREDICTED: calcium/calmodulin-dependent	0.850	0.531	0.804	1e-139

>gi|91079668|ref|XP_966888.1| PREDICTED: similar to Ca2+/calmodulin-dependent protein kinase II [Tribolium castaneum]

 Score =  506 bits (1302), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 251/307 (81%), Positives = 259/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKAKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPGKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIIVK 322

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 323 KGDGSQV 329

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270003360|gb|EEZ99807.1| hypothetical protein TcasGA2_TC002587 [Tribolium castaneum]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 251/307 (81%), Positives = 259/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKAKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP KRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPGKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIIVK 322

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 323 KGDGSQV 329

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321466397|gb|EFX77393.1| hypothetical protein DAPPUDRAFT_198415 [Daphnia pulex]

 Score =  504 bits (1298), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 248/307 (80%), Positives = 260/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS+VRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 22  GAFSIVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 81

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct: 82  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 141

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 142 LLASKAKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 201

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP+KRIT
Sbjct: 202 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPAKRIT 261

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           A+EALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 262 AAEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIINK 321

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 322 KSDGSNV 328

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242022287|ref|XP_002431572.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212516875|gb|EEB18834.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis]

 Score =  502 bits (1293), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 248/307 (80%), Positives = 259/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 40  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 99

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH+NGVVHRDLKPENL
Sbjct: 100 ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHTNGVVHRDLKPENL 159

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGE QAWF                            GV
Sbjct: 160 LLASKIKGAAVKLADFGLAIEVQGENQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 219

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP+PEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 220 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPTPEWDTVTPEAKNLINQMLTVNPSKRIT 279

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           AS+ALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 280 ASDALKHPWICQRERVASMVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIITK 339

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 340 KGDGSQV 346

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322510318|gb|ADX05544.1| calcium/calmodulin-dependent protein kinase II isoform D [Periplaneta americana]

 Score =  501 bits (1289), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/279 (87%), Positives = 249/279 (89%), Gaps = 28/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH +GVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQDGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKQKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLK 301

Source: Periplaneta americana

Species: Periplaneta americana

Genus: Periplaneta

Family: Blattidae

Order: Blattodea

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322510316|gb|ADX05543.1| calcium/calmodulin-dependent protein kinase II isoform C [Periplaneta americana]

 Score =  500 bits (1288), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/279 (87%), Positives = 249/279 (89%), Gaps = 28/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH +GVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQDGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKQKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLK 301

Source: Periplaneta americana

Species: Periplaneta americana

Genus: Periplaneta

Family: Blattidae

Order: Blattodea

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322510314|gb|ADX05542.1| calcium/calmodulin-dependent protein kinase II isoform B [Periplaneta americana]

 Score =  500 bits (1287), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/279 (87%), Positives = 249/279 (89%), Gaps = 28/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH +GVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQDGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKQKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLK 301

Source: Periplaneta americana

Species: Periplaneta americana

Genus: Periplaneta

Family: Blattidae

Order: Blattodea

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322510312|gb|ADX05541.1| calcium/calmodulin-dependent protein kinase II isoform A [Periplaneta americana]

 Score =  500 bits (1287), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/279 (87%), Positives = 249/279 (89%), Gaps = 28/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH +GVVHRDLKPENL
Sbjct: 83  ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQDGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 143 LLASKQKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLK 301

Source: Periplaneta americana

Species: Periplaneta americana

Genus: Periplaneta

Family: Blattidae

Order: Blattodea

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380011195|ref|XP_003689696.1| PREDICTED: calcium/calmodulin-dependent protein kinase type II alpha chain-like isoform 2 [Apis florea]

 Score =  499 bits (1286), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 248/307 (80%), Positives = 258/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TG EFAAKIINTKKL+ARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGHEFAAKIINTKKLTARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESV+HCH NGVVHRDLKPENL
Sbjct: 83  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVHHCHHNGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG----------------------------V 152
           LLASKAKGAAVKLADFGLAIEVQGE QAWFG                            V
Sbjct: 143 LLASKAKGAAVKLADFGLAIEVQGEAQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAG+YDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGSYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIITK 322

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 323 KGDGSQV 329

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340713027|ref|XP_003395053.1| PREDICTED: calcium/calmodulin-dependent protein kinase type II alpha chain-like isoform 3 [Bombus terrestris]

 Score =  499 bits (1285), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 247/307 (80%), Positives = 258/307 (84%), Gaps = 28/307 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCVQK+TG EFAAKIINTKKL+ARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 23  GAFSVVRRCVQKSTGYEFAAKIINTKKLTARDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESV+HCH NGVVHRDLKPENL
Sbjct: 83  ENHHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVHHCHHNGVVHRDLKPENL 142

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG----------------------------V 152
           LLASKAKGAAVKLADFGLAIEVQGE QAWFG                            V
Sbjct: 143 LLASKAKGAAVKLADFGLAIEVQGEAQAWFGFAGTPGYLSPEVLKKEPYGKPVDIWACGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAG+YDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT
Sbjct: 203 ILYILLVGYPPFWDEDQHRLYAQIKAGSYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 262

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQRERVAS+VHRQETVDCLKKFNARRKLK +       T  + S  ++ K
Sbjct: 263 ASEALKHPWICQRERVASVVHRQETVDCLKKFNARRKLKGAILTTMLATRNFSSRSIITK 322

Query: 273 EPYGKPV 279
           +  G  V
Sbjct: 323 KGDGSQV 329

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	328
FB|FBgn0264607	530	CaMKII "Calcium/calmodulin-dep	0.460	0.284	0.940	2.3e-129
UNIPROTKB|Q7QEK3	490	AGAP000028 "AGAP000028-PA" [An	0.460	0.308	0.940	8.9e-128
UNIPROTKB|F1NG22	456	CAMK2D "Calcium/calmodulin-dep	0.460	0.331	0.894	5.8e-122
UNIPROTKB|Q5ZKI0	479	CAMK2D "Calcium/calmodulin-dep	0.460	0.315	0.894	5.8e-122
RGD|2263	533	Camk2d "calcium/calmodulin-dep	0.460	0.283	0.887	1.2e-121
UNIPROTKB|P15791	533	Camk2d "Calcium/calmodulin-dep	0.460	0.283	0.887	1.2e-121
UNIPROTKB|A5D9F0	478	CAMK2D "Calcium/calmodulin-dep	0.460	0.315	0.887	1.5e-121
UNIPROTKB|Q13557	499	CAMK2D "Calcium/calmodulin-dep	0.460	0.302	0.887	1.5e-121
UNIPROTKB|Q95266	499	CAMK2D "Calcium/calmodulin-dep	0.460	0.302	0.887	1.5e-121
MGI|MGI:1341265	499	Camk2d "calcium/calmodulin-dep	0.460	0.302	0.887	1.5e-121

FB|FBgn0264607 CaMKII "Calcium/calmodulin-dependent protein kinase II" [Drosophila melanogaster (taxid:7227)]

 Score = 747 (268.0 bits), Expect = 2.3e-129, Sum P(2) = 2.3e-129
 Identities = 142/151 (94%), Positives = 147/151 (97%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFS+V+RCVQK+TG EFAAKIINTKKL+ARDFQKLEREARICRKL HPNIVRLHDSIQE
Sbjct:    23 GAFSIVKRCVQKSTGFEFAAKIINTKKLTARDFQKLEREARICRKLHHPNIVRLHDSIQE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct:    83 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASKAKGAAVKLADFGLAIEVQG+ QAWFG
Sbjct:   143 LLASKAKGAAVKLADFGLAIEVQGDHQAWFG 173

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS;IDA

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=ISS

GO:0007611 "learning or memory" evidence=NAS;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;IDA

GO:0007268 "synaptic transmission" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;NAS;TAS

GO:0005516 "calmodulin binding" evidence=IEA;TAS

GO:0007528 "neuromuscular junction development" evidence=NAS

GO:0007619 "courtship behavior" evidence=TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0008049 "male courtship behavior" evidence=IMP

GO:0051489 "regulation of filopodium assembly" evidence=IMP

GO:0007616 "long-term memory" evidence=IMP

GO:0030424 "axon" evidence=IDA

GO:0045211 "postsynaptic membrane" evidence=IDA

GO:0048786 "presynaptic active zone" evidence=IDA

GO:0030425 "dendrite" evidence=IDA

GO:0060278 "regulation of ovulation" evidence=IGI

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q7QEK3 AGAP000028 "AGAP000028-PA" [Anopheles gambiae (taxid:7165)]

 Score = 750 (269.1 bits), Expect = 8.9e-128, Sum P(2) = 8.9e-128
 Identities = 142/151 (94%), Positives = 149/151 (98%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFS+V+RCVQK+TG EFAAKIINTKKL++RDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct:    23 GAFSIVKRCVQKSTGFEFAAKIINTKKLTSRDFQKLEREARICRKLQHPNIVRLHDSIQE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             EN+HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH NGVVHRDLKPENL
Sbjct:    83 ENFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHQNGVVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASKAKGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKAKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

UNIPROTKB|F1NG22 CAMK2D "Calcium/calmodulin-dependent protein kinase type II delta chain" [Gallus gallus (taxid:9031)]

 Score = 704 (252.9 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
 Identities = 135/151 (89%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:     2 GAFSVVRRCMKITTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 61

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    62 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 121

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQGEQQAWFG
Sbjct:   122 LLASKSKGAAVKLADFGLAIEVQGEQQAWFG 152

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q5ZKI0 CAMK2D "Calcium/calmodulin-dependent protein kinase type II delta chain" [Gallus gallus (taxid:9031)]

 Score = 704 (252.9 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
 Identities = 135/151 (89%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKITTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQGEQQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGEQQAWFG 173

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

RGD|2263 Camk2d "calcium/calmodulin-dependent protein kinase II delta" [Rattus norvegicus (taxid:10116)]

 Score = 700 (251.5 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=ISO

GO:0001666 "response to hypoxia" evidence=IMP

GO:0002028 "regulation of sodium ion transport" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA;IDA;IMP

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006816 "calcium ion transport" evidence=ISO

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=IMP

GO:0010613 "positive regulation of cardiac muscle hypertrophy" evidence=ISO

GO:0014704 "intercalated disc" evidence=ISO

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=IMP

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0030007 "cellular potassium ion homeostasis" evidence=IMP

GO:0030315 "T-tubule" evidence=ISO

GO:0031594 "neuromuscular junction" evidence=ISO

GO:0035022 "positive regulation of Rac protein signal transduction" evidence=IMP

GO:0043025 "neuronal cell body" evidence=ISO

GO:0043194 "axon initial segment" evidence=ISO

GO:0043234 "protein complex" evidence=IDA

GO:0044325 "ion channel binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

GO:0050998 "nitric-oxide synthase binding" evidence=IPI

GO:0060048 "cardiac muscle contraction" evidence=ISO

GO:0060341 "regulation of cellular localization" evidence=ISO

GO:0061049 "cell growth involved in cardiac muscle cell development" evidence=IMP

GO:0070374 "positive regulation of ERK1 and ERK2 cascade" evidence=IMP

UNIPROTKB|P15791 Camk2d "Calcium/calmodulin-dependent protein kinase type II subunit delta" [Rattus norvegicus (taxid:10116)]

 Score = 700 (251.5 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0002028 "regulation of sodium ion transport" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0006816 "calcium ion transport" evidence=IEA

GO:0010613 "positive regulation of cardiac muscle hypertrophy" evidence=ISS

GO:0014704 "intercalated disc" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0030315 "T-tubule" evidence=IEA

GO:0031594 "neuromuscular junction" evidence=IEA

GO:0033017 "sarcoplasmic reticulum membrane" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043194 "axon initial segment" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0060048 "cardiac muscle contraction" evidence=IEA

GO:0060341 "regulation of cellular localization" evidence=ISS

UNIPROTKB|A5D9F0 CAMK2D "Calcium/calmodulin-dependent protein kinase type II subunit delta" [Bos taurus (taxid:9913)]

 Score = 700 (251.5 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0005524 "ATP binding" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

UNIPROTKB|Q13557 CAMK2D "Calcium/calmodulin-dependent protein kinase type II subunit delta" [Homo sapiens (taxid:9606)]

 Score = 700 (251.5 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0005516 "calmodulin binding" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0002028 "regulation of sodium ion transport" evidence=IEA

GO:0006816 "calcium ion transport" evidence=IEA

GO:0014704 "intercalated disc" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0030315 "T-tubule" evidence=IEA

GO:0031594 "neuromuscular junction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043194 "axon initial segment" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0060048 "cardiac muscle contraction" evidence=IEA

GO:0033017 "sarcoplasmic reticulum membrane" evidence=IEA

GO:0001558 "regulation of cell growth" evidence=NAS

GO:0005524 "ATP binding" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IDA;NAS

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

GO:0010613 "positive regulation of cardiac muscle hypertrophy" evidence=IMP

GO:0060341 "regulation of cellular localization" evidence=IMP

GO:0008016 "regulation of heart contraction" evidence=TAS

GO:0010881 "regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion" evidence=TAS

GO:0060314 "regulation of ryanodine-sensitive calcium-release channel activity" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005886 "plasma membrane" evidence=TAS

GO:0007268 "synaptic transmission" evidence=TAS

GO:0019221 "cytokine-mediated signaling pathway" evidence=TAS

GO:0030666 "endocytic vesicle membrane" evidence=TAS

GO:0060333 "interferon-gamma-mediated signaling pathway" evidence=TAS

UNIPROTKB|Q95266 CAMK2D "Calcium/calmodulin-dependent protein kinase type II subunit delta" [Sus scrofa (taxid:9823)]

 Score = 700 (251.5 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060341 "regulation of cellular localization" evidence=ISS

GO:0010613 "positive regulation of cardiac muscle hypertrophy" evidence=ISS

GO:0033017 "sarcoplasmic reticulum membrane" evidence=IEA

GO:0060048 "cardiac muscle contraction" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043194 "axon initial segment" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0031594 "neuromuscular junction" evidence=IEA

GO:0030315 "T-tubule" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0014704 "intercalated disc" evidence=IEA

GO:0006816 "calcium ion transport" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0002028 "regulation of sodium ion transport" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

MGI|MGI:1341265 Camk2d "calcium/calmodulin-dependent protein kinase II, delta" [Mus musculus (taxid:10090)]

 Score = 700 (251.5 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
 Identities = 134/151 (88%), Positives = 143/151 (94%)

Query:     1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
             GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct:    23 GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 82

Query:    61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct:    83 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 142

Query:   121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG 151
             LLASK+KGAAVKLADFGLAIEVQG+QQAWFG
Sbjct:   143 LLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001666 "response to hypoxia" evidence=ISO

GO:0002028 "regulation of sodium ion transport" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;IMP

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=ISO

GO:0005886 "plasma membrane" evidence=IEA

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006816 "calcium ion transport" evidence=IDA;IMP

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=ISO

GO:0010613 "positive regulation of cardiac muscle hypertrophy" evidence=ISO

GO:0014704 "intercalated disc" evidence=IDA

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016529 "sarcoplasmic reticulum" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0030007 "cellular potassium ion homeostasis" evidence=ISO

GO:0030315 "T-tubule" evidence=IDA

GO:0031594 "neuromuscular junction" evidence=IDA

GO:0035022 "positive regulation of Rac protein signal transduction" evidence=ISO

GO:0043025 "neuronal cell body" evidence=IDA

GO:0043194 "axon initial segment" evidence=IDA

GO:0043234 "protein complex" evidence=ISO

GO:0044325 "ion channel binding" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO;IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

GO:0050998 "nitric-oxide synthase binding" evidence=ISO

GO:0060048 "cardiac muscle contraction" evidence=IDA

GO:0060341 "regulation of cellular localization" evidence=ISO

GO:0061049 "cell growth involved in cardiac muscle cell development" evidence=ISO

GO:0070374 "positive regulation of ERK1 and ERK2 cascade" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O77708	KCC2D_RABIT	2, ., 7, ., 1, 1, ., 1, 7	0.7370	0.8536	0.5253	yes	N/A
Q6DGS3	KC2D2_DANRE	2, ., 7, ., 1, 1, ., 1, 7	0.7346	0.8536	0.5054	yes	N/A
Q5ZKI0	KCC2D_CHICK	2, ., 7, ., 1, 1, ., 1, 7	0.7565	0.8414	0.5762	yes	N/A
Q13557	KCC2D_HUMAN	2, ., 7, ., 1, 1, ., 1, 7	0.7532	0.8414	0.5531	yes	N/A
Q00168	KCC2A_DROME	2, ., 7, ., 1, 1, ., 1, 7	0.7915	0.8506	0.5264	yes	N/A
Q6PHZ2	KCC2D_MOUSE	2, ., 7, ., 1, 1, ., 1, 7	0.7532	0.8414	0.5531	yes	N/A
Q2HJF7	KCC2D_BOVIN	2, ., 7, ., 1, 1, ., 1, 7	0.76	0.8292	0.5573	yes	N/A
P15791	KCC2D_RAT	2, ., 7, ., 1, 1, ., 1, 7	0.7435	0.8536	0.5253	yes	N/A
Q95266	KCC2D_PIG	2, ., 7, ., 1, 1, ., 1, 7	0.7532	0.8414	0.5531	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.17	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	328
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-88
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-73
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-45
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-44
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-43
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-37
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-35
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-34
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-33
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-30
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-28
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-28
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-27
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-26
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-26
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-26
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-24
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-23
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-22
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-22
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-22
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-22
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-21
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-21
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-20
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-18
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-17
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-11
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-09
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-09
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-08
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-07
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-06
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-05
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-05
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-05
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-05
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-05
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-04
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-04
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-04
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-04
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-04
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-04
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-04
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	0.001
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	0.002
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.002
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.002
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	0.003
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	0.003
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.003
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.003
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.004
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	0.004
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  264 bits (678), Expect = 2e-88
 Identities = 101/250 (40%), Positives = 143/250 (57%), Gaps = 33/250 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V     K TG   A K+I  KK   +D +++ RE +I +KL+HPNIVRL+D  ++
Sbjct: 10  GSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNIVRLYDVFED 68

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E+  YLV +   GG+LF+ +  R   SE +A   ++QIL ++ + HS G+VHRDLKPEN+
Sbjct: 69  EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENI 128

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-FGVI 153
           LL        VKLADFGLA ++   ++                           W  GVI
Sbjct: 129 LLDEDGH---VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVI 185

Query: 154 LYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           LY LL G PPF  +DQ   L+ +I      +P PEWD ++PEAK+LI ++L  +P KR+T
Sbjct: 186 LYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRKLLVKDPEKRLT 244

Query: 213 ASEALKHPWI 222
           A EAL+HP+ 
Sbjct: 245 AEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  225 bits (577), Expect = 5e-73
 Identities = 95/254 (37%), Positives = 133/254 (52%), Gaps = 35/254 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +   K TG   A KI+  +   ++  Q   RE RI R+L HPNIVRL D+ ++
Sbjct: 10  GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFED 69

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +++ YLV +   GG+LF+ +      SE +A     QIL  + + HSNG++HRDLKPEN+
Sbjct: 70  KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENI 129

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W-FG 151
           LL        VK+ADFGLA ++     +                            W  G
Sbjct: 130 LLDEN---GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186

Query: 152 VILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           VILY LL G PPF  E   DQ +L  +I     ++  P+W + + EAK+LI + L  +PS
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPS 246

Query: 209 KRITASEALKHPWI 222
           KR TA E L+HPW 
Sbjct: 247 KRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  174 bits (444), Expect = 3e-53
 Identities = 81/253 (32%), Positives = 127/253 (50%), Gaps = 39/253 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V    +K TG  +A K++  KK+  R   +    E  I  ++ HP IV+LH + Q
Sbjct: 4   GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ 63

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            E   YLV +   GGELF  +     +SE  A     +I+ ++ + HS G+++RDLKPEN
Sbjct: 64  TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123

Query: 120 LLLASKAKGAAVKLADFGLA-IEVQGEQQAW---------------------------FG 151
           +LL   A G  +KL DFGLA        +                              G
Sbjct: 124 ILL--DADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V+LY +L G PPF+ ED+  +Y +I      +P    + ++PEA++LI+ +L  +P+KR+
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPTKRL 236

Query: 212 TA--SEALK-HPW 221
            +  +E +K HP+
Sbjct: 237 GSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (403), Expect = 2e-47
 Identities = 79/241 (32%), Positives = 111/241 (46%), Gaps = 50/241 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V     K TG + A KII  K+ S+   ++L RE  I +KL HPNIV+L+   ++
Sbjct: 4   GGFGTVYLARDKKTGKKVAIKIIK-KEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED 62

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           EN+ YLV +   GG L  D++       SE +    + QILE + + HSNG++HRDLKPE
Sbjct: 63  ENHLYLVMEYCEGGSLK-DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKA 178
           N+LL   +    VKLADFGL+                               +   +   
Sbjct: 122 NILL--DSDNGKVKLADFGLS-------------------------KLLTSDKSLLKTIV 154

Query: 179 GAYDYPSPE----WDTVT---------------PEAKNLINQMLTVNPSKRITASEALKH 219
           G   Y +PE        +               PE K+LI +ML  +P KR +A E L+H
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEH 214

Query: 220 P 220
            
Sbjct: 215 L 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  155 bits (395), Expect = 2e-45
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 63/276 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G+FS V    +K T  E+A KI++ ++L      K   +E+E  + R   HP I++L+ +
Sbjct: 12  GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGHPGIIKLYYT 70

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q+E   Y V +    GEL + I       E        +IL ++ + HS G++HRDLKP
Sbjct: 71  FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKP 130

Query: 118 ENLLLASKAKGAAVKLADFGLAI------------------------------------- 140
           EN+LL        +K+ DFG A                                      
Sbjct: 131 ENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE 187

Query: 141 ----EVQGEQQA------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 189
               E+  E+ A      W  G I+Y +L G PPF   +++  + +I    Y +P P + 
Sbjct: 188 YVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP-PNFP 246

Query: 190 TVTPEAKNLINQMLTVNPSKRITAS---EALK-HPW 221
              P+AK+LI ++L ++P  R+  +   + LK HP+
Sbjct: 247 ---PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  152 bits (386), Expect = 2e-44
 Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 45/262 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA+  V    +K+TG  +A K+I    +  ++   ++  E  I  + Q P +V+L+ S Q
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            +   YLV + + GG+L   +       E  A   I +I+ ++ + HSNG++HRDLKP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 120 LLLASKAKGAAVKLADFGL-----------------------------AIEV-----QGE 145
           +L+ S      +KL DFGL                             A EV       +
Sbjct: 124 ILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 146 QQAWF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W+  G ILY  LVG PPF  E    ++  I  G      PE   V+ EA +LI+++L
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDVEVSDEAIDLISKLL 238

Query: 204 TVNPSKRITA---SEALKHPWI 222
             +P KR+ A    E   HP+ 
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  149 bits (378), Expect = 3e-43
 Identities = 75/256 (29%), Positives = 116/256 (45%), Gaps = 40/256 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G F  V     K+    FA K +  + +     Q+ +  E  I  +  HP IV+L+ + +
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y++ +   GGEL+  +  R  + E  A   I  ++ +  + H+ G+++RDLKPEN
Sbjct: 64  DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPEN 123

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LLL S      VKL DFG A +++  Q+ W                            G+
Sbjct: 124 LLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 153 ILYILLVGYPPFW--DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           +LY LL G PPF   DED   +Y  I  G      P +  +   AK+LI Q+L  NP +R
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLRRNPEER 238

Query: 211 I-----TASEALKHPW 221
           +        +  KH W
Sbjct: 239 LGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (377), Expect = 5e-43
 Identities = 77/257 (29%), Positives = 112/257 (43%), Gaps = 42/257 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-LHDSIQ 59
           G+F  V   + K TG   A K +     S  + + LERE RI   LQHPNIVR       
Sbjct: 11  GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD 70

Query: 60  EENYHYLVF-DLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           EE     +F + V+GG L   ++ + F    E       +QILE + + HSNG+VHRD+K
Sbjct: 71  EEKNTLNIFLEYVSGGSL-SSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIK 128

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------- 148
             N+L+ S      VKLADFG A  +   +                              
Sbjct: 129 GANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185

Query: 149 -W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVTPEAKNLINQMLTV 205
            W  G  +  +  G PP+ +       A +         PE  + ++ EAK+ + + L  
Sbjct: 186 IWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243

Query: 206 NPSKRITASEALKHPWI 222
           +P KR TA E L+HP++
Sbjct: 244 DPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  149 bits (379), Expect = 5e-43
 Identities = 80/252 (31%), Positives = 130/252 (51%), Gaps = 38/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++  K+   +  + +  E RI + ++HP +V L+ S Q
Sbjct: 12  GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +++  YLV + V GGELF  +     + E  A     Q++ ++ + HS  +V+RDLKPEN
Sbjct: 72  DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPEN 131

Query: 120 LLLASKAKGAAVKLADFG------------------LAIEV---QGEQQAW----FGVIL 154
           LLL S      +K+ DFG                  LA E+   +G  +A      G+++
Sbjct: 132 LLLDSDGY---IKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR---- 210
           Y +L GYPPF+D++  ++Y +I  G   +PS      +P+AK+LI  +L V+ +KR    
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----FSPDAKDLIRNLLQVDLTKRLGNL 244

Query: 211 ITASEALK-HPW 221
                 +K HPW
Sbjct: 245 KNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  142 bits (361), Expect = 1e-40
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 38/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V    +K+ G  +  K I+   +S ++ +    E +I +KL HPNI++ ++S +E
Sbjct: 11  GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +V +   GG+L + I  +    + + E        Q+  ++ + HS  ++HRD+K
Sbjct: 71  KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------W 149
           P+N+ L S      VKL DFG++  +                                 W
Sbjct: 131 PQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             G +LY L     PF  E+   L  +I  G Y  P P     + E +NL++ +L  +P 
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPS--QYSSELRNLVSSLLQKDPE 244

Query: 209 KRITASEALKHPWI 222
           +R + ++ L+ P+I
Sbjct: 245 ERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (339), Expect = 1e-37
 Identities = 69/252 (27%), Positives = 121/252 (48%), Gaps = 40/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V +   K TG E A K+I  +       +K+  E +I +K +HPNIV+ + S  +
Sbjct: 11  GGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK 68

Query: 61  ENYHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           ++  ++V +  +GG L +D++    +   +E+  ++  +++L+ + + HSNG++HRD+K 
Sbjct: 69  KDELWIVMEFCSGGSL-KDLLKSTNQTL-TESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-F 150
            N+LL S  +   VKL DFGL+ ++   +                            W  
Sbjct: 127 ANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL 183

Query: 151 GVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           G+    L  G PP+ +    + L+     G     +PE    + E K+ + + L  NP K
Sbjct: 184 GITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK--WSDEFKDFLKKCLQKNPEK 241

Query: 210 RITASEALKHPW 221
           R TA + LKHP+
Sbjct: 242 RPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  137 bits (344), Expect = 3e-37
 Identities = 74/277 (26%), Positives = 110/277 (39%), Gaps = 56/277 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKL-EREARICRKLQHP-NIVRLHDSI 58
           G+F  V     +      A K++  K  S     +   RE +I   L HP NIV+L+D  
Sbjct: 11  GSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67

Query: 59  QEENYHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           Q+E   YLV + V GG L    + I  +   SE++A   + QIL ++ + HS G++HRD+
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
           KPEN+LL     G  VKL DFGLA  +                                 
Sbjct: 128 KPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185

Query: 150 -----------FGVILYILLVGYPPF----WDEDQHRLYAQIKAGAYDYPSPEWDTVTP- 193
                       G+ LY LL G PPF          +    I        +       P 
Sbjct: 186 AYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPE 245

Query: 194 ----EAKNLINQMLTVNPSKRITASEALKHPWICQRE 226
                A +L+ ++L  +P  R+++S  L H  +   +
Sbjct: 246 LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 9e-37
 Identities = 75/250 (30%), Positives = 118/250 (47%), Gaps = 34/250 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV + +   TG   A K I+ +K+     + + +E  + + L+HPNIV+   SI+ 
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y++ +    G L + I     + E+  +  + Q+L+ + + H  GV+HRD+K  N+
Sbjct: 71  SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI 130

Query: 121 LLASKAKGAAVKLADFGLA------------------------IEVQGEQQA---W-FGV 152
           L     K   VKLADFG+A                        IE+ G   A   W  G 
Sbjct: 131 LTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
            +  LL G PP++D +      +I       P PE   ++PE K+ + Q    +P+ R T
Sbjct: 188 TVIELLTGNPPYYDLNPMAALFRI-VQDDHPPLPE--GISPELKDFLMQCFQKDPNLRPT 244

Query: 213 ASEALKHPWI 222
           A + LKHPWI
Sbjct: 245 AKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  129 bits (328), Expect = 1e-35
 Identities = 81/303 (26%), Positives = 120/303 (39%), Gaps = 111/303 (36%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G + VV +   K TG   A K I           +L+           RE  + ++L+HP
Sbjct: 10  GTYGVVYKARDKKTGEIVALKKI-----------RLDNEEEGIPSTALREISLLKELKHP 58

Query: 50  NIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------------- 95
           NIV+L D I  E   YLVF+                Y + D    +              
Sbjct: 59  NIVKLLDVIHTERKLYLVFE----------------YCDMDLKKYLDKRPGPLSPNLIKS 102

Query: 96  --QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----I-------EV 142
              Q+L  + +CHS+ ++HRDLKP+N+L+        +KLADFGLA    I       EV
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRD---GVLKLADFGLARAFGIPLRTYTHEV 159

Query: 143 Q-----------GEQQ------AW-FGVILYILLVGYPPFW-DEDQHRLYA--------- 174
                       G +        W  G I   ++ G P F  D +  +L+          
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219

Query: 175 -QIKAGAYDYPS-----PEWD---------TVTPEAKNLINQMLTVNPSKRITASEALKH 219
            +   G    P      P++           + PE  +L+++ML  NP+KRI+A EALKH
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279

Query: 220 PWI 222
           P+ 
Sbjct: 280 PYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 4e-35
 Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 60/278 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I  +  S    +   RE ++ ++L HPNI++L D  + 
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +   YLVF+ +   +L++ I  R+    E+     + Q+L+ +  CHS+G++HRDLKPEN
Sbjct: 70  KGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPEN 128

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA--------WF--------------------- 150
           LL+ ++     +KLADFGLA       +         W+                     
Sbjct: 129 LLINTE---GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185

Query: 151 GVILYILLVGYPPF-------------------WDEDQHRLYAQIKAGAYDYPSP---EW 188
           G I   LL   P F                     E   +  +  +   + +P       
Sbjct: 186 GCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL 245

Query: 189 DTVTP----EAKNLINQMLTVNPSKRITASEALKHPWI 222
             + P    +A +L++QML  +P KRITA +AL HP+ 
Sbjct: 246 PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  128 bits (323), Expect = 2e-34
 Identities = 77/238 (32%), Positives = 122/238 (51%), Gaps = 35/238 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  VR    K TG  +A K +  ++ L  +  Q + +E  I  +L HP IV +  S Q
Sbjct: 29  GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88

Query: 60  EENYHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +EN  Y + + V GGELF  +  A  F ++    +  + +L +  + HS  +++RDLKPE
Sbjct: 89  DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL-AFEYLHSKDIIYRDLKPE 147

Query: 119 NLLLASKAKGAAVKLADFGLA---------------------IEVQGEQQA--WF--GVI 153
           NLLL +K     VK+ DFG A                     I+ +G  +A  W+  GV+
Sbjct: 148 NLLLDNKGH---VKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVL 204

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           LY  + GYPPF+D+   R+Y +I AG   +P+  W      A++L+  +L  + +KR+
Sbjct: 205 LYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  125 bits (316), Expect = 3e-34
 Identities = 69/257 (26%), Positives = 111/257 (43%), Gaps = 44/257 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  V    ++ T   FA K +N +K +     + +  E RI ++L HP +V L  S Q
Sbjct: 11  GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +E   YLV DL+ GG+L   +  +  +SE      I +I+ ++ + HS G++HRD+KP+N
Sbjct: 71  DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDN 130

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------WF--GV 152
           +LL  +     V + DF +A +V  +                            W+  GV
Sbjct: 131 ILLDEQGH---VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGV 187

Query: 153 ILYILLVGYPPFWDEDQHRL-----YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
             Y  L G  P+     H           +  A       W   + EA + IN++L  +P
Sbjct: 188 TAYECLRGKRPY---RGHSRTIRDQIRAKQETADVLYPATW---STEAIDAINKLLERDP 241

Query: 208 SKRI--TASEALKHPWI 222
            KR+     +   HP+ 
Sbjct: 242 QKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  125 bits (315), Expect = 1e-33
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 43/266 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V +   +ATG E A K +   +L  ++ + +  E  I +  +HPNIV  +DS   
Sbjct: 30  GASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
            +  ++V + + GG L  DI+ + F   +E   ++  +++L+ + + HS  V+HRD+K +
Sbjct: 87  GDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQ---------AW-------------------F 150
           N+LL+       VKLADFG A ++  E+           W                    
Sbjct: 146 NILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           G++   +  G PP+  E   R    I   G     +PE    +PE K+ +N+ L  +P K
Sbjct: 203 GIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE--KWSPEFKDFLNKCLVKDPEK 260

Query: 210 RITASEALKHPWI---CQRERVASIV 232
           R +A E L+HP++   C +E  A ++
Sbjct: 261 RPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 2e-33
 Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 38/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V     + +   +A K++   + +  +  Q +  E R+ +++ HP I+RL  +  
Sbjct: 12  GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ + Y++ + V GGELF  +     +S +       +I+ ++ + HS  +V+RDLKPEN
Sbjct: 72  DQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPEN 131

Query: 120 LLLASKAKGAAVKLADFGLAIEV---------------------QGEQQA--WF--GVIL 154
           +LL    K   +KL DFG A ++                     +G  +A  W+  G+++
Sbjct: 132 ILL---DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +LVGYPPF+D++   +Y +I AG  ++P      +   AK+LI ++L V+ ++R+   
Sbjct: 189 YEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNM 244

Query: 212 --TASEALKHPW 221
              A +   H W
Sbjct: 245 KNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 2e-32
 Identities = 74/252 (29%), Positives = 123/252 (48%), Gaps = 36/252 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ----KLEREARICRKLQHPNIVRLHD 56
           GAF  V    +++TG  FA K++    + A++ Q    K ER A +  + + P + +L+ 
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAER-AIMMIQGESPYVAKLYY 64

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           S Q ++Y YLV + + GG+    I       E  A   I +++  V   H  G++HRD+K
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 117 PENLLLASKAKGAAVKLADFGLA--------------------IEVQGEQQA---W-FGV 152
           PENLL+        +KL DFGL+                    I   G+ +    W  G 
Sbjct: 125 PENLLIDQTGH---LKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           +++  L GYPPF  E    ++  I +   ++P    +  +PEA +LIN++L ++P+KR+ 
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLG 241

Query: 213 AS---EALKHPW 221
           A+   E   HP+
Sbjct: 242 ANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (289), Expect = 3e-30
 Identities = 71/255 (27%), Positives = 123/255 (48%), Gaps = 40/255 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G+  VV +   K TG  +A K I+       +F+K L RE +  R  + P +V+ + +  
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 60  EENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSN-GVVHRDLKP 117
           +E    +V + + GG L  D++ +     E   ++  +QIL+ +++ H+   ++HRD+KP
Sbjct: 70  KEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP 128

Query: 118 ENLLLASKAKGAAVKLADFGLA--IE--------------------VQGEQQA-----W- 149
            NLL+ SK     VK+ADFG++  +E                    +QGE  +     W 
Sbjct: 129 SNLLINSK---GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWS 185

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKNLINQMLTVNP 207
            G+ L    +G  PF    Q   +  ++A     P P    +  +PE ++ I+  L  +P
Sbjct: 186 LGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFRDFISACLQKDP 244

Query: 208 SKRITASEALKHPWI 222
            KR +A+E L+HP+I
Sbjct: 245 KKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  115 bits (289), Expect = 3e-30
 Identities = 69/262 (26%), Positives = 112/262 (42%), Gaps = 48/262 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V   V   TG   A K I  +    +  +++  E ++   L+HPN+V+ +     
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESVNHCHSNGVVHRDLK 116
               Y+  +  +GG L E  +    +      H I+    Q+LE + + HS+G+VHRD+K
Sbjct: 71  REKVYIFMEYCSGGTLEE--LLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQ-------GEQQAWFG--------VILYILLVGY 161
           P N+ L        +KL DFG A++++        E Q+  G        VI      G+
Sbjct: 127 PANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 162 --------------------PPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKNLIN 200
                                P W E  +        GA   P  P+   ++PE K+ ++
Sbjct: 184 GRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242

Query: 201 QMLTVNPSKRITASEALKHPWI 222
           + L  +P KR TASE L+HP++
Sbjct: 243 RCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 5e-29
 Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 76/251 (30%)

Query: 38  REARICRKLQHPNIVRLHDSIQEE--NYHYLVF-----DLVTGGELFEDIVAREFY--SE 88
           RE ++ +KL+HPNIVRL + +  +     Y+VF     DL TG      ++       +E
Sbjct: 47  REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDL-TG------LLDSPEVKFTE 99

Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
           +     ++Q+LE + + HSNG++HRD+K  N+L+ +      +KLADFGLA        A
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSA 156

Query: 149 ---------WF---------------------GVILYILLVGYPPF-------------- 164
                    W+                     G IL  L +G P F              
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 165 ---------WDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKNLINQMLTVNPSKRI 211
                    W       + +       Y     +       P A +L++++LT++P KRI
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276

Query: 212 TASEALKHPWI 222
           +A +AL+H + 
Sbjct: 277 SADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  110 bits (276), Expect = 1e-28
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 34/249 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF +V  C +KA       K I  ++++  +    + E ++ + L HPNI+  +++  E
Sbjct: 11  GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +    +V +   GG L E I  R      E    H   QIL +++H H+  ++HRDLK +
Sbjct: 71  DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQ 130

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FG 151
           N+LL        VK+ DFG++  +  + +A+                            G
Sbjct: 131 NILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALG 188

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            +LY L      F   +   L  +I +G +   +P  D  +P+ + LI  ML ++PSKR 
Sbjct: 189 CVLYELASLKRAFEAANLPALVLKIMSGTF---APISDRYSPDLRQLILSMLNLDPSKRP 245

Query: 212 TASEALKHP 220
             S+ +  P
Sbjct: 246 QLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  111 bits (280), Expect = 2e-28
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 40/254 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G   +VR+      G  +A K++    L  RD  + + E  I  ++ HP IV+LH + Q 
Sbjct: 10  GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YL+ D + GG+LF  +     ++E D    + ++  +++H HS G+++RDLKPEN+
Sbjct: 70  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 129

Query: 121 LLASKAKGAAVKLADFGLAIE-VQGEQQAW---------------------------FGV 152
           LL  +     +KL DFGL+ E +  E++A+                           FGV
Sbjct: 130 LLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 186

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           +++ +L G  PF  +D+      I       P      ++PEA++L+  +   NP+ R+ 
Sbjct: 187 LMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRLG 242

Query: 213 AS-----EALKHPW 221
           A      E  +HP+
Sbjct: 243 AGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  109 bits (274), Expect = 1e-27
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 81/288 (28%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-------DFQKLEREARICRKLQHPNIVR 53
           G ++VV +   K TG   A K I   KL  R       +F  L RE ++ ++L+HPNI+ 
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVH 112
           L D    ++   LVF+ +   +L + I  +    + AD    +   L  + + HSN ++H
Sbjct: 67  LLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILH 125

Query: 113 RDLKPENLLLASKAKGAAVKLADF----------------------------------GL 138
           RDLKP NLL+AS      +KLADF                                  G+
Sbjct: 126 RDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGV 182

Query: 139 AIEVQGEQQAW-FGVILYILLVGYPPFW---DEDQ-HRLYAQIK-------AGAYDYPSP 186
            +++      W  G I   LL+  P      D DQ  +++  +         G    P  
Sbjct: 183 GVDM------WSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236

Query: 187 -EWDTVTP------------EAKNLINQMLTVNPSKRITASEALKHPW 221
            E+    P            +A +L+ ++LT+NP+KRITA +AL+HP+
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (270), Expect = 2e-27
 Identities = 76/271 (28%), Positives = 116/271 (42%), Gaps = 65/271 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  VR+  +K+ G     K I+   ++ ++ Q+L  E  I R+L+HPNIVR +D I +
Sbjct: 11  GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID 70

Query: 61  ENYH--YLVFDLVTGGELF--------------EDIVAREFYSEADASHCIQQILESVNH 104
            +    Y+V +   GG+L               E+ + R             Q+L ++  
Sbjct: 71  RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL----------TQLLLALYE 120

Query: 105 CH-----SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA----------- 148
           CH      N V+HRDLKP N+ L +      VKL DFGLA  +  +              
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177

Query: 149 ----------------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 191
                           W  G ++Y L    PPF   +Q +L ++IK G +    P     
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIP--YRY 234

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           + E   +I  ML V+P KR +  E L+ P I
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  106 bits (267), Expect = 1e-26
 Identities = 74/255 (29%), Positives = 120/255 (47%), Gaps = 41/255 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  S Q
Sbjct: 6   GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ 65

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     +SE  A     +I+ ++ + HS  VV+RDLK EN
Sbjct: 66  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125

Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAWFG-- 151
           L+L    K   +K+ DFGL                     A EV      G    W+G  
Sbjct: 126 LMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  +L+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 238

Query: 212 -----TASEALKHPW 221
                 A E ++H +
Sbjct: 239 GGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 57/145 (39%), Positives = 79/145 (54%), Gaps = 8/145 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           G F  V     K TG   A K +  K  S  +   L RE +  RKL  HPNIV+L +  +
Sbjct: 10  GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLKEVFR 68

Query: 60  EENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           E +  Y VF+ + G  L++ +  R+   +SE+     I QIL+ + H H +G  HRDLKP
Sbjct: 69  ENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKP 127

Query: 118 ENLLLASKAKGAAVKLADFGLAIEV 142
           ENLL++       VK+ADFGLA E+
Sbjct: 128 ENLLVSGP---EVVKIADFGLAREI 149

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 4e-26
 Identities = 75/311 (24%), Positives = 134/311 (43%), Gaps = 63/311 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  VR   +K TG  +A K +   ++  +D    ++ E  +  +   P +V L+ S Q
Sbjct: 12  GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +  Y YL+ + + GG+L   ++  + +SE      + + + ++   H  G +HRD+KP+N
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDN 131

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAG 179
           +L+    +G  +KL+DFGL+                        F  +     Y ++  G
Sbjct: 132 ILI---DRGGHIKLSDFGLSTG----------------------FHKQHDSAYYQKLLQG 166

Query: 180 AYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
                     +      N  +  +    S  +T S                    ++ + 
Sbjct: 167 ---------KSNKNRIDNRNSVAVD---SINLTMSS-------------------KDQIA 195

Query: 240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
             KK   RR +  ST     GTP Y++PE+  ++ YG+  D W+ G I++  L+G+PPF 
Sbjct: 196 TWKK--NRRLMAYST----VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249

Query: 300 DEDQHRLYAQI 310
            E+ H  Y +I
Sbjct: 250 SENSHETYRKI 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 74/251 (29%), Positives = 120/251 (47%), Gaps = 42/251 (16%)

Query: 6   VRRCVQKATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEENY 63
           VR+     TG  FA K++    +  + +D    + E  I   ++HP IV L  + Q    
Sbjct: 15  VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74

Query: 64  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLA 123
            YL+ + ++GGELF  +     + E  A   + +I  ++ H H  G+++RDLKPEN+LL 
Sbjct: 75  LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134

Query: 124 SKAKGAAVKLADFGL---------------------AIEV-----QGEQQAWF--GVILY 155
           ++     VKL DFGL                     A E+      G+   W+  G ++Y
Sbjct: 135 AQGH---VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY 191

Query: 156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI---- 211
            +L G PPF  E++ +   +I  G  + P      +TPEA++L+ ++L  NPS R+    
Sbjct: 192 DMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKKLLKRNPSSRLGAGP 247

Query: 212 -TASEALKHPW 221
             A+E   HP+
Sbjct: 248 GDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  101 bits (253), Expect = 4e-25
 Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 36/253 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 57
           G+F  V   +    G  FA K   + +  +      ++LE+E  +  KLQHPNIV+   +
Sbjct: 11  GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            +EE+  Y+  +LV GG L + +     + E       +QIL  + + H    VHRD+K 
Sbjct: 71  EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKG 130

Query: 118 ENLLLASKAKGAAVKLADFGLA--IEVQGE-----------------QQAWFGVILYILL 158
            N+L+ +      VKLADFG+A  +                      QQ  +G+   I  
Sbjct: 131 ANILVDTNG---VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187

Query: 159 VG---------YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           +G          PP+       + A  K G      P  D ++ EAK+ I + L  +PS 
Sbjct: 188 LGCTVLEMATGKPPW--SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSL 245

Query: 210 RITASEALKHPWI 222
           R TA+E L+HP++
Sbjct: 246 RPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  100 bits (252), Expect = 1e-24
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 75/284 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----REARICRKLQ-HPNIVRL 54
           G FS V +   + TG  +A K +         F+ LE     RE +  R+L  HPNI+RL
Sbjct: 10  GTFSEVLKAQSRKTGKYYAIKCMKKH------FKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 55  HDSIQEE--NYHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESVNHCHSNGVV 111
            + + +       LVF+L+    L+E I  R+    E      + Q+L+S++H H NG+ 
Sbjct: 64  IEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------QAWF-------------- 150
           HRD+KPEN+L+    K   +KLADFG    +  +          W+              
Sbjct: 123 HRDIKPENILI----KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178

Query: 151 -------GVILYILLVGYPPFWDEDQ-------H--------RLYAQIKAGA---YDYPS 185
                  G + + +L  +P F   ++       H         +  + +      Y++PS
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238

Query: 186 PEWDT--------VTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            +  T         + E  +L+ ++L  +P +RITA +AL+HP+
Sbjct: 239 KK-GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.4 bits (248), Expect = 3e-24
 Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 41/263 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V     K+TG + A K ++ +K   R+   L  E  I R  QHPNIV ++ S   
Sbjct: 30  GSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSSYLV 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  DIV     +E   +     +L++++  H+ GV+HRD+K +++
Sbjct: 88  GDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI 146

Query: 121 LLASKAKGAAVKLADFG---------------------LAIEV------QGEQQAW-FGV 152
           LL S  +   VKL+DFG                     +A EV        E   W  G+
Sbjct: 147 LLTSDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWDTVTPEAKNLINQMLTVNPSK 209
           ++  ++ G PP+++E   +   +I+    D   P       V+P  ++ +++ML  +P++
Sbjct: 204 MVIEMVDGEPPYFNEPPLQAMKRIR----DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQ 259

Query: 210 RITASEALKHPWICQRERVASIV 232
           R TA+E L HP++ +    +SIV
Sbjct: 260 RATAAELLNHPFLAKAGPPSSIV 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 96.9 bits (241), Expect = 3e-23
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 37/261 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A K +N ++   ++   +  E  + R+ +HPNIV   DS   
Sbjct: 30  GASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDSYLV 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 88  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 146

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AWFGVI 153
           LL       +VKL DFG   ++  EQ                             W   I
Sbjct: 147 LLGMDG---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203

Query: 154 LYILLV-GYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           + I +V G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 204 MAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRG 261

Query: 212 TASEALKHPWICQRERVASIV 232
           +A E L+HP++   + ++S+ 
Sbjct: 262 SAKELLQHPFLKIAKPLSSLT 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.4 bits (240), Expect = 4e-23
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 46/259 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K ++ K+L  R  +++   E +I  K+    IV L  + +
Sbjct: 4   GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE 63

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  V    + EA A     QI+  + H H   +V+RDLKP
Sbjct: 64  TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------WF-- 150
           EN+LL        V+++D GLA+E++G ++                          WF  
Sbjct: 124 ENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 151 GVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           G  LY ++ G  PF       ++  L  +    A +YP    D  +PEAK+L   +L  +
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP----DKFSPEAKDLCEALLQKD 236

Query: 207 PSKRI-----TASEALKHP 220
           P KR+     +A E  +HP
Sbjct: 237 PEKRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 95.7 bits (239), Expect = 4e-23
 Identities = 68/253 (26%), Positives = 103/253 (40%), Gaps = 42/253 (16%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V +           +E A K +     S +  ++  REARI RKL HPN+V+L  
Sbjct: 10  GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPNVVKLLG 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
              EE   Y+V + + GG+L   +   R   S +D      QI   + +  S   +HRDL
Sbjct: 69  VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDL 128

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQ----------AW---------------- 149
              N L+        VK++DFGL+ ++  +             W                
Sbjct: 129 AARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSD 185

Query: 150 ---FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
              FGV+L+ I  +G  P+       +   +K G Y  P P      PE  +L+ Q    
Sbjct: 186 VWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQPP--NCPPELYDLMLQCWAE 242

Query: 206 NPSKRITASEALK 218
           +P  R T SE ++
Sbjct: 243 DPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 96.4 bits (240), Expect = 5e-23
 Identities = 70/240 (29%), Positives = 105/240 (43%), Gaps = 59/240 (24%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG-ELFEDIVA-REFYSEADASHCI 95
           RE  + ++L+H NIVRLHD I  EN   LVF+ +    + + D    R            
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----IEVQGEQQA--- 148
            Q+L+ +  CH N V+HRDLKP+NLL+  + +   +KLADFGLA    I V         
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVT 163

Query: 149 -WF---------------------GVILYILLVGYPPFW---DEDQHRLYAQIKAGAYD- 182
            W+                     G I+  ++ G P F    +EDQ     +I     + 
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223

Query: 183 -YP----SPEWDTVTPEAK----------------NLINQMLTVNPSKRITASEALKHPW 221
            +P     PE+    P                   +L++++L +NP  RI+A +AL+HPW
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 95.6 bits (239), Expect = 5e-23
 Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 55/257 (21%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V +       + T  + A K +  +  S  + ++   EA I +KL HPNIVRL  
Sbjct: 10  GAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLSHPNIVRLLG 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREF-------YSEADASHCIQQILESVNHCHSNG 109
              +    Y+V + + GG+L       +F        +  D      QI + + +  S  
Sbjct: 69  VCTQGEPLYIVTEYMPGGDL------LDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ-----------AW--------- 149
            VHRDL   N L+        VK++DFGL+ ++  +              W         
Sbjct: 123 FVHRDLAARNCLVTENLV---VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 150 ----------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL 198
                     FGV+L+ I  +G  P+       +   ++ G   Y  P  +    E   L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPENCPDELYEL 236

Query: 199 INQMLTVNPSKRITASE 215
           + Q    +P  R T SE
Sbjct: 237 MLQCWAYDPEDRPTFSE 253

Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 5e-23
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 26/201 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K TG  +A K++    +  R+     R  R I      P IV+L+ S Q
Sbjct: 12  GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71

Query: 60  EENYHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +E + YLV + + GG+L         F +  AR FY        I +++ +++  H  G 
Sbjct: 72  DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETAR-FY--------IAELVLALDSVHKLGF 122

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPP----FWD 166
           +HRD+KP+N+L+ +      +KLADFGL  ++   +   + +     L+          D
Sbjct: 123 IHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 167 EDQHRLYAQIKAGAYDYPSPE 187
             Q R+ A    G  DY +PE
Sbjct: 180 HKQRRVRANSTVGTPDYIAPE 200

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 41/253 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 6   GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 65

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 66  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 125

Query: 120 LLLASKAKGAAVKLADFG---------------------LAIEV-----QGEQQAWF--G 151
           L+L    K   +K+ DFG                     LA EV      G    W+  G
Sbjct: 126 LML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 183 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 238

Query: 212 -----TASEALKH 219
                 A E ++H
Sbjct: 239 GGGPSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 69/246 (28%), Positives = 110/246 (44%), Gaps = 39/246 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G+F  V     KA G  +A K++  K +  +  QK    ER   + + ++HP +V LH S
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-KNVKHPFLVGLHYS 64

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q  +  Y V D V GGELF  +     + E  A     +I  ++ + HS  +++RDLKP
Sbjct: 65  FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKP 124

Query: 118 ENLLLASKAKGAAVKLADFGLAIE-VQGEQQA-------------------------WF- 150
           EN+LL S+     V L DFGL  E ++  +                           W+ 
Sbjct: 125 ENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 151 -GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G +LY +L G PPF+  D   +Y  I              ++  A++L+  +L  + +K
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP----NISVSARHLLEGLLQKDRTK 237

Query: 210 RITASE 215
           R+ A +
Sbjct: 238 RLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 66/254 (25%), Positives = 101/254 (39%), Gaps = 43/254 (16%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V +           +E A K +     S +  ++  REARI RKL HPNIV+L  
Sbjct: 10  GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPNIVKLLG 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRD 114
              EE    +V + + GG+L + +        S +D      QI   + +  S   +HRD
Sbjct: 69  VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRD 128

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ----------AW--------------- 149
           L   N L+    +   VK++DFGL+ ++  +             W               
Sbjct: 129 LAARNCLV---GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKS 185

Query: 150 ----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
               FGV+L+ I  +G  P+       +   +K G    P P      PE   L+ Q   
Sbjct: 186 DVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL-PKPP--NCPPELYKLMLQCWA 242

Query: 205 VNPSKRITASEALK 218
            +P  R T SE ++
Sbjct: 243 EDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 33/74 (44%), Positives = 40/74 (54%), Gaps = 1/74 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIK 311
                F GTP Y++PEVL  + YGK VDIW+ GVILY LL G PPF  +DQ   L+ +I 
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210

Query: 312 AGAYDDEPKHKSAS 325
                  P     S
Sbjct: 211 KPKPPFPPPEWDIS 224

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 44/260 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLH 55
           G   +VR+      G  +A K++    +  +   K     R  R++     + P +V LH
Sbjct: 14  GKVFLVRKVGGHDAGKLYAMKVLKKATIVQK--AKTAEHTRTERQVLEAVRRCPFLVTLH 71

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            + Q +   +L+ D V GGELF  +  RE ++E++    I +I+ +++H H  G+++RD+
Sbjct: 72  YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           K EN+LL S+     V L DFGL+ E   E++                            
Sbjct: 132 KLENILLDSEGH---VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKA 188

Query: 149 --WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
             W+  GV+ + LL G  PF  + +    ++I         P   T++ EA++ I ++L 
Sbjct: 189 VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLE 248

Query: 205 VNPSKRI---TASEALKHPW 221
            +P KR+    A E   HP+
Sbjct: 249 KDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (233), Expect = 5e-22
 Identities = 72/256 (28%), Positives = 118/256 (46%), Gaps = 39/256 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V +  ++ T   +A K I    + +R +      E  +  ++  P IV L  S Q
Sbjct: 4   GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ 63

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                YLV   + GGELF  +     +  + A     ++L ++ + H   V++RDLKPEN
Sbjct: 64  SPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123

Query: 120 LLLASKAKGAAVKLADFG---------------------LAIEV---QGEQQA--WF--G 151
           +LL  +     + L DFG                     LA E+    G  +A  W+  G
Sbjct: 124 ILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V+LY +L G PPF+DE+ + +Y +I      +P    D    +AK+L+  +L+ +P++R+
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRL 236

Query: 212 ---TASEALKHPWICQ 224
               A E   HP+  Q
Sbjct: 237 GYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 94.0 bits (233), Expect = 6e-22
 Identities = 71/255 (27%), Positives = 123/255 (48%), Gaps = 41/255 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KA+G  +A KI+  + + A+D       E+R+ +  +HP +  L  S Q
Sbjct: 6   GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ 65

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            ++    V + V GGELF  +     +SE        +I+ ++++ HS  +V+RDLK EN
Sbjct: 66  TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLEN 125

Query: 120 LLLASKAKGAAVKLADFG---------------------LAIEV-----QGEQQAWF--G 151
           L+L    K   +K+ DFG                     LA EV      G    W+  G
Sbjct: 126 LML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  +L+  I      +P     T++ +AK+L++ +L  +P+KR+
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDPNKRL 238

Query: 212 -----TASEALKHPW 221
                 A E ++H +
Sbjct: 239 GGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.3 bits (232), Expect = 7e-22
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 75/254 (29%)

Query: 38  REARICRKLQHPNIVRLHDSI----------QEENYHYLVFDLVTG---GELFEDIVARE 84
           RE +I R+L H NIV L + +          +++   YLVF+ +     G L   +V   
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-- 112

Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
            +SE      ++Q+LE +N+CH    +HRD+K  N+LL +K +   +KLADFGLA     
Sbjct: 113 -FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNS 168

Query: 145 EQQA---------WF---------------------GVILYILLVGYPPFW-DEDQHRLY 173
           E+           W+                     G IL  L    P F  +++  +L 
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228

Query: 174 AQIKAGAYDYPS--------PEWDTVTP-----------------EAKNLINQMLTVNPS 208
              +      P+        P ++T+ P                  A +L++ MLT++PS
Sbjct: 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS 288

Query: 209 KRITASEALKHPWI 222
           KR TA EAL  PW+
Sbjct: 289 KRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 8e-22
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 15/145 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-----FQKLEREARICRKLQHPNIVRLH 55
           GA+ VV +C  KATG     +I+  KK    +      +   RE ++ R+L+H NIV L 
Sbjct: 12  GAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH-CIQQILESVNHCHSNGVVHRD 114
           ++ + +   YLVF+ V    L E + A       DA    I Q+L+++ +CHS+ ++HRD
Sbjct: 67  EAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 115 LKPENLLLASKAKGAAVKLADFGLA 139
           +KPEN+L+   ++   +KL DFG A
Sbjct: 126 IKPENILV---SESGVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.3 bits (230), Expect = 8e-22
 Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 51/258 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V + + K TG   A K++  ++    D Q++ +E  I ++   P IV+ + S  +
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 61  ENYHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
               ++V +    G    DI+    +  +E + +  + Q L+ + + HSN  +HRD+K  
Sbjct: 70  NTDLWIVMEYCGAGS-VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128

Query: 119 NLLLASKAKGAAVKLADFGLA---IEVQGEQQAWFGVILY-----ILLVGY--------- 161
           N+LL  +      KLADFG++    +   ++    G   +     I  +GY         
Sbjct: 129 NILLNEE---GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185

Query: 162 -----------PPFWDEDQHRLYAQIKAGAYDYPSP------EWDTVTPEAKNLINQMLT 204
                      PP+ D    R    I     + P P      +W   +PE  + + + L 
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFMIP----NKPPPTLSDPEKW---SPEFNDFVKKCLV 238

Query: 205 VNPSKRITASEALKHPWI 222
            +P +R +A + L+HP+I
Sbjct: 239 KDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 43/258 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKL-QHPNIVRLHD 56
           G F  V +  +K T   +A K+++ K++ A+        ER   +   L + P IV L  
Sbjct: 4   GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKF 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           S Q ++  YLV D ++GGELF  +     +SE  A   I +++ ++ H H   +V+RDLK
Sbjct: 64  SFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQAW------ 149
           PEN+LL +      + L DFGL                     A EV  +++ +      
Sbjct: 124 PENILLDATGH---IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 150 --FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
              GV+++ +  G+ PF+ ED  ++Y  I  G   +P    + ++ E +  +  +L  NP
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNP 237

Query: 208 SKRI----TASEALKHPW 221
             R+     A E  +HP+
Sbjct: 238 QHRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 5/140 (3%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA  +V +   + TG   A K +  ++L      +  RE +  +  QHP +V+L D    
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            +   LV + +    L E +   E    EA     ++ +L+ V + H+NG++HRDLKP N
Sbjct: 71  GSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPAN 129

Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+++      +K+ADFGLA
Sbjct: 130 LLISAD---GVLKIADFGLA 146

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 65/264 (24%), Positives = 107/264 (40%), Gaps = 50/264 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA +VV   +      + A K I+ +K       +L +E +   +  HPN+V+ + S   
Sbjct: 12  GATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV 70

Query: 61  ENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            +  +LV   ++GG L + +     R    EA  +  ++++L+ + + HSNG +HRD+K 
Sbjct: 71  GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA 130

Query: 118 ENLLLASKAKGAAVKLADFG-------------------------LAIEVQGEQQA---- 148
            N+LL       +VK+ADFG                         +A EV  +       
Sbjct: 131 GNILLGED---GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187

Query: 149 ---W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK------NL 198
              W FG+    L  G  P+      ++             P  +T     K       +
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN----DPPSLETGADYKKYSKSFRKM 243

Query: 199 INQMLTVNPSKRITASEALKHPWI 222
           I+  L  +PSKR TA E LKH + 
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 52/140 (37%), Positives = 73/140 (52%), Gaps = 4/140 (2%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 11  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 70

Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D               + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 71  ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 130

Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 131 LLINTE---GAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 90.9 bits (225), Expect = 4e-21
 Identities = 64/248 (25%), Positives = 118/248 (47%), Gaps = 42/248 (16%)

Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103

Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L  DIV     +E   +     +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 104 L-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 159

Query: 136 FGLAIEVQGEQQ---------------------------AW-FGVILYILLVGYPPFWDE 167
           FG   +V  E                              W  G+++  ++ G PP+++E
Sbjct: 160 FGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P+      V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 220 PPLKAMKMIR----DNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Query: 225 RERVASIV 232
               + IV
Sbjct: 276 AGPPSCIV 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 89.9 bits (223), Expect = 6e-21
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 36/241 (14%)

Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLV 71
           K  G ++  K IN  K+S ++ ++  +E  +   ++HPNIV+  +S +E    Y+V D  
Sbjct: 22  KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81

Query: 72  TGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGA 129
            GG+L++ I A+    + E        QI  ++ H H   ++HRD+K +N+ L    K  
Sbjct: 82  EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDG 138

Query: 130 AVKLADFGLA------IEV---------------------QGEQQAW-FGVILYILLVGY 161
            +KL DFG+A      +E+                       +   W  G +LY +    
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Query: 162 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
             F   +   L  +I  G+Y   S  +   + + +NL++Q+   NP  R + +  L+  +
Sbjct: 199 HAFEAGNMKNLVLKIIRGSYPPVSSHY---SYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255

Query: 222 I 222
           I
Sbjct: 256 I 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.9 bits (223), Expect = 8e-21
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 65/272 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-------FQKLEREARICRKLQHPNIVR 53
           G+F  V   +  ++G   A K +    +SA            L RE  + ++LQH NIV+
Sbjct: 11  GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70

Query: 54  LHDSIQEENYHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESVNH 104
              S  + ++  +  + V GG +         FE+ + R F         ++QIL+ +N+
Sbjct: 71  YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF---------VRQILKGLNY 121

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV----------------QG---- 144
            H+ G++HRD+K  N+L+ +K     +K++DFG++ ++                QG    
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 145 -------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 190
                        +   W  G ++  +L G  PF D  Q  L A  K G    P      
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIGENASPEIP-SN 235

Query: 191 VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           ++ EA + + +   ++ +KR TA+E LKHP++
Sbjct: 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 90.9 bits (226), Expect = 8e-21
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 40/236 (16%)

Query: 12  KATGLEFAAKIINTKKLSARD-FQKLEREARI---CRKLQHPNIVRLHDSIQEENYHYLV 67
           K TG  +A K +    + ARD  + L  E RI       +HP +V L    Q E++   V
Sbjct: 21  KKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80

Query: 68  FDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK 127
            +   GG+L   I   + +SE  A      ++  + + H N +V+RDLK +NLLL ++  
Sbjct: 81  MEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139

Query: 128 GAAVKLADFGL---------------------AIEVQGEQQ-----AW--FGVILYILLV 159
              VK+ADFGL                     A EV  E        W   GV++Y +LV
Sbjct: 140 ---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV 196

Query: 160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
           G  PF  +D+  ++  I      YP      ++ EA +++ ++L  NP +R+ + E
Sbjct: 197 GESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRRNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 46/262 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLH 55
           G   +VR+     +G  +A K++  KK +     K     R  R++     Q P +V LH
Sbjct: 14  GKVFLVRKVSGHDSGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 71

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            + Q +   +L+ D + GGELF  +  RE + E +      +I+ ++ H H  G+++RD+
Sbjct: 72  YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDI 131

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEV---------------------------QGEQQA 148
           K EN+LL S      V L DFGL+ E                             G  +A
Sbjct: 132 KLENILLDSNGH---VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKA 188

Query: 149 --WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
             W+  GV++Y LL G  PF  + +    A+I         P    ++  AK++I ++L 
Sbjct: 189 VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLM 248

Query: 205 VNPSKRI-----TASEALKHPW 221
            +P KR+      A E  KHP+
Sbjct: 249 KDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 36/230 (15%)

Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI 80
           K +N  +LS ++ +    E  I   LQHPNI+  ++   ++N   +  +   GG L++ I
Sbjct: 31  KEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI 90

Query: 81  VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL 138
           V ++   + E      + QI+ +V++ H  G++HRD+K  N+ L    K   +KL DFG+
Sbjct: 91  VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGI 147

Query: 139 AIE----------------------VQGEQ-----QAW-FGVILYILLVGYPPFWDEDQH 170
           +                         QG +       W  G +LY LL     F   +  
Sbjct: 148 SKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207

Query: 171 RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
            L  +I  G Y   +P     + E  +L++ +L  +P KR TA E L  P
Sbjct: 208 NLVVKIVQGNY---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.8 bits (222), Expect = 1e-20
 Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A K IN +K   ++   +  E  + ++L++PNIV   DS   
Sbjct: 30  GASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDSFLV 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      EA  +   ++ L+++   H+N V+HRD+K +N+
Sbjct: 88  GDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 147 LLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++P  ++ +N+ L ++  KR 
Sbjct: 204 MAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKRG 261

Query: 212 TASEALKHPWI 222
           +A E L+HP++
Sbjct: 262 SAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 81/301 (26%), Positives = 116/301 (38%), Gaps = 96/301 (31%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIVRLHD 56
           GA+ +V     K TG++ A      KK+S  +     Q+  RE +I R+ +H NI+ + D
Sbjct: 16  GAYGMVCSATHKPTGVKVA-----IKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADA-----------SHC---IQQILESV 102
            I+  ++           E F D+   +   E D             H    + QIL  +
Sbjct: 71  IIRPPSF-----------ESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA-IEVQGEQQA----------WF- 150
            + HS  V+HRDLKP NLLL +      +K+ DFGLA I                  W+ 
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 151 --------------------GVILYILLVGYPPFWDEDQHR----------------LYA 174
                               G IL  +L   P F  +D                   L  
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 175 QIKAGAYDY-------PSPEWDTVTPEAKN----LINQMLTVNPSKRITASEALKHPWIC 223
            I   A +Y       P   W+ + P A      L+++MLT NP KRIT  EAL HP++ 
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296

Query: 224 Q 224
           Q
Sbjct: 297 Q 297

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.7 bits (220), Expect = 2e-20
 Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 41/257 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V  C    TG E A K +     S    ++   LE E ++ + LQH  IV+ +  
Sbjct: 13  GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           ++++    +  + + GG + + + A    +E       +QILE V + HSN +VHRD+K 
Sbjct: 73  LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKG 132

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GE-----QQ 147
            N+L  S      VKL DFG +  +Q                         GE       
Sbjct: 133 ANILRDSAGN---VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 189

Query: 148 AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVTPEAKNLINQMLTV 205
            W  G  +  +L   PP W E      A I   A    +P+    V+P+A+N + +    
Sbjct: 190 VWSVGCTVVEMLTEKPP-WAE--FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246

Query: 206 NPSKRITASEALKHPWI 222
           N  KR +A E L+H ++
Sbjct: 247 NAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 69/277 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA+  V     K T   FA K IN + L  R+  Q++  E  I    ++P +V +  S +
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71

Query: 60  EENYHYLVFDLVTGGE---LFEDI------VAREFYSEADASHCIQQILESVNHCHSNGV 110
            + +  +V + V GG+   L ++I      +AR +++E         +L ++ + H+ G+
Sbjct: 72  TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET--------VL-ALEYLHNYGI 122

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGL-------------------------------- 138
           VHRDLKP+NLL+ S      +KL DFGL                                
Sbjct: 123 VHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 139 ----AIEV---QGEQQA--WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
               A EV   QG  +   W+  G+ILY  LVG  PF+ +    L+ Q+ +   ++P  +
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239

Query: 188 WDTVTPEAKNLINQMLTVNPSKRI---TASEALKHPW 221
            + +  +A++LI+++L  NP +R+    A E  +H +
Sbjct: 240 -EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 45/261 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLH 55
           G   +VR+     TG  +A K++    L  +   K     R  R +     Q P +V LH
Sbjct: 14  GKVFLVRKVTGHDTGKLYAMKVLQKAALVQK--AKTVEHTRTERNVLEHVRQSPFLVTLH 71

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            + Q E   +L+ D V+GGE+F  +  R+ +SE +      +I+ ++ H H  G+V+RD+
Sbjct: 72  YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDI 131

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           K EN+LL S+     V L DFGL+ E   E++                            
Sbjct: 132 KLENILLDSEGH---VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAV 188

Query: 149 -WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
            W+  G++++ LL G  PF  E +    +++         P    + PEA++L++++L  
Sbjct: 189 DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRK 248

Query: 206 NPSKRI-----TASEALKHPW 221
           +P KR+      ASE  +HP+
Sbjct: 249 DPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 35/207 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G+F  V    +K  G  +A K++  K +  R  QK    ER   + + ++HP +V LH S
Sbjct: 6   GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHYS 64

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q     Y V D V GGELF  +     + E  A     +I  ++ + HS  +V+RDLKP
Sbjct: 65  FQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKP 124

Query: 118 ENLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQ-----AWF- 150
           EN+LL S+     V L DFGL                     A EV  +Q       W+ 
Sbjct: 125 ENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181

Query: 151 -GVILYILLVGYPPFWDEDQHRLYAQI 176
            G +LY +L G PPF+  D   +Y  I
Sbjct: 182 LGAVLYEMLYGLPPFYCRDVAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 48/258 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G +  V +    ATG   A K+I   KL   D F+ +++E  + ++ +HPNIV    S  
Sbjct: 14  GTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
             +  ++V +   GG L +DI  V R   SE   ++  ++ L+ + + H  G +HRD+K 
Sbjct: 71  RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKG 129

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQ---GEQQAWFG--------VILYILLVGY----- 161
            N+LL        VKLADFG++ ++     +++++ G        V       GY     
Sbjct: 130 ANILLTE---DGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186

Query: 162 ---------------PPFWDEDQHRLYAQIKAGAYDYPSPE----WDTVTPEAKNLINQM 202
                          PP +D    R    I    +  P  +    W   +P   + I + 
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW---SPVFHDFIKKC 243

Query: 203 LTVNPSKRITASEALKHP 220
           LT +P KR TA++ L+HP
Sbjct: 244 LTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 42/254 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 6   GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 65

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 66  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 125

Query: 119 NLLLASKAKGAAVKLADFG---------------------LAIEV-----QGEQQAWF-- 150
           NL+L    K   +K+ DFG                     LA EV      G    W+  
Sbjct: 126 NLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y ++ G  PF+++D  +L+  I      +P     T++PEAK+L++ +L  +P +R
Sbjct: 183 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKDPKQR 238

Query: 211 I-----TASEALKH 219
           +      A E ++H
Sbjct: 239 LGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.2 bits (216), Expect = 6e-20
 Identities = 67/261 (25%), Positives = 107/261 (40%), Gaps = 58/261 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F VV + V+KA    +A K I+  K++ R+ ++   EAR+  KL    I+R ++S  +
Sbjct: 11  GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD 70

Query: 61  ENYHYLVFDLVTGGELF------------EDIVAREFYSEADASHCIQQILESVNHCHSN 108
           +    +V +    G+L             ED V R F           QIL  + H HS 
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI----------QILLGLAHLHSK 120

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ---------------------- 146
            ++HRD+K  NL L        VK+ D G+A ++  +                       
Sbjct: 121 KILHRDIKSLNLFL---DAYDNVKIGDLGVA-KLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 147 ------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
                   W  GV+LY    G  PF   +Q  L  +I  G +    P     + +   LI
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLI 233

Query: 200 NQMLTVNPSKRITASEALKHP 220
           +Q LT +  +R    + L++P
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 7e-20
 Identities = 30/59 (50%), Positives = 39/59 (66%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           S    F GTP YL+PEVL  + YGK VD W+ GV+LY +L G PPF+ ED+  +Y +I 
Sbjct: 148 SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 87.1 bits (216), Expect = 9e-20
 Identities = 51/152 (33%), Positives = 80/152 (52%), Gaps = 27/152 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G + VV +   K TG     +I+  KK+      +LE           RE  + ++LQHP
Sbjct: 11  GTYGVVYKGRNKKTG-----QIVAMKKI------RLESEEEGVPSTAIREISLLKELQHP 59

Query: 50  NIVRLHDSIQEENYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           NIV L D + +E+  YL+F+ ++    +  + +   ++         + QIL+ +  CHS
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             V+HRDLKP+NLL+ +K     +KLADFGLA
Sbjct: 120 RRVLHRDLKPQNLLIDNK---GVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 63/255 (24%), Positives = 122/255 (47%), Gaps = 41/255 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V    +K +G + A K+++ +K   R+   L  E  I R  QH N+V ++ S   
Sbjct: 32  GSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLV 89

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG L  DIV++   +E   +   + +L+++ + HS GV+HRD+K +++
Sbjct: 90  GEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148

Query: 121 LLASKAKGAAVKLADFGLAIEVQG---------------------------EQQAW-FGV 152
           LL    +   VKL+DFG   ++                             E   W  G+
Sbjct: 149 LLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGI 205

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE---WDTVTPEAKNLINQMLTVNPSK 209
           ++  ++ G PP++ +   +   +++    D P P+      ++P  ++ + +MLT  P +
Sbjct: 206 MVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNAHKISPVLRDFLERMLTREPQE 261

Query: 210 RITASEALKHPWICQ 224
           R TA E L HP++ Q
Sbjct: 262 RATAQELLDHPFLLQ 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 2/127 (1%)

Query: 14  TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS-IQEENYHYLVFDLV 71
           TG E A K++ T          +  RE  +C +L HPNIV L DS        + VF+ V
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 72  TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
            G  L E + A       +    + Q+L+++   H+ G+VHRDLKP+N++++        
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 132 KLADFGL 138
           K+ DFG+
Sbjct: 122 KVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 33/206 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVRLHDSI 58
           G+F  V    +K+ G  +A K++  K +  +  Q   +     + + L+HP +V LH S 
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q     Y V D V GGELF  +     + E  A     ++  ++ + HS  +++RDLKPE
Sbjct: 66  QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPE 125

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------WF-- 150
           N+LL S+     V L DFGL  E    ++                           W+  
Sbjct: 126 NILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQI 176
           G +LY +L G PPF+  D  ++Y  I
Sbjct: 183 GAVLYEMLYGLPPFYSRDVSQMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 4e-19
 Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V +  + +    +A K ++   +S ++ +    E RI   + HPNI+   ++  +
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 61  ENYHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            N   +V +    G+L + I  R+        +      I Q+L  +   H   ++HRDL
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALHEQKILHRDL 129

Query: 116 KPENLLLASKAKGAAVKLADFG-------------------LAIEVQGEQ------QAW- 149
           K  N+LL +      VK+ D G                   +A EV   +        W 
Sbjct: 130 KSANILLVA---NDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWS 186

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G +LY +    PPF       L  +++ G Y    P     + + +N I  ML V P  
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---PIPPIYSQDLQNFIRSMLQVKPKL 243

Query: 210 RITASEALKHP 220
           R    + L  P
Sbjct: 244 RPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 37/245 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVRLHDSI 58
           G+F  V     KA    +A K++  K +  +  +K  +     + + ++HP +V LH S 
Sbjct: 6   GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V D + GGELF  +     + E  A     +I  ++ + HS  +V+RDLKPE
Sbjct: 66  QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 125

Query: 119 NLLLASKAKGAAVKLADFG---------------------LAIEVQGEQQ-----AWF-- 150
           N+LL S+     + L DFG                     LA EV  +Q       W+  
Sbjct: 126 NILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY +L G PPF+  +   +Y  I     + P      +T  A++L+  +L  + +KR
Sbjct: 183 GAVLYEMLYGLPPFYSRNTAEMYDNI----LNKPLQLKPNITNSARHLLEGLLQKDRTKR 238

Query: 211 ITASE 215
           + A +
Sbjct: 239 LGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 35/193 (18%)

Query: 47  QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           +HP +  L  + Q + + + V + + GG+L   I +   + EA A     +I+  +   H
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA-IEVQGEQQA----------------- 148
             G+++RDLK +N+LL    K   +K+ADFG+    + GE +A                 
Sbjct: 114 KKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 149 ---------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL 198
                    W FGV+LY +L+G  PF  ED+  L+  I      +P      ++ EAK+ 
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDC 226

Query: 199 INQMLTVNPSKRI 211
           ++++   +P+KR+
Sbjct: 227 LSKLFERDPTKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 7e-19
 Identities = 44/107 (41%), Positives = 61/107 (57%), Gaps = 12/107 (11%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADAS 92
           RE  + ++L HPNIVRL D +  EN  YLVF     DL    + + D             
Sbjct: 47  REISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIK 102

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             + Q+L+ + +CHS+ V+HRDLKP+NLL+  +    A+KLADFGLA
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE---GALKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 67/254 (26%), Positives = 111/254 (43%), Gaps = 39/254 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRLHDS 57
           G +  V    +K TG   A K +      KL+       ER+  I    +   +V+L  +
Sbjct: 12  GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD--ILTTTKSEWLVKLLYA 69

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q++ Y YL  + V GG+    +      SE  A   + ++ E+V+  H  G +HRDLKP
Sbjct: 70  FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP 129

Query: 118 ENLLLASKAKGAAVKLADFGLAIE-------------------VQGEQ-----QAW-FGV 152
           EN L+ +      +KL DFGL+                     ++G+        W  G 
Sbjct: 130 ENFLIDASGH---IKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGC 186

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT----VTPEAKNLINQMLTVNPS 208
           +LY  L G+PPF     +  +  +K        P +D     ++ EA +LI +++  +PS
Sbjct: 187 MLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPS 245

Query: 209 KRITASEALK-HPW 221
           +R  + E +K HP+
Sbjct: 246 RRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 83.7 bits (208), Expect = 1e-18
 Identities = 68/264 (25%), Positives = 102/264 (38%), Gaps = 54/264 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL----SARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V +   K  G +     +  K L    S  + +   +EAR+ +KL HPN+VRL  
Sbjct: 6   GAFGEVYKG--KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 57  SIQEENYHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESVNHCH 106
              EE   YLV + + GG+L          F         S  D      QI + + +  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAKGMEYLA 122

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------W------ 149
           S   VHRDL   N L+        VK++DFGL+ +V  +              W      
Sbjct: 123 SKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 150 -------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 195
                        FGV+L+ I  +G  P+       +   ++ G Y  P PE+     E 
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEY--CPDEL 236

Query: 196 KNLINQMLTVNPSKRITASEALKH 219
             L+     ++P  R T SE ++ 
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)

Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           E +I   + HP  V L+ S ++E+Y YLV + V GGE F  +   + +          QI
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ--------------- 143
           +    +  S  +V+RDLKPENLLL    K   +K+ DFG A  V                
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAP 197

Query: 144 --------GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 193
                   G+   W+  G+ +Y +LVG PPF+  +   +Y +I  G   +P      +  
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDN 253

Query: 194 EAKNLINQMLTVNPSKRI-----TASEALKHPW 221
             K+L+ ++L+ + +KR       A    +HPW
Sbjct: 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 43/261 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA   V + + + TG  +A K+I    + + R  +++ RE  I R + HPN+V+ HD   
Sbjct: 85  GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCHDMFD 142

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                 ++ + + GG L           E   +   +QIL  + + H   +VHRD+KP N
Sbjct: 143 HNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198

Query: 120 LLLASKAKGAAVKLADFGLA------------------------IEVQGEQQAW------ 149
           LL+ S      VK+ADFG++                        I       A+      
Sbjct: 199 LLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255

Query: 150 ---FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
               GV +    +G  PF    Q    + + A     P     T + E ++ I+  L   
Sbjct: 256 IWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQRE 315

Query: 207 PSKRITASEALKHPWICQRER 227
           P+KR +A + L+HP+I + + 
Sbjct: 316 PAKRWSAMQLLQHPFILRAQP 336

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 65/251 (25%), Positives = 118/251 (47%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A K +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 30  GASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L++++  HSN V+HRD+K +N+
Sbjct: 88  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 147 LLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  +R 
Sbjct: 204 MAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRRG 261

Query: 212 TASEALKHPWI 222
           +A E L+HP++
Sbjct: 262 SAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 46/259 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TGL  AAKII  +  S  + +    E  I  + +HPNIV L+++   
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  +++ +   GG L   ++  E   +E    +  +Q+LE++N  HS+ V+HRDLK  N
Sbjct: 74  ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA---------W--------------------- 149
           +LL        VKLADFG++ + +   Q          W                     
Sbjct: 134 ILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKAD 190

Query: 150 ---FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV---TPEAKNLINQML 203
               G+ L  L    PP  + +  R+  +I         P  D     +    + +   L
Sbjct: 191 IWSLGITLIELAQMEPPHHELNPMRVLLKILKS----EPPTLDQPSKWSSSFNDFLKSCL 246

Query: 204 TVNPSKRITASEALKHPWI 222
             +P  R TA+E LKHP++
Sbjct: 247 VKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.7 bits (204), Expect = 3e-18
 Identities = 62/252 (24%), Positives = 110/252 (43%), Gaps = 35/252 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  +     K+       K I+  K+  ++ +  ++E  +  K++HPNIV    S QE
Sbjct: 11  GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE 70

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
               ++V +   GG+L + I  +    +SE        QI   + H H   ++HRD+K +
Sbjct: 71  NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQ 130

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AW-F 150
           N+ L+    G   KL DFG+A ++    +                            W  
Sbjct: 131 NIFLSKN--GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY L     PF   + H+L  +I  G +   SP +   + + ++LI+Q+  V+P  R
Sbjct: 189 GCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF---SRDLRSLISQLFKVSPRDR 245

Query: 211 ITASEALKHPWI 222
            + +  LK P++
Sbjct: 246 PSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 67/243 (27%), Positives = 108/243 (44%), Gaps = 41/243 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPN-IVRLHD 56
           G+F  V    +K T   +A KI+  KK   +   D +    E R+      P  + +LH 
Sbjct: 11  GSFGKVMLAERKGTDELYAIKIL--KKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHS 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  Y V + V GG+L   I     + E  A     +I   +   HS G+++RDLK
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128

Query: 117 PENLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW- 149
            +N++L ++     +K+ADFG+                          A +  G+   W 
Sbjct: 129 LDNVMLDAEGH---IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+LY +L G PPF  ED+  L+  I      YP     +++ EA ++   +LT +P+
Sbjct: 186 AFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTKHPA 241

Query: 209 KRI 211
           KR+
Sbjct: 242 KRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 6e-18
 Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 45/267 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ--KLEREARICRKLQH---PNIVRLH 55
           GA+  V R     TG   A KIIN   L   D     ++RE  +  +L+    PNI + +
Sbjct: 12  GAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            S  +    +++ +   GG +   + A    +E   S  I+++L ++ + H  GV+HRD+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPI-AEKYISVIIREVLVALKYIHKVGVIHRDI 127

Query: 116 KPENLLLASKAKGAAVKLADFG---------------------LAIEVQGEQQAW----- 149
           K  N+L+ +      VKL DFG                     +A EV  E + +     
Sbjct: 128 KAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184

Query: 150 ---FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
               G+ +Y +  G PP+ D D  R +    K+     P  E +  +   +  +   L  
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP---PRLEDNGYSKLLREFVAACLDE 241

Query: 206 NPSKRITASEALKHPWICQRERVASIV 232
            P +R++A E LK  WI    +    +
Sbjct: 242 EPKERLSAEELLKSKWIKAHSKTPVSI 268

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 51/149 (34%), Positives = 68/149 (45%), Gaps = 34/149 (22%)

Query: 194 EAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR----------QETVDCLKK 243
           EAK +  Q+L             L++           I+HR          +  V  +  
Sbjct: 99  EAKKIALQIL-----------RGLEY---LHSNG---IIHRDLKPENILLDENGVVKIAD 141

Query: 244 F-NARRKLKVSTR-QGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWD 300
           F  A++ LK S+    F GTP Y++PEVL     YG  VD+W+ GVILY LL G PPF  
Sbjct: 142 FGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG 201

Query: 301 E---DQHRLYAQIKAGAYD-DEPKHKSAS 325
           E   DQ +L  +I     + DEPK  S S
Sbjct: 202 ENILDQLQLIRRILGPPLEFDEPKWSSGS 230

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 53/154 (34%), Positives = 82/154 (53%), Gaps = 32/154 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-----SARDFQKLEREARICRKL-QHPNIVRL 54
           GA+ +V + + + T      +++  KK+     +A D Q+  RE    ++L  HPNIV+L
Sbjct: 18  GAYGIVWKAIDRRTK-----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 55  HDSIQEENYH--YLVFDL-------VTGGELFEDIVAREFYSEADASHCIQQILESVNHC 105
            + I+ EN    YLVF+        V    + ED+  R         + + Q+L+++ + 
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR---------YIMYQLLKALKYI 123

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           HS  V+HRDLKP N+LL S  +   VKLADFGLA
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCR---VKLADFGLA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 71/257 (27%), Positives = 109/257 (42%), Gaps = 46/257 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKL-QHPNIVRLHD 56
           G+F  V     K T   +A K++  KK   L   D +    E R+     +HP + +LH 
Sbjct: 6   GSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q ++  + V + V GG+L   I     + E  A     +I+  +   H  G+++RDLK
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQ-----AW- 149
            +N+LL S+     +K+ADFG+                     A E+   Q       W 
Sbjct: 124 LDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GV+LY +L G  PF  +D+  L+  I      Y  P W +   EAK+++   LT NP 
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY--PRWLSK--EAKSILKSFLTKNPE 236

Query: 209 KRITASEA-----LKHP 220
           KR+            HP
Sbjct: 237 KRLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.4 bits (201), Expect = 9e-18
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 47/252 (18%)

Query: 1   GAFSVVRRCVQKATGLEF-AAKIIN--------TKKLSARDFQKLEREARICRK-LQHPN 50
           GAF  V +  +K  G    A K IN         K+   +    +  E  I ++ L+HPN
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCH 106
           IVR + +  E +  Y+V DL+ G  L E   +    ++ ++E    +   Q++ ++ + H
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130

Query: 107 SNG-VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------ 147
               +VHRDL P N++L    K   V + DFGLA + Q E +                  
Sbjct: 131 KEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 148 --------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL 198
                    W FG ILY +    PPF+  +   L  +I    Y+ P PE    + +  ++
Sbjct: 188 EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPE-GMYSEDVTDV 245

Query: 199 INQMLTVNPSKR 210
           I   LT +   R
Sbjct: 246 ITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 45/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII----NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAFS   +     TG   A K +    NT        + L +E R+  +L HP+I+R+  
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +  E+++  L  + + GG +   +     + EA   +  +Q+L  +++ H N ++HRD+K
Sbjct: 71  ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130

Query: 117 PENLLLASKAKGAAVKLADFGLAI-------------------------EV-QGEQ---- 146
             NLL+ S   G  +++ADFG A                          EV +GEQ    
Sbjct: 131 GANLLIDST--GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS 188

Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIK---AGAYDYPS-PEWDTVTPEAKNLIN 200
              W  G ++  +    PP W+ ++H  +  +    A A   PS PE   ++P  +++  
Sbjct: 189 CDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTAPSIPE--HLSPGLRDVTL 245

Query: 201 QMLTVNPSKRITASEALKHP 220
           + L + P  R  + E LKHP
Sbjct: 246 RCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 48/276 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K++   +A K+++  ++  R       E R I        IV+LH + Q
Sbjct: 54  GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L   +   +   E  A     +++ +++  HS G +HRD+KP+N
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 173 MLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV LY +LVG  PF+ +     Y++I         P+   ++ +AK+LI   LT  
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDR 289

Query: 207 PSK--RITASEALKHP--------WICQRERVASIV 232
             +  R    E   HP        +   RE VA +V
Sbjct: 290 EVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVV 325

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 63/253 (24%), Positives = 119/253 (47%), Gaps = 41/253 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V    +K TG + A K ++ +K   R+   L  E  I R   H N+V +++S   
Sbjct: 33  GSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNSYLV 90

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L + +       E  A+ C+  +L ++++ H+ GV+HRD+K +++
Sbjct: 91  GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIKSDSI 149

Query: 121 LLASKAKGAAVKLADFGLAIEVQGE---------QQAW-------------------FGV 152
           LL S  +   +KL+DFG   +V  E            W                    G+
Sbjct: 150 LLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWDTVTPEAKNLINQMLTVNPSK 209
           ++  ++ G PP+++E   +   +I+    D   P   +   V+   +  ++ ML   PS+
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIR----DNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262

Query: 210 RITASEALKHPWI 222
           R TA E L+HP++
Sbjct: 263 RATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 21/159 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+ VV   V K TG + A K I+        F  L       RE ++ R L+H NI+ L
Sbjct: 11  GAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 55  HDSI---QEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
            D +     E+++  Y+V +L+   +L + I + +  ++    + + QIL  + + HS  
Sbjct: 65  LDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
           V+HRDLKP N+L+ S      +K+ DFGLA  V  ++  
Sbjct: 124 VIHRDLKPSNILVNSNCD---LKICDFGLARGVDPDEDE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 73/269 (27%), Positives = 114/269 (42%), Gaps = 60/269 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K TG  +A KI+N  ++  R      RE R +        I  LH + Q
Sbjct: 12  GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71

Query: 60  EENYHYLVFDLVTGGEL------FEDIVARE---FYSEADASHCIQQILESVNHCHSNGV 110
           +EN  YLV D   GG+L      FED +  +   FY        + +++ +++  H  G 
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--------LAEMVLAIDSVHQLGY 123

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ--------------------------- 143
           VHRD+KP+N+LL    K   ++LADFG  + +                            
Sbjct: 124 VHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 144 -----GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPE 194
                G +  W+  GV +Y +L G  PF+ E     Y +I      + +P    D V+ E
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-VSEE 239

Query: 195 AKNLINQMLTVNPSK--RITASEALKHPW 221
           AK+LI +++    ++  R    +   HP+
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 74/291 (25%), Positives = 115/291 (39%), Gaps = 85/291 (29%)

Query: 13  ATGLEFAA------KIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENY 63
           + GL F+A      K +  KK+   D Q ++   RE +I R+L H NIV++++ +     
Sbjct: 17  SNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG- 75

Query: 64  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHC--------------HSNG 109
             L  D+ +  EL    + +E Y E D ++ ++Q   S  H               HS  
Sbjct: 76  SDLTEDVGSLTELNSVYIVQE-YMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN 134

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-----------QGEQQAWF-------- 150
           V+HRDLKP N+ + ++     +K+ DFGLA  V           +G    W+        
Sbjct: 135 VLHRDLKPANVFINTED--LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192

Query: 151 -------------GVILYILLVGYPPF-------------------WDEDQHRLYAQI-- 176
                        G I   +L G P F                    +ED++ L   I  
Sbjct: 193 PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS 252

Query: 177 KAGAYD-YPSPEWDTVTPE----AKNLINQMLTVNPSKRITASEALKHPWI 222
                   P      + P     A + + Q+LT NP  R+TA EAL HP++
Sbjct: 253 FVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 51/263 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+   +KATG  +A K++    L A++     E E  I      P I +L  + Q
Sbjct: 12  GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71

Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +++  YLV +   GG+L      +ED      + E  A   + +++ +++  H  G VHR
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQ-----FDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 114 DLKPENLLLASKAKGAAVKLADFG----------------------LAIEV--------- 142
           D+KPEN+L+    +   +KLADFG                      +A EV         
Sbjct: 127 DIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 143 --QGEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL 198
              G +  W+  GVI Y ++ G  PF +    + Y  I         PE   V+ +  +L
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243

Query: 199 INQMLTVNPSKRITASEALKHPW 221
           I  +L     +R+       HP+
Sbjct: 244 IQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 50/148 (33%), Positives = 73/148 (49%), Gaps = 16/148 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRLHDS 57
           G    V     K TG  FA K+++ K++  R+  K++R   E  I   L HP +  L+ S
Sbjct: 12  GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRN--KVKRVLTEQEILATLDHPFLPTLYAS 69

Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESVNHCHSNGVVH 112
            Q E Y  LV D   GGELF      +       SE  A     ++L ++ + H  G+V+
Sbjct: 70  FQTETYLCLVMDYCPGGELF---RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI 140
           RDLKPEN+LL    +   + L+DF L+ 
Sbjct: 127 RDLKPENILL---HESGHIMLSDFDLSK 151

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 65/254 (25%), Positives = 119/254 (46%), Gaps = 42/254 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICR-KLQHPNIVRLHD 56
           G+F  V     K  G  FA K +  KK   L   D +    E R+     ++P +  L+ 
Sbjct: 6   GSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYC 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           + Q + + + V + + GG+L   I  +  +    A+    +I+  +   HS G+++RDLK
Sbjct: 64  TFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQA-------------------------W- 149
            +N++L    +   +K+ADFG+  E V G+ +A                         W 
Sbjct: 124 LDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+LY +L+G  PF  +D+  L+  I+     Y  P W  +T E+K+++ ++   +P+
Sbjct: 181 SFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY--PRW--ITKESKDILEKLFERDPT 236

Query: 209 KRITASEALK-HPW 221
           +R+     ++ HP+
Sbjct: 237 RRLGVVGNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 7e-17
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 88

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 148 LLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG 262

Query: 212 TASEALKHPWI 222
           +A E L+H ++
Sbjct: 263 SAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 8e-17
 Identities = 26/54 (48%), Positives = 40/54 (74%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + YGK VD WA G+++Y +L GYPPF+D++  ++Y +I  G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 46/142 (32%), Positives = 84/142 (59%), Gaps = 10/142 (7%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ----KLEREARICRKLQHPNIVRLHD 56
           GAF  VR   +K TG  +A K +   ++  ++ Q    + ER+  I  +  +P +V+L+ 
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE-QVAHVRAERD--ILAEADNPWVVKLYY 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           S Q+ENY YL+ + + GG++   ++ ++ ++E +    I + + +++  H  G +HRD+K
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 117 PENLLLASKAKGAAVKLADFGL 138
           P+NLLL +K     +KL+DFGL
Sbjct: 129 PDNLLLDAKGH---IKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 24/61 (39%), Positives = 34/61 (55%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GTP Y++PEV+  + + K VD W+ G ILY  LVG PPF  E    ++  I  G  
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI 218

Query: 316 D 316
           +
Sbjct: 219 E 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 37/247 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F          +  ++A K I   K S+   +   +EA +  K++HPNIV   +S + 
Sbjct: 11  GSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA 69

Query: 61  ENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + + Y+V +   GG+L + I  +  + + E        Q+   V H H   V+HRD+K +
Sbjct: 70  DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSK 129

Query: 119 NLLLASKAKGAAVKLADFGLA---------------------------IEVQGEQQAW-F 150
           N+ L    K   VKL DFG A                           +    +   W  
Sbjct: 130 NIFLTQNGK---VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G ILY L     PF       L  ++  G+Y    P     + E ++LI QM   NP  R
Sbjct: 187 GCILYELCTLKHPFQANSWKNLILKVCQGSY---KPLPSHYSYELRSLIKQMFKRNPRSR 243

Query: 211 ITASEAL 217
            +A+  L
Sbjct: 244 PSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 54/168 (32%), Positives = 76/168 (45%), Gaps = 49/168 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G + VV R   K TG     +I+  KKL      K+E           RE  I  KLQHP
Sbjct: 16  GTYGVVYRARDKKTG-----EIVALKKL------KMEKEKEGFPITSLREINILLKLQHP 64

Query: 50  NIVRL--------HDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQ 96
           NIV +         D I      Y+V      DL +   L E +  ++ + +++    + 
Sbjct: 65  NIVTVKEVVVGSNLDKI------YMVMEYVEHDLKS---LMETM--KQPFLQSEVKCLML 113

Query: 97  QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
           Q+L  V H H N ++HRDLK  NLLL ++     +K+ DFGLA E   
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGS 158

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 41/108 (37%), Positives = 61/108 (56%), Gaps = 15/108 (13%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS---EADASHC 94
           RE  + ++L+H NIVRL+D +  +    LVF      E  +  + + F S   + D    
Sbjct: 48  REICLLKELKHKNIVRLYDVLHSDKKLTLVF------EYCDQDLKKYFDSCNGDIDPEIV 101

Query: 95  ---IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              + Q+L+ +  CHS+ V+HRDLKP+NLL+    K   +KLADFGLA
Sbjct: 102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 77/289 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           GA+ +V       T  + A K I     +  D ++  RE ++ R L H N++ + D +  
Sbjct: 16  GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPP 75

Query: 59  -QEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHCHSNGVVH 112
              E ++  Y+V++L+   +L + I + +  S+    HC   + Q+L  + + HS  V+H
Sbjct: 76  PHREAFNDVYIVYELMDT-DLHQIIRSSQTLSD---DHCQYFLYQLLRGLKYIHSANVLH 131

Query: 113 RDLKPENLLLASK----------AKGAAVKL---------------------ADFGLAIE 141
           RDLKP NLLL +           A+  + K                      +++  AI+
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAID 191

Query: 142 VQGEQQAW-FGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAY- 181
           V      W  G I   LL   P F  +D   Q +L  ++               KA  Y 
Sbjct: 192 V------WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 182 ----DYP----SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                 P    +  +    P A +L+ +ML  +PSKRIT  EAL HP++
Sbjct: 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 59/251 (23%), Positives = 110/251 (43%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + + K T    A K+I+ ++ +  + + +++E +   + + P I + + S  +
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  +++ +   GG   + +   +   E   +  ++++L  + + H  G +HRD+K  N+
Sbjct: 71  GSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129

Query: 121 LLASKAKGAAVKLADFG---------------------LAIEV--QGEQQA----W-FGV 152
           LL+ +     VKLADFG                     +A EV  Q         W  G+
Sbjct: 130 LLSEEGD---VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
               L  G PP  D    R L+   K      PS E +  +   K+ ++  L  +P +R 
Sbjct: 187 TAIELAKGEPPLSDLHPMRVLFLIPKNNP---PSLEGNKFSKPFKDFVSLCLNKDPKERP 243

Query: 212 TASEALKHPWI 222
           +A E LKH +I
Sbjct: 244 SAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 58/274 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           GA   V +C  K TG+ FA K I T      D QK + RE  I +  + P IV+ + +  
Sbjct: 12  GAGGSVTKCRLKNTGMIFALKTITTD--PNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69

Query: 60  EENYH--YLVFDLVTGGELFEDIVAREFYSEAD--ASHCIQQILESV----NHCHSNGVV 111
           +E+     +  +   GG L  D + ++            + +I ESV    ++ HS  ++
Sbjct: 70  DESSSSIGIAMEYCEGGSL--DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIE--------------------VQGEQQA--- 148
           HRD+KP N+LL  K     VKL DFG++ E                    +QG+  +   
Sbjct: 128 HRDIKPSNILLTRK---GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITS 184

Query: 149 --W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--DYPSPE----------WDTVTP 193
             W  G+ L  +     PF  E +  L   I+  +Y  + P+PE          W   + 
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVNMPNPELKDEPGNGIKW---SE 240

Query: 194 EAKNLINQMLTVNPSKRITASEALKHPWICQRER 227
           E K+ I Q L  +P++R T  + L+HPWI  + +
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 67/244 (27%), Positives = 106/244 (43%), Gaps = 36/244 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +N K+L  R  ++    E RI  K+    IV L  + Q
Sbjct: 4   GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ 63

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREF--YSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +    LV  ++ GG+L   I  V  E   + E  A     QI+  + H H   +++RDL
Sbjct: 64  TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123

Query: 116 KPENLLLASKAKGAAVKLADFGLAIE----------------------VQGEQQAW---- 149
           KPEN+LL +      V+++D GLA+E                      +QGE+  +    
Sbjct: 124 KPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 150 --FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
              GV LY ++    PF    +     ++K    +      D  +P +K+    +L  +P
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240

Query: 208 SKRI 211
            KR+
Sbjct: 241 EKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 61/261 (23%), Positives = 108/261 (41%), Gaps = 41/261 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G   VV + + + TG   A K I  +   A   Q L RE  I  K   P IV  + +   
Sbjct: 12  GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-RELDILHKCNSPYIVGFYGAFYN 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYS---EADASHCIQQILESVNHCHSN-GVVHRDLK 116
                +  + + GG L  D + +E      E         +L+ + + H    ++HRD+K
Sbjct: 71  NGDISICMEYMDGGSL--DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128

Query: 117 PENLLLASKAKGAAVKLADFGLAIE--------------------VQGEQ-----QAW-F 150
           P N+L+ S+ +   +KL DFG++ +                    +QG         W  
Sbjct: 129 PSNILVNSRGQ---IKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSL 185

Query: 151 GVILYILLVG-YP-PFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKNLINQMLTVN 206
           G+ L  L  G +P P  ++    ++  ++    + P P       +P+ ++ +N  L  +
Sbjct: 186 GLSLIELATGRFPYPPENDPPDGIFELLQY-IVNEPPPRLPSGKFSPDFQDFVNLCLIKD 244

Query: 207 PSKRITASEALKHPWICQRER 227
           P +R +  E L+HP+I + E 
Sbjct: 245 PRERPSYKELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 69/282 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKL-----EREARICRKLQHPNIVRLH 55
           G++ +V +C  K TG     +I+  KK    +  K+      RE R+ ++L+H N+V L 
Sbjct: 12  GSYGMVMKCKHKETG-----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           +  + +   YLVF+ V    L +         E+     + QIL  +  CHS+ ++HRD+
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------WF----------------- 150
           KPEN+L+   ++   VKL DFG A  +    +         W+                 
Sbjct: 127 KPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 151 ----GVILYILLVGYPPF---WDEDQ---------------------HRLYAQIKAGAYD 182
               G ++  +L G P F    D DQ                     + L+A ++     
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243

Query: 183 YPSP---EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
              P    +  ++    +L  Q L ++P  R ++S+ L H +
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 16/147 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII----NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GA+ VV   +   +G + A K I    +   L+ R      RE +I R  +H NI+ + D
Sbjct: 16  GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIAIRD 71

Query: 57  SIQEENYH----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
            ++         Y+V DL+   +L   I + +  +E    + + Q+L  + + HS  V+H
Sbjct: 72  ILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIH 130

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA 139
           RDLKP NLL+    +   +++ DFG+A
Sbjct: 131 RDLKPSNLLVNEDCE---LRIGDFGMA 154

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 8e-16
 Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 20/115 (17%)

Query: 38  REARICRKLQ---HPNIVRLHDSIQEENYH-----YLVF-----DLVTGGELFEDIVARE 84
           RE  + ++L+   HPNIVRL D              LVF     DL T    +     + 
Sbjct: 47  REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT----YLSKCPKP 102

Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                     ++Q+L  V+  HS+ +VHRDLKP+N+L+ S  +   VK+ADFGLA
Sbjct: 103 GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 41/243 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPN-IVRLHD 56
           G+F  V    +K T   +A KI+  KK   +   D +    E R+      P  + +LH 
Sbjct: 11  GSFGKVMLAERKGTDELYAIKIL--KKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  Y V + V GG+L   I     + E  A     +I   +   H  G+++RDLK
Sbjct: 69  CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK 128

Query: 117 PENLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW- 149
            +N++L S+     +K+ADFG+                          A +  G+   W 
Sbjct: 129 LDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            +GV+LY +L G PPF  ED+  L+  I      YP     +++ EA ++   ++T +PS
Sbjct: 186 AYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPS 241

Query: 209 KRI 211
           KR+
Sbjct: 242 KRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 67/260 (25%), Positives = 113/260 (43%), Gaps = 48/260 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICR-KLQHPNIVRLHD 56
           G+F  V     K T   +A K++  KK   L   D      E RI     +HP +  LH 
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTALHC 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q ++  + V + V GG+L   I     + E  +     ++  ++   H +GV++RDLK
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQ-----AWF 150
            +N+LL ++      KLADFG+                     A E+  E +      W+
Sbjct: 124 LDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GV++Y ++ G PPF  +++  L+  I      YP   W  ++ EA +++   +T NP+
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVSILKAFMTKNPN 236

Query: 209 KRI-------TASEALKHPW 221
           KR+             +HP+
Sbjct: 237 KRLGCVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 49/252 (19%)

Query: 15  GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH------DSIQEENYHY--L 66
           G  FA K+++ + +S  D  + + E          +IV+ H      D    EN     L
Sbjct: 57  GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116

Query: 67  VFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           V D    G+L ++I +R      + E +A     Q+L +V+H HS  ++HRD+K  N+LL
Sbjct: 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176

Query: 123 ASKAKGAAVKLADFGL----AIEVQGE-------------QQAW-------------FGV 152
            S      VKL DFG     A  V  +              + W              GV
Sbjct: 177 CSN---GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGV 233

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           +LY LL    PF  E+   +  +  AG YD P P   +++PE + ++  +L+ +P +R +
Sbjct: 234 LLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLP--PSISPEMQEIVTALLSSDPKRRPS 290

Query: 213 ASEALKHPWICQ 224
           +S+ L  P IC+
Sbjct: 291 SSKLLNMP-ICK 301

Length = 496

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 78/318 (24%), Positives = 134/318 (42%), Gaps = 60/318 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICR-KLQHPNIVRLHD 56
           G+F  V     K +G  +A K++  KK   L   D +    E RI      HP + +L+ 
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQLYC 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  + V + V GG+L   I     + EA A     +I  ++   H  G+++RDLK
Sbjct: 64  CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQ-----AWF 150
            +N+LL  +      KLADFG+                     A E+  E        W+
Sbjct: 124 LDNVLLDHEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GV+LY +L G+ PF  E++  L+  I      YP+  W  ++ +A +++   +T NP+
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNPT 236

Query: 209 KRITA------SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTP 262
            R+ +         L+HP+  + +    +  RQ       +  +R    VS         
Sbjct: 237 MRLGSLTLGGEEAILRHPFFKELDW-EKLNRRQIEPPFRPRIKSRE--DVSN-------- 285

Query: 263 GYLSPEVLKKEPYGKPVD 280
               P+ +K++P   P++
Sbjct: 286 --FDPDFIKEDPVLTPIE 301

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 64/283 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V   + + TG + A K +     S    ++  RE R+ + ++H N++ L D    
Sbjct: 26  GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85

Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S+   +  YLV   +  G     ++  E  SE      + Q+L+ + + H+ G++HRD
Sbjct: 86  DLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA +   E        W+                   
Sbjct: 144 LKPGNLAVNEDCE---LKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200

Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAYDYPSPEWD- 189
             G I+  +L G P F   D      +I                   A  Y    P +  
Sbjct: 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRK 260

Query: 190 --------TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
                      P A N++ +ML ++   RITA+EAL HP+  +
Sbjct: 261 KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 74/283 (26%), Positives = 112/283 (39%), Gaps = 64/283 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 28  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87

Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 88  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 145

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 146 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 202

Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI----------------KAGAYDY-------PS 185
             G I+  LL G   F   D       I                   A +Y       P 
Sbjct: 203 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 262

Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 263 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 48/260 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TG+  AAK+I+TK  S  + +    E  I     HPNIV+L D+   
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           EN  +++ +   GG +  D V  E     +E       +Q LE++N+ H N ++HRDLK 
Sbjct: 74  ENNLWILIEFCAGGAV--DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131

Query: 118 ENLLLASKAKGAAVKLADFG---------------------LAIEV-----------QGE 145
            N+L         +KLADFG                     +A EV             +
Sbjct: 132 GNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188

Query: 146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSP-EWDTVTPEAKNLINQM 202
              W  G+ L  +    PP  + +  R+  +I K+       P  W   + E K+ + + 
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKDFLKKC 245

Query: 203 LTVNPSKRITASEALKHPWI 222
           L  N   R T ++ L+HP++
Sbjct: 246 LEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 48/276 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K++   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 54  GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G++HRD+KP+N
Sbjct: 114 DDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 172

Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 173 MLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV L+ +LVG  PF+ +     Y++I         PE   ++  AKNLI   LT  
Sbjct: 230 WWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDR 289

Query: 207 PSK--RITASEALKHP--------WICQRERVASIV 232
             +  R    E  +HP        W   RE  A +V
Sbjct: 290 EVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVV 325

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 48/276 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K+T   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 54  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G +HRD+KP+N
Sbjct: 114 DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 173 MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV LY +LVG  PF+ +     Y++I         P+ + ++ EAKNLI   LT  
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 289

Query: 207 PSK--RITASEALKHP--------WICQRERVASIV 232
             +  R    E  +H         W   R+ VA +V
Sbjct: 290 EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 325

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 44/109 (40%), Positives = 62/109 (56%), Gaps = 15/109 (13%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS---HC 94
           RE  + +++QH NIVRL D +  E   YLVF      E  +  + +   S  D +     
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVF------EYLDLDLKKHMDSSPDFAKNPRL 103

Query: 95  IQ----QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           I+    QIL  + +CHS+ V+HRDLKP+NLL+  +    A+KLADFGLA
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA 150

Length = 294

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 38/255 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 11  GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 70

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  +    + E  A     +I   +   H   +V+RDLKP
Sbjct: 71  TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------WFGV 152
           EN+LL        ++++D GLA+E+   +                           W+G+
Sbjct: 131 ENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187

Query: 153 --ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
             ++Y ++ G  PF    +     +++    +      +  +  A+++  Q+LT +P  R
Sbjct: 188 GCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Query: 211 I-----TASEALKHP 220
           +      A E   HP
Sbjct: 248 LGCRGEGAEEVKAHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 73/257 (28%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS---HC 94
           RE  + + L+H NIV LHD I  E    LVF+       + D   +++  +   S   H 
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFE-------YLDKDLKQYLDDCGNSINMHN 105

Query: 95  IQ----QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----------- 139
           ++    Q+L  +N+CH   V+HRDLKP+NLL+  + +   +KLADFGLA           
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYS 162

Query: 140 -----------------IEVQGEQQAW-FGVILYILLVGYPPF----WDEDQHRLY---- 173
                             +   +   W  G I Y +  G P F     +E  H ++    
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222

Query: 174 -----------AQIKAGAYDYPSPEWDTVTPEAK-------NLINQMLTVNPSKRITASE 215
                      +  +  +Y+YP    D +   A         L++++L     KRI+A E
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282

Query: 216 ALKHPWI-CQRERVASI 231
           A+KHP+  C  ER+  +
Sbjct: 283 AMKHPYFHCLGERIHKL 299

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 41/245 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH----PNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 5   GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTY 64

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SE +      +I+  + H H+  VV+RDLK
Sbjct: 65  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLK 124

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------------------QAWF- 150
           P N+LL        V+++D GLA +   ++                           WF 
Sbjct: 125 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFS 181

Query: 151 -GVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +         + P    D+ +PE K+L+  +L  +
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP----DSFSPELKSLLEGLLQRD 237

Query: 207 PSKRI 211
            SKR+
Sbjct: 238 VSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 41/243 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARI-CRKLQHPNIVRLHD 56
           G+F  V    +K T   +A KI+  KK   +   D +    E R+     + P + +LH 
Sbjct: 11  GSFGKVMLAERKGTDELYAIKIL--KKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHS 68

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  Y V + V GG+L   I     + E  A     +I   +   HS G+++RDLK
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128

Query: 117 PENLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW- 149
            +N++L S+     +K+ADFG+                          A +  G+   W 
Sbjct: 129 LDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+LY +L G  PF  ED+  L+  I      YP     +++ EA  +   ++T +P 
Sbjct: 186 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPG 241

Query: 209 KRI 211
           KR+
Sbjct: 242 KRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 39/113 (34%), Positives = 59/113 (52%), Gaps = 15/113 (13%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADASH-- 93
           RE  + R+L+H N+V L +   E      YL+FD     +L++ I   +F+ +A      
Sbjct: 51  REIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQII---KFHRQAKRVSIP 106

Query: 94  ------CIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLA 139
                  + QIL  V++ HSN V+HRDLKP N+L+  +      VK+ D GLA
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 74/285 (25%), Positives = 116/285 (40%), Gaps = 75/285 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL--SARD--FQKLE-REARICRKLQHPNIVRLH 55
           G++ VV +C  + TG     +I+  KK   S  D   +K+  RE R+ ++L+HPN+V L 
Sbjct: 12  GSYGVVFKCRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           +  + +   +LVF+      L E         E      I Q L++VN CH +  +HRD+
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------WF----------------- 150
           KPEN+L+    K   +KL DFG A  + G            W+                 
Sbjct: 127 KPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 151 ----GVILYILLVGYPPFW----DEDQHRLYAQIKA------------------GAYDYP 184
               G +   LL G  P W    D DQ  LY   K                        P
Sbjct: 184 VWAIGCVFAELLTG-QPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240

Query: 185 SPE--------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            PE        +  ++  A + +   L ++P++R++  E L+HP+
Sbjct: 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 72/285 (25%), Positives = 111/285 (38%), Gaps = 74/285 (25%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+++ V + + +  G   A K+I+ K      F  + REA + + L+H NIV LHD I  
Sbjct: 16  GSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLHDIIHT 74

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESVNHCHSNGVVHRD 114
           +     VF      E     +A+         H         Q+L  + + H   ++HRD
Sbjct: 75  KETLTFVF------EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128

Query: 115 LKPENLLLASKAKGAAVKLADFGLA----------------------------IEVQGEQ 146
           LKP+NLL++   +   +KLADFGLA                             +     
Sbjct: 129 LKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185

Query: 147 QAW-FGVILYILLVGYPPFWD-----EDQHRLYA-------QIKAGAYDYPS--PEWDTV 191
             W  G I   +L G P F       E   +++            G    P+  PEW   
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245

Query: 192 T---------------PEAKNLINQMLTVNPSKRITASEALKHPW 221
                           P+A++L +QML + P  RI+A +AL HP+
Sbjct: 246 CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 73.0 bits (180), Expect = 8e-15
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 43/209 (20%)

Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           +PN ++L+ S+     H L+ D +  G+LF+ +      SEA+    I+Q++E++N  H 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------------------IEVQGEQQ 147
           + ++H D+K EN+L         + L D+GL                     I+      
Sbjct: 128 HNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDV 185

Query: 148 A--WF--GVILYILLVGYPPFWD--------EDQHRLYAQIKAGAYDYPSPEWDTVTPEA 195
           +  W+  GV+ Y LL G  PF +        E   +   +        P  +   V+  A
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIK--NVSKNA 237

Query: 196 KNLINQMLTVNPSKR-ITASEALKHPWIC 223
            + +  ML  N + R    +E +KHP++ 
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 40/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G FSVV + +    G   A K +   ++  A+  Q   +E  + ++L HPN+++   S  
Sbjct: 13  GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72

Query: 60  EENYHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E N   +V +L   G+L   I      +    E        Q+  ++ H HS  ++HRD+
Sbjct: 73  ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           KP N+ +   A G  VKL D GL      +  A                           
Sbjct: 133 KPANVFIT--ATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 149 W-FGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
           W  G +LY +     PF+ +    + L  +I+    DYP    D  + E ++L+++ +  
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYSEELRDLVSRCINP 247

Query: 206 NPSKRITASEAL 217
           +P KR   S  L
Sbjct: 248 DPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 2/80 (2%)

Query: 234 RQETVDCLKKFNARRKLKVSTRQGFA--GTPGYLSPEVLKKEPYGKPVDIWACGVILYIL 291
               +        RR  K    +  +  GTP Y++PEVL+  PYG   D W+ GVILY +
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 292 LVGYPPFWDEDQHRLYAQIK 311
           L G+PPF+ +     Y +I 
Sbjct: 224 LYGFPPFYSDTLQETYNKII 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 81/294 (27%)

Query: 1   GAFSVVRRCVQKATGLEFAAKI-------INTKKLSARDFQKLEREARICRKLQ-HPNIV 52
           GA+ +V  C  +         +       + +KK+ A+   +  RE ++ R  + H NI 
Sbjct: 11  GAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAK---RALRELKLLRHFRGHKNIT 65

Query: 53  RLHDS--IQEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            L+D   +   N++  YL  +L+   +L + I + +  ++A     I QIL  + + HS 
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA---IEVQGEQQA---------WF------ 150
            V+HRDLKP NLL+ +  +   +K+ DFGLA    E  GE            W+      
Sbjct: 125 NVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 151 ---------------GVILYILLVGYPPFW------------------DEDQHRLYAQIK 177
                          G IL  LL   P F                   DE+        K
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241

Query: 178 AGAYDYPSPEWDTV---------TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           A  Y    P               P A +L+ ++L  +P+KRI+  EAL+HP++
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 68/260 (26%), Positives = 114/260 (43%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL----QHPNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 5   GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 64

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEA+      +I+  + H H+  VV+RDLK
Sbjct: 65  AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLK 124

Query: 117 PENLLLASKAKGAAVKLADFGLAI-------------------EVQGEQQA------WF- 150
           P N+LL        V+++D GLA                    EV  +  A      WF 
Sbjct: 125 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 181

Query: 151 -GVILYILLVGYPPF---WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 237

Query: 207 PSKRI-----TASEALKHPW 221
            ++R+      A E  +HP+
Sbjct: 238 VNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 69/266 (25%), Positives = 105/266 (39%), Gaps = 49/266 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQK-------LEREARICRKLQHPNIV 52
           G +  V   +   TG   A K +      A R   +       L  E    + L H NIV
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +       E Y  +  + V GG +   +     + E       +Q+LE + + HS G++H
Sbjct: 72  QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH 131

Query: 113 RDLKPENLLLASKAKGAAVKLADFG-----------------------LAIEV-QGEQQA 148
           RDLK +NLL+   A G   K++DFG                       +A EV     Q 
Sbjct: 132 RDLKADNLLV--DADGIC-KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 149 W--------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--PSPE--WDTVTPEAK 196
           +         G ++  +  G  P+ DE+   + A  K G      P P      ++P A 
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKLGNKRSAPPIPPDVSMNLSPVAL 246

Query: 197 NLINQMLTVNPSKRITASEALKHPWI 222
           + +N   T+NP  R TA E L+HP+I
Sbjct: 247 DFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 7/141 (4%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+ VV +C  K T    A K     + +    +   RE ++ R L+  NIV L ++ + 
Sbjct: 12  GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71

Query: 61  ENYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
               YLVF+ V     EL E++       +  +   I Q++++++ CH N +VHRD+KPE
Sbjct: 72  RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY--IYQLIKAIHWCHKNDIVHRDIKPE 129

Query: 119 NLLLASKAKGAAVKLADFGLA 139
           NLL++       +KL DFG A
Sbjct: 130 NLLISHN---DVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 43/244 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICR-KLQHPNIVRLHD 56
           G+F  V     K T   FA K +  KK   L   D +    E R+     +HP +  L+ 
Sbjct: 6   GSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYC 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           + Q +   + V + + GG+L   I +   +    A+    +I+  +   HS G+V+RDLK
Sbjct: 64  TFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLK 123

Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQA-------------------------W- 149
            +N+LL        +K+ADFG+  E + G+ +                          W 
Sbjct: 124 LDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKNLINQMLTVNP 207
            FGV+LY +L+G  PF   D+  L+  I+    D P  P W  +T EAK+++ ++    P
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEELFQSIRM---DNPCYPRW--LTREAKDILVKLFVREP 235

Query: 208 SKRI 211
            +R+
Sbjct: 236 ERRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 27/155 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAK-IINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDS 57
           G F  V +  Q  TG   A K I+     + +D   +   RE +I +KL+HPN+V L D 
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 58  IQEE--------NYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNH 104
             E            Y+V      DL +G  L E+       +E+     + Q+LE +N+
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDL-SG--LLEN--PSVKLTESQIKCYMLQLLEGINY 130

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            H N ++HRD+K  N+L+ ++     +K+ADFGLA
Sbjct: 131 LHENHILHRDIKAANILIDNQ---GILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 28/54 (51%), Positives = 39/54 (72%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PEV++ + +GK VD W  GV+LY  + GYPPF+D+   R+Y +I AG
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230

Length = 329

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 75/257 (29%), Positives = 103/257 (40%), Gaps = 91/257 (35%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVF-----DLVT-----GGELFEDIVAREFYS 87
           REA + + L+H NIV LHD I  +    LVF     DL       GG L    V R F  
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNV-RLF-- 108

Query: 88  EADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA-------- 139
                  + Q+L  + +CH   V+HRDLKP+NLL++ + +   +KLADFGLA        
Sbjct: 109 -------LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSK 158

Query: 140 --------------------IEVQGEQQAW-FGVILYILLVGYPPF----WDEDQ-HRLY 173
                                E       W  G I Y +  G P F      EDQ H+++
Sbjct: 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218

Query: 174 AQIKAGAYDYPSPE-WDTVTP------------EAKNLIN----------------QMLT 204
             +       P+ E W  V+               + LIN                + L 
Sbjct: 219 RVLGT-----PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQ 273

Query: 205 VNPSKRITASEALKHPW 221
             P KRI+A+EA+KHP+
Sbjct: 274 YEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 29/57 (50%), Positives = 39/57 (68%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T + F GTP Y++PE++  +PYGK VD WA GV+LY +L G PPF  ED+  L+  I
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 40/256 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + +V      +T +  A K I  +   +R  Q L  E  +   L+H NIV+   S  E
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQILESVNHCHSNGVVHRDLK 116
             +  +  + V GG L   ++  ++    D    I    +QILE + + H N +VHRD+K
Sbjct: 77  NGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 117 PENLLLASKAKGAAVKLADFG---------------------LAIEV--QGEQ------Q 147
            +N+L+ + +    VK++DFG                     +A EV  +G +       
Sbjct: 136 GDNVLVNTYS--GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193

Query: 148 AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            W  G  +  +  G PPF  E      A  K G +       ++++ EAKN I +    +
Sbjct: 194 IWSLGCTIVEMATGKPPFI-ELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252

Query: 207 PSKRITASEALKHPWI 222
           P KR +A + L+ P++
Sbjct: 253 PDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 24/203 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  VR   +K TG  +A KI+     L       +  E  I  +     +V++  S Q
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   YL+ + + GG++   ++ ++  SE      I + + +++  H  G +HRD+KP+N
Sbjct: 72  DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDN 131

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPP---------------F 164
           LLL +K     VKL+DFGL   ++   +  F    Y  L   PP                
Sbjct: 132 LLLDAKGH---VKLSDFGLCTGLKKAHRTEF----YRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 165 WDEDQHRLYAQIKAGAYDYPSPE 187
           W +++ +L A    G  DY +PE
Sbjct: 185 WKKNRRQL-AYSTVGTPDYIAPE 206

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 34/251 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQ 59
           G F  V     K TG  +A K ++ K+L  +  +K+   E  I  K+  P IV L  + +
Sbjct: 4   GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE 63

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            + +  LV  L+ GG+L   I  V           H   QI   + H HS  +V+RD+KP
Sbjct: 64  SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKP 123

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQG----EQQA---------------------WF-- 150
           EN+LL  +      +L+D GLA+E++      Q+A                     WF  
Sbjct: 124 ENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           G  +Y ++ G  PF D  +     ++K     D    E    T E+K++    L   P  
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240

Query: 210 RITASEALKHP 220
           R+ + E    P
Sbjct: 241 RLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 74/267 (27%), Positives = 112/267 (41%), Gaps = 71/267 (26%)

Query: 23  INTKKLSARDFQKL------EREARICRKLQHPNIVRLHD------SIQEENYHYLVFDL 70
           +  KKLS R FQ L       RE R+ + ++H N++ L D      SI+  N  YLV +L
Sbjct: 43  VAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101

Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +  G    +IV  +  S+      I Q+L  + + HS G++HRDLKP N+ +    +   
Sbjct: 102 M--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--- 156

Query: 131 VKLADFGLAIEVQGEQQA-----WF---------------------GVILYILLVGYPPF 164
           +++ DFGLA +   E        W+                     G I+  LL G   F
Sbjct: 157 LRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Query: 165 WDED---------------QHRLYAQIKA-GAYDY-----PSPEWDT------VTPEAKN 197
              D                  +  +I +  A  Y       P+ D         P A +
Sbjct: 217 PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAID 276

Query: 198 LINQMLTVNPSKRITASEALKHPWICQ 224
           L+ +ML ++  KRI+ASEAL HP+  Q
Sbjct: 277 LLEKMLVLDSDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 61/267 (22%), Positives = 107/267 (40%), Gaps = 62/267 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TG   AAK+I TK  S  + +    E  I     HP IV+L  +   
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +   +++ +   GG +  D +  E     +E       +Q+LE++ + HS  ++HRDLK 
Sbjct: 81  DGKLWIMIEFCPGGAV--DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138

Query: 118 ENLLLASKAKGAAVKLADFGLA---IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYA 174
            N+LL        +KLADFG++   ++    + ++ G           P+W   +  +  
Sbjct: 139 GNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGT----------PYWMAPEVVMCE 185

Query: 175 QIKAGAYDYPSPEW---------------------------------------DTVTPEA 195
            +K   YDY +  W                                          + E 
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245

Query: 196 KNLINQMLTVNPSKRITASEALKHPWI 222
           ++ +   L  +P  R +A++ L+HP++
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.9 bits (171), Expect = 9e-14
 Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 63/270 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII----NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GA+  V  C     G   A K +    +    + ++++KL+ E  + + L+H NIV+   
Sbjct: 11  GAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69

Query: 57  SIQEENYHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESVNHCHS 107
           +  ++N   +  + V GG +           + V  ++          +QIL+ V + H+
Sbjct: 70  TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKY---------TKQILDGVAYLHN 120

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFG---------------------------LAI 140
           N VVHRD+K  N++L        +KL DFG                           +A 
Sbjct: 121 NCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 141 EVQGE------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVT 192
           EV  E         W  G  ++ +  G PP    D  RL A    GA+    P   D+ +
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD--RLAAMFYIGAHRGLMPRLPDSFS 235

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWI 222
             A + +   LT +  +R +A + L+H ++
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 26/51 (50%), Positives = 36/51 (70%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y++PEV+ ++ YGKPVD WA G+ILY  LVG  PF+ +    L+ Q+
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 15/109 (13%)

Query: 38  REARICRKLQHPNIVRLHDSI--QEENYHYLVF-----DLVTGGELFEDIVAREFYSEAD 90
           RE  +   L+HPNIV L + +  +  +  +LV      DL     L +++     +SE+ 
Sbjct: 55  REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPTP--FSESQ 109

Query: 91  ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
               + Q+L  + + H N ++HRDLK  NLLL  K     +K+ADFGLA
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 68.3 bits (168), Expect = 2e-13
 Identities = 26/66 (39%), Positives = 33/66 (50%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
             GTP YLSPE+ + +PY    DIW+ G +LY L     PF  E+   L  +I  G Y  
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP 222

Query: 318 EPKHKS 323
            P   S
Sbjct: 223 IPSQYS 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 28/58 (48%), Positives = 36/58 (62%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            T   F GTP YL+PEVL+K+PY + VD W  G +LY +L G PPF+  D   +Y  I
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 27/57 (47%), Positives = 35/57 (61%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T   F GTP YL+PEV++K+PY   VD W  G +LY +L G PPF+  D   +Y  I
Sbjct: 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 29/57 (50%), Positives = 37/57 (64%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T   F GTP YL+PEVL+KEPY + VD W  G +LY +L G PPF+  D  ++Y  I
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 29/66 (43%), Positives = 38/66 (57%), Gaps = 4/66 (6%)

Query: 245 NARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH 304
             RR L  ST     GTP Y++PEV  +  Y K  D W+ GVI+Y +LVGYPPF  ++  
Sbjct: 190 RNRRALAYST----VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245

Query: 305 RLYAQI 310
             Y +I
Sbjct: 246 ETYRKI 251

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 31/59 (52%), Positives = 41/59 (69%), Gaps = 1/59 (1%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           V+TR  F GTP Y++PE++  +PYGK VD WA GV+LY +L G PPF  ED+  L+  I
Sbjct: 156 VTTRT-FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 28/57 (49%), Positives = 38/57 (66%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T + F GTP Y++PE++  +PYGK VD WA GV+LY +L G  PF  ED+  L+  I
Sbjct: 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 74/270 (27%), Positives = 110/270 (40%), Gaps = 71/270 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K T   +A KI+N  ++  R      RE R +        I  LH + Q
Sbjct: 12  GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71

Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +ENY YLV D   GG+L      FED +  +      A   I +++ +++  H    VHR
Sbjct: 72  DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-----ARFYIAEMVLAIHSIHQLHYVHR 126

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------------ 143
           D+KP+N+LL        ++LADFG  +++                               
Sbjct: 127 DIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 144 --GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKN 197
             G +  W+  GV +Y +L G  PF+ E     Y +I      + +PS   D V+ EAK+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD-VSEEAKD 242

Query: 198 LINQMLTVNPSKRITASEALKHPWICQRER 227
           LI ++                   IC RER
Sbjct: 243 LIQRL-------------------ICSRER 253

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 38/255 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 11  GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE 70

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  +    + E  A     +I   +   H   +V+RDLKP
Sbjct: 71  TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------WF-- 150
           EN+LL        ++++D GLA+ V   Q                           W+  
Sbjct: 131 ENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY ++ G  PF    +     +++    +      +  +P+A++L   +L  +P +R
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Query: 211 I-----TASEALKHP 220
           +      A E  +HP
Sbjct: 248 LGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 38/244 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G FS V R      G+  A K +    L  A+      +E  + ++L HPN+++ + S  
Sbjct: 13  GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72

Query: 60  EENYHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+N   +V +L   G+L   I      +    E        Q+  ++ H HS  V+HRD+
Sbjct: 73  EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           KP N+ + +      VKL D GL      +  A                           
Sbjct: 133 KPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKA-GAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W  G +LY +     PF+  D+  LY+  K     DYP    D  + E + L+N  +  +
Sbjct: 190 WSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Query: 207 PSKR 210
           P KR
Sbjct: 249 PEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 63/272 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLH---- 55
           G +  V +   K TG   A KI++  +    +   ++ E  I RK   HPNI   +    
Sbjct: 17  GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSNHPNIATFYGAFI 73

Query: 56  --DSIQEENYHYLVFDLVTGG---ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNG 109
             +    ++  +LV +L  GG   +L + +  + +   E   ++ +++ L  + + H N 
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ---------AWFG--VI----- 153
           V+HRD+K +N+LL    K A VKL DFG++ ++               W    VI     
Sbjct: 134 VIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ 190

Query: 154 -------------LYI----LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 196
                        L I    L  G PP  D    R   +I       P P   T+     
Sbjct: 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN----PPP---TLKSPEN 243

Query: 197 ------NLINQMLTVNPSKRITASEALKHPWI 222
                 + I++ L  N  +R    E L+HP+I
Sbjct: 244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 40/253 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ- 59
           G  S+VR    +  G ++  K +N +  S R+ +  E+EA++  +L+HPNIV   +S + 
Sbjct: 14  GEVSLVR---HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70

Query: 60  EENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           E+   Y+V     GG+L+  +  +  +   E        QI  ++ + H   ++HRDLK 
Sbjct: 71  EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKT 130

Query: 118 ENLLLASKAKGAAVKLADFGLA--IEVQGEQQA-------------------------W- 149
           +N+ L    +   +K+ D G+A  +E Q +  +                         W 
Sbjct: 131 QNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G  +Y +      F  +D + L  +I  G    P P+    +PE   LI  ML+  P K
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPK--DYSPELGELIATMLSKRPEK 244

Query: 210 RITASEALKHPWI 222
           R +    L+ P+I
Sbjct: 245 RPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 77/289 (26%), Positives = 112/289 (38%), Gaps = 82/289 (28%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+  V       TG + A      KKLS R FQ         RE R+ + + H N++ L
Sbjct: 26  GAYGQVCSAFDTKTGRKVA-----IKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGL 79

Query: 55  HD------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            D      S+++    YLV  L+ G +L  +IV  +  S+      + QIL  + + HS 
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-----QQAWF------------- 150
           G++HRDLKP N+ +    +   +K+ DFGLA     E        W+             
Sbjct: 138 GIIHRDLKPSNIAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 194

Query: 151 --------GVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYPSPEWDT--VTPEAKNL 198
                   G I+  LL G   F   D      +I    G    P  E      +  A+N 
Sbjct: 195 QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT---PDEELLQKISSESARNY 251

Query: 199 INQM--------------------------LTVNPSKRITASEALKHPW 221
           I  +                          L ++P KRITA+EAL HP+
Sbjct: 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 77/286 (26%), Positives = 118/286 (41%), Gaps = 77/286 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHPNIVRL 54
           GA+  V   + K TG + A      KKLS R FQ      +  RE  + + +QH N++ L
Sbjct: 26  GAYGSVCSAIDKRTGEKVA-----IKKLS-RPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 55  HD------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            D      S  E    YLV   +      + I+     SE    + + Q+L  + + HS 
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPL-SEDKVQYLVYQMLCGLKYIHSA 136

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------- 150
           G++HRDLKP NL +    +   +K+ DFGLA     E        W+             
Sbjct: 137 GIIHRDLKPGNLAVNEDCE---LKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYN 193

Query: 151 --------GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAY--- 181
                   G I+  +L G   F  +D      QI                   A +Y   
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253

Query: 182 --DYPSPEWDTVTPEAK----NLINQMLTVNPSKRITASEALKHPW 221
              YP  ++ T+ P+A     +L+ +ML ++  KR+TA+EAL+HP+
Sbjct: 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 9/144 (6%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-----LH 55
           G++ VV   +   TG + A K IN       D  ++ RE ++ R L+HP+IV      L 
Sbjct: 11  GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 70

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            S +E    Y+VF+L+   +L + I A +  +       + Q+L ++ + H+  V HRDL
Sbjct: 71  PSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDL 129

Query: 116 KPENLLLASKAKGAAVKLADFGLA 139
           KP+N+L  +  K   +K+ DFGLA
Sbjct: 130 KPKNILANADCK---LKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 29/156 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII---NTKK---LSARDFQKLEREARICRKLQHPNIVRL 54
           G F  V +   K T    A K +   N K+   ++A       RE +I + L+H N+V L
Sbjct: 23  GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNL 76

Query: 55  HD-----SIQEENYH---YLVFDLVT---GGELFEDIVAREFYSEADASHCIQQILESVN 103
            +     +     Y    YLVF+       G L    V    ++ ++    ++ +L  + 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVMKMLLNGLY 133

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           + H N ++HRD+K  N+L+    K   +KLADFGLA
Sbjct: 134 YIHRNKILHRDMKAANILI---TKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 38/257 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 11  GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE 70

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  ++ GG+L   I  +    + E  A     +IL  +   H    V+RDLKP
Sbjct: 71  TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP 130

Query: 118 ENLLLASKAKGAAVKLADFGLAIEV-QGE------------------------QQAWFGV 152
           EN+LL        ++++D GLA+++ +GE                           ++G+
Sbjct: 131 ENILLDDYGH---IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGL 187

Query: 153 --ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
             ++Y ++ G  PF    +     ++     +         + EAK++   +LT +P +R
Sbjct: 188 GCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Query: 211 I-----TASEALKHPWI 222
           +      A E  +HP+ 
Sbjct: 248 LGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 29/62 (46%), Positives = 45/62 (72%), Gaps = 1/62 (1%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP YL+PEV++ + + K VD WA G+++Y +LVGYPPF+D++   +Y +I AG   + P
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFP 218

Query: 320 KH 321
           +H
Sbjct: 219 RH 220

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 63/249 (25%), Positives = 96/249 (38%), Gaps = 78/249 (31%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ- 96
           RE  + + L+H NIV LHD I  E    LVF+       + D   +++         +  
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFE-------YLDSDLKQYLDNCGNLMSMHN 104

Query: 97  ------QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----------- 139
                 Q+L  +++CH   ++HRDLKP+NLL+  K +   +KLADFGLA           
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYS 161

Query: 140 -----------------IEVQGEQQAW-FGVILYILLVGYPPF----------------- 164
                             E       W  G ILY +  G P F                 
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221

Query: 165 ------W------DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
                 W      +E +  L+ Q +A      +P  DT   +  +L++ +L      RI+
Sbjct: 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDT---DGIDLLSSLLLYETKSRIS 278

Query: 213 ASEALKHPW 221
           A  AL+H +
Sbjct: 279 AEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 4/151 (2%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  VR   +K TG  +A KI+     L       +  E  I  +     +V++  S Q
Sbjct: 12  GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   YL+ + + GG++   ++ ++  +E +    I + + +++  H  G +HRD+KP+N
Sbjct: 72  DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDN 131

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF 150
           LLL SK     VKL+DFGL   ++   +  F
Sbjct: 132 LLLDSKGH---VKLSDFGLCTGLKKAHRTEF 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.6 bits (163), Expect = 9e-13
 Identities = 46/145 (31%), Positives = 67/145 (46%), Gaps = 14/145 (9%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLH 55
           G+F VVRR     +G +    A K + + KLS    DF    +EA I   L H N++RL+
Sbjct: 6   GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL---KEAAIMHSLDHENLIRLY 62

Query: 56  DSIQEENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
             +       +V +L   G L + +   A   +  +       QI   + +  S   +HR
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121

Query: 114 DLKPENLLLASKAKGAAVKLADFGL 138
           DL   N+LLAS  K   VK+ DFGL
Sbjct: 122 DLAARNILLASDDK---VKIGDFGL 143

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 26/54 (48%), Positives = 35/54 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           F GTP Y++PE+L  +PYG  VD WA GV+LY +L G  PF  +D+  L+  I 
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 60/261 (22%), Positives = 109/261 (41%), Gaps = 46/261 (17%)

Query: 3   FSVVRRCVQKATGLEFAAKIINTKKLSA---------RDFQKLEREARICRKLQHPNIVR 53
           F +++R      G  + A+ +NT +L+A          DF  +++E  + +  +H NIV 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
              S    +  ++  +   GG L +        SE+  ++  ++ L+ + + HS G +HR
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------------EQQAWFG 151
           D+K  N+LL        VKLADFG++ ++                        E++  + 
Sbjct: 131 DIKGANILLTDNGH---VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 152 VILYILLVGY---------PPFWDEDQHRLYAQIKAGAYDYPSPEWDTV--TPEAKNLIN 200
            +  I  VG          PP +D    R    +    +  P  + D +  +    + + 
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK-DKMKWSNSFHHFVK 246

Query: 201 QMLTVNPSKRITASEALKHPW 221
             LT NP KR TA + L+HP+
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 42/142 (29%), Positives = 77/142 (54%), Gaps = 8/142 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRLHDS 57
           GAF  V    +K     +A K++    +  ++     + ER+A    K   P IV L+ S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYS 72

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +Q  N  YLV + + GG++   +    ++ E  A   I ++  ++++ H +G++HRDLKP
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132

Query: 118 ENLLLASKAKGAAVKLADFGLA 139
           +N+L++++     +KL DFGL+
Sbjct: 133 DNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 26/58 (44%), Positives = 39/58 (67%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 32/70 (45%), Positives = 43/70 (61%), Gaps = 3/70 (4%)

Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD 300
           L K N +   K +T   F GTP YL+PE+L    Y K VD W  GV+LY +L G PPF+D
Sbjct: 139 LCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195

Query: 301 EDQHRLYAQI 310
           E+ + +Y +I
Sbjct: 196 ENVNEMYRKI 205

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 54/263 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E RI  K+    +V L  + +
Sbjct: 11  GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE 70

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  ++ GG+L   I  +    + E  A     ++   +       +V+RDLKP
Sbjct: 71  TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP 130

Query: 118 ENLLLASKAKGAAVKLADFGLAIEV-QGE------------------------QQAWFGV 152
           EN+LL  +     ++++D GLA+++ +GE                           W+G+
Sbjct: 131 ENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187

Query: 153 --ILYILLVGYPPF--------WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
             ++Y ++ G  PF         +E   R    +K    +Y     +  + +AK++   +
Sbjct: 188 GCLIYEMIQGQSPFRKRKERVKREEVDRR----VKEDQEEYS----EKFSEDAKSICRML 239

Query: 203 LTVNPSKRI-----TASEALKHP 220
           LT NP +R+      A+   +HP
Sbjct: 240 LTKNPKERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 8/148 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V  C    TG E AAK +     S   +++   LE E ++ + LQH  IV+ +  
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72

Query: 58  IQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           +++  E    +  + + GG + + + A    +E+      +QILE +++ HSN +VHRD+
Sbjct: 73  LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ 143
           K  N+L  S      VKL DFG +  +Q
Sbjct: 133 KGANILRDSAGN---VKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 31/80 (38%), Positives = 43/80 (53%), Gaps = 4/80 (5%)

Query: 248 RKLKVSTRQ-GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW--DEDQH 304
           +KLK   +   F GTP Y++PE++  + Y   VD W+ G++LY LL G PPF   DED  
Sbjct: 141 KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200

Query: 305 RLYAQIKAGAYDDE-PKHKS 323
            +Y  I  G    E P +  
Sbjct: 201 EIYNDILKGNGKLEFPNYID 220

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 25/66 (37%), Positives = 36/66 (54%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           + GTP Y+SPE L    Y +  DIW+ G ++Y L    PPF   +Q +L ++IK G +  
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229

Query: 318 EPKHKS 323
            P   S
Sbjct: 230 IPYRYS 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 27/58 (46%), Positives = 35/58 (60%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            T   F GTP YL+PEVL K+PY + VD W  G +LY +L G PPF+  +   +Y  I
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 24/149 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+++ V +   K  G   A K+I  ++     F  + REA + + L+H NIV LHD I  
Sbjct: 16  GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLHDIIHT 74

Query: 61  ENYHYLVFDLVTG----------GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +    LVF+ V            G L  + V    +          Q+L  +++ H   +
Sbjct: 75  KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLF----------QLLRGLSYIHQRYI 124

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRDLKP+NLL++   +   +KLADFGLA
Sbjct: 125 LHRDLKPQNLLISDTGE---LKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 68/244 (27%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCI 95
           RE  + + L+H NIV LHD +  +    LVF+ +     +  +D       S  +    +
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDD--CGNIMSMHNVKIFL 110

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA---------------- 139
            QIL  + +CH   V+HRDLKP+NLL+  + +   +KLADFGLA                
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVT 167

Query: 140 ------------IEVQGEQQAW-FGVILYILLVGYPPF----WDEDQHRLYAQIKAGA-- 180
                        E   +   W  G I + +  G P F     +++ H ++  +      
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Query: 181 -------------YDYP----------SPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
                        Y++P          +P  DT   E   L+ + L     KRI+A EA+
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDT---EGIELLTKFLQYESKKRISAEEAM 284

Query: 218 KHPW 221
           KH +
Sbjct: 285 KHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 1   GAFSVVRRCVQKATGLEFA---AKIINTKKLSARDFQKLE---------REARICRKLQH 48
           G +  V +     TG   A    KII       +D Q +          RE +I  +++H
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79

Query: 49  PNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            NI+ L D   E ++  LV D++   +L + +  +   +E+     + QIL  +N  H  
Sbjct: 80  ENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW 138

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             +HRDL P N+ + SK      K+ADFGLA
Sbjct: 139 YFMHRDLSPANIFINSK---GICKIADFGLA 166

Length = 335

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 24/59 (40%), Positives = 36/59 (61%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F GT  Y+SPE+L ++P GK  D+WA G I+Y +L G PPF   +++  + +I    Y 
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 45/219 (20%)

Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREF------YSEADAS 92
           EA++  KL HP IV+ H S  E +   ++ +   G +L  D    E        SE    
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDL--DCKLEELKHTGKTLSENQVC 109

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL-------------- 138
               Q+L  V++ H   ++HRDLK +N+ L    K   +K+ DFG+              
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTF 165

Query: 139 ----------AIEVQG---EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 184
                     A++ QG   +   W  G ILY +      F  E Q+ L   ++      P
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF--EGQNFLSVVLRIVEGPTP 223

Query: 185 S-PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           S PE  T + +  +++  ML  +PS R +A+E L++P+I
Sbjct: 224 SLPE--TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 24/57 (42%), Positives = 37/57 (64%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T   F GTP Y++PE+L++  YG  VD WA GV++Y ++ G PPF  +++  L+  I
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 8/148 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN---TKKLSARDFQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V  C    TG E A K +      + ++++   LE E ++ + L+H  IV+ +  
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72

Query: 58  IQ--EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           ++  EE    +  + + GG + + + A    +E       +QIL+ V++ HSN +VHRD+
Sbjct: 73  LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ 143
           K  N+L  S      VKL DFG +  +Q
Sbjct: 133 KGANILRDSAGN---VKLGDFGASKRIQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 43/118 (36%), Positives = 58/118 (49%), Gaps = 26/118 (22%)

Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSEA 89
           RE  + ++L+   HPNIVRL D         E    LVF+ V       D   R +  + 
Sbjct: 48  REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-------DQDLRTYLDKV 100

Query: 90  DA--------SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                        ++Q L  ++  H+N +VHRDLKPEN+L+ S   G  VKLADFGLA
Sbjct: 101 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 10/141 (7%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV     +   ++ A K+I    +S  DF +   EA++  KL HPN+V+L+    +
Sbjct: 15  GQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVCTK 70

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   ++V + +  G L   +  R+    +E     C   + E++ +  SNG +HRDL   
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC-SDVCEAMEYLESNGFIHRDLAAR 129

Query: 119 NLLLASKAKGAAVKLADFGLA 139
           N L+        VK++DFGLA
Sbjct: 130 NCLVGED---NVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 25/58 (43%), Positives = 39/58 (67%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 25/58 (43%), Positives = 39/58 (67%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 30/68 (44%), Positives = 42/68 (61%), Gaps = 3/68 (4%)

Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED 302
           K N   + K ST   F GTP Y++PE+LK + Y + VD W+ GV+LY +L+G  PF  ED
Sbjct: 144 KENMNGEGKAST---FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 303 QHRLYAQI 310
           +  L+  I
Sbjct: 201 EDELFDSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 8/148 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V  C    TG E A K +     S   +++   LE E ++ + L H  IV+ +  
Sbjct: 13  GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72

Query: 58  IQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           +++  E    +  + + GG + + + +    +E       +QILE V++ HSN +VHRD+
Sbjct: 73  LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ 143
           K  N+L  S      VKL DFG +  +Q
Sbjct: 133 KGANILRDSVGN---VKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 25/61 (40%), Positives = 39/61 (63%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I  
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209

Query: 313 G 313
            
Sbjct: 210 E 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 4/139 (2%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  V    +  T   +A K +  K +  R+    ++ E  I  +  +  +VRL+ S Q
Sbjct: 12  GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +++  Y V D + GG++   ++    + E  A   I ++  +V   H  G +HRD+KP+N
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDN 131

Query: 120 LLLASKAKGAAVKLADFGL 138
           +L+    +   +KL DFGL
Sbjct: 132 ILI---DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 36/243 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G FS V R          A K +   + + A+  Q   +E  + ++L HPN+++  DS  
Sbjct: 13  GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72

Query: 60  EENYHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+N   +V +L   G+L + I      +    E        Q+  +V H HS  V+HRD+
Sbjct: 73  EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDI 132

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           KP N+ + +      VKL D GL      +  A                           
Sbjct: 133 KPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
           W  G +LY +     PF+ +  +      K    DYP    +  + + + L++  +  +P
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249

Query: 208 SKR 210
            +R
Sbjct: 250 DQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 53/150 (35%), Positives = 71/150 (47%), Gaps = 26/150 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII----NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF +V     + TG   A K I    +T  L+ R +    RE ++ + L+H NI+ L D
Sbjct: 21  GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLKHLRHENIISLSD 76

Query: 57  ---SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESVNHCHSNG 109
              S  E+ Y       VT  EL    + R   S       IQ    QIL  + + HS G
Sbjct: 77  IFISPLEDIY------FVT--ELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           VVHRDLKP N+L+        +K+ DFGLA
Sbjct: 129 VVHRDLKPSNILINENCD---LKICDFGLA 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 52/246 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K     FA KI+N  ++  R      RE R +     +  I  LH + Q
Sbjct: 12  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71

Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +EN  YLV D   GG+L      FED +  +      A   + +++ +++  H    VHR
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-----ARFYLAEMVIAIDSVHQLHYVHR 126

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------------ 143
           D+KP+N+L+        ++LADFG  +++                               
Sbjct: 127 DIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 144 --GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKN 197
             G +  W+  GV +Y +L G  PF+ E     Y +I      + +P+   D V+ +AK+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-VSEDAKD 242

Query: 198 LINQML 203
           LI +++
Sbjct: 243 LIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 60/270 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQ-HPNIVRLH--- 55
           G +  V + + K  G + A KI++       D  +++E E  I + L  HPN+V+ +   
Sbjct: 29  GTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 56  --DSIQEENYHYLVFDLVTGG---ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNG 109
               ++  +  +LV +L  GG   +L +  + R E   E   ++ + + L  + H H N 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------------EQQ 147
            +HRD+K  N+LL +      VKL DFG++ ++                        EQQ
Sbjct: 145 TIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ 201

Query: 148 ----------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---PE-WDTVT 192
                      W  G+    L  G PP    D H + A  K      P+   PE W    
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL--ADLHPMRALFKIPRNPPPTLHQPELWSN-- 257

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWI 222
            E  + I + LT +  KR T S+ L+H +I
Sbjct: 258 -EFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 38/272 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++ +  + + +++E  +  +   P + + + S  +
Sbjct: 15  GSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG   + + A  F  E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 74  GTKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+ +     VKLADFG+A ++   Q                             W  G+
Sbjct: 133 LLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP  + D H +         + P+   +  +   K  I+  L  +PS R T
Sbjct: 190 TAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLTGE-FSKPFKEFIDACLNKDPSFRPT 246

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKF 244
           A E LKH +I +  +  S  +  E +D  K++
Sbjct: 247 AKELLKHKFIVKNAKKTS--YLTELIDRFKRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 61.1 bits (149), Expect = 9e-11
 Identities = 17/52 (32%), Positives = 27/52 (51%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
            R    GTP +++PEV+  +PY    DIW+ G+    L  G PP+ +    +
Sbjct: 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK 204

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 4/139 (2%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           GAF  V    +  T   +A K +  K +  R+    ++ E  I  +  +  +V+L+ S Q
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +++  Y V D + GG++   ++  E + E  A   I ++  ++   H  G +HRD+KP+N
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDN 131

Query: 120 LLLASKAKGAAVKLADFGL 138
           +L+        +KL DFGL
Sbjct: 132 ILIDLDGH---IKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 26/57 (45%), Positives = 37/57 (64%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T   F GTP Y++PE+L++  YG  VD WA GV+LY +L G+ PF  E++  L+  I
Sbjct: 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 8/141 (5%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V    +  T   +A K +    +  R+     K ER+  I  +  +  +V+L+ S
Sbjct: 12  GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERD--ILAEADNEWVVKLYYS 69

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q+++  Y V D + GG++   ++    + E  A   I ++  ++   H  G +HRD+KP
Sbjct: 70  FQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 129

Query: 118 ENLLLASKAKGAAVKLADFGL 138
           +N+L+    +   +KL DFGL
Sbjct: 130 DNILI---DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 40/140 (28%), Positives = 60/140 (42%), Gaps = 6/140 (4%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSI 58
           G F  V + V      +     + T K       K E  REA +  +L HP IVRL    
Sbjct: 6   GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + E    LV +L   G L + +  R     +D      Q+   + +  S   VHRDL   
Sbjct: 66  KGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAAR 124

Query: 119 NLLLASKAKGAAVKLADFGL 138
           N+LL ++ +    K++DFG+
Sbjct: 125 NVLLVNRHQ---AKISDFGM 141

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 24/65 (36%), Positives = 32/65 (49%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP Y++PEV K  PY    DIW+ G +LY +    PPF       L  +++ G Y   P
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222

Query: 320 KHKSA 324
              S 
Sbjct: 223 PIYSQ 227

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 28/64 (43%), Positives = 38/64 (59%), Gaps = 4/64 (6%)

Query: 247 RRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
           RR+L  ST     GTP Y++PEV  +  Y K  D W+ GVI+Y +L+GYPPF  E     
Sbjct: 189 RRQLAYST----VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 307 YAQI 310
           Y ++
Sbjct: 245 YRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 28/64 (43%), Positives = 38/64 (59%), Gaps = 4/64 (6%)

Query: 247 RRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
           RR+L  ST     GTP Y++PEV  +  Y K  D W+ GVI+Y +L+GYPPF  E     
Sbjct: 189 RRQLAFST----VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 307 YAQI 310
           Y ++
Sbjct: 245 YKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 42/205 (20%)

Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESVN 103
           H  IV+  D  + ++   L+ +  +GG+L + I  R      + E +      QI+ +++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG-----------------------LAI 140
             HS  ++HRDLK  N+ L        +KL DFG                       LA 
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 141 EVQGEQQ------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVT 192
           E+   ++       W  GVILY LL  + PF    Q  +  Q+  G YD +P P    V+
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP----VS 296

Query: 193 PEAKNLINQMLTVNPSKRITASEAL 217
              K L++ +L+ NP+ R T  + L
Sbjct: 297 SGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 58/269 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G +  V +   K  G   A KI++   +S  D +++E E  I + L  HPN+V+ +    
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILD--PISDVD-EEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 60  EENYH-----YLVFDLVTGG---ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGV 110
           + +       +LV +L  GG   EL + ++   +   EA  S+ +   L  + H H+N +
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------------EQQ- 147
           +HRD+K  N+LL ++     VKL DFG++ ++                        EQQ 
Sbjct: 150 IHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 148 ---------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---PE-WDTVTP 193
                     W  G+    L  G PP +  D H +    K      P+   PE W     
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLF--DMHPVKTLFKIPRNPPPTLLHPEKW---CR 261

Query: 194 EAKNLINQMLTVNPSKRITASEALKHPWI 222
              + I+Q L  +   R + +  L+HP+I
Sbjct: 262 SFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 19/117 (16%)

Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEA--------- 89
           EA I  K  H NIVRL     E    +++ +L+ GG+L      + F  E          
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSS 112

Query: 90  ----DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
               D   C + + +   +   N  +HRD+   N LL  K  G   K+ADFG+A ++
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 53/150 (35%), Positives = 72/150 (48%), Gaps = 25/150 (16%)

Query: 11  QKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQH-PNIVRLHDSI 58
           +   G  + A+  NT KL A    +LE           RE  + + L     IVRL D  
Sbjct: 11  EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVE 70

Query: 59  QEENYH-----YLVFD-LVTGGELFEDIVAREFYSEADASHCIQ----QILESVNHCHSN 108
             E  +     YLVF+ L +  + F D   R       A   I+    Q+L+ V HCH +
Sbjct: 71  HVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK-TIKSFMYQLLKGVAHCHKH 129

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGL 138
           GV+HRDLKP+NLL+  K KG  +K+AD GL
Sbjct: 130 GVMHRDLKPQNLLV-DKQKG-LLKIADLGL 157

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI-VAREFYSEADAS 92
           +K  +EA I R+  HP+IV+L   +  EN  ++V +L   GEL   + V +     A   
Sbjct: 52  EKFLQEAYIMRQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI 110

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL--AIEVQGEQQA-- 148
               Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL   +E +   +A  
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYYKASK 167

Query: 149 ------W-------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYD 182
                 W                   FGV ++ IL++G  PF     + +  +I+ G   
Sbjct: 168 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-R 226

Query: 183 YPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
            P P      P   +L+ +    +PSKR   +E
Sbjct: 227 LPMPP--NCPPTLYSLMTKCWAYDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 36/260 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++ +  + + +++E  +  +   P I R + S  +
Sbjct: 15  GSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 74  GTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 132

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+ +     VKLADFG+A ++   Q                             W  G+
Sbjct: 133 LLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP  D    R+   I   +   P+ E     P  K  +   L  +P  R T
Sbjct: 190 TAIELAKGEPPNSDLHPMRVLFLIPKNS--PPTLEGQYSKP-FKEFVEACLNKDPRFRPT 246

Query: 213 ASEALKHPWICQRERVASIV 232
           A E LKH +I +  +  S +
Sbjct: 247 AKELLKHKFITRYTKKTSFL 266

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 25/64 (39%), Positives = 39/64 (60%), Gaps = 4/64 (6%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GTP +L+PEVL +  Y + VD W  GV++Y +LVG  PF  +D+  ++  I     +D
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----VND 216

Query: 318 EPKH 321
           E ++
Sbjct: 217 EVRY 220

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 25/55 (45%), Positives = 34/55 (61%), Gaps = 4/55 (7%)

Query: 260 GTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  PF+ +     Y++I
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 25/51 (49%), Positives = 33/51 (64%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP YL+PE+L  +P+G  VD WA GV L+  L G PPF DE   +++  I
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNI 592

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 44/260 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V + + + TG+  A K I  + L    F ++  E  I  K   P IV  + +   
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 61  ENYHYLVFDLVTGG---ELFEDIVAREFYSE---ADASHCIQQILESVNHCHSNGVVHRD 114
           E   Y+  + +  G   +L+   VA E   E      ++ + + L+ +   H+  ++HRD
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRD 128

Query: 115 LKPENLLLASKAKGAAVKLADFGLA----------------------IEVQGEQQA---- 148
           +KP N+L+    +   VKL DFG++                      I+  G  Q     
Sbjct: 129 VKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYT 185

Query: 149 -----W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
                W  G+ +  + +G  P+  E    ++AQ+ A     P       + +A++ + + 
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKC 245

Query: 203 LTVNPSKRITASEALKHPWI 222
           L   P++R T ++ L+HPW+
Sbjct: 246 LNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 38/272 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++ +  + + +++E  +  +   P + + + S  +
Sbjct: 15  GSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 74  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+   +   VKLADFG+A ++   Q                             W  G+
Sbjct: 133 LLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 189

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP    + H +         + P+ E +   P  K  +   L   PS R T
Sbjct: 190 TAIELAKGEPP--HSELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPT 246

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKF 244
           A E LKH +I +  +  S  +  E +D  K++
Sbjct: 247 AKELLKHKFIVRFAKKTS--YLTELIDRYKRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 23/54 (42%), Positives = 34/54 (62%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           F GTP Y++PE+L  + Y   VD W+ GV+LY +L+G  PF   D+  L+  I+
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 19/126 (15%)

Query: 26  KKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDLVTG 73
           KKLS R FQ +    R  R+L       H NI+ L        S++E    YLV +L+  
Sbjct: 47  KKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA 105

Query: 74  GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL 133
                 ++  +   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      +K+
Sbjct: 106 N--LCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKI 159

Query: 134 ADFGLA 139
            DFGLA
Sbjct: 160 LDFGLA 165

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 27/62 (43%), Positives = 37/62 (59%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GTP YL+PE+ +++ Y K  D+W+ GVILY LL  + PF    Q  +  Q+  G YD 
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290

Query: 318 EP 319
            P
Sbjct: 291 FP 292

Length = 478

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 19  AAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A KI+ +   L  +DFQK   E +  ++L+H +++ L          Y++ +L+  G L 
Sbjct: 34  AIKILKSDDLLKQQDFQK---EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90

Query: 78  EDIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA 134
             + + E       +  I    Q+ E + +      +HRDL   N+L+    +    K+A
Sbjct: 91  AFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVA 146

Query: 135 DFGLA--------------IEVQ-------------GEQQAW-FGVILY-ILLVGYPPFW 165
           DFGLA              I  +              +   W FG++LY +   G  P+ 
Sbjct: 147 DFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206

Query: 166 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
             + H +Y QI AG Y  P P       E   ++ +     P  R
Sbjct: 207 GMNNHEVYDQITAG-YRMPCPA--KCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 8e-10
 Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V +     TG   A KII  +     DF  +++E  + ++ +H NIV    S   
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               ++  +   GG L +        SE   ++  ++ L+ + + HS G +HRD+K  N+
Sbjct: 78  REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137

Query: 121 LLASKAKGAAVKLADFGLAIEVQG----------------------EQQAWFGVILYILL 158
           LL        VKLADFG+A ++                        E+   +  +  I  
Sbjct: 138 LLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWA 194

Query: 159 VGY---------PPFWDEDQHRLYAQIKAGAYDYPSPEWDTV-TPEAKNLINQMLTVNPS 208
           VG          PP +D    R    +    +  P  +  T  +    N +   LT NP 
Sbjct: 195 VGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPK 254

Query: 209 KRITASEALKH 219
           KR TA   L H
Sbjct: 255 KRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.6 bits (141), Expect = 9e-10
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 43/265 (16%)

Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG--ELFE 78
           K+  + K S   +Q + +E +  ++++HPN +        E+  +LV +   G   +L E
Sbjct: 57  KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLE 116

Query: 79  DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG- 137
             V ++   E + +      L+ + + HS+ ++HRD+K  N+LL    +   VKLADFG 
Sbjct: 117 --VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGS 171

Query: 138 ----------------LAIEV---------QGEQQAW-FGVILYILLVGYPPFWDED-QH 170
                           +A EV          G+   W  G+    L    PP ++ +   
Sbjct: 172 ASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231

Query: 171 RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS 230
            LY   +  +    S EW   +   +N ++  L   P  R T+ E LKH ++  RER  +
Sbjct: 232 ALYHIAQNESPTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL-RERPET 287

Query: 231 IVHR--QETVDCLKKFN--ARRKLK 251
           ++    Q T D +++ +    RK+K
Sbjct: 288 VLIDLIQRTKDAVRELDNLQYRKMK 312

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 43/115 (37%), Positives = 56/115 (48%), Gaps = 20/115 (17%)

Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVF-----DLVTGGELFEDIVARE 84
           RE  + R L+   HPN+VRL D         E    LVF     DL T    + D V   
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT----YLDKVPEP 105

Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                     + Q+L  ++  HS+ VVHRDLKP+N+L+ S      +KLADFGLA
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 20/129 (15%)

Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +    +S   F +   EA+I +KL+H  +V+L+    EE   Y+V + ++ G L  
Sbjct: 34  AVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL- 89

Query: 79  DIVAREFYSEADAS--HCIQ------QILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
                +F    +       Q      QI E + +  S   +HRDL   N+L+    +   
Sbjct: 90  -----DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLV 141

Query: 131 VKLADFGLA 139
            K+ADFGLA
Sbjct: 142 CKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 23/56 (41%), Positives = 31/56 (55%), Gaps = 1/56 (1%)

Query: 244 FNARRKLKVSTR-QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           FN   K+   T     +GTPGY++PEVL ++ Y   VD W+ GV  Y  L G  P+
Sbjct: 144 FNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 7/85 (8%)

Query: 226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACG 285
           E  + I   +     L++   R+  +        GTP Y++PEVL +  Y +  D W+ G
Sbjct: 175 EEWSEIDRCRLKP--LERRRKRQHQRC-LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231

Query: 286 VILYILLVGYPPFWD----EDQHRL 306
           VILY +LVG PPF      E Q ++
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKV 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 9/132 (6%)

Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K I    +S  DF +   EA++  KL HP +V+L+    E +   LVF+ +  G L
Sbjct: 30  KVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86

Query: 77  FEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA 134
            + + A+   F  E     C+  + E + +  S+ V+HRDL   N L+    +   VK++
Sbjct: 87  SDYLRAQRGKFSQETLLGMCL-DVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVS 142

Query: 135 DFGLAIEVQGEQ 146
           DFG+   V  +Q
Sbjct: 143 DFGMTRFVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 20/56 (35%), Positives = 29/56 (51%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           F GTP YL+PE +      K  D W+ G +++  L GYPPF  E    ++  I + 
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 5/143 (3%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSI 58
           G+++ V     K T   +A K++  + ++   D   ++ E  +  +   HP +V LH   
Sbjct: 6   GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 65

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 66  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 119 NLLLASKAKGAAVKLADFGLAIE 141
           N+LL S+     +KL D+G+  E
Sbjct: 126 NVLLDSEGH---IKLTDYGMCKE 145

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 10/148 (6%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV     +A  ++ A K IN   +S  DF +   EA++  KL HP +V+L+    +
Sbjct: 15  GQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGVCTQ 70

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   Y+V + +  G L   +  R+     +   S C Q + E + +   N  +HRDL   
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC-QDVCEGMEYLERNSFIHRDLAAR 129

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQ 146
           N L++S      VK++DFG+   V  ++
Sbjct: 130 NCLVSST---GVVKVSDFGMTRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 22/46 (47%), Positives = 29/46 (63%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
              +G AGTPGY++PEVL+ E Y   VD +A G  LY ++ G  PF
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 9/90 (10%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PEV+ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 164 FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223

Query: 304 HRLYAQIKAGAYDDEPK-----HKSASVVK 328
            +   +I+    D+ P      HK +SV++
Sbjct: 224 LQAMRRIR----DNLPPRVKDSHKVSSVLR 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 23/54 (42%), Positives = 35/54 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           F GTP Y++PE+L+   Y   VD W+ GV+LY +L+G  PF  +D+  L+  I+
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 9/142 (6%)

Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLV 71
           K T    A K IN    S  D + L++E    R+LQHPNI+    S   ++  Y+V  L+
Sbjct: 22  KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81

Query: 72  TGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKG 128
             G   ED++   F     E   +  ++ +L ++++ HS G +HR +K  ++LL+   K 
Sbjct: 82  AYGSC-EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK- 139

Query: 129 AAVKLADFGLAIEV--QGEQQA 148
             V L+    ++ +   G++Q 
Sbjct: 140 --VVLSGLRYSVSMIKHGKRQR 159

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 55.6 bits (135), Expect = 6e-09
 Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 2/62 (3%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
             GTP +++PEV++ E YG+  DIW+ G  +  +  G PP+ +       A +       
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSG 220

Query: 318 EP 319
           EP
Sbjct: 221 EP 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 254 TRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           T   F GT  YL+PEVL  E  Y K VD W+ GV+++ +  G+ PF+ ED  ++Y  I  
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211

Query: 313 G 313
           G
Sbjct: 212 G 212

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 26/66 (39%), Positives = 39/66 (59%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GTP Y++PE+ +++PY K  D+++ GV+LY LL    PF  E+   +  +  AG YD 
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264

Query: 318 EPKHKS 323
            P   S
Sbjct: 265 LPPSIS 270

Length = 496

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 25/78 (32%), Positives = 46/78 (58%), Gaps = 4/78 (5%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PEV+ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 161 FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Query: 304 HRLYAQIKAGAYDDEPKH 321
            +   +I+    D+ P  
Sbjct: 221 LQAMKRIR----DNLPPK 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 26/71 (36%), Positives = 37/71 (52%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
           A++K   S      GT  Y  PE++K EPYG+  D+WA G ILY +    PPF+  +   
Sbjct: 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220

Query: 306 LYAQIKAGAYD 316
           L  +I    Y+
Sbjct: 221 LATKIVEAVYE 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 7e-09
 Identities = 26/67 (38%), Positives = 40/67 (59%)

Query: 259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE 318
           AGT GY++PE+LK+EPY  PVD +A G  +Y ++ G  PF D  +     ++K    +DE
Sbjct: 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE 214

Query: 319 PKHKSAS 325
            K +  +
Sbjct: 215 VKFEHQN 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 43/248 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 73

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKP 117
           E   Y++ + +T G L  D +      E +A   +    QI  ++ +      +HRDL  
Sbjct: 74  EPPFYIITEFMTYGNLL-DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGE----------------------------QQAW 149
            N L+    +   VK+ADFGL+  + G+                               W
Sbjct: 133 RNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189

Query: 150 -FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            FGV+L+ I   G  P+   D  ++Y  ++ G Y    PE     P+   L+      NP
Sbjct: 190 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPE--GCPPKVYELMRACWQWNP 246

Query: 208 SKRITASE 215
           S R + +E
Sbjct: 247 SDRPSFAE 254

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 25/132 (18%)

Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    YLV   
Sbjct: 49  VAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM-- 105

Query: 71  VTGGELFEDIVAREFYSEAD---ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK 127
               EL +  + +  + E D    S+ + Q+L  + H HS G++HRDLKP N+++ S   
Sbjct: 106 ----ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-- 159

Query: 128 GAAVKLADFGLA 139
              +K+ DFGLA
Sbjct: 160 -CTLKILDFGLA 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 73/289 (25%), Positives = 107/289 (37%), Gaps = 80/289 (27%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F VV   +   T  + A K +       +D Q   RE  I + L H NI+ L D    
Sbjct: 77  GSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDYYYT 130

Query: 61  E----NYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------QILESVNHCHS 107
           E    N   +  ++V   E     V +     A  +H +          Q+  ++ + HS
Sbjct: 131 ECFKKNEKNIFLNVVM--EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------- 148
             + HRDLKP+NLL+        +KL DFG A  +   Q++                   
Sbjct: 189 KFICHRDLKPQNLLIDPNTH--TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246

Query: 149 --------W-FGVILYILLVGYPPFW------------------DEDQHRL----YAQIK 177
                   W  G I+  +++GYP F                    EDQ +     YA IK
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306

Query: 178 AGAYDYPSPEWDTVTP-----EAKNLINQMLTVNPSKRITASEALKHPW 221
               D    +   V P     +A N I+Q L   P KR+   EAL  P+
Sbjct: 307 FP--DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353

Length = 440

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 19/150 (12%)

Query: 1   GAFSVVRRC----VQKATGLEFAAKIINTK--KLSARDFQKLEREARICRKLQHPNIVRL 54
           G F  V  C    +   TG + A K +N    +    DF   ERE  I R L H NIV+ 
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF---EREIEILRTLDHENIVKY 71

Query: 55  HD--SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESVNHCHSNG 109
                        L+ + +  G L      +    + +    +    QI + +++  S  
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +HRDL   N+L+ S+     VK++DFGLA
Sbjct: 130 YIHRDLAARNILVESEDL---VKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 24/56 (42%), Positives = 33/56 (58%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP YLSPE+ + +PY +  D+WA GV+LY    G  PF   +Q  L  +I  G +
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 42/285 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       T    A K ++ + K +   +Q + +E +  ++L+HPN +       
Sbjct: 32  GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91

Query: 60  EENYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +E+  +LV +   G   +L E  V ++   E + +      L+ + + HS+ ++HRD+K 
Sbjct: 92  KEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149

Query: 118 ENLLLASKAKGAAVKLADFG-----------------LAIEV---------QGEQQAW-F 150
            N+LL    +   VKLADFG                 +A EV          G+   W  
Sbjct: 150 GNILLTEPGQ---VKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G+    L    PP ++   + + A       D P+ + +  T   +  ++  L   P +R
Sbjct: 207 GITCIELAERKPPLFN--MNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQER 264

Query: 211 ITASEALKHPWICQRERVASIVHR--QETVDCLKKFN--ARRKLK 251
             ++E L+H ++ +R+R A ++    Q T D +++ +    RK+K
Sbjct: 265 PASAELLRHDFV-RRDRPARVLIDLIQRTKDAVRELDNLQYRKMK 308

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 60/262 (22%), Positives = 99/262 (37%), Gaps = 50/262 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKL----EREARICRKLQHPNIVRLHD 56
           G F  V     K    E    ++  K L     + L     RE  + RKL H N+VRL  
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG 75

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQILESVNHCHS 107
             +E   HY++ +    G+L + + A +   E                 QI   ++H  +
Sbjct: 76  LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN 135

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-----QAW------------- 149
              VHRDL   N L++S+ +   VK++   L+ +V   +      A              
Sbjct: 136 ARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192

Query: 150 -----------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-K 196
                      FGV+++ +   G  PF+      +  +++AG  + P PE     P    
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE---GCPSRLY 249

Query: 197 NLINQMLTVNPSKRITASEALK 218
            L+ +   VNP  R + SE + 
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 19/39 (48%), Positives = 27/39 (69%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           G+P Y++PEVL+ + Y   VD W+ G +LY  L G+PPF
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 41/264 (15%)

Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG--GELFE 78
           K+  + K S   +Q + +E R  +KL+HPN ++       E+  +LV +   G   +L E
Sbjct: 47  KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106

Query: 79  DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG- 137
             V ++   E + +      L+ + + HS+ ++HRD+K  N+LL+       VKL DFG 
Sbjct: 107 --VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGS 161

Query: 138 ----------------LAIEV---------QGEQQAW-FGVILYILLVGYPPFWDEDQHR 171
                           +A EV          G+   W  G+    L    PP +  + + 
Sbjct: 162 ASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNA 219

Query: 172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI 231
           + A       + P+ +    +   +N ++  L   P  R T+   LKH ++  RER  ++
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-RERPPTV 278

Query: 232 VHR--QETVDCLKKFN--ARRKLK 251
           +    Q T D +++ +    RK+K
Sbjct: 279 IMDLIQRTKDAVRELDNLQYRKMK 302

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 42/196 (21%)

Query: 49  PNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
           PN+V LH  I  E+  +LV     GG+L+  I       E        +++ +++  H  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------------------EQQ 147
           G+V RDL P N+LL  +     ++L  F    EV+                      E +
Sbjct: 105 GIVCRDLNPNNILLDDRGH---IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETE 161

Query: 148 A--W--FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---PEWDTVTPEAKNLIN 200
           A  W   G IL+ LL G           L     +G   + +   PEW  V+ EA++L+ 
Sbjct: 162 ACDWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEW--VSEEARSLLQ 210

Query: 201 QMLTVNPSKRITASEA 216
           Q+L  NP++R+ A  A
Sbjct: 211 QLLQFNPTERLGAGVA 226

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 21/45 (46%), Positives = 30/45 (66%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 19/125 (15%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSE----- 88
           ++ + EA +  +LQHPNIV L   + +E    ++F   +  +L E +V R  +S+     
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 89  -----------ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
                      AD  H + QI   +    S+ VVH+DL   N+L+  K     VK++D G
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLG 169

Query: 138 LAIEV 142
           L  EV
Sbjct: 170 LFREV 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 21/58 (36%), Positives = 39/58 (67%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E
Sbjct: 162 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 19/125 (15%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS- 92
           Q+  +EA +   LQHPNIV L     +E    ++F+ +  G+L E +V    +S+  A  
Sbjct: 53  QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 93  ---------------HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
                          H   QI   + +  S+  VHRDL   N L+    +G  VK++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFG 169

Query: 138 LAIEV 142
           L+ ++
Sbjct: 170 LSRDI 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 21/45 (46%), Positives = 30/45 (66%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 64/258 (24%), Positives = 106/258 (41%), Gaps = 40/258 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       T    A K ++ + K S   +Q + +E R  ++L+HPN +       
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            E+  +LV +   G     DI  V ++   E + +      L+ + + HS+  +HRD+K 
Sbjct: 86  REHTAWLVMEYCLGSA--SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKA 143

Query: 118 ENLLLASKAKGAAVKLADFG-----------------LAIEV---------QGEQQAW-F 150
            N+LL        VKLADFG                 +A EV          G+   W  
Sbjct: 144 GNILLTEP---GTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200

Query: 151 GVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           G+    L    PP ++ +    LY   +  +    S +W   +   +N ++  L   P  
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVDSCLQKIPQD 257

Query: 210 RITASEALKHPWICQRER 227
           R ++ E LKH ++  RER
Sbjct: 258 RPSSEELLKHRFV-LRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 3/94 (3%)

Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           HP +V LH   Q E+  + V + V+GG+L   +  +    E  A     +I  ++N  H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            G+++RDLK +N+LL ++     +KL D+G+  E
Sbjct: 115 RGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKE 145

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.4 bits (130), Expect = 5e-08
 Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 61/279 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G F  V     K T   F  K I+ + L  R+  +L  E  + R+L+H NIVR  D    
Sbjct: 24  GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQILESVNHCHS-----NG 109
           +     Y++ +    G+L  +I            H I    +Q+L ++ +CH+     NG
Sbjct: 84  KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143

Query: 110 --VVHRDLKPENLLL-------------ASKAKGAAV-KLADFGLAIEVQGEQQA----- 148
             V+HRDLKP+N+ L             A+   G  + K+ DFGL+  +  E  A     
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG 203

Query: 149 ----W--------------------FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDY 183
               W                     G I+Y L  G  PF   +   +L +++K G    
Sbjct: 204 TPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG---- 259

Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           P       + E   LI  +L ++  +R +A + L +  I
Sbjct: 260 PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298

Length = 1021

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 21/45 (46%), Positives = 30/45 (66%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 22/53 (41%), Positives = 33/53 (62%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           A ++ +        GTP Y++PEVL ++ Y +  D W+ GVIL+ +LVG PPF
Sbjct: 196 ATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 21/58 (36%), Positives = 37/58 (63%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           F A+    V  R+   GTP +++PEV+ + PYG  VDIW+ G+++  ++ G PP++ +
Sbjct: 163 FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 43/129 (33%), Positives = 63/129 (48%), Gaps = 19/129 (14%)

Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    YLV +L
Sbjct: 45  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 104 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 157

Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 158 LKILDFGLA 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 48/176 (27%)

Query: 98  ILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLA----------------- 139
           I++++ + HS   V+HRD+KP N+L+    +   VKL DFG++                 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQ---VKLCDFGISGYLVDSVAKTIDAGCKP 168

Query: 140 ------IEVQGEQQAW--------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 185
                 I  +  Q+ +         G+ +  L  G  P+  +     + Q+K    + PS
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEE-PS 225

Query: 186 PEW--DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
           P+   +  +PE ++ +N+ L  N  +R    E L+HP+           H  +  D
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL--------HLSKNTD 273

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)

Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 164

Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 2/72 (2%)

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GVILY +L G+PPF+ +     Y +I         P    V+PEA +LI ++L  +P  R
Sbjct: 217 GVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDR 275

Query: 211 IT-ASEALKHPW 221
           +    E   HP+
Sbjct: 276 LGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 19/40 (47%), Positives = 24/40 (60%), Gaps = 1/40 (2%)

Query: 251 KVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILY 289
             S  +   GTP Y++PEVL  K  Y +  DIW+ GVILY
Sbjct: 146 DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY 185

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 1/63 (1%)

Query: 252 VSTRQ-GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           V TR     GTP Y++PE+L    +GK  D W  G+ +Y +LVG PPF+  +   +Y +I
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240

Query: 311 KAG 313
             G
Sbjct: 241 LEG 243

Length = 340

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 14/26 (53%), Positives = 23/26 (88%)

Query: 197 NLINQMLTVNPSKRITASEALKHPWI 222
           +L+N++LT +P+KRI+A +ALKHP+ 
Sbjct: 268 DLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 29/69 (42%), Positives = 36/69 (52%), Gaps = 12/69 (17%)

Query: 260 GTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  PF        YA    G Y
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--------YADSLVGTY 256

Query: 316 DDEPKHKSA 324
                HK++
Sbjct: 257 SKIMNHKNS 265

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 24/53 (45%), Positives = 32/53 (60%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           A R+ +        GTP Y++PEVL +  Y +  D W+ GVILY +LVG PPF
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 16/114 (14%)

Query: 35  KLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE-------DIVAREFYS 87
           K  +EARI ++  HPNIVRL     ++   Y+V +LV GG+           +  +E   
Sbjct: 39  KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98

Query: 88  EADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
             + +    + LES  HC     +HRDL   N L+  K     +K++DFG++ E
Sbjct: 99  MVENAAAGMEYLES-KHC-----IHRDLAARNCLVTEK---NVLKISDFGMSRE 143

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 22/60 (36%), Positives = 34/60 (56%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           + S R    GTP +++PEV+K++ YG  VDIW+ G++   +  G PP+  E   R    I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 28/77 (36%), Positives = 37/77 (48%), Gaps = 2/77 (2%)

Query: 241 LKKFNARRKLKVSTR--QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           L  F   R+L  S        GTP YLSPE+ +  PY    DIW+ G +LY L     PF
Sbjct: 143 LGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Query: 299 WDEDQHRLYAQIKAGAY 315
              + H+L  +I  G +
Sbjct: 203 EGNNLHQLVLKICQGYF 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 17/32 (53%), Positives = 23/32 (71%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
             +PEA +L+ +ML  +P KRITA EAL HP+
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           +P +V LH   Q  +  +LV + V GG+L   +  +    E  A     +I  ++N  H 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            G+++RDLK +N+LL +      +KL D+G+  E
Sbjct: 115 RGIIYRDLKLDNVLLDADGH---IKLTDYGMCKE 145

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 38/146 (26%), Positives = 68/146 (46%), Gaps = 14/146 (9%)

Query: 1   GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + V    G    +  A K++  +  S +  +++  EA +   + HP++VRL  
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLL- 75

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHR 113
            I   +   L+  L+  G L + +  R       + + +    QI + +++     +VHR
Sbjct: 76  GICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133

Query: 114 DLKPENLLLASKAKGAAVKLADFGLA 139
           DL   N+L+ +      VK+ DFGLA
Sbjct: 134 DLAARNVLVKTPQH---VKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 48/214 (22%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           Q    EA +   L+HPN+V+L   + + N  Y+V + +  G L + + +R          
Sbjct: 45  QAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-------RA 97

Query: 94  CI---QQILESVNHC------HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
            I   QQ+  +++ C           VHRDL   N+L++        K++DFGLA E   
Sbjct: 98  VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED---LVAKVSDFGLAKEASQ 154

Query: 145 EQQA------W-------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKA 178
            Q +      W                   FG++L+ I   G  P+       +   ++ 
Sbjct: 155 GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214

Query: 179 GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           G Y   +PE     PE   ++     ++P+KR T
Sbjct: 215 G-YRMEAPE--GCPPEVYKVMKDCWELDPAKRPT 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 21/54 (38%), Positives = 32/54 (59%), Gaps = 1/54 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
           S R  F GTP +++PEV+ + + Y    DIW+ G+ +Y +  G PP+ D D  R
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 22/62 (35%), Positives = 38/62 (61%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Query: 304 HR 305
            R
Sbjct: 221 LR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 22/62 (35%), Positives = 38/62 (61%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Query: 304 HR 305
            R
Sbjct: 221 LR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 22/62 (35%), Positives = 38/62 (61%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Query: 304 HR 305
            R
Sbjct: 222 LR 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 37/128 (28%), Positives = 54/128 (42%), Gaps = 11/128 (8%)

Query: 23  INTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL---F 77
           + T +  A D +K E  +EA +     HPNIV+L          Y++ +L+ GG+L    
Sbjct: 31  VKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL 90

Query: 78  EDIVAREFYSEA-DASHCIQQILESVNHCH---SNGVVHRDLKPENLLLASKAKGA--AV 131
            D     F          +   L+    C        +HRDL   N L++ K   A   V
Sbjct: 91  RDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV 150

Query: 132 KLADFGLA 139
           K+ DFGLA
Sbjct: 151 KIGDFGLA 158

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 24/144 (16%)

Query: 20  AKIINTKKL----SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           A+++  K L    + + + + ++EA +  +L HPNIV L   + +E    ++F+ +  G+
Sbjct: 34  AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 76  LFEDIVAREFYSEADAS-----------------HCIQQILESVNHCHSNGVVHRDLKPE 118
           L E ++ R  +S+   S                 H   QI   + +  S+  VH+DL   
Sbjct: 94  LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153

Query: 119 NLLLASKAKGAAVKLADFGLAIEV 142
           N+L+  +     VK++D GL+ E+
Sbjct: 154 NILIGEQLH---VKISDLGLSREI 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 22/130 (16%)

Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +    +  +DF     EA+I +KL+HP +++L+     E   Y+V +L+  G L E
Sbjct: 34  AVKTLKPGTMDPKDFL---AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90

Query: 79  DIVAREFYSEADASHCIQ---------QILESVNHCHSNGVVHRDLKPENLLLASKAKGA 129
                  Y +  A   ++         Q+   + +  +   +HRDL   N+L+    +  
Sbjct: 91  -------YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENN 140

Query: 130 AVKLADFGLA 139
             K+ADFGLA
Sbjct: 141 ICKVADFGLA 150

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 21/46 (45%), Positives = 31/46 (67%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           S  +G+AGTPG+++PE+L+ E Y   VD +A GV LY ++    PF
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 50/255 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V + V K    E A K   +  L     +K  +EA I ++  HPNIV+L     +
Sbjct: 6   GNFGDVYKGVLK-GNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ 63

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVN---HCHSNGVVHRDLKP 117
           +   Y+V +LV GG L   +  R+  +       +Q  L++     +  S   +HRDL  
Sbjct: 64  KQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQG-----------------------------EQQA 148
            N L+        +K++DFG++ E +G                             E   
Sbjct: 122 RNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 149 W-FGVILY-ILLVGYPPF--WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KNLINQML 203
           W +G++L+    +G  P+      Q R   +I++G Y  P+P+   + PE    L+ Q  
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQTR--ERIESG-YRMPAPQ---LCPEEIYRLMLQCW 232

Query: 204 TVNPSKRITASEALK 218
             +P  R + SE   
Sbjct: 233 AYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 50.1 bits (118), Expect = 8e-07
 Identities = 21/44 (47%), Positives = 25/44 (56%), Gaps = 3/44 (6%)

Query: 258 FAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPF 298
             GTPGY++PEVL            DIW+ G+ LY LL G PPF
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211

Length = 384

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 22/56 (39%), Positives = 35/56 (62%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           F GT  Y++PE+L +  +GK VD W+ G ++Y +L G PPF  E++ +   +I  G
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG 215

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 18/50 (36%), Positives = 31/50 (62%), Gaps = 2/50 (4%)

Query: 256 QG-FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH 304
           QG   GT  +++PEVL+ E YG+  D+W+ G ++  +    PP W+ ++H
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKH 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 28/69 (40%), Positives = 36/69 (52%), Gaps = 12/69 (17%)

Query: 260 GTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP Y+SPEVLK +     YG+  D W+ GV L+ +LVG  PF        YA    G Y
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--------YADSLVGTY 256

Query: 316 DDEPKHKSA 324
                HK++
Sbjct: 257 SKIMDHKNS 265

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 23/56 (41%), Positives = 31/56 (55%), Gaps = 5/56 (8%)

Query: 260 GTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y+SPE+L+     K  YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 10/91 (10%)

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GVI+Y +LVGYPPF  ++    Y +I         P+   ++PEAK+LI ++      +R
Sbjct: 226 GVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERR 284

Query: 211 I---TASEALKHP------WICQRERVASIV 232
           +     +E   HP      W   RER A I+
Sbjct: 285 LGNNGVNEIKSHPFFKGVDWEHIRERPAPII 315

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 85/289 (29%)

Query: 5   VVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRL-----HD-- 56
           VV + + + +GL  A K+I+ + K + R   ++ RE ++  +   P IV        D  
Sbjct: 16  VVTKVLHRPSGLIMARKLIHLEIKPAIR--NQIIRELKVLHECNSPYIVGFYGAFYSDGE 73

Query: 57  -SIQEENYHYLVFDLV--TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
            SI  E+      D V    G + E+I+ +        S  + + L  +   H   ++HR
Sbjct: 74  ISICMEHMDGGSLDQVLKKAGRIPENILGK-------ISIAVLRGLTYLREKHK--IMHR 124

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIE--------------------VQGEQQA----- 148
           D+KP N+L+ S+ +   +KL DFG++ +                    +QG         
Sbjct: 125 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDI 181

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYA----QIKAGA----------------------- 180
           W  G+ L  + +G  P    D   L A     +  G                        
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241

Query: 181 -YDY----PSP--EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             DY    P P       + E ++ +++ L  NP +R    E  KHP+I
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 14/121 (11%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE--------DIVAREFYSEA 89
           REA+I   L HP IV ++    + +  Y     + G  L          + +++E   + 
Sbjct: 51  REAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT 110

Query: 90  DASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
                +    +I  ++ + HS GV+HRDLKP+N+LL        V + D+G AI  + E+
Sbjct: 111 SVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEE 167

Query: 147 Q 147
           +
Sbjct: 168 E 168

Length = 932

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 17/32 (53%), Positives = 23/32 (71%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
             +PEA +LI  ML  +P KR TAS+AL+HP+
Sbjct: 251 NASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 24/77 (31%), Positives = 44/77 (57%), Gaps = 1/77 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIK 311
           S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+  R LY    
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 312 AGAYDDEPKHKSASVVK 328
            G  + +   K +++ +
Sbjct: 230 NGTPELQNPEKLSAIFR 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 24/67 (35%), Positives = 32/67 (47%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP YLSPE+ +  PY    DIWA G +LY +      F   +   L  +I  G+Y    
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS 222

Query: 320 KHKSASV 326
            H S  +
Sbjct: 223 SHYSYDL 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 24/66 (36%), Positives = 32/66 (48%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           + GTP Y+ PE+ +  PY    DIW+ G ILY L     PF       L  ++  G+Y  
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219

Query: 318 EPKHKS 323
            P H S
Sbjct: 220 LPSHYS 225

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 21/150 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRL 54
           GAF VV        G     K +  KK+    FQ L    R+ R+L+      H N++  
Sbjct: 11  GAFGVVWSVTDPRDG-----KRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 55  HDSIQEEN---YH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
            D +Q  +   +   Y+V +L+   +L + IV+ +  S       + QIL  + + HS G
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ++HRD+KP NLL+ S      +K+ DFGLA
Sbjct: 124 ILHRDIKPGNLLVNSNCV---LKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 19/117 (16%)

Query: 38  REARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASH-- 93
           RE  + R+L+HPN++ L        +   +L+FD     +L+  I   +F+  + A+   
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII---KFHRASKANKKP 102

Query: 94  ----------CIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLA 139
                      + QIL+ +++ H+N V+HRDLKP N+L+  +  +   VK+AD G A
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 19/117 (16%)

Query: 38  REARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASH-- 93
           RE  + R+L+HPN++ L        +   +L+FD     +L+  I   +F+  + A+   
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHII---KFHRASKANKKP 102

Query: 94  ----------CIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLA 139
                      + QIL+ +++ H+N V+HRDLKP N+L+  +  +   VK+AD G A
Sbjct: 103 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.2 bits (114), Expect = 2e-06
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 54/266 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G +  V +     TG   A K+++   ++  + +++++E  + +K   H NI   + +  
Sbjct: 17  GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 60  EEN------YHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           ++N        +LV +    G   +L ++        E  A  C ++IL  ++H H + V
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC-REILRGLSHLHQHKV 132

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ---GEQQAWFGVILYI----------- 156
           +HRD+K +N+LL   A+   VKL DFG++ ++    G +  + G   ++           
Sbjct: 133 IHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 189

Query: 157 -------------------LLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAK 196
                              +  G PP  D    R L+   +  A    S +W   + + +
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQ 246

Query: 197 NLINQMLTVNPSKRITASEALKHPWI 222
           + I   L  N S+R T  + +KHP+I
Sbjct: 247 SFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 26/102 (25%), Positives = 52/102 (50%), Gaps = 5/102 (4%)

Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-Q 97
           EA + + + HP+++R+ D++       +V    +  +L+  +  R      D +  I+ Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 98  ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ILE + + H+  ++HRD+K EN+ +    +   V + D G A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAA 204

Length = 357

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 40/143 (27%), Positives = 73/143 (51%), Gaps = 10/143 (6%)

Query: 1   GAFSVVRRCVQK--ATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 57
           G F  V++ V K     ++ A K++ N  + S RD  ++ REA I  +L +P IVR+   
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD--EMMREAEIMHQLDNPYIVRMIGV 63

Query: 58  IQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
            + E    LV ++ +GG L + +   ++  + ++    + Q+   + +      VHRDL 
Sbjct: 64  CEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122

Query: 117 PENLLLASKAKGAAVKLADFGLA 139
             N+LL ++      K++DFGL+
Sbjct: 123 ARNVLLVNQHYA---KISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 20/62 (32%), Positives = 29/62 (46%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GT  Y+SPE ++ E Y    DIW+ G+ L    +G  PF    Q   +  ++A     
Sbjct: 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP 219

Query: 318 EP 319
            P
Sbjct: 220 PP 221

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 5/57 (8%)

Query: 170 HRLYAQIKAGAYDYPS-----PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
             L    K   Y   S      +      +  +L+ ++L  +P+KRITA EAL+HP+
Sbjct: 259 DTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 25/64 (39%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 258 FAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F GT  Y++PEV+ K P  YG P DIW+ G  +  +  G PPF  E      A  K G +
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-ELGEPQAAMFKVGMF 227

Query: 316 DDEP 319
              P
Sbjct: 228 KIHP 231

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 60/274 (21%), Positives = 103/274 (37%), Gaps = 70/274 (25%)

Query: 1   GAFSVVRRCVQKATGLEFAAK---IINTKKLSARDFQKLE--REARICRKLQHPNIVRLH 55
           GAF  V + + K +G   A K       +K   R    L+    +  C     P IV+ +
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-----PYIVKFY 69

Query: 56  D---------------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 100
                            I  + ++  V++ V    + E+I+ +   +   A + +++ L+
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------------------- 139
                    ++HRD+KP N+LL    +   +KL DFG++                     
Sbjct: 129 ---------IIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176

Query: 140 --IEVQGEQ------QAW-FGVILYILLVG-YP-PFWDEDQHRLYAQIKAGAYDYPSPEW 188
             I+             W  G+ LY +  G +P P W+    +L   +K       + E 
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236

Query: 189 DTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
              +P   N IN  L  + SKR    E L+HP+I
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 6/141 (4%)

Query: 1   GAFSVVRRCVQKATGLE--FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V++ + K    E   A KI+           +L REA + ++L +P IVR+    
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + E++  LV +L   G L + +   +  +E + +  + Q+   + +      VHRDL   
Sbjct: 66  EAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAAR 124

Query: 119 NLLLASKAKGAAVKLADFGLA 139
           N+LL ++      K++DFGL+
Sbjct: 125 NVLLVTQHYA---KISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 11/158 (6%)

Query: 3   FSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           FS++      A G  FA     T +   + A        EA I R + HP+I++L  +  
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFT 153

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
              +  L+       +L+  + A+   +  D     + +L ++ + H N ++HRD+K EN
Sbjct: 154 YNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212

Query: 120 LLLASKAKGAAVKLADFGLA---IEV-QGEQQAWFGVI 153
           + +        V L DFG A   +++   +   W G I
Sbjct: 213 IFINHPGD---VCLGDFGAACFPVDINANKYYGWAGTI 247

Length = 391

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 4/74 (5%)

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G I++  L+G+PPF  E+ H  Y +I         P+   ++ EA++LI +++T N   R
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR 293

Query: 211 I---TASEALKHPW 221
           +    A E   HP+
Sbjct: 294 LGRGGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 23/78 (29%), Positives = 41/78 (52%), Gaps = 7/78 (8%)

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
           W  G++LY +L G  PF   ++   ++ I     +   P    V+  A++LI ++L  +P
Sbjct: 216 WTLGILLYEMLYGTTPFKGSNRDETFSNILKK--EVTFPGSPPVSSSARDLIRKLLVKDP 273

Query: 208 SKRI----TASEALKHPW 221
           SKR+     A+E  +HP+
Sbjct: 274 SKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 17/46 (36%), Positives = 31/46 (67%)

Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED 302
           G+AGT    +PE+L ++PYG  VDIW+ G++L+ +   +   +++D
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287

Length = 391

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 54/261 (20%), Positives = 104/261 (39%), Gaps = 48/261 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+ S V+      TG   A K+++    S+   Q L RE +I  + + P IV  + +   
Sbjct: 19  GSVSKVKH---IPTGTVMAKKVVHIGAKSSVRKQIL-RELQIMHECRSPYIVSFYGAFLN 74

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHS-NGVVHRDLKP 117
           EN   +  + +  G L  D + ++               ++E + + ++ + ++HRD+KP
Sbjct: 75  ENNICMCMEFMDCGSL--DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP 132

Query: 118 ENLLLASKAKGAAVKLADFGLAIEV--------------------QGEQ-----QAW-FG 151
            N+L+ S+ +   +KL DFG++ E+                    QG +       W  G
Sbjct: 133 SNILVNSRGQ---IKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-------PSPEW--DTVTPEAKNLINQM 202
           + +  L +G  PF   +          G  D        P P         + ++ ++  
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDAC 249

Query: 203 LTVNPSKRITASEALK-HPWI 222
           L  +P++R T  +     P+I
Sbjct: 250 LLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 19/53 (35%), Positives = 31/53 (58%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+  + +G  VD W  G++LY +L G  PF   ++   ++ I
Sbjct: 192 FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 17/47 (36%), Positives = 28/47 (59%), Gaps = 4/47 (8%)

Query: 187 EWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA 229
            W  +    +PEA +L++QML  +P +RIT  +AL+HP++ Q     
Sbjct: 258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 33/127 (25%), Positives = 59/127 (46%), Gaps = 7/127 (5%)

Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K      Q    EA + + LQH  +VRL+  + +E   Y++ + +  G L  D + 
Sbjct: 35  VKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL-DFLK 93

Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +   +      I    QI E + +      +HRDL+  N+L+   ++    K+ADFGLA
Sbjct: 94  SDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLA 150

Query: 140 IEVQGEQ 146
             ++  +
Sbjct: 151 RVIEDNE 157

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 18/110 (16%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC--- 94
           +EA+I +KL+H  +V L+  + EE   Y+V + +  G L       +F  E D  +    
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLL------DFLKEGDGKYLKLP 102

Query: 95  -----IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                  QI + + +      +HRDL+  N+L+         K+ADFGLA
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 4/104 (3%)

Query: 36  LEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI 95
             RE  I + + H  I+ L  + + ++   +V       +LF  +          A    
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +++LE++ + H  G++HRD+K EN+ L       AV L DFG A
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAV-LGDFGAA 232

Length = 392

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 19/55 (34%), Positives = 31/55 (56%), Gaps = 2/55 (3%)

Query: 258 FAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV++     + K VD W+ GV+ + LL G  PF  + +    ++I
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 30/155 (19%)

Query: 1   GAFSVVRRC----VQKATGLEFAA--KIINTKKLSARDFQKLEREARICRKLQHPNIVRL 54
           G F  V  C    +Q  TG E  A  K+ ++     RDF   ERE  I + LQH NIV+ 
Sbjct: 15  GNFGSVELCRYDPLQDNTG-EVVAVKKLQHSTAEHLRDF---EREIEILKSLQHDNIVKY 70

Query: 55  HD---SIQEENYHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQ---QILESVNH 104
                S    N   LV + +  G L      R++  +     D    +    QI + + +
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             S   VHRDL   N+L+ S+ +   VK+ DFGL 
Sbjct: 124 LGSKRYVHRDLATRNILVESENR---VKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 8/104 (7%)

Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQHP +VRL+  + +E   Y++ + +  G L  D +      +   +  I   
Sbjct: 51  EANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPEGIKLTINKLIDMA 108

Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++        K+ADFGLA
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVSET---LCCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 46.1 bits (109), Expect = 8e-06
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 8/108 (7%)

Query: 35  KLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           K   EARI ++  HPNIV+L     +    Y+V +LV GG+    +  R+   E      
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQL 95

Query: 95  IQQILESVN---HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ++  L++     +  S   +HRDL   N L+    +   +K++DFG++
Sbjct: 96  VKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 3/66 (4%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
                 GTP +++PEV++        DIW+ G  +  LL G PP++D +      +I   
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--- 211

Query: 314 AYDDEP 319
             DD P
Sbjct: 212 VQDDHP 217

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 18/43 (41%), Positives = 26/43 (60%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +G  GT GY++PEV+K E Y    D W  G ++Y ++ G  PF
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 46.1 bits (109), Expect = 9e-06
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 18/128 (14%)

Query: 24  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR 83
           +  K +  DF K   E +I  +L++PNI+RL      ++   ++ + +  G+L + +  R
Sbjct: 55  DVTKTARNDFLK---EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR 111

Query: 84  EFYSE------------ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
           E  S             A+  +   QI   + +  S   VHRDL   N L+        +
Sbjct: 112 EIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTI 168

Query: 132 KLADFGLA 139
           K+ADFG++
Sbjct: 169 KIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 8/120 (6%)

Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K  +   +    EA + + LQH  +V+LH  + +E   Y++ + +  G L  D + 
Sbjct: 35  VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL-DFLK 92

Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +  S+      I    QI E +        +HRDL+  N+L+   +     K+ADFGLA
Sbjct: 93  SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 15/32 (46%), Positives = 25/32 (78%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
            +A +L+ ++L  NP+KR+TA EAL+HP++ Q
Sbjct: 269 DDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 16/32 (50%), Positives = 23/32 (71%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            +  E  +L+ +MLT NP KRI+A EAL+HP+
Sbjct: 255 EICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 23/56 (41%), Positives = 31/56 (55%), Gaps = 5/56 (8%)

Query: 260 GTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y+SPE+L+     K  YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 20/126 (15%)

Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA--REF--- 85
           +DF+   REA +    QH NIV+ +    E +   +VF+ +  G+L + + +   +    
Sbjct: 53  KDFE---REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFL 109

Query: 86  ---------YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
                     + +       QI   + +  S   VHRDL   N L+        VK+ DF
Sbjct: 110 KSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD---LVVKIGDF 166

Query: 137 GLAIEV 142
           G++ +V
Sbjct: 167 GMSRDV 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 20/48 (41%), Positives = 32/48 (66%), Gaps = 3/48 (6%)

Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
           ++Q+L  +   H  G+VHRD+KPENLL+    +   VK+ DFG A+++
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDM 359

Length = 507

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 17/33 (51%), Positives = 23/33 (69%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILL 292
           GTP Y+SPE+ + +PY +  DIWA G +LY L 
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 15/31 (48%), Positives = 25/31 (80%)

Query: 191 VTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            +PEA +L+  +L  +PSKR++A+EAL+HP+
Sbjct: 254 ASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 23/65 (35%), Positives = 30/65 (46%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP Y+SPE+ +   Y    DIWA G +LY LL     F   +   L  +I  G Y    
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV 222

Query: 320 KHKSA 324
              S+
Sbjct: 223 SVYSS 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 6/66 (9%)

Query: 241 LKKFNARRKLKVSTRQG-----FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY 295
           L  F A ++L+     G       GTP ++SPEV+  E YG+  D+W+ G  +  +L   
Sbjct: 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Query: 296 PPFWDE 301
           PP W E
Sbjct: 205 PP-WAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 19/52 (36%), Positives = 28/52 (53%), Gaps = 3/52 (5%)

Query: 252 VSTRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWD 300
           ++ R+ F GTP +++PEV    +K  Y    DIWA G+    L    PP +D
Sbjct: 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 22/57 (38%), Positives = 29/57 (50%), Gaps = 6/57 (10%)

Query: 260 GTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y++PEVL       K  YG   D W+ GVI Y ++ G  PF +    + Y  I
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 19/45 (42%), Positives = 27/45 (60%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           S R  F GTP +++PEV+K+  Y +  DIW+ G+    L  G PP
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 21/45 (46%), Positives = 28/45 (62%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T +G  GT GY++PEV+K E Y    D WA G +LY ++ G  PF
Sbjct: 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 36/109 (33%), Positives = 49/109 (44%), Gaps = 23/109 (21%)

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF--GVILYILLVGYPPFWDEDQHRL 172
           L PE  LL  K  G AV                 W+  GV L+  L G PPF DE   ++
Sbjct: 547 LAPE--LLLGKPHGPAVD----------------WWALGVCLFEFLTGIPPFNDETPQQV 588

Query: 173 YAQIKAGAYDYPSPEWDTV-TPEAKNLINQMLTVNPSKRITASEALKHP 220
           +  I     D P PE +   +  A+N I  +LT++P+KR    E  +HP
Sbjct: 589 FQNIL--NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 6/66 (9%)

Query: 241 LKKFNARRKLKVSTRQG-----FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY 295
           L  F A ++L+     G       GTP ++SPEV+  E YG+  DIW+ G  +  +L   
Sbjct: 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Query: 296 PPFWDE 301
           PP W E
Sbjct: 207 PP-WAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 29/128 (22%)

Query: 67  VFDLVT---GGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLA 123
           V DLV    G  L ED +A          +  ++IL  + H H++ V+HRD+K +N+LL 
Sbjct: 106 VTDLVKNTKGNALKEDWIA----------YICREILRGLAHLHAHKVIHRDIKGQNVLLT 155

Query: 124 SKAKGAAVKLADFGLAIEVQ---GEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGA 180
             A+   VKL DFG++ ++    G +  + G           P+W   +     +     
Sbjct: 156 ENAE---VKLVDFGVSAQLDRTVGRRNTFIGT----------PYWMAPEVIACDENPDAT 202

Query: 181 YDYPSPEW 188
           YDY S  W
Sbjct: 203 YDYRSDIW 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 35/145 (24%), Positives = 69/145 (47%), Gaps = 19/145 (13%)

Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLV-----FDLVTG 73
           A ++    + +     +LE E     +L H NI+++ + ++ E   Y++     FDL + 
Sbjct: 197 AKRVKAGSRAAI----QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYS- 251

Query: 74  GELF-EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVK 132
             ++ E    ++          ++Q+L +V + H   ++HRD+K EN+ L    K   + 
Sbjct: 252 -FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK---IV 307

Query: 133 LADFGLAIEVQGEQQA----WFGVI 153
           L DFG A+  + E++A    W G +
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTV 332

Length = 501

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 28/144 (19%)

Query: 19  AAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A K++  K+ ++ D Q   +REA +  +  HPNIV+L           L+F+ +  G+L 
Sbjct: 39  AVKML--KEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 78  EDIVAREFYSEADASH---------------------CI-QQILESVNHCHSNGVVHRDL 115
           E +  R   ++   SH                     CI +Q+   + +      VHRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 116 KPENLLLASKAKGAAVKLADFGLA 139
              N L+    +   VK+ADFGL+
Sbjct: 157 ATRNCLV---GENMVVKIADFGLS 177

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 33/154 (21%), Positives = 60/154 (38%), Gaps = 19/154 (12%)

Query: 1   GAFSVV-----RRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G+F +V     +  V+       A K +N    S R+  +   EA + ++    ++VRL 
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLL 75

Query: 56  DSIQEENYHYLVFDLVTGGEL-------FEDIVAREFYSEADASHCIQ---QILESVNHC 105
             +       +V +L+  G+L         +               IQ   +I + + + 
Sbjct: 76  GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL 135

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +   VHRDL   N ++A       VK+ DFG+ 
Sbjct: 136 AAKKFVHRDLAARNCMVAED---LTVKIGDFGMT 166

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 40/128 (31%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 14  TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG 73
           TG + A K I    ++A+ F +   E  +  KL H N+VRL   I   N  Y+V +L++ 
Sbjct: 28  TGQKVAVKNIKCD-VTAQAFLE---ETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82

Query: 74  GEL--FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
           G L  F     R   S          + E + +  S  +VHRDL   N+L+   ++    
Sbjct: 83  GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVA 139

Query: 132 KLADFGLA 139
           K++DFGLA
Sbjct: 140 KVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 30/167 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V R + K  GL+  A I   K+ ++    RDF   E E  +C+   HPNI+ L  
Sbjct: 13  GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEV-LCKLGHHPNIINLLG 70

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD----------ASHCIQQILE------ 100
           + +   Y Y+  +    G L  D + +    E D          ++   QQ+L+      
Sbjct: 71  ACENRGYLYIAIEYAPYGNLL-DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 101 -SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
             + +      +HRDL   N+L+    +  A K+ADFGL+   +GE+
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGEE 170

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 22/56 (39%), Positives = 30/56 (53%), Gaps = 5/56 (8%)

Query: 260 GTPGYLSPEVLKKE-----PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y+SPE+L+        YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 23/141 (16%)

Query: 19  AAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A K +    L+AR DFQ   REA +   LQH +IV+ +    + +   +VF+ +  G+L 
Sbjct: 39  AVKALKDPTLAARKDFQ---REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 78  EDIVA-------------REFYSEADAS---HCIQQILESVNHCHSNGVVHRDLKPENLL 121
           + + A             R+   E   S   H   QI   + +  S   VHRDL   N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 122 LASKAKGAAVKLADFGLAIEV 142
           + +      VK+ DFG++ +V
Sbjct: 156 VGA---NLLVKIGDFGMSRDV 173

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 27/160 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V +   K  GL   A I   K+ ++    RDF   E E  +C+   HPNI+ L  
Sbjct: 18  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEV-LCKLGHHPNIINLLG 75

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----------QQIL------- 99
           + +   Y YL  +    G L  D + +    E D +  I          QQ+L       
Sbjct: 76  ACEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             +++      +HRDL   N+L+    +    K+ADFGL+
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 9/70 (12%)

Query: 244 FNARRKLKVSTR------QGFAGTPGYLSPEVLKKEP---YGKPVDIWACGVILYILLVG 294
           F    KLK +T       Q  AGTP Y++PEV+       +G+  DIW+ G ++  +  G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202

Query: 295 YPPFWDEDQH 304
             P+ + D  
Sbjct: 203 KRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 14/32 (43%), Positives = 27/32 (84%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            + PE  +L++++L+++P KR+TAS+AL+HP+
Sbjct: 279 KLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 17/43 (39%), Positives = 25/43 (58%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +G  GT GY++PEVL  + Y    D W  G ++Y ++ G  PF
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 6/66 (9%)

Query: 241 LKKFNARRKLKVSTRQG-----FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY 295
           L  F A ++L+     G       GTP ++SPEV+  E YG+  D+W+ G  +  +L   
Sbjct: 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Query: 296 PPFWDE 301
           PP W E
Sbjct: 207 PP-WAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 14/40 (35%), Positives = 27/40 (67%), Gaps = 1/40 (2%)

Query: 184 PSPEWDTVTPE-AKNLINQMLTVNPSKRITASEALKHPWI 222
            S   + +    A++L+++ML ++P KRI+  +AL+HP+I
Sbjct: 275 DSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 17/45 (37%), Positives = 31/45 (68%), Gaps = 2/45 (4%)

Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ++QIL +++  HS G+VHRD+KP+N++ +  +   + K+ D G A
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG--SFKIIDLGAA 303

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 29/119 (24%)

Query: 39  EARICRKLQHPNIVRLHD-------------SIQEENYHYLVFDLVTGGELFEDIVAREF 85
           EAR+ R+L HP ++ L D               + + Y YL   L   G      VAR  
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR-- 267

Query: 86  YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
                      Q+L ++++ H  G++HRD+K EN+L+        + L DFG A   +G
Sbjct: 268 -----------QLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARG 312

Length = 461

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 19/46 (41%), Positives = 26/46 (56%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD 300
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP  D
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 50/205 (24%)

Query: 23  INTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI 80
           I T K  + D Q+L+   EA I  +  HPNI+RL   + +     ++ + +  G L    
Sbjct: 37  IKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL---- 92

Query: 81  VAREFYSEADASHCIQQILE-------SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL 133
              +F  E D    + Q++         + +      VHRDL   N+L+ S       K+
Sbjct: 93  --DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN---LVCKV 147

Query: 134 ADFGL--------------------------AIEVQGEQQA---W-FGVILY-ILLVGYP 162
           +DFGL                          AI  +    A   W FG++++ ++  G  
Sbjct: 148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207

Query: 163 PFWDEDQHRLYAQIKAGAYDYPSPE 187
           P+WD     +   ++ G Y  P P 
Sbjct: 208 PYWDMSNQDVIKAVEDG-YRLPPPM 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 19/54 (35%), Positives = 34/54 (62%), Gaps = 1/54 (1%)

Query: 258 FAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PE+++ K  +GK VD W+ G++++ LL G  PF  E +    +++
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF--------WDEDQHR 305
           T +G  GT GY++PEV+  E Y    D W  G ++Y ++ G  PF         +E   R
Sbjct: 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR 216

Query: 306 L 306
           +
Sbjct: 217 V 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 18/32 (56%), Positives = 21/32 (65%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILY 289
           F GTP Y+SPE LK + Y    DIW+ G ILY
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILY 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 10/128 (7%)

Query: 21  KIINTKKLSARDFQKLE----REARICRKLQHPNIVRLHD--SIQEENYHYLVFDLVTGG 74
           +++  K L     Q+      +E  I + L H NIV+     S Q      L+ + V  G
Sbjct: 34  EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93

Query: 75  ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA 134
            L  D + +   + A      QQI E + + HS   +HRDL   N+LL +      VK+ 
Sbjct: 94  SL-RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---RLVKIG 149

Query: 135 DFGLAIEV 142
           DFGLA  V
Sbjct: 150 DFGLAKAV 157

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 30/167 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V +   K  GL   A I   K+ ++    RDF   E E  +C+   HPNI+ L  
Sbjct: 6   GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEV-LCKLGHHPNIINLLG 63

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQILES----------- 101
           + +   Y YL  +    G L  D + +    E D +    +     L S           
Sbjct: 64  ACEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 102 --VNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
             +++      +HRDL   N+L+    +    K+ADFGL+   +G++
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQE 163

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 7e-05
 Identities = 19/39 (48%), Positives = 21/39 (53%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           GT  Y SPE +K   Y    D WA GV+ Y LL G  PF
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 19/50 (38%), Positives = 28/50 (56%), Gaps = 2/50 (4%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH 304
           R  F GTP +++PEV+++  Y    DIW+ G+    L  G PP  + D H
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDMH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 18/43 (41%), Positives = 25/43 (58%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 8/117 (6%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGELFEDIVAREFYSEADAS 92
           Q    EA +  +L+H N+V+L   I EE    Y+V + +  G L + + +R   S     
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGD 102

Query: 93  HCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
             ++    + E++ +  +N  VHRDL   N+L++        K++DFGL  E    Q
Sbjct: 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASSTQ 156

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.0 bits (101), Expect = 9e-05
 Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 2/56 (3%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP +++PEV+ +  YG+  DIW+ G  ++ +  G PP    D  RL A    GA+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD--RLAAMFYIGAH 223

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 17/54 (31%), Positives = 33/54 (61%), Gaps = 1/54 (1%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPF 298
           A++ ++ S  + F G+P +++PEV+ ++  YG   DIW+ G  +  +  G PP+
Sbjct: 149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 16/46 (34%), Positives = 26/46 (56%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD 300
           R    GTP +++PEV+++  Y    DIW+ G+    +  G PP+ D
Sbjct: 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 14/43 (32%), Positives = 26/43 (60%), Gaps = 4/43 (9%)

Query: 183 YPSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHPW 221
           +   +   V P    +  +L+++ML  +P+KRI+A  AL+HP+
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 2/56 (3%)

Query: 258 FAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIK 311
           +  T  Y +PE+L  +  YG+ VDIWA G ++  +L G P F  D D  +LY  IK
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 12/26 (46%), Positives = 16/26 (61%)

Query: 264 YLSPEVLKKEPYGKPVDIWACGVILY 289
           Y +PEVL +  Y  PVD+W+ G I  
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFA 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 15/33 (45%), Positives = 23/33 (69%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
              P A +L+ +ML  +P KRI+A+EAL HP++
Sbjct: 259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 15/31 (48%), Positives = 24/31 (77%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           T EA +L+ +ML  +P KRI+A++AL HP++
Sbjct: 261 THEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 14/85 (16%)

Query: 231 IVHRQ--------ETVD--CLKKFNARR-KLKVSTRQGFAGTPGYLSPEVLKKEPYGKPV 279
           I+HR           VD  C+    A +  +      G AGT    +PEVL ++ Y    
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA 237

Query: 280 DIWACGVILYILLVGYPP--FWDED 302
           DIW+ G++L+ +L  YP   F D  
Sbjct: 238 DIWSAGIVLFEML-AYPSTIFEDPP 261

Length = 357

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)

Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 35  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG 93

Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 94  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 149

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 37/142 (26%), Positives = 67/142 (47%), Gaps = 12/142 (8%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++  KL H  +V+L+    +
Sbjct: 15  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMKLSHEKLVQLYGVCTK 70

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKP 117
           +   Y+V + ++ G L   +  RE       S  ++    + E + +  S   +HRDL  
Sbjct: 71  QRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAA 128

Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N L+  +     VK++DFGL+
Sbjct: 129 RNCLVDDQ---GCVKVSDFGLS 147

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 21/129 (16%)

Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +    +S   F  LE EA+I +KL+H  +V+L+  + EE   Y+V + ++ G L  
Sbjct: 34  AVKTLKPGTMSPESF--LE-EAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLL- 88

Query: 79  DIVAREFYSEADASHC--------IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
                +F  + +              Q+   + +      +HRDL+  N+L+     G  
Sbjct: 89  -----DFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLV 140

Query: 131 VKLADFGLA 139
            K+ADFGLA
Sbjct: 141 CKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 19/133 (14%)

Query: 18  FAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
            A K++  +    +  DF    +E +I  +L  PNI RL      +    ++ + +  G+
Sbjct: 49  VAVKVLRPDASDNAREDF---LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 76  LFEDIVAREFYSEADAS-----------HCIQQILESVNHCHSNGVVHRDLKPENLLLAS 124
           L + +      +   A            +   QI   + +  S   VHRDL   N L+  
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165

Query: 125 KAKGAAVKLADFG 137
                 +K+ADFG
Sbjct: 166 NYT---IKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 32/132 (24%), Positives = 58/132 (43%), Gaps = 20/132 (15%)

Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 63  TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  S  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVM 179

Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 180 KIADFGLARDIH 191

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 22/48 (45%), Positives = 28/48 (58%), Gaps = 8/48 (16%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPF 298
           V+TR        Y +PE+L  +  YGKPVD+WA G I+  LL G P F
Sbjct: 162 VATRW-------YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 21/71 (29%), Positives = 37/71 (52%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           R    G+  +++PEV+K+  Y +  DIW+ G ++  +L G  PF D  Q +   +I   A
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228

Query: 315 YDDEPKHKSAS 325
             + P + S+ 
Sbjct: 229 SPEIPSNISSE 239

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 19/60 (31%), Positives = 29/60 (48%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F    +L  S  + F GT  Y++PE ++   Y    DIW+ G+ L  L  G  P+  E+ 
Sbjct: 145 FGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 1/69 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           K +      GTP Y+SPE + +  Y    DIW+ G +LY +     PF+  D+  LY+  
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLC 217

Query: 311 KAGAYDDEP 319
           K     D P
Sbjct: 218 KKIEQCDYP 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 14/32 (43%), Positives = 23/32 (71%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            ++PE  +L+ +ML  +P+KRI+A  AL HP+
Sbjct: 262 DLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 18/137 (13%)

Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +     +AR  +   REA +   LQH +IV+ +    E +   +VF+ +  G+L +
Sbjct: 39  AVKTLKDASDNAR--KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96

Query: 79  DIVAR-------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK 125
            + A                 +++   H  QQI   + +  S   VHRDL   N L+   
Sbjct: 97  FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--- 153

Query: 126 AKGAAVKLADFGLAIEV 142
            +   VK+ DFG++ +V
Sbjct: 154 GENLLVKIGDFGMSRDV 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 17/53 (32%), Positives = 30/53 (56%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+ +  + +  D W+ GV+++ +L G  PF  +D+      I
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 2/63 (3%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDD 317
           GTP Y+SPE + +  Y    DIW+ G +LY +     PF+ +    + L  +I+   Y  
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227

Query: 318 EPK 320
            P 
Sbjct: 228 LPA 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 21/46 (45%), Positives = 26/46 (56%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           +  T  Y SPE+L   PYGK VD+W+ G IL  L  G P F  E +
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 11/25 (44%), Positives = 16/25 (64%)

Query: 197 NLINQMLTVNPSKRITASEALKHPW 221
            L+N +L  +P KR TA EAL+  +
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 6/66 (9%)

Query: 241 LKKFNARRKLKVSTRQG-----FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY 295
           L  F A ++++     G       GTP ++SPEV+  E YG+  D+W+    +  +L   
Sbjct: 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Query: 296 PPFWDE 301
           PP W E
Sbjct: 207 PP-WAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 6/75 (8%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED------QHRLYAQIKAG 313
           GTP Y++PE L   P  +  DI+A GVILY +L    P+  +       +  + + I+  
Sbjct: 193 GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVA 252

Query: 314 AYDDEPKHKSASVVK 328
            Y + P   S   +K
Sbjct: 253 PYREIPPFLSQIAMK 267

Length = 932

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 51/227 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSI 58
           G F  V R + K  G +  A  I T K    + Q+ +   EA I  +  H NI+RL   +
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------ILESVNHCHSNGVV 111
            +     ++ + +  G L       ++  + D      Q       I   + +      V
Sbjct: 76  TKFKPAMIITEYMENGAL------DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------W---------- 149
           HRDL   N+L+ S  +    K++DFGL+  ++ + +             W          
Sbjct: 130 HRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 150 ---------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 186
                    FG++++ ++  G  P+WD   H +   I  G +  P+P
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAP 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)

Query: 34  QKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGEL--FEDIVAREFYSEAD 90
           + L  E +I   L  H NIV L  +        ++ +    G+L  F       F +  D
Sbjct: 83  EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142

Query: 91  ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                 Q+ + +    S   +HRDL   N+LL     G  VK+ DFGLA
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---GKIVKICDFGLA 188

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 22/160 (13%)

Query: 1   GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL-- 54
           GAF  V + +    G    +  A KI+N       + + ++ EA I   + HP++VRL  
Sbjct: 18  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLVRLLG 76

Query: 55  ---HDSIQEENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNG 109
                +IQ      LV  L+  G L + +   +    S+   + C+Q I + + +     
Sbjct: 77  VCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ-IAKGMMYLEERR 129

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
           +VHRDL   N+L+ S      VK+ DFGLA  ++G+++ +
Sbjct: 130 LVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEY 166

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 1/46 (2%)

Query: 254 TRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPF 298
            R+ F GTP +++PEV++    Y    DIW+ G+    L  G  P+
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 19/42 (45%), Positives = 32/42 (76%), Gaps = 2/42 (4%)

Query: 183 YPS-PEWDTV-TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           +PS  E D + T +A++L+++ML ++P KRI+  EAL+HP+I
Sbjct: 277 FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 27/151 (17%)

Query: 10  VQKATGLEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLV 67
           V+K   L  A KI+  +  K +  DF K   E +I  +L+ PNI+RL     +E+   ++
Sbjct: 41  VRKGRPLLVAVKILRPDANKNARNDFLK---EVKILSRLKDPNIIRLLGVCVDEDPLCMI 97

Query: 68  FDLVTGGELFEDIVAREFYSEADAS-------------------HCIQQILESVNHCHSN 108
            + +  G+L + + +     + +                     H   QI   + +  S 
Sbjct: 98  TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             VHRDL   N L+        +K+ADFG++
Sbjct: 158 NFVHRDLATRNCLVGEN---LTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 43/195 (22%), Positives = 75/195 (38%), Gaps = 52/195 (26%)

Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+ L   + +     +V + +  G L        F  + D
Sbjct: 50  RDFL---SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHD 100

Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
               + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 101 GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---LVCKVSDFGLSRVLE 157

Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++++ ++  G  P+W+     
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Query: 172 LYAQIKAGAYDYPSP 186
           +   I+ G Y  P+P
Sbjct: 218 VIKAIEEG-YRLPAP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 32/132 (24%), Positives = 58/132 (43%), Gaps = 20/132 (15%)

Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 60  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVM 176

Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA +V 
Sbjct: 177 KIADFGLARDVN 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.6 bits (96), Expect = 6e-04
 Identities = 20/48 (41%), Positives = 24/48 (50%), Gaps = 8/48 (16%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPF 298
           VSTR        Y +PE+L +   Y  PVDIWA G I+  L    P F
Sbjct: 159 VSTRW-------YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 6/115 (5%)

Query: 36  LEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           L++E  I R L H NIV+      E+  N   L+ + +  G L E +   +         
Sbjct: 53  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112

Query: 94  CIQ-QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
               QI + +++  S   VHRDL   N+L+ S+ +   VK+ DFGL   ++ +++
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKE 164

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 26/130 (20%), Positives = 51/130 (39%), Gaps = 13/130 (10%)

Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIV-RLHDSIQEENYHYLVFD 69
                ++  KI      S       ERE  I + L +    V ++  S + + + YL+ +
Sbjct: 18  GTKDEDYVLKINP----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73

Query: 70  LVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGA 129
            + G  L E         + D +  + ++L  ++      + H DL P N+L+     G 
Sbjct: 74  WIEGETLDE----VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGK 126

Query: 130 AVKLADFGLA 139
            + + D+  A
Sbjct: 127 ILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 22/69 (31%), Positives = 33/69 (47%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP Y+SPE+   +PY    D+WA G  +Y +      F  +D + L  +I  G     P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP 223

Query: 320 KHKSASVVK 328
           K  S  + +
Sbjct: 224 KDYSPELGE 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 17/51 (33%), Positives = 26/51 (50%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           K +      GTP Y+SPE + +  Y    DIW+ G +LY +     PF+ +
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 2/64 (3%)

Query: 258 FAGTPGYLSPEVLKKEPYG--KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F GT  Y++P++++    G  K VD W+ GV++Y LL G  PF  + +    A+I     
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225

Query: 316 DDEP 319
             EP
Sbjct: 226 KSEP 229

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 10/105 (9%)

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            GVI+Y +L+GYPPF  E     Y ++         P    ++ +AK+LI +  T +   
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSEN 280

Query: 210 RITAS---EALKHP------WICQRERVASIVHRQETVDCLKKFN 245
           RI ++   E   HP      W   RER A+I    +++D    F+
Sbjct: 281 RIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFD 325

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 26/70 (37%), Positives = 35/70 (50%), Gaps = 8/70 (11%)

Query: 158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-WDTVTPE----AKNLINQMLTVNPSKRIT 212
           L+G PP   ED       +  GA+    P    +V PE       L+ +MLT NP KRI+
Sbjct: 222 LIGLPP---EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278

Query: 213 ASEALKHPWI 222
           A  AL+HP+ 
Sbjct: 279 AFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 4/119 (3%)

Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLV 71
           K TG     + IN +  +      L+ E  + +   HPNIV    +   +N  ++V   +
Sbjct: 22  KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 72  TGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK 127
             G   +D++   F    SE   ++ +Q +L+++++ H  G VHR +K  ++L++   K
Sbjct: 82  AYGSA-KDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 139

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 19/113 (16%)

Query: 47  QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEAD 90
           +H NI+ L     +E   Y++ +    G L E + AR                E  S  D
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 91  ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
              C  Q+   + +  S   +HRDL   N+L+        +K+ADFGLA  V 
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED---NVMKIADFGLARGVH 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 11/51 (21%)

Query: 182 DYPS--PEW-----DTVTP----EAKNLINQMLTVNPSKRITASEALKHPW 221
           DY    P+W       V P    + ++L++QML  +P+KRI+A  AL HP+
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 14/42 (33%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 184 PSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHPW 221
            +     V P      ++L+  +L  NP +RI+A EAL+HP+
Sbjct: 242 ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 20/51 (39%), Positives = 30/51 (58%), Gaps = 11/51 (21%)

Query: 182 DYPS--PEWD---------TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
           DY S  P+W          T+ P   +L+++ML ++PSKRITA  AL+H +
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 12/25 (48%), Positives = 19/25 (76%)

Query: 197 NLINQMLTVNPSKRITASEALKHPW 221
           +L+  +L +NP +RI+A EALKH +
Sbjct: 291 DLLQSLLKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 23/78 (29%), Positives = 33/78 (42%), Gaps = 12/78 (15%)

Query: 151 GVILYILLVGYPPFWD----EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           GVILY +LVG PPF      E Q +    +         P    ++ EA +LI ++    
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLK----VINWETTLHIPSQAKLSREASDLILRLCC-G 285

Query: 207 PSKRI---TASEALKHPW 221
              R+    A E   HP+
Sbjct: 286 AEDRLGKNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 20/130 (15%)

Query: 31  RDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR------ 83
           +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR      
Sbjct: 59  KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118

Query: 84  ----------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL 133
                     E  +  D   C  Q+   + +  S   +HRDL   N+L+        +K+
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED---NVMKI 175

Query: 134 ADFGLAIEVQ 143
           ADFGLA +V 
Sbjct: 176 ADFGLARDVH 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 10/116 (8%)

Query: 12  KATGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDL 70
              G++F  K IN    + + +   +        KLQHPNIV+L    + E   YL+ + 
Sbjct: 712 IKNGMQFVVKEINDVNSIPSSEIADM-------GKLQHPNIVKLIGLCRSEKGAYLIHEY 764

Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCH-SNGVVHRDLKPENLLLASK 125
           + G  L E +    +      +  I + L  + HC  S  VV  +L PE +++  K
Sbjct: 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFL-HCRCSPAVVVGNLSPEKIIIDGK 819

Length = 968

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 17/119 (14%)

Query: 32  DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADA 91
           DF K   E +I  +L+ PNI+RL       +   ++ + +  G+L + +   E    A+ 
Sbjct: 65  DFLK---EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 92  SHCI-----------QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +  +            QI   + +  S   VHRDL   N L+    K   +K+ADFG++
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 16/31 (51%), Positives = 22/31 (70%), Gaps = 3/31 (9%)

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           GV+HRD+KP N+LL +      VKL DFG++
Sbjct: 135 GVIHRDVKPSNILLDASGN---VKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 8/103 (7%)

Query: 44  RKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----I 98
           R+L HPN+++      E   + LV +    G+L   + +        A   + Q     +
Sbjct: 50  RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109

Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
              +   H    +H DL   N  L +     +VK+ D+GLA+E
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLALE 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 16  GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 73

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V +E      A    ++IL  V+     G         +
Sbjct: 74  SDGEISICMEHMDGGSL--DQVLKE------AKRIPEEILGKVSIAVLRGLAYLREKHQI 125

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 126 MHRDVKPSNILVNSRGE---IKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 38.6 bits (91), Expect = 0.003
 Identities = 16/46 (34%), Positives = 24/46 (52%), Gaps = 2/46 (4%)

Query: 264 YLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFW-DEDQHRLY 307
           Y +PE+L     Y   VDIW+ G I   ++ G P F  D +  +L+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 5/57 (8%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPP 297
           A+ K  +  R  F GTP +++PEV+     K  PY    DIW+ G+ L  L    PP
Sbjct: 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.0 bits (90), Expect = 0.003
 Identities = 23/57 (40%), Positives = 31/57 (54%), Gaps = 3/57 (5%)

Query: 260 GTPGYLSPEVLKKE--PYGKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAG 313
           GTP Y SPE+L  E   Y    D+WA G I+Y L  G  PF   +   +L +++K G
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 14/29 (48%), Positives = 26/29 (89%)

Query: 194 EAKNLINQMLTVNPSKRITASEALKHPWI 222
           +A++L+++ML ++P+KRI+  EAL+HP+I
Sbjct: 286 QARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 16  GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 73

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 74  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 125

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 126 MHRDVKPSNILVNSRGE---IKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 20/71 (28%), Positives = 35/71 (49%), Gaps = 5/71 (7%)

Query: 245 NARRKLKVSTRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPFW 299
           +A+    +  R  F GTP +++PEV+     K  PY    D+W+ G+ L  +    PP  
Sbjct: 150 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209

Query: 300 DEDQHRLYAQI 310
           + +  R+  +I
Sbjct: 210 ELNPMRVLLKI 220

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 16/51 (31%), Positives = 25/51 (49%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           S    F GT  Y+SPE ++   Y    D+W+ G+ +  L +G  PF   + 
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 22/140 (15%)

Query: 19  AAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A K +     SAR DFQ   REA +   LQH +IVR +    E     +VF+ +  G+L 
Sbjct: 39  AVKALKEASESARQDFQ---REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 78  EDIVAR----EFYSEADASHCIQ-----------QILESVNHCHSNGVVHRDLKPENLLL 122
             + +     +  +  +     Q           QI   + +  S   VHRDL   N L+
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155

Query: 123 ASKAKGAAVKLADFGLAIEV 142
               +G  VK+ DFG++ ++
Sbjct: 156 ---GQGLVVKIGDFGMSRDI 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	328
KOG0033|consensus	355		100.0
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0605|consensus	550		100.0
KOG0616|consensus	355		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0592|consensus	604		100.0
KOG0591|consensus	375		100.0
KOG0581|consensus	364		100.0
KOG0583|consensus	370		100.0
KOG0588|consensus	786		100.0
KOG0611|consensus	668		100.0
KOG0694|consensus	694		100.0
KOG0597|consensus	808		100.0
KOG0610|consensus	459		100.0
KOG0593|consensus	396		100.0
KOG0032|consensus	382		100.0
KOG0585|consensus	576		100.0
KOG0600|consensus	560		100.0
KOG0192|consensus	362		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0661|consensus	538		100.0
KOG0580|consensus	281		100.0
KOG0198|consensus	313		100.0
KOG0690|consensus	516		100.0
KOG0663|consensus	419		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0599|consensus	411		100.0
KOG0659|consensus	318		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0696|consensus	683		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0578|consensus	550		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0586|consensus	596		100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0660|consensus	359		100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0667|consensus	586		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594|consensus	323		100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0608|consensus	1034		100.0
KOG0607|consensus	463		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0612|consensus	1317		100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0197|consensus	468		100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG4236|consensus	888		100.0
KOG0604|consensus	400		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582|consensus	516		100.0
KOG4250|consensus	732		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0614|consensus	732		100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0658|consensus	364		100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4721|consensus	904		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0986|consensus	591		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4645|consensus	1509		100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0193|consensus	678		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0584|consensus	632		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989|consensus	738		100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0695|consensus	593		100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0574|consensus	502		100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG1187|consensus	361		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4279|consensus	1226		100.0
KOG0194|consensus	474		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0579|consensus	1187		100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0577|consensus	948		100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1026|consensus	774		100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0983|consensus	391		100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1035|consensus	1351		100.0
KOG1095|consensus	1025		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596|consensus	677		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0662|consensus	292		100.0
KOG0196|consensus	996		100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1151|consensus	775		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0984|consensus	282		100.0
KOG0666|consensus	438		100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG1006|consensus	361		100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0603|consensus	612		100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG1152|consensus	772		100.0
KOG0664|consensus	449		100.0
KOG0671|consensus	415		100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0199|consensus	1039		100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0669|consensus	376		100.0
KOG4257|consensus	974		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0576|consensus	829		100.0
KOG0587|consensus	953		100.0
KOG2345|consensus	302		100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG0665|consensus	369		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4278|consensus	1157		100.0
KOG0668|consensus	338		100.0
KOG1094|consensus	807		99.98
KOG0200|consensus	609		99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0603|consensus	612		99.97
KOG0670|consensus	752		99.97
KOG1167|consensus	418		99.97
KOG1027|consensus	903		99.97
KOG1025|consensus	1177		99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG3653|consensus	534		99.96
KOG1290|consensus	590		99.96
KOG2052|consensus	513		99.96
KOG1345|consensus	378		99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1024|consensus	563		99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
KOG1164|consensus	322		99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
KOG0606|consensus	1205		99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG0590|consensus	601		99.9
PRK10345	210	hypothetical protein; Provisional	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1163|consensus	341		99.89
KOG1165|consensus	449		99.87
smart00090	237	RIO RIO-like kinase.	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.79
KOG1166|consensus	974		99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
KOG0033|consensus	355		99.75
KOG0590|consensus	601		99.72
KOG1033|consensus	516		99.72
KOG0195|consensus	448		99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG4158|consensus	598		99.69
KOG1240|consensus	1431		99.69
KOG0606|consensus	1205		99.65
KOG1023|consensus	484		99.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG0601|consensus	524		99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG0615|consensus	475		99.42
KOG0599|consensus	411		99.36
KOG1243|consensus	690		99.35
KOG3087|consensus	229		99.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
KOG3741|consensus	655		99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
KOG0032|consensus	382		99.14
KOG0604|consensus	400		99.14
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.1
KOG0575|consensus	592		99.09
KOG0607|consensus	463		99.08
KOG0601|consensus	524		99.07
KOG1266|consensus	458		99.05
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.03
KOG0588|consensus	786		99.01
KOG0610|consensus	459		98.99
KOG0592|consensus	604		98.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	98.94
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	98.94
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	98.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	98.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	98.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	98.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	98.86
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	98.85
KOG0605|consensus	550		98.85
KOG0577|consensus	948		98.83
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	98.82
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.81
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.81
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	98.8
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	98.8
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	98.79
KOG0578|consensus	550		98.79
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	98.79
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	98.78
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	98.77
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	98.77
KOG0581|consensus	364		98.77
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	98.76
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	98.75
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	98.74
KOG0585|consensus	576		98.74
KOG0616|consensus	355		98.73
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	98.71
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	98.71
KOG4717|consensus	864		98.69
KOG0583|consensus	370		98.69
KOG2345|consensus	302		98.68
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	98.68
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	98.68
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	98.67
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	98.66
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	98.66
PTZ00284	467	protein kinase; Provisional	98.66
KOG0660|consensus	359		98.66

>KOG0033|consensus

Probab=100.00  E-value=3.2e-61  Score=395.43  Aligned_cols=259  Identities=87%  Similarity=1.344  Sum_probs=245.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.|++|++|.+..||+.||+|+|+..+++..+.+.+.+|++|.+.|+|||||+|.+.+......|+|+|++.|++|...+
T Consensus        22 G~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eI  101 (355)
T KOG0033|consen   22 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI  101 (355)
T ss_pred             CchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHH
Confidence            88999999999999999999999999998889999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC--------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------  146 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~--------------  146 (328)
                      ..+..++|..+..+++||+.+|.|+|.+||||||+||+|+|+.++.+...+||+|||+|.++++..              
T Consensus       102 V~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  102 VAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSP  181 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCH
Confidence            888899999999999999999999999999999999999999999888899999999998776321              


Q ss_pred             ------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         147 ------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       147 ------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                                  +.| .|+++|.++.|.+||+++++..++++|..+.+++|++.|+++++++++|+.+||..||.+|+|+
T Consensus       182 Evvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta  261 (355)
T KOG0033|consen  182 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITA  261 (355)
T ss_pred             HHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccH
Confidence                        123 6999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhcc
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFA  259 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (328)
                      .|+|+|||++++++.++..+++++++++++||++|+++.+...+..
T Consensus       262 ~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~  307 (355)
T KOG0033|consen  262 DEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVI  307 (355)
T ss_pred             HHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999876655433

>KOG0595|consensus

Probab=100.00  E-value=1.1e-58  Score=405.44  Aligned_cols=215  Identities=39%  Similarity=0.632  Sum_probs=199.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.++..||||.|.+.++..+..+.+..|+++|+.++|||||++++++++++.+|||||||.||||.+++
T Consensus        21 GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi  100 (429)
T KOG0595|consen   21 GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYI  100 (429)
T ss_pred             cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHH
Confidence            89999999999999999999999999988888899999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCC---CcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKG---AAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~---~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ..++.++|..++.++.||+.||++||+++||||||||.||||+.....   -.+||+|||+|+.++..            
T Consensus       101 ~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~------------  168 (429)
T KOG0595|consen  101 RRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG------------  168 (429)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch------------
Confidence            999999999999999999999999999999999999999999876232   57999999999765321            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (429)
T KOG0595|consen  169 --------------------------------------------------------------------------------  168 (429)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ....+.+|||-|||||++....|+.|+|+||+|+|||||++|++||.++++.+|+-.|++|...+
T Consensus       169 ---------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~  233 (429)
T KOG0595|consen  169 ---------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV  233 (429)
T ss_pred             ---------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence                           12234689999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCcc
Q psy2131         318 EPKHK  322 (328)
Q Consensus       318 ~~~~~  322 (328)
                      |..+-
T Consensus       234 ~~~~~  238 (429)
T KOG0595|consen  234 PVLPA  238 (429)
T ss_pred             Cchhh
Confidence            77654

>KOG0598|consensus

Probab=100.00  E-value=4.6e-58  Score=397.78  Aligned_cols=215  Identities=38%  Similarity=0.656  Sum_probs=195.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+|+.++.+.|++.||+|++++...... +.+....|..||.+++||+||+++..|++...+|+|+||+.||+|+..
T Consensus        36 G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~h  115 (357)
T KOG0598|consen   36 GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYH  115 (357)
T ss_pred             cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHH
Confidence            8999999999999999999999998776543 677889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      |.+.+.|+|..++.|+.+|+.||.|||++||||||||||||||+.++   .++|+|||||+..-...             
T Consensus       116 L~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G---Hi~LtDFgL~k~~~~~~-------------  179 (357)
T KOG0598|consen  116 LQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG---HIKLTDFGLCKEDLKDG-------------  179 (357)
T ss_pred             HHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC---cEEEeccccchhcccCC-------------
Confidence            99999999999999999999999999999999999999999998665   49999999986532111             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (357)
T KOG0598|consen  180 --------------------------------------------------------------------------------  179 (357)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                   ....+++||+.|||||++.+.+|+.++|||||||+|||||+|.+||.+++......+|.+++...+|
T Consensus       180 -------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p  246 (357)
T KOG0598|consen  180 -------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP  246 (357)
T ss_pred             -------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC
Confidence                         1123478999999999999999999999999999999999999999999999999999999976777


Q ss_pred             Ccccc
Q psy2131         320 KHKSA  324 (328)
Q Consensus       320 ~~~~~  324 (328)
                      ...+.
T Consensus       247 ~~ls~  251 (357)
T KOG0598|consen  247 GYLSE  251 (357)
T ss_pred             ccCCH
Confidence            65543

>KOG0605|consensus

Probab=100.00  E-value=6.6e-56  Score=399.45  Aligned_cols=258  Identities=29%  Similarity=0.534  Sum_probs=200.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+.+.||..||+|++++..+ ...++..+..|-.||...++|+||+||-+|++.+++||||||++|||+..+
T Consensus       152 GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTL  231 (550)
T KOG0605|consen  152 GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTL  231 (550)
T ss_pred             ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHH
Confidence            8999999999999999999999987654 345667889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      |...+.++++.+++|+.+++.|+..||+.|+|||||||+|+||+..|+   +||+|||||..+......           
T Consensus       232 L~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~~~~-----------  297 (550)
T KOG0605|consen  232 LMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKKHRI-----------  297 (550)
T ss_pred             HHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhhhhh-----------
Confidence            999999999999999999999999999999999999999999987654   999999998544221110           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHH-HhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN-QMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~-~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                 +.+.                    ....+. .+-...|..+++.    +.++              ...
T Consensus       298 -----------~~~~--------------------~~~~~~~~~~~~~~~~~~~~----~~~~--------------~~~  328 (550)
T KOG0605|consen  298 -----------ESYR--------------------LDEQMQINLSEAKPSDFPKF----NTPR--------------STM  328 (550)
T ss_pred             -----------hhhc--------------------chhhhhhhhccCCCcccccc----cccc--------------chh
Confidence                       0000                    000000 0011133333322    0000              000


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc--CC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YD  316 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~  316 (328)
                      +....+..-++.+.....+++|||.|||||++.+.+|+..||+|||||||||||.|.|||.++++.+++.+|....  +.
T Consensus       329 ~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~  408 (550)
T KOG0605|consen  329 SRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK  408 (550)
T ss_pred             hHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc
Confidence            1111111222223334556899999999999999999999999999999999999999999999999999999988  54


Q ss_pred             CCCCc
Q psy2131         317 DEPKH  321 (328)
Q Consensus       317 ~~~~~  321 (328)
                      .|+..
T Consensus       409 fP~~~  413 (550)
T KOG0605|consen  409 FPEEV  413 (550)
T ss_pred             CCCcC
Confidence            44443

>KOG0616|consensus

Probab=100.00  E-value=1.1e-55  Score=371.66  Aligned_cols=208  Identities=34%  Similarity=0.661  Sum_probs=193.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|.+++++.+|..||+|+++++.. ..++.+...+|..+|+.+.||+++++++.|.+.+.+|+||||++||.|+.+
T Consensus        55 GSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~  134 (355)
T KOG0616|consen   55 GSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSY  134 (355)
T ss_pred             CccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHH
Confidence            8999999999999999999999987654 345667788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +++.++|++..+++|++||+.||+|||+++|++||+||||||++.+|   .+||+|||+|+.+.+.              
T Consensus       135 Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G---~iKitDFGFAK~v~~r--------------  197 (355)
T KOG0616|consen  135 LRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG---HIKITDFGFAKRVSGR--------------  197 (355)
T ss_pred             HHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC---cEEEEeccceEEecCc--------------
Confidence            99999999999999999999999999999999999999999998654   5999999999876432              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (355)
T KOG0616|consen  198 --------------------------------------------------------------------------------  197 (355)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     ..+.+|||.|+|||++..++|+.++|||||||++|||+.|.+||.+.++..++++|+.|.+..|+
T Consensus       198 ---------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~  262 (355)
T KOG0616|consen  198 ---------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS  262 (355)
T ss_pred             ---------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc
Confidence                           22468999999999999999999999999999999999999999999999999999999998876


Q ss_pred             C
Q psy2131         320 K  320 (328)
Q Consensus       320 ~  320 (328)
                      .
T Consensus       263 ~  263 (355)
T KOG0616|consen  263 Y  263 (355)
T ss_pred             c
Confidence            5

>KOG0575|consensus

Probab=100.00  E-value=5.1e-55  Score=399.37  Aligned_cols=214  Identities=36%  Similarity=0.600  Sum_probs=194.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |||+.||++++..+|+.||+|+|.+..+ .....+++.+||+|.++|+|||||++|++|++.+++|||.|+|..|+|.++
T Consensus        29 GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el  108 (592)
T KOG0575|consen   29 GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMEL  108 (592)
T ss_pred             CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHH
Confidence            8999999999999999999999987544 344567899999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.+++.++|.+++.++.||+.||.|||+++|||||||..|++|+++   ..|||+|||||..+....             
T Consensus       109 ~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~---~~VKIgDFGLAt~le~~~-------------  172 (592)
T KOG0575|consen  109 LKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN---MNVKIGDFGLATQLEYDG-------------  172 (592)
T ss_pred             HHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc---CcEEecccceeeeecCcc-------------
Confidence            9999999999999999999999999999999999999999999754   459999999997653211             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (592)
T KOG0575|consen  173 --------------------------------------------------------------------------------  172 (592)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                   ..+.+.+|||.|+|||++...+++..+||||+|||||.||+|+|||...+-.+++.+|+...|..| 
T Consensus       173 -------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-  238 (592)
T KOG0575|consen  173 -------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-  238 (592)
T ss_pred             -------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-
Confidence                         123457899999999999999999999999999999999999999999999999999999999654 


Q ss_pred             Ccccc
Q psy2131         320 KHKSA  324 (328)
Q Consensus       320 ~~~~~  324 (328)
                      .+.|+
T Consensus       239 ~~ls~  243 (592)
T KOG0575|consen  239 SHLSA  243 (592)
T ss_pred             cccCH
Confidence            46664

>KOG0615|consensus

Probab=100.00  E-value=3.7e-55  Score=383.03  Aligned_cols=225  Identities=40%  Similarity=0.731  Sum_probs=204.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.|.+|..+.||+.||||+|++.+...     .....+.+|++||++|+|||||+++++|+..+..|+||||++||+
T Consensus       183 Gafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGe  262 (475)
T KOG0615|consen  183 GAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGE  262 (475)
T ss_pred             CceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCcc
Confidence            899999999999999999999998765432     123346799999999999999999999999999999999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-----------
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-----------  144 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-----------  144 (328)
                      |++++..++.+.|...+.+++|++.|+.|||++||+||||||+|||+..+.+...+||+|||+|+....           
T Consensus       263 Lfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTp  342 (475)
T KOG0615|consen  263 LFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTP  342 (475)
T ss_pred             HHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCc
Confidence            999999999999999999999999999999999999999999999999887788899999999975421           


Q ss_pred             ------------------CCcch-HHHHHHHHHhCCCCCCCCcHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcc
Q psy2131         145 ------------------EQQAW-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       145 ------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~  204 (328)
                                        ..+.| +||++|.+++|.+||.+..+.. +.++|..+.|.+-++.|..+|+++.+||.+||.
T Consensus       343 sYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~  422 (475)
T KOG0615|consen  343 SYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLV  422 (475)
T ss_pred             cccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhE
Confidence                              11334 8999999999999999887665 999999999999999999999999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCc
Q psy2131         205 VNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .||++|||++|+|+|||+...
T Consensus       423 VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  423 VDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             eCcccCcCHHHHhcChhhhcc
Confidence            999999999999999999643

>KOG0592|consensus

Probab=100.00  E-value=4.9e-53  Score=380.93  Aligned_cols=224  Identities=34%  Similarity=0.587  Sum_probs=194.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+|++|++|+++.+++.||||++.+..+..+ .+..+.+|-.+|.+| +||.||+||..|+++..+|+|+||+++|+|++
T Consensus        84 GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~  163 (604)
T KOG0592|consen   84 GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLD  163 (604)
T ss_pred             ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHH
Confidence            8999999999999999999999987765433 345677899999999 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +|.+.+.|++..+++|+.||+.||+|||++||||||||||||||+.+   +.+||+|||.|+.+.+.....         
T Consensus       164 ~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d---mhikITDFGsAK~l~~~~~~~---------  231 (604)
T KOG0592|consen  164 LIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD---GHIKITDFGSAKILSPSQKSQ---------  231 (604)
T ss_pred             HHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC---CcEEEeeccccccCChhhccc---------
Confidence            99999999999999999999999999999999999999999999865   459999999997764432110         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                 .|+....              
T Consensus       232 -----------------------------------------------------------~~~~~~~--------------  238 (604)
T KOG0592|consen  232 -----------------------------------------------------------ENPVDPN--------------  238 (604)
T ss_pred             -----------------------------------------------------------cCccCcc--------------
Confidence                                                                       0000000              


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                 -..+.+.+++||..|.+||+|....-+..+|+|+||||||+|+.|++||.+.++.-+|++|..-.|.+|
T Consensus       239 -----------~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  239 -----------QASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             -----------cccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence                       000114579999999999999999999999999999999999999999999999999999999999888


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |-
T Consensus       308 ~~  309 (604)
T KOG0592|consen  308 EG  309 (604)
T ss_pred             CC
Confidence            74

>KOG0591|consensus

Probab=100.00  E-value=2.8e-53  Score=354.85  Aligned_cols=210  Identities=31%  Similarity=0.527  Sum_probs=188.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEE-EEEeCCE-EEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD-SIQEENY-HYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~-~~~~~~~-~~lv~E~~~gg~L~~   78 (328)
                      |+||+||++.+..+|..+|.|.|+-..++.+..+.+..|+.+|++|+|||||++|+ .|.+++. ++||||||.+|||.+
T Consensus        30 GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsq  109 (375)
T KOG0591|consen   30 GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQ  109 (375)
T ss_pred             CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHH
Confidence            89999999999999999999999988888888889999999999999999999998 5655555 999999999999988


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          79 DIVA----REFYSEADASHCIQQILESVNHCHS--NG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        79 ~l~~----~~~~~~~~~~~~~~qll~~L~ylH~--~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      .++.    ++.++|..++.++.|++.||..+|+  .+  |+||||||.||+|+.   ++.+||+||||++.+....    
T Consensus       110 mIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~---~gvvKLGDfGL~r~l~s~~----  182 (375)
T KOG0591|consen  110 MIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA---NGVVKLGDFGLGRFLSSKT----  182 (375)
T ss_pred             HHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC---CCceeeccchhHhHhcchh----
Confidence            8753    4579999999999999999999999  45  999999999999975   4579999999986543211    


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       183 --------------------------------------------------------------------------------  182 (375)
T KOG0591|consen  183 --------------------------------------------------------------------------------  182 (375)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                            +-..+.+|||.||+||.+.+.+|+.+|||||+||++|||..=++||.|.+..+|..+|
T Consensus       183 ----------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI  240 (375)
T KOG0591|consen  183 ----------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI  240 (375)
T ss_pred             ----------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence                                  1234578999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCC
Q psy2131         311 KAGAYDDEP  319 (328)
Q Consensus       311 ~~~~~~~~~  319 (328)
                      .+|.|-+-|
T Consensus       241 ~qgd~~~~p  249 (375)
T KOG0591|consen  241 EQGDYPPLP  249 (375)
T ss_pred             HcCCCCCCc
Confidence            999986666

>KOG0581|consensus

Probab=100.00  E-value=3.4e-51  Score=355.18  Aligned_cols=208  Identities=28%  Similarity=0.418  Sum_probs=185.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-YHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-~~~lv~E~~~gg~L~~~   79 (328)
                      |+.|+||+|+|+.|++.||+|+|.. .......+++.+|+++++.++||+||++|++|.... .++|+||||+||+|.+.
T Consensus        90 G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~  168 (364)
T KOG0581|consen   90 GNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDI  168 (364)
T ss_pred             CCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHH
Confidence            7889999999999999999999943 345566788999999999999999999999999998 49999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +..-+.++|.....++.+|++||.|||+ .+||||||||+|||+++++   .|||||||.+..+..              
T Consensus       169 ~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG---eVKicDFGVS~~lvn--------------  231 (364)
T KOG0581|consen  169 LKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG---EVKICDFGVSGILVN--------------  231 (364)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---CEEeccccccHHhhh--------------
Confidence            8888899999999999999999999996 9999999999999998765   599999998754311              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       232 --------------------------------------------------------------------------------  231 (364)
T KOG0581|consen  232 --------------------------------------------------------------------------------  231 (364)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-----cHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~  313 (328)
                                    +...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||...     +..+|+..|+-+
T Consensus       232 --------------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  232 --------------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE  297 (364)
T ss_pred             --------------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence                          1244688999999999999999999999999999999999999999986     899999999987


Q ss_pred             cCCCCCC
Q psy2131         314 AYDDEPK  320 (328)
Q Consensus       314 ~~~~~~~  320 (328)
                      .--..|.
T Consensus       298 ppP~lP~  304 (364)
T KOG0581|consen  298 PPPRLPE  304 (364)
T ss_pred             CCCCCCc
Confidence            6544444

>KOG0583|consensus

Probab=100.00  E-value=5.2e-51  Score=371.86  Aligned_cols=212  Identities=41%  Similarity=0.728  Sum_probs=188.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH---HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~---~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+|+.|.+..+|+.||+|+++.+....   ...+.+.+|+.+++.++ ||||+++++++.....+|+|||||.||+|
T Consensus        28 GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL  107 (370)
T KOG0583|consen   28 GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDL  107 (370)
T ss_pred             CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccH
Confidence            899999999999999999999888763321   23456779999999999 99999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ++++...+++.|.+++.+++|++.|++|||++||+||||||||||++.+.  +.+||+|||++.......          
T Consensus       108 ~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~~~~~----------  175 (370)
T KOG0583|consen  108 FDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAISPGED----------  175 (370)
T ss_pred             HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEeccccccccCCCC----------
Confidence            99999999999999999999999999999999999999999999998652  569999999985431000          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (370)
T KOG0583|consen  176 --------------------------------------------------------------------------------  175 (370)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-C-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-Y-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ....+++|||.|+|||++.+.. | +.++||||+||+||.|++|+.||.+.+...++.+|.+|.
T Consensus       176 ----------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~  239 (370)
T KOG0583|consen  176 ----------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE  239 (370)
T ss_pred             ----------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence                            0123468999999999999988 9 799999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q psy2131         315 YDDEPK  320 (328)
Q Consensus       315 ~~~~~~  320 (328)
                      |..|..
T Consensus       240 ~~~p~~  245 (370)
T KOG0583|consen  240 FKIPSY  245 (370)
T ss_pred             ccCCCC
Confidence            977654

>KOG0588|consensus

Probab=100.00  E-value=1.8e-51  Score=378.02  Aligned_cols=208  Identities=39%  Similarity=0.694  Sum_probs=190.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccC-CCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~-~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+-|.|.+|++..||+..|||+|.+. .++......+++|+-||+.+.||||+++|++|++...+|+|.||++||.|+++
T Consensus        23 Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdy  102 (786)
T KOG0588|consen   23 GSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDY  102 (786)
T ss_pred             CCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHH
Confidence            77899999999999999999999876 55666667899999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +..++.+++.++.++++||+.|+.|||..+|+|||+||||+||+.+++   |||+|||+|..-.+.              
T Consensus       103 lv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~g--------------  165 (786)
T KOG0588|consen  103 LVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPG--------------  165 (786)
T ss_pred             HHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCC--------------
Confidence            999999999999999999999999999999999999999999987643   999999998432110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (786)
T KOG0588|consen  166 --------------------------------------------------------------------------------  165 (786)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   +.-.+.+|+|.|+|||++.|.+| |.++||||+|||||.||||+.||.|.|-..|+.||++|.|.-|
T Consensus       166 -------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP  232 (786)
T KOG0588|consen  166 -------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP  232 (786)
T ss_pred             -------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence                         11235689999999999999999 8999999999999999999999999999999999999999776

>KOG0611|consensus

Probab=100.00  E-value=5.5e-51  Score=356.16  Aligned_cols=215  Identities=38%  Similarity=0.659  Sum_probs=196.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|.+|+....|+.||||.|++++.. +.+...+.||++||+.|+||||+++|++|++.+.+.|||||..+|+|+++
T Consensus        64 GTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDY  143 (668)
T KOG0611|consen   64 GTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDY  143 (668)
T ss_pred             CcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHH
Confidence            89999999999999999999999988765 45677899999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +..++.++|.+++.+++||++|+.|||.++++|||||.+|||++.++   .+||+||||+-.....              
T Consensus       144 iSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~---NiKIADFGLSNly~~~--------------  206 (668)
T KOG0611|consen  144 ISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN---NIKIADFGLSNLYADK--------------  206 (668)
T ss_pred             HHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC---Ceeeeccchhhhhccc--------------
Confidence            99999999999999999999999999999999999999999998654   4999999997432111              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       207 --------------------------------------------------------------------------------  206 (668)
T KOG0611|consen  207 --------------------------------------------------------------------------------  206 (668)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .-.++|+|+|-|++||+++|.+| |+.+|.|||||+||.|+.|..||.|-|...+...|++|.|.-|
T Consensus       207 -------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP  273 (668)
T KOG0611|consen  207 -------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP  273 (668)
T ss_pred             -------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence                         11356899999999999999999 8999999999999999999999999999999999999999888


Q ss_pred             CCccccC
Q psy2131         319 PKHKSAS  325 (328)
Q Consensus       319 ~~~~~~~  325 (328)
                      |.|--++
T Consensus       274 ~~PSdA~  280 (668)
T KOG0611|consen  274 ETPSDAS  280 (668)
T ss_pred             CCCchHH
Confidence            7765443

>KOG0694|consensus

Probab=100.00  E-value=9.3e-51  Score=375.53  Aligned_cols=212  Identities=33%  Similarity=0.585  Sum_probs=188.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+|+++..+.+++.||||++++... ..++++..+.|.+|+... +||.++.+|.+|++.+++|+||||+.||++ .
T Consensus       379 GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm-~  457 (694)
T KOG0694|consen  379 GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDL-M  457 (694)
T ss_pred             CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcE-E
Confidence            8999999999999999999999998754 466788899999999877 499999999999999999999999999994 4


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .++..+.|++..+++|+++|+.||+|||++|||+||||.+||||+.+|   .+||+||||+++.....            
T Consensus       458 ~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG---h~kiADFGlcKe~m~~g------------  522 (694)
T KOG0694|consen  458 HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG---HVKIADFGLCKEGMGQG------------  522 (694)
T ss_pred             EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC---cEEecccccccccCCCC------------
Confidence            455667899999999999999999999999999999999999998765   49999999997642211            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       523 --------------------------------------------------------------------------------  522 (694)
T KOG0694|consen  523 --------------------------------------------------------------------------------  522 (694)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .+..+++|||.|||||++.+..|+.++|||||||+|||||+|+.||.|+|+.++|..|+...+ .=
T Consensus       523 --------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~y  587 (694)
T KOG0694|consen  523 --------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RY  587 (694)
T ss_pred             --------------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CC
Confidence                          124468999999999999999999999999999999999999999999999999999998877 33


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |+.+|
T Consensus       588 P~~ls  592 (694)
T KOG0694|consen  588 PRFLS  592 (694)
T ss_pred             CCccc
Confidence            45444

>KOG0597|consensus

Probab=100.00  E-value=8.8e-51  Score=367.38  Aligned_cols=209  Identities=33%  Similarity=0.575  Sum_probs=191.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+.+.|.+.||||.+.+.+.++++...+.+|++|++.++|||||.++++|++..++|+|+|||.| +|+.++
T Consensus        13 Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il   91 (808)
T KOG0597|consen   13 GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL   91 (808)
T ss_pred             CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHH
Confidence            8999999999999999999999999988888999999999999999999999999999999999999999988 999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.++|+.++.+..|++.||.|||+++|+|||+||.|||+.   .++.+|+||||+|+.....               
T Consensus        92 ~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~---------------  153 (808)
T KOG0597|consen   92 EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTN---------------  153 (808)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccC---------------
Confidence            9999999999999999999999999999999999999999996   4567999999998653211               


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (808)
T KOG0597|consen  154 --------------------------------------------------------------------------------  153 (808)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                 .....+..|||-|||||.+++.+|+..+|.||+|||+|||++|+|||.+..-.+|..+|+..+..+|+
T Consensus       154 -----------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~  221 (808)
T KOG0597|consen  154 -----------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS  221 (808)
T ss_pred             -----------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc
Confidence                       01223356999999999999999999999999999999999999999999999999999998874443

>KOG0610|consensus

Probab=100.00  E-value=7.9e-50  Score=349.96  Aligned_cols=268  Identities=24%  Similarity=0.393  Sum_probs=195.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |.-|+||+|+.+.++..||+|++.+..+. .+...+++.|..||+.++||.++.||..|+.++..|+|||||+||+|...
T Consensus        88 GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~L  167 (459)
T KOG0610|consen   88 GDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSL  167 (459)
T ss_pred             CCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHH
Confidence            56799999999999999999999987665 44567788999999999999999999999999999999999999999887


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+++  +.|++..+++|+++|+.||+|||-.|||.|||||||||+..+|   .|.|+||.|+..........        
T Consensus       168 rqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG---HIMLsDFDLS~~~~~~Pt~~--------  236 (459)
T KOG0610|consen  168 RQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG---HIMLSDFDLSLRCPVSPTLV--------  236 (459)
T ss_pred             HhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC---cEEeeeccccccCCCCCeee--------
Confidence            7654  4699999999999999999999999999999999999998655   59999999987652211100        


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                       ....|                  ..........+.....|..+++..+-.++-  .+             .+  ..   
T Consensus       237 -~s~~~------------------~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k--~~-------------~~--~~---  277 (459)
T KOG0610|consen  237 -KSSSP------------------RSSGSQPSCRSRQPSCFSPRCLSSSKKRKK--KD-------------ES--AS---  277 (459)
T ss_pred             -ccCCC------------------CCCCCCcccccccccccccchhcccccccc--cc-------------cc--cc---
Confidence             00000                  000000000000000000111111100000  00             00  00   


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                       ..++.  ...........+++||-.|.|||++.|.++|.++|||+|||.|||||.|++||.|.+..+++-+|+.-...+
T Consensus       278 -~~~p~--~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F  354 (459)
T KOG0610|consen  278 -RSLPE--LVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF  354 (459)
T ss_pred             -ccchh--hhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC
Confidence             00000  001112344667999999999999999999999999999999999999999999999999999999999888


Q ss_pred             CCCc
Q psy2131         318 EPKH  321 (328)
Q Consensus       318 ~~~~  321 (328)
                      |-.+
T Consensus       355 p~~~  358 (459)
T KOG0610|consen  355 PEEP  358 (459)
T ss_pred             CCCC
Confidence            8776

>KOG0593|consensus

Probab=100.00  E-value=2.3e-50  Score=340.49  Aligned_cols=212  Identities=29%  Similarity=0.482  Sum_probs=181.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+|++|+++.||+.||||.+....-++.-.+-..||+++|++|+|+|+|.++++|.....+++|+|||+.. +++.+
T Consensus        13 GSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT-vL~eL   91 (396)
T KOG0593|consen   13 GSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT-VLHEL   91 (396)
T ss_pred             CcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH-HHHHH
Confidence            89999999999999999999999765544444455689999999999999999999999999999999999884 44555


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..|++|++.|+.|+|+++||||||||||||++.   ++.+||||||+|+.+......           
T Consensus        92 e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~---~gvvKLCDFGFAR~L~~pgd~-----------  157 (396)
T KOG0593|consen   92 ERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ---NGVVKLCDFGFARTLSAPGDN-----------  157 (396)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec---CCcEEeccchhhHhhcCCcch-----------
Confidence            43 456999999999999999999999999999999999999975   457999999999776432211           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (396)
T KOG0593|consen  158 --------------------------------------------------------------------------------  157 (396)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ...++.|..|+|||.+.| -+||.++||||+||++.||+||.+.|.|....+++-.|..-.=+.+
T Consensus       158 ---------------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  158 ---------------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             ---------------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC
Confidence                           123467899999999988 7899999999999999999999999999998888888877666667


Q ss_pred             CCcc
Q psy2131         319 PKHK  322 (328)
Q Consensus       319 ~~~~  322 (328)
                      |+|-
T Consensus       223 prhq  226 (396)
T KOG0593|consen  223 PRHQ  226 (396)
T ss_pred             HHHH
Confidence            7663

>KOG0032|consensus

Probab=100.00  E-value=2.5e-47  Score=347.63  Aligned_cols=214  Identities=49%  Similarity=0.826  Sum_probs=192.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |.||+||+|+++.||+.+|+|+|.+..... .....+.+|++||+++. |||||+++++|++.+.+|+|||+|.||+|++
T Consensus        46 G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd  125 (382)
T KOG0032|consen   46 GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFD  125 (382)
T ss_pred             CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHH
Confidence            899999999999999999999998776543 34567899999999998 9999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC-CCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~-~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+... .++|.++..++.|++.+++|||+.|||||||||||+|+....+ ...+|++|||+|......            
T Consensus       126 ~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~------------  192 (382)
T KOG0032|consen  126 RIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG------------  192 (382)
T ss_pred             HHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC------------
Confidence            99877 4999999999999999999999999999999999999988754 358999999998654321            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       193 --------------------------------------------------------------------------------  192 (382)
T KOG0032|consen  193 --------------------------------------------------------------------------------  192 (382)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ......+|||.|+|||++.+.+|+..+|+||+||++|.|++|.+||++++....+.+|.+|.+++
T Consensus       193 ---------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  193 ---------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF  257 (382)
T ss_pred             ---------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence                           01234679999999999999999999999999999999999999999999999999999999977


Q ss_pred             CCCcc
Q psy2131         318 EPKHK  322 (328)
Q Consensus       318 ~~~~~  322 (328)
                      ...+.
T Consensus       258 ~~~~w  262 (382)
T KOG0032|consen  258 TSEPW  262 (382)
T ss_pred             CCCCc
Confidence            76554

>KOG0585|consensus

Probab=100.00  E-value=1.6e-47  Score=340.20  Aligned_cols=216  Identities=32%  Similarity=0.560  Sum_probs=179.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH------------HHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYL   66 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~------------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~l   66 (328)
                      |.||.|.+|++..+++.||||++.+......            ..+++.+||.||++|+|||||+|+++..+.  +.+||
T Consensus       108 G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~Yl  187 (576)
T KOG0585|consen  108 GQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYL  187 (576)
T ss_pred             CccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEE
Confidence            8999999999999999999999986543211            235788999999999999999999999864  67999


Q ss_pred             EEEccCCCCcHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          67 VFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        67 v~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |+|||..|.+...- ..+. +++.+++.|+++++.||.|||.+|||||||||+|+|++++   +++||+|||.+......
T Consensus       188 Vley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~---g~VKIsDFGVs~~~~~~  263 (576)
T KOG0585|consen  188 VLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD---GTVKISDFGVSNEFPQG  263 (576)
T ss_pred             EEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC---CcEEeeccceeeecccC
Confidence            99999999885433 3344 9999999999999999999999999999999999999754   56999999997543211


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..                                                                              
T Consensus       264 ~~------------------------------------------------------------------------------  265 (576)
T KOG0585|consen  264 SD------------------------------------------------------------------------------  265 (576)
T ss_pred             Cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCC-CCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPY-GKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~-~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                               +...+.              ....+|||.++|||.+.+   ..| |.+.||||+||+||.|+.|+.||.++
T Consensus       266 ---------~~~d~~--------------L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  266 ---------EGSDDQ--------------LSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             ---------cccHHH--------------HhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence                     000000              112579999999999977   344 89999999999999999999999999


Q ss_pred             cHHHHHHHHhcccCCCCCCc
Q psy2131         302 DQHRLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       302 ~~~~~~~~i~~~~~~~~~~~  321 (328)
                      ...+|+.+|+..++..|..+
T Consensus       323 ~~~~l~~KIvn~pL~fP~~p  342 (576)
T KOG0585|consen  323 FELELFDKIVNDPLEFPENP  342 (576)
T ss_pred             hHHHHHHHHhcCcccCCCcc
Confidence            99999999999999888765

>KOG0600|consensus

Probab=100.00  E-value=2.6e-47  Score=341.29  Aligned_cols=202  Identities=30%  Similarity=0.468  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|++..||+.||+|.++.+...........|||.||++|+|||||+|.+...+.  ..+|+|+|||++ ||.-
T Consensus       128 GTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~G  206 (560)
T KOG0600|consen  128 GTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSG  206 (560)
T ss_pred             cchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhh
Confidence            8999999999999999999999998776665566678999999999999999999998876  789999999987 7776


Q ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ++...+ .|++.++..|++||+.||.|||++||+|||||.+||||+.+   +.+||+|||||+........         
T Consensus       207 Ll~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~---G~LKiaDFGLAr~y~~~~~~---------  274 (560)
T KOG0600|consen  207 LLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN---GVLKIADFGLARFYTPSGSA---------  274 (560)
T ss_pred             hhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC---CCEEeccccceeeccCCCCc---------
Confidence            666543 69999999999999999999999999999999999999754   56999999999765432210         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       275 --------------------------------------------------------------------------------  274 (560)
T KOG0600|consen  275 --------------------------------------------------------------------------------  274 (560)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                      ...+.+-|..|.|||.|.|. .||.++|+||+||||.||++|++.|.|.++.+.+.+|-
T Consensus       275 ----------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf  333 (560)
T KOG0600|consen  275 ----------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF  333 (560)
T ss_pred             ----------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH
Confidence                            01123569999999999884 79999999999999999999999999999999888874

>KOG0192|consensus

Probab=100.00  E-value=1.1e-45  Score=334.12  Aligned_cols=213  Identities=29%  Similarity=0.469  Sum_probs=181.3

Q ss_pred             CCceEEEEEEEccCCcE-EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLE-FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-YHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~-~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||++..+.  +. +|||++.....+.+..+.+.+|+.+|.+++|||||++++++.+.. .+.|||||+++|+|.+
T Consensus        52 G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~  129 (362)
T KOG0192|consen   52 GSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSV  129 (362)
T ss_pred             CCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHH
Confidence            8999999997754  45 999999987766666778999999999999999999999999988 7999999999999999


Q ss_pred             HHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          79 DIVA--REFYSEADASHCIQQILESVNHCHSNG-VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        79 ~l~~--~~~~~~~~~~~~~~qll~~L~ylH~~~-ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      ++..  ...++...+..++.||+.|+.|||+++ ||||||||+|||++.+.  -.+||+|||+++......         
T Consensus       130 ~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~~~~---------  198 (362)
T KOG0192|consen  130 LLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKVISK---------  198 (362)
T ss_pred             HHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeecccc---------
Confidence            9987  578999999999999999999999999 99999999999997543  269999999986532110         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       199 --------------------------------------------------------------------------------  198 (362)
T KOG0192|consen  199 --------------------------------------------------------------------------------  198 (362)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc--cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                       ....+..||+.|||||++.  ..+|+.++|||||||+||||+||+.||.+..+.++...++.+
T Consensus       199 -----------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~  261 (362)
T KOG0192|consen  199 -----------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG  261 (362)
T ss_pred             -----------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence                             0111246999999999999  669999999999999999999999999999988888777744


Q ss_pred             cCCCC-CCccc
Q psy2131         314 AYDDE-PKHKS  323 (328)
Q Consensus       314 ~~~~~-~~~~~  323 (328)
                      ...++ |..|.
T Consensus       262 ~~Rp~~p~~~~  272 (362)
T KOG0192|consen  262 GLRPPIPKECP  272 (362)
T ss_pred             CCCCCCCccCC
Confidence            44344 55443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9e-46  Score=340.68  Aligned_cols=240  Identities=30%  Similarity=0.549  Sum_probs=183.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.||+|+++..... ......+.+|+.++.+++||||+++++++.+...+|+|||||+||+|.++
T Consensus        12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~   91 (363)
T cd05628          12 GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTL   91 (363)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHH
Confidence            89999999999999999999999764332 33446678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++.........-          
T Consensus        92 l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~---~~vkL~DFGla~~~~~~~~~~----------  158 (363)
T cd05628          92 LMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTE----------  158 (363)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CCEEEeeccCccccccccccc----------
Confidence            9888899999999999999999999999999999999999999754   469999999987543211100          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                          +..           ......+.        ..   ...  ..+. .+.                 .          
T Consensus       159 ----~~~-----------~~~~~~~~--------~~---~~~--~~~~-~~~-----------------~----------  182 (363)
T cd05628         159 ----FYR-----------NLNHSLPS--------DF---TFQ--NMNS-KRK-----------------A----------  182 (363)
T ss_pred             ----ccc-----------cccccccc--------cc---ccc--cccc-ccc-----------------c----------
Confidence                000           00000000        00   000  0000 000                 0          


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                           ...+........+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++..++.+|....
T Consensus       183 -----~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~  252 (363)
T cd05628         183 -----ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK  252 (363)
T ss_pred             -----chhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc
Confidence                 0000000111234579999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0589|consensus

Probab=100.00  E-value=1.7e-46  Score=338.50  Aligned_cols=216  Identities=34%  Similarity=0.517  Sum_probs=196.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-EEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY-HYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~-~~lv~E~~~gg~L~~~   79 (328)
                      |+||.++.++++..+..+++|.|+....+....+...+|+.++++++|||||.+++.|..++. ++|||+||+||++.+.
T Consensus        15 GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~   94 (426)
T KOG0589|consen   15 GAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQL   94 (426)
T ss_pred             cccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHH
Confidence            899999999999999999999999999888888888999999999999999999999998887 9999999999999999


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...+  .++|+.+..|+.|++.|+.|||+++|+|||||+.||+++.++   .|||+|||+|+.+....           
T Consensus        95 i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~---~VkLgDfGlaK~l~~~~-----------  160 (426)
T KOG0589|consen   95 IKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK---KVKLGDFGLAKILNPED-----------  160 (426)
T ss_pred             HHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---ceeecchhhhhhcCCch-----------
Confidence            86543  699999999999999999999999999999999999997654   48999999987653221           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (426)
T KOG0589|consen  161 --------------------------------------------------------------------------------  160 (426)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     +...+.+|||.||+||++.+.+|+.++|+|||||++|||++=+++|.+.|-..|..+|.++.+.+
T Consensus       161 ---------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P  225 (426)
T KOG0589|consen  161 ---------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP  225 (426)
T ss_pred             ---------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC
Confidence                           11234679999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccC
Q psy2131         318 EPKHKSAS  325 (328)
Q Consensus       318 ~~~~~~~~  325 (328)
                      .|.+-+..
T Consensus       226 lp~~ys~e  233 (426)
T KOG0589|consen  226 LPSMYSSE  233 (426)
T ss_pred             CCccccHH
Confidence            99887654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-45  Score=332.99  Aligned_cols=209  Identities=33%  Similarity=0.570  Sum_probs=182.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|+++.... .......+.+|+.++++++||||+++++++.+.+.+|+||||++||+|.+.
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   85 (323)
T cd05571           6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH   85 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            8999999999999999999999986433 233456678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        86 l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~-------------  149 (323)
T cd05571          86 LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDG-------------  149 (323)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEeeCCCCcccccCC-------------
Confidence            9888889999999999999999999999999999999999999754   459999999874321000             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       150 --------------------------------------------------------------------------------  149 (323)
T cd05571         150 --------------------------------------------------------------------------------  149 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+...++..+..+....|
T Consensus       150 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p  215 (323)
T cd05571         150 -------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  215 (323)
T ss_pred             -------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                         001124599999999999999999999999999999999999999999999999999988877544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0661|consensus

Probab=100.00  E-value=1e-46  Score=335.26  Aligned_cols=201  Identities=36%  Similarity=0.603  Sum_probs=177.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC-EEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEEN-YHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~-~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|+.+.+|..||||.+++...+.++..+ .||++.|++|+ |||||++.+++.+.+ .+|+|||||+. +|++
T Consensus        21 GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYq   98 (538)
T KOG0661|consen   21 GTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQ   98 (538)
T ss_pred             CcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHH
Confidence            89999999999999999999999988777655444 58999999998 999999999999888 99999999975 8999


Q ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+..+. .|++.+++.|+.||++||+|+|.+|+.|||+||||||+..   ...|||+|||||+++...            
T Consensus        99 LmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev~Sk------------  163 (538)
T KOG0661|consen   99 LMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREVRSK------------  163 (538)
T ss_pred             HHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEecccccccccccC------------
Confidence            987654 6999999999999999999999999999999999999974   346999999999887432            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                          +||                                                                         
T Consensus       164 ----pPY-------------------------------------------------------------------------  166 (538)
T KOG0661|consen  164 ----PPY-------------------------------------------------------------------------  166 (538)
T ss_pred             ----CCc-------------------------------------------------------------------------
Confidence                222                                                                         


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                        ..++.|..|+|||+|.. .-|+.++|+||+|||++|+.+=++.|.|.++.+...+|.+-
T Consensus       167 ------------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V  225 (538)
T KOG0661|consen  167 ------------------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV  225 (538)
T ss_pred             ------------------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence                              12567999999999876 45799999999999999999999999999999999999864

>KOG0580|consensus

Probab=100.00  E-value=9.1e-47  Score=309.13  Aligned_cols=207  Identities=33%  Similarity=0.582  Sum_probs=186.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHH-HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~-~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |.||.||.|+.+.++-.+|+|++-++.+..... .++.||++|-+.|+||||+++|++|-++...|+++||..+|+|+..
T Consensus        33 gkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~  112 (281)
T KOG0580|consen   33 GKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKD  112 (281)
T ss_pred             CccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHH
Confidence            789999999999999999999997665433333 4688999999999999999999999999999999999999999999


Q ss_pred             HH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IV--AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~--~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      |.  ....+++..+..|++|++.||.|+|.+++|||||||+|+|++..+   .+||+|||.+....              
T Consensus       113 L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~---~lkiAdfGwsV~~p--------------  175 (281)
T KOG0580|consen  113 LQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAP--------------  175 (281)
T ss_pred             HHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---CeeccCCCceeecC--------------
Confidence            98  556799999999999999999999999999999999999998665   49999999863311              


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (281)
T KOG0580|consen  176 --------------------------------------------------------------------------------  175 (281)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    ...+.+.+||..|.+||+.++..++.++|+|++||..||+|.|.+||..+...++++.|.+..+..
T Consensus       176 --------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~  241 (281)
T KOG0580|consen  176 --------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF  241 (281)
T ss_pred             --------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC
Confidence                          012445789999999999999999999999999999999999999999999999999999999977


Q ss_pred             C
Q psy2131         318 E  318 (328)
Q Consensus       318 ~  318 (328)
                      |
T Consensus       242 p  242 (281)
T KOG0580|consen  242 P  242 (281)
T ss_pred             C
Confidence            7

>KOG0198|consensus

Probab=100.00  E-value=9.1e-46  Score=325.58  Aligned_cols=210  Identities=31%  Similarity=0.477  Sum_probs=174.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--YHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||++.+..+|+.+|||.+.....  ...+.+.+|+++|++++|||||++++......  .+++.|||++||+|.+
T Consensus        28 Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~  105 (313)
T KOG0198|consen   28 GSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSD  105 (313)
T ss_pred             ccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHH
Confidence            8999999999999999999999976522  22677899999999999999999999855444  6999999999999999


Q ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+...+ .++|..++.+.+|+++||.|||++|||||||||+|||++..  ++.+||+|||++.........         
T Consensus       106 ~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~~~~~---------  174 (313)
T KOG0198|consen  106 LIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLESKGTK---------  174 (313)
T ss_pred             HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccccccc---------
Confidence            998876 79999999999999999999999999999999999999762  356999999998665321100         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (313)
T KOG0198|consen  175 --------------------------------------------------------------------------------  174 (313)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCCCC-ccHHHHHHHHhcccC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAY  315 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~  315 (328)
                                    ......+.|||.|||||++.+.. -+.++|||||||++.||+||++||.+ .......-.|.....
T Consensus       175 --------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~  240 (313)
T KOG0198|consen  175 --------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS  240 (313)
T ss_pred             --------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC
Confidence                          00112356999999999999632 24599999999999999999999998 677777777777764


Q ss_pred             CC
Q psy2131         316 DD  317 (328)
Q Consensus       316 ~~  317 (328)
                      .|
T Consensus       241 ~P  242 (313)
T KOG0198|consen  241 LP  242 (313)
T ss_pred             CC
Confidence            33

>KOG0690|consensus

Probab=100.00  E-value=1.6e-46  Score=320.07  Aligned_cols=209  Identities=33%  Similarity=0.582  Sum_probs=189.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|.+|+.+.+|+.||||+++++..- .+++.....|-++|+..+||.+..+--.|++.+.+++||||..||.|+.+
T Consensus       179 GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~H  258 (516)
T KOG0690|consen  179 GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFH  258 (516)
T ss_pred             CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeee
Confidence            89999999999999999999999987643 45567778899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      |.+...++|+.+++|-.+|++||.|||+++||.||||.+|+|++.++   .+||+||||+++-....             
T Consensus       259 Lsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG---HIKitDFGLCKE~I~~g-------------  322 (516)
T KOG0690|consen  259 LSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG---HIKITDFGLCKEEIKYG-------------  322 (516)
T ss_pred             hhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC---ceEeeecccchhccccc-------------
Confidence            99999999999999999999999999999999999999999998665   59999999986531110             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       323 --------------------------------------------------------------------------------  322 (516)
T KOG0690|consen  323 --------------------------------------------------------------------------------  322 (516)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .+..+++|||.|.|||++....||.++|||.+||+||||++|+.||+..++..||..|.-+...+|
T Consensus       323 -------------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP  388 (516)
T KOG0690|consen  323 -------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP  388 (516)
T ss_pred             -------------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence                         123468999999999999999999999999999999999999999999999999999999888554

>KOG0663|consensus

Probab=100.00  E-value=8.6e-46  Score=316.50  Aligned_cols=202  Identities=30%  Similarity=0.408  Sum_probs=171.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.|++.||+|.++.+.-..----.-.|||.+|.+++|||||.+-++...  -+.+|+|||||+. ||..
T Consensus        87 GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLks  165 (419)
T KOG0663|consen   87 GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKS  165 (419)
T ss_pred             CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHH
Confidence            899999999999999999999998775221111235799999999999999999999874  4579999999987 7877


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+..- .+|...++..++.|++.||+|||.+.|+||||||+|+|++..   +.+||+|||||+.+.....          
T Consensus       166 l~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~---G~lKiaDFGLAR~ygsp~k----------  232 (419)
T KOG0663|consen  166 LMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK---GILKIADFGLAREYGSPLK----------  232 (419)
T ss_pred             HHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC---CcEEecccchhhhhcCCcc----------
Confidence            77654 479999999999999999999999999999999999999754   5699999999987633211          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       233 --------------------------------------------------------------------------------  232 (419)
T KOG0663|consen  233 --------------------------------------------------------------------------------  232 (419)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                      .....+-|..|.|||.|.| ..|++++|+||+|||+.||++++|-|.|..+.+.+.+|-+
T Consensus       233 ----------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  233 ----------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK  292 (419)
T ss_pred             ----------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence                            0112356899999999988 5689999999999999999999999999999999988865

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-45  Score=328.16  Aligned_cols=210  Identities=32%  Similarity=0.548  Sum_probs=183.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||+|+++.... .......+.+|+.++++++||||+++++++.+.+..|+|||||+||+|.+.
T Consensus         4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~   83 (312)
T cd05585           4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHH   83 (312)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHH
Confidence            8999999999999999999999975432 334456778999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        84 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~------------  148 (312)
T cd05585          84 LQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDD------------  148 (312)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC---CcEEEEECcccccCccCCC------------
Confidence            9888889999999999999999999999999999999999999754   4599999999743210000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       149 --------------------------------------------------------------------------------  148 (312)
T cd05585         149 --------------------------------------------------------------------------------  148 (312)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                    ......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+...++..+.++....|+
T Consensus       149 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  214 (312)
T cd05585         149 --------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD  214 (312)
T ss_pred             --------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC
Confidence                          011235899999999999999999999999999999999999999999999999999988775543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-45  Score=331.46  Aligned_cols=206  Identities=37%  Similarity=0.661  Sum_probs=182.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|+++.... .....+.+.+|+.++++++||||+++++++.+.+..|+|||||.||+|.+.
T Consensus        29 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  108 (329)
T PTZ00263         29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTH  108 (329)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHH
Confidence            8999999999999999999999975432 223456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++......              
T Consensus       109 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~--------------  171 (329)
T PTZ00263        109 LRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPDR--------------  171 (329)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC---CCEEEeeccCceEcCCC--------------
Confidence            9888889999999999999999999999999999999999999754   45999999997532110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (329)
T PTZ00263        172 --------------------------------------------------------------------------------  171 (329)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     .....||+.|+|||++.+..++.++|||||||++|||+||++||.+.++.+++.+|..+....|
T Consensus       172 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p  235 (329)
T PTZ00263        172 ---------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP  235 (329)
T ss_pred             ---------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence                           0013589999999999999999999999999999999999999999999999999999876543

>KOG0599|consensus

Probab=100.00  E-value=1.1e-45  Score=308.33  Aligned_cols=221  Identities=42%  Similarity=0.790  Sum_probs=197.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC---C--HHH-HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL---S--ARD-FQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~---~--~~~-~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |.-++|.+|.++.||.++|+|+|....-   +  ... .+...+|+.||+++ .||+|+++.++|+++..+++|+|.|+-
T Consensus        28 gvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~pr  107 (411)
T KOG0599|consen   28 GVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPR  107 (411)
T ss_pred             cchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhccc
Confidence            4557888999999999999999974321   1  122 23457899999998 799999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------  146 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------  146 (328)
                      |.|+++|...-.++|.+++.+++|++.|+.|||..+||||||||||||++++   ..+||+|||+|+++.+..       
T Consensus       108 GELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn---~~i~isDFGFa~~l~~GekLrelCG  184 (411)
T KOG0599|consen  108 GELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN---MNIKISDFGFACQLEPGEKLRELCG  184 (411)
T ss_pred             chHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc---cceEEeccceeeccCCchhHHHhcC
Confidence            9999999999999999999999999999999999999999999999999864   459999999998764321       


Q ss_pred             -------------------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHH
Q psy2131         147 -------------------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN  200 (328)
Q Consensus       147 -------------------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  200 (328)
                                               +.| +|+|+|.++.|.+||+...+.-++..|..|.+.|.++.|..+|.+.+|||.
T Consensus       185 TPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIs  264 (411)
T KOG0599|consen  185 TPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLIS  264 (411)
T ss_pred             CCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHH
Confidence                                     224 799999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCC
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ++|+.||++|.|+.|+|.|||+.+
T Consensus       265 rlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHHeeCchhcccHHHHhcChHHHH
Confidence            999999999999999999999853

>KOG0659|consensus

Probab=100.00  E-value=5.9e-45  Score=302.62  Aligned_cols=211  Identities=31%  Similarity=0.452  Sum_probs=180.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..||+.||||.|+.....+-.-....||++.|+.++|+||+.+.++|...+.+-||+||++. +|...+
T Consensus        13 G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vI   91 (318)
T KOG0659|consen   13 GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVI   91 (318)
T ss_pred             cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHh
Confidence            8999999999999999999999987755433345678999999999999999999999999999999999975 776666


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .... .++..++..|+.+++.||+|||++.|+||||||.|+|++++   +.+||+|||+|+.+......           
T Consensus        92 kd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~---g~lKiADFGLAr~f~~p~~~-----------  157 (318)
T KOG0659|consen   92 KDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD---GQLKIADFGLARFFGSPNRI-----------  157 (318)
T ss_pred             cccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC---CcEEeecccchhccCCCCcc-----------
Confidence            5543 68999999999999999999999999999999999999754   56999999999765321100           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (318)
T KOG0659|consen  158 --------------------------------------------------------------------------------  157 (318)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ...-+-|..|.|||.+.| +.||..+|+||.|||+.||+-|.|-|.|++..+.+..|-+..=+|.
T Consensus       158 ---------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  158 ---------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPT  222 (318)
T ss_pred             ---------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCC
Confidence                           000145889999999987 5789999999999999999999999999999999999988877666


Q ss_pred             CCc
Q psy2131         319 PKH  321 (328)
Q Consensus       319 ~~~  321 (328)
                      |..
T Consensus       223 ~~~  225 (318)
T KOG0659|consen  223 PDQ  225 (318)
T ss_pred             ccc
Confidence            653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=324.83  Aligned_cols=207  Identities=32%  Similarity=0.624  Sum_probs=182.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||+|++...... .+..+.+.+|+.++++++||||+++++++.+.+.+|+||||++||+|.++
T Consensus        12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   91 (291)
T cd05612          12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY   91 (291)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHH
Confidence            89999999999999999999999754332 23456688999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++......              
T Consensus        92 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~---~~~kl~Dfg~~~~~~~~--------------  154 (291)
T cd05612          92 LRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE---GHIKLTDFGFAKKLRDR--------------  154 (291)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEEecCcchhccCC--------------
Confidence            9888889999999999999999999999999999999999999754   46999999987432100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (291)
T cd05612         155 --------------------------------------------------------------------------------  154 (291)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+++.|.++....|+
T Consensus       155 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  219 (291)
T cd05612         155 ---------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR  219 (291)
T ss_pred             ---------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc
Confidence                           01135899999999999999999999999999999999999999999999999999999875543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-44  Score=327.28  Aligned_cols=209  Identities=33%  Similarity=0.578  Sum_probs=182.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|++..... .......+.+|+++++.++||||+++++++.+.+.+|+||||++||+|...
T Consensus         6 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~   85 (328)
T cd05593           6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH   85 (328)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence            8999999999999999999999986533 234456788999999999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        86 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kL~DfG~~~~~~~~~-------------  149 (328)
T cd05593          86 LSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDA-------------  149 (328)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC---CcEEEecCcCCccCCCcc-------------
Confidence            8888889999999999999999999999999999999999999754   459999999974321000             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       150 --------------------------------------------------------------------------------  149 (328)
T cd05593         150 --------------------------------------------------------------------------------  149 (328)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+..+.+..|
T Consensus       150 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p  215 (328)
T cd05593         150 -------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP  215 (328)
T ss_pred             -------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC
Confidence                         001124589999999999999999999999999999999999999999999999999888877544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-44  Score=334.22  Aligned_cols=252  Identities=27%  Similarity=0.475  Sum_probs=182.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||+|++..... .......+.+|+.++++++|||||++++++.+.+.+|+|||||+||+|.+.
T Consensus        12 G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~   91 (382)
T cd05625          12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL   91 (382)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            8999999999999999999999975432 233456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||++.........-          
T Consensus        92 l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~---g~~kL~DFGla~~~~~~~~~~----------  158 (382)
T cd05625          92 LIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSK----------  158 (382)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEeECCCCcccccccccc----------
Confidence            9888889999999999999999999999999999999999999754   469999999985432111000          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                         .+.. ...     .......        .+..         ..++...-... ..                  ..  
T Consensus       159 ---~~~~-~~~-----~~~~~~~--------~~~~---------~~~~~~~~~~~-~~------------------~~--  191 (382)
T cd05625         159 ---YYQS-GDH-----VRQDSMD--------FSNE---------WGDPANCRCGD-RL------------------KP--  191 (382)
T ss_pred             ---cccc-ccc-----ccccccc--------cccc---------ccccccccccc-cc------------------cc--
Confidence               0000 000     0000000        0000         00000000000 00                  00  


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                       .. ....+........+.+||+.|+|||++.+..|+.++|||||||+||||+||++||.+.++.....+|....
T Consensus       192 -~~-~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  264 (382)
T cd05625         192 -LE-RRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ  264 (382)
T ss_pred             -hh-hhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccC
Confidence             00 00000011112234679999999999999999999999999999999999999999999888887777643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.3e-44  Score=325.20  Aligned_cols=209  Identities=33%  Similarity=0.574  Sum_probs=181.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|..||+|+++.... .......+.+|+++++.++||||+++++++.+.+.+|+|||||+||+|...
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~   85 (323)
T cd05595           6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH   85 (323)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHH
Confidence            8999999999999999999999986532 233456678899999999999999999999999999999999999999988


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        86 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~-------------  149 (323)
T cd05595          86 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDG-------------  149 (323)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC---CCEEecccHHhccccCCC-------------
Confidence            8888889999999999999999999999999999999999999754   469999999874321000             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       150 --------------------------------------------------------------------------------  149 (323)
T cd05595         150 --------------------------------------------------------------------------------  149 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+..|+.++|+|||||++|||++|+.||.+.+...++..+..+....|
T Consensus       150 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p  215 (323)
T cd05595         150 -------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP  215 (323)
T ss_pred             -------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                         001123589999999999999999999999999999999999999999999999999988877544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0696|consensus

Probab=100.00  E-value=4.4e-46  Score=326.11  Aligned_cols=213  Identities=35%  Similarity=0.562  Sum_probs=188.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.|.+|..+.|.+.||||+++++...+ ++++.-..|-++|... +-|.+++++.+|++-+.+|+||||+.||+|..
T Consensus       360 GSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMy  439 (683)
T KOG0696|consen  360 GSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMY  439 (683)
T ss_pred             CccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhh
Confidence            899999999999999999999999876543 4566677888888876 57899999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+++-+.+.|..+.+|+.+|+.||-|||++|||.||||..|||++++++   +||+|||++++-.-..            
T Consensus       440 hiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~~------------  504 (683)
T KOG0696|consen  440 HIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFDG------------  504 (683)
T ss_pred             HHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccCC------------
Confidence            9999999999999999999999999999999999999999999987654   9999999986531110            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       505 --------------------------------------------------------------------------------  504 (683)
T KOG0696|consen  505 --------------------------------------------------------------------------------  504 (683)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .+..+++|||.|+|||++...+||.++||||+||+|||||.|++||.++|+.+||+.|..-+. .=
T Consensus       505 --------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-sy  569 (683)
T KOG0696|consen  505 --------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SY  569 (683)
T ss_pred             --------------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cC
Confidence                          123468999999999999999999999999999999999999999999999999999988776 33


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |.++|
T Consensus       570 PKslS  574 (683)
T KOG0696|consen  570 PKSLS  574 (683)
T ss_pred             ccccc
Confidence            44444

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-44  Score=328.10  Aligned_cols=207  Identities=32%  Similarity=0.531  Sum_probs=180.8

Q ss_pred             CCceEEEEEEEccCC-cEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATG-LEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..++ ..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||||.||+|.+
T Consensus        41 G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~  120 (340)
T PTZ00426         41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT  120 (340)
T ss_pred             cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            899999999876655 6899999975432 23345678899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......             
T Consensus       121 ~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---~~ikL~DFG~a~~~~~~-------------  184 (340)
T PTZ00426        121 FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD---GFIKMTDFGFAKVVDTR-------------  184 (340)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---CCEEEecCCCCeecCCC-------------
Confidence            99888889999999999999999999999999999999999999654   46999999997532100             


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (340)
T PTZ00426        185 --------------------------------------------------------------------------------  184 (340)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                      .....||+.|+|||++.+..++.++|+|||||++|||+||++||.+.++..+.+.|.++....|
T Consensus       185 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  248 (340)
T PTZ00426        185 ----------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP  248 (340)
T ss_pred             ----------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                            0123589999999999999999999999999999999999999999999999999999987544


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       249 ~  249 (340)
T PTZ00426        249 K  249 (340)
T ss_pred             C
Confidence            3

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-44  Score=333.67  Aligned_cols=251  Identities=26%  Similarity=0.461  Sum_probs=182.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        12 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~   91 (381)
T cd05626          12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL   91 (381)
T ss_pred             cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHH
Confidence            8999999999999999999999976543 234456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++.........-          
T Consensus        92 l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~---~~~kL~DFGl~~~~~~~~~~~----------  158 (381)
T cd05626          92 LIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSK----------  158 (381)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC---CCEEEeeCcCCcccccccccc----------
Confidence            9888889999999999999999999999999999999999999754   469999999986542111000          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                         .+            ..+. ..                     ..+..+++  ++....-.+..      ..+..   
T Consensus       159 ---~~------------~~~~-~~---------------------~~~~~~~~--~~~~~~~~~~~------~~~~~---  190 (381)
T cd05626         159 ---YY------------QKGS-HI---------------------RQDSMEPS--DLWDDVSNCRC------GDRLK---  190 (381)
T ss_pred             ---cc------------cccc-cc---------------------cccccCcc--ccccccccccc------ccccc---
Confidence               00            0000 00                     00000000  00000000000      00000   


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      .+... ...........+..||+.|+|||++.+..|+.++|||||||++|||+||++||.+.++.....+|...
T Consensus       191 ~~~~~-~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~  263 (381)
T cd05626         191 TLEQR-ATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW  263 (381)
T ss_pred             hhhcc-ccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc
Confidence            00000 00000011123467999999999999999999999999999999999999999999888777777643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0578|consensus

Probab=100.00  E-value=5.4e-45  Score=331.12  Aligned_cols=200  Identities=33%  Similarity=0.575  Sum_probs=177.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+-|.||.|+...+++.||||.+.......  .+.+.+|+.+|+..+|+|||.+++.|.-.+.+|.||||++||+|.+.+
T Consensus       284 gaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV  361 (550)
T KOG0578|consen  284 GATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV  361 (550)
T ss_pred             ccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh
Confidence            678999999999999999999998776544  356789999999999999999999999999999999999999976544


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                       ....++|.+++.++++++.||.|||.+||+|||||.+|||++.++   .+||+|||+|.++...+              
T Consensus       362 -t~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g---~vKltDFGFcaqi~~~~--------------  423 (550)
T KOG0578|consen  362 -TKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG---SVKLTDFGFCAQISEEQ--------------  423 (550)
T ss_pred             -hcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC---cEEEeeeeeeecccccc--------------
Confidence             556699999999999999999999999999999999999997654   59999999987654322              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       424 --------------------------------------------------------------------------------  423 (550)
T KOG0578|consen  424 --------------------------------------------------------------------------------  423 (550)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                  ..+.+.+|||.|||||++..+.||+++||||||++..||+-|++||..+++-+.+..|-.
T Consensus       424 ------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~  483 (550)
T KOG0578|consen  424 ------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  483 (550)
T ss_pred             ------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence                        124457899999999999999999999999999999999999999999998877777653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=333.24  Aligned_cols=252  Identities=27%  Similarity=0.506  Sum_probs=183.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.++.+|+.||||++..... ..+....+.+|++++++++|||||++++++.+.+.+|+|||||+||+|.++
T Consensus        12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~   91 (377)
T cd05629          12 GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTM   91 (377)
T ss_pred             cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHH
Confidence            8999999999999999999999875432 233456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..++.++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+++........-.   .-.+..
T Consensus        92 l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~~~---~~~~~~  165 (377)
T cd05629          92 LIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG---GHIKLSDFGLSTGFHKQHDSAY---YQKLLQ  165 (377)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---CCEEEeeccccccccccccccc---cccccc
Confidence            9888889999999999999999999999999999999999999754   4699999999975432111000   000000


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                      +......              .....                ....++.....                       ....
T Consensus       166 ~~~~~~~--------------~~~~~----------------~~~~~~~~~~~-----------------------~~~~  192 (377)
T cd05629         166 GKSNKNR--------------IDNRN----------------SVAVDSINLTM-----------------------SSKD  192 (377)
T ss_pred             ccccccc--------------ccccc----------------ccccccccccc-----------------------cchh
Confidence            0000000              00000                00000000000                       0000


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                      ..   ............+.+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+....+.+|....
T Consensus       193 ~~---~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  264 (377)
T cd05629         193 QI---ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR  264 (377)
T ss_pred             hh---hhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC
Confidence            00   0000001111224579999999999999999999999999999999999999999999888888887643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=330.34  Aligned_cols=244  Identities=30%  Similarity=0.587  Sum_probs=183.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        12 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~   91 (364)
T cd05599          12 GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTL   91 (364)
T ss_pred             cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHH
Confidence            89999999999999999999999764322 23445678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++..+........    +....
T Consensus        92 l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~----~~~~~  164 (364)
T cd05599          92 LMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEF----YRILS  164 (364)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEeecccceeccccccccc----ccccc
Confidence            9888889999999999999999999999999999999999999754   4699999999865432211000    00000


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                      ...+.                 ..+                     +....+.........|                  
T Consensus       165 ~~~~~-----------------~~~---------------------~~~~~~~~~~~~~~~~------------------  188 (364)
T cd05599         165 HALPS-----------------NFL---------------------DFISKPMSSKRKAETW------------------  188 (364)
T ss_pred             ccccc-----------------ccc---------------------ccccccccccccccch------------------
Confidence            00000                 000                     0000000000000000                  


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                              ...+.....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.++.....++..+..
T Consensus       189 --------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~  256 (364)
T cd05599         189 --------KRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE  256 (364)
T ss_pred             --------hhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence                    00001112345799999999999999999999999999999999999999999999988888877654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-44  Score=331.93  Aligned_cols=239  Identities=31%  Similarity=0.579  Sum_probs=183.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.++.+++.||+|+++.... .......+.+|+.++..++||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus        12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~   91 (360)
T cd05627          12 GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTL   91 (360)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHH
Confidence            8999999999999999999999975432 233456788899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..+........    +.-..
T Consensus        92 l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~---~~vkL~DfG~~~~~~~~~~~~~----~~~~~  164 (360)
T cd05627          92 LMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEF----YRNLT  164 (360)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---CCEEEeeccCCccccccccccc----ccccc
Confidence            9888889999999999999999999999999999999999999754   4699999999875532211000    00000


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                      ..+|                      ..   .+  +    .   ..+. .+. ..                         
T Consensus       165 ~~~~----------------------~~---~~--~----~---~~~~-~~~-~~-------------------------  183 (360)
T cd05627         165 HNPP----------------------SD---FS--F----Q---NMNS-KRK-AE-------------------------  183 (360)
T ss_pred             cCCc----------------------cc---cc--c----c---cccc-ccc-cc-------------------------
Confidence            0000                      00   00  0    0   0000 000 00                         


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                            ...........+.+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.++...+.+|...
T Consensus       184 ------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~  251 (360)
T cd05627         184 ------TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW  251 (360)
T ss_pred             ------cccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcC
Confidence                  00000011122457999999999999999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.6e-44  Score=331.54  Aligned_cols=248  Identities=26%  Similarity=0.467  Sum_probs=181.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+++.||+|++..... .......+.+|+.+|+.++||||+++++.+.+.+.+|+|||||+||+|.++
T Consensus        12 G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~   91 (376)
T cd05598          12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL   91 (376)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            8999999999999999999999975432 223346678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|..+.......          
T Consensus        92 i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~---~~ikL~DFG~a~~~~~~~~~~----------  158 (376)
T cd05598          92 LIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSK----------  158 (376)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC---CCEEEEeCCCCcccccccccc----------
Confidence            9888889999999999999999999999999999999999999754   469999999985432110000          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                         .+....      ......                        .++..+.+  +....+                 ..
T Consensus       159 ---~~~~~~------~~~~~~------------------------~~~~~~~~--~~~~~~-----------------~~  186 (376)
T cd05598         159 ---YYQKGD------HHRQDS------------------------MEPSEEWS--EIDRCR-----------------LK  186 (376)
T ss_pred             ---cccccc------cccccc------------------------cccccccc--cccccc-----------------cc
Confidence               000000      000000                        00000000  000000                 00


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                      .+.... .+........+..||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++......+....
T Consensus       187 ~~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  260 (376)
T cd05598         187 PLERRR-KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE  260 (376)
T ss_pred             chhhhh-hhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC
Confidence            000000 00000112234679999999999999999999999999999999999999999999888877776543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717|consensus

Probab=100.00  E-value=1.5e-44  Score=323.88  Aligned_cols=209  Identities=37%  Similarity=0.606  Sum_probs=190.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.|++|.+|+|.-||+.||||+|.++++.......+.+|++.|+.++|||||+||++..+...+|||+|+=.+|+|++++
T Consensus        29 GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyI  108 (864)
T KOG4717|consen   29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYI  108 (864)
T ss_pred             CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHH
Confidence            78999999999999999999999999988777778999999999999999999999999999999999999999999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .++ ..+.|+-++.|+.||+.|+.|+|+..+|||||||||+++..+  .+.|||+|||++-.+.+.+.            
T Consensus       109 mKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~PG~k------------  174 (864)
T KOG4717|consen  109 MKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQPGKK------------  174 (864)
T ss_pred             HhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee--cCceEeeeccccccCCCcch------------
Confidence            776 469999999999999999999999999999999999999754  57899999999754433211            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (864)
T KOG4717|consen  175 --------------------------------------------------------------------------------  174 (864)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCC-CCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYG-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ..+++|+..|-|||+|.|..|+ +++||||||||||-|++|++||...+..+++-.|.-++|++|
T Consensus       175 ---------------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP  239 (864)
T KOG4717|consen  175 ---------------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP  239 (864)
T ss_pred             ---------------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc
Confidence                           1246899999999999999995 799999999999999999999999999999999999999775

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.5e-44  Score=322.21  Aligned_cols=209  Identities=31%  Similarity=0.519  Sum_probs=181.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..+++.||+|+++.... ..+..+.+..|.+++..+ +||||+++++++.+.+..|+|||||+||+|..
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~   85 (321)
T cd05591           6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMF   85 (321)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHH
Confidence            8999999999999999999999976432 233456677899998866 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---~~~kL~Dfg~~~~~~~~~------------  150 (321)
T cd05591          86 QIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFGMCKEGILNG------------  150 (321)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeecccceecccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999874321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (321)
T cd05591         151 --------------------------------------------------------------------------------  150 (321)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.++..++..|..+....|
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p  216 (321)
T cd05591         151 --------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP  216 (321)
T ss_pred             --------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          001123589999999999999999999999999999999999999999999999999999887544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0586|consensus

Probab=100.00  E-value=1.2e-44  Score=331.47  Aligned_cols=208  Identities=39%  Similarity=0.653  Sum_probs=192.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.|++|..+++..|+..||||+|.++.++....+.+.+|+++|+.|+|||||++|.+.+....+|+||||+.||.+++++
T Consensus        67 g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl  146 (596)
T KOG0586|consen   67 GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYL  146 (596)
T ss_pred             ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHH
Confidence            78999999999999999999999999988888888999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ..++...+.+++.++.|++.|++|||+++|||||||++||||+.+   ..+||+|||++..+...               
T Consensus       147 ~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~---mnikIaDfgfS~~~~~~---------------  208 (596)
T KOG0586|consen  147 VKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN---MNIKIADFGFSTFFDYG---------------  208 (596)
T ss_pred             HhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc---cceeeeccccceeeccc---------------
Confidence            999999999999999999999999999999999999999999754   34999999998654211               


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       209 --------------------------------------------------------------------------------  208 (596)
T KOG0586|consen  209 --------------------------------------------------------------------------------  208 (596)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                  ...++++|+|.|+|||++.|..| |+.+|+||+||+||.|+.|.+||.+.+...|-...++|+|..|
T Consensus       209 ------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp  275 (596)
T KOG0586|consen  209 ------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP  275 (596)
T ss_pred             ------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc
Confidence                        12456789999999999999999 8999999999999999999999999999999999999999665

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-44  Score=323.05  Aligned_cols=209  Identities=33%  Similarity=0.567  Sum_probs=181.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|++...... ......+.+|+++++.++||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus         6 G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~   85 (325)
T cd05594           6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH   85 (325)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            89999999999999999999999865432 33456678899999999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.....+++.++..++.||+.||.|||+ .||+||||||+|||++.+   +.+||+|||++........           
T Consensus        86 l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---~~~kL~Dfg~~~~~~~~~~-----------  151 (325)
T cd05594          86 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGA-----------  151 (325)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC---CCEEEecCCCCeecCCCCc-----------
Confidence            8888889999999999999999999997 799999999999999754   4699999999753211000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       152 --------------------------------------------------------------------------------  151 (325)
T cd05594         152 --------------------------------------------------------------------------------  151 (325)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+...++..|..+....|
T Consensus       152 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p  216 (325)
T cd05594         152 ---------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  216 (325)
T ss_pred             ---------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                           00123589999999999999999999999999999999999999999999999999888876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0660|consensus

Probab=100.00  E-value=1.3e-44  Score=312.88  Aligned_cols=205  Identities=34%  Similarity=0.464  Sum_probs=177.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-----~~~~~lv~E~~~gg~   75 (328)
                      |+||.|+.|.++.||+.||||.|.....+.-+.++..||+++|+.++|+|||.+++++..     -+.+|+|+|+| +.+
T Consensus        33 GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etD  111 (359)
T KOG0660|consen   33 GAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETD  111 (359)
T ss_pred             cceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhH
Confidence            899999999999999999999998766677778899999999999999999999999865     35689999999 458


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.....+++..++.++.|++.||+|+|+.||+|||+||+|+|++.+   +.+||+|||+|+.......        
T Consensus       112 L~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~---c~lKI~DFGLAR~~~~~~~--------  180 (359)
T KOG0660|consen  112 LHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD---CDLKICDFGLARYLDKFFE--------  180 (359)
T ss_pred             HHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---CCEEeccccceeeccccCc--------
Confidence            88878777779999999999999999999999999999999999999754   4589999999976532100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (359)
T KOG0660|consen  181 --------------------------------------------------------------------------------  180 (359)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ..--...+.|..|.|||++. ...|+.++||||+||||.|||+|++-|.|.+....++.|..-
T Consensus       181 ----------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  181 ----------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             ----------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence                            00012356799999999975 578999999999999999999999999999999888887653

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-43  Score=321.49  Aligned_cols=210  Identities=32%  Similarity=0.520  Sum_probs=181.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+++.||+|+++.... .......+.+|+.++..+ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~   85 (320)
T cd05590           6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMF   85 (320)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHH
Confidence            8999999999999999999999976432 223455677888888876 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~------------  150 (320)
T cd05590          86 HIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNG------------  150 (320)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCC------------
Confidence            99888889999999999999999999999999999999999999754   459999999874321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (320)
T cd05590         151 --------------------------------------------------------------------------------  150 (320)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...++..|.++....|
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  216 (320)
T cd05590         151 --------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  216 (320)
T ss_pred             --------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                          001123589999999999999999999999999999999999999999999999999998877544


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       217 ~  217 (320)
T cd05590         217 T  217 (320)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-43  Score=321.55  Aligned_cols=210  Identities=36%  Similarity=0.631  Sum_probs=178.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|++..+|+.||+|++...... ......+.+|.. +++.++||||+++++++.+.+..|+|||||+||+|..
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   85 (321)
T cd05603           6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF   85 (321)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHH
Confidence            89999999999999999999999754322 223344555654 6788999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~------------  150 (321)
T cd05603          86 HLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPE------------  150 (321)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEccCCCCccCCCCC------------
Confidence            88888889999999999999999999999999999999999999754   469999999874311000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (321)
T cd05603         151 --------------------------------------------------------------------------------  150 (321)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++..|..+....|
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (321)
T cd05603         151 --------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP  216 (321)
T ss_pred             --------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                          001124589999999999999999999999999999999999999999999999999998877555


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      |
T Consensus       217 ~  217 (321)
T cd05603         217 G  217 (321)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-43  Score=321.34  Aligned_cols=210  Identities=33%  Similarity=0.596  Sum_probs=180.8

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|++.   .+++.||+|+++....  .......+.+|+.+|+.++||||+++++++.+++..|+||||+.||+
T Consensus         7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   86 (323)
T cd05584           7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGE   86 (323)
T ss_pred             cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCch
Confidence            899999999864   5789999999976432  12334567889999999999999999999999999999999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......         
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~---------  154 (323)
T cd05584          87 LFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEG---------  154 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEeeCcCCeecccCC---------
Confidence            99999888889999999999999999999999999999999999999754   469999999975321100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (323)
T cd05584         155 --------------------------------------------------------------------------------  154 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                       .......||+.|+|||++.+..++.++|||||||+||||++|++||.+.+.......+.++..
T Consensus       155 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~  217 (323)
T cd05584         155 -----------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL  217 (323)
T ss_pred             -----------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence                             001123589999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCC
Q psy2131         316 DDEP  319 (328)
Q Consensus       316 ~~~~  319 (328)
                      ..||
T Consensus       218 ~~~~  221 (323)
T cd05584         218 NLPP  221 (323)
T ss_pred             CCCC
Confidence            6554

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-43  Score=321.65  Aligned_cols=210  Identities=35%  Similarity=0.624  Sum_probs=177.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+++.||+|++...... ......+.+|.. +++.++||||+++++++.+.+..|+|||||+||+|.+
T Consensus         6 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~   85 (325)
T cd05602           6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY   85 (325)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHH
Confidence            89999999999999999999999754322 122334444544 5678999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---~~~kl~DfG~a~~~~~~~------------  150 (325)
T cd05602          86 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHN------------  150 (325)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEEccCCCCcccccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999975321100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (325)
T cd05602         151 --------------------------------------------------------------------------------  150 (325)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..|..+....+
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (325)
T cd05602         151 --------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK  216 (325)
T ss_pred             --------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC
Confidence                          001124599999999999999999999999999999999999999999999999999988877655


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      |
T Consensus       217 ~  217 (325)
T cd05602         217 P  217 (325)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0201|consensus

Probab=100.00  E-value=6.1e-46  Score=327.69  Aligned_cols=202  Identities=27%  Similarity=0.491  Sum_probs=181.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..|++.||||+++.+.. .++.+.+++|+.+|.+++++||.++|+.|..+..+|++||||.||++.+.+
T Consensus        24 GsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL  102 (467)
T KOG0201|consen   24 GSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL  102 (467)
T ss_pred             cccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh
Confidence            8999999999999999999999987653 445678899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....++|.++..++++++.||.|||.++.+|||||+.|||+..+   +.+|++|||.+.++....              
T Consensus       103 ~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~--------------  165 (467)
T KOG0201|consen  103 KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTV--------------  165 (467)
T ss_pred             ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechh--------------
Confidence            888888999999999999999999999999999999999999865   459999999986542211              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (467)
T KOG0201|consen  166 --------------------------------------------------------------------------------  165 (467)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                  ..+.+++|||.|||||++++..|+.++||||||++.|||.+|.|||.+..|.+++..|-.
T Consensus       166 ------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk  225 (467)
T KOG0201|consen  166 ------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK  225 (467)
T ss_pred             ------------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC
Confidence                        123568899999999999999999999999999999999999999999999777666544

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-43  Score=321.47  Aligned_cols=211  Identities=36%  Similarity=0.621  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..+|+.+|+|++..... .......+.+|.. +++.++||||+++++++...+..|+|||||.||+|..
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   85 (325)
T cd05604           6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFF   85 (325)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHH
Confidence            8999999999999999999999975432 2233345556655 4677999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---~~~kL~DfG~~~~~~~~~------------  150 (325)
T cd05604          86 HLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQS------------  150 (325)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEeecCCcccCCCCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999974321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (325)
T cd05604         151 --------------------------------------------------------------------------------  150 (325)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.++..+....+
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~  216 (325)
T cd05604         151 --------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR  216 (325)
T ss_pred             --------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC
Confidence                          001124589999999999999999999999999999999999999999999999999999887666


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       217 ~~  218 (325)
T cd05604         217 PG  218 (325)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=321.63  Aligned_cols=203  Identities=30%  Similarity=0.527  Sum_probs=179.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+++.||+|+++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||||+||+|.++
T Consensus        12 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~   91 (333)
T cd05600          12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTL   91 (333)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence            89999999999999999999999765332 23456678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....               
T Consensus        92 l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kL~Dfg~a~~~~~---------------  153 (333)
T cd05600          92 LNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS---GHIKLTDFGLSKGIVT---------------  153 (333)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEEEeCcCCccccc---------------
Confidence            9888889999999999999999999999999999999999999754   4699999999743210               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (333)
T cd05600         154 --------------------------------------------------------------------------------  153 (333)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                    ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus       154 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  215 (333)
T cd05600         154 --------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE  215 (333)
T ss_pred             --------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc
Confidence                          01124589999999999999999999999999999999999999999999998888876543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-43  Score=325.78  Aligned_cols=205  Identities=31%  Similarity=0.539  Sum_probs=174.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+++.+|+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        54 G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~  133 (370)
T cd05621          54 GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL  133 (370)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence            8999999999999999999999975332 223345678899999999999999999999999999999999999999988


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|........            
T Consensus       134 l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~---~~~kL~DFG~a~~~~~~~~------------  197 (370)
T cd05621         134 MSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDETGM------------  197 (370)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEEecccceecccCCc------------
Confidence            754 468999999999999999999999999999999999999754   4699999999854321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (370)
T cd05621         198 --------------------------------------------------------------------------------  197 (370)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC----CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   .......||+.|+|||++.+.+    |+.++|+||+||+||||+||++||.+.+....+..|....
T Consensus       198 -------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05621         198 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             -------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence                         0011245999999999997653    7899999999999999999999999999988999888754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-43  Score=318.81  Aligned_cols=206  Identities=31%  Similarity=0.544  Sum_probs=176.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRK-LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..+++.||+|+++..... ....+.+..|..++.. .+||||+++++++...+.+|+|||||+||+|.+
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~   85 (316)
T cd05592           6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMF   85 (316)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHH
Confidence            89999999999999999999999865322 2334555667777765 489999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~------------  150 (316)
T cd05592          86 HIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---GHIKIADFGMCKENMNGE------------  150 (316)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC---CCEEEccCcCCeECCCCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999975321100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (316)
T cd05592         151 --------------------------------------------------------------------------------  150 (316)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|.....
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  213 (316)
T cd05592         151 --------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP  213 (316)
T ss_pred             --------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence                          001124589999999999999999999999999999999999999999999999998877654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-43  Score=319.99  Aligned_cols=210  Identities=37%  Similarity=0.642  Sum_probs=179.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+|+.||+|++...... ......+.+|.. +++.++||||+++++++.+.+..|+|||||+||+|.+
T Consensus         6 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   85 (323)
T cd05575           6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF   85 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHH
Confidence            89999999999999999999999754322 223344555555 5678999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~------------  150 (323)
T cd05575          86 HLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIEHS------------  150 (323)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeccCCCcccccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999874321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (323)
T cd05575         151 --------------------------------------------------------------------------------  150 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..|..+....+
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (323)
T cd05575         151 --------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK  216 (323)
T ss_pred             --------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          001123589999999999999999999999999999999999999999999999999998887665


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      |
T Consensus       217 ~  217 (323)
T cd05575         217 P  217 (323)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-43  Score=319.23  Aligned_cols=209  Identities=33%  Similarity=0.546  Sum_probs=180.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|++..+++.||+|+++..... ......+..|..++..+ +|++|+++++++.+.+.+|+||||++||+|.+
T Consensus        11 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~   90 (323)
T cd05616          11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY   90 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHH
Confidence            89999999999999999999999865432 23345567788888877 58999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        91 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kL~DfG~~~~~~~~~------------  155 (323)
T cd05616          91 QIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENMWDG------------  155 (323)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC---CcEEEccCCCceecCCCC------------
Confidence            99888889999999999999999999999999999999999999754   459999999975321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (323)
T cd05616         156 --------------------------------------------------------------------------------  155 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+.+|+.++|+|||||++|||+||++||.+.+...+++.|..+....|
T Consensus       156 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p  221 (323)
T cd05616         156 --------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  221 (323)
T ss_pred             --------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          001124589999999999999999999999999999999999999999999999999998877543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0667|consensus

Probab=100.00  E-value=7.6e-44  Score=329.16  Aligned_cols=206  Identities=32%  Similarity=0.448  Sum_probs=177.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CC-----CcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HP-----NIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~-----nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.|.+|++..|++.||||+|++..   .-..+...|++||..|+ |.     |+|+++++|...+++|||+|++. .
T Consensus       197 GtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~  272 (586)
T KOG0667|consen  197 GSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-T  272 (586)
T ss_pred             cccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-h
Confidence            899999999999999999999998653   34566778999999997 43     89999999999999999999995 4


Q ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          75 ELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        75 ~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      +|++++...+  .++...++.++.||+.||.+||+.+|||+|||||||||...+.. .|||+|||.|+......      
T Consensus       273 NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGSSc~~~q~v------  345 (586)
T KOG0667|consen  273 NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDFGSSCFESQRV------  345 (586)
T ss_pred             hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEecccccccCCcc------
Confidence            9999998765  48899999999999999999999999999999999999876654 79999999986542211      


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       346 --------------------------------------------------------------------------------  345 (586)
T KOG0667|consen  346 --------------------------------------------------------------------------------  345 (586)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                             .+..-+..|+|||+|.|.+|+.++|+||||||++||+||.+.|.|+++.+++..|..
T Consensus       346 -----------------------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e  402 (586)
T KOG0667|consen  346 -----------------------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE  402 (586)
T ss_pred             -----------------------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence                                   012346779999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCCCc
Q psy2131         313 GAYDDEPKH  321 (328)
Q Consensus       313 ~~~~~~~~~  321 (328)
                      =- -.||+.
T Consensus       403 ~l-G~Pp~~  410 (586)
T KOG0667|consen  403 VL-GLPPPK  410 (586)
T ss_pred             Hh-CCCCHH
Confidence            33 344443

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-43  Score=318.60  Aligned_cols=209  Identities=33%  Similarity=0.550  Sum_probs=180.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHP-NIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~-nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+++.||+|++..... .....+.+..|++++..++|+ +|+++++++.+.+.+|+|||||+||+|.+
T Consensus        11 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~   90 (324)
T cd05587          11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY   90 (324)
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHH
Confidence            8999999999999999999999986533 234456778899999999765 58899999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        91 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~------------  155 (324)
T cd05587          91 HIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE---GHIKIADFGMCKENIFGG------------  155 (324)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC---CCEEEeecCcceecCCCC------------
Confidence            99888889999999999999999999999999999999999999754   459999999874310000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (324)
T cd05587         156 --------------------------------------------------------------------------------  155 (324)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+.+|+.++|+||+||++|||+||++||.+.+...++..|..+....|
T Consensus       156 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T cd05587         156 --------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP  221 (324)
T ss_pred             --------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          001124589999999999999999999999999999999999999999999999999998876544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0594|consensus

Probab=100.00  E-value=2.3e-43  Score=305.84  Aligned_cols=203  Identities=33%  Similarity=0.430  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCC------EEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN-IVRLHDSIQEEN------YHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~------~~~lv~E~~~g   73 (328)
                      |+||+||+|+++.+|+.||+|.++.+...+-.-....||+.+|+.|+|+| ||.+++++.+.+      .+|+|+||++-
T Consensus        22 Gtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~  101 (323)
T KOG0594|consen   22 GTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR  101 (323)
T ss_pred             CCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc
Confidence            89999999999999999999999876543222245689999999999999 999999998877      89999999965


Q ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          74 GELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        74 g~L~~~l~~~~----~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                       +|..++....    .++...++.+++||+.||+|||+++|+||||||.|||+++   .+.+||+|||+|+...-..   
T Consensus       102 -DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~---~G~lKlaDFGlAra~~ip~---  174 (323)
T KOG0594|consen  102 -DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS---SGVLKLADFGLARAFSIPM---  174 (323)
T ss_pred             -cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC---CCcEeeeccchHHHhcCCc---
Confidence             8888886654    5788899999999999999999999999999999999986   4569999999986321100   


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (323)
T KOG0594|consen  175 --------------------------------------------------------------------------------  174 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYA  308 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~  308 (328)
                                             ......++|..|.|||++.|. .|++.+|+||+|||++||+++++.|.+..+.+++.
T Consensus       175 -----------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  175 -----------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             -----------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence                                   001224589999999999986 78999999999999999999999999999988888


Q ss_pred             HHhcc
Q psy2131         309 QIKAG  313 (328)
Q Consensus       309 ~i~~~  313 (328)
                      +|=+-
T Consensus       232 ~If~~  236 (323)
T KOG0594|consen  232 RIFRL  236 (323)
T ss_pred             HHHHH
Confidence            87543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.5e-43  Score=317.52  Aligned_cols=208  Identities=28%  Similarity=0.502  Sum_probs=178.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.++.+|+.||+|+++..... .........|..++..+ +||||+++++++.+.+.+|+|||||.||+|.+
T Consensus         6 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~   85 (316)
T cd05620           6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMF   85 (316)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHH
Confidence            89999999999999999999999864321 23445567788888754 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~------------  150 (316)
T cd05620          86 HIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGD------------  150 (316)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEeCccCCCeecccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999874311000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (316)
T cd05620         151 --------------------------------------------------------------------------------  150 (316)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...++..+..+....
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (316)
T cd05620         151 --------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY  215 (316)
T ss_pred             --------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence                          00112458999999999999999999999999999999999999999999999999988776544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0608|consensus

Probab=100.00  E-value=2e-44  Score=329.71  Aligned_cols=244  Identities=29%  Similarity=0.499  Sum_probs=189.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+|.+++...|...||+|.+++.. +...++..++.|-.||..-+.+-||+||-.|++.+.+|+||||++||++..+
T Consensus       640 GAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSL  719 (1034)
T KOG0608|consen  640 GAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL  719 (1034)
T ss_pred             cccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHH
Confidence            899999999999999999999997643 3344566788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      |.+-+.|.|..+++|+.++..|+++.|..|+|||||||+||||+.+++   |||+|||||..+...-+.     -|+= .
T Consensus       720 LIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTHds-----kYYq-~  790 (1034)
T KOG0608|consen  720 LIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS-----KYYQ-E  790 (1034)
T ss_pred             HHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc---eeeeeccccccceecccc-----cccc-C
Confidence            999999999999999999999999999999999999999999987654   999999998654221100     0000 0


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                      |..+=              ..-.-++++|...+...+-|..+                                      
T Consensus       791 gdH~R--------------qDSmep~~e~~d~~~~lkvL~~r--------------------------------------  818 (1034)
T KOG0608|consen  791 GDHHR--------------QDSMEPSPEWADISKCLKVLERR--------------------------------------  818 (1034)
T ss_pred             CCccc--------------cccCCCchhhccccccchHHHHH--------------------------------------
Confidence            11100              00011233333333322211111                                      


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                            +.+..+.-+.-+.+||+.|+|||+|...+|+-.|||||.|||||||+.|++||-+..+-++..+|+
T Consensus       819 ------a~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~  884 (1034)
T KOG0608|consen  819 ------AMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI  884 (1034)
T ss_pred             ------HHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee
Confidence                  112223334455789999999999999999999999999999999999999999998877766654

>KOG0607|consensus

Probab=100.00  E-value=9.4e-44  Score=302.42  Aligned_cols=222  Identities=36%  Similarity=0.744  Sum_probs=200.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+|+.|--|....||.+||||+|.++.  .....++.||++++.++ .|+||++|+++|+++..+|||||-|.||.|+.+
T Consensus        89 GAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLsh  166 (463)
T KOG0607|consen   89 GAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSH  166 (463)
T ss_pred             ccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHH
Confidence            899999999999999999999998763  33457889999999998 699999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc----------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ----------------  143 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~----------------  143 (328)
                      ++++..|+|.++..++++|+.||.|||.+||.|||+||||||..+.++-..||||||.|...+.                
T Consensus       167 I~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tP  246 (463)
T KOG0607|consen  167 IQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTP  246 (463)
T ss_pred             HHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCc
Confidence            9999999999999999999999999999999999999999999877776779999998753221                


Q ss_pred             -----------------------CCCcch-HHHHHHHHHhCCCCCCCC---------------cHHHHHHHHHhCCCCCC
Q psy2131         144 -----------------------GEQQAW-FGVILYILLVGYPPFWDE---------------DQHRLYAQIKAGAYDYP  184 (328)
Q Consensus       144 -----------------------~~~~~~-~G~~~~~~~~g~~pf~~~---------------~~~~~~~~i~~~~~~~~  184 (328)
                                             ...+.| +|+++|.|+.|++||.+.               -+..+++.|+.+.|.||
T Consensus       247 vGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP  326 (463)
T KOG0607|consen  247 VGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP  326 (463)
T ss_pred             ccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCC
Confidence                                   111223 899999999999999653               25788999999999999


Q ss_pred             CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       185 ~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ...|..+|.+.++++..+|..|+.+|.++.+.++|||+..
T Consensus       327 dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  327 DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence            9999999999999999999999999999999999999864

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5e-43  Score=323.11  Aligned_cols=206  Identities=32%  Similarity=0.541  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        54 G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~  133 (371)
T cd05622          54 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL  133 (371)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence            8999999999999999999999975332 223345678899999999999999999999999999999999999999887


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       134 ~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~---~~ikL~DfG~a~~~~~~~~------------  197 (371)
T cd05622         134 MSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGM------------  197 (371)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC---CCEEEEeCCceeEcCcCCc------------
Confidence            754 458999999999999999999999999999999999999754   4699999999854321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (371)
T cd05622         198 --------------------------------------------------------------------------------  197 (371)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC----CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......||+.|+|||++.+..    |+.++|||||||++|||++|++||.+.+....+.+|.....
T Consensus       198 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~  264 (371)
T cd05622         198 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN  264 (371)
T ss_pred             -------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence                         0011245999999999997643    78999999999999999999999999999999999887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-43  Score=319.68  Aligned_cols=209  Identities=31%  Similarity=0.570  Sum_probs=181.4

Q ss_pred             CCceEEEEEEE---ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQ---KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~---~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||++++   ..+|+.+|+|++............+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.
T Consensus         7 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   86 (318)
T cd05582           7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF   86 (318)
T ss_pred             CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHH
Confidence            89999999876   468899999999865544445566788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.+.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......           
T Consensus        87 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~-----------  152 (318)
T cd05582          87 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHE-----------  152 (318)
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---CcEEEeeccCCcccCCCC-----------
Confidence            999888889999999999999999999999999999999999999754   459999999875321100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       153 --------------------------------------------------------------------------------  152 (318)
T cd05582         153 --------------------------------------------------------------------------------  152 (318)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+...|.++.+..
T Consensus       153 ---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~  217 (318)
T cd05582         153 ---------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM  217 (318)
T ss_pred             ---------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                           00112458999999999999999999999999999999999999999999999999998888765


Q ss_pred             C
Q psy2131         318 E  318 (328)
Q Consensus       318 ~  318 (328)
                      |
T Consensus       218 p  218 (318)
T cd05582         218 P  218 (318)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.7e-43  Score=317.06  Aligned_cols=209  Identities=33%  Similarity=0.554  Sum_probs=179.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.++.+|+.||+|+++..... ....+.+..|+.+++.+. |++|+++++++.+.+.+|+|||||+||+|.+
T Consensus        11 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~   90 (323)
T cd05615          11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY   90 (323)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHH
Confidence            89999999999999999999999864322 234456778999998885 5778899999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        91 ~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---~~ikL~Dfg~~~~~~~~~------------  155 (323)
T cd05615          91 HIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDG------------  155 (323)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeccccccccCCCC------------
Confidence            99888889999999999999999999999999999999999999754   459999999874321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (323)
T cd05615         156 --------------------------------------------------------------------------------  155 (323)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..++.++|+||+||++|||+||++||.+.+...+.+.|..+....|
T Consensus       156 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p  221 (323)
T cd05615         156 --------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP  221 (323)
T ss_pred             --------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          001123589999999999999999999999999999999999999999999999999998887544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.5e-43  Score=315.31  Aligned_cols=207  Identities=30%  Similarity=0.511  Sum_probs=177.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRK-LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|++..+++.||||+++..... .........|..+++. ++||||+++++++.+.+.+|+||||++||+|.+
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~   85 (316)
T cd05619           6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMF   85 (316)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            89999999999999999999999865322 2334556778888876 499999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~------------  150 (316)
T cd05619          86 HIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGD------------  150 (316)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEccCCcceECCCCC------------
Confidence            99887889999999999999999999999999999999999999754   459999999874321000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (316)
T cd05619         151 --------------------------------------------------------------------------------  150 (316)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+...++..+..+...
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~  214 (316)
T cd05619         151 --------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC  214 (316)
T ss_pred             --------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence                          0011235899999999999999999999999999999999999999999999999998877653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.8e-43  Score=316.63  Aligned_cols=209  Identities=30%  Similarity=0.518  Sum_probs=176.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.++.+++.||+|+++..... ......+.+|+.++..+ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~   85 (329)
T cd05588           6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF   85 (329)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHH
Confidence            89999999999999999999999865433 23456678899999988 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~~------------  150 (329)
T cd05588          86 HMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPG------------  150 (329)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEECcCccccccccCC------------
Confidence            88888889999999999999999999999999999999999999754   469999999874311000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (329)
T cd05588         151 --------------------------------------------------------------------------------  150 (329)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC---------ccHHHHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD---------EDQHRLYAQ  309 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---------~~~~~~~~~  309 (328)
                                    .......||+.|+|||++.+..|+.++|+|||||++|||+||+.||..         .....+.+.
T Consensus       151 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05588         151 --------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV  216 (329)
T ss_pred             --------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence                          001124589999999999999999999999999999999999999963         223456777


Q ss_pred             HhcccCCCC
Q psy2131         310 IKAGAYDDE  318 (328)
Q Consensus       310 i~~~~~~~~  318 (328)
                      +..+....|
T Consensus       217 ~~~~~~~~p  225 (329)
T cd05588         217 ILEKQIRIP  225 (329)
T ss_pred             HHcCCCCCC
Confidence            777766443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0612|consensus

Probab=100.00  E-value=1.5e-44  Score=348.72  Aligned_cols=211  Identities=33%  Similarity=0.530  Sum_probs=185.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|..++++.|++.||+|++++-.+ ...+...|..|-.+|..-+.+-|++++-+|++..++|+||||++||||..+
T Consensus        86 GaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltL  165 (1317)
T KOG0612|consen   86 GAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTL  165 (1317)
T ss_pred             cccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHH
Confidence            8999999999999999999999986332 234556788899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.-+++|+.+|+.||.-||+.|+|||||||+||||+..|+   |||+|||.|..+..++..           
T Consensus       166 lSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGsClkm~~dG~V-----------  231 (1317)
T KOG0612|consen  166 LSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGSCLKMDADGTV-----------  231 (1317)
T ss_pred             HhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---EeeccchhHHhcCCCCcE-----------
Confidence            988889999999999999999999999999999999999999987654   999999987554322210           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       232 --------------------------------------------------------------------------------  231 (1317)
T KOG0612|consen  232 --------------------------------------------------------------------------------  231 (1317)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccc----c-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc-
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK----K-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-  313 (328)
                                    .....+|||.|++||+|.    + ..||+.|||||+||++||||.|.+||+++.-..++-+|..- 
T Consensus       232 --------------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk  297 (1317)
T KOG0612|consen  232 --------------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK  297 (1317)
T ss_pred             --------------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence                          122357999999999995    3 56899999999999999999999999999999999999876 


Q ss_pred             -cCCCCC
Q psy2131         314 -AYDDEP  319 (328)
Q Consensus       314 -~~~~~~  319 (328)
                       .+.+|+
T Consensus       298 ~~l~FP~  304 (1317)
T KOG0612|consen  298 ESLSFPD  304 (1317)
T ss_pred             hhcCCCc
Confidence             666663

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-43  Score=316.33  Aligned_cols=208  Identities=33%  Similarity=0.537  Sum_probs=176.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHH---HhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARIC---RKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il---~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+..+|+.||||+++.... .....+.+.+|++++   +.++||||+++++++.+.+..|+|||||+||+|
T Consensus        10 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   89 (324)
T cd05589          10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL   89 (324)
T ss_pred             cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcH
Confidence            8999999999999999999999976432 223445667776665   567899999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ...+. .+.+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++.......          
T Consensus        90 ~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~----------  155 (324)
T cd05589          90 MMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFG----------  155 (324)
T ss_pred             HHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CcEEeCcccCCccCCCCC----------
Confidence            87764 4579999999999999999999999999999999999999754   469999999874321000          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (324)
T cd05589         156 --------------------------------------------------------------------------------  155 (324)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..|..+...
T Consensus       156 ----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (324)
T cd05589         156 ----------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR  219 (324)
T ss_pred             ----------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence                            0011246899999999999999999999999999999999999999999999999999888775


Q ss_pred             CC
Q psy2131         317 DE  318 (328)
Q Consensus       317 ~~  318 (328)
                      .|
T Consensus       220 ~p  221 (324)
T cd05589         220 YP  221 (324)
T ss_pred             CC
Confidence            44

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-43  Score=319.56  Aligned_cols=211  Identities=34%  Similarity=0.573  Sum_probs=178.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL---QHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||+|++...... ........+|..++..+   +||||+++++++.+.+..|+||||+.||+|
T Consensus         4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L   83 (330)
T cd05586           4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL   83 (330)
T ss_pred             CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChH
Confidence            89999999999999999999999754322 22344456677777765   799999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++.......          
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~----------  150 (330)
T cd05586          84 FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDN----------  150 (330)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEecCCcCcCCCCCC----------
Confidence            9999888889999999999999999999999999999999999999754   459999999974321100          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (330)
T cd05586         151 --------------------------------------------------------------------------------  150 (330)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..++++.|..+..
T Consensus       151 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  214 (330)
T cd05586         151 ----------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV  214 (330)
T ss_pred             ----------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC
Confidence                            001124589999999999765 589999999999999999999999999999999999999887


Q ss_pred             CCCCC
Q psy2131         316 DDEPK  320 (328)
Q Consensus       316 ~~~~~  320 (328)
                      ..+..
T Consensus       215 ~~~~~  219 (330)
T cd05586         215 RFPKN  219 (330)
T ss_pred             CCCCc
Confidence            66543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0197|consensus

Probab=100.00  E-value=4.7e-43  Score=317.34  Aligned_cols=214  Identities=24%  Similarity=0.388  Sum_probs=184.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |-||+|+.|..+.+ ..||+|.++...++.   +.+.+|+++|++|+|+|||++|+++..+..+||||||++.|+|.++|
T Consensus       217 G~FG~V~~g~~~~~-~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL  292 (468)
T KOG0197|consen  217 GQFGEVWLGKWNGS-TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL  292 (468)
T ss_pred             CccceEEEEEEcCC-CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence            78999999987543 479999998765554   34568999999999999999999999999999999999999999999


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ..  +..+...+...++.||++|++||+++++|||||-..|||+++   +..+||+|||||+.+.++...          
T Consensus       293 r~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~---~~~vKIsDFGLAr~~~d~~Y~----------  359 (468)
T KOG0197|consen  293 RTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE---DLVVKISDFGLARLIGDDEYT----------  359 (468)
T ss_pred             hhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc---CceEEEcccccccccCCCcee----------
Confidence            87  457999999999999999999999999999999999999964   457999999999843322110          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       360 --------------------------------------------------------------------------------  359 (468)
T KOG0197|consen  360 --------------------------------------------------------------------------------  359 (468)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     .+.+.--...|.|||++....|+.|||||||||+||||+| |+.||.+....++++.|.+|...+
T Consensus       360 ---------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  360 ---------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP  424 (468)
T ss_pred             ---------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence                           0000001234999999999999999999999999999997 899999999999999999999999


Q ss_pred             CCCccccCc
Q psy2131         318 EPKHKSASV  326 (328)
Q Consensus       318 ~~~~~~~~~  326 (328)
                      +|..|+..+
T Consensus       425 ~P~~CP~~v  433 (468)
T KOG0197|consen  425 RPEGCPDEV  433 (468)
T ss_pred             CCCCCCHHH
Confidence            999998753

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2e-42  Score=314.31  Aligned_cols=209  Identities=30%  Similarity=0.514  Sum_probs=175.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|++..+++.||+|+++..... ......+.+|+.++.++ +||||+++++++.+.+..|+|||||+||+|..
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~   85 (329)
T cd05618           6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF   85 (329)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHH
Confidence            89999999999999999999999865432 33456678899988876 89999999999999999999999999999998


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus        86 ~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---~~~kL~DfG~~~~~~~~~~-----------  151 (329)
T cd05618          86 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGD-----------  151 (329)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CCEEEeeCCccccccCCCC-----------
Confidence            88888889999999999999999999999999999999999999754   4599999999743210000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       152 --------------------------------------------------------------------------------  151 (329)
T cd05618         152 --------------------------------------------------------------------------------  151 (329)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC---------ccHHHHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD---------EDQHRLYAQ  309 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---------~~~~~~~~~  309 (328)
                                     ......||+.|+|||++.+..|+.++|+|||||++|||+||+.||..         .....+.+.
T Consensus       152 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05618         152 ---------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  216 (329)
T ss_pred             ---------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH
Confidence                           01124589999999999999999999999999999999999999952         224456677


Q ss_pred             HhcccCCCC
Q psy2131         310 IKAGAYDDE  318 (328)
Q Consensus       310 i~~~~~~~~  318 (328)
                      +..+....|
T Consensus       217 i~~~~~~~p  225 (329)
T cd05618         217 ILEKQIRIP  225 (329)
T ss_pred             HhcCCCCCC
Confidence            777766544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-42  Score=320.33  Aligned_cols=206  Identities=32%  Similarity=0.539  Sum_probs=174.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+++.||+|+++..... ......+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        54 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~  133 (370)
T cd05596          54 GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL  133 (370)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHH
Confidence            89999999999999999999999754322 22345577899999999999999999999999999999999999999887


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       134 l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---~~~kL~DfG~~~~~~~~~~------------  197 (370)
T cd05596         134 MSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMDANGM------------  197 (370)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC---CCEEEEeccceeeccCCCc------------
Confidence            754 468999999999999999999999999999999999999754   4699999999754311100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (370)
T cd05596         198 --------------------------------------------------------------------------------  197 (370)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC----CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE----PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......||+.|+|||++.+.    .++.++|||||||++|||++|++||.+.+...++.+|..+..
T Consensus       198 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  264 (370)
T cd05596         198 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN  264 (370)
T ss_pred             -------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence                         001124599999999999754    378999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=320.89  Aligned_cols=239  Identities=31%  Similarity=0.567  Sum_probs=185.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||+++...... .....+.+|+.++..++||||+++++++.+.+..|+|||||+|++|.+.
T Consensus        12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   91 (350)
T cd05573          12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL   91 (350)
T ss_pred             CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHH
Confidence            899999999999999999999998654322 3456688999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..........          
T Consensus        92 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~----------  158 (350)
T cd05573          92 LIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKDRE----------  158 (350)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEeecCCCCccCcccCccc----------
Confidence            9888889999999999999999999999999999999999999754   459999999986543321100          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                         .+..                 ...   ..+.                +.   ....+.                   
T Consensus       159 ---~~~~-----------------~~~---~~~~----------------~~---~~~~~~-------------------  177 (350)
T cd05573         159 ---YYLN-----------------DSH---NLLF----------------RD---NVLVRR-------------------  177 (350)
T ss_pred             ---cccc-----------------ccc---cccc----------------cc---cccccc-------------------
Confidence               0000                 000   0000                00   000000                   


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc--ccCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDD  317 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~  317 (328)
                            ..............||+.|+|||++.+..++.++|||||||++|||++|++||.+.+......+|..  .....
T Consensus       178 ------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (350)
T cd05573         178 ------RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF  251 (350)
T ss_pred             ------cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccC
Confidence                  0000001112235699999999999999999999999999999999999999999998888888887  44444


Q ss_pred             CC
Q psy2131         318 EP  319 (328)
Q Consensus       318 ~~  319 (328)
                      |+
T Consensus       252 p~  253 (350)
T cd05573         252 PP  253 (350)
T ss_pred             CC
Confidence            33

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-42  Score=313.29  Aligned_cols=209  Identities=32%  Similarity=0.551  Sum_probs=180.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..+++.||+|+++..... ......+.+|+.+++.+ +||||+++++++.+.+.+|+|||||+||+|..
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   85 (318)
T cd05570           6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMF   85 (318)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHH
Confidence            89999999999999999999999865322 33456677899999888 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus        86 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~------------  150 (318)
T cd05570          86 HIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGG------------  150 (318)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---CcEEecccCCCeecCcCC------------
Confidence            88888889999999999999999999999999999999999999754   469999999874311000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (318)
T cd05570         151 --------------------------------------------------------------------------------  150 (318)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .......||+.|+|||++.+..|+.++|+|||||++|+|+||+.||.+.+...++..|.++....|
T Consensus       151 --------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~  216 (318)
T cd05570         151 --------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP  216 (318)
T ss_pred             --------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          001123589999999999999999999999999999999999999999999999999988877543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG4236|consensus

Probab=100.00  E-value=1.5e-43  Score=318.14  Aligned_cols=213  Identities=33%  Similarity=0.568  Sum_probs=189.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.||+||-+.++.+|+.||||+|.+.+...++..++.+|+.||+.++||.||.+...|++.+.++.|||-+.| +.++.+
T Consensus       575 GQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMI  653 (888)
T KOG4236|consen  575 GQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMI  653 (888)
T ss_pred             CcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHH
Confidence            7899999999999999999999999888877778899999999999999999999999999999999999966 666666


Q ss_pred             H--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 V--AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~--~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .  .++.+++....+++.||+.||+|||.+||||+||||||||+.+...-..+||||||+|+.+....            
T Consensus       654 LSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------------  721 (888)
T KOG4236|consen  654 LSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------------  721 (888)
T ss_pred             HHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------------
Confidence            4  35689999999999999999999999999999999999999988777789999999997653211            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       722 --------------------------------------------------------------------------------  721 (888)
T KOG4236|consen  722 --------------------------------------------------------------------------------  721 (888)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     -+.+.+|||.|.|||+|.+++|+..-|+||.|||+|.-|+|..||...  +++...|..+.|+.|
T Consensus       722 ---------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyP  784 (888)
T KOG4236|consen  722 ---------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYP  784 (888)
T ss_pred             ---------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccC
Confidence                           123468999999999999999999999999999999999999999754  356677788999999


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |.|-+
T Consensus       785 p~PW~  789 (888)
T KOG4236|consen  785 PNPWS  789 (888)
T ss_pred             CCchh
Confidence            98754

>KOG0604|consensus

Probab=100.00  E-value=9.3e-44  Score=300.00  Aligned_cols=221  Identities=40%  Similarity=0.682  Sum_probs=194.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh-CCCCCcceeEEEEEe----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQE----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~   75 (328)
                      |-.|.|..|.++.||+.||+|++..       ..+..||+++--. -.|||||.++++|++    ...+.+|||.++||+
T Consensus        73 GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGe  145 (400)
T KOG0604|consen   73 GINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGE  145 (400)
T ss_pred             ccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchH
Confidence            5578999999999999999999852       3456678887444 479999999998864    567899999999999


Q ss_pred             cHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC--------
Q psy2131          76 LFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE--------  145 (328)
Q Consensus        76 L~~~l~~~~~--~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~--------  145 (328)
                      |+..++.++.  |+|.++..|++||..|+.|||+.+|.||||||||+|....+.+..+||+|||+|++.+..        
T Consensus       146 Lfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~  225 (400)
T KOG0604|consen  146 LFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCF  225 (400)
T ss_pred             HHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcc
Confidence            9999988765  999999999999999999999999999999999999999988999999999999865421        


Q ss_pred             ------------------Cc-chHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHh
Q psy2131         146 ------------------QQ-AWFGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM  202 (328)
Q Consensus       146 ------------------~~-~~~G~~~~~~~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  202 (328)
                                        .+ +.+|+++|.|++|+|||.....    ..+..+|..+.|.||.++|+.+|++.+++|.++
T Consensus       226 TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~L  305 (400)
T KOG0604|consen  226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKL  305 (400)
T ss_pred             cccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHH
Confidence                              12 2389999999999999976543    356788999999999999999999999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         203 LTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      |..+|++|.|+.+.++|||+.+....
T Consensus       306 Lkt~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  306 LKTEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             hcCCchhheeHHHhhcCchhcccccC
Confidence            99999999999999999999886543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-42  Score=313.66  Aligned_cols=206  Identities=32%  Similarity=0.524  Sum_probs=175.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+++.||+|++.... ........+.+|+.++..++|+||+++++++.+.+..|+|||||+||+|.++
T Consensus        12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~   91 (331)
T cd05624          12 GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTL   91 (331)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            899999999999999999999997532 2223345578899999999999999999999999999999999999999999


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus        92 l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~-----------  157 (331)
T cd05624          92 LSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT-----------  157 (331)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC---CCEEEEeccceeeccCCCc-----------
Confidence            876 4679999999999999999999999999999999999999754   4599999999854321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (331)
T cd05624         158 --------------------------------------------------------------------------------  157 (331)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    .......||+.|+|||++.+     ..++.++|+||+||+||||++|+.||.+.+..+.+.+|...
T Consensus       158 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05624         158 --------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             --------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence                          00011358999999999976     56889999999999999999999999999988888888775


Q ss_pred             c
Q psy2131         314 A  314 (328)
Q Consensus       314 ~  314 (328)
                      .
T Consensus       224 ~  224 (331)
T cd05624         224 E  224 (331)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.7e-42  Score=312.32  Aligned_cols=208  Identities=29%  Similarity=0.520  Sum_probs=176.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..+++.||+|+++..... ....+.+.+|+.++.++ +||||+++++++.+.+.+|+|||||+||+|..
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   85 (327)
T cd05617           6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMF   85 (327)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            89999999999999999999999865433 33456688999999888 69999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus        86 ~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~-----------  151 (327)
T cd05617          86 HMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGD-----------  151 (327)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---CCEEEeccccceeccCCCC-----------
Confidence            88887889999999999999999999999999999999999999754   4599999998743210000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       152 --------------------------------------------------------------------------------  151 (327)
T cd05617         152 --------------------------------------------------------------------------------  151 (327)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC-------ccHHHHHHHHh
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD-------EDQHRLYAQIK  311 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-------~~~~~~~~~i~  311 (328)
                                     ......||+.|+|||++.+..|+.++|||||||+||||+||+.||..       .....+++.+.
T Consensus       152 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  216 (327)
T cd05617         152 ---------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL  216 (327)
T ss_pred             ---------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence                           01124589999999999999999999999999999999999999953       23456777777


Q ss_pred             cccCCC
Q psy2131         312 AGAYDD  317 (328)
Q Consensus       312 ~~~~~~  317 (328)
                      .+....
T Consensus       217 ~~~~~~  222 (327)
T cd05617         217 EKPIRI  222 (327)
T ss_pred             hCCCCC
Confidence            766543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.3e-42  Score=325.55  Aligned_cols=214  Identities=27%  Similarity=0.440  Sum_probs=182.0

Q ss_pred             CCceEEEEEEEccC-CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKAT-GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~-~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+ ++.+|+|.+...  .......+.+|+.+|+.++|||||++++++...+.+|||||||+||+|.+.
T Consensus        78 G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~  155 (478)
T PTZ00267         78 NPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ  155 (478)
T ss_pred             CCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHH
Confidence            78999999998887 788999987543  233445678899999999999999999999999999999999999999887


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++........        
T Consensus       156 l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~---~~~kL~DFgla~~~~~~~~--------  224 (478)
T PTZ00267        156 IKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVS--------  224 (478)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC---CcEEEEeCcCceecCCccc--------
Confidence            643    3468999999999999999999999999999999999999754   4699999999865321100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       225 --------------------------------------------------------------------------------  224 (478)
T PTZ00267        225 --------------------------------------------------------------------------------  224 (478)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+...++..+..|.+
T Consensus       225 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~  288 (478)
T PTZ00267        225 ----------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY  288 (478)
T ss_pred             ----------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence                            0001134699999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       289 ~~~~~~~s  296 (478)
T PTZ00267        289 DPFPCPVS  296 (478)
T ss_pred             CCCCccCC
Confidence            76665554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.1e-42  Score=306.05  Aligned_cols=193  Identities=29%  Similarity=0.519  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|++....... .....+.+|+.++++++|+||+++++++.+.+..|+|||||++|+|.+.
T Consensus        11 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~   90 (285)
T cd05631          11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH   90 (285)
T ss_pred             CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHH
Confidence            899999999999999999999997654332 2234577899999999999999999999999999999999999999877


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...  ..+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.......           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~-----------  156 (285)
T cd05631          91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR---GHIRISDLGLAVQIPEGE-----------  156 (285)
T ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeCCCcEEcCCCC-----------
Confidence            7543  368999999999999999999999999999999999999754   459999999975431100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (285)
T cd05631         157 --------------------------------------------------------------------------------  156 (285)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                      ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus       157 ----------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         157 ----------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             ----------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence                            00123589999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582|consensus

Probab=100.00  E-value=2.3e-42  Score=305.49  Aligned_cols=205  Identities=32%  Similarity=0.506  Sum_probs=174.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.-++||+|+...+++.||||+++.++-+.+ ++.+.+|++.|+.++||||++++.+|..+..+|+||.||.+|++++.+
T Consensus        37 G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIi  115 (516)
T KOG0582|consen   37 GASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDII  115 (516)
T ss_pred             cceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHH
Confidence            4557999999999999999999998776554 788999999999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..++|..+..++++++.||.|||++|-||||||+.||||+++   |.|||+|||.+..+.....           
T Consensus       116 k~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d---G~VkLadFgvsa~l~~~G~-----------  181 (516)
T KOG0582|consen  116 KTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD---GTVKLADFGVSASLFDSGD-----------  181 (516)
T ss_pred             HHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC---CcEEEcCceeeeeecccCc-----------
Confidence            764  359999999999999999999999999999999999999865   4599999998644321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                 |    
T Consensus       182 ---------------------------------------------------------------------------R----  182 (516)
T KOG0582|consen  182 ---------------------------------------------------------------------------R----  182 (516)
T ss_pred             ---------------------------------------------------------------------------e----
Confidence                                                                                       0    


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH-HHHHHh
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIK  311 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~  311 (328)
                                  .......++|||.|||||++..  .+|+.|+|||||||+..||.+|..||..-.|.. |+.++.
T Consensus       183 ------------~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq  246 (516)
T KOG0582|consen  183 ------------QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ  246 (516)
T ss_pred             ------------eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence                        0001146789999999999754  689999999999999999999999999988666 444543

>KOG4250|consensus

Probab=100.00  E-value=2.1e-43  Score=327.72  Aligned_cols=193  Identities=35%  Similarity=0.539  Sum_probs=167.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||.||+++++.||+.+|||.++... ..+..++.-+|+++|++|+|+|||+++++-++..      ...+|||||.||
T Consensus        24 Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gG  102 (732)
T KOG4250|consen   24 GAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGG  102 (732)
T ss_pred             CccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCC
Confidence            899999999999999999999998754 3445677889999999999999999999876544      458999999999


Q ss_pred             CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCC-cEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIVAR---EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGA-AVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~~~---~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~-~vkl~DfGla~~~~~~~~~~~  150 (328)
                      ||...+.+.   ..++|.+...++..+..||.|||++|||||||||.||++....++. ..||+|||.|+.++++.    
T Consensus       103 sL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----  178 (732)
T KOG4250|consen  103 SLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----  178 (732)
T ss_pred             cHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----
Confidence            999988754   3599999999999999999999999999999999999997654333 35999999998875432    


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       179 --------------------------------------------------------------------------------  178 (732)
T KOG4250|consen  179 --------------------------------------------------------------------------------  178 (732)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                             ...+++||+.|.+||+++. +.|+..+|.|||||++|+..||..||.--
T Consensus       179 -----------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  179 -----------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             -----------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence                                   1235789999999999995 88999999999999999999999999744

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-42  Score=311.12  Aligned_cols=205  Identities=32%  Similarity=0.542  Sum_probs=173.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+.+.+|+||||++||+|.++
T Consensus        12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   91 (331)
T cd05597          12 GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTL   91 (331)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHH
Confidence            8999999999999999999999975322 233455678899999999999999999999999999999999999999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||++........           
T Consensus        92 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~-----------  157 (331)
T cd05597          92 LSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN---GHIRLADFGSCLRLLADGT-----------  157 (331)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC---CCEEEEECCceeecCCCCC-----------
Confidence            876 4579999999999999999999999999999999999999654   4599999999754321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (331)
T cd05597         158 --------------------------------------------------------------------------------  157 (331)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||.+.+..+.+..|...
T Consensus       158 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05597         158 --------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             --------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence                          00011358999999999973     45789999999999999999999999999988888888654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.3e-42  Score=305.88  Aligned_cols=204  Identities=32%  Similarity=0.491  Sum_probs=171.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+++.+|+|+++.........+.+.+|+.+++.++||||+++++++.+.+..|+||||++++.+....
T Consensus        12 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~   91 (287)
T cd07848          12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE   91 (287)
T ss_pred             cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH
Confidence            78999999999999999999999866544445567789999999999999999999999999999999999987765444


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++..+..++.|++.||.|||+.+|+||||||+|||++.+   +.+||+|||++........             
T Consensus        92 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~-------------  155 (287)
T cd07848          92 EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSN-------------  155 (287)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccCccccccccc-------------
Confidence            445679999999999999999999999999999999999999754   4699999999754311000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (287)
T cd07848         156 --------------------------------------------------------------------------------  155 (287)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                  .......||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+....+..+.+
T Consensus       156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~  215 (287)
T cd07848         156 ------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK  215 (287)
T ss_pred             ------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                        000123589999999999999999999999999999999999999999876665555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0614|consensus

Probab=100.00  E-value=3.9e-44  Score=320.68  Aligned_cols=204  Identities=32%  Similarity=0.575  Sum_probs=186.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|-++..+.....+|+|++++...- .++.+.+..|-+||..++.|.||++|-.|.++.++|+.||-|-||.|+..
T Consensus       431 GgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTi  510 (732)
T KOG0614|consen  431 GGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTI  510 (732)
T ss_pred             CccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhh
Confidence            89999999987776667999999876543 44566788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +..++.|++..+++|+..+++|+.|||.+|||.|||||||+|++.   .+-+||.|||+|+.+......           
T Consensus       511 LrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~---~Gy~KLVDFGFAKki~~g~KT-----------  576 (732)
T KOG0614|consen  511 LRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN---RGYLKLVDFGFAKKIGSGRKT-----------  576 (732)
T ss_pred             hhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc---CCceEEeehhhHHHhccCCce-----------
Confidence            999999999999999999999999999999999999999999975   456999999999876544333           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       577 --------------------------------------------------------------------------------  576 (732)
T KOG0614|consen  577 --------------------------------------------------------------------------------  576 (732)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      .+++|||.|.|||++.+++++.++|.|||||.+||||||.|||.+.|+..+++.|.+|.
T Consensus       577 ----------------wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi  635 (732)
T KOG0614|consen  577 ----------------WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI  635 (732)
T ss_pred             ----------------eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence                            35789999999999999999999999999999999999999999999999999999995

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-41  Score=310.06  Aligned_cols=207  Identities=30%  Similarity=0.511  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+++++.+++.+|+|++..... .......+.+|+.++..++|+||+++++++.+.+.+|+|||||+||+|.++
T Consensus        12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~   91 (332)
T cd05623          12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTL   91 (332)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHH
Confidence            8999999999999999999999965322 222344578899999999999999999999999999999999999999999


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++..+.....           
T Consensus        92 l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~---~~~kL~DfG~a~~~~~~~~-----------  157 (332)
T cd05623          92 LSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT-----------  157 (332)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEeecchheecccCCc-----------
Confidence            876 4678999999999999999999999999999999999999754   4699999998754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (332)
T cd05623         158 --------------------------------------------------------------------------------  157 (332)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    .......||+.|+|||++.     ...|+.++|||||||++|||++|++||.+.+..+.+.+|...
T Consensus       158 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (332)
T cd05623         158 --------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (332)
T ss_pred             --------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence                          0011235999999999986     346899999999999999999999999999999999998876


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       224 ~~  225 (332)
T cd05623         224 KE  225 (332)
T ss_pred             Cc
Confidence            53

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0658|consensus

Probab=100.00  E-value=7.6e-43  Score=302.53  Aligned_cols=196  Identities=30%  Similarity=0.455  Sum_probs=164.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--C---EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--N---YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~---~~~lv~E~~~gg~   75 (328)
                      |+||+||+|....+++.+|||.+-.+..      --.+|+++|+.++|||||+|.-+|...  +   .+.+||||++. +
T Consensus        35 GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-t  107 (364)
T KOG0658|consen   35 GSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-T  107 (364)
T ss_pred             cccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-H
Confidence            8999999999999999999998865532      124799999999999999998888532  2   45689999976 8


Q ss_pred             cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          76 LFEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        76 L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      |.+.+..    +..++..+++.|..||+.||.|||+.||+||||||.|+|++.+  .+.+||||||.|+.+.....    
T Consensus       108 L~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKicDFGSAK~L~~~ep----  181 (364)
T KOG0658|consen  108 LYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKICDFGSAKVLVKGEP----  181 (364)
T ss_pred             HHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEeccCCcceeeccCCC----
Confidence            8888764    5678999999999999999999999999999999999999864  57899999999976533210    


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       182 --------------------------------------------------------------------------------  181 (364)
T KOG0658|consen  182 --------------------------------------------------------------------------------  181 (364)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                             ..++.-|..|+|||.+.| ..|++++||||.||||.||+-|++-|.|++...++.-|
T Consensus       182 -----------------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI  238 (364)
T KOG0658|consen  182 -----------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI  238 (364)
T ss_pred             -----------------------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence                                   113446888999999987 57999999999999999999999999999877776665


Q ss_pred             hc
Q psy2131         311 KA  312 (328)
Q Consensus       311 ~~  312 (328)
                      ..
T Consensus       239 ik  240 (364)
T KOG0658|consen  239 IK  240 (364)
T ss_pred             HH
Confidence            54

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=324.57  Aligned_cols=216  Identities=31%  Similarity=0.512  Sum_probs=185.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--------EEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--------YHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--------~~~lv~E~~~   72 (328)
                      |+||+||+|++..+|+.||||++.....+......+.+|+.++..++|+||+++++.+...+        .+++||||++
T Consensus        43 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~  122 (496)
T PTZ00283         43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYAN  122 (496)
T ss_pred             CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCC
Confidence            89999999999999999999999887777777778899999999999999999998876432        3789999999


Q ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          73 GGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        73 gg~L~~~l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      +|+|.+.+..+    ..+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||+++....... 
T Consensus       123 ~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~---~~vkL~DFGls~~~~~~~~-  198 (496)
T PTZ00283        123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN---GLVKLGDFGFSKMYAATVS-  198 (496)
T ss_pred             CCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC---CCEEEEecccCeecccccc-
Confidence            99999888643    468999999999999999999999999999999999999754   4699999999854311100 


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       199 --------------------------------------------------------------------------------  198 (496)
T PTZ00283        199 --------------------------------------------------------------------------------  198 (496)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYA  308 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~  308 (328)
                                             ........||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...++.
T Consensus       199 -----------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~  255 (496)
T PTZ00283        199 -----------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH  255 (496)
T ss_pred             -----------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence                                   000112469999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCCCCCCccc
Q psy2131         309 QIKAGAYDDEPKHKS  323 (328)
Q Consensus       309 ~i~~~~~~~~~~~~~  323 (328)
                      ++..+.+.+.|...+
T Consensus       256 ~~~~~~~~~~~~~~~  270 (496)
T PTZ00283        256 KTLAGRYDPLPPSIS  270 (496)
T ss_pred             HHhcCCCCCCCCCCC
Confidence            999998877666554

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-42  Score=312.08  Aligned_cols=206  Identities=32%  Similarity=0.537  Sum_probs=176.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+..|+|||||+||+|.++
T Consensus        12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   91 (330)
T cd05601          12 GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSL   91 (330)
T ss_pred             ccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHH
Confidence            8999999999999999999999986543 233456678999999999999999999999999999999999999999999


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........          
T Consensus        92 l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~----------  158 (330)
T cd05601          92 LNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT---GHIKLADFGSAARLTANKMV----------  158 (330)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC---CCEEeccCCCCeECCCCCce----------
Confidence            8775 679999999999999999999999999999999999999754   45999999998543211000          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (330)
T cd05601         159 --------------------------------------------------------------------------------  158 (330)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc------cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                     ......||+.|+|||++.      +..|+.++|||||||++|||++|+.||.+.+....+.+|.+
T Consensus       159 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  223 (330)
T cd05601         159 ---------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN  223 (330)
T ss_pred             ---------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence                           001125899999999987      56788999999999999999999999999998888888876


Q ss_pred             cc
Q psy2131         313 GA  314 (328)
Q Consensus       313 ~~  314 (328)
                      ..
T Consensus       224 ~~  225 (330)
T cd05601         224 FQ  225 (330)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.8e-42  Score=304.07  Aligned_cols=202  Identities=32%  Similarity=0.434  Sum_probs=169.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+++.||+|+++..... .....+.+|++++++++||||+++++++.+.+..|+||||+.+ +|.+.+
T Consensus        16 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l   93 (288)
T cd07871          16 GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL   93 (288)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHH
Confidence            89999999999999999999999754322 2234567899999999999999999999999999999999985 888888


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+ .+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~DfG~~~~~~~~~~------------  158 (288)
T cd07871          94 DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLARAKSVPTK------------  158 (288)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEECcCcceeeccCCCc------------
Confidence            6544 57999999999999999999999999999999999999754   4599999999753211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (288)
T cd07871         159 --------------------------------------------------------------------------------  158 (288)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    ......||+.|+|||++.+ ..|+.++|+||+||++|||+||++||.+.+..+.+..+.+.
T Consensus       159 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  219 (288)
T cd07871         159 --------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL  219 (288)
T ss_pred             --------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                          0011347999999999876 56899999999999999999999999999887777776654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-41  Score=302.24  Aligned_cols=193  Identities=35%  Similarity=0.604  Sum_probs=164.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.++.+|+.||+|++....... ...+.+..|+++++.++|+||+++++++.+.+..|+|||||+||+|.+.
T Consensus         4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   83 (280)
T cd05608           4 GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYH   83 (280)
T ss_pred             CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHH
Confidence            899999999999999999999997654332 2345678899999999999999999999999999999999999999877


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++........        
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~--------  152 (280)
T cd05608          84 IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND---GNVRISDLGLAVELKDGQS--------  152 (280)
T ss_pred             HHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCccceecCCCCc--------
Confidence            642    3468999999999999999999999999999999999999653   4699999999754311100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       153 --------------------------------------------------------------------------------  152 (280)
T cd05608         153 --------------------------------------------------------------------------------  152 (280)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                        ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus       153 ------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         153 ------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             ------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                              0112358999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.7e-42  Score=310.58  Aligned_cols=203  Identities=29%  Similarity=0.465  Sum_probs=167.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|+++.+|+.||||+++...........+.+|+++++.++||||+++++++...     ..+|+|||||. ++
T Consensus        11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~   89 (338)
T cd07859          11 GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SD   89 (338)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CC
Confidence            8999999999999999999999975544444556788999999999999999999988643     35899999995 68


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus        90 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~-------  159 (338)
T cd07859          90 LHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPT-------  159 (338)
T ss_pred             HHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEccCccccccccccCc-------
Confidence            98888887889999999999999999999999999999999999999754   46999999997532110000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (338)
T cd07859         160 --------------------------------------------------------------------------------  159 (338)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                      ........||+.|+|||++.+  ..|+.++|||||||++|||+||++||.+.+....+..+
T Consensus       160 ----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~  220 (338)
T cd07859         160 ----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI  220 (338)
T ss_pred             ----------------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence                            000112458999999999976  67899999999999999999999999988765555443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.7e-41  Score=305.67  Aligned_cols=206  Identities=33%  Similarity=0.553  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLS--ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++.   .+++.||+|++......  ....+.+.+|+.+++.+ +||||+++++++.+.+.+|+|||||+||
T Consensus        11 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g   90 (332)
T cd05614          11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGG   90 (332)
T ss_pred             cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCC
Confidence            899999998764   57899999999754322  22345678899999999 5999999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+..+..+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++........       
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---~~~kl~DfG~~~~~~~~~~-------  160 (332)
T cd05614          91 EMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEEK-------  160 (332)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---CCEEEeeCcCCccccccCC-------
Confidence            999999888889999999999999999999999999999999999999754   4699999999754211000       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (332)
T cd05614         161 --------------------------------------------------------------------------------  160 (332)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCc----cHHHHHHH
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQ  309 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~  309 (328)
                                        .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...    ....+...
T Consensus       161 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  222 (332)
T cd05614         161 ------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR  222 (332)
T ss_pred             ------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence                              001124599999999999875 4799999999999999999999999753    23444555


Q ss_pred             Hhccc
Q psy2131         310 IKAGA  314 (328)
Q Consensus       310 i~~~~  314 (328)
                      +....
T Consensus       223 ~~~~~  227 (332)
T cd05614         223 ILKCD  227 (332)
T ss_pred             HhcCC
Confidence            55444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4721|consensus

Probab=100.00  E-value=2.2e-42  Score=313.15  Aligned_cols=192  Identities=29%  Similarity=0.483  Sum_probs=170.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+.|.||+++.  .++.||||.++..         -+.+|+-|++|+|||||.|.++|.....++||||||..|.|++.|
T Consensus       135 GaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL  203 (904)
T KOG4721|consen  135 GAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL  203 (904)
T ss_pred             Ccccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence            78899999975  5678999987632         245789999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+.......|..+|+.|++|||.+.|||||||.-||||..+   ..|||+|||.++...                 
T Consensus       204 ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~---d~VKIsDFGTS~e~~-----------------  263 (904)
T KOG4721|consen  204 KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD---DVVKISDFGTSKELS-----------------  263 (904)
T ss_pred             hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc---ceEEeccccchHhhh-----------------
Confidence            999999999999999999999999999999999999999999754   469999999875431                 


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       264 --------------------------------------------------------------------------------  263 (904)
T KOG4721|consen  264 --------------------------------------------------------------------------------  263 (904)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                +++++.+|+||..|||||+|++.+.+.|+|||||||||||||||..||.+-+-..+...+-+-
T Consensus       264 ----------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN  326 (904)
T KOG4721|consen  264 ----------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN  326 (904)
T ss_pred             ----------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence                      135677899999999999999999999999999999999999999999998887776664443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-41  Score=305.82  Aligned_cols=215  Identities=22%  Similarity=0.374  Sum_probs=169.5

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-CEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE-NYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~-~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+     ..+++.||+|+++.. ........+.+|+.+|+.+ +|||||++++++... +.+|+|||||+|
T Consensus        18 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~   96 (338)
T cd05102          18 GAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKY   96 (338)
T ss_pred             CCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCC
Confidence            89999999975     345678999999753 2334456788999999999 899999999988764 468999999999


Q ss_pred             CCcHHHHHhc--------------------------------------------------------------CCCCHHHH
Q psy2131          74 GELFEDIVAR--------------------------------------------------------------EFYSEADA   91 (328)
Q Consensus        74 g~L~~~l~~~--------------------------------------------------------------~~~~~~~~   91 (328)
                      |+|.+++...                                                              ..+++.++
T Consensus        97 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  176 (338)
T cd05102          97 GNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDL  176 (338)
T ss_pred             CcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHH
Confidence            9999888642                                                              23677888


Q ss_pred             HHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHH
Q psy2131          92 SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHR  171 (328)
Q Consensus        92 ~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~  171 (328)
                      ..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++........                       
T Consensus       177 ~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~-----------------------  230 (338)
T cd05102         177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDY-----------------------  230 (338)
T ss_pred             HHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC---CcEEEeecccccccccCcch-----------------------
Confidence            8999999999999999999999999999999754   46999999998543111000                       


Q ss_pred             HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhh
Q psy2131         172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK  251 (328)
Q Consensus       172 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (328)
                                                                                                      
T Consensus       231 --------------------------------------------------------------------------------  230 (338)
T cd05102         231 --------------------------------------------------------------------------------  230 (338)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCcc-HHHHHHHHhcccCCCCCCccc
Q psy2131         252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDED-QHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       252 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  323 (328)
                       .......+|+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+ ...+...+..+.....|..++
T Consensus       231 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (338)
T cd05102         231 -VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENAT  303 (338)
T ss_pred             -hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCC
Confidence             00011236788999999999999999999999999999997 999999865 345556666666544454443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-40  Score=296.30  Aligned_cols=203  Identities=16%  Similarity=0.168  Sum_probs=172.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH-HHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~   75 (328)
                      |++|.||+|..  +|+.||||+++......+. .+.+.+|+.+|++++|||||++++++.+    ...+++|||||+||+
T Consensus        31 g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~  108 (283)
T PHA02988         31 NDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGY  108 (283)
T ss_pred             CCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCc
Confidence            78999999986  7889999999865443332 4678899999999999999999999877    457899999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      |.+.+...+.+++.....++.|++.||.|||+ .+++||||||+|||++.+   +.+||+|||++......         
T Consensus       109 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~---~~~kl~dfg~~~~~~~~---------  176 (283)
T PHA02988        109 LREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN---YKLKIICHGLEKILSSP---------  176 (283)
T ss_pred             HHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC---CcEEEcccchHhhhccc---------
Confidence            99999888889999999999999999999998 499999999999999754   46999999987432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       177 --------------------------------------------------------------------------------  176 (283)
T PHA02988        177 --------------------------------------------------------------------------------  176 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                          .....||+.|+|||++.+  ..|+.++|||||||++|||+||+.||.+.+..+++..+..
T Consensus       177 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~  236 (283)
T PHA02988        177 --------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN  236 (283)
T ss_pred             --------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence                                001247899999999977  6899999999999999999999999999999999988876


Q ss_pred             ccCCC
Q psy2131         313 GAYDD  317 (328)
Q Consensus       313 ~~~~~  317 (328)
                      +...+
T Consensus       237 ~~~~~  241 (283)
T PHA02988        237 KNNSL  241 (283)
T ss_pred             cCCCC
Confidence            65443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.8e-40  Score=301.67  Aligned_cols=199  Identities=26%  Similarity=0.408  Sum_probs=173.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+|..+|+|++.... .......+.+|+++|++++||||+++++++.+.+..|+||||++||+|.+++
T Consensus        16 G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (331)
T cd06649          16 GNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL   94 (331)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHH
Confidence            899999999999999999999997643 3444567899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .....+++..+..++.|++.||.|||+. +|+||||||+|||++.+   +.+||+|||++......              
T Consensus        95 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~--------------  157 (331)
T cd06649          95 KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS--------------  157 (331)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---CcEEEccCccccccccc--------------
Confidence            8888899999999999999999999986 69999999999999754   45999999987432110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (331)
T cd06649         158 --------------------------------------------------------------------------------  157 (331)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                    ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..++...+.
T Consensus       158 --------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~  215 (331)
T cd06649         158 --------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG  215 (331)
T ss_pred             --------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence                          0112358999999999999999999999999999999999999999888777655443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-40  Score=293.37  Aligned_cols=205  Identities=33%  Similarity=0.496  Sum_probs=169.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+++++.+|+.||+|++..+..... ....+..|++++++++||||+++++++.+....|+||||++|++|.+.
T Consensus         4 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   83 (277)
T cd05607           4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYH   83 (277)
T ss_pred             CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999975443322 223456799999999999999999999999999999999999999887


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +....  .+++..+..++.|++.||+|||+.||+||||||+|||++.+   +.++|+|||++........          
T Consensus        84 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~~l~Dfg~~~~~~~~~~----------  150 (277)
T cd05607          84 IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGKT----------  150 (277)
T ss_pred             HHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC---CCEEEeeceeeeecCCCce----------
Confidence            75433  58889999999999999999999999999999999999754   4599999998754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (277)
T cd05607         151 --------------------------------------------------------------------------------  150 (277)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc----HHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~  313 (328)
                                       .....||+.|+|||++.+..++.++|+||+||++|||++|+.||.+..    ...+...+..+
T Consensus       151 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  213 (277)
T cd05607         151 -----------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED  213 (277)
T ss_pred             -----------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc
Confidence                             001248999999999999999999999999999999999999998653    34555555555


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       214 ~~  215 (277)
T cd05607         214 EV  215 (277)
T ss_pred             cc
Confidence            44

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-40  Score=298.69  Aligned_cols=191  Identities=30%  Similarity=0.419  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+++.||+|+++..... .....+.+|+.+++.++||||+++++++.+.+..|+|||||. ++|.+.+
T Consensus        16 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~   93 (303)
T cd07869          16 GSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYM   93 (303)
T ss_pred             cCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHH
Confidence            89999999999999999999999754322 223456789999999999999999999999999999999996 5787777


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... +.+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~------------  158 (303)
T cd07869          94 DKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT---GELKLADFGLARAKSVPSH------------  158 (303)
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECCCCcceeccCCCc------------
Confidence            654 568999999999999999999999999999999999999754   4599999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (303)
T cd07869         159 --------------------------------------------------------------------------------  158 (303)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                    ......||+.|+|||++.+ ..|+.++||||+||++|||+||++||.+.+
T Consensus       159 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         159 --------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             --------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                          0012347999999999876 457999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=294.29  Aligned_cols=196  Identities=31%  Similarity=0.513  Sum_probs=166.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||++.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++.+++.+|+|||||.||+|.+.
T Consensus        11 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (285)
T cd05605          11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH   90 (285)
T ss_pred             CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHH
Confidence            8999999999999999999999976543322 234567899999999999999999999999999999999999999887


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||++.......           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~-----------  156 (285)
T cd05605          91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY---GHIRISDLGLAVEIPEGE-----------  156 (285)
T ss_pred             HHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC---CCEEEeeCCCceecCCCC-----------
Confidence            7543  458999999999999999999999999999999999999754   469999999875421100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (285)
T cd05605         157 --------------------------------------------------------------------------------  156 (285)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....
T Consensus       157 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~  209 (285)
T cd05605         157 ----------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK  209 (285)
T ss_pred             ----------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence                            00123589999999999999999999999999999999999999998766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0986|consensus

Probab=100.00  E-value=5.8e-42  Score=303.21  Aligned_cols=192  Identities=33%  Similarity=0.559  Sum_probs=171.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHH-HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~-~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||-|+.+.||+-||+|.+.++++..+.- ....+|..||.+++.+.||.+--+|++.+.+++||..|+||||..+
T Consensus       196 GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfH  275 (591)
T KOG0986|consen  196 GGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFH  275 (591)
T ss_pred             ccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEE
Confidence            899999999999999999999998776554433 3457899999999999999999999999999999999999999888


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      |-..+  .|++..+.+|+++|+.||.+||+.+||.||+||+|||+++.++   ++|+|+|||.++...+.          
T Consensus       276 iyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~~g~~----------  342 (591)
T KOG0986|consen  276 IYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIPEGKP----------  342 (591)
T ss_pred             eeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecCCCCc----------
Confidence            86655  7999999999999999999999999999999999999987654   99999999987754321          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       343 --------------------------------------------------------------------------------  342 (591)
T KOG0986|consen  343 --------------------------------------------------------------------------------  342 (591)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                       ..+.+||.+|||||++.+..|+...||||+||++|||+.|..||..-.
T Consensus       343 -----------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  343 -----------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             -----------------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence                             112379999999999999999999999999999999999999998664

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-40  Score=307.22  Aligned_cols=184  Identities=26%  Similarity=0.468  Sum_probs=159.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+++.||+|....        ..+.+|+++|++++|||||+++++|......++|||++. ++|...+
T Consensus       103 G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l  173 (391)
T PHA03212        103 GAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYL  173 (391)
T ss_pred             CCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHH
Confidence            8999999999999999999997532        345789999999999999999999999999999999995 6898888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++.++..++.|++.||.|||++|||||||||+|||++..   +.+||+|||+|.......              
T Consensus       174 ~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---~~vkL~DFG~a~~~~~~~--------------  236 (391)
T PHA03212        174 AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---GDVCLGDFGAACFPVDIN--------------  236 (391)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---CCEEEEeCCccccccccc--------------
Confidence            888889999999999999999999999999999999999999754   459999999974321000              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       237 --------------------------------------------------------------------------------  236 (391)
T PHA03212        237 --------------------------------------------------------------------------------  236 (391)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                 ........||+.|+|||++.+.+|+.++|||||||++|||+||+.||.+.
T Consensus       237 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        237 -----------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             -----------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence                       00011346999999999999999999999999999999999999988753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-40  Score=306.24  Aligned_cols=203  Identities=29%  Similarity=0.392  Sum_probs=172.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-----YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-----~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.+..+|+.||||++...........++.+|+.+++.++||||+++++++...+     ..|+||||+. ++
T Consensus        11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~   89 (372)
T cd07853          11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SD   89 (372)
T ss_pred             CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cC
Confidence            89999999999999999999999765444445567889999999999999999999998776     7899999997 57


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........        
T Consensus        90 l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~a~~~~~~~~--------  158 (372)
T cd07853          90 LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDES--------  158 (372)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC---CCEEeccccceeecccCcc--------
Confidence            88888777889999999999999999999999999999999999999754   4699999999754211000        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (372)
T cd07853         159 --------------------------------------------------------------------------------  158 (372)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       .......||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.++...+..|..
T Consensus       159 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  219 (372)
T cd07853         159 -----------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD  219 (372)
T ss_pred             -----------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence                             000113478999999999875 479999999999999999999999999988887777654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.8e-40  Score=293.82  Aligned_cols=206  Identities=30%  Similarity=0.378  Sum_probs=167.1

Q ss_pred             CCceEEEEEEEcc-CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC---CCCCcceeEEEEE-----eCCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQKA-TGLEFAAKIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHDSIQ-----EENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~-----~~~~~~lv~E~~   71 (328)
                      |+||+||+|++.. +|+.+|+|+++...........+.+|+.+++.+   +||||+++++++.     ....+++||||+
T Consensus        12 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~   91 (290)
T cd07862          12 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV   91 (290)
T ss_pred             CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccC
Confidence            8999999999854 578899999976544333334456777777665   6999999999985     345689999999


Q ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          72 TGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        72 ~gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      . ++|.+++...  ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......   
T Consensus        92 ~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~---  164 (290)
T cd07862          92 D-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQM---  164 (290)
T ss_pred             C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---CCEEEccccceEeccCCc---
Confidence            7 5888887653  358999999999999999999999999999999999999754   469999999975321100   


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (290)
T cd07862         165 --------------------------------------------------------------------------------  164 (290)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                              ......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+....+.+
T Consensus       165 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  220 (290)
T cd07862         165 ------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  220 (290)
T ss_pred             ------------------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence                                    01123589999999999999999999999999999999999999999998888888


Q ss_pred             HhcccCCC
Q psy2131         310 IKAGAYDD  317 (328)
Q Consensus       310 i~~~~~~~  317 (328)
                      |..+.-.+
T Consensus       221 i~~~~~~~  228 (290)
T cd07862         221 ILDVIGLP  228 (290)
T ss_pred             HHHHhCCC
Confidence            87654433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-40  Score=301.46  Aligned_cols=198  Identities=28%  Similarity=0.416  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+      .+|+||||+.+ 
T Consensus        32 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-  110 (359)
T cd07876          32 GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-  110 (359)
T ss_pred             CCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-
Confidence            89999999999999999999999866555555677889999999999999999999986543      57999999976 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......        
T Consensus       111 ~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~--------  177 (359)
T cd07876         111 NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNF--------  177 (359)
T ss_pred             CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEecCCCccccccCc--------
Confidence            5655553  348899999999999999999999999999999999999754   469999999974321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       178 --------------------------------------------------------------------------------  177 (359)
T cd07876         178 --------------------------------------------------------------------------------  177 (359)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                         ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+....+..+.
T Consensus       178 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~  235 (359)
T cd07876         178 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI  235 (359)
T ss_pred             -------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               0012358999999999999999999999999999999999999999888766555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4645|consensus

Probab=100.00  E-value=3.6e-42  Score=336.02  Aligned_cols=216  Identities=29%  Similarity=0.503  Sum_probs=188.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.||.||-|.+..||+..|+|.|+-+....+....+.+|..+|..++|||+|++|++-.+++.+||.||||+||+|.+.+
T Consensus      1246 G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll 1325 (1509)
T KOG4645|consen 1246 GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL 1325 (1509)
T ss_pred             cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH
Confidence            78999999999999999999999877655666677899999999999999999999999999999999999999999988


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+..+|...+.+..|++.|+.|||++|||||||||+||+++.+   +.+|++|||.|..+......            
T Consensus      1326 ~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~---g~iK~~DFGsa~ki~~~~~~------------ 1390 (1509)
T KOG4645|consen 1326 EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN---GLIKYGDFGSAVKIKNNAQT------------ 1390 (1509)
T ss_pred             HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC---CcEEeecccceeEecCchhc------------
Confidence            888888999999999999999999999999999999999999864   47999999999776442110            


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                            .|                                                        
T Consensus      1391 ----------------------~~-------------------------------------------------------- 1392 (1509)
T KOG4645|consen 1391 ----------------------MP-------------------------------------------------------- 1392 (1509)
T ss_pred             ----------------------CC--------------------------------------------------------
Confidence                                  00                                                        


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhcccCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYD  316 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~  316 (328)
                                  ..-++.+|||.|||||++.+   ++.+.+.||||||||+.||.||+.||..-| +++++-++..|+--
T Consensus      1393 ------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1393 ------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             ------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence                        01235679999999999954   678899999999999999999999999775 99999999999875


Q ss_pred             CCCCc
Q psy2131         317 DEPKH  321 (328)
Q Consensus       317 ~~~~~  321 (328)
                      ..|-.
T Consensus      1461 q~P~~ 1465 (1509)
T KOG4645|consen 1461 QIPER 1465 (1509)
T ss_pred             CCchh
Confidence            55543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.8e-40  Score=287.79  Aligned_cols=214  Identities=20%  Similarity=0.316  Sum_probs=177.2

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.++   ..+..+|+|.++... +......+.+|+.++++++||||+++++++...+..|+||||+++|+|.
T Consensus        16 G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (266)
T cd05064          16 GRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD   94 (266)
T ss_pred             cCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHH
Confidence            899999999765   456789999997643 3344567889999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... ..+++.++..++.|++.||+|||++|++||||||+|||++.+   +.+|++|||.+........         
T Consensus        95 ~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~---~~~~l~dfg~~~~~~~~~~---------  162 (266)
T cd05064          95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD---LVCKISGFRRLQEDKSEAI---------  162 (266)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC---CcEEECCCcccccccccch---------
Confidence            888764 478999999999999999999999999999999999999653   4699999997532110000         


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (266)
T cd05064         163 --------------------------------------------------------------------------------  162 (266)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+.++..
T Consensus       163 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~  226 (266)
T cd05064         163 ----------------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR  226 (266)
T ss_pred             ----------------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC
Confidence                            00001235678999999999999999999999999999775 9999999999999999998876


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       227 ~~~~~~~~  234 (266)
T cd05064         227 LPAPRNCP  234 (266)
T ss_pred             CCCCCCCC
Confidence            66565544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-39  Score=295.21  Aligned_cols=197  Identities=25%  Similarity=0.398  Sum_probs=170.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+..|+||||++||+|.+++
T Consensus        16 g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (333)
T cd06650          16 GNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL   94 (333)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHH
Confidence            799999999999999999999987643 3444567889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+   +.+||+|||++......              
T Consensus        95 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~--------------  157 (333)
T cd06650          95 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS--------------  157 (333)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---CCEEEeeCCcchhhhhh--------------
Confidence            8888899999999999999999999985 79999999999999754   45999999987432100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (333)
T cd06650         158 --------------------------------------------------------------------------------  157 (333)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                    ......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+...+...
T Consensus       158 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  213 (333)
T cd06650         158 --------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM  213 (333)
T ss_pred             --------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence                          00123589999999999999999999999999999999999999998776555443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.9e-40  Score=301.71  Aligned_cols=200  Identities=26%  Similarity=0.378  Sum_probs=169.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++...      ...|+||||+.+ 
T Consensus        35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-  113 (364)
T cd07875          35 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-  113 (364)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-
Confidence            8999999999999999999999986655555566788999999999999999999988643      357999999976 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......        
T Consensus       114 ~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~--------  180 (364)
T cd07875         114 NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  180 (364)
T ss_pred             CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC---CcEEEEeCCCccccCCCC--------
Confidence            67666643  48889999999999999999999999999999999999754   469999999975321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (364)
T cd07875         181 --------------------------------------------------------------------------------  180 (364)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.++...
T Consensus       181 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         181 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             -------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                               001235899999999999999999999999999999999999999999988888887654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-40  Score=309.17  Aligned_cols=196  Identities=26%  Similarity=0.388  Sum_probs=160.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--------NYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--------~~~~lv~E~~~   72 (328)
                      |+||+||+|.+..+++.||||++....      ....+|+.+|+.++|||||+++++|...        ..+++|||||+
T Consensus        77 G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~  150 (440)
T PTZ00036         77 GSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP  150 (440)
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC
Confidence            899999999999999999999986432      2235799999999999999999887432        25789999998


Q ss_pred             CCCcHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          73 GGELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        73 gg~L~~~l~----~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      + +|.+.+.    ....+++..+..++.|++.||+|||++|||||||||+|||++.+  +..+||+|||+|+.+....  
T Consensus       151 ~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~--~~~vkL~DFGla~~~~~~~--  225 (440)
T PTZ00036        151 Q-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQ--  225 (440)
T ss_pred             c-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCC--CCceeeeccccchhccCCC--
Confidence            6 6666554    34579999999999999999999999999999999999999743  2469999999985431100  


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       226 --------------------------------------------------------------------------------  225 (440)
T PTZ00036        226 --------------------------------------------------------------------------------  225 (440)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  307 (328)
                                               ...+..||+.|+|||++.+. .|+.++|||||||+||||+||.+||.+.+....+
T Consensus       226 -------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  280 (440)
T PTZ00036        226 -------------------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL  280 (440)
T ss_pred             -------------------------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                                     01124589999999998764 7899999999999999999999999999877666


Q ss_pred             HHHhc
Q psy2131         308 AQIKA  312 (328)
Q Consensus       308 ~~i~~  312 (328)
                      ..|.+
T Consensus       281 ~~i~~  285 (440)
T PTZ00036        281 VRIIQ  285 (440)
T ss_pred             HHHHH
Confidence            66654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-39  Score=283.51  Aligned_cols=211  Identities=31%  Similarity=0.495  Sum_probs=184.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.||+|.+............+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (256)
T cd08529          11 GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL   90 (256)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHH
Confidence            78999999999999999999999876666667778899999999999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.+   +.++|+|||++........           
T Consensus        91 ~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---~~~~l~df~~~~~~~~~~~-----------  156 (256)
T cd08529          91 KMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTN-----------  156 (256)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---CCEEEcccccceeccCccc-----------
Confidence            764  568999999999999999999999999999999999999754   4599999998754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd08529         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|||+||+.||...+...+..++.++.+...
T Consensus       157 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08529         157 ---------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV  221 (256)
T ss_pred             ---------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                           00113478899999999999999999999999999999999999999999999999998887655


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       222 ~~  223 (256)
T cd08529         222 SQ  223 (256)
T ss_pred             cc
Confidence            54

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0193|consensus

Probab=100.00  E-value=3.3e-41  Score=307.96  Aligned_cols=208  Identities=24%  Similarity=0.439  Sum_probs=178.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++-.   .||||+++.+..+.++.+.|++|+.++++-+|.||+-+.+++..... .||+-+|+|.+|+.++
T Consensus       403 GsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hl  478 (678)
T KOG0193|consen  403 GSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHL  478 (678)
T ss_pred             ccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhc
Confidence            8999999998755   59999999999999999999999999999999999999999999887 9999999999999998


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .- +..|+......|++|+++|+.|||.++|||||||..||++..+   ++|||+||||+.--.    .|.         
T Consensus       479 Hv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~---~kVkIgDFGLatvk~----~w~---------  542 (678)
T KOG0193|consen  479 HVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED---LKVKIGDFGLATVKT----RWS---------  542 (678)
T ss_pred             cchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC---CcEEEecccceeeee----eec---------
Confidence            64 4579999999999999999999999999999999999999643   579999999974210    000         


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                      |...                                                                            
T Consensus       543 g~~q----------------------------------------------------------------------------  546 (678)
T KOG0193|consen  543 GEQQ----------------------------------------------------------------------------  546 (678)
T ss_pred             cccc----------------------------------------------------------------------------
Confidence            0000                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                     ...-.|...|||||++..   .+|+..+|||||||++|||+||..||..++..+++..+-+|...
T Consensus       547 ---------------~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~  611 (678)
T KOG0193|consen  547 ---------------LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM  611 (678)
T ss_pred             ---------------cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence                           000126778999999964   58999999999999999999999999999999999999999776


Q ss_pred             CCC
Q psy2131         317 DEP  319 (328)
Q Consensus       317 ~~~  319 (328)
                      +.+
T Consensus       612 pd~  614 (678)
T KOG0193|consen  612 PDL  614 (678)
T ss_pred             ccc
Confidence            554

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.5e-40  Score=300.08  Aligned_cols=200  Identities=26%  Similarity=0.367  Sum_probs=167.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+++.+|+|++............+.+|+.+++.++||||+++++++...      ...|+||||+++ 
T Consensus        28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-  106 (355)
T cd07874          28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-  106 (355)
T ss_pred             cCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-
Confidence            8999999999999999999999987655555667788999999999999999999998644      357999999976 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++......        
T Consensus       107 ~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~---~~~kl~Dfg~~~~~~~~~--------  173 (355)
T cd07874         107 NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  173 (355)
T ss_pred             cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC---CCEEEeeCcccccCCCcc--------
Confidence            56666543  48899999999999999999999999999999999999754   469999999975321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (355)
T cd07874         174 --------------------------------------------------------------------------------  173 (355)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                         ......||+.|+|||++.+..|+.++|+|||||++|||++|+.||.+.+....+..+...
T Consensus       174 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (355)
T cd07874         174 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_pred             -------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                               001235899999999999999999999999999999999999999998876666655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=320.86  Aligned_cols=208  Identities=32%  Similarity=0.513  Sum_probs=172.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+..++..+|+|++............+.+|+.+|++|+|||||+++++|.+  ...+|||||||++|+|.+
T Consensus        24 GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~  103 (1021)
T PTZ00266         24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR  103 (1021)
T ss_pred             CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHH
Confidence            899999999999999999999998777666677788999999999999999999999864  457999999999999998


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeecCCCCcEEEeeCC--------------CCCcEEE
Q psy2131          79 DIVA----REFYSEADASHCIQQILESVNHCHSN-------GVVHRDLKPENLLLASKA--------------KGAAVKL  133 (328)
Q Consensus        79 ~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~-------~ivHrDiKp~NiLl~~~~--------------~~~~vkl  133 (328)
                      .+..    ...+++..+..|+.||+.||.|||+.       +||||||||+|||++...              ....+||
T Consensus       104 lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKL  183 (1021)
T PTZ00266        104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI  183 (1021)
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEE
Confidence            8864    25699999999999999999999984       499999999999996421              1245899


Q ss_pred             eeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         134 ADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       134 ~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      +|||++.......                                                                   
T Consensus       184 sDFGlAr~l~~~s-------------------------------------------------------------------  196 (1021)
T PTZ00266        184 GDFGLSKNIGIES-------------------------------------------------------------------  196 (1021)
T ss_pred             ccCCccccccccc-------------------------------------------------------------------
Confidence            9999975321100                                                                   


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHH
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyel  291 (328)
                                                              ......||+.|+|||++.+  ..|+.++||||||||||||
T Consensus       197 ----------------------------------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        197 ----------------------------------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             ----------------------------------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence                                                    0112358999999999964  4589999999999999999


Q ss_pred             HhcCCCCCCcc-HHHHHHHHhcccC
Q psy2131         292 LVGYPPFWDED-QHRLYAQIKAGAY  315 (328)
Q Consensus       292 ltG~~Pf~~~~-~~~~~~~i~~~~~  315 (328)
                      +||+.||...+ ...++..+..+..
T Consensus       237 LTGk~PF~~~~~~~qli~~lk~~p~  261 (1021)
T PTZ00266        237 CSGKTPFHKANNFSQLISELKRGPD  261 (1021)
T ss_pred             HHCCCCCCcCCcHHHHHHHHhcCCC
Confidence            99999998765 4556666666543

>KOG0584|consensus

Probab=100.00  E-value=4.8e-41  Score=308.37  Aligned_cols=203  Identities=27%  Similarity=0.490  Sum_probs=181.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE--EEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEENY--HYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~--~~lv~E~~~gg~L   76 (328)
                      |+|=+||+|.|..+|..||+-.++...+.  ....+++..|+.+|+.|+|||||++|++|.+...  +.+|+|++..|+|
T Consensus        51 GafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtL  130 (632)
T KOG0584|consen   51 GAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTL  130 (632)
T ss_pred             ccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcH
Confidence            78899999999999999999887755443  4556899999999999999999999999987655  8999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSN--GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~--~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ..++.+.+.++...+..|++||+.||.|||++  .|||||||.+||+++  |+.|.|||+|+|||.....          
T Consensus       131 r~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~----------  198 (632)
T KOG0584|consen  131 REYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK----------  198 (632)
T ss_pred             HHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc----------
Confidence            99999999999999999999999999999998  499999999999996  5678999999999843211          


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       199 --------------------------------------------------------------------------------  198 (632)
T KOG0584|consen  199 --------------------------------------------------------------------------------  198 (632)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~  313 (328)
                                        +...+..|||.+||||+.. ..|+..+||||||+.|+||.|+..||..+ ++.++++++.+|
T Consensus       199 ------------------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  199 ------------------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG  259 (632)
T ss_pred             ------------------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence                              1122367999999999999 78999999999999999999999999998 599999999999


Q ss_pred             c
Q psy2131         314 A  314 (328)
Q Consensus       314 ~  314 (328)
                      .
T Consensus       260 i  260 (632)
T KOG0584|consen  260 I  260 (632)
T ss_pred             C
Confidence            5

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.5e-40  Score=301.91  Aligned_cols=205  Identities=23%  Similarity=0.380  Sum_probs=164.9

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+|     ..||+|+++.... .+....+.+|+++++.+ +|+|||++++++.+.+..|+|||||++|
T Consensus        49 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g  127 (374)
T cd05106          49 GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYG  127 (374)
T ss_pred             CCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCC
Confidence            899999999865444     5799999976542 34456788999999999 8999999999999999999999999999


Q ss_pred             CcHHHHHhc----------------------------------------------------------------------C
Q psy2131          75 ELFEDIVAR----------------------------------------------------------------------E   84 (328)
Q Consensus        75 ~L~~~l~~~----------------------------------------------------------------------~   84 (328)
                      +|.+++...                                                                      .
T Consensus       128 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (374)
T cd05106         128 DLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSW  207 (374)
T ss_pred             cHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCC
Confidence            999887542                                                                      2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCC
Q psy2131          85 FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPF  164 (328)
Q Consensus        85 ~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf  164 (328)
                      .+++.++..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++.........                
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~---~~~~kL~DfGla~~~~~~~~~----------------  268 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD---GRVAKICDFGLARDIMNDSNY----------------  268 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC---CCeEEEeeceeeeeccCCcce----------------
Confidence            3678889999999999999999999999999999999974   346999999997543111000                


Q ss_pred             CCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhH
Q psy2131         165 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKF  244 (328)
Q Consensus       165 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
                                                                                                      
T Consensus       269 --------------------------------------------------------------------------------  268 (374)
T cd05106         269 --------------------------------------------------------------------------------  268 (374)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHH-HHHHhcc
Q psy2131         245 NARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRL-YAQIKAG  313 (328)
Q Consensus       245 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~-~~~i~~~  313 (328)
                              .......+++.|+|||++.+..|+.++|||||||++|||++ |+.||.+...... .+.+..+
T Consensus       269 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~  331 (374)
T cd05106         269 --------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG  331 (374)
T ss_pred             --------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc
Confidence                    00001225678999999999999999999999999999997 9999998765444 4444433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989|consensus

Probab=100.00  E-value=3.6e-40  Score=313.59  Aligned_cols=216  Identities=30%  Similarity=0.432  Sum_probs=172.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEE-EEe------CCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS-IQE------ENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~-~~~------~~~~~lv~E~~~   72 (328)
                      |||+.||.|.+...|..||+|++-..  ++...+.+.+||.+|++|+ |+|||.+++. ...      .-.++|.||||.
T Consensus        48 GGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~  125 (738)
T KOG1989|consen   48 GGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCK  125 (738)
T ss_pred             CCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhcc
Confidence            89999999999988899999998654  5566788899999999996 9999999993 221      235789999999


Q ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          73 GGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        73 gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      ||.|.+++..+  ..|+|.++..|+.|+++|+.+||...  |||||||-|||||+.++   ..||||||.|........ 
T Consensus       126 gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDFGSatt~~~~~~-  201 (738)
T KOG1989|consen  126 GGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDFGSATTKILSPT-  201 (738)
T ss_pred             CCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCcccccccccCCCc-
Confidence            99999998743  46999999999999999999999987  99999999999997654   599999999754211100 


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                 +.+-..++.                            
T Consensus       202 -------------------------------------------~~~e~~~ve----------------------------  210 (738)
T KOG1989|consen  202 -------------------------------------------SAQEVNYVE----------------------------  210 (738)
T ss_pred             -------------------------------------------cHHHHHHHH----------------------------
Confidence                                                       000000000                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc---ccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                +.+.+               --||.|+|||++   .+.+.+.|+|||||||+||-|+..+.||.+.-.  
T Consensus       211 ----------~eI~k---------------~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--  263 (738)
T KOG1989|consen  211 ----------EEIEK---------------YTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--  263 (738)
T ss_pred             ----------HHHHh---------------hCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence                      00100               138999999997   578899999999999999999999999998844  


Q ss_pred             HHHHHhcccCCCCCCcc
Q psy2131         306 LYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~~~  322 (328)
                        ..|..|.|..||.+.
T Consensus       264 --laIlng~Y~~P~~p~  278 (738)
T KOG1989|consen  264 --LAILNGNYSFPPFPN  278 (738)
T ss_pred             --eeEEeccccCCCCcc
Confidence              357889999999643

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.7e-39  Score=282.57  Aligned_cols=216  Identities=22%  Similarity=0.379  Sum_probs=179.5

Q ss_pred             CCceEEEEEEE--ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQ--KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~--~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|..  ..++..+|+|+++.........+.+.+|+.+++.++||||+++++++.. +..++||||+++|+|.+
T Consensus         6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~   84 (257)
T cd05116           6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNK   84 (257)
T ss_pred             cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHH
Confidence            89999999964  5678899999998665555556778999999999999999999998864 46799999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++..+..++.|++.||+|||++||+||||||.|||++.+   +.+||+|||++..........         
T Consensus        85 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---~~~kl~Dfg~~~~~~~~~~~~---------  152 (257)
T cd05116          85 FLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYY---------  152 (257)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC---CeEEECCCccccccCCCCCee---------
Confidence            99887889999999999999999999999999999999999999753   469999999975432111000         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       153 --------------------------------------------------------------------------------  152 (257)
T cd05116         153 --------------------------------------------------------------------------------  152 (257)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......+++.|+|||.+.+..++.++|+|||||++|||+| |++||.+.+...+...|.++...+
T Consensus       153 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~  218 (257)
T cd05116         153 --------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME  218 (257)
T ss_pred             --------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence                          00001235678999999998899999999999999999998 999999999999999999987755


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       219 ~~~~~~  224 (257)
T cd05116         219 CPQRCP  224 (257)
T ss_pred             CCCCCC
Confidence            554443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=297.91  Aligned_cols=199  Identities=29%  Similarity=0.456  Sum_probs=166.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+..+++.||||++............+.+|+++|++++||||+++++++...      ...|++||++ |+
T Consensus        26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~  104 (343)
T cd07878          26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GA  104 (343)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CC
Confidence            8999999999999999999999976544444556678999999999999999999988643      4579999998 67


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+ ....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......         
T Consensus       105 ~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~---------  171 (343)
T cd07878         105 DLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED---CELRILDFGLARQADDE---------  171 (343)
T ss_pred             CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC---CCEEEcCCccceecCCC---------
Confidence            886655 44579999999999999999999999999999999999999754   45999999997532110         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (343)
T cd07878         172 --------------------------------------------------------------------------------  171 (343)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          ..+..||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus       172 --------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         172 --------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             --------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence                                012358999999999987 57899999999999999999999999998877766666543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-39  Score=287.68  Aligned_cols=216  Identities=25%  Similarity=0.390  Sum_probs=179.8

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+...+     ..+|+|.++... .......+.+|+.+++.++||||+++++++.+....|++|||+++++
T Consensus        16 G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   94 (283)
T cd05048          16 GAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD   94 (283)
T ss_pred             ccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCc
Confidence            789999999876655     679999987543 33445678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          76 LFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        76 L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      |.+++...                ..+++.++..++.|++.||.|||+++++||||||+||+++.+   +.+||+|||++
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~---~~~~L~dfg~~  171 (283)
T cd05048          95 LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG---LTVKISDFGLS  171 (283)
T ss_pred             HHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC---CcEEECCCcce
Confidence            99988754                457888999999999999999999999999999999999754   46999999997


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .........                                                                       
T Consensus       172 ~~~~~~~~~-----------------------------------------------------------------------  180 (283)
T cd05048         172 RDIYSADYY-----------------------------------------------------------------------  180 (283)
T ss_pred             eeccccccc-----------------------------------------------------------------------
Confidence            543110000                                                                       


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf  298 (328)
                                                       .......+++.|+|||.+.+..++.++|||||||++|||+| |..||
T Consensus       181 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~  227 (283)
T cd05048         181 ---------------------------------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY  227 (283)
T ss_pred             ---------------------------------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence                                             00011236788999999999999999999999999999998 99999


Q ss_pred             CCccHHHHHHHHhcccCCCCCCcccc
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      .+.+..++...|..+.....|..++.
T Consensus       228 ~~~~~~~~~~~i~~~~~~~~~~~~~~  253 (283)
T cd05048         228 YGFSNQEVIEMIRSRQLLPCPEDCPA  253 (283)
T ss_pred             CCCCHHHHHHHHHcCCcCCCcccCCH
Confidence            99999999999998887665655543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-39  Score=286.85  Aligned_cols=206  Identities=37%  Similarity=0.677  Sum_probs=180.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.+|+|++..... .......+.+|++++++++||||+++++++.+.+..|+||||+++++|.++
T Consensus        12 g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   91 (290)
T cd05580          12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH   91 (290)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHH
Confidence            7899999999999999999999975433 233456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++..+..++.|++.||.|||+.||+||||+|+|||++.+   +.+||+|||++......              
T Consensus        92 ~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~--------------  154 (290)
T cd05580          92 LRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---GYIKITDFGFAKRVKGR--------------  154 (290)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEeeCCCccccCCC--------------
Confidence            9888889999999999999999999999999999999999999754   45999999987432110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (290)
T cd05580         155 --------------------------------------------------------------------------------  154 (290)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     .....|++.|+|||.+.+..++.++|+|||||++|+|++|++||.+.+.....+.+..+....|
T Consensus       155 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  218 (290)
T cd05580         155 ---------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP  218 (290)
T ss_pred             ---------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC
Confidence                           0113478999999999998999999999999999999999999999998888999888776443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0695|consensus

Probab=100.00  E-value=1.5e-40  Score=284.74  Aligned_cols=213  Identities=30%  Similarity=0.543  Sum_probs=184.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+|+.|..++++.|.+.||+|+++++..+. ++...++.|-.+..+- +||.+|.++.+|+++..+++|.||++||+|.-
T Consensus       261 gsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmf  340 (593)
T KOG0695|consen  261 GSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMF  340 (593)
T ss_pred             cchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceee
Confidence            789999999999999999999999876654 4566777787777665 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+++...++|+.+++|..+|+.||.|||+.|||.||||..|+|++.+++   +||+|+|++++--...+           
T Consensus       341 hmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh---ikltdygmcke~l~~gd-----------  406 (593)
T KOG0695|consen  341 HMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGLGPGD-----------  406 (593)
T ss_pred             ehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc---eeecccchhhcCCCCCc-----------
Confidence            9999999999999999999999999999999999999999999987654   99999999865322111           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       407 --------------------------------------------------------------------------------  406 (593)
T KOG0695|consen  407 --------------------------------------------------------------------------------  406 (593)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC-------Cc-cHHHHHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW-------DE-DQHRLYAQI  310 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~-------~~-~~~~~~~~i  310 (328)
                                     +..+++|||.|+|||++.|..||..+|||+|||+|+||+.|+.||.       ++ .+.-||+.|
T Consensus       407 ---------------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi  471 (593)
T KOG0695|consen  407 ---------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI  471 (593)
T ss_pred             ---------------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence                           2346899999999999999999999999999999999999999996       33 366788887


Q ss_pred             hcccCCCCCCccc
Q psy2131         311 KAGAYDDEPKHKS  323 (328)
Q Consensus       311 ~~~~~~~~~~~~~  323 (328)
                      ..... -.|+..|
T Consensus       472 lekqi-riprsls  483 (593)
T KOG0695|consen  472 LEKQI-RIPRSLS  483 (593)
T ss_pred             hhhcc-cccceee
Confidence            76554 4555543

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-39  Score=307.19  Aligned_cols=200  Identities=22%  Similarity=0.322  Sum_probs=163.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC------CCcceeEEEEEeC-CEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRLHDSIQEE-NYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H------~nIv~l~~~~~~~-~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+..+++.||||+++...   ........|+++++.++|      .++++++++|... ..+|+|||++ |
T Consensus       140 G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g  215 (467)
T PTZ00284        140 GTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-G  215 (467)
T ss_pred             ccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-C
Confidence            899999999999999999999996432   122344567777776654      4589999998765 5789999998 7


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCC-------------CCcEEEeecccc
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAK-------------GAAVKLADFGLA  139 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~-------------~~~vkl~DfGla  139 (328)
                      ++|.+++...+.+++.++..++.||+.||.|||+ .|||||||||+|||++..+.             ...+||+|||++
T Consensus       216 ~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~  295 (467)
T PTZ00284        216 PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC  295 (467)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcc
Confidence            7899999888889999999999999999999998 59999999999999976432             125999999976


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .....                                                                           
T Consensus       296 ~~~~~---------------------------------------------------------------------------  300 (467)
T PTZ00284        296 CDERH---------------------------------------------------------------------------  300 (467)
T ss_pred             ccCcc---------------------------------------------------------------------------
Confidence            32100                                                                           


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                                        .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.
T Consensus       301 ----------------------------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        301 ----------------------------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             ----------------------------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                                              0112468999999999999999999999999999999999999999


Q ss_pred             CccHHHHHHHHhcc
Q psy2131         300 DEDQHRLYAQIKAG  313 (328)
Q Consensus       300 ~~~~~~~~~~i~~~  313 (328)
                      +.+..+.+..|...
T Consensus       347 ~~~~~~~~~~i~~~  360 (467)
T PTZ00284        347 THDNLEHLHLMEKT  360 (467)
T ss_pred             CCChHHHHHHHHHH
Confidence            98877766665543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-39  Score=285.78  Aligned_cols=199  Identities=29%  Similarity=0.503  Sum_probs=168.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.+|+|.+........ ....+.+|+++|+.++|+||+.+++++.+++..|++|||+.+++|.+.
T Consensus        11 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (285)
T cd05632          11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH   90 (285)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHH
Confidence            8999999999999999999999976544332 234567899999999999999999999999999999999999999887


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++.......           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~-----------  156 (285)
T cd05632          91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGE-----------  156 (285)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---CCEEEecCCcceecCCCC-----------
Confidence            7543  369999999999999999999999999999999999999754   459999999874321100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (285)
T cd05632         157 --------------------------------------------------------------------------------  156 (285)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                      ......||+.|+|||++.+..++.++|+||+||++|||+||+.||.+.++......
T Consensus       157 ----------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~  212 (285)
T cd05632         157 ----------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE  212 (285)
T ss_pred             ----------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                            00123589999999999999999999999999999999999999998776544333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0574|consensus

Probab=100.00  E-value=1.3e-41  Score=287.44  Aligned_cols=196  Identities=26%  Similarity=0.467  Sum_probs=174.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.|+.+|+.+|||.+..+    .+.+++.+|+.||++++.|++|++|+.|.....+|||||||..|+..+.+
T Consensus        44 GSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~  119 (502)
T KOG0574|consen   44 GSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIM  119 (502)
T ss_pred             CcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHH
Confidence            89999999999999999999998754    46788999999999999999999999999999999999999999999988


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. +++++|+++..+++.-+.||+|||...-||||||..|||++.++   ..||+|||.|.++.+               
T Consensus       120 R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G---~AKLADFGVAGQLTD---------------  181 (502)
T KOG0574|consen  120 RARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG---IAKLADFGVAGQLTD---------------  181 (502)
T ss_pred             HHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc---hhhhhhccccchhhh---------------
Confidence            64 56799999999999999999999999999999999999997654   489999999854321               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       182 --------------------------------------------------------------------------------  181 (502)
T KOG0574|consen  182 --------------------------------------------------------------------------------  181 (502)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                 .++.+.+..|||.|||||++..-+|++++||||||++..||.-|++||.+-.|.+..--
T Consensus       182 -----------TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM  240 (502)
T KOG0574|consen  182 -----------TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM  240 (502)
T ss_pred             -----------hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence                       12234567799999999999999999999999999999999999999999887665433

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.8e-39  Score=279.66  Aligned_cols=213  Identities=30%  Similarity=0.523  Sum_probs=182.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+.+.+|++|||+++++|.+++
T Consensus        11 g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   89 (255)
T cd08219          11 GSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI   89 (255)
T ss_pred             cCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHH
Confidence            7899999999999999999999975432 334567788999999999999999999999999999999999999999888


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.+   +.++++|||++........           
T Consensus        90 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~-----------  155 (255)
T cd08219          90 KLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPGA-----------  155 (255)
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC---CcEEEcccCcceeeccccc-----------
Confidence            643  358999999999999999999999999999999999999754   4599999998754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (255)
T cd08219         156 --------------------------------------------------------------------------------  155 (255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+.......+.++.+.+.
T Consensus       156 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  220 (255)
T cd08219         156 ---------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL  220 (255)
T ss_pred             ---------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC
Confidence                           00123588999999999999999999999999999999999999999999888899988888766


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |...+
T Consensus       221 ~~~~~  225 (255)
T cd08219         221 PSHYS  225 (255)
T ss_pred             CcccC
Confidence            65443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.3e-39  Score=282.08  Aligned_cols=205  Identities=28%  Similarity=0.468  Sum_probs=172.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+++.||+|+++...  ......+.+|+.+++.++||||+++++++...+..|+|||||++++|.+++
T Consensus        20 g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~   97 (267)
T cd06645          20 GTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY   97 (267)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHH
Confidence            899999999999999999999997543  233456788999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.......              
T Consensus        98 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~--------------  160 (267)
T cd06645          98 HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN---GHVKLADFGVSAQITATI--------------  160 (267)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECcceeeeEccCcc--------------
Confidence            888889999999999999999999999999999999999999754   459999999875431100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (267)
T cd06645         161 --------------------------------------------------------------------------------  160 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                  .......||+.|+|||++.   ...++.++|+||+||++|+|++|++||.+.++......+..+.+.
T Consensus       161 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~  227 (267)
T cd06645         161 ------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ  227 (267)
T ss_pred             ------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC
Confidence                        0001234899999999985   456889999999999999999999999887765555555555544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-38  Score=278.06  Aligned_cols=211  Identities=29%  Similarity=0.461  Sum_probs=185.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.|+.+++..+++.+++|.+.....+......+.+|+.++++++|+||+++++++.+.+.++++||||++++|.+.+
T Consensus        11 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~   90 (256)
T cd08221          11 GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI   90 (256)
T ss_pred             cCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHH
Confidence            78999999999999999999999877766777778899999999999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.|++.||.|||+.|++||||||+||+++.+   +.+||+|||++........           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---~~~kl~d~~~~~~~~~~~~-----------  156 (256)
T cd08221          91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFGISKILGSEYS-----------  156 (256)
T ss_pred             HhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---CCEEECcCcceEEcccccc-----------
Confidence            764  468999999999999999999999999999999999999754   4599999998754311100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd08221         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|||++|..||.+.+..++...+.++.+.+.
T Consensus       157 ---------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08221         157 ---------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV  221 (256)
T ss_pred             ---------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                           00123489999999999998899999999999999999999999999999999999999988665


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       222 ~~  223 (256)
T cd08221         222 VS  223 (256)
T ss_pred             cc
Confidence            53

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-39  Score=286.31  Aligned_cols=201  Identities=31%  Similarity=0.429  Sum_probs=163.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC---CCCCcceeEEEEEe-----CCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHDSIQE-----ENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~-----~~~~~lv~E~~~   72 (328)
                      |+||+||+|+++.+|+.||+|.++...........+.+|+.+++.+   +||||+++++++.+     ....+++|||+.
T Consensus        11 g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~   90 (288)
T cd07863          11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD   90 (288)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc
Confidence            8999999999999999999999976433222223445677776655   79999999999864     346899999998


Q ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          73 GGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        73 gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      + +|.+++...  ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......    
T Consensus        91 ~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~kl~dfg~~~~~~~~~----  162 (288)
T cd07863          91 Q-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQM----  162 (288)
T ss_pred             c-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccCccccccCcc----
Confidence            5 888877653  348999999999999999999999999999999999999754   459999999874321100    


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (288)
T cd07863         163 --------------------------------------------------------------------------------  162 (288)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                             ......||+.|+|||++.+..++.++||||+||++|||++|++||.+.+....+.++
T Consensus       163 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~  219 (288)
T cd07863         163 -----------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI  219 (288)
T ss_pred             -----------------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence                                   001134789999999999999999999999999999999999999998877777666


Q ss_pred             hc
Q psy2131         311 KA  312 (328)
Q Consensus       311 ~~  312 (328)
                      ..
T Consensus       220 ~~  221 (288)
T cd07863         220 FD  221 (288)
T ss_pred             HH
Confidence            54

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG1187|consensus

Probab=100.00  E-value=2.3e-39  Score=294.76  Aligned_cols=188  Identities=26%  Similarity=0.379  Sum_probs=159.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-YHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.... |..||||.++......  ..+|.+|+.+|.+++|||+|+|+++|.+.+ ..+||+||+++|+|.++
T Consensus        86 Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~  162 (361)
T KOG1187|consen   86 GGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDH  162 (361)
T ss_pred             CCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHH
Confidence            7899999998754 4899999887654332  345999999999999999999999999988 59999999999999999


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-CCcchHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNG---VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-EQQAWFGVI  153 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~---ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-~~~~~~G~~  153 (328)
                      |....  .+++..-..|+.+++.||+|||...   ||||||||+||||+.+   ...||+|||+|+.... ..       
T Consensus       163 L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~---~~aKlsDFGLa~~~~~~~~-------  232 (361)
T KOG1187|consen  163 LHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED---FNAKLSDFGLAKLGPEGDT-------  232 (361)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC---CCEEccCccCcccCCcccc-------
Confidence            97765  7899999999999999999999854   9999999999999854   4599999999854321 00       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       233 --------------------------------------------------------------------------------  232 (361)
T KOG1187|consen  233 --------------------------------------------------------------------------------  232 (361)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhc-cCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGF-AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                          ..... .||.+|+|||++.....+.++|||||||+|+||+||+.|....
T Consensus       233 --------------------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  233 --------------------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             --------------------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence                                00011 5999999999999988999999999999999999999887753

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.9e-39  Score=291.02  Aligned_cols=194  Identities=30%  Similarity=0.466  Sum_probs=155.2

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++  .+++.+|+|.+......    ..+.+|+++|++++||||+++++++..  ....|++|||+.+ +|
T Consensus        12 G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l   86 (317)
T cd07868          12 GTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL   86 (317)
T ss_pred             CCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CH
Confidence            899999999965  47789999999765432    345789999999999999999999864  4578999999965 78


Q ss_pred             HHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCC
Q psy2131          77 FEDIVAR---------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        77 ~~~l~~~---------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~  146 (328)
                      .+.+...         ..+++..+..++.|++.||.|||++||+||||||+|||+... ...+.+||+|||++.......
T Consensus        87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~  166 (317)
T cd07868          87 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL  166 (317)
T ss_pred             HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCC
Confidence            7776432         248999999999999999999999999999999999999643 234579999999985432110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .               +                                                               
T Consensus       167 ~---------------~---------------------------------------------------------------  168 (317)
T cd07868         167 K---------------P---------------------------------------------------------------  168 (317)
T ss_pred             c---------------c---------------------------------------------------------------
Confidence            0               0                                                               


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                               ........||+.|+|||++.+ ..|+.++|+||+||++|||++|++||...+
T Consensus       169 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         169 -------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             -------------------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence                                     000112458999999999987 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=279.28  Aligned_cols=209  Identities=30%  Similarity=0.472  Sum_probs=175.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH---HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+++.+|+|++.......   ...+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.
T Consensus        13 g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   92 (263)
T cd06625          13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVK   92 (263)
T ss_pred             CCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHH
Confidence            789999999999999999999987654332   23456889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.+...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.++|+|||++........          
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---~~~~l~dfg~~~~~~~~~~----------  159 (263)
T cd06625          93 DQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICS----------  159 (263)
T ss_pred             HHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecccccc----------
Confidence            999888889999999999999999999999999999999999999754   4599999999754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (263)
T cd06625         160 --------------------------------------------------------------------------------  159 (263)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .........|++.|+|||++.+..++.++|+|||||++|||++|++||.+.+......++.....
T Consensus       160 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  224 (263)
T cd06625         160 -------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT  224 (263)
T ss_pred             -------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC
Confidence                         00000123478899999999999999999999999999999999999998877766666655543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-39  Score=316.40  Aligned_cols=215  Identities=27%  Similarity=0.354  Sum_probs=167.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||+|+++..... ....+++.+|++++++++||||+++++++.+.+..|+|||||+||+|.+.
T Consensus        13 GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~l   92 (932)
T PRK13184         13 GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSL   92 (932)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHH
Confidence            89999999999999999999999765332 33346788999999999999999999999999999999999999999888


Q ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          80 IVAR-----------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        80 l~~~-----------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      +...           ...+...+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++.........
T Consensus        93 L~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d---g~vKLiDFGLAk~i~~~~~~  169 (932)
T PRK13184         93 LKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF---GEVVILDWGAAIFKKLEEED  169 (932)
T ss_pred             HHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC---CCEEEEecCcceeccccccc
Confidence            7531           224556778899999999999999999999999999999754   45999999998654211100


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      .                             ......                        .+.+                
T Consensus       170 ~-----------------------------~~l~~~------------------------~~~s----------------  180 (932)
T PRK13184        170 L-----------------------------LDIDVD------------------------ERNI----------------  180 (932)
T ss_pred             c-----------------------------cccccc------------------------cccc----------------
Confidence            0                             000000                        0000                


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                         ...........+||+.|+|||++.+.+++.++|||||||++|||+||++||.+.+...+
T Consensus       181 -------------------~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        181 -------------------CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             -------------------cccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence                               00000011234699999999999999999999999999999999999999988765443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.7e-39  Score=289.04  Aligned_cols=201  Identities=30%  Similarity=0.415  Sum_probs=166.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|+++.+++.+|+|+++..... .....+.+|++++++++||||+++++++..++..|+||||+++ +|.+.+
T Consensus        17 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~   94 (309)
T cd07872          17 GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYM   94 (309)
T ss_pred             cCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHH
Confidence            89999999999999999999999754322 2233567899999999999999999999999999999999986 787777


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        95 ~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~------------  159 (309)
T cd07872          95 DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSVPTK------------  159 (309)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECccccceecCCCcc------------
Confidence            654 458999999999999999999999999999999999999754   4599999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (309)
T cd07872         160 --------------------------------------------------------------------------------  159 (309)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                    ......||+.|+|||++.+ ..++.++|||||||++|||+||++||.+.+....+..+.+
T Consensus       160 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  219 (309)
T cd07872         160 --------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR  219 (309)
T ss_pred             --------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                          0011247899999999875 5689999999999999999999999999887666655544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.2e-39  Score=283.24  Aligned_cols=215  Identities=23%  Similarity=0.322  Sum_probs=179.1

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .+++.+|+|+++... ..+..+.+.+|+++|+.++|+||+++++++......|+||||++|++
T Consensus        16 g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   94 (280)
T cd05049          16 GAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGD   94 (280)
T ss_pred             cCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCC
Confidence            799999999874     346889999987543 23345678999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          76 LFEDIVAR--------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        76 L~~~l~~~--------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      |.+++...              ..+++.++..++.|++.||.|||++|++||||||+|||++.+   +.+||+|||++..
T Consensus        95 L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---~~~kl~d~g~~~~  171 (280)
T cd05049          95 LNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD---LVVKIGDFGMSRD  171 (280)
T ss_pred             HHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC---CeEEECCccccee
Confidence            99998654              247888999999999999999999999999999999999754   5699999999754


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .......                                                                         
T Consensus       172 ~~~~~~~-------------------------------------------------------------------------  178 (280)
T cd05049         172 VYTTDYY-------------------------------------------------------------------------  178 (280)
T ss_pred             cccCcce-------------------------------------------------------------------------
Confidence            3110000                                                                         


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                     .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       179 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         179 -------------------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             -------------------------------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence                                           00011235788999999999999999999999999999999 9999999


Q ss_pred             ccHHHHHHHHhcccCCCCCCccc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .+..+....+.+|....+|...+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~  250 (280)
T cd05049         228 LSNEEVIECITQGRLLQRPRTCP  250 (280)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCC
Confidence            99999999999998876665443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.5e-39  Score=296.69  Aligned_cols=207  Identities=22%  Similarity=0.369  Sum_probs=166.7

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+     ..++..||+|+++.... ....+.+.+|+++|+.+ +|||||++++++.+.+..|+|||||+||
T Consensus        46 G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g  124 (375)
T cd05104          46 GAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYG  124 (375)
T ss_pred             CccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCC
Confidence            89999999964     45677899999975432 33456788999999999 8999999999999999999999999999


Q ss_pred             CcHHHHHhcC----------------------------------------------------------------------
Q psy2131          75 ELFEDIVARE----------------------------------------------------------------------   84 (328)
Q Consensus        75 ~L~~~l~~~~----------------------------------------------------------------------   84 (328)
                      +|.+++....                                                                      
T Consensus       125 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (375)
T cd05104         125 DLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEIL  204 (375)
T ss_pred             cHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHH
Confidence            9998886421                                                                      


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          85 -----FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        85 -----~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                           .+++..+..++.|++.||.|||++||+||||||+|||++.+   ..+||+|||++.........           
T Consensus       205 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~-----------  270 (375)
T cd05104         205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG---RITKICDFGLARDIRNDSNY-----------  270 (375)
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC---CcEEEecCccceeccCcccc-----------
Confidence                 36778888999999999999999999999999999999753   46999999998543211000           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       271 --------------------------------------------------------------------------------  270 (375)
T cd05104         271 --------------------------------------------------------------------------------  270 (375)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCcc-HHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDED-QHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~-~~~~~~~i~~~~~  315 (328)
                                   .......+++.|+|||++.+..++.++|||||||++|||+| |.+||.+.. .....+.+..+..
T Consensus       271 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~  335 (375)
T cd05104         271 -------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR  335 (375)
T ss_pred             -------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence                         00001235678999999999999999999999999999998 999998765 4455566665544

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-38  Score=276.76  Aligned_cols=210  Identities=27%  Similarity=0.517  Sum_probs=178.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||++.++.+++.+|+|.+..........+.+.+|++++++++|+|++++++.+.. ...+|++|||+++++|.+.
T Consensus        11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~   90 (257)
T cd08223          11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHK   90 (257)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHH
Confidence            789999999999999999999998766556666778899999999999999999998874 4568999999999999988


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...  ..+++.++..++.|++.||.|||++||+||||||+||+++.+   +.++|+|||++........          
T Consensus        91 l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~----------  157 (257)
T cd08223          91 LKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT---NIIKVGDLGIARVLENQCD----------  157 (257)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC---CcEEEecccceEEecccCC----------
Confidence            8653  458999999999999999999999999999999999999754   4699999998754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (257)
T cd08223         158 --------------------------------------------------------------------------------  157 (257)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                      ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.++....
T Consensus       158 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  221 (257)
T cd08223         158 ----------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP  221 (257)
T ss_pred             ----------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence                            0011347899999999999999999999999999999999999999998888888888887644


Q ss_pred             CC
Q psy2131         318 EP  319 (328)
Q Consensus       318 ~~  319 (328)
                      .|
T Consensus       222 ~~  223 (257)
T cd08223         222 MP  223 (257)
T ss_pred             Cc
Confidence            44

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4279|consensus

Probab=100.00  E-value=4.2e-40  Score=304.08  Aligned_cols=205  Identities=31%  Similarity=0.557  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||-|++..|+...|||.|....  .+..+-+..||.+-++|+|.|||++++++.+.+.+-|.||-++||+|.+++
T Consensus       586 GTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLL  663 (1226)
T KOG4279|consen  586 GTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLL  663 (1226)
T ss_pred             CceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHH
Confidence            899999999999999999999997532  234455778999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          81 VAR-EFY--SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        81 ~~~-~~~--~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ... +++  .|..+.+|.+||++||.|||++.|||||||-+|+|++.-  .|.+||+|||.++.+.+-            
T Consensus       664 rskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy--SGvlKISDFGTsKRLAgi------------  729 (1226)
T KOG4279|consen  664 RSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY--SGVLKISDFGTSKRLAGI------------  729 (1226)
T ss_pred             HhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec--cceEEecccccchhhccC------------
Confidence            764 566  889999999999999999999999999999999999754  478999999998765221            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                      +|                              
T Consensus       730 ------------------------------------------------nP------------------------------  731 (1226)
T KOG4279|consen  730 ------------------------------------------------NP------------------------------  731 (1226)
T ss_pred             ------------------------------------------------Cc------------------------------
Confidence                                                            10                              


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhccc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGA  314 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~  314 (328)
                                      ...++-||..|||||++..  ++||.++|||||||++.||.||+|||... +++..+-++  |-
T Consensus       732 ----------------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--Gm  793 (1226)
T KOG4279|consen  732 ----------------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GM  793 (1226)
T ss_pred             ----------------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cc
Confidence                            1224669999999999964  57999999999999999999999999976 455555543  44


Q ss_pred             CCC
Q psy2131         315 YDD  317 (328)
Q Consensus       315 ~~~  317 (328)
                      |-+
T Consensus       794 yKv  796 (1226)
T KOG4279|consen  794 YKV  796 (1226)
T ss_pred             eec
Confidence            443

>KOG0194|consensus

Probab=100.00  E-value=2.6e-39  Score=297.07  Aligned_cols=213  Identities=26%  Similarity=0.371  Sum_probs=178.8

Q ss_pred             CCceEEEEEEEccCCc---E-EEEEEeccC-CCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGL---E-FAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~-~AiK~i~~~-~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|..+..+.   . ||||..+.+ ....+....+.+|+++|++++|||||++|++......+|+|||+|+||+
T Consensus       168 GaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGs  247 (474)
T KOG0194|consen  168 GAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGS  247 (474)
T ss_pred             ccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCc
Confidence            8999999998765432   3 899998863 4677788899999999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          76 LFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        76 L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      |.++|...+ .++..+-..++.+.+.||+|||++++|||||-..|+|++.+   ..+||+||||++.-.....       
T Consensus       248 L~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~---~~vKISDFGLs~~~~~~~~-------  317 (474)
T KOG0194|consen  248 LDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK---GVVKISDFGLSRAGSQYVM-------  317 (474)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC---CeEEeCccccccCCcceee-------
Confidence            999998876 59999999999999999999999999999999999999753   4589999999854320000       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                         +                            
T Consensus       318 ---------------------------------------------------~----------------------------  318 (474)
T KOG0194|consen  318 ---------------------------------------------------K----------------------------  318 (474)
T ss_pred             ---------------------------------------------------c----------------------------
Confidence                                                               0                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHH-hc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQI-KA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i-~~  312 (328)
                                          .....-...|+|||.+...-|+.++|||||||++||.++ |..||.+....++..+| ..
T Consensus       319 --------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~  378 (474)
T KOG0194|consen  319 --------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN  378 (474)
T ss_pred             --------------------cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence                                000001234999999999999999999999999999999 89999999999999999 55


Q ss_pred             ccCCCCCCcc
Q psy2131         313 GAYDDEPKHK  322 (328)
Q Consensus       313 ~~~~~~~~~~  322 (328)
                      |...++|...
T Consensus       379 ~~r~~~~~~~  388 (474)
T KOG0194|consen  379 GYRMPIPSKT  388 (474)
T ss_pred             CccCCCCCCC
Confidence            6665555543

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.8e-38  Score=281.75  Aligned_cols=214  Identities=24%  Similarity=0.360  Sum_probs=177.9

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||++.+     ..++..+|+|.+...  .......+.+|+.++++++||||+++++++...+..|+||||+++++
T Consensus        16 G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   93 (288)
T cd05093          16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD   93 (288)
T ss_pred             cCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCC
Confidence            78999999975     345667999988643  34445678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          76 LFEDIVARE-------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        76 L~~~l~~~~-------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      |.+++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.+   +.+||+|||++...
T Consensus        94 L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~  170 (288)
T cd05093          94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMSRDV  170 (288)
T ss_pred             HHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC---CcEEeccCCccccc
Confidence            999886543             38999999999999999999999999999999999999754   46999999997543


Q ss_pred             cCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         143 QGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       143 ~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      ......                                                                          
T Consensus       171 ~~~~~~--------------------------------------------------------------------------  176 (288)
T cd05093         171 YSTDYY--------------------------------------------------------------------------  176 (288)
T ss_pred             cCCcee--------------------------------------------------------------------------
Confidence            111000                                                                          


Q ss_pred             CCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCc
Q psy2131         223 CQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDE  301 (328)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~  301 (328)
                                                    .......+++.|+|||++.+..++.++|+|||||++|||+| |.+||.+.
T Consensus       177 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         177 ------------------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             ------------------------------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                                          00011236788999999999999999999999999999999 99999999


Q ss_pred             cHHHHHHHHhcccCCCCCCccc
Q psy2131         302 DQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       302 ~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      +.......|..+.....|...+
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~  248 (288)
T cd05093         227 SNNEVIECITQGRVLQRPRTCP  248 (288)
T ss_pred             CHHHHHHHHHcCCcCCCCCCCC
Confidence            9999999999998766665443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-38  Score=288.08  Aligned_cols=210  Identities=23%  Similarity=0.330  Sum_probs=168.8

Q ss_pred             CceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHH
Q psy2131           2 AFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIV   81 (328)
Q Consensus         2 ~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~   81 (328)
                      +||+||++.++.+|+.||+|.++.+.........+.+|+.+++.++||||+++++++.+++..|+|||||++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~   91 (327)
T cd08227          12 DLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC   91 (327)
T ss_pred             ceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHH
Confidence            68999999999999999999998765555556678889999999999999999999999999999999999999998886


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          82 AR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        82 ~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ..  ..+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.++++|||.+........            
T Consensus        92 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~~~~~~~------------  156 (327)
T cd08227          92 THFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMINHGQ------------  156 (327)
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---CcEEEcccchhhccccccc------------
Confidence            53  458999999999999999999999999999999999999754   4599999986432211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                        +..    ..+                    
T Consensus       157 --------------------------------------------------~~~----~~~--------------------  162 (327)
T cd08227         157 --------------------------------------------------RLR----VVH--------------------  162 (327)
T ss_pred             --------------------------------------------------ccc----ccc--------------------
Confidence                                                              000    000                    


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   .......++..|+|||++.+  ..|+.++|||||||++|||++|+.||.+............+
T Consensus       163 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  225 (327)
T cd08227         163 -------------DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  225 (327)
T ss_pred             -------------cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC
Confidence                         00011246778999999976  46899999999999999999999999987655555444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=278.60  Aligned_cols=216  Identities=20%  Similarity=0.330  Sum_probs=178.4

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEEcc
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY------HYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~------~~lv~E~~   71 (328)
                      |+||.||+|....   ++..+|+|.++.+.........+.+|+.+++.++||||+++++++.....      .+++|||+
T Consensus        10 G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~   89 (273)
T cd05035          10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM   89 (273)
T ss_pred             CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEecc
Confidence            8999999998765   34789999998776666667788999999999999999999998865554      79999999


Q ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          72 TGGELFEDIVAR------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        72 ~gg~L~~~l~~~------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      ++|+|...+...      ..+++..+..++.|++.||.|||+++|+||||||+||+++++   +.+||+|||+++.....
T Consensus        90 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~  166 (273)
T cd05035          90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED---MTVCVADFGLSKKIYSG  166 (273)
T ss_pred             CCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC---CeEEECCccceeecccc
Confidence            999998887432      358999999999999999999999999999999999999754   46999999997643211


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       167 ~~~-----------------------------------------------------------------------------  169 (273)
T cd05035         167 DYY-----------------------------------------------------------------------------  169 (273)
T ss_pred             ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..
T Consensus       170 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~  222 (273)
T cd05035         170 ---------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH  222 (273)
T ss_pred             ---------------------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                                       00001124667999999999999999999999999999999 99999999999


Q ss_pred             HHHHHHhcccCCCCCCccc
Q psy2131         305 RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~~  323 (328)
                      +++..+..+.....|..++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~  241 (273)
T cd05035         223 EIYDYLRHGNRLKQPEDCL  241 (273)
T ss_pred             HHHHHHHcCCCCCCCcCCC
Confidence            9999999887766665554

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-38  Score=276.26  Aligned_cols=212  Identities=25%  Similarity=0.375  Sum_probs=174.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.+|+|.+... ...+....+.+|+++++.++||||+++++++.+.+..|+||||+.+++|.+++
T Consensus         6 g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   84 (252)
T cd05084           6 GNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL   84 (252)
T ss_pred             ccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHH
Confidence            78999999999999999999998643 23444567889999999999999999999999999999999999999999988


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        85 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~------------  149 (252)
T cd05084          85 RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVY------------  149 (252)
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC---CcEEECccccCcccccccc------------
Confidence            6543 58999999999999999999999999999999999999754   4599999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                              .                                                       
T Consensus       150 ------------------------~-------------------------------------------------------  150 (252)
T cd05084         150 ------------------------A-------------------------------------------------------  150 (252)
T ss_pred             ------------------------c-------------------------------------------------------
Confidence                                    0                                                       


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.......+..+.....
T Consensus       151 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  217 (252)
T cd05084         151 -------------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC  217 (252)
T ss_pred             -------------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence                         00000113456999999999999999999999999999998 9999998888777777776644333


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       218 ~~  219 (252)
T cd05084         218 PE  219 (252)
T ss_pred             cc
Confidence            33

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-38  Score=286.38  Aligned_cols=214  Identities=21%  Similarity=0.317  Sum_probs=173.4

Q ss_pred             CCceEEEEEEEccCCcE----EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~----~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..+++.    ||+|+++.. ......+.+.+|+.+++.++||||+++++++... ..++++||+++|+|
T Consensus        18 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l   95 (316)
T cd05108          18 GAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL   95 (316)
T ss_pred             CCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCH
Confidence            89999999998766664    899998643 2334456788999999999999999999998865 57899999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+++........       
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~-------  165 (316)
T cd05108          96 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGADEKE-------  165 (316)
T ss_pred             HHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC---CcEEEccccccccccCCCcc-------
Confidence            9998764 468889999999999999999999999999999999999754   45999999998543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (316)
T cd05108         166 --------------------------------------------------------------------------------  165 (316)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       ....+..++..|+|||++.+..++.++|||||||++|||+| |++||.+....++.+.+..+.
T Consensus       166 -----------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (316)
T cd05108         166 -----------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  228 (316)
T ss_pred             -----------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC
Confidence                             00001224678999999999999999999999999999998 999999988888877777776


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ..+.|+.++
T Consensus       229 ~~~~~~~~~  237 (316)
T cd05108         229 RLPQPPICT  237 (316)
T ss_pred             CCCCCCCCC
Confidence            655555443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-38  Score=284.00  Aligned_cols=223  Identities=30%  Similarity=0.492  Sum_probs=180.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||++.+..+++.||+|.+...... ......+.+|+++++.++||||+++++.+.+++.+|+||||++|++|.++
T Consensus        12 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   91 (305)
T cd05609          12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATL   91 (305)
T ss_pred             CCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHH
Confidence            78999999999999999999999765432 23445678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++..+..++.|++.||.|||+++++||||||+||+++..   +.+||+|||+++........           
T Consensus        92 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~---~~~~l~dfg~~~~~~~~~~~-----------  157 (305)
T cd05609          92 LKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTT-----------  157 (305)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC---CCEEEeeCCCccccCcCccc-----------
Confidence            9888889999999999999999999999999999999999999754   46999999987532110000           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                         ..                +  ..                ...                                   
T Consensus       158 ---~~----------------~--~~----------------~~~-----------------------------------  165 (305)
T cd05609         158 ---NL----------------Y--EG----------------HIE-----------------------------------  165 (305)
T ss_pred             ---cc----------------c--cc----------------ccc-----------------------------------
Confidence               00                0  00                000                                   


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                              ............|++.|+|||.+.+..++.++|+|||||++|||++|+.||.+.++.+++..+..+....
T Consensus       166 --------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         166 --------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             --------cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                    0000000112357899999999999999999999999999999999999999999999999988886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-38  Score=278.98  Aligned_cols=205  Identities=29%  Similarity=0.449  Sum_probs=171.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|++.....  .....+.+|+.++++++||||+++++++...+..|+||||+++++|.+.+
T Consensus        20 g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~   97 (267)
T cd06646          20 GTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY   97 (267)
T ss_pred             CCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence            7899999999999999999999975432  23456788999999999999999999999999999999999999999988


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++.......              
T Consensus        98 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~~--------------  160 (267)
T cd06646          98 HVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITATI--------------  160 (267)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEECcCccceeecccc--------------
Confidence            877889999999999999999999999999999999999999754   459999999975431100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (267)
T cd06646         161 --------------------------------------------------------------------------------  160 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                  .......|++.|+|||++.   ...++.++|+||+||++|||++|+.||.+.++......+....+.
T Consensus       161 ------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  227 (267)
T cd06646         161 ------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ  227 (267)
T ss_pred             ------------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC
Confidence                        0001234889999999985   345788999999999999999999999887766555555555543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-38  Score=277.64  Aligned_cols=209  Identities=24%  Similarity=0.418  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.+|+|++..+.   .....+.+|+++++.++||||+++++++...+.++++|||+++++|.+.+
T Consensus        17 g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (263)
T cd05052          17 GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL   93 (263)
T ss_pred             cccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHH
Confidence            789999999999999999999987542   23456788999999999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||+++++||||||+|||++.+   +.+||+|||++........           
T Consensus        94 ~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~df~~~~~~~~~~~-----------  159 (263)
T cd05052          94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTY-----------  159 (263)
T ss_pred             HhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---CcEEeCCCcccccccccee-----------
Confidence            653  358899999999999999999999999999999999999653   4699999999754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (263)
T cd05052         160 --------------------------------------------------------------------------------  159 (263)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+...++..+.++.-..
T Consensus       160 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  225 (263)
T cd05052         160 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME  225 (263)
T ss_pred             --------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence                          00001124678999999999999999999999999999998 999999999999999988875433


Q ss_pred             CCC
Q psy2131         318 EPK  320 (328)
Q Consensus       318 ~~~  320 (328)
                      .|.
T Consensus       226 ~~~  228 (263)
T cd05052         226 RPE  228 (263)
T ss_pred             CCC
Confidence            333

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.2e-38  Score=284.54  Aligned_cols=203  Identities=22%  Similarity=0.344  Sum_probs=164.2

Q ss_pred             CCceEEEEEEEcc----------------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKA----------------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~----------------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||.||+|.+..                ++..||+|++.... .......+.+|+++|++++||||+++++++.+.+..
T Consensus        16 G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   94 (304)
T cd05096          16 GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL   94 (304)
T ss_pred             cCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCce
Confidence            8999999997532                34579999997543 344456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCcHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC
Q psy2131          65 YLVFDLVTGGELFEDIVARE-------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK  125 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~  125 (328)
                      |+||||+.+|+|.+++....                   .++...+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~  174 (304)
T cd05096          95 CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN  174 (304)
T ss_pred             EEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCC
Confidence            99999999999998885432                   35677888999999999999999999999999999999754


Q ss_pred             CCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhccc
Q psy2131         126 AKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       126 ~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  205 (328)
                         +.+||+|||++.........                                                         
T Consensus       175 ---~~~kl~DfG~~~~~~~~~~~---------------------------------------------------------  194 (304)
T cd05096         175 ---LTIKIADFGMSRNLYAGDYY---------------------------------------------------------  194 (304)
T ss_pred             ---ccEEECCCccceecccCcee---------------------------------------------------------
Confidence               46999999997543111000                                                         


Q ss_pred             CCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhh
Q psy2131         206 NPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACG  285 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlG  285 (328)
                                                                     .......+++.|+|||++.+..++.++||||||
T Consensus       195 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  227 (304)
T cd05096         195 -----------------------------------------------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFG  227 (304)
T ss_pred             -----------------------------------------------EecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence                                                           000112367889999999999999999999999


Q ss_pred             hHHHHHHh--cCCCCCCccHHHHHHHHh
Q psy2131         286 VILYILLV--GYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       286 vilyellt--G~~Pf~~~~~~~~~~~i~  311 (328)
                      |++|||++  |..||.+.+..++...+.
T Consensus       228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~  255 (304)
T cd05096         228 VTLWEILMLCKEQPYGELTDEQVIENAG  255 (304)
T ss_pred             HHHHHHHHccCCCCCCcCCHHHHHHHHH
Confidence            99999986  678998877776666553

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.7e-38  Score=275.72  Aligned_cols=215  Identities=22%  Similarity=0.394  Sum_probs=174.1

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|...  .++..+|+|++.... .....+.+.+|+.++++++||||+++++++.. +..|+||||+++++|.+
T Consensus         6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~   83 (257)
T cd05115           6 GNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNK   83 (257)
T ss_pred             CCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHH
Confidence            899999999765  456679999987543 33445678899999999999999999998864 56899999999999998


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ++.. ...+++.++..++.|++.||.|||++|++||||||+|||++.+   +.+||+|||++.........         
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~~~---------  151 (257)
T cd05115          84 FLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADDSY---------  151 (257)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC---CcEEeccCCccccccCCccc---------
Confidence            8875 4578999999999999999999999999999999999999653   46999999987532111000         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       152 --------------------------------------------------------------------------------  151 (257)
T cd05115         152 --------------------------------------------------------------------------------  151 (257)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    ........+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+...+...+.+|...
T Consensus       152 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  217 (257)
T cd05115         152 --------------YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL  217 (257)
T ss_pred             --------------eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence                          000001124678999999999899999999999999999996 99999999999999999888765


Q ss_pred             CCCCccc
Q psy2131         317 DEPKHKS  323 (328)
Q Consensus       317 ~~~~~~~  323 (328)
                      ..|..++
T Consensus       218 ~~~~~~~  224 (257)
T cd05115         218 DCPAECP  224 (257)
T ss_pred             CCCCCCC
Confidence            5554443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.7e-38  Score=280.09  Aligned_cols=213  Identities=22%  Similarity=0.374  Sum_probs=174.5

Q ss_pred             CCceEEEEEEEc----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|...    .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||+.+++|
T Consensus        16 g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   94 (283)
T cd05090          16 CAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL   94 (283)
T ss_pred             cCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcH
Confidence            899999999853    456789999997533 344556788999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          77 FEDIVAR-----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        77 ~~~l~~~-----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      .+++...                 ..+++.++..++.|++.||.|||+++|+||||||+|||++.+   ..+||+|||++
T Consensus        95 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~  171 (283)
T cd05090          95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ---LHVKISDLGLS  171 (283)
T ss_pred             HHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC---CcEEecccccc
Confidence            9888532                 247888889999999999999999999999999999999754   45999999998


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .........                                                                       
T Consensus       172 ~~~~~~~~~-----------------------------------------------------------------------  180 (283)
T cd05090         172 REIYSADYY-----------------------------------------------------------------------  180 (283)
T ss_pred             ccccCCcce-----------------------------------------------------------------------
Confidence            553211000                                                                       


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf  298 (328)
                                                       .......++..|+|||++.+..++.++|+|||||++|||++ |.+||
T Consensus       181 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~  227 (283)
T cd05090         181 ---------------------------------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY  227 (283)
T ss_pred             ---------------------------------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence                                             00011235678999999999999999999999999999999 99999


Q ss_pred             CCccHHHHHHHHhcccCCCCCCc
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~  321 (328)
                      .+.++..+.+.+..+...+.|..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~  250 (283)
T cd05090         228 YGFSNQEVIEMVRKRQLLPCSED  250 (283)
T ss_pred             CCCCHHHHHHHHHcCCcCCCCCC
Confidence            99988888888877776544443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.6e-38  Score=273.91  Aligned_cols=213  Identities=30%  Similarity=0.506  Sum_probs=184.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|.+.....+......+.+|++++++++||||+++++.+...+..++||||++|++|.+++
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   90 (256)
T cd08220          11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI   90 (256)
T ss_pred             cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHH
Confidence            78999999999999999999999877666666778899999999999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||+|||++|++|+||||+||+++.+  +..+||+|||++.......            
T Consensus        91 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~~------------  156 (256)
T cd08220          91 QKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKS------------  156 (256)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEEccCCCceecCCCc------------
Confidence            764  358999999999999999999999999999999999999643  3468999999875431100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd08220         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+...+...+.++.....
T Consensus       157 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08220         157 ---------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI  221 (256)
T ss_pred             ---------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC
Confidence                           00113478899999999999999999999999999999999999999998899999888877655


Q ss_pred             CCcc
Q psy2131         319 PKHK  322 (328)
Q Consensus       319 ~~~~  322 (328)
                      |...
T Consensus       222 ~~~~  225 (256)
T cd08220         222 SDRY  225 (256)
T ss_pred             CCCc
Confidence            5443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.4e-38  Score=281.74  Aligned_cols=200  Identities=25%  Similarity=0.403  Sum_probs=172.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..++..+|+|.+.... ......++.+|++++++++||||+++++++.+++.+|+||||++|++|.+++
T Consensus        12 G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l   90 (308)
T cd06615          12 GNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL   90 (308)
T ss_pred             CCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHH
Confidence            899999999999999999999987542 3444567889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+.+++..+..++.|++.||.|||+ .+++||||||+|||++.+   +.+||+|||++......              
T Consensus        91 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~--------------  153 (308)
T cd06615          91 KKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS--------------  153 (308)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---CcEEEccCCCccccccc--------------
Confidence            888889999999999999999999998 699999999999999754   45999999986432100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (308)
T cd06615         154 --------------------------------------------------------------------------------  153 (308)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                    ......|++.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+...+...+..
T Consensus       154 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~  212 (308)
T cd06615         154 --------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR  212 (308)
T ss_pred             --------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC
Confidence                          00123588999999999998899999999999999999999999998886666555443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0579|consensus

Probab=100.00  E-value=5.8e-40  Score=300.54  Aligned_cols=202  Identities=33%  Similarity=0.535  Sum_probs=178.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.++...|.|+|..+  +.+..+.+.-||.||..++||+||+|+++|...+.+||..|||.||.....+
T Consensus        43 GAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaim  120 (1187)
T KOG0579|consen   43 GAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIM  120 (1187)
T ss_pred             ccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHH
Confidence            89999999999999999999999754  4566777888999999999999999999999999999999999999987766


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+.+.+++.+++|++.||.|||+++|||||||..|||+.-+|+   |+|+|||.+...                 
T Consensus       121 lEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn-----------------  180 (1187)
T KOG0579|consen  121 LELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKN-----------------  180 (1187)
T ss_pred             HHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---Eeeecccccccc-----------------
Confidence            54 457999999999999999999999999999999999999987654   999999986221                 


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (1187)
T KOG0579|consen  181 --------------------------------------------------------------------------------  180 (1187)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccc-----ccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-----~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                               +...-.+.+|.|||.|||||+.     +..||+.++|||||||+|.||.-+.||..+.++.+++-+|...
T Consensus       181 ---------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS  250 (1187)
T KOG0579|consen  181 ---------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  250 (1187)
T ss_pred             ---------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc
Confidence                     1111235678899999999986     5789999999999999999999999999999999999998764

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.6e-38  Score=284.06  Aligned_cols=208  Identities=25%  Similarity=0.403  Sum_probs=170.5

Q ss_pred             CCceEEEEEEEccCCcE--EEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLE--FAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~--~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.++.++..  +|+|.++. .........+.+|+.++.++ +||||+++++++.+.+..|+||||+++++|.
T Consensus        18 G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   96 (303)
T cd05088          18 GNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL   96 (303)
T ss_pred             CCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHH
Confidence            89999999998888765  46666653 22344556788999999999 8999999999999999999999999999999


Q ss_pred             HHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +++....                .+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++..
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~---~~~kl~dfg~~~~  173 (303)
T cd05088          97 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRG  173 (303)
T ss_pred             HHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC---CcEEeCccccCcc
Confidence            9886432                47899999999999999999999999999999999999754   4699999998632


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      ....                                                                            
T Consensus       174 ~~~~----------------------------------------------------------------------------  177 (303)
T cd05088         174 QEVY----------------------------------------------------------------------------  177 (303)
T ss_pred             cchh----------------------------------------------------------------------------
Confidence            1000                                                                            


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                     .......+++.|+|||++.+..++.++|||||||++|||+| |.+||.+
T Consensus       178 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         178 -------------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             -------------------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence                                           00000124567999999999999999999999999999998 9999999


Q ss_pred             ccHHHHHHHHhcccCCCCC
Q psy2131         301 EDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~  319 (328)
                      .+..+++..+..+.....|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~  245 (303)
T cd05088         227 MTCAELYEKLPQGYRLEKP  245 (303)
T ss_pred             CChHHHHHHHhcCCcCCCC
Confidence            9988999888776543333

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-38  Score=279.35  Aligned_cols=218  Identities=25%  Similarity=0.405  Sum_probs=177.9

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..     ++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+.+..|+||||++|++
T Consensus        17 g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~   95 (277)
T cd05036          17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGD   95 (277)
T ss_pred             CCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCC
Confidence            7899999999987     78899999886543 23334567889999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          76 LFEDIVARE-------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        76 L~~~l~~~~-------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      |.+++....       .+++.++..++.|++.||.|||+++++||||||+|||++.++....+||+|||++.........
T Consensus        96 L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~  175 (277)
T cd05036          96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY  175 (277)
T ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce
Confidence            999886543       4888999999999999999999999999999999999987665567999999998654211000


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      .                                                                               
T Consensus       176 ~-------------------------------------------------------------------------------  176 (277)
T cd05036         176 R-------------------------------------------------------------------------------  176 (277)
T ss_pred             e-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~  307 (328)
                                               ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+...+.
T Consensus       177 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~  231 (277)
T cd05036         177 -------------------------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM  231 (277)
T ss_pred             -------------------------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                                     0000123457999999999999999999999999999997 99999999888888


Q ss_pred             HHHhcccCCCCCCccc
Q psy2131         308 AQIKAGAYDDEPKHKS  323 (328)
Q Consensus       308 ~~i~~~~~~~~~~~~~  323 (328)
                      ..+..+.....|..++
T Consensus       232 ~~~~~~~~~~~~~~~~  247 (277)
T cd05036         232 EFVTGGGRLDPPKGCP  247 (277)
T ss_pred             HHHHcCCcCCCCCCCC
Confidence            8887765544444443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-37  Score=276.62  Aligned_cols=204  Identities=32%  Similarity=0.528  Sum_probs=172.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|.+...  .....+.+.+|+++++.++||||+++++++...+..|+||||+++++|...+
T Consensus        16 g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~   93 (282)
T cd06643          16 GAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM   93 (282)
T ss_pred             CCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHH
Confidence            78999999999999999999998643  3445667889999999999999999999999999999999999999998877


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        94 ~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~-------------  157 (282)
T cd06643          94 LELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTI-------------  157 (282)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---CCEEEccccccccccccc-------------
Confidence            54 4568999999999999999999999999999999999999754   459999999874321100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (282)
T cd06643         158 --------------------------------------------------------------------------------  157 (282)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   .......||+.|+|||++.     +..++.++|+||+||++|||++|++||.+.++.+...++.++.
T Consensus       158 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  224 (282)
T cd06643         158 -------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE  224 (282)
T ss_pred             -------------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC
Confidence                         0011234889999999984     4567889999999999999999999999998888888887765


Q ss_pred             C
Q psy2131         315 Y  315 (328)
Q Consensus       315 ~  315 (328)
                      .
T Consensus       225 ~  225 (282)
T cd06643         225 P  225 (282)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-38  Score=274.78  Aligned_cols=215  Identities=28%  Similarity=0.436  Sum_probs=183.7

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+...   +..+|+|++....... ..+.+.+|+++++.++|+||+++++++.+....++||||+++++|.
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   84 (262)
T cd00192           6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLL   84 (262)
T ss_pred             CCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHH
Confidence            89999999999866   8999999998654433 4677889999999999999999999999999999999999999999


Q ss_pred             HHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          78 EDIVAR---------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        78 ~~l~~~---------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      +.+...         ..+++.++..++.|++.||.|||+++++||||||+||+++.+   +.+||+|||.+.........
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~~~~~~~~  161 (262)
T cd00192          85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---LVVKISDFGLSRDVYDDDYY  161 (262)
T ss_pred             HHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---CcEEEccccccccccccccc
Confidence            999875         679999999999999999999999999999999999999764   46999999997543211000


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (262)
T cd00192         162 --------------------------------------------------------------------------------  161 (262)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~  307 (328)
                                              .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+...+.
T Consensus       162 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  217 (262)
T cd00192         162 ------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL  217 (262)
T ss_pred             ------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence                                    00112347889999999998899999999999999999999 69999999999999


Q ss_pred             HHHhcccCCCCCCccc
Q psy2131         308 AQIKAGAYDDEPKHKS  323 (328)
Q Consensus       308 ~~i~~~~~~~~~~~~~  323 (328)
                      +.+..+.....|..++
T Consensus       218 ~~~~~~~~~~~~~~~~  233 (262)
T cd00192         218 EYLRKGYRLPKPEYCP  233 (262)
T ss_pred             HHHHcCCCCCCCccCC
Confidence            9999877666565543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6e-38  Score=274.62  Aligned_cols=208  Identities=26%  Similarity=0.415  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++..+ .+..+|+|.+......   ...+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+.+
T Consensus        15 G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~   90 (256)
T cd05114          15 GQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL   90 (256)
T ss_pred             CcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence            899999999875 4567999998755433   245778999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++........            
T Consensus        91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~d~g~~~~~~~~~~------------  155 (256)
T cd05114          91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDEY------------  155 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC---CeEEECCCCCccccCCCce------------
Confidence            653 468999999999999999999999999999999999999753   4699999998754311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (256)
T cd05114         156 --------------------------------------------------------------------------------  155 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......++..|+|||++.+..++.++|+|||||++|||++ |++||.+.+...+...+.++.....
T Consensus       156 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~  222 (256)
T cd05114         156 -------------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR  222 (256)
T ss_pred             -------------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence                         00011235667999999999999999999999999999999 9999999999999999999876544


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       223 ~~  224 (256)
T cd05114         223 PK  224 (256)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-38  Score=274.19  Aligned_cols=216  Identities=23%  Similarity=0.375  Sum_probs=179.0

Q ss_pred             CCceEEEEEEEccCC---cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~---~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|....++   ..+|+|.+...... ...+.+.+|+++++.++||||+++++++.. +..++||||+++|+|.
T Consensus         6 G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~   83 (257)
T cd05060           6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLL   83 (257)
T ss_pred             cCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHH
Confidence            899999999876555   78999999866543 345678899999999999999999998764 4689999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +++.....+++..+..++.|++.||.|||+.+++||||||+|||++.+   +.+||+|||++.........         
T Consensus        84 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~~~~---------  151 (257)
T cd05060          84 KYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---HQAKISDFGMSRALGAGSDY---------  151 (257)
T ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---CcEEeccccccceeecCCcc---------
Confidence            999887789999999999999999999999999999999999999754   45999999997543211000         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                            +                                                                         
T Consensus       152 ------~-------------------------------------------------------------------------  152 (257)
T cd05060         152 ------Y-------------------------------------------------------------------------  152 (257)
T ss_pred             ------c-------------------------------------------------------------------------
Confidence                  0                                                                         


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                     .......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..++...+.++...
T Consensus       153 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~  217 (257)
T cd05060         153 ---------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL  217 (257)
T ss_pred             ---------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC
Confidence                           00001124567999999999999999999999999999998 99999999999999999998876


Q ss_pred             CCCCcccc
Q psy2131         317 DEPKHKSA  324 (328)
Q Consensus       317 ~~~~~~~~  324 (328)
                      ..|..++.
T Consensus       218 ~~~~~~~~  225 (257)
T cd05060         218 PRPEECPQ  225 (257)
T ss_pred             CCCCCCCH
Confidence            66665543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.5e-38  Score=281.66  Aligned_cols=212  Identities=24%  Similarity=0.400  Sum_probs=173.7

Q ss_pred             CCceEEEEEEEccCCc--EEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGL--EFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~--~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|....++.  .+|+|.++.. ......+.+.+|+++++++ +||||+++++++.+.+..|++|||+++++|.
T Consensus        13 g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~   91 (297)
T cd05089          13 GNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLL   91 (297)
T ss_pred             CCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHH
Confidence            8999999999887775  4688887632 2334456788999999999 7999999999999999999999999999999


Q ss_pred             HHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +++....                .+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++..
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~  168 (297)
T cd05089          92 DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN---LASKIADFGLSRG  168 (297)
T ss_pred             HHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC---CeEEECCcCCCcc
Confidence            9886532                47888999999999999999999999999999999999753   4699999998642


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .....                                                                           
T Consensus       169 ~~~~~---------------------------------------------------------------------------  173 (297)
T cd05089         169 EEVYV---------------------------------------------------------------------------  173 (297)
T ss_pred             cccee---------------------------------------------------------------------------
Confidence            10000                                                                           


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                      .......+..|+|||++.+..++.++|||||||++|||+| |.+||.+
T Consensus       174 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         174 --------------------------------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             --------------------------------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence                                            0000112456999999999999999999999999999998 9999999


Q ss_pred             ccHHHHHHHHhcccCCCCCCccc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .+...++.++.++.....|..++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd05089         222 MTCAELYEKLPQGYRMEKPRNCD  244 (297)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCC
Confidence            99999999998886555555443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.1e-38  Score=278.20  Aligned_cols=205  Identities=29%  Similarity=0.496  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHH-HHHHHH---HHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLERE---ARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~-~~~~~E---~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|++..+++.||+|.+..+....... .....|   +++++..+||||+++++++.+.+..|+||||+.||+|
T Consensus         5 g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L   84 (278)
T cd05606           5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL   84 (278)
T ss_pred             CCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcH
Confidence            899999999999999999999998654332211 122233   3455556899999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+.+...+.+++.++..++.|++.||.|||+.+|+||||||+||+++.+   +.+||+|||++......           
T Consensus        85 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~---~~~kl~dfg~~~~~~~~-----------  150 (278)
T cd05606          85 HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-----------  150 (278)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC---CCEEEccCcCccccCcc-----------
Confidence            9888887889999999999999999999999999999999999999754   46999999987432100           


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       151 --------------------------------------------------------------------------------  150 (278)
T cd05606         151 --------------------------------------------------------------------------------  150 (278)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~  312 (328)
                                       ......||+.|+|||++.+ ..++.++|+||+||++|||++|+.||.+.   +.......+..
T Consensus       151 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  213 (278)
T cd05606         151 -----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT  213 (278)
T ss_pred             -----------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc
Confidence                             0001248999999999975 46899999999999999999999999887   44555555544


Q ss_pred             ccCC
Q psy2131         313 GAYD  316 (328)
Q Consensus       313 ~~~~  316 (328)
                      ....
T Consensus       214 ~~~~  217 (278)
T cd05606         214 MAVE  217 (278)
T ss_pred             cCCC
Confidence            4443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.1e-38  Score=287.59  Aligned_cols=217  Identities=29%  Similarity=0.447  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||||++.... .......+.+|+++++.++|+||+++++++.+.+.+|+|||||++|+|..  
T Consensus        85 G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~--  161 (353)
T PLN00034         85 GAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--  161 (353)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc--
Confidence            899999999999999999999996543 23345678899999999999999999999999999999999999999854  


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                        ....++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..+..                
T Consensus       162 --~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a  236 (353)
T PLN00034        162 --THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---KNVKIADFGVSRILAQTMDPCNSSVGTIAYMS  236 (353)
T ss_pred             --cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEcccccceecccccccccccccCccccC
Confidence              2346778888999999999999999999999999999999754   4699999998753210                


Q ss_pred             ----------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCC
Q psy2131         145 ----------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP  207 (328)
Q Consensus       145 ----------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  207 (328)
                                      ..+.| +|+++|+|++|..||...........+.......+.......+.++++||.+||..||
T Consensus       237 PE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  316 (353)
T PLN00034        237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREP  316 (353)
T ss_pred             ccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCCh
Confidence                            12334 8999999999999997543332222222222222233345688999999999999999


Q ss_pred             CCCCCHHHHhcCcccCCc
Q psy2131         208 SKRITASEALKHPWICQR  225 (328)
Q Consensus       208 ~~R~t~~~~l~h~~~~~~  225 (328)
                      ++|||+.|++.|||+...
T Consensus       317 ~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        317 AKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             hhCcCHHHHhcCcccccC
Confidence            999999999999999764

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.4e-38  Score=279.55  Aligned_cols=216  Identities=26%  Similarity=0.359  Sum_probs=178.1

Q ss_pred             CCceEEEEEEEccC-----CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKAT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~-----~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.+..+     +..+|+|+++... .....+.+.+|+.+++.++||||+++++++.+.+..++++||+.+++
T Consensus        16 G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~   94 (283)
T cd05091          16 DRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD   94 (283)
T ss_pred             CCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCc
Confidence            78999999987543     5789999997543 23344668899999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          76 LFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        76 L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      |.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++
T Consensus        95 l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~kl~Dfg~~  171 (283)
T cd05091          95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK---LNVKISDLGLF  171 (283)
T ss_pred             HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC---CceEecccccc
Confidence            99887532                347888899999999999999999999999999999999754   45999999997


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +........                                                                       
T Consensus       172 ~~~~~~~~~-----------------------------------------------------------------------  180 (283)
T cd05091         172 REVYAADYY-----------------------------------------------------------------------  180 (283)
T ss_pred             cccccchhe-----------------------------------------------------------------------
Confidence            543211000                                                                       


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf  298 (328)
                                                       .......+++.|+|||++.+..++.++|||||||++|||+| |.+||
T Consensus       181 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  227 (283)
T cd05091         181 ---------------------------------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  227 (283)
T ss_pred             ---------------------------------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence                                             00001235788999999998899999999999999999998 99999


Q ss_pred             CCccHHHHHHHHhcccCCCCCCcccc
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      .+....++...|..+...+.|..++.
T Consensus       228 ~~~~~~~~~~~i~~~~~~~~~~~~~~  253 (283)
T cd05091         228 CGYSNQDVIEMIRNRQVLPCPDDCPA  253 (283)
T ss_pred             CCCCHHHHHHHHHcCCcCCCCCCCCH
Confidence            99999999999999988766665554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.2e-38  Score=276.76  Aligned_cols=215  Identities=19%  Similarity=0.331  Sum_probs=175.4

Q ss_pred             CCceEEEEEEEccCCc--EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGL--EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~--~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~   72 (328)
                      |+||.||+|....++.  .+|+|.++....+....+.+.+|+++++.++||||+++++.+...      ...+++|||+.
T Consensus        10 G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~   89 (272)
T cd05075          10 GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK   89 (272)
T ss_pred             ccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCC
Confidence            8999999999887775  599999987666666678889999999999999999999976432      24699999999


Q ss_pred             CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          73 GGELFEDIVA------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        73 gg~L~~~l~~------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      +|+|.+++..      ...+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||++.......
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  166 (272)
T cd05075          90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVCVADFGLSKKIYNGD  166 (272)
T ss_pred             CCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC---CCEEECCCCcccccCccc
Confidence            9999887742      2347899999999999999999999999999999999999653   469999999975432110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       167 ~~------------------------------------------------------------------------------  168 (272)
T cd05075         167 YY------------------------------------------------------------------------------  168 (272)
T ss_pred             ce------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                                .......+++.|+|||++.+..++.++|+|||||++|||++ |++||.+.+..+
T Consensus       169 --------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  222 (272)
T cd05075         169 --------------------------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE  222 (272)
T ss_pred             --------------------------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                                      00001125678999999999999999999999999999999 899999999999


Q ss_pred             HHHHHhcccCCCCCCcc
Q psy2131         306 LYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~~~  322 (328)
                      +...+..+.....|..+
T Consensus       223 ~~~~~~~~~~~~~~~~~  239 (272)
T cd05075         223 IYDYLRQGNRLKQPPDC  239 (272)
T ss_pred             HHHHHHcCCCCCCCCCC
Confidence            99999988764444444

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-38  Score=276.85  Aligned_cols=204  Identities=34%  Similarity=0.527  Sum_probs=173.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|++...  .....+.+.+|+.++++++||||+++++.+.+....|+||||+++++|.+++
T Consensus        16 g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (280)
T cd06611          16 GAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM   93 (280)
T ss_pred             CCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHH
Confidence            78999999999999999999999754  3445567889999999999999999999999999999999999999998888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||++.......             
T Consensus        94 ~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~-------------  157 (280)
T cd06611          94 LELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---GDVKLADFGVSAKNKSTL-------------  157 (280)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC---CCEEEccCccchhhcccc-------------
Confidence            664 569999999999999999999999999999999999999754   469999999864321000             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (280)
T cd06611         158 --------------------------------------------------------------------------------  157 (280)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   .......||+.|+|||++.     +.+++.++|+|||||++|||++|++||.+.++.+...++..+.
T Consensus       158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (280)
T cd06611         158 -------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE  224 (280)
T ss_pred             -------------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC
Confidence                         0011235899999999985     3457889999999999999999999999999888888887764


Q ss_pred             C
Q psy2131         315 Y  315 (328)
Q Consensus       315 ~  315 (328)
                      .
T Consensus       225 ~  225 (280)
T cd06611         225 P  225 (280)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6e-38  Score=291.29  Aligned_cols=214  Identities=25%  Similarity=0.385  Sum_probs=169.1

Q ss_pred             CCceEEEEEEEccC-----CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKAT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~-----~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+...     +..||||+++... .....+.+.+|+++|++++ |||||++++++.+.+..|||||||++|
T Consensus        48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g  126 (400)
T cd05105          48 GAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYG  126 (400)
T ss_pred             CCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCC
Confidence            89999999987433     3469999997543 3344567899999999996 999999999999999999999999999


Q ss_pred             CcHHHHHhc-----------------------------------------------------------------------
Q psy2131          75 ELFEDIVAR-----------------------------------------------------------------------   83 (328)
Q Consensus        75 ~L~~~l~~~-----------------------------------------------------------------------   83 (328)
                      +|.+++...                                                                       
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (400)
T cd05105         127 DLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRS  206 (400)
T ss_pred             cHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccC
Confidence            998887542                                                                       


Q ss_pred             -------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccc
Q psy2131          84 -------------------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL  138 (328)
Q Consensus        84 -------------------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGl  138 (328)
                                               ..+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||+
T Consensus       207 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~---~~~kL~DfGl  283 (400)
T cd05105         207 NYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG---KIVKICDFGL  283 (400)
T ss_pred             cccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC---CEEEEEeCCc
Confidence                                     136777888999999999999999999999999999999754   4699999999


Q ss_pred             cccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         139 AIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       139 a~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +........                                                                       
T Consensus       284 a~~~~~~~~-----------------------------------------------------------------------  292 (400)
T cd05105         284 ARDIMHDSN-----------------------------------------------------------------------  292 (400)
T ss_pred             ceecccccc-----------------------------------------------------------------------
Confidence            754311000                                                                       


Q ss_pred             CcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCC
Q psy2131         219 HPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPP  297 (328)
Q Consensus       219 h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~P  297 (328)
                                                       ........|++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       293 ---------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         293 ---------------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             ---------------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence                                             000112346788999999999999999999999999999997 9999


Q ss_pred             CCCccH-HHHHHHHhcccCCCCCCcc
Q psy2131         298 FWDEDQ-HRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       298 f~~~~~-~~~~~~i~~~~~~~~~~~~  322 (328)
                      |.+... ......+..+.....|.++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (400)
T cd05105         340 YPGMIVDSTFYNKIKSGYRMAKPDHA  365 (400)
T ss_pred             CcccchhHHHHHHHhcCCCCCCCccC
Confidence            988753 4455666666443334333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-38  Score=273.80  Aligned_cols=205  Identities=31%  Similarity=0.531  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHH-HhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARIC-RKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il-~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|+.||+|++...... ......+..|..++ ...+|+||+++++++...+..|+||||++|++|.+
T Consensus         7 g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   86 (260)
T cd05611           7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS   86 (260)
T ss_pred             CCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHH
Confidence            78999999999999999999999765432 22233445555544 45689999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.+   +.+||+|||++.....              
T Consensus        87 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~--------------  149 (260)
T cd05611          87 LIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE--------------  149 (260)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEeecccceeccc--------------
Confidence            98887889999999999999999999999999999999999999754   4599999998632100              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       150 --------------------------------------------------------------------------------  149 (260)
T cd05611         150 --------------------------------------------------------------------------------  149 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                      .....|++.|+|||.+.+..++.++||||+||++|+|+||.+||...+...++..+..+....+
T Consensus       150 ----------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  213 (260)
T cd05611         150 ----------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP  213 (260)
T ss_pred             ----------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                            0013478899999999998899999999999999999999999999999999888887765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-37  Score=274.07  Aligned_cols=207  Identities=30%  Similarity=0.467  Sum_probs=170.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~   75 (328)
                      |+||.||++.+..+|+.||+|++......   ......+.+|++++++++||||+++++++.+.  ..+|++|||++|++
T Consensus        13 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~   92 (265)
T cd06652          13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS   92 (265)
T ss_pred             CCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCc
Confidence            78999999999999999999998644322   23456788999999999999999999998763  57899999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+++.....+++..+..++.|++.||.|||+++|+|+||||+|||++.+   +.++|+|||++.........       
T Consensus        93 L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~-------  162 (265)
T cd06652          93 IKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLS-------  162 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC---CCEEECcCcccccccccccc-------
Confidence            99998877788999999999999999999999999999999999999754   46999999987543110000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (265)
T cd06652         163 --------------------------------------------------------------------------------  162 (265)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ........||..|+|||++.+..++.++|+|||||++|||++|+.||.+.+.......+...
T Consensus       163 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  224 (265)
T cd06652         163 ----------------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ  224 (265)
T ss_pred             ----------------ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC
Confidence                            00001124788999999999999999999999999999999999999987655555554433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-38  Score=275.40  Aligned_cols=212  Identities=27%  Similarity=0.475  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..+++.+|+|.+.......       ...+.+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus        11 g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06628          11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPG   90 (267)
T ss_pred             CCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCC
Confidence            789999999999999999999987543321       1235678999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++.........     
T Consensus        91 ~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~-----  162 (267)
T cd06628          91 GSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLS-----  162 (267)
T ss_pred             CCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC---CCEEecccCCCccccccccc-----
Confidence            9999999888889999999999999999999999999999999999999654   46999999997654211000     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                         .+                           
T Consensus       163 ---------------------------------------------------~~---------------------------  164 (267)
T cd06628         163 ---------------------------------------------------TK---------------------------  164 (267)
T ss_pred             ---------------------------------------------------CC---------------------------
Confidence                                                               00                           


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                       .........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+..+
T Consensus       165 -----------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  227 (267)
T cd06628         165 -----------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN  227 (267)
T ss_pred             -----------------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc
Confidence                             000011234889999999999999999999999999999999999999988776666665554


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       228 ~~  229 (267)
T cd06628         228 AS  229 (267)
T ss_pred             CC
Confidence            44

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-38  Score=275.68  Aligned_cols=211  Identities=24%  Similarity=0.391  Sum_probs=173.1

Q ss_pred             CCceEEEEEEEccCCcE--EEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLE--FAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~--~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..++..  +|+|.++.. ......+.+.+|+++++++ +||||+++++++...+..|++|||+++|+|.
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   84 (270)
T cd05047           6 GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL   84 (270)
T ss_pred             CCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHH
Confidence            89999999999888764  588887632 2334456788999999999 8999999999999999999999999999999


Q ss_pred             HHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +++....                .+++.++..++.|++.||+|||+.|++||||||+|||++.+   +.+||+|||++..
T Consensus        85 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~---~~~kl~dfgl~~~  161 (270)
T cd05047          85 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRG  161 (270)
T ss_pred             HHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC---CeEEECCCCCccc
Confidence            9886532                47888999999999999999999999999999999999754   4699999998632


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      ....                                                                            
T Consensus       162 ~~~~----------------------------------------------------------------------------  165 (270)
T cd05047         162 QEVY----------------------------------------------------------------------------  165 (270)
T ss_pred             cchh----------------------------------------------------------------------------
Confidence            1000                                                                            


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                     ........++.|+|||++.+..++.++|+|||||++|||+| |..||.+
T Consensus       166 -------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         166 -------------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             -------------------------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence                                           00000113567999999999999999999999999999997 9999999


Q ss_pred             ccHHHHHHHHhcccCCCCCCcc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      .+...+++.+..+.....|..+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05047         215 MTCAELYEKLPQGYRLEKPLNC  236 (270)
T ss_pred             cCHHHHHHHHhCCCCCCCCCcC
Confidence            9999999998887655445443

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.5e-38  Score=278.51  Aligned_cols=203  Identities=31%  Similarity=0.477  Sum_probs=168.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+|+.||+|++..........+.+.+|++++++++||||+++++++.+....|+||||+++++|...+
T Consensus        12 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~   91 (286)
T cd07847          12 GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELE   91 (286)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHH
Confidence            78999999999999999999998755433333345778999999999999999999999999999999999998887766


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++........             
T Consensus        92 ~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~-------------  155 (286)
T cd07847          92 KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---GQIKLCDFGFARILTGPGD-------------  155 (286)
T ss_pred             hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---CcEEECccccceecCCCcc-------------
Confidence            666679999999999999999999999999999999999999754   4699999999754321100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (286)
T cd07847         156 --------------------------------------------------------------------------------  155 (286)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                   ......|+..|+|||++.+ ..++.++|+|||||++|||+||++||.+.+..+....+.+
T Consensus       156 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  215 (286)
T cd07847         156 -------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK  215 (286)
T ss_pred             -------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                         0001236788999999876 5689999999999999999999999998876555555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=272.76  Aligned_cols=204  Identities=30%  Similarity=0.482  Sum_probs=173.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|++.....  ...+.+.+|+.++++++||||+++++++.+.+.+|++|||+.+++|.+++
T Consensus        14 g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~   91 (262)
T cd06613          14 GTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY   91 (262)
T ss_pred             CCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence            7899999999999999999999976532  25577889999999999999999999999999999999999999999888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||+++|+|+||||+||+++.+   +.+||+|||++.......             
T Consensus        92 ~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~-------------  155 (262)
T cd06613          92 QVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATI-------------  155 (262)
T ss_pred             HhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---CCEEECccccchhhhhhh-------------
Confidence            765 689999999999999999999999999999999999999754   459999999874321100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (262)
T cd06613         156 --------------------------------------------------------------------------------  155 (262)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC---CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE---PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......|+..|+|||++.+.   .++.++|+|||||++|||+||++||.+.++......+....+
T Consensus       156 -------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~  221 (262)
T cd06613         156 -------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF  221 (262)
T ss_pred             -------------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence                         001123478899999999877   889999999999999999999999999887666666655544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.3e-38  Score=275.22  Aligned_cols=210  Identities=30%  Similarity=0.503  Sum_probs=174.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+++.||||.++.... ..+....+.+|+.+++.++||||+++++++.+.+..|++|||+++|+|.+.
T Consensus        13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   92 (267)
T cd08228          13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQM   92 (267)
T ss_pred             CCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHH
Confidence            7899999999999999999999875432 344456688999999999999999999999999999999999999999877


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++..+..++.|++.||.|||+++++||||||+||+++.+   +.++|+|||++.......         
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---~~~~l~d~g~~~~~~~~~---------  160 (267)
T cd08228          93 IKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKT---------  160 (267)
T ss_pred             HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---CCEEECccccceeccchh---------
Confidence            743    3458999999999999999999999999999999999999754   459999999874321100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (267)
T cd08228         161 --------------------------------------------------------------------------------  160 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc--cHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~  313 (328)
                                       .......|++.|+|||.+.+..++.++|+||+||++|||++|+.||...  +...+...+..+
T Consensus       161 -----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08228         161 -----------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC  223 (267)
T ss_pred             -----------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC
Confidence                             0001234788999999999999999999999999999999999999766  346777777776


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      .+.+.|
T Consensus       224 ~~~~~~  229 (267)
T cd08228         224 DYPPLP  229 (267)
T ss_pred             CCCCCC
Confidence            654433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-37  Score=272.47  Aligned_cols=213  Identities=31%  Similarity=0.564  Sum_probs=182.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+|+.||+|.+............+.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+.+
T Consensus        11 g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   90 (256)
T cd08218          11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI   90 (256)
T ss_pred             CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHH
Confidence            78999999999999999999999866555556677899999999999999999999999999999999999999999988


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++.++..++.|++.||.|||+++++|+||+|+|||++.+   +.++|+|||++........           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---~~~~l~d~~~~~~~~~~~~-----------  156 (256)
T cd08218          91 NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTVE-----------  156 (256)
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEEeeccceeecCcchh-----------
Confidence            6543  57899999999999999999999999999999999999754   4599999998743211000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd08218         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|+|+||+.||...+.......+..+.+.+.
T Consensus       157 ---------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08218         157 ---------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV  221 (256)
T ss_pred             ---------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC
Confidence                           00113478899999999999999999999999999999999999999998888888888887555


Q ss_pred             CCcc
Q psy2131         319 PKHK  322 (328)
Q Consensus       319 ~~~~  322 (328)
                      |...
T Consensus       222 ~~~~  225 (256)
T cd08218         222 SSHY  225 (256)
T ss_pred             cccC
Confidence            5443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-37  Score=273.11  Aligned_cols=204  Identities=34%  Similarity=0.622  Sum_probs=177.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.+|+|++...... ....+.+.+|+.+++.++||||+++++.+.+.+..|++|||++|++|.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   83 (262)
T cd05572           4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTI   83 (262)
T ss_pred             CCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHH
Confidence            78999999999999999999999865433 23446788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++..+..++.|++.||+|||+++++|+||||+||+++.+   +.++|+|||++.......             
T Consensus        84 l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~-------------  147 (262)
T cd05572          84 LRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQ-------------  147 (262)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---CCEEEeeCCcccccCccc-------------
Confidence            9887789999999999999999999999999999999999999754   469999999875431100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       148 --------------------------------------------------------------------------------  147 (262)
T cd05572         148 --------------------------------------------------------------------------------  147 (262)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc--HHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~  314 (328)
                                    ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+  +.+++.++..+.
T Consensus       148 --------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  210 (262)
T cd05572         148 --------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN  210 (262)
T ss_pred             --------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence                          0011347889999999999899999999999999999999999999887  888888888543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-37  Score=274.93  Aligned_cols=212  Identities=21%  Similarity=0.296  Sum_probs=164.0

Q ss_pred             CCceEEEEEEEcc--CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKA--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~--~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|....  ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||+++|+|.+
T Consensus         6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~   84 (269)
T cd05042           6 GWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN   84 (269)
T ss_pred             cCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHH
Confidence            8999999996432  44568888776432 33445667889999999999999999999999999999999999999999


Q ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          79 DIVARE-----FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        79 ~l~~~~-----~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ++....     ..++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||++.........     
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~-----  156 (269)
T cd05042          85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLALEQYPEDYY-----  156 (269)
T ss_pred             HHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---CcEEEeccccccccccchhe-----
Confidence            886542     24677888999999999999999999999999999999754   46999999987432110000     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (269)
T cd05042         157 --------------------------------------------------------------------------------  156 (269)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-------cCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-------KEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                         .......+++.|+|||++.       ...++.++|||||||++|||++ |..||....+..
T Consensus       157 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (269)
T cd05042         157 -------------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ  217 (269)
T ss_pred             -------------------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence                               0001123577899999974       3456889999999999999999 899998887666


Q ss_pred             HHHHHhcccCCCCCC
Q psy2131         306 LYAQIKAGAYDDEPK  320 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~  320 (328)
                      ++..+........|.
T Consensus       218 ~~~~~~~~~~~~~~~  232 (269)
T cd05042         218 VLKQVVREQDIKLPK  232 (269)
T ss_pred             HHHHHhhccCccCCC
Confidence            666655544433333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-38  Score=294.26  Aligned_cols=187  Identities=25%  Similarity=0.411  Sum_probs=158.7

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|...  .++..+|+|.+....       ...+|+++|++++|||||++++++......|++||++. ++|.+
T Consensus       103 G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~  174 (392)
T PHA03207        103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFT  174 (392)
T ss_pred             CCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHH
Confidence            899999999754  466789999886432       24579999999999999999999999999999999996 58888


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||++.........          
T Consensus       175 ~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~---~~~~l~DfG~a~~~~~~~~~----------  241 (392)
T PHA03207        175 YVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP---ENAVLGDFGAACKLDAHPDT----------  241 (392)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEccCccccccCccccc----------
Confidence            88777789999999999999999999999999999999999999754   45999999997543211000          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       242 --------------------------------------------------------------------------------  241 (392)
T PHA03207        242 --------------------------------------------------------------------------------  241 (392)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                    .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus       242 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        242 --------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             --------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence                          00112469999999999999999999999999999999999999998764

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=274.88  Aligned_cols=204  Identities=26%  Similarity=0.485  Sum_probs=175.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|++.... .......+.+|+++++.++|+||+++++++.+....|+|+||+.+++|.+.+
T Consensus        12 g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (274)
T cd06609          12 GSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL   90 (274)
T ss_pred             CCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHH
Confidence            789999999999999999999997543 3344567889999999999999999999999999999999999999999888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ... .+++..+..++.|++.||.|||+++++||||+|+||+++.+   +.++|+|||++........             
T Consensus        91 ~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~-------------  153 (274)
T cd06609          91 KPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMS-------------  153 (274)
T ss_pred             hhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEcccccceeeccccc-------------
Confidence            754 78999999999999999999999999999999999999764   4599999999765421100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (274)
T cd06609         154 --------------------------------------------------------------------------------  153 (274)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ......|++.|+|||++.+..++.++|+|||||++|+|+||++||.+.++......+..+..
T Consensus       154 -------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  215 (274)
T cd06609         154 -------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP  215 (274)
T ss_pred             -------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence                         00113478899999999998999999999999999999999999998887777777776644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-37  Score=275.43  Aligned_cols=214  Identities=22%  Similarity=0.314  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCCcE----EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~----~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..+|+.    ||+|+++... .......+.+|+.+++.++||||+++++++... ..+++|||+++|+|
T Consensus        18 G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l   95 (279)
T cd05109          18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCL   95 (279)
T ss_pred             CCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCH
Confidence            89999999998777764    8999987543 334456788999999999999999999998754 47899999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... +.+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........       
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~---~~~kL~dfG~~~~~~~~~~~-------  165 (279)
T cd05109          96 LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP---NHVKITDFGLARLLDIDETE-------  165 (279)
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCCCceeecccccce-------
Confidence            9998764 568999999999999999999999999999999999999653   45999999998654211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (279)
T cd05109         166 --------------------------------------------------------------------------------  165 (279)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......+++.|+|||++.+..++.++|||||||++|||+| |.+||.+.....+...+..+.
T Consensus       166 -----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05109         166 -----------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE  228 (279)
T ss_pred             -----------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence                             00001125678999999999999999999999999999998 999999988888888888877


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ..+.|..++
T Consensus       229 ~~~~~~~~~  237 (279)
T cd05109         229 RLPQPPICT  237 (279)
T ss_pred             cCCCCccCC
Confidence            665555543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.3e-37  Score=304.33  Aligned_cols=139  Identities=28%  Similarity=0.477  Sum_probs=126.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||+.|++|.++
T Consensus        15 G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~l   94 (669)
T cd05610          15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSL   94 (669)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHH
Confidence            8999999999999999999999976443 334456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +...+.+++..+..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+++..
T Consensus        95 i~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~---g~vkL~DFGls~~~  154 (669)
T cd05610          95 LHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE---GHIKLTDFGLSKVT  154 (669)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC---CCEEEEeCCCCccc
Confidence            9887889999999999999999999999999999999999999754   46999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-37  Score=275.47  Aligned_cols=185  Identities=24%  Similarity=0.381  Sum_probs=159.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+++.+|+|++.... ..+....+.+|++++++++||||+++++.+...+..++||||+++++|... 
T Consensus        12 g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-   89 (279)
T cd06619          12 GNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-   89 (279)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-
Confidence            789999999999999999999997543 344456788999999999999999999999999999999999999988543 


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                         ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+   +.+||+|||++......               
T Consensus        90 ---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~---~~~~l~dfg~~~~~~~~---------------  148 (279)
T cd06619          90 ---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNS---------------  148 (279)
T ss_pred             ---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC---CCEEEeeCCcceecccc---------------
Confidence               357889999999999999999999999999999999999754   46999999997432110               


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       149 --------------------------------------------------------------------------------  148 (279)
T cd06619         149 --------------------------------------------------------------------------------  148 (279)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                   ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus       149 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         149 -------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             -------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence                         001235899999999999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-37  Score=276.16  Aligned_cols=215  Identities=22%  Similarity=0.345  Sum_probs=173.2

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.++     .++..+|+|+++... .......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus        17 G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~   95 (277)
T cd05062          17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD   95 (277)
T ss_pred             ccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCC
Confidence            899999999864     345789999986432 23345568899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          76 LFEDIVARE----------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        76 L~~~l~~~~----------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |.+++....          .++...+..++.|++.||.|||+.+++||||||+|||++.+   +.+||+|||++......
T Consensus        96 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~---~~~~l~dfg~~~~~~~~  172 (277)
T cd05062          96 LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYET  172 (277)
T ss_pred             HHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC---CCEEECCCCCccccCCc
Confidence            998886522          25677888899999999999999999999999999999754   46999999997543211


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       173 ~~~-----------------------------------------------------------------------------  175 (277)
T cd05062         173 DYY-----------------------------------------------------------------------------  175 (277)
T ss_pred             cee-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.++.
T Consensus       176 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~  228 (277)
T cd05062         176 ---------------------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE  228 (277)
T ss_pred             ---------------------------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence                                       00000135778999999999999999999999999999999 79999999988


Q ss_pred             HHHHHHhcccCCCCCCccc
Q psy2131         305 RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~~  323 (328)
                      .....+..+.....|..++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~  247 (277)
T cd05062         229 QVLRFVMEGGLLDKPDNCP  247 (277)
T ss_pred             HHHHHHHcCCcCCCCCCCC
Confidence            8888888776655554433

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.3e-38  Score=275.21  Aligned_cols=202  Identities=34%  Similarity=0.578  Sum_probs=173.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||+|++....... ...+.+.+|++++++++||||+++++.+.+.+..|+|+||+.|++|.+.
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (258)
T cd05578          11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYH   90 (258)
T ss_pred             CCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHH
Confidence            799999999999999999999998654433 4567789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||+++++|+||||+||+++.+   +.++|+|||++.......             
T Consensus        91 l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~-------------  154 (258)
T cd05578          91 LSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDT-------------  154 (258)
T ss_pred             HHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---CCEEEeecccccccCCCc-------------
Confidence            8877789999999999999999999999999999999999999754   459999999864321100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (258)
T cd05578         155 --------------------------------------------------------------------------------  154 (258)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc---HHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~  312 (328)
                                    ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+   ...+.+.+.+
T Consensus       155 --------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  216 (258)
T cd05578         155 --------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET  216 (258)
T ss_pred             --------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc
Confidence                          0011247888999999999889999999999999999999999999887   4555555444

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.7e-37  Score=274.95  Aligned_cols=203  Identities=31%  Similarity=0.493  Sum_probs=170.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|.+...  .....+.+.+|+.+++.++||||+++++++..++..|+||||++|++|...+
T Consensus        23 g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~  100 (292)
T cd06644          23 GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM  100 (292)
T ss_pred             CCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHH
Confidence            78999999999999999999998754  3455677889999999999999999999999999999999999999998776


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..++.|++.||.|||+++++||||||+||+++.+   +.+||+|||++........            
T Consensus       101 ~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~~~------------  165 (292)
T cd06644         101 LELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---GDIKLADFGVSAKNVKTLQ------------  165 (292)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC---CCEEEccCccceecccccc------------
Confidence            54 4568999999999999999999999999999999999999653   4599999998643211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (292)
T cd06644         166 --------------------------------------------------------------------------------  165 (292)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                    ......|++.|+|||++.     ...++.++|+|||||++|||++|.+||.+.++.....++.++.
T Consensus       166 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  231 (292)
T cd06644         166 --------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE  231 (292)
T ss_pred             --------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC
Confidence                          001234788999999984     4567889999999999999999999999888877777766553

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-38  Score=283.07  Aligned_cols=194  Identities=30%  Similarity=0.454  Sum_probs=154.4

Q ss_pred             CCceEEEEEEEcc--CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKA--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~--~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.++.  ++..+|+|.+......    ..+.+|+++++.++||||+++++++.  .....|+||||+.+ +|
T Consensus        12 G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l   86 (317)
T cd07867          12 GTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DL   86 (317)
T ss_pred             CCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cH
Confidence            8999999998654  6689999999754332    34678999999999999999999985  45678999999875 77


Q ss_pred             HHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCC
Q psy2131          77 FEDIVAR---------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        77 ~~~l~~~---------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~  146 (328)
                      .+.+...         ..+++..+..++.|++.||.|||+++|+||||||+|||+..+ ...+.+||+|||+++......
T Consensus        87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~  166 (317)
T cd07867          87 WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL  166 (317)
T ss_pred             HHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCc
Confidence            7766421         247899999999999999999999999999999999999543 234579999999985432110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       167 ~~------------------------------------------------------------------------------  168 (317)
T cd07867         167 KP------------------------------------------------------------------------------  168 (317)
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                               ........||+.|+|||++.+ ..++.++|||||||++|||+||++||...+
T Consensus       169 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         169 -------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             -------------------------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence                                     000112458999999999977 458999999999999999999999997643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-37  Score=271.38  Aligned_cols=213  Identities=36%  Similarity=0.606  Sum_probs=182.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|..+|+|++..+.......+.+.+|+++++.++||||+++++.+..  ....|++|||+++++|.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~   90 (265)
T cd08217          11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ   90 (265)
T ss_pred             CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHH
Confidence            789999999999999999999998776667777788999999999999999999998763  457899999999999998


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          79 DIVA----REFYSEADASHCIQQILESVNHCH-----SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        79 ~l~~----~~~~~~~~~~~~~~qll~~L~ylH-----~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      .+..    ...+++..+..++.|++.||.|||     +.+++|+||||+||+++.+   +.+||+|||++........  
T Consensus        91 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~---~~~kl~d~g~~~~~~~~~~--  165 (265)
T cd08217          91 LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFGLAKILGHDSS--  165 (265)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---CCEEEecccccccccCCcc--
Confidence            8865    357899999999999999999999     9999999999999999754   4699999998754311100  


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (265)
T cd08217         166 --------------------------------------------------------------------------------  165 (265)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                              ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+...
T Consensus       166 ------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  221 (265)
T cd08217         166 ------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK  221 (265)
T ss_pred             ------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH
Confidence                                    00113478999999999999999999999999999999999999999998899999


Q ss_pred             HhcccCCCCCCcc
Q psy2131         310 IKAGAYDDEPKHK  322 (328)
Q Consensus       310 i~~~~~~~~~~~~  322 (328)
                      +..+.+...|...
T Consensus       222 ~~~~~~~~~~~~~  234 (265)
T cd08217         222 IKEGKFRRIPYRY  234 (265)
T ss_pred             HhcCCCCCCcccc
Confidence            9888876555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-37  Score=274.93  Aligned_cols=213  Identities=23%  Similarity=0.328  Sum_probs=172.7

Q ss_pred             CCceEEEEEEEccCCcE----EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~----~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|....+++.    +|+|.+... ........+..|+.++++++||||+++++++.. ...++++||+++|+|
T Consensus        18 G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL   95 (279)
T cd05111          18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSL   95 (279)
T ss_pred             cCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcH
Confidence            89999999998877774    667776432 223345677889999999999999999998754 457899999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++.. ...+++..+..++.|++.||.|||+++++||||||+|||++.+   +.+||+|||+++........       
T Consensus        96 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~---~~~kl~Dfg~~~~~~~~~~~-------  165 (279)
T cd05111          96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD---SIVQIADFGVADLLYPDDKK-------  165 (279)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---CcEEEcCCccceeccCCCcc-------
Confidence            999875 4568999999999999999999999999999999999999753   56999999997543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (279)
T cd05111         166 --------------------------------------------------------------------------------  165 (279)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......|+..|+|||++.+..|+.++|||||||++|||+| |+.||.+.++..+...+..+.
T Consensus       166 -----------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05111         166 -----------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE  228 (279)
T ss_pred             -----------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence                             00011236778999999999999999999999999999998 999999999888888888887


Q ss_pred             CCCCCCcc
Q psy2131         315 YDDEPKHK  322 (328)
Q Consensus       315 ~~~~~~~~  322 (328)
                      ....|..+
T Consensus       229 ~~~~~~~~  236 (279)
T cd05111         229 RLAQPQIC  236 (279)
T ss_pred             cCCCCCCC
Confidence            66555544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-37  Score=276.85  Aligned_cols=213  Identities=23%  Similarity=0.339  Sum_probs=176.2

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .++..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        16 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   93 (291)
T cd05094          16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD   93 (291)
T ss_pred             cCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCc
Confidence            789999999754     355679999986443  3344568899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          76 LFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        76 L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      |.+++....                .+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||++
T Consensus        94 L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~dfg~a  170 (291)
T cd05094          94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS  170 (291)
T ss_pred             HHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC---CcEEECCCCcc
Confidence            999886532                37889999999999999999999999999999999999754   46999999997


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .........                                                                       
T Consensus       171 ~~~~~~~~~-----------------------------------------------------------------------  179 (291)
T cd05094         171 RDVYSTDYY-----------------------------------------------------------------------  179 (291)
T ss_pred             cccCCCcee-----------------------------------------------------------------------
Confidence            543111000                                                                       


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf  298 (328)
                                                       .......|++.|+|||++.+..++.++|+|||||++|||+| |++||
T Consensus       180 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  226 (291)
T cd05094         180 ---------------------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW  226 (291)
T ss_pred             ---------------------------------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                                             00011346788999999999999999999999999999999 99999


Q ss_pred             CCccHHHHHHHHhcccCCCCCCcc
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      ...+.......+..+.....|..+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T cd05094         227 FQLSNTEVIECITQGRVLERPRVC  250 (291)
T ss_pred             CCCCHHHHHHHHhCCCCCCCCccC
Confidence            999998899999988876655544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-37  Score=279.06  Aligned_cols=202  Identities=27%  Similarity=0.559  Sum_probs=171.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++.....  .....+.+|+.+++.++||||+++++.+...+..|++|||+++++|...+
T Consensus        32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~  109 (297)
T cd06659          32 GSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV  109 (297)
T ss_pred             CCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH
Confidence            7899999999999999999999975432  23456788999999999999999999999999999999999999997765


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . ...+++..+..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++.......              
T Consensus       110 ~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~~~~--------------  171 (297)
T cd06659         110 S-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDV--------------  171 (297)
T ss_pred             h-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---CcEEEeechhHhhccccc--------------
Confidence            4 4568999999999999999999999999999999999999754   469999999864321100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (297)
T cd06659         172 --------------------------------------------------------------------------------  171 (297)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                  .......|++.|+|||++.+..++.++|+|||||++|||++|+.||...++......+....
T Consensus       172 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  233 (297)
T cd06659         172 ------------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP  233 (297)
T ss_pred             ------------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence                        00012358899999999999999999999999999999999999999888877777766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=271.91  Aligned_cols=207  Identities=23%  Similarity=0.358  Sum_probs=172.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+. +++.+|+|.++.....   .+.+.+|+.++++++||||+++++++...+..|++|||+.|++|.+++
T Consensus        17 g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   92 (261)
T cd05068          17 GQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL   92 (261)
T ss_pred             cCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence            789999999875 4568999999765432   355788999999999999999999999999999999999999999998


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++........           
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~-----------  158 (261)
T cd05068          93 QGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN---NICKVADFGLARVIKEDIY-----------  158 (261)
T ss_pred             hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---CCEEECCcceEEEccCCcc-----------
Confidence            7644  68999999999999999999999999999999999999754   4599999999865421000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (261)
T cd05068         159 --------------------------------------------------------------------------------  158 (261)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    ....+..++..|+|||++.+..++.++|+|||||++|||+| |++||.+.+...++..+.++.-.+
T Consensus       159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05068         159 --------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP  224 (261)
T ss_pred             --------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00001123457999999999999999999999999999999 999999999999999988764333


Q ss_pred             CC
Q psy2131         318 EP  319 (328)
Q Consensus       318 ~~  319 (328)
                      .|
T Consensus       225 ~~  226 (261)
T cd05068         225 CP  226 (261)
T ss_pred             CC
Confidence            33

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=274.53  Aligned_cols=214  Identities=21%  Similarity=0.330  Sum_probs=175.7

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.++..+     ..+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+++|+
T Consensus        17 g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   95 (277)
T cd05032          17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGD   95 (277)
T ss_pred             CCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCC
Confidence            899999999886544     889999986443 33445667899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          76 LFEDIVARE----------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        76 L~~~l~~~~----------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |.+++....          .+++..+..++.|++.||.|||+.+|+||||||+|||++.+   +.+||+|||+++.+...
T Consensus        96 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~---~~~kl~dfg~~~~~~~~  172 (277)
T cd05032          96 LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED---LTVKIGDFGMTRDIYET  172 (277)
T ss_pred             HHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC---CCEEECCcccchhhccC
Confidence            998886432          36778899999999999999999999999999999999754   46999999987543111


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       173 ~~~-----------------------------------------------------------------------------  175 (277)
T cd05032         173 DYY-----------------------------------------------------------------------------  175 (277)
T ss_pred             ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......+|..|+|||.+.+..++.++|+|||||++|||+| |..||.+.++.
T Consensus       176 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  228 (277)
T cd05032         176 ---------------------------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE  228 (277)
T ss_pred             ---------------------------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence                                       00001236788999999998899999999999999999998 99999999999


Q ss_pred             HHHHHHhcccCCCCCCcc
Q psy2131         305 RLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~  322 (328)
                      ...+.+..+.....|..+
T Consensus       229 ~~~~~~~~~~~~~~~~~~  246 (277)
T cd05032         229 EVLKFVIDGGHLDLPENC  246 (277)
T ss_pred             HHHHHHhcCCCCCCCCCC
Confidence            999998877665555544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=270.99  Aligned_cols=209  Identities=26%  Similarity=0.413  Sum_probs=172.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++ ++..+|+|++.......   ..+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        15 G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (256)
T cd05059          15 GQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL   90 (256)
T ss_pred             CCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence            789999999876 56789999987544332   35678999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||+++.......            
T Consensus        91 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~dfg~~~~~~~~~~------------  155 (256)
T cd05059          91 RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED---NVVKVSDFGLARYVLDDQY------------  155 (256)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC---CcEEECCcccceecccccc------------
Confidence            653 468999999999999999999999999999999999999754   4699999998753211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (256)
T cd05059         156 --------------------------------------------------------------------------------  155 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......++..|+|||.+.+..++.++|+|||||++|||+| |++||.+.+..+....+..+.-...
T Consensus       156 -------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05059         156 -------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR  222 (256)
T ss_pred             -------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence                         00001124567999999999999999999999999999999 8999998888888888887754344


Q ss_pred             CCc
Q psy2131         319 PKH  321 (328)
Q Consensus       319 ~~~  321 (328)
                      |..
T Consensus       223 ~~~  225 (256)
T cd05059         223 PKL  225 (256)
T ss_pred             CCC
Confidence            433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-37  Score=276.65  Aligned_cols=199  Identities=31%  Similarity=0.554  Sum_probs=168.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+++.+|+|.+......  ..+.+.+|+.+++.++|+||+++++.+......|+||||++|++|.+++
T Consensus        31 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  108 (296)
T cd06654          31 GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  108 (296)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHH
Confidence            78999999999999999999999765433  3456788999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++........             
T Consensus       109 ~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~---~~~kl~dfg~~~~~~~~~~-------------  171 (296)
T cd06654         109 TE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQS-------------  171 (296)
T ss_pred             Hh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEECccccchhcccccc-------------
Confidence            54 468999999999999999999999999999999999999654   4699999998643211000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (296)
T cd06654         172 --------------------------------------------------------------------------------  171 (296)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                   ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.++......+.
T Consensus       172 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~  229 (296)
T cd06654         172 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (296)
T ss_pred             -------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence                         0011348899999999999999999999999999999999999999887655444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-37  Score=271.24  Aligned_cols=215  Identities=21%  Similarity=0.391  Sum_probs=177.4

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|..+.+   ...+|||+++... .......+.+|+.+++.++||||+++++.+.+.+..|++|||+++++|.
T Consensus        15 g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   93 (266)
T cd05033          15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLD   93 (266)
T ss_pred             CccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHH
Confidence            89999999988654   4679999987543 3334566888999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........        
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~~~~~~~~--------  162 (266)
T cd05033          94 KFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN---LVCKVSDFGLSRRLEDSEAT--------  162 (266)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CCEEECccchhhcccccccc--------
Confidence            988654 468999999999999999999999999999999999999754   45999999997543210000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (266)
T cd05033         163 --------------------------------------------------------------------------------  162 (266)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+.++..
T Consensus       163 ----------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  226 (266)
T cd05033         163 ----------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR  226 (266)
T ss_pred             ----------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence                            00001225678999999999999999999999999999998 9999999988889999988866


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       227 ~~~~~~~~  234 (266)
T cd05033         227 LPPPMDCP  234 (266)
T ss_pred             CCCCCCCC
Confidence            55555443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-37  Score=273.26  Aligned_cols=212  Identities=22%  Similarity=0.399  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.++.++.   .+|+|.++... .......+.+|+.++++++||||+++++++.+.+..|+||||++|++|.
T Consensus        15 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (267)
T cd05066          15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD   93 (267)
T ss_pred             cCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHH
Confidence            7899999998875544   79999987543 3445567889999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... +.+++.++..++.|++.||.|||+++++||||||+|||++.+   +.++|+|||++.........        
T Consensus        94 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~~~--------  162 (267)
T cd05066          94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEA--------  162 (267)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC---CeEEeCCCCcccccccccce--------
Confidence            988764 468999999999999999999999999999999999999653   46999999997543211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (267)
T cd05066         163 --------------------------------------------------------------------------------  162 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                     ........+++.|+|||++.+..++.++|+|||||++||+++ |..||.+.+..+....+.++..
T Consensus       163 ---------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~  227 (267)
T cd05066         163 ---------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR  227 (267)
T ss_pred             ---------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc
Confidence                           000001124567999999999999999999999999999887 9999999998888999888754


Q ss_pred             CCCC
Q psy2131         316 DDEP  319 (328)
Q Consensus       316 ~~~~  319 (328)
                      .+.|
T Consensus       228 ~~~~  231 (267)
T cd05066         228 LPAP  231 (267)
T ss_pred             CCCC
Confidence            3333

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-37  Score=274.27  Aligned_cols=190  Identities=29%  Similarity=0.514  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH-HHHHHHHHH---HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREAR---ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~-~~~~~~E~~---il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||++.+..+++.+|+|.+......... .....+|..   ++...+||||+.+++++...+..|+||||++||+|
T Consensus         5 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   84 (279)
T cd05633           5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   84 (279)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCH
Confidence            89999999999999999999999765443222 122334443   34445899999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.++|+|||++.......          
T Consensus        85 ~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~---~~~~l~dfg~~~~~~~~~----------  151 (279)
T cd05633          85 HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK----------  151 (279)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---CCEEEccCCcceeccccC----------
Confidence            9988888889999999999999999999999999999999999999754   469999999874321000          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       152 --------------------------------------------------------------------------------  151 (279)
T cd05633         152 --------------------------------------------------------------------------------  151 (279)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                        .....||+.|+|||++. +..++.++|+||+||++|||++|..||.+.
T Consensus       152 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         152 ------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             ------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence                              00124899999999986 467899999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.8e-37  Score=272.33  Aligned_cols=217  Identities=21%  Similarity=0.375  Sum_probs=176.2

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.++.++.   .||+|.+... ........+.+|+.+++.++||||+++++++.++...++||||+++++|.
T Consensus        15 g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (269)
T cd05065          15 GEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD   93 (269)
T ss_pred             CCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHH
Confidence            7999999999887665   5999998754 34555677899999999999999999999999999999999999999998


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... +.+++.++..++.|++.||.|||++|++||||||+||+++.+   ..+||+|||++.........        
T Consensus        94 ~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~~~~--------  162 (269)
T cd05065          94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSD--------  162 (269)
T ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC---CcEEECCCccccccccCccc--------
Confidence            888653 568999999999999999999999999999999999999643   46999999987543211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                 +                                   .                
T Consensus       163 ---------------------------~-----------------------------------~----------------  164 (269)
T cd05065         163 ---------------------------P-----------------------------------T----------------  164 (269)
T ss_pred             ---------------------------c-----------------------------------c----------------
Confidence                                       0                                   0                


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                     .....+..++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......|.++..
T Consensus       165 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~  229 (269)
T cd05065         165 ---------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR  229 (269)
T ss_pred             ---------------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence                           000000112457999999999999999999999999999886 9999999999999999877655


Q ss_pred             CCCCCcc
Q psy2131         316 DDEPKHK  322 (328)
Q Consensus       316 ~~~~~~~  322 (328)
                      .++|..+
T Consensus       230 ~~~~~~~  236 (269)
T cd05065         230 LPPPMDC  236 (269)
T ss_pred             CCCcccC
Confidence            4544444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-37  Score=272.08  Aligned_cols=205  Identities=31%  Similarity=0.490  Sum_probs=169.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..++..||+|.+......   .+....+.+|+.+++.++||||+++++.+.+  ...++++|||+++++
T Consensus        13 g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~   92 (266)
T cd06651          13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGS   92 (266)
T ss_pred             CCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCc
Confidence            79999999999999999999998755332   2345678899999999999999999999875  467899999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.....+++.....++.|++.||.|||+++|+||||||+||+++.+   +.+||+|||++.........       
T Consensus        93 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~-------  162 (266)
T cd06651          93 VKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMS-------  162 (266)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCCCcccccccccc-------
Confidence            99999887789999999999999999999999999999999999999754   45999999997543110000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (266)
T cd06651         163 --------------------------------------------------------------------------------  162 (266)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                      ........|+..|+|||.+.+..++.++|+||+||++|||++|++||.+.+......++.
T Consensus       163 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~  222 (266)
T cd06651         163 ----------------GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA  222 (266)
T ss_pred             ----------------CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence                            000011247889999999999999999999999999999999999999887555444443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-37  Score=274.90  Aligned_cols=214  Identities=23%  Similarity=0.328  Sum_probs=175.6

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|..     ..++..+|+|.+...  .......+.+|+++++.++|+||+++++++.+.+..|++|||+++++
T Consensus        16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   93 (280)
T cd05092          16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGD   93 (280)
T ss_pred             ccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCC
Confidence            79999999964     345678999988643  34455678999999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccc
Q psy2131          76 LFEDIVARE---------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus        76 L~~~l~~~~---------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~  140 (328)
                      |.+++....               .+++..+..++.|++.||+|||++|++||||||+|||++.+   +.+||+|||++.
T Consensus        94 L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~---~~~kL~dfg~~~  170 (280)
T cd05092          94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG---LVVKIGDFGMSR  170 (280)
T ss_pred             HHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC---CCEEECCCCcee
Confidence            999886543               47889999999999999999999999999999999999753   469999999975


Q ss_pred             cccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         141 EVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       141 ~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      ........                                                                        
T Consensus       171 ~~~~~~~~------------------------------------------------------------------------  178 (280)
T cd05092         171 DIYSTDYY------------------------------------------------------------------------  178 (280)
T ss_pred             EcCCCcee------------------------------------------------------------------------
Confidence            43110000                                                                        


Q ss_pred             ccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCC
Q psy2131         221 WICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFW  299 (328)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~  299 (328)
                                                      .......+++.|+|||++.+..++.++|+|||||++|||++ |.+||.
T Consensus       179 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         179 --------------------------------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             --------------------------------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence                                            00011235788999999999999999999999999999998 999999


Q ss_pred             CccHHHHHHHHhcccCCCCCCccc
Q psy2131         300 DEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       300 ~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      +....+....+..+.....|..++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~  250 (280)
T cd05092         227 QLSNTEAIECITQGRELERPRTCP  250 (280)
T ss_pred             cCCHHHHHHHHHcCccCCCCCCCC
Confidence            988888888888886655555443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.4e-37  Score=278.19  Aligned_cols=215  Identities=24%  Similarity=0.414  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEcc-------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKA-------TGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~-------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.+..       ++..+|+|.++... .......+.+|+.+++.+ +||||+++++++...+..|+||||+.
T Consensus        29 G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (307)
T cd05098          29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  107 (307)
T ss_pred             CCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCC
Confidence            8999999998643       33579999997643 344566788899999999 79999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|+|.+++....                .++..++..++.|++.||+|||++|++||||||+|||++.+   +.+||+||
T Consensus       108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~---~~~kL~df  184 (307)
T cd05098         108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADF  184 (307)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC---CcEEECCC
Confidence            999999987542                47888999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       185 g~a~~~~~~~~~--------------------------------------------------------------------  196 (307)
T cd05098         185 GLARDIHHIDYY--------------------------------------------------------------------  196 (307)
T ss_pred             cccccccccchh--------------------------------------------------------------------
Confidence            987543110000                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......+++.|+|||++.+..++.++|+|||||++|||++ |.
T Consensus       197 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         197 ------------------------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             ------------------------------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence                                                00001124578999999999999999999999999999998 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .||.+.+..+++..+.++.....|..++
T Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T cd05098         241 SPYPGVPVEELFKLLKEGHRMDKPSNCT  268 (307)
T ss_pred             CCCCcCCHHHHHHHHHcCCCCCCCCcCC
Confidence            9999999999999998887655554443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-37  Score=273.61  Aligned_cols=210  Identities=29%  Similarity=0.497  Sum_probs=174.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+|+.+|||.+..... .......+.+|+.+++.++||||+++++++.+.+..+++|||++|++|.++
T Consensus        13 g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   92 (267)
T cd08229          13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM   92 (267)
T ss_pred             cCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHH
Confidence            7899999999999999999998875433 334456788999999999999999999999999999999999999999887


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.+   +.++|+|||++........        
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~--------  161 (267)
T cd08229          93 IKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTT--------  161 (267)
T ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEECcchhhhccccCCc--------
Confidence            753    3468999999999999999999999999999999999999754   4699999998643211000        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (267)
T cd08229         162 --------------------------------------------------------------------------------  161 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc--HHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~  313 (328)
                                        ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+..  .......+..+
T Consensus       162 ------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08229         162 ------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  223 (267)
T ss_pred             ------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC
Confidence                              0012347899999999999999999999999999999999999998664  45666777766


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      .+.+.|
T Consensus       224 ~~~~~~  229 (267)
T cd08229         224 DYPPLP  229 (267)
T ss_pred             CCCCCC
Confidence            654433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0577|consensus

Probab=100.00  E-value=8.4e-38  Score=284.51  Aligned_cols=263  Identities=25%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccC-CCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~-~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||-|++..+.+.||||.++.. +.+.+.++.+.+|++.|++++|||+|.+-++|..+...|||||||-| +-.++
T Consensus        37 GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDl  115 (948)
T KOG0577|consen   37 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDL  115 (948)
T ss_pred             CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHH
Confidence            89999999999999999999999865 34567788999999999999999999999999999999999999976 55565


Q ss_pred             HH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc----------------
Q psy2131          80 IV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV----------------  142 (328)
Q Consensus        80 l~-~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~----------------  142 (328)
                      +. .++++.+.++..|..+.+.||+|||+.+.||||||..|||++.   .+.|||+|||.|...                
T Consensus       116 leVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse---~g~VKLaDFGSAsi~~PAnsFvGTPywMAPE  192 (948)
T KOG0577|consen  116 LEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE---PGLVKLADFGSASIMAPANSFVGTPYWMAPE  192 (948)
T ss_pred             HHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC---CCeeeeccccchhhcCchhcccCCccccchh
Confidence            53 4567999999999999999999999999999999999999974   467999999987432                


Q ss_pred             ----------cCCCcch-HHHHHHHHHhCCCCCCCCcHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCC
Q psy2131         143 ----------QGEQQAW-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       143 ----------~~~~~~~-~G~~~~~~~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                                ++..+.| +|++..++...+||.++.+..+ ++....+.....++   ..+|..+++|+..||++-|..|
T Consensus       193 VILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeR  269 (948)
T KOG0577|consen  193 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQER  269 (948)
T ss_pred             HheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccC
Confidence                      2233444 8999999999999998877655 45555555555554   4579999999999999999999


Q ss_pred             CCHHHHhcCcccCCcccchh---hhhh-hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc
Q psy2131         211 ITASEALKHPWICQRERVAS---IVHR-QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK  271 (328)
Q Consensus       211 ~t~~~~l~h~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~  271 (328)
                      ||++++++|+|+........   ...| .+.+..+.++ ..++.++-..+....+|+-.+||--.
T Consensus       270 ptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNl-qYrKMkKilf~e~~ng~~ae~~e~ee  333 (948)
T KOG0577|consen  270 PTSEELLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL-QYRKMKKILFQEAPNGPGAEGPEEEE  333 (948)
T ss_pred             CcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHhhhh-hHHHHHHHHhhccCCCCCCCCCchhh
Confidence            99999999999864322211   1111 2222333332 24566666666666668888888543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.1e-37  Score=270.57  Aligned_cols=211  Identities=28%  Similarity=0.495  Sum_probs=176.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|.++..... ......+.+|++++++++|+||+++++++.+.+..++||||+++++|.+.
T Consensus        13 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   92 (267)
T cd08224          13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRM   92 (267)
T ss_pred             CCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHH
Confidence            78999999999999999999999754333 33466788999999999999999999999999999999999999999888


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.++|+|||++........        
T Consensus        93 l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~--------  161 (267)
T cd08224          93 IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTT--------  161 (267)
T ss_pred             HHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---CcEEEeccceeeeccCCCc--------
Confidence            753    3458999999999999999999999999999999999999754   4599999998754211000        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (267)
T cd08224         162 --------------------------------------------------------------------------------  161 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc--cHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~  313 (328)
                                        ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...  +..++...+..+
T Consensus       162 ------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08224         162 ------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC  223 (267)
T ss_pred             ------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC
Confidence                              001124788999999999999999999999999999999999999765  456777787777


Q ss_pred             cCCCCCC
Q psy2131         314 AYDDEPK  320 (328)
Q Consensus       314 ~~~~~~~  320 (328)
                      .+.+-|.
T Consensus       224 ~~~~~~~  230 (267)
T cd08224         224 DYPPLPA  230 (267)
T ss_pred             CCCCCCh
Confidence            7654443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-37  Score=280.25  Aligned_cols=213  Identities=21%  Similarity=0.297  Sum_probs=171.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+|+.||+|++.......+..+.+.+|+.+++.++||||++++++|...+..|+||||+.+++|.+++
T Consensus        11 ~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l   90 (328)
T cd08226          11 CNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL   90 (328)
T ss_pred             cCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHH
Confidence            58999999999999999999999876666666778899999999999999999999999999999999999999999888


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+|++|||.+........           
T Consensus        91 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~-----------  156 (328)
T cd08226          91 KTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQ-----------  156 (328)
T ss_pred             HhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCc-----------
Confidence            754  358999999999999999999999999999999999999754   4599999976422110000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                               +.                            ...                      
T Consensus       157 -------------------------~~----------------------------~~~----------------------  161 (328)
T cd08226         157 -------------------------KA----------------------------KVV----------------------  161 (328)
T ss_pred             -------------------------cc----------------------------ccc----------------------
Confidence                                     00                            000                      


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC--CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE--PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ........++..|+|||++.+.  .|+.++|+|||||++|||++|++||.+.+..+....+..+..
T Consensus       162 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  227 (328)
T cd08226         162 -------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP  227 (328)
T ss_pred             -------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence                         0000012356779999999764  578999999999999999999999999886666655555433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-37  Score=277.18  Aligned_cols=201  Identities=29%  Similarity=0.569  Sum_probs=171.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..++..+|||.+....  ....+.+.+|+.+++.++|+||+++++.+...+..|+||||+++++|.+++
T Consensus        33 g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~  110 (292)
T cd06658          33 GSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV  110 (292)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHH
Confidence            789999999999999999999986532  334556889999999999999999999999999999999999999998876


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . .+.+++.++..++.|++.||.|||+++|+||||||+||+++.+   +.+||+|||++.......              
T Consensus       111 ~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kL~dfg~~~~~~~~~--------------  172 (292)
T cd06658         111 T-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEV--------------  172 (292)
T ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEccCcchhhccccc--------------
Confidence            4 4568999999999999999999999999999999999999754   469999999864321100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (292)
T cd06658         173 --------------------------------------------------------------------------------  172 (292)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                  .......|++.|+|||++.+..++.++|+|||||++|||++|+.||.+.++...+..+...
T Consensus       173 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  233 (292)
T cd06658         173 ------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN  233 (292)
T ss_pred             ------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence                        0001234889999999999999999999999999999999999999999887777766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.5e-37  Score=274.58  Aligned_cols=201  Identities=32%  Similarity=0.570  Sum_probs=170.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.+|+|.+......  ....+.+|+.+++.++||||+++++++...+..|+|+||+.|++|.+.+
T Consensus        30 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (296)
T cd06655          30 GASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV  107 (296)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHH
Confidence            78999999999999999999999754332  3456788999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++........             
T Consensus       108 ~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~---~~~kl~dfg~~~~~~~~~~-------------  170 (296)
T cd06655         108 TE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQS-------------  170 (296)
T ss_pred             Hh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccchhcccccc-------------
Confidence            54 468999999999999999999999999999999999999754   4699999998743211000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (296)
T cd06655         171 --------------------------------------------------------------------------------  170 (296)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.++......+..+
T Consensus       171 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~  230 (296)
T cd06655         171 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN  230 (296)
T ss_pred             -------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence                         001134789999999999999999999999999999999999999998876665555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-37  Score=292.28  Aligned_cols=200  Identities=26%  Similarity=0.404  Sum_probs=164.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||||....        ..+.+|+++|++++|+|||++++++...+..++|||++. ++|.+++
T Consensus       180 G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l  250 (461)
T PHA03211        180 GSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYL  250 (461)
T ss_pred             CCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHH
Confidence            7999999999999999999996432        234689999999999999999999999999999999995 5888887


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||++|||||||||+|||++.+   +.+||+|||+++.......            
T Consensus       251 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---~~vkL~DFGla~~~~~~~~------------  315 (461)
T PHA03211        251 GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---EDICLGDFGAACFARGSWS------------  315 (461)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---CCEEEcccCCceecccccc------------
Confidence            654 469999999999999999999999999999999999999754   4599999999854321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       316 --------------------------------------------------------------------------------  315 (461)
T PHA03211        316 --------------------------------------------------------------------------------  315 (461)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc--------cHHHHHHHHh
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQIK  311 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~  311 (328)
                                  ........||+.|+|||++.+..|+.++|||||||+||||++|..|+...        ....+...|.
T Consensus       316 ------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        316 ------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             ------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence                        00011246999999999999999999999999999999999998766532        2456666776


Q ss_pred             cccCC
Q psy2131         312 AGAYD  316 (328)
Q Consensus       312 ~~~~~  316 (328)
                      .+.+.
T Consensus       384 ~~~~~  388 (461)
T PHA03211        384 QAQVH  388 (461)
T ss_pred             hhccc
Confidence            66553

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-37  Score=272.25  Aligned_cols=213  Identities=23%  Similarity=0.393  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.++.++.   .+|+|.++... .....+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.
T Consensus        16 g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   94 (268)
T cd05063          16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD   94 (268)
T ss_pred             CCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHH
Confidence            7899999999876665   79999986543 3445567889999999999999999999999999999999999999998


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... +.+++.++..++.|++.||+|||+.|++||||||+||+++.+   +.+||+|||++..........       
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~~~~~-------  164 (268)
T cd05063          95 KYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN---LECKVSDFGLSRVLEDDPEGT-------  164 (268)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC---CcEEECCCccceecccccccc-------
Confidence            888654 568999999999999999999999999999999999999753   469999999875432110000       


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (268)
T cd05063         165 --------------------------------------------------------------------------------  164 (268)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+...+...|..+..
T Consensus       165 ----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~  228 (268)
T cd05063         165 ----------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR  228 (268)
T ss_pred             ----------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC
Confidence                            00001123567999999999899999999999999999998 9999999998899999988755


Q ss_pred             CCCCC
Q psy2131         316 DDEPK  320 (328)
Q Consensus       316 ~~~~~  320 (328)
                      .+.|.
T Consensus       229 ~~~~~  233 (268)
T cd05063         229 LPAPM  233 (268)
T ss_pred             CCCCC
Confidence            44443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.3e-37  Score=270.59  Aligned_cols=206  Identities=22%  Similarity=0.381  Sum_probs=171.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|... ++..+|+|.+.....   ..+.+.+|+.+++.++|+||+++++++.+.+..|++|||+++++|.+++
T Consensus        17 g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   92 (261)
T cd05072          17 GQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL   92 (261)
T ss_pred             cCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence            789999999864 567799999865432   3466789999999999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||+|||+.+++||||||+||+++.+   +.+||+|||++........           
T Consensus        93 ~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~-----------  158 (261)
T cd05072          93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES---LMCKIADFGLARVIEDNEY-----------  158 (261)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC---CcEEECCCccceecCCCce-----------
Confidence            653  458888999999999999999999999999999999999754   4699999999754311100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (261)
T cd05072         159 --------------------------------------------------------------------------------  158 (261)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......++..|+|||++.+..++.++|+|||||++|+|+| |..||.+.+...+...+.++...+
T Consensus       159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05072         159 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP  224 (261)
T ss_pred             --------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00011235678999999999999999999999999999999 999999998888999888775433


Q ss_pred             C
Q psy2131         318 E  318 (328)
Q Consensus       318 ~  318 (328)
                      .
T Consensus       225 ~  225 (261)
T cd05072         225 R  225 (261)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4e-37  Score=271.45  Aligned_cols=207  Identities=21%  Similarity=0.276  Sum_probs=163.8

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|...  .++..+|+|.++.+.. ......+.+|+.++++++||||+++++++.+....|+||||+++|+|.+
T Consensus         6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   84 (269)
T cd05087           6 GWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG   84 (269)
T ss_pred             cCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHH
Confidence            899999999754  4667899999876542 2334467889999999999999999999999999999999999999998


Q ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          79 DIVARE-----FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        79 ~l~~~~-----~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ++....     ..++..+..++.|++.||.|||+.+++||||||+||+++.+   +.+||+|||++........      
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~---~~~kL~dfg~~~~~~~~~~------  155 (269)
T cd05087          85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD---LTVKIGDYGLSHNKYKEDY------  155 (269)
T ss_pred             HHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---CcEEECCccccccccCcce------
Confidence            886432     35677788899999999999999999999999999999753   4699999998743211000      


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (269)
T cd05087         156 --------------------------------------------------------------------------------  155 (269)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-------CCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-------PYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                        ........|++.|+|||++.+.       .++.++|+|||||++|||++ |+.||...++.+
T Consensus       156 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  217 (269)
T cd05087         156 ------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ  217 (269)
T ss_pred             ------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence                              0001123478889999998643       46889999999999999996 999999887776


Q ss_pred             HHHHHhcccC
Q psy2131         306 LYAQIKAGAY  315 (328)
Q Consensus       306 ~~~~i~~~~~  315 (328)
                      .......+..
T Consensus       218 ~~~~~~~~~~  227 (269)
T cd05087         218 VLTYTVREQQ  227 (269)
T ss_pred             HHHHHhhccc
Confidence            6655544433

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-37  Score=275.75  Aligned_cols=214  Identities=24%  Similarity=0.409  Sum_probs=175.6

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||++.+....     ..+|+|.+.... .......+.+|+.+++++ +|+||+++++++...+.+|++|||+++|
T Consensus        23 g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~  101 (293)
T cd05053          23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG  101 (293)
T ss_pred             cccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCC
Confidence            789999999876443     789999987543 344556788999999999 8999999999999999999999999999


Q ss_pred             CcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccc
Q psy2131          75 ELFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL  138 (328)
Q Consensus        75 ~L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGl  138 (328)
                      +|.+++...                ..+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||+
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~---~~~kL~Dfg~  178 (293)
T cd05053         102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADFGL  178 (293)
T ss_pred             cHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC---CeEEeCcccc
Confidence            999988542                358889999999999999999999999999999999999653   5699999999


Q ss_pred             cccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         139 AIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       139 a~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.........                                                                      
T Consensus       179 ~~~~~~~~~~----------------------------------------------------------------------  188 (293)
T cd05053         179 ARDIHHIDYY----------------------------------------------------------------------  188 (293)
T ss_pred             ccccccccce----------------------------------------------------------------------
Confidence            7543211000                                                                      


Q ss_pred             CcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCC
Q psy2131         219 HPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPP  297 (328)
Q Consensus       219 h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~P  297 (328)
                                                        .......+++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       189 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         189 ----------------------------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             ----------------------------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence                                              00000124677999999999999999999999999999998 9999


Q ss_pred             CCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         298 FWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       298 f~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      |.+.+..++++.+.++.....|..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~  259 (293)
T cd05053         235 YPGIPVEELFKLLKEGYRMEKPQNC  259 (293)
T ss_pred             CCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            9999999999998888755544443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=270.30  Aligned_cols=206  Identities=29%  Similarity=0.465  Sum_probs=170.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..+++.+|+|++....   ........+.+|+.++++++|+||+++++++.+.  ..++++|||++|++
T Consensus        13 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~   92 (264)
T cd06653          13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS   92 (264)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCc
Confidence            789999999999999999999986432   1234456788999999999999999999998764  56899999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+...+.+++..+..++.|++.||.|||+++++||||||+||+++.+   +.++|+|||++........        
T Consensus        93 L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~--------  161 (264)
T cd06653          93 IKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICM--------  161 (264)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECccccccccccccc--------
Confidence            99998877789999999999999999999999999999999999999754   4599999999754311000        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (264)
T cd06653         162 --------------------------------------------------------------------------------  161 (264)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                     .........|+..|+|||++.+..++.++|+|||||++|+|++|++||.+........++..
T Consensus       162 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  223 (264)
T cd06653         162 ---------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT  223 (264)
T ss_pred             ---------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence                           00001123478999999999998899999999999999999999999998876665555543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.8e-37  Score=283.17  Aligned_cols=199  Identities=28%  Similarity=0.418  Sum_probs=167.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|+.||+|++............+.+|+.++++++||||++++++|...      ...|+|||||.+ 
T Consensus        27 g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-  105 (353)
T cd07850          27 GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-  105 (353)
T ss_pred             CCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-
Confidence            7899999999999999999999976554555556778899999999999999999998644      357999999965 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+...  +++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......        
T Consensus       106 ~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~--------  172 (353)
T cd07850         106 NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  172 (353)
T ss_pred             CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCccceeCCCCC--------
Confidence            787776543  8999999999999999999999999999999999999754   459999999975431100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (353)
T cd07850         173 --------------------------------------------------------------------------------  172 (353)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++.+
T Consensus       173 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  231 (353)
T cd07850         173 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE  231 (353)
T ss_pred             -------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence                               00112478899999999999999999999999999999999999999988777777654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-37  Score=271.48  Aligned_cols=213  Identities=22%  Similarity=0.335  Sum_probs=176.6

Q ss_pred             CCceEEEEEEEccCCc----EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.++.+|.    .+|+|.+..... ......+.+|+.++++++||||+++++++.+ ...++||||+++|+|
T Consensus        18 g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L   95 (279)
T cd05057          18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCL   95 (279)
T ss_pred             CCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcH
Confidence            8999999999877765    589998875532 4445678899999999999999999999987 788999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... ..+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||++.........+      
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kL~dfg~~~~~~~~~~~~------  166 (279)
T cd05057          96 LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEY------  166 (279)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---CeEEECCCcccccccCcccce------
Confidence            9988764 468999999999999999999999999999999999999754   459999999985432111000      


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (279)
T cd05057         167 --------------------------------------------------------------------------------  166 (279)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                        ......+++.|+|||.+.+..++.++|+|||||++|||+| |+.||.+.+..++.+.+..+.
T Consensus       167 ------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05057         167 ------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE  228 (279)
T ss_pred             ------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence                              0001124567999999999999999999999999999999 999999999999999999887


Q ss_pred             CCCCCCcc
Q psy2131         315 YDDEPKHK  322 (328)
Q Consensus       315 ~~~~~~~~  322 (328)
                      ..+.|..+
T Consensus       229 ~~~~~~~~  236 (279)
T cd05057         229 RLPQPPIC  236 (279)
T ss_pred             CCCCCCCC
Confidence            65555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-37  Score=271.47  Aligned_cols=203  Identities=27%  Similarity=0.488  Sum_probs=173.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++.+.+.+..|+||||++|++|.+++
T Consensus        15 g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   93 (277)
T cd06640          15 GSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL   93 (277)
T ss_pred             CCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence            789999999999999999999987543 2344567889999999999999999999999999999999999999999887


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||+.+++|+||+|+||+++.+   +.++|+|||++........             
T Consensus        94 ~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~-------------  156 (277)
T cd06640          94 RA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI-------------  156 (277)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---CCEEEcccccceeccCCcc-------------
Confidence            54 568999999999999999999999999999999999999754   4599999998754311000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (277)
T cd06640         157 --------------------------------------------------------------------------------  156 (277)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   ......|+..|+|||++.+..++.++|+|||||++|||+||++||.+.++..+...+..+.
T Consensus       157 -------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  217 (277)
T cd06640         157 -------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN  217 (277)
T ss_pred             -------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC
Confidence                         0011247888999999999999999999999999999999999999988877777665543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.3e-37  Score=270.81  Aligned_cols=201  Identities=26%  Similarity=0.456  Sum_probs=165.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC------CEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE------NYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~------~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..+++.+|+|++.....   ....+.+|+.+++++ +|+||+++++++...      ...|++|||+.+
T Consensus        17 g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~   93 (272)
T cd06637          17 GTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA   93 (272)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCC
Confidence            7899999999999999999999975432   235677899999998 799999999998753      468999999999


Q ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          74 GELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        74 g~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      ++|.+++...  ..+++..+..++.|++.||+|||+++|+||||||+||+++.+   +.+||+|||++.......     
T Consensus        94 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~---~~~~l~Dfg~~~~~~~~~-----  165 (272)
T cd06637          94 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTV-----  165 (272)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC---CCEEEccCCCceeccccc-----
Confidence            9999988763  368999999999999999999999999999999999999754   459999999975431100     


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (272)
T cd06637         166 --------------------------------------------------------------------------------  165 (272)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                           .......|++.|+|||++.     +..|+.++|+|||||++|||++|+.||.+.++...
T Consensus       166 ---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~  224 (272)
T cd06637         166 ---------------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  224 (272)
T ss_pred             ---------------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence                                 0011234899999999986     34688999999999999999999999988776666


Q ss_pred             HHHHhcc
Q psy2131         307 YAQIKAG  313 (328)
Q Consensus       307 ~~~i~~~  313 (328)
                      ...+.+.
T Consensus       225 ~~~~~~~  231 (272)
T cd06637         225 LFLIPRN  231 (272)
T ss_pred             HHHHhcC
Confidence            6555544

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-37  Score=274.67  Aligned_cols=203  Identities=28%  Similarity=0.472  Sum_probs=172.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|.++.... ....+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+.+
T Consensus        15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (277)
T cd06642          15 GSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL   93 (277)
T ss_pred             CCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHh
Confidence            7899999999999999999999875432 334567889999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . ...+++..+..++.|++.||.|||+++++|+||+|+||+++.+   +.++|+|||++..+.....             
T Consensus        94 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~-------------  156 (277)
T cd06642          94 K-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI-------------  156 (277)
T ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---CCEEEccccccccccCcch-------------
Confidence            5 4568999999999999999999999999999999999999754   4699999998744311000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (277)
T cd06642         157 --------------------------------------------------------------------------------  156 (277)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   ......|+..|+|||++.+..++.++|+|||||++|||+||++||.+.++......+..+.
T Consensus       157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  217 (277)
T cd06642         157 -------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS  217 (277)
T ss_pred             -------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC
Confidence                         0011347889999999999999999999999999999999999999887777666655543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.5e-37  Score=274.16  Aligned_cols=214  Identities=22%  Similarity=0.352  Sum_probs=173.9

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..     ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..|++|||+.+|+
T Consensus        11 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (290)
T cd05045          11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS   89 (290)
T ss_pred             cCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCC
Confidence            8999999998753     33578999887543 33445678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          76 LFEDIVAR------------------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        76 L~~~l~~~------------------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      |.+++...                        ..+++..+..++.|++.||.|||+++|+||||||+|||++++   +.+
T Consensus        90 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~---~~~  166 (290)
T cd05045          90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG---RKM  166 (290)
T ss_pred             HHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCC---CcE
Confidence            98887542                        247788889999999999999999999999999999999653   469


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||++.........                                                               
T Consensus       167 kl~dfg~~~~~~~~~~~---------------------------------------------------------------  183 (290)
T cd05045         167 KISDFGLSRDVYEEDSY---------------------------------------------------------------  183 (290)
T ss_pred             EeccccccccccCccch---------------------------------------------------------------
Confidence            99999997543211000                                                               


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                               .......++..|+|||++.+..++.++|||||||++|||
T Consensus       184 -----------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el  222 (290)
T cd05045         184 -----------------------------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI  222 (290)
T ss_pred             -----------------------------------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHH
Confidence                                                     000012356779999999999999999999999999999


Q ss_pred             Hh-cCCCCCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         292 LV-GYPPFWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       292 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      +| |++||.+..+.++++.+.++.-.+.|...
T Consensus       223 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T cd05045         223 VTLGGNPYPGIAPERLFNLLKTGYRMERPENC  254 (290)
T ss_pred             HhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence            99 99999999999999998887654444433

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-37  Score=275.69  Aligned_cols=215  Identities=24%  Similarity=0.423  Sum_probs=175.4

Q ss_pred             CCceEEEEEEEc-------cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQK-------ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~-------~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|++.       .++..+|+|.+... ......+.+.+|+.+++.+ +||||+++++++......|+||||+.
T Consensus        26 G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  104 (304)
T cd05101          26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  104 (304)
T ss_pred             cCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCC
Confidence            899999999753       24457999998754 2344567788999999999 89999999999999999999999999


Q ss_pred             CCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|+|.+++...                ..++..++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~---~~~kl~D~  181 (304)
T cd05101         105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADF  181 (304)
T ss_pred             CCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC---CcEEECCC
Confidence            99999988753                246777888999999999999999999999999999999753   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       182 g~~~~~~~~~~~--------------------------------------------------------------------  193 (304)
T cd05101         182 GLARDVNNIDYY--------------------------------------------------------------------  193 (304)
T ss_pred             ccceeccccccc--------------------------------------------------------------------
Confidence            998543211000                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......+++.|+|||++.+..|+.++|||||||++|||++ |.
T Consensus       194 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         194 ------------------------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             ------------------------------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence                                                00001235778999999999999999999999999999998 89


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .||.+.+...+++.+..+.-...|..++
T Consensus       238 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (304)
T cd05101         238 SPYPGIPVEELFKLLKEGHRMDKPANCT  265 (304)
T ss_pred             CCcccCCHHHHHHHHHcCCcCCCCCCCC
Confidence            9999999999999998887655555443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9e-37  Score=266.06  Aligned_cols=211  Identities=23%  Similarity=0.349  Sum_probs=173.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|... ++..+|+|+++... ..+....+.+|+++++.++||||+++++++...+..|+||||+++++|.+++
T Consensus         6 g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   83 (250)
T cd05085           6 GNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL   83 (250)
T ss_pred             CCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHH
Confidence            899999999864 68899999987543 3334456889999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.+|.|+|++|++||||||+||+++.+   +.+||+|||++........            
T Consensus        84 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~------------  148 (250)
T cd05085          84 RKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSRQEDDGIY------------  148 (250)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC---CeEEECCCccceecccccc------------
Confidence            653 457899999999999999999999999999999999999754   4699999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       149 --------------------------------------------------------------------------------  148 (250)
T cd05085         149 --------------------------------------------------------------------------------  148 (250)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+.......+..+.....
T Consensus       149 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  215 (250)
T cd05085         149 -------------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC  215 (250)
T ss_pred             -------------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                         00000124567999999999899999999999999999999 9999999988888888887755443


Q ss_pred             CCc
Q psy2131         319 PKH  321 (328)
Q Consensus       319 ~~~  321 (328)
                      |..
T Consensus       216 ~~~  218 (250)
T cd05085         216 PQK  218 (250)
T ss_pred             CCC
Confidence            433

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.8e-37  Score=269.13  Aligned_cols=209  Identities=23%  Similarity=0.379  Sum_probs=173.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||++.... +..+|+|.+......   ...+.+|+.++++++||||+++++++.+.+..|++|||+.+|+|.+++
T Consensus        15 G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i   90 (256)
T cd05113          15 GQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL   90 (256)
T ss_pred             cccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence            7899999997654 456999998755433   245788999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+   +.+||+|||++........            
T Consensus        91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~d~g~~~~~~~~~~------------  155 (256)
T cd05113          91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ---GCVKVSDFGLSRYVLDDEY------------  155 (256)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CCEEECCCccceecCCCce------------
Confidence            763 468999999999999999999999999999999999999753   4699999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (256)
T cd05113         156 --------------------------------------------------------------------------------  155 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   ....+..++..|+|||++.+..++.++|+|||||++|||+| |+.||...+...+..++.++.....
T Consensus       156 -------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05113         156 -------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR  222 (256)
T ss_pred             -------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC
Confidence                         00001235677999999998899999999999999999999 9999999998889999988876554


Q ss_pred             CCc
Q psy2131         319 PKH  321 (328)
Q Consensus       319 ~~~  321 (328)
                      |..
T Consensus       223 ~~~  225 (256)
T cd05113         223 PHL  225 (256)
T ss_pred             CCC
Confidence            443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-37  Score=270.48  Aligned_cols=211  Identities=23%  Similarity=0.382  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+.. +..+|+|++....  ......+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++
T Consensus        17 g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (261)
T cd05148          17 GYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL   93 (261)
T ss_pred             CCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHH
Confidence            7899999999987 8899999987543  223456788999999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++........           
T Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---~~~kl~d~g~~~~~~~~~~-----------  159 (261)
T cd05148          94 RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---LVCKVADFGLARLIKEDVY-----------  159 (261)
T ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---ceEEEccccchhhcCCccc-----------
Confidence            753  458999999999999999999999999999999999999754   4699999998744311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (261)
T cd05148         160 --------------------------------------------------------------------------------  159 (261)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ...+..+++.|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+...++..+..+.-.+
T Consensus       160 ---------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05148         160 ---------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP  224 (261)
T ss_pred             ---------------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC
Confidence                           0001235678999999999999999999999999999998 899999999888888888764444


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       225 ~~~~~~  230 (261)
T cd05148         225 CPAKCP  230 (261)
T ss_pred             CCCCCC
Confidence            444443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.4e-37  Score=276.38  Aligned_cols=214  Identities=25%  Similarity=0.421  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEcc-------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKA-------TGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~-------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.+..       .+..+|+|.++... .......+.+|+++++++ +||||+++++++.+.+..|++|||++
T Consensus        23 G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  101 (314)
T cd05099          23 GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA  101 (314)
T ss_pred             CCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCC
Confidence            8999999997642       34579999987543 344566788999999999 69999999999999999999999999


Q ss_pred             CCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|+|.+++...                ..++..++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~---~~~kL~Df  178 (314)
T cd05099         102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED---NVMKIADF  178 (314)
T ss_pred             CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC---CcEEEccc
Confidence            99999988653                247888899999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |+++........                                                                    
T Consensus       179 g~~~~~~~~~~~--------------------------------------------------------------------  190 (314)
T cd05099         179 GLARGVHDIDYY--------------------------------------------------------------------  190 (314)
T ss_pred             cccccccccccc--------------------------------------------------------------------
Confidence            998543211000                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       191 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~  234 (314)
T cd05099         191 ------------------------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG  234 (314)
T ss_pred             ------------------------------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCC
Confidence                                                00000124567999999999999999999999999999999 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      .||.+.+...++..+..+.....|..+
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (314)
T cd05099         235 SPYPGIPVEELFKLLREGHRMDKPSNC  261 (314)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            999999999999998888654444443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.5e-37  Score=279.42  Aligned_cols=207  Identities=23%  Similarity=0.376  Sum_probs=164.0

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe-CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE-ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~-~~~~~lv~E~~~g   73 (328)
                      |+||.||+|++.     .+++.||+|+++... .....+.+.+|+.+++++ +|+||+++++++.. ...+|++|||+++
T Consensus        18 G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~   96 (337)
T cd05054          18 GAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKF   96 (337)
T ss_pred             CcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCC
Confidence            899999999754     345789999997543 344556778999999999 89999999998764 4678999999999


Q ss_pred             CCcHHHHHhc-------------------------------------------------------------CCCCHHHHH
Q psy2131          74 GELFEDIVAR-------------------------------------------------------------EFYSEADAS   92 (328)
Q Consensus        74 g~L~~~l~~~-------------------------------------------------------------~~~~~~~~~   92 (328)
                      ++|.+.+...                                                             ..+++..+.
T Consensus        97 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  176 (337)
T cd05054          97 GNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLI  176 (337)
T ss_pred             CCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHH
Confidence            9998887542                                                             257888899


Q ss_pred             HHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHH
Q psy2131          93 HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRL  172 (328)
Q Consensus        93 ~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~  172 (328)
                      .++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..+......                        
T Consensus       177 ~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~---~~vkL~DfG~a~~~~~~~~~------------------------  229 (337)
T cd05054         177 SYSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDY------------------------  229 (337)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC---CcEEEeccccchhcccCcch------------------------
Confidence            999999999999999999999999999999754   46999999998543211000                        


Q ss_pred             HHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhh
Q psy2131         173 YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKV  252 (328)
Q Consensus       173 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (328)
                                                                                                      
T Consensus       230 --------------------------------------------------------------------------------  229 (337)
T cd05054         230 --------------------------------------------------------------------------------  229 (337)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH-HHHHHHhcccC
Q psy2131         253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH-RLYAQIKAGAY  315 (328)
Q Consensus       253 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~-~~~~~i~~~~~  315 (328)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .+...+..+..
T Consensus       230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~  294 (337)
T cd05054         230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR  294 (337)
T ss_pred             hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence            00011235778999999999999999999999999999998 99999886543 34444555444

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-38  Score=274.06  Aligned_cols=217  Identities=33%  Similarity=0.486  Sum_probs=179.5

Q ss_pred             CCceEEEEEEEc----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|...    ..+..|+||.++. ....+..+.+.+|++++++++||||+++++++...+..++|||||++|+|
T Consensus        10 G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L   88 (259)
T PF07714_consen   10 GSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSL   88 (259)
T ss_dssp             ESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBH
T ss_pred             CCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccccccccccc
Confidence            899999999887    5567899999965 33455578899999999999999999999999988889999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+++...  ..+++.....++.|++.||.|||+++++|+||+++|||++.+   +.+||+|||++.........      
T Consensus        89 ~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~---~~~Kl~~f~~~~~~~~~~~~------  159 (259)
T PF07714_consen   89 DDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN---GQVKLSDFGLSRPISEKSKY------  159 (259)
T ss_dssp             HHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT---TEEEEESTTTGEETTTSSSE------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc------
Confidence            9999886  679999999999999999999999999999999999999854   46999999997654111000      


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (259)
T PF07714_consen  160 --------------------------------------------------------------------------------  159 (259)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~  313 (328)
                                        .......+...|+|||.+.+..++.++||||||+++||++| |+.||.+.+...+..++..+
T Consensus       160 ------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~  221 (259)
T PF07714_consen  160 ------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG  221 (259)
T ss_dssp             ------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT
T ss_pred             ------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                              00111235667999999999999999999999999999999 78999999999999999999


Q ss_pred             cCCCCCCccccC
Q psy2131         314 AYDDEPKHKSAS  325 (328)
Q Consensus       314 ~~~~~~~~~~~~  325 (328)
                      .....|.+++..
T Consensus       222 ~~~~~~~~~~~~  233 (259)
T PF07714_consen  222 QRLPIPDNCPKD  233 (259)
T ss_dssp             EETTSBTTSBHH
T ss_pred             ccceeccchhHH
Confidence            887777766543

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1026|consensus

Probab=100.00  E-value=3.6e-38  Score=298.93  Aligned_cols=218  Identities=28%  Similarity=0.407  Sum_probs=184.5

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+-.     .....||||.++... +....+.|+||+.+|..++|||||+|++++.+++.+|+|+|||..||
T Consensus       497 gaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GD  575 (774)
T KOG1026|consen  497 GAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGD  575 (774)
T ss_pred             chhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEeccccc
Confidence            789999999643     234679999997543 44467789999999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          76 LFEDIVARE--------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        76 L~~~l~~~~--------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      |.++|..+.              .++..+...++.||+.|+.||-++.+|||||-..|+|++   ++..|||+||||++.
T Consensus       576 L~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l~VKIsDfGLsRd  652 (774)
T KOG1026|consen  576 LHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENLVVKISDFGLSRD  652 (774)
T ss_pred             HHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cceEEEecccccchh
Confidence            999996431              277888999999999999999999999999999999996   456799999999987


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      +-..+.+-.                                                                  ..+.|
T Consensus       653 iYssDYYk~------------------------------------------------------------------~~~t~  666 (774)
T KOG1026|consen  653 IYSSDYYKV------------------------------------------------------------------RGNTL  666 (774)
T ss_pred             hhhhhhhcc------------------------------------------------------------------cCCce
Confidence            643321100                                                                  00000


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                            =...|||||.|....|+++|||||+||+|||++| |+.||++
T Consensus       667 --------------------------------------lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  667 --------------------------------------LPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             --------------------------------------eeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence                                                  1234999999999999999999999999999886 8999999


Q ss_pred             ccHHHHHHHHhcccCCCCCCccccCc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHKSASV  326 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~~~~~  326 (328)
                      ...+++.+-|.+|.....|..|+.++
T Consensus       709 lSn~EVIe~i~~g~lL~~Pe~CP~~v  734 (774)
T KOG1026|consen  709 LSNQEVIECIRAGQLLSCPENCPTEV  734 (774)
T ss_pred             cchHHHHHHHHcCCcccCCCCCCHHH
Confidence            99999999999999999999998764

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.3e-37  Score=267.70  Aligned_cols=204  Identities=26%  Similarity=0.433  Sum_probs=171.0

Q ss_pred             CCceEEEEEEEcc-CCc--EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKA-TGL--EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~--~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+.. .++  .+|+|.+...... ...+.+.+|++++++++||||+++++.+.+ ...++||||+++++|.
T Consensus         6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~   83 (257)
T cd05040           6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLL   83 (257)
T ss_pred             cCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHH
Confidence            7999999998765 333  6999999876544 556778999999999999999999999988 8899999999999999


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          78 EDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        78 ~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +.+....  .+++..+..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++..+......       
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~-------  153 (257)
T cd05040          84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDH-------  153 (257)
T ss_pred             HHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccc-------
Confidence            9987654  68999999999999999999999999999999999999764   46999999997543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                       +              
T Consensus       154 -----------------------------------------------------------------~--------------  154 (257)
T cd05040         154 -----------------------------------------------------------------Y--------------  154 (257)
T ss_pred             -----------------------------------------------------------------e--------------
Confidence                                                                             0              


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~  312 (328)
                                       .......++..|+|||++.+..++.++|+|||||++|||+| |+.||.+.+..++...+..
T Consensus       155 -----------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         155 -----------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             -----------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence                             00001246788999999999999999999999999999999 9999998888888777664

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.4e-37  Score=270.91  Aligned_cols=217  Identities=21%  Similarity=0.383  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEccCC------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATG------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.++...      +.+|||.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++|+
T Consensus         6 g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (269)
T cd05044           6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG   84 (269)
T ss_pred             ccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCC
Confidence            799999999876544      789999886432 2334567889999999999999999999999999999999999999


Q ss_pred             CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeeccccccccCC
Q psy2131          75 ELFEDIVAR-------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        75 ~L~~~l~~~-------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~~~  145 (328)
                      +|.+++...       ..+++.++..++.|++.||.|||+.+++|+||||+||+++.++  ....+||+|||++......
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~  164 (269)
T cd05044          85 DLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS  164 (269)
T ss_pred             cHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccc
Confidence            999988642       3478899999999999999999999999999999999998654  2236999999997543111


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       165 ~~~-----------------------------------------------------------------------------  167 (269)
T cd05044         165 DYY-----------------------------------------------------------------------------  167 (269)
T ss_pred             ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......+++.|+|||++.+..++.++|||||||++|||+| |+.||...+..
T Consensus       168 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~  220 (269)
T cd05044         168 ---------------------------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ  220 (269)
T ss_pred             ---------------------------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH
Confidence                                       00001135678999999999999999999999999999998 99999998888


Q ss_pred             HHHHHHhcccCCCCCCcc
Q psy2131         305 RLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~  322 (328)
                      .+...+..+.....|...
T Consensus       221 ~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         221 EVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             HHHHHHhcCCccCCcccc
Confidence            888888776544444433

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-36  Score=267.95  Aligned_cols=208  Identities=27%  Similarity=0.462  Sum_probs=175.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..|++||+++|++|.+.+
T Consensus        12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~   90 (267)
T cd06610          12 GATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM   90 (267)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHH
Confidence            789999999999999999999997654443 5677899999999999999999999999999999999999999999988


Q ss_pred             Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          81 VAR---EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        81 ~~~---~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ...   ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.++|+|||++.........         
T Consensus        91 ~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---~~~~l~df~~~~~~~~~~~~---------  158 (267)
T cd06610          91 KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLADGGDR---------  158 (267)
T ss_pred             HHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccchHHHhccCccc---------
Confidence            763   458999999999999999999999999999999999999754   45999999987543211000         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (267)
T cd06610         159 --------------------------------------------------------------------------------  158 (267)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   .........|++.|+|||++... .++.++|+|||||++|||++|+.||.+.++...+.++.++.
T Consensus       159 -------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (267)
T cd06610         159 -------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND  223 (267)
T ss_pred             -------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC
Confidence                         00011224589999999999877 78999999999999999999999999988887777776663

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-36  Score=270.88  Aligned_cols=221  Identities=27%  Similarity=0.455  Sum_probs=176.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||+|.+........ ....+.+|+.++++++|+||+.+++.+.+.+..|+||||++|++|.+.
T Consensus        11 G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   90 (285)
T cd05630          11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH   90 (285)
T ss_pred             CCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHH
Confidence            8999999999999999999999876543322 234567899999999999999999999999999999999999999888


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      +...  ..+++.++..++.|++.||.|||+.+|+||||||+||+++.+   +.++|+|||++.....             
T Consensus        91 l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y  167 (285)
T cd05630          91 IYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVGY  167 (285)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeccceeecCCCccccCCCCCccc
Confidence            7543  358999999999999999999999999999999999999754   4599999998753211             


Q ss_pred             -------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCC
Q psy2131         145 -------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       145 -------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                                   ..+.| +|+++|+|++|.+||...................+.......++++.+++.+||+.||.+|
T Consensus       168 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  247 (285)
T cd05630         168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER  247 (285)
T ss_pred             cChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHc
Confidence                         11233 7999999999999997654321111111110111111234678999999999999999999


Q ss_pred             CC-----HHHHhcCcccCC
Q psy2131         211 IT-----ASEALKHPWICQ  224 (328)
Q Consensus       211 ~t-----~~~~l~h~~~~~  224 (328)
                      +|     ++++++|||+.+
T Consensus       248 ~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         248 LGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             cCCCCCchHHHHcChhhhc
Confidence            99     999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-37  Score=275.05  Aligned_cols=204  Identities=30%  Similarity=0.491  Sum_probs=170.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|++..........+.+.+|+++++.++||||+++++++.+.+..|+||||+++++|.+..
T Consensus        12 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   91 (286)
T cd07846          12 GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLE   91 (286)
T ss_pred             CCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHH
Confidence            78999999999999999999998765443333456788999999999999999999999999999999999998887766


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++.++..++.|++.||.|||+.+|+||||+|+||+++++   +.++|+|||++........             
T Consensus        92 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~---~~~~l~dfg~~~~~~~~~~-------------  155 (286)
T cd07846          92 KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGE-------------  155 (286)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CcEEEEeeeeeeeccCCcc-------------
Confidence            666679999999999999999999999999999999999999754   4699999999754311100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (286)
T cd07846         156 --------------------------------------------------------------------------------  155 (286)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   ......|++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.+.
T Consensus       156 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  216 (286)
T cd07846         156 -------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC  216 (286)
T ss_pred             -------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Confidence                         0011347888999999976 45789999999999999999999999988776666665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.1e-37  Score=267.54  Aligned_cols=209  Identities=30%  Similarity=0.536  Sum_probs=177.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.++.+|..+|+|.+........+.+.+.+|+++++.++|+||+++++.+.+.+..|+|+||+++++|.+++
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   90 (257)
T cd08225          11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI   90 (257)
T ss_pred             CCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHH
Confidence            78999999999999999999999876555555667889999999999999999999999999999999999999999988


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++  ..+||+|||.+........           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~~-----------  157 (257)
T cd08225          91 NRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSME-----------  157 (257)
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCcc-----------
Confidence            6543  478999999999999999999999999999999999997543  3579999998743211000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (257)
T cd08225         158 --------------------------------------------------------------------------------  157 (257)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....+..+....
T Consensus       158 ---------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (257)
T cd08225         158 ---------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP  221 (257)
T ss_pred             ---------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC
Confidence                           0011248899999999999899999999999999999999999999888777777777766543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=265.85  Aligned_cols=212  Identities=24%  Similarity=0.366  Sum_probs=174.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+.. ++.||+|.+...... +....+.+|++++++++|+||+++++++.+....|+||||+.|++|.+++
T Consensus         6 g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l   83 (251)
T cd05041           6 GNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL   83 (251)
T ss_pred             CCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHH
Confidence            7899999999877 999999998765433 45567889999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||+++++||||||+|||++.+   +.+||+|||++........            
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~------------  148 (251)
T cd05041          84 RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIY------------  148 (251)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC---CcEEEeeccccccccCCcc------------
Confidence            653 468899999999999999999999999999999999999754   4699999998754311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                              .                                                       
T Consensus       149 ------------------------~-------------------------------------------------------  149 (251)
T cd05041         149 ------------------------T-------------------------------------------------------  149 (251)
T ss_pred             ------------------------e-------------------------------------------------------
Confidence                                    0                                                       


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......++..|+|||++.+..++.++|+|||||++|||+| |..||.+..+......+..+.-...
T Consensus       150 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~  216 (251)
T cd05041         150 -------------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA  216 (251)
T ss_pred             -------------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC
Confidence                         00000123567999999999999999999999999999999 8999999988888888877643333


Q ss_pred             CCc
Q psy2131         319 PKH  321 (328)
Q Consensus       319 ~~~  321 (328)
                      |..
T Consensus       217 ~~~  219 (251)
T cd05041         217 PQL  219 (251)
T ss_pred             Ccc
Confidence            333

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-36  Score=269.29  Aligned_cols=221  Identities=24%  Similarity=0.416  Sum_probs=182.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|..+|+|.+... ........+.+|+.++++++||||+++++++...+..|+|||||+|++|.+++
T Consensus        12 g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   90 (286)
T cd06622          12 GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLY   90 (286)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHH
Confidence            79999999999999999999998754 34445677889999999999999999999999999999999999999998877


Q ss_pred             Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc-------------
Q psy2131          81 VAR---EFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------  143 (328)
Q Consensus        81 ~~~---~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~-------------  143 (328)
                      ...   ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.+   +.+||+|||++....             
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~y  167 (286)
T cd06622          91 AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVSGNLVASLAKTNIGCQSY  167 (286)
T ss_pred             HhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC---CCEEEeecCCcccccCCccccCCCccCc
Confidence            653   378999999999999999999997 599999999999999753   469999999875320             


Q ss_pred             ------------------CCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcc
Q psy2131         144 ------------------GEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       144 ------------------~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~  204 (328)
                                        ...+.| +|+++|+|++|..||...+.......+.......+......+++++.+++.+||.
T Consensus       168 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (286)
T cd06622         168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLN  247 (286)
T ss_pred             cCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcc
Confidence                              012334 7999999999999997765554444333222222223334589999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCc
Q psy2131         205 VNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|.+||++.++++|||+...
T Consensus       248 ~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         248 KIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             cCcccCCCHHHHhcChhhhhc
Confidence            999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=272.79  Aligned_cols=204  Identities=33%  Similarity=0.521  Sum_probs=171.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.||+|+++...........+.+|++++++++|+||+++++++.+.+..|++|||++++.+....
T Consensus        12 g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~   91 (288)
T cd07833          12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE   91 (288)
T ss_pred             cCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH
Confidence            78999999999999999999999765544444567889999999999999999999999999999999999987666555


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++.++..++.|++.||.|||+++++||||+|+||+++.+   +.+||+|||++........             
T Consensus        92 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~---~~~kl~d~g~~~~~~~~~~-------------  155 (288)
T cd07833          92 ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES---GVLKLCDFGFARALRARPA-------------  155 (288)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEEeeecccccCCCcc-------------
Confidence            555679999999999999999999999999999999999999753   5699999999754321100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (288)
T cd07833         156 --------------------------------------------------------------------------------  155 (288)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                  .......|++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+..
T Consensus       156 ------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~  216 (288)
T cd07833         156 ------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK  216 (288)
T ss_pred             ------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                        001123578899999999888 889999999999999999999999998876665555544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.7e-37  Score=274.12  Aligned_cols=197  Identities=31%  Similarity=0.556  Sum_probs=166.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|.+......  ..+.+.+|+.+++.++|+||+++++++...+..|+||||++|++|.+++
T Consensus        30 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (297)
T cd06656          30 GASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  107 (297)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHH
Confidence            78999999999999999999999754432  3356788999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||+.||+||||||+|||++.+   +.++|+|||++........             
T Consensus       108 ~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~---~~~~l~Dfg~~~~~~~~~~-------------  170 (297)
T cd06656         108 TE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQS-------------  170 (297)
T ss_pred             Hh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEECcCccceEccCCcc-------------
Confidence            54 568999999999999999999999999999999999999754   4699999998743211100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (297)
T cd06656         171 --------------------------------------------------------------------------------  170 (297)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                   ......|++.|+|||.+.+..++.++|+|||||++|+|++|++||.+.++......
T Consensus       171 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~  226 (297)
T cd06656         171 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (297)
T ss_pred             -------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence                         00112478899999999999999999999999999999999999998876544333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.4e-37  Score=275.24  Aligned_cols=203  Identities=28%  Similarity=0.365  Sum_probs=167.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|+.||+|+++...........+.+|+.++++++|+||+++++++.+.  +..|+||||+.+ +|.+
T Consensus        18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   96 (309)
T cd07845          18 GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLAS   96 (309)
T ss_pred             cCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHH
Confidence            7899999999999999999999976543332233456899999999999999999999765  578999999975 7877


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+.. ...+++.++..++.|++.||.|||+.|++||||||+||+++.+   +.+||+|||++........          
T Consensus        97 ~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~kL~dfg~~~~~~~~~~----------  163 (309)
T cd07845          97 LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAK----------  163 (309)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccceeeecCCccC----------
Confidence            7765 3568999999999999999999999999999999999999754   4699999999754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (309)
T cd07845         164 --------------------------------------------------------------------------------  163 (309)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ......+++.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+....+..+.+.
T Consensus       164 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~  224 (309)
T cd07845         164 ----------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL  224 (309)
T ss_pred             ----------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                            0001235788999999876 56899999999999999999999999999999988888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.6e-36  Score=268.67  Aligned_cols=202  Identities=31%  Similarity=0.582  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+++.+|+|+++...  ....+.+.+|+.+++.++||||+++++++...+..|+++||++|++|.+.+
T Consensus        30 g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~  107 (285)
T cd06648          30 GSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV  107 (285)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHH
Confidence            789999999999999999999986432  233456789999999999999999999999999999999999999998887


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||+|||++||+||||||+||+++.+   +.++|+|||++.......              
T Consensus       108 ~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~d~g~~~~~~~~~--------------  169 (285)
T cd06648         108 TH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEV--------------  169 (285)
T ss_pred             Hh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC---CcEEEcccccchhhccCC--------------
Confidence            76 678999999999999999999999999999999999999754   469999999864321000              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (285)
T cd06648         170 --------------------------------------------------------------------------------  169 (285)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                  .......|++.|+|||++.+..++.++|+||+||++|||++|+.||.+.++......+..+.
T Consensus       170 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  231 (285)
T cd06648         170 ------------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL  231 (285)
T ss_pred             ------------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC
Confidence                        00112348899999999999999999999999999999999999999999888888877763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-37  Score=269.52  Aligned_cols=219  Identities=36%  Similarity=0.612  Sum_probs=180.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+++.||+|++..............+|+.++++++||||+++++++.+....++||||+.+++|.+++
T Consensus        10 G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l   89 (260)
T PF00069_consen   10 GGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYL   89 (260)
T ss_dssp             ESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHH
T ss_pred             CCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccc
Confidence            89999999999999999999999877554444445567999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                      .....+++.++..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||.+.....                
T Consensus        90 ~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~a  166 (260)
T PF00069_consen   90 QKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN---GEVKLIDFGSSVKLSENNENFNPFVGTPEYMA  166 (260)
T ss_dssp             HHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT---SEEEESSGTTTEESTSTTSEBSSSSSSGGGSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            877889999999999999999999999999999999999999743   4689999999853100                


Q ss_pred             -------C-----Cc-chHHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         145 -------E-----QQ-AWFGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       145 -------~-----~~-~~~G~~~~~~~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                             .     .+ +.+|+++++|++|..||....   ...............+.......++++.+++.+||..||+
T Consensus       167 PE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  246 (260)
T PF00069_consen  167 PEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPE  246 (260)
T ss_dssp             HHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGG
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChh
Confidence                   0     01 127999999999999998873   3333333332222222222223348999999999999999


Q ss_pred             CCCCHHHHhcCccc
Q psy2131         209 KRITASEALKHPWI  222 (328)
Q Consensus       209 ~R~t~~~~l~h~~~  222 (328)
                      +||++.++++|||+
T Consensus       247 ~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  247 QRPSAEELLKHPWF  260 (260)
T ss_dssp             GSTTHHHHHTSGGG
T ss_pred             HCcCHHHHhcCCCC
Confidence            99999999999996

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-36  Score=267.12  Aligned_cols=201  Identities=24%  Similarity=0.395  Sum_probs=166.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++ .+|+|.++......   ..+.+|+++++.++||||+++++.+.+ +..|+||||+++|+|.+++
T Consensus        17 g~~~~v~~~~~~~~~-~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   91 (262)
T cd05071          17 GCFGEVWMGTWNGTT-RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL   91 (262)
T ss_pred             CCCCcEEEEEecCCc-eEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHH
Confidence            799999999887654 59999997644332   457889999999999999999998754 5589999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||+.+|+||||||+||+++.+   +.+||+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~---~~~~L~dfg~~~~~~~~~~-----------  157 (262)
T cd05071          92 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEY-----------  157 (262)
T ss_pred             hhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC---CcEEeccCCceeecccccc-----------
Confidence            753  357899999999999999999999999999999999999754   4599999999754321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (262)
T cd05071         158 --------------------------------------------------------------------------------  157 (262)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                    .......++..|+|||++.+..++.++|+|||||++|||+| |.+||.+.+...+...+..+.
T Consensus       158 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~  220 (262)
T cd05071         158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  220 (262)
T ss_pred             --------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC
Confidence                          00011236778999999999999999999999999999999 999999988888888877664

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-36  Score=268.50  Aligned_cols=221  Identities=32%  Similarity=0.500  Sum_probs=181.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||+|++....... .....+.+|+++|++++||||+++++++...+..|+||||++|++|.++
T Consensus         4 g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   83 (277)
T cd05577           4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYH   83 (277)
T ss_pred             CCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHH
Confidence            899999999999999999999997654332 2344567899999999999999999999999999999999999999988


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      +....  .+++.++..++.|++.||.|||+.|++||||+|+||+++.+   +.+||+|||++.....             
T Consensus        84 l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          84 IYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEccCcchhhhccCCccccccCCCCc
Confidence            87655  69999999999999999999999999999999999999754   4699999998754310             


Q ss_pred             -------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCC
Q psy2131         145 -------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       145 -------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                                   ..+.| +|+++|+|++|..||...........+.......+.......++++.+++.+||..||.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence                         11223 7999999999999997665422223333333333333345679999999999999999999


Q ss_pred             C-----CHHHHhcCcccCC
Q psy2131         211 I-----TASEALKHPWICQ  224 (328)
Q Consensus       211 ~-----t~~~~l~h~~~~~  224 (328)
                      |     ++.+++.|||+..
T Consensus       241 ~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         241 LGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             cCCCcccHHHHHhChhhhc
Confidence            9     8999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-36  Score=265.12  Aligned_cols=197  Identities=24%  Similarity=0.386  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||++..  .|..+|+|.++...    ..+.+.+|+.++++++|+|++++++++. +.+..|++|||+++++|.++
T Consensus        17 g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (256)
T cd05082          17 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY   90 (256)
T ss_pred             cCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHH
Confidence            78999999965  47889999986542    2356788999999999999999999754 55678999999999999998


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +....  .+++..+..++.|++.||+|||++|++||||||+||+++.+   +.+||+|||++.......           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~-----------  156 (256)
T cd05082          91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASSTQ-----------  156 (256)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC---CcEEecCCccceeccccC-----------
Confidence            87643  48899999999999999999999999999999999999754   469999999874321100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd05082         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                        ....++..|+|||++.+..++.++|||||||++|||++ |++||...+...+...+.++.-
T Consensus       157 ------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~  217 (256)
T cd05082         157 ------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK  217 (256)
T ss_pred             ------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence                              01124567999999999999999999999999999998 9999999999999998887743

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=271.61  Aligned_cols=199  Identities=32%  Similarity=0.447  Sum_probs=162.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.||+|.+....... ....+.+|++++++++|+||+++++++.+.+..|+||||+.+ +|.+++
T Consensus        16 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~   93 (291)
T cd07844          16 GSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYM   93 (291)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHH
Confidence            789999999999999999999997543221 223456899999999999999999999999999999999985 898887


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++........            
T Consensus        94 ~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~------------  158 (291)
T cd07844          94 DDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPSK------------  158 (291)
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---CCEEECccccccccCCCCc------------
Confidence            653 468999999999999999999999999999999999999754   4599999998743210000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (291)
T cd07844         159 --------------------------------------------------------------------------------  158 (291)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQI  310 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i  310 (328)
                                    ......+++.|+|||++.+ ..++.++||||+||++|||++|++||.+.+ ..+.+..+
T Consensus       159 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~  217 (291)
T cd07844         159 --------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI  217 (291)
T ss_pred             --------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence                          0001136788999999876 568999999999999999999999998776 44444443

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-36  Score=265.19  Aligned_cols=202  Identities=23%  Similarity=0.380  Sum_probs=167.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+. .+..+|+|.+.......   +.+.+|+.++++++|+||+++++++.. +..|++|||+.+++|.+.+
T Consensus        17 g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   91 (260)
T cd05070          17 GQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL   91 (260)
T ss_pred             ccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHH
Confidence            899999999765 56679999998655433   457889999999999999999998854 5689999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~---~~~~l~dfg~~~~~~~~~~-----------  157 (260)
T cd05070          92 KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG---LVCKIADFGLARLIEDNEY-----------  157 (260)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC---ceEEeCCceeeeeccCccc-----------
Confidence            653  358999999999999999999999999999999999999753   4699999999754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (260)
T cd05070         158 --------------------------------------------------------------------------------  157 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                    ....+..++..|+|||++.+..++.++|+|||||++|||++ |.+||.+.+..++...+..+.-
T Consensus       158 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  221 (260)
T cd05070         158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR  221 (260)
T ss_pred             --------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence                          00011235667999999999999999999999999999999 9999999998888888887643

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-36  Score=281.79  Aligned_cols=214  Identities=24%  Similarity=0.401  Sum_probs=169.0

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++.     .+++.||+|+++... .....+.+.+|+++|.++. |||||++++++...+..|+|||||++|
T Consensus        48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g  126 (401)
T cd05107          48 GAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG  126 (401)
T ss_pred             CCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCC
Confidence            899999999853     455789999997643 2334456889999999997 999999999999999999999999999


Q ss_pred             CcHHHHHhcC----------------------------------------------------------------------
Q psy2131          75 ELFEDIVARE----------------------------------------------------------------------   84 (328)
Q Consensus        75 ~L~~~l~~~~----------------------------------------------------------------------   84 (328)
                      +|.+++...+                                                                      
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (401)
T cd05107         127 DLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIES  206 (401)
T ss_pred             cHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhc
Confidence            9999885431                                                                      


Q ss_pred             ----------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          85 ----------------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        85 ----------------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                                                  .++..++..++.|++.||.|||+.+|+||||||+|||++..   +.+||+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~---~~~kL~Df  283 (401)
T cd05107         207 SNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG---KLVKICDF  283 (401)
T ss_pred             cCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC---CEEEEEec
Confidence                                        25666778899999999999999999999999999999753   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       284 Gla~~~~~~~~~--------------------------------------------------------------------  295 (401)
T cd05107         284 GLARDIMRDSNY--------------------------------------------------------------------  295 (401)
T ss_pred             Ccceeccccccc--------------------------------------------------------------------
Confidence            997543110000                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......|++.|+|||++.+..++.++|+|||||++|||++ |.
T Consensus       296 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~  339 (401)
T cd05107         296 ------------------------------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG  339 (401)
T ss_pred             ------------------------------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCC
Confidence                                                00011246888999999999999999999999999999998 99


Q ss_pred             CCCCCccH-HHHHHHHhcccCCCCCCcc
Q psy2131         296 PPFWDEDQ-HRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       296 ~Pf~~~~~-~~~~~~i~~~~~~~~~~~~  322 (328)
                      .||..... ..+...+..+.....|...
T Consensus       340 ~P~~~~~~~~~~~~~~~~~~~~~~p~~~  367 (401)
T cd05107         340 TPYPELPMNEQFYNAIKRGYRMAKPAHA  367 (401)
T ss_pred             CCCCCCCchHHHHHHHHcCCCCCCCCCC
Confidence            99987654 4455666666544444433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-36  Score=275.89  Aligned_cols=214  Identities=24%  Similarity=0.415  Sum_probs=174.1

Q ss_pred             CCceEEEEEEEccC-------CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKAT-------GLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~-------~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|++...       +..+|+|+++.. ......+.+.+|+++++++ +||||+++++++...+..|++|||++
T Consensus        23 G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  101 (334)
T cd05100          23 GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS  101 (334)
T ss_pred             ccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCC
Confidence            89999999986432       236899988743 3344567788999999999 89999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|+|.+++....                .++..++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~---~~~kL~Df  178 (334)
T cd05100         102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED---NVMKIADF  178 (334)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCc
Confidence            999999886532                36778888899999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |+++........                                                                    
T Consensus       179 g~~~~~~~~~~~--------------------------------------------------------------------  190 (334)
T cd05100         179 GLARDVHNIDYY--------------------------------------------------------------------  190 (334)
T ss_pred             ccceeccccccc--------------------------------------------------------------------
Confidence            997543211000                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       191 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  234 (334)
T cd05100         191 ------------------------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  234 (334)
T ss_pred             ------------------------------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence                                                00001124567999999999999999999999999999999 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      .||.+.+...++..+.++.....|..+
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (334)
T cd05100         235 SPYPGIPVEELFKLLKEGHRMDKPANC  261 (334)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            999999999999999888765555443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-36  Score=264.12  Aligned_cols=213  Identities=28%  Similarity=0.462  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEccCC----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+...+    ..+|+|+++.... ......+.+|+.+++.++|+||+++++.+.+.+..|++|||+++++|
T Consensus        10 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l   88 (258)
T smart00219       10 GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDL   88 (258)
T ss_pred             CCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCH
Confidence            899999999998776    8999999965432 22556788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~~~--~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+.+.....  +++..+..++.|++.||.|||+.+++||||||+||+++.+   +.++|+|||++........       
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~-------  158 (258)
T smart00219       89 LDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDY-------  158 (258)
T ss_pred             HHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC---CeEEEcccCCceecccccc-------
Confidence            998876544  8999999999999999999999999999999999999754   4699999999754321100       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                         .            
T Consensus       159 -------------------------------------------------------------------~------------  159 (258)
T smart00219      159 -------------------------------------------------------------------Y------------  159 (258)
T ss_pred             -------------------------------------------------------------------c------------
Confidence                                                                               0            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~  313 (328)
                                         ......+++.|+|||.+.+..++.++|+||+||++|+|++ |.+||.+.+...+.+.+.++
T Consensus       160 -------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~  220 (258)
T smart00219      160 -------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG  220 (258)
T ss_pred             -------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence                               0000126788999999988889999999999999999999 89999999999999999998


Q ss_pred             cCCCCCCcc
Q psy2131         314 AYDDEPKHK  322 (328)
Q Consensus       314 ~~~~~~~~~  322 (328)
                      .....|...
T Consensus       221 ~~~~~~~~~  229 (258)
T smart00219      221 YRLPKPENC  229 (258)
T ss_pred             CCCCCCCcC
Confidence            876665553

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.5e-36  Score=269.09  Aligned_cols=213  Identities=21%  Similarity=0.346  Sum_probs=171.3

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|..+.     .+..+|+|.++... .......+.+|+.+++.++||||+++++++.+.+..|+||||+++|+
T Consensus        17 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   95 (288)
T cd05061          17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD   95 (288)
T ss_pred             CCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCC
Confidence            8999999997642     35589999987543 23334457889999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          76 LFEDIVAR----------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        76 L~~~l~~~----------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |.+++...          ...+...+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||+++.....
T Consensus        96 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~---~~~~L~Dfg~~~~~~~~  172 (288)
T cd05061          96 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIYET  172 (288)
T ss_pred             HHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC---CcEEECcCCcccccccc
Confidence            99998652          234567888999999999999999999999999999999754   46999999997543111


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       173 ~~~-----------------------------------------------------------------------------  175 (288)
T cd05061         173 DYY-----------------------------------------------------------------------------  175 (288)
T ss_pred             ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+.+..
T Consensus       176 ---------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~  228 (288)
T cd05061         176 ---------------------------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE  228 (288)
T ss_pred             ---------------------------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                                       00001235677999999999999999999999999999999 89999999988


Q ss_pred             HHHHHHhcccCCCCCCc
Q psy2131         305 RLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~  321 (328)
                      ++...+..+.+...|..
T Consensus       229 ~~~~~~~~~~~~~~~~~  245 (288)
T cd05061         229 QVLKFVMDGGYLDQPDN  245 (288)
T ss_pred             HHHHHHHcCCCCCCCCC
Confidence            88888887766544433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.8e-36  Score=267.54  Aligned_cols=203  Identities=33%  Similarity=0.541  Sum_probs=173.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|++.....   ....+.+|+++++.++|+||+++++.+...+..|+++||++|++|.+.+
T Consensus        30 g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  106 (286)
T cd06614          30 GASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII  106 (286)
T ss_pred             CCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence            7899999999998999999999976533   4566789999999999999999999999999999999999999999999


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .... .+++.++..++.|++.||.|||+.||+|+||||+||+++.+   +.++|+|||++.......             
T Consensus       107 ~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~-------------  170 (286)
T cd06614         107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD---GSVKLADFGFAAQLTKEK-------------  170 (286)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC---CCEEECccchhhhhccch-------------
Confidence            8776 89999999999999999999999999999999999999754   459999999863321100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (286)
T cd06614         171 --------------------------------------------------------------------------------  170 (286)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.++......+.....
T Consensus       171 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~  233 (286)
T cd06614         171 -------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI  233 (286)
T ss_pred             -------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence                         000112478899999999999999999999999999999999999999887776666655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-36  Score=263.89  Aligned_cols=202  Identities=31%  Similarity=0.498  Sum_probs=172.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..+++.+|+|.+.....   ..+..+.+.+|+.+++.++|+||+++++++.+....|++|||++|++|.
T Consensus        11 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (258)
T cd06632          11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLA   90 (258)
T ss_pred             cCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHH
Confidence            7899999999998999999999875432   2345577889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.+   +.+||+|||++.......           
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~---~~~kl~d~~~~~~~~~~~-----------  156 (258)
T cd06632          91 KLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFS-----------  156 (258)
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccceeccccc-----------
Confidence            998877779999999999999999999999999999999999999754   469999999864321100           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (258)
T cd06632         157 --------------------------------------------------------------------------------  156 (258)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                      ......|++.|+|||.+.... ++.++|+|||||++|+|++|++||..........++..
T Consensus       157 ----------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (258)
T cd06632         157 ----------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR  216 (258)
T ss_pred             ----------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence                            001134789999999998776 89999999999999999999999988876666555554

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-36  Score=268.86  Aligned_cols=191  Identities=24%  Similarity=0.379  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++.+.+..|+||||+++++|.+.+
T Consensus        16 g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   94 (284)
T cd06620          16 GNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY   94 (284)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHH
Confidence            789999999999999999999987543 2334567889999999999999999999999999999999999999999888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.+   +.++|+|||++......              
T Consensus        95 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---~~~~l~d~gl~~~~~~~--------------  157 (284)
T cd06620          95 KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR---GQIKLCDFGVSGELINS--------------  157 (284)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC---CcEEEccCCcccchhhh--------------
Confidence            877789999999999999999999997 699999999999999754   46999999986321000              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (284)
T cd06620         158 --------------------------------------------------------------------------------  157 (284)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                    ......||..|+|||++.+..++.++|+|||||++|+|+||+.||...+.
T Consensus       158 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         158 --------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             --------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence                          00113489999999999988999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-36  Score=265.32  Aligned_cols=216  Identities=24%  Similarity=0.349  Sum_probs=170.8

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+..   .+..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..|++|||+.+|+|
T Consensus         6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L   84 (262)
T cd05058           6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL   84 (262)
T ss_pred             cCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCH
Confidence            8999999998653   34679999885422 3344567889999999999999999999765 45568999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++... ...++..+..++.|++.||.|||+.+++||||||+|||++.+   +.+||+|||++..........      
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~---~~~kl~dfg~~~~~~~~~~~~------  155 (262)
T cd05058          85 RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES---FTVKVADFGLARDIYDKEYYS------  155 (262)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC---CcEEECCccccccccCCccee------
Confidence            9988654 346777888899999999999999999999999999999754   469999999975432110000      


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (262)
T cd05058         156 --------------------------------------------------------------------------------  155 (262)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+...+...+.++.
T Consensus       156 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~  219 (262)
T cd05058         156 ----------------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR  219 (262)
T ss_pred             ----------------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence                            000011235778999999999999999999999999999999 578898888888888888887


Q ss_pred             CCCCCCcc
Q psy2131         315 YDDEPKHK  322 (328)
Q Consensus       315 ~~~~~~~~  322 (328)
                      ....|..+
T Consensus       220 ~~~~~~~~  227 (262)
T cd05058         220 RLLQPEYC  227 (262)
T ss_pred             CCCCCCcC
Confidence            65555443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=263.96  Aligned_cols=202  Identities=24%  Similarity=0.401  Sum_probs=171.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|...  |+.+|+|.++....   ..+++.+|+.+++.++|+||+++++++.+.+..|+||||+++++|.+++
T Consensus        17 g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   91 (256)
T cd05039          17 GEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL   91 (256)
T ss_pred             CCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHH
Confidence            789999999864  78999999975532   4567889999999999999999999999999999999999999999998


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++.......            
T Consensus        92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~---~~~~l~d~g~~~~~~~~~------------  156 (256)
T cd05039          92 RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED---LVAKVSDFGLAKEASQGQ------------  156 (256)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC---CCEEEccccccccccccc------------
Confidence            7665  68999999999999999999999999999999999999754   469999999875421000            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (256)
T cd05039         157 --------------------------------------------------------------------------------  156 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                       ....++..|+|||++.+..++.++|+|||||++|||++ |+.||...+...+...+.++....
T Consensus       157 -----------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd05039         157 -----------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME  219 (256)
T ss_pred             -----------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence                             00113456999999998899999999999999999997 999999999999988888775433


Q ss_pred             CC
Q psy2131         318 EP  319 (328)
Q Consensus       318 ~~  319 (328)
                      .|
T Consensus       220 ~~  221 (256)
T cd05039         220 AP  221 (256)
T ss_pred             Cc
Confidence            33

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-36  Score=269.04  Aligned_cols=203  Identities=31%  Similarity=0.446  Sum_probs=171.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|..+|+|++............+.+|+.++++++||||+++++++......|+||||+ |++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~   89 (286)
T cd07832          11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVL   89 (286)
T ss_pred             CCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHH
Confidence            78999999999999999999999876544444567889999999999999999999999999999999999 99999888


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.|++.||.|||+.|++|+||||+||+++.+   +.++|+|||++........            
T Consensus        90 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~---~~~~l~dfg~~~~~~~~~~------------  154 (286)
T cd07832          90 RDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD---GVLKIADFGLARLFSEEEP------------  154 (286)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC---CcEEEeeeeecccccCCCC------------
Confidence            64 3568999999999999999999999999999999999999764   4599999998754311100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (286)
T cd07832         155 --------------------------------------------------------------------------------  154 (286)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                   .......|++.|+|||++.+. .++.++||||+||++|||+||++||.+.+....+..+.+
T Consensus       155 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~  215 (286)
T cd07832         155 -------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR  215 (286)
T ss_pred             -------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence                         000113488999999998764 469999999999999999999999998887777666554

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-37  Score=268.66  Aligned_cols=197  Identities=17%  Similarity=0.262  Sum_probs=160.1

Q ss_pred             CCceEEEEEEEccCCcE-------EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLE-------FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~-------~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..++..       +|+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++|||||++
T Consensus         6 G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd05078           6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKF   83 (258)
T ss_pred             ccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCC
Confidence            89999999998665543       8888875432  23345678899999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC-----CCcEEEeeccccccccCCCc
Q psy2131          74 GELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-----GAAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus        74 g~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~-----~~~vkl~DfGla~~~~~~~~  147 (328)
                      |+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.     ...++++|||++.....   
T Consensus        84 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---  160 (258)
T cd05078          84 GSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---  160 (258)
T ss_pred             CcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---
Confidence            99999887644 5899999999999999999999999999999999999986542     12478999998632100   


Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (258)
T cd05078         161 --------------------------------------------------------------------------------  160 (258)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             chhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhc-CCCCCCccHHH
Q psy2131         228 VASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVG-YPPFWDEDQHR  305 (328)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG-~~Pf~~~~~~~  305 (328)
                                                 .....|++.|+|||++.+ ..++.++|+|||||++|||++| .+||...++..
T Consensus       161 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~  213 (258)
T cd05078         161 ---------------------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK  213 (258)
T ss_pred             ---------------------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence                                       001247888999999987 4579999999999999999999 57777766665


Q ss_pred             HHHH
Q psy2131         306 LYAQ  309 (328)
Q Consensus       306 ~~~~  309 (328)
                      ....
T Consensus       214 ~~~~  217 (258)
T cd05078         214 KLQF  217 (258)
T ss_pred             HHHH
Confidence            5443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-36  Score=264.41  Aligned_cols=209  Identities=24%  Similarity=0.382  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+. .++.+|+|.+......   ...+.+|+.++++++|+||+++++++.+....|+||||+++++|.+++
T Consensus        17 g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i   92 (261)
T cd05034          17 GQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL   92 (261)
T ss_pred             CcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence            789999999875 4578999999865443   345788999999999999999999999989999999999999999988


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++.++..++.|++.||.|||++|++|+||||+||+++.+   +.+||+|||++........           
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~-----------  158 (261)
T cd05034          93 KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIEDDEY-----------  158 (261)
T ss_pred             hccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC---CCEEECccccceeccchhh-----------
Confidence            7643  68999999999999999999999999999999999999754   5699999998754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (261)
T cd05034         159 --------------------------------------------------------------------------------  158 (261)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......++..|+|||.+.+..++.++|+|||||++|+|+| |+.||.+.+....+.++.++...+
T Consensus       159 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05034         159 --------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP  224 (261)
T ss_pred             --------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00001224677999999999999999999999999999999 999999999888999988876544


Q ss_pred             CCCc
Q psy2131         318 EPKH  321 (328)
Q Consensus       318 ~~~~  321 (328)
                      .|..
T Consensus       225 ~~~~  228 (261)
T cd05034         225 RPPN  228 (261)
T ss_pred             CCCC
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-36  Score=266.53  Aligned_cols=213  Identities=26%  Similarity=0.363  Sum_probs=173.5

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+...   ...+|||...... ..+..+.+.+|+.+++.++||||+++++++.+. ..|+||||+++|+|.
T Consensus        17 g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~   94 (270)
T cd05056          17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELR   94 (270)
T ss_pred             ccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHH
Confidence            79999999987544   4568999886443 244556788999999999999999999998764 578999999999999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++.... .+++..+..++.|++.||.|||+.|++||||||+|||++..   +.+||+|||++.........        
T Consensus        95 ~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~~--------  163 (270)
T cd05056          95 SYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYY--------  163 (270)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC---CCeEEccCceeeecccccce--------
Confidence            9987643 58999999999999999999999999999999999999754   46999999987543211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (270)
T cd05056         164 --------------------------------------------------------------------------------  163 (270)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                       ......+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+......++..+..
T Consensus       164 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  226 (270)
T cd05056         164 -----------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER  226 (270)
T ss_pred             -----------------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc
Confidence                             0001124577999999999999999999999999999996 9999999998888889888876


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      ...|..++
T Consensus       227 ~~~~~~~~  234 (270)
T cd05056         227 LPMPPNCP  234 (270)
T ss_pred             CCCCCCCC
Confidence            65554443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-36  Score=266.18  Aligned_cols=207  Identities=22%  Similarity=0.376  Sum_probs=170.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|..+ +++.+|+|.+......   ...+.+|+.++++++|+||+++++++. .+..|++|||+.+++|.+++
T Consensus        17 G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05067          17 GQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFL   91 (260)
T ss_pred             CccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHH
Confidence            899999999864 6788999999765543   346788999999999999999999874 45689999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.|++.||+|||+.|++||||||+||+++.+   +.++|+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~-----------  157 (260)
T cd05067          92 KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET---LCCKIADFGLARLIEDNEY-----------  157 (260)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC---CCEEEccCcceeecCCCCc-----------
Confidence            653  358899999999999999999999999999999999999754   4699999998754321000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (260)
T cd05067         158 --------------------------------------------------------------------------------  157 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......++..|+|||++.+..++.++|+|||||++|||++ |++||.+.+...+...+.++...+
T Consensus       158 --------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05067         158 --------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP  223 (260)
T ss_pred             --------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence                          00011235678999999999999999999999999999999 999999999888888888775544


Q ss_pred             CCC
Q psy2131         318 EPK  320 (328)
Q Consensus       318 ~~~  320 (328)
                      .|.
T Consensus       224 ~~~  226 (260)
T cd05067         224 RPD  226 (260)
T ss_pred             CCC
Confidence            443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-36  Score=270.50  Aligned_cols=214  Identities=25%  Similarity=0.368  Sum_probs=174.9

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .++..+|+|++.... .......+.+|+.++++++||||+++++++.+.+..|++|||+++|+
T Consensus        16 g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   94 (288)
T cd05050          16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD   94 (288)
T ss_pred             cccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCC
Confidence            789999999874     367899999987543 33445678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEE
Q psy2131          76 LFEDIVARE----------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL  133 (328)
Q Consensus        76 L~~~l~~~~----------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl  133 (328)
                      |.+++....                      .+++.++..++.|++.||.|||+++++||||||+|||++.+   +.+||
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l  171 (288)
T cd05050          95 LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVVKI  171 (288)
T ss_pred             HHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC---CceEE
Confidence            999886432                      36778889999999999999999999999999999999654   46999


Q ss_pred             eeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         134 ADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       134 ~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      +|||++.........                                                                 
T Consensus       172 ~dfg~~~~~~~~~~~-----------------------------------------------------------------  186 (288)
T cd05050         172 ADFGLSRNIYSADYY-----------------------------------------------------------------  186 (288)
T ss_pred             CccccceecccCccc-----------------------------------------------------------------
Confidence            999987543111000                                                                 


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV  293 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt  293 (328)
                                                             .......+++.|+|||++.+..++.++|||||||++|||++
T Consensus       187 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  227 (288)
T cd05050         187 ---------------------------------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  227 (288)
T ss_pred             ---------------------------------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence                                                   00001124567999999999999999999999999999998


Q ss_pred             -cCCCCCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         294 -GYPPFWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       294 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                       |..||.+.+..++...+..+.....|..+
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (288)
T cd05050         228 YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC  257 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence             99999999989999999888875545443

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-36  Score=270.66  Aligned_cols=203  Identities=31%  Similarity=0.418  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.++.+++.+|+|.++...........+.+|+.++++++||||+++++++...  +..|+||||+.+ +|.+
T Consensus        16 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~   94 (293)
T cd07843          16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKS   94 (293)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHH
Confidence            7899999999999999999999986654433334567899999999999999999999877  899999999975 8888


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+... ..+++.++..++.|++.||+|||+++++||||||+|||++.+   +.+||+|||++........          
T Consensus        95 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~----------  161 (293)
T cd07843          95 LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLK----------  161 (293)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CcEEEeecCceeeccCCcc----------
Confidence            77654 358999999999999999999999999999999999999754   5699999998754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (293)
T cd07843         162 --------------------------------------------------------------------------------  161 (293)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ......+++.|+|||++.+. .++.++|+||+||++|||++|.+||.+.+......++.+.
T Consensus       162 ----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (293)
T cd07843         162 ----------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL  222 (293)
T ss_pred             ----------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence                            00012368889999999765 4689999999999999999999999999887777776543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0983|consensus

Probab=100.00  E-value=1.5e-37  Score=259.65  Aligned_cols=199  Identities=21%  Similarity=0.379  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+-|+|++++.+.+|...|||.+..+. +.++.+++.+.+.++... +.|.||+.|++|.....+++.||.|.. . .+.
T Consensus       103 GtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C-~ek  179 (391)
T KOG0983|consen  103 GTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C-AEK  179 (391)
T ss_pred             CCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H-HHH
Confidence            788999999999999999999998765 445667788888877665 489999999999999999999999843 2 344


Q ss_pred             HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVA--REFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~--~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      |..  .++++|..+.++...++.||.||-+ ++|||||+||+|||++..+   .+|+||||++..+.+..          
T Consensus       180 Llkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G---niKlCDFGIsGrlvdSk----------  246 (391)
T KOG0983|consen  180 LLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---NIKLCDFGISGRLVDSK----------  246 (391)
T ss_pred             HHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC---CEEeecccccceeeccc----------
Confidence            332  4679999999999999999999965 6999999999999998665   59999999985542210          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       247 --------------------------------------------------------------------------------  246 (391)
T KOG0983|consen  247 --------------------------------------------------------------------------------  246 (391)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~  312 (328)
                                       .....+|.+.|||||-+..   ..|+..+|||||||+|+||.||+.||.+.+ +.+++-+|..
T Consensus       247 -----------------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  247 -----------------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             -----------------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence                             0112369999999999853   478999999999999999999999999986 8888888876

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-36  Score=271.00  Aligned_cols=205  Identities=23%  Similarity=0.389  Sum_probs=166.4

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+     ..++..+|+|.++... .....+.+.+|+.+++++ +||||+++++++...+..|++|||+.+|
T Consensus        46 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~  124 (302)
T cd05055          46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG  124 (302)
T ss_pred             cCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCC
Confidence            78999999975     3456689999987543 234456788999999999 7999999999999999999999999999


Q ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          75 ELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        75 ~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      +|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+|||++.   ++.+||+|||++.........    
T Consensus       125 ~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~dfg~~~~~~~~~~~----  197 (302)
T cd05055         125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---GKIVKICDFGLARDIMNDSNY----  197 (302)
T ss_pred             cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC---CCeEEECCCcccccccCCCce----
Confidence            9999886543  3899999999999999999999999999999999999964   346999999997543110000    


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (302)
T cd05055         198 --------------------------------------------------------------------------------  197 (302)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH-HHH
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY-AQI  310 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~-~~i  310 (328)
                                          .......+++.|+|||++.+..++.++||||+||++|||+| |.+||.+.+....+ ..+
T Consensus       198 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~  257 (302)
T cd05055         198 --------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI  257 (302)
T ss_pred             --------------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence                                00011236788999999999999999999999999999998 99999988755544 444


Q ss_pred             hcc
Q psy2131         311 KAG  313 (328)
Q Consensus       311 ~~~  313 (328)
                      .++
T Consensus       258 ~~~  260 (302)
T cd05055         258 KEG  260 (302)
T ss_pred             HcC
Confidence            444

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-36  Score=265.44  Aligned_cols=199  Identities=19%  Similarity=0.247  Sum_probs=162.5

Q ss_pred             CCceEEEEEEEccCC----------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEc
Q psy2131           1 GAFSVVRRCVQKATG----------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDL   70 (328)
Q Consensus         1 G~fg~V~~~~~~~~~----------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~   70 (328)
                      |+||.||+|.+..++          ..+++|++....   .....+.+|+.++++++||||+++++++.. ...|+||||
T Consensus         6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~   81 (259)
T cd05037           6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEY   81 (259)
T ss_pred             cccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEc
Confidence            899999999998777          357888775432   125677899999999999999999999988 778999999


Q ss_pred             cCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC----CCCcEEEeeccccccccCC
Q psy2131          71 VTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA----KGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        71 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~----~~~~vkl~DfGla~~~~~~  145 (328)
                      +++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++    ....+||+|||++..... 
T Consensus        82 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-  160 (259)
T cd05037          82 VKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-  160 (259)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-
Confidence            99999999887665 789999999999999999999999999999999999998654    122599999998743210 


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (259)
T cd05037         161 --------------------------------------------------------------------------------  160 (259)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC--CCCCCcchhhhhhHHHHHHh-cCCCCCCcc
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE--PYGKPVDIWACGVILYILLV-GYPPFWDED  302 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~~DvwSlGvilyellt-G~~Pf~~~~  302 (328)
                                                   .....++..|+|||++.+.  .++.++|+|||||++|||++ |..||.+.+
T Consensus       161 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         161 -----------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             -----------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence                                         0012366779999999887  78999999999999999999 688998876


Q ss_pred             HHHHHHHHhcc
Q psy2131         303 QHRLYAQIKAG  313 (328)
Q Consensus       303 ~~~~~~~i~~~  313 (328)
                      ...........
T Consensus       212 ~~~~~~~~~~~  222 (259)
T cd05037         212 SSEKERFYQDQ  222 (259)
T ss_pred             chhHHHHHhcC
Confidence            55444444433

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-36  Score=272.24  Aligned_cols=208  Identities=25%  Similarity=0.352  Sum_probs=169.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |++|.|+.+++..+++.||+|+++...........+.+|+++++.++|+||+++++++.+.+..|++||||++|+|.+++
T Consensus        11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            56788888888899999999999876566667788999999999999999999999999999999999999999998888


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||.+..........         
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~~---------  158 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKRQ---------  158 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeeccccccc---------
Confidence            653  458999999999999999999999999999999999999754   459999999875432110000         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                    ..+                               
T Consensus       159 ----------------------------------------------~~~-------------------------------  161 (314)
T cd08216         159 ----------------------------------------------RVV-------------------------------  161 (314)
T ss_pred             ----------------------------------------------ccc-------------------------------
Confidence                                                          000                               


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH-HHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQI  310 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i  310 (328)
                                   ........++..|+|||++.+  ..|+.++|+||+||++|||++|++||.+.+... +..++
T Consensus       162 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~  223 (314)
T cd08216         162 -------------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV  223 (314)
T ss_pred             -------------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                         000112347888999999976  468999999999999999999999999876443 33443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-37  Score=280.59  Aligned_cols=180  Identities=24%  Similarity=0.369  Sum_probs=152.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|+....        ....|+.++++++||||+++++++.+.+..|+||||+. ++|.+++
T Consensus        77 G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l  147 (357)
T PHA03209         77 GSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYL  147 (357)
T ss_pred             CCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHH
Confidence            89999999999999999999985432        12469999999999999999999999999999999996 5788877


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.||+.||.|||++|||||||||+|||++..   +.+||+|||++......              
T Consensus       148 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~--------------  210 (357)
T PHA03209        148 TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVA--------------  210 (357)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEecCccccccccC--------------
Confidence            65 4568999999999999999999999999999999999999754   45999999987421000              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       211 --------------------------------------------------------------------------------  210 (357)
T PHA03209        211 --------------------------------------------------------------------------------  210 (357)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                   ....+..||+.|+|||++.+..|+.++|||||||++|||+++..|+.
T Consensus       211 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        211 -------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             -------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence                         00112458999999999999999999999999999999998655553

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.4e-36  Score=268.64  Aligned_cols=201  Identities=28%  Similarity=0.472  Sum_probs=163.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEE-----eCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ-----EENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~-----~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+..+++.+|+|+++....   ....+.+|+.+++.+ +||||+++++++.     +++..|+||||++|+
T Consensus        29 g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~  105 (286)
T cd06638          29 GTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG  105 (286)
T ss_pred             CCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCC
Confidence            7899999999999999999999865321   224577899999999 7999999999874     456789999999999


Q ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      +|.+.+..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.+||+|||++........   
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~---  179 (286)
T cd06638         106 SVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRL---  179 (286)
T ss_pred             CHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEEEccCCceeecccCCC---
Confidence            99887642    3468899999999999999999999999999999999999764   3599999999754311000   


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (286)
T cd06638         180 --------------------------------------------------------------------------------  179 (286)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                             ......||+.|+|||++..     ..|+.++||||+||++|||++|+.||.+.++..
T Consensus       180 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~  236 (286)
T cd06638         180 -----------------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR  236 (286)
T ss_pred             -----------------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence                                   0011248999999999853     458899999999999999999999999888766


Q ss_pred             HHHHHhcc
Q psy2131         306 LYAQIKAG  313 (328)
Q Consensus       306 ~~~~i~~~  313 (328)
                      ...++.++
T Consensus       237 ~~~~~~~~  244 (286)
T cd06638         237 ALFKIPRN  244 (286)
T ss_pred             HHhhcccc
Confidence            65554443

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-36  Score=270.89  Aligned_cols=213  Identities=24%  Similarity=0.339  Sum_probs=171.0

Q ss_pred             CCceEEEEEEEccCCc----EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+..+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++++... ..++++||+++|+|
T Consensus        18 G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l   95 (303)
T cd05110          18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCL   95 (303)
T ss_pred             CCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCH
Confidence            8999999999888876    468888865432 33344678999999999999999999998754 46899999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........       
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~-------  165 (303)
T cd05110          96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKE-------  165 (303)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC---CceEEccccccccccCcccc-------
Confidence            99887644 58999999999999999999999999999999999999653   45999999997543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (303)
T cd05110         166 --------------------------------------------------------------------------------  165 (303)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....+...+..+.
T Consensus       166 -----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (303)
T cd05110         166 -----------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE  228 (303)
T ss_pred             -----------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence                             00001235778999999999999999999999999999998 999999887777777777666


Q ss_pred             CCCCCCcc
Q psy2131         315 YDDEPKHK  322 (328)
Q Consensus       315 ~~~~~~~~  322 (328)
                      ..+.|+.+
T Consensus       229 ~~~~~~~~  236 (303)
T cd05110         229 RLPQPPIC  236 (303)
T ss_pred             CCCCCCCC
Confidence            55444433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-36  Score=263.09  Aligned_cols=198  Identities=27%  Similarity=0.481  Sum_probs=169.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|.++...    ..+.+.+|++++++++||||+++++.+.+....|+++||+.+++|.+.+
T Consensus        14 g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l   89 (256)
T cd06612          14 GSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM   89 (256)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHH
Confidence            789999999999989999999987542    2567889999999999999999999999999999999999999999988


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.+   +.+||+|||++........            
T Consensus        90 ~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---~~~~l~dfg~~~~~~~~~~------------  154 (256)
T cd06612          90 KITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTMA------------  154 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---CcEEEcccccchhcccCcc------------
Confidence            65 4578999999999999999999999999999999999999754   4599999999754311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (256)
T cd06612         155 --------------------------------------------------------------------------------  154 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                    ......|++.|+|||++.+..++.++|+|||||++|+|++|++||...++......+.
T Consensus       155 --------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~  212 (256)
T cd06612         155 --------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP  212 (256)
T ss_pred             --------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc
Confidence                          0011237889999999999999999999999999999999999999887666554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6e-36  Score=265.13  Aligned_cols=203  Identities=26%  Similarity=0.480  Sum_probs=172.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|++..... ......+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++
T Consensus        15 G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i   93 (277)
T cd06641          15 GSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL   93 (277)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHH
Confidence            7899999999999999999999865432 334567889999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++..+..++.|++.|+.|||+.|++|+||||+||+++.+   +.++|+|||++..+.....             
T Consensus        94 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~~~~~~-------------  156 (277)
T cd06641          94 EP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQI-------------  156 (277)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---CCEEEeecccceecccchh-------------
Confidence            54 568999999999999999999999999999999999999754   4599999998754311000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (277)
T cd06641         157 --------------------------------------------------------------------------------  156 (277)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   ......|+..|+|||++.+..++.++|+||+||++|+|++|.+||.+.++......+..+.
T Consensus       157 -------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  217 (277)
T cd06641         157 -------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN  217 (277)
T ss_pred             -------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC
Confidence                         0011247888999999999889999999999999999999999999888877777766554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.5e-36  Score=263.35  Aligned_cols=207  Identities=29%  Similarity=0.438  Sum_probs=176.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++...... .....+.+|+.++++++|+||+++++++...+..|+||||+++++|.+.+
T Consensus        12 g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (264)
T cd06623          12 GSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL   90 (264)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHH
Confidence            78999999999999999999999765432 44567889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .....+++..+..++.|++.||.|||+ .+++||||+|+||+++.+   +.++|+|||++........            
T Consensus        91 ~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~---~~~~l~df~~~~~~~~~~~------------  155 (264)
T cd06623          91 KKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLD------------  155 (264)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC---CCEEEccCccceecccCCC------------
Confidence            887889999999999999999999999 999999999999999754   5699999998754311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (264)
T cd06623         156 --------------------------------------------------------------------------------  155 (264)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhcccCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYD  316 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~  316 (328)
                                    ......|+..|+|||.+.+..++.++|+|||||++|+|+||+.||...   ...++...+.++...
T Consensus       156 --------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  221 (264)
T cd06623         156 --------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP  221 (264)
T ss_pred             --------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC
Confidence                          001234788899999999999999999999999999999999999888   566677776655443


Q ss_pred             C
Q psy2131         317 D  317 (328)
Q Consensus       317 ~  317 (328)
                      .
T Consensus       222 ~  222 (264)
T cd06623         222 S  222 (264)
T ss_pred             C
Confidence            3

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-36  Score=269.38  Aligned_cols=202  Identities=32%  Similarity=0.444  Sum_probs=165.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.||+|.+............+.+|++++++++||||+++++++.+.+..|+||||+++ +|.+.+
T Consensus        13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   91 (294)
T PLN00009         13 GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM   91 (294)
T ss_pred             CCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHH
Confidence            7899999999999999999999876544333445678899999999999999999999999999999999964 787777


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.||+.||+|||+++++||||||+||+++..  ++.+||+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~--~~~~kl~dfg~~~~~~~~~~-----------  158 (294)
T PLN00009         92 DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVR-----------  158 (294)
T ss_pred             HhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECC--CCEEEEcccccccccCCCcc-----------
Confidence            6543  35788888999999999999999999999999999999753  24699999999743211000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (294)
T PLN00009        159 --------------------------------------------------------------------------------  158 (294)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                     ......|++.|+|||++.+ ..++.++||||+||++|+|+||++||.+.++.....++.
T Consensus       159 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~  217 (294)
T PLN00009        159 ---------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF  217 (294)
T ss_pred             ---------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                           0001246889999999876 467999999999999999999999999887665555543

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=259.55  Aligned_cols=212  Identities=29%  Similarity=0.497  Sum_probs=182.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+++.+|+|.+............+.+|++++++++|||++++++++.+.+..|++|||+++++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (254)
T cd06627          11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII   90 (254)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence            78999999999999999999999887666567778999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++..+..++.|++.||.|||++||+||||||+||+++.+   +.++|+|||++........             
T Consensus        91 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~-------------  154 (254)
T cd06627          91 KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD---GVVKLADFGVATKLNDVSK-------------  154 (254)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC---CCEEEeccccceecCCCcc-------------
Confidence            887889999999999999999999999999999999999999753   5699999999754321100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (254)
T cd06627         155 --------------------------------------------------------------------------------  154 (254)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                                   ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+......++........|.
T Consensus       155 -------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (254)
T cd06627         155 -------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPE  221 (254)
T ss_pred             -------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence                         0011247888999999998889999999999999999999999999888766666666555544444


Q ss_pred             c
Q psy2131         321 H  321 (328)
Q Consensus       321 ~  321 (328)
                      .
T Consensus       222 ~  222 (254)
T cd06627         222 G  222 (254)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8e-37  Score=278.10  Aligned_cols=206  Identities=27%  Similarity=0.411  Sum_probs=168.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.++.+|+.||+|++............+.+|+.+|++++||||+++++++..    ....|+||||+. ++|
T Consensus        16 g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l   94 (334)
T cd07855          16 GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDL   94 (334)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhH
Confidence            789999999999999999999998654333445667889999999999999999998863    457899999996 589


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+.+.....+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.+||+|||++.........        
T Consensus        95 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~--------  163 (334)
T cd07855          95 HHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED---CELRIGDFGMARGLSSSPTE--------  163 (334)
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEecccccceeecccCcC--------
Confidence            8888777789999999999999999999999999999999999999754   46999999997543211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                    +                 
T Consensus       164 --------------------------------------------------------------~-----------------  164 (334)
T cd07855         164 --------------------------------------------------------------H-----------------  164 (334)
T ss_pred             --------------------------------------------------------------C-----------------
Confidence                                                                          0                 


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                     ........|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+.+....+..+..
T Consensus       165 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         165 ---------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             ---------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence                           000112358899999999866 5689999999999999999999999999887665554443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.1e-36  Score=267.98  Aligned_cols=199  Identities=27%  Similarity=0.438  Sum_probs=166.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||+|++.... ...+..+.+.+|+.+++.++||||+++++++.+.+..|+||||+.| ++.+.
T Consensus        26 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~  104 (307)
T cd06607          26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDI  104 (307)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHH
Confidence            789999999999999999999997543 3344556788999999999999999999999999999999999975 66666


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.|++.||.|||+.||+||||+|+||+++.+   +.+||+|||++.....              
T Consensus       105 ~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~---~~~kL~dfg~~~~~~~--------------  167 (307)
T cd06607         105 LEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP---GTVKLADFGSASLVSP--------------  167 (307)
T ss_pred             HHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC---CCEEEeecCcceecCC--------------
Confidence            653 4568999999999999999999999999999999999999754   4699999998632110              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (307)
T cd06607         168 --------------------------------------------------------------------------------  167 (307)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      .....|++.|+|||++.   ...++.++|||||||++|||+||++||.+.+.......+..+
T Consensus       168 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~  229 (307)
T cd06607         168 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  229 (307)
T ss_pred             ----------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Confidence                            00124788899999984   456889999999999999999999999998876666555543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.8e-36  Score=263.21  Aligned_cols=206  Identities=22%  Similarity=0.308  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEccC--CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKAT--GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~--~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||++.....  ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+|||||++|+|.+
T Consensus         6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   84 (268)
T cd05086           6 GWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS   84 (268)
T ss_pred             CcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHH
Confidence            89999999975433  3346677665433 23345678899999999999999999999999999999999999999999


Q ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          79 DIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        79 ~l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ++...    ...++..+..++.|++.||+|||+.+++||||||+|||++.+   +.+||+|||++........       
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~---~~~~l~Dfg~~~~~~~~~~-------  154 (268)
T cd05086          85 YLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD---LTVKVGDYGIGPSRYKEDY-------  154 (268)
T ss_pred             HHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---ccEEecccccccccCcchh-------
Confidence            88653    235677788899999999999999999999999999999754   4599999998632100000       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (268)
T cd05086         155 --------------------------------------------------------------------------------  154 (268)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-------CCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHH
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-------EPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRL  306 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~  306 (328)
                                       ........|++.|+|||++..       ..++.++|||||||++|||++ |..||...++...
T Consensus       155 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~  217 (268)
T cd05086         155 -----------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV  217 (268)
T ss_pred             -----------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence                             000112357889999999853       345789999999999999997 5889988888777


Q ss_pred             HHHHhccc
Q psy2131         307 YAQIKAGA  314 (328)
Q Consensus       307 ~~~i~~~~  314 (328)
                      +.++..+.
T Consensus       218 ~~~~~~~~  225 (268)
T cd05086         218 LNHVIKDQ  225 (268)
T ss_pred             HHHHHhhc
Confidence            77665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.5e-36  Score=260.62  Aligned_cols=214  Identities=31%  Similarity=0.528  Sum_probs=186.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+...+..++|+||+++++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (258)
T cd08215          11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI   90 (258)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHH
Confidence            78999999999999999999999877666666778899999999999999999999999999999999999999999988


Q ss_pred             Hhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          81 VAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        81 ~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ...    ..+++.++..++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||++.......          
T Consensus        91 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~----------  157 (258)
T cd08215          91 KKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN---GLVKLGDFGISKVLSSTV----------  157 (258)
T ss_pred             HHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC---CcEEECCccceeecccCc----------
Confidence            764    679999999999999999999999999999999999999753   469999999874321100          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (258)
T cd08215         158 --------------------------------------------------------------------------------  157 (258)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                      .......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..++...+.++...
T Consensus       158 ----------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (258)
T cd08215         158 ----------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP  221 (258)
T ss_pred             ----------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC
Confidence                            0011134889999999999999999999999999999999999999999999999998888876


Q ss_pred             CCCCccc
Q psy2131         317 DEPKHKS  323 (328)
Q Consensus       317 ~~~~~~~  323 (328)
                      ..|..++
T Consensus       222 ~~~~~~~  228 (258)
T cd08215         222 PIPSQYS  228 (258)
T ss_pred             CCCCCCC
Confidence            6665444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.2e-36  Score=269.51  Aligned_cols=201  Identities=25%  Similarity=0.426  Sum_probs=168.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||++.+..++..+|+|++..... ..+....+.+|+++++.++|||++++++++.+++..|+||||+.| +|.+.
T Consensus        36 G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~  114 (317)
T cd06635          36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDL  114 (317)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHH
Confidence            7899999999999999999999975533 334456788999999999999999999999999999999999975 77776


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.|++.||.|||+++|+||||+|+||+++.+   +.+||+|||++.....              
T Consensus       115 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~---~~~kl~dfg~~~~~~~--------------  177 (317)
T cd06635         115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASIASP--------------  177 (317)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC---CCEEEecCCCccccCC--------------
Confidence            654 4568999999999999999999999999999999999999654   4599999998632100              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       178 --------------------------------------------------------------------------------  177 (317)
T cd06635         178 --------------------------------------------------------------------------------  177 (317)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .....|++.|+|||++.   +..++.++|+|||||++|||++|++||.+.+.......+..+..
T Consensus       178 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~  241 (317)
T cd06635         178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  241 (317)
T ss_pred             ----------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC
Confidence                            00124788999999984   45688999999999999999999999999887776666665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-36  Score=275.31  Aligned_cols=201  Identities=31%  Similarity=0.458  Sum_probs=166.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++...      ...|+++|++ |+
T Consensus        28 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~  106 (345)
T cd07877          28 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA  106 (345)
T ss_pred             cCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-cc
Confidence            7899999999999999999999976544444456678899999999999999999988643      3478899887 77


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+. ...+++..+..++.|++.||+|||++||+||||||+||+++.+   +.+||+|||++......         
T Consensus       107 ~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~dfg~~~~~~~~---------  173 (345)
T cd07877         107 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDE---------  173 (345)
T ss_pred             CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---CCEEEeccccccccccc---------
Confidence            8876654 4468999999999999999999999999999999999999754   45999999986432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (345)
T cd07877         174 --------------------------------------------------------------------------------  173 (345)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.+.
T Consensus       174 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         174 --------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             --------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                                011347889999999877 57899999999999999999999999998887777777665


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       234 ~~  235 (345)
T cd07877         234 VG  235 (345)
T ss_pred             hC
Confidence            54

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-36  Score=266.65  Aligned_cols=200  Identities=16%  Similarity=0.211  Sum_probs=160.1

Q ss_pred             CCceEEEEEEEccC------------------------CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEE
Q psy2131           1 GAFSVVRRCVQKAT------------------------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD   56 (328)
Q Consensus         1 G~fg~V~~~~~~~~------------------------~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~   56 (328)
                      |+||.||++....+                        ...+|+|++....  .+....+.+|+.+++.++||||+++++
T Consensus         6 G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv~~~~   83 (274)
T cd05076           6 GTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHG   83 (274)
T ss_pred             ccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            89999999975322                        2458888886432  223456788999999999999999999


Q ss_pred             EEEeCCEEEEEEEccCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC----CCCcE
Q psy2131          57 SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA----KGAAV  131 (328)
Q Consensus        57 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~----~~~~v  131 (328)
                      ++.+....|+|||||++|+|...+.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++..+    ....+
T Consensus        84 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~  163 (274)
T cd05076          84 VCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFI  163 (274)
T ss_pred             EEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcccee
Confidence            99999999999999999999888765 45789999999999999999999999999999999999997542    12348


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      |++|||++.....                                                                   
T Consensus       164 kl~d~g~~~~~~~-------------------------------------------------------------------  176 (274)
T cd05076         164 KLSDPGVSFTALS-------------------------------------------------------------------  176 (274)
T ss_pred             eecCCcccccccc-------------------------------------------------------------------
Confidence            9999998632100                                                                   


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYI  290 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilye  290 (328)
                                                                 .....|++.|+|||.+.+ ..++.++|+|||||++||
T Consensus       177 -------------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e  213 (274)
T cd05076         177 -------------------------------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE  213 (274)
T ss_pred             -------------------------------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence                                                       001136778999999876 568999999999999999


Q ss_pred             H-HhcCCCCCCccHHHHHHHHhc
Q psy2131         291 L-LVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       291 l-ltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      | ++|+.||.+..+.+....+..
T Consensus       214 l~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         214 ICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             HHhCCCCCccccChHHHHHHHHh
Confidence            8 579999998876665444333

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1035|consensus

Probab=100.00  E-value=1.8e-37  Score=301.94  Aligned_cols=222  Identities=30%  Similarity=0.509  Sum_probs=170.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--------------------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--------------------   60 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--------------------   60 (328)
                      ||||.||+|+++-+|+.||||.|.... +.....++.+|+++|++|+|||||++|.+|.+                    
T Consensus       490 GGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQ  568 (1351)
T KOG1035|consen  490 GGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQ  568 (1351)
T ss_pred             CCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcc
Confidence            899999999999999999999998776 66677889999999999999999999876632                    


Q ss_pred             --------------------------------------------------------------------------------
Q psy2131          61 --------------------------------------------------------------------------------   60 (328)
Q Consensus        61 --------------------------------------------------------------------------------   60 (328)
                                                                                                      
T Consensus       569 s~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~es  648 (1351)
T KOG1035|consen  569 SASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSES  648 (1351)
T ss_pred             cCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhh
Confidence                                                                                            


Q ss_pred             -----------C--------CEEEEEEEccCCCCcHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcE
Q psy2131          61 -----------E--------NYHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESVNHCHSNGVVHRDLKPENL  120 (328)
Q Consensus        61 -----------~--------~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~Ni  120 (328)
                                 +        ..+||-||||+..++.+.+...... ..+.++.+++||+.||.|+|++|||||||||.||
T Consensus       649 s~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NI  728 (1351)
T KOG1035|consen  649 SESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNI  728 (1351)
T ss_pred             hhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCccee
Confidence                       0        2469999999986665555444443 4788899999999999999999999999999999


Q ss_pred             EEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHH
Q psy2131         121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN  200 (328)
Q Consensus       121 Ll~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  200 (328)
                      ++++++   .|||+|||+|......                                                  .+.+.
T Consensus       729 FLd~~~---~VKIGDFGLAt~~~~~--------------------------------------------------~~~~d  755 (1351)
T KOG1035|consen  729 FLDSRN---SVKIGDFGLATDLKEN--------------------------------------------------LESID  755 (1351)
T ss_pred             EEcCCC---Ceeecccccchhhhhh--------------------------------------------------hhhHh
Confidence            998544   5999999998652100                                                  00000


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhh-hhhhhhccCCCCCCCccccccCC---CC
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK-VSTRQGFAGTPGYLSPEVLKKEP---YG  276 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~---~~  276 (328)
                      ++.               .+|                        ..+... .....+.+||.-|+|||++.+..   |+
T Consensus       756 ~~~---------------~~~------------------------~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  756 QDL---------------SFS------------------------TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             hcc---------------Ccc------------------------ccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            000               000                        000000 11234568999999999997755   99


Q ss_pred             CCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhcccCCCC
Q psy2131         277 KPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       277 ~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~  318 (328)
                      .|+|+||||||++||+.   ||... ....+++++.+|.+-.+
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~  836 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP  836 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence            99999999999999974   57654 68889999888887333

>KOG1095|consensus

Probab=100.00  E-value=8.9e-37  Score=298.97  Aligned_cols=218  Identities=24%  Similarity=0.377  Sum_probs=182.6

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.-....     ..||||.++.. .+..+...|.+|+.+|+.++|||||++++++.+....+|++|||+|||
T Consensus       703 G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGD  781 (1025)
T KOG1095|consen  703 GAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGD  781 (1025)
T ss_pred             ccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCc
Confidence            899999999765433     24899988753 345667889999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          76 LFEDIVAR-------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        76 L~~~l~~~-------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      |..+|+..       ..++..+...++.||+.|++||++++.|||||-..|+|++.+   ..+||+|||+|+.+...+.+
T Consensus       782 L~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaDFGlArDiy~~~yy  858 (1025)
T KOG1095|consen  782 LLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIADFGLARDIYDKDYY  858 (1025)
T ss_pred             HHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcccchhHhhhhchhe
Confidence            99999865       348899999999999999999999999999999999999865   56999999999854332211


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      ..                                                                          ..  
T Consensus       859 r~--------------------------------------------------------------------------~~--  862 (1025)
T KOG1095|consen  859 RK--------------------------------------------------------------------------HG--  862 (1025)
T ss_pred             ec--------------------------------------------------------------------------cC--
Confidence            00                                                                          00  


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~  307 (328)
                                                .  ..=-..|||||.++...++.++|||||||+|||++| |..||.+.+..+++
T Consensus       863 --------------------------~--a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~  914 (1025)
T KOG1095|consen  863 --------------------------E--AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL  914 (1025)
T ss_pred             --------------------------c--cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence                                      0  000234999999999999999999999999999987 79999999999999


Q ss_pred             HHHhcccCCCCCCccccCc
Q psy2131         308 AQIKAGAYDDEPKHKSASV  326 (328)
Q Consensus       308 ~~i~~~~~~~~~~~~~~~~  326 (328)
                      .-...|-..++|+.|+.++
T Consensus       915 ~~~~~ggRL~~P~~CP~~l  933 (1025)
T KOG1095|consen  915 LDVLEGGRLDPPSYCPEKL  933 (1025)
T ss_pred             HHHHhCCccCCCCCCChHH
Confidence            9666666889999998764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.2e-36  Score=267.14  Aligned_cols=219  Identities=31%  Similarity=0.462  Sum_probs=176.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|.++...... ....+.+|+.+++.++||||+++++++.+.+..|+||||+.+ +|.+.+
T Consensus        17 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l   94 (301)
T cd07873          17 GTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL   94 (301)
T ss_pred             CcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHH
Confidence            789999999999999999999997543221 234567899999999999999999999999999999999974 888877


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC---------------
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------------  144 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~---------------  144 (328)
                      ... ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....               
T Consensus        95 ~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~  171 (301)
T cd07873          95 DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYSNEVVTLWYR  171 (301)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---CcEEECcCcchhccCCCCCcccccceeeccc
Confidence            653 468999999999999999999999999999999999999754   4599999998753210               


Q ss_pred             -------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------------CCCCC------
Q psy2131         145 -------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------------------YDYPS------  185 (328)
Q Consensus       145 -------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~-------------------~~~~~------  185 (328)
                                   ..+.| +|+++|+|++|.+||...+..+....+....                   ..++.      
T Consensus       172 ~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (301)
T cd07873         172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL  251 (301)
T ss_pred             CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccH
Confidence                         01223 7999999999999998877654443332211                   01111      


Q ss_pred             -CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         186 -PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       186 -~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                       .....+++++++++.+||..||.+|||++++++|||+..
T Consensus       252 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         252 HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             012357889999999999999999999999999999954

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.4e-36  Score=261.84  Aligned_cols=219  Identities=34%  Similarity=0.544  Sum_probs=188.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.+|+|++...... ......+.+|++++++++||||+++++.+...+..|++|||+.|++|.+.
T Consensus         4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   83 (265)
T cd05579           4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASL   83 (265)
T ss_pred             CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHH
Confidence            78999999999999999999999765432 34456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC--------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE--------------  145 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~--------------  145 (328)
                      +...+.+++..+..++.|++.||.|||+++++||||+|+||+++.+   +.++|+|||++......              
T Consensus        84 l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          84 LENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccccccccccccC
Confidence            8887789999999999999999999999999999999999999754   45999999986532111              


Q ss_pred             ---------------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         146 ---------------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       146 ---------------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                           .+.| +|++++++++|..||...+.......+..+....+.  ....++.+.+++.+|+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l  238 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLISKLL  238 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc--cccCCHHHHHHHHHHh
Confidence                                 1223 799999999999999888888777777665544332  2336899999999999


Q ss_pred             ccCCCCCCCH---HHHhcCcccCC
Q psy2131         204 TVNPSKRITA---SEALKHPWICQ  224 (328)
Q Consensus       204 ~~~p~~R~t~---~~~l~h~~~~~  224 (328)
                      +.+|.+|||+   .++++|||+..
T Consensus       239 ~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         239 VPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             cCCHhhcCCCccHHHHhcCccccC
Confidence            9999999999   99999999963

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-35  Score=264.00  Aligned_cols=218  Identities=32%  Similarity=0.495  Sum_probs=174.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|+++...........+.+|+.++++++||||+++++++.+++..|+||||+. ++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~   89 (285)
T cd07861          11 GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYL   89 (285)
T ss_pred             cCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHH
Confidence            789999999999999999999997654433344667889999999999999999999999999999999997 5787777


Q ss_pred             Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc--------------
Q psy2131          81 VAR---EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ--------------  143 (328)
Q Consensus        81 ~~~---~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~--------------  143 (328)
                      ...   ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++....              
T Consensus        90 ~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  166 (285)
T cd07861          90 DSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLW  166 (285)
T ss_pred             hcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---CcEEECcccceeecCCCcccccCCccccc
Confidence            542   468999999999999999999999999999999999999754   459999999874321              


Q ss_pred             --------CC------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-------------------------CC
Q psy2131         144 --------GE------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-------------------------DY  183 (328)
Q Consensus       144 --------~~------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-------------------------~~  183 (328)
                              +.      .+.| +|+++++|++|.+||.+.+.......+.....                         ..
T Consensus       167 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (285)
T cd07861         167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGS  246 (285)
T ss_pred             ccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcch
Confidence                    00      1123 79999999999999987655332222111000                         00


Q ss_pred             CCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       184 ~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .......+++++.+++.+||..||.+|||+.++++|||+
T Consensus       247 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         247 LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            001123478999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.6e-36  Score=261.49  Aligned_cols=208  Identities=26%  Similarity=0.405  Sum_probs=173.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+. .+..+|+|.+.......   ..+.+|++++++++||||+++++++......|+||||+++++|.+++
T Consensus        15 g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (256)
T cd05112          15 GQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL   90 (256)
T ss_pred             cccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHH
Confidence            789999999875 46789999987654433   35778999999999999999999999999999999999999999888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||+.+++||||||+||+++.+   +.+||+|||++........            
T Consensus        91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~------------  155 (256)
T cd05112          91 RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN---QVVKVSDFGMTRFVLDDQY------------  155 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC---CeEEECCCcceeecccCcc------------
Confidence            754 468999999999999999999999999999999999999743   4699999998754311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (256)
T cd05112         156 --------------------------------------------------------------------------------  155 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......++..|+|||++.+..++.++|+|||||++|||++ |++||.+.+...+.+.+..+.....
T Consensus       156 -------------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05112         156 -------------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK  222 (256)
T ss_pred             -------------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC
Confidence                         00011235678999999999999999999999999999998 9999999999999999887755444


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       223 ~~  224 (256)
T cd05112         223 PR  224 (256)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=267.80  Aligned_cols=203  Identities=33%  Similarity=0.458  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |++|.||+|.++.+|..||+|++............+.+|+++++.++||||+++++++.+.+..|++|||++ ++|.+++
T Consensus        10 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~   88 (283)
T cd07835          10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYM   88 (283)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHH
Confidence            789999999999999999999998665444444567889999999999999999999999999999999995 5898888


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.|++.||.|||+++++||||+|+||+++.+   +.++|+|||++........           
T Consensus        89 ~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~-----------  154 (283)
T cd07835          89 DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE---GALKLADFGLARAFGVPVR-----------  154 (283)
T ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CcEEEeecccccccCCCcc-----------
Confidence            7655  68999999999999999999999999999999999999763   4699999999743211000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (283)
T cd07835         155 --------------------------------------------------------------------------------  154 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                     ......+++.|+|||++.+. .++.++|+|||||++|+|+||++||.+.+....+.++.+.
T Consensus       155 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  215 (283)
T cd07835         155 ---------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRT  215 (283)
T ss_pred             ---------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                           00011368889999998764 5799999999999999999999999988766665555554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596|consensus

Probab=100.00  E-value=5.4e-37  Score=277.54  Aligned_cols=191  Identities=28%  Similarity=0.440  Sum_probs=156.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      ||-+.||++... ..+.||+|.+.....+.....-+.+|+.+|.+| .|.+||+||++-..++.+|+||||= ..||...
T Consensus       372 GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~ki  449 (677)
T KOG0596|consen  372 GGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKI  449 (677)
T ss_pred             CCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHH
Confidence            788899999764 445678887776666667778899999999999 5999999999999999999999974 4588888


Q ss_pred             HHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~~~-~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      |.++.. .+.-.+++|+.|+++++.++|++||||.||||.|+|+..    |.+||+|||+|..+......          
T Consensus       450 L~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~DTTs----------  515 (677)
T KOG0596|consen  450 LKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPDTTS----------  515 (677)
T ss_pred             HHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCccccc----------
Confidence            877654 333588999999999999999999999999999999974    46999999998665432110          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       516 --------------------------------------------------------------------------------  515 (677)
T KOG0596|consen  516 --------------------------------------------------------------------------------  515 (677)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-----------CCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-----------YGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                    -.+.+-+||+.||+||.+....           .++++||||||||||+|+.|++||..=
T Consensus       516 --------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  516 --------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             --------------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence                          0122336999999999986433           458999999999999999999999743

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-36  Score=267.46  Aligned_cols=202  Identities=32%  Similarity=0.459  Sum_probs=167.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||||+++.... ......+.+|+.++++++||||+++++++.+.+..|+||||+.+ +|.+++
T Consensus        11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   88 (284)
T cd07836          11 GTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM   88 (284)
T ss_pred             CCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHH
Confidence            7899999999999999999999976532 22345667899999999999999999999999999999999986 888877


Q ss_pred             Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          81 VAR---EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        81 ~~~---~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ...   ..+++..+..++.|++.||.|||+.|++||||||+||+++++   +.++|+|||++.......           
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---~~~~l~d~g~~~~~~~~~-----------  154 (284)
T cd07836          89 DTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIPV-----------  154 (284)
T ss_pred             HhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CcEEEeecchhhhhcCCc-----------
Confidence            653   358999999999999999999999999999999999999754   459999999874321000           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (284)
T cd07836         155 --------------------------------------------------------------------------------  154 (284)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                     .......+|+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+...
T Consensus       155 ---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~  216 (284)
T cd07836         155 ---------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI  216 (284)
T ss_pred             ---------------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence                           000112468889999998764 5789999999999999999999999999877777766543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.9e-36  Score=264.80  Aligned_cols=215  Identities=21%  Similarity=0.363  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEcc
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~   71 (328)
                      |+||.||+|...   .+++.+|||++..+.......+.+.+|+++++.++||||+++++++....      ..++++||+
T Consensus        10 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (273)
T cd05074          10 GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM   89 (273)
T ss_pred             CCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecC
Confidence            899999999864   46789999999877666666778899999999999999999999886532      347899999


Q ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          72 TGGELFEDIVAR------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        72 ~gg~L~~~l~~~------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      .+|+|.+++...      ..++...+..++.|++.||+|||+.||+||||||+||+++.+   ..+||+|||++......
T Consensus        90 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~---~~~kl~dfg~~~~~~~~  166 (273)
T cd05074          90 KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN---MTVCVADFGLSKKIYSG  166 (273)
T ss_pred             CCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC---CCEEECcccccccccCC
Confidence            999998776432      247888999999999999999999999999999999999643   45999999987543110


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...                                                                             
T Consensus       167 ~~~-----------------------------------------------------------------------------  169 (273)
T cd05074         167 DYY-----------------------------------------------------------------------------  169 (273)
T ss_pred             cce-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                 .......+++.|++||.+.+..++.++|||||||++|||++ |++||.+.+..
T Consensus       170 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~  222 (273)
T cd05074         170 ---------------------------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS  222 (273)
T ss_pred             ---------------------------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH
Confidence                                       00001124567999999999999999999999999999999 99999999999


Q ss_pred             HHHHHHhcccCCCCCCcc
Q psy2131         305 RLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~  322 (328)
                      .++..+..+.....|+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~  240 (273)
T cd05074         223 EIYNYLIKGNRLKQPPDC  240 (273)
T ss_pred             HHHHHHHcCCcCCCCCCC
Confidence            999888877654444433

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.1e-36  Score=268.46  Aligned_cols=205  Identities=20%  Similarity=0.292  Sum_probs=170.2

Q ss_pred             CCceEEEEEEEccCC----------------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKATG----------------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~~----------------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||.||+|.+..++                ..+|+|.+.... .......+.+|++++++++||||+++++++...+..
T Consensus        16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   94 (296)
T cd05051          16 GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL   94 (296)
T ss_pred             CCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCc
Confidence            899999999877644                558999987543 334567788999999999999999999999999999


Q ss_pred             EEEEEccCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEE
Q psy2131          65 YLVFDLVTGGELFEDIVARE-----------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL  133 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl  133 (328)
                      +++|||+.+++|.+++....           .+++..+..++.|++.||.|||++||+||||||+||+++.+   +.++|
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~---~~~~l  171 (296)
T cd05051          95 CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKI  171 (296)
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCC---CceEE
Confidence            99999999999999887655           68999999999999999999999999999999999999754   56999


Q ss_pred             eeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         134 ADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       134 ~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      +|||++.........                                                                 
T Consensus       172 ~dfg~~~~~~~~~~~-----------------------------------------------------------------  186 (296)
T cd05051         172 ADFGMSRNLYSSDYY-----------------------------------------------------------------  186 (296)
T ss_pred             ccccceeecccCcce-----------------------------------------------------------------
Confidence            999987543111000                                                                 


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV  293 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt  293 (328)
                                                             .......+++.|+|||++.+..++.++|||||||++|||++
T Consensus       187 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  227 (296)
T cd05051         187 ---------------------------------------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT  227 (296)
T ss_pred             ---------------------------------------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence                                                   00011236788999999998889999999999999999998


Q ss_pred             --cCCCCCCccHHHHHHHHhcc
Q psy2131         294 --GYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       294 --G~~Pf~~~~~~~~~~~i~~~  313 (328)
                        |..||...+...++..+...
T Consensus       228 ~~~~~p~~~~~~~~~~~~~~~~  249 (296)
T cd05051         228 LCREQPYEHLTDQQVIENAGHF  249 (296)
T ss_pred             cCCCCCCCCcChHHHHHHHHhc
Confidence              88999888777777776543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-36  Score=263.47  Aligned_cols=202  Identities=26%  Similarity=0.399  Sum_probs=171.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.+|+|.+..... ......+.+|++++++++||||+++++.+...+..|+++||+.+++|.+.+
T Consensus        12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   90 (265)
T cd06605          12 GNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL   90 (265)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHH
Confidence            7899999999999999999999976543 345567889999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+   +.++|+|||++......             
T Consensus        91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~---~~~~l~d~g~~~~~~~~-------------  154 (265)
T cd06605          91 KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR---GQIKLCDFGVSGQLVNS-------------  154 (265)
T ss_pred             HHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC---CCEEEeecccchhhHHH-------------
Confidence            765 789999999999999999999999 999999999999999754   46999999986332000             


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (265)
T cd06605         155 --------------------------------------------------------------------------------  154 (265)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-----cHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~  313 (328)
                                     ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...     ......+.+.++
T Consensus       155 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         155 ---------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             ---------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence                           000135788999999999999999999999999999999999999765     345555555554


Q ss_pred             c
Q psy2131         314 A  314 (328)
Q Consensus       314 ~  314 (328)
                      .
T Consensus       220 ~  220 (265)
T cd06605         220 P  220 (265)
T ss_pred             C
Confidence            3

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.8e-36  Score=267.58  Aligned_cols=191  Identities=31%  Similarity=0.438  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|..||+|++...... .....+.+|+.+++.++|+||+++++++.+.+..|+||||+. ++|.+.+
T Consensus        16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   93 (291)
T cd07870          16 GSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYM   93 (291)
T ss_pred             cCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHH
Confidence            78999999999999999999999754322 222356789999999999999999999999999999999996 5777766


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++........            
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~------------  158 (291)
T cd07870          94 IQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPSQ------------  158 (291)
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---CcEEEeccccccccCCCCC------------
Confidence            54 3567888999999999999999999999999999999999754   4599999998743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (291)
T cd07870         159 --------------------------------------------------------------------------------  158 (291)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                    ......+++.|+|||++.+. .++.++|+|||||++|||+||+.||.+.+
T Consensus       159 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         159 --------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             --------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence                          00112368899999999764 57899999999999999999999998765

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.2e-36  Score=262.16  Aligned_cols=201  Identities=24%  Similarity=0.387  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++ .+|+|.+......   .+.+.+|+++++.++|||++++++++. .+..|++|||+.+++|.+++
T Consensus        17 g~~~~v~~~~~~~~~-~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05069          17 GCFGEVWMGTWNGTT-KVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFL   91 (260)
T ss_pred             cCCCeEEEEEEcCCc-eEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHH
Confidence            789999999876554 6999988754432   345778999999999999999999875 45689999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||+.||+||||||+||+++++   +.++|+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~---~~~~l~dfg~~~~~~~~~~-----------  157 (260)
T cd05069          92 KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN---LVCKIADFGLARLIEDNEY-----------  157 (260)
T ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---CeEEECCCccceEccCCcc-----------
Confidence            653  347899999999999999999999999999999999999754   4599999999754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (260)
T cd05069         158 --------------------------------------------------------------------------------  157 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                    .......++..|+|||++.+..++.++|+|||||++|||+| |.+||.+.+..+....+.++.
T Consensus       158 --------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  220 (260)
T cd05069         158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY  220 (260)
T ss_pred             --------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence                          00001235678999999999999999999999999999999 999999998888888887764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.7e-36  Score=266.26  Aligned_cols=201  Identities=29%  Similarity=0.483  Sum_probs=163.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-----CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE-----NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+++.+|+|++.....   ....+.+|+.+++++ +||||+++++++...     +..|+||||++|+
T Consensus        33 g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~  109 (291)
T cd06639          33 GTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG  109 (291)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCC
Confidence            7899999999999999999999975422   234567899999999 899999999998754     3689999999999


Q ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      +|.+.+..    ...+++..+..++.|++.||+|||+.+|+||||||+||+++.+   +.+||+|||++........   
T Consensus       110 sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~---  183 (291)
T cd06639         110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRL---  183 (291)
T ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEeecccchhcccccc---
Confidence            99887752    3568999999999999999999999999999999999999754   4599999998754311000   


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       184 --------------------------------------------------------------------------------  183 (291)
T cd06639         184 --------------------------------------------------------------------------------  183 (291)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-----CCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-----PYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                             ......|++.|+|||++...     .++.++|+|||||++|||++|++||...++..
T Consensus       184 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         184 -----------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             -----------------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence                                   00112478899999998643     36899999999999999999999999888766


Q ss_pred             HHHHHhcc
Q psy2131         306 LYAQIKAG  313 (328)
Q Consensus       306 ~~~~i~~~  313 (328)
                      ....+.++
T Consensus       241 ~~~~~~~~  248 (291)
T cd06639         241 TLFKIPRN  248 (291)
T ss_pred             HHHHHhcC
Confidence            65565554

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-36  Score=261.65  Aligned_cols=209  Identities=27%  Similarity=0.492  Sum_probs=181.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.++.+++.+|+|.+............+.+|+++++.++|+||+++++++.+....|+||||+++++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (256)
T cd08530          11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI   90 (256)
T ss_pred             CCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHH
Confidence            78999999999999999999999876656666677889999999999999999999999999999999999999998887


Q ss_pred             Hh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          81 VA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        81 ~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+   +.+||+|||++.......          
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~---~~~kl~d~g~~~~~~~~~----------  157 (256)
T cd08530          91 SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN---DLVKIGDLGISKVLKKNM----------  157 (256)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC---CcEEEeeccchhhhccCC----------
Confidence            65    3568999999999999999999999999999999999999764   459999999874321100          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (256)
T cd08530         158 --------------------------------------------------------------------------------  157 (256)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                        .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..++...+..+.+.
T Consensus       158 ------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (256)
T cd08530         158 ------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP  219 (256)
T ss_pred             ------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence                              00123788999999999999999999999999999999999999999999998898888876


Q ss_pred             CCCC
Q psy2131         317 DEPK  320 (328)
Q Consensus       317 ~~~~  320 (328)
                      ..|.
T Consensus       220 ~~~~  223 (256)
T cd08530         220 PIPP  223 (256)
T ss_pred             CCch
Confidence            5544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.6e-36  Score=264.60  Aligned_cols=189  Identities=25%  Similarity=0.373  Sum_probs=154.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.++.+|+.||||+++........ ..+..|+.+ ++.++||||+++++++...+..|++|||++ |+|.+.
T Consensus        12 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~   89 (283)
T cd06617          12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKF   89 (283)
T ss_pred             cCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHH
Confidence            89999999999999999999999866444333 344556665 667799999999999999999999999997 577666


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +..    ...+++..+..++.|++.||.|||++ +++||||||+|||++.+   +.+||+|||++.......        
T Consensus        90 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~--------  158 (283)
T cd06617          90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN---GQVKLCDFGISGYLVDSV--------  158 (283)
T ss_pred             HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeeccccccccccc--------
Confidence            643    24689999999999999999999997 99999999999999754   469999999874321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (283)
T cd06617         159 --------------------------------------------------------------------------------  158 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc----CCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK----EPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                         ......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||...
T Consensus       159 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         159 -------------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             -------------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence                               0011247889999999865    56789999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-35  Score=259.19  Aligned_cols=217  Identities=26%  Similarity=0.403  Sum_probs=179.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+ .+|+.+|+|.+......    .+....+.+|++++++++|+||+++++++.+.+..|++|||++|++|
T Consensus        11 g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (265)
T cd06631          11 GAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSI   89 (265)
T ss_pred             cCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcH
Confidence            79999999976 58899999998754322    23345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc-------------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------  143 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~-------------  143 (328)
                      .+++.....+++..+..++.|++.||.|||+.+|+|+||||+||+++++   +.++|+|||++....             
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~  166 (265)
T cd06631          90 SSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLK  166 (265)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC---CeEEeccchhhHhhhhcccccccccccc
Confidence            9999887889999999999999999999999999999999999999754   469999999875421             


Q ss_pred             --------------------CCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHh
Q psy2131         144 --------------------GEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM  202 (328)
Q Consensus       144 --------------------~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  202 (328)
                                          ...+.| +|++++++++|.+||...+.......+.......+ ......+.++.+++.+|
T Consensus       167 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~  245 (265)
T cd06631         167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAAIDFVTSC  245 (265)
T ss_pred             ccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCCCHHHHHHHHHH
Confidence                                001223 79999999999999987665544444433322222 12345789999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q psy2131         203 LTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~  222 (328)
                      |..+|.+||++.+++.|||+
T Consensus       246 l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         246 LTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             hcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=260.21  Aligned_cols=209  Identities=40%  Similarity=0.676  Sum_probs=180.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.+|+|+++..... ......+.+|+.++++++||||+++++.+...+..|+||||+.+++|.++
T Consensus         4 G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   83 (250)
T cd05123           4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH   83 (250)
T ss_pred             CCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHH
Confidence            89999999999999999999999765433 23456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||+.+++|+||||+||+++.+   +.++|+|||++.......             
T Consensus        84 l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~-------------  147 (250)
T cd05123          84 LSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEG-------------  147 (250)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---CcEEEeecCcceecccCC-------------
Confidence            9888789999999999999999999999999999999999999754   469999999874431100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       148 --------------------------------------------------------------------------------  147 (250)
T cd05123         148 --------------------------------------------------------------------------------  147 (250)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+...+...+.++....+
T Consensus       148 -------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  213 (250)
T cd05123         148 -------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP  213 (250)
T ss_pred             -------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                         001123478899999999998899999999999999999999999999998888888888665433

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7e-36  Score=264.98  Aligned_cols=211  Identities=21%  Similarity=0.304  Sum_probs=172.9

Q ss_pred             CCceEEEEEEEcc----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..    ++..+|+|.+... ........+.+|+.++++++||||+++++++.. ....++++||+.+++
T Consensus        17 g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~   95 (280)
T cd05043          17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGN   95 (280)
T ss_pred             cCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCc
Confidence            7999999999876    3688999988643 345556778899999999999999999998765 577899999999999


Q ss_pred             cHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCc
Q psy2131          76 LFEDIVAR--------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus        76 L~~~l~~~--------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~  147 (328)
                      |.+++...        ..+++.++..++.|++.||+|||+++++||||||+||+++.+   +.+||+|||+++.+.....
T Consensus        96 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kl~d~g~~~~~~~~~~  172 (280)
T cd05043          96 LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE---LQVKITDNALSRDLFPMDY  172 (280)
T ss_pred             HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC---CcEEECCCCCcccccCCce
Confidence            99888653        358899999999999999999999999999999999999754   5699999999864321100


Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                      .                                                                               
T Consensus       173 ~-------------------------------------------------------------------------------  173 (280)
T cd05043         173 H-------------------------------------------------------------------------------  173 (280)
T ss_pred             E-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             chhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHH
Q psy2131         228 VASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRL  306 (328)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~  306 (328)
                                               .......++..|+|||++.+..++.++|||||||++||+++ |++||.+.++.++
T Consensus       174 -------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  228 (280)
T cd05043         174 -------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM  228 (280)
T ss_pred             -------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence                                     00001124667999999999999999999999999999999 9999999999999


Q ss_pred             HHHHhcccCCCCC
Q psy2131         307 YAQIKAGAYDDEP  319 (328)
Q Consensus       307 ~~~i~~~~~~~~~  319 (328)
                      ...+..+.....+
T Consensus       229 ~~~~~~~~~~~~~  241 (280)
T cd05043         229 AAYLKDGYRLAQP  241 (280)
T ss_pred             HHHHHcCCCCCCC
Confidence            8888887543333

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-36  Score=268.70  Aligned_cols=202  Identities=21%  Similarity=0.324  Sum_probs=163.9

Q ss_pred             CCceEEEEEEEccCC--------------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q psy2131           1 GAFSVVRRCVQKATG--------------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYL   66 (328)
Q Consensus         1 G~fg~V~~~~~~~~~--------------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l   66 (328)
                      |+||.||+|++..++              ..||+|.++... .......+.+|++++++++|+||+++++++...+..|+
T Consensus        16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l   94 (295)
T cd05097          16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCM   94 (295)
T ss_pred             CCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEE
Confidence            899999999876433              358999997543 34455678899999999999999999999999999999


Q ss_pred             EEEccCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEe
Q psy2131          67 VFDLVTGGELFEDIVARE------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA  134 (328)
Q Consensus        67 v~E~~~gg~L~~~l~~~~------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~  134 (328)
                      |||||.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+|||++.+   +.+||+
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~---~~~kl~  171 (295)
T cd05097          95 ITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH---YTIKIA  171 (295)
T ss_pred             EEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCC---CcEEec
Confidence            999999999998885432            36788889999999999999999999999999999999753   459999


Q ss_pred             eccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         135 DFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       135 DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                      |||++.........                                                                  
T Consensus       172 dfg~~~~~~~~~~~------------------------------------------------------------------  185 (295)
T cd05097         172 DFGMSRNLYSGDYY------------------------------------------------------------------  185 (295)
T ss_pred             ccccccccccCcce------------------------------------------------------------------
Confidence            99987542110000                                                                  


Q ss_pred             HHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-
Q psy2131         215 EALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-  293 (328)
Q Consensus       215 ~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-  293 (328)
                                                            .......+++.|+|||++.+..++.++|+|||||++|||++ 
T Consensus       186 --------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         186 --------------------------------------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             --------------------------------------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence                                                  00011235778999999999999999999999999999988 


Q ss_pred             -cCCCCCCccHHHHHHHH
Q psy2131         294 -GYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       294 -G~~Pf~~~~~~~~~~~i  310 (328)
                       |..||...+.......+
T Consensus       228 ~~~~p~~~~~~~~~~~~~  245 (295)
T cd05097         228 CKEQPYSLLSDEQVIENT  245 (295)
T ss_pred             CCCCCCcccChHHHHHHH
Confidence             78899987766665554

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-36  Score=262.78  Aligned_cols=182  Identities=27%  Similarity=0.354  Sum_probs=155.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.||.||+|+++.+|+.||+|.+....       ...+|...+....||||+++++++.+.+..|+||||++||+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999999999999999997542       1234555555667999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+||+++.+   +.++++|||++......               
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~---------------  138 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDS---------------  138 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEecccchhccccc---------------
Confidence            887789999999999999999999999999999999999999754   45999999975332110               


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       139 --------------------------------------------------------------------------------  138 (237)
T cd05576         139 --------------------------------------------------------------------------------  138 (237)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                    ..+..+++.|+|||++.+.+++.++|+||+||++|||++|+.||...
T Consensus       139 --------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         139 --------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             --------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence                          00123567799999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-36  Score=262.60  Aligned_cols=196  Identities=19%  Similarity=0.262  Sum_probs=157.8

Q ss_pred             CCceEEEEEEEcc------------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q psy2131           1 GAFSVVRRCVQKA------------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVF   68 (328)
Q Consensus         1 G~fg~V~~~~~~~------------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~   68 (328)
                      |+||.||+|....            ....+|+|++....  .+....+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   83 (262)
T cd05077           6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVE   83 (262)
T ss_pred             CCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEE
Confidence            8999999997532            23358888876532  233456788999999999999999999999999999999


Q ss_pred             EccCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC----CCcEEEeecccccccc
Q psy2131          69 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK----GAAVKLADFGLAIEVQ  143 (328)
Q Consensus        69 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~----~~~vkl~DfGla~~~~  143 (328)
                      ||+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.    ...+|++|||++....
T Consensus        84 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~  163 (262)
T cd05077          84 EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL  163 (262)
T ss_pred             ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc
Confidence            999999997777643 56899999999999999999999999999999999999975432    1238999999863220


Q ss_pred             CCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         144 GEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       144 ~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      .                                                                               
T Consensus       164 ~-------------------------------------------------------------------------------  164 (262)
T cd05077         164 S-------------------------------------------------------------------------------  164 (262)
T ss_pred             C-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             CcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHH-hcCCCCCCc
Q psy2131         224 QRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILL-VGYPPFWDE  301 (328)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyell-tG~~Pf~~~  301 (328)
                                                     .....|+..|+|||.+. +..++.++|||||||++|||+ +|..||.+.
T Consensus       165 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         165 -------------------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             -------------------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence                                           01124788899999987 567899999999999999997 699999887


Q ss_pred             cHHHHHH
Q psy2131         302 DQHRLYA  308 (328)
Q Consensus       302 ~~~~~~~  308 (328)
                      ...+...
T Consensus       214 ~~~~~~~  220 (262)
T cd05077         214 TLAEKER  220 (262)
T ss_pred             chhHHHH
Confidence            6555443

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.7e-36  Score=264.96  Aligned_cols=200  Identities=27%  Similarity=0.465  Sum_probs=163.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe------CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE------ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~------~~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..+++.+|+|++....   .....+.+|+.+++++ +|+||+++++++..      .+..|++||||.+
T Consensus        27 g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~  103 (282)
T cd06636          27 GTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGA  103 (282)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCC
Confidence            799999999999999999999986542   3345678899999998 79999999999853      4678999999999


Q ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          74 GELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        74 g~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      |+|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.++|+|||++.......     
T Consensus       104 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~---~~~~l~dfg~~~~~~~~~-----  175 (282)
T cd06636         104 GSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTV-----  175 (282)
T ss_pred             CcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCcchhhhhccc-----
Confidence            9999888653  358888899999999999999999999999999999999754   459999999874321000     


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (282)
T cd06636         176 --------------------------------------------------------------------------------  175 (282)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                           .......|++.|+|||++.     +..|+.++|+|||||++|||++|++||.+..+...
T Consensus       176 ---------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         176 ---------------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             ---------------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence                                 0011235899999999986     45688899999999999999999999988776555


Q ss_pred             HHHHhc
Q psy2131         307 YAQIKA  312 (328)
Q Consensus       307 ~~~i~~  312 (328)
                      ...+..
T Consensus       235 ~~~~~~  240 (282)
T cd06636         235 LFLIPR  240 (282)
T ss_pred             hhhHhh
Confidence            444433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7e-36  Score=267.27  Aligned_cols=202  Identities=21%  Similarity=0.325  Sum_probs=162.9

Q ss_pred             CCceEEEEEEEcc----------------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKA----------------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~----------------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||.||+|.+..                ++..+|+|++.... .......+.+|+++++.++|+||+++++++.+.+..
T Consensus        16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~   94 (296)
T cd05095          16 GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL   94 (296)
T ss_pred             CCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            8999999986432                34579999987542 334456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEE
Q psy2131          65 YLVFDLVTGGELFEDIVARE-----------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL  133 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl  133 (328)
                      |+||||+.+|+|.+++....           .+++.++..++.|++.||+|||+.||+||||||+|||++.+   +.++|
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~---~~~~l  171 (296)
T cd05095          95 CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN---YTIKI  171 (296)
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCC---CCEEe
Confidence            99999999999998886542           36677899999999999999999999999999999999753   46999


Q ss_pred             eeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         134 ADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       134 ~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      +|||++.........                                                                 
T Consensus       172 ~dfg~~~~~~~~~~~-----------------------------------------------------------------  186 (296)
T cd05095         172 ADFGMSRNLYSGDYY-----------------------------------------------------------------  186 (296)
T ss_pred             ccCcccccccCCcce-----------------------------------------------------------------
Confidence            999997543111000                                                                 


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV  293 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt  293 (328)
                                                             .......+++.|+|||+..+..++.++|+|||||++|||+|
T Consensus       187 ---------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~  227 (296)
T cd05095         187 ---------------------------------------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT  227 (296)
T ss_pred             ---------------------------------------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence                                                   00001124678999999988899999999999999999998


Q ss_pred             --cCCCCCCccHHHHHHHH
Q psy2131         294 --GYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       294 --G~~Pf~~~~~~~~~~~i  310 (328)
                        |..||...+..+...+.
T Consensus       228 ~~~~~p~~~~~~~~~~~~~  246 (296)
T cd05095         228 LCKEQPYSQLSDEQVIENT  246 (296)
T ss_pred             hCCCCCccccChHHHHHHH
Confidence              88999888766655543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.8e-35  Score=257.64  Aligned_cols=218  Identities=29%  Similarity=0.520  Sum_probs=183.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.+|+|+++.........+.+.+|+.+++.++|+||+++++.+.+.+..++|+||+++++|.+.+
T Consensus        11 G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   90 (264)
T cd06626          11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL   90 (264)
T ss_pred             CCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHH
Confidence            89999999999999999999999877655556788999999999999999999999999999999999999999999998


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                      .....+++..+..++.|++.||.|||+.||+|+||+|+||+++.+   +.+||+|||++.....                
T Consensus        91 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T cd06626          91 EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP  167 (264)
T ss_pred             hhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEcccccccccCCCCCcccccccCCcCCc
Confidence            887779999999999999999999999999999999999999753   4699999998754210                


Q ss_pred             ------------------CCcch-HHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcc
Q psy2131         145 ------------------EQQAW-FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       145 ------------------~~~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~  204 (328)
                                        ..+.| +|++++++++|..||...+. ......+.. ......+.+...++...+++.+|++
T Consensus       168 ~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~  246 (264)
T cd06626         168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLE  246 (264)
T ss_pred             CccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHHHHHHHHHHcc
Confidence                              01223 79999999999999976532 233223322 2222334445668999999999999


Q ss_pred             cCCCCCCCHHHHhcCccc
Q psy2131         205 VNPSKRITASEALKHPWI  222 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~  222 (328)
                      .+|.+|||+.+++.|||+
T Consensus       247 ~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         247 SDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-35  Score=264.43  Aligned_cols=193  Identities=27%  Similarity=0.358  Sum_probs=156.2

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg   74 (328)
                      |+||+||++.    ...++..+|+|+++... .......+.+|+++|+.++||||+++++++...  ..+|++|||++++
T Consensus        15 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~   93 (283)
T cd05080          15 GHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG   93 (283)
T ss_pred             CCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCC
Confidence            8999998764    44678899999997543 233456678999999999999999999988653  4689999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+++.. ..+++.++..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........      
T Consensus        94 ~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~------  163 (283)
T cd05080          94 SLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEY------  163 (283)
T ss_pred             CHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC---CcEEEeecccccccCCcchh------
Confidence            99888865 459999999999999999999999999999999999999754   46999999997543211000      


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (283)
T cd05080         164 --------------------------------------------------------------------------------  163 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                       ........++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       164 -----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         164 -----------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             -----------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence                             00000112466799999999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=266.24  Aligned_cols=219  Identities=32%  Similarity=0.521  Sum_probs=186.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.+|+|.+....... .....+.+|+++++.++||||+++++.+.+....|+||||+.|++|.++
T Consensus        12 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   91 (316)
T cd05574          12 GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRL   91 (316)
T ss_pred             CccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHH
Confidence            789999999999999999999998765443 3456788999999999999999999999999999999999999999998


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      +...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.+   +.++|+|||++.....             
T Consensus        92 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  168 (316)
T cd05574          92 LQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---GHIMLSDFDLSKQSDVEPPPVSKALRKGS  168 (316)
T ss_pred             HHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---CCEEEeecchhhccccccccccccccccc
Confidence            8653  468999999999999999999999999999999999999754   4599999998653210             


Q ss_pred             -------------------------------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC
Q psy2131         145 -------------------------------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGA  180 (328)
Q Consensus       145 -------------------------------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~  180 (328)
                                                                 ..+.| +|+++|+|++|..||.+.+....+..+....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (316)
T cd05574         169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE  248 (316)
T ss_pred             ccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC
Confidence                                                       01223 7999999999999998888777666665544


Q ss_pred             CCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccCC
Q psy2131         181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT----ASEALKHPWICQ  224 (328)
Q Consensus       181 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t----~~~~l~h~~~~~  224 (328)
                      ..++.  ....++++++++.+||..||.+|||    +.++++|||+.+
T Consensus       249 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         249 VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            44332  2337899999999999999999999    999999999965

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.9e-36  Score=266.25  Aligned_cols=201  Identities=29%  Similarity=0.549  Sum_probs=169.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++..+.+|+.+|||++....  ......+.+|+.+++.++|+||+++++.+...+..|+||||+++++|.+.+
T Consensus        31 g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  108 (292)
T cd06657          31 GSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV  108 (292)
T ss_pred             CCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHH
Confidence            789999999999999999999986432  234456889999999999999999999999999999999999999998765


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . ...+++..+..++.|++.||+|||++|++|+||||+||+++.+   +.++|+|||++........             
T Consensus       109 ~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~~-------------  171 (292)
T cd06657         109 T-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVP-------------  171 (292)
T ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEcccccceecccccc-------------
Confidence            4 4568999999999999999999999999999999999999754   4599999998643211000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (292)
T cd06657         172 --------------------------------------------------------------------------------  171 (292)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   ......||+.|+|||.+.+..++.++|+||+||++|+|++|++||.+.+.......+..+
T Consensus       172 -------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~  231 (292)
T cd06657         172 -------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN  231 (292)
T ss_pred             -------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Confidence                         001134789999999999889999999999999999999999999998877766666544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-35  Score=260.48  Aligned_cols=206  Identities=21%  Similarity=0.387  Sum_probs=169.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+. .+..+|+|.+....   ...+.+.+|+++++.++|+||+++++.+.+ ...|++|||+++++|.+++
T Consensus        17 g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05073          17 GQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL   91 (260)
T ss_pred             ccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHH
Confidence            799999999764 55679999887532   234568889999999999999999999888 7789999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..++...+..++.|++.||.|||+.|++||||||+||+++..   +.+||+|||++........           
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~-----------  157 (260)
T cd05073          92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEY-----------  157 (260)
T ss_pred             HhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC---CcEEECCCcceeeccCCCc-----------
Confidence            753  357888899999999999999999999999999999999654   4699999998754311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (260)
T cd05073         158 --------------------------------------------------------------------------------  157 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......++..|+|||++.+..++.++|+|||||++|+|+| |.+||.+.+...+...+.++...+
T Consensus       158 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05073         158 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP  223 (260)
T ss_pred             --------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence                          00001125677999999999899999999999999999999 999999999888888888875443


Q ss_pred             CC
Q psy2131         318 EP  319 (328)
Q Consensus       318 ~~  319 (328)
                      .|
T Consensus       224 ~~  225 (260)
T cd05073         224 RP  225 (260)
T ss_pred             Cc
Confidence            33

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.8e-36  Score=263.88  Aligned_cols=207  Identities=24%  Similarity=0.392  Sum_probs=171.8

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+.+.     +...+|+|.+.... .......+.+|++++++++|+||+++++++.+.+..|+||||+++|+
T Consensus        16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   94 (275)
T cd05046          16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD   94 (275)
T ss_pred             cceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCc
Confidence            8999999999754     34679999886543 22345678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          76 LFEDIVARE---------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        76 L~~~l~~~~---------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      |.+++....         .+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.++++|||++.......
T Consensus        95 L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~~~~~~~~~~~~~  171 (275)
T cd05046          95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---REVKVSLLSLSKDVYNSE  171 (275)
T ss_pred             HHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC---CcEEEcccccccccCccc
Confidence            999987655         68999999999999999999999999999999999999764   459999999864321100


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .                                                                               
T Consensus       172 ~-------------------------------------------------------------------------------  172 (275)
T cd05046         172 Y-------------------------------------------------------------------------------  172 (275)
T ss_pred             c-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                                .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus       173 --------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~  226 (275)
T cd05046         173 --------------------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE  226 (275)
T ss_pred             --------------------------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence                                      00011235777999999998889999999999999999999 899999888888


Q ss_pred             HHHHHhcccCC
Q psy2131         306 LYAQIKAGAYD  316 (328)
Q Consensus       306 ~~~~i~~~~~~  316 (328)
                      ....++.+...
T Consensus       227 ~~~~~~~~~~~  237 (275)
T cd05046         227 VLNRLQAGKLE  237 (275)
T ss_pred             HHHHHHcCCcC
Confidence            88888877653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.4e-36  Score=272.04  Aligned_cols=211  Identities=22%  Similarity=0.371  Sum_probs=164.2

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe-CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE-ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~-~~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+     ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++.. ...++++||||++
T Consensus        18 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~   96 (343)
T cd05103          18 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF   96 (343)
T ss_pred             CccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCC
Confidence            89999999984     3567899999997543 234456788999999999 68999999998765 4568999999999


Q ss_pred             CCcHHHHHhc-------------------------------------------------------------------CCC
Q psy2131          74 GELFEDIVAR-------------------------------------------------------------------EFY   86 (328)
Q Consensus        74 g~L~~~l~~~-------------------------------------------------------------------~~~   86 (328)
                      |+|.+++...                                                                   ..+
T Consensus        97 g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (343)
T cd05103          97 GNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVL  176 (343)
T ss_pred             CcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccC
Confidence            9999888642                                                                   135


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCC
Q psy2131          87 SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWD  166 (328)
Q Consensus        87 ~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~  166 (328)
                      +...+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++.........                  
T Consensus       177 ~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~------------------  235 (343)
T cd05103         177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDY------------------  235 (343)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC---CcEEEEecccccccccCcch------------------
Confidence            677788899999999999999999999999999999754   46999999997543110000                  


Q ss_pred             CcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHH
Q psy2131         167 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNA  246 (328)
Q Consensus       167 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (328)
                                                                                                      
T Consensus       236 --------------------------------------------------------------------------------  235 (343)
T cd05103         236 --------------------------------------------------------------------------------  235 (343)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCcc-HHHHHHHHhcccCCCCC
Q psy2131         247 RRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDED-QHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       247 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~  319 (328)
                            .......+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.. .......+..+.....|
T Consensus       236 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (343)
T cd05103         236 ------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP  304 (343)
T ss_pred             ------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC
Confidence                  00001235678999999999999999999999999999997 999998765 33444555555543333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=272.75  Aligned_cols=202  Identities=33%  Similarity=0.497  Sum_probs=161.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.+..+|+.||+|+++... .......+.+|+.++++++||||+++++++...     ...|++|||+.+ +
T Consensus        16 G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~   93 (336)
T cd07849          16 GAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-D   93 (336)
T ss_pred             cCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-C
Confidence            789999999999999999999996432 122345677899999999999999999887644     358999999975 7


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+ ....+++..+..++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++.........       
T Consensus        94 l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~-------  162 (336)
T cd07849          94 LYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDH-------  162 (336)
T ss_pred             HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---CCEEECcccceeeccccccc-------
Confidence            77666 44579999999999999999999999999999999999999754   45999999997543110000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (336)
T cd07849         163 --------------------------------------------------------------------------------  162 (336)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                      ........||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+....+..+.
T Consensus       163 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~  223 (336)
T cd07849         163 ----------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL  223 (336)
T ss_pred             ----------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                            000112358999999998755 568999999999999999999999999887655554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0662|consensus

Probab=100.00  E-value=3.5e-36  Score=237.38  Aligned_cols=220  Identities=29%  Similarity=0.418  Sum_probs=177.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+++.||+|.++.+.-.+-.-....||+-+|+.++|.|||+++++.-.++.+-+|+|||.. +|..+.
T Consensus        13 gtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyf   91 (292)
T KOG0662|consen   13 GTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF   91 (292)
T ss_pred             CcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHH
Confidence            8999999999999999999999987654433345678999999999999999999999999999999999965 676665


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC--------------
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE--------------  145 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~--------------  145 (328)
                      .. .+.++.+.++.++.|++.||.|+|++++.|||+||.|+||+.+   +.+|++|||+++.+.-.              
T Consensus        92 dslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n---gelkladfglarafgipvrcysaevvtlwyr  168 (292)
T KOG0662|consen   92 DSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN---GELKLADFGLARAFGIPVRCYSAEVVTLWYR  168 (292)
T ss_pred             HhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC---CcEEecccchhhhcCCceEeeeceeeeeecc
Confidence            44 5679999999999999999999999999999999999999755   55999999998743211              


Q ss_pred             ---------------CcchHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCC---------------------CCc
Q psy2131         146 ---------------QQAWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPS---------------------PEW  188 (328)
Q Consensus       146 ---------------~~~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------~~~  188 (328)
                                     +.+..|||+.++.. |.|.|.+.+-.+....|...-.....                     ..|
T Consensus       169 ppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw  248 (292)
T KOG0662|consen  169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW  248 (292)
T ss_pred             CcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH
Confidence                           11226999999875 77888888776666655432111110                     111


Q ss_pred             ----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         189 ----DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       189 ----~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                          +.++...+++++++|..+|.+|++++.++.|||+..
T Consensus       249 sqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  249 SQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             HHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                245677899999999999999999999999999864

>KOG0196|consensus

Probab=100.00  E-value=3.3e-37  Score=288.32  Aligned_cols=218  Identities=22%  Similarity=0.399  Sum_probs=187.8

Q ss_pred             CCceEEEEEEEccCC---cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~---~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |.||+|++++.+..|   ..||||.++. ..++++...|+.|+.||.+++||||++|.++......+.||+|||++|+|.
T Consensus       640 GEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLD  718 (996)
T KOG0196|consen  640 GEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLD  718 (996)
T ss_pred             ccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHH
Confidence            789999999988777   4599999975 456777888999999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+|..+ +.|...+...+++.|+.|++||-++|.|||||-..|||+++   +...|++||||++.+.++....     |.
T Consensus       719 sFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs---nLvCKVsDFGLSRvledd~~~~-----yt  790 (996)
T KOG0196|consen  719 SFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAA-----YT  790 (996)
T ss_pred             HHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc---ceEEEeccccceeecccCCCcc-----cc
Confidence            999764 56888899999999999999999999999999999999975   4679999999998664332100     00


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                      -..|+                                                                           
T Consensus       791 t~GGK---------------------------------------------------------------------------  795 (996)
T KOG0196|consen  791 TLGGK---------------------------------------------------------------------------  795 (996)
T ss_pred             ccCCc---------------------------------------------------------------------------
Confidence            00011                                                                           


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHH-HHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYI-LLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilye-lltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                             -...|.|||.|..+.++.+|||||+||+||| |-.|..||++...+++.+.|..|..
T Consensus       796 -----------------------IPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR  852 (996)
T KOG0196|consen  796 -----------------------IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR  852 (996)
T ss_pred             -----------------------cceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC
Confidence                                   1234899999999999999999999999997 6679999999999999999999999


Q ss_pred             CCCCCccccC
Q psy2131         316 DDEPKHKSAS  325 (328)
Q Consensus       316 ~~~~~~~~~~  325 (328)
                      .|||.+|++.
T Consensus       853 LPpPmDCP~a  862 (996)
T KOG0196|consen  853 LPPPMDCPAA  862 (996)
T ss_pred             CCCCCCCcHH
Confidence            9999999864

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-35  Score=262.93  Aligned_cols=199  Identities=33%  Similarity=0.534  Sum_probs=164.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE--NYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+++.+|+|+++......... ...+|+.+++++. |+||+++++++.+.  +.+|+||||+++ +|.
T Consensus        10 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~   87 (282)
T cd07831          10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLY   87 (282)
T ss_pred             cccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHH
Confidence            789999999999999999999987654333222 3457899999885 99999999999987  889999999975 888


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +.+... ..+++.++..++.|++.||.|||+.|++||||||+||+++.    +.+||+|||++.......          
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~----------  153 (282)
T cd07831          88 ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP----------  153 (282)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC----------
Confidence            887653 57899999999999999999999999999999999999975    569999999875431100          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (282)
T cd07831         154 --------------------------------------------------------------------------------  153 (282)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       ......||+.|+|||++.. ..++.++|+||+||++|||++|++||.+.++.+.+..+..
T Consensus       154 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~  213 (282)
T cd07831         154 -----------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD  213 (282)
T ss_pred             -----------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence                             0001247889999998754 4568999999999999999999999999888777666654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-35  Score=258.91  Aligned_cols=201  Identities=26%  Similarity=0.400  Sum_probs=167.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.  .+++.+|+|.++...    ....+.+|+.+++.++||||+++++++... ..|++|||+.+++|.+++
T Consensus        17 g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l   89 (254)
T cd05083          17 GEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL   89 (254)
T ss_pred             CCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHH
Confidence            7999999985  478899999986532    235678899999999999999999998765 479999999999999998


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++..+..++.|++.||.|||+.|++||||||+||+++.+   +.+||+|||++......             
T Consensus        90 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---~~~kl~Dfg~~~~~~~~-------------  153 (254)
T cd05083          90 RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---GVAKVSDFGLARVGSMG-------------  153 (254)
T ss_pred             HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CcEEECCCccceecccc-------------
Confidence            7643  57899999999999999999999999999999999999654   46999999987432100             


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (254)
T cd05083         154 --------------------------------------------------------------------------------  153 (254)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                      ......+..|+|||++.+..++.++|+|||||++|||++ |++||.+.+..++...+.++....
T Consensus       154 ----------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (254)
T cd05083         154 ----------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME  217 (254)
T ss_pred             ----------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC
Confidence                            000113456999999999999999999999999999998 999999999989999988885544


Q ss_pred             CCC
Q psy2131         318 EPK  320 (328)
Q Consensus       318 ~~~  320 (328)
                      +|.
T Consensus       218 ~~~  220 (254)
T cd05083         218 PPE  220 (254)
T ss_pred             CCC
Confidence            443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-35  Score=262.70  Aligned_cols=192  Identities=27%  Similarity=0.404  Sum_probs=157.9

Q ss_pred             CCceEEEEEEE----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ----KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg   74 (328)
                      |+||.||+|..    ..++..+|+|.++... .......+.+|+++++.++||||+++++++.+.  ...|+||||++|+
T Consensus        15 g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~   93 (284)
T cd05079          15 GHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG   93 (284)
T ss_pred             CCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCC
Confidence            89999999973    5678899999987543 234456789999999999999999999998875  6789999999999


Q ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++... ..+++.++..++.|++.||+|||++|++||||||+|||++.+   +.+||+|||++..+......     
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~~l~dfg~~~~~~~~~~~-----  165 (284)
T cd05079          94 SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEY-----  165 (284)
T ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC---CCEEECCCccccccccCccc-----
Confidence            999988654 358999999999999999999999999999999999999753   46999999997543211000     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (284)
T cd05079         166 --------------------------------------------------------------------------------  165 (284)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                        ........|+..|+|||++.+..++.++|+|||||++|||+||+.|+.
T Consensus       166 ------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         166 ------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             ------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence                              000011336778999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.1e-36  Score=264.67  Aligned_cols=218  Identities=29%  Similarity=0.433  Sum_probs=172.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|+++.+|+.+|+|.++...........+.+|+.++++++||||+++++++.+.+..|+|+||+.+ +|.+.+
T Consensus        11 g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   89 (284)
T cd07839          11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF   89 (284)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHH
Confidence            7899999999999999999999976543333345677899999999999999999999999999999999975 787777


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC---------------
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------------  144 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~---------------  144 (328)
                      .. ...+++..+..++.||+.||.|||+++|+||||||+||+++.+   +.+||+|||++.....               
T Consensus        90 ~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~  166 (284)
T cd07839          90 DSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVRCYSAEVVTLWYR  166 (284)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---CcEEECccchhhccCCCCCCcCCCccccCCc
Confidence            54 4679999999999999999999999999999999999999754   4599999998753210               


Q ss_pred             -------------CCcch-HHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCC--------------CC---CCC-------
Q psy2131         145 -------------EQQAW-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGA--------------YD---YPS-------  185 (328)
Q Consensus       145 -------------~~~~~-~G~~~~~~~~g~~pf~~-~~~~~~~~~i~~~~--------------~~---~~~-------  185 (328)
                                   ..+.| +|+++|+|++|..|+.. .+.......+....              ..   ++.       
T Consensus       167 aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd07839         167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSL  246 (284)
T ss_pred             ChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchh
Confidence                         01223 79999999998888643 33333333322110              00   000       


Q ss_pred             -CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         186 -PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       186 -~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                       .....+++++++++.+||..||.+|||++++++|||+
T Consensus       247 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         247 VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             1123578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-35  Score=259.15  Aligned_cols=220  Identities=25%  Similarity=0.384  Sum_probs=178.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||++.+..+++.+|+|++......    .+..+.+.+|++++++++|+||+++++++.+.+..++||||+.|++|
T Consensus        11 g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L   90 (268)
T cd06630          11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV   90 (268)
T ss_pred             cCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcH
Confidence            78999999999999999999999754422    12346788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC------------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG------------  144 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~------------  144 (328)
                      .+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++  ..+||+|||++.....            
T Consensus        91 ~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~  168 (268)
T cd06630          91 SHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAKGTGAGEFQGQL  168 (268)
T ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccccccCCcccccc
Confidence            99988878899999999999999999999999999999999999996532  3699999998753211            


Q ss_pred             --------------------CCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-CCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         145 --------------------EQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKA-GAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       145 --------------------~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                          .+.+.+|++++++++|..||...+.......+.. .............++++.+++.+||
T Consensus       169 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  248 (268)
T cd06630         169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCL  248 (268)
T ss_pred             ccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHc
Confidence                                1122379999999999999965543222222211 1111112222357899999999999


Q ss_pred             ccCCCCCCCHHHHhcCccc
Q psy2131         204 TVNPSKRITASEALKHPWI  222 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~  222 (328)
                      ..+|.+||++.++++|||+
T Consensus       249 ~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         249 ELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             CCCcccCcCHHHHhcCccc
Confidence            9999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1151|consensus

Probab=100.00  E-value=7.5e-37  Score=270.37  Aligned_cols=228  Identities=29%  Similarity=0.414  Sum_probs=183.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC--CHH---HHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL--SAR---DFQKLEREARICRKLQHPNIVRLHDSIQ-EENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~--~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lv~E~~~gg   74 (328)
                      |+|+.||+|.+...++.||+|+-...+.  .++   -.+...||.+|-+.|+||-||++|++|. +.+.++-|+|||+|.
T Consensus       474 GGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGN  553 (775)
T KOG1151|consen  474 GGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGN  553 (775)
T ss_pred             ccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCC
Confidence            8999999999999999999998754331  111   1234678999999999999999999996 667899999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch-HH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSN--GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-FG  151 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~--~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~-~G  151 (328)
                      +|.-+|..++.++|.+++.|+-||+.||.||.+.  .|||-||||.|||+.+.+..+.+||+||||++...++.... .|
T Consensus       554 DLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdG  633 (775)
T KOG1151|consen  554 DLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDG  633 (775)
T ss_pred             chhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccc
Confidence            9998999999999999999999999999999876  69999999999999988788899999999997665432210 00


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       634 --------------------------------------------------------------------------------  633 (775)
T KOG1151|consen  634 --------------------------------------------------------------------------------  633 (775)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc----CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK----EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRL  306 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~  306 (328)
                                          +.....++||..|.+||.+.-    -..+.++||||+|||+|+.|.|+-||.... ...+
T Consensus       634 --------------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  634 --------------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             --------------------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence                                011223579999999998742    245899999999999999999999998653 3333


Q ss_pred             HH---HHhcccCCCCCCccccCccC
Q psy2131         307 YA---QIKAGAYDDEPKHKSASVVK  328 (328)
Q Consensus       307 ~~---~i~~~~~~~~~~~~~~~~~~  328 (328)
                      ++   .|+.-...+||.|--+|.+|
T Consensus       694 LqeNTIlkAtEVqFP~KPvVsseAk  718 (775)
T KOG1151|consen  694 LQENTILKATEVQFPPKPVVSSEAK  718 (775)
T ss_pred             HhhhchhcceeccCCCCCccCHHHH
Confidence            32   35566678888887766543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=271.14  Aligned_cols=199  Identities=31%  Similarity=0.478  Sum_probs=164.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++....      ..|+||||+ |+
T Consensus        26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~  104 (343)
T cd07880          26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GT  104 (343)
T ss_pred             cCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CC
Confidence            88999999999999999999999755434444556789999999999999999999997654      459999999 67


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++......         
T Consensus       105 ~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~---------  171 (343)
T cd07880         105 DLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQTDSE---------  171 (343)
T ss_pred             CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccccccccC---------
Confidence            8876654 4579999999999999999999999999999999999999754   45999999987432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (343)
T cd07880         172 --------------------------------------------------------------------------------  171 (343)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          .....|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+....+.++.+.
T Consensus       172 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07880         172 --------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV  231 (343)
T ss_pred             --------------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                                011247889999999976 45899999999999999999999999998876666665543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-35  Score=262.50  Aligned_cols=221  Identities=32%  Similarity=0.461  Sum_probs=179.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+|+.||||.++.....   ......+.+|++++++++|+||+++++++.+.+..|+||||+ +|+|.
T Consensus        11 g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   89 (298)
T cd07841          11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLE   89 (298)
T ss_pred             ccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHH
Confidence            78999999999999999999999865543   223345678999999999999999999999999999999999 88999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-----------
Q psy2131          78 EDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-----------  145 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-----------  145 (328)
                      +.+.... .+++.++..++.||+.||.|||++||+|+||||+|||++.+   +.+||+|||++......           
T Consensus        90 ~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~  166 (298)
T cd07841          90 KVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSPNRKMTHQVVTR  166 (298)
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---CCEEEccceeeeeccCCCccccccccce
Confidence            9887765 79999999999999999999999999999999999999754   46999999987543210           


Q ss_pred             -----------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC--------------------C--
Q psy2131         146 -----------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--------------------S--  185 (328)
Q Consensus       146 -----------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------~--  185 (328)
                                       .+.| +|+++++|++|.+||.+.+.......+........                    .  
T Consensus       167 ~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (298)
T cd07841         167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTP  246 (298)
T ss_pred             eeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcc
Confidence                             1123 79999999999888877766554444322110000                    0  


Q ss_pred             --CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         186 --PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       186 --~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                        ......+.++.+++.+||..||++|||+.+++.|+|+.+.
T Consensus       247 ~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         247 LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence              0113457889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=265.65  Aligned_cols=198  Identities=32%  Similarity=0.565  Sum_probs=166.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..++..||+|.+.....  ...+.+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.+++
T Consensus        30 g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (293)
T cd06647          30 GASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  107 (293)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHH
Confidence            7899999999999999999999865432  23456788999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++........             
T Consensus       108 ~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~---~~~kL~dfg~~~~~~~~~~-------------  170 (293)
T cd06647         108 TE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQS-------------  170 (293)
T ss_pred             hh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC---CCEEEccCcceeccccccc-------------
Confidence            54 458899999999999999999999999999999999999754   4699999998743211000             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (293)
T cd06647         171 --------------------------------------------------------------------------------  170 (293)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                   ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+
T Consensus       171 -------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~  227 (293)
T cd06647         171 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (293)
T ss_pred             -------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence                         001134888999999999888999999999999999999999999988765544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.8e-36  Score=271.94  Aligned_cols=201  Identities=29%  Similarity=0.452  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.+..+++.||||.+............+.+|+.+++.++|+||+++++++...     ...|+||||+. ++
T Consensus        16 G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   94 (337)
T cd07858          16 GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TD   94 (337)
T ss_pred             CCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CC
Confidence            7899999999999999999999976543444455677899999999999999999988644     35899999996 68


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+...+.+++..+..++.|++.||.|||+++++||||||+|||++.+   +.+||+|||++........        
T Consensus        95 L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~--------  163 (337)
T cd07858          95 LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGD--------  163 (337)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECcCccccccCCCcc--------
Confidence            98888877889999999999999999999999999999999999999754   4599999998754311000        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (337)
T cd07858         164 --------------------------------------------------------------------------------  163 (337)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                        ......||..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+.
T Consensus       164 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  222 (337)
T cd07858         164 ------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT  222 (337)
T ss_pred             ------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence                              0001247888999999875 568999999999999999999999999887555444443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.8e-36  Score=263.45  Aligned_cols=230  Identities=32%  Similarity=0.537  Sum_probs=183.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|+.||+|++..+... ......+.+|+.++++++ ||||+++++++.+.+..|+||||+++++|.+
T Consensus        12 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (280)
T cd05581          12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQ   91 (280)
T ss_pred             CCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHH
Confidence            78999999999999999999999765432 334466789999999998 9999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+...+.+++.++..++.|++.||.|||+.|++|+||||+||+++.+   +.++|+|||++.........          
T Consensus        92 ~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~---~~~~l~df~~~~~~~~~~~~----------  158 (280)
T cd05581          92 YIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSSP----------  158 (280)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEecCCccccccCCcccc----------
Confidence            99888889999999999999999999999999999999999999754   45999999997654221100          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                ........            .++.                              
T Consensus       159 --------------------------~~~~~~~~------------~~~~------------------------------  170 (280)
T cd05581         159 --------------------------ESNKGDAT------------NIDS------------------------------  170 (280)
T ss_pred             --------------------------ccCCCCCc------------cccc------------------------------
Confidence                                      00000000            0000                              


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                              .............|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+....++.+....+..+
T Consensus       171 --------~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (280)
T cd05581         171 --------QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP  242 (280)
T ss_pred             --------cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC
Confidence                    000000112235689999999999998899999999999999999999999999998888888887777555


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       243 ~  243 (280)
T cd05581         243 P  243 (280)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-35  Score=269.77  Aligned_cols=209  Identities=30%  Similarity=0.363  Sum_probs=168.7

Q ss_pred             CCceEEEEEEEccC--CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe----CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKAT--GLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE----ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~--~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~----~~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..+  +..||+|.+..........+.+.+|+.+++++ +||||+++++.+..    ....|+++||+. 
T Consensus        11 G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-   89 (332)
T cd07857          11 GAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-   89 (332)
T ss_pred             cCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-
Confidence            78999999999888  99999999875433333455678899999999 59999999987542    256799999986 


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ++|.+.+.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........     
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~-----  161 (332)
T cd07857          90 ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGFSENPGE-----  161 (332)
T ss_pred             CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---CCEEeCcCCCceeccccccc-----
Confidence            5898888888889999999999999999999999999999999999999754   45999999998653211000     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (332)
T cd07857         162 --------------------------------------------------------------------------------  161 (332)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       .........||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+....++.+..
T Consensus       162 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~  224 (332)
T cd07857         162 -----------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ  224 (332)
T ss_pred             -----------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence                             0000112458999999998866 5789999999999999999999999999887777766665


Q ss_pred             ccC
Q psy2131         313 GAY  315 (328)
Q Consensus       313 ~~~  315 (328)
                      ..-
T Consensus       225 ~~~  227 (332)
T cd07857         225 VLG  227 (332)
T ss_pred             HhC
Confidence            443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-35  Score=260.82  Aligned_cols=200  Identities=29%  Similarity=0.433  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.+  .+.+|+||||++|++|.+
T Consensus        12 g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (287)
T cd06621          12 GAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS   90 (287)
T ss_pred             CCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHH
Confidence            7899999999999999999999975432 2445678899999999999999999998864  447899999999999987


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          79 DIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        79 ~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+   +.++|+|||++.......        
T Consensus        91 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~--------  159 (287)
T cd06621          91 IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGELVNSL--------  159 (287)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---CeEEEeeccccccccccc--------
Confidence            7643    3458899999999999999999999999999999999999754   459999999864321000        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (287)
T cd06621         160 --------------------------------------------------------------------------------  159 (287)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-----cHHHHHHH
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQ  309 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~  309 (328)
                                          .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...     .+..+...
T Consensus       160 --------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  219 (287)
T cd06621         160 --------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY  219 (287)
T ss_pred             --------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH
Confidence                                00123678899999999999999999999999999999999999876     34555555


Q ss_pred             Hhc
Q psy2131         310 IKA  312 (328)
Q Consensus       310 i~~  312 (328)
                      +.+
T Consensus       220 ~~~  222 (287)
T cd06621         220 IVN  222 (287)
T ss_pred             Hhc
Confidence            554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.9e-35  Score=262.04  Aligned_cols=190  Identities=23%  Similarity=0.412  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..|++|||+.+ ++.+.
T Consensus        15 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l   92 (288)
T cd06616          15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKF   92 (288)
T ss_pred             CCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHH
Confidence            88999999999999999999999765433 44567889999999996 99999999999999999999999865 44332


Q ss_pred             ---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          80 ---IV--AREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        80 ---l~--~~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                         +.  ....+++..+..++.|++.||+|||+. +|+||||||+|||++.+   +.+||+|||++.......       
T Consensus        93 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~-------  162 (288)
T cd06616          93 YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQLVDSI-------  162 (288)
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC---CcEEEeecchhHHhccCC-------
Confidence               22  235699999999999999999999985 99999999999999754   469999999874321100       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (288)
T cd06616         163 --------------------------------------------------------------------------------  162 (288)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC---CCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE---PYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                          ......||+.|+|||++.+.   .++.++|||||||++|||++|++||...+
T Consensus       163 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         163 --------------------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             --------------------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence                                00112478899999999876   68999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0984|consensus

Probab=100.00  E-value=5.6e-36  Score=240.85  Aligned_cols=202  Identities=21%  Similarity=0.340  Sum_probs=166.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.|-+.++..+|...|+|.|..... .+...++.+|+.+..+. .+|.+|.+|+.+.+....||.||.|.. +|..+
T Consensus        57 GayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkf  134 (282)
T KOG0984|consen   57 GAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKF  134 (282)
T ss_pred             CccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHH
Confidence            7899999999999999999999987544 44556778899886654 899999999999999999999999964 66433


Q ss_pred             ----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          80 ----IVAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        80 ----l~~~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                          +...+.++|..+-+++-.++.||.|||++ .+||||+||+|||++.++   .+|+||||.+..+.+.-        
T Consensus       135 y~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G---qVKiCDFGIsG~L~dSi--------  203 (282)
T KOG0984|consen  135 YRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG---QVKICDFGISGYLVDSI--------  203 (282)
T ss_pred             HHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC---cEEEcccccceeehhhh--------
Confidence                23456799999999999999999999986 899999999999998654   59999999975432110        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       204 --------------------------------------------------------------------------------  203 (282)
T KOG0984|consen  204 --------------------------------------------------------------------------------  203 (282)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc----cCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHH
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK----KEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQ  309 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~  309 (328)
                                         ...--+|.-.|||||.+.    ...|+.++||||||+++.||.+++.||..- .|.+++..
T Consensus       204 -------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  204 -------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             -------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence                               000124788899999985    458999999999999999999999999865 58888888


Q ss_pred             Hhccc
Q psy2131         310 IKAGA  314 (328)
Q Consensus       310 i~~~~  314 (328)
                      ++..+
T Consensus       265 vVeep  269 (282)
T KOG0984|consen  265 VVEEP  269 (282)
T ss_pred             HhcCC
Confidence            87654

>KOG0666|consensus

Probab=100.00  E-value=3e-37  Score=261.93  Aligned_cols=198  Identities=31%  Similarity=0.452  Sum_probs=159.5

Q ss_pred             CCceEEEEEEEccCCc----EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|..+.++-    .+|||.++.++-..---...-||+.+++.++|||||.|..+|.+ +..+|+++||.+. +
T Consensus        35 GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-D  113 (438)
T KOG0666|consen   35 GTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-D  113 (438)
T ss_pred             cccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-h
Confidence            8999999997665543    68999998663211111334589999999999999999999987 8899999999987 8


Q ss_pred             cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC-CCCcEEEeeccccccccCCCcch
Q psy2131          76 LFEDIVAR-----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        76 L~~~l~~~-----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~-~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      |++.+..+     ..++...+..++.||+.|+.|||++-|+||||||.|||+..++ +.+.|||+|||+++.+...-.  
T Consensus       114 L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk--  191 (438)
T KOG0666|consen  114 LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLK--  191 (438)
T ss_pred             HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccc--
Confidence            88888643     3588999999999999999999999999999999999998653 247899999999876432110  


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                   |                                                                  
T Consensus       192 -------------p------------------------------------------------------------------  192 (438)
T KOG0666|consen  192 -------------P------------------------------------------------------------------  192 (438)
T ss_pred             -------------c------------------------------------------------------------------
Confidence                         0                                                                  


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                            .......+-|..|.|||.|.|. -|+.++|+||+|||+.||||-+|-|.+..
T Consensus       193 ----------------------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  193 ----------------------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             ----------------------cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence                                  0011234578999999999885 57999999999999999999999998753

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-35  Score=260.91  Aligned_cols=218  Identities=33%  Similarity=0.478  Sum_probs=175.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+|+.+|||+++.+.........+.+|++++++++||||+++++++.+.+..|+||||+. ++|.+++
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~   89 (284)
T cd07860          11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM   89 (284)
T ss_pred             CCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHH
Confidence            789999999999999999999997655444444678899999999999999999999999999999999996 5788877


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC--------------
Q psy2131          81 VA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG--------------  144 (328)
Q Consensus        81 ~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~--------------  144 (328)
                      ..  ...+++..+..++.|++.||+|||+.+++||||+|+||+++.+   +.+||+|||++.....              
T Consensus        90 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y  166 (284)
T cd07860          90 DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWY  166 (284)
T ss_pred             HhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEeeccchhhcccCccccccccccccc
Confidence            54  3468999999999999999999999999999999999999754   4599999998653210              


Q ss_pred             --------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC------------------CCCCC-----
Q psy2131         145 --------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------------------DYPSP-----  186 (328)
Q Consensus       145 --------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~------------------~~~~~-----  186 (328)
                                    ..+.| +|+++|+|++|..||...+......++.....                  .++..     
T Consensus       167 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd07860         167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF  246 (284)
T ss_pred             cCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH
Confidence                          01123 79999999999999987665443333221100                  01100     


Q ss_pred             --CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         187 --EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       187 --~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                        ....+++++++++.+||..||.+|||+.+++.|||+
T Consensus       247 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         247 SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              012468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-35  Score=269.29  Aligned_cols=207  Identities=33%  Similarity=0.481  Sum_probs=166.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe--CCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+|+.+|+|.+............+.+|+.+++++ +||||+++++++..  ....|+||||+.+ +|.
T Consensus        18 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~   96 (337)
T cd07852          18 GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLH   96 (337)
T ss_pred             CCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHH
Confidence            7899999999999999999999865444444556677899999999 99999999999864  3468999999975 888


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.+... .+++.....++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++..........        
T Consensus        97 ~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~---~~~kl~d~g~~~~~~~~~~~~--------  164 (337)
T cd07852          97 AVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENP--------  164 (337)
T ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccchhccccccccc--------
Confidence            877655 78899999999999999999999999999999999999754   469999999875432110000        


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (337)
T cd07852         165 --------------------------------------------------------------------------------  164 (337)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   .........||+.|+|||++.+ ..++.++|+|||||++|+|+||++||.+.........+...
T Consensus       165 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         165 -------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             -------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence                         0000112358999999998865 56789999999999999999999999988766665554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.7e-35  Score=256.48  Aligned_cols=219  Identities=26%  Similarity=0.437  Sum_probs=179.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS--------ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~--------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.+..+|+.+|+|.++.....        ....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        12 g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   91 (272)
T cd06629          12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVP   91 (272)
T ss_pred             cCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCC
Confidence            79999999999999999999998643211        1123457889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC--------
Q psy2131          73 GGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG--------  144 (328)
Q Consensus        73 gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~--------  144 (328)
                      |++|.+.+...+.+++..+..++.|++.||.|||+++++||||||+||+++.+   +.++|+|||++.....        
T Consensus        92 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~  168 (272)
T cd06629          92 GGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD---GICKISDFGISKKSDDIYDNDQNM  168 (272)
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC---CeEEEeeccccccccccccccccc
Confidence            99999999887889999999999999999999999999999999999999753   5699999998753210        


Q ss_pred             -----------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCCCCcCCCCHHHHHH
Q psy2131         145 -----------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKNL  198 (328)
Q Consensus       145 -----------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~l  198 (328)
                                             ..+.| +|++++++++|..||...+.......+....  ..++......++.++.++
T Consensus       169 ~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (272)
T cd06629         169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDF  248 (272)
T ss_pred             cccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHH
Confidence                                   01223 8999999999999997665544333332222  222222334578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q psy2131         199 INQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      +.+|+..+|.+||++.+++.|||+
T Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         249 LNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHhcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG1006|consensus

Probab=100.00  E-value=1.3e-37  Score=258.87  Aligned_cols=202  Identities=25%  Similarity=0.430  Sum_probs=160.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+|++-.++.+|+..|||.|+.... .++..++..|... ++.-+.||||++|++...++.-||.||+|.- +|..+
T Consensus        75 G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDkl  152 (361)
T KOG1006|consen   75 GAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKL  152 (361)
T ss_pred             CcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHH
Confidence            8999999999999999999999987654 4556677778776 4556899999999999999999999999953 55322


Q ss_pred             H-----HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          80 I-----VAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        80 l-----~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      .     ..+..++|+-+..+.-..+.||.||-. ..|||||+||+|||++..+   .+||||||++.++.+.-       
T Consensus       153 Yk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G---~vKLCDFGIcGqLv~Si-------  222 (361)
T KOG1006|consen  153 YKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG---DVKLCDFGICGQLVDSI-------  222 (361)
T ss_pred             HHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC---CEeeecccchHhHHHHH-------
Confidence            2     234568999999998889999999965 6899999999999998655   59999999975431100       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       223 --------------------------------------------------------------------------------  222 (361)
T KOG1006|consen  223 --------------------------------------------------------------------------------  222 (361)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc--cCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQI  310 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i  310 (328)
                                          ....-+|...|||||-+.  +.+|+.+|||||||++|||+.||+.||.+=+ -.+.+..+
T Consensus       223 --------------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V  282 (361)
T KOG1006|consen  223 --------------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV  282 (361)
T ss_pred             --------------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence                                011135889999999995  4569999999999999999999999998765 44445555


Q ss_pred             hccc
Q psy2131         311 KAGA  314 (328)
Q Consensus       311 ~~~~  314 (328)
                      +.|.
T Consensus       283 v~gd  286 (361)
T KOG1006|consen  283 VIGD  286 (361)
T ss_pred             HcCC
Confidence            5553

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-36  Score=268.52  Aligned_cols=216  Identities=27%  Similarity=0.313  Sum_probs=166.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--------CEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--------NYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--------~~~~lv~E~~~   72 (328)
                      |+||.||+|.++.+++.+|+|++............+.+|+++++.++||||+++++++.+.        ..+|+||||+.
T Consensus        19 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~   98 (311)
T cd07866          19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD   98 (311)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC
Confidence            7899999999999999999999876543332334567899999999999999999987543        35799999997


Q ss_pred             CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          73 GGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        73 gg~L~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      + +|...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++++   +.+||+|||++..........  
T Consensus        99 ~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~--  172 (311)
T cd07866          99 H-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNP--  172 (311)
T ss_pred             c-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECcCccchhccCCCccc--
Confidence            5 67666654 3479999999999999999999999999999999999999754   469999999985432211000  


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                      .                         ..       +.           
T Consensus       173 --------------------------------~-------------------------~~-------~~-----------  177 (311)
T cd07866         173 --------------------------------K-------------------------GG-------GG-----------  177 (311)
T ss_pred             --------------------------------c-------------------------cC-------Cc-----------
Confidence                                            0                         00       00           


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                        ..........|++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+
T Consensus       178 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         178 ------------------GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ------------------ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                              00001122458999999999866 45899999999999999999999999999887777766


Q ss_pred             hcccC
Q psy2131         311 KAGAY  315 (328)
Q Consensus       311 ~~~~~  315 (328)
                      .+..-
T Consensus       240 ~~~~~  244 (311)
T cd07866         240 FKLCG  244 (311)
T ss_pred             HHHhC
Confidence            55433

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5e-35  Score=257.88  Aligned_cols=210  Identities=33%  Similarity=0.561  Sum_probs=174.6

Q ss_pred             CCceEEEEEEEcc-CCcEEEEEEeccCC--------CCHHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEEc
Q psy2131           1 GAFSVVRRCVQKA-TGLEFAAKIINTKK--------LSARDFQKLEREARICRK-LQHPNIVRLHDSIQEENYHYLVFDL   70 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~~~AiK~i~~~~--------~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~~~~~~lv~E~   70 (328)
                      |+||.||+|.+.. +++.+|+|.+....        .......++.+|+.++.+ ++||||+++++++.+.+..|++|||
T Consensus        11 G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   90 (269)
T cd08528          11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDL   90 (269)
T ss_pred             CCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEec
Confidence            7899999999987 78899999986432        223345567789998875 7999999999999999999999999


Q ss_pred             cCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          71 VTGGELFEDIVA----REFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        71 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      ++|++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.+   +.+||+|||++......
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~  167 (269)
T cd08528          91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITDFGLAKQKQPE  167 (269)
T ss_pred             CCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC---CcEEEecccceeecccc
Confidence            999999887643    3468999999999999999999996 689999999999999754   46999999987432110


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .                                                                               
T Consensus       168 ~-------------------------------------------------------------------------------  168 (269)
T cd08528         168 S-------------------------------------------------------------------------------  168 (269)
T ss_pred             c-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                                  ......|+..|+|||++.+..++.++|+|||||++|||++|++||...+...
T Consensus       169 ----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~  220 (269)
T cd08528         169 ----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS  220 (269)
T ss_pred             ----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence                                        0012347889999999999999999999999999999999999999999888


Q ss_pred             HHHHHhcccCCCCCC
Q psy2131         306 LYAQIKAGAYDDEPK  320 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~  320 (328)
                      ....+..+.+.+.+.
T Consensus       221 ~~~~~~~~~~~~~~~  235 (269)
T cd08528         221 LATKIVEAVYEPLPE  235 (269)
T ss_pred             HHHHHhhccCCcCCc
Confidence            888888888765443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.4e-35  Score=262.72  Aligned_cols=214  Identities=14%  Similarity=0.156  Sum_probs=155.2

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHH-HH--------HHHHHHHHHHHhCCCCCcceeEEEEEeCC----EE
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSAR-DF--------QKLEREARICRKLQHPNIVRLHDSIQEEN----YH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~-~~--------~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~   64 (328)
                      |+||+||+|.+..+   +..+|+|+......... +.        .....+...+..++|+||++++++.....    ..
T Consensus        23 G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  102 (294)
T PHA02882         23 GGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYR  102 (294)
T ss_pred             CCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEE
Confidence            89999999998877   67788887543322110 00        11223445566789999999999766543    45


Q ss_pred             EEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC
Q psy2131          65 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG  144 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~  144 (328)
                      |+++|++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.+   +.++|+|||+|+....
T Consensus       103 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~---~~~~l~DFGla~~~~~  178 (294)
T PHA02882        103 FILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN---NRGYIIDYGIASHFII  178 (294)
T ss_pred             EEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CcEEEEEcCCceeecc
Confidence            788998754 565666555557888999999999999999999999999999999999754   4599999999865421


Q ss_pred             CCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         145 EQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       145 ~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ....                                .                                           
T Consensus       179 ~~~~--------------------------------~-------------------------------------------  183 (294)
T PHA02882        179 HGKH--------------------------------I-------------------------------------------  183 (294)
T ss_pred             CCcc--------------------------------c-------------------------------------------
Confidence            1100                                0                                           


Q ss_pred             cccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-H
Q psy2131         225 RERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED-Q  303 (328)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~  303 (328)
                                              ...........||+.|+|||+..+..|+.++|||||||+||||++|++||.+.. .
T Consensus       184 ------------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        184 ------------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             ------------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence                                    000001112459999999999999999999999999999999999999998773 2


Q ss_pred             H--------HHHHHHhcccCCC
Q psy2131         304 H--------RLYAQIKAGAYDD  317 (328)
Q Consensus       304 ~--------~~~~~i~~~~~~~  317 (328)
                      .        .....+..+.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~  261 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEGKIKI  261 (294)
T ss_pred             hHHHHHhHHHHHHHhhhhhhcc
Confidence            2        2345556665533

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=260.96  Aligned_cols=204  Identities=31%  Similarity=0.456  Sum_probs=170.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|+.+|+|++............+.+|++++++++|+|++++++++.+.  +..|+||||+++ +|.+
T Consensus        10 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   88 (287)
T cd07840          10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTG   88 (287)
T ss_pred             CCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHH
Confidence            7899999999999999999999987643333445678899999999999999999999988  899999999975 8888


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      .+... ..+++.++..++.|++.||+|||+.|++|+||||+||+++.+   +.+||+|||++........          
T Consensus        89 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~---~~~~l~d~g~~~~~~~~~~----------  155 (287)
T cd07840          89 LLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---GVLKLADFGLARPYTKRNS----------  155 (287)
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC---CCEEEccccceeeccCCCc----------
Confidence            77665 579999999999999999999999999999999999999754   4699999998754321100          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (287)
T cd07840         156 --------------------------------------------------------------------------------  155 (287)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                     .......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.+.+.......+.+.
T Consensus       156 ---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~  217 (287)
T cd07840         156 ---------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL  217 (287)
T ss_pred             ---------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence                           00001236788999998765 46799999999999999999999999999888777776654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8e-35  Score=262.02  Aligned_cols=201  Identities=26%  Similarity=0.429  Sum_probs=167.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+++.+|+|.+..... .......+.+|+++++.++|+|++++++++...+..|+||||+. |+|.+.
T Consensus        26 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~  104 (308)
T cd06634          26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL  104 (308)
T ss_pred             CCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHH
Confidence            7899999999999999999999975432 33445678899999999999999999999999999999999997 577776


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.|++.||.|||+.+++||||||+|||++.+   +.+||+|||++.....              
T Consensus       105 ~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~--------------  167 (308)
T cd06634         105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP--------------  167 (308)
T ss_pred             HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC---CcEEECCcccceeecC--------------
Confidence            643 4568999999999999999999999999999999999999653   4699999998643210              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (308)
T cd06634         168 --------------------------------------------------------------------------------  167 (308)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .....|++.|+|||++.   ...++.++|||||||++|||++|+.||.+.+.......+.++..
T Consensus       168 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  231 (308)
T cd06634         168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  231 (308)
T ss_pred             ----------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC
Confidence                            00124788999999985   35678899999999999999999999998876666666555543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-34  Score=255.84  Aligned_cols=213  Identities=29%  Similarity=0.452  Sum_probs=170.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.++.++..+|+|++........       |+..... .+||||+++++++...+..|+||||++|++|.++
T Consensus        27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             CCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            7899999999999999999999976533221       2222221 2799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC---------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------------  144 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~---------------  144 (328)
                      +.....+++.++..++.|++.||.|||+.|++||||||+||+++.++  ..++|+|||++.....               
T Consensus       100 l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~  177 (267)
T PHA03390        100 LKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTPSCYDGTLDYFSPEK  177 (267)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCCccCCCCCcccChhh
Confidence            98877899999999999999999999999999999999999997643  2699999998753221               


Q ss_pred             --------CCcc-hHHHHHHHHHhCCCCCCCCcHHHHH-HHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-H
Q psy2131         145 --------EQQA-WFGVILYILLVGYPPFWDEDQHRLY-AQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-A  213 (328)
Q Consensus       145 --------~~~~-~~G~~~~~~~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-~  213 (328)
                              ..+. .+|+++|+|++|..||......... ....... ..+.......|+.+.+++.+||+.||.+|++ .
T Consensus       178 ~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  256 (267)
T PHA03390        178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNY  256 (267)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchH
Confidence                    1122 3799999999999999765433221 1111111 2222334478999999999999999999996 5


Q ss_pred             HHHhcCcccC
Q psy2131         214 SEALKHPWIC  223 (328)
Q Consensus       214 ~~~l~h~~~~  223 (328)
                      +++++|||+.
T Consensus       257 ~~~l~h~~~~  266 (267)
T PHA03390        257 NEIIKHPFLK  266 (267)
T ss_pred             HHHhcCCccc
Confidence            9999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-36  Score=285.09  Aligned_cols=190  Identities=27%  Similarity=0.428  Sum_probs=146.3

Q ss_pred             CCceEEEEEEEccC-CcEEEEEEecc---------------CCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKAT-GLEFAAKIINT---------------KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~-~~~~AiK~i~~---------------~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||+||+|..+.. +...+.|.++.               ..........+.+|+.+|++++|||||++++++.+.+..
T Consensus       159 G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  238 (501)
T PHA03210        159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANT  238 (501)
T ss_pred             CCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCee
Confidence            89999999976533 23333332211               011122345678999999999999999999999999999


Q ss_pred             EEEEEccCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          65 YLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      |+|+|++. ++|++++...     ......++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||++
T Consensus       239 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~---~~vkL~DFGla  314 (501)
T PHA03210        239 YMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD---GKIVLGDFGTA  314 (501)
T ss_pred             EEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEEeCCCc
Confidence            99999995 4777776432     223466788899999999999999999999999999999754   45999999998


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      ..+.....                                                                        
T Consensus       315 ~~~~~~~~------------------------------------------------------------------------  322 (501)
T PHA03210        315 MPFEKERE------------------------------------------------------------------------  322 (501)
T ss_pred             eecCcccc------------------------------------------------------------------------
Confidence            54321100                                                                        


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                                       ....+..||+.|+|||++.+..|+.++|||||||+||||++|..|+.
T Consensus       323 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        323 ---------------------------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             ---------------------------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence                                             00112469999999999999999999999999999999999986544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-34  Score=258.40  Aligned_cols=220  Identities=30%  Similarity=0.422  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE-----EEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENY-----HYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~-----~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++ ||||+++++++...+.     .|+||||+++ 
T Consensus        12 g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-   90 (295)
T cd07837          12 GTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-   90 (295)
T ss_pred             cCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-
Confidence            78999999999999999999998765433333456788999999995 6999999999987665     8999999986 


Q ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-----
Q psy2131          75 ELFEDIVAR-----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-----  144 (328)
Q Consensus        75 ~L~~~l~~~-----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-----  144 (328)
                      +|.+++...     ..+++..+..++.||+.||.|||++||+||||||+||+++.+  ++.+||+|||++.....     
T Consensus        91 ~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg~~~~~~~~~~~~  168 (295)
T cd07837          91 DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLGLGRAFSIPVKSY  168 (295)
T ss_pred             CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecccceecCCCcccc
Confidence            788877542     357999999999999999999999999999999999999752  35699999998753210     


Q ss_pred             -----------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----------------C
Q psy2131         145 -----------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----------------Y  183 (328)
Q Consensus       145 -----------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~-----------------~  183 (328)
                                             ..+.| +|+++|+|++|.+||.+.+.......+......                 +
T Consensus       169 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T cd07837         169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF  248 (295)
T ss_pred             CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhc
Confidence                                   11223 799999999999999877665443333221100                 0


Q ss_pred             C-------CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         184 P-------SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       184 ~-------~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      +       ......+++++.++|.+||..||.+||++.+++.|||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         249 PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            0       001235788999999999999999999999999999973

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-35  Score=269.04  Aligned_cols=197  Identities=31%  Similarity=0.453  Sum_probs=161.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+|+.+|+|++............+.+|+.+++.++||||+++++++...      ...|+||||+.+ 
T Consensus        26 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-  104 (342)
T cd07879          26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-  104 (342)
T ss_pred             cCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-
Confidence            7899999999999999999999976543333345678999999999999999999998754      346999999964 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|....  ...+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++......         
T Consensus       105 ~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~---~~~kL~dfg~~~~~~~~---------  170 (342)
T cd07879         105 DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED---CELKILDFGLARHADAE---------  170 (342)
T ss_pred             CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCCCCcCCCCC---------
Confidence            665543  3468999999999999999999999999999999999999754   46999999987432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (342)
T cd07879         171 --------------------------------------------------------------------------------  170 (342)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                          .....||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+....+..+..
T Consensus       171 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~  229 (342)
T cd07879         171 --------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  229 (342)
T ss_pred             --------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                                011347888999999876 5689999999999999999999999999886666655544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-35  Score=258.60  Aligned_cols=193  Identities=27%  Similarity=0.404  Sum_probs=156.4

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.    +..++..||+|.+...  .....+.+.+|+++++.++||||+++++++..  ...+|+||||+++|
T Consensus        15 g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   92 (284)
T cd05081          15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG   92 (284)
T ss_pred             CCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCC
Confidence            8999999997    4567899999998754  34456678899999999999999999998753  45689999999999


Q ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..........    
T Consensus        93 ~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~~~~----  165 (284)
T cd05081          93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYY----  165 (284)
T ss_pred             CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC---CeEEECCCcccccccCCCcce----
Confidence            999988654 468999999999999999999999999999999999999754   459999999975432110000    


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (284)
T cd05081         166 --------------------------------------------------------------------------------  165 (284)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                         .......++..|+|||++.+..++.++|+|||||++|||++|..|+...
T Consensus       166 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  214 (284)
T cd05081         166 -------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP  214 (284)
T ss_pred             -------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence                               0000012345699999999999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=258.29  Aligned_cols=201  Identities=32%  Similarity=0.419  Sum_probs=166.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCE-----EEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHDSIQEENY-----HYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~-----~~lv~E~~~   72 (328)
                      |+||.||+|.++.+++.||+|+++...........+.+|+.+++++   +||||+++++++.+.+.     .|++|||+.
T Consensus        10 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~   89 (287)
T cd07838          10 GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD   89 (287)
T ss_pred             cCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc
Confidence            7899999999998999999999986543333334566788777666   69999999999988776     999999997


Q ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          73 GGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        73 gg~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      + +|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+   +.+||+|||++.......    
T Consensus        90 ~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~~~~~~~----  161 (287)
T cd07838          90 Q-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLARIYSFEM----  161 (287)
T ss_pred             c-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcceeccCCc----
Confidence            5 7888776533  58999999999999999999999999999999999999765   569999999874431100    


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (287)
T cd07838         162 --------------------------------------------------------------------------------  161 (287)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                             ......|++.|+|||++.+..++.++|+|||||++|||++|++||.+....+.+.++
T Consensus       162 -----------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~  218 (287)
T cd07838         162 -----------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI  218 (287)
T ss_pred             -----------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence                                   000123688899999999999999999999999999999999999999888877776


Q ss_pred             hc
Q psy2131         311 KA  312 (328)
Q Consensus       311 ~~  312 (328)
                      .+
T Consensus       219 ~~  220 (287)
T cd07838         219 FD  220 (287)
T ss_pred             HH
Confidence            54

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=265.83  Aligned_cols=199  Identities=32%  Similarity=0.432  Sum_probs=159.9

Q ss_pred             CCceEEEEEEEcc--CCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA--TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~--~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..  +++.||+|.+...... ......+.+|+.+++.++||||+++++++.+.  +.+|+||||+++ +
T Consensus        11 g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~   89 (316)
T cd07842          11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-D   89 (316)
T ss_pred             CCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-C
Confidence            7899999999988  8999999999864321 12235567899999999999999999999988  889999999975 6


Q ss_pred             cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC-CCCcEEEeeccccccccCCCcch
Q psy2131          76 LFEDIVAR-----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        76 L~~~l~~~-----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~-~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      |.+.+...     ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ ..+.+||+|||++......... 
T Consensus        90 l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-  168 (316)
T cd07842          90 LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-  168 (316)
T ss_pred             HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc-
Confidence            76665432     2689999999999999999999999999999999999997622 2467999999997543111000 


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (316)
T cd07842         169 --------------------------------------------------------------------------------  168 (316)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                            ........||+.|+|||++.+ ..++.++|+|||||+||+|++|++||.+.+.
T Consensus       169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         169 ----------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ----------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence                                  000112357899999998876 4689999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=267.87  Aligned_cols=207  Identities=32%  Similarity=0.453  Sum_probs=174.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-----YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-----~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++...+     .+|++|||+.+ +
T Consensus        11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~   89 (330)
T cd07834          11 GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-D   89 (330)
T ss_pred             CCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-h
Confidence            78999999999999999999999765433445567889999999999999999999998775     78999999984 8


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.++|+|||++.........       
T Consensus        90 l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---~~~~L~dfg~~~~~~~~~~~-------  159 (330)
T cd07834          90 LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---CDLKICDFGLARGVDPDEDE-------  159 (330)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccCceEeecccccc-------
Confidence            88888777789999999999999999999999999999999999999754   56999999997543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (330)
T cd07834         160 --------------------------------------------------------------------------------  159 (330)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+....+..|.+..
T Consensus       160 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (330)
T cd07834         160 ----------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL  223 (330)
T ss_pred             ----------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence                            0001112478899999999888 88999999999999999999999999999888888776643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-34  Score=252.35  Aligned_cols=216  Identities=26%  Similarity=0.431  Sum_probs=174.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..++..+|+|.+....  ....+.+.+|+.++++++|+||+++++++...+..|+++||+++++|.+.+
T Consensus        19 g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (268)
T cd06624          19 GTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL   96 (268)
T ss_pred             CCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHH
Confidence            789999999999999999999987543  345567889999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          81 VAR-EFY--SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        81 ~~~-~~~--~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      ... ..+  ++..+..++.|++.||.|||++||+||||||+||+++..  .+.++|+|||++.....             
T Consensus        97 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  174 (268)
T cd06624          97 RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCTETFTGTLQ  174 (268)
T ss_pred             HHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCCCccccCCCCcc
Confidence            754 445  888899999999999999999999999999999999642  34699999998743210             


Q ss_pred             ----------------CCc-chHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccC
Q psy2131         145 ----------------EQQ-AWFGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN  206 (328)
Q Consensus       145 ----------------~~~-~~~G~~~~~~~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~  206 (328)
                                      ..+ +.+|++++++++|.+||........ .....  ............++++.+++.+||..+
T Consensus       175 ~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~  252 (268)
T cd06624         175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--MFKIHPEIPESLSAEAKNFILRCFEPD  252 (268)
T ss_pred             ccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--hhccCCCCCcccCHHHHHHHHHHcCCC
Confidence                            112 2389999999999999975433211 11111  111111122457889999999999999


Q ss_pred             CCCCCCHHHHhcCccc
Q psy2131         207 PSKRITASEALKHPWI  222 (328)
Q Consensus       207 p~~R~t~~~~l~h~~~  222 (328)
                      |.+|||+.+++.|||+
T Consensus       253 p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         253 PDKRASAHDLLQDPFL  268 (268)
T ss_pred             chhCCCHHHHHhCCCC
Confidence            9999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.6e-35  Score=264.45  Aligned_cols=195  Identities=31%  Similarity=0.477  Sum_probs=160.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.+|+|++..........+.+.+|+.+++.++||||++++++|.. ....|++|||+ +++|.+.
T Consensus        21 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~   99 (328)
T cd07856          21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRL   99 (328)
T ss_pred             cCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHH
Confidence            789999999999999999999987654444445667889999999999999999999875 56789999998 5578766


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +. ...+++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++......              
T Consensus       100 ~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~---~~~~l~dfg~~~~~~~~--------------  161 (328)
T cd07856         100 LT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN---CDLKICDFGLARIQDPQ--------------  161 (328)
T ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC---CCEEeCccccccccCCC--------------
Confidence            54 4568888999999999999999999999999999999999753   46999999986421100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (328)
T cd07856         162 --------------------------------------------------------------------------------  161 (328)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                     ..+..|++.|+|||++.+ ..++.++|+|||||++|+|+||++||.+.++...+..
T Consensus       162 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~  217 (328)
T cd07856         162 ---------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI  217 (328)
T ss_pred             ---------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                           011246888999999876 6789999999999999999999999998776544433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-35  Score=269.21  Aligned_cols=199  Identities=31%  Similarity=0.477  Sum_probs=167.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY------HYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~------~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++...+.      .|+|+||+ |+
T Consensus        26 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~  104 (343)
T cd07851          26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GA  104 (343)
T ss_pred             CCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CC
Confidence            789999999999999999999987654444455677889999999999999999998876654      89999999 56


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++......         
T Consensus       105 ~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~---~~~kL~dfg~~~~~~~~---------  171 (343)
T cd07851         105 DLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDDE---------  171 (343)
T ss_pred             CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEcccccccccccc---------
Confidence            88777654 579999999999999999999999999999999999999754   45999999997432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (343)
T cd07851         172 --------------------------------------------------------------------------------  171 (343)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+....+..|...
T Consensus       172 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         172 --------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             --------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence                                011247888999999866 46789999999999999999999999999887777776654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=258.93  Aligned_cols=203  Identities=34%  Similarity=0.525  Sum_probs=170.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.+|+|.++...........+.+|++++++++|+||+++++++.+.+..|+||||+++ +|.+.+
T Consensus        10 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l   88 (283)
T cd05118          10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLI   88 (283)
T ss_pred             CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHH
Confidence            7899999999999999999999986654444456788899999999999999999999999999999999976 888877


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||+++|+|+||||+||+++.+   +.+||+|||.+........            
T Consensus        89 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~df~~~~~~~~~~~------------  153 (283)
T cd05118          89 KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE---GVLKLADFGLARSFGSPVR------------  153 (283)
T ss_pred             HhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC---CcEEEeeeeeeEecCCCcc------------
Confidence            664 578999999999999999999999999999999999999753   4699999998754311100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (283)
T cd05118         154 --------------------------------------------------------------------------------  153 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    ......++..|+|||.+.+. .++.++|+|||||++|+|+||++||.+.+....+.++...
T Consensus       154 --------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~  214 (283)
T cd05118         154 --------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT  214 (283)
T ss_pred             --------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                          00012367889999999876 7899999999999999999999999998877776666543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-34  Score=257.01  Aligned_cols=194  Identities=26%  Similarity=0.386  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEc----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|...    .++..+|+|+++..... .....+.+|+++++.++||||+++++++..  ....|++|||++++
T Consensus        15 g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~   93 (284)
T cd05038          15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG   93 (284)
T ss_pred             CCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCC
Confidence            789999999854    45889999999865443 345678999999999999999999999887  66899999999999


Q ss_pred             CcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+   +.++|+|||++.........+    
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~----  166 (284)
T cd05038          94 SLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---DLVKISDFGLAKVLPEDKDYY----  166 (284)
T ss_pred             CHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccccccccccCCcce----
Confidence            9999887654 58999999999999999999999999999999999999754   569999999975442111000    


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (284)
T cd05038         167 --------------------------------------------------------------------------------  166 (284)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                         .......++..|+|||.+.+..++.++|+|||||++|||+||..||...
T Consensus       167 -------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         167 -------------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             -------------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence                               0000112456699999999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.1e-35  Score=267.13  Aligned_cols=204  Identities=28%  Similarity=0.395  Sum_probs=164.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--------------CEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--------------NYHYL   66 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--------------~~~~l   66 (328)
                      |+||.||+|.+..+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++...              ...|+
T Consensus        16 g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l   93 (342)
T cd07854          16 GSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI   93 (342)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEE
Confidence            7899999999999999999999976543  3446678899999999999999999876643              35799


Q ss_pred             EEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          67 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        67 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      ||||+++ +|.+.+. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+  +..+||+|||++.......
T Consensus        94 v~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~--~~~~kl~dfg~~~~~~~~~  169 (342)
T cd07854          94 VQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE--DLVLKIGDFGLARIVDPHY  169 (342)
T ss_pred             Eeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC--CceEEECCcccceecCCcc
Confidence            9999974 8877664 4568999999999999999999999999999999999999743  3468999999875431100


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       170 ~~------------------------------------------------------------------------------  171 (342)
T cd07854         170 SH------------------------------------------------------------------------------  171 (342)
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                               ........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.++..
T Consensus       172 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  226 (342)
T cd07854         172 -------------------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE  226 (342)
T ss_pred             -------------------------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                                     000011247889999998754 568999999999999999999999999988777


Q ss_pred             HHHHHhcc
Q psy2131         306 LYAQIKAG  313 (328)
Q Consensus       306 ~~~~i~~~  313 (328)
                      ....+...
T Consensus       227 ~~~~~~~~  234 (342)
T cd07854         227 QMQLILES  234 (342)
T ss_pred             HHHHHHHh
Confidence            77766544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0603|consensus

Probab=100.00  E-value=1.2e-35  Score=273.77  Aligned_cols=210  Identities=35%  Similarity=0.604  Sum_probs=177.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+|..|.+..+++.+|+|++....      ....+|+.++.. -+||||+++.+++.+..+.|+|||++.|+.+++.
T Consensus       333 gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~r  406 (612)
T KOG0603|consen  333 GSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRR  406 (612)
T ss_pred             CCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHH
Confidence            789999999999999999999998652      122456655554 4899999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC---------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------------  144 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~---------------  144 (328)
                      +.....+. .++..|++||+.|+.|||++|+|||||||+|||+.  +..+.++|+|||.+++...               
T Consensus       407 i~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APE  483 (612)
T KOG0603|consen  407 IRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPE  483 (612)
T ss_pred             HHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhhcccchhhcccChh
Confidence            88776665 88889999999999999999999999999999996  3345699999999865432               


Q ss_pred             ---------CCcch-HHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         145 ---------EQQAW-FGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       145 ---------~~~~~-~G~~~~~~~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                               ..++| +|+++|+|++|.+||..-... .+...+..+.+.      ..+|.++++|+++||+.||.+|+++
T Consensus       484 vl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~  557 (612)
T KOG0603|consen  484 VLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGA  557 (612)
T ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcCh
Confidence                     23445 899999999999999765544 666666555443      5789999999999999999999999


Q ss_pred             HHHhcCcccCCc
Q psy2131         214 SEALKHPWICQR  225 (328)
Q Consensus       214 ~~~l~h~~~~~~  225 (328)
                      .+++.|||+.+.
T Consensus       558 ~~i~~h~w~~~~  569 (612)
T KOG0603|consen  558 DEIGAHPWFLSH  569 (612)
T ss_pred             hhhccCcchhcC
Confidence            999999999433

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=252.57  Aligned_cols=219  Identities=29%  Similarity=0.479  Sum_probs=180.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+++.+|+|+++.+. .......+.+|+.+++.++   |||++++++++.+....|+||||++|++|.
T Consensus        12 g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~   90 (277)
T cd06917          12 GAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR   90 (277)
T ss_pred             cCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHH
Confidence            789999999999999999999987543 2344567889999999997   999999999999999999999999999998


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      +++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+   +.++|+|||++.....             
T Consensus        91 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  166 (277)
T cd06917          91 TLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT---GNVKLCDFGVAALLNQNSSKRSTFVGTPY  166 (277)
T ss_pred             HHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC---CCEEEccCCceeecCCCccccccccCCcc
Confidence            87755 478999999999999999999999999999999999999764   4699999997743211             


Q ss_pred             ---------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         145 ---------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       145 ---------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                                     ..+.| +|+++|+|++|.+||.+.+.......+...  ..+.......+.++.+++.+||..||+
T Consensus       167 y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~  244 (277)
T cd06917         167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPK  244 (277)
T ss_pred             eeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcc
Confidence                           11223 799999999999999877665544333222  122222234788999999999999999


Q ss_pred             CCCCHHHHhcCcccCCcc
Q psy2131         209 KRITASEALKHPWICQRE  226 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~~  226 (328)
                      +||++.+++.|+|+.+..
T Consensus       245 ~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         245 ERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCcCHHHHhhChHhhccc
Confidence            999999999999996543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.7e-34  Score=256.64  Aligned_cols=218  Identities=25%  Similarity=0.371  Sum_probs=170.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--------EEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--------YHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--------~~~lv~E~~~   72 (328)
                      |+||.||+|.+..+++.||||.+............+.+|++++++++||||+++++++....        ..|+||||+.
T Consensus        23 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~  102 (310)
T cd07865          23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE  102 (310)
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC
Confidence            78999999999999999999998755433333345578999999999999999999987654        4599999997


Q ss_pred             CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------
Q psy2131          73 GGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------  144 (328)
Q Consensus        73 gg~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------  144 (328)
                      + +|.+.+.... .+++.++..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++.....       
T Consensus       103 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~  178 (310)
T cd07865         103 H-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGLARAFSLSKNSKPN  178 (310)
T ss_pred             c-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CcEEECcCCCcccccCCcccCCC
Confidence            5 7777776543 68999999999999999999999999999999999999754   4699999998743210       


Q ss_pred             -------------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC--------------
Q psy2131         145 -------------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--------------  184 (328)
Q Consensus       145 -------------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  184 (328)
                                               ..+.| +|+++|+|++|.+||.+.+.......+.......+              
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (310)
T cd07865         179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK  258 (310)
T ss_pred             CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhh
Confidence                                     01223 79999999999999987766544433332111111              


Q ss_pred             -----CCC---------cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         185 -----SPE---------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       185 -----~~~---------~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                           ...         ....++.+.+++.+||..||.+|||+++++.|||+
T Consensus       259 ~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                 000         01235778899999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=251.11  Aligned_cols=215  Identities=27%  Similarity=0.436  Sum_probs=175.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC------EEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEEN------YHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~------~~~lv~E~~~g   73 (328)
                      |+||.||+|.++.+++.+|+|++.....   ..+.+.+|+.+++++ +|+||+++++++.+..      ..|+||||+++
T Consensus        17 g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~   93 (275)
T cd06608          17 GTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGG   93 (275)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCC
Confidence            7899999999999999999999875432   345688999999999 7999999999997654      48999999999


Q ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc------
Q psy2131          74 GELFEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------  143 (328)
Q Consensus        74 g~L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~------  143 (328)
                      ++|.+.+..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.+   +.+||+|||++....      
T Consensus        94 ~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~  170 (275)
T cd06608          94 GSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDFGVSAQLDSTLGRR  170 (275)
T ss_pred             CcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC---CeEEECCCccceecccchhhh
Confidence            999888754    3578999999999999999999999999999999999999754   459999999864211      


Q ss_pred             --------------------------CCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHH
Q psy2131         144 --------------------------GEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  196 (328)
Q Consensus       144 --------------------------~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  196 (328)
                                                ...+.| +|+++|+|++|.+||...+.......+...... .......++.+++
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  249 (275)
T cd06608         171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP-TLKSPENWSKKFN  249 (275)
T ss_pred             cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC-CCCchhhcCHHHH
Confidence                                      012334 799999999999999876655554444433221 1111234788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         197 NLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       197 ~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      +++.+||..||++|||+.+++.|||+
T Consensus       250 ~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         250 DFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG1152|consensus

Probab=100.00  E-value=6.2e-36  Score=271.76  Aligned_cols=189  Identities=34%  Similarity=0.623  Sum_probs=165.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHH------HHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF------QKLEREARICRKLQ---HPNIVRLHDSIQEENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~------~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~~lv~E~~   71 (328)
                      |+||.|+.|.++.....|+||.|.+++.-.+.+      -.+--|++||..|+   |+||+++++.|++++++||+||--
T Consensus       572 GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~h  651 (772)
T KOG1152|consen  572 GAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVH  651 (772)
T ss_pred             cccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCC
Confidence            899999999999999999999998876433322      23456999999998   999999999999999999999964


Q ss_pred             -CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          72 -TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        72 -~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                       +|-+|++++..+..++|.++..|++||+.|+++||++||||||||-||+.++++   +.+||+|||.|....       
T Consensus       652 g~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~---g~~klidfgsaa~~k-------  721 (772)
T KOG1152|consen  652 GEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN---GFVKLIDFGSAAYTK-------  721 (772)
T ss_pred             CCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC---CeEEEeeccchhhhc-------
Confidence             578999999999999999999999999999999999999999999999999754   579999999874321       


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                 .+                                                   
T Consensus       722 ---------------------------sg---------------------------------------------------  723 (772)
T KOG1152|consen  722 ---------------------------SG---------------------------------------------------  723 (772)
T ss_pred             ---------------------------CC---------------------------------------------------
Confidence                                       11                                                   


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                                             ....++||.+|+|||++.|.+| |..-|||++||+||..+.-..||+.
T Consensus       724 -----------------------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  724 -----------------------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -----------------------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence                                   1224789999999999999999 9999999999999999999999974

>KOG0664|consensus

Probab=100.00  E-value=3.9e-37  Score=257.24  Aligned_cols=202  Identities=28%  Similarity=0.401  Sum_probs=169.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-----YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-----~~~lv~E~~~gg~   75 (328)
                      |+||+||.+.+.++|+.+|.|.+..-..+-...+++.+|+++|..++|.|++..++..+-..     .+|.++|+++. +
T Consensus        64 GAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-D  142 (449)
T KOG0664|consen   64 GAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-D  142 (449)
T ss_pred             cceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-h
Confidence            89999999999999999999998765555555678899999999999999999998876543     35899999975 8


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |...+.....++.+.+.-+++||+.||+|||+.||.||||||.|+|+++   ++.+||||||+++-....+.        
T Consensus       143 LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS---NCvLKICDFGLARvee~d~~--------  211 (449)
T KOG0664|consen  143 LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS---NCILKICDFGLARTWDQRDR--------  211 (449)
T ss_pred             hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc---CceEEecccccccccchhhh--------
Confidence            8888888889999999999999999999999999999999999999964   46799999999864311100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                             .                       .
T Consensus       212 -------------------------------------------------------~-----------------------h  213 (449)
T KOG0664|consen  212 -------------------------------------------------------L-----------------------N  213 (449)
T ss_pred             -------------------------------------------------------h-----------------------h
Confidence                                                                   0                       0


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                      .                  . ..+-|-.|.|||++.|. .|+.++||||.|||+.|||-.+..|.+.+|.+.++.|-
T Consensus       214 M------------------T-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt  271 (449)
T KOG0664|consen  214 M------------------T-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII  271 (449)
T ss_pred             h------------------H-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence            0                  0 01236679999999985 68999999999999999999999999999998888764

>KOG0671|consensus

Probab=100.00  E-value=1e-35  Score=258.85  Aligned_cols=199  Identities=29%  Similarity=0.429  Sum_probs=164.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--C----CcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--P----NIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H--~----nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.|.+|.+..++..||+|+|+.-.   +-.+..+-|+++|.++.+  |    -+|++.++|.-.++.+||+|.+ |-
T Consensus       100 GtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~  175 (415)
T KOG0671|consen  100 GTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GL  175 (415)
T ss_pred             CcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-Ch
Confidence            899999999999999999999997431   223345669999999942  2    2789999999999999999998 66


Q ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC-----------------CCCcEEEee
Q psy2131          75 ELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-----------------KGAAVKLAD  135 (328)
Q Consensus        75 ~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~-----------------~~~~vkl~D  135 (328)
                      ++++++...+  +++...++.+.+|++.+++|||+.+++|-||||||||+.+..                 +...|+|+|
T Consensus       176 S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vID  255 (415)
T KOG0671|consen  176 STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVID  255 (415)
T ss_pred             hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEe
Confidence            9999998765  588999999999999999999999999999999999987521                 234589999


Q ss_pred             ccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy2131         136 FGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE  215 (328)
Q Consensus       136 fGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~  215 (328)
                      ||.|+.....                                                                      
T Consensus       256 FGsAtf~~e~----------------------------------------------------------------------  265 (415)
T KOG0671|consen  256 FGSATFDHEH----------------------------------------------------------------------  265 (415)
T ss_pred             cCCcceeccC----------------------------------------------------------------------
Confidence            9987542111                                                                      


Q ss_pred             HhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcC
Q psy2131         216 ALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY  295 (328)
Q Consensus       216 ~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~  295 (328)
                                                             ....+.|..|.|||++.|.+++.+|||||+||||+||.||.
T Consensus       266 ---------------------------------------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  266 ---------------------------------------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             ---------------------------------------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                                                   11245799999999999999999999999999999999999


Q ss_pred             CCCCCccHH---HHHHHHhc
Q psy2131         296 PPFWDEDQH---RLYAQIKA  312 (328)
Q Consensus       296 ~Pf~~~~~~---~~~~~i~~  312 (328)
                      ..|..-+..   +.++.|.+
T Consensus       307 ~LFqtHen~EHLaMMerIlG  326 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILG  326 (415)
T ss_pred             eecccCCcHHHHHHHHHhhC
Confidence            999977633   36677665

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.8e-34  Score=259.86  Aligned_cols=221  Identities=29%  Similarity=0.412  Sum_probs=179.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH------------HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD------------FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVF   68 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~------------~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~   68 (328)
                      |+||+||+|++..+++.||+|+++........            ...+.+|+++++.++|+||+++++++...+..|+||
T Consensus        20 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   99 (335)
T PTZ00024         20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVM   99 (335)
T ss_pred             CCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEE
Confidence            89999999999999999999998754332210            124678999999999999999999999999999999


Q ss_pred             EccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc-----
Q psy2131          69 DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-----  143 (328)
Q Consensus        69 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~-----  143 (328)
                      ||+. |+|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++....     
T Consensus       100 e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~---~~~kl~dfg~~~~~~~~~~~  175 (335)
T PTZ00024        100 DIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYS  175 (335)
T ss_pred             eccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC---CCEEECCccceeeccccccc
Confidence            9997 5899988877789999999999999999999999999999999999999754   469999999875332     


Q ss_pred             --------------------------C-----------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC
Q psy2131         144 --------------------------G-----------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS  185 (328)
Q Consensus       144 --------------------------~-----------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~  185 (328)
                                                +           ..+.| +|+++++|++|.+||.+.+.......+.......+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~  255 (335)
T PTZ00024        176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE  255 (335)
T ss_pred             ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch
Confidence                                      0           01123 799999999999999888776655444321110000


Q ss_pred             ------------------------CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         186 ------------------------PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       186 ------------------------~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                                              ......+.++.+++.+||..+|++|||+++++.|||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence                                    0112457889999999999999999999999999999754

>KOG0199|consensus

Probab=100.00  E-value=2.3e-35  Score=273.04  Aligned_cols=216  Identities=29%  Similarity=0.476  Sum_probs=184.5

Q ss_pred             CCceEEEEEEEcc-CC--cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKA-TG--LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~--~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+|++|.+.. .|  ..||||.++...... ....|.+|+.+|.+|+|+|+|+||++..+ ..+.+|||+++.|+|+
T Consensus       121 GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLl  198 (1039)
T KOG0199|consen  121 GSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLL  198 (1039)
T ss_pred             cceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHH
Confidence            8999999997654 33  358999999877665 66789999999999999999999999998 6789999999999999


Q ss_pred             HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          78 EDIVA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        78 ~~l~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +.|..  +..|.....-.|+.||+.|+.||.++++|||||-..|+|+.+.   ..|||+||||.+.+....+.|      
T Consensus       199 drLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp---rtVKI~DFGLmRaLg~ned~Y------  269 (1039)
T KOG0199|consen  199 DRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP---RTVKICDFGLMRALGENEDMY------  269 (1039)
T ss_pred             HHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc---ceeeeecccceeccCCCCcce------
Confidence            99976  3457788888999999999999999999999999999999763   469999999998775544322      


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                      .|.                                                |.        .+                 
T Consensus       270 vm~------------------------------------------------p~--------rk-----------------  276 (1039)
T KOG0199|consen  270 VMA------------------------------------------------PQ--------RK-----------------  276 (1039)
T ss_pred             Eec------------------------------------------------CC--------Cc-----------------
Confidence            000                                                00        00                 


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                              -...|.|||.|+...++.++|||++||++|||+| |.-||.|....+++++|-.|.
T Consensus       277 ------------------------vPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e  332 (1039)
T KOG0199|consen  277 ------------------------VPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE  332 (1039)
T ss_pred             ------------------------CcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence                                    1234899999999999999999999999999998 599999999999999999999


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ..++|+.|+.
T Consensus       333 rLpRPk~cse  342 (1039)
T KOG0199|consen  333 RLPRPKYCSE  342 (1039)
T ss_pred             cCCCCCCChH
Confidence            9999999974

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-33  Score=244.68  Aligned_cols=217  Identities=34%  Similarity=0.479  Sum_probs=181.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..++..+++|++..........+.+.+|+.++++++||||+++++.+.+.  ...+++|||+++++|.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (260)
T cd06606          11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS   90 (260)
T ss_pred             cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHH
Confidence            7899999999999999999999987665556678889999999999999999999999988  89999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-------------
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-------------  145 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-------------  145 (328)
                      .+.....+++.++..++.|++.||.|||+.+++|+||+|+||+++.+   +.++|+|||.+......             
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  167 (260)
T cd06606          91 LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIETGEGTGSVRGTP  167 (260)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEcccccEEecccccccccccCCCCCc
Confidence            98887789999999999999999999999999999999999999753   46999999987543221             


Q ss_pred             ----------------Ccc-hHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCC
Q psy2131         146 ----------------QQA-WFGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP  207 (328)
Q Consensus       146 ----------------~~~-~~G~~~~~~~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  207 (328)
                                      .+. .+|++++++++|..||...+ .......+...  ..........+..+.+++.+|+..||
T Consensus       168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p  245 (260)
T cd06606         168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEAKDFLRKCLRRDP  245 (260)
T ss_pred             cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHHHHHHHHhCcCCh
Confidence                            112 37999999999999997765 22222222211  11112223568999999999999999


Q ss_pred             CCCCCHHHHhcCccc
Q psy2131         208 SKRITASEALKHPWI  222 (328)
Q Consensus       208 ~~R~t~~~~l~h~~~  222 (328)
                      .+||++.+++.|||+
T Consensus       246 ~~Rp~~~~ll~~~~~  260 (260)
T cd06606         246 KKRPTADELLQHPFL  260 (260)
T ss_pred             hhCCCHHHHhhCCCC
Confidence            999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=254.76  Aligned_cols=200  Identities=37%  Similarity=0.550  Sum_probs=166.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|....+++.+|||.+....... +.....+|+..+++++ |+||+++++++.+.+..|+||||+ +|+|.+.
T Consensus        10 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~   87 (283)
T cd07830          10 GTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQL   87 (283)
T ss_pred             CCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHH
Confidence            789999999999999999999987654332 2233457999999999 999999999999999999999999 7899888


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +....  .+++.++..++.|++.+|.|||++|++|+||+|+||+++.+   +.++|+|||++........          
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~---~~~~l~d~~~~~~~~~~~~----------  154 (283)
T cd07830          88 MKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP---EVVKIADFGLAREIRSRPP----------  154 (283)
T ss_pred             HHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CCEEEeecccceeccCCCC----------
Confidence            87654  78999999999999999999999999999999999999754   4599999998754311000          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (283)
T cd07830         155 --------------------------------------------------------------------------------  154 (283)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       .....|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+.+......++.+
T Consensus       155 -----------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~  213 (283)
T cd07830         155 -----------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS  213 (283)
T ss_pred             -----------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence                             001247888999998854 5679999999999999999999999998887766666554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.9e-33  Score=249.62  Aligned_cols=220  Identities=22%  Similarity=0.384  Sum_probs=180.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|..+|+|++..... .......+.+|+++++.++|||++++++++.+.+..|+|||||.| +|.+.
T Consensus        32 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~  110 (313)
T cd06633          32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDL  110 (313)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHH
Confidence            7899999999999999999999975533 334456788999999999999999999999999999999999965 77776


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc-------------C-
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------G-  144 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~-------------~-  144 (328)
                      +.. ...+++.++..++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++....             + 
T Consensus       111 l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~---~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE  187 (313)
T cd06633         111 LEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASKSSPANSFVGTPYWMAPE  187 (313)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC---CCEEEeecCCCcccCCCCCccccccccChh
Confidence            654 4568999999999999999999999999999999999999654   469999999864321             0 


Q ss_pred             ------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         145 ------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       145 ------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                                  ..+.| +|+++++|++|.+||...+.......+....  .+......++..+++++.+||+.+|.+||
T Consensus       188 ~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rp  265 (313)
T cd06633         188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQSNEWTDSFRGFVDYCLQKIPQERP  265 (313)
T ss_pred             hccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCccccCHHHHHHHHHHccCChhhCc
Confidence                        01223 7999999999999998877655554443322  22223345678899999999999999999


Q ss_pred             CHHHHhcCcccCCcc
Q psy2131         212 TASEALKHPWICQRE  226 (328)
Q Consensus       212 t~~~~l~h~~~~~~~  226 (328)
                      ++.+++.|||+....
T Consensus       266 ~~~~~l~~~~~~~~~  280 (313)
T cd06633         266 ASAELLRHDFVRRDR  280 (313)
T ss_pred             CHHHHhcCcccCCCc
Confidence            999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-34  Score=252.74  Aligned_cols=209  Identities=29%  Similarity=0.456  Sum_probs=171.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||++.+..++..+++|+++...   ........+.+|+.+++.++||||+++++++.+....++||||+++++|.
T Consensus        11 g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   90 (260)
T cd08222          11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLD   90 (260)
T ss_pred             CCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHH
Confidence            899999999999888888888776432   22333445678999999999999999999999999999999999999998


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          78 EDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        78 ~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +.+..    ...+++.++..++.|++.||.|||+.|++|+||||+||+++.    +.+||+|||++........      
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~~~~~~------  160 (260)
T cd08222          91 CKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLLMGSCD------  160 (260)
T ss_pred             HHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeecCCCcc------
Confidence            87753    356899999999999999999999999999999999999963    3499999998744311100      


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (260)
T cd08222         161 --------------------------------------------------------------------------------  160 (260)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+...+..++..+
T Consensus       161 --------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~  220 (260)
T cd08222         161 --------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG  220 (260)
T ss_pred             --------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence                                000124788999999999989999999999999999999999999988888888887776


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      .....|
T Consensus       221 ~~~~~~  226 (260)
T cd08222         221 PTPSLP  226 (260)
T ss_pred             CCCCCc
Confidence            543333

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-33  Score=243.01  Aligned_cols=215  Identities=30%  Similarity=0.507  Sum_probs=179.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+++.+++|++.....  +....+.+|+.+++.++|+||+++++.+...+..++++||++|++|.+.+
T Consensus        11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   88 (253)
T cd05122          11 GGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL   88 (253)
T ss_pred             CCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHH
Confidence            7899999999999999999999976543  35567889999999999999999999999999999999999999999888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC--------------
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE--------------  145 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~--------------  145 (328)
                      ... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||.+......              
T Consensus        89 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  165 (253)
T cd05122          89 KSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKARNTMVGTPYWMA  165 (253)
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC---CeEEEeeccccccccccccccceecCCcccC
Confidence            765 579999999999999999999999999999999999999753   46999999987654321              


Q ss_pred             ------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         146 ------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       146 ------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                  .+.| +|+++++|++|..||...+.......+...... ..+....++..+.+++.+|+..||++|||
T Consensus       166 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~t  244 (253)
T cd05122         166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLKKCLQKNPEKRPT  244 (253)
T ss_pred             HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-CcCcccccCHHHHHHHHHHccCChhhCCC
Confidence                        1223 799999999999999877554444333321111 11122234889999999999999999999


Q ss_pred             HHHHhcCcc
Q psy2131         213 ASEALKHPW  221 (328)
Q Consensus       213 ~~~~l~h~~  221 (328)
                      +.+++.|||
T Consensus       245 ~~~~l~~~~  253 (253)
T cd05122         245 AEQLLKHPF  253 (253)
T ss_pred             HHHHhcCCC
Confidence            999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=254.73  Aligned_cols=202  Identities=33%  Similarity=0.450  Sum_probs=169.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++............+.+|+.++++++|+||+++++++.+.+..|+||||+++ +|.+.+
T Consensus        10 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i   88 (282)
T cd07829          10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL   88 (282)
T ss_pred             cCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHH
Confidence            7899999999999999999999987643333446678899999999999999999999999999999999985 898888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||++||+||||+|+||+++.+   +.+||+|||++........            
T Consensus        89 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~---~~~~l~d~g~~~~~~~~~~------------  153 (282)
T cd07829          89 DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD---GVLKLADFGLARAFGIPLR------------  153 (282)
T ss_pred             HhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC---CCEEEecCCcccccCCCcc------------
Confidence            776 579999999999999999999999999999999999999753   5699999998754211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (282)
T cd07829         154 --------------------------------------------------------------------------------  153 (282)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                    ......++..|+|||++.+. .++.++|+|||||++|||++|++||.+.+....+.++.+
T Consensus       154 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  213 (282)
T cd07829         154 --------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ  213 (282)
T ss_pred             --------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence                          00012356789999999776 889999999999999999999999999887776666654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.8e-34  Score=252.84  Aligned_cols=218  Identities=30%  Similarity=0.522  Sum_probs=177.7

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLS--ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+.   .+|+.||+|+++.....  ....+.+.+|+++++++ +|+||++++++++.+...|+||||++++
T Consensus        11 G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (290)
T cd05613          11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGG   90 (290)
T ss_pred             CCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCC
Confidence            899999999875   48899999999754321  12345678899999999 6999999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------  144 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------  144 (328)
                      +|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.+   +.+||+|||++.....          
T Consensus        91 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~  167 (290)
T cd05613          91 ELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFHEDEVERAYSFC  167 (290)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC---CCEEEeeCccceeccccccccccccc
Confidence            999999888889999999999999999999999999999999999999754   4699999998754311          


Q ss_pred             --------------------CCcch-HHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCcCCCCHHHHHHH
Q psy2131         145 --------------------EQQAW-FGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLI  199 (328)
Q Consensus       145 --------------------~~~~~-~G~~~~~~~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  199 (328)
                                          ..+.| +|+++|+|++|..||.....    ......+......+    ....++.+.+++
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll  243 (290)
T cd05613         168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDII  243 (290)
T ss_pred             CCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----CccCCHHHHHHH
Confidence                                12234 79999999999999964332    22333333322222    235789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccCCc
Q psy2131         200 NQMLTVNPSKRI-----TASEALKHPWICQR  225 (328)
Q Consensus       200 ~~~l~~~p~~R~-----t~~~~l~h~~~~~~  225 (328)
                      .+|+..||.+|+     ++.+++.|||+...
T Consensus       244 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            999999999997     89999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-33  Score=253.02  Aligned_cols=218  Identities=33%  Similarity=0.492  Sum_probs=174.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----------EEEEEEEc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----------YHYLVFDL   70 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----------~~~lv~E~   70 (328)
                      |+||.||+|.++.+|+.||+|+++...........+.+|+++++.++||||+++++++.+..          .+|+|+||
T Consensus        18 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~   97 (302)
T cd07864          18 GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY   97 (302)
T ss_pred             cCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcc
Confidence            78999999999999999999999765433333456678999999999999999999987655          79999999


Q ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-----
Q psy2131          71 VTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-----  144 (328)
Q Consensus        71 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-----  144 (328)
                      +++ ++...+... ..+++..+..++.|++.||+|||+.||+||||||+||+++.+   +.+||+|||++.....     
T Consensus        98 ~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~~~~~  173 (302)
T cd07864          98 MDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRP  173 (302)
T ss_pred             cCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CcEEeCcccccccccCCcccc
Confidence            986 676666543 468999999999999999999999999999999999999754   4699999998753210     


Q ss_pred             ------------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC--------------
Q psy2131         145 ------------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------------  185 (328)
Q Consensus       145 ------------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------  185 (328)
                                              ..+.| +|+++++|++|.+||...+.......+.......+.              
T Consensus       174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T cd07864         174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT  253 (302)
T ss_pred             cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccc
Confidence                                    01223 799999999999999877665554444332111100              


Q ss_pred             ------------CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         186 ------------PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       186 ------------~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                                  ..+..+++.+.+++.+||..||.+||++.+++.|||+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         254 MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                        1123468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0669|consensus

Probab=100.00  E-value=1.4e-35  Score=245.16  Aligned_cols=224  Identities=26%  Similarity=0.398  Sum_probs=177.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE--------eCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--------EENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--------~~~~~~lv~E~~~   72 (328)
                      |+||+||+|+.+.+|+.||+|++-.+....---....+|+++|..|+|+|++.+++.+.        +...+|+|+++|+
T Consensus        28 GtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce  107 (376)
T KOG0669|consen   28 GTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE  107 (376)
T ss_pred             chHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh
Confidence            88999999999999999999987543221111234578999999999999999887764        3456899999998


Q ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------
Q psy2131          73 GGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------  144 (328)
Q Consensus        73 gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------  144 (328)
                      . +|.-.+... ..++..++..++.+++.||.|+|.+.|+|||+||+|+||+.+   +.+||+|||+++.+..       
T Consensus       108 h-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d---gilklADFGlar~fs~~~n~~kp  183 (376)
T KOG0669|consen  108 H-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD---GILKLADFGLARAFSTSKNVVKP  183 (376)
T ss_pred             h-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC---ceEEeeccccccceecccccCCC
Confidence            7 787777655 479999999999999999999999999999999999999754   5799999999864321       


Q ss_pred             -------------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCC--------
Q psy2131         145 -------------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT--------  190 (328)
Q Consensus       145 -------------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--------  190 (328)
                                               .-+.| .||++.+|.++.+-+.+.+++..+..|..-..++....|+.        
T Consensus       184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~  263 (376)
T KOG0669|consen  184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQ  263 (376)
T ss_pred             CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHH
Confidence                                     11223 69999999999999999988777766654333322222221        


Q ss_pred             -----------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         191 -----------------------VTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       191 -----------------------~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                             -++++.+|+.++|..||.+|++++++++|.||......
T Consensus       264 sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  264 SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                                   24578899999999999999999999999999876544

>KOG4257|consensus

Probab=100.00  E-value=2.4e-34  Score=263.37  Aligned_cols=214  Identities=26%  Similarity=0.390  Sum_probs=181.3

Q ss_pred             CCceEEEEEEEc----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |-||.||+|.-.    ....-||||..+.+. +.++.+.|..|+.+|+.++|||||++++++.+. ..|||||+++-|.|
T Consensus       400 GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GEL  477 (974)
T KOG4257|consen  400 GQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGEL  477 (974)
T ss_pred             CcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhH
Confidence            789999999643    233458999987654 445578899999999999999999999999876 48999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      ..+|+.++ .++......|+.||+.||.|||+.+.|||||-..|||+.+.   .+|||+||||++.+..+..+       
T Consensus       478 r~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp---~CVKLaDFGLSR~~ed~~yY-------  547 (974)
T KOG4257|consen  478 REYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP---QCVKLADFGLSRYLEDDAYY-------  547 (974)
T ss_pred             HHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc---ceeeecccchhhhccccchh-------
Confidence            99998754 68889999999999999999999999999999999999753   57999999999877554321       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                      ....|+.                                                                         
T Consensus       548 kaS~~kL-------------------------------------------------------------------------  554 (974)
T KOG4257|consen  548 KASRGKL-------------------------------------------------------------------------  554 (974)
T ss_pred             hcccccc-------------------------------------------------------------------------
Confidence            0001111                                                                         


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHH-hcCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILL-VGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyell-tG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                               ...|||||.++-+.++.++|||-|||.|||.| -|.-||.+-...++.-+|..|.
T Consensus       555 -------------------------PIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe  609 (974)
T KOG4257|consen  555 -------------------------PIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE  609 (974)
T ss_pred             -------------------------ceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC
Confidence                                     22399999999999999999999999999855 6999999999999999999999


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ..|-|+.|+.
T Consensus       610 RlP~P~nCPp  619 (974)
T KOG4257|consen  610 RLPCPPNCPP  619 (974)
T ss_pred             CCCCCCCCCh
Confidence            9999999974

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-33  Score=249.35  Aligned_cols=218  Identities=30%  Similarity=0.522  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLS--ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+.   .+++.+|+|+++.....  ......+.+|++++.++ +||||+++++.+......|+||||+.+|
T Consensus        11 G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (288)
T cd05583          11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG   90 (288)
T ss_pred             CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCC
Confidence            799999999854   46789999999754322  22345678899999999 6999999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------  144 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------  144 (328)
                      +|.+.+.....+++..+..++.|++.||.|||+.+++||||||+||+++.+   +.++|+|||++.....          
T Consensus        91 ~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~  167 (288)
T cd05583          91 ELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE---GHVVLTDFGLSKEFLAEEEERAYSFC  167 (288)
T ss_pred             cHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEEECcccccccccccccccccc
Confidence            999998877789999999999999999999999999999999999999754   4599999998753210          


Q ss_pred             --------------------CCcch-HHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCcCCCCHHHHHHH
Q psy2131         145 --------------------EQQAW-FGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLI  199 (328)
Q Consensus       145 --------------------~~~~~-~G~~~~~~~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  199 (328)
                                          ..+.| +|+++++|++|..||...+.    ......+.....    +....+++.+.+++
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li  243 (288)
T cd05583         168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PFPKTMSAEARDFI  243 (288)
T ss_pred             CCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CCCcccCHHHHHHH
Confidence                                11223 89999999999999964332    222233332222    22245789999999


Q ss_pred             HHhcccCCCCCCC---HHHHhcCcccCCc
Q psy2131         200 NQMLTVNPSKRIT---ASEALKHPWICQR  225 (328)
Q Consensus       200 ~~~l~~~p~~R~t---~~~~l~h~~~~~~  225 (328)
                      .+||+.||++|||   +.++++|||+...
T Consensus       244 ~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         244 QKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            9999999999998   5677999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0576|consensus

Probab=100.00  E-value=6e-35  Score=269.14  Aligned_cols=295  Identities=25%  Similarity=0.383  Sum_probs=234.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+++++.+++..|+|+++...  .+++.-+.+|+-+++..+|||||.+++.+...+.+|++||||.||+|.+..
T Consensus        26 gTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy  103 (829)
T KOG0576|consen   26 GTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY  103 (829)
T ss_pred             CcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee
Confidence            899999999999999999999998653  345677889999999999999999999999999999999999999999888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                      .--++++|.++....++.+.||+|||++|-+|||||-.|||+++.++   +|+.|||.+.++..                
T Consensus       104 ~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitati~KrksfiGtpywma  180 (829)
T KOG0576|consen  104 HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITATIAKRKSFIGTPYWMA  180 (829)
T ss_pred             eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhhhhhhhcccCCccccc
Confidence            88889999999999999999999999999999999999999987654   99999998755421                


Q ss_pred             --------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-CcCCCCHHHHHHHHHhcccCCC
Q psy2131         145 --------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-EWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       145 --------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~  208 (328)
                                    ..+.| .|+...++..-.+|.++..+.....-+.+..+..|.. +..++++.+.+|++.+|.++|.
T Consensus       181 pEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpK  260 (829)
T KOG0576|consen  181 PEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPK  260 (829)
T ss_pred             hhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCc
Confidence                          11223 5888889988899998888887777777777766643 4567999999999999999999


Q ss_pred             CCCCHHHHhcCcccCCcccchh----------------------------------------hhhhhhhHHHHHhHHH--
Q psy2131         209 KRITASEALKHPWICQRERVAS----------------------------------------IVHRQETVDCLKKFNA--  246 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~--  246 (328)
                      +||+++.+|.|||+.+.....-                                        .......-..+..+..  
T Consensus       261 kRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~  340 (829)
T KOG0576|consen  261 KRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAY  340 (829)
T ss_pred             cCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhh
Confidence            9999999999999865311000                                        0000000000000000  


Q ss_pred             --------------h----h-----------hh---------hhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHH
Q psy2131         247 --------------R----R-----------KL---------KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVIL  288 (328)
Q Consensus       247 --------------~----~-----------~~---------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvil  288 (328)
                                    .    +           ..         .......+.||+.++|||+..+..|....|+||+|+--
T Consensus       341 ~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~  420 (829)
T KOG0576|consen  341 PLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSA  420 (829)
T ss_pred             hhhhhcccccccccccccCcccccccccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcch
Confidence                          0    0           00         00113346799999999999999999999999999988


Q ss_pred             HHHHhcCCCCCC
Q psy2131         289 YILLVGYPPFWD  300 (328)
Q Consensus       289 yelltG~~Pf~~  300 (328)
                      -+|--|.+|-..
T Consensus       421 ~~~ap~~pPr~~  432 (829)
T KOG0576|consen  421 IQMAPGLPPRSS  432 (829)
T ss_pred             hhcCCCCCCCCC
Confidence            888888877443

>KOG0587|consensus

Probab=100.00  E-value=1.2e-33  Score=267.66  Aligned_cols=200  Identities=28%  Similarity=0.496  Sum_probs=171.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEE-----eCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ-----EENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~-----~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+++++.+++..|+|+.....   +.-+.++.|.++|+.+ +|||++.+|++|.     .++.+|||||||.||
T Consensus        30 Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gG  106 (953)
T KOG0587|consen   30 GTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGG  106 (953)
T ss_pred             ccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCc
Confidence            889999999999999999999987653   3335667789999877 7999999999986     357899999999999


Q ss_pred             CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          75 ELFEDIVA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        75 ~L~~~l~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      +.-+++..  ...+.|.-+..|++.++.||.+||.+.++|||||-.|||++.++   .|||+|||.+.+++...      
T Consensus       107 SVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~---~VKLvDFGvSaQldsT~------  177 (953)
T KOG0587|consen  107 SVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA---EVKLVDFGVSAQLDSTV------  177 (953)
T ss_pred             cHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC---cEEEeeeeeeeeeeccc------
Confidence            99887754  35688999999999999999999999999999999999998654   59999999986653211      


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       178 --------------------------------------------------------------------------------  177 (953)
T KOG0587|consen  178 --------------------------------------------------------------------------------  177 (953)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHH
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY  307 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  307 (328)
                                          ..+.++.|||.|||||++.     ...|+..+|+||||++-.||--|.||+.+..|.+.+
T Consensus       178 --------------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL  237 (953)
T KOG0587|consen  178 --------------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL  237 (953)
T ss_pred             --------------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence                                1344678999999999995     235788999999999999999999999999999988


Q ss_pred             HHHhc
Q psy2131         308 AQIKA  312 (328)
Q Consensus       308 ~~i~~  312 (328)
                      -+|-+
T Consensus       238 F~IpR  242 (953)
T KOG0587|consen  238 FLIPR  242 (953)
T ss_pred             ccCCC
Confidence            88754

>KOG2345|consensus

Probab=100.00  E-value=3e-34  Score=236.71  Aligned_cols=211  Identities=29%  Similarity=0.442  Sum_probs=173.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-----~~~~~lv~E~~~gg~   75 (328)
                      |||+-|+.+.+..++..||+|.|....  .++.+..++|++..++++|||+++++++...     ....||++.|...|+
T Consensus        32 GGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gs  109 (302)
T KOG2345|consen   32 GGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGS  109 (302)
T ss_pred             CCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcccc
Confidence            899999999999999999999998654  5677889999999999999999999887643     345899999999999


Q ss_pred             cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccc-------
Q psy2131          76 LFEDIVA----REFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-------  142 (328)
Q Consensus        76 L~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~-------  142 (328)
                      |++.+..    ...++|.++..|+.+|+.||++||+..  ..||||||.|||+.+.   +.++|.|||.+...       
T Consensus       110 l~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~---~~~vl~D~GS~~~a~i~i~~~  186 (302)
T KOG2345|consen  110 LLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS---GLPVLMDLGSATQAPIQIEGS  186 (302)
T ss_pred             HHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC---CceEEEeccCccccceEeech
Confidence            9998864    237999999999999999999999998  9999999999999763   46999999987532       


Q ss_pred             --------------------------------cCCCcch-HHHHHHHHHhCCCCCCCCcH--HHHHHHHHhCCCCCCCCC
Q psy2131         143 --------------------------------QGEQQAW-FGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPE  187 (328)
Q Consensus       143 --------------------------------~~~~~~~-~G~~~~~~~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~  187 (328)
                                                      +...+.| +||++|.|+.|..||...-+  .++.-.+.++.+.+|.  
T Consensus       187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~--  264 (302)
T KOG2345|consen  187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN--  264 (302)
T ss_pred             HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC--
Confidence                                            1122334 89999999999999954322  1222233444444443  


Q ss_pred             cCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         188 WDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       188 ~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      ....|+.+.++|+.||+.||.+||++.+++.
T Consensus       265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~  295 (302)
T KOG2345|consen  265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLS  295 (302)
T ss_pred             CCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            3459999999999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-32  Score=234.50  Aligned_cols=210  Identities=41%  Similarity=0.595  Sum_probs=178.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||++.+..+++.+|+|.+...... .....+.+|++.+++++|+|++++++.+......++++||+.+++|.+.+
T Consensus        10 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   88 (225)
T smart00221       10 GAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYL   88 (225)
T ss_pred             CCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHH
Confidence            78999999999988999999999865433 24567889999999999999999999999999999999999999999988


Q ss_pred             HhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~-~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ..... +++..+..++.+++.++.|||+.+++|+||+|+||+++..   ..++|+|||++........            
T Consensus        89 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~------------  153 (225)
T smart00221       89 RKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLA------------  153 (225)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCccc------------
Confidence            77666 8999999999999999999999999999999999999764   4699999998754311100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       154 --------------------------------------------------------------------------------  153 (225)
T smart00221      154 --------------------------------------------------------------------------------  153 (225)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccc-ccCCCCCCcchhhhhhHHHHHHhcCCCCCC--ccHHHHHHHHhcccCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYD  316 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~  316 (328)
                                   .......|+..|++||.+ ...+++.++|+||||+++|||++|++||.+  .+...+.++|..|...
T Consensus       154 -------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      154 -------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             -------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence                         001123478889999999 777888899999999999999999999988  4566999999999875


Q ss_pred             CCC
Q psy2131         317 DEP  319 (328)
Q Consensus       317 ~~~  319 (328)
                      +.|
T Consensus       221 ~~~  223 (225)
T smart00221      221 LWE  223 (225)
T ss_pred             ccc
Confidence            555

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665|consensus

Probab=100.00  E-value=1.4e-34  Score=246.54  Aligned_cols=199  Identities=27%  Similarity=0.413  Sum_probs=168.7

Q ss_pred             EEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCCCcHH
Q psy2131           5 VVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         5 ~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg~L~~   78 (328)
                      .|.-|.+..+++.+|+|.+..........++..+|..++..++|+||++++.+|.-.      ..+|+||||+.+ +|.+
T Consensus        31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~  109 (369)
T KOG0665|consen   31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQ  109 (369)
T ss_pred             eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHH
Confidence            477788889999999999887776666778889999999999999999999999644      356999999965 7877


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .+.  ..++-..+..++.|++.|++|||+.||+||||||+||++..+   +.+||.|||+|+.....             
T Consensus       110 vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~---~~lKi~dfg~ar~e~~~-------------  171 (369)
T KOG0665|consen  110 VIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD---CTLKILDFGLARTEDTD-------------  171 (369)
T ss_pred             HHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch---hheeeccchhhcccCcc-------------
Confidence            765  447788899999999999999999999999999999999754   56999999998543110             


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                               .                      
T Consensus       172 ---------------------------------------------------------~----------------------  172 (369)
T KOG0665|consen  172 ---------------------------------------------------------F----------------------  172 (369)
T ss_pred             ---------------------------------------------------------c----------------------
Confidence                                                                     0                      


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                     +-..++.|.-|.|||++.+.+|...+||||+|||+.||++|+.-|.|.+....+.+|.+..=+
T Consensus       173 ---------------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  173 ---------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT  235 (369)
T ss_pred             ---------------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence                           011245788899999999999999999999999999999999999999999999998765443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.7e-33  Score=286.10  Aligned_cols=177  Identities=27%  Similarity=0.330  Sum_probs=147.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|..||+|.+......      ...|++++++++|||||++++++.+.+..|+|||||++|+|.+++
T Consensus       701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  774 (968)
T PLN00113        701 GKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL  774 (968)
T ss_pred             CCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence            89999999999999999999998643221      134688999999999999999999999999999999999999888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCH---SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH---~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ..   +++.+...++.|++.||+|||   +.+|+||||||+||+++.+.   ..++. ||.+....              
T Consensus       775 ~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---~~~~~-~~~~~~~~--------------  833 (968)
T PLN00113        775 RN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---EPHLR-LSLPGLLC--------------  833 (968)
T ss_pred             hc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC---ceEEE-eccccccc--------------
Confidence            53   788899999999999999999   67999999999999997543   34443 44321100              


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       834 --------------------------------------------------------------------------------  833 (968)
T PLN00113        834 --------------------------------------------------------------------------------  833 (968)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                                      ......||+.|+|||++.+..|+.++|||||||+||||+||+.||..
T Consensus       834 ----------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        834 ----------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ----------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence                            00012478999999999999999999999999999999999999854

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.7e-32  Score=240.50  Aligned_cols=220  Identities=22%  Similarity=0.313  Sum_probs=171.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.+|+|.++..... .....+.+|+.++.+. +||||+++++++.+....|++|||+.+ +|.+.
T Consensus        26 g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l  103 (296)
T cd06618          26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKL  103 (296)
T ss_pred             cCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHH
Confidence            78999999999999999999999765332 2344566677766666 599999999999999999999999854 66655


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------  144 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------  144 (328)
                      +.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.+   +.+||+|||++..+..             
T Consensus       104 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~y  180 (296)
T cd06618         104 LKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS---GNVKLCDFGISGRLVDSKAKTRSAGCAAY  180 (296)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC---CCEEECccccchhccCCCcccCCCCCccc
Confidence            544 4578999999999999999999997 599999999999999743   4699999998753210             


Q ss_pred             -----------------CCcc-hHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhccc
Q psy2131         145 -----------------EQQA-WFGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       145 -----------------~~~~-~~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  205 (328)
                                       ..+. .+|+++|+|++|..||..... ......+....... .+.....+.++.+++.+||..
T Consensus       181 ~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  259 (296)
T cd06618         181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEGFSPDFCSFVDLCLTK  259 (296)
T ss_pred             cCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHHHccC
Confidence                             1122 389999999999999976433 23333333322111 112225788999999999999


Q ss_pred             CCCCCCCHHHHhcCcccCCcc
Q psy2131         206 NPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ||.+||++.+++.|+|+....
T Consensus       260 ~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         260 DHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ChhhCCCHHHHhcChhhhccc
Confidence            999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4278|consensus

Probab=100.00  E-value=2.8e-33  Score=256.41  Aligned_cols=215  Identities=24%  Similarity=0.403  Sum_probs=184.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |.||.||.++++.-..-+|||.++.+.+   .+++|+.|+.+|+.++|||+|+|+++|..+..+|||+|||..|+|+++|
T Consensus       278 GQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL  354 (1157)
T KOG4278|consen  278 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL  354 (1157)
T ss_pred             Ccccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHH
Confidence            7799999999999999999999976543   5678999999999999999999999999999999999999999999999


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  -++.-....++.||..|+.||..+++|||||-..|+|+.   ++..||++||||++...++...-         
T Consensus       355 Recnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTA---------  422 (1157)
T KOG4278|consen  355 RECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTA---------  422 (1157)
T ss_pred             HHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceec---------
Confidence            8754  366666778889999999999999999999999999995   45679999999997654432100         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       423 --------------------------------------------------------------------------------  422 (1157)
T KOG4278|consen  423 --------------------------------------------------------------------------------  422 (1157)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                      ..+.--...|.|||-|....++.++|||+|||+|||+.| |--||.+-+..+++..+..|..+.
T Consensus       423 ----------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  423 ----------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD  486 (1157)
T ss_pred             ----------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence                            000001234899999999999999999999999999875 889999999999999999999999


Q ss_pred             CCCccccCc
Q psy2131         318 EPKHKSASV  326 (328)
Q Consensus       318 ~~~~~~~~~  326 (328)
                      .|--|+..+
T Consensus       487 ~PeGCPpkV  495 (1157)
T KOG4278|consen  487 GPEGCPPKV  495 (1157)
T ss_pred             CCCCCCHHH
Confidence            999887543

>KOG0668|consensus

Probab=100.00  E-value=2.7e-32  Score=222.91  Aligned_cols=214  Identities=27%  Similarity=0.471  Sum_probs=169.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--EEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEEN--YHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~--~~~lv~E~~~gg~L~   77 (328)
                      |.|++||.|++..+++.++||++++-     ..+.+.||++||..|. |||||++++...+..  ..-||+||+++.+..
T Consensus        49 GKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk  123 (338)
T KOG0668|consen   49 GKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFK  123 (338)
T ss_pred             ccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHH
Confidence            78999999999999999999999753     3467899999999996 999999999998654  568999999986654


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-----------
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-----------  146 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-----------  146 (328)
                      ...   ..++..+++.++.|++.||.|||++||+|||+||.|+||+...  ..++|+|+|||....+.+           
T Consensus       124 ~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--rkLrlIDWGLAEFYHp~~eYnVRVASRyf  198 (338)
T KOG0668|consen  124 QLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYF  198 (338)
T ss_pred             HHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--ceeeeeecchHhhcCCCceeeeeeehhhc
Confidence            333   4588899999999999999999999999999999999998654  479999999986543221           


Q ss_pred             -----------------cchHHHHHHHHHhCCCCCCC-CcHHHHHHHH-------------HhCCCCC------------
Q psy2131         147 -----------------QAWFGVILYILLVGYPPFWD-EDQHRLYAQI-------------KAGAYDY------------  183 (328)
Q Consensus       147 -----------------~~~~G~~~~~~~~g~~pf~~-~~~~~~~~~i-------------~~~~~~~------------  183 (328)
                                       .+.+||.+..|...+.||+. .++.+.+..|             ..-....            
T Consensus       199 KGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~  278 (338)
T KOG0668|consen  199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHS  278 (338)
T ss_pred             CCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccc
Confidence                             12389999999999999854 3333322222             1111111            


Q ss_pred             --------CCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         184 --------PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       184 --------~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                              ++.+....++++.||+.++|..|-..|+||.|++.||||..
T Consensus       279 rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  279 RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                    11223346899999999999999999999999999999854

>KOG1094|consensus

Probab=99.98  E-value=1.7e-32  Score=249.63  Aligned_cols=215  Identities=21%  Similarity=0.320  Sum_probs=170.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |-||+|.+|.-. .+..||+|.++... .......|.+|+++|.+|+|||||+++++|..++.+++||||++.|+|.+++
T Consensus       549 GqFGEVhLCeve-g~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl  626 (807)
T KOG1094|consen  549 GQFGEVHLCEVE-GPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFL  626 (807)
T ss_pred             cccceeEEEEec-CceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHH
Confidence            789999999754 47899999998653 2334577999999999999999999999999999999999999999999999


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ..+.  .........++.||+.|++||.+.++|||||.+.|+|++.+   ..+||+|||+++.+-..+.+-         
T Consensus       627 ~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e---~~iKiadfgmsR~lysg~yy~---------  694 (807)
T KOG1094|consen  627 SAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE---FTIKIADFGMSRNLYSGDYYR---------  694 (807)
T ss_pred             HhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc---ccEEecCcccccccccCCcee---------
Confidence            8774  33445566799999999999999999999999999999754   469999999998653322110         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                       +                                                              
T Consensus       695 -----------------v--------------------------------------------------------------  695 (807)
T KOG1094|consen  695 -----------------V--------------------------------------------------------------  695 (807)
T ss_pred             -----------------e--------------------------------------------------------------
Confidence                             0                                                              


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHH--hcCCCCCCccHHHHHHHHh-----
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILL--VGYPPFWDEDQHRLYAQIK-----  311 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyell--tG~~Pf~~~~~~~~~~~i~-----  311 (328)
                                      ...++=...|||+|.+....+++++|+|+|||+|||++  ....||......++..+-.     
T Consensus       696 ----------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~  759 (807)
T KOG1094|consen  696 ----------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD  759 (807)
T ss_pred             ----------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence                            00011134599999999999999999999999999865  5688999887777766633     


Q ss_pred             --cccCCCCCCcccc
Q psy2131         312 --AGAYDDEPKHKSA  324 (328)
Q Consensus       312 --~~~~~~~~~~~~~  324 (328)
                        ...|...|+-|+.
T Consensus       760 ~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  760 QGRQVVLSRPPACPQ  774 (807)
T ss_pred             CCcceeccCCCcCcH
Confidence              2334455555543

>KOG0200|consensus

Probab=99.98  E-value=2.8e-31  Score=257.93  Aligned_cols=215  Identities=27%  Similarity=0.432  Sum_probs=180.2

Q ss_pred             CCceEEEEEEEc----c---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQK----A---TGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~----~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |.||.|++|.-.    .   ....||||.++..... .+.+.+..|+++|+.+ +|+||+.+.+++..++.+++|+|||.
T Consensus       307 g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~  385 (609)
T KOG0200|consen  307 GAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAE  385 (609)
T ss_pred             ccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEecc
Confidence            789999999633    1   1457999999866544 6778899999999998 59999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      .|+|.+++...+                .++..+...+..||+.|++||++.++|||||-..|||+..   +..+||+||
T Consensus       386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~---~~~~kIaDF  462 (609)
T KOG0200|consen  386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK---NKVIKIADF  462 (609)
T ss_pred             CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC---CCEEEEccc
Confidence            999999998765                3788899999999999999999999999999999999964   357999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |+|+.......+-                                                                   
T Consensus       463 Glar~~~~~~~y~-------------------------------------------------------------------  475 (609)
T KOG0200|consen  463 GLARDHYNKDYYR-------------------------------------------------------------------  475 (609)
T ss_pred             cceeccCCCCceE-------------------------------------------------------------------
Confidence            9997643322100                                                                   


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCC--CCCCCccccccCCCCCCcchhhhhhHHHHHHh-
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT--PGYLSPEVLKKEPYGKPVDIWACGVILYILLV-  293 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt--~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-  293 (328)
                                                            ..+..|+  ..|||||.+....|+.++|||||||+|||++| 
T Consensus       476 --------------------------------------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  476 --------------------------------------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             --------------------------------------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence                                                  0001121  23999999999999999999999999999987 


Q ss_pred             cCCCCCCcc-HHHHHHHHhcccCCCCCCcccc
Q psy2131         294 GYPPFWDED-QHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       294 G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      |..||.+-. ...+++.+.+|.....|.+|+.
T Consensus       518 G~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~  549 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLEFLKEGNRMEQPEHCSD  549 (609)
T ss_pred             CCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence            699999865 7778999999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2e-30  Score=223.72  Aligned_cols=216  Identities=43%  Similarity=0.708  Sum_probs=180.8

Q ss_pred             CceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHH
Q psy2131           2 AFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIV   81 (328)
Q Consensus         2 ~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~   81 (328)
                      +||.||+|.+..+|+.+|+|++........ .+.+.+|++.+++++|+||+++++.+......++++||+.+++|.+.+.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            699999999999999999999976543321 5678899999999999999999999999999999999999999999887


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC----------------
Q psy2131          82 AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE----------------  145 (328)
Q Consensus        82 ~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~----------------  145 (328)
                      ....++...+..++.+++.++.|||+.+++|+||+|.||+++.+   +.++|+|||.+......                
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            76668999999999999999999999999999999999999754   46999999987644221                


Q ss_pred             ----------Ccch-HHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         146 ----------QQAW-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       146 ----------~~~~-~G~~~~~~~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                                .+.| +|++++++++|..||.. .+.......+........ ......+.++.+++.+|+..+|.+||++
T Consensus       157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccCH
Confidence                      1222 79999999999999977 555555555554433322 2222278899999999999999999999


Q ss_pred             HHHhcCccc
Q psy2131         214 SEALKHPWI  222 (328)
Q Consensus       214 ~~~l~h~~~  222 (328)
                      .++++|||+
T Consensus       236 ~~~~~~~~~  244 (244)
T smart00220      236 EEALQHPFF  244 (244)
T ss_pred             HHHhhCCCC
Confidence            999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603|consensus

Probab=99.97  E-value=9.1e-33  Score=254.85  Aligned_cols=212  Identities=29%  Similarity=0.521  Sum_probs=177.3

Q ss_pred             CCceEEEEEE---EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCV---QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~---~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.|++++   ....|..+|+|+.++.............|..++..++ ||.+|+++..|+.+..+|++++|..||+|
T Consensus         5 g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~l   84 (612)
T KOG0603|consen    5 GSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDL   84 (612)
T ss_pred             CCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchh
Confidence            7899988664   3457788999999876654444345567888999887 99999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc-------------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------  143 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~-------------  143 (328)
                      +..+.....+.+.+.+.+..+++.+++++|+.+|+|||+|++||+++.+|   .+++.|||++++..             
T Consensus        85 ft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G---hi~~tdfglske~v~~~~~cgt~eymA  161 (612)
T KOG0603|consen   85 FTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG---HIKLTDFGLSKEAVKEKIACGTYEYRA  161 (612)
T ss_pred             hhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC---ccccCCchhhhHhHhhhhcccchhhhh
Confidence            99998888999999999999999999999999999999999999998665   49999999986531             


Q ss_pred             --------CCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC---
Q psy2131         144 --------GEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI---  211 (328)
Q Consensus       144 --------~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~---  211 (328)
                              ...++| +|++.++|++|..||..    +...+|.......|    ..++..+++++.+++..+|.+|.   
T Consensus       162 pEI~~gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r~p~nrLg~~  233 (612)
T KOG0603|consen  162 PEIINGHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----RELSAEARSLFRQLFKRNPENRLGAG  233 (612)
T ss_pred             hHhhhccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhhCHHHHhccC
Confidence                    122344 69999999999999988    55556665555544    36789999999999999999997   


Q ss_pred             --CHHHHhcCcccC
Q psy2131         212 --TASEALKHPWIC  223 (328)
Q Consensus       212 --t~~~~l~h~~~~  223 (328)
                        -+.++.+|+++.
T Consensus       234 ~~~~~eik~h~f~~  247 (612)
T KOG0603|consen  234 PDGVDEIKQHEFFQ  247 (612)
T ss_pred             cchhHHHhccchhe
Confidence              457888988873

>KOG0670|consensus

Probab=99.97  E-value=3.9e-32  Score=244.46  Aligned_cols=189  Identities=29%  Similarity=0.424  Sum_probs=157.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC------CCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H------~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |-||+|.+|.+...|..||||+|.+...   -...=++|++||++|+.      -|+++|+..|...+++|||+|-+. .
T Consensus       443 GvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-l  518 (752)
T KOG0670|consen  443 GVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-L  518 (752)
T ss_pred             ceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-c
Confidence            6799999999999999999999986432   22334689999999963      489999999999999999999884 4


Q ss_pred             CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          75 ELFEDIVARE---FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        75 ~L~~~l~~~~---~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      +|.+.|..-+   .+....++.|+.|+..||..|-..||+|.||||.|||++..  ...+||||||.|........+   
T Consensus       519 NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~--k~iLKLCDfGSA~~~~eneit---  593 (752)
T KOG0670|consen  519 NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES--KNILKLCDFGSASFASENEIT---  593 (752)
T ss_pred             hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC--cceeeeccCcccccccccccc---
Confidence            8888887654   37778899999999999999999999999999999999764  357999999998554322110   


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                          |           
T Consensus       594 --------------------------------------------------------------------P-----------  594 (752)
T KOG0670|consen  594 --------------------------------------------------------------------P-----------  594 (752)
T ss_pred             --------------------------------------------------------------------H-----------
Confidence                                                                                0           


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                                +.-+..|.|||++.|.+|+...|+||.||+||||.||+..|.|...
T Consensus       595 --------------------------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  595 --------------------------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             --------------------------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence                                      1124459999999999999999999999999999999999999853

>KOG1167|consensus

Probab=99.97  E-value=5.2e-32  Score=238.64  Aligned_cols=230  Identities=27%  Similarity=0.406  Sum_probs=163.5

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+|++||++.+..   .++.||+|.|....    ...++.+|+++|..+ .+.||+++.+++...+...+|+||+++.+.
T Consensus        47 GsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f  122 (418)
T KOG1167|consen   47 GSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRF  122 (418)
T ss_pred             cchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCH
Confidence            8999999998887   88999999997653    345688999999998 689999999999999999999999999776


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+++..   ++..+++.|++.++.||.++|.+|||||||||+|+|.+...  +.-.|+|||||...+..+..-       
T Consensus       123 ~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t--~rg~LvDFgLA~~~d~~~~~~-------  190 (418)
T KOG1167|consen  123 RDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT--QRGVLVDFGLAQRYDGYQQTE-------  190 (418)
T ss_pred             HHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc--CCceEEechhHHHHHhhhhhh-------
Confidence            665543   67889999999999999999999999999999999998654  456799999996422211000       


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                          ....+..+     ..++.        -..++.....+.-.....+.+             
T Consensus       191 --------------------~s~~~~~~-----~~~~~--------~g~~~~~~~~~~~~~p~g~~~-------------  224 (418)
T KOG1167|consen  191 --------------------HSRSYSGR-----HATPA--------MGKDVHCQSVATASKPAGYYR-------------  224 (418)
T ss_pred             --------------------hhhhhhcc-----cCCcc--------ccCcccccccccccCCCCcee-------------
Confidence                                00000000     00000        000000000000000000000             


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                               ..+..+...+...+|||||.|||++..- ..++++|+||.|||++-+++++.||.-.
T Consensus       225 ---------~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  225 ---------RCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             ---------ccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence                     0012233445566899999999999775 4589999999999999999999999854

>KOG1027|consensus

Probab=99.97  E-value=1.7e-31  Score=252.09  Aligned_cols=204  Identities=32%  Similarity=0.526  Sum_probs=161.5

Q ss_pred             CCce-EEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFS-VVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg-~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+-| .||+|.-  .|+.||||.+-.+     ......|||..|+.- +|||||++|+.-.++...||+.|.|.- +|.+
T Consensus       520 Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d  591 (903)
T KOG1027|consen  520 GSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD  591 (903)
T ss_pred             CCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence            3344 6899875  6779999987543     345668999999987 699999999999999999999999975 8988


Q ss_pred             HHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC--CCcEEEeeccccccccCCCcchHHH
Q psy2131          79 DIVAREF----YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK--GAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        79 ~l~~~~~----~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~--~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      ++.....    ....+....+.|++.||++||+.+||||||||.||||...+.  ...++|+|||+++.+...+..    
T Consensus       592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS----  667 (903)
T KOG1027|consen  592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS----  667 (903)
T ss_pred             HHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch----
Confidence            8876311    111345778899999999999999999999999999987422  246899999999876543321    


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       668 --------------------------------------------------------------------------------  667 (903)
T KOG1027|consen  668 --------------------------------------------------------------------------------  667 (903)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhc-CCCCCCccHHHHHHHHh
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG-~~Pf~~~~~~~~~~~i~  311 (328)
                                         -+...+.+||.+|+|||++.+..-+.++|++|+||++|..++| ..||.+.-..+  .+|+
T Consensus       668 -------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl  726 (903)
T KOG1027|consen  668 -------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANIL  726 (903)
T ss_pred             -------------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhh
Confidence                               0123456799999999999999989999999999999988888 99998765443  4677


Q ss_pred             cccCCC
Q psy2131         312 AGAYDD  317 (328)
Q Consensus       312 ~~~~~~  317 (328)
                      .|.|+.
T Consensus       727 ~~~~~L  732 (903)
T KOG1027|consen  727 TGNYTL  732 (903)
T ss_pred             cCccce
Confidence            777753

>KOG1025|consensus

Probab=99.97  E-value=5.2e-31  Score=247.94  Aligned_cols=214  Identities=24%  Similarity=0.347  Sum_probs=179.9

Q ss_pred             CCceEEEEEEEccCCc----EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||++.....|+    .||||++.... +.+....+..|+-+|.+++|||++++++++..+. +-||++|+++|+|
T Consensus       707 gAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~L  784 (1177)
T KOG1025|consen  707 GAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCL  784 (1177)
T ss_pred             ccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchH
Confidence            8999999998765554    57888886543 3444567889999999999999999999998877 8899999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +++++.+ ..+...+...|..||++|+.|||++++|||||-..|||+.+-+   .+||.|||+|+.+......+      
T Consensus       785 lDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~---hvkitdfgla~ll~~d~~ey------  855 (1177)
T KOG1025|consen  785 LDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN---HVKITDFGLAKLLAPDEKEY------  855 (1177)
T ss_pred             HHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---eEEEEecchhhccCcccccc------
Confidence            9999764 5788999999999999999999999999999999999997643   59999999997764433211      


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                .                                                     
T Consensus       856 --------------------------~-----------------------------------------------------  856 (1177)
T KOG1025|consen  856 --------------------------S-----------------------------------------------------  856 (1177)
T ss_pred             --------------------------c-----------------------------------------------------
Confidence                                      0                                                     


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                         ..+..-.+.|||-|.+...+|+.++|||||||++||++| |.-|+.+-.-.++-+.+..|.
T Consensus       857 -------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge  917 (1177)
T KOG1025|consen  857 -------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE  917 (1177)
T ss_pred             -------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence                               000112345899999999999999999999999999887 899999999999999999999


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ...-|+-|+
T Consensus       918 RLsqPpiCt  926 (1177)
T KOG1025|consen  918 RLSQPPICT  926 (1177)
T ss_pred             cCCCCCCcc
Confidence            988888776

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.6e-29  Score=242.01  Aligned_cols=217  Identities=23%  Similarity=0.328  Sum_probs=146.0

Q ss_pred             CCceEEEEEEEccC----CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEE------EEeCCEEEEEEEc
Q psy2131           1 GAFSVVRRCVQKAT----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS------IQEENYHYLVFDL   70 (328)
Q Consensus         1 G~fg~V~~~~~~~~----~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~------~~~~~~~~lv~E~   70 (328)
                      |+||.||+|.+..+    +..||+|.+......    +....|  .++...+.+++.+...      ..+....|+||||
T Consensus       143 G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey  216 (566)
T PLN03225        143 GAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRY  216 (566)
T ss_pred             CCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEe
Confidence            89999999999998    999999998643211    111111  1222223333332222      2456779999999


Q ss_pred             cCCCCcHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCc
Q psy2131          71 VTGGELFEDIVAREF--------------------YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA  130 (328)
Q Consensus        71 ~~gg~L~~~l~~~~~--------------------~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~  130 (328)
                      +.+++|.+.+.....                    ..+..+..++.|++.||.|||+++||||||||+|||++.+  .+.
T Consensus       217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~--~~~  294 (566)
T PLN03225        217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG--SGS  294 (566)
T ss_pred             cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC--CCc
Confidence            999999888765321                    1233466789999999999999999999999999999743  346


Q ss_pred             EEEeeccccccccC------------------C--------------------------------Ccch-HHHHHHHHHh
Q psy2131         131 VKLADFGLAIEVQG------------------E--------------------------------QQAW-FGVILYILLV  159 (328)
Q Consensus       131 vkl~DfGla~~~~~------------------~--------------------------------~~~~-~G~~~~~~~~  159 (328)
                      +||+|||+|+.+..                  +                                .+.| +||++|+|++
T Consensus       295 ~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~  374 (566)
T PLN03225        295 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF  374 (566)
T ss_pred             EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHh
Confidence            99999999863210                  0                                0444 8999999998


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCC----------CCC-------CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDY----------PSP-------EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~----------~~~-------~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      +..|+.. +...+...+.....+.          ..+       .....+....+|+.+||+.||.+|||+.++++|||+
T Consensus       375 ~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff  453 (566)
T PLN03225        375 PNLRSDS-NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYF  453 (566)
T ss_pred             CcCCCch-HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCc
Confidence            7666432 2222222232222111          000       011123345689999999999999999999999999


Q ss_pred             CCcc
Q psy2131         223 CQRE  226 (328)
Q Consensus       223 ~~~~  226 (328)
                      ....
T Consensus       454 ~~~~  457 (566)
T PLN03225        454 DREG  457 (566)
T ss_pred             CCCC
Confidence            7644

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.3e-29  Score=233.82  Aligned_cols=219  Identities=22%  Similarity=0.334  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEc----------------cCCcEEEEEEeccCCCCHH------------HHHHHHHHHHHHHhCCCCCc-
Q psy2131           1 GAFSVVRRCVQK----------------ATGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNI-   51 (328)
Q Consensus         1 G~fg~V~~~~~~----------------~~~~~~AiK~i~~~~~~~~------------~~~~~~~E~~il~~l~H~nI-   51 (328)
                      |+||+||+|...                ..++.||||.++.......            ..+....|+.++.+++|.++ 
T Consensus       156 GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~  235 (507)
T PLN03224        156 GNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIA  235 (507)
T ss_pred             CCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccch
Confidence            899999999752                3456799999875432110            01123457778888877654 


Q ss_pred             ----ceeEEEEEe--------CCEEEEEEEccCCCCcHHHHHhc------------------------CCCCHHHHHHHH
Q psy2131          52 ----VRLHDSIQE--------ENYHYLVFDLVTGGELFEDIVAR------------------------EFYSEADASHCI   95 (328)
Q Consensus        52 ----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~   95 (328)
                          ++++++|..        .+..|+||||+++++|.+++...                        ..+++..+..++
T Consensus       236 ~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~  315 (507)
T PLN03224        236 AASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVM  315 (507)
T ss_pred             hhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHH
Confidence                566666642        35689999999999998887532                        123456788899


Q ss_pred             HHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-------------------------------
Q psy2131          96 QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-------------------------------  144 (328)
Q Consensus        96 ~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-------------------------------  144 (328)
                      .|++.||.|||+.+|+||||||+|||++.+   +.+||+|||++.....                               
T Consensus       316 ~ql~~aL~~lH~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~  392 (507)
T PLN03224        316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAP  392 (507)
T ss_pred             HHHHHHHHHHHHCCeecCCCchHhEEECCC---CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccc
Confidence            999999999999999999999999999754   4599999998743100                               


Q ss_pred             --------------------CCcchHHHHHHHHHhCCC-CCCCCcHH-----------HHHHHHHhCCCCCCCCCcCCCC
Q psy2131         145 --------------------EQQAWFGVILYILLVGYP-PFWDEDQH-----------RLYAQIKAGAYDYPSPEWDTVT  192 (328)
Q Consensus       145 --------------------~~~~~~G~~~~~~~~g~~-pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s  192 (328)
                                          .+.+.+||++++|+++.. ||.+....           ..........++++  .+...+
T Consensus       393 ~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~d~~s  470 (507)
T PLN03224        393 APAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LLDRNK  470 (507)
T ss_pred             hhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc--cccccC
Confidence                                012237999999999875 66532110           11112222333333  467789


Q ss_pred             HHHHHHHHHhcccCC---CCCCCHHHHhcCcccCC
Q psy2131         193 PEAKNLINQMLTVNP---SKRITASEALKHPWICQ  224 (328)
Q Consensus       193 ~~~~~li~~~l~~~p---~~R~t~~~~l~h~~~~~  224 (328)
                      +..++|+.+||..+|   .+|+|++|+|+|||+..
T Consensus       471 ~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        471 EAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            999999999999876   68999999999999853

>KOG3653|consensus

Probab=99.96  E-value=1.4e-29  Score=225.95  Aligned_cols=132  Identities=25%  Similarity=0.392  Sum_probs=113.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHH--hCCCCCcceeEEEEEeCC----EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEEN----YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~--~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg   74 (328)
                      |.||.||+|..  +++.||||++..     .+.+.+.+|-+|.+  .++|+||++++++-+...    .+|||+||-+.|
T Consensus       221 Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG  293 (534)
T KOG3653|consen  221 GRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG  293 (534)
T ss_pred             Cccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence            89999999964  568999999864     35567777777766  468999999999887655    789999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHS---------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ  143 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~---------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~  143 (328)
                      +|.++|.. ..++..+...++..++.||+|||+         ..|+|||||..|||+.++   .+.-|+|||||..+.
T Consensus       294 sL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D---lTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  294 SLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND---LTCCIADFGLALRLE  367 (534)
T ss_pred             cHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC---CcEEeeccceeEEec
Confidence            99999875 468999999999999999999997         369999999999999654   568899999997654

>KOG1290|consensus

Probab=99.96  E-value=1.3e-28  Score=220.37  Aligned_cols=121  Identities=24%  Similarity=0.365  Sum_probs=103.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-----C---CCcceeEEEEEe----CCEEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----H---PNIVRLHDSIQE----ENYHYLVF   68 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-----H---~nIv~l~~~~~~----~~~~~lv~   68 (328)
                      |.|++||+|++..+.+.||+|+.+...   .-.+....||++|++++     |   .+||+|++.|..    +.++++|+
T Consensus        89 GHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVf  165 (590)
T KOG1290|consen   89 GHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVF  165 (590)
T ss_pred             cccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEe
Confidence            789999999999999999999997432   22345678999999883     3   369999999974    56899999


Q ss_pred             EccCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeC
Q psy2131          69 DLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASK  125 (328)
Q Consensus        69 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~  125 (328)
                      |++ |.+|+.+|....  .++...++.|++|||.||.|||. .||||-||||||||+...
T Consensus       166 EvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  166 EVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             hhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            998 668999887653  58999999999999999999997 599999999999999754

>KOG2052|consensus

Probab=99.96  E-value=3.6e-28  Score=215.53  Aligned_cols=131  Identities=28%  Similarity=0.425  Sum_probs=110.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC----EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK--LQHPNIVRLHDSIQEEN----YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg   74 (328)
                      |.||+||+|..  .|+.||||++...     +.+.+.||.+|.+.  |+|+||..++++-..++    .+|||+||-+.|
T Consensus       222 GRyGEVwrG~w--rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G  294 (513)
T KOG2052|consen  222 GRFGEVWRGRW--RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG  294 (513)
T ss_pred             ccccceeeccc--cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence            88999999965  6789999999743     23456677777664  69999999998876443    589999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSN--------GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~--------~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +|+++|.+ ..++-+.+..++..++.||+|||-.        .|.|||||..|||+..   ++..-|+|+|||...
T Consensus       295 SL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk---n~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  295 SLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCCIADLGLAVRH  366 (513)
T ss_pred             cHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc---CCcEEEeeceeeEEe
Confidence            99999987 6799999999999999999999962        4999999999999965   456899999998654

>KOG1345|consensus

Probab=99.96  E-value=4.8e-29  Score=208.53  Aligned_cols=136  Identities=26%  Similarity=0.364  Sum_probs=115.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEE-EEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDS-IQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~-~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |.||.+.+|+|+.++..+++|.+....-   ..+.|.+|..---.| .|.||+.-|++ |++.+...++||||+-|+|.+
T Consensus        35 G~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~s  111 (378)
T KOG1345|consen   35 GRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRS  111 (378)
T ss_pred             cceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhh
Confidence            7899999999999999999999876543   345677787755555 58999988875 888999999999999999987


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      -+.. ..+.|.....++.|+++|+.|+|++++||||||.+|||+-+.+ ...|||||||+.+.
T Consensus       112 nv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  112 NVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRK  172 (378)
T ss_pred             hcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccc
Confidence            7654 4588999999999999999999999999999999999997643 45899999998754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=9.3e-27  Score=195.95  Aligned_cols=138  Identities=43%  Similarity=0.624  Sum_probs=122.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|....+|+.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++||++.|++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~   82 (215)
T cd00180           4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL   82 (215)
T ss_pred             CCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHH
Confidence            789999999998889999999998654322 3467889999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      ... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++..  ...++|+|||.+..
T Consensus        83 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~  142 (215)
T cd00180          83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKL  142 (215)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEE
Confidence            765 478999999999999999999999999999999999999752  34699999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.3e-28  Score=244.69  Aligned_cols=183  Identities=17%  Similarity=0.191  Sum_probs=121.5

Q ss_pred             HhCCC-CCcceeEEEE-------EeCCEEEEEEEccCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeec
Q psy2131          44 RKLQH-PNIVRLHDSI-------QEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRD  114 (328)
Q Consensus        44 ~~l~H-~nIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrD  114 (328)
                      +.++| +||.+++++|       .....+++++|++ +++|.+++.. ...+++.++..++.||+.||.|||++||||||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            35566 6888888887       3345678889987 5699999865 34699999999999999999999999999999


Q ss_pred             CCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHH
Q psy2131         115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  194 (328)
Q Consensus       115 iKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  194 (328)
                      |||+|||++..+   .+|++|||++..........                          ++...+.....        
T Consensus       106 lKP~NiLl~~~~---~~k~~d~~~~~~~~~~~~~~--------------------------~ki~DfG~a~~--------  148 (793)
T PLN00181        106 VRPSCFVMSSFN---HVSFIESASCSDSGSDEDAT--------------------------TKSREIGSSRR--------  148 (793)
T ss_pred             CCchhEEEcccC---cEEEeeccccCcccccccCc--------------------------ccccccccccc--------
Confidence            999999997543   48899998875432111000                          00000000000        


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC
Q psy2131         195 AKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP  274 (328)
Q Consensus       195 ~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~  274 (328)
                              ....+ .+.         +                 ......  ............+||+.|||||++.+.+
T Consensus       149 --------~~~~~-~~~---------~-----------------~~~~~~--~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        149 --------EEILS-ERR---------I-----------------EKLEEV--KKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             --------ccccc-ccc---------h-----------------hhhhcc--ccCCCcccccccCCCcceEChhhhccCC
Confidence                    00000 000         0                 000000  0000000112246999999999999999


Q ss_pred             CCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         275 YGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       275 ~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                      |+.++|||||||+||||++|.+||...
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            999999999999999999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.8e-26  Score=207.87  Aligned_cols=128  Identities=22%  Similarity=0.232  Sum_probs=101.9

Q ss_pred             CCceEEEEEEEcc-CCcEEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcce-eEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-TGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVR-LHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~~~AiK~i~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~-l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|++.. +++.+|||++.....   .......+.+|+++|++++|+|++. +++.    +..|+|||||+|++
T Consensus        29 G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~  104 (365)
T PRK09188         29 DVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVP  104 (365)
T ss_pred             cCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCC
Confidence            8999999999876 788889998763311   2233566899999999999999984 5542    45799999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL-KPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDi-Kp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      |.. ..   ...   ...++.|++.+|.|||++||+|||| ||+|||++.+   +.+||+|||+|+.+
T Consensus       105 L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~---~~ikLiDFGlA~~~  162 (365)
T PRK09188        105 LHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD---GEAAVIDFQLASVF  162 (365)
T ss_pred             HHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC---CCEEEEECccceec
Confidence            862 21   111   1467899999999999999999999 9999999643   45999999998765

>KOG1024|consensus

Probab=99.93  E-value=9.2e-26  Score=197.42  Aligned_cols=217  Identities=20%  Similarity=0.341  Sum_probs=175.2

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|..+...     +.+-+|.++. ..++-+...+..|...+..+.|||+..+.++.. +....+.++.+..-|
T Consensus       295 GtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~g  373 (563)
T KOG1024|consen  295 GTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVG  373 (563)
T ss_pred             CchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcc
Confidence            899999999655322     3355566643 345556777889999999999999999998865 456678899999999


Q ss_pred             CcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          75 ELFEDIVAR--------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        75 ~L~~~l~~~--------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      +|..++...        ..++..+...++.|++.|+.|||+.|+||.||-..|.+|++.   ..+||+|=.|++.+.+.+
T Consensus       374 NLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~---LqVkltDsaLSRDLFP~D  450 (563)
T KOG1024|consen  374 NLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ---LQVKLTDSALSRDLFPGD  450 (563)
T ss_pred             hHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---eeEEeccchhccccCccc
Confidence            999988722        236677788889999999999999999999999999999753   569999999988764433


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .-.+|                                                      |-+.|                
T Consensus       451 YhcLG------------------------------------------------------DnEnR----------------  460 (563)
T KOG1024|consen  451 YHCLG------------------------------------------------------DNENR----------------  460 (563)
T ss_pred             ccccC------------------------------------------------------CCCCC----------------
Confidence            21111                                                      11111                


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                                        ...||+||.+.+..|+.++|+|||||+||||+| |+.||.+-||.+
T Consensus       461 ----------------------------------PvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE  506 (563)
T KOG1024|consen  461 ----------------------------------PVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE  506 (563)
T ss_pred             ----------------------------------cccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence                                              234999999999999999999999999999887 899999999999


Q ss_pred             HHHHHhcccCCCCCCccccC
Q psy2131         306 LYAQIKAGAYDDEPKHKSAS  325 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~~~~~~  325 (328)
                      ..--++.|...--|-+|++.
T Consensus       507 m~~ylkdGyRlaQP~NCPDe  526 (563)
T KOG1024|consen  507 MEHYLKDGYRLAQPFNCPDE  526 (563)
T ss_pred             HHHHHhccceecCCCCCcHH
Confidence            99999999999999998864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.4e-24  Score=194.42  Aligned_cols=210  Identities=36%  Similarity=0.536  Sum_probs=170.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHP-NIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~-nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||++.+.   ..+|+|.+........ ....+.+|+.+++.+.|+ +|+++++.+......++++||+.++++.+
T Consensus        11 g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~   87 (384)
T COG0515          11 GSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED   87 (384)
T ss_pred             CCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHH
Confidence            789999999887   7889999987654443 567789999999999988 79999999988888999999999999996


Q ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          79 DIVARE---FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        79 ~l~~~~---~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+....   .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+  ..++++|||++..........      
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~------  159 (384)
T COG0515          88 LLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG--RVVKLIDFGLAKLLPDPGSTS------  159 (384)
T ss_pred             HHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC--CeEEEeccCcceecCCCCccc------
Confidence            666554   799999999999999999999999999999999999997543  158999999975322111000      


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                  ..        .                                         
T Consensus       160 ----------------------------~~--------~-----------------------------------------  162 (384)
T COG0515         160 ----------------------------SI--------P-----------------------------------------  162 (384)
T ss_pred             ----------------------------cc--------c-----------------------------------------
Confidence                                        00        0                                         


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCccH----HHHHH
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYA  308 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~~~  308 (328)
                                       .......||+.|+|||.+.+   ..++...|+||+|++++++++|..||.....    ..+..
T Consensus       163 -----------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         163 -----------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             -----------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence                             01223569999999999988   5789999999999999999999999888873    56666


Q ss_pred             HHhcccC
Q psy2131         309 QIKAGAY  315 (328)
Q Consensus       309 ~i~~~~~  315 (328)
                      .+.....
T Consensus       226 ~~~~~~~  232 (384)
T COG0515         226 IILELPT  232 (384)
T ss_pred             HHHhcCC
Confidence            6555554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.3e-25  Score=187.47  Aligned_cols=135  Identities=23%  Similarity=0.238  Sum_probs=107.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH------------------------HHHHHHHHHHHHhCCCCCcceeEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD------------------------FQKLEREARICRKLQHPNIVRLHD   56 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~------------------------~~~~~~E~~il~~l~H~nIv~l~~   56 (328)
                      |+||.||+|.+. +|+.||+|+++....+...                        .....+|+++|.++.++++...+.
T Consensus         8 G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~   86 (190)
T cd05147           8 GKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEP   86 (190)
T ss_pred             ccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcE
Confidence            899999999987 8999999999865322111                        122346999999998887754443


Q ss_pred             EEEeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCcEEEeeCCCCCcEEEee
Q psy2131          57 SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHC-HSNGVVHRDLKPENLLLASKAKGAAVKLAD  135 (328)
Q Consensus        57 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~yl-H~~~ivHrDiKp~NiLl~~~~~~~~vkl~D  135 (328)
                      .....  .+|||||++|+++.........+++.++..++.|++.+|.|+ |+.||+||||||+|||++.    +.++|+|
T Consensus        87 ~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~----~~v~LiD  160 (190)
T cd05147          87 ILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD----GKLYIID  160 (190)
T ss_pred             EEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----CcEEEEE
Confidence            32222  389999999987765545556799999999999999999999 7999999999999999973    3599999


Q ss_pred             ccccccc
Q psy2131         136 FGLAIEV  142 (328)
Q Consensus       136 fGla~~~  142 (328)
                      ||+|...
T Consensus       161 FG~a~~~  167 (190)
T cd05147         161 VSQSVEH  167 (190)
T ss_pred             ccccccC
Confidence            9998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1164|consensus

Probab=99.93  E-value=5.3e-25  Score=199.14  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=158.7

Q ss_pred             CCceEEEEEEEccCC-cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC----CCcceeEEEE-EeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATG-LEFAAKIINTKKLSARDFQKLEREARICRKLQH----PNIVRLHDSI-QEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H----~nIv~l~~~~-~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||.|.+..++ ..+|+|+.........  ..+..|+.++..+..    +++.++++.. .....-|+||+.+ |.
T Consensus        29 G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~  105 (322)
T KOG1164|consen   29 GGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GP  105 (322)
T ss_pred             cCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-Cc
Confidence            899999999988775 6899998875432221  156778899888873    6899999999 5788899999998 77


Q ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeecccccccc--CCCcc
Q psy2131          75 ELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQ--GEQQA  148 (328)
Q Consensus        75 ~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~--~~~~~  148 (328)
                      +|.++....  +.++..++..++.|++.+|.++|+.|+|||||||+|++++...  +...+.|.|||+|+...  .....
T Consensus       106 sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~  185 (322)
T KOG1164|consen  106 SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGG  185 (322)
T ss_pred             cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCc
Confidence            888766433  5799999999999999999999999999999999999998653  22569999999997321  11000


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                     ..                            |                  
T Consensus       186 -------------------------------~~----------------------------~------------------  188 (322)
T KOG1164|consen  186 -------------------------------NL----------------------------R------------------  188 (322)
T ss_pred             -------------------------------cc----------------------------c------------------
Confidence                                           00                            0                  


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                           ........+.||..|+++.+-.+...+.+-|+||++-++.||+.|..||.+..
T Consensus       189 ---------------------~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  189 ---------------------PPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ---------------------cCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence                                 00001134569999999999999999999999999999999999999997765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=1.7e-24  Score=181.07  Aligned_cols=137  Identities=23%  Similarity=0.281  Sum_probs=109.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----------------------HH--HHHHHHHHHHHHhCCCCCcceeEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----------------------RD--FQKLEREARICRKLQHPNIVRLHD   56 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----------------------~~--~~~~~~E~~il~~l~H~nIv~l~~   56 (328)
                      |+||.||+|.+. +|+.||||+++......                      ..  ...+.+|.+.+.++.|+++.....
T Consensus         8 G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~   86 (190)
T cd05145           8 GKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEP   86 (190)
T ss_pred             CCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceE
Confidence            899999999987 99999999998653210                      00  123468999999999998855444


Q ss_pred             EEEeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEee
Q psy2131          57 SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLAD  135 (328)
Q Consensus        57 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~D  135 (328)
                      +....  .||||||++|+++.........+++.++..++.|++.+|.++|+ .||+||||||+|||++ +   +.++|+|
T Consensus        87 ~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~---~~~~liD  160 (190)
T cd05145          87 ILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D---GKPYIID  160 (190)
T ss_pred             EEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C---CCEEEEE
Confidence            43333  48999999998665544445678889999999999999999999 9999999999999997 2   4599999


Q ss_pred             ccccccccC
Q psy2131         136 FGLAIEVQG  144 (328)
Q Consensus       136 fGla~~~~~  144 (328)
                      ||+|.....
T Consensus       161 FG~a~~~~~  169 (190)
T cd05145         161 VSQAVELDH  169 (190)
T ss_pred             cccceecCC
Confidence            999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.4e-23  Score=174.17  Aligned_cols=125  Identities=20%  Similarity=0.256  Sum_probs=96.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+|+.+..  .+..++.+.+.....  ..-....+.+|+++|++|+ |++|++++++    +..|++|||+.|.+|.
T Consensus        13 ~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~   86 (218)
T PRK12274         13 DTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMY   86 (218)
T ss_pred             CCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHH
Confidence            68999997754  677787777654332  1112235789999999995 5889999886    4469999999999886


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL-KPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDi-Kp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +.+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+   +.++|+|||+|..
T Consensus        87 ~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~---g~i~LIDFG~A~~  141 (218)
T PRK12274         87 QRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED---GSPAVIDFQLAVR  141 (218)
T ss_pred             hhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC---CCEEEEECCCcee
Confidence            54321      1 2357789999999999999999999 7999999743   4599999999864

>KOG0606|consensus

Probab=99.91  E-value=8e-25  Score=211.91  Aligned_cols=187  Identities=34%  Similarity=0.525  Sum_probs=133.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||.++|+.+.+.||+ .|+++.+-.       |-  ||.....|.+|                     ||=...+
T Consensus        94 gAygavylvrh~~trqrfa~-kiNkq~lil-------Rn--ilt~a~npfvv---------------------gDc~tll  142 (1205)
T KOG0606|consen   94 GAYGAVYLVRHKETRQRFAM-KINKQNLIL-------RN--ILTFAGNPFVV---------------------GDCATLL  142 (1205)
T ss_pred             CCCCceeeeeccccccchhh-cccccchhh-------hc--cccccCCccee---------------------chhhhhc
Confidence            79999999999999999999 555443211       11  44445566655                     3333444


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ..-+.++.+        ++.+++|+|+.||+|||+||+|+||..-+   .+|++|||+++..--...    ..+|+.   
T Consensus       143 k~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG---hiKlTDfgLsk~GLms~a----tnl~eg---  204 (1205)
T KOG0606|consen  143 KNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG---HIKLTDFGLSKKGLMSLA----TNLKEG---  204 (1205)
T ss_pred             ccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc---cccccchhhhhhhhhhcc----chhhhc---
Confidence            444455443        37899999999999999999999998765   499999999743200000    000000   


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                   .+..+.                                             
T Consensus       205 -----------------------------~I~k~t---------------------------------------------  210 (1205)
T KOG0606|consen  205 -----------------------------HIEKDT---------------------------------------------  210 (1205)
T ss_pred             -----------------------------chHHHH---------------------------------------------
Confidence                                         000000                                             


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                                ........+|||.|+||||+..++||..+||||+|+|+||++.|+.||.++.+++||..+.+-....|..
T Consensus       211 ----------~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  211 ----------HEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             ----------HHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                      0111223579999999999999999999999999999999999999999999999999999887766544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=9.6e-24  Score=174.22  Aligned_cols=118  Identities=24%  Similarity=0.316  Sum_probs=95.4

Q ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          74 GELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        74 g~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      |+|.+.+..+ ..+++.++..++.|++.||.|||+++      ||+|||++.+   +.+|+  ||++......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~---~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD---GLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc---cceee--ccceEeeccc-------
Confidence            6888888764 46999999999999999999999999      9999999654   45788  9986432100       


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus        63 --------------------------------------------------------------------------------   62 (176)
T smart00750       63 --------------------------------------------------------------------------------   62 (176)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH-HHHHHHHh
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIK  311 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~  311 (328)
                                              ...||+.|+|||++.+..|+.++|||||||++|||+||+.||.+... ...+..+.
T Consensus        63 ------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~  118 (176)
T smart00750       63 ------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL  118 (176)
T ss_pred             ------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH
Confidence                                    01378999999999999999999999999999999999999987653 33444444


Q ss_pred             cc
Q psy2131         312 AG  313 (328)
Q Consensus       312 ~~  313 (328)
                      .+
T Consensus       119 ~~  120 (176)
T smart00750      119 NG  120 (176)
T ss_pred             HH
Confidence            43

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590|consensus

Probab=99.90  E-value=4.6e-25  Score=212.30  Aligned_cols=198  Identities=30%  Similarity=0.503  Sum_probs=155.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEecc---CCCCHHHH-HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINT---KKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~---~~~~~~~~-~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.|+.+........++.|..+.   ......+. ..+..|.-+-..+.|||++.....+.+....+-.||||++ +|
T Consensus       329 ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dl  407 (601)
T KOG0590|consen  329 GAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DL  407 (601)
T ss_pred             cccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HH
Confidence            6778777777777777777776552   12222222 2266788888889999998887777776666666999999 99


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +..+...+.+...++..+++|++.|++|+|+.||.|||+||+|+++...   +.+||+|||.+.-..             
T Consensus       408 f~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~-------------  471 (601)
T KOG0590|consen  408 FSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFR-------------  471 (601)
T ss_pred             HHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeec-------------
Confidence            9999888889999999999999999999999999999999999999754   469999999863221             


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                           .|+                                                         ..             
T Consensus       472 -----~~~---------------------------------------------------------e~-------------  476 (601)
T KOG0590|consen  472 -----YPW---------------------------------------------------------EK-------------  476 (601)
T ss_pred             -----cCc---------------------------------------------------------ch-------------
Confidence                 010                                                         00             


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHH
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQH  304 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~  304 (328)
                                    ......+++|+..|+|||++.+..| ...+||||.|||+..|.+|+.||......
T Consensus       477 --------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  477 --------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             --------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence                          0012335779999999999999999 56899999999999999999999866533

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=5.7e-23  Score=173.23  Aligned_cols=131  Identities=18%  Similarity=0.199  Sum_probs=104.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-----CCCCcceeEEEEEeCC---EE-EEEEEc-
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEEN---YH-YLVFDL-   70 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~l~~~~~~~~---~~-~lv~E~-   70 (328)
                      |+||.||.  ++.++.. +||++......  ..+.+.+|+++++.+     +||||+++|++++++.   .+ .+|||| 
T Consensus        13 G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~   87 (210)
T PRK10345         13 GRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFD   87 (210)
T ss_pred             CCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCC
Confidence            89999995  7777666 69998764322  345689999999999     6799999999999874   43 479999 


Q ss_pred             -cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeecCCCCcEEEeeCC-CCCcEEEeecccc
Q psy2131          71 -VTGGELFEDIVAREFYSEADASHCIQQILESV-NHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLA  139 (328)
Q Consensus        71 -~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L-~ylH~~~ivHrDiKp~NiLl~~~~-~~~~vkl~DfGla  139 (328)
                       +.+|+|.+++... .+++.  ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+-+
T Consensus        88 G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         88 GKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             5589999999653 46655  35678888888 999999999999999999998644 2347999995444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.5e-23  Score=176.16  Aligned_cols=126  Identities=15%  Similarity=0.157  Sum_probs=100.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH-HHH------HHHHHHHHHhCCCCCcceeEEEEEeC--------CEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQK------LEREARICRKLQHPNIVRLHDSIQEE--------NYHY   65 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~-~~~------~~~E~~il~~l~H~nIv~l~~~~~~~--------~~~~   65 (328)
                      |+||.||++..  ++..+|+|+++......+. .++      +.+|++.+.++.|++|..+.+++...        ...+
T Consensus        42 ~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~  119 (232)
T PRK10359         42 IDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYI  119 (232)
T ss_pred             CCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeE
Confidence            78999999644  4678999999866544332 233      57999999999999999999887643        3579


Q ss_pred             EEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccc
Q psy2131          66 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus        66 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~  140 (328)
                      |+|||++|.+|.+..    .+++    ....+++.+|..+|+.|++|||+||+||+++.+   + ++|+|||...
T Consensus       120 lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g-i~liDfg~~~  182 (232)
T PRK10359        120 MLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G-LRIIDLSGKR  182 (232)
T ss_pred             EEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C-EEEEECCCcc
Confidence            999999999987653    2333    245699999999999999999999999999743   3 9999999764

>KOG1163|consensus

Probab=99.89  E-value=2.9e-23  Score=171.33  Aligned_cols=216  Identities=23%  Similarity=0.325  Sum_probs=171.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.+|.|....+|+.||||+=+...    ...++..|.++.+.|++ ..|..++.+..+..+-.+|||++ |.+|.++
T Consensus        26 GSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdL  100 (341)
T KOG1163|consen   26 GSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDL  100 (341)
T ss_pred             CchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHH
Confidence            899999999999999999999865432    22456789999998865 67888888999999999999998 6788776


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ..-. ..++..++.-++-|++.-++|+|.++.|||||||+|+|++-..+...+.++|||||+..-+....          
T Consensus       101 fnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~----------  170 (341)
T KOG1163|consen  101 FNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR----------  170 (341)
T ss_pred             HHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc----------
Confidence            6543 46899999999999999999999999999999999999987777778999999999764221100          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                       ...|+                                                                          
T Consensus       171 -~HIpy--------------------------------------------------------------------------  175 (341)
T KOG1163|consen  171 -QHIPY--------------------------------------------------------------------------  175 (341)
T ss_pred             -ccCcc--------------------------------------------------------------------------
Confidence             00011                                                                          


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc---HHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~  315 (328)
                                    .......||..|++--...+...+..-|.=|+|-+|..+..|..||.+-.   ..+=+.+|..-+.
T Consensus       176 --------------re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  176 --------------REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             --------------ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence                          01112459999999988888888899999999999999999999999764   5555666766666


Q ss_pred             CCCCC
Q psy2131         316 DDEPK  320 (328)
Q Consensus       316 ~~~~~  320 (328)
                      .+|+.
T Consensus       242 s~~ie  246 (341)
T KOG1163|consen  242 STPIE  246 (341)
T ss_pred             CCCHH
Confidence            55543

>KOG1165|consensus

Probab=99.87  E-value=1e-21  Score=169.05  Aligned_cols=215  Identities=22%  Similarity=0.309  Sum_probs=171.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+.+.+.+.-+++.||||.=....    +..++..|.+..+.| ..++|...|-+..++.+-.||+|++ |-+|-++
T Consensus        39 GsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDL  113 (449)
T KOG1165|consen   39 GSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDL  113 (449)
T ss_pred             CcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHH
Confidence            899999999999999999999754332    234566788888877 5789999998888888889999998 6788766


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ..- ...|+...+..++.|++.-++|+|++.+|.|||||+|+||+.-+  +...|.|+|||+|++..+...-        
T Consensus       114 FD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk--------  185 (449)
T KOG1165|consen  114 FDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK--------  185 (449)
T ss_pred             HHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc--------
Confidence            644 35699999999999999999999999999999999999998643  2456899999999876432210        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                         ...||                                                                        
T Consensus       186 ---qHIPY------------------------------------------------------------------------  190 (449)
T KOG1165|consen  186 ---QHIPY------------------------------------------------------------------------  190 (449)
T ss_pred             ---ccCcc------------------------------------------------------------------------
Confidence               00111                                                                        


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhcc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAG  313 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~  313 (328)
                                      ....+..||..||+--.-.|+..+..-|+=|||=++..+|.|.+||-|.   +..+=+++|-.-
T Consensus       191 ----------------rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~  254 (449)
T KOG1165|consen  191 ----------------REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET  254 (449)
T ss_pred             ----------------ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence                            1122346999999999999999999999999999999999999999876   466677777666


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      +...|+
T Consensus       255 Kr~T~i  260 (449)
T KOG1165|consen  255 KRSTPI  260 (449)
T ss_pred             cccCCH
Confidence            555444

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1.9e-21  Score=167.71  Aligned_cols=136  Identities=24%  Similarity=0.260  Sum_probs=105.9

Q ss_pred             CCceEEEEEE-EccCCcEEEEEEeccCCCC--------------------HH--HHHHHHHHHHHHHhCCCCC--cceeE
Q psy2131           1 GAFSVVRRCV-QKATGLEFAAKIINTKKLS--------------------AR--DFQKLEREARICRKLQHPN--IVRLH   55 (328)
Q Consensus         1 G~fg~V~~~~-~~~~~~~~AiK~i~~~~~~--------------------~~--~~~~~~~E~~il~~l~H~n--Iv~l~   55 (328)
                      |+||.||+|. +..+|+.||+|+++.....                    ..  ....+.+|+.+++++.+.+  +.+++
T Consensus        39 G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~  118 (237)
T smart00090       39 GKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPI  118 (237)
T ss_pred             CcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence            8999999999 7789999999999754321                    00  1123578999999997632  34444


Q ss_pred             EEEEeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCcEEEeeCCCCCcEEEe
Q psy2131          56 DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG-VVHRDLKPENLLLASKAKGAAVKLA  134 (328)
Q Consensus        56 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~-ivHrDiKp~NiLl~~~~~~~~vkl~  134 (328)
                      +.   . ..|+||||+.|++|.........+.+.++..++.|++.+|.+||+.| |+||||||+||+++ .   +.++|+
T Consensus       119 ~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~---~~i~Li  190 (237)
T smart00090      119 AW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D---GKVVII  190 (237)
T ss_pred             Ee---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C---CCEEEE
Confidence            32   2 35899999999888665544555677778899999999999999999 99999999999997 2   459999


Q ss_pred             eccccccccC
Q psy2131         135 DFGLAIEVQG  144 (328)
Q Consensus       135 DfGla~~~~~  144 (328)
                      |||+|.....
T Consensus       191 DFg~a~~~~~  200 (237)
T smart00090      191 DVSQSVELDH  200 (237)
T ss_pred             EChhhhccCC
Confidence            9999876543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6e-20  Score=156.14  Aligned_cols=131  Identities=24%  Similarity=0.304  Sum_probs=108.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH------HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |++|.||+|..  .|..+++|+.........      ...++.+|+.++..+.|++|+....++.+.+..+++|||++|+
T Consensus         7 G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~   84 (211)
T PRK14879          7 GAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGE   84 (211)
T ss_pred             CceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCc
Confidence            88999999987  677899998764432211      1245788999999999999888777777778889999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +|.+.+.....    +...++.+++.+|.++|+.+++|||++|+|||++    .+.++|+|||++..
T Consensus        85 ~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         85 PLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             CHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            99888765322    7788899999999999999999999999999997    24599999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1e-19  Score=153.27  Aligned_cols=129  Identities=21%  Similarity=0.245  Sum_probs=102.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||++.  .+|..+++|+........      ....++.+|++++..++|+++....-++.+.+..++||||++|+
T Consensus         5 G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~   82 (199)
T TIGR03724         5 GAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGK   82 (199)
T ss_pred             CceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCc
Confidence            8999999998  467889999865432211      12356788999999999887665555555666779999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +|.+.+.....       .++.|++.+|.++|+.|++|+|++|+|||++    ++.++++|||++...
T Consensus        83 ~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        83 PLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             cHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            99887654321       7889999999999999999999999999997    245999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.9e-19  Score=150.46  Aligned_cols=130  Identities=22%  Similarity=0.295  Sum_probs=99.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH--------------------HHHHHHHHHHHHHhCCCCC--cceeEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR--------------------DFQKLEREARICRKLQHPN--IVRLHDSI   58 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~--------------------~~~~~~~E~~il~~l~H~n--Iv~l~~~~   58 (328)
                      |+||.||+|... +|+.+|||+++.......                    ......+|..++..+.|++  ++..++  
T Consensus        26 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~--  102 (198)
T cd05144          26 GKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID--  102 (198)
T ss_pred             CcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee--
Confidence            899999999874 899999999875431100                    0123567999999998874  444443  


Q ss_pred             EeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccc
Q psy2131          59 QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL  138 (328)
Q Consensus        59 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGl  138 (328)
                        ....++||||++|++|.+...      ......++.+++.++.++|+.||+||||||+||+++.   ++.++|+|||+
T Consensus       103 --~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~---~~~~~liDfg~  171 (198)
T cd05144         103 --WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD---DEKIYIIDWPQ  171 (198)
T ss_pred             --cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC---CCcEEEEECCc
Confidence              244689999999998865432      1345678899999999999999999999999999975   35699999999


Q ss_pred             cccccC
Q psy2131         139 AIEVQG  144 (328)
Q Consensus       139 a~~~~~  144 (328)
                      +.....
T Consensus       172 ~~~~~~  177 (198)
T cd05144         172 MVSTDH  177 (198)
T ss_pred             cccCCC
Confidence            966544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=9.7e-19  Score=168.64  Aligned_cols=128  Identities=19%  Similarity=0.238  Sum_probs=101.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||++.....  .+++|+........      ...+++.+|+++++.++|++++..+.++.+....++||||++|+
T Consensus       344 G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~  421 (535)
T PRK09605        344 GAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGK  421 (535)
T ss_pred             CCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCC
Confidence            89999999976443  34444432221111      12356789999999999999998887777777889999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +|.+.+.        ....++.|++.+|.|||+.|++||||||+|||++    ++.++|+|||+++..
T Consensus       422 ~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~~  477 (535)
T PRK09605        422 DLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKYS  477 (535)
T ss_pred             cHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence            9988774        3567899999999999999999999999999993    235999999999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.79  E-value=1.1e-18  Score=145.53  Aligned_cols=134  Identities=25%  Similarity=0.307  Sum_probs=96.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHH----------------------HHHHHHHHHhCCCCC--cceeEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK----------------------LEREARICRKLQHPN--IVRLHD   56 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~----------------------~~~E~~il~~l~H~n--Iv~l~~   56 (328)
                      |+||.||+|.+. +|+.||||+++...........                      ...|...+.++.+..  +.+.++
T Consensus         8 G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~   86 (187)
T cd05119           8 GKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPID   86 (187)
T ss_pred             ccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEe
Confidence            899999999886 8999999998764332211111                      145677777765543  455554


Q ss_pred             EEEeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEee
Q psy2131          57 SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLAD  135 (328)
Q Consensus        57 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~D  135 (328)
                      .    ...++||||++|+++.......... ..++..++.+++.++.++|. .+|+||||||+||+++    ++.++|+|
T Consensus        87 ~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~~~~liD  157 (187)
T cd05119          87 L----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DGKVYIID  157 (187)
T ss_pred             c----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CCcEEEEE
Confidence            3    2358999999996543221111111 16788899999999999999 9999999999999997    24599999


Q ss_pred             ccccccccC
Q psy2131         136 FGLAIEVQG  144 (328)
Q Consensus       136 fGla~~~~~  144 (328)
                      ||.+.....
T Consensus       158 fg~a~~~~~  166 (187)
T cd05119         158 VPQAVEIDH  166 (187)
T ss_pred             CcccccccC
Confidence            999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166|consensus

Probab=99.79  E-value=4.6e-19  Score=174.86  Aligned_cols=186  Identities=22%  Similarity=0.325  Sum_probs=145.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+.. |+.||+|+=+...  ..++-   -=.+++.+|+   -+.|+.++.++...+.-++|+||.+-|+|+
T Consensus       709 g~y~~vy~a~~~~-~~~~alK~e~P~~--~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtll  782 (974)
T KOG1166|consen  709 GSYGSVYVATHSN-GKLVALKVEKPPN--PWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLL  782 (974)
T ss_pred             ccceEEEEeecCC-CcEEEEEeecCCC--ceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHH
Confidence            8999999999877 9999999876542  11100   0012223333   246777778888888889999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC----CCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK----AKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~----~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +++...+.+++.-+.+++.|++.-+..||..+|||+||||+|+||...    .....++|+|||-+....-         
T Consensus       783 d~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l---------  853 (974)
T KOG1166|consen  783 DLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL---------  853 (974)
T ss_pred             HhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE---------
Confidence            999988889999999999999999999999999999999999999752    2234699999998744311         


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                |.                                        |                           
T Consensus       854 ----------fp----------------------------------------~---------------------------  856 (974)
T KOG1166|consen  854 ----------FP----------------------------------------D---------------------------  856 (974)
T ss_pred             ----------cC----------------------------------------C---------------------------
Confidence                      00                                        0                           


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCC
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYP  296 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~  296 (328)
                                        ..+..+..+|-++-++|+..|++++=.+|.|.|+.++|.||.|+.
T Consensus       857 ------------------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  857 ------------------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ------------------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence                              011234567888999999999999999999999999999999964

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=3.6e-18  Score=149.01  Aligned_cols=136  Identities=27%  Similarity=0.387  Sum_probs=84.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCC----------CCcceeEEEE---------Ee
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQH----------PNIVRLHDSI---------QE   60 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H----------~nIv~l~~~~---------~~   60 (328)
                      |+||.||.+.+..||+.+|+|+....... ....+.+.+|.-....+.+          -.++..++..         +.
T Consensus        23 g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~  102 (288)
T PF14531_consen   23 GGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFER  102 (288)
T ss_dssp             ETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEE
T ss_pred             CCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceec
Confidence            68999999999999999999998655432 3456777777655544332          1222223322         11


Q ss_pred             C---C-----EEEEEEEccCCCCcHHHHH---hcCCC---CHHHHH-HHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC
Q psy2131          61 E---N-----YHYLVFDLVTGGELFEDIV---AREFY---SEADAS-HCIQQILESVNHCHSNGVVHRDLKPENLLLASK  125 (328)
Q Consensus        61 ~---~-----~~~lv~E~~~gg~L~~~l~---~~~~~---~~~~~~-~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~  125 (328)
                      .   .     +.+++|+-+.+ ||.+.+.   .....   ....++ .+..|++..+++||..|+||+||||+|++++.+
T Consensus       103 ~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~  181 (288)
T PF14531_consen  103 GPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQD  181 (288)
T ss_dssp             CETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TT
T ss_pred             CCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCC
Confidence            1   1     23678887754 7766543   22222   112222 344899999999999999999999999999754


Q ss_pred             CCCCcEEEeeccccc
Q psy2131         126 AKGAAVKLADFGLAI  140 (328)
Q Consensus       126 ~~~~~vkl~DfGla~  140 (328)
                         +.++|+||+...
T Consensus       182 ---G~v~Lg~F~~~~  193 (288)
T PF14531_consen  182 ---GGVFLGDFSSLV  193 (288)
T ss_dssp             ---S-EEE--GGGEE
T ss_pred             ---CCEEEcChHHHe
Confidence               569999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.2e-17  Score=144.43  Aligned_cols=133  Identities=18%  Similarity=0.195  Sum_probs=100.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-----------CHHHHHHHHHHHHHHHhCCCCCc--ceeEEEEEeC-CE---
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-----------SARDFQKLEREARICRKLQHPNI--VRLHDSIQEE-NY---   63 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-----------~~~~~~~~~~E~~il~~l~H~nI--v~l~~~~~~~-~~---   63 (328)
                      |+.|+||.+...  +..+++|.+.....           +.....++.+|+.++.+|+|++|  ++.+++.... ..   
T Consensus        43 ~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~  120 (239)
T PRK01723         43 KGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR  120 (239)
T ss_pred             CCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence            678899998763  77899998864321           11223567899999999998885  6777764432 22   


Q ss_pred             EEEEEEccCC-CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          64 HYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        64 ~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      .++|||+++| .+|.+.+.. ..+++..    +.|++.+|.+||++||+||||||+|||++.+   +.++|+|||.+...
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~---~~v~LIDfg~~~~~  192 (239)
T PRK01723        121 ADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPD---GKFWLIDFDRGELR  192 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCC---CCEEEEECCCcccC
Confidence            3599999998 577776644 4455543    5789999999999999999999999999754   35999999998664


Q ss_pred             c
Q psy2131         143 Q  143 (328)
Q Consensus       143 ~  143 (328)
                      .
T Consensus       193 ~  193 (239)
T PRK01723        193 T  193 (239)
T ss_pred             C
Confidence            3

>KOG0033|consensus

Probab=99.75  E-value=1.2e-18  Score=144.43  Aligned_cols=68  Identities=84%  Similarity=1.492  Sum_probs=64.3

Q ss_pred             hhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCCcc
Q psy2131         255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       255 ~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  322 (328)
                      .-+++|||+|||||+++..+|+..+||||.|||||.||.|.+||++++.+++++.|++|.|+.+|+--
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w  236 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW  236 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence            44578999999999999999999999999999999999999999999999999999999999999643

>KOG0590|consensus

Probab=99.72  E-value=2.7e-19  Score=172.50  Aligned_cols=197  Identities=30%  Similarity=0.457  Sum_probs=155.6

Q ss_pred             CCceEEEEEEEc-cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK-ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~-~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+|+.|-.+... .+...+|.|.+............+..|..+-..+. |+|++++++...+.+..++++||..|+++++
T Consensus        31 gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~  110 (601)
T KOG0590|consen   31 GSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFS  110 (601)
T ss_pred             cccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccc
Confidence            567777666553 34456777777765544444556667888877776 9999999999999999999999999999999


Q ss_pred             HH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          79 DI-VARE-FYSEADASHCIQQILESVNHCH-SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        79 ~l-~~~~-~~~~~~~~~~~~qll~~L~ylH-~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+.  .+|+.|||+|.......         
T Consensus       111 ~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~~~---------  179 (601)
T KOG0590|consen  111 KISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRNKN---------  179 (601)
T ss_pred             ccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccccccC---------
Confidence            88 5554 6788899999999999999999 999999999999999986542  58999999985432100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (601)
T KOG0590|consen  180 --------------------------------------------------------------------------------  179 (601)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccC-CCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAG-TPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~G-t~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                    .........+| ++.|+|||...+..| +...|+||+|+++.-+++|..|+....
T Consensus       180 --------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  180 --------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             --------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence                          00001112357 999999999999766 889999999999999999999987554

>KOG1033|consensus

Probab=99.72  E-value=2.2e-18  Score=157.07  Aligned_cols=152  Identities=30%  Similarity=0.498  Sum_probs=114.6

Q ss_pred             CEEEEEEEccCCCCcHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccc
Q psy2131          62 NYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL  138 (328)
Q Consensus        62 ~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGl  138 (328)
                      .++||.|++|.-.+|-+++..+..   .+...+..++.|+..|+.|   ++.+|||+||.||++..+   ..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d---~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD---DQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc---hhhhhhhhhh
Confidence            368999999999999999975543   5667788899999999999   999999999999999654   3699999999


Q ss_pred             cccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         139 AIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       139 a~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      ........            ++.++                                                       
T Consensus       403 ~ts~~~~~------------~~~~~-------------------------------------------------------  415 (516)
T KOG1033|consen  403 VTSQDKDE------------TVAPA-------------------------------------------------------  415 (516)
T ss_pred             eeecccCC------------cccch-------------------------------------------------------
Confidence            75432211            00000                                                       


Q ss_pred             CcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-----
Q psy2131         219 HPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-----  293 (328)
Q Consensus       219 h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-----  293 (328)
                                                       .+.....+||..||+||.|.+..|+.++||||||+||+||++     
T Consensus       416 ---------------------------------~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~  462 (516)
T KOG1033|consen  416 ---------------------------------AASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQ  462 (516)
T ss_pred             ---------------------------------hhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccH
Confidence                                             011223469999999999999999999999999999999999     


Q ss_pred             ------------cCCC--CCCccHH--HHHHHHhcccCCCCC
Q psy2131         294 ------------GYPP--FWDEDQH--RLYAQIKAGAYDDEP  319 (328)
Q Consensus       294 ------------G~~P--f~~~~~~--~~~~~i~~~~~~~~~  319 (328)
                                  |..|  |...+|.  .+++...+-.-.-+|
T Consensus       463 ~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP  504 (516)
T KOG1033|consen  463 FERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERP  504 (516)
T ss_pred             HHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCc
Confidence                        7777  6555433  455555444433333

>KOG0195|consensus

Probab=99.71  E-value=4.1e-18  Score=143.40  Aligned_cols=206  Identities=21%  Similarity=0.326  Sum_probs=153.4

Q ss_pred             ceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHHh
Q psy2131           3 FSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA   82 (328)
Q Consensus         3 fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   82 (328)
                      -|+.|+++.  .|..+++|+++....+...-+.|..|.-.|+.+.||||+.+++++....++.++..||+-|+|+..+..
T Consensus       203 sgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe  280 (448)
T KOG0195|consen  203 SGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE  280 (448)
T ss_pred             Ccccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc
Confidence            467888865  445667788876655554445677888889999999999999999999999999999999999999876


Q ss_pred             cCC--CCHHHHHHHHHHHHHHHHHHHHCC-Ceee-cCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          83 REF--YSEADASHCIQQILESVNHCHSNG-VVHR-DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        83 ~~~--~~~~~~~~~~~qll~~L~ylH~~~-ivHr-DiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  .+..++..++.+++.|+.|||+.. ++-| -|....++++.+-. ..+..+|-.++.+.                
T Consensus       281 ~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt-arismad~kfsfqe----------------  343 (448)
T KOG0195|consen  281 QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSFQE----------------  343 (448)
T ss_pred             CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-hheecccceeeeec----------------
Confidence            543  678899999999999999999974 4433 47777888864321 11222222111100                


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       344 --------------------------------------------------------------------------------  343 (448)
T KOG0195|consen  344 --------------------------------------------------------------------------------  343 (448)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCC---CCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh-ccc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYG---KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGA  314 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~---~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~-~~~  314 (328)
                                       .+..=+|.||+||.+..++-+   .++|.|||+|+++||-|...||.+-.+.++=.+|. .|.
T Consensus       344 -----------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl  406 (448)
T KOG0195|consen  344 -----------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL  406 (448)
T ss_pred             -----------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence                             011237889999999877653   58999999999999999999999999888877664 555


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      .-..|+-.+.
T Consensus       407 rv~ippgis~  416 (448)
T KOG0195|consen  407 RVHIPPGISR  416 (448)
T ss_pred             cccCCCCccH
Confidence            5555555443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.8e-16  Score=126.58  Aligned_cols=125  Identities=24%  Similarity=0.308  Sum_probs=104.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |.++.||++....  ..+++|.......    ...+.+|+.+++.++|  .++++++.++...+..|++|||+.|+.+..
T Consensus         9 g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~   82 (155)
T cd05120           9 GLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE   82 (155)
T ss_pred             ccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence            7899999998744  6899999865432    3467889999999977  589999999988889999999999987754


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSN---GVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~---~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      .       +......++.+++.+|.++|..   +++|+|++|+|||++.   .+.++++|||++..
T Consensus        83 ~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~  138 (155)
T cd05120          83 V-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY  138 (155)
T ss_pred             C-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence            3       5556677889999999999985   6999999999999975   34699999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG4158|consensus

Probab=99.69  E-value=1.3e-16  Score=140.93  Aligned_cols=166  Identities=30%  Similarity=0.455  Sum_probs=121.3

Q ss_pred             CCCCcceeEEEEEe---------------------------CCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHH
Q psy2131          47 QHPNIVRLHDSIQE---------------------------ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL   99 (328)
Q Consensus        47 ~H~nIv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll   99 (328)
                      +|||||++..+|.+                           ...+|+||.-... +|.+++..+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999887743                           3467999997765 788877654 356667788999999


Q ss_pred             HHHHHHHHCCCeeecCCCCcEEEeeCCC-CCcEEEeecccccccc-----------------------------------
Q psy2131         100 ESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLAIEVQ-----------------------------------  143 (328)
Q Consensus       100 ~~L~ylH~~~ivHrDiKp~NiLl~~~~~-~~~vkl~DfGla~~~~-----------------------------------  143 (328)
                      +|+.|||++||.|||+|.+|||+.-+.+ .-.+.|+|||.+.-..                                   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999965433 3357899999763110                                   


Q ss_pred             ----CCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         144 ----GEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       144 ----~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                          +..+.| .|.+.|++++..-||.+.....+-..-  ..-+..++..+.+++..++++..+|+.||++|++..-+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhh--hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence                112334 699999999999999874432211110  11111233445789999999999999999999985543

>KOG1240|consensus

Probab=99.69  E-value=9.3e-18  Score=163.77  Aligned_cols=207  Identities=27%  Similarity=0.418  Sum_probs=150.3

Q ss_pred             CceEEEEEEEccCCcEEEEEEeccCC--CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           2 AFSVVRRCVQKATGLEFAAKIINTKK--LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         2 ~fg~V~~~~~~~~~~~~AiK~i~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      .|=+|.+|++. .|. ++||++-++.  .+-+...+-..|++ ...++|||++.+--+.++....|+|-+|..+ +|+++
T Consensus        35 RFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDR  110 (1431)
T KOG1240|consen   35 RFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDR  110 (1431)
T ss_pred             hhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhh
Confidence            35567778764 454 8899986543  34445555556777 6678999999998888888889999999976 89999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc------------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE------------------  141 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~------------------  141 (328)
                      +..+..+..-+-..|+.|++.||.-+|..||+|+|||.||||+.+-+  + +.|+||..-+.                  
T Consensus       111 lSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W-~~LtDFAsFKPtYLPeDNPadf~fFFDTS  187 (1431)
T KOG1240|consen  111 LSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--W-LYLTDFASFKPTYLPEDNPADFTFFFDTS  187 (1431)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--h-hhhhcccccCCccCCCCCcccceEEEecC
Confidence            99999999999999999999999999999999999999999998753  2 67889864211                  


Q ss_pred             ------------c------cCCCcc----------hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcC-CC
Q psy2131         142 ------------V------QGEQQA----------WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-TV  191 (328)
Q Consensus       142 ------------~------~~~~~~----------~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~  191 (328)
                                  .      +..+..          .+||++.|+++ |.|||.-    +.+-.-+.+.-..+..... --
T Consensus       188 rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ie  263 (1431)
T KOG1240|consen  188 RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIE  263 (1431)
T ss_pred             CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCc
Confidence                        0      011112          26999999876 6788731    1111111121111111011 12


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         192 TPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       192 s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +...++++..|++.||++|.+|++.|+.
T Consensus       264 d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  264 DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            4578999999999999999999999874

>KOG0606|consensus

Probab=99.65  E-value=1.7e-17  Score=161.52  Aligned_cols=237  Identities=27%  Similarity=0.389  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.++.+....+|..+++|+...... ...+.+.+.++-.++-..+||.+++..-.+.-....+++++|..|++|...
T Consensus       815 ~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Sk  894 (1205)
T KOG0606|consen  815 GSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSK  894 (1205)
T ss_pred             CCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhh
Confidence            5677888777778888888887754322 222344445555555556778888777777778889999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+..+++-++.++..+.++++|||...++|||++|.|+|+...+   ..++.|||+.....--              
T Consensus       895 l~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g---h~~l~~~~t~~~vg~~--------------  957 (1205)
T KOG0606|consen  895 LHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG---HRPLTDFGTLSKVGLI--------------  957 (1205)
T ss_pred             hhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC---CcccCccccccccccc--------------
Confidence            98888889889999999999999999999999999999999997554   5899999954322100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                        +|-.+..                                     -+.++.+....-.+      .+...         
T Consensus       958 --~p~~~~s-------------------------------------g~~~~~~~~~~~~~------~~~~~---------  983 (1205)
T KOG0606|consen  958 --PPTTDLS-------------------------------------GPSSSGTPRRLSRS------ERRPQ---------  983 (1205)
T ss_pred             --cCcCCcc-------------------------------------cccccCcccccccc------ccccc---------
Confidence              0000000                                     00000000000000      00000         


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                       +..-      ....+....||+.|.+||.+.+...+.++|+|+.|++++|.++|.+||.+..+++++.+|..+..
T Consensus       984 -l~~~------~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~ 1052 (1205)
T KOG0606|consen  984 -LSAD------EARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDI 1052 (1205)
T ss_pred             -cccc------hhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCC
Confidence             0000      01123346799999999999999999999999999999999999999999999999999988765

>KOG1023|consensus

Probab=99.64  E-value=1.7e-15  Score=140.47  Aligned_cols=95  Identities=22%  Similarity=0.304  Sum_probs=83.7

Q ss_pred             HHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC-eeecCCCCcE
Q psy2131          43 CRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGV-VHRDLKPENL  120 (328)
Q Consensus        43 l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~i-vHrDiKp~Ni  120 (328)
                      |+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+... ..++..-...++++++.||.|+|.-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999988763 346666677788999999999999877 9999999999


Q ss_pred             EEeeCCCCCcEEEeeccccc
Q psy2131         121 LLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus       121 Ll~~~~~~~~vkl~DfGla~  140 (328)
                      +++.   .+.+||+|||+..
T Consensus        81 lvd~---~w~lklt~~Gl~~   97 (484)
T KOG1023|consen   81 LVDS---RWVLKLTDFGLNS   97 (484)
T ss_pred             eeee---eEEEEechhhhcc
Confidence            9975   4789999999853

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.64  E-value=1.3e-15  Score=144.60  Aligned_cols=141  Identities=18%  Similarity=0.300  Sum_probs=92.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC---------------------------CHH----H-HHH------HHHHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL---------------------------SAR----D-FQK------LEREARI   42 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~---------------------------~~~----~-~~~------~~~E~~i   42 (328)
                      |++|.||+|+.+.+|+.||||++++...                           ...    + .+.      +.+|+..
T Consensus       130 aSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N  209 (537)
T PRK04750        130 ASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAAN  209 (537)
T ss_pred             CCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHH
Confidence            7899999999988899999999975421                           000    1 111      2344444


Q ss_pred             HHhCC----CCCcceeEEEEEe-CCEEEEEEEccCCCCcHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q psy2131          43 CRKLQ----HPNIVRLHDSIQE-ENYHYLVFDLVTGGELFED--IVARE----FYSEADASHCIQQILESVNHCHSNGVV  111 (328)
Q Consensus        43 l~~l~----H~nIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~----~~~~~~~~~~~~qll~~L~ylH~~~iv  111 (328)
                      +.++.    +.+.+.+-.++.+ ....+||||||.|+.+.+.  +...+    .+.+..+..++.|+       +..|++
T Consensus       210 ~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~Gff  282 (537)
T PRK04750        210 ASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFF  282 (537)
T ss_pred             HHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCee
Confidence            44442    4444444444432 3446799999999999663  32222    23344444445554       358999


Q ss_pred             eecCCCCcEEEeeCC-CCCcEEEeeccccccccCCCcc
Q psy2131         112 HRDLKPENLLLASKA-KGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus       112 HrDiKp~NiLl~~~~-~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      |+|+||.||+++.++ ..+.++++|||++..++.....
T Consensus       283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~r~  320 (537)
T PRK04750        283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKEDKR  320 (537)
T ss_pred             eCCCChHHeEEecCCCCCCeEEEEecceEEECCHHHHH
Confidence            999999999997653 2236999999999888665443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=2.4e-14  Score=134.12  Aligned_cols=140  Identities=20%  Similarity=0.269  Sum_probs=92.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH--HH-----------------------------H-------HHHHHHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA--RD-----------------------------F-------QKLEREARI   42 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~--~~-----------------------------~-------~~~~~E~~i   42 (328)
                      |++|.||+|+.+ +|+.||||+.+......  .+                             .       -.+.+|++.
T Consensus       128 aSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n  206 (437)
T TIGR01982       128 ASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAAN  206 (437)
T ss_pred             eehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHH
Confidence            689999999864 79999999986542100  00                             0       013456666


Q ss_pred             HHhCC----CCCcceeEEEEE-eCCEEEEEEEccCCCCcHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCCeeecC
Q psy2131          43 CRKLQ----HPNIVRLHDSIQ-EENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILE-SVNHCHSNGVVHRDL  115 (328)
Q Consensus        43 l~~l~----H~nIv~l~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~-~L~ylH~~~ivHrDi  115 (328)
                      +.++.    |.+-+.+-.++. .....+|||||++|++|.+..... ...+   ...++.+++. .+..+|..|++|+|+
T Consensus       207 ~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~  283 (437)
T TIGR01982       207 ASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADL  283 (437)
T ss_pred             HHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCC
Confidence            66552    333333333332 233469999999999997765432 1222   2344555554 467889999999999


Q ss_pred             CCCcEEEeeCCCCCcEEEeeccccccccCCCc
Q psy2131         116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus       116 Kp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~  147 (328)
                      +|.||+++.+   +.++++|||++..+.....
T Consensus       284 hPgNilv~~~---g~i~liDfG~~~~l~~~~r  312 (437)
T TIGR01982       284 HPGNIFVLKD---GKIIALDFGIVGRLSEEDR  312 (437)
T ss_pred             CcccEEECCC---CcEEEEeCCCeeECCHHHH
Confidence            9999999654   4699999999988765443

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.54  E-value=4e-15  Score=138.19  Aligned_cols=288  Identities=20%  Similarity=0.204  Sum_probs=185.9

Q ss_pred             CCceEEEEEEE--ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQ--KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~--~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |.+|.||.+..  ..++..+|+|.=+...-...+...-.+|+.--+++ .|+|.++.+..+++.+.+|+-+|+|. .+|.
T Consensus       127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~  205 (524)
T KOG0601|consen  127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQ  205 (524)
T ss_pred             CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhH
Confidence            78999999888  88999999998433222222222234566666666 49999999999999999999999995 6777


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCc-----
Q psy2131          78 EDIVARE-FYSEADASHCIQQILE----SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ-----  147 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~----~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~-----  147 (328)
                      .+-.... .+++..++.++.+...    ||.++|..+|+|-|+||+||++..+.  ...+++|||+...+.....     
T Consensus       206 ~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~df~~v~~i~~~~~~~~~~  283 (524)
T KOG0601|consen  206 SYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTDFGLVSKISDGNFSSVFK  283 (524)
T ss_pred             HhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCCcceeEEccCCcccccee
Confidence            7765544 4889999999999999    99999999999999999999997542  5689999998766533210     


Q ss_pred             ---------------------------chHHHHHHHHHhCCCCCCCC--cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHH
Q psy2131         148 ---------------------------AWFGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL  198 (328)
Q Consensus       148 ---------------------------~~~G~~~~~~~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  198 (328)
                                                 ..+|.+..+...+..+....  +.-....   .  ...|.......+.+.+..
T Consensus       284 ~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---~--~~ip~e~~~~~s~~l~~~  358 (524)
T KOG0601|consen  284 VSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---Q--GYIPLEFCEGGSSSLRSV  358 (524)
T ss_pred             eeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---c--ccCchhhhcCcchhhhhH
Confidence                                       01455555554444433221  0000000   0  001111222456667778


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccCCcccchh-----hhhhhh--hHHHHHhHHHhhhhhhhhhhhccCCCCCC--Cccc
Q psy2131         199 INQMLTVNPSKRITASEALKHPWICQRERVAS-----IVHRQE--TVDCLKKFNARRKLKVSTRQGFAGTPGYL--SPEV  269 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~--aPE~  269 (328)
                      +.+|+..+|-.|++++.+++++++.+......     ...-..  ....+..+........... .+.++-.+.  +++.
T Consensus       359 ~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~  437 (524)
T KOG0601|consen  359 TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEIL  437 (524)
T ss_pred             HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc-cccccccccccchhh
Confidence            99999999999999999999999864322111     000000  1111111110100001111 112333344  5666


Q ss_pred             cccCCCCCCcchhhhhhHHHHHHhcCCC
Q psy2131         270 LKKEPYGKPVDIWACGVILYILLVGYPP  297 (328)
Q Consensus       270 l~~~~~~~~~DvwSlGvilyelltG~~P  297 (328)
                      .+...+..+.|++|||..++|.++|.+-
T Consensus       438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  438 LEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccccccccccccccccccccccccCccc
Confidence            6778999999999999999999888543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.54  E-value=1.1e-13  Score=114.77  Aligned_cols=134  Identities=19%  Similarity=0.194  Sum_probs=97.2

Q ss_pred             ceEEEEEEEcc------CCcEEEEEEeccCCC----------------------CHHHH--HHHHHHHHHHHhCCC--CC
Q psy2131           3 FSVVRRCVQKA------TGLEFAAKIINTKKL----------------------SARDF--QKLEREARICRKLQH--PN   50 (328)
Q Consensus         3 fg~V~~~~~~~------~~~~~AiK~i~~~~~----------------------~~~~~--~~~~~E~~il~~l~H--~n   50 (328)
                      =+.||.|....      .+..+|||+.+....                      +....  ...++|++.|+++..  -+
T Consensus        10 Ea~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~Gv~   89 (197)
T cd05146          10 ESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAGIP   89 (197)
T ss_pred             ceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            36899997543      357899999864321                      00111  123489999999854  46


Q ss_pred             cceeEEEEEeCCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCcEEEeeCCCCC
Q psy2131          51 IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHC-HSNGVVHRDLKPENLLLASKAKGA  129 (328)
Q Consensus        51 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~yl-H~~~ivHrDiKp~NiLl~~~~~~~  129 (328)
                      +.+.+++    ...+|||||+.++.+..-......+++.++..+..|++.+|..+ |+.||||+||++.|||+..    +
T Consensus        90 vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~----~  161 (197)
T cd05146          90 CPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD----G  161 (197)
T ss_pred             CCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC----C
Confidence            7777765    45689999998765533223334466677778889999999999 8999999999999999963    3


Q ss_pred             cEEEeeccccccccC
Q psy2131         130 AVKLADFGLAIEVQG  144 (328)
Q Consensus       130 ~vkl~DfGla~~~~~  144 (328)
                      .+.|+|||.+...+.
T Consensus       162 ~v~iIDF~qav~~~h  176 (197)
T cd05146         162 KVWFIDVSQSVEPTH  176 (197)
T ss_pred             cEEEEECCCceeCCC
Confidence            599999999877654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2.2e-13  Score=111.50  Aligned_cols=122  Identities=20%  Similarity=0.250  Sum_probs=89.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-VRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |.++.||++...  +..|++|+......   ......+|+.+++.+.+.++ .+++....  ...++||||++|.++...
T Consensus         9 G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~   81 (170)
T cd05151           9 GMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE   81 (170)
T ss_pred             cccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc
Confidence            668899998764  77899999764421   11234679999998865554 45665543  335899999999887542


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGV-----VHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~i-----vHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                              ......++.+++.+|..||+.++     +|+|++|+||+++ +   +.++++|||.+..
T Consensus        82 --------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~---~~~~liDf~~a~~  136 (170)
T cd05151          82 --------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D---GRLWLIDWEYAGM  136 (170)
T ss_pred             --------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C---CeEEEEecccccC
Confidence                    11123457889999999999985     9999999999997 2   3589999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0615|consensus

Probab=99.42  E-value=2.3e-14  Score=127.15  Aligned_cols=69  Identities=41%  Similarity=0.708  Sum_probs=58.9

Q ss_pred             hhhhhhccCCCCCCCccccccCCC---CCCcchhhhhhHHHHHHhcCCCCCCccHH-HHHHHHhcccCCCCCC
Q psy2131         252 VSTRQGFAGTPGYLSPEVLKKEPY---GKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDDEPK  320 (328)
Q Consensus       252 ~~~~~~~~Gt~~y~aPE~l~~~~~---~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~  320 (328)
                      .+-..+++|||.|.|||++.++++   +.++|+||+|||||.+|+|.+||.++... .+.+.|.+|.|..-|+
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            334456899999999999987654   45899999999999999999999999744 4999999999988764

>KOG0599|consensus

Probab=99.36  E-value=5.3e-13  Score=112.79  Aligned_cols=65  Identities=48%  Similarity=0.963  Sum_probs=59.0

Q ss_pred             hccCCCCCCCccccc------cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCCc
Q psy2131         257 GFAGTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  321 (328)
                      ..+|||+|.|||.++      ..+|+..+|.||+|||||.||.|.+||+.....-.+..|.+|.|.+..+.
T Consensus       181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            468999999999984      35789999999999999999999999999999999999999999887653

>KOG1243|consensus

Probab=99.35  E-value=1.2e-11  Score=116.62  Aligned_cols=125  Identities=20%  Similarity=0.265  Sum_probs=101.7

Q ss_pred             EEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHHhcCCCC
Q psy2131           8 RCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS   87 (328)
Q Consensus         8 ~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~   87 (328)
                      .|..+.++..+.|.+.+....  .....+.+-++-|+.++||||+++++.++.++.+|||+|-+.-  |-..+...   .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l---~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL---G  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh---H
Confidence            356678899999999876543  3455677889999999999999999999999999999999854  44445443   3


Q ss_pred             HHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          88 EADASHCIQQILESVNHCH-SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        88 ~~~~~~~~~qll~~L~ylH-~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      ...+..-+.||+.||.||| +.+++|++|.-..|+++..+   .-||++|-++...
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~  155 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEecc
Confidence            6677778899999999997 67899999999999997655   4899999886543

>KOG3087|consensus

Probab=99.33  E-value=2.5e-11  Score=97.53  Aligned_cols=139  Identities=23%  Similarity=0.248  Sum_probs=98.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH------HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCC-
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG-   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~g-   73 (328)
                      |+=+.|+++.  ..|+.+.||.=..+.....      ...+..+|+++|.++.--.|.---=+|.+...-.|.|||++| 
T Consensus        18 GAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~   95 (229)
T KOG3087|consen   18 GAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGA   95 (229)
T ss_pred             cceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccch
Confidence            4445677774  4677777775333322211      235678899999998755554444455566667899999987 


Q ss_pred             CCcHHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          74 GELFEDIVARE-FYSEADA-SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        74 g~L~~~l~~~~-~~~~~~~-~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      .++.+++.... .-.+++. ...+.++=..+.-||.++|||+||..+||++.+++....+.++|||++..
T Consensus        96 ~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   96 STVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             hHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            35566665432 2222233 67788888889999999999999999999999988877789999999743

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=6.7e-11  Score=95.44  Aligned_cols=128  Identities=22%  Similarity=0.285  Sum_probs=88.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH------HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD------FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~------~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+=+.++.+..  -|..+.+|.=-++......      ..+..+|++++.+++--.|..-+=++.+.+...|+|||++|-
T Consensus         7 GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~   84 (204)
T COG3642           7 GAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGE   84 (204)
T ss_pred             CcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCCh
Confidence            34456666633  3445555532222222111      245678999999987665555555556677788999999998


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      .|.+.+...       ...++..+=.-+.-||..||||+||.++||++...    .+.++||||+..
T Consensus        85 ~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----~i~~IDfGLg~~  140 (204)
T COG3642          85 LLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----RIYFIDFGLGEF  140 (204)
T ss_pred             hHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----cEEEEECCcccc
Confidence            877777654       13456667777888999999999999999999643    389999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=4.5e-11  Score=101.97  Aligned_cols=137  Identities=18%  Similarity=0.247  Sum_probs=98.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeC---CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEE---NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~---~~~~lv~E~~~gg~   75 (328)
                      |.++.||++... .|..+++|+....... .....+.+|+++++.+.+  .++.+++.+....   +..|+||||++|.+
T Consensus         9 G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~   86 (223)
T cd05154           9 GQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRV   86 (223)
T ss_pred             CccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEe
Confidence            678899999764 3678999998654321 123457889999999976  4467777776654   25689999999988


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHS------------------------------------------------  107 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~------------------------------------------------  107 (328)
                      +.+.+.. ..+++.+...++.+++.+|..||+                                                
T Consensus        87 l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (223)
T cd05154          87 LRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLE  165 (223)
T ss_pred             cCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHH
Confidence            8664421 346666666777777777777773                                                


Q ss_pred             --------CCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131         108 --------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus       108 --------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                              ..++|+|+.|.|||++.+ ..+.+.|+||+.+..
T Consensus       166 ~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         166 AHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             hhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                    236999999999999753 124578999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=3.4e-10  Score=99.12  Aligned_cols=129  Identities=14%  Similarity=0.122  Sum_probs=91.3

Q ss_pred             cCCcEEEEEEeccCCCCH--HH-------HHHHHHHHHHHHhCCCCCc--ceeEEEEEe-----CCEEEEEEEccCCC-C
Q psy2131          13 ATGLEFAAKIINTKKLSA--RD-------FQKLEREARICRKLQHPNI--VRLHDSIQE-----ENYHYLVFDLVTGG-E   75 (328)
Q Consensus        13 ~~~~~~AiK~i~~~~~~~--~~-------~~~~~~E~~il~~l~H~nI--v~l~~~~~~-----~~~~~lv~E~~~gg-~   75 (328)
                      ..|+.|.||.........  +.       ...+.+|.+.+.+|..-+|  +....+.+.     ....+||||+++|. +
T Consensus        43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s  122 (268)
T PRK15123         43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS  122 (268)
T ss_pred             ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence            467789999764332110  00       1136789988888744333  344444443     23578999999986 6


Q ss_pred             cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC----CCCCcEEEeecccccc
Q psy2131          76 LFEDIVA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK----AKGAAVKLADFGLAIE  141 (328)
Q Consensus        76 L~~~l~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~----~~~~~vkl~DfGla~~  141 (328)
                      |.+.+..  ....++.....++.++...+.-||+.||+|+|++++|||++.+    +++..+.++||+.+..
T Consensus       123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            7766643  2445667788999999999999999999999999999999752    2346799999998753

>KOG3741|consensus

Probab=99.20  E-value=7e-10  Score=101.98  Aligned_cols=198  Identities=17%  Similarity=0.240  Sum_probs=144.1

Q ss_pred             EEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE----eCCEEEEEEEccCC-CCcHHH
Q psy2131           5 VVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ----EENYHYLVFDLVTG-GELFED   79 (328)
Q Consensus         5 ~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~----~~~~~~lv~E~~~g-g~L~~~   79 (328)
                      +.|+|....+|..|..|.+.-.+.-  .......-++.++++.|+|||.+.++|.    .+..+.+|++|.++ ++|+++
T Consensus       291 Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  291 TTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             eeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            6799999999999999999422211  0111223467889999999999999987    35578999999886 567665


Q ss_pred             HHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC
Q psy2131          80 IVA---------------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG  144 (328)
Q Consensus        80 l~~---------------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~  144 (328)
                      ...               ....+|..++.|+.|+..||.++|+.|..-+-|.|.+||+..+   ..++|+..|....++.
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---MRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---ceEEEecccceeeecC
Confidence            421               2246789999999999999999999999989999999999743   2588887776554433


Q ss_pred             CC-----------cchHHHHHHHHHhCCCCCCCCc-HHHH-HHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         145 EQ-----------QAWFGVILYILLVGYPPFWDED-QHRL-YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       145 ~~-----------~~~~G~~~~~~~~g~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      +.           -..+|.++..+.+|..--+..+ .++. ...|.           ...|.++++++.-+..-++.. -
T Consensus       446 d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-k  513 (655)
T KOG3741|consen  446 DPTEPLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-K  513 (655)
T ss_pred             CCCcchhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-c
Confidence            32           2348999999999965432222 2222 22222           357889999999888888876 6


Q ss_pred             CHHHHhcC
Q psy2131         212 TASEALKH  219 (328)
Q Consensus       212 t~~~~l~h  219 (328)
                      +..+++.+
T Consensus       514 sI~~llp~  521 (655)
T KOG3741|consen  514 SIQDLLPM  521 (655)
T ss_pred             cHHHHHHH
Confidence            77777754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=2.6e-10  Score=94.42  Aligned_cols=128  Identities=26%  Similarity=0.355  Sum_probs=82.7

Q ss_pred             EEEEEEEccCCcEEEEEEeccCCC----------------------CHH--HHHHHHHHHHHHHhCCCC--CcceeEEEE
Q psy2131           5 VVRRCVQKATGLEFAAKIINTKKL----------------------SAR--DFQKLEREARICRKLQHP--NIVRLHDSI   58 (328)
Q Consensus         5 ~V~~~~~~~~~~~~AiK~i~~~~~----------------------~~~--~~~~~~~E~~il~~l~H~--nIv~l~~~~   58 (328)
                      .||.|.. ..|..+|+|+.+....                      ...  ......+|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3898977 4677999999864311                      000  123467899999999766  567777552


Q ss_pred             EeCCEEEEEEEccC--CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeecCCCCcEEEeeCCCCCcEEEee
Q psy2131          59 QEENYHYLVFDLVT--GGELFEDIVAREFYSEADASHCIQQILESVNH-CHSNGVVHRDLKPENLLLASKAKGAAVKLAD  135 (328)
Q Consensus        59 ~~~~~~~lv~E~~~--gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~y-lH~~~ivHrDiKp~NiLl~~~~~~~~vkl~D  135 (328)
                        .  ..|||||++  |..+. .+.... ++..+...++.+++..+.. +|..||||+|+.+.|||++.+    .+.|+|
T Consensus        80 --~--~~ivME~I~~~G~~~~-~l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID  149 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLP-RLKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID  149 (188)
T ss_dssp             --T--TEEEEE--EETTEEGG-CHHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred             --C--CEEEEEecCCCccchh-hHHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence              2  369999998  54443 333221 2244566778888886555 589999999999999999743    599999


Q ss_pred             cccccccc
Q psy2131         136 FGLAIEVQ  143 (328)
Q Consensus       136 fGla~~~~  143 (328)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0032|consensus

Probab=99.14  E-value=2.4e-10  Score=105.00  Aligned_cols=80  Identities=45%  Similarity=0.990  Sum_probs=75.5

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+.| +|+++|.|+.|.+||.+.+.......+..+.++++.+.|+.+|..+++|+.+||..||.+|+|+.++|.|||+..
T Consensus       219 ~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  219 VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence            3445 899999999999999999999999999999999999999999999999999999999999999999999999986


Q ss_pred             c
Q psy2131         225 R  225 (328)
Q Consensus       225 ~  225 (328)
                      .
T Consensus       299 ~  299 (382)
T KOG0032|consen  299 I  299 (382)
T ss_pred             C
Confidence            4

>KOG0604|consensus

Probab=99.14  E-value=2.3e-11  Score=104.21  Aligned_cols=66  Identities=41%  Similarity=0.777  Sum_probs=57.4

Q ss_pred             hhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH----HHHHHHhcccCCCCCCc
Q psy2131         256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~  321 (328)
                      ++-+-||.|.|||++....|+..+|+||+|||||.||.|-+||+.....    -.-.+|..|.|.+|-+.
T Consensus       221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE  290 (400)
T KOG0604|consen  221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE  290 (400)
T ss_pred             cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence            3456799999999999999999999999999999999999999988653    34568899999998654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=4.1e-09  Score=89.12  Aligned_cols=110  Identities=17%  Similarity=0.235  Sum_probs=85.9

Q ss_pred             HHHHHHHHHHHhCCCC--CcceeEEEEEeC----CEEEEEEEccCCC-CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy2131          34 QKLEREARICRKLQHP--NIVRLHDSIQEE----NYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCH  106 (328)
Q Consensus        34 ~~~~~E~~il~~l~H~--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH  106 (328)
                      .+..+|...+..|..-  .+++.+.+.+..    ...+||||+++|. +|.+.+......+......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            4677888888877543  345556665543    2458999999984 78777766455777788899999999999999


Q ss_pred             HCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc
Q psy2131         107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ  143 (328)
Q Consensus       107 ~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~  143 (328)
                      ++||+|+|+++.|||+..++....+.++||+-+....
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999999999999876544569999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0575|consensus

Probab=99.09  E-value=1.7e-10  Score=107.45  Aligned_cols=75  Identities=40%  Similarity=0.765  Sum_probs=70.0

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+.| +||++|.|+.|.|||...+-.+.+..|+...+.+|+    .+|.++++||.+||+.||.+|||+++++.|+|+.+
T Consensus       199 vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  199 VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            3445 899999999999999999999999999999999987    78999999999999999999999999999999954

>KOG0607|consensus

Probab=99.08  E-value=8.2e-11  Score=101.72  Aligned_cols=65  Identities=40%  Similarity=0.814  Sum_probs=55.0

Q ss_pred             hccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCc---------------cHHHHHHHHhcccCC
Q psy2131         257 GFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDE---------------DQHRLYAQIKAGAYD  316 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~---------------~~~~~~~~i~~~~~~  316 (328)
                      +-+|+..|||||+..     ..-|+.++|.||||||||.||+|.+||.|.               =...||..|..|+|.
T Consensus       245 tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYe  324 (463)
T KOG0607|consen  245 TPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYE  324 (463)
T ss_pred             CcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCc
Confidence            347999999999863     345899999999999999999999999853               146789999999999


Q ss_pred             CCCCc
Q psy2131         317 DEPKH  321 (328)
Q Consensus       317 ~~~~~  321 (328)
                      +|...
T Consensus       325 FPdkd  329 (463)
T KOG0607|consen  325 FPDKD  329 (463)
T ss_pred             CChhh
Confidence            98653

>KOG0601|consensus

Probab=99.07  E-value=7.9e-11  Score=109.86  Aligned_cols=139  Identities=25%  Similarity=0.259  Sum_probs=113.0

Q ss_pred             CCceEEEEEEEc-cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK-ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~-~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |.|+.|+.+... .++..|++|.+.+......+...-..|+.+...+ .|.++++++..|..-...|+--|||+|+++..
T Consensus       276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l  355 (524)
T KOG0601|consen  276 GNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSL  355 (524)
T ss_pred             CccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhh
Confidence            467777776544 7888999999877655544433445677777666 59999999999988888899999999999877


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      .......+++........|++.++.++|+..++|+|+||+||++..++  ...++.|||....
T Consensus       356 ~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  356 RSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTR  416 (524)
T ss_pred             hhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccc
Confidence            776566788999999999999999999999999999999999997643  5578999998753

>KOG1266|consensus

Probab=99.05  E-value=4.6e-10  Score=97.64  Aligned_cols=90  Identities=17%  Similarity=0.286  Sum_probs=74.5

Q ss_pred             HHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CC
Q psy2131          42 ICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSN--GV  110 (328)
Q Consensus        42 il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qll~~L~ylH~~--~i  110 (328)
                      .|-++.|.|||+++.+|.+.     ....+++||+..|++.++|++-    ..+......+|+-||+.||.|||+.  .|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            45567899999999998654     3479999999999999988653    3578888899999999999999997  49


Q ss_pred             eeecCCCCcEEEeeCCCCCcEEEe
Q psy2131         111 VHRDLKPENLLLASKAKGAAVKLA  134 (328)
Q Consensus       111 vHrDiKp~NiLl~~~~~~~~vkl~  134 (328)
                      +|+++...-|++.   +++.||+.
T Consensus       200 ihgnlTc~tifiq---~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQ---HNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeec---CCceEEec
Confidence            9999999999996   34456653

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.03  E-value=2.1e-10  Score=103.38  Aligned_cols=63  Identities=30%  Similarity=0.610  Sum_probs=55.3

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.......++
T Consensus       191 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (316)
T cd05574         191 SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG  253 (316)
T ss_pred             CCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC
Confidence            457999999999999999999999999999999999999999999988888887766654433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0588|consensus

Probab=99.01  E-value=7.9e-10  Score=104.00  Aligned_cols=74  Identities=39%  Similarity=0.714  Sum_probs=69.2

Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .|.+|||+|.|++|+.||.+++...++..++.|.|+.|    ..+|+++++|+.+||..||++|+|.+|+++|||+..
T Consensus       195 VWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  195 VWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             cchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            34489999999999999999999999999999999998    579999999999999999999999999999999854

>KOG0610|consensus

Probab=98.99  E-value=1.3e-09  Score=97.40  Aligned_cols=77  Identities=32%  Similarity=0.635  Sum_probs=69.8

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCc
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT----ASEALKHP  220 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t----~~~~l~h~  220 (328)
                      .+|| +||.+|||+.|.+||.+.+....+.+|......+|...  .+|..++|||.++|.+||++|..    |+|+-.||
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence            3456 89999999999999999999999999999988887543  78899999999999999999998    99999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      ||..
T Consensus       394 FF~g  397 (459)
T KOG0610|consen  394 FFEG  397 (459)
T ss_pred             cccC
Confidence            9854

>KOG0592|consensus

Probab=98.98  E-value=1.3e-09  Score=100.28  Aligned_cols=75  Identities=32%  Similarity=0.729  Sum_probs=69.6

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+.| +||++|.|+.|.|||.+.++.-++..|..-.+.+|.    .+++.++|||.++|..||.+|+|+.++-.||||..
T Consensus       268 sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  268 SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            4456 899999999999999999999999999999999885    67899999999999999999999999999999964

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=98.94  E-value=5.6e-10  Score=99.25  Aligned_cols=45  Identities=42%  Similarity=0.806  Sum_probs=42.0

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ..||+.|+|||++.+..++.++|+||+||++|+|++|++||.+..
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            468999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=98.94  E-value=1.1e-09  Score=95.93  Aligned_cols=57  Identities=32%  Similarity=0.637  Sum_probs=48.9

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|++||...+.......+...
T Consensus       167 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~  223 (265)
T cd06631         167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH  223 (265)
T ss_pred             ccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc
Confidence            346899999999999999999999999999999999999999987766555555544

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=98.92  E-value=8.7e-10  Score=97.05  Aligned_cols=46  Identities=41%  Similarity=0.811  Sum_probs=42.2

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                      ..|++.|+|||++.+..++.++|+||+||++|||++|+.||.+...
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  211 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED  211 (267)
T ss_pred             CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence            4589999999999999999999999999999999999999986643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=98.90  E-value=1.1e-09  Score=98.11  Aligned_cols=56  Identities=25%  Similarity=0.374  Sum_probs=47.5

Q ss_pred             ccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         258 FAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      ..+++.|+|||++.+. .++.++|||||||++|||+||++||.+.+.......+.+.
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~  220 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI  220 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            4578999999998764 5789999999999999999999999998877766665543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=98.89  E-value=1.9e-09  Score=94.15  Aligned_cols=62  Identities=39%  Similarity=0.743  Sum_probs=56.0

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ..+++.|+|||++.+..++.++|+|||||++|+|++|+.||...++...+..+..+.+..++
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE  222 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc
Confidence            45889999999999988999999999999999999999999999999999999887765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=98.89  E-value=1.6e-09  Score=95.10  Aligned_cols=58  Identities=31%  Similarity=0.578  Sum_probs=47.9

Q ss_pred             hccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         257 GFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                      ...|++.|+|||++..     ..++.++|+|||||+||+|+||++||.+.+.......+..+.
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  234 (275)
T cd06608         172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP  234 (275)
T ss_pred             CccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence            3468999999999854     346789999999999999999999999887766666666654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=98.86  E-value=1.6e-09  Score=99.37  Aligned_cols=45  Identities=33%  Similarity=0.508  Sum_probs=38.0

Q ss_pred             hccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         257 GFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                      ...||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            3569999999999853     23467999999999999999999999854

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=98.85  E-value=2e-09  Score=95.42  Aligned_cols=52  Identities=27%  Similarity=0.560  Sum_probs=43.2

Q ss_pred             ccCCCCCCCccccccC------CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         258 FAGTPGYLSPEVLKKE------PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~------~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                      ..|++.|+|||++.+.      .++.++|+|||||++|+|++|+.||...+....+..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  218 (286)
T cd06622         161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ  218 (286)
T ss_pred             CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH
Confidence            4588999999998553      458899999999999999999999987766555544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0605|consensus

Probab=98.85  E-value=4.9e-09  Score=96.50  Aligned_cols=79  Identities=38%  Similarity=0.657  Sum_probs=71.3

Q ss_pred             CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCc
Q psy2131         145 EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI---TASEALKHP  220 (328)
Q Consensus       145 ~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~---t~~~~l~h~  220 (328)
                      ..++| +|||+|+|+.|+|||..++..+.+..|..-......|.-..++++++|||.++|. ||.+|.   .++|+-.||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP  446 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP  446 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence            34566 8999999999999999999999999999888777777778899999999999999 999997   599999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      ||..
T Consensus       447 fF~~  450 (550)
T KOG0605|consen  447 FFKG  450 (550)
T ss_pred             cccc
Confidence            9975

>KOG0577|consensus

Probab=98.83  E-value=3e-09  Score=99.03  Aligned_cols=63  Identities=25%  Similarity=0.527  Sum_probs=55.5

Q ss_pred             hhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         253 STRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       253 ~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                      ....+|+|||.|||||||.   .+.|+-++|||||||++.||.-.+||.+..|-...+-.|.+...
T Consensus       177 ~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes  242 (948)
T KOG0577|consen  177 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  242 (948)
T ss_pred             CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC
Confidence            4567799999999999985   45799999999999999999999999999998888888877544

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=98.82  E-value=2.8e-09  Score=94.36  Aligned_cols=51  Identities=31%  Similarity=0.451  Sum_probs=42.8

Q ss_pred             ccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHH
Q psy2131         258 FAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYA  308 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~  308 (328)
                      ..|++.|+|||++.+. +++.++|+|||||++|||+||++||.+.+......
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~  212 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF  212 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            3578999999998764 57999999999999999999999999876544433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.81  E-value=4.2e-09  Score=95.79  Aligned_cols=55  Identities=33%  Similarity=0.445  Sum_probs=47.9

Q ss_pred             ccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         258 FAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      ..+++.|+|||++.+. .++.++|+|||||++|||+||++||.+.+....+..|..
T Consensus       193 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            3578999999999774 469999999999999999999999999988887776655

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.81  E-value=4.2e-09  Score=93.27  Aligned_cols=53  Identities=26%  Similarity=0.353  Sum_probs=44.3

Q ss_pred             cCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         259 AGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       259 ~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                      .+++.|+|||++.+.. ++.++|+|||||++|||+||+.||.+.+.......+.
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~  214 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF  214 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            4788999999987754 5899999999999999999999999887655554444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=98.80  E-value=3.6e-09  Score=94.20  Aligned_cols=54  Identities=31%  Similarity=0.436  Sum_probs=46.5

Q ss_pred             cCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         259 AGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       259 ~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      .+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+......++.+
T Consensus       172 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~  226 (295)
T cd07837         172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK  226 (295)
T ss_pred             ccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            47889999999865 5679999999999999999999999999887776666654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=98.80  E-value=6.4e-09  Score=89.83  Aligned_cols=56  Identities=30%  Similarity=0.622  Sum_probs=48.2

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      ...|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  211 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT  211 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence            45689999999999988899999999999999999999999998865555555554

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=98.79  E-value=4.2e-09  Score=93.25  Aligned_cols=54  Identities=26%  Similarity=0.334  Sum_probs=43.0

Q ss_pred             ccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCC-CCccHHHHHHHHh
Q psy2131         258 FAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIK  311 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~  311 (328)
                      ..+++.|+|||++.+. .++.++|||||||++|||+||..|| .+.+....+..|.
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  214 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  214 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHH
Confidence            4578999999998775 4799999999999999999998885 4445555555543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0578|consensus

Probab=98.79  E-value=1.2e-08  Score=94.47  Aligned_cols=165  Identities=14%  Similarity=0.170  Sum_probs=102.8

Q ss_pred             CCcceeEEEEEeCCEEEEEEEccCC-CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC
Q psy2131          49 PNIVRLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK  127 (328)
Q Consensus        49 ~nIv~l~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~  127 (328)
                      .++--+.++.+.+...-+|.+++-. +.+.       .+..+....+..-=..|+.|.+-+--.+..-+-.++-|.+   
T Consensus       343 deLWVVMEym~ggsLTDvVt~~~~~E~qIA-------~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltD---  412 (550)
T KOG0578|consen  343 DELWVVMEYMEGGSLTDVVTKTRMTEGQIA-------AICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTD---  412 (550)
T ss_pred             ceeEEEEeecCCCchhhhhhcccccHHHHH-------HHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEee---
Confidence            4444555665555544566666411 1111       1222222222222234666666566666777777777754   


Q ss_pred             CCcEEEeecccccc----------------------ccCCCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC
Q psy2131         128 GAAVKLADFGLAIE----------------------VQGEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  184 (328)
Q Consensus       128 ~~~vkl~DfGla~~----------------------~~~~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~  184 (328)
                         ...|+......                      .....+.| +|+++.||..|.|||.+++...-...|... ....
T Consensus       413 ---FGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~  488 (550)
T KOG0578|consen  413 ---FGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK  488 (550)
T ss_pred             ---eeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC
Confidence               23444433211                      12233445 899999999999999987776555444332 2223


Q ss_pred             CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       185 ~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                      ...+..+|+++++|+.+||+.|+.+|++|.++|.|||+.....
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            3456789999999999999999999999999999999955433

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=98.79  E-value=5.4e-09  Score=93.68  Aligned_cols=55  Identities=27%  Similarity=0.466  Sum_probs=46.2

Q ss_pred             ccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         258 FAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      ..++..|+|||.+.+. .++.++|+|||||++|||+||++||.+.++......+.+
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~  238 (310)
T cd07865         183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ  238 (310)
T ss_pred             cccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            4578899999998764 478999999999999999999999998887666555444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=98.78  E-value=7.5e-09  Score=93.30  Aligned_cols=57  Identities=28%  Similarity=0.581  Sum_probs=48.6

Q ss_pred             ccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         258 FAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                      ..|++.|+|||++.   +..++.++|+|||||++|||++|.+||.+.+......++..+.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  236 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND  236 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence            46899999999984   4568899999999999999999999999988777777766543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=98.77  E-value=4.8e-09  Score=92.69  Aligned_cols=46  Identities=46%  Similarity=0.821  Sum_probs=42.0

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                      ..|+..|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            4588999999999988899999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=98.77  E-value=1.1e-08  Score=89.42  Aligned_cols=57  Identities=30%  Similarity=0.685  Sum_probs=46.7

Q ss_pred             ccCCCCCCCccccccCC---CCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhccc
Q psy2131         258 FAGTPGYLSPEVLKKEP---YGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGA  314 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~---~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~  314 (328)
                      ..|++.|+|||++.+..   ++.++|+|||||++|+|++|+.||.+. +.......+..+.
T Consensus       163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  223 (264)
T cd06626         163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH  223 (264)
T ss_pred             CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC
Confidence            46889999999998776   899999999999999999999999876 3445555555543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0581|consensus

Probab=98.77  E-value=1.9e-08  Score=88.85  Aligned_cols=78  Identities=28%  Similarity=0.488  Sum_probs=62.5

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCC-----cHHHHHHHHHhCCC-CCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDE-----DQHRLYAQIKAGAY-DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~-----~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+.| +|+.+.|+++|+.||...     +..+++..|..+.. ..|..   .+|+++++||..||++||..|+++.|++.
T Consensus       258 sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  258 SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3444 999999999999999774     55677777765432 22221   59999999999999999999999999999


Q ss_pred             CcccCCcc
Q psy2131         219 HPWICQRE  226 (328)
Q Consensus       219 h~~~~~~~  226 (328)
                      |||+....
T Consensus       335 Hpfi~~~~  342 (364)
T KOG0581|consen  335 HPFIKKFE  342 (364)
T ss_pred             CHHHhhcc
Confidence            99997543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=98.76  E-value=1e-08  Score=91.58  Aligned_cols=57  Identities=25%  Similarity=0.487  Sum_probs=45.6

Q ss_pred             ccCCCCCCCccccccCC----CCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhccc
Q psy2131         258 FAGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGA  314 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~----~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~  314 (328)
                      ..|++.|+|||.+.+..    ++.++|+|||||++|+|++|+.||.... ..+.+..+..+.
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  235 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE  235 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence            35788999999997654    8899999999999999999999997643 345555555544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=98.75  E-value=6e-09  Score=91.35  Aligned_cols=45  Identities=33%  Similarity=0.808  Sum_probs=41.6

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ..||..|+|||++.+..++.++|+||+||++|+|++|..||...+
T Consensus       168 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             cccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            458999999999999999999999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=98.74  E-value=7.2e-09  Score=91.42  Aligned_cols=55  Identities=36%  Similarity=0.767  Sum_probs=46.3

Q ss_pred             ccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         258 FAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      ..|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~  216 (277)
T cd06917         161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK  216 (277)
T ss_pred             ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc
Confidence            468999999999865 5579999999999999999999999998877666555443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0585|consensus

Probab=98.74  E-value=1.5e-08  Score=92.12  Aligned_cols=77  Identities=32%  Similarity=0.742  Sum_probs=70.7

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +|+++|.++.|..||.+.....++..|.+....+|..  ..++++++++|.+||++||++|++..++-.|||.+..
T Consensus       301 DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  301 DIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            445 8999999999999999999999999999999888754  4789999999999999999999999999999999764

>KOG0616|consensus

Probab=98.73  E-value=1.8e-08  Score=86.52  Aligned_cols=76  Identities=34%  Similarity=0.818  Sum_probs=69.0

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcC
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKH  219 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h  219 (328)
                      .++| +|+++|+|+.|.+||.+.+...+++.|..+...+|+    .+|+++++|+.++|+.|-++|.     ...++.+|
T Consensus       222 vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H  297 (355)
T KOG0616|consen  222 VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH  297 (355)
T ss_pred             hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence            4556 899999999999999999999999999999999996    6899999999999999999994     57889999


Q ss_pred             cccCCc
Q psy2131         220 PWICQR  225 (328)
Q Consensus       220 ~~~~~~  225 (328)
                      ||+...
T Consensus       298 ~wF~~v  303 (355)
T KOG0616|consen  298 PWFKGV  303 (355)
T ss_pred             cccccc
Confidence            999743

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=98.71  E-value=3.3e-08  Score=87.94  Aligned_cols=74  Identities=23%  Similarity=0.337  Sum_probs=55.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-------------------CCC-------CCcCCCCHHHHHHHHHh
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-------------------YPS-------PEWDTVTPEAKNLINQM  202 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~-------------------~~~-------~~~~~~s~~~~~li~~~  202 (328)
                      .+|+++|+|++|.+||.+.+..+....+......                   +|.       ......++++.+|+.+|
T Consensus       189 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m  268 (288)
T cd07871         189 GVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSL  268 (288)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHh
Confidence            3899999999999999887765554443221110                   111       01234688999999999


Q ss_pred             cccCCCCCCCHHHHhcCccc
Q psy2131         203 LTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~  222 (328)
                      |+.||.+|+|++|+++|||+
T Consensus       269 L~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         269 LLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCcCcccCCCHHHHhcCCCC
Confidence            99999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=98.71  E-value=7.6e-09  Score=92.34  Aligned_cols=55  Identities=29%  Similarity=0.422  Sum_probs=47.7

Q ss_pred             cCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         259 AGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       259 ~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      .+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.++...+.++.+.
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~  218 (298)
T cd07841         163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA  218 (298)
T ss_pred             ccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence            46888999999865 56799999999999999999999999999888877777654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4717|consensus

Probab=98.69  E-value=2.6e-08  Score=91.56  Aligned_cols=75  Identities=35%  Similarity=0.709  Sum_probs=68.9

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +|+|+|++.+|.+||...++.+.+-.|....|..|+    .+|.++++||.+||..||.+|.+.+++..++|+...
T Consensus       201 DiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  201 DIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             hhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            445 999999999999999999999999999999888875    689999999999999999999999999999998754

>KOG0583|consensus

Probab=98.69  E-value=4.7e-08  Score=89.83  Aligned_cols=73  Identities=47%  Similarity=0.810  Sum_probs=67.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|.|++|..||.+.+...++..|..+.+.+|.-..   |+++++|+.+||..||.+|+|+.+++.|||+..
T Consensus       208 S~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  208 SLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             hhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            3899999999999999999999999999999888875322   999999999999999999999999999999986

>KOG2345|consensus

Probab=98.68  E-value=9.2e-09  Score=86.26  Aligned_cols=41  Identities=32%  Similarity=0.588  Sum_probs=36.2

Q ss_pred             CCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         260 GTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       260 Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                      .|..|.|||.+.=   ...+.++|||||||+||+|+.|.-||.-
T Consensus       200 Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  200 CTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             CCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            6888999999854   4558899999999999999999999973

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=98.68  E-value=2.8e-08  Score=88.12  Aligned_cols=76  Identities=25%  Similarity=0.386  Sum_probs=55.1

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-------------------CCCCC---------CcCCCCHHHHH
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-------------------DYPSP---------EWDTVTPEAKN  197 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-------------------~~~~~---------~~~~~s~~~~~  197 (328)
                      +.| +|+++|+|++|.+||.+.+..+....+.....                   ..+..         ....+|+++.+
T Consensus       183 DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  262 (287)
T cd07848         183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLD  262 (287)
T ss_pred             hHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHH
Confidence            344 89999999999999987765444333222110                   01110         01236888999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         198 LINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       198 li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      |+.+||+.||.+|||++++++|||+
T Consensus       263 ll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         263 LMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=98.68  E-value=2.4e-08  Score=87.84  Aligned_cols=50  Identities=28%  Similarity=0.610  Sum_probs=42.8

Q ss_pred             ccCCCCCCCccccccCC--CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHH
Q psy2131         258 FAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQHRLY  307 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~--~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  307 (328)
                      ..|+..|+|||++....  ++.++|+|||||++|||++|..||.+.+.....
T Consensus       170 ~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  221 (272)
T cd06629         170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM  221 (272)
T ss_pred             ccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence            45899999999997754  899999999999999999999999877654433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=98.67  E-value=5.6e-08  Score=86.36  Aligned_cols=75  Identities=25%  Similarity=0.258  Sum_probs=57.2

Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-----------------------CcCCCCHHHHHHHHHhcc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-----------------------EWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~s~~~~~li~~~l~  204 (328)
                      +.+|+++|+|++|.+||.+.+.......+..........                       .....++..++++.+||+
T Consensus       193 wslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  272 (290)
T cd07862         193 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT  272 (290)
T ss_pred             HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhc
Confidence            348999999999999999887766665554321110000                       113467888999999999


Q ss_pred             cCCCCCCCHHHHhcCccc
Q psy2131         205 VNPSKRITASEALKHPWI  222 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~  222 (328)
                      .||++|||+.++++|||+
T Consensus       273 ~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         273 FNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cCchhcCCHHHHhcCCCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=98.66  E-value=2e-08  Score=89.67  Aligned_cols=55  Identities=33%  Similarity=0.502  Sum_probs=46.4

Q ss_pred             cCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         259 AGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       259 ~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      .+++.|+|||.+.+ ..++.++|||||||++|||++|++||...+....+..+.+.
T Consensus       178 ~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~  233 (302)
T cd07864         178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL  233 (302)
T ss_pred             eeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            46788999998865 45799999999999999999999999988877766666554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=98.66  E-value=1.3e-08  Score=88.69  Aligned_cols=56  Identities=45%  Similarity=0.841  Sum_probs=47.2

Q ss_pred             hhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHh
Q psy2131         256 QGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIK  311 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~  311 (328)
                      ....||+.|+|||++. +..++.++|+||+|+++|+|++|..||.+.   +....+..+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~  215 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL  215 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence            3456899999999998 888999999999999999999999999988   4444444443

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00284 protein kinase; Provisional

Probab=98.66  E-value=3e-08  Score=94.48  Aligned_cols=78  Identities=22%  Similarity=0.339  Sum_probs=55.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC------------------------CC--------------
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------------------PE--------------  187 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------~~--------------  187 (328)
                      +.| +||++|+|++|.+||.+.+.......+......+|.                        ..              
T Consensus       327 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (467)
T PTZ00284        327 DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVR  406 (467)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchh
Confidence            445 899999999999999887765544433322111110                        00              


Q ss_pred             cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         188 WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       188 ~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ....++.+.+||.+||++||.+|+|+.|+++|||+.+
T Consensus       407 ~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        407 EVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             hhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            0012456789999999999999999999999999964

>KOG0660|consensus

Probab=98.66  E-value=4.6e-08  Score=86.15  Aligned_cols=77  Identities=34%  Similarity=0.456  Sum_probs=59.5

Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-----------------------CCCC----CCcCCCCHHHHHHHH
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-----------------------DYPS----PEWDTVTPEAKNLIN  200 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~----~~~~~~s~~~~~li~  200 (328)
                      |..|||+.+|++|++-|.+.+....+..|..-..                       ..|.    ..++..++.+.+|+.
T Consensus       212 WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle  291 (359)
T KOG0660|consen  212 WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE  291 (359)
T ss_pred             hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence            3489999999999999998876555544432111                       1111    134578999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCC
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +||..||.+|+|++|+|.|||+.+
T Consensus       292 kmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  292 KMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHhccCccccCCHHHHhcChhhhh
Confidence            999999999999999999999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	328
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-132
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-31
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-130
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-31
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-130
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-32
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-126
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-30
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-125
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-31
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-125
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-31
3soa_A	444	Full-Length Human Camkii Length = 444		1e-123
3soa_A	444	Full-Length Human Camkii Length = 444		6e-31
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-121
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-31
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-121
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-31
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-114
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-31
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-57
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-14
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-54
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-14
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-54
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-51
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-50
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-50
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-50
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-49
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-49
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-49
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-49
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-49
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-49
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-48
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-48
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-48
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-48
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-46
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-46
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-46
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-45
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-43
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-42
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-42
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-41
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-41
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-41
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-41
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-41
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-40
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-40
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-40
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-39
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-39
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-39
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-39
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-39
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-39
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-39
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-38
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-38
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-38
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-38
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-37
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-37
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-37
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-37
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-37
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-37
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-37
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-37
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-37
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-36
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-36
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-36
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-36
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-36
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-36
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-36
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-35
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-35
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-35
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-35
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-35
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-35
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-33
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-33
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-33
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-33
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-33
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-33
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-33
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-33
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-32
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-32
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-32
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-32
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-32
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-32
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-32
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-32
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-32
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-32
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-32
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-32
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-32
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-32
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-32
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-31
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-31
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-30
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-30
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-29
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-29
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-29
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-29
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-28
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-28
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-28
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-27
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-27
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-26
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-26
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-26
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-26
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-26
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-26
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-26
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-26
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-26
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-26
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-26
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-26
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-26
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-26
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-26
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-26
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-26
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-26
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-26
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-26
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-26
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-26
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-26
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-26
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-26
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-26
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-25
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-25
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-25
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-25
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-23
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-23
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-22
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-22
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-22
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-22
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-22
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-22
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-22
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-22
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-22
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-22
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-22
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-21
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-21
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-21
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-21
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-21
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-21
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-21
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-21
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-21
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-21
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-21
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-21
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-21
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-21
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-21
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-21
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-21
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-21
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-21
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-21
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-21
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-21
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-21
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-21
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-21
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-21
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-21
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-21
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-20
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-20
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-20
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-20
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-20
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-20
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-20
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-20
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-20
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-20
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-20
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-20
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-19
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-19
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-18
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-06
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		6e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		8e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-04
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-04
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-04
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-04

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  466 bits (1200), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/304 (75%), Positives = 250/304 (82%), Gaps = 28/304 (9%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 134
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 135 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 194
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 195 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 254
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK +       T  + + + L K
Sbjct: 255 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLK 314
Query: 273 EPYG 276
           +P G
Sbjct: 315 KPDG 318

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 59/60 (98%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+K+PYGKPVD+WACGVILYILLVGYPPFWDEDQHRLY QIKAGAYD
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 224

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  460 bits (1183), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 224/279 (80%), Positives = 240/279 (86%), Gaps = 28/279 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRC++  TG E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILESVNHCH NG+VHRDLKPENL
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENL 134
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK+KGAAVKLADFGLAIEVQG+QQAWF                            GV
Sbjct: 135 LLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV 194
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NP+KRIT
Sbjct: 195 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRIT 254
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEALKHPWICQR  VAS++HRQETVDCLKKFNARRKLK
Sbjct: 255 ASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK 293

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 59/60 (98%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+K+PYGKPVD+WACGVILYILLVGYPPFWDEDQHRLY QIKAGAYD
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 224

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  459 bits (1182), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 232/311 (74%), Positives = 248/311 (79%), Gaps = 31/311 (9%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 99
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 219 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGY--LSPEVL 270
           A +ALK PWIC RERVAS +HRQ+TVDCLKKFNARRKLK +       T     L   +L
Sbjct: 279 ADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLL 338
Query: 271 KKEPYGKPVDI 281
            K+  G P  I
Sbjct: 339 NKKEQGPPSTI 349

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 58/61 (95%), Positives = 59/61 (96%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 316 D 316
           D
Sbjct: 248 D 248

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  447 bits (1151), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 220/279 (78%), Positives = 235/279 (84%), Gaps = 28/279 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV+  TG E+AAKIINTKKLSARD QKLEREARICR L+H NIVRLHDSI E
Sbjct: 15  GAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISE 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCIQQILE+V HCH  GVVHRDLKPENL
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENL 134
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFG----------------------------V 152
           LLASK KGAAVKLADFGLAIEVQG+QQAWFG                            V
Sbjct: 135 LLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGV 194
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQH+LY QIKAGAYD+PSPEWDTVTPEAKNLINQMLT+NP+KRIT
Sbjct: 195 ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRIT 254
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A EALKHPW+CQR  VAS++HRQETV+CLKKFNARRKLK
Sbjct: 255 AHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK 293

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 58/60 (96%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+KE YGKPVDIWACGVILYILLVGYPPFWDEDQH+LY QIKAGAYD
Sbjct: 165 GFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYD 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  445 bits (1144), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 217/279 (77%), Positives = 234/279 (83%), Gaps = 28/279 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV+K    E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 42  GAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 101
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYLVFDLVTGGELFEDIVARE+YSEADASHCI QILESVNH H + +VHRDLKPENL
Sbjct: 102 EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENL 161
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEVQGEQQAWF                            GV
Sbjct: 162 LLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGV 221
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQH+LY QIKAGAYD+PSPEWDTVTPEAKNLINQMLT+NP+KRIT
Sbjct: 222 ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRIT 281
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A +ALKHPW+CQR  VAS++HRQETV+CL+KFNARRKLK
Sbjct: 282 ADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLK 320

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 59/60 (98%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+K+PYGKPVDIWACGVILYILLVGYPPFWDEDQH+LY QIKAGAYD
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYD 251

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  443 bits (1139), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/279 (78%), Positives = 233/279 (83%), Gaps = 28/279 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV+   G E+AAKIINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 33  GAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYL+FDLVTGGELFEDIVARE+YSEADASHCIQQILE+V HCH  GVVHRDLKPENL
Sbjct: 93  EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENL 152
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEV+GEQQAWF                            GV
Sbjct: 153 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 212
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NPSKRIT
Sbjct: 213 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 272
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A+EALKHPWI  R  VAS +HRQETVDCLKKFNARRKLK
Sbjct: 273 AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 311

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 59/60 (98%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+K+PYGKPVD+WACGVILYILLVGYPPFWDEDQHRLY QIKAGAYD
Sbjct: 183 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 242

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  439 bits (1128), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 217/279 (77%), Positives = 232/279 (83%), Gaps = 28/279 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV+   G E+AA IINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYL+FDLVTGGELFEDIVARE+YSEADASHCIQQILE+V HCH  GVVHR+LKPENL
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEV+GEQQAWF                            GV
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NPSKRIT
Sbjct: 202 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A+EALKHPWI  R  VAS +HRQETVDCLKKFNARRKLK
Sbjct: 262 AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 56/60 (93%), Positives = 59/60 (98%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GFAGTPGYLSPEVL+K+PYGKPVD+WACGVILYILLVGYPPFWDEDQHRLY QIKAGAYD
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 231

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  431 bits (1108), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 214/269 (79%), Positives = 227/269 (84%), Gaps = 29/269 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCL 241
           A +ALK PWIC RERVAS +HRQ+ VDCL
Sbjct: 256 ADQALKVPWICNRERVASAIHRQDXVDCL 284

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 58/61 (95%), Positives = 59/61 (96%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 316 D 316
           D
Sbjct: 225 D 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  429 bits (1104), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 213/268 (79%), Positives = 226/268 (84%), Gaps = 29/268 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 16  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 76  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 136 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 194
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 195 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 254
Query: 213 ASEALKHPWICQRERVASIVHRQETVDC 240
           A +ALK PWIC RERVAS +HRQ+ VDC
Sbjct: 255 ADQALKVPWICNRERVASAIHRQDXVDC 282

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 58/61 (95%), Positives = 59/61 (96%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 164 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 223
Query: 316 D 316
           D
Sbjct: 224 D 224

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  407 bits (1047), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 203/254 (79%), Positives = 214/254 (84%), Gaps = 29/254 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255
Query: 213 ASEALKHPWICQRE 226
           A +ALK PWIC RE
Sbjct: 256 ADQALKVPWICNRE 269

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 58/61 (95%), Positives = 59/61 (96%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 316 D 316
           D
Sbjct: 225 D 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 122/287 (42%), Positives = 173/287 (60%), Gaps = 38/287 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDS 57
           GAFSVVRRC+ + TG +FA KI++  K ++      + L+REA IC  L+HP+IV L ++
Sbjct: 35  GAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHR 113
              +   Y+VF+ + G +L  +IV R      YSEA ASH ++QILE++ +CH N ++HR
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 154
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------------------- 146
           D+KPEN+LLASK   A VKL DFG+AI++ GE                            
Sbjct: 155 DVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  GVIL+ILL G  PF+   + RL+  I  G Y     +W  ++  AK+L+ +ML 
Sbjct: 214 VDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272
Query: 205 VNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ++P++RIT  EAL HPW+ +R+R A  +H  ETV+ L+KFNARRKLK
Sbjct: 273 LDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 35/67 (52%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           G  GTP +++PEV+K+EPYGKPVD+W CGVIL+ILL G  PF+   + RL+  I  G Y 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYK 250
Query: 317 DEPKHKS 323
             P+  S
Sbjct: 251 MNPRQWS 257

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 118/287 (41%), Positives = 169/287 (58%), Gaps = 38/287 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDS 57
           G FSVVRRC+ + TG +FA KI++  K ++      + L+REA IC  L+HP+IV L ++
Sbjct: 37  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 96
Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHR 113
              +   Y+VF+ + G +L  +IV R      YSEA ASH ++QILE++ +CH N ++HR
Sbjct: 97  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 156
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------------------- 146
           D+KP  +LLASK   A VKL  FG+AI++ GE                            
Sbjct: 157 DVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREPYGKP 215
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  GVIL+ILL G  PF+   + RL+  I  G Y     +W  ++  AK+L+ +ML 
Sbjct: 216 VDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 274
Query: 205 VNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ++P++RIT  EAL HPW+ +R+R A  +H  ETV+ L+KFNARRKLK
Sbjct: 275 LDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 321

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 35/67 (52%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           G  GTP +++PEV+K+EPYGKPVD+W CGVIL+ILL G  PF+   + RL+  I  G Y 
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYK 252
Query: 317 DEPKHKS 323
             P+  S
Sbjct: 253 MNPRQWS 259

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 118/287 (41%), Positives = 169/287 (58%), Gaps = 38/287 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDS 57
           G FSVVRRC+ + TG +FA KI++  K ++      + L+REA IC  L+HP+IV L ++
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHR 113
              +   Y+VF+ + G +L  +IV R      YSEA ASH ++QILE++ +CH N ++HR
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 154
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------------------- 146
           D+KP  +LLASK   A VKL  FG+AI++ GE                            
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  GVIL+ILL G  PF+   + RL+  I  G Y     +W  ++  AK+L+ +ML 
Sbjct: 214 VDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272
Query: 205 VNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ++P++RIT  EAL HPW+ +R+R A  +H  ETV+ L+KFNARRKLK
Sbjct: 273 LDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 35/67 (52%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           G  GTP +++PEV+K+EPYGKPVD+W CGVIL+ILL G  PF+   + RL+  I  G Y 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYK 250
Query: 317 DEPKHKS 323
             P+  S
Sbjct: 251 MNPRQWS 257

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 165/280 (58%), Gaps = 30/280 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +C  + T  E+A K+IN      +D   + RE  + +KL HPNI++L + +++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y+V +L TGGELF++I+ R+ +SE DA+  I+Q+   + + H + +VHRDLKPEN+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVIL 154
           LL SK K   +K+ DFGL+   Q   +       A++                   GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL G PPF+ ++++ +  +++ G Y +  P+W T++ +AK+LI +MLT +PS RITA+
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 215 EALKHPWI----CQRERVASIVHRQETVDCLKKFNARRKL 250
           + L+HPWI     +   ++ +   +  +  +++F A +KL
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKL 312

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 39/56 (69%), Gaps = 1/56 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GT  Y++PEVL+   Y +  D+W+ GVILYILL G PPF+ ++++ +  +++ G Y
Sbjct: 185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 159/288 (55%), Gaps = 33/288 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V    +KATG  FA K I  K L  ++   +E E  + RK++H NIV L D  + 
Sbjct: 33  GAFSEVVLAEEKATGKLFAVKCIPKKALKGKE-SSIENEIAVLRKIKHENIVALEDIYES 91
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N+ YLV  LV+GGELF+ IV + FY+E DAS  I+Q+L++V + H  G+VHRDLKPENL
Sbjct: 92  PNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENL 151
Query: 121 LLASKAKGAAVKLADFGLA-IEVQGEQQA-------------------------W-FGVI 153
           L  S+ + + + ++DFGL+ +E +G+  +                         W  GVI
Sbjct: 152 LYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P+KR T 
Sbjct: 212 AYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTC 271
Query: 214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT 261
            +A +HPWI     +   +H   +    K F      K   RQ F  T
Sbjct: 272 EQAARHPWIAGDTALNKNIHESVSAQIRKNF-----AKSKWRQAFNAT 314

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 35/61 (57%), Positives = 45/61 (73%), Gaps = 1/61 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+  +L+ QI    Y+ D 
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDS 243
Query: 319 P 319
           P
Sbjct: 244 P 244

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  194 bits (493), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 94/248 (37%), Positives = 151/248 (60%), Gaps = 26/248 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +C  + T  E+A K+IN      +D   + RE  + +KL HPNI++L + +++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y+V +L TGGELF++I+ R+ +SE DA+  I+Q+   + + H + +VHRDLKPEN+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVIL 154
           LL SK K   +K+ DFGL+   Q   +       A++                   GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL G PPF+ ++++ +  +++ G Y +  P+W T++ +AK+LI +MLT +PS RITA+
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 215 EALKHPWI 222
           + L+HPWI
Sbjct: 273 QCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/67 (40%), Positives = 45/67 (67%), Gaps = 2/67 (2%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GT  Y++PEVL+   Y +  D+W+ GVILYILL G PPF+ ++++ +  +++ G Y  D 
Sbjct: 185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 319 PKHKSAS 325
           P+ ++ S
Sbjct: 244 PQWRTIS 250

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 94/248 (37%), Positives = 151/248 (60%), Gaps = 26/248 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +C  + T  E+A K+IN      +D   + RE  + +KL HPNI++L + +++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y+V +L TGGELF++I+ R+ +SE DA+  I+Q+   + + H + +VHRDLKPEN+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVIL 154
           LL SK K   +K+ DFGL+   Q   +       A++                   GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL G PPF+ ++++ +  +++ G Y +  P+W T++ +AK+LI +MLT +PS RITA+
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 215 EALKHPWI 222
           + L+HPWI
Sbjct: 273 QCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/67 (40%), Positives = 45/67 (67%), Gaps = 2/67 (2%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GT  Y++PEVL+   Y +  D+W+ GVILYILL G PPF+ ++++ +  +++ G Y  D 
Sbjct: 185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 319 PKHKSAS 325
           P+ ++ S
Sbjct: 244 PQWRTIS 250

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 97/249 (38%), Positives = 154/249 (61%), Gaps = 27/249 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI++L++  +
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 156
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVI 153
           LLL SK+K A +++ DFGL+   +  ++       A++                   GVI
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 216
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI +MLT  PS RI+A
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276
Query: 214 SEALKHPWI 222
            +AL H WI
Sbjct: 277 RDALDHEWI 285

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 47/83 (56%), Gaps = 7/83 (8%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A +K+K        GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   ++
Sbjct: 179 FEASKKMKDKI-----GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 304 HRLYAQIKAGAYDDE-PKHKSAS 325
           + +  +++ G Y  E P+ K  S
Sbjct: 233 YDILKKVEKGKYTFELPQWKKVS 255

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 97/249 (38%), Positives = 154/249 (61%), Gaps = 27/249 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI++L++  +
Sbjct: 43  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 103 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVI 153
           LLL SK+K A +++ DFGL+   +  ++       A++                   GVI
Sbjct: 163 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 222
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI +MLT  PS RI+A
Sbjct: 223 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 282
Query: 214 SEALKHPWI 222
            +AL H WI
Sbjct: 283 RDALDHEWI 291

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 47/83 (56%), Gaps = 7/83 (8%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A +K+K        GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   ++
Sbjct: 185 FEASKKMKDKI-----GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 238
Query: 304 HRLYAQIKAGAYDDE-PKHKSAS 325
           + +  +++ G Y  E P+ K  S
Sbjct: 239 YDILKKVEKGKYTFELPQWKKVS 261

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 97/249 (38%), Positives = 154/249 (61%), Gaps = 27/249 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI++L++  +
Sbjct: 60  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 119
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 120 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 179
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVI 153
           LLL SK+K A +++ DFGL+   +  ++       A++                   GVI
Sbjct: 180 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 239
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI +MLT  PS RI+A
Sbjct: 240 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 299
Query: 214 SEALKHPWI 222
            +AL H WI
Sbjct: 300 RDALDHEWI 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 6/72 (8%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A +K+K        GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   ++
Sbjct: 202 FEASKKMKDKI-----GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 255
Query: 304 HRLYAQIKAGAY 315
           + +  +++ G Y
Sbjct: 256 YDILKKVEKGKY 267

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 97/249 (38%), Positives = 154/249 (61%), Gaps = 27/249 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI++L++  +
Sbjct: 61  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 120
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 121 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 180
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVI 153
           LLL SK+K A +++ DFGL+   +  ++       A++                   GVI
Sbjct: 181 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 240
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI +MLT  PS RI+A
Sbjct: 241 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 300
Query: 214 SEALKHPWI 222
            +AL H WI
Sbjct: 301 RDALDHEWI 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 6/72 (8%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A +K+K        GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   ++
Sbjct: 203 FEASKKMKDKI-----GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 256
Query: 304 HRLYAQIKAGAY 315
           + +  +++ G Y
Sbjct: 257 YDILKKVEKGKY 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 112/290 (38%), Positives = 165/290 (56%), Gaps = 36/290 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA S+V RC QK T   +A K++        D + +  E  +  +L HPNI++L +  + 
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
                LV +LVTGGELF+ IV + +YSE DA+  ++QILE+V + H NG+VHRDLKPENL
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179
Query: 121 LLASKAKGAAVKLADFGLAIEVQ--------------------------GEQQAW-FGVI 153
           L A+ A  A +K+ADFGL+  V+                           E   W  G+I
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 154 LYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            YILL G+ PF+DE  DQ  ++ +I    Y + SP WD V+  AK+L+ +++ ++P KR+
Sbjct: 240 TYILLCGFEPFYDERGDQF-MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298
Query: 212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT 261
           T  +AL+HPW+    + A+ VH       L++FNARRKLK + +   A +
Sbjct: 299 TTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASS 346

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 24/42 (57%), Positives = 32/42 (76%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           GTPGY +PE+L+   YG  VD+W+ G+I YILL G+ PF+DE
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  191 bits (485), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 102/280 (36%), Positives = 155/280 (55%), Gaps = 30/280 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V  C  K T +E A KII    +S     KL  E  + + L HPNI++L+D  ++
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +  +YLV +   GGELF++I+ R  ++E DA+  I+Q+L  V + H + +VHRDLKPENL
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------AW-FGVIL 154
           LL SK K A +K+ DFGL+   + +++                          W  GVIL
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVIL 227
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           +ILL GYPPF  +    +  +++ G Y + SPEW  V+  AK+LI QML  +  +RI+A 
Sbjct: 228 FILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287
Query: 215 EALKHPWI----CQRERVASIVHRQETVDCLKKFNARRKL 250
           +AL+HPWI     ++E    +      ++ ++KF   +KL
Sbjct: 288 QALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKL 327

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 44/67 (65%), Gaps = 2/67 (2%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GT  Y++PEVL+K+ Y +  D+W+ GVIL+ILL GYPPF  +    +  +++ G Y  D 
Sbjct: 200 GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
Query: 319 PKHKSAS 325
           P+ K+ S
Sbjct: 259 PEWKNVS 265

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 96/249 (38%), Positives = 152/249 (61%), Gaps = 27/249 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI +L++  +
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFE 96
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPEN 156
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF-------------------GVI 153
           LLL SK+K A +++ DFGL+   +  ++       A++                   GVI
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 216
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI + LT  PS RI+A
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISA 276
Query: 214 SEALKHPWI 222
            +AL H WI
Sbjct: 277 RDALDHEWI 285

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 36/56 (64%), Gaps = 1/56 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   +++ +  +++ G Y
Sbjct: 190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  187 bits (476), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 160/281 (56%), Gaps = 31/281 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA+  V  C  K TG E A KII    ++   +   L  E  + ++L HPNI++L++  +
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++  +YLV ++  GGELF++I+ R+ +SE DA+  ++Q+L    + H + +VHRDLKPEN
Sbjct: 75  DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPEN 134
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQ-----AWF-------------------GVI 153
           LLL SK++ A +K+ DFGL+   EV G+ +     A++                   GVI
Sbjct: 135 LLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGVI 194
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL GYPPF  +    +  +++ G + +  P+W  V+ EAK L+  MLT  PSKRI+A
Sbjct: 195 LYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 254
Query: 214 SEALKHPWI---CQRERVASIVHR-QETVDCLKKFNARRKL 250
            EAL HPWI   C ++      H     +  +KKF + +KL
Sbjct: 255 EEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKL 295

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 41/60 (68%), Gaps = 1/60 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GT  Y++PEVL+K+ Y +  D+W+CGVILYILL GYPPF  +    +  +++ G +  +P
Sbjct: 168 GTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDP 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 98/251 (39%), Positives = 148/251 (58%), Gaps = 27/251 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA+  V  C  K TG E A KII    ++   +   L  E  + ++L HPNI++L++  +
Sbjct: 32  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 91
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++  +YLV ++  GGELF++I+ R+ +SE DA+  ++Q+L    + H + +VHRDLKPEN
Sbjct: 92  DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPEN 151
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQ-----AWF-------------------GVI 153
           LLL SK++ A +K+ DFGL+   EV G+ +     A++                   GVI
Sbjct: 152 LLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGVI 211
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL GYPPF  +    +  +++ G + +  P+W  V+ EAK L+  MLT  PSKRI+A
Sbjct: 212 LYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 271
Query: 214 SEALKHPWICQ 224
            EAL HPWI +
Sbjct: 272 EEALNHPWIVK 282

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 41/60 (68%), Gaps = 1/60 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GT  Y++PEVL+K+ Y +  D+W+CGVILYILL GYPPF  +    +  +++ G +  +P
Sbjct: 185 GTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDP 243

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  187 bits (474), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 104/248 (41%), Positives = 143/248 (57%), Gaps = 28/248 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V    Q+ TG  FA K I  KK  A     LE E  + +K++H NIV L D  + 
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             ++YLV  LV+GGELF+ I+ R  Y+E DAS  IQQ+L +V + H NG+VHRDLKPENL
Sbjct: 78  TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137
Query: 121 LLASKAKGAAVKLADFGL-------------------AIEVQGEQ------QAW-FGVIL 154
           L  +  + + + + DFGL                   A EV  ++        W  GVI 
Sbjct: 138 LYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL GYPPF++E + +L+ +IK G Y++ SP WD ++  AK+ I  +L  +P++R T  
Sbjct: 198 YILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCE 257
Query: 215 EALKHPWI 222
           +AL HPWI
Sbjct: 258 KALSHPWI 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 34/59 (57%), Positives = 46/59 (77%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF++E + +L+ +IK G Y+ E
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 154/288 (53%), Gaps = 33/288 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V     K T    A K I  K L  ++   +E E  +  K++HPNIV L D  + 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDDIYES 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YL+  LV+GGELF+ IV + FY+E DAS  I Q+L++V + H  G+VHRDLKPENL
Sbjct: 88  GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 147
Query: 121 LLASKAKGAAVKLADFGL--------------------AIEVQGEQ------QAW-FGVI 153
           L  S  + + + ++DFGL                    A EV  ++        W  GVI
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P KR T 
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 267
Query: 214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT 261
            +AL+HPWI     +   +H Q   + +KK  A+ K K    Q F  T
Sbjct: 268 EQALQHPWIAGDTALDKNIH-QSVSEQIKKNFAKSKWK----QAFNAT 310

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 35/61 (57%), Positives = 45/61 (73%), Gaps = 1/61 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+  +L+ QI    Y+ D 
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 319 P 319
           P
Sbjct: 240 P 240

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 154/288 (53%), Gaps = 33/288 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V     K T    A K I  + L  ++   +E E  +  K++HPNIV L D  + 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDDIYES 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YL+  LV+GGELF+ IV + FY+E DAS  I Q+L++V + H  G+VHRDLKPENL
Sbjct: 88  GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 147
Query: 121 LLASKAKGAAVKLADFGL--------------------AIEVQGEQ------QAW-FGVI 153
           L  S  + + + ++DFGL                    A EV  ++        W  GVI
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P KR T 
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 267
Query: 214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT 261
            +AL+HPWI     +   +H Q   + +KK  A+ K K    Q F  T
Sbjct: 268 EQALQHPWIAGDTALDKNIH-QSVSEQIKKNFAKSKWK----QAFNAT 310

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 35/61 (57%), Positives = 45/61 (73%), Gaps = 1/61 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+  +L+ QI    Y+ D 
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 319 P 319
           P
Sbjct: 240 P 240

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 154/288 (53%), Gaps = 33/288 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V     K T    A K I  + L  ++   +E E  +  K++HPNIV L D  + 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDDIYES 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YL+  LV+GGELF+ IV + FY+E DAS  I Q+L++V + H  G+VHRDLKPENL
Sbjct: 88  GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 147
Query: 121 LLASKAKGAAVKLADFGL--------------------AIEVQGEQ------QAW-FGVI 153
           L  S  + + + ++DFGL                    A EV  ++        W  GVI
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P KR T 
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 267
Query: 214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGT 261
            +AL+HPWI     +   +H Q   + +KK  A+ K K    Q F  T
Sbjct: 268 EQALQHPWIAGDTALDKNIH-QSVSEQIKKNFAKSKWK----QAFNAT 310

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 35/61 (57%), Positives = 45/61 (73%), Gaps = 1/61 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+  +L+ QI    Y+ D 
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 319 P 319
           P
Sbjct: 240 P 240

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 143/261 (54%), Gaps = 28/261 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V     K T    A K I  + L  ++   +E E  +  K++HPNIV L D  + 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHPNIVALDDIYES 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YL+  LV+GGELF+ IV + FY+E DAS  I Q+L++V + H  G+VHRDLKPENL
Sbjct: 88  GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 147
Query: 121 LLASKAKGAAVKLADFGL--------------------AIEVQGEQ------QAW-FGVI 153
           L  S  + + + ++DFGL                    A EV  ++        W  GVI
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P KR T 
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 267
Query: 214 SEALKHPWICQRERVASIVHR 234
            +AL+HPWI     +   +H+
Sbjct: 268 EQALQHPWIAGDTALDKNIHQ 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 35/61 (57%), Positives = 45/61 (73%), Gaps = 1/61 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DE 318
           GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+  +L+ QI    Y+ D 
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 239
Query: 319 P 319
           P
Sbjct: 240 P 240

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 107/318 (33%), Positives = 164/318 (51%), Gaps = 36/318 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ HPNI+ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I A +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNARRKLKVSTRQGFAGTPGYLS 266
           KR+T  EAL+HPWI   +   ++V R+  V+    KK   RR+ K+S          +L+
Sbjct: 263 KRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSF--SIVSLCNHLT 320
Query: 267 PEVLKKEPYGKPVDIWAC 284
             ++KK       D+  C
Sbjct: 321 RSLMKKVHLRTSEDLRNC 338

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I A +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 88/248 (35%), Positives = 138/248 (55%), Gaps = 28/248 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V+  VQK T +  AAK I   K    D  + ++E  I + L HPNI+RL+++ ++
Sbjct: 37  GSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 94
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               YLV +L TGGELFE +V +  + E+DA+  ++ +L +V +CH   V HRDLKPEN 
Sbjct: 95  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 154
Query: 121 LLASKAKGAAVKLADFGLAIEVQ-------------------------GEQQAWF-GVIL 154
           L  + +  + +KL DFGLA   +                          E   W  GV++
Sbjct: 155 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMM 214
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           Y+LL GYPPF       +  +I+ G + +P  +W  V+P+A++LI ++LT +P +RIT+ 
Sbjct: 215 YVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 274
Query: 215 EALKHPWI 222
           +AL+H W 
Sbjct: 275 QALEHEWF 282

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GTP Y+SP+VL+   YG   D W+ GV++Y+LL GYPPF       +  +I+ G +
Sbjct: 186 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF 241

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 88/248 (35%), Positives = 138/248 (55%), Gaps = 28/248 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V+  VQK T +  AAK I   K    D  + ++E  I + L HPNI+RL+++ ++
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               YLV +L TGGELFE +V +  + E+DA+  ++ +L +V +CH   V HRDLKPEN 
Sbjct: 78  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137
Query: 121 LLASKAKGAAVKLADFGLAIEVQ-------------------------GEQQAWF-GVIL 154
           L  + +  + +KL DFGLA   +                          E   W  GV++
Sbjct: 138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMM 197
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           Y+LL GYPPF       +  +I+ G + +P  +W  V+P+A++LI ++LT +P +RIT+ 
Sbjct: 198 YVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257
Query: 215 EALKHPWI 222
           +AL+H W 
Sbjct: 258 QALEHEWF 265

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GTP Y+SP+VL+   YG   D W+ GV++Y+LL GYPPF       +  +I+ G +
Sbjct: 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF 224

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/287 (34%), Positives = 153/287 (53%), Gaps = 34/287 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I A +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNARRKLKVS 253
           KR+T  EAL+HPWI   +   ++V R+  V+    +K   RR+ K++
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLA 309

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I A +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 98/286 (34%), Positives = 152/286 (53%), Gaps = 34/286 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I A +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNARRKLKV 252
           KR+T  EAL+HPWI   +   ++V R+  V+    +K   RR+ K+
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKL 308

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I A +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 98/287 (34%), Positives = 153/287 (53%), Gaps = 34/287 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I + +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNARRKLKVS 253
           KR+T  EAL+HPWI   +   ++V R+  V+    +K   RR+ K+S
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLS 309

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I + +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 144/262 (54%), Gaps = 43/262 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKI--INTKKLSARDFQKLE----REARICRKLQ-HPNIVR 53
           G  SVVRRCV +ATG EFA KI  +  ++LS    +++     RE  I R++  HP+I+ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           L DS +  ++ +LVFDL+  GELF+ +  +   SE +    ++ +LE+V+  H+N +VHR
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR 224
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ-GEQ-------------------------- 146
           DLKPEN+LL    +   ++L+DFG +  ++ GE+                          
Sbjct: 225 DLKPENILLDDNMQ---IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
Query: 147 -----QAWF-GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN 200
                  W  GVIL+ LL G PPFW   Q  +   I  G Y + SPEWD  +   K+LI+
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341
Query: 201 QMLTVNPSKRITASEALKHPWI 222
           ++L V+P  R+TA +AL+HP+ 
Sbjct: 342 RLLQVDPEARLTAEQALQHPFF 363

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 34/64 (53%), Positives = 39/64 (60%), Gaps = 6/64 (9%)
Query: 258 FAGTPGYLSPEVLK-----KEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
             GTPGYL+PE+LK       P YGK VD+WACGVIL+ LL G PPFW   Q  +   I 
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318
Query: 312 AGAY 315
            G Y
Sbjct: 319 EGQY 322

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 153/287 (53%), Gaps = 34/287 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I + +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNARRKLKVS 253
           KR+T  EAL+HPWI   +   ++V R+  V+    +K   RR+ K++
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLA 309

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I + +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 140/254 (55%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++VR+C QK TG E+AAK I  ++LS+       +++ERE  I R+++HPNI+ LHD
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV+GGELF+ +  +E  +E +A+  ++QIL+ V++ HS  + H DLK
Sbjct: 76  IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 135
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFG+A +++                           E   W
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  E +      I A  YD+    +   +  AK+ I ++L  +P 
Sbjct: 196 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPK 255
Query: 209 KRITASEALKHPWI 222
           +R+T +++L+H WI
Sbjct: 256 RRMTIAQSLEHSWI 269

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 33/57 (57%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  E +      I A  YD
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/254 (36%), Positives = 143/254 (56%), Gaps = 37/254 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++SV +RC+ KAT +EFA KII+  K   RD    E    + R  QHPNI+ L D   +
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIIDKSK---RD--PTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             Y Y+V +L+ GGEL + I+ ++F+SE +AS  +  I ++V + H+ GVVHRDLKP N+
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 121 LLASKAKGA-AVKLADFGLA------------------------IEVQGEQQA---W-FG 151
           L   ++    ++++ DFG A                        +E QG   A   W  G
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 152 VILYILLVGYPPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           V+LY +L GY PF    D+    + A+I +G +      W++V+  AK+L+++ML V+P 
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267
Query: 209 KRITASEALKHPWI 222
           +R+TA+  L+HPWI
Sbjct: 268 QRLTAALVLRHPWI 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIKAGAY 315
           T  +++PEVL+++ Y    DIW+ GV+LY +L GY PF    D+    + A+I +G +
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++VR+C QK TG E+AAK I  ++LS+       +++ERE  I R+++HPNI+ LHD
Sbjct: 23  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV+GGELF+ +  +E  +E +A+  ++QIL+ V++ HS  + H DLK
Sbjct: 83  IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 142
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFG+A +++                           E   W
Sbjct: 143 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  E +      I A  YD+    +   +  AK+ I ++L  +P 
Sbjct: 203 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPK 262
Query: 209 KRITASEALKHPWI 222
           +R+  +++L+H WI
Sbjct: 263 RRMXIAQSLEHSWI 276

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 38/66 (57%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  E +      I A  YD + 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 239
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 240 EYFSNT 245

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 142/266 (53%), Gaps = 32/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFGLA E++                           E   W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I + +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 209 KRITASEALKHPWICQRERVASIVHR 234
           KR+T  EAL+HPWI   +   ++V R
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 35/57 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A I + +YD
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 134/265 (50%), Gaps = 44/265 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK---KLSARDFQKLE----REARICRKLQ-HPNIV 52
           G  SVVRRC+ K T  E+A KII+       SA + Q+L     +E  I RK+  HPNI+
Sbjct: 15  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 74
Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L D+ +   + +LVFDL+  GELF+ +  +   SE +    ++ +LE +   H   +VH
Sbjct: 75  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 134
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI---------EVQG------------------- 144
           RDLKPEN+LL        +KL DFG +          EV G                   
Sbjct: 135 RDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 191
Query: 145 ----EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
               E   W  GVI+Y LL G PPFW   Q  +   I +G Y + SPEWD  +   K+L+
Sbjct: 192 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 251
Query: 200 NQMLTVNPSKRITASEALKHPWICQ 224
           ++ L V P KR TA EAL HP+  Q
Sbjct: 252 SRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/63 (46%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 259 AGTPGYLSPEVLK-----KEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
            GTP YL+PE+++       P YGK VD+W+ GVI+Y LL G PPFW   Q  +   I +
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 230
Query: 313 GAY 315
           G Y
Sbjct: 231 GNY 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 134/265 (50%), Gaps = 44/265 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK---KLSARDFQKLE----REARICRKLQ-HPNIV 52
           G  SVVRRC+ K T  E+A KII+       SA + Q+L     +E  I RK+  HPNI+
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L D+ +   + +LVFDL+  GELF+ +  +   SE +    ++ +LE +   H   +VH
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 147
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI---------EVQG------------------- 144
           RDLKPEN+LL        +KL DFG +          EV G                   
Sbjct: 148 RDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 145 ----EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
               E   W  GVI+Y LL G PPFW   Q  +   I +G Y + SPEWD  +   K+L+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 200 NQMLTVNPSKRITASEALKHPWICQ 224
           ++ L V P KR TA EAL HP+  Q
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 29/63 (46%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 259 AGTPGYLSPEVLK-----KEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
            GTP YL+PE+++       P YGK VD+W+ GVI+Y LL G PPFW   Q  +   I +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 313 GAY 315
           G Y
Sbjct: 244 GNY 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 135/265 (50%), Gaps = 44/265 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK---KLSARDFQKLE----REARICRKLQ-HPNIV 52
           G  SVVRRC+ K T  E+A KII+       SA + Q+L     +E  I RK+  HPNI+
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L D+ +   + +LVFDL+  GELF+ +  +   SE +    ++ +LE +   H   +VH
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 147
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQ-GEQ------------------------- 146
           RDLKPEN+LL        +KL DFG + ++  GE+                         
Sbjct: 148 RDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHP 204
Query: 147 ------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
                   W  GVI+Y LL G PPFW   Q  +   I +G Y + SPEWD  +   K+L+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 200 NQMLTVNPSKRITASEALKHPWICQ 224
           ++ L V P KR TA EAL HP+  Q
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 29/63 (46%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 259 AGTPGYLSPEVLK-----KEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
            GTP YL+PE+++       P YGK VD+W+ GVI+Y LL G PPFW   Q  +   I +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 313 GAY 315
           G Y
Sbjct: 244 GNY 246

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 140/254 (55%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SAR---DFQKLEREARICRKLQHPNIVRLHD 56
           G F++VR+C QK TG E+AAK I  ++L S+R     +++ERE  I R+++HPNI+ LHD
Sbjct: 37  GQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHD 96
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV+GGELF+ +  +E  +E +A+  ++QIL+ V++ HS  + H DLK
Sbjct: 97  IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 156
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  K      +KL DFG+A +++                           E   W
Sbjct: 157 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 216
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  E +      I A  YD+    +   +  AK+ I ++L  +P 
Sbjct: 217 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPK 276
Query: 209 KRITASEALKHPWI 222
           +R+  +++L+H WI
Sbjct: 277 RRMXIAQSLEHSWI 290

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 38/66 (57%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  E +      I A  YD + 
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 253
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 254 EYFSNT 259

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/260 (33%), Positives = 144/260 (55%), Gaps = 37/260 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++S  +RCV KAT +E+A K+I+  K   RD    E    + R  QHPNI+ L D   +
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSK---RDPS--EEIEILLRYGQHPNIITLKDVYDD 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YLV +L+ GGEL + I+ ++F+SE +AS  +  I ++V + HS GVVHRDLKP N+
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNI 152
Query: 121 LLASKAKGA-AVKLADFGLAIEVQGEQ---------------------------QAW-FG 151
           L   ++     +++ DFG A +++ E                              W  G
Sbjct: 153 LYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 152 VILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           ++LY +L GY PF +   +    +  +I +G +      W+TV+  AK+L+++ML V+P 
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPH 272
Query: 209 KRITASEALKHPWICQRERV 228
           +R+TA + L+HPW+ Q++++
Sbjct: 273 QRLTAKQVLQHPWVTQKDKL 292

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 239 DCLKKFNARRKLKVSTRQGFAGTPGY----LSPEVLKKEPYGKPVDIWACGVILYILLVG 294
           +CL+  +     ++    G   TP Y    ++PEVLK++ Y +  DIW+ G++LY +L G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 295 YPPF 298
           Y PF
Sbjct: 222 YTPF 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/260 (33%), Positives = 144/260 (55%), Gaps = 37/260 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++S  +RCV KAT +E+A K+I+  K   RD    E    + R  QHPNI+ L D   +
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSK---RDPS--EEIEILLRYGQHPNIITLKDVYDD 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YLV +L+ GGEL + I+ ++F+SE +AS  +  I ++V + HS GVVHRDLKP N+
Sbjct: 93  GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNI 152
Query: 121 LLASKAKGA-AVKLADFGLAIEVQGEQ---------------------------QAW-FG 151
           L   ++     +++ DFG A +++ E                              W  G
Sbjct: 153 LYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 152 VILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           ++LY +L GY PF +   +    +  +I +G +      W+TV+  AK+L+++ML V+P 
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPH 272
Query: 209 KRITASEALKHPWICQRERV 228
           +R+TA + L+HPW+ Q++++
Sbjct: 273 QRLTAKQVLQHPWVTQKDKL 292

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 239 DCLKKFNARRKLKVSTRQGFAGTPGY----LSPEVLKKEPYGKPVDIWACGVILYILLVG 294
           +CL+  +     ++    G   TP Y    ++PEVLK++ Y +  DIW+ G++LY +L G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 295 YPPF 298
           Y PF
Sbjct: 222 YTPF 225

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 149/281 (53%), Gaps = 34/281 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC--LKKFNAR 247
           KR+T  ++L+HPWI  ++   ++  +   V+    KKF AR
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAAR 302

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 152/293 (51%), Gaps = 46/293 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLER-------EARICRKLQHP 49
           GA+  V  C +K    E A K+I   +      + D + +E+       E  + + L HP
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106
Query: 50  NIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           NI++L D  +++ Y YLV +   GGELFE I+ R  + E DA++ ++QIL  + + H + 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ-------AWF------------ 150
           +VHRD+KPEN+LL +K     +K+ DFGL+     + +       A++            
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNE 226
Query: 151 -------GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
                  GVI+YILL GYPPF  ++   +  +++ G Y +   +W  ++ EAK LI  ML
Sbjct: 227 KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286
Query: 204 TVNPSKRITASEALKHPWICQRERVASIVHRQE------TVDCLKKFNARRKL 250
           T + +KR TA EAL   WI   ++ A+ +++ +       +  ++KF   +KL
Sbjct: 287 TYDYNKRCTAEEALNSRWI---KKYANNINKSDQKTLCGALSNMRKFEGSQKL 336

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 27/56 (48%), Positives = 39/56 (69%), Gaps = 1/56 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GT  Y++PEVLKK  Y +  D+W+CGVI+YILL GYPPF  ++   +  +++ G Y
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 139/254 (54%), Gaps = 37/254 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++SV +RC+ KAT  EFA KII+  K   RD    E    + R  QHPNI+ L D   +
Sbjct: 33  GSYSVCKRCIHKATNXEFAVKIIDKSK---RD--PTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             Y Y+V +L  GGEL + I+ ++F+SE +AS  +  I ++V + H+ GVVHRDLKP N+
Sbjct: 88  GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 121 LLASKAKGA-AVKLADFGLA------------------------IEVQGEQQA---W-FG 151
           L   ++    ++++ DFG A                        +E QG   A   W  G
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 152 VILYILLVGYPPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           V+LY  L GY PF    D+    + A+I +G +      W++V+  AK+L+++ L V+P 
Sbjct: 208 VLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPH 267
Query: 209 KRITASEALKHPWI 222
           +R+TA+  L+HPWI
Sbjct: 268 QRLTAALVLRHPWI 281

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 35/58 (60%), Gaps = 3/58 (5%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIKAGAY 315
           T  +++PEVL+++ Y    DIW+ GV+LY  L GY PF    D+    + A+I +G +
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF 240

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 86/250 (34%), Positives = 136/250 (54%), Gaps = 31/250 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV RCV+KATG  F AK INT      D   ++ E  I  +L HP ++ LHD+ ++
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    L+ + ++GGELF+ I A ++  SEA+  + ++Q  E + H H + +VH D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQ--------------------------QAW-FGV 152
           ++  +K K ++VK+ DFGLA ++  ++                            W  GV
Sbjct: 180 IMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + Y+LL G  PF  ED       +K   +++    + +V+PEAK+ I  +L   P KR+T
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
Query: 213 ASEALKHPWI 222
             +AL+HPW+
Sbjct: 299 VHDALEHPWL 308

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 11/92 (11%)
Query: 222 ICQRERVASIVHRQETVD--CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPV 279
           +C+ ++ +S+    + +D     K N    +KV+T      T  + +PE++ +EP G   
Sbjct: 181 MCETKKASSV----KIIDFGLATKLNPDEIVKVTT-----ATAEFAAPEIVDREPVGFYT 231
Query: 280 DIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           D+WA GV+ Y+LL G  PF  ED       +K
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 143/265 (53%), Gaps = 39/265 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+FS+ R+CV K +   FA KII +K++ A + QK     ++C    HPNIV+LH+   +
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKII-SKRMEA-NTQKEITALKLCEG--HPNIVKLHEVFHD 77
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           + + +LV +L+ GGELFE I  ++ +SE +AS+ +++++ +V+H H  GVVHRDLKPENL
Sbjct: 78  QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137
Query: 121 LLASKAKGAAVKLADFGLA------------------------IEVQGEQQA---W-FGV 152
           L   +     +K+ DFG A                        +   G  ++   W  GV
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
Query: 153 ILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
           ILY +L G  PF   D+         +  +IK G + +    W  V+ EAK+LI  +LTV
Sbjct: 198 ILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257
Query: 206 NPSKRITASEALKHPWICQRERVAS 230
           +P+KR+  S    + W+    +++S
Sbjct: 258 DPNKRLKMSGLRYNEWLQDGSQLSS 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 26/43 (60%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           T  Y +PE+L +  Y +  D+W+ GVILY +L G  PF   D+
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 32/272 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC 240
           KR+T  ++L+HPWI  ++   ++  +   V+ 
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 32/272 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC 240
           KR+T  ++L+HPWI  ++   ++  +   V+ 
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 32/272 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC 240
           KR+T  ++L+HPWI  ++   ++  +   V+ 
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 32/272 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDC 240
           KR+T  ++L+HPWI  ++   ++  +   V+ 
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLA--IEVQGEQQAWF----------------------- 150
           PEN++L  +      +K+ DFGLA  I+   E +  F                       
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  150 bits (379), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 200
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 201 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 260
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 261 KRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 238 EYFSNT 243

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 200
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 201 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 260
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 261 KRMTIQDSLQHPWI 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 238 EYFSNT 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK--KLSARDFQK--LEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  +  K S R   +  +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQG--------------------------EQQAW 149
           PEN++L  +      +K+ DFGLA ++                            E   W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 262 KRMTIQDSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +    A + A  Y+ E 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 320 KHKSAS 325
           ++ S +
Sbjct: 239 EYFSNT 244

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/246 (37%), Positives = 133/246 (54%), Gaps = 26/246 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 80
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-----QAW-FGVILYILLVGYPPFWD 166
           RD+KPENLL  SK   A +KL DFG A E  GE+       W  GVI+YILL GYPPF+ 
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 167 ED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                    +  +I+ G Y++P+PEW  V+ E K LI  +L   P++R+T +E + HPWI
Sbjct: 201 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260
Query: 223 CQRERV 228
            Q  +V
Sbjct: 261 MQSTKV 266

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 28/48 (58%), Gaps = 4/48 (8%)
Query: 273 EPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 139/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 81  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------LAIEV------QGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                    LA EV       G  +A
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 260 VVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 139/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 81  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------LAIEV------QGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                    LA EV       G  +A
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 260 VVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 139/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 20  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 79
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 80  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 138
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------LAIEV------QGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                    LA EV       G  +A
Sbjct: 139 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 198
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 199 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 258
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 259 VVDPKARFTTEEALRHPWL 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 152 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 211
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 212 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 241

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 139/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 81  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------LAIEV------QGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                    LA EV       G  +A
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 260 VVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/259 (35%), Positives = 139/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 27  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 86
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 87  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 145
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------LAIEV------QGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                    LA EV       G  +A
Sbjct: 146 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 205
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 206 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 265
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 266 VVDPKARFTTEEALRHPWL 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 159 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 218
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 219 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 248

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 138/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A +II+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 160 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 219
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 220 KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 278
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------------LAIEVQGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                          +++   G  +A
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 338
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 339 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 398
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 399 VVDPKARFTTEEALRHPWL 417

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 292 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 351
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 352 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 381

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 138/259 (53%), Gaps = 38/259 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQ---KLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A +II+ +K    SAR+      +E E  I +KL HP I+++
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 206 KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 264
Query: 115 LKPENLLLASKAKGAAVKLADFG--------------------------LAIEVQGEQQA 148
           LKPEN+LL+S+ +   +K+ DFG                          +++   G  +A
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 149 ---W-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              W  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++L
Sbjct: 325 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 384
Query: 204 TVNPSKRITASEALKHPWI 222
            V+P  R T  EAL+HPW+
Sbjct: 385 VVDPKARFTTEEALRHPWL 403

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 239 DCLKKFNARRKLKV----STRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYIL 291
           DCL K       K+    S  +   GTP YL+PEVL       Y + VD W+ GVIL+I 
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 292 LVGYPPFWD-EDQHRLYAQIKAGAYDDEPK 320
           L GYPPF +   Q  L  QI +G Y+  P+
Sbjct: 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 128/250 (51%), Gaps = 37/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      TG + A KIIN K L+  D Q ++ERE    R L+HP+I++L+D I+
Sbjct: 25  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 84
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            ++   +V +   G ELF+ IV R+  SE +A    QQI+ +V +CH + +VHRDLKPEN
Sbjct: 85  SKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLA-IEVQG--------------------------EQQAWF-G 151
           LLL        VK+ADFGL+ I   G                          E   W  G
Sbjct: 144 LLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 200
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY++L    PF DE    L+  I  G Y  P      ++P A  LI +ML VNP  RI
Sbjct: 201 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRI 256
Query: 212 TASEALKHPW 221
           +  E ++  W
Sbjct: 257 SIHEIMQDDW 266

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           G+P Y +PEV+  + Y  P VD+W+CGVILY++L    PF DE    L+  I  G Y
Sbjct: 174 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY 230

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 31/251 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V +C + ATGL+ AAKII T+ +  +D ++++ E  +  +L H N+++L+D+ + 
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFES 157
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   LV + V GGELF+ I+   +  +E D    ++QI E + H H   ++H DLKPEN
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ--------------------------AW-FGV 152
           +L  ++     +K+ DFGLA   +  ++                           W  GV
Sbjct: 218 ILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           I Y+LL G  PF  ++       I A  +D    E+  ++ EAK  I+++L    S RI+
Sbjct: 277 IAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS 336
Query: 213 ASEALKHPWIC 223
           ASEALKHPW+ 
Sbjct: 337 ASEALKHPWLS 347

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           +++  R KLKV+      GTP +L+PEV+  +    P D+W+ GVI Y+LL G  PF  +
Sbjct: 237 RRYKPREKLKVNF-----GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291
Query: 302 DQHRLYAQIKAGAYDDE 318
           +       I A  +D E
Sbjct: 292 NDAETLNNILACRWDLE 308

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 128/250 (51%), Gaps = 37/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      TG + A KIIN K L+  D Q ++ERE    R L+HP+I++L+D I+
Sbjct: 24  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            ++   +V +   G ELF+ IV R+  SE +A    QQI+ +V +CH + +VHRDLKPEN
Sbjct: 84  SKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 142
Query: 120 LLLASKAKGAAVKLADFGLA-IEVQG--------------------------EQQAW-FG 151
           LLL        VK+ADFGL+ I   G                          E   W  G
Sbjct: 143 LLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 199
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY++L    PF DE    L+  I  G Y  P      ++P A  LI +ML VNP  RI
Sbjct: 200 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRI 255
Query: 212 TASEALKHPW 221
           +  E ++  W
Sbjct: 256 SIHEIMQDDW 265

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           G+P Y +PEV+  + Y  P VD+W+CGVILY++L    PF DE    L+  I  G Y
Sbjct: 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY 229

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 128/250 (51%), Gaps = 37/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      TG + A KIIN K L+  D Q ++ERE    R L+HP+I++L+D I+
Sbjct: 15  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            ++   +V +   G ELF+ IV R+  SE +A    QQI+ +V +CH + +VHRDLKPEN
Sbjct: 75  SKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 133
Query: 120 LLLASKAKGAAVKLADFGLA-IEVQG--------------------------EQQAW-FG 151
           LLL        VK+ADFGL+ I   G                          E   W  G
Sbjct: 134 LLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 190
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY++L    PF DE    L+  I  G Y  P      ++P A  LI +ML VNP  RI
Sbjct: 191 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRI 246
Query: 212 TASEALKHPW 221
           +  E ++  W
Sbjct: 247 SIHEIMQDDW 256

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           G+P Y +PEV+  + Y  P VD+W+CGVILY++L    PF DE    L+  I  G Y
Sbjct: 164 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 128/250 (51%), Gaps = 37/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      TG + A KIIN K L+  D Q ++ERE    R L+HP+I++L+D I+
Sbjct: 19  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            ++   +V +   G ELF+ IV R+  SE +A    QQI+ +V +CH + +VHRDLKPEN
Sbjct: 79  SKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 137
Query: 120 LLLASKAKGAAVKLADFGLA-IEVQG--------------------------EQQAW-FG 151
           LLL        VK+ADFGL+ I   G                          E   W  G
Sbjct: 138 LLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 194
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY++L    PF DE    L+  I  G Y  P      ++P A  LI +ML VNP  RI
Sbjct: 195 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRI 250
Query: 212 TASEALKHPW 221
           +  E ++  W
Sbjct: 251 SIHEIMQDDW 260

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 35/57 (61%), Gaps = 1/57 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           G+P Y +PEV+  + Y  P VD+W+CGVILY++L    PF DE    L+  I  G Y
Sbjct: 168 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY 224

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 129/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 18  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 77
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA  +  E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 78  EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 137
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 138 LLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 194
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 195 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 250
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 251 LEQIMKDRWM 260

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 129/251 (51%), Gaps = 31/251 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV R  ++ATG  FAAK + T   S  D + + +E +    L+HP +V LHD+ ++
Sbjct: 62  GAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED 119
Query: 61  ENYHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   ++++ ++GGELFE +       SE +A   ++Q+ + + H H N  VH DLKPEN
Sbjct: 120 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 179
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-FGV 152
           ++  +K +   +KL DFGL   +  +Q                            W  GV
Sbjct: 180 IMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 238
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + YILL G  PF  E+       +K+  ++     +  ++ + K+ I ++L  +P+ R+T
Sbjct: 239 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 298
Query: 213 ASEALKHPWIC 223
             +AL+HPW+ 
Sbjct: 299 IHQALEHPWLT 309

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/69 (33%), Positives = 38/69 (55%), Gaps = 5/69 (7%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
            + ++ +KV+T     GT  + +PEV + +P G   D+W+ GV+ YILL G  PF  E+ 
Sbjct: 201 LDPKQSVKVTT-----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 255
Query: 304 HRLYAQIKA 312
                 +K+
Sbjct: 256 DETLRNVKS 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 129/251 (51%), Gaps = 31/251 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV R  ++ATG  FAAK + T   S  D + + +E +    L+HP +V LHD+ ++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 61  ENYHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   ++++ ++GGELFE +       SE +A   ++Q+ + + H H N  VH DLKPEN
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-FGV 152
           ++  +K +   +KL DFGL   +  +Q                            W  GV
Sbjct: 286 IMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + YILL G  PF  E+       +K+  ++     +  ++ + K+ I ++L  +P+ R+T
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404
Query: 213 ASEALKHPWIC 223
             +AL+HPW+ 
Sbjct: 405 IHQALEHPWLT 415

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/69 (33%), Positives = 38/69 (55%), Gaps = 5/69 (7%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
            + ++ +KV+T     GT  + +PEV + +P G   D+W+ GV+ YILL G  PF  E+ 
Sbjct: 307 LDPKQSVKVTT-----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 304 HRLYAQIKA 312
                 +K+
Sbjct: 362 DETLRNVKS 370

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 128/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 258 LEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 128/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 258 LEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 128/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADMN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 258 LEQIMKDRWM 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 257 GFAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            F G P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 128/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A +II+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 258 LEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 128/250 (51%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A +II+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADMN---IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPWI 222
             + +K  W+
Sbjct: 258 LEQIMKDRWM 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 124
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 184
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 304
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKV 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 126/250 (50%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L+    QKL RE RI + L HPNIV+L + I+ 
Sbjct: 23  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 82
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YL+ +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 83  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 142
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 143 LLDADMN---IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 199
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NP KR T
Sbjct: 200 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGT 255
Query: 213 ASEALKHPWI 222
             + +K  WI
Sbjct: 256 LEQIMKDRWI 265

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 228

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 80
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 200
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKV 287

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/39 (61%), Positives = 30/39 (76%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 220

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 79  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 130
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 131 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 190
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 250
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 251 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 310
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKV 337

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 232 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 291

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 35  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 86
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 87  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 146
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 206
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 207 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 266
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKV 293

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 188 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 247

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/250 (34%), Positives = 127/250 (50%), Gaps = 35/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L+    QKL RE RI + L HPNIV+L + I+ 
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YL+ +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 121 LLASKAKGAAVKLADFGLAIE--VQGEQQAW--------------------------FGV 152
           LL +      +K+ADFG + E  V G+  A+                           GV
Sbjct: 146 LLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NP KR T
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGT 258
Query: 213 ASEALKHPWI 222
             + +K  WI
Sbjct: 259 LEQIMKDRWI 268

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 80
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 200
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKV 287

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/39 (61%), Positives = 30/39 (76%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 220

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 43  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 94
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 95  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 154
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 214
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 215 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 274
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKV 301

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 196 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 255

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 27  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 78
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 138
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 198
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKV 285

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 239

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 34  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 85
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 86  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 145
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 205
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 206 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 265
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKV 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 187 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 246

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 28  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 79
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 80  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 139
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 199
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 200 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 259
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKV 286

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 181 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 240

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 33  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 84
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 85  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 144
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 204
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 205 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 264
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKV 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 186 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 245

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 47/267 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 27  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD-VY 78
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + H
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 138
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSC 198
Query: 148 -AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 202 MLTVNPSKRITASEALKHPWICQRERV 228
           +L   P++R+T +E + HPWI Q  +V
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKV 285

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
           TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 239

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/249 (35%), Positives = 125/249 (50%), Gaps = 35/249 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L++   QKL RE RI + L HPNIV+L + I+ 
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIET 84
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 85  EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL +      +K+ADFG + E                      QG      E   W  GV
Sbjct: 145 LLDADXN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P       + + +NL+ + L +NPSKR T
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YXSTDCENLLKKFLILNPSKRGT 257
Query: 213 ASEALKHPW 221
             +  K  W
Sbjct: 258 LEQIXKDRW 266

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 172 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 58/278 (20%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           GA++ V+  V    G E+A KII  +   +R   ++ RE     + Q + NI+ L +  +
Sbjct: 24  GAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR--SRVFREVETLYQCQGNKNILELIEFFE 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   YLVF+ + GG +   I  ++ ++E +AS  ++ +  +++  H+ G+ HRDLKPEN
Sbjct: 82  DDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLA-------------------------------IEVQGEQQA 148
           +L  S  K + VK+ DF L                                +EV  +Q  
Sbjct: 142 ILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQAT 201
Query: 149 WF---------GVILYILLVGYPPF---------WDED------QHRLYAQIKAGAYDYP 184
           ++         GV+LYI+L GYPPF         WD        Q++L+  I+ G Y++P
Sbjct: 202 FYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP 261
Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             +W  ++ EAK+LI+++L  +  +R++A++ L+HPW+
Sbjct: 262 DKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 20/78 (25%)
Query: 259 AGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPF---------WDED-- 302
            G+  Y++PEV+     +   Y K  D+W+ GV+LYI+L GYPPF         WD    
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEV 241
Query: 303 ----QHRLYAQIKAGAYD 316
               Q++L+  I+ G Y+
Sbjct: 242 CRVCQNKLFESIQEGKYE 259

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 37/260 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F+ V R     TGLE A K+I+ K +  A   Q+++ E +I  +L+HP+I+ L++  +
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + NY YLV ++   GE+   +  R + +SE +A H + QI+  + + HS+G++HRDL   
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQG---------------------------EQQAW-F 150
           NLLL    +   +K+ADFGLA +++                            E   W  
Sbjct: 142 NLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G + Y LL+G PPF  +       ++    Y+ PS     ++ EAK+LI+Q+L  NP+ R
Sbjct: 199 GCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADR 254
Query: 211 ITASEALKHPWICQRERVAS 230
           ++ S  L HP++ +     S
Sbjct: 255 LSLSSVLDHPFMSRNSSTKS 274

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 18/41 (43%), Positives = 26/41 (63%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
             GTP Y+SPE+  +  +G   D+W+ G + Y LL+G PPF
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 126/269 (46%), Gaps = 51/269 (18%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           G    V +   K T  +FA K +       +D  K  RE  +  R  Q P+IVR+ D + 
Sbjct: 73  GINGKVLQIFNKRTQEKFALKXL-------QDCPKARREVELHWRASQCPHIVRIVD-VY 124
Query: 60  EENYH-----YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E  Y       +V + + GGELF  I  R  + ++E +AS   + I E++ + HS  + H
Sbjct: 125 ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAH 184
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------------------- 147
           RD+KPENLL  SK   A +KL DFG A E                               
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 148 -AW-FGVILYILLVGYPPFWDEDQHRL------YAQIKAGAYDYPSPEWDTVTPEAKNLI 199
             W  GVI YILL GYPPF+    H L        +I+ G Y++P+PEW  V+ E K LI
Sbjct: 245 DXWSLGVIXYILLCGYPPFYS--NHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLI 302
Query: 200 NQMLTVNPSKRITASEALKHPWICQRERV 228
             +L   P++R T +E   HPWI Q  +V
Sbjct: 303 RNLLKTEPTQRXTITEFXNHPWIXQSTKV 331

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 24/39 (61%), Positives = 28/39 (71%)
Query: 261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
           TP Y++PEVL  E Y K  D W+ GVI YILL GYPPF+
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFY 264

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 58/278 (20%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           GA + V+ C+   T  E+A KII  +    R   ++ RE  +  + Q H N++ L +  +
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EE+  YLVF+ + GG +   I  R  ++E +AS  +Q +  +++  H+ G+ HRDLKPEN
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLA-------------------------------IEVQGEQQA 148
           +L     + + VK+ DFGL                                +E   E+ +
Sbjct: 142 ILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 149 WF---------GVILYILLVGYPPF---------WDED------QHRLYAQIKAGAYDYP 184
            +         GVILYILL GYPPF         WD        Q+ L+  I+ G Y++P
Sbjct: 202 IYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP 261
Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             +W  ++  AK+LI+++L  +  +R++A++ L+HPW+
Sbjct: 262 DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 20/78 (25%)
Query: 259 AGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPF---------WDED-- 302
            G+  Y++PEV++        Y K  D+W+ GVILYILL GYPPF         WD    
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 303 ----QHRLYAQIKAGAYD 316
               Q+ L+  I+ G Y+
Sbjct: 242 CPACQNMLFESIQEGKYE 259

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 124/253 (49%), Gaps = 36/253 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+    + TG + A KI+N +K+ + D   K++RE +  +  +HP+I++L+  I 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++V + V+GGELF+ I       E +A    QQIL +V++CH + VVHRDLKPEN
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLA---------------------------IEVQGEQQAW-FG 151
           +LL +       K+ADFGL+                           +    E   W  G
Sbjct: 142 VLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY LL G  PF DE    L+ +I+ G +  P    + +      L+  ML V+P KR 
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRA 254
Query: 212 TASEALKHPWICQ 224
           T  +  +H W  Q
Sbjct: 255 TIKDIREHEWFKQ 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/58 (48%), Positives = 36/58 (62%), Gaps = 1/58 (1%)
Query: 259 AGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            G+P Y +PEV+    Y  P VDIW+CGVILY LL G  PF DE    L+ +I+ G +
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 124/253 (49%), Gaps = 36/253 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+    + TG + A KI+N +K+ + D   K++RE +  +  +HP+I++L+  I 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++V + V+GGELF+ I       E +A    QQIL +V++CH + VVHRDLKPEN
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLA---------------------------IEVQGEQQAW-FG 151
           +LL +       K+ADFGL+                           +    E   W  G
Sbjct: 142 VLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY LL G  PF DE    L+ +I+ G +  P    + +      L+  ML V+P KR 
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRA 254
Query: 212 TASEALKHPWICQ 224
           T  +  +H W  Q
Sbjct: 255 TIKDIREHEWFKQ 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/58 (48%), Positives = 36/58 (62%), Gaps = 1/58 (1%)
Query: 259 AGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            G+P Y +PEV+    Y  P VDIW+CGVILY LL G  PF DE    L+ +I+ G +
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 127/250 (50%), Gaps = 37/250 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      T  + A K I+ + L   D   ++ERE    + L+HP+I++L+D I 
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                 +V +   GGELF+ IV ++  +E +     QQI+ ++ +CH + +VHRDLKPEN
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLA-IEVQG--------------------------EQQAWF-G 151
           LLL        VK+ADFGL+ I   G                          E   W  G
Sbjct: 139 LLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           ++LY++LVG  PF DE    L+ ++ +  Y  P    D ++P A++LI +M+  +P +RI
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRI 251
Query: 212 TASEALKHPW 221
           T  E  + PW
Sbjct: 252 TIQEIRRDPW 261

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 38/57 (66%), Gaps = 1/57 (1%)
Query: 260 GTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           G+P Y +PEV+  + Y  P VD+W+CG++LY++LVG  PF DE    L+ ++ +  Y
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 31/267 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQ 59
           G F+VVR+C+ K+TG E+AAK +  ++       ++  E  +    +  P ++ LH+  +
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 60  EENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
             +   L+ +   GGE+F   +    E  SE D    I+QILE V + H N +VH DLKP
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159
Query: 118 ENLLLASKAKGAAVKLADFGLA---------IEVQGEQQ-----------------AW-F 150
           +N+LL+S      +K+ DFG++          E+ G  +                  W  
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G+I Y+LL    PF  ED    Y  I     DY    + +V+  A + I  +L  NP KR
Sbjct: 220 GIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR 279
Query: 211 ITASEALKHPWICQRERVASIVHRQET 237
            TA   L H W+ Q+    ++ H +ET
Sbjct: 280 PTAEICLSHSWL-QQWDFENLFHPEET 305

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 29/57 (50%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           GTP YL+PE+L  +P     D+W  G+I Y+LL    PF  ED    Y  I     D
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 46/262 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G    V  C  + TG + A K++     S +  Q+++   +       P+IV + D    
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGG---PHIVCILDVY-- 91
Query: 61  ENYHY------LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           EN H+      ++ + + GGELF  I  R  + ++E +A+  ++ I  ++   HS+ + H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 151
Query: 113 RDLKPENLLLASKAKGAAVKLADFG-------------------LAIEVQGEQQ------ 147
           RD+KPENLL  SK K A +KL DFG                   +A EV G ++      
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 148 AW-FGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAKNLINQM 202
            W  GVI+YILL G+PPF+      +      +I+ G Y +P+PEW  V+ +AK LI  +
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 271
Query: 203 LTVNPSKRITASEALKHPWICQ 224
           L  +P++R+T ++ + HPWI Q
Sbjct: 272 LKTDPTERLTITQFMNHPWINQ 293

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 36/59 (61%)
Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
           L  F   ++   +  Q    TP Y++PEVL  E Y K  D+W+ GVI+YILL G+PPF+
Sbjct: 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 46/262 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G    V  C  + TG + A K++     S +  Q+++   +       P+IV + D    
Sbjct: 21  GVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGG---PHIVCILDVY-- 72
Query: 61  ENYHY------LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVH 112
           EN H+      ++ + + GGELF  I  R  + ++E +A+  ++ I  ++   HS+ + H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 132
Query: 113 RDLKPENLLLASKAKGAAVKLADFG-------------------LAIEVQGEQQ------ 147
           RD+KPENLL  SK K A +KL DFG                   +A EV G ++      
Sbjct: 133 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 192
Query: 148 AW-FGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAKNLINQM 202
            W  GVI+YILL G+PPF+      +      +I+ G Y +P+PEW  V+ +AK LI  +
Sbjct: 193 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 252
Query: 203 LTVNPSKRITASEALKHPWICQ 224
           L  +P++R+T ++ + HPWI Q
Sbjct: 253 LKTDPTERLTITQFMNHPWINQ 274

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 36/59 (61%)
Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW 299
           L  F   ++   +  Q    TP Y++PEVL  E Y K  D+W+ GVI+YILL G+PPF+
Sbjct: 153 LTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 211

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 93/291 (31%), Positives = 142/291 (48%), Gaps = 46/291 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L+    QKL RE RI + L HPNIV+L + I+ 
Sbjct: 26  GNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YLV +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 86  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENL 145
Query: 121 LLASKAKGAAVKLADFGLAIE---------------------VQG------EQQAW-FGV 152
           LL        +K+ADFG + E                      QG      E   W  GV
Sbjct: 146 LLDGDMN---IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ ++L +NP KR +
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKKLLVLNPIKRGS 258
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKK----FNARRKLKVSTRQGFA 259
             + +K  W+       ++ H +E +    +    FN  +++ +    GFA
Sbjct: 259 LEQIMKDRWM-------NVGHEEEELKPYTEPDPDFNDTKRIDIMVTMGFA 302

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 258 FAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F G+P Y +PE+ + + Y  P VD+W+ GVILY L+ G  PF  ++   L  ++  G Y
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 58/278 (20%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           GA + V+ C+   T  E+A KII  +    R   ++ RE  +  + Q H N++ L +  +
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EE+  YLVF+ + GG +   I  R  ++E +AS  +Q +  +++  H+ G+ HRDLKPEN
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 120 LLLASKAKGAAVKLADF--GLAIEVQGEQQA----------------------------- 148
           +L     + + VK+ DF  G  I++ G+                                
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 149 --------W-FGVILYILLVGYPPF---------WDED------QHRLYAQIKAGAYDYP 184
                   W  GVILYILL GYPPF         WD        Q+ L+  I+ G Y++P
Sbjct: 202 IYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP 261
Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             +W  ++  AK+LI+++L  +  +R++A++ L+HPW+
Sbjct: 262 DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 20/78 (25%)
Query: 259 AGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPF---------WDED-- 302
            G+  Y++PEV++        Y K  D+W+ GVILYILL GYPPF         WD    
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 303 ----QHRLYAQIKAGAYD 316
               Q+ L+  I+ G Y+
Sbjct: 242 CPACQNMLFESIQEGKYE 259

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 123/253 (48%), Gaps = 36/253 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+    + TG + A KI+N +K+ + D   K+ RE +  +  +HP+I++L+  I 
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +  ++V + V+GGELF+ I       E ++    QQIL  V++CH + VVHRDLKPEN
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPEN 146
Query: 120 LLLASKAKGAAVKLADFGLAIEVQG---------------------------EQQAW-FG 151
           +LL +       K+ADFGL+  +                             E   W  G
Sbjct: 147 VLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY LL G  PF D+    L+ +I  G +  P      + P   +L+  ML V+P KR 
Sbjct: 204 VILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKHMLQVDPMKRA 259
Query: 212 TASEALKHPWICQ 224
           T  +  +H W  Q
Sbjct: 260 TIKDIREHEWFKQ 272

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 41/70 (58%), Gaps = 2/70 (2%)
Query: 259 AGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
            G+P Y +PEV+    Y  P VDIW+ GVILY LL G  PF D+    L+ +I  G +  
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y 234
Query: 318 EPKHKSASVV 327
            P++ + SV+
Sbjct: 235 TPQYLNPSVI 244

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 32/254 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V    ++++GLE   K IN K  S    +++E E  + + L HPNI+++ +  ++
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESVNHCHSNGVVHRDLK 116
            +  Y+V +   GGEL E IV+ +      SE   +  ++Q++ ++ + HS  VVH+DLK
Sbjct: 92  YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151
Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------WF- 150
           PEN+L    +  + +K+ DFGLA   + ++ +                         W  
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSA 211
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y LL G  PF       +  +      +Y + E   +TP+A +L+ QMLT +P +R
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-AVECRPLTPQAVDLLKQMLTKDPERR 270
Query: 211 ITASEALKHPWICQ 224
            +A++ L H W  Q
Sbjct: 271 PSAAQVLHHEWFKQ 284

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           AGT  Y++PEV K++   K  DIW+ GV++Y LL G  PF
Sbjct: 187 AGTALYMAPEVFKRDVTFK-CDIWSAGVVMYFLLTGCLPF 225

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GE+++++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 84  DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 144 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 256
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 257 REVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GE+++++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 84  DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 144 LLLGS---AGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 256
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 257 REVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 166 SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S  +   +K+ADFG ++     ++A                         W  GV+
Sbjct: 142 LLLGSAGE---LKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 255 REVLEHPWITANSSKPSNCQNKESAS 280

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 118/250 (47%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++A                         W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 252 REVLEHPWIT 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 118/250 (47%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++A                         W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQDTYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 252 REVLEHPWIT 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 120/249 (48%), Gaps = 34/249 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    ++ +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 142
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S  +   +K+ADFG ++     ++                          W  GV+
Sbjct: 143 LLLGSNGE---LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  N S+R+T 
Sbjct: 200 CYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRLLKHNASQRLTL 255
Query: 214 SEALKHPWI 222
           +E L+HPWI
Sbjct: 256 AEVLEHPWI 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 130/263 (49%), Gaps = 33/263 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F +V RCV+ ++   + AK +   K+   D   +++E  I    +H NI+ LH+S + 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++F+ ++G ++FE I    F  +E +    + Q+ E++   HS+ + H D++PEN
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 120 LLLASKAKGAAVKLADFGLAIE--------------------------VQGEQQAW-FGV 152
           ++  ++ + + +K+ +FG A +                          V      W  G 
Sbjct: 133 IIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ++Y+LL G  PF  E   ++   I    Y +    +  ++ EA + ++++L      R+T
Sbjct: 192 LVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 213 ASEALKHPWICQR-ERVASIVHR 234
           ASEAL+HPW+ Q+ ERV++ V R
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIR 274

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 262 PGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-DEPK 320
           P Y +PEV + +      D+W+ G ++Y+LL G  PF  E   ++   I    Y  DE  
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 321 HKSASV 326
            K  S+
Sbjct: 227 FKEISI 232

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 34/249 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    ++ +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 142
Query: 120 LLLASKAKGAAVKLADFGLAIE--------------------VQGEQQ-----AW-FGVI 153
           LLL S  +   +K+ADFG ++                     ++G         W  GV+
Sbjct: 143 LLLGSNGE---LKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  N S+R+T 
Sbjct: 200 CYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRLLKHNASQRLTL 255
Query: 214 SEALKHPWI 222
           +E L+HPWI
Sbjct: 256 AEVLEHPWI 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 165 SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 84  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 144 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 256
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 257 REVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 140 LLLGS---AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 252
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 253 REVLEHPWITANSSKPSNCQNKESAS 278

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 142 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 255 REVLEHPWITANSSKPSNCQNKESAS 280

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 118/250 (47%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 23  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 142
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S  +   +K+ADFG ++     ++                          W  GV+
Sbjct: 143 LLLGSAGE---LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 199
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 200 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 255
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 256 REVLEHPWIT 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 84  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 144 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVL 200
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPXL 256
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 257 REVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE ++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 166 SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 78/301 (25%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDS 57
           G++ VVR  ++  T    A KI+N  K+   + +D ++++ E R+ +KL HPNI RL++ 
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96
Query: 58  IQEENYHYLVFDLVTGGELFE---------------DIVARE------------------ 84
            ++E Y  LV +L  GG L +               D+V  +                  
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156
Query: 85  FYSEAD-------ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
           F    D        S+ ++QI  ++++ H+ G+ HRD+KPEN L ++  K   +KL DFG
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFG 215
Query: 138 LAIEV----QGEQ-----------------------------QAWF-GVILYILLVGYPP 163
           L+ E      GE                               AW  GV+L++LL+G  P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
Query: 164 FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC 223
           F   +     +Q+      + +P ++ ++P A++L++ +L  N  +R  A  AL+HPWI 
Sbjct: 276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
Query: 224 Q 224
           Q
Sbjct: 336 Q 336

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/42 (50%), Positives = 29/42 (69%), Gaps = 2/42 (4%)
Query: 259 AGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYPPF 298
           AGTP +++PEVL    E YG   D W+ GV+L++LL+G  PF
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 252 REVLEHPWITANSSKPSNCQNKESAS 277

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 104
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 105 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 164
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 165 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 221
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 222 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 277
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 278 REVLEHPWITANSSKPSNCQNKESAS 303

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 187 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 244

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 252 REVLEHPWITANSSKPSNCQNKESAS 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 34/264 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWICQRERVASIVHRQET 237
            E L+HPWI       S    +E+
Sbjct: 252 REVLEHPWITANSSKPSNCQNKES 275

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 142 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 255 REVLEHPWIT 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 84  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 143
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 144 LLLGS---AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 200
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 201 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 256
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 257 REVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 166 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 36  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 95
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 96  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 155
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 156 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 212
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 213 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 268
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 269 REVLEHPWITANSSKPSNCQNKESAS 294

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 178 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 235

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 80
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 81  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 140
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 141 LLLGS---AGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 197
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 198 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 253
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 254 REVLEHPWITANSSKPSNCQNKESAS 279

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 163 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 34/264 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWICQRERVASIVHRQET 237
            E L+HPWI       S    +E+
Sbjct: 252 REVLEHPWITANSSKPSNCQNKES 275

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 252 REVLEHPWIT 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 18  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 77
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 78  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 137
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 138 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 194
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 195 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 250
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 251 REVLEHPWIT 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 160 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------AW-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 140 LLLGS---AGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 252
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 253 REVLEHPWITANSSKPSNCQNKESAS 278

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 162 SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 79  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 139 LLLGS---AGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 195
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 196 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 251
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 252 REVLEHPWIT 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 161 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 142 LLLGS---AGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 255 REVLEHPWIT 264

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 104
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 105 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 164
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------AW-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 165 LLLGS---AGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 221
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 222 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 277
Query: 214 SEALKHPWICQRERVASIVHRQETV 238
            E L+HPWI       S    +E+ 
Sbjct: 278 REVLEHPWITANSSKPSNCQNKESA 302

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 187 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 244

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 118/250 (47%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------AW-FGVI 153
           LLL S  +   +K+ADFG ++     ++                          W  GV+
Sbjct: 142 LLLGSAGE---LKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 255 REVLEHPWIT 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K      A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 16  GKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 76  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 135
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG ++     ++                          W  GV+
Sbjct: 136 LLLGS---AGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 192
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 193 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 248
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 249 REVLEHPWIT 258

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 158 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 80
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 81  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 140
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+A+FG ++     ++                          W  GV+
Sbjct: 141 LLLGS---AGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 197
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 198 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 253
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 254 REVLEHPWITANSSKPSNCQNKESAS 279

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 163 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 34/266 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+ADFG +      ++                          W  GV+
Sbjct: 140 LLLGS---AGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 252
Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 253 REVLEHPWITANSSKPSNSQNKESAS 278

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R   +GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 162 SRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     + +L RE  I   L+HPNI+RL+    
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 82  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 141
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S      +K+A+FG ++     ++                          W  GV+
Sbjct: 142 LLLGS---AGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 198
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 199 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 254
Query: 214 SEALKHPWIC 223
            E L+HPWI 
Sbjct: 255 REVLEHPWIT 264

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 40/246 (16%)
Query: 1   GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G+F  V   V+K +G +    +A K++    L  RD  + + E  I  ++ HP IV+LH 
Sbjct: 36  GSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHY 94
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           + Q E   YL+ D + GG+LF  +     ++E D    + ++  +++H HS G+++RDLK
Sbjct: 95  AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 154
Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQAW-------------------------- 149
           PEN+LL  +     +KL DFGL+ E +  E++A+                          
Sbjct: 155 PENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 211
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+++ +L G  PF  +D+      I       P      ++PEA++L+  +   NP+
Sbjct: 212 SFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPA 267
Query: 209 KRITAS 214
            R+ A 
Sbjct: 268 NRLGAG 273

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 30/53 (56%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+ +  + +  D W+ GV+++ +L G  PF  +D+      I
Sbjct: 187 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 40/246 (16%)
Query: 1   GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G+F  V   V+K +G +    +A K++    L  RD  + + E  I  ++ HP IV+LH 
Sbjct: 35  GSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHY 93
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           + Q E   YL+ D + GG+LF  +     ++E D    + ++  +++H HS G+++RDLK
Sbjct: 94  AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153
Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQAW-------------------------- 149
           PEN+LL  +     +KL DFGL+ E +  E++A+                          
Sbjct: 154 PENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+++ +L G  PF  +D+      I       P      ++PEA++L+  +   NP+
Sbjct: 211 SFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPA 266
Query: 209 KRITAS 214
            R+ A 
Sbjct: 267 NRLGAG 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 30/53 (56%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+ +  + +  D W+ GV+++ +L G  PF  +D+      I
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 40/246 (16%)
Query: 1   GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G+F  V   V+K +G +    +A K++    L  RD  + + E  I  ++ HP IV+LH 
Sbjct: 35  GSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHY 93
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           + Q E   YL+ D + GG+LF  +     ++E D    + ++  +++H HS G+++RDLK
Sbjct: 94  AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153
Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQAW-------------------------- 149
           PEN+LL  +     +KL DFGL+ E +  E++A+                          
Sbjct: 154 PENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+++ +L G  PF  +D+      I       P      ++PEA++L+  +   NP+
Sbjct: 211 SFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPA 266
Query: 209 KRITAS 214
            R+ A 
Sbjct: 267 NRLGAG 272

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 30/53 (56%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+ +  + +  D W+ GV+++ +L G  PF  +D+      I
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G   +VR+  +  +G  +A K++    L  RD  + + E  I   + HP +V+LH + Q 
Sbjct: 42  GKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQT 101
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YL+ D + GG+LF  +     ++E D    + ++   ++H HS G+++RDLKPEN+
Sbjct: 102 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENI 161
Query: 121 LLASKAKGAAVKLADFGLAIE-VQGEQQAW---------------------------FGV 152
           LL  +     +KL DFGL+ E +  E++A+                           +GV
Sbjct: 162 LLDEEGH---IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGV 218
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           +++ +L G  PF  +D+      I       P      ++ EA++L+  +   NP+ R+ 
Sbjct: 219 LMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQSLLRALFKRNPANRLG 274
Query: 213 AS 214
           + 
Sbjct: 275 SG 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/46 (34%), Positives = 29/46 (63%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F GT  Y++PEV+ ++ +    D W+ GV+++ +L G  PF  +D+
Sbjct: 190 FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 122/251 (48%), Gaps = 34/251 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K T    A K I  ++ +A D + ++RE    R L+HPNIVR  + I  
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYI--ERGAAID-ENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  ++ +  +GGEL+E I     +SE +A    QQ+L  V++CHS  + HRDLK EN 
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147
Query: 121 LLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AW-FGV 152
           LL   +    +K+ DFG                    +A EV   Q+        W  GV
Sbjct: 148 LL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 153 ILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            LY++LVG  PF D ++ R Y +   +  +  Y  P+   ++PE  +LI+++   +P+ R
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATR 266
Query: 211 ITASEALKHPW 221
           I+  E   H W
Sbjct: 267 ISIPEIKTHSW 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 27/56 (48%), Positives = 38/56 (67%), Gaps = 1/56 (1%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLY 307
           S  +   GTP Y++PEVL ++ Y GK  D+W+CGV LY++LVG  PF D ++ R Y
Sbjct: 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 36/255 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F V R    K +    A K I   +K++A     ++RE    R L+HPNIVR  + I 
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREIINHRSLRHPNIVRFKEVIL 85
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
              +  +V +  +GGELFE I     +SE +A    QQ++  V++CH+  V HRDLK EN
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 145
Query: 120 LLLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AW-FG 151
            LL   +    +K+ DFG                    +A EV  +++        W  G
Sbjct: 146 TLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG 204
Query: 152 VILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           V LY++LVG  PF D ++ + + +   +     Y  P++  ++PE ++LI+++   +P+K
Sbjct: 205 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAK 264
Query: 210 RITASEALKHPWICQ 224
           RI+  E   H W  +
Sbjct: 265 RISIPEIRNHEWFLK 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 26/52 (50%), Positives = 36/52 (69%), Gaps = 1/52 (1%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           S  +   GTP Y++PEVL K+ Y GK  D+W+CGV LY++LVG  PF D ++
Sbjct: 171 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K +    A K I   +   +  + ++RE    R L+HPNIVR  + I  
Sbjct: 29  GNFGVARLMRDKQSNELVAVKYIERGE---KIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +V +  +GGELFE I     +SE +A    QQ++  V++CH+  V HRDLK EN 
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 145
Query: 121 LLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AW-FGV 152
           LL   +    +K+ DFG                    +A EV  +++        W  GV
Sbjct: 146 LL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 204
Query: 153 ILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            LY++LVG  PF D ++ + + +   +     Y  P++  ++PE ++LI+++   +P+KR
Sbjct: 205 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKR 264
Query: 211 ITASEALKHPWICQ 224
           I+  E   H W  +
Sbjct: 265 ISIPEIRNHEWFLK 278

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 26/52 (50%), Positives = 36/52 (69%), Gaps = 1/52 (1%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           S  +   GTP Y++PEVL K+ Y GK  D+W+CGV LY++LVG  PF D ++
Sbjct: 170 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 63/281 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------------------------DFQKL 36
           G++ VV+    +     +A K+++ KKL  +                          +++
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83
Query: 37  EREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
            +E  I +KL HPN+V+L + + +  E++ Y+VF+LV  G + E +   +  SE  A   
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFY 142
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------- 146
            Q +++ + + H   ++HRD+KP NLL+        +K+ADFG++ E +G          
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFKGSDALLSNTVG 199
Query: 147 ----------------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 183
                                   W  GV LY  + G  PF DE    L+++IK+ A ++
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259
Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
           P  +   +  + K+LI +ML  NP  RI   E   HPW+ +
Sbjct: 260 P--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/66 (40%), Positives = 40/66 (60%), Gaps = 5/66 (7%)
Query: 259 AGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA- 314
            GTP +++PE L   +K   GK +D+WA GV LY  + G  PF DE    L+++IK+ A 
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 315 -YDDEP 319
            + D+P
Sbjct: 258 EFPDQP 263

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 122/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K      A K I   +   +  + ++RE    R L+HPNIVR  + I  
Sbjct: 30  GNFGVARLMRDKQANELVAVKYIERGE---KIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +V +  +GGELFE I     +SE +A    QQ++  V++ H+  V HRDLK EN 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENT 146
Query: 121 LLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AWF-GV 152
           LL   +    +K+ADFG                    +A EV  +++        W  GV
Sbjct: 147 LL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 153 ILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            LY++LVG  PF D ++ + + +   +     Y  P++  ++PE ++LI+++   +P+KR
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKR 265
Query: 211 ITASEALKHPWICQ 224
           I+  E   H W  +
Sbjct: 266 ISIPEIRNHEWFLK 279

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 25/45 (55%), Positives = 34/45 (75%), Gaps = 1/45 (2%)
Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           GTP Y++PEVL K+ Y GK  D+W+CGV LY++LVG  PF D ++
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  FA KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKDGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  FA KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKDGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  FA KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 122/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K +    A K I   +   +  + ++RE    R L+HPNIVR  + I  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGE---KIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +V +  +GGELFE I     +SE +A    QQ++  V++CH+  V HRDLK EN 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 146
Query: 121 LLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AW-FGV 152
           LL   +    +K+  FG                    +A EV  +++        W  GV
Sbjct: 147 LL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 153 ILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            LY++LVG  PF D ++ + + +   +     Y  P++  ++PE ++LI+++   +P+KR
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKR 265
Query: 211 ITASEALKHPWICQ 224
           I+  E   H W  +
Sbjct: 266 ISIPEIRNHEWFLK 279

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 25/45 (55%), Positives = 34/45 (75%), Gaps = 1/45 (2%)
Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           GTP Y++PEVL K+ Y GK  D+W+CGV LY++LVG  PF D ++
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 122/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K +    A K I   +   +  + ++RE    R L+HPNIVR  + I  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGE---KIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +V +  +GGELFE I     +SE +A    QQ++  V++CH+  V HRDLK EN 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 146
Query: 121 LLASKAKGAAVKLADFG--------------------LAIEVQGEQQ-------AW-FGV 152
           LL   +    +K+  FG                    +A EV  +++        W  GV
Sbjct: 147 LL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 153 ILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            LY++LVG  PF D ++ + + +   +     Y  P++  ++PE ++LI+++   +P+KR
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKR 265
Query: 211 ITASEALKHPWICQ 224
           I+  E   H W  +
Sbjct: 266 ISIPEIRNHEWFLK 279

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 26/52 (50%), Positives = 36/52 (69%), Gaps = 1/52 (1%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           S  +   GTP Y++PEVL K+ Y GK  D+W+CGV LY++LVG  PF D ++
Sbjct: 171 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIXNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +K+ADFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +K+ADFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 73  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 133 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 192
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 193 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 247
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 248 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 303
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 304 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 341

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 274

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 164
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 165 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 219
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 220 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 275
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 276 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 313

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 246

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 122/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K      A K++   +L     + +L RE  I   L+HPNI+R+++   
Sbjct: 26  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 85
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GEL++++     + E  ++  ++++ +++++CH   V+HRD+KPEN
Sbjct: 86  DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPEN 145
Query: 120 LLLASKAKGAAVKLADFGLAIE--------------------VQGEQQ-----AW-FGVI 153
           LL+  K +   +K+ADFG ++                     ++G+        W  GV+
Sbjct: 146 LLMGYKGE---LKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 202
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        + +I      +P      ++  +K+LI+++L  +P +R+  
Sbjct: 203 CYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPL 258
Query: 214 SEALKHPWICQRER 227
              ++HPW+    R
Sbjct: 259 KGVMEHPWVKANSR 272

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           R+   GT  YL PE+++ + + + VD+W  GV+ Y  LVG PPF
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 122/254 (48%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K      A K++   +L     + +L RE  I   L+HPNI+R+++   
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GEL++++     + E  ++  ++++ +++++CH   V+HRD+KPEN
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPEN 144
Query: 120 LLLASKAKGAAVKLADFGLAIE--------------------VQGEQQ-----AW-FGVI 153
           LL+  K +   +K+ADFG ++                     ++G+        W  GV+
Sbjct: 145 LLMGYKGE---LKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        + +I      +P      ++  +K+LI+++L  +P +R+  
Sbjct: 202 CYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPL 257
Query: 214 SEALKHPWICQRER 227
              ++HPW+    R
Sbjct: 258 KGVMEHPWVKANSR 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           R+   GT  YL PE+++ + + + VD+W  GV+ Y  LVG PPF
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ ++  ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 38/54 (70%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ ++  ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSG 253

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 25/55 (45%), Positives = 38/55 (69%)
Query: 259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           AGTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 36/54 (66%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+P ++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 173 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLPNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 39  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 98
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 99  DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 158
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 159 LLIDEQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 213
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 214 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 269
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 270 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 307

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 187 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 240

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 36/54 (66%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP  L+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   ++ +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFGLA  V+G  + W                            GV
Sbjct: 172 LMIDQQ---GYIKVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 192
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-----------------------WF--GVIL 154
           LL+  +     +++ DFG A  V+G                           W+  GV++
Sbjct: 193 LLIDQQ---GYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR    
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNL 305
Query: 212 --TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
               ++   H W    + +A I  R+     + KF  
Sbjct: 306 KNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 341

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 164
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 165 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 219
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 220 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 275
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 276 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 313

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 246

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + + GG++F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +K+ADFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + + GG++F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +K+ADFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKDGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LIIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 97
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 98  DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 157
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-----------------------WF--GVIL 154
           LL+  +     +++ DFG A  V+G                           W+  GV++
Sbjct: 158 LLIDQQ---GYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 214
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR    
Sbjct: 215 YEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNL 270
Query: 212 --TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
               ++   H W    + +A I  R+     + KF  
Sbjct: 271 KDGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 306

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 186 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     ++E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKDGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   ++ +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +++ DFGLA  V+G  + W                            GV
Sbjct: 172 LMIDQQ---GYIQVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 192
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 193 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 247
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 248 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 303
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 304 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 341

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 274

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 47  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 106
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 107 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 166
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 167 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 221
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 222 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 277
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 278 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 315

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 195 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 248

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 172 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK--- 209
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +K   
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKAFG 282
Query: 210 --RITASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
             +   ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           LL+  +     +++ DFG A  V+G  + W                            GV
Sbjct: 173 LLIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA K++  +  L     +K+  E  I + L +P++V  H   +
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++++ Y+V ++     L E    R+  +E +A + ++Q ++ V + H+N V+HRDLK  N
Sbjct: 113 DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGN 172
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQA-------------------------W-FG 151
           L L        VK+ DFGLA  IE  GE++                          W  G
Sbjct: 173 LFLNDDMD---VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            ILY LLVG PPF        Y +IK   Y  P      + P A  LI +ML  +P+ R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRP 285
Query: 212 TASEAL 217
           + +E L
Sbjct: 286 SVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/67 (44%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VDIW+ G ILY LLVG PPF        Y +IK   
Sbjct: 199 KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 258
Query: 315 YDDEPKH 321
           Y   P+H
Sbjct: 259 Y-SVPRH 264

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA K++  +  L     +K+  E  I + L +P++V  H   +
Sbjct: 37  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 96
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++++ Y+V ++     L E    R+  +E +A + ++Q ++ V + H+N V+HRDLK  N
Sbjct: 97  DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGN 156
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQA-------------------------W-FG 151
           L L        VK+ DFGLA  IE  GE++                          W  G
Sbjct: 157 LFLNDDMD---VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLG 213
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            ILY LLVG PPF        Y +IK   Y  P      + P A  LI +ML  +P+ R 
Sbjct: 214 CILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRP 269
Query: 212 TASEAL 217
           + +E L
Sbjct: 270 SVAELL 275

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/67 (44%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VDIW+ G ILY LLVG PPF        Y +IK   
Sbjct: 183 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 242
Query: 315 YDDEPKH 321
           Y   P+H
Sbjct: 243 Y-SVPRH 248

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA K++  +  L     +K+  E  I + L +P++V  H   +
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++++ Y+V ++     L E    R+  +E +A + ++Q ++ V + H+N V+HRDLK  N
Sbjct: 113 DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGN 172
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQA-------------------------W-FG 151
           L L        VK+ DFGLA  IE  GE++                          W  G
Sbjct: 173 LFLNDDMD---VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            ILY LLVG PPF        Y +IK   Y  P      + P A  LI +ML  +P+ R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRP 285
Query: 212 TASEAL 217
           + +E L
Sbjct: 286 SVAELL 291

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/67 (44%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VDIW+ G ILY LLVG PPF        Y +IK   
Sbjct: 199 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 258
Query: 315 YDDEPKH 321
           Y   P+H
Sbjct: 259 Y-SVPRH 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA K++  +  L     +K+  E  I + L +P++V  H   +
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++++ Y+V ++     L E    R+  +E +A + ++Q ++ V + H+N V+HRDLK  N
Sbjct: 113 DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGN 172
Query: 120 LLLASKAKGAAVKLADFGLA--IEVQGEQQA-------------------------W-FG 151
           L L        VK+ DFGLA  IE  GE++                          W  G
Sbjct: 173 LFLNDDMD---VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            ILY LLVG PPF        Y +IK   Y  P      + P A  LI +ML  +P+ R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRP 285
Query: 212 TASEAL 217
           + +E L
Sbjct: 286 SVAELL 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/67 (44%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VDIW+ G ILY LLVG PPF        Y +IK   
Sbjct: 199 KKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNE 258
Query: 315 YDDEPKH 321
           Y   P+H
Sbjct: 259 Y-SVPRH 264

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P + +L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 173 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +++ DFG A  V+G  + W                            GV
Sbjct: 172 LMIDQQ---GYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P + +L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 173 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 34/254 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   ++     + +L RE  I   L HPNI+RL++   
Sbjct: 34  GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFY 93
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GEL++++     + E   +  ++++ +++ +CH   V+HRD+KPEN
Sbjct: 94  DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPEN 153
Query: 120 LLLASKAKGAAVKLADFGLAIE--------------------VQGEQQ-----AW-FGVI 153
                      +K+ADFG ++                     ++G         W  GV+
Sbjct: 154 ---LLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVL 210
Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y LLVG PPF     +  Y +I      +P+    +V   A++LI+++L  NPS+R+  
Sbjct: 211 CYELLVGNPPFESASHNETYRRIVKVDLKFPA----SVPTGAQDLISKLLRHNPSERLPL 266
Query: 214 SEALKHPWICQRER 227
           ++   HPW+    R
Sbjct: 267 AQVSAHPWVRANSR 280

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 32/56 (57%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           R+   GT  YL PE+++   + + VD+W  GV+ Y LLVG PPF     +  Y +I
Sbjct: 178 RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 172 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 283 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 320

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 42/252 (16%)
Query: 6   VRRCVQKATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEENY 63
           VR+     TG  FA K++    +  +A+D    + E  I  +++HP IV L  + Q    
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95
Query: 64  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLA 123
            YL+ + ++GGELF  +     + E  A   + +I  ++ H H  G+++RDLKPEN++L 
Sbjct: 96  LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 124 SKAKGAAVKLADFGLAIEV------------------------QGEQQA---W-FGVILY 155
            +     VKL DFGL  E                          G  +A   W  G ++Y
Sbjct: 156 HQGH---VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI---- 211
            +L G PPF  E++ +   +I     + P      +T EA++L+ ++L  N + R+    
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGP 268
Query: 212 -TASEALKHPWI 222
             A E   HP+ 
Sbjct: 269 GDAGEVQAHPFF 280

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 19/53 (35%), Positives = 33/53 (62%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PE+L +  + + VD W+ G ++Y +L G PPF  E++ +   +I
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 42/252 (16%)
Query: 6   VRRCVQKATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEENY 63
           VR+     TG  FA K++    +  +A+D    + E  I  +++HP IV L  + Q    
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95
Query: 64  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLA 123
            YL+ + ++GGELF  +     + E  A   + +I  ++ H H  G+++RDLKPEN++L 
Sbjct: 96  LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 124 SKAKGAAVKLADFGLAIEV------------------------QGEQQA---W-FGVILY 155
            +     VKL DFGL  E                          G  +A   W  G ++Y
Sbjct: 156 HQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI---- 211
            +L G PPF  E++ +   +I     + P      +T EA++L+ ++L  N + R+    
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGP 268
Query: 212 -TASEALKHPWI 222
             A E   HP+ 
Sbjct: 269 GDAGEVQAHPFF 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 19/53 (35%), Positives = 33/53 (62%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PE+L +  + + VD W+ G ++Y +L G PPF  E++ +   +I
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 136 LMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 248
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 19  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 79  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 138
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 139 LMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 195
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 196 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 251
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 252 GGGPSDAKEVMEHRFF 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 163 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 136 LMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 248
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 136 LMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 248
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 136 LMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 248
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 136 LMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 248
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 21  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 80
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 81  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 140
Query: 120 LLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--FG 151
           L+L    K   +K+ DFGL                     A EV      G    W   G
Sbjct: 141 LMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 197
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 198 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 253
Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 254 GGGPSDAKEVMEHRFF 269

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V       TG  +A KI++ +K+   +  +    E RI + +  P + +L  S +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V +   GGE+F  +     + E  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           L++  +     +K+ DFG A  V+G  + W                            GV
Sbjct: 173 LMIDQQ---GYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 283
Query: 212 ----TASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
                 ++   H W    + +A I  R+     + KF  
Sbjct: 284 NLKNGVNDIKNHKWFATTDWIA-IYQRKVEAPFIPKFKG 321

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 37/54 (68%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 86  DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 146 LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 258
Query: 212 TASEAL 217
           T +E L
Sbjct: 259 TINELL 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 232 YSI-PKH 237

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 50  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 109
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 110 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 169
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 170 LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 282
Query: 212 TASEAL 217
           T +E L
Sbjct: 283 TINELL 288

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 196 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 255
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 256 YSI-PKH 261

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 87
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 88  DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 147
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 148 LFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 260
Query: 212 TASEAL 217
           T +E L
Sbjct: 261 TINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 233
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 234 YSI-PKH 239

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 172 LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 284
Query: 212 TASEAL 217
           T +E L
Sbjct: 285 TINELL 290

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 258 YSI-PKH 263

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 32  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 91
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 92  DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 151
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 152 LFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 264
Query: 212 TASEAL 217
           T +E L
Sbjct: 265 TINELL 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 178 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 237
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 238 YSI-PKH 243

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+  +  L     +K+  E  I R L H ++V  H   +
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 87
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 88  DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 147
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ--GEQQ-------------------------AW-FG 151
           L L    +   VK+ DFGLA +V+  GE++                          W  G
Sbjct: 148 LFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK   Y  P      + P A +LI +ML  +P+ R 
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARP 260
Query: 212 TASEAL 217
           T +E L
Sbjct: 261 TINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
           ++   GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 233
Query: 315 YDDEPKH 321
           Y   PKH
Sbjct: 234 YSI-PKH 239

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   ++  ++A+I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   ++  ++A+I    YD
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   ++  ++A+I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   ++  ++A+I    YD
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 20  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 80  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 139
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL    +   +++ DFG A                        E+  E+ A      W 
Sbjct: 140 ILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 196
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 197 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 252
Query: 210 RITASE 215
           R+   E
Sbjct: 253 RLGCEE 258

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 229

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 18  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 77
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 78  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 137
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL    +   +++ DFG A                        E+  E+ A      W 
Sbjct: 138 ILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 194
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 195 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 250
Query: 210 RITASE 215
           R+   E
Sbjct: 251 RLGCEE 256

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 21  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 80
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 81  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 140
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL    +   +++ DFG A                        E+  E+ A      W 
Sbjct: 141 ILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 197
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 198 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 253
Query: 210 RITASE 215
           R+   E
Sbjct: 254 RLGCEE 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 230

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 120/270 (44%), Gaps = 47/270 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAWF 150
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 151 -GVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPWI-------CQRERVAS 230
           S RIT  +  K  W         +R RV S
Sbjct: 250 SARITIPDIKKDRWYNKPLKKGAKRPRVTS 279

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL    +   +++ DFG A                        E+  E+ A      W 
Sbjct: 139 ILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 195
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 251
Query: 210 RITASE 215
           R+   E
Sbjct: 252 RLGCEE 257

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 228

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 46  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 105
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 106 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 165
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 166 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 222
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P+  +    P+A++L+ ++L ++ +K
Sbjct: 223 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFF----PKARDLVEKLLVLDATK 278
Query: 210 RITASE 215
           R+   E
Sbjct: 279 RLGCEE 284

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 145 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 255

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAWF 150
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 151 -GVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 161 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 273
Query: 210 RITASE 215
           R+   E
Sbjct: 274 RLGCEE 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 164 ILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 276
Query: 210 RITASE 215
           R+   E
Sbjct: 277 RLGCEE 282

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 253

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 161 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 273
Query: 210 RITASE 215
           R+   E
Sbjct: 274 RLGCEE 279

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 161 ILLNEDMH---IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 273
Query: 210 RITASE 215
           R+   E
Sbjct: 274 RLGCEE 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 120/270 (44%), Gaps = 47/270 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAWF 150
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 151 -GVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPWI-------CQRERVAS 230
           S RIT  +  K  W         +R RV S
Sbjct: 250 SARITIPDIKKDRWYNKPLKKGAKRPRVTS 279

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 160 ILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 216
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 272
Query: 210 RITASE 215
           R+   E
Sbjct: 273 RLGCEE 278

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 249

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 160 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 216
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 272
Query: 210 RITASE 215
           R+   E
Sbjct: 273 RLGCEE 278

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 249

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 164 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 276
Query: 210 RITASE 215
           R+   E
Sbjct: 277 RLGCEE 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 253

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 25  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 84
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 85  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 144
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL    +   +++ DFG A                        E+  E+ A      W 
Sbjct: 145 ILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 201
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 202 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 257
Query: 210 RITASE 215
           R+   E
Sbjct: 258 RLGCEE 263

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 124 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAWFG- 151
           NL+L    K   +K+ DFGL                     A EV      G    W+G 
Sbjct: 279 NLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 152 -VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            V++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 391
Query: 211 I-TASEALKHPWICQRERVASIV 232
           +   SE  K   I Q    A IV
Sbjct: 392 LGGGSEDAKE--IMQHRFFAGIV 412

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 221
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 222 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 281
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAWFG- 151
           NL+L    K   +K+ DFGL                     A EV      G    W+G 
Sbjct: 282 NLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 338
Query: 152 -VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
            V++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 339 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 394
Query: 211 I-TASEALKHPWICQRERVASIV 232
           +   SE  K   I Q    A IV
Sbjct: 395 LGGGSEDAKE--IMQHRFFAGIV 415

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 307 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 121/263 (46%), Gaps = 40/263 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 19  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 78
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 79  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 138
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--F 150
           NL+L    K   +K+ DFGL                     A EV      G    W   
Sbjct: 139 NLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 195
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 196 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 251
Query: 211 I-TASEALKHPWICQRERVASIV 232
           +   SE  K   I Q    A IV
Sbjct: 252 LGGGSEDAKE--IMQHRFFAGIV 272

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 164 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 121/263 (46%), Gaps = 40/263 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 20  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 80  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 139
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--F 150
           NL+L    K   +K+ DFGL                     A EV      G    W   
Sbjct: 140 NLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 197 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 252
Query: 211 I-TASEALKHPWICQRERVASIV 232
           +   SE  K   I Q    A IV
Sbjct: 253 LGGGSEDAKE--IMQHRFFAGIV 273

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 121/263 (46%), Gaps = 40/263 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 21  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 80
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 81  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 140
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV-----QGEQQAW--F 150
           NL+L    K   +K+ DFGL                     A EV      G    W   
Sbjct: 141 NLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 197
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 198 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 253
Query: 211 I-TASEALKHPWICQRERVASIV 232
           +   SE  K   I Q    A IV
Sbjct: 254 LGGGSEDAKE--IMQHRFFAGIV 274

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 39/58 (67%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 166 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 116/255 (45%), Gaps = 42/255 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           GA+  V+  V + T    A KI++ K+  A D  + +++E  I + L H N+V+ +   +
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           E N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPEN
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW 149
           LLL  +     +K++DFGLA                              E   E    W
Sbjct: 136 LLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 150 -FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
             G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  N
Sbjct: 193 SCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVEN 249
Query: 207 PSKRITASEALKHPW 221
           PS RIT  +  K  W
Sbjct: 250 PSARITIPDIKKDRW 264

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 75  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 135 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 192 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 248
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 249 SARITIPDIKKDRW 262

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 154 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+   Q
Sbjct: 48  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQ 107
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 108 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 167
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 168 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 224
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 280
Query: 210 RITASE 215
           R+   E
Sbjct: 281 RLGCEE 286

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 147 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 257

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 158 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 213
Query: 136 FGLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDE 167
           FG   +V                             E   W  G+++  ++ G PP+++E
Sbjct: 214 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 274 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329
Query: 225 RERVASIV 232
               ASIV
Sbjct: 330 AGPPASIV 337

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 42/68 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 216 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275
Query: 304 HRLYAQIK 311
            +    I+
Sbjct: 276 LKAMKMIR 283

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS      + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 41  GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 120 LLLASKAKGAAVKLADFGLAI-----------------------EVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 161 ILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 273
Query: 210 RITASE 215
           R+   E
Sbjct: 274 RLGCEE 279

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 48  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 107
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 108 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 163
Query: 136 FGLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDE 167
           FG   +V                             E   W  G+++  ++ G PP+++E
Sbjct: 164 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 224 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 279
Query: 225 RERVASIV 232
               ASIV
Sbjct: 280 AGPPASIV 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 39/58 (67%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E
Sbjct: 166 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 55  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 114
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 115 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 170
Query: 136 FGLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDE 167
           FG   +V                             E   W  G+++  ++ G PP+++E
Sbjct: 171 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 231 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 286
Query: 225 RERVASIV 232
               ASIV
Sbjct: 287 AGPPASIV 294

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 42/68 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 173 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 232
Query: 304 HRLYAQIK 311
            +    I+
Sbjct: 233 LKAMKMIR 240

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 104 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 159
Query: 136 FGLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDE 167
           FG   +V                             E   W  G+++  ++ G PP+++E
Sbjct: 160 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 220 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
Query: 225 RERVASIV 232
               ASIV
Sbjct: 276 AGPPASIV 283

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 42/68 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 162 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221
Query: 304 HRLYAQIK 311
            +    I+
Sbjct: 222 LKAMKMIR 229

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 53  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 112
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 113 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 168
Query: 136 FGLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDE 167
           FG   +V                             E   W  G+++  ++ G PP+++E
Sbjct: 169 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 229 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284
Query: 225 RERVASIV 232
               ASIV
Sbjct: 285 AGPPASIV 292

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 42/68 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 171 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 230
Query: 304 HRLYAQIK 311
            +    I+
Sbjct: 231 LKAMKMIR 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 42/248 (16%)
Query: 19  AAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           + K++  KK+  R  Q+ E    E  I R  QH N+V +++S    +  ++V + + GG 
Sbjct: 175 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L + +       E  A+ C+  +L++++  H+ GV+HRD+K +++LL    +   VKL+D
Sbjct: 235 LTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 290
Query: 136 FGLAIEVQGE---------QQAW-------------------FGVILYILLVGYPPFWDE 167
           FG   +V  E            W                    G+++  ++ G PP+++E
Sbjct: 291 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350
Query: 168 DQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              +    I+    D   P       V+P  K  ++++L  +P++R TA+E LKHP++ +
Sbjct: 351 PPLKAMKMIR----DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406
Query: 225 RERVASIV 232
               ASIV
Sbjct: 407 AGPPASIV 414

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 42/68 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PE++ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 293 FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352
Query: 304 HRLYAQIK 311
            +    I+
Sbjct: 353 LKAMKMIR 360

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+ +    + +++E  I   L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINAMLNHENVVKFYGHRRE 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 194 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 250
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 251 SARITIPDIKKDRW 264

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 156 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 210

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V+  V + T    A KI++ K+ +    + +++E  I + L H N+V+ +   +E
Sbjct: 17  GAAGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE 75
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 76  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 121 LLASKAKGAAVKLADFGLAI-----------------------------EVQGEQ-QAW- 149
           LL  +     +K++DFGLA                              E   E    W 
Sbjct: 136 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 192
Query: 150 FGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            G++L  +L G  P WD+  D  + Y+  K     Y +P W  +      L++++L  NP
Sbjct: 193 CGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKK-TYLNP-WKKIDSAPLALLHKILVENP 249
Query: 208 SKRITASEALKHPW 221
           S RIT  +  K  W
Sbjct: 250 SARITIPDIKKDRW 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 243 KFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++N R +L         GT  Y++PE+LK+ E + +PVD+W+CG++L  +L G  P WD+
Sbjct: 155 RYNNRERL----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQ 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        G L + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 103 DDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 120 LLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------W- 149
           +LL        +++ DFG A                        E+  E+ A      W 
Sbjct: 163 ILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWA 219
Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 275
Query: 210 RITASE 215
           R+   E
Sbjct: 276 RLGCEE 281

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 211 ITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLKVSTRQG----FAGTPGYL 265
           ++A E L    I  R+ +  +I+  ++    +  F   + L   ++Q     F GT  Y+
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 266 SPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 130/276 (47%), Gaps = 46/276 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V    +K +G + A K+++ +K   R+   L  E  I R  QH N+V ++ S   
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG L  DIV++   +E   +   + +L+++ + H+ GV+HRD+K +++
Sbjct: 114 GEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172
Query: 121 LLASKAKGAAVKLADFGLAIEVQ---------------------------GEQQAW-FGV 152
           LL    +   VKL+DFG   ++                             E   W  G+
Sbjct: 173 LLTLDGR---VKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT---VTPEAKNLINQMLTVNPSK 209
           ++  ++ G PP++ +   +   +++    D P P+      V+P  ++ + +ML  +P +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285
Query: 210 RITASEALKHPWICQRERVASIV-----HRQETVDC 240
           R TA E L HP++ Q      +V     +R++T  C
Sbjct: 286 RATAQELLDHPFLLQTGLPECLVPLIQLYRKQTSTC 321

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/58 (32%), Positives = 35/58 (60%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           F A+    V  R+   GTP +++PEV+ +  Y   VDIW+ G+++  ++ G PP++ +
Sbjct: 187 FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 115/253 (45%), Gaps = 38/253 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     +  G  +A K++  +  +  +  +    E  +   + HP I+R+  + Q
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    +++ D + GGELF  +   + +    A     ++  ++ + HS  +++RDLKPEN
Sbjct: 77  DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 136
Query: 120 LLLASKAKGAAVKLADFGLAIEV-----------------------QGEQQAW--FGVIL 154
           +LL    K   +K+ DFG A  V                         +   W  FG+++
Sbjct: 137 ILL---DKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +L GY PF+D +  + Y +I      +P         + K+L+++++T + S+R+   
Sbjct: 194 YEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNL 249
Query: 212 -TASEALK-HPWI 222
              +E +K HPW 
Sbjct: 250 QNGTEDVKNHPWF 262

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 36/51 (70%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           GTP Y++PEV+  +PY K +D W+ G+++Y +L GY PF+D +  + Y +I
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLH 55
           G   +VR+     TG  +A K++  KK +     K     R  R++     Q P +V LH
Sbjct: 68  GKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            + Q E   +L+ D + GGELF  +  RE ++E +    + +I+ ++ H H  G+++RD+
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEV---------------------------QGEQQA 148
           K EN+LL S      V L DFGL+ E                             G  +A
Sbjct: 186 KLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 149 --W--FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
             W   GV++Y LL G  PF  + +    A+I         P    ++  AK+LI ++L 
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLM 302
Query: 205 VNPSKRI 211
            +P KR+
Sbjct: 303 KDPKKRL 309

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 2/64 (3%)
Query: 258 FAGTPGYLSPEVLKKEPYG--KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F GT  Y++P++++    G  K VD W+ GV++Y LL G  PF  + +    A+I     
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 316 DDEP 319
             EP
Sbjct: 280 KSEP 283

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVRLHDSI 58
           G+F  V     KA  + +A K++  K +  +  +K  +     + + ++HP +V LH S 
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V D + GGELF  +     + E  A     +I  ++ + HS  +V+RDLKPE
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 168
Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEVQGEQQ-----AW--F 150
           N+LL S+     + L DFGL                     A EV  +Q       W   
Sbjct: 169 NILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY +L G PPF+  +   +Y  I     + P      +T  A++L+  +L  + +KR
Sbjct: 226 GAVLYEMLYGLPPFYSRNTAEMYDNI----LNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
Query: 211 ITASE 215
           + A +
Sbjct: 282 LGAKD 286

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 28/58 (48%), Positives = 36/58 (62%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           ST   F GTP YL+PEVL K+PY + VD W  G +LY +L G PPF+  +   +Y  I
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F           G ++  K IN  ++S+++ ++  RE  +   ++HPNIV+  +S +E
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94
Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
               Y+V D   GG+LF+ I A++   + E        QI  ++ H H   ++HRD+K +
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 119 NLLLASKAKGAAVKLADFGLA------IEV---------------------QGEQQAW-F 150
           N+ L    K   V+L DFG+A      +E+                       +   W  
Sbjct: 155 NIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL 211
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY L      F       L  +I +G++   S  +   + + ++L++Q+   NP  R
Sbjct: 212 GCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY---SYDLRSLVSQLFKRNPRDR 268
Query: 211 ITASEALKHPWICQRERVASIVHRQETVD--CLKKFN 245
            + +  L+  +I +  R+   +  Q   +  CLK F+
Sbjct: 269 PSVNSILEKGFIAK--RIEKFLSPQLIAEEFCLKTFS 303

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 30/56 (53%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP YLSPE+ + +PY    DIWA G +LY L      F       L  +I +G++
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 55/260 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V    +K TG + A K ++ +K   R+   L  E  I R   H N+V ++ S   
Sbjct: 56  GSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHDNVVDMYSSYLV 113
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L + +       E  A+ C+  +L ++++ H+ GV+HRD+K +++
Sbjct: 114 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIKSDSI 172
Query: 121 LLASKAKGAAVKLADFGLAIEVQ---------------------------GEQQAW-FGV 152
           LL S  +   +KL+DFG   +V                             E   W  G+
Sbjct: 173 LLTSDGR---IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGI 229
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL----------INQM 202
           ++  ++ G PP+++E   +   +I+           D++ P  K+L          ++ M
Sbjct: 230 MVIEMIDGEPPYFNEPPLQAMRRIR-----------DSLPPRVKDLHKVSSVLRGFLDLM 278
Query: 203 LTVNPSKRITASEALKHPWI 222
           L   PS+R TA E L HP++
Sbjct: 279 LVREPSQRATAQELLGHPFL 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 9/90 (10%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   +V  R+   GTP +++PEV+ + PYG  VDIW+ G+++  ++ G PP+++E  
Sbjct: 187 FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 246
Query: 304 HRLYAQIKAGAYDDEPK-----HKSASVVK 328
            +   +I+    D  P      HK +SV++
Sbjct: 247 LQAMRRIR----DSLPPRVKDLHKVSSVLR 272

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 75/140 (53%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ ++   + F D  A            + Q+L+ +  CHS+ V+HRDLKPEN
Sbjct: 77  ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPEN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 75/140 (53%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ ++   + F D  A            + Q+L+ +  CHS+ V+HRDLKPEN
Sbjct: 75  ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPEN 134
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 135 LLINTE---GAIKLADFGLA 151

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKPEN
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPEN 135
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 136 LLINTE---GAIKLADFGLA 152

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKPEN
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPEN 134
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 135 LLINTE---GAIKLADFGLA 151

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 75/140 (53%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ ++   + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 77  ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 75/140 (53%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ ++   + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 76  ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 135
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 136 LLINTE---GAIKLADFGLA 152

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 75/140 (53%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ ++ CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 77  ENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKPEN
Sbjct: 74  ENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPEN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 88
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 148 LLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRG 262
Query: 212 TASEALKHPWI 222
           +A E L+H ++
Sbjct: 263 SAKELLQHQFL 273

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 38/62 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 162 FCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 304 HR 305
            R
Sbjct: 222 LR 223

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 88
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 148 LLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG 262
Query: 212 TASEALKHPWI 222
           +A E L+H ++
Sbjct: 263 SAKELLQHQFL 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 38/62 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 304 HR 305
            R
Sbjct: 222 LR 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 88
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 148 LLGMD---GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG 262
Query: 212 TASEALKHPWI 222
           +A E L+H ++
Sbjct: 263 SAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 38/62 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 162 FCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 304 HR 305
            R
Sbjct: 222 LR 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 80
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 81  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 140
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 141 LLINTE---GAIKLADFGLA 157

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 56/316 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICR-KLQHPNIVRLHDSI 58
           G+F  V     K TG  +A K++     L   D +    E RI      HP + +L    
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  + V + V GG+L   I     + EA A     +I+ ++   H  G+++RDLK +
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 119 NLLLASKAKGAAVKLADFGLAIE--VQGEQQAWF-------------------------- 150
           N+LL  +      KLADFG+  E    G   A F                          
Sbjct: 154 NVLLDHEGH---CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L G+ PF  E++  L+  I      YP+  W  +  +A  ++   +T NP+ R
Sbjct: 211 GVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LHEDATGILKSFMTKNPTMR 266
Query: 211 ITA------SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGY 264
           + +         L+HP+  + +  A + HRQ             + ++ +R+  +     
Sbjct: 267 LGSLTQGGEHAILRHPFFKEIDW-AQLNHRQ--------IEPPFRPRIKSREDVSN---- 313
Query: 265 LSPEVLKKEPYGKPVD 280
             P+ +K+EP   P+D
Sbjct: 314 FDPDFIKEEPVLXPID 329

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 37/57 (64%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T   F GTP Y++PE+L++  YG  VD WA GV+LY +L G+ PF  E++  L+  I
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 80
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 81  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 140
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 141 LLINTE---GAIKLADFGLA 157

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 77  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ V    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/140 (38%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ V    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 77  ENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 77  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 136
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 137 LLINTE---GAIKLADFGLA 153

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 135
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 136 LLINTE---GAIKLADFGLA 152

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 76  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 135
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 136 LLINTE---GAIKLADFGLA 152

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 77
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 78  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 137
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 138 LLINTE---GAIKLADFGLA 154

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 134
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 135 LLINTE---GAIKLADFGLA 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 77
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 78  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 137
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 138 LLINTE---GAIKLADFGLA 154

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 134
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 135 LLINTE---GAIKLADFGLA 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 75  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 134
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 135 LLINTE---GAIKLADFGLA 151

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 74/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 89
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 90  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 148
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 149 LLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 205
Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 206 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRG 263
Query: 212 TASEALKHPWI 222
           +A E ++H ++
Sbjct: 264 SAKELIQHQFL 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 38/62 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 163 FCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 222
Query: 304 HR 305
            R
Sbjct: 223 LR 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 70/296 (23%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G ++ V + + K TG+  A K +            + RE  + ++L+H NIVRL+D I  
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELKHENIVRLYDVIHT 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYS-----EADASHCIQ-QILESVNHCHSNGVVHRD 114
           EN   LVF+ +   +L + + +R   +     E +     Q Q+L+ +  CH N ++HRD
Sbjct: 75  ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRD 133
Query: 115 LKPENLLLASKAKGAAVKLADFGLA----IEVQGEQQA----WF---------------- 150
           LKP+NLL+  + +   +KL DFGLA    I V          W+                
Sbjct: 134 LKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 151 -----GVILYILLVGYPPF---WDEDQHRLYAQIKAGAYD--YPS----PEWD------- 189
                G IL  ++ G P F    DE+Q +L   I     +  +PS    P+++       
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 190 -----------TVTPEAKNLIN---QMLTVNPSKRITASEALKHPWICQRERVASI 231
                      T  P   NL++    +L +NP  R++A +AL HPW  +    AS+
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 45/263 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G++   ++  +K+ G     K ++   ++  + Q L  E  + R+L+HPNIVR +D I  
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 59  QEENYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCH--SNG--- 109
           +     Y+V +   GG+L   I      R++  E      + Q+  ++  CH  S+G   
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA---------------------------IEV 142
           V+HRDLKP N+ L  K     VKL DFGLA                           +  
Sbjct: 137 VLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSY 193
Query: 143 QGEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             +   W  G +LY L    PPF    Q  L  +I+ G +      +   + E   +I +
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY---SDELNEIITR 250
Query: 202 MLTVNPSKRITASEALKHPWICQ 224
           ML +    R +  E L++P I +
Sbjct: 251 MLNLKDYHRPSVEEILENPLILE 273

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 33/62 (53%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GTP Y+SPE + +  Y +  DIW+ G +LY L    PPF    Q  L  +I+ G +  
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235
Query: 318 EP 319
            P
Sbjct: 236 IP 237

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 45/263 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G++   ++  +K+ G     K ++   ++  + Q L  E  + R+L+HPNIVR +D I  
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 59  QEENYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCH--SNG--- 109
           +     Y+V +   GG+L   I      R++  E      + Q+  ++  CH  S+G   
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA---------------------------IEV 142
           V+HRDLKP N+ L  K     VKL DFGLA                           +  
Sbjct: 137 VLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 143 QGEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             +   W  G +LY L    PPF    Q  L  +I+ G +      +   + E   +I +
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY---SDELNEIITR 250
Query: 202 MLTVNPSKRITASEALKHPWICQ 224
           ML +    R +  E L++P I +
Sbjct: 251 MLNLKDYHRPSVEEILENPLILE 273

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/68 (36%), Positives = 35/68 (51%)
Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
            S  + F GTP Y+SPE + +  Y +  DIW+ G +LY L    PPF    Q  L  +I+
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229
Query: 312 AGAYDDEP 319
            G +   P
Sbjct: 230 EGKFRRIP 237

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 45/263 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G++   ++  +K+ G     K ++   ++  + Q L  E  + R+L+HPNIVR +D I  
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 59  QEENYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCH--SNG--- 109
           +     Y+V +   GG+L   I      R++  E      + Q+  ++  CH  S+G   
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA---------------------------IEV 142
           V+HRDLKP N+ L  K     VKL DFGLA                           +  
Sbjct: 137 VLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 193
Query: 143 QGEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
             +   W  G +LY L    PPF    Q  L  +I+ G +      +   + E   +I +
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY---SDELNEIITR 250
Query: 202 MLTVNPSKRITASEALKHPWICQ 224
           ML +    R +  E L++P I +
Sbjct: 251 MLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/68 (36%), Positives = 35/68 (51%)
Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
            S  + F GTP Y+SPE + +  Y +  DIW+ G +LY L    PPF    Q  L  +I+
Sbjct: 170 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229
Query: 312 AGAYDDEP 319
            G +   P
Sbjct: 230 EGKFRRIP 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 48/276 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K+T   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G +HRD+KP+N
Sbjct: 140 DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 198
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 199 MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV LY +LVG  PF+ +     Y++I         P+ + ++ EAKNLI   LT  
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 315
Query: 207 PSK--RITASEALKH--------PWICQRERVASIV 232
             +  R    E  +H         W   R+ VA +V
Sbjct: 316 EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 351

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 36/70 (51%), Gaps = 12/70 (17%)
Query: 259 AGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
            GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  PF        YA    G 
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--------YADSLVGT 281
Query: 315 YDDEPKHKSA 324
           Y     HK++
Sbjct: 282 YSKIMNHKNS 291

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 48/276 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K+T   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 144
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G +HRD+KP+N
Sbjct: 145 DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 204 MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV LY +LVG  PF+ +     Y++I         P+ + ++ EAKNLI   LT  
Sbjct: 261 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 320
Query: 207 PSK--RITASEALKH--------PWICQRERVASIV 232
             +  R    E  +H         W   R+ VA +V
Sbjct: 321 EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 356

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 36/70 (51%), Gaps = 12/70 (17%)
Query: 259 AGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
            GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  PF        YA    G 
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--------YADSLVGT 286
Query: 315 YDDEPKHKSA 324
           Y     HK++
Sbjct: 287 YSKIMNHKNS 296

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 48/276 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    K+T   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 144
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G +HRD+KP+N
Sbjct: 145 DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 204 MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV LY +LVG  PF+ +     Y++I         P+ + ++ EAKNLI   LT  
Sbjct: 261 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 320
Query: 207 PSK--RITASEALKH--------PWICQRERVASIV 232
             +  R    E  +H         W   R+ VA +V
Sbjct: 321 EVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 356

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 36/70 (51%), Gaps = 12/70 (17%)
Query: 259 AGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
            GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  PF        YA    G 
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--------YADSLVGT 286
Query: 315 YDDEPKHKSA 324
           Y     HK++
Sbjct: 287 YSKIMNHKNS 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 73/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A   I     +        RE  + ++L HPNIV+L D I  
Sbjct: 14  GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 74  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 134 LLINTE---GAIKLADFGLA 150

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 73/140 (52%), Gaps = 4/140 (2%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A   I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 61  ENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132
Query: 120 LLLASKAKGAAVKLADFGLA 139
           LL+ ++    A+KLADFGLA
Sbjct: 133 LLINTE---GAIKLADFGLA 149

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 89
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HR++K +N+
Sbjct: 90  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNI 148
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------W-------------------FGV 152
           LL       +VKL DFG   ++  EQ           W                    G+
Sbjct: 149 LLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 205
Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 206 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRG 263
Query: 212 TASEALKHPWI 222
           +A E ++H ++
Sbjct: 264 SAKELIQHQFL 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 38/62 (61%)
Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F A+   + S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+ 
Sbjct: 163 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 222
Query: 304 HR 305
            R
Sbjct: 223 LR 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPN-IVRLHDSI 58
           G+F  V    +K T   +A KI+     +   D +    E R+   L  P  + +LH   
Sbjct: 30  GSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCF 89
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V + V GG+L   I     + E  A     +I   +   H  G+++RDLK +
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLD 149
Query: 119 NLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW--F 150
           N++L S+     +K+ADFG+                          A +  G+   W  +
Sbjct: 150 NVMLDSEGH---IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAY 206
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L G PPF  ED+  L+  I      YP     +++ EA ++   ++T +P+KR
Sbjct: 207 GVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPAKR 262
Query: 211 I 211
           +
Sbjct: 263 L 263

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 31/59 (52%), Positives = 42/59 (71%), Gaps = 1/59 (1%)
Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           V+TR+ F GTP Y++PE++  +PYGK VD WA GV+LY +L G PPF  ED+  L+  I
Sbjct: 175 VTTRE-FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 232

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 106/241 (43%), Gaps = 62/241 (25%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ- 96
           RE  + ++L HPNIV L D I  E    LVF+ +      + ++        D+   I  
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYL 125
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----IEVQGEQQA--- 148
            Q+L  V HCH + ++HRDLKP+NLL+ S     A+KLADFGLA    I V+        
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 149 -WF---------------------GVILYILLVGYPPF---WDEDQ------------HR 171
            W+                     G I   ++ G P F    D+DQ             R
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 172 LYAQI------KAGAYD-YPSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHP 220
            + Q+      K   +  +    W ++ P    E  +L++ ML  +P+KRI+A +A+ HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 221 W 221
           +
Sbjct: 303 Y 303

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 106/241 (43%), Gaps = 62/241 (25%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ- 96
           RE  + ++L HPNIV L D I  E    LVF+ +      + ++        D+   I  
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYL 125
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----IEVQGEQQA--- 148
            Q+L  V HCH + ++HRDLKP+NLL+ S     A+KLADFGLA    I V+        
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 149 -WF---------------------GVILYILLVGYPPF---WDEDQ------------HR 171
            W+                     G I   ++ G P F    D+DQ             R
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 172 LYAQI------KAGAYD-YPSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHP 220
            + Q+      K   +  +    W ++ P    E  +L++ ML  +P+KRI+A +A+ HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 221 W 221
           +
Sbjct: 303 Y 303

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 41/245 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH----PNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 199 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 258
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 259 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 318
Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------------------QAWF- 150
           P N+LL        V+++D GLA +   ++                           WF 
Sbjct: 319 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 375
Query: 151 -GVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 376 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 431
Query: 207 PSKRI 211
            ++R+
Sbjct: 432 VNRRL 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 41/245 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH----PNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319
Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------------------QAWF- 150
           P N+LL        V+++D GLA +   ++                           WF 
Sbjct: 320 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 151 -GVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 432
Query: 207 PSKRI 211
            ++R+
Sbjct: 433 VNRRL 437

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 41/245 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL----QHPNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319
Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------------------QAWF- 150
           P N+LL        V+++D GLA +   ++                           WF 
Sbjct: 320 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 151 -GVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 432
Query: 207 PSKRI 211
            ++R+
Sbjct: 433 VNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 41/245 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL----QHPNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L    RI   L      P IV +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319
Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------------------QAWF- 150
           P N+LL        V+++D GLA +   ++                           WF 
Sbjct: 320 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 151 -GVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF     +D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 432
Query: 207 PSKRI 211
            ++R+
Sbjct: 433 VNRRL 437

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 115/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       +GL+ A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 62  GAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 121
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 122 ATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 179
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 180 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIW 236
Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAYDYPSPE--- 187
             G I+  LL G   F   D      QI                  +A  Y    P+   
Sbjct: 237 SVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPK 296
Query: 188 ------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
                 +    P A +L+ +ML ++  KRITASEAL HP+  Q
Sbjct: 297 RNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K T +  AAK+I+TK  S  + +    E  I     HPNIV+L D+   
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           EN  +++ +   GG +  D V  E     +E+      +Q L+++N+ H N ++HRDLK 
Sbjct: 106 ENNLWILIEFCAGGAV--DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQ---AWFGVILYILLVGYPPFWDEDQHRLYA 174
            N+L         +KLADFG++ +     Q   ++ G           P+W   +  +  
Sbjct: 164 GNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGT----------PYWMAPEVVMCE 210
Query: 175 QIKAGAYDYPSPEW 188
             K   YDY +  W
Sbjct: 211 TSKDRPYDYKADVW 224

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K T +  AAK+I+TK  S  + +    E  I     HPNIV+L D+   
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           EN  +++ +   GG +  D V  E     +E+      +Q L+++N+ H N ++HRDLK 
Sbjct: 106 ENNLWILIEFCAGGAV--DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQ---AWFGVILYILLVGYPPFWDEDQHRLYA 174
            N+L         +KLADFG++ +     Q   ++ G           P+W   +  +  
Sbjct: 164 GNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGT----------PYWMAPEVVMCE 210
Query: 175 QIKAGAYDYPSPEW 188
             K   YDY +  W
Sbjct: 211 TSKDRPYDYKADVW 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 36  LEREARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGG--ELFEDIVAREF-YSEAD 90
           +++E ++ R+L+H N+++L D +  +E+   Y+V +    G  E+ + +  + F   +A 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 91  ASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-------- 142
              C  Q+++ + + HS G+VH+D+KP NLLL +   G  +K++  G+A  +        
Sbjct: 113 GYFC--QLIDGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDT 167
Query: 143 ----QGEQ-------------------QAWF-GVILYILLVGYPPFWDEDQHRLYAQIKA 178
               QG                       W  GV LY +  G  PF  ++ ++L+  I  
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227
Query: 179 GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           G+Y  P        P   +L+  ML   P+KR +  +  +H W 
Sbjct: 228 GSYAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 55/139 (39%), Gaps = 24/139 (17%)
Query: 199 INQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKK-----FNARRKLKVS 253
           + +ML   P KR    +A  H + CQ       +H Q  V    K           LK+S
Sbjct: 94  MQEMLDSVPEKRFPVCQA--HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKIS 151
Query: 254 ---------------TRQGFAGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYP 296
                          T +   G+P +  PE+        G  VDIW+ GV LY +  G  
Sbjct: 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211
Query: 297 PFWDEDQHRLYAQIKAGAY 315
           PF  ++ ++L+  I  G+Y
Sbjct: 212 PFEGDNIYKLFENIGKGSY 230

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 48/276 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V+    KA+   +A K+++  ++  R       E R I      P +V+L  + Q
Sbjct: 86  GAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 145
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y Y+V + + GG+L  ++++     E  A     +++ +++  HS G++HRD+KP+N
Sbjct: 146 DDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 204
Query: 120 LLLASKAKGAAVKLADFGLAIEVQ-------------------------------GEQQA 148
           +LL    K   +KLADFG  +++                                G +  
Sbjct: 205 MLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECD 261
Query: 149 WF--GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W+  GV L+ +LVG  PF+ +     Y++I         PE   ++  AKNLI   LT  
Sbjct: 262 WWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDR 321
Query: 207 PSK--RITASEALKHP--------WICQRERVASIV 232
             +  R    E  +HP        W   RE  A +V
Sbjct: 322 EVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVV 357

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/69 (40%), Positives = 36/69 (52%), Gaps = 12/69 (17%)
Query: 260 GTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP Y+SPEVLK +     YG+  D W+ GV L+ +LVG  PF        YA    G Y
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--------YADSLVGTY 288
Query: 316 DDEPKHKSA 324
                HK++
Sbjct: 289 SKIMDHKNS 297

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 32/164 (19%)
Query: 33  FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS 92
            ++ ERE     +L H NIV + D  +E++ +YLV + + G  L E I +    S   A 
Sbjct: 55  LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI 114
Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA------------- 139
           +   QIL+ + H H   +VHRD+KP+N+L+ S      +K+ DFG+A             
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDS---NKTLKIFDFGIAKALSETSLTQTNH 171
Query: 140 ----IEVQGEQQA------------WFGVILYILLVGYPPFWDE 167
               ++    +QA              G++LY +LVG PPF  E
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 26/42 (61%)
Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           GT  Y SPE  K E   +  DI++ G++LY +LVG PPF  E
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K T +  AAK+I+TK  S  + +    E  I     HPNIV+L D+   
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           EN  +++ +   GG +  D V  E     +E+      +Q L+++N+ H N ++HRDLK 
Sbjct: 106 ENNLWILIEFCAGGAV--DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+L         +KLADFG++
Sbjct: 164 GNILFTLDGD---IKLADFGVS 182

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 40/203 (19%)
Query: 48  HPNIVRLHDSIQEENYHYLVFDL-VTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           HP ++RL D  + +    LV +  +   +LF+ I  +    E  +     Q++ ++ HCH
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------- 150
           S GVVHRD+K EN+L+  + +G A KL DFG    +  E    F                
Sbjct: 157 SRGVVHRDIKDENILIDLR-RGCA-KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQ 214
Query: 151 -----------GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
                      G++LY ++ G  PF + DQ  L A++   A+         V+P+   LI
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPF-ERDQEILEAELHFPAH---------VSPDCCALI 264
Query: 200 NQMLTVNPSKRITASEALKHPWI 222
            + L   PS R +  E L  PW+
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDXE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 38/251 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICR-KLQHPNIVRLHDSI 58
           G+F  V     K T   FA K +     L   D +    E R+     +HP +  +  + 
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q +   + V + + GG+L   I +   +  + A+    +I+  +   HS G+V+RDLK +
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA-------------------------W--F 150
           N+LL    K   +K+ADFG+  E + G+ +                          W  F
Sbjct: 148 NILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSF 204
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L+G  PF  +D+  L+  I+     Y  P W  +  EAK+L+ ++    P KR
Sbjct: 205 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRW--LEKEAKDLLVKLFVREPEKR 260
Query: 211 ITASEALK-HP 220
           +     ++ HP
Sbjct: 261 LGVRGDIRQHP 271

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 35/54 (64%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           F GTP Y++PE+L  + Y   VD W+ GV+LY +L+G  PF  +D+  L+  I+
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 94
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 95  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +   ++   +K+ DFGLA     E        W+                   
Sbjct: 153 LKPSNLAVNEDSE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 38/251 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICR-KLQHPNIVRLHDSI 58
           G+F  V     K T   FA K +     L   D +    E R+     +HP +  +  + 
Sbjct: 29  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 88
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q +   + V + + GG+L   I +   +  + A+    +I+  +   HS G+V+RDLK +
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA-------------------------W--F 150
           N+LL    K   +K+ADFG+  E + G+ +                          W  F
Sbjct: 149 NILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSF 205
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L+G  PF  +D+  L+  I+     Y  P W  +  EAK+L+ ++    P KR
Sbjct: 206 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRW--LEKEAKDLLVKLFVREPEKR 261
Query: 211 ITASEALK-HP 220
           +     ++ HP
Sbjct: 262 LGVRGDIRQHP 272

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 35/54 (64%)
Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           F GTP Y++PE+L  + Y   VD W+ GV+LY +L+G  PF  +D+  L+  I+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 79/148 (53%), Gaps = 21/148 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKL-----EREARICRKLQHPNIVRLH 55
           G++ +V +C  K TG     +I+  KK    D  K+      RE ++ ++L+H N+V L 
Sbjct: 36  GSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESVNHCHSNGVV 111
           +  +++   YLVF+ V    + +D+   E +        +Q    QI+  +  CHS+ ++
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRD+KPEN+L+   ++   VKL DFG A
Sbjct: 147 HRDIKPENILV---SQSGVVKLCDFGFA 171

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 98
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 99  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +   ++   +K+ DFGLA     E        W+                   
Sbjct: 157 LKPSNLAVNEDSE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 86/298 (28%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH- 55
           GA+ VV     K TG     +I+  KK+   D      +  RE +I +  +H NI+ +  
Sbjct: 22  GAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 56  ----DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
               DS +  N  Y++ +L+        +++ +  S+    + I Q L +V   H + V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA----------IEVQGEQQA--------WF--- 150
           HRDLKP NLL+ S      +K+ DFGLA           E  G+Q          W+   
Sbjct: 135 HRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 151 ------------------GVILYILLVGYPPFWDED-QHRL---YAQIKAGAYD------ 182
                             G IL  L +  P F   D +H+L   +  I     D      
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 183 --------------YPSPEWDT----VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                         YP+   +     V P+  +L+ +ML  +P+KRITA EAL+HP++
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 86/298 (28%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH- 55
           GA+ VV     K TG     +I+  KK+   D      +  RE +I +  +H NI+ +  
Sbjct: 22  GAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 56  ----DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
               DS +  N  Y++ +L+        +++ +  S+    + I Q L +V   H + V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA----------IEVQGEQQA--------WF--- 150
           HRDLKP NLL+ S      +K+ DFGLA           E  G+Q          W+   
Sbjct: 135 HRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 151 ------------------GVILYILLVGYPPFWDED-QHRL---YAQIKAGAYD------ 182
                             G IL  L +  P F   D +H+L   +  I     D      
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 183 --------------YPSPEWDT----VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                         YP+   +     V P+  +L+ +ML  +P+KRITA EAL+HP++
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 86/298 (28%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH- 55
           GA+ VV     K TG     +I+  KK+   D      +  RE +I +  +H NI+ +  
Sbjct: 22  GAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 56  ----DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
               DS +  N  Y++ +L+        +++ +  S+    + I Q L +V   H + V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA----------IEVQGEQQA--------WF--- 150
           HRDLKP NLL+ S      +K+ DFGLA           E  G+Q          W+   
Sbjct: 135 HRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 151 ------------------GVILYILLVGYPPFWDED-QHRL---YAQIKAGAYD------ 182
                             G IL  L +  P F   D +H+L   +  I     D      
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 183 --------------YPSPEWDT----VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                         YP+   +     V P+  +L+ +ML  +P+KRITA EAL+HP++
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 104
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 105 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 163 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 97
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 98  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 156 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 53  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 112
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 113 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 171 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 287
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 115
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 116 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 173
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 174 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 230
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 231 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 290
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 291 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 31  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 90
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 91  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 148
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 149 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 206 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 265
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 266 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 52  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 111
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 112 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 170 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 227 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 286
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 287 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 104
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 105 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 163 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 115
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 116 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 173
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 174 LKPSNLAVNEDCE---LKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIW 230
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 231 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 290
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 291 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +   ++   +K+ DFGL      E        W+                   
Sbjct: 151 LKPSNLAVNEDSE---LKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 104
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 105 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 163 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 103
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 104 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 161
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 162 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 219 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 278
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 279 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 103
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 104 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 161
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 162 LKPSNLAVNEDXE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 219 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 278
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 279 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 100 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 158 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 94
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 95  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 153 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 89
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 90  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 148 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 205 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 264
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 265 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 89  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 147 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 94
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 95  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 153 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 89
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 90  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 148 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 205 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 264
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 265 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 94
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 95  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 153 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 98
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 99  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 157 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 98
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 99  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 157 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 97
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 98  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 156 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 32  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 91
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 92  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 149
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 150 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 206
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 207 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 266
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 267 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 97
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 98  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 156 LKPSNLAVNEDXE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 77/287 (26%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE----REARICRKLQHPNIVRLHD 56
           G++ VV +C  + TG   A K    K L + D   ++    RE R+ ++L+HPN+V L +
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESVNHCHSNGVVH 112
             + +   +LVF+      L E     + Y      H ++    Q L++VN CH +  +H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHE----LDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ--------AWF-------------- 150
           RD+KPEN+L+    K + +KL DFG A  + G            W+              
Sbjct: 126 RDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 151 -------GVILYILLVGYPPFW--DEDQHRLYAQIKA------------------GAYDY 183
                  G +   LL G  P W    D  +LY   K                        
Sbjct: 183 PVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 184 PSPE--------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           P PE        +  ++  A  L+   L ++P++R+T  + L HP+ 
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 100 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 158 LKPSNLAVNEDCE---LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 97
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 98  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 156 LKPSNLAVNEDXE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 100 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 158 LKPSNLAVNEDCE---LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 100 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 158 LKPSNLAVNEDCE---LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARI-CRKLQHPNIVRLHDSI 58
           G+F  V    +K T   +A KI+     +   D +    E R+     + P + +LH   
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V + V GG+L   I     + E  A     +I   +    S G+++RDLK +
Sbjct: 91  QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 119 NLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW--F 150
           N++L S+     +K+ADFG+                          A +  G+   W  F
Sbjct: 151 NVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L G  PF  ED+  L+  I      YP     +++ EA  +   ++T +P KR
Sbjct: 208 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKR 263
Query: 211 I 211
           +
Sbjct: 264 L 264

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/57 (49%), Positives = 38/57 (66%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T + F GTP Y++PE++  +PYGK VD WA GV+LY +L G  PF  ED+  L+  I
Sbjct: 177 TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARI-CRKLQHPNIVRLHDSI 58
           G+F  V    +K T   +A KI+     +   D +    E R+     + P + +LH   
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V + V GG+L   I     + E  A     +I   +    S G+++RDLK +
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 119 NLLLASKAKGAAVKLADFGL--------------------------AIEVQGEQQAW--F 150
           N++L S+     +K+ADFG+                          A +  G+   W  F
Sbjct: 472 NVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L G  PF  ED+  L+  I      YP     +++ EA  +   ++T +P KR
Sbjct: 529 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKR 584
Query: 211 I 211
           +
Sbjct: 585 L 585

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 28/57 (49%), Positives = 38/57 (66%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           T + F GTP Y++PE++  +PYGK VD WA GV+LY +L G  PF  ED+  L+  I
Sbjct: 498 TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 65/281 (23%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V   + K +G + A K ++    S    ++  RE  + + +QH N++ L D    
Sbjct: 53  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++     YLV   +      + I+  EF SE    + + Q+L+ + + HS GVVHRD
Sbjct: 113 ASSLRNFYDFYLVMPFMQTD--LQKIMGMEF-SEEKIQYLVYQMLKGLKYIHSAGVVHRD 169
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 170 LKPGNLAVNEDCE---LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 226
Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAYDYPSPE--- 187
             G I+  +L G   F  +D      QI                   A +Y    P+   
Sbjct: 227 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 286
Query: 188 ------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                 +   +P+A +L+ +ML ++  KR+TA++AL HP+ 
Sbjct: 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 102/252 (40%), Gaps = 70/252 (27%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVFDLVTGG-ELFEDIVAREFYSE 88
           RE  + R+L+   HPN+VRL D         E    LVF+ V      + D         
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
                 ++Q L  ++  H+N +VHRDLKPEN+L+ S   G  VKLADFGLA  +   Q A
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLA-RIYSYQMA 167
Query: 149 WFGVILYIL-------------------------------------------------LV 159
            F V++ +                                                  L+
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 160 GYPPFWDEDQHRLYAQIKAGAYDYPSPE-WDTVTPEAK----NLINQMLTVNPSKRITAS 214
           G PP   ED       +  GA+    P    +V PE +     L+ +MLT NP KRI+A 
Sbjct: 228 GLPP---EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 284
Query: 215 EALKHPWICQRE 226
            AL+H ++ + E
Sbjct: 285 RALQHSYLHKDE 296

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ D+GLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 10/166 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAFS V     K TG  +A KI+N   +  R      RE R +        I +LH + Q
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131
Query: 60  EENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +ENY YLV +   GG+L   +    E      A   + +I+ +++  H  G VHRD+KP+
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPF 164
           N+LL    +   ++LADFG  ++++ +     G +  ++ VG P +
Sbjct: 192 NILL---DRCGHIRLADFGSCLKLRAD-----GTVRSLVAVGTPDY 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 26/150 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +  Q   G  FA K I  +K          RE  I ++L+H NIV+L+D I  
Sbjct: 13  GTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 61  ENYHYLVF-----------DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           +    LVF           D+  GG   E + A+ F         + Q+L  + +CH   
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSF---------LLQLLNGIAYCHDRR 120
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           V+HRDLKP+NLL+  + +   +K+ADFGLA
Sbjct: 121 VLHRDLKPQNLLINREGE---LKIADFGLA 147

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 26/150 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +  Q   G  FA K I  +K          RE  I ++L+H NIV+L+D I  
Sbjct: 13  GTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 61  ENYHYLVF-----------DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           +    LVF           D+  GG   E + A+ F         + Q+L  + +CH   
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSF---------LLQLLNGIAYCHDRR 120
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           V+HRDLKP+NLL+  + +   +K+ADFGLA
Sbjct: 121 VLHRDLKPQNLLINREGE---LKIADFGLA 147

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 26/150 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +  Q   G  FA K I  +K          RE  I ++L+H NIV+L+D I  
Sbjct: 13  GTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 61  ENYHYLVF-----------DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           +    LVF           D+  GG   E + A+ F         + Q+L  + +CH   
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSF---------LLQLLNGIAYCHDRR 120
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           V+HRDLKP+NLL+  + +   +K+ADFGLA
Sbjct: 121 VLHRDLKPQNLLINREGE---LKIADFGLA 147

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 78/250 (31%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLV----------TGGELFEDIVAREFYS 87
           RE  + ++L+H NIVRLHD +  +    LVF+              G+L  +IV    + 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF- 108
Query: 88  EADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----IEVQ 143
                    Q+L+ +  CHS  V+HRDLKP+NLL+    +   +KLA+FGLA    I V+
Sbjct: 109 ---------QLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156
Query: 144 G-----------EQQAWFGVILYILLV---------------GYPPF----WDEDQHRLY 173
                            FG  LY   +               G P F     D+   R++
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 174 AQIKAGAY----------DY-PSPEWDTVTP----------EAKNLINQMLTVNPSKRIT 212
             +               DY P P +   T             ++L+  +L  NP +RI+
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 213 ASEALKHPWI 222
           A EAL+HP+ 
Sbjct: 277 AEEALQHPYF 286

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 112
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 113 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 171 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 287
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 52  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 111
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 112 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 170 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 227 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 286
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 287 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+  FGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 89  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 147 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 112
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 113 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 171 LKPSNLAVNEDCE---LKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 287
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 65/281 (23%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V   + K +G + A K ++    S    ++  RE  + + +QH N++ L D    
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++     YLV   +      + I+  +F SE    + + Q+L+ + + HS GVVHRD
Sbjct: 95  ASSLRNFYDFYLVMPFMQTD--LQKIMGLKF-SEEKIQYLVYQMLKGLKYIHSAGVVHRD 151
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 152 LKPGNLAVNEDCE---LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208
Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAYDYPSPE--- 187
             G I+  +L G   F  +D      QI                   A +Y    P+   
Sbjct: 209 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268
Query: 188 ------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                 +   +P+A +L+ +ML ++  KR+TA++AL HP+ 
Sbjct: 269 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    YLV  L+ G +L++ ++  +  S 
Sbjct: 86  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYK-LLKTQHLSN 143
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDH 200
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 261 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 320
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 321 RIEVEQALAHPYLEQ 335

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 43  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 102
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 103 ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 160
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 161 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 217
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 218 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 277
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 278 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 107/257 (41%), Gaps = 57/257 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           F  + +  K++    F   +RE ++ R+  +HPN++R   + ++  + Y+  +L      
Sbjct: 46  FDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--- 102
Query: 77  FEDIVAREFYSEADASHC-------IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGA 129
                 +E+  + D +H        +QQ    + H HS  +VHRDLKP N+L++      
Sbjct: 103 ----TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158
Query: 130 AVK--LADFGLAIEVQGEQ------------QAWFG-----------------------V 152
            +K  ++DFGL  ++   +            + W                         V
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKNLINQMLTVNPSKR 210
             Y++  G  PF    Q +    + A + D  +P    D +   A+ LI +M+ ++P KR
Sbjct: 219 FYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI---ARELIEKMIAMDPQKR 275
Query: 211 ITASEALKHPWICQRER 227
            +A   LKHP+    E+
Sbjct: 276 PSAKHVLKHPFFWSLEK 292

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 89  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 147 LKPSNLAVNEDCE---LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 62/267 (23%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TG   AAK+I TK  S  + +    E  I     HP IV+L  +   
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +   +++ +   GG +  D +  E     +E       +Q+LE++N  HS  ++HRDLK 
Sbjct: 88  DGKLWIMIEFCPGGAV--DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145
Query: 118 ENLLLASKAKGAAVKLADFGLA---IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYA 174
            N+L+  +     ++LADFG++   ++   ++ ++ G           P+W   +  +  
Sbjct: 146 GNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGT----------PYWMAPEVVMCE 192
Query: 175 QIKAGAYDYPSPEWD----------------------------------TVTP-----EA 195
            +K   YDY +  W                                    +TP     E 
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 196 KNLINQMLTVNPSKRITASEALKHPWI 222
           ++ +   L  NP  R +A++ L+HP++
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 39  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 98
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 99  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 157 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 273
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 62/267 (23%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TG   AAK+I TK  S  + +    E  I     HP IV+L  +   
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH 79
Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +   +++ +   GG +  D +  E     +E       +Q+LE++N  HS  ++HRDLK 
Sbjct: 80  DGKLWIMIEFCPGGAV--DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 137
Query: 118 ENLLLASKAKGAAVKLADFGLA---IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYA 174
            N+L+  +     ++LADFG++   ++   ++ ++ G           P+W   +  +  
Sbjct: 138 GNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGT----------PYWMAPEVVMCE 184
Query: 175 QIKAGAYDYPSPEWD----------------------------------TVTP-----EA 195
            +K   YDY +  W                                    +TP     E 
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 244
Query: 196 KNLINQMLTVNPSKRITASEALKHPWI 222
           ++ +   L  NP  R +A++ L+HP++
Sbjct: 245 RDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ D GLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ D GLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 115/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV     ++      I QIL  + + HS  ++HRD
Sbjct: 89  ARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA     E        W+                   
Sbjct: 147 LKPSNLAVNEDCE---LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ D GLA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 101/252 (40%), Gaps = 70/252 (27%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVFDLVTGG-ELFEDIVAREFYSE 88
           RE  + R+L+   HPN+VRL D         E    LVF+ V      + D         
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
                 ++Q L  ++  H+N +VHRDLKPEN+L+ S   G  VKLADFGLA  +   Q A
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLA-RIYSYQMA 175
Query: 149 WFGVILYIL-------------------------------------------------LV 159
              V++ +                                                  L+
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 160 GYPPFWDEDQHRLYAQIKAGAYDYPSPE-WDTVTPEAK----NLINQMLTVNPSKRITAS 214
           G PP   ED       +  GA+    P    +V PE +     L+ +MLT NP KRI+A 
Sbjct: 236 GLPP---EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 215 EALKHPWICQRE 226
            AL+H ++ + E
Sbjct: 293 RALQHSYLHKDE 304

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 101/252 (40%), Gaps = 70/252 (27%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVFDLVTGG-ELFEDIVAREFYSE 88
           RE  + R+L+   HPN+VRL D         E    LVF+ V      + D         
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
                 ++Q L  ++  H+N +VHRDLKPEN+L+ S   G  VKLADFGLA  +   Q A
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLA-RIYSYQMA 167
Query: 149 WFGVILYIL-------------------------------------------------LV 159
              V++ +                                                  L+
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 160 GYPPFWDEDQHRLYAQIKAGAYDYPSPE-WDTVTPEAK----NLINQMLTVNPSKRITAS 214
           G PP   ED       +  GA+    P    +V PE +     L+ +MLT NP KRI+A 
Sbjct: 228 GLPP---EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 284
Query: 215 EALKHPWICQRE 226
            AL+H ++ + E
Sbjct: 285 RALQHSYLHKDE 296

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 106/246 (43%), Gaps = 52/246 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K T   +A KI+N  ++  R      RE R +        I  LH + Q
Sbjct: 101 GAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQ 160
Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +EN+ YLV D   GG+L      FED +  +      A   I +++ +++  H    VHR
Sbjct: 161 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM-----ARFYIGEMVLAIDSIHQLHYVHR 215
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------------ 143
           D+KP+N+LL        ++LADFG  +++                               
Sbjct: 216 DIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 144 --GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKN 197
             G +  W+  GV +Y +L G  PF+ E     Y +I      + +PS   D V+ EAK+
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD-VSEEAKD 331
Query: 198 LINQML 203
           LI +++
Sbjct: 332 LIQRLI 337

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 5/57 (8%)
Query: 259 AGTPGYLSPEVLKKEP-----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            GTP Y+SPE+L+        YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 309

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 106/246 (43%), Gaps = 52/246 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K T   +A KI+N  ++  R      RE R +        I  LH + Q
Sbjct: 85  GAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQ 144
Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +EN+ YLV D   GG+L      FED +  +      A   I +++ +++  H    VHR
Sbjct: 145 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM-----ARFYIGEMVLAIDSIHQLHYVHR 199
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------------ 143
           D+KP+N+LL        ++LADFG  +++                               
Sbjct: 200 DIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 144 --GEQQAWF--GVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKN 197
             G +  W+  GV +Y +L G  PF+ E     Y +I      + +PS   D V+ EAK+
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD-VSEEAKD 315
Query: 198 LINQML 203
           LI +++
Sbjct: 316 LIQRLI 321

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 5/57 (8%)
Query: 259 AGTPGYLSPEVLKKEP-----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            GTP Y+SPE+L+        YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 98/250 (39%), Gaps = 78/250 (31%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLV----------TGGELFEDIVAREFYS 87
           RE  + ++L+H NIVRLHD +  +    LVF+              G+L  +IV    + 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF- 108
Query: 88  EADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA----IEVQ 143
                    Q+L+ +  CHS  V+HRDLKP+NLL+    +   +KLADFGLA    I V+
Sbjct: 109 ---------QLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR 156
Query: 144 G-----------EQQAWFGVILYILLVGY---------------PPFWDEDQHRLYAQIK 177
                            FG  LY   +                 P F   D      +I 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIF 216
Query: 178 AGAYDYPSPEWDTVT-----------PEAKNLIN--------------QMLTVNPSKRIT 212
                    +W ++T           P   +L+N               +L  NP +RI+
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 213 ASEALKHPWI 222
           A EAL+HP+ 
Sbjct: 277 AEEALQHPYF 286

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I    +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 68  QRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 125
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 182
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 243 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 302
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 303 RIEVEQALAHPYLAQ 317

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 68  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 125
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 182
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 243 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 302
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 303 RIEVEQALAHPYLEQ 317

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 123
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 180
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 241 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 300
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 301 RIEVEQALAHPYLEQ 315

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I    +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 68  QRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 125
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL + +    +K+ DFGLA         
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDH 182
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 243 LGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 302
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 303 RIEVEQALAHPYLAQ 317

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 86  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 143
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 200
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 261 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 320
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 321 RIEVEQALAHPYLEQ 335

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 64  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 121
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 178
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 239 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 298
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 299 RIEVEQALAHPYLEQ 313

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 123
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDH 180
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 241 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 300
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 301 RIEVEQALAHPYLEQ 315

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 101/252 (40%), Gaps = 70/252 (27%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVFDLVTGG-ELFEDIVAREFYSE 88
           RE  + R+L+   HPN+VRL D         E    LVF+ V      + D         
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
                 ++Q L  ++  H+N +VHRDLKPEN+L+ S   G  VKLADFGLA  +   Q A
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLA-RIYSYQMA 167
Query: 149 WFGVILYIL-------------------------------------------------LV 159
              V++ +                                                  L+
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 160 GYPPFWDEDQHRLYAQIKAGAYDYPSPE-WDTVTPEAK----NLINQMLTVNPSKRITAS 214
           G PP   ED       +  GA+    P    +V PE +     L+ +MLT NP KRI+A 
Sbjct: 228 GLPP---EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 284
Query: 215 EALKHPWICQRE 226
            AL+H ++ + E
Sbjct: 285 RALQHSYLHKDE 296

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 123
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDH 180
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 241 LGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 300
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 301 RIEVEQALAHPYLEQ 315

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 64  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 121
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 178
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 239 LGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 298
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 299 RIEVEQALAHPYLEQ 313

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 74  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 131
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 132 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 188
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 189 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 248
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 249 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 308
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 309 RIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 123
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 180
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 241 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 300
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 301 RIEVEQALAHPYLEQ 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 123
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDH 180
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 241 LGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 300
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 301 RIEVEQALAHPYLEQ 315

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 71  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 128
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 185
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 186 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 246 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 305
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 306 RIEVEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 72  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 129
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 130 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 186
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 187 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 247 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 306
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 307 RIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 63  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 120
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 121 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 177
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 178 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 238 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 297
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 298 RIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 64/281 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V   V   TG + A K +     S    ++  RE R+ + ++H N++ L D    
Sbjct: 36  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             ++ +    YLV   +  G     ++  E   E      + Q+L+ + + H+ G++HRD
Sbjct: 96  DETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 153
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DFGLA +   E        W+                   
Sbjct: 154 LKPGNLAVNEDCE---LKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIW 210
Query: 151 --GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAYDYPSPEWD- 189
             G I+  ++ G   F   D      +I                  +A  Y    PE + 
Sbjct: 211 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 270
Query: 190 --------TVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                     +P A NL+ +ML ++  +R+TA EAL HP+ 
Sbjct: 271 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 71/267 (26%)
Query: 23  INTKKLSARDFQKL------EREARICRKLQHPNIVRLHD------SIQEENYHYLVFDL 70
           +  KKLS R FQ L       RE R+ + L+H N++ L D      SI++ +  YLV  L
Sbjct: 56  VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +  G    +IV  +  S+      + Q+L  + + HS G++HRDLKP N+ +   ++   
Sbjct: 115 M--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE--- 169
Query: 131 VKLADFGLAIEVQGEQQA-----WF---------------------GVILYILLVGYPPF 164
           +++ DFGLA +   E        W+                     G I+  LL G   F
Sbjct: 170 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229
Query: 165 WDED---------------QHRLYAQIKAG-AYDY-----PSPEWDTVT------PEAKN 197
              D                  + A+I +  A  Y     P P+ D  +      P A +
Sbjct: 230 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAID 289
Query: 198 LINQMLTVNPSKRITASEALKHPWICQ 224
           L+ +ML ++  +R++A+EAL H +  Q
Sbjct: 290 LLGRMLVLDSDQRVSAAEALAHAYFSQ 316

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 19  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 76
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ + +    +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 77  RLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 136
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 137 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 194
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 195 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 244
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 245 LRPSDRPTFEEIQNHPWM 262

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 71  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 128
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 185
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 186 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 246 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 305
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 306 RIEVEQALAHPYLEQ 320

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 68/245 (27%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCI 95
           RE  + + L+H NIV LHD I  E    LVF+ +     +  +D       +  +    +
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFL 106
Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA---------------- 139
            Q+L  + +CH   V+HRDLKP+NLL+  + +   +KLADFGLA                
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVT 163
Query: 140 ------------IEVQGEQQAW-FGVILYILLVGYPPF----WDEDQHRLY--------- 173
                        +   +   W  G I Y +  G P F     +E  H ++         
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 174 ------AQIKAGAYDYP----------SPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
                 +  +   Y+YP          +P  D+   +  +L+ ++L      RI+A +A+
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDS---DGADLLTKLLQFEGRNRISAEDAM 280
Query: 218 KHPWI 222
           KHP+ 
Sbjct: 281 KHPFF 285

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 108/255 (42%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H N++ + D ++          Y+V DL+   +L++ + +++  S 
Sbjct: 86  QRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQL-SN 143
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ- 147
               + + QIL  + + HS  V+HRDLKP NLL+ +      +K+ DFGLA     E   
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDH 200
Query: 148 ----------AWF---------------------GVILYILLVGYPPF-----WDEDQHR 171
                      W+                     G IL  +L   P F      D+  H 
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTP----EAKNLINQMLTVNPSK 209
           L                +KA  Y    P      W  + P    +A +L+++MLT NP+K
Sbjct: 261 LGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNK 320
Query: 210 RITASEALKHPWICQ 224
           RIT  EAL HP++ Q
Sbjct: 321 RITVEEALAHPYLEQ 335

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKTQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA + V R   K TG  FA K+ N    L   D Q   RE  + +KL H NIV+L  +I+
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHKNIVKLF-AIE 76
Query: 60  EEN---YHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           EE    +  L+ +    G L+   E+        E++    ++ ++  +NH   NG+VHR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 114 DLKPENLLLASKAKGAAV-KLADFGLAIEVQGEQQ--AWFGVILYILLVGYPPFWDEDQH 170
           ++KP N++      G +V KL DFG A E++ ++Q  + +G   Y+    +P  ++    
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL----HPDMYERAVL 192
Query: 171 RLYAQIKAGA 180
           R   Q K GA
Sbjct: 193 RKDHQKKYGA 202

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 75/142 (52%), Gaps = 8/142 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           GA+ +V + + + TG   A K I     ++ D Q+  RE  I  +L  H NIV L + ++
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79
Query: 60  EENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            +N    YLVFD +        ++           + + Q+++ + + HS G++HRD+KP
Sbjct: 80  ADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+LL ++     VK+ADFGL+
Sbjct: 138 SNILLNAECH---VKVADFGLS 156

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           GA + V R   K TG  FA K+ N    L   D Q   RE  + +KL H NIV+L  +I+
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHKNIVKLF-AIE 76
Query: 60  EEN---YHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           EE    +  L+ +    G L+   E+        E++    ++ ++  +NH   NG+VHR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 114 DLKPENLLLASKAKGAAV-KLADFGLAIEVQGEQQ 147
           ++KP N++      G +V KL DFG A E++ ++Q
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 38/244 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G FS V R      G+  A K +    L  A+      +E  + ++L HPN+++ + S  
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 60  EENYHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+N   +V +L   G+L   I      +    E        Q+  ++ H HS  V+HRD+
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           KP N+ + +      VKL D GL      +  A                           
Sbjct: 163 KPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKA-GAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           W  G +LY +     PF+  D+  LY+  K     DYP    D  + E + L+N  +  +
Sbjct: 220 WSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 207 PSKR 210
           P KR
Sbjct: 279 PEKR 282

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 1/69 (1%)
Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           K +      GTP Y+SPE + +  Y    DIW+ G +LY +     PF+  D+  LY+  
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLC 247
Query: 311 KAGAYDDEP 319
           K     D P
Sbjct: 248 KKIEQCDYP 256

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 69/255 (27%)
Query: 34  QKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           Q+  RE +I  + +H NI+ ++D     +I++    Y+V DL+   +L++ ++  +  S 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYK-LLKCQHLSN 127
Query: 89  ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA--------- 139
               + + QIL  + + HS  V+HRDLKP NLLL +      +K+ DFGLA         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDH 184
Query: 140 -------------------IEVQGEQQA---W-FGVILYILLVGYPPF-----WDEDQHR 171
                              +  +G  ++   W  G IL  +L   P F      D+  H 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 172 L-------------YAQIKAGAYDYPSPE-----WDTVTPEAK----NLINQMLTVNPSK 209
           L                +KA  Y    P      W+ + P A     +L+++MLT NP K
Sbjct: 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304
Query: 210 RITASEALKHPWICQ 224
           RI   +AL HP++ Q
Sbjct: 305 RIEVEQALAHPYLEQ 319

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 72
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 73  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVL 132
Query: 112 HRDLKPENLLLASKAKGAAVKLADFG--------LAIEVQGEQ----------------- 146
           HRD+K EN+L+        +KL DFG        +  +  G +                 
Sbjct: 133 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 190
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 191 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSXECQHLIRWCLA 240
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 241 LRPSDRPTFEEIQNHPWM 258

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 66/288 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ- 59
           GA+ VV    ++ TG + A K I        + ++  RE +I +  +H NI+ + D ++ 
Sbjct: 65  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124
Query: 60  -----EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
                E    Y+V DL+   +L + I + +  +     + + Q+L  + + HS  V+HRD
Sbjct: 125 TVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD 183
Query: 115 LKPENLLLAS-----------------------------------KAKGAAVKLADFGLA 139
           LKP NLL+                                     +A    + L ++  A
Sbjct: 184 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA 243
Query: 140 I----------EVQGEQQAWFG------VILYILLVGYPP---FWDEDQHRLYAQIKAGA 180
           I          E+   +Q + G      + L ++++G P           R+ A I++  
Sbjct: 244 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP 303
Query: 181 YDYPSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              P P W+TV P    +A +L+ +ML   PS RI+A+ AL+HP++ +
Sbjct: 304 PRQPVP-WETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 71/267 (26%)
Query: 23  INTKKLSARDFQKL------EREARICRKLQHPNIVRLHD------SIQEENYHYLVFDL 70
           +  KKLS R FQ L       RE R+ + L+H N++ L D      SI++ +  YLV  L
Sbjct: 56  VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +  G    +IV  +  S+      + Q+L  + + HS G++HRDLKP N+ +   ++   
Sbjct: 115 M--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE--- 169
Query: 131 VKLADFGLAIEVQGEQQA-----WF---------------------GVILYILLVGYPPF 164
           +++ DFGLA +   E        W+                     G I+  LL G   F
Sbjct: 170 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229
Query: 165 WDED---------------QHRLYAQIKAG-AYDY-----PSPEWDTVT------PEAKN 197
              D                  + A+I +  A  Y     P P+ D  +      P A +
Sbjct: 230 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAID 289
Query: 198 LINQMLTVNPSKRITASEALKHPWICQ 224
           L+ +ML ++  +R++A+EAL H +  Q
Sbjct: 290 LLGRMLVLDSDQRVSAAEALAHAYFSQ 316

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 48/264 (18%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRL 54
           GAF  V   V K    E   K I  +K      +      K+  E  I  +++H NI+++
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 55  HDSIQEENYHYLVFDL-VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
            D  + + +  LV +   +G +LF  I       E  AS+  +Q++ +V +     ++HR
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ---------------------------GEQ 146
           D+K EN+++   A+   +KL DFG A  ++                            E 
Sbjct: 155 DIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211
Query: 147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
           + W  GV LY L+    PF +     L   ++A  +    P +  V+ E  +L++ +L  
Sbjct: 212 EMWSLGVTLYTLVFEENPFCE-----LEETVEAAIH----PPY-LVSKELMSLVSGLLQP 261
Query: 206 NPSKRITASEALKHPWICQRERVA 229
            P +R T  + +  PW+ Q   +A
Sbjct: 262 VPERRTTLEKLVTDPWVTQPVNLA 285

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 19  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 76
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 77  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 136
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 137 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 194
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 195 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 244
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 245 LRPSDRPTFEEIQNHPWM 262

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V + V K +G   A K I +        Q L     + R    P IV+ + ++  
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92
Query: 61  ENYHYLVFDLVTGG---------ELFEDIVAREFYSEADASHCIQQILESVNHCHSN-GV 110
           E   ++  +L++            + +D++  E   +   +      ++++NH   N  +
Sbjct: 93  EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA-----TVKALNHLKENLKI 147
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQ 147
           +HRD+KP N+LL    +   +KL DFG++                       I+    +Q
Sbjct: 148 IHRDIKPSNILLD---RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 148 AW--------FGVILYILLVGYPPF--WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKN 197
            +         G+ LY L  G  P+  W+    +L   +K       + E    +P   N
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264
Query: 198 LINQMLTVNPSKRITASEALKHPWICQRERVA 229
            +N  LT + SKR    E LKHP+I   E  A
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 20  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 77
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 78  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 137
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 138 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 195
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 196 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 245
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 246 LRPSDRPTFEEIQNHPWM 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 72
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 73  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 112 HRDLKPENLLLASKAKGAAVKLADFG--------LAIEVQGEQ----------------- 146
           HRD+K EN+L+        +KL DFG        +  +  G +                 
Sbjct: 133 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 190
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 191 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 240
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 241 LRPSDRPTFEEIQNHPWM 258

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 115/283 (40%), Gaps = 64/283 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA+  V       TG   A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             S++E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 93  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------------- 150
           LKP NL +    +   +K+ DF LA     E        W+                   
Sbjct: 151 LKPSNLAVNEDCE---LKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 151 --GVILYILLVG---YPPFWDEDQHRLYAQI-------------KAGAYDY-------PS 185
             G I+  LL G   +P     DQ +L  ++                A +Y       P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 186 PEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
             +  V     P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 171
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 172 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 229
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 230 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 279
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 280 LRPSDRPTFEEIQNHPWM 297

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 20  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 77
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 78  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 137
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 138 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 195
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 196 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 245
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 246 LRPSDRPTFEEIQNHPWM 263

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 35  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 92
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 93  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 152
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 153 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 210
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 211 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 260
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 261 LRPSDRPTFEEIQNHPWM 278

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 34  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 91
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 92  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 151
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 152 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 209
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 210 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 259
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 260 LRPSDRPTFEEIQNHPWM 277

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 20  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 77
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 78  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 137
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 138 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 195
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 196 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 245
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 246 LRPSDRPTFEEIQNHPWM 263

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +   A +          C  L  P IV L+ +++E
Sbjct: 85  GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA-------CAGLTSPRIVPLYGAVRE 137
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + +  +    E  A + + Q LE + + HS  ++H D+K +N+
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 121 LLASKAKGAAVKLADFGLAIEVQ 143
           LL+S    AA  L DFG A+ +Q
Sbjct: 198 LLSSDGSHAA--LCDFGHAVCLQ 218

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 18  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 75
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 76  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 135
Query: 112 HRDLKPENLLLASKAKGAAVKLADFG--------LAIEVQGEQ----------------- 146
           HRD+K EN+L+        +KL DFG        +  +  G +                 
Sbjct: 136 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 193
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 194 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSSECQHLIRWCLA 243
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 244 LRPSDRPTFEEIQNHPWM 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 66/288 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ- 59
           GA+ VV    ++ TG + A K I        + ++  RE +I +  +H NI+ + D ++ 
Sbjct: 66  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 125
Query: 60  -----EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
                E    Y+V DL+   +L + I + +  +     + + Q+L  + + HS  V+HRD
Sbjct: 126 TVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD 184
Query: 115 LKPENLLLAS-----------------------------------KAKGAAVKLADFGLA 139
           LKP NLL+                                     +A    + L ++  A
Sbjct: 185 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA 244
Query: 140 I----------EVQGEQQAWFG------VILYILLVGYPP---FWDEDQHRLYAQIKAGA 180
           I          E+   +Q + G      + L ++++G P           R+ A I++  
Sbjct: 245 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP 304
Query: 181 YDYPSPEWDTVTP----EAKNLINQMLTVNPSKRITASEALKHPWICQ 224
              P P W+TV P    +A +L+ +ML   PS RI+A+ AL+HP++ +
Sbjct: 305 PRQPVP-WETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 351

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 34  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 91
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 92  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 151
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 152 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 209
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 210 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSXECQHLIRWCLA 259
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 260 LRPSDRPTFEEIQNHPWM 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 35  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 92
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 93  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 152
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 153 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 210
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 211 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSXECQHLIRWCLA 260
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 261 LRPSDRPTFEEIQNHPWM 278

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 38/255 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254
Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  + +  + EA A     +I   +   H   +V+RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-F 150
           EN+LL        ++++D GLA+ V   Q                            W  
Sbjct: 315 ENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY ++ G  PF    +     +++    + P    +  +P+A++L +Q+L  +P++R
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
Query: 211 I-----TASEALKHP 220
           +     +A E  +HP
Sbjct: 432 LGCRGGSAREVKEHP 446

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 28/45 (62%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T +G  GT GY++PEV+K E Y    D WA G +LY ++ G  PF
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 47  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 104
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 105 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 164
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 165 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 222
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 223 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSSECQHLIRWCLA 272
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 273 LRPSDRPTFEEIQNHPWM 290

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 62  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 119
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 120 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 179
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 180 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 237
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 238 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSSECQHLIRWCLA 287
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 288 LRPSDRPTFEEIQNHPWM 305

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +   A +          C  L  P IV L+ +++E
Sbjct: 104 GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA-------CAGLTSPRIVPLYGAVRE 156
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + +  +    E  A + + Q LE + + HS  ++H D+K +N+
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 121 LLASKAKGAAVKLADFGLAIEVQ 143
           LL+S    AA  L DFG A+ +Q
Sbjct: 217 LLSSDGSHAA--LCDFGHAVCLQ 237

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 42  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 99
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 100 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 159
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 160 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 217
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 218 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQ---------RVSXECQHLIRWCLA 267
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 268 LRPSDRPTFEEIQNHPWM 285

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 72
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 73  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 112 HRDLKPENLLLASKAKGAAVKLADFG--------LAIEVQGEQ----------------- 146
           HRD+K EN+L+        +KL DFG        +  +  G +                 
Sbjct: 133 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 190
Query: 147 -QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 191 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFRQ---------RVSSECQHLIRWCLA 240
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 241 LRPSDRPTFEEIQNHPWM 258

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 38/255 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254
Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  + +  + EA A     +I   +   H   +V+RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-F 150
           EN+LL        ++++D GLA+ V   Q                            W  
Sbjct: 315 ENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY ++ G  PF    +     +++    + P    +  +P+A++L +Q+L  +P++R
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
Query: 211 I-----TASEALKHP 220
           +     +A E  +HP
Sbjct: 432 LGCRGGSAREVKEHP 446

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 28/45 (62%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T +G  GT GY++PEV+K E Y    D WA G +LY ++ G  PF
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 71/267 (26%)
Query: 23  INTKKLSARDFQKL------EREARICRKLQHPNIVRLHD------SIQEENYHYLVFDL 70
           +  KKLS R FQ L       RE R+ + L+H N++ L D      SI++ +  YLV  L
Sbjct: 48  VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 106
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +  G    +IV  +  S+      + Q+L  + + HS G++HRDLKP N+ +    +   
Sbjct: 107 M--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--- 161
Query: 131 VKLADFGLAIEVQGEQQA-----WF---------------------GVILYILLVGYPPF 164
           +++ DFGLA +   E        W+                     G I+  LL G   F
Sbjct: 162 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221
Query: 165 WDED---------------QHRLYAQIKAG-AYDY-----PSPEWDTVT------PEAKN 197
              D                  + A+I +  A  Y     P P+ D  +      P A +
Sbjct: 222 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAID 281
Query: 198 LINQMLTVNPSKRITASEALKHPWICQ 224
           L+ +ML ++  +R++A+EAL H +  Q
Sbjct: 282 LLGRMLVLDSDQRVSAAEALAHAYFSQ 308

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 48  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 105
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 106 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 165
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 166 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 223
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 224 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSSECQHLIRWCLA 273
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 274 LRPSDRPTFEEIQNHPWM 291

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 67  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 124
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 125 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 184
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 185 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 242
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 243 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSXECQHLIRWCLA 292
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 293 LRPSDRPTFEEIQNHPWM 310

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 48  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 105
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 106 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 165
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 166 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 223
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 224 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSSECQHLIRWCLA 273
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 274 LRPSDRPTFEEIQNHPWM 291

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 47  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 104
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 105 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 164
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 165 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 222
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 223 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSSECQHLIRWCLA 272
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 273 LRPSDRPTFEEIQNHPWM 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 47  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 104
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 105 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 164
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 165 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 222
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 223 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSSECQHLIRWCLA 272
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 273 LRPSDRPTFEEIQNHPWM 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 62  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 119
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 120 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 179
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 180 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 237
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 238 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSXECQHLIRWCLA 287
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 288 LRPSDRPTFEEIQNHPWM 305

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V    +  T   +A K +N +K   R+  + + +E +I + L+HP +V L  S Q
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +E   ++V DL+ GG+L   +     + E      I +++ ++++  +  ++HRD+KP+N
Sbjct: 86  DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W-- 149
           +LL        V + DF +A  +  E Q                             W  
Sbjct: 146 ILLDEHGH---VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 150 FGVILYILLVGYPPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            GV  Y LL G  P+          +    +     YPS  W   + E  +L+ ++L  N
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA-W---SQEMVSLLKKLLEPN 258
Query: 207 PSKRITA-SEALKHPWI 222
           P +R +  S+    P++
Sbjct: 259 PDQRFSQLSDVQNFPYM 275

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 48  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 105
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 106 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 165
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 166 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 223
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 224 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSXECQHLIRWCLA 273
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 274 LRPSDRPTFEEIQNHPWM 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 48  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 105
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 106 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 165
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 166 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 223
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 224 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSXECQHLIRWCLA 273
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 274 LRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 47  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 104
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 105 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 164
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 165 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 222
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 223 AAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR---------QRVSXECQHLIRWCLA 272
Query: 205 VNPSKRITASEALKHPWI 222
           + PS R T  E   HPW+
Sbjct: 273 LRPSDRPTFEEIQNHPWM 290

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++D+ + E       Y+V + V G  L  DIV 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVH 108
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            E   +   A   I    +++N  H NG++HRD+KP N+L+++     AVK+ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISAT---NAVKVVDFGIARA 165
Query: 142 VQ-------------------GEQQA------------WFGVILYILLVGYPPF-WDEDQ 169
           +                      +QA              G +LY +L G PPF  D   
Sbjct: 166 IADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 226 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++D+ + E       Y+V + V G  L  DIV 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVH 108
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            E   +   A   I    +++N  H NG++HRD+KP N+++++     AVK+ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARA 165
Query: 142 VQ-------------------GEQQA------------WFGVILYILLVGYPPF-WDEDQ 169
           +                      +QA              G +LY +L G PPF  D   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 226 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++D+ + E       Y+V + V G  L  DIV 
Sbjct: 67  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVH 125
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA-- 139
            E   +   A   I    +++N  H NG++HRD+KP N+++++     AVK+ DFG+A  
Sbjct: 126 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARA 182
Query: 140 -----------IEVQGEQQAW------------------FGVILYILLVGYPPF-WDEDQ 169
                        V G  Q                     G +LY +L G PPF  D   
Sbjct: 183 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 243 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 288

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 106/258 (41%), Gaps = 50/258 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL--------QHPNIV 52
           G F  V   ++ +  L  A K +   ++S  D+ +L    R+  ++            ++
Sbjct: 35  GGFGSVYSGIRVSDNLPVAIKHVEKDRIS--DWGELPNGTRVPMEVVLLKKVSSGFSGVI 92
Query: 53  RLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+
Sbjct: 93  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 152
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------------------------GEQ 146
           HRD+K EN+L+        +KL DFG    ++                         G  
Sbjct: 153 HRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 210
Query: 147 QA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
            A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI   L 
Sbjct: 211 AAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSXECQHLIRWCLA 260
Query: 205 VNPSKRITASEALKHPWI 222
           + P  R T  E   HPW+
Sbjct: 261 LRPXDRPTFEEIQNHPWM 278

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++D+ + E       Y+V + V G  L  DIV 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVH 108
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            E   +   A   I    +++N  H NG++HRD+KP N+++++     AVK+ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARA 165
Query: 142 VQ-------------------GEQQA------------WFGVILYILLVGYPPF-WDEDQ 169
           +                      +QA              G +LY +L G PPF  D   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 226 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV  C  K    + A K I     S  + +    E R   ++ HPNIV+L+ +   
Sbjct: 20  GAFGVV--CKAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 61  ENYHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESVNHCHS---NGVVHRD 114
            N   LV +   GG L+  +   E   +Y+ A A     Q  + V + HS     ++HRD
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           LKP NLLL   A G  +K+ DFG A ++Q
Sbjct: 132 LKPPNLLLV--AGGTVLKICDFGTACDIQ 158

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++D+ + E       Y+V + V G  L  DIV 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVH 108
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            E   +   A   I    +++N  H NG++HRD+KP N+++++     AVK+ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARA 165
Query: 142 VQ-------------------GEQQA------------WFGVILYILLVGYPPF-WDEDQ 169
           +                      +QA              G +LY +L G PPF  D   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 226 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV  C  K    + A K I     S  + +    E R   ++ HPNIV+L+ +   
Sbjct: 19  GAFGVV--CKAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 61  ENYHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESVNHCHS---NGVVHRD 114
            N   LV +   GG L+  +   E   +Y+ A A     Q  + V + HS     ++HRD
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           LKP NLLL   A G  +K+ DFG A ++Q
Sbjct: 131 LKPPNLLLV--AGGTVLKICDFGTACDIQ 157

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 52/246 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQ 59
           GAF  V     K     FA KI+N  ++  R      RE R +        I  LH + Q
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144
Query: 60  EENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           ++N  YLV D   GG+L      FED +  E      A   + +++ +++  H    VHR
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-----ARFYLAEMVIAIDSVHQLHYVHR 199
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------------ 143
           D+KP+N+L+        ++LADFG  +++                               
Sbjct: 200 DIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 144 --GEQQAW--FGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKN 197
             G +  W   GV +Y +L G  PF+ E     Y +I      + +P+   D V+  AK+
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD-VSENAKD 315
Query: 198 LINQML 203
           LI +++
Sbjct: 316 LIRRLI 321

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 31/57 (54%), Gaps = 5/57 (8%)
Query: 259 AGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            GTP Y+SPE+L+     K  YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 78/147 (53%), Gaps = 12/147 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA +VV+         + A K IN +K       +L +E +   +  HPNIV  + S   
Sbjct: 21  GATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNIVSYYTSFVV 79
Query: 61  ENYHYLVFDLVTGG---ELFEDIVARE-----FYSEADASHCIQQILESVNHCHSNGVVH 112
           ++  +LV  L++GG   ++ + IVA+         E+  +  ++++LE + + H NG +H
Sbjct: 80  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 139
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA 139
           RD+K  N+LL    +  +V++ADFG++
Sbjct: 140 RDVKAGNILL---GEDGSVQIADFGVS 163

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 34/253 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS--- 57
           G+F  V + +   T +E A   +  +KL+  + Q+ + EA   + LQHPNIVR +DS   
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWES 96
Query: 58  -IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRD 114
            ++ +    LV +L T G L   +   +           +QIL+ +   H+    ++HRD
Sbjct: 97  TVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLA-IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLY 173
           LK +N+ +       +VK+ D GLA ++     +A  G   +     Y   +DE    +Y
Sbjct: 157 LKCDNIFITGPT--GSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEKYDESVD-VY 213
Query: 174 A----QIKAGAYDYPSPE-------------------WDTVT-PEAKNLINQMLTVNPSK 209
           A     ++    +YP  E                   +D V  PE K +I   +  N  +
Sbjct: 214 AFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 273
Query: 210 RITASEALKHPWI 222
           R +  + L H + 
Sbjct: 274 RYSIKDLLNHAFF 286

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 78/147 (53%), Gaps = 12/147 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA +VV+         + A K IN +K       +L +E +   +  HPNIV  + S   
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNIVSYYTSFVV 84
Query: 61  ENYHYLVFDLVTGG---ELFEDIVARE-----FYSEADASHCIQQILESVNHCHSNGVVH 112
           ++  +LV  L++GG   ++ + IVA+         E+  +  ++++LE + + H NG +H
Sbjct: 85  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA 139
           RD+K  N+LL    +  +V++ADFG++
Sbjct: 145 RDVKAGNILL---GEDGSVQIADFGVS 168

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLHDSI 58
           G F VV     K     +A K I   +L  R+   +K+ RE +   KL+HP IVR  ++ 
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 59  QEEN------------YHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVN 103
            E+N            Y Y+   L     L + +  R    E + S C+    QI E+V 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
             HS G++HRDLKP N+          VK+ DFGL   +  +++
Sbjct: 133 FLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEE 173

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 38/274 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +     + + + S  +
Sbjct: 34  GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSSYVTKYYGSYLK 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  +++ + + GG   + + A  F  E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 93  GSKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 151
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+ +     VKLADFG+A ++   Q                             W  G+
Sbjct: 152 LLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 208
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP  + D H +         + P+   D  T   K  I+  L  +PS R T
Sbjct: 209 TAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLVGD-FTKSFKEFIDACLNKDPSFRPT 265
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
           A E LKH +I +  +  S  +  E +D  K++ A
Sbjct: 266 AKELLKHKFIVKNSKKTS--YLTELIDRFKRWKA 297

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 2/52 (3%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
           R  F GTP +++PEV+++  Y    DIW+ G+    L  G PP  + D H +
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDMHPM 226

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 44/248 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K +N K+L  R  +Q    E +I  K+    IV L  + +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 60  EENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +    LV  ++ GG++   I   +     + E  A     QI+  + H H   +++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ----------------------GEQQAW---- 149
           KPEN+LL        V+++D GLA+E++                      GE+  +    
Sbjct: 316 KPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 150 --FGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              GV LY ++    PF       +   L  ++   A  YP    D  +P +K+    +L
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALL 428
Query: 204 TVNPSKRI 211
             +P KR+
Sbjct: 429 QKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/46 (43%), Positives = 30/46 (65%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +  +G+AGTPG+++PE+L  E Y   VD +A GV LY ++    PF
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 44/248 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K +N K+L  R  +Q    E +I  K+    IV L  + +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 60  EENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +    LV  ++ GG++   I   +     + E  A     QI+  + H H   +++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ----------------------GEQQAW---- 149
           KPEN+LL        V+++D GLA+E++                      GE+  +    
Sbjct: 316 KPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 150 --FGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              GV LY ++    PF       +   L  ++   A  YP    D  +P +K+    +L
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALL 428
Query: 204 TVNPSKRI 211
             +P KR+
Sbjct: 429 QKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +G+AGTPG+++PE+L  E Y   VD +A GV LY ++    PF
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 40/201 (19%)
Query: 50  NIVRLHDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            ++RL D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------------------------- 143
           GV+HRD+K EN+L+        +KL DFG    ++                         
Sbjct: 177 GVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 144 GEQQA-W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
           G   A W  G++LY ++ G  PF + D+  +  Q+              V+ E ++LI  
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR---------QRVSSECQHLIRW 284
Query: 202 MLTVNPSKRITASEALKHPWI 222
            L + PS R T  E   HPW+
Sbjct: 285 CLALRPSDRPTFEEIQNHPWM 305

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 44/248 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K +N K+L  R  +Q    E +I  K+    IV L  + +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 60  EENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +    LV  ++ GG++   I   +     + E  A     QI+  + H H   +++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ----------------------GEQQAW---- 149
           KPEN+LL        V+++D GLA+E++                      GE+  +    
Sbjct: 316 KPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 150 --FGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              GV LY ++    PF       +   L  ++   A  YP    D  +P +K+    +L
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALL 428
Query: 204 TVNPSKRI 211
             +P KR+
Sbjct: 429 QKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +G+AGTPG+++PE+L  E Y   VD +A GV LY ++    PF
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 44/248 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K +N K+L  R  +Q    E +I  K+    IV L  + +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 60  EENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +    LV  ++ GG++   I   +     + E  A     QI+  + H H   +++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQ----------------------GEQQAW---- 149
           KPEN+LL        V+++D GLA+E++                      GE+  +    
Sbjct: 316 KPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 150 --FGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
              GV LY ++    PF       +   L  ++   A  YP    D  +P +K+    +L
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALL 428
Query: 204 TVNPSKRI 211
             +P KR+
Sbjct: 429 QKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +G+AGTPG+++PE+L  E Y   VD +A GV LY ++    PF
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 72  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 131
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 132 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 185
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 186 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 243
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 244 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 303
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 304 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 113 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 172
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 173 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 226
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 227 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 284
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 285 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 344
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 345 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 385

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 70  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 129
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 130 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 183
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 184 IKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 241
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 242 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 301
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 302 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 342

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 62  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 121
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 122 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 175
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 176 IKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 233
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 234 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 293
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 294 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 334

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 128 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 182 IKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 239
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 240 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 39  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 98
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 99  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 152
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 153 IKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 210
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
               G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 211 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 270
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 271 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 311

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 23  INTKKLSARDF---QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED 79
           I  K++  RD    Q L  E  + + L+H NIV+   S  E  +  +  + V GG L   
Sbjct: 36  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SA 94
Query: 80  IVAREFYSEADASHCI----QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           ++  ++    D    I    +QILE + + H N +VHRD+K +N+L+ + +    +K++D
Sbjct: 95  LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS--GVLKISD 152
Query: 136 FGLAIEVQGEQ---QAWFGVILYI---------------------------LLVGYPPFW 165
           FG +  + G     + + G + Y+                           +  G PPF+
Sbjct: 153 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212
Query: 166 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
           +  + +  A  K G +       ++++ EAK  I +    +P KR  A++ L
Sbjct: 213 ELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 263

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 258 FAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F GT  Y++PE++ K P  YGK  DIW+ G  +  +  G PPF++  + +  A  K G +
Sbjct: 169 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMF 227
Query: 316 DDEPK 320
              P+
Sbjct: 228 KVHPE 232

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 23  INTKKLSARDF---QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED 79
           I  K++  RD    Q L  E  + + L+H NIV+   S  E  +  +  + V GG L   
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SA 108
Query: 80  IVAREFYSEADASHCI----QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           ++  ++    D    I    +QILE + + H N +VHRD+K +N+L+ + +    +K++D
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS--GVLKISD 166
Query: 136 FGLAIEVQGEQ---QAWFGVILYI---------------------------LLVGYPPFW 165
           FG +  + G     + + G + Y+                           +  G PPF+
Sbjct: 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226
Query: 166 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
           +  + +  A  K G +       ++++ EAK  I +    +P KR  A++ L
Sbjct: 227 ELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 258 FAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           F GT  Y++PE++ K P  YGK  DIW+ G  +  +  G PPF++  + +  A  K G +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMF 241
Query: 316 DDEPK 320
              P+
Sbjct: 242 KVHPE 246

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 94  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 148 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 205
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
               G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 47  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 106
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 107 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 160
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF----------------------- 150
           +KP+NLLL      A +KL DFG A + V+GE    +                       
Sbjct: 161 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 218
Query: 151 ----GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
               G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 219 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 278
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 279 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 319

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +     +          C  L  P IV L+ +++E
Sbjct: 85  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA-------CAGLSSPRIVPLYGAVRE 137
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + I       E  A + + Q LE + + H+  ++H D+K +N+
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 121 LLASKAKGAAVKLADFGLAIEVQ 143
           LL+S    AA  L DFG A+ +Q
Sbjct: 198 LLSSDGSRAA--LCDFGHALCLQ 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV---RLHDS 57
           G F  V R + + TG + A K    ++LS ++ ++   E +I +KL HPN+V    + D 
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 58  IQE---ENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSN 108
           +Q+    +   L  +   GG+L      FE+        E      +  I  ++ + H N
Sbjct: 84  LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSALRYLHEN 140
Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-QGEQQAWF-GVILYI 156
            ++HRDLKPEN++L    +    K+ D G A E+ QGE    F G + Y+
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +     +          C  L  P IV L+ +++E
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA-------CAGLSSPRIVPLYGAVRE 121
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + I       E  A + + Q LE + + H+  ++H D+K +N+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 121 LLASKAKGAAVKLADFGLAIEVQ 143
           LL+S    AA  L DFG A+ +Q
Sbjct: 182 LLSSDGSRAA--LCDFGHALCLQ 202

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV---RLHDS 57
           G F  V R + + TG + A K    ++LS ++ ++   E +I +KL HPN+V    + D 
Sbjct: 26  GGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 84
Query: 58  IQE---ENYHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESVNHCHSN 108
           +Q+    +   L  +   GG+L      FE+        E      +  I  ++ + H N
Sbjct: 85  LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSALRYLHEN 141
Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-QGEQQAWF-GVILYI 156
            ++HRDLKPEN++L    +    K+ D G A E+ QGE    F G + Y+
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +     +          C  L  P IV L+ +++E
Sbjct: 83  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA-------CAGLSSPRIVPLYGAVRE 135
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + I       E  A + + Q LE + + H+  ++H D+K +N+
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 121 LLASKAKGAAVKLADFGLAIEVQ 143
           LL+S    AA  L DFG A+ +Q
Sbjct: 196 LLSSDGSRAA--LCDFGHALCLQ 216

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 61/230 (26%)
Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQIL 99
           HPN++R + S   + + Y+  +L       +D+V  +  S        E +    ++QI 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAA----------VKLADFGLAIEVQGEQ--- 146
             V H HS  ++HRDLKP+N+L+++ ++  A          + ++DFGL  ++   Q   
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 147 ----------QAWFG-----------------------VILYILLVGYPPFWDEDQHRLY 173
                       W                         V  YIL  G  PF   D++   
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 261
Query: 174 AQIKAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
           + I  G +     +     ++  EA +LI+QM+  +P KR TA + L+HP
Sbjct: 262 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 61/230 (26%)
Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQIL 99
           HPN++R + S   + + Y+  +L       +D+V  +  S        E +    ++QI 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAA----------VKLADFGLAIEVQGEQ--- 146
             V H HS  ++HRDLKP+N+L+++ ++  A          + ++DFGL  ++   Q   
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 147 ----------QAWFG-----------------------VILYILLVGYPPFWDEDQHRLY 173
                       W                         V  YIL  G  PF   D++   
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 261
Query: 174 AQIKAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
           + I  G +     +     ++  EA +LI+QM+  +P KR TA + L+HP
Sbjct: 262 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 85/292 (29%)
Query: 13  ATGLEFAA------KIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENY 63
             GL F+A      K +  KK+   D Q ++   RE +I R+L H NIV++ + +     
Sbjct: 23  GNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82
Query: 64  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------ILESVNHCHSNG 109
             L  D+ +  EL    + +E Y E D ++ ++Q              +L  + + HS  
Sbjct: 83  Q-LTDDVGSLTELNSVYIVQE-YMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN 140
Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEV-----------QGEQQAWF-------- 150
           V+HRDLKP NL +    +   +K+ DFGLA  +           +G    W+        
Sbjct: 141 VLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198
Query: 151 -------------GVILYILLVG-------------------YPPFWDEDQHRLYAQIKA 178
                        G I   +L G                    P   +ED+  L + I  
Sbjct: 199 PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPV 258
Query: 179 GA-YDYPSPE------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC 223
               D   P          ++ EA + + Q+LT +P  R+TA EAL HP++ 
Sbjct: 259 YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS----- 92
           RE  + ++LQH NI+ L   I   +  +L+F      E  E+ + +      D S     
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNHRLHLIF------EYAENDLKKYMDKNPDVSMRVIK 135
Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLL--ASKAKGAAVKLADFGLA 139
             + Q++  VN CHS   +HRDLKP+NLLL  +  ++   +K+ DFGLA
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 117/290 (40%), Gaps = 82/290 (28%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH----- 55
           G+F VV +     +G   A K    K L  + F+   RE +I RKL H NIVRL      
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYS 84
Query: 56  -DSIQEENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHC 105
               ++E Y  LV D V      E +  VAR  YS A  +  +        Q+  S+ + 
Sbjct: 85  SGEKKDEVYLNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF-------------- 150
           HS G+ HRD+KP+NLLL      A +KL DFG A + V+GE    +              
Sbjct: 139 HSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 151 -------------GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GA 180
                        G +L  LL+G P F  D    +L   IK                   
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 181 YDYPSPE---WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           + +P  +   W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDF--QKLEREARICRKLQHPNIVRLHDS 57
           G F+ V +   K T    A K I     S A+D   +   RE ++ ++L HPNI+ L D+
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHCHSNGVVHRD 114
              ++   LVFD +   E   +++ ++       SH    +   L+ + + H + ++HRD
Sbjct: 81  FGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
           LKP NLLL    +   +KLADFGLA       +A+
Sbjct: 138 LKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY 169

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 117/290 (40%), Gaps = 82/290 (28%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH----- 55
           G+F VV +     +G   A K    K L  + F+   RE +I RKL H NIVRL      
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYS 84
Query: 56  -DSIQEENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHC 105
               ++E Y  LV D V      E +  VAR  YS A  +  +        Q+  S+ + 
Sbjct: 85  SGEKKDEVYLNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQAWF-------------- 150
           HS G+ HRD+KP+NLLL      A +KL DFG A + V+GE    +              
Sbjct: 139 HSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 151 -------------GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GA 180
                        G +L  LL+G P F  D    +L   IK                   
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 181 YDYPSPE---WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           + +P  +   W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 257 FAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 128 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 182 IKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 239
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
            W  G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 240 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 106 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 159
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 160 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 217
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 218 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 277
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 278 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 35  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 94
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 95  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 148
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 149 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 206
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 207 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 266
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 267 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 307

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 30  ARD---FQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGELFEDIVA 82
           ARD   + +  REA+    L HP IV ++ + + E       Y+V + V G  L  DIV 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL-RDIVH 108
Query: 83  REF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
            E   +   A   I    +++N  H NG++HRD+KP N+++++     AVK+ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARA 165
Query: 142 VQ-------------------GEQQA------------WFGVILYILLVGYPPF-WDEDQ 169
           +                      +QA              G +LY +L G PPF  D   
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
Query: 170 HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASE 215
              Y  ++      PS   + ++ +   ++ + L  NP  R  TA+E
Sbjct: 226 SVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 53  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 112
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 113 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 166
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 167 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 224
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 225 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 284
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 285 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 325

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 94  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 148 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 205
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 106 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 159
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 160 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 217
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYP---SP 186
            W  G +L  LL+G P F  D    +L   IK                   + +P   + 
Sbjct: 218 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 277
Query: 187 EWDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 278 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 38  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 97
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 98  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 151
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 152 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 209
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 210 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 269
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 270 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 310

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 94  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 148 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 205
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRLH------DSIQEENY 63
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL          ++E Y
Sbjct: 42  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 101
Query: 64  HYLVFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
             LV D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 102 LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 155
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 156 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 213
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 214 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 273
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 274 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 314

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 65/234 (27%)
Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQIL 99
           HPN++R + S   + + Y+  +L       +D+V  +  S        E +    ++QI 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAA----------VKLADFGLAIEVQGEQQAW 149
             V H HS  ++HRDLKP+N+L+++ ++  A          + ++DFGL  ++   Q ++
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 150 ---------------------------------------FG-VILYILLVGYPPFWDEDQ 169
                                                   G V  YIL  G  PF   D+
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DK 243
Query: 170 HRLYAQIKAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
           +   + I  G +     +     ++  EA +LI+QM+  +P KR TA + L+HP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 117/276 (42%), Gaps = 38/276 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +   P + + + S  +
Sbjct: 18  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLK 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 77  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+   +   VKLADFG+A ++   Q                             W  G+
Sbjct: 136 LLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGI 192
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP    + H +         + P+ E +   P  K  +   L   PS R T
Sbjct: 193 TAIELARGEPPH--SELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPT 249
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARR 248
           A E LKH +I +  +  S  +  E +D  K++ A +
Sbjct: 250 AKELLKHKFILRNAKKTS--YLTELIDRYKRWKAEQ 283

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 25/43 (58%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP
Sbjct: 161 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 115/288 (39%), Gaps = 78/288 (27%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH----- 55
           G+F VV +     +G   A K    K L  + F+   RE +I RKL H NIVRL      
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYS 84
Query: 56  -DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------QQILESVNHCHS 107
               ++E Y  LV D V         VAR  YS A  +  +        Q+  S+ + HS
Sbjct: 85  SGEKKDEVYLNLVLDYVPATVYR---VARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ------------------- 147
            G+ HRD+KP+NLLL      A +KL DFG A + V+GE                     
Sbjct: 141 FGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 148 -------AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYD 182
                   W  G +L  LL+G P F  D    +L   IK                   + 
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFA 258
Query: 183 YPSPE---WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           +P  +   W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 117/276 (42%), Gaps = 38/276 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +   P + + + S  +
Sbjct: 18  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLK 76
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 77  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+   +   VKLADFG+A ++   Q                             W  G+
Sbjct: 136 LLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 192
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP    + H +         + P+ E +   P  K  +   L   PS R T
Sbjct: 193 TAIELARGEPPH--SELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPT 249
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARR 248
           A E LKH +I +  +  S  +  E +D  K++ A +
Sbjct: 250 AKELLKHKFILRNAKKTS--YLTELIDRYKRWKAEQ 283

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 25/43 (58%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP
Sbjct: 161 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 117/276 (42%), Gaps = 38/276 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +   P + + + S  +
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLK 91
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 92  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+   +   VKLADFG+A ++   Q                             W  G+
Sbjct: 151 LLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP    + H +         + P+ E +   P  K  +   L   PS R T
Sbjct: 208 TAIELARGEPPH--SELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPT 264
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARR 248
           A E LKH +I +  +  S  +  E +D  K++ A +
Sbjct: 265 AKELLKHKFILRNAKKTS--YLTELIDRYKRWKAEQ 298

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 25/43 (58%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 65/234 (27%)
Query: 48  HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQIL 99
           HPN++R + S   + + Y+  +L       +D+V  +  S        E +    ++QI 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAA----------VKLADFGLAIEVQGEQ--- 146
             V H HS  ++HRDLKP+N+L+++ ++  A          + ++DFGL  ++   Q   
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 147 ----------QAWFG---------------------------VILYILLVGYPPFWDEDQ 169
                       W                             V  YIL  G  PF   D+
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DK 243
Query: 170 HRLYAQIKAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
           +   + I  G +     +     ++  EA +LI+QM+  +P KR TA + L+HP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   +  G + A KI+  +   A    +  RE  I ++L+HPNIV    ++ +
Sbjct: 48  GSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 61  ENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNG--VVHRDL 115
                +V + ++ G L+  +    ARE   E         + + +N+ H+    +VHRDL
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDL 165
Query: 116 KPENLLLASKAKGAAVKLADFGLA 139
           K  NLL+  K     VK+ DFGL+
Sbjct: 166 KSPNLLVDKK---YTVKVCDFGLS 186

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V     K T    A K +N       D +++ RE  I  +L+   I+RL+D I  
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96
Query: 61  ENYH-----YLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           ++       Y+V ++      +LF+  +   F +E      +  +L   N  H +G++HR
Sbjct: 97  DDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
           DLKP N LL    +  +VK+ DFGLA  +  E+  
Sbjct: 154 DLKPANCLL---NQDCSVKVCDFGLARTINSEKDT 185

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 119/281 (42%), Gaps = 81/281 (28%)
Query: 15  GLEFAAKIINTKKLSA-----RDFQKLEREARICRKLQHPNIVRL----HDSIQEENYHY 65
           G+ + AK+ ++ +L A     +D +   RE +I RKL H NIVRL    + S ++++  Y
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVY 93
Query: 66  L--VFDLVTGGELFEDI--VAREFYSEADASHCI-------QQILESVNHCHSNGVVHRD 114
           L  V D V      E +  VAR  YS A  +  +        Q+  S+ + HS G+ HRD
Sbjct: 94  LNLVLDYVP-----ETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIE-VQGEQQ-------------------------- 147
           +KP+NLLL      A +KL DFG A + V+GE                            
Sbjct: 148 IKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSID 205
Query: 148 AWF-GVILYILLVGYPPF-WDEDQHRLYAQIKA----------------GAYDYPSPE-- 187
            W  G +L  LL+G P F  D    +L   IK                   + +P  +  
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 188 -WDTV-----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            W  V      PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 43/254 (16%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V + + K TG   A K +  +     D Q++ +E  I ++   P++V+ + S  +
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 61  ENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
               ++V +    G + + I  R +  +E + +  +Q  L+ + + H    +HRD+K  N
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN 155
Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FG 151
           +LL ++      KLADFG+A ++                                 W  G
Sbjct: 156 ILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAG---AYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           +    +  G PP+ D    R    I       +  P    D  T    + + Q L  +P 
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT----DFVKQCLVKSPE 268
Query: 209 KRITASEALKHPWI 222
           +R TA++ L+HP++
Sbjct: 269 QRATATQLLQHPFV 282

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 115/279 (41%), Gaps = 80/279 (28%)
Query: 15  GLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRL------HDSIQEENYH 64
           G+ F AK++ + +++ +    D +   RE +I R ++HPN+V L      +   ++E + 
Sbjct: 54  GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 65  YLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------QILESVNHCHSNGVVHRDL 115
            LV + V       + V R     A     +          Q+L S+ + HS G+ HRD+
Sbjct: 114 NLVLEYVP------ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDI 167
Query: 116 KPENLLLASKAKGAAVKLADFGLA-IEVQGEQQA-------------------------- 148
           KP+NLLL   +    +KL DFG A I + GE                             
Sbjct: 168 KPQNLLLDPPS--GVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDI 225
Query: 149 W-FGVILYILLVGYPPFWDE---DQ---------HRLYAQIKAGAYDY---------PSP 186
           W  G ++  L+ G P F  E   DQ              QIK    +Y         P P
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 187 EWDT----VTPEAKNLINQMLTVNPSKRITASEALKHPW 221
                     P+A +LI+++L   PS R+TA EAL HP+
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S    A 
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DAT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 38/274 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +   P I R   S  +
Sbjct: 30  GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYITRYFGSYLK 88
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 89  STKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 147
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+ +     VKLADFG+A ++   Q                             W  G+
Sbjct: 148 LLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGI 204
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP  + D H +           P+ E     P  K  +   L  +P  R T
Sbjct: 205 TAIELAKGEPP--NSDLHPMRVLFLIPKNSPPTLEGQHSKP-FKEFVEACLNKDPRFRPT 261
Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNA 246
           A E LKH +I +  +  S +   E +D  K++ +
Sbjct: 262 AKELLKHKFITRYTKKTSFL--TELIDRYKRWKS 293

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 26/46 (56%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD 300
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP  D
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S    A 
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DAT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 64/132 (48%), Gaps = 21/132 (15%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVF-----DLVTGGELFEDIVARE 84
           RE  + R L+   HPN+VRL D         E    LVF     DL T    + D V   
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT----YLDKVPEP 115
Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
                     + Q+L  ++  HS+ VVHRDLKP+N+L+ S  +   +KLADFGLA  +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLA-RIYS 171
Query: 145 EQQAWFGVILYI 156
            Q A   V++ +
Sbjct: 172 FQMALTSVVVTL 183

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S    A 
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DAT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 13/153 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V     K      A K +N       D +++ RE  I  +L+   I+RLHD I  
Sbjct: 39  GSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIP 98
Query: 61  ENYH-----YLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           E+       Y+V ++      +LF+  +   F +E      +  +L      H +G++HR
Sbjct: 99  EDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
           DLKP N LL    +  +VK+ DFGLA  +  ++
Sbjct: 156 DLKPANCLL---NQDCSVKICDFGLARTINSDK 185

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 64/132 (48%), Gaps = 21/132 (15%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVF-----DLVTGGELFEDIVARE 84
           RE  + R L+   HPN+VRL D         E    LVF     DL T    + D V   
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT----YLDKVPEP 115
Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
                     + Q+L  ++  HS+ VVHRDLKP+N+L+ S  +   +KLADFGLA  +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLA-RIYS 171
Query: 145 EQQAWFGVILYI 156
            Q A   V++ +
Sbjct: 172 FQMALTSVVVTL 183

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LXQVIQMELDHER-MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 64/132 (48%), Gaps = 21/132 (15%)
Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVF-----DLVTGGELFEDIVARE 84
           RE  + R L+   HPN+VRL D         E    LVF     DL T    + D V   
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT----YLDKVPEP 115
Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG 144
                     + Q+L  ++  HS+ VVHRDLKP+N+L+ S  +   +KLADFGLA  +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLA-RIYS 171
Query: 145 EQQAWFGVILYI 156
            Q A   V++ +
Sbjct: 172 FQMALTSVVVTL 183

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 115/264 (43%), Gaps = 41/264 (15%)
Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFD--LVTGGELFE 78
           K+  + K S   +Q + +E R  +KL+HPN ++       E+  +LV +  L +  +L E
Sbjct: 86  KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 145
Query: 79  DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG- 137
             V ++   E + +      L+ + + HS+ ++HRD+K  N+LL+       VKL DFG 
Sbjct: 146 --VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGS 200
Query: 138 ----------------LAIEV---------QGEQQAW-FGVILYILLVGYPPFWDEDQHR 171
                           +A EV          G+   W  G+    L    PP +  + + 
Sbjct: 201 ASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNA 258
Query: 172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI 231
           + A       + P+ +    +   +N ++  L   P  R T+   LKH ++  RER  ++
Sbjct: 259 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-RERPPTV 317
Query: 232 VHR--QETVDCLKKFN--ARRKLK 251
           +    Q T D +++ +    RK+K
Sbjct: 318 IMDLIQRTKDAVRELDNLQYRKMK 341

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   +  G + A KI+  +   A    +  RE  I ++L+HPNIV    ++ +
Sbjct: 48  GSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 61  ENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNG--VVHRDL 115
                +V + ++ G L+  +    ARE   E         + + +N+ H+    +VHR+L
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165
Query: 116 KPENLLLASKAKGAAVKLADFGLA 139
           K  NLL+  K     VK+ DFGL+
Sbjct: 166 KSPNLLVDKK---YTVKVCDFGLS 186

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSI 58
           G+++ V     K T   +A K++  + ++   D   ++ E  +  +   HP +V LH   
Sbjct: 20  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 80  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139
Query: 119 NLLLASKAKGAAVKLADFGLAIE----------------------VQGEQQAW------F 150
           N+LL S+     +KL D+G+  E                      ++GE   +       
Sbjct: 140 NVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 196
Query: 151 GVILYILLVGYPPF 164
           GV+++ ++ G  PF
Sbjct: 197 GVLMFEMMAGRSPF 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 21/46 (45%), Positives = 30/46 (65%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
            T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 165 DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSI 58
           G+++ V     K T   +A K++  + ++   D   ++ E  +  +   HP +V LH   
Sbjct: 16  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 75
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 76  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 135
Query: 119 NLLLASKAKGAAVKLADFGLAIE----------------------VQGEQQAW------F 150
           N+LL S+     +KL D+G+  E                      ++GE   +       
Sbjct: 136 NVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 192
Query: 151 GVILYILLVGYPPF 164
           GV+++ ++ G  PF
Sbjct: 193 GVLMFEMMAGRSPF 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 21/46 (45%), Positives = 30/46 (65%)
Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
            T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 161 DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 115/264 (43%), Gaps = 41/264 (15%)
Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG--GELFE 78
           K+  + K S   +Q + +E R  +KL+HPN ++       E+  +LV +   G   +L E
Sbjct: 47  KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 79  DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG- 137
             V ++   E + +      L+ + + HS+ ++HRD+K  N+LL   ++   VKL DFG 
Sbjct: 107 --VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGS 161
Query: 138 ----------------LAIEV---------QGEQQAW-FGVILYILLVGYPPFWDEDQHR 171
                           +A EV          G+   W  G+    L    PP +  + + 
Sbjct: 162 ASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNA 219
Query: 172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI 231
           + A       + P+ +    +   +N ++  L   P  R T+   LKH ++  RER  ++
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-RERPPTV 278
Query: 232 VHR--QETVDCLKKFN--ARRKLK 251
           +    Q T D +++ +    RK+K
Sbjct: 279 IMDLIQRTKDAVRELDNLQYRKMK 302

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S    A 
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DAT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 108/258 (41%), Gaps = 36/258 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++      + +++E  +  +   P + + + S  +
Sbjct: 38  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLK 96
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 97  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 155
Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQ---------------------------QAW-FGV 152
           LL+   +   VKLADFG+A ++   Q                             W  G+
Sbjct: 156 LLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 212
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L  G PP    + H +         + P+ E +   P  K  +   L   PS R T
Sbjct: 213 TAIELARGEPPH--SELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPT 269
Query: 213 ASEALKHPWICQRERVAS 230
           A E LKH +I +  +  S
Sbjct: 270 AKELLKHKFILRNAKKTS 287

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 25/43 (58%)
Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSI 58
           G+++ V     K T   +A K++  + ++   D   ++ E  +  +   HP +V LH   
Sbjct: 31  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 90
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 91  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 150
Query: 119 NLLLASKAKGAAVKLADFGLAIE----------------------VQGEQQAW------F 150
           N+LL S+     +KL D+G+  E                      ++GE   +       
Sbjct: 151 NVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 207
Query: 151 GVILYILLVGYPPF 164
           GV+++ ++ G  PF
Sbjct: 208 GVLMFEMMAGRSPF 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 177 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S    A 
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DAT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LXQVIQMELDHER-MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 78
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 139 NCLV---GENHLVKVADFGLSRLMTGD 162

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 45  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 104 MDAN--LXQVIQMELDHER-MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXT 157
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 158 LKILDFGLA 166

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 1   GAFSVVRRCV--QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  VR+ V   +   ++ A K++      A D +++ REA+I  +L +P IVRL    
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVC 79
Query: 59  QEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           Q E    LV ++  GG L + +V  RE    ++ +  + Q+   + +      VHRDL  
Sbjct: 80  QAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+LL ++      K++DFGL+
Sbjct: 139 RNVLLVNR---HYAKISDFGLS 157

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 78
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 139 NCLV---GENHLVKVADFGLSRLMTGD 162

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 6/142 (4%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA  +V        G+  A K ++    +    ++  RE  + + + H NI+ L +    
Sbjct: 35  GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 94
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESVNHCHSNGVVHRDLKP 117
           +       D+    EL +  + +  + E D    S+ + Q+L  + H HS G++HRDLKP
Sbjct: 95  QKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 154
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+++ S      +K+ DFGLA
Sbjct: 155 SNIVVKS---DCTLKILDFGLA 173

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/31 (48%), Positives = 26/31 (83%)
Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           T +A++L+++ML ++P KRI+  EAL+HP+I
Sbjct: 291 TSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSI 58
           G+++ V     K T   +A +++  + ++   D   ++ E  +  +   HP +V LH   
Sbjct: 63  GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 119 NLLLASKAKGAAVKLADFGLAIE----------------------VQGEQQAW------F 150
           N+LL S+     +KL D+G+  E                      ++GE   +       
Sbjct: 183 NVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 151 GVILYILLVGYPPF 164
           GV+++ ++ G  PF
Sbjct: 240 GVLMFEMMAGRSPF 253

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           T   F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LXQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 6/142 (4%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA  +V        G+  A K ++    +    ++  RE  + + + H NI+ L +    
Sbjct: 33  GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 92
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESVNHCHSNGVVHRDLKP 117
           +       D+    EL +  + +  + E D    S+ + Q+L  + H HS G++HRDLKP
Sbjct: 93  QKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 152
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+++ S      +K+ DFGLA
Sbjct: 153 SNIVVKSD---CTLKILDFGLA 171

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/31 (48%), Positives = 26/31 (83%)
Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           T +A++L+++ML ++P KRI+  EAL+HP+I
Sbjct: 289 TSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 85
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 146 NCLV---GENHLVKVADFGLSRLMTGD 169

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 85
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 146 NCLV---GENHLVKVADFGLSRLMTGD 169

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 78
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 139 NCLV---GENHLVKVADFGLSRLMTGD 162

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 81
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 142 NCLV---GENHLVKVADFGLSRLMTGD 165

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LSQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 1   GAFSVVRRCV--QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  VR+ V   +   ++ A K++      A D +++ REA+I  +L +P IVRL    
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVC 405
Query: 59  QEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           Q E    LV ++  GG L + +V  RE    ++ +  + Q+   + +      VHR+L  
Sbjct: 406 QAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 118 ENLLLASKAKGAAVKLADFGLA 139
            N+LL ++      K++DFGL+
Sbjct: 465 RNVLLVNR---HYAKISDFGLS 483

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 74/255 (29%)
Query: 34  QKLEREARICRKLQHPNIVRLHD---SIQEENYH--YLVFDLVTG--GELFEDIVAREFY 86
           +++ RE R+     HPNI+ L D     +E   H  YLV +L+     ++  D   R   
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVI 131
Query: 87  SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG--------- 137
           S     + +  IL  ++  H  GVVHRDL P N+LLA       + + DF          
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADA 188
Query: 138 ---------------LAIEVQG------------------EQQAWF-GVILY------IL 157
                          L ++ +G                   ++A F G   Y      + 
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 158 LVGYPPFWDEDQHRLYAQIKAGAY------DYPSPEWDTVTPEAK----NLINQMLTVNP 207
           +VG P   D     +++   A  Y      + P+  W  V P A     +LI +ML  NP
Sbjct: 249 VVGTPKIEDV---VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 208 SKRITASEALKHPWI 222
            +RI+  +AL+HP+ 
Sbjct: 306 QRRISTEQALRHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 74/255 (29%)
Query: 34  QKLEREARICRKLQHPNIVRLHD---SIQEENYH--YLVFDLVTG--GELFEDIVAREFY 86
           +++ RE R+     HPNI+ L D     +E   H  YLV +L+     ++  D   R   
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVI 131
Query: 87  SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG--------- 137
           S     + +  IL  ++  H  GVVHRDL P N+LLA       + + DF          
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADA 188
Query: 138 ---------------LAIEVQG------------------EQQAWF-GVILY------IL 157
                          L ++ +G                   ++A F G   Y      + 
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 158 LVGYPPFWDEDQHRLYAQIKAGAY------DYPSPEWDTVTPEAK----NLINQMLTVNP 207
           +VG P   D     +++   A  Y      + P+  W  V P A     +LI +ML  NP
Sbjct: 249 VVGTPKIEDV---VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 208 SKRITASEALKHPWI 222
            +RI+  +AL+HP+ 
Sbjct: 306 QRRISTEQALRHPYF 320

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 84
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 145 NCLV---GENHLVKVADFGLSRLMTGD 168

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQ------KLEREARICRKLQHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      +  RE  + + + H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 85
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 146 NCLV---GENHLVKVADFGLSRLMTGD 169

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 141 NCLV---GENHLVKVADFGLSRLMTGD 164

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 85
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 146 NCLV---GENHLVKVADFGLSRLMTGD 169

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 82
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 143 NCLV---GENHLVKVADFGLSRLMTGD 166

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 81
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 142 NCLV---GENHLVKVADFGLSRLMTGD 165

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 82
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 143 NCLV---GENHLVKVADFGLSRLMTGD 166

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 85
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 146 NCLV---GENHLVKVADFGLSRLMTGD 169

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 93
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 154 NCLV---GENHLVKVADFGLSRLMTGD 177

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 53  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 112 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 165
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 166 LKILDFGLA 174

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 51  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 110 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 163
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 164 LKILDFGLA 172

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 82
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 143 NCLV---GENHLVKVADFGLSRLMTGD 166

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 19/145 (13%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQ 59
           G +S V   +      +   KI+   K +     K++RE +I   L+  PNI+ L D ++
Sbjct: 48  GKYSEVFEAINITNNEKVVVKILKPVKKN-----KIKREIKILENLRGGPNIITLADIVK 102
Query: 60  E--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVNHCHSNGVVHRD 114
           +       LVF+ V   +       ++ Y   ++ D    + +IL+++++CHS G++HRD
Sbjct: 103 DPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 115 LKPENLLLASKAKGAAVKLADFGLA 139
           +KP N+++  + +   ++L D+GLA
Sbjct: 157 VKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 53  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 112 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 165
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 166 LKILDFGLA 174

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 90  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 149 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 202
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 203 LKILDFGLA 211

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 45  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 104 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 157
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 158 LKILDFGLA 166

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 46  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 105 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 158
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 159 LKILDFGLA 167

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 46  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 105 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 158
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 159 LKILDFGLA 167

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        +++E    YLV +L
Sbjct: 90  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 149 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 202
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 203 LKILDFGLA 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 54/220 (24%)
Query: 33  FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS 92
           FQ+ +RE  I   L HPNIV+L+  +   N   +V + V  G+L+  ++        D +
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLL--------DKA 116
Query: 93  HCIQ---------QILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAV--KLADFGLA 139
           H I+          I   + +  +    +VHRDL+  N+ L S  + A V  K+ADFGL+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 140 IE-------------------VQGEQQAW--------FGVILYILLVGYPPF--WDEDQH 170
            +                   +  E++++        F +ILY +L G  PF  +   + 
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 171 RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           +    I+        PE     P  +N+I    + +P KR
Sbjct: 237 KFINMIREEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 109/274 (39%), Gaps = 69/274 (25%)
Query: 1   GAFSVVRRCVQKATGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHD-- 56
           G F+ V       +G E+A K +++ ++   R    + +E    +KL  HPNIV+     
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 57  SIQEENY-----HYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSN 108
           SI +E        +L+   +  G+L E +   E          ++   Q   +V H H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 109 G--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ----------------------- 143
              ++HRDLK ENLLL+++     +KL DFG A  +                        
Sbjct: 156 KPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 144 ------------------GEQQ-AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 183
                             GE+Q  W  G ILY+L     PF D  + R    I  G Y  
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSI 268
Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
           P    DT      +LI  ML VNP +R++ +E +
Sbjct: 269 PP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 54  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 113 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 166
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 167 LKILDFGLA 175

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 53  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 112 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CT 165
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 166 LKILDFGLA 174

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 46  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 104
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 105 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 158
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 159 LKILDFGLA 167

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 57  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 115
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 116 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 169
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 170 LKILDFGLA 178

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 35/169 (20%)
Query: 30  ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEA 89
           ++  + + +EA++   L+HPNI+ L     +E    LV +   GG L   +  +    + 
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI 106
Query: 90  DASHCIQQILESVNHCHSNGVV---HRDLKPENLLLASKAKGA-----AVKLADFGLAIE 141
             +  + QI   +N+ H   +V   HRDLK  N+L+  K +        +K+ DFGLA E
Sbjct: 107 LVNWAV-QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 142 VQGEQQ-------AW-------------------FGVILYILLVGYPPF 164
                +       AW                   +GV+L+ LL G  PF
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/58 (32%), Positives = 33/58 (56%)
Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           +  F   R+   +T+   AG   +++PEV++   + K  D+W+ GV+L+ LL G  PF
Sbjct: 157 ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 287
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 348 NCLV---GENHLVKVADFGLSRLMTGD 371

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  INTKKLSARDFQKLEREARICRKL------QHPNIVRL------HDSIQEENYHYLVFDL 70
           +  KKLS R FQ      R  R+L       H NI+ L        S++E    Y+V +L
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 71  VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAA 130
           +        ++  E   E   S+ + Q+L  + H HS G++HRDLKP N+++ S      
Sbjct: 111 MDAN--LCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 164
Query: 131 VKLADFGLA 139
           +K+ DFGLA
Sbjct: 165 LKILDFGLA 173

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 46  LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESVNH 104
           L+  N V+   ++++++  ++  +    G L++ I +     + D      +QILE++++
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
            HS G++HRDLKP N+ +    +   VK+ DFGLA  V 
Sbjct: 132 IHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVH 167

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 144 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 174

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 144 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 174

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 19/125 (15%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEA---- 89
           ++   EA +  +LQHPN+V L   + ++    ++F   + G+L E +V R  +S+     
Sbjct: 57  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 90  ------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
                       D  H + QI   + +  S+ VVH+DL   N+L+  K     VK++D G
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLG 173
Query: 138 LAIEV 142
           L  EV
Sbjct: 174 LFREV 178

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 3/144 (2%)
Query: 35  KLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           + +REAR   +LQ P++V +HD  + +   Y+   L+ G +L   +  +   +   A   
Sbjct: 80  RXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAI 139
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL 154
           ++QI  +++  H+ G  HRD+KPEN+L+++        L DFG+A     E+    G  +
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 155 YILLVGYPPFWDEDQHRLYAQIKA 178
             L    P  + E      A I A
Sbjct: 197 GTLYYXAPERFSESHATYRADIYA 220

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 164 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 194

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 19/125 (15%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEA---- 89
           ++   EA +  +LQHPN+V L   + ++    ++F   + G+L E +V R  +S+     
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 90  ------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
                       D  H + QI   + +  S+ VVH+DL   N+L+  K     VK++D G
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLG 190
Query: 138 LAIEV 142
           L  EV
Sbjct: 191 LFREV 195

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 145 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 175

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A KI+     +   FQ    E  + RK +H NI+     + ++N   +V     G  L
Sbjct: 60  DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLA-IVTQWCEGSSL 118
Query: 77  FEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           ++ +  +E  +         +Q  + +++ H+  ++HRD+K  N+ L    +G  VK+ D
Sbjct: 119 YKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGD 175
Query: 136 FGLA 139
           FGLA
Sbjct: 176 FGLA 179

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQEENYHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNIV+L D +++++     L+F+ V   +     V     ++ D  + I ++L+++++CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 143 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 173

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 54/220 (24%)
Query: 33  FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS 92
           FQ+ +RE  I   L HPNIV+L+  +   N   +V + V  G+L+  ++        D +
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLL--------DKA 116
Query: 93  HCIQ---------QILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAV--KLADFG-- 137
           H I+          I   + +  +    +VHRDL+  N+ L S  + A V  K+ADFG  
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS 176
Query: 138 ----------------LAIEVQG-EQQAW--------FGVILYILLVGYPPF--WDEDQH 170
                           +A E  G E++++        F +ILY +L G  PF  +   + 
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 171 RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           +    I+        PE     P  +N+I    + +P KR
Sbjct: 237 KFINMIREEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTL 99
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y+V + +  G L + +    RE  +     +   QI  ++ +      +HRDL   
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 159
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 160 NCLV---GENHVVKVADFGLSRLMTGD 183

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 48/173 (27%)
Query: 95  IQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFG-----LAIEVQGEQQA 148
           I+ +L S ++ H+   + HRD+KP N+L+    K   VKL+DFG     +  +++G +  
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 149 W-----------------------FGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYP 184
           +                        G+ LY++     PF        L+  I+    +YP
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 185 ---------------SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                          +   + ++ E  + +   L  NP++RIT+ +ALKH W+
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+F    D + 
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLAS 112
Query: 94  CI---QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------- 143
            I    Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++       
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTXXKA 169
Query: 144 ---------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA 180
                                     W FGV ++ IL+ G  PF     + +  +I+ G 
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
              P P      P   +L+ +    +PS+R   +E
Sbjct: 230 -RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)
Query: 35  KLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           K  +EARI ++  HPNIVRL     ++   Y+V +LV GG+         F     A   
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL------TFLRTEGARLR 211
Query: 95  IQQILESVN-------HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
           ++ +L+ V        +  S   +HRDL   N L+  K     +K++DFG++ E
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSRE 262

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)
Query: 35  KLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           K  +EARI ++  HPNIVRL     ++   Y+V +LV GG+         F     A   
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL------TFLRTEGARLR 211
Query: 95  IQQILESVN-------HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE 141
           ++ +L+ V        +  S   +HRDL   N L+  K     +K++DFG++ E
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSRE 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 326
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  +     +   QI  ++ +      +HR+L   
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 386
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGE 145
           N L+    +   VK+ADFGL+  + G+
Sbjct: 387 NCLV---GENHLVKVADFGLSRLMTGD 410

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD--SI 58
           G F  V +   + TG + A K +  +           RE +I + L+H N+V L +    
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 59  QEENYH------YLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +   Y+      YLVFD        L  +++ +  ++ ++    +Q +L  + + H N +
Sbjct: 89  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKI 146
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+K  N+L+    +   +KLADFGLA
Sbjct: 147 LHRDMKAANVLI---TRDGVLKLADFGLA 172

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD--SI 58
           G F  V +   + TG + A K +  +           RE +I + L+H N+V L +    
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 59  QEENYH------YLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +   Y+      YLVFD        L  +++ +  ++ ++    +Q +L  + + H N +
Sbjct: 89  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKI 146
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+K  N+L+    +   +KLADFGLA
Sbjct: 147 LHRDMKAANVLI---TRDGVLKLADFGLA 172

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD--SI 58
           G F  V +   + TG + A K +  +           RE +I + L+H N+V L +    
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87
Query: 59  QEENYH------YLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +   Y+      YLVFD        L  +++ +  ++ ++    +Q +L  + + H N +
Sbjct: 88  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKI 145
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+K  N+L+    +   +KLADFGLA
Sbjct: 146 LHRDMKAANVLI---TRDGVLKLADFGLA 171

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD--SI 58
           G F  V +   + TG + A K +  +           RE +I + L+H N+V L +    
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 59  QEENYH------YLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           +   Y+      YLVFD        L  +++ +  ++ ++    +Q +L  + + H N +
Sbjct: 89  KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKI 146
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+K  N+L+    +   +KLADFGLA
Sbjct: 147 LHRDMKAANVLI---TRDGVLKLADFGLA 172

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 103/270 (38%), Gaps = 52/270 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G FS V        G  +A K I   +   +D ++ +REA + R   HPNI+RL      
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 61  E----NYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVH 112
           E    +  +L+      G L+ +I   +    F +E      +  I   +   H+ G  H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA-IEVQGEQQA-----W--------------FGV 152
           RDLKP N+LL  + +   + L     A I V+G +QA     W              F V
Sbjct: 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217
Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKN--------------- 197
             + ++      W             G YD    + D+V    +N               
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALW 277
Query: 198 -LINQMLTVNPSKR------ITASEALKHP 220
            L+N M+TV+P +R      ++  EAL+ P
Sbjct: 278 QLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 54/220 (24%)
Query: 33  FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS 92
           FQ+ +RE  I   L HPNIV+L+  +   N   +V + V  G+L+  ++        D +
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLL--------DKA 116
Query: 93  HCIQ---------QILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAV--KLADFGLA 139
           H I+          I   + +  +    +VHRDL+  N+ L S  + A V  K+ADF L+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS 176
Query: 140 IE-------------------VQGEQQAW--------FGVILYILLVGYPPF--WDEDQH 170
            +                   +  E++++        F +ILY +L G  PF  +   + 
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 171 RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           +    I+        PE     P  +N+I    + +P KR
Sbjct: 237 KFINMIREEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 113
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 114 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 229
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 230 RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 113
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 114 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 229
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 230 RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 118
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKAS 175
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 234
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 235 RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 266

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 93/313 (29%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP------NIVRL 54
           G+F  V +          A K++  +K   R  ++   E RI   L+        N++ +
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVH 112
            ++    N+  + F+L++   L+E I   +F  +S          IL+ ++  H N ++H
Sbjct: 165 LENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI----EVQGEQQAWF------------------ 150
            DLKPEN+LL  + + + +K+ DFG +      V    Q+ F                  
Sbjct: 224 CDLKPENILLKQQGR-SGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDM 282
Query: 151 ---GVILYILLVGYPPFWDED----------------QHRLYAQIKAGAYDYPS--PEWD 189
              G IL  LL GYP    ED                Q  L A  +A  +      P + 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYC 342
Query: 190 TVT----------------------PEAK---------------NLINQMLTVNPSKRIT 212
           TVT                      PE++               + + Q L  +P+ R+T
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402
Query: 213 ASEALKHPWICQR 225
             +AL+HPW+ +R
Sbjct: 403 PGQALRHPWLRRR 415

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           Y +PEV+    YG P+D+W+ G IL  LL GYP    ED+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 53  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 110
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKAS 167
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 227 RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTE 258

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 84  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 141
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 142 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKAS 198
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 257
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 258 RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 289

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 93/313 (29%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP------NIVRL 54
           G+F  V +          A K++  +K   R  ++   E RI   L+        N++ +
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVH 112
            ++    N+  + F+L++   L+E I   +F  +S          IL+ ++  H N ++H
Sbjct: 165 LENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI----EVQGEQQAWF------------------ 150
            DLKPEN+LL  + + + +K+ DFG +      V    Q+ F                  
Sbjct: 224 CDLKPENILLKQQGR-SGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDM 282
Query: 151 ---GVILYILLVGYPPFWDED----------------QHRLYAQIKAGAY----DYP--- 184
              G IL  LL GYP    ED                Q  L A  +A  +     YP   
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYC 342
Query: 185 ---------------------------SPEWDTVT-----PEAKNLINQMLTVNPSKRIT 212
                                      S EW         P   + + Q L  +P+ R+T
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402
Query: 213 ASEALKHPWICQR 225
             +AL+HPW+ +R
Sbjct: 403 PGQALRHPWLRRR 415

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           Y +PEV+    YG P+D+W+ G IL  LL GYP    ED+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 58  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 115
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 116 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKAS 172
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 173 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 231
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 232 RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTE 263

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+F    D + 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLAS 492
Query: 94  CI---QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------- 143
            I    Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++       
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKA 549
Query: 144 ---------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA 180
                                     W FGV ++ IL+ G  PF     + +  +I+ G 
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
              P P      P   +L+ +    +PS+R   +E
Sbjct: 610 -RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 641

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+ YS   AS 
Sbjct: 59  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASL 116
Query: 94  CIQ--QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ-------- 143
            +   Q+  ++ +  S   VHRD+   N+L++S      VKL DFGL+  ++        
Sbjct: 117 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKAS 173
Query: 144 --------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                    W FGV ++ IL+ G  PF     + +  +I+ G  
Sbjct: 174 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 232
Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
             P P      P   +L+ +    +PS+R   +E
Sbjct: 233 RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTE 264

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+F    D + 
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLAS 112
Query: 94  CI---QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------- 143
            I    Q+  ++ +  S   VHRD+   N+L+++      VKL DFGL+  ++       
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKA 169
Query: 144 ---------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA 180
                                     W FGV ++ IL+ G  PF     + +  +I+ G 
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
              P P      P   +L+ +    +PS+R   +E
Sbjct: 230 -RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 39  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 97
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 98  LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 153
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 154 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213
Query: 155 YILLVGYPPFWD--EDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF        +L+A I      ++P  PE D      ++++   L  +P +R
Sbjct: 214 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD-----LQDVLKCCLKRDPKQR 268
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 269 ISIPELLAHPYV 280

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 35  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 93
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 94  LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 149
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209
Query: 155 YILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF      ++  QI K  A   P+ E    D    + ++++   L  +P +R
Sbjct: 210 YYMTYGKTPF-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 264
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 265 ISIPELLAHPYV 276

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 141
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 197
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 155 YILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF      ++  QI K  A   P+ E    D    + ++++   L  +P +R
Sbjct: 258 YYMTYGKTPF-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 313 ISIPELLAHPYV 324

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 36  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 94
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 95  LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 150
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 155 YILLVGYPPFWD--EDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF        +L+A I      ++P  PE D      ++++   L  +P +R
Sbjct: 211 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD-----LQDVLKCCLKRDPKQR 265
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 266 ISIPELLAHPYV 277

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 55  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 113
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 114 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 169
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 155 YILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF      ++  QI K  A   P+ E    D    + ++++   L  +P +R
Sbjct: 230 YYMTYGKTPF-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 285 ISIPELLAHPYV 296

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 141
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 197
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 155 YILLVGYPPFWD--EDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF        +L+A I      ++P  PE D      ++++   L  +P +R
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL-----QDVLKCCLKRDPKQR 312
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 313 ISIPELLAHPYV 324

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 141
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 197
Query: 136 FGLAIEVQGEQQA----------------------------------------W-FGVIL 154
           FG+A ++Q +  +                                        W  G IL
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 155 YILLVGYPPFWD--EDQHRLYAQIKAG-AYDYPS-PEWDTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF        +L+A I      ++P  PE D      ++++   L  +P +R
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL-----QDVLKCCLKRDPKQR 312
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 313 ISIPELLAHPYV 324

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 99/252 (39%), Gaps = 57/252 (22%)
Query: 18  FAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGE 75
           +A K +N ++   +       E     KLQ     I+RL+D    + Y Y+V +     +
Sbjct: 55  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID 113
Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           L   +  ++     +     + +LE+V+  H +G+VH DLKP N L+        +KL D
Sbjct: 114 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 169
Query: 136 FGLAIEVQGE----------------------------------------QQAW-FGVIL 154
           FG+A ++Q +                                           W  G IL
Sbjct: 170 FGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 155 YILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKR 210
           Y +  G  PF      ++  QI K  A   P+ E    D    + ++++   L  +P +R
Sbjct: 230 YYMTYGKTPF-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284
Query: 211 ITASEALKHPWI 222
           I+  E L HP++
Sbjct: 285 ISIPELLAHPYV 296

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/313 (22%), Positives = 118/313 (37%), Gaps = 93/313 (29%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP------NIVRL 54
           G F  V +          A K++  +K   R  ++   E RI   L+        N++ +
Sbjct: 108 GXFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVH 112
            ++    N+  + F+L++   L+E I   +F  +S          IL+ ++  H N ++H
Sbjct: 165 LENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAI----EVQGEQQAWF------------------ 150
            DLKPEN+LL  + + + +K+ DFG +      V    Q+ F                  
Sbjct: 224 CDLKPENILLKQQGR-SGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGARYGMPIDM 282
Query: 151 ---GVILYILLVGYPPFWDED----------------QHRLYAQIKAGAYDYPS--PEWD 189
              G IL  LL GYP    ED                Q  L A  +A  +      P + 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYC 342
Query: 190 TVT----------------------PEAK---------------NLINQMLTVNPSKRIT 212
           TVT                      PE++               + + Q L  +P+ R+T
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402
Query: 213 ASEALKHPWICQR 225
             +AL+HPW+ +R
Sbjct: 403 PGQALRHPWLRRR 415

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           Y +PEV+    YG P+D+W+ G IL  LL GYP    ED+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 56/93 (60%), Gaps = 7/93 (7%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH 106
           PNI+ L D +++       LVF+ V   +  +    R+  ++ D    + +IL+++++CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQ---LRQTLTDYDIRFYMYEILKALDYCH 148
Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 47  QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHC 105
           QHP  VRL  + +E    YL  +L  G  L +   A      EA     ++  L ++ H 
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
           HS G+VH D+KP N+ L  + +    KL DFGL +E+
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVEL 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/304 (21%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G +  V +     TG   A K+++   ++  + +++++E  + +K   H NI   + +  
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 60  EEN------YHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
           ++N        +LV +    G   +L ++        E  A  C ++IL  ++H H + V
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC-REILRGLSHLHQHKV 150
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ---GEQQAWFGVILYI----------- 156
           +HRD+K +N+LL   A+   VKL DFG++ ++    G +  + G   ++           
Sbjct: 151 IHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207
Query: 157 -------------------LLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAK 196
                              +  G PP  D    R L+   +  A    S +W   + + +
Sbjct: 208 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQ 264
Query: 197 NLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQ 256
           + I   L  N S+R    + +KHP+I  R++      R +  D + +   +R  K  T  
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFI--RDQPNERQVRIQLKDHIDRTKKKRGEKDETEY 322
Query: 257 GFAG 260
            ++G
Sbjct: 323 EYSG 326

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 46  LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESVNH 104
           L+  N V+   ++++++  ++  +      L++ I +     + D      +QILE++++
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
            HS G++HRDLKP N+ +    +   VK+ DFGLA  V 
Sbjct: 132 IHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVH 167

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 7/120 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K      Q    EA + + LQH  +VRL+  + +E   Y++ + +  G L  D + 
Sbjct: 41  VKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL-DFLK 99
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +   +      I    QI E + +      +HRDL+  N+L+   ++    K+ADFGLA
Sbjct: 100 SDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLA 156

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 62/118 (52%), Gaps = 13/118 (11%)
Query: 32  DFQKLEREARICRKLQHPNIVRLHD-----SIQEENYHYLVFDLVTGG--ELFEDIVARE 84
           D +++ RE  I  +L H ++V++ D      +++ +  Y+V ++      +LF   V   
Sbjct: 95  DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV--- 151
Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
           + +E      +  +L  V + HS G++HRDLKP N L+    +  +VK+ DFGLA  V
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTV 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
           +K  +EA   R+  HP+IV+L   I E N  +++ +L T GEL   +  R+F    D + 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLAS 492
Query: 94  CI---QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ------- 143
            I    Q+  ++ +  S   VHRD+   N+L+++      VKL DFGL+  ++       
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKA 549
Query: 144 ---------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA 180
                                     W FGV ++ IL+ G  PF     + +  +I+ G 
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE 215
              P P      P   +L+ +    +PS+R   +E
Sbjct: 610 -RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTE 641

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 57/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  KL H NIVR      +    +++ +L+ GG+
Sbjct: 62  LQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 121 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 174
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 175 TCPGPGRVAKIGDFGMARDI 194

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K I    +S  DF +   EA +  KL HP +V+L+    E+    LVF+ +  G L +
Sbjct: 35  AIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 79  DIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
            +  +   F +E     C+  + E + +     V+HRDL   N L+    +   +K++DF
Sbjct: 92  YLRTQRGLFAAETLLGMCL-DVCEGMAYLEEASVIHRDLAARNCLV---GENQVIKVSDF 147
Query: 137 GLAIEVQGEQ 146
           G+   V  +Q
Sbjct: 148 GMTRFVLDDQ 157

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 57/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  KL H NIVR      +    +++ +L+ GG+
Sbjct: 76  LQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 135 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 188
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 189 TCPGPGRVAKIGDFGMARDI 208

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 7/120 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K      Q    EA + + LQH  +VRL+  +  E   Y++ + +  G L  D + 
Sbjct: 42  VKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL-DFLK 100
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +   +      I    QI E + +      +HRDL+  N+L+   ++    K+ADFGLA
Sbjct: 101 SDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLA 157

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 58/92 (63%), Gaps = 7/92 (7%)
Query: 50  NIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           NI++L D++++       LVF+ +   + F+ +   +  ++ D    + ++L+++++CHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLY--QILTDFDIRFYMYELLKALDYCHS 155
Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            G++HRD+KP N+++  + K   ++L D+GLA
Sbjct: 156 KGIMHRDVKPHNVMIDHQQK--KLRLIDWGLA 185

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 58/92 (63%), Gaps = 7/92 (7%)
Query: 50  NIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS 107
           NI++L D++++       LVF+ +   + F+ +   +  ++ D    + ++L+++++CHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLY--QILTDFDIRFYMYELLKALDYCHS 150
Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            G++HRD+KP N+++  + K   ++L D+GLA
Sbjct: 151 KGIMHRDVKPHNVMIDHQQK--KLRLIDWGLA 180

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHP-NIVRLHDS 57
           G+F  +      A G E A K+  + TK        +L  E++I + +Q    I  +   
Sbjct: 20  GSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 58  IQEENYHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             E +Y+ +V +L+  G   ED+    +R+F S         Q++  + + HS   +HRD
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKNFIHRD 130
Query: 115 LKPENLLLASKAKGAAVKLADFGLA 139
           +KP+N L+    KG  V + DFGLA
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 19/117 (16%)
Query: 38  REARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADAS--- 92
           RE  + R+L+HPN++ L        +   +L+FD     +L+  I   +F+  + A+   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII---KFHRASKANKKP 122
Query: 93  ---------HCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLA 139
                      + QIL+ +++ H+N V+HRDLKP N+L+  +  +   VK+AD G A
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K I    +S  DF +   EA +  KL HP +V+L+    E+    LVF+ +  G L +
Sbjct: 33  AIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 79  DIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
            +  +   F +E     C+  + E + +     V+HRDL   N L+    +   +K++DF
Sbjct: 90  YLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDF 145
Query: 137 GLAIEVQGEQ 146
           G+   V  +Q
Sbjct: 146 GMTRFVLDDQ 155

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K I    +S  DF +   EA +  KL HP +V+L+    E+    LVF+ +  G L +
Sbjct: 38  AIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94
Query: 79  DIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
            +  +   F +E     C+  + E + +     V+HRDL   N L+    +   +K++DF
Sbjct: 95  YLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDF 150
Query: 137 GLAIEVQGEQ 146
           G+   V  +Q
Sbjct: 151 GMTRFVLDDQ 160

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K  +   +    EA + + LQH  +V+LH  + +E   Y++ + +  G L  D + 
Sbjct: 44  VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL-DFLK 101
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +  S+      I    QI E +        +HRDL+  N+L+++       K+ADFGLA
Sbjct: 102 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLA 158

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 1   GAFSVVRRCVQKATGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHP-NIVRLHDS 57
           G+F  +      A G E A K+  + TK        +L  E++I + +Q    I  +   
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 58  IQEENYHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             E +Y+ +V +L+  G   ED+    +R+F S         Q++  + + HS   +HRD
Sbjct: 72  GAEGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 115 LKPENLLLASKAKGAAVKLADFGLA 139
           +KP+N L+    KG  V + DFGLA
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 106
Query: 77  FEDIVAREFYSEADASHCI-QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + A E   E      I +Q    +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGD 163
Query: 136 FGLAIEV-------QGEQQA----W----------------------FGVILYILLVGYP 162
           FGLA E        Q EQ +    W                      FG++LY L+ G  
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 163 PF 164
           P+
Sbjct: 224 PY 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K I    +S  DF +   EA +  KL HP +V+L+    E+    LVF+ +  G L +
Sbjct: 35  AIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 79  DIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
            +  +   F +E     C+  + E + +     V+HRDL   N L+    +   +K++DF
Sbjct: 92  YLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDF 147
Query: 137 GLAIEVQGEQ 146
           G+   V  +Q
Sbjct: 148 GMTRFVLDDQ 157

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K I    +S  DF +   EA +  KL HP +V+L+    E+    LVF+ +  G L +
Sbjct: 55  AIKTIKEGSMSEDDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 111
Query: 79  DIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
            +  +   F +E     C+  + E + +     V+HRDL   N L+    +   +K++DF
Sbjct: 112 YLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDF 167
Query: 137 GLAIEVQGEQ 146
           G+   V  +Q
Sbjct: 168 GMTRFVLDDQ 177

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 36/156 (23%)
Query: 34  QKLEREARICRKLQHPNIVRLH--------------DSIQEENYH--------------- 64
           +K ERE +   KL H NIV  +              DS++  +Y                
Sbjct: 50  EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCL 109
Query: 65  YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           ++  +    G L + I  R  E   +  A    +QI + V++ HS  ++HRDLKP N+ L
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL 169
Query: 123 ASKAKGAAVKLADFGLAIEVQ--GEQQAWFGVILYI 156
               +   VK+ DFGL   ++  G++    G + Y+
Sbjct: 170 VDTKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYM 202

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+L+  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVLIDHEHR--KLRLIDWGLA 179

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 60  EENYHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           E +Y+ +V +L+  G   ED+    +R+F S         Q++  + + HS   +HRD+K
Sbjct: 76  EGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKNFIHRDVK 132
Query: 117 PENLLLASKAKGAAVKLADFGLA 139
           P+N L+    KG  V + DFGLA
Sbjct: 133 PDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 5/128 (3%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G F  V +CV++  G  +A K        + D Q   RE      L QH ++VR   +  
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+++  +  +   GG L + I        ++ EA+    + Q+   + + HS  +VH D+
Sbjct: 80  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 139
Query: 116 KPENLLLA 123
           KP N+ ++
Sbjct: 140 KPSNIFIS 147

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 5/128 (3%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G F  V +CV++  G  +A K        + D Q   RE      L QH ++VR   +  
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81
Query: 60  EENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+++  +  +   GG L + I        ++ EA+    + Q+   + + HS  +VH D+
Sbjct: 82  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 141
Query: 116 KPENLLLA 123
           KP N+ ++
Sbjct: 142 KPSNIFIS 149

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 5/128 (3%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G F  V +CV++  G  +A K        + D Q   RE      L QH ++VR   +  
Sbjct: 18  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 77
Query: 60  EENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+++  +  +   GG L + I        ++ EA+    + Q+   + + HS  +VH D+
Sbjct: 78  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 137
Query: 116 KPENLLLA 123
           KP N+ ++
Sbjct: 138 KPSNIFIS 145

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K  +   +    EA + + LQH  +V+LH  + +E   Y++ + +  G L  D + 
Sbjct: 211 VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL-DFLK 268
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +  S+      I    QI E +        +HRDL+  N+L+++       K+ADFGLA
Sbjct: 269 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLA 325

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 33/257 (12%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           E A ++I+ ++ +    +  +RE    R+ +H N+V    +     +  ++  L  G  L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 77  FEDIVAREFYSEADASHCI-QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  +   +   + + +  I Q+I++ + + H+ G++H+DLK +N+   +      V + D
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN----GKVVITD 172
Query: 136 FGLAIEVQGEQQA------------WFGVILYILLVGYPPFWDED-----QHRLYAQIKA 178
           FGL   + G  QA            W   +   ++    P  +ED     +H     +  
Sbjct: 173 FGL-FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 179 GAYDYPSPEWDTVTPEAKNLINQMLT--------VNPSKRITASEALKHPWICQRERVAS 230
             Y+  + EW   T  A+ +I QM T        +   K I  S+ L   W  ++E   +
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEI--SDILLFCWAFEQEERPT 289
Query: 231 IVHRQETVDCLKKFNAR 247
                + ++ L K N R
Sbjct: 290 FTKLMDMLEKLPKRNRR 306

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           + T K  +   +    EA + + LQH  +V+LH  + +E   Y++ + +  G L  D + 
Sbjct: 217 VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL-DFLK 274
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +  S+      I    QI E +        +HRDL+  N+L+++       K+ADFGLA
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLA 331

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 5/128 (3%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G F  V +CV++  G  +A K        + D Q   RE      L QH ++VR   +  
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 79
Query: 60  EENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+++  +  +   GG L + I        ++ EA+    + Q+   + + HS  +VH D+
Sbjct: 80  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 139
Query: 116 KPENLLLA 123
           KP N+ ++
Sbjct: 140 KPSNIFIS 147

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 65/299 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLER----EARICRKLQHPNI- 51
            AF V+R+      G     + I+ KK  A    R+ +K  R    EA I +K+Q+ +I 
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 52  ----VRLHDSIQEENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVN 103
               V+ H      ++  L+F+ + G  L+E I+ R     F+ E    +CI+ IL+++N
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE-IITRNNYNGFHIEDIKLYCIE-ILKALN 151
Query: 104 HCHSNGVVHRDLKPENLLLAS----------------------KAKGAAVKLADFGLAIE 141
           +     + H DLKPEN+LL                        + K   +KL DFG A  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 142 VQGEQQAWFGVILY-----ILLVGYPPFWDEDQHR-----LYAQIKAGAYDYPSPEW--- 188
                 +      Y     IL +G    WD          + A++  G+  + + E    
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLG----WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 189 -----DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLK 242
                  + P  KN++ +    N SK +   E LK  W      + SI H ++ +   K
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDE-LKLAWPENASSINSIKHVKKCLPLYK 325

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L           +V     G  L
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL 106
Query: 77  FEDIVAREFYSEADASHCI-QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + A E   E      I +Q    +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGD 163
Query: 136 FGLAIE 141
           FGLA E
Sbjct: 164 FGLATE 169

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 53  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 111
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 112 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 165
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 166 TCPGPGRVAKIGDFGMARDI 185

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 19/147 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH----PNIVRLHD 56
           G+F  +       T  E A K+ N K        +L  E++I R LQ     PN+     
Sbjct: 18  GSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFG- 72
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQILESVNHCHSNGVVH 112
              E +Y+ LV DL+  G   ED+    F S   +   +     Q++  V   HS   +H
Sbjct: 73  --VEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA 139
           RD+KP+N L+    +   V + DFGLA
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLA 153

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 23/154 (14%)
Query: 1   GAFSVVRRCVQKATGLEFA-AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD--- 56
           G F  V+   +K+TG+  A  K+I   +   R+ Q ++  A     L HPNIV+L     
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLA----VLHHPNIVQLQSYFY 89
Query: 57  SIQEENYHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQ------QILESVN--HC 105
           ++ E +   +  ++V   E   D +    R +Y    A   I       Q++ S+   H 
Sbjct: 90  TLGERDRRDIYLNVVM--EYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            S  V HRD+KP N+L+ ++A G  +KL DFG A
Sbjct: 148 PSVNVCHRDIKPHNVLV-NEADG-TLKLCDFGSA 179

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 46  LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESVNH 104
           L+  N V+   ++++++  ++  +      L++ I +     + D      +QILE++++
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
            HS G++HR+LKP N+ +    +   VK+ DFGLA  V 
Sbjct: 132 IHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVH 167

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 68/180 (37%), Gaps = 55/180 (30%)
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGL---------------- 138
           I Q+  +V   HS G+ HRD+KP+NLL+ SK     +KL DFG                 
Sbjct: 147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAXICS 204
Query: 139 -----------AIEVQGEQQAW-FGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYD- 182
                      A E       W  G +   L++G P F  E   DQ     QI       
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE 264
Query: 183 -------------YPS---PEWDTVTPE-----AKNLINQMLTVNPSKRITASEALKHPW 221
                        +P+    +W  + PE     A +L+ Q+L   P  RI   EA+ HP+
Sbjct: 265 QMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 15/127 (11%)
Query: 26  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREF 85
           K  +  + +K   EA I + L HP+IV+L   I+EE   +++ +L   GEL         
Sbjct: 62  KDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGEL-----GHYL 115
Query: 86  YSEADASHCIQQILESVNHC------HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
               ++   +  +L S+  C       S   VHRD+   N+L+AS      VKL DFGL+
Sbjct: 116 ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP---ECVKLGDFGLS 172
Query: 140 IEVQGEQ 146
             ++ E 
Sbjct: 173 RYIEDED 179

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 62  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 121 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 174
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 175 TCPGPGRVAKIGDFGMARDI 194

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 62  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 121 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 174
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 175 TCPGPGRVAKIGDFGMAQDI 194

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 61  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 120 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 174 TCPGPGRVAKIGDFGMARDI 193

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 61  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 119
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 120 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 174 TCPGPGRVAKIGDFGMARDI 193

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 21/130 (16%)
Query: 26  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE------- 78
           K  +  + +K   EA I + L HP+IV+L   I+EE   +++ +L   GEL         
Sbjct: 46  KDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKN 104
Query: 79  --DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
              ++    YS         QI +++ +  S   VHRD+   N+L+AS      VKL DF
Sbjct: 105 SLKVLTLVLYS--------LQICKAMAYLESINCVHRDIAVRNILVASP---ECVKLGDF 153
Query: 137 GLAIEVQGEQ 146
           GL+  ++ E 
Sbjct: 154 GLSRYIEDED 163

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 19/127 (14%)
Query: 29  SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           S +D      EA I  K  H NIVR      +    +++ +L+ GG+L      + F  E
Sbjct: 80  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRE 133
Query: 89  A-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
                         D  H  + I     +   N  +HRD+   N LL     G   K+ D
Sbjct: 134 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 193
Query: 136 FGLAIEV 142
           FG+A ++
Sbjct: 194 FGMARDI 200

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 102 LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 161 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 215 TCPGPGRVAKIGDFGMARDI 234

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 21/130 (16%)
Query: 26  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE------- 78
           K  +  + +K   EA I + L HP+IV+L   I+EE   +++ +L   GEL         
Sbjct: 50  KDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKN 108
Query: 79  --DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF 136
              ++    YS         QI +++ +  S   VHRD+   N+L+AS      VKL DF
Sbjct: 109 SLKVLTLVLYS--------LQICKAMAYLESINCVHRDIAVRNILVASP---ECVKLGDF 157
Query: 137 GLAIEVQGEQ 146
           GL+  ++ E 
Sbjct: 158 GLSRYIEDED 167

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 78  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 137 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 190
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 191 TCPGPGRVAKIGDFGMARDI 210

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 76  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 134
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 135 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 188
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 189 TCPGPGRVAKIGDFGMARDI 208

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 143
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 177

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 20/140 (14%)
Query: 16  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE 75
           L+ A K +  +  S +D      EA I  K  H NIVR      +    +++ +L+ GG+
Sbjct: 79  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 76  LFEDIVAREFYSEA-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLL 122
           L      + F  E              D  H  + I     +   N  +HRD+   N LL
Sbjct: 138 L------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 191
Query: 123 ASKAKGAAVKLADFGLAIEV 142
                G   K+ DFG+A ++
Sbjct: 192 TCPGPGRVAKIGDFGMARDI 211

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 19/127 (14%)
Query: 29  SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           S +D      EA I  K  H NIVR      +    +++ +L+ GG+L      + F  E
Sbjct: 88  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRE 141
Query: 89  A-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
                         D  H  + I     +   N  +HRD+   N LL     G   K+ D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 136 FGLAIEV 142
           FG+A ++
Sbjct: 202 FGMARDI 208

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 144
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 178

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 150
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 151 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 184

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 144
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 178

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 13/96 (13%)
Query: 49  PNIVRLHDSIQE--ENYHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVN 103
           PNI+ L D +++       LVF+ V   +       ++ Y   ++ D    + +IL++++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +CHS G++HRD+KP N+++  + +   ++L D+GLA
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA 179

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/313 (23%), Positives = 109/313 (34%), Gaps = 96/313 (30%)
Query: 1   GAFSVVRRCV-QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPN----IVR 53
           GAF  V  C+  KA G   A KI+   K   R  +    E ++   L    PN     V+
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGV 110
           + +  +   +  +VF+L+  G    D +    +      H  +   QI +SVN  HSN +
Sbjct: 82  MLEWFEHHGHICIVFELL--GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 111 VHRDLKPENLLLASKAKGAA----------------VKLADFG----------------- 137
            H DLKPEN+L        A                +K+ DFG                 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVXXRH 199
Query: 138 -------LAIEVQGEQQAW-FGVILYILLVGYPPFWDED----------------QHRLY 173
                  LA+        W  G IL    +G+  F   D                +H + 
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 174 AQIKAGAYDYPSPEWDTVTPEAK------------------------NLINQMLTVNPSK 209
              K   + +   +WD  +   +                        +LI +ML  +P+K
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 210 RITASEALKHPWI 222
           RIT  EALKHP+ 
Sbjct: 320 RITLREALKHPFF 332

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/313 (23%), Positives = 109/313 (34%), Gaps = 96/313 (30%)
Query: 1   GAFSVVRRCV-QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPN----IVR 53
           GAF  V  C+  KA G   A KI+   K   R  +    E ++   L    PN     V+
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGV 110
           + +  +   +  +VF+L+  G    D +    +      H  +   QI +SVN  HSN +
Sbjct: 82  MLEWFEHHGHICIVFELL--GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 111 VHRDLKPENLLLASKAKGAA----------------VKLADFG----------------- 137
            H DLKPEN+L        A                +K+ DFG                 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH 199
Query: 138 -------LAIEVQGEQQAW-FGVILYILLVGYPPFWDED----------------QHRLY 173
                  LA+        W  G IL    +G+  F   D                +H + 
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 174 AQIKAGAYDYPSPEWDTVTPEAK------------------------NLINQMLTVNPSK 209
              K   + +   +WD  +   +                        +LI +ML  +P+K
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 210 RITASEALKHPWI 222
           RIT  EALKHP+ 
Sbjct: 320 RITLREALKHPFF 332

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 19/127 (14%)
Query: 29  SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSE 88
           S +D      EA I  K  H NIVR      +    +++ +L+ GG+L      + F  E
Sbjct: 100 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRE 153
Query: 89  A-------------DASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
                         D  H  + I     +   N  +HRD+   N LL     G   K+ D
Sbjct: 154 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 213
Query: 136 FGLAIEV 142
           FG+A ++
Sbjct: 214 FGMARDI 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 73/297 (24%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 39  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 95
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ----------- 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++            
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 144 ------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAG-AYD 182
                              +   W FGV+L+ I  +G  P+       L+  +K G   D
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 183 YPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
            PS      T E   ++       PS+R T  + ++       +R+ ++   QE +D
Sbjct: 273 KPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVE-----DLDRIVALTSNQEXLD 320

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   +       +V + +  G L        F    D
Sbjct: 95  RDFLS---EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL------DTFLRTHD 145
Query: 91  ASHCIQQIL-------ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
               I Q++         + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN---LVCKVSDFGLSRVLE 202
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            +  A            W                   FGV+++ +L  G  P+W+     
Sbjct: 203 DDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
Query: 172 LYAQIKAGAYDYPSP 186
           + + ++ G Y  P+P
Sbjct: 263 VISSVEEG-YRLPAP 276

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   +       +V + +  G L        F    D
Sbjct: 95  RDFLS---EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL------DTFLRTHD 145
Query: 91  ASHCIQQIL-------ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
               I Q++         + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN---LVCKVSDFGLSRVLE 202
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            +  A            W                   FGV+++ +L  G  P+W+     
Sbjct: 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
Query: 172 LYAQIKAGAYDYPSP 186
           + + ++ G Y  P+P
Sbjct: 263 VISSVEEG-YRLPAP 276

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 25/159 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G F  V +   K  GL   A I   K+ +++D  +    E E  +C+   HPNI+ L  +
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNIINLLGA 94
Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----------QQIL-------E 100
            +   Y YL  +    G L  D + +    E D +  I          QQ+L        
Sbjct: 95  CEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +++      +HRDL   N+L+    +    K+ADFGL+
Sbjct: 154 GMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS 189

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 90
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 91  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 147
Query: 136 FGLAIE 141
           FGLA E
Sbjct: 148 FGLATE 153

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 25/159 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G F  V +   K  GL   A I   K+ +++D  +    E E  +C+   HPNI+ L  +
Sbjct: 26  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNIINLLGA 84
Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----------QQIL-------E 100
            +   Y YL  +    G L  D + +    E D +  I          QQ+L        
Sbjct: 85  CEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 143
Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +++      +HRDL   N+L+    +    K+ADFGL+
Sbjct: 144 GMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS 179

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 73/297 (24%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 39  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 95
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ----------- 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++            
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 144 ------------------GEQQAW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAG-AYD 182
                              +   W FGV+L+ I  +G  P+       L+  +K G   D
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 183 YPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
            PS      T E   ++       PS+R T  + ++       +R+ ++   QE +D
Sbjct: 273 KPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVE-----DLDRIVALTSNQEYLD 320

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 57/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 36  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 94
Query: 77  FEDIVAREFYSEADASHCI-QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + A E   E      I +Q    +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 95  YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGD 151
Query: 136 FGLA 139
           FGLA
Sbjct: 152 FGLA 155

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 19  AAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A K +    L+AR DFQ   REA +   LQH +IV+ +    + +   +VF+ +  G+L 
Sbjct: 49  AVKALKDPTLAARKDFQ---REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 78  EDIVA-------------REFYSEADAS---HCIQQILESVNHCHSNGVVHRDLKPENLL 121
           + + A             R+   E   S   H   QI   + +  S   VHRDL   N L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165
Query: 122 LASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQI--KAG 179
           + +      VK+ DFG++ +V      ++ V  + +L   P  W   +  +Y +   ++ 
Sbjct: 166 VGAN---LLVKIGDFGMSRDVYSTD--YYRVGGHTML---PIRWMPPESIMYRKFTTESD 217
Query: 180 AYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE 226
            + +    W+  T   K    Q+      + IT    L+ P +C +E
Sbjct: 218 VWSFGVILWEIFT-YGKQPWFQLSNTEVIECITQGRVLERPRVCPKE 263

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 89  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 148 AARNLLLATR---DLVKIGDFGL 167

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 52  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 110
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 111 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 167
Query: 136 FGLAIE 141
           FGLA E
Sbjct: 168 FGLATE 173

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 79  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 138 AARNLLLATR---DLVKIGDFGL 157

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 83  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 141
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 142 AARNLLLATR---DLVKIGDFGL 161

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 8/141 (5%)
Query: 1   GAFSVVRRCVQKATGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F    +   + TG     K +I   + + R F K   E ++ R L+HPN+++    + 
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKFIGVLY 77
Query: 60  EENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           ++     + + + GG L   I + +  Y  +      + I   + + HS  ++HRDL   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 119 NLLLASKAKGAAVKLADFGLA 139
           N L+        V +ADFGLA
Sbjct: 138 NCLVRENKN---VVVADFGLA 155

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 89  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 148 AARNLLLATR---DLVKIGDFGL 167

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 79  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 138 AARNLLLATR---DLVKIGDFGL 157

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 79  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 138 AARNLLLATR---DLVKIGDFGL 157

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGLA  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLARVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 118
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 119 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 175
Query: 136 FGLAIE 141
           FGLA E
Sbjct: 176 FGLATE 181

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 83  VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 141
Query: 116 KPENLLLASKAKGAAVKLADFGL 138
              NLLLA++     VK+ DFGL
Sbjct: 142 AARNLLLATR---DLVKIGDFGL 161

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 62  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHD 112
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 169
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 229
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 230 VIKAVDEG-YRLPPP 243

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 79  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 129
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 186
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 187 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 246
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 247 VIKAVDEG-YRLPPP 260

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 62  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 112
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 169
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 229
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 230 VIKAVDEG-YRLPPP 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/65 (43%), Positives = 37/65 (56%), Gaps = 5/65 (7%)
Query: 248 RKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWD-EDQHR 305
           R+ +V+ R   AGTPG+ +PEVL K P     +D+W+ GVI   LL G  PF+   D   
Sbjct: 199 RRQQVAPR---AGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255
Query: 306 LYAQI 310
             AQI
Sbjct: 256 ALAQI 260

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 114/266 (42%), Gaps = 57/266 (21%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 75  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIE--------------------VQG-----E 145
           +HRD+KP N+L+ S+ +   +KL DFG++ +                    +QG     +
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 146 QQAW-FGVILYILLVGY----PPFWDEDQHRLYAQIKAGAY--DYPSPEWDT--VTPEAK 196
              W  G+ L  + VG     PP   ED     A  +   Y  + P P+  +   + E +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 243
Query: 197 NLINQMLTVNPSKRITASEALKHPWI 222
           + +N+ L  NP++R    + + H +I
Sbjct: 244 DFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/315 (22%), Positives = 112/315 (35%), Gaps = 96/315 (30%)
Query: 1   GAFSVVRRCV-QKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPN------IV 52
           G F  V +CV  +  G   A KII N +K      +    E  +  K+   +       V
Sbjct: 44  GTFGRVVQCVDHRRGGARVALKIIKNVEKYK----EAARLEINVLEKINEKDPDNKNLCV 99
Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGV 110
           ++ D      +  + F+L+ G   F+ +    +  Y      H   Q+ ++V   H N +
Sbjct: 100 QMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKL 158
Query: 111 VHRDLKPENLLLAS----------------KAKGAAVKLADFGLA--------------- 139
            H DLKPEN+L  +                  K  AV++ DFG A               
Sbjct: 159 THTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRH 218
Query: 140 -------IEVQGEQ--QAW-FGVILYILLVGYPPFWDEDQH---------------RLYA 174
                  +E+   Q    W  G I++   VG+  F   D                 R+  
Sbjct: 219 YRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIR 278
Query: 175 QIKAGAYDYPSP-EWDT------------------VTPEAK------NLINQMLTVNPSK 209
           + +   Y Y    +WD                   +T EA+      +LI  ML   P+K
Sbjct: 279 KTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAK 338
Query: 210 RITASEALKHPWICQ 224
           R+T  EAL+HP+  +
Sbjct: 339 RLTLGEALQHPFFAR 353

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 19/127 (14%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 89  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 139
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 140 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 196
Query: 144 GEQQAWF 150
            + +A +
Sbjct: 197 DDPEAAY 203

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 19/127 (14%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQAWF 150
            + +A +
Sbjct: 199 DDPEAAY 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 36  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL-DFLK 93
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 94  GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 150

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 90
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 91  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 147
Query: 136 FGLA 139
           FGLA
Sbjct: 148 FGLA 151

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 48  HPNIVRLHDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESV 102
           HP+IV++ + ++  + H     Y+V + V G  L      +   +EA A   + +IL ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPAL 195
Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
           ++ HS G+V+ DLKPEN++L  +     +KL D G
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE----QLKLIDLG 226

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 38  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL-DFLK 95
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 96  GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 152

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 40  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG 98
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 99  ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 154

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 34  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 92
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 93  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 149
Query: 136 FGLA 139
           FGLA
Sbjct: 150 FGLA 153

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 23/143 (16%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH----------------YLVFDLVTGGELF 77
           +K ERE +   KL H NIV  +      +Y                 ++  +    G L 
Sbjct: 49  EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 78  EDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           + I  R  E   +  A    +QI + V++ HS  +++RDLKP N+ L    +   VK+ D
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGD 165
Query: 136 FGLAIEVQ--GEQQAWFGVILYI 156
           FGL   ++  G++    G + Y+
Sbjct: 166 FGLVTSLKNDGKRXRSKGTLRYM 188

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 95
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 96  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 152
Query: 136 FGLA 139
           FGLA
Sbjct: 153 FGLA 156

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 74/195 (37%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+RL   + +     +V + +  G L        F  + D
Sbjct: 91  RDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHD 141
Query: 91  ASHCIQQ-------ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
           A   + Q       I   + +    G VHRDL   N+L+ S       K++DFGL   ++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLGRVLE 198
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++L+ ++  G  P+W+     
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 172 LYAQIKAGAYDYPSP 186
           +   +  G Y  P P
Sbjct: 259 VIKAVDEG-YRLPPP 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 32  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 88
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 149 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 194

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 1   GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + +    G    +  A KI+N       + + ++ EA I   + HP++VRL  
Sbjct: 49  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLVRLLG 107
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRD 114
                    LV  L+  G L E +   +    S+   + C+Q I + + +     +VHRD
Sbjct: 108 VCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ-IAKGMMYLEERRLVHRD 165
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
           L   N+L+ S      VK+ DFGLA  ++G+++ +
Sbjct: 166 LAARNVLVKSPNH---VKITDFGLARLLEGDEKEY 197

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 95
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 96  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 152
Query: 136 FGLA 139
           FGLA
Sbjct: 153 FGLA 156

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 39  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 95
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVARE----------------FYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + ARE                  S  D   C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 39  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 95
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 80  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 136
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 197 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 242

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 31  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 87
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 148 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 193

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 28  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 84
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 145 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 190

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 25/159 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVRLHDS 57
           G F  V +   K  GL   A I   K+ +++D  +    E E  +C+   HPNI+ L  +
Sbjct: 33  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNIINLLGA 91
Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCI----------QQIL-------E 100
            +   Y YL  +    G L  D + +    E D +  I          QQ+L        
Sbjct: 92  CEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 150
Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +++      +HR+L   N+L+    +    K+ADFGL+
Sbjct: 151 GMDYLSQKQFIHRNLAARNILV---GENYVAKIADFGLS 186

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +    EA+I +KL+H  +V+L+  + EE   Y+V + +  G L + +  
Sbjct: 38  IKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKD 96
Query: 83  REFYSE--ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E  +    +      Q+   + +      +HRDL+  N+L+ +   G   K+ADFGLA
Sbjct: 97  GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGN---GLICKIADFGLA 152

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 1   GAFSVVRRCVQKATGLE---------FAAKIINTKKLSARDFQKLEREARICRKL-QHPN 50
           GAF  V   + +A GL+          A K++ +   + +D   L  E  + + + +H N
Sbjct: 24  GAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKN 80
Query: 51  IVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR----------------EFYSEADASHC 94
           I+ L  +  ++   Y++ +  + G L E + AR                E  S  D   C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
             Q+   + +  S   +HRDL   N+L+    +   +K+ADFGLA ++ 
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 186

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    K    + A K+I    +S  +F    +EA+   KL HP +V+ +    +
Sbjct: 19  GQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFF---QEAQTMMKLSHPKLVKFYGVCSK 74
Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---ILESVNHCHSNGVVHRDLKP 117
           E   Y+V + ++ G L   +  R      + S  ++    + E +    S+  +HRDL  
Sbjct: 75  EYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
            N L+    +   VK++DFG+   V  +Q
Sbjct: 133 RNCLV---DRDLCVKVSDFGMTRYVLDDQ 158

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 59  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 117
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 118 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 174
Query: 136 FGLA 139
           FGLA
Sbjct: 175 FGLA 178

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L      +    +V     G  L
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL 118
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 119 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 175
Query: 136 FGLA 139
           FGLA
Sbjct: 176 FGLA 179

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLV 71
           K TG     + IN +  S      L+ E  + +   HPNIV    +   +N  ++V   +
Sbjct: 49  KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 72  TGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK 127
             G   +D++   F    +E   ++ +Q +L+++++ H  G VHR +K  ++L++   K
Sbjct: 109 AYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 166

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 5/124 (4%)
Query: 17  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL 76
           + A K++N    + +  Q  + E  + RK +H NI+ L           +V     G  L
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL 90
Query: 77  FEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           +  + +    +         +Q  + +++ H+  ++HRDLK  N+ L    +   VK+ D
Sbjct: 91  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGD 147
Query: 136 FGLA 139
           FGLA
Sbjct: 148 FGLA 151

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 12  KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLV 71
           K TG     + IN +  S      L+ E  + +   HPNIV    +   +N  ++V   +
Sbjct: 33  KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 92
Query: 72  TGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK 127
             G   +D++   F    +E   ++ +Q +L+++++ H  G VHR +K  ++L++   K
Sbjct: 93  AYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 150

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 51/260 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 36  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 93
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 94  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 145
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIE--------------------VQG-----E 145
           +HRD+KP N+L+ S+ +   +KL DFG++ +                    +QG     +
Sbjct: 146 MHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 202
Query: 146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT--VTPEAKNLINQM 202
              W  G+ L  + VG  P           ++     + P P+  +   + E ++ +N+ 
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 262
Query: 203 LTVNPSKRITASEALKHPWI 222
           L  NP++R    + + H +I
Sbjct: 263 LIKNPAERADLKQLMVHAFI 282

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
           H   QI E+V   HS G++HRDLKP N+          VK+ DFGL   +  +++
Sbjct: 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEE 219

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG 271
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 327

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG 271
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 327

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + +  G L + +  
Sbjct: 44  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKG 102
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 103 ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 158

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 296 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG 354
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 410

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 10/120 (8%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGELFEDIVAREFYSEADAS 92
           Q    EA +  +L+H N+V+L   I EE    Y+V + +  G L + + +R         
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGG 288
Query: 93  HCIQQ----ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
            C+ +    + E++ +   N  VHRDL   N+L+   ++    K++DFGL  E    Q  
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQDT 345

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 1   GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + +    G    +  A KI+N       + + ++ EA I   + HP++VRL  
Sbjct: 26  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLVRLLG 84
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRD 114
                    LV  L+  G L E +   +    S+   + C+Q I + + +     +VHRD
Sbjct: 85  VCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ-IAKGMMYLEERRLVHRD 142
Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
           L   N+L+ S      VK+ DFGLA  ++G+++ +
Sbjct: 143 LAARNVLVKSPNH---VKITDFGLARLLEGDEKEY 174

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +K++H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + +  G L + +  
Sbjct: 44  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKG 102
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 103 ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 158

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L + +  
Sbjct: 213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKG 271
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 327

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 35  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 90
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 149
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  ++        Y   VG  +P  W   +  +Y++ 
Sbjct: 150 NCLVNDQ---GVVKVSDFGLSRYVLDDE--------YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 199 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 233

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGELFEDIVAREFYSEADAS 92
           Q    EA +  +L+H N+V+L   I EE    Y+V + +  G L + + +R         
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGG 116
Query: 93  HCIQQ----ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
            C+ +    + E++ +   N  VHRDL   N+L+   ++    K++DFGL  E    Q
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 171

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 56/120 (46%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL   N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILV---GENLVCKVADFGLA 161

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGELFEDIVAREFYSEADAS 92
           Q    EA +  +L+H N+V+L   I EE    Y+V + +  G L + + +R         
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGG 107
Query: 93  HCIQQ----ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
            C+ +    + E++ +   N  VHRDL   N+L+   ++    K++DFGL  E    Q
Sbjct: 108 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 162

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 5   VVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSIQEEN 62
           V +  ++ ++G +     I T K    + Q+++   EA I  +  H NI+RL   I +  
Sbjct: 60  VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 63  YHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------ILESVNHCHSNGVVHRDL 115
              ++ + +  G L       +F  E D    + Q       I   + +  +   VHRDL
Sbjct: 120 PMMIITEYMENGAL------DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------W-------------- 149
              N+L+ S       K++DFGL+  ++ + +A            W              
Sbjct: 174 AARNILVNSN---LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 150 -----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 186
                FG++++ ++  G  P+W+   H +   I  G +  P+P
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTP 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 26  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 81
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 140
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  ++        Y   VG  +P  W   +  +Y++ 
Sbjct: 141 NCLVNDQ---GVVKVSDFGLSRYVLDDE--------YTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 190 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 20  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 75
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 134
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  ++        Y   VG  +P  W   +  +Y++ 
Sbjct: 135 NCLVNDQ---GVVKVSDFGLSRYVLDDE--------YTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 184 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 218

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 43/223 (19%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER--EARICRKLQHPNIVRLHDSI 58
           G F  V     K  G    A  I T K+   + Q+ +   EA I  +  HPN+V L   +
Sbjct: 54  GEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVV 113
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDL 115
                  +V + +  G L  D   R+    ++       ++ I   + +    G VHRDL
Sbjct: 114 TRGKPVMIVIEFMENGAL--DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDL 171
Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------W-------------- 149
              N+L+ S       K++DFGL+  ++ + +A            W              
Sbjct: 172 AARNILVNSN---LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSA 228
Query: 150 -----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 186
                +G++++ ++  G  P+WD     +   I+ G Y  P+P
Sbjct: 229 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLPAP 270

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 20/133 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 242
Query: 132 KLADFGLAIEVQG 144
           K+ADFGLA ++  
Sbjct: 243 KIADFGLARDINN 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 10/120 (8%)
Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGELFEDIVAREFYSEADAS 92
           Q    EA +  +L+H N+V+L   I EE    Y+V + +  G L + + +R         
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGG 101
Query: 93  HCIQQ----ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA 148
            C+ +    + E++ +   N  VHRDL   N+L+   ++    K++DFGL  E    Q  
Sbjct: 102 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQDT 158

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 20/133 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 67  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 126
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV---TENNVM 183
Query: 132 KLADFGLAIEVQG 144
           K+ADFGLA ++  
Sbjct: 184 KIADFGLARDINN 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 19  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 74
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 133
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  ++        Y   VG  +P  W   +  +Y++ 
Sbjct: 134 NCLVNDQ---GVVKVSDFGLSRYVLDDE--------YTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 183 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  D + 
Sbjct: 47  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLL-DFLK 104
Query: 83  REFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            E          +    QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 105 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 161

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 69  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 128
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 185
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 186 KIADFGLARDIN 197

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 15  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 70
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 129
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  ++        Y   VG  +P  W   +  +Y++ 
Sbjct: 130 NCLVNDQ---GVVKVSDFGLSRYVLDDE--------YTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 179 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 72  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 131
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 188
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 189 KIADFGLARDIN 200

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 37  EREARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           +RE  I R L H +IV+       Q E    LV + V  G L  D + R     A     
Sbjct: 59  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLAQLLLF 117
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
            QQI E + + H+   +HR L   N+LL +      VK+ DFGLA  V
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDND---RLVKIGDFGLAKAV 162

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 23/160 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 20  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 77
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 78  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 129
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF 150
           +HRD+KP N+L+ S+ +   +KL DFG++ ++  E    F
Sbjct: 130 MHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDEMANEF 166

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 37  EREARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           +RE  I R L H +IV+       Q E    LV + V  G L  D + R     A     
Sbjct: 58  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLAQLLLF 116
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
            QQI E + + H+   +HR L   N+LL +      VK+ DFGLA  V
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDND---RLVKIGDFGLAKAV 161

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +     +AR  +   REA +   LQH +IV+ +    E +   +VF+ +  G+L +
Sbjct: 47  AVKTLKDASDNAR--KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 104
Query: 79  DIVAR-------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK 125
            + A                 +++   H  QQI   + +  S   VHRDL   N L+   
Sbjct: 105 FLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--- 161
Query: 126 AKGAAVKLADFGLAIEV 142
            +   VK+ DFG++ +V
Sbjct: 162 GENLLVKIGDFGMSRDV 178

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 61/148 (41%), Gaps = 18/148 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSI 58
           G F  V R   KA G + +   I T K    + Q+ E   EA I  + +HPNI+RL   +
Sbjct: 25  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVV 84
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN-------GVV 111
                  ++ + +  G L        F    D    + Q++  +    S          V
Sbjct: 85  TNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ S       K++DFGL+
Sbjct: 139 HRDLAARNILVNSN---LVCKVSDFGLS 163

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 19  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE 78
           A K +    +S   F +   EA++ +KL+H  +V+L+  + EE   Y+V + ++ G L  
Sbjct: 213 AIKTLKPGNMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL- 267
Query: 79  DIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLAD 135
           D +  E          +    QI   + +      VHRDL+  N+L+    +    K+AD
Sbjct: 268 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVAD 324
Query: 136 FGLA 139
           FGL 
Sbjct: 325 FGLG 328

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 80
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L E +   +E            QI + + +  +   +
Sbjct: 81  GVCYSAGRRNLK-LIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 139
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 140 HRDLATRNILVENENR---VKIGDFGLT 164

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 79  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 136
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 137 SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 188
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 189 MHRDVKPSNILVNSRGE---IKLCDFGVS 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 75  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVS 152

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++    + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/132 (22%), Positives = 58/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           ++ADFGLA ++ 
Sbjct: 197 RIADFGLARDIN 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 75  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVS 152

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           +  D   L  E  + + + +H NI+ L  +  ++   Y++ +  + G L E + AR    
Sbjct: 80  TEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/111 (23%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++  +
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENXY 168

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 35  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 90
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 149
Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG--YPPFWDEDQHRLYAQI 176
           N L+  +     VK++DFGL+  V  +++           VG  +P  W   +  +Y++ 
Sbjct: 150 NCLVNDQ---GVVKVSDFGLSRYVLDDEET--------SSVGSKFPVRWSPPEVLMYSKF 198
Query: 177 --KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
             K+  + +    W+  +          L   P +R T SE  +H
Sbjct: 199 SSKSDIWAFGVLMWEIYS----------LGKMPYERFTNSETAEH 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 75  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 74
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 75  SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVS 152

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 61/148 (41%), Gaps = 18/148 (12%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSI 58
           G F  V R   KA G + +   I T K    + Q+ E   EA I  + +HPNI+RL   +
Sbjct: 27  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVV 86
Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN-------GVV 111
                  ++ + +  G L        F    D    + Q++  +    S          V
Sbjct: 87  TNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ S       K++DFGL+
Sbjct: 141 HRDLAARNILVNSN---LVCKVSDFGLS 165

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 56/119 (47%), Gaps = 6/119 (5%)
Query: 23  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           I T K      +   +EA++ +KL+H  +V+L+  + EE    +V + ++ G L + +  
Sbjct: 37  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIX-IVTEYMSKGSLLDFLKG 95
Query: 83  R--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              ++           QI   + +      VHRDL+  N+L+    +    K+ADFGLA
Sbjct: 96  ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 151

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 50/108 (46%), Gaps = 6/108 (5%)
Query: 37  EREARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           ++E  I R L H +I++       Q E    LV + V  G L  D + R     A     
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLAQLLLF 122
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
            QQI E + + HS   +HR+L   N+LL +      VK+ DFGLA  V
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDND---RLVKIGDFGLAKAV 167

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 52/195 (26%)
Query: 31  RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD 90
           RDF     EA I  +  HPNI+ L   + +     +V + +  G L        F  + D
Sbjct: 68  RDFLG---EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKND 118
Query: 91  ASHCIQQIL-------ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ 143
               + Q++         + +    G VHRDL   N+L+ S       K++DFGL+  ++
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLSRVLE 175
Query: 144 GEQQA------------W-------------------FGVILY-ILLVGYPPFWDEDQHR 171
            + +A            W                   +G++++ ++  G  P+W+     
Sbjct: 176 DDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQD 235
Query: 172 LYAQIKAGAYDYPSP 186
           +   ++ G Y  PSP
Sbjct: 236 VIKAVEEG-YRLPSP 249

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 182

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 20/132 (15%)
Query: 29  SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR---- 83
           + +D   L  E  + + + +H NI+ L  +  ++   Y++    + G L E + AR    
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPG 139
Query: 84  ------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV 131
                       E  +  D   C  Q+   + +  S   +HRDL   N+L+    +   +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVM 196
Query: 132 KLADFGLAIEVQ 143
           K+ADFGLA ++ 
Sbjct: 197 KIADFGLARDIN 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 166

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 134
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 135 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 180

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/111 (23%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 478
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++  +
Sbjct: 479 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYY 526

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   K +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 101
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V ++      A    +QIL  V+     G         +
Sbjct: 102 SDGEISICMEHMDGGSL--DQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKHKI 153
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 154 MHRDVKPSNILVNSRGE---IKLCDFGVS 179

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/111 (23%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 479
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW 149
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++  +
Sbjct: 480 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYY 527

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 172

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 162

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 66  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 123
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 124 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 164

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 4/109 (3%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 98
           EA + ++L +P IVR+    + E++  LV ++   G L + +       + +    + Q+
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 114
Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
              + +   +  VHRDL   N+LL ++      K++DFGL+  ++ ++ 
Sbjct: 115 SMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADEN 160

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 121
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 162

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 121
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 122 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 162

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 115
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 156

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 115
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 156

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 67  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 124
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 125 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 165

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F +   EA++   L H  +V+L+    +
Sbjct: 20  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVCTK 75
Query: 61  ENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ + +  G L   +  +   F ++     C + + E++ +  S   +HRDL   
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-KDVCEAMEYLESKQFLHRDLAAR 134
Query: 119 NLLLASKAKGAAVKLADFGLA 139
           N L+  +     VK++DFGL+
Sbjct: 135 NCLVNDQ---GVVKVSDFGLS 152

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 68  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 125
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 126 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 60  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 117
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 118 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 158

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 63  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 120
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 121 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 161

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 59  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 116
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 117 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 157

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 115
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 156

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 80
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + + A  E            QI + + +  +   +
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYI 139
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 140 HRDLATRNILVENENR---VKIGDFGLT 164

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 115
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 156

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 1   GAFSVVRRCVQKATGL---EFAAKI-INTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F VV +     T +   + AA + I T++L     Q+ ++E ++  K QH N+V L  
Sbjct: 36  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK----QQFDQEIKVMAKCQHENLVELLG 91
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESVNHCHSNGVVHR 113
              + +   LV+  +  G L + +   +              Q     +N  H N  +HR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 114 DLKPENLLLASKAKGAAVKLADFGLA 139
           D+K  N+LL    +    K++DFGLA
Sbjct: 152 DIKSANILL---DEAFTAKISDFGLA 174

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 6/108 (5%)
Query: 37  EREARICRKLQHPNIVRLHDSIQEENYHYL--VFDLVTGGELFEDIVAREFYSEADASHC 94
           ++E  I R L H +I++     ++     L  V + V  G L  D + R     A     
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL-RDYLPRHSIGLAQLLLF 139
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
            QQI E + + H+   +HRDL   N+LL +      VK+ DFGLA  V
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAV 184

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 23/149 (15%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   VV +   + +GL  A K+I+ + K + R+  ++ RE ++  +   P IV  + +  
Sbjct: 27  GNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFY 84
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---------V 110
            +    +  + + GG L  D V +E      A    ++IL  V+     G         +
Sbjct: 85  SDGEISICMEHMDGGSL--DQVLKE------AKRIPEEILGKVSIAVLRGLAYLREKHQI 136
Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +HRD+KP N+L+ S+ +   +KL DFG++
Sbjct: 137 MHRDVKPSNILVNSRGE---IKLCDFGVS 162

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 39  EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 96
           EA + ++LQH  +VRL+  + +E   Y++ + +  G L  D +      +   +  +   
Sbjct: 53  EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV-DFLKTPSGIKLTINKLLDMA 110
Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            QI E +        +HRDL+  N+L++      + K+ADFGLA
Sbjct: 111 AQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLA 151

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 1   GAFSVVRRCVQKATGL---EFAAKI-INTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F VV +     T +   + AA + I T++L     Q+ ++E ++  K QH N+V L  
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK----QQFDQEIKVMAKCQHENLVELLG 97
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESVNHCHSNGVVHR 113
              + +   LV+  +  G L + +   +              Q     +N  H N  +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 114 DLKPENLLLASKAKGAAVKLADFGLA 139
           D+K  N+LL    +    K++DFGLA
Sbjct: 158 DIKSANILL---DEAFTAKISDFGLA 180

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 6/108 (5%)
Query: 37  EREARICRKLQHPNIVRLHDSI--QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
           ++E  I R L H +I++       Q E    LV + V  G L  D + R     A     
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLAQLLLF 122
Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 142
            QQI E + + H+   +HR+L   N+LL +      VK+ DFGLA  V
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDND---RLVKIGDFGLAKAV 167

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 108
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 109 GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 167
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 168 HRDLATRNILVENENR---VKIGDFGLT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 14/146 (9%)
Query: 1   GAFSVVRRCVQKATGL---EFAAKI-INTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F VV +     T +   + AA + I T++L     Q+ ++E ++  K QH N+V L  
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK----QQFDQEIKVMAKCQHENLVELLG 97
Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHR 113
              + +   LV+  +  G L + +   +     S        Q     +N  H N  +HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 114 DLKPENLLLASKAKGAAVKLADFGLA 139
           D+K  N+LL    +    K++DFGLA
Sbjct: 158 DIKSANILL---DEAFTAKISDFGLA 180

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 77
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 136
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 137 HRDLATRNILVENENR---VKIGDFGLT 161

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 95
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 154
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 155 HRDLATRNILVENENR---VKIGDFGLT 179

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 75
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 134
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 135 HRDLATRNILVENENR---VKIGDFGLT 159

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 77
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 136
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 137 HRDLATRNILVENENR---VKIGDFGLT 161

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 84
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 85  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 143
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 144 HRDLATRNILVENENR---VKIGDFGLT 168

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 77
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 136
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV 152
           HRDL   N+L+ ++ +   VK+ DFGL  +V  + + +F V
Sbjct: 137 HRDLATRNILVENENR---VKIGDFGLT-KVLPQDKEFFKV 173

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 95
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 154
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 155 HRDLATRNILVENENR---VKIGDFGLT 179

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 116/281 (41%), Gaps = 63/281 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRLHDSIQ 59
           GA+ VV +     +G   A K I    +++++ ++L  +  I  R +  P  V  + ++ 
Sbjct: 62  GAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 120
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQ---------ILESVNHCHSN- 108
            E   ++  +L+       D    +FY +  D    I +         I++++ H HS  
Sbjct: 121 REGDVWICMELM-------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA-----------------------IEVQGE 145
            V+HRD+KP N+L+ +  +   VK+ DFG++                       I  +  
Sbjct: 174 SVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 230
Query: 146 QQAW--------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEA 195
           Q+ +         G+ +  L +   P+  +     + Q+K    + PSP+   D  + E 
Sbjct: 231 QKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQ-VVEEPSPQLPADKFSAEF 287
Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQRER----VASIV 232
            +  +Q L  N  +R T  E ++HP+    E     VAS V
Sbjct: 288 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFV 328

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 116/281 (41%), Gaps = 63/281 (22%)
Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRLHDSIQ 59
           GA+ VV +     +G   A K I    +++++ ++L  +  I  R +  P  V  + ++ 
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76
Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEA-DASHCIQQ---------ILESVNHCHSN- 108
            E   ++  +L+       D    +FY +  D    I +         I++++ H HS  
Sbjct: 77  REGDVWICMELM-------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA-----------------------IEVQGE 145
            V+HRD+KP N+L+ +  +   VK+ DFG++                       I  +  
Sbjct: 130 SVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 146 QQAW--------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEA 195
           Q+ +         G+ +  L +   P+  +     + Q+K    + PSP+   D  + E 
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQ-VVEEPSPQLPADKFSAEF 243
Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQRER----VASIV 232
            +  +Q L  N  +R T  E ++HP+    E     VAS V
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFV 284

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 76
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 135
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 136 HRDLATRNILVENENR---VKIGDFGLT 160

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 83
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 84  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 142
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 143 HRDLATRNILVENENR---VKIGDFGLT 167

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 81
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 140
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 141 HRDLATRNILVENENR---VKIGDFGLT 165

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 80
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 139
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 140 HRDLATRNILVENENR---VKIGDFGLT 164

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 1   GAFSVVRRC----VQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C    +Q  TG   A K + ++ +   RDF   ERE  I + LQH NIV+  
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILKSLQHDNIVKYK 82
Query: 56  D---SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVV 111
               S    N   L+ + +  G L + +   +E            QI + + +  +   +
Sbjct: 83  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 141
Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 142 HRDLATRNILVENENR---VKIGDFGLT 166

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	328
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-155
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-154
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-35
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-150
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-35
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-144
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-32
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-134
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-132
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-32
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-129
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-128
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-127
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-126
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-126
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-126
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-124
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-124
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-122
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-122
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-122
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-121
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-121
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-120
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-120
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-25
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-118
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-118
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-117
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-117
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-116
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-116
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-115
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-114
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-114
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-112
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-28
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-108
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-107
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-86
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-78
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-76
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-76
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-76
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-75
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-74
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-74
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-74
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-73
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-73
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-72
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-72
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-17
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-71
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-71
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-71
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-71
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-71
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-70
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-70
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-70
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-17
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-69
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-67
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-67
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-66
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-66
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-65
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-64
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-62
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-60
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-57
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-14
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-55
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-16
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-53
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-51
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-51
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-49
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-47
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-46
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-45
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-45
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-10
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-44
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-41
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-40
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-39
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-08
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-06
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-38
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-38
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-37
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-37
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-36
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-04
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-36
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-36
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-35
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-31
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-31
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-04
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-07
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-05
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-06
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-04
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-08
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-07
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-06
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-05
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-04
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-04
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-23
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-08
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-04
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-23
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-04
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-22
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-08
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-22
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-07
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-21
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-05
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-20
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-05
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-05
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-20
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-08
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-19
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-08
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-18
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-16
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-14
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-14
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-05
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-14
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-14
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-05
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-13
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-04
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-13
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-13
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-13
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-13
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-04
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-13
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-13
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-13
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-12
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-11
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-11
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-11
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-11
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-11
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-08
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-04

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  438 bits (1129), Expect = e-155
 Identities = 225/279 (80%), Positives = 238/279 (85%), Gaps = 29/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 99

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 219 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A +ALK PWIC RERVAS +HRQ+TVDCLKKFNARRKLK
Sbjct: 279 ADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLK 317

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  129 bits (327), Expect = 5e-35
 Identities = 58/61 (95%), Positives = 59/61 (96%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247

Query: 316 D 316
           D
Sbjct: 248 D 248

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  438 bits (1129), Expect = e-154
 Identities = 217/279 (77%), Positives = 232/279 (83%), Gaps = 28/279 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV+   G E+AA IINTKKLSARD QKLEREARICR L+HPNIVRLHDSI E
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E +HYL+FDLVTGGELFEDIVARE+YSEADASHCIQQILE+V HCH  GVVHR+LKPENL
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASK KGAAVKLADFGLAIEV+GEQQAWF                            GV
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLY QIKAGAYD+PSPEWDTVTPEAK+LIN+MLT+NPSKRIT
Sbjct: 202 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           A+EALKHPWI  R  VAS +HRQETVDCLKKFNARRKLK
Sbjct: 262 AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  130 bits (329), Expect = 9e-35
 Identities = 56/61 (91%), Positives = 59/61 (96%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVL+K+PYGKPVD+WACGVILYILLVGYPPFWDEDQHRLY QIKAGAY
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230

Query: 316 D 316
           D
Sbjct: 231 D 231

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  423 bits (1090), Expect = e-150
 Identities = 215/269 (79%), Positives = 228/269 (84%), Gaps = 29/269 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFSVVRRCV K TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E++HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES+ +CHSNG+VHR+LKPENL
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------GV 152
           LLASKAKGAAVKLADFGLAIEV  + +AW                             GV
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK+LI+ MLTVNP KRIT
Sbjct: 196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCL 241
           A +ALK PWIC RERVAS +HRQ+TVDCL
Sbjct: 256 ADQALKVPWICNRERVASAIHRQDTVDCL 284

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  128 bits (324), Expect = 3e-35
 Identities = 58/61 (95%), Positives = 59/61 (96%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            GFAGTPGYLSPEVLKK+PY KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224

Query: 316 D 316
           D
Sbjct: 225 D 225

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  410 bits (1056), Expect = e-144
 Identities = 115/286 (40%), Positives = 166/286 (58%), Gaps = 36/286 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDS 57
           G FSVVRRC+ + TG +FA KI++  K ++      + L+REA IC  L+HP+IV L ++
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94

Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHR 113
              +   Y+VF+ + G +L  +IV R      YSEA ASH ++QILE++ +CH N ++HR
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 154

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------- 150
           D+KP  +LLASK   A VKL  FG+AI++                               
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPV 214

Query: 151 -----GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
                GVIL+ILL G  PF+   + RL+  I  G Y     +W  ++  AK+L+ +ML +
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML 273

Query: 206 NPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           +P++RIT  EAL HPW+ +R+R A  +H  ETV+ L+KFNARRKLK
Sbjct: 274 DPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  120 bits (304), Expect = 8e-32
 Identities = 33/61 (54%), Positives = 43/61 (70%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
            G  GTP +++PEV+K+EPYGKPVD+W CGVIL+ILL G  PF+   + RL+  I  G Y
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKY 249

Query: 316 D 316
            
Sbjct: 250 K 250

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  383 bits (986), Expect = e-134
 Identities = 99/286 (34%), Positives = 152/286 (53%), Gaps = 36/286 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ HPNI+ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142

Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQGEQQAWF------------------------- 150
           PEN++L  K      +KL DFGLA E++ +   +                          
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201

Query: 151 ---GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
              GVI YILL G  PF  + +    A I A +YD+    +   +  AK+ I ++L    
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKET 261

Query: 208 SKRITASEALKHPWICQRERVASIVHRQETV--DCLKKFNARRKLK 251
            KR+T  EAL+HPWI   +   ++V R+  V  +  KK   RR+ K
Sbjct: 262 RKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  120 bits (303), Expect = 1e-31
 Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            +     + K        GTP +++PE++  EP G   D+W+ GVI YILL G  PF  +
Sbjct: 167 HEIEDGVEFKN-----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

Query: 302 DQHRLYAQIKAGAYD-DEP 319
            +    A I A +YD DE 
Sbjct: 222 TKQETLANITAVSYDFDEE 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  121 bits (307), Expect = 1e-32
 Identities = 33/59 (55%), Positives = 45/59 (76%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
             GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF++E + +L+ +IK G Y+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  372 bits (957), Expect = e-129
 Identities = 108/279 (38%), Positives = 159/279 (56%), Gaps = 34/279 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA S+V RC QK T   +A K++        D + +  E  +  +L HPNI++L +  + 
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
                LV +LVTGGELF+ IV + +YSE DA+  ++QILE+V + H NG+VHRDLKPENL
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-FGVI 153
           L A+ A  A +K+ADFGL+  V+ +                             W  G+I
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

Query: 154 LYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
            YILL G+ PF+DE     ++ +I    Y + SP WD V+  AK+L+ +++ ++P KR+T
Sbjct: 240 TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
             +AL+HPW+  +   A+ VH       L++FNARRKLK
Sbjct: 300 TFQALQHPWVTGKA--ANFVHMDTAQKKLQEFNARRKLK 336

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  117 bits (295), Expect = 1e-30
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGAY 315
              GTPGY +PE+L+   YG  VD+W+ G+I YILL G+ PF+DE     ++ +I    Y
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268

Query: 316 D 316
            
Sbjct: 269 Y 269

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  369 bits (949), Expect = e-128
 Identities = 96/285 (33%), Positives = 151/285 (52%), Gaps = 34/285 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F++V++C +K+TGLE+AAK I  ++  A       +++ERE  I R++ H N++ LHD
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +      L+ +LV+GGELF+ +  +E  SE +A+  I+QIL+ VN+ H+  + H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142

Query: 117 PENLLLASKAKGAA-VKLADFGLAIEVQGEQQA--------------------------W 149
           PEN++L  K      +KL DFGLA E++   +                           W
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A I + +YD+    +   +  AK+ I ++L     
Sbjct: 203 SIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR 262

Query: 209 KRITASEALKHPWICQRERVASIVHRQETV--DCLKKFNARRKLK 251
           KR+T  EAL+HPWI   +   ++V R+  V  +  +K   RR+ K
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWK 307

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  116 bits (294), Expect = 1e-30
 Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 5/75 (6%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            +     + K        GTP +++PE++  EP G   D+W+ GVI YILL G  PF  +
Sbjct: 167 HEIEDGVEFKN-----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221

Query: 302 DQHRLYAQIKAGAYD 316
            +    A I + +YD
Sbjct: 222 TKQETLANITSVSYD 236

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  364 bits (937), Expect = e-127
 Identities = 88/285 (30%), Positives = 150/285 (52%), Gaps = 34/285 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  ++  +       + +ERE  I +++QHPN++ LH+
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141

Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQGEQQA--------------------------W 149
           PEN++L  +      +K+ DFGLA ++    +                           W
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261

Query: 209 KRITASEALKHPWICQRERVASIVHRQETV--DCLKKFNARRKLK 251
           KR+T  ++L+HPWI  ++   ++  +   V  +  KKF AR+K  
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSN 306

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 5e-30
 Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 5/75 (6%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            K +   + K        GTP +++PE++  EP G   D+W+ GVI YILL G  PF  +
Sbjct: 166 HKIDFGNEFKN-----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

Query: 302 DQHRLYAQIKAGAYD 316
            +    A + A  Y+
Sbjct: 221 TKQETLANVSAVNYE 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  370 bits (951), Expect = e-126
 Identities = 98/281 (34%), Positives = 163/281 (58%), Gaps = 30/281 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +C  + T  E+A K+IN      +D   + RE  + +KL HPNI++L + +++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y+V +L TGGELF++I+ R+ +SE DA+  I+Q+   + + H + +VHRDLKPEN+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVIL 154
           LL SK K   +K+ DFGL+   Q   +                          W  GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL G PPF+ ++++ +  +++ G Y +  P+W T++ +AK+LI +MLT +PS RITA+
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272

Query: 215 EALKHPWICQRER----VASIVHRQETVDCLKKFNARRKLK 251
           + L+HPWI +       ++ +   +  +  +++F A +KL 
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLA 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (265), Expect = 1e-25
 Identities = 24/61 (39%), Positives = 40/61 (65%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GT  Y++PEVL+   Y +  D+W+ GVILYILL G PPF+ ++++ +  +++ G Y
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 316 D 316
            
Sbjct: 240 A 240

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  362 bits (931), Expect = e-126
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 35/284 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQ 59
           G F+VVR+C+ K+TG E+AAK +  ++       ++  E  +    +  P ++ LH+  +
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99

Query: 60  EENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
             +   L+ +   GGE+F   +    E  SE D    I+QILE V + H N +VH DLKP
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF--------------------------- 150
           +N+LL+S      +K+ DFG++ ++ G                                 
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEILNYDPITTATDMWN 218

Query: 151 -GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G+I Y+LL    PF  ED    Y  I     DY    + +V+  A + I  +L  NP K
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278

Query: 210 RITASEALKHPWICQRERVASIVHRQETV--DCLKKFNARRKLK 251
           R TA   L H W+ Q+    ++ H +ET      +  + R    
Sbjct: 279 RPTAEICLSHSWL-QQWDFENLFHPEETSSSSQTQDHSVRSSED 321

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  118 bits (297), Expect = 6e-31
 Identities = 26/79 (32%), Positives = 35/79 (44%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           +K     +L+        GTP YL+PE+L  +P     D+W  G+I Y+LL    PF  E
Sbjct: 182 RKIGHACELRE-----IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236

Query: 302 DQHRLYAQIKAGAYD-DEP 319
           D    Y  I     D  E 
Sbjct: 237 DNQETYLNISQVNVDYSEE 255

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  360 bits (927), Expect = e-126
 Identities = 94/250 (37%), Positives = 150/250 (60%), Gaps = 26/250 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +C  + T  E+A K+IN      +D   + RE  + +KL HPNI++L + +++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  Y+V +L TGGELF++I+ R+ +SE DA+  I+Q+   + + H + +VHRDLKPEN+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVIL 154
           LL SK K   +K+ DFGL+   Q   +                          W  GVIL
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           YILL G PPF+ ++++ +  +++ G Y +  P+W T++ +AK+LI +MLT +PS RITA+
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272

Query: 215 EALKHPWICQ 224
           + L+HPWI +
Sbjct: 273 QCLEHPWIQK 282

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  113 bits (286), Expect = 1e-29
 Identities = 24/61 (39%), Positives = 40/61 (65%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GT  Y++PEVL+   Y +  D+W+ GVILYILL G PPF+ ++++ +  +++ G Y
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 316 D 316
            
Sbjct: 240 A 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  364 bits (937), Expect = e-124
 Identities = 100/281 (35%), Positives = 163/281 (58%), Gaps = 30/281 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V  C  K TG E A K+I+ +++  + D + L RE ++ ++L HPNI++L++  +
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ Y YLV ++ TGGELF++I++R+ +SE DA+  I+Q+L  + + H N +VHRDLKPEN
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 156

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL SK+K A +++ DFGL+   +  ++                          W  GVI
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVI 216

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
           LYILL G PPF   +++ +  +++ G Y +  P+W  V+  AK+LI +MLT  PS RI+A
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276

Query: 214 SEALKHPWI---CQRERVASIVHRQETVDCLKKFNARRKLK 251
            +AL H WI    + +    +      +  +++F   +KL 
Sbjct: 277 RDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLA 317

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  104 bits (261), Expect = 4e-25
 Identities = 24/61 (39%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GT  Y++PEVL    Y +  D+W+ GVILYILL G PPF   +++ +  +++ G Y
Sbjct: 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244

Query: 316 D 316
            
Sbjct: 245 T 245

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  364 bits (935), Expect = e-124
 Identities = 102/281 (36%), Positives = 155/281 (55%), Gaps = 30/281 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V  C  K T +E A KII    +S     KL  E  + + L HPNI++L+D  ++
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +  +YLV +   GGELF++I+ R  ++E DA+  I+Q+L  V + H + +VHRDLKPENL
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------AW-FGVIL 154
           LL SK K A +K+ DFGL+   + +++                          W  GVIL
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVIL 227

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           +ILL GYPPF  +    +  +++ G Y + SPEW  V+  AK+LI QML  +  +RI+A 
Sbjct: 228 FILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287

Query: 215 EALKHPWICQ----RERVASIVHRQETVDCLKKFNARRKLK 251
           +AL+HPWI +    +E    +      ++ ++KF   +KL 
Sbjct: 288 QALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 9e-24
 Identities = 25/61 (40%), Positives = 38/61 (62%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GT  Y++PEVL+K  Y +  D+W+ GVIL+ILL GYPPF  +    +  +++ G Y
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254

Query: 316 D 316
            
Sbjct: 255 T 255

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  353 bits (908), Expect = e-122
 Identities = 90/291 (30%), Positives = 151/291 (51%), Gaps = 45/291 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++SV +RC+ KAT +EFA KII+  K         E    + R  QHPNI+ L D   +
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIITLKDVYDD 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             Y Y+V +L+ GGEL + I+ ++F+SE +AS  +  I ++V + H+ GVVHRDLKP N+
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147

Query: 121 LLASKAKGA-AVKLADFGLAIEVQGEQQAWF----------------------------G 151
           L   ++    ++++ DFG A +++ E                                 G
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207

Query: 152 VILYILLVGYPPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           V+LY +L GY PF    D+    + A+I +G +      W++V+  AK+L+++ML V+P 
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267

Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFA 259
           +R+TA+  L+HPWI   +++            L + +A   +K +    ++
Sbjct: 268 QRLTAALVLRHPWIVHWDQLPQ--------YQLNRQDAPHLVKGAMAATYS 310

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (282), Expect = 9e-29
 Identities = 22/62 (35%), Positives = 36/62 (58%), Gaps = 3/62 (4%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIKAGA 314
              T  +++PEVL+++ Y    DIW+ GV+LY +L GY PF    D+    + A+I +G 
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 315 YD 316
           + 
Sbjct: 240 FS 241

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  352 bits (905), Expect = e-122
 Identities = 89/289 (30%), Positives = 141/289 (48%), Gaps = 46/289 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A KII+ +K +            +E E  I +KL HP I+++
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 81  KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 139

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF------------------------ 150
           LKPEN+LL+S+ +   +K+ DFG +  + GE                             
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198

Query: 151 -------GVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
                  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++
Sbjct: 199 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKL 258

Query: 203 LTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           L V+P  R T  EAL+HPW+   +       +++  D L + N    L 
Sbjct: 259 LVVDPKARFTTEEALRHPWLQDEDM------KRKFQDLLSEENESTALP 301

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (277), Expect = 3e-28
 Identities = 30/63 (47%), Positives = 37/63 (58%), Gaps = 4/63 (6%)

Query: 258 FAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAG 313
             GTP YL+PEVL       Y + VD W+ GVIL+I L GYPPF +   Q  L  QI +G
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

Query: 314 AYD 316
            Y+
Sbjct: 236 KYN 238

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  350 bits (900), Expect = e-122
 Identities = 88/259 (33%), Positives = 140/259 (54%), Gaps = 32/259 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLEREARICRKLQHPNIVRLHD 56
           G F++VR+C QK TG E+AAK I  ++LS        +++ERE  I R+++HPNI+ LHD
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV+GGELF+ +  +E  +E +A+  ++QIL+ V++ HS  + H DLK
Sbjct: 76  IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 135

Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQGEQQA--------------------------W 149
           PEN++L  K      +KL DFG+A +++   +                           W
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 195

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  E +      I A  YD+    +   +  AK+ I ++L  +P 
Sbjct: 196 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPK 255

Query: 209 KRITASEALKHPWICQRER 227
           +R+T +++L+H WI    R
Sbjct: 256 RRMTIAQSLEHSWIKAIRR 274

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  117 bits (295), Expect = 4e-31
 Identities = 30/79 (37%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            K  A  + K        GTP +++PE++  EP G   D+W+ GVI YILL G  PF  E
Sbjct: 160 HKIEAGNEFKN-----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214

Query: 302 DQHRLYAQIKAGAYD-DEP 319
            +      I A  YD DE 
Sbjct: 215 TKQETLTNISAVNYDFDEE 233

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  348 bits (896), Expect = e-121
 Identities = 86/250 (34%), Positives = 139/250 (55%), Gaps = 28/250 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V+  VQK T +  AAK I    +   D  + ++E  I + L HPNI+RL+++ ++
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED 77

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               YLV +L TGGELFE +V +  + E+DA+  ++ +L +V +CH   V HRDLKPEN 
Sbjct: 78  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVIL 154
           L  + +  + +KL DFGLA   +  +                           W  GV++
Sbjct: 138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMM 197

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
           Y+LL GYPPF       +  +I+ G + +P  +W  V+P+A++LI ++LT +P +RIT+ 
Sbjct: 198 YVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257

Query: 215 EALKHPWICQ 224
           +AL+H W  +
Sbjct: 258 QALEHEWFEK 267

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (281), Expect = 4e-29
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GTP Y+SP+VL+   YG   D W+ GV++Y+LL GYPPF       +  +I+ G +
Sbjct: 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224

Query: 316 D 316
            
Sbjct: 225 T 225

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  349 bits (899), Expect = e-121
 Identities = 66/279 (23%), Positives = 127/279 (45%), Gaps = 36/279 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F +V RCV+ ++   + AK +  K     D   +++E  I    +H NI+ LH+S + 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++F+ ++G ++FE I    F  +E +    + Q+ E++   HS+ + H D++PEN
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------GV 152
           ++  ++ + + +K+ +FG A +++                                  G 
Sbjct: 133 IIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ++Y+LL G  PF  E   ++   I    Y +    +  ++ EA + ++++L      R+T
Sbjct: 192 LVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           ASEAL+HPW+ Q+    S    +     LK       L 
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLI 286

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  113 bits (286), Expect = 2e-29
 Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           ++       ++         P Y +PEV + +      D+W+ G ++Y+LL G  PF  E
Sbjct: 152 RQLKPGDNFRL-----LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206

Query: 302 DQHRLYAQIKAGAYD-DEP 319
              ++   I    Y  DE 
Sbjct: 207 TNQQIIENIMNAEYTFDEE 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  349 bits (897), Expect = e-120
 Identities = 91/297 (30%), Positives = 146/297 (49%), Gaps = 51/297 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           G+FS+ R+CV K +   FA KII+ +  +       ++E    +  + HPNIV+LH+   
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISKRMEA-----NTQKEITALKLCEGHPNIVKLHEVFH 76

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++ + +LV +L+ GGELFE I  ++ +SE +AS+ +++++ +V+H H  GVVHRDLKPEN
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------------G 151
           LL   +     +K+ DFG A     + Q                               G
Sbjct: 137 LLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG 196

Query: 152 VILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
           VILY +L G  PF   D+         +  +IK G + +    W  V+ EAK+LI  +LT
Sbjct: 197 VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT 256

Query: 205 VNPSKRITASEALKHPWICQRERVASIVHRQETV---------DCLKK-FNARRKLK 251
           V+P+KR+  S    + W+    +++S       +          C+K  F+A  K K
Sbjct: 257 VDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYK 313

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  108 bits (272), Expect = 2e-27
 Identities = 21/68 (30%), Positives = 33/68 (48%), Gaps = 7/68 (10%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYA 308
           +    T  Y +PE+L +  Y +  D+W+ GVILY +L G  PF   D+         +  
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226

Query: 309 QIKAGAYD 316
           +IK G + 
Sbjct: 227 KIKKGDFS 234

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  353 bits (907), Expect = e-120
 Identities = 89/291 (30%), Positives = 144/291 (49%), Gaps = 40/291 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA-----------RDFQKLEREARICRKLQHP 49
           GA+  V  C +K    E A K+I   +              +  +++  E  + + L HP
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106

Query: 50  NIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           NI++L D  +++ Y YLV +   GGELFE I+ R  + E DA++ ++QIL  + + H + 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------- 148
           +VHRD+KPEN+LL +K     +K+ DFGL+     + +                      
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNE 226

Query: 149 ----W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
               W  GVI+YILL GYPPF  ++   +  +++ G Y +   +W  ++ EAK LI  ML
Sbjct: 227 KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286

Query: 204 TVNPSKRITASEALKHPWICQRERVASIVHRQ---ETVDCLKKFNARRKLK 251
           T + +KR TA EAL   WI +     +   ++     +  ++KF   +KL 
Sbjct: 287 TYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLA 337

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  103 bits (259), Expect = 7e-25
 Identities = 27/61 (44%), Positives = 41/61 (67%), Gaps = 1/61 (1%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           +   GT  Y++PEVLKK+ Y +  D+W+CGVI+YILL GYPPF  ++   +  +++ G Y
Sbjct: 206 RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264

Query: 316 D 316
            
Sbjct: 265 Y 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  343 bits (881), Expect = e-118
 Identities = 92/268 (34%), Positives = 136/268 (50%), Gaps = 26/268 (9%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLH---- 55
           G    V +   K T  +FA K++       +D  K  RE  +  +  Q P+IVR+     
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYE 81

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +         +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGE---QQA--W-FGVILYILLVGYPPFWDE 167
           D+KPENLL  SK   A +KL DFG A E  GE   +    W  GVI+YILL GYPPF+  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201

Query: 168 D----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC 223
                   +  +I+ G Y++P+PEW  V+ E K LI  +L   P++R+T +E + HPWI 
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

Query: 224 QRERVASIVHRQETVDCLKKFNARRKLK 251
           Q  +V        T   LK+   R +  
Sbjct: 262 QSTKVPQTPL--HTSRVLKEDKERWEDV 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 89.7 bits (223), Expect = 8e-21
 Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 5/56 (8%)

Query: 265 LSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYD 316
            + E    E Y K  D+W+ GVI+YILL GYPPF+          +  +I+ G Y+
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  345 bits (886), Expect = e-118
 Identities = 88/279 (31%), Positives = 143/279 (51%), Gaps = 36/279 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV RCV+KATG  F AK INT      D   ++ E  I  +L HP ++ LHD+ ++
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFED 119

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    L+ + ++GGELF+ I A ++  SEA+  + ++Q  E + H H + +VH D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------GV 152
           ++  +K K ++VK+ DFGLA ++  ++                               GV
Sbjct: 180 IMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + Y+LL G  PF  ED       +K   +++    + +V+PEAK+ I  +L   P KR+T
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
             +AL+HPW+          +    +   +    R+K+K
Sbjct: 299 VHDALEHPWLKGDH-----SNLTSRIPSSRYNKIRQKIK 332

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (287), Expect = 3e-29
 Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            K N    +KV+       T  + +PE++ +EP G   D+WA GV+ Y+LL G  PF  E
Sbjct: 199 TKLNPDEIVKVT-----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253

Query: 302 DQHRLYAQIKAGAYD-DEP 319
           D       +K   ++ DE 
Sbjct: 254 DDLETLQNVKRCDWEFDED 272

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  339 bits (872), Expect = e-117
 Identities = 92/274 (33%), Positives = 135/274 (49%), Gaps = 45/274 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-------LEREARICRKL-QHPNIV 52
           G  SVVRRC+ K T  E+A KII+     +   ++         +E  I RK+  HPNI+
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L D+ +   + +LVFDL+  GELF+ +  +   SE +    ++ +LE +   H   +VH
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 147

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------ 148
           RDLKPEN+LL        +KL DFG + ++   ++                         
Sbjct: 148 RDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204

Query: 149 --------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
                   W  GVI+Y LL G PPFW   Q  +   I +G Y + SPEWD  +   K+L+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264

Query: 200 NQMLTVNPSKRITASEALKHPWICQRERVASIVH 233
           ++ L V P KR TA EAL HP+  Q+  V  + H
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFF-QQYVVEEVRH 297

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (282), Expect = 4e-29
 Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 6/63 (9%)

Query: 260 GTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           GTP YL+PE+++         YGK VD+W+ GVI+Y LL G PPFW   Q  +   I +G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 314 AYD 316
            Y 
Sbjct: 245 NYQ 247

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  340 bits (875), Expect = e-117
 Identities = 91/264 (34%), Positives = 138/264 (52%), Gaps = 43/264 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKL-QHPNIVR 53
           G  SVVRRCV +ATG EFA KI+                +   RE  I R++  HP+I+ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
           L DS +  ++ +LVFDL+  GELF+ +  +   SE +    ++ +LE+V+  H+N +VHR
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR 224

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------- 147
           DLKPEN+LL    +   ++L+DFG +  ++  ++                          
Sbjct: 225 DLKPENILLDDNMQ---IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281

Query: 148 ------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN 200
                  W  GVIL+ LL G PPFW   Q  +   I  G Y + SPEWD  +   K+LI+
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341

Query: 201 QMLTVNPSKRITASEALKHPWICQ 224
           ++L V+P  R+TA +AL+HP+  +
Sbjct: 342 RLLQVDPEARLTAEQALQHPFFER 365

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (283), Expect = 9e-29
 Identities = 33/65 (50%), Positives = 38/65 (58%), Gaps = 6/65 (9%)

Query: 258 FAGTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
             GTPGYL+PE+LK         YGK VD+WACGVIL+ LL G PPFW   Q  +   I 
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318

Query: 312 AGAYD 316
            G Y 
Sbjct: 319 EGQYQ 323

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  340 bits (874), Expect = e-116
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 33/277 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V +C + ATGL+ AAKII T+ +  +D ++++ E  +  +L H N+++L+D+ + 
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFES 157

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   LV + V GGELF+ I+   +  +E D    ++QI E + H H   ++H DLKPEN
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------GV 152
           +L  ++     +K+ DFGLA   +  ++                              GV
Sbjct: 218 ILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           I Y+LL G  PF  ++       I A  +D    E+  ++ EAK  I+++L    S RI+
Sbjct: 277 IAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS 336

Query: 213 ASEALKHPWICQRERVASIVHR--QETVDCLKKFNAR 247
           ASEALKHPW+   +  + +  +  +      + F  +
Sbjct: 337 ASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQDFVTK 373

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (286), Expect = 3e-29
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 6/79 (7%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           +++  R KLKV+      GTP +L+PEV+  +    P D+W+ GVI Y+LL G  PF  +
Sbjct: 237 RRYKPREKLKVN-----FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291

Query: 302 DQHRLYAQIKAGAYD-DEP 319
           +       I A  +D ++ 
Sbjct: 292 NDAETLNNILACRWDLEDE 310

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  340 bits (874), Expect = e-116
 Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 43/276 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRL 54
           GA   V+   ++ T  + A +II+ +K +            +E E  I +KL HP I+++
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    E+Y Y+V +L+ GGELF+ +V  +   EA       Q+L +V + H NG++HRD
Sbjct: 206 KNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 264

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF------------------------ 150
           LKPEN+LL+S+ +   +K+ DFG +  + GE                             
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323

Query: 151 -------GVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
                  GVIL+I L GYPPF +   Q  L  QI +G Y++    W  V+ +A +L+ ++
Sbjct: 324 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKL 383

Query: 203 LTVNPSKRITASEALKHPWICQ---RERVASIVHRQ 235
           L V+P  R T  EAL+HPW+     + +   ++  +
Sbjct: 384 LVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 9e-27
 Identities = 30/65 (46%), Positives = 38/65 (58%), Gaps = 4/65 (6%)

Query: 256 QGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIK 311
           +   GTP YL+PEVL       Y + VD W+ GVIL+I L GYPPF +   Q  L  QI 
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

Query: 312 AGAYD 316
           +G Y+
Sbjct: 359 SGKYN 363

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  338 bits (869), Expect = e-115
 Identities = 89/289 (30%), Positives = 132/289 (45%), Gaps = 47/289 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLH---- 55
           G    V +   K T  +FA K++       +D  K  RE  +  +    P+IVR+     
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYE 125

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHR 113
           +         +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ-------------------------- 147
           D+KPENLL  SK   A +KL DFG A E                                
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245

Query: 148 AW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
            W  GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305

Query: 203 LTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
           L   P++R+T +E + HPWI Q  +V        T   LK+   R +  
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPL--HTSRVLKEDKERWEDV 352

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  109 bits (273), Expect = 4e-27
 Identities = 27/65 (41%), Positives = 37/65 (56%), Gaps = 4/65 (6%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIK 311
                TP Y++PEVL  E Y K  D+W+ GVI+YILL GYPPF+          +  +I+
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280

Query: 312 AGAYD 316
            G Y+
Sbjct: 281 MGQYE 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  342 bits (878), Expect = e-114
 Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 33/279 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV R  ++ATG  FAAK + T   S  D + + +E +    L+HP +V LHD+ ++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED 225

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   ++++ ++GGELFE +       SE +A   ++Q+ + + H H N  VH DLKPEN
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------GV 152
           ++  +K +   +KL DFGL   +  +Q                               GV
Sbjct: 286 IMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + YILL G  PF  E+       +K+  ++     +  ++ + K+ I ++L  +P+ R+T
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
             +AL+HPW+            Q       K     K K
Sbjct: 405 IHQALEHPWLTPGNAPGR--DSQIPSSRYTKIRDSIKTK 441

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 2e-27
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 5/75 (6%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
              + ++ +KV+      GT  + +PEV + +P G   D+W+ GV+ YILL G  PF  E
Sbjct: 305 AHLDPKQSVKVT-----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359

Query: 302 DQHRLYAQIKAGAYD 316
           +       +K+  ++
Sbjct: 360 NDDETLRNVKSCDWN 374

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  332 bits (854), Expect = e-114
 Identities = 79/278 (28%), Positives = 132/278 (47%), Gaps = 58/278 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           GA + V+ C+   T  E+A KII  +    R   ++ RE  +  + Q H N++ L +  +
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFE 81

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EE+  YLVF+ + GG +   I  R  ++E +AS  +Q +  +++  H+ G+ HRDLKPEN
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------------- 148
           +L     + + VK+ DF L   ++                                    
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201

Query: 149 --------W-FGVILYILLVGYPPFWDE---------------DQHRLYAQIKAGAYDYP 184
                   W  GVILYILL GYPPF                   Q+ L+  I+ G Y++P
Sbjct: 202 IYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP 261

Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             +W  ++  AK+LI+++L  +  +R++A++ L+HPW+
Sbjct: 262 DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.3 bits (248), Expect = 4e-24
 Identities = 27/81 (33%), Positives = 38/81 (46%), Gaps = 20/81 (24%)

Query: 256 QGFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDE--------- 301
               G+  Y++PEV++        Y K  D+W+ GVILYILL GYPPF            
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

Query: 302 ------DQHRLYAQIKAGAYD 316
                  Q+ L+  I+ G Y+
Sbjct: 239 GEACPACQNMLFESIQEGKYE 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  327 bits (840), Expect = e-112
 Identities = 75/254 (29%), Positives = 127/254 (50%), Gaps = 32/254 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V    ++++GLE   K IN K  S    +++E E  + + L HPNI+++ +  ++
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91

Query: 61  ENYHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
            +  Y+V +   GGEL E IV+ +      SE   +  ++Q++ ++ + HS  VVH+DLK
Sbjct: 92  YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-F 150
           PEN+L    +  + +K+ DFGLA   + ++ +                         W  
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSA 211

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y LL G  PF       +  +      +Y   E   +TP+A +L+ QMLT +P +R
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERR 270

Query: 211 ITASEALKHPWICQ 224
            +A++ L H W  Q
Sbjct: 271 PSAAQVLHHEWFKQ 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 1e-28
 Identities = 20/72 (27%), Positives = 32/72 (44%), Gaps = 3/72 (4%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
              AGT  Y++PEV K++      DIW+ GV++Y LL G  PF       +  +      
Sbjct: 184 TNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

Query: 316 D--DEPKHKSAS 325
           +   E +  +  
Sbjct: 243 NYAVECRPLTPQ 254

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  318 bits (818), Expect = e-108
 Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 44/285 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH----D 56
           G    V  C  + TG + A K++     + ++           +    P+IV +     +
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH------WQASGGPHIVCILDVYEN 93

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRD 114
               +    ++ + + GGELF  I  R  + ++E +A+  ++ I  ++   HS+ + HRD
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W 149
           +KPENLL  SK K A +KL DFG A E                                W
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213

Query: 150 -FGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
             GVI+YILL G+PPF+          +  +I+ G Y +P+PEW  V+ +AK LI  +L 
Sbjct: 214 SLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLK 273

Query: 205 VNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRK 249
            +P++R+T ++ + HPWI Q   V        T   L++      
Sbjct: 274 TDPTERLTITQFMNHPWINQSMVVPQT--PLHTARVLQEDKDHWD 316

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  107 bits (268), Expect = 9e-27
 Identities = 27/65 (41%), Positives = 37/65 (56%), Gaps = 4/65 (6%)

Query: 256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIK 311
           Q    TP Y++PEVL  E Y K  D+W+ GVI+YILL G+PPF+          +  +I+
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246

Query: 312 AGAYD 316
            G Y 
Sbjct: 247 LGQYG 251

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  316 bits (812), Expect = e-107
 Identities = 76/302 (25%), Positives = 131/302 (43%), Gaps = 78/302 (25%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDS 57
           G++ VVR  ++  T    A KI+N  K+   + +D ++++ E R+ +KL HPNI RL++ 
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAR---------------------------------- 83
            ++E Y  LV +L  GG L + +                                     
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 84  ------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
                     E   S+ ++QI  ++++ H+ G+ HRD+KPEN L ++  K   +KL DFG
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFG 215

Query: 138 LAIEVQGEQQA---------------------------------W-FGVILYILLVGYPP 163
           L+ E                                        W  GV+L++LL+G  P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

Query: 164 FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC 223
           F   +     +Q+      + +P ++ ++P A++L++ +L  N  +R  A  AL+HPWI 
Sbjct: 276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335

Query: 224 QR 225
           Q 
Sbjct: 336 QF 337

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (278), Expect = 3e-28
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 2/77 (2%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYPPFW 299
           K+F      +       AGTP +++PEVL    E YG   D W+ GV+L++LL+G  PF 
Sbjct: 218 KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP 277

Query: 300 DEDQHRLYAQIKAGAYD 316
             +     +Q+      
Sbjct: 278 GVNDADTISQVLNKKLC 294

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  265 bits (680), Expect = 1e-86
 Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 51/290 (17%)

Query: 1   GAF-SVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI 58
           GA  ++V R        + A K I  +  S       +RE ++ R+  +HPN++R   + 
Sbjct: 35  GAEGTIVYRG--MFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTE 87

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           ++  + Y+  +L     L E +  ++F +   +    +QQ    + H HS  +VHRDLKP
Sbjct: 88  KDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146

Query: 118 ENLLLASKAKGAA--VKLADFGLAIEVQGEQQA--------------------------- 148
            N+L++           ++DFGL  ++   + +                           
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206

Query: 149 ------W-FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN 200
                 +  G + Y ++  G  PF    Q +    + A + D   P        A+ LI 
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP-EKHEDVIARELIE 265

Query: 201 QMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKL 250
           +M+ ++P KR +A   LKHP+    E+       Q+  D ++K +    +
Sbjct: 266 KMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFF--QDVSDRIEKESLDGPI 313

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 24/79 (30%), Positives = 37/79 (46%), Gaps = 4/79 (5%)

Query: 253 STRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYA 308
           S R G  GT G+++PE+L    KE     VDI++ G + Y ++  G  PF    Q +   
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240

Query: 309 QIKAGAYDDEPKHKSASVV 327
            + A + D     K   V+
Sbjct: 241 LLGACSLDCLHPEKHEDVI 259

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  240 bits (615), Expect = 5e-78
 Identities = 84/250 (33%), Positives = 124/250 (49%), Gaps = 35/250 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F+ V+      TG E A KII+  +L+    QKL RE RI + L HPNIV+L + I+ 
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   YL+ +  +GGE+F+ +VA     E +A    +QI+ +V +CH   +VHRDLK ENL
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AW-FGV 152
           LL +      +K+ADFG + E     +                            W  GV
Sbjct: 146 LLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ILY L+ G  PF  ++   L  ++  G Y  P      ++ + +NL+ + L +NP KR T
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGT 258

Query: 213 ASEALKHPWI 222
             + +K  WI
Sbjct: 259 LEQIMKDRWI 268

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 2/70 (2%)

Query: 258 FAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F G P Y +PE+ + + Y G  VD+W+ GVILY L+ G  PF  ++   L  ++  G Y 
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY- 231

Query: 317 DEPKHKSASV 326
             P + S   
Sbjct: 232 RIPFYMSTDC 241

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  236 bits (603), Expect = 2e-76
 Identities = 59/299 (19%), Positives = 100/299 (33%), Gaps = 67/299 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA + V R   K TG  FA K+ N      R      RE  + +KL H NIV+L    +E
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78

Query: 61  EN--YHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
               +  L+ +    G L+  +          E++    ++ ++  +NH   NG+VHR++
Sbjct: 79  TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138

Query: 116 KPENLLLASKAKGAA-VKLADFGLAIEVQGEQQA-------------------------- 148
           KP N++      G +  KL DFG A E++ ++Q                           
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198

Query: 149 --------W-FGVILYILLVGYPPFWDEDQHR----LYAQIKAGAY-------------- 181
                   W  GV  Y    G  PF   +  R    +  +I  G                
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258

Query: 182 ---DYPSPEWDTVTPEAKN----LINQMLTVNPSKRITASEALKHPWICQRERVASIVH 233
                  P   +++   +     ++  +L  +  K     +             +   H
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHH 317

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 12/74 (16%)

Query: 258 FAGTPGYLSPEVLKK--------EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR---- 305
             GT  YL P++ ++        + YG  VD+W+ GV  Y    G  PF   +  R    
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 306 LYAQIKAGAYDDEP 319
           +  +I  G      
Sbjct: 235 VMYKIITGKPSGAI 248

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  234 bits (598), Expect = 7e-76
 Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 65/279 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +         +A K I   +        +  E  +   L H  +VR + +  E
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLE 73

Query: 61  ENYH-------------YLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESVNHCH 106
                            ++  +    G L++ I +     + D      +QILE++++ H
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------- 150
           S G++HRDLKP N+ +        VK+ DFGLA  V                        
Sbjct: 134 SQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190

Query: 151 ---------------------------GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 183
                                      G+I + ++  YP     ++  +  ++++ + ++
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEF 248

Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           P    D      K +I  ++  +P+KR  A   L   W+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 16/86 (18%), Positives = 39/86 (45%), Gaps = 3/86 (3%)

Query: 235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLV 293
             ++D LK  +              GT  Y++ EVL     Y + +D+++ G+I + ++ 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI- 225

Query: 294 GYPPFWDEDQHRLYAQIKAGAYDDEP 319
            YP     ++  +  ++++ + +  P
Sbjct: 226 -YPFSTGMERVNILKKLRSVSIEFPP 250

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  234 bits (598), Expect = 7e-76
 Identities = 72/253 (28%), Positives = 109/253 (43%), Gaps = 36/253 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+    L      +K+  E  I R L H ++V  H   +
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 86  DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145

Query: 120 LLLASKAKGAAVKLADFGLAIEVQ---------------------------GEQQAW-FG 151
           L L    +   VK+ DFGLA +V+                            E   W  G
Sbjct: 146 LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK    +Y  P+   + P A +LI +ML  +P+ R 
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARP 258

Query: 212 TASEALKHPWICQ 224
           T +E L   +   
Sbjct: 259 TINELLNDEFFTS 271

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 93.4 bits (233), Expect = 3e-22
 Identities = 29/67 (43%), Positives = 38/67 (56%), Gaps = 1/67 (1%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y   P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIP 235

Query: 320 KHKSASV 326
           KH +   
Sbjct: 236 KHINPVA 242

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  234 bits (599), Expect = 1e-75
 Identities = 72/253 (28%), Positives = 109/253 (43%), Gaps = 36/253 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F+         T   FA KI+    L      +K+  E  I R L H ++V  H   +
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + ++ ++V +L     L E    R+  +E +A + ++QI+    + H N V+HRDLK  N
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171

Query: 120 LLLASKAKGAAVKLADFGLAIEVQ---------------------------GEQQAW-FG 151
           L L    +   VK+ DFGLA +V+                            E   W  G
Sbjct: 172 LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            I+Y LLVG PPF        Y +IK    +Y  P+   + P A +LI +ML  +P+ R 
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARP 284

Query: 212 TASEALKHPWICQ 224
           T +E L   +   
Sbjct: 285 TINELLNDEFFTS 297

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 29/67 (43%), Positives = 38/67 (56%), Gaps = 1/67 (1%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP 319
           GTP Y++PEVL K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y   P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIP 261

Query: 320 KHKSASV 326
           KH +   
Sbjct: 262 KHINPVA 268

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  229 bits (587), Expect = 2e-74
 Identities = 79/254 (31%), Positives = 132/254 (51%), Gaps = 37/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F+ V R     TGLE A K+I+ K +  A   Q+++ E +I  +L+HP+I+ L++  +
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 60  EENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + NY YLV ++   GE+   +  R   +SE +A H + QI+  + + HS+G++HRDL   
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AW-F 150
           NLLL        +K+ADFGLA +++   +                            W  
Sbjct: 142 NLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G + Y LL+G PPF  +       ++    Y+ PS     ++ EAK+LI+Q+L  NP+ R
Sbjct: 199 GCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADR 254

Query: 211 ITASEALKHPWICQ 224
           ++ S  L HP++ +
Sbjct: 255 LSLSSVLDHPFMSR 268

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.0 bits (232), Expect = 4e-22
 Identities = 19/56 (33%), Positives = 30/56 (53%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GTP Y+SPE+  +  +G   D+W+ G + Y LL+G PPF  +       ++    Y
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  229 bits (586), Expect = 3e-74
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 34/266 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L       +L RE  I   L+HPNI+RL+    
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LLL S  +   +K+ADFG ++     ++                          W  GV+
Sbjct: 140 LLLGSAGE---LKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P      VT  A++LI+++L  NPS+R   
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPML 252

Query: 214 SEALKHPWICQRERVASIVHRQETVD 239
            E L+HPWI       S    +E+  
Sbjct: 253 REVLEHPWITANSSKPSNCQNKESAS 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 22/63 (34%), Positives = 32/63 (50%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF        Y +I  
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

Query: 313 GAY 315
             +
Sbjct: 222 VEF 224

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  233 bits (597), Expect = 5e-74
 Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 72/306 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G+   V        G   A K +               E ++  +   HPN++R + S  
Sbjct: 26  GSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSET 79

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILESVNHCHSNGVVH 112
            + + Y+  +L     L + + ++           E +    ++QI   V H HS  ++H
Sbjct: 80  TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138

Query: 113 RDLKPENLLLASKAKGAA----------VKLADFGLAIEVQGEQQA-------------- 148
           RDLKP+N+L+++ ++  A          + ++DFGL  ++   Q +              
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 149 ------------------------W-FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY- 181
                                   +  G + Y +L  G  PF D+      + I  G + 
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--ESNIIRGIFS 256

Query: 182 --DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
             +       ++  EA +LI+QM+  +P KR TA + L+HP    + +    +   +  D
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFL--LKVSD 314

Query: 240 CLKKFN 245
            L+  N
Sbjct: 315 RLEIEN 320

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 20/83 (24%), Positives = 38/83 (45%), Gaps = 10/83 (12%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLK-------KEPYGKPVDIWACGVILYILLV- 293
           KK ++ +    +     +GT G+ +PE+L+       K    + +DI++ G + Y +L  
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 294 GYPPFWDEDQHRLYAQIKAGAYD 316
           G  PF D+      + I  G + 
Sbjct: 236 GKHPFGDKYSR--ESNIIRGIFS 256

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  227 bits (581), Expect = 1e-73
 Identities = 87/251 (34%), Positives = 125/251 (49%), Gaps = 36/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+    + TG + A KI+N +K+ S     K++RE +  +  +HP+I++L+  I 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++V + V+GGELF+ I       E +A    QQIL +V++CH + VVHRDLKPEN
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPEN 141

Query: 120 LLLASKAKGAAVKLADFGL--------------------AIEV-QGEQQA------W-FG 151
           +LL +       K+ADFGL                    A EV  G   A      W  G
Sbjct: 142 VLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY LL G  PF DE    L+ +I+ G   +  PE+  +      L+  ML V+P KR 
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMHMLQVDPLKRA 254

Query: 212 TASEALKHPWI 222
           T  +  +H W 
Sbjct: 255 TIKDIREHEWF 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 31/68 (45%), Positives = 42/68 (61%), Gaps = 2/68 (2%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE 318
           G+P Y +PEV+    Y G  VDIW+CGVILY LL G  PF DE    L+ +I+ G +   
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YI 230

Query: 319 PKHKSASV 326
           P++ + SV
Sbjct: 231 PEYLNRSV 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  225 bits (577), Expect = 7e-73
 Identities = 62/249 (24%), Positives = 118/249 (47%), Gaps = 34/249 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K      A K++   +L     +  L RE  I   L+HPNI+R+++   
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    GEL++++     + E  ++  ++++ +++++CH   V+HRD+KPEN
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPEN 144

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           LL+  K +   +K+ADFG ++     ++                          W  GV+
Sbjct: 145 LLMGYKGE---LKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        + +I      +P      ++  +K+LI+++L  +P +R+  
Sbjct: 202 CYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPL 257

Query: 214 SEALKHPWI 222
              ++HPW+
Sbjct: 258 KGVMEHPWV 266

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 90.7 bits (226), Expect = 3e-21
 Identities = 19/56 (33%), Positives = 29/56 (51%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           GT  YL PE+++ + + + VD+W  GV+ Y  LVG PPF        + +I     
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  225 bits (575), Expect = 1e-72
 Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 38/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+      + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE 76

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF------------------------------ 150
           LL  +     +K++DFGLA   +   +                                 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193

Query: 151 -GVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            G++L  +L G  P+       + Y+  K          W  +      L++++L  NPS
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPS 251

Query: 209 KRITASEALKHPWI 222
            RIT  +  K  W 
Sbjct: 252 ARITIPDIKKDRWY 265

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.6 bits (192), Expect = 1e-16
 Identities = 19/58 (32%), Positives = 33/58 (56%), Gaps = 2/58 (3%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY 315
           GT  Y++PE+LK+  +  +PVD+W+CG++L  +L G  P+       + Y+  K    
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  224 bits (573), Expect = 7e-72
 Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 54/267 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDSI 58
           G  S V + + +     +A K +N ++   +       E     KLQ  +  I+RL+D  
Sbjct: 39  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
             + Y Y+V +     +L   +  ++     +     + +LE+V+  H +G+VH DLKP 
Sbjct: 98  ITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 156

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------- 150
           N L+        +KL DFG+A ++Q +  +                              
Sbjct: 157 NFLIVD----GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212

Query: 151 -------------GVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEA 195
                        G ILY +  G  PF        +L+A I     ++     D    + 
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIEFPDIPEKDL 269

Query: 196 KNLINQMLTVNPSKRITASEALKHPWI 222
           ++++   L  +P +RI+  E L HP++
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYV 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 19/86 (22%), Positives = 29/86 (33%), Gaps = 13/86 (15%)

Query: 255 RQGFAGTPGYLSPEVLKKEP-----------YGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           +    GT  Y+ PE +K                   D+W+ G ILY +  G  PF     
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244

Query: 304 H--RLYAQIKAGAYDDEPKHKSASVV 327
              +L+A I      + P      + 
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQ 270

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  224 bits (572), Expect = 2e-71
 Identities = 59/310 (19%), Positives = 117/310 (37%), Gaps = 60/310 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDSI 58
           G  S V + + +     +A K +N ++   +       E     KLQ  +  I+RL+D  
Sbjct: 20  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
             + Y Y+V +     +L   +  ++     +     + +LE+V+  H +G+VH DLKP 
Sbjct: 79  ITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWF---------------------------- 150
           N L+        +KL DFG+A ++Q +  +                              
Sbjct: 138 NFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193

Query: 151 -------------GVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEA 195
                        G ILY +  G  PF        +L+A I     ++     D    + 
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIEFPDIPEKDL 250

Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR------QETVDCLKKFNARRK 249
           ++++   L  +P +RI+  E L HP++  +    + + +      +  +  L   N+   
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 310

Query: 250 LKVSTRQGFA 259
           +  + +  + 
Sbjct: 311 ILKAAKTLYE 320

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 13/86 (15%)

Query: 255 RQGFAGTPGYLSPEVLK-----------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           +    GT  Y+ PE +K           K       D+W+ G ILY +  G  PF     
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225

Query: 304 H--RLYAQIKAGAYDDEPKHKSASVV 327
              +L+A I      + P      + 
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQ 251

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  223 bits (571), Expect = 2e-71
 Identities = 82/251 (32%), Positives = 130/251 (51%), Gaps = 37/251 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V+      T  + A K I+ + L  +    ++ERE    + L+HP+I++L+D I 
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                 +V +   GGELF+ IV ++  +E +     QQI+ ++ +CH + +VHRDLKPEN
Sbjct: 80  TPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN 138

Query: 120 LLLASKAKGAAVKLADFGL--------------------AIEV-QGEQQA------W-FG 151
           LLL        VK+ADFGL                    A EV  G+  A      W  G
Sbjct: 139 LLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           ++LY++LVG  PF DE    L+ ++ +    Y  P++  ++P A++LI +M+  +P +RI
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRRMIVADPMQRI 251

Query: 212 TASEALKHPWI 222
           T  E  + PW 
Sbjct: 252 TIQEIRRDPWF 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 26/68 (38%), Positives = 40/68 (58%), Gaps = 2/68 (2%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE 318
           G+P Y +PEV+  + Y G  VD+W+CG++LY++LVG  PF DE    L+ ++ +  Y   
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY-VM 227

Query: 319 PKHKSASV 326
           P   S   
Sbjct: 228 PDFLSPGA 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  227 bits (581), Expect = 3e-71
 Identities = 86/253 (33%), Positives = 127/253 (50%), Gaps = 36/253 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V+    + TG + A KI+N +K+ S     K+ RE +  +  +HP+I++L+  I 
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +  ++V + V+GGELF+ I       E ++    QQIL  V++CH + VVHRDLKPEN
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPEN 146

Query: 120 LLLASKAKGAAVKLADFGL--------------------AIEV-QGEQQA------W-FG 151
           +LL +       K+ADFGL                    A EV  G   A      W  G
Sbjct: 147 VLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           VILY LL G  PF D+    L+ +I  G   + +P++  + P   +L+  ML V+P KR 
Sbjct: 204 VILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKHMLQVDPMKRA 259

Query: 212 TASEALKHPWICQ 224
           T  +  +H W  Q
Sbjct: 260 TIKDIREHEWFKQ 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 29/68 (42%), Positives = 40/68 (58%), Gaps = 2/68 (2%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE 318
           G+P Y +PEV+    Y G  VDIW+ GVILY LL G  PF D+    L+ +I  G +   
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YT 235

Query: 319 PKHKSASV 326
           P++ + SV
Sbjct: 236 PQYLNPSV 243

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  222 bits (569), Expect = 3e-71
 Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 38/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++ K+      + +++E  I + L H N+V+ +   +E
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE 76

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 77  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWF------------------------------ 150
           LL  +     +K++DFGLA   +   +                                 
Sbjct: 137 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193

Query: 151 -GVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            G++L  +L G  P+       + Y+  K          W  +      L++++L  NPS
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPS 251

Query: 209 KRITASEALKHPWI 222
            RIT  +  K  W 
Sbjct: 252 ARITIPDIKKDRWY 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 19/58 (32%), Positives = 33/58 (56%), Gaps = 2/58 (3%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY 315
           GT  Y++PE+LK+  +  +PVD+W+CG++L  +L G  P+       + Y+  K    
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  220 bits (562), Expect = 2e-70
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 63/279 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL------------------------SARDFQKL 36
           G++ VV+    +     +A K+++ KKL                             +++
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 37  EREARICRKLQHPNIVRLHDSIQ--EENYHYLVFDLVTGGELFEDIVAREFYSEADASHC 94
            +E  I +KL HPN+V+L + +    E++ Y+VF+LV  G +  ++   +  SE  A   
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLKPLSEDQARFY 142

Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------ 148
            Q +++ + + H   ++HRD+KP NLL+        +K+ADFG++ E +G          
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFKGSDALLSNTVG 199

Query: 149 ------------------------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 183
                                   W  GV LY  + G  PF DE    L+++IK+ A ++
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259

Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           P      +  + K+LI +ML  NP  RI   E   HPW+
Sbjct: 260 PD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 6e-18
 Identities = 24/61 (39%), Positives = 37/61 (60%), Gaps = 3/61 (4%)

Query: 258 FAGTPGYLSPEVL--KKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
             GTP +++PE L   ++ + GK +D+WA GV LY  + G  PF DE    L+++IK+ A
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256

Query: 315 Y 315
            
Sbjct: 257 L 257

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  223 bits (569), Expect = 2e-70
 Identities = 63/334 (18%), Positives = 110/334 (32%), Gaps = 79/334 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA + V R   K TG  FA K+ N      R      RE  + +KL H NIV+L    +E
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78

Query: 61  EN--YHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
               +  L+ +    G L+  +          E++    ++ ++  +NH   NG+VHR++
Sbjct: 79  TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138

Query: 116 KPENLLLASKAKG-AAVKLADFGLAIEVQGEQQA-------------------------- 148
           KP N++      G +  KL DFG A E++ ++Q                           
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198

Query: 149 --------W-FGVILYILLVGYPPFWDEDQHR----LYAQIKAGAY-------------- 181
                   W  GV  Y    G  PF   +  R    +  +I  G                
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258

Query: 182 ---DYPSPEWDTVTPEAK----NLINQMLTVNPSKRITASEALKHPWICQRERVASI--- 231
                  P   +++   +     ++  +L  +  K     +            V  +   
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSL 318

Query: 232 ---------VHRQETVDCLKKFNARRKLKVSTRQ 256
                    +H   T     +   ++   +S+ Q
Sbjct: 319 QQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQ 352

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 12/74 (16%)

Query: 258 FAGTPGYLSPEVLKK--------EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR---- 305
             GT  YL P++ ++        + YG  VD+W+ GV  Y    G  PF   +  R    
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 306 LYAQIKAGAYDDEP 319
           +  +I  G      
Sbjct: 235 VMYKIITGKPSGAI 248

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  221 bits (564), Expect = 4e-70
 Identities = 78/254 (30%), Positives = 112/254 (44%), Gaps = 38/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F V R    K T    A K I          + ++RE    R L+HPNIVR  + I  
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  ++ +  +GGEL+E I     +SE +A    QQ+L  V++CHS  + HRDLK EN 
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147

Query: 121 LLASKAKGAAVKLADFGL-AIEVQGEQ------------------------QA--W-FGV 152
           LL        +K+ DFG     V   Q                         A  W  GV
Sbjct: 148 LLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206

Query: 153 ILYILLVGYPPFWDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            LY++LVG  PF D ++ R Y     +I +  Y  P      ++PE  +LI+++   +P+
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVADPA 264

Query: 209 KRITASEALKHPWI 222
            RI+  E   H W 
Sbjct: 265 TRISIPEIKTHSWF 278

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 28/61 (45%), Positives = 40/61 (65%), Gaps = 5/61 (8%)

Query: 260 GTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLY----AQIKAGA 314
           GTP Y++PEVL ++ Y GK  D+W+CGV LY++LVG  PF D ++ R Y     +I +  
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238

Query: 315 Y 315
           Y
Sbjct: 239 Y 239

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  219 bits (559), Expect = 5e-69
 Identities = 60/310 (19%), Positives = 118/310 (38%), Gaps = 60/310 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDSI 58
           G  S V + + +     +A K +N ++   +       E     KLQ  +  I+RL+D  
Sbjct: 67  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
             + Y Y+V +     +L   +  ++     +     + +LE+V+  H +G+VH DLKP 
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------------ 148
           N L+        +KL DFG+A ++Q +  +                              
Sbjct: 185 NFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240

Query: 149 ----------W-FGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEA 195
                     W  G ILY +  G  PF        +L+A I     ++     D    + 
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIEFPDIPEKDL 297

Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR------QETVDCLKKFNARRK 249
           ++++   L  +P +RI+  E L HP++  +    + + +      +  +  L   N+   
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357

Query: 250 LKVSTRQGFA 259
           +  + +  + 
Sbjct: 358 ILKAAKTLYE 367

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 19/83 (22%), Positives = 28/83 (33%), Gaps = 13/83 (15%)

Query: 258 FAGTPGYLSPEVLK-----------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQH-- 304
             G   Y+ PE +K           K       D+W+ G ILY +  G  PF        
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275

Query: 305 RLYAQIKAGAYDDEPKHKSASVV 327
           +L+A I      + P      + 
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQ 298

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  213 bits (545), Expect = 2e-67
 Identities = 51/290 (17%), Positives = 99/290 (34%), Gaps = 73/290 (25%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL---------------SARDFQKLEREARICRK 45
           G F+ +  C  +     +A K      L                   +   + E +I   
Sbjct: 42  GKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 46  LQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQ 97
           +++   +     I   +  Y++++ +    + +              F         I+ 
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159

Query: 98  ILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE--------------- 141
           +L S ++ H+   + HRD+KP N+L+    +   VKL+DFG +                 
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSDFGESEYMVDKKIKGSRGTYEF 216

Query: 142 -----VQGEQQA-------W-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPS-- 185
                   E          W  G+ LY++     PF  +     L+  I+    +YP   
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276

Query: 186 -------------PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                           + ++ E  + +   L  NP++RIT+ +ALKH W+
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 3/66 (4%)

Query: 253 STRQGFAGTPGYLSPEVL--KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQ 309
              +G  GT  ++ PE    +    G  VDIW+ G+ LY++     PF  +     L+  
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 310 IKAGAY 315
           I+    
Sbjct: 265 IRTKNI 270

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  212 bits (541), Expect = 3e-67
 Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G++  V+  +   T    A KI+  KKL         +++E ++ R+L+H N+++L D +
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75

Query: 59  QEE--NYHYLVFDLVTGG--ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             E     Y+V +    G  E+ + +  + F     A     Q+++ + + HS G+VH+D
Sbjct: 76  YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF-PVCQAHGYFCQLIDGLEYLHSQGIVHKD 134

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF------------------------ 150
           +KP NLLL +      +K++  G+A  +                                
Sbjct: 135 IKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191

Query: 151 --------GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
                   GV LY +  G  PF  ++ ++L+  I  G   Y  P      P   +L+  M
Sbjct: 192 FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CGPPLSDLLKGM 247

Query: 203 LTVNPSKRITASEALKHPWI 222
           L   P+KR +  +  +H W 
Sbjct: 248 LEYEPAKRFSIRQIRQHSWF 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 3/69 (4%)

Query: 260 GTPGYLSPEVLK-KEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           G+P +  PE+    + + G  VDIW+ GV LY +  G  PF  ++ ++L+  I  G+Y  
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-A 231

Query: 318 EPKHKSASV 326
            P      +
Sbjct: 232 IPGDCGPPL 240

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  219 bits (559), Expect = 3e-66
 Identities = 54/277 (19%), Positives = 97/277 (35%), Gaps = 57/277 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V R + + TG + A K    ++LS ++ ++   E +I +KL HPN+V   +    
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83

Query: 61  EN------YHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESVNHCHSNGVV 111
                      L  +   GG+L + +   E      E      +  I  ++ + H N ++
Sbjct: 84  LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRII 143

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------- 148
           HRDLKPEN++L    +    K+ D G A E+   +                         
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203

Query: 149 ---W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT------------ 192
              W FG + +  + G+ PF    Q   +        +     +D +T            
Sbjct: 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263

Query: 193 --------PEAKNLINQMLTVNPSKRITASEALKHPW 221
                    + +  +  ML  +  +R T  +      
Sbjct: 264 NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 17/62 (27%), Positives = 30/62 (48%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GT  YL+PE+L+++ Y   VD W+ G + +  + G+ PF    Q   +        ++
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 318 EP 319
             
Sbjct: 243 HI 244

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  210 bits (536), Expect = 4e-66
 Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 48/259 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA------RDFQKLEREARICRKLQHPNIVRL 54
           GAF  V   V K    E   K I  +K+            K+  E  I  +++H NI+++
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 55  HDSIQEENYHYLVFDL-VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
            D  + + +  LV +   +G +LF  I       E  AS+  +Q++ +V +     ++HR
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154

Query: 114 DLKPENLLLASKAKGAAVKLADFGL--------------------AIEV-QG------EQ 146
           D+K EN+++A       +KL DFG                     A EV  G      E 
Sbjct: 155 DIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211

Query: 147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
           + W  GV LY L+    PF +        +    A   P      V+ E  +L++ +L  
Sbjct: 212 EMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYL----VSKELMSLVSGLLQP 261

Query: 206 NPSKRITASEALKHPWICQ 224
            P +R T  + +  PW+ Q
Sbjct: 262 VPERRTTLEKLVTDPWVTQ 280

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 22/67 (32%), Positives = 30/67 (44%), Gaps = 8/67 (11%)

Query: 258 FAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F GT  Y +PEVL   PY G  +++W+ GV LY L+    PF +        +    A  
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI- 241

Query: 317 DEPKHKS 323
             P   S
Sbjct: 242 HPPYLVS 248

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  206 bits (526), Expect = 9e-65
 Identities = 62/256 (24%), Positives = 105/256 (41%), Gaps = 46/256 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLEREARICRKLQH--PNIVRL 54
           G F  V   ++ +  L  A K +   ++S      +  ++  E  + +K+      ++RL
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113

Query: 55  HDSIQEENYHYLVFDLVTG-GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
            D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+HR
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 173

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQG--------------------------EQQ 147
           D+K EN+L+        +KL DFG    ++                              
Sbjct: 174 DIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231

Query: 148 AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            W  G++LY ++ G  PF  ++      +I  G   +       V+ E ++LI   L + 
Sbjct: 232 VWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ----RVSSECQHLIRWCLALR 281

Query: 207 PSKRITASEALKHPWI 222
           PS R T  E   HPW+
Sbjct: 282 PSDRPTFEEIQNHPWM 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 18/67 (26%), Positives = 31/67 (46%), Gaps = 8/67 (11%)

Query: 258 FAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F GT  Y  PE ++   Y G+   +W+ G++LY ++ G  PF  ++      +I  G   
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV- 260

Query: 317 DEPKHKS 323
              +  S
Sbjct: 261 FFRQRVS 267

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  204 bits (520), Expect = 5e-64
 Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 48/258 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKL----QHPNIV 52
           G F  V    +    L+ A K+I   ++       D      E  +  K+     HP ++
Sbjct: 42  GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101

Query: 53  RLHDSIQEENYHYLVFDL-VTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           RL D  + +    LV +  +   +LF+ I  +    E  +     Q++ ++ HCHS GVV
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVV 161

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQG--------------------------E 145
           HRD+K EN+L+  +      KL DFG    +                             
Sbjct: 162 HRDIKDENILIDLRRG--CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALP 219

Query: 146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
              W  G++LY ++ G  PF  +       +I      +P+     V+P+   LI + L 
Sbjct: 220 ATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA----HVSPDCCALIRRCLA 269

Query: 205 VNPSKRITASEALKHPWI 222
             PS R +  E L  PW+
Sbjct: 270 PKPSSRPSLEEILLDPWM 287

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 19/68 (27%), Positives = 29/68 (42%), Gaps = 8/68 (11%)

Query: 258 FAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F GT  Y  PE + +  Y   P  +W+ G++LY ++ G  PF  +       +I      
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL- 250

Query: 317 DEPKHKSA 324
             P H S 
Sbjct: 251 HFPAHVSP 258

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  198 bits (506), Expect = 3e-62
 Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 45/264 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++   ++  +K+ G     K ++   ++  + Q L  E  + R+L+HPNIVR +D I +
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76

Query: 61  E--NYHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESVNHCHS-----NG 109
                 Y+V +   GG+L   I      R++  E      + Q+  ++  CH      + 
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------- 148
           V+HRDLKP N+ L  K     VKL DFGLA  +  +                        
Sbjct: 137 VLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193

Query: 149 ------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
                 W  G +LY L    PPF    Q  L  +I+ G +          + E   +I +
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIPYRYSDELNEIITR 250

Query: 202 MLTVNPSKRITASEALKHPWICQR 225
           ML +    R +  E L++P I + 
Sbjct: 251 MLNLKDYHRPSVEEILENPLILEH 274

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 25/66 (37%), Positives = 34/66 (51%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           F GTP Y+SPE + +  Y +  DIW+ G +LY L    PPF    Q  L  +I+ G +  
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235

Query: 318 EPKHKS 323
            P   S
Sbjct: 236 IPYRYS 241

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  195 bits (498), Expect = 3e-60
 Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 36/286 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F           G ++  K IN  ++S+++ ++  RE  +   ++HPNIV+  +S +E
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94

Query: 61  ENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
               Y+V D   GG+LF+ I A+    + E        QI  ++ H H   ++HRD+K +
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------W-F 150
           N+ L    K   V+L DFG+A  +    +                            W  
Sbjct: 155 NIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL 211

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           G +LY L      F       L  +I +G++  P       + + ++L++Q+   NP  R
Sbjct: 212 GCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSL--HYSYDLRSLVSQLFKRNPRDR 268

Query: 211 ITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQ 256
            + +  L+  +I +R              CLK F+      +  ++
Sbjct: 269 PSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 81.7 bits (202), Expect = 9e-18
 Identities = 24/66 (36%), Positives = 32/66 (48%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
             GTP YLSPE+ + +PY    DIWA G +LY L      F       L  +I +G++  
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244

Query: 318 EPKHKS 323
              H S
Sbjct: 245 VSLHYS 250

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  187 bits (478), Expect = 1e-57
 Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 39/251 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G++  V +   K  G  +A K   +     +D  +   E     K+ QHP  VRL  + +
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 60  EENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E    YL  +L  G  L +   A      EA     ++  L ++ H HS G+VH D+KP 
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGV 152
           N+ L  + +    KL DFGL +E+                               +  G+
Sbjct: 187 NIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGL 243

Query: 153 ILYILLVGYP-PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
            +  +      P   E   +L           P      ++ E ++++  ML  +P  R 
Sbjct: 244 TILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVMMLEPDPKLRA 297

Query: 212 TASEALKHPWI 222
           TA   L  P +
Sbjct: 298 TAEALLALPVL 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 2/59 (3%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYP-PFWDEDQHRLYAQI 310
              +   G P Y++PE+L+   YG   D+++ G+ +  +      P   E   +L    
Sbjct: 211 GAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  187 bits (475), Expect = 1e-56
 Identities = 43/295 (14%), Positives = 82/295 (27%), Gaps = 68/295 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRL----- 54
           G  SVV          +FA K+       S  + ++L        +L   +         
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 55  ----HDSIQEENY-----------------HYLVF-----DLVTGGELFEDIVAREFYSE 88
                D++  ++                  + L+      DL       + +        
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 89  ADASHCI-QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI------- 140
             A H +  Q++    +  S G+VH    P+NL +    +   + L D            
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR---LMLGDVSALWKVGTRGP 249

Query: 141 -----------EVQGEQQ--------AW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGA 180
                      E              AW  G+ +Y +   + PF         +  +   
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309

Query: 181 YDYPSPEWD-----TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS 230
               +          +    K LI + L  +  +R+   EA++ P   Q +   S
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 8/69 (11%), Positives = 19/69 (27%), Gaps = 2/69 (2%)

Query: 253 STRQGFAGTPGYLSPEVLKKE--PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +     +    Y   E L      +   ++ W  G+ +Y +   + PF         +  
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 311 KAGAYDDEP 319
           +        
Sbjct: 306 RPSLRVPGT 314

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  183 bits (466), Expect = 6e-56
 Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 56/273 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G FS V        G  +A K I   +   R  ++ +REA + R   HPNI+RL      
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLVAYCLR 97

Query: 61  E----NYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVH 112
           E    +  +L+      G L+ +I        F +E      +  I   +   H+ G  H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA----IEVQGEQQA-------------------- 148
           RDLKP N+LL  + +     L D G      I V+G +QA                    
Sbjct: 158 RDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 149 ---------------W-FGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTV 191
                          W  G +LY ++ G  P+    Q     A         P       
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS--PRH 272

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
           +     L+N M+TV+P +R      L      Q
Sbjct: 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 63.9 bits (156), Expect = 9e-12
 Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 4/83 (4%)

Query: 237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY---GKPVDIWACGVILYILLV 293
              C+    +R+ L +        T  Y +PE+   + +    +  D+W+ G +LY ++ 
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241

Query: 294 GYPPFWDEDQH-RLYAQIKAGAY 315
           G  P+    Q     A       
Sbjct: 242 GEGPYDMVFQKGDSVALAVQNQL 264

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  182 bits (462), Expect = 9e-55
 Identities = 37/303 (12%), Positives = 82/303 (27%), Gaps = 81/303 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ------------ 47
                      + TG  F   +    +   +   ++++ E    R L+            
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 48  -------------HPNIVRLHDSIQEENYHYLVF-------DLVT-GGELFEDIVAREFY 86
                           ++R+    ++       F       +L T G  L       +  
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 87  SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI------ 140
                     Q++  +   H  G+VH  L+P +++L  +     V L  F   +      
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGFEHLVRDGARV 260

Query: 141 -----------EVQGEQQ-----------------AW-FGVILYILLVGYPPFWDEDQHR 171
                      E++  +                  AW  G+++Y +     P   +    
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320

Query: 172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI-CQRERVAS 230
               I     + P           + L+   L      R+   +A++ P     R  +++
Sbjct: 321 GSEWIFRSCKNIP--------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372

Query: 231 IVH 233
            + 
Sbjct: 373 ALP 375

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 11/77 (14%), Positives = 23/77 (29%), Gaps = 11/77 (14%)

Query: 251 KVSTRQGFAGTPGYLSPEVLK-----------KEPYGKPVDIWACGVILYILLVGYPPFW 299
           +   R   + + G+  PE+             +       D WA G+++Y +     P  
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314

Query: 300 DEDQHRLYAQIKAGAYD 316
            +        I     +
Sbjct: 315 KDAALGGSEWIFRSCKN 331

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  176 bits (448), Expect = 1e-53
 Identities = 55/272 (20%), Positives = 98/272 (36%), Gaps = 62/272 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V +   +  G  +  K +          +K ERE +   KL H NIV  +     
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDG 75

Query: 61  ENYH----------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESV 102
            +Y                 ++  +    G L + I  R  E   +  A    +QI + V
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------- 148
           ++ HS  +++RDLKP N+ L    +   VK+ DFGL   ++ + +               
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 192

Query: 149 ------------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 195
                       +  G+IL  LL         +  + +  ++ G         D    + 
Sbjct: 193 ISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS------DIFDKKE 244

Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQRER 227
           K L+ ++L+  P  R   SE L+   + ++  
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 2/65 (3%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
             R    GT  Y+SPE +  + YGK VD++A G+IL  LL         +  + +  ++ 
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRD 233

Query: 313 GAYDD 317
           G   D
Sbjct: 234 GIISD 238

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (437), Expect = 1e-51
 Identities = 62/270 (22%), Positives = 102/270 (37%), Gaps = 40/270 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G FS V R      G+  A K +    L  A+      +E  + ++L HPN+++ + S  
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102

Query: 60  EENYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+N   +V +L   G+L   I      +    E        Q+  ++ H HS  V+HRD+
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
           KP N+ + +      VKL D GL      +  A                           
Sbjct: 163 KPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219

Query: 149 W-FGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
           W  G +LY +     PF+ +  +   L  +I+   Y  P P  D  + E + L+N  +  
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPS-DHYSEELRQLVNMCINP 277

Query: 206 NPSKRITASEALKHPWICQRERVASIVHRQ 235
           +P KR   +              +S+ H  
Sbjct: 278 DPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 2/65 (3%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAY 315
             GTP Y+SPE + +  Y    DIW+ G +LY +     PF+ +  +   L  +I+   Y
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 255

Query: 316 DDEPK 320
              P 
Sbjct: 256 PPLPS 260

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  171 bits (435), Expect = 2e-51
 Identities = 65/292 (22%), Positives = 106/292 (36%), Gaps = 64/292 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV     K     +A K I          +K+ RE +   KL+HP IVR  ++  E
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLE 74

Query: 61  ENYH------------YLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESVNHC 105
           +N              Y+   L     L + +  R    E + S C+    QI E+V   
Sbjct: 75  KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------- 148
           HS G++HRDLKP N+          VK+ DFGL   +  +++                  
Sbjct: 135 HSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191

Query: 149 ----------------------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 185
                                 +  G+IL+ LL  YP     ++ R    ++   +    
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDVRNLKF---P 246

Query: 186 PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET 237
           P +    P    ++  ML+ +P +R  A   +++      +     V RQ +
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 75.5 bits (186), Expect = 8e-16
 Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 2/90 (2%)

Query: 234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV 293
                D  ++         +   G  GT  Y+SPE +    Y   VDI++ G+IL+ LL 
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL- 224

Query: 294 GYPPFWDEDQHRLYAQIKAGAYDDEPKHKS 323
            YP     ++ R    ++   +      K 
Sbjct: 225 -YPFSTQMERVRTLTDVRNLKFPPLFTQKY 253

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  167 bits (424), Expect = 1e-49
 Identities = 66/260 (25%), Positives = 117/260 (45%), Gaps = 48/260 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDS 57
           G+FS V    + AT  E+A KI+  + +   +  K+    RE  +  +L HP  V+L+ +
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKLYFT 98

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKP
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 158

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------- 148
           EN+LL        +++ DFG A  +  E +                              
Sbjct: 159 ENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 215

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
           W  G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ 
Sbjct: 216 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDA 271

Query: 208 SKRITA-----SEALK-HPW 221
           +KR+          LK HP+
Sbjct: 272 TKRLGCEEMEGYGPLKAHPF 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 23/59 (38%), Positives = 36/59 (61%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           F GT  Y+SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++ +I    YD
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  163 bits (415), Expect = 4e-48
 Identities = 68/277 (24%), Positives = 104/277 (37%), Gaps = 67/277 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS-- 57
           G F+ V       +G E+A K + + +      + + +E    +KL  HPNIV+   +  
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAAS 96

Query: 58  -----IQEENYHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESVNHCHSNG 109
                       +L+   +  G+L E +    +R   S         Q   +V H H   
Sbjct: 97  IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK 156

Query: 110 --VVHRDLKPENLLLASKAKGAAVKLADFGLA---------------------------- 139
             ++HRDLK ENLLL+++     +KL DFG A                            
Sbjct: 157 PPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 140 --------IEVQGEQQA------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 184
                   I++            W  G ILY+L     PF  ED  +L  +I  G Y  P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKL--RIVNGKYSIP 269

Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
               DT      +LI  ML VNP +R++ +E +    
Sbjct: 270 P--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 26/69 (37%), Positives = 34/69 (49%), Gaps = 8/69 (11%)

Query: 260 GTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
            TP Y +PE++      P G+  DIWA G ILY+L     PF  ED  +L  +I  G Y 
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKL--RIVNGKY- 266

Query: 317 DEPKHKSAS 325
             P H +  
Sbjct: 267 SIPPHDTQY 275

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  161 bits (409), Expect = 5e-47
 Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 42/254 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRLHDS 57
           G+F  V     K +G  +A KI++ +K+           E+  RI + +  P +V+L  S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK--RILQAVNFPFLVKLEFS 109

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++ +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKP
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQG---------EQQA---------------W-FGV 152
           ENLL+  +     +++ DFG A  V+G         E  A               W  GV
Sbjct: 170 ENLLIDQQGY---IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI- 211
           ++Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR  
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFG 282

Query: 212 ----TASEALKHPW 221
                 ++   H W
Sbjct: 283 NLKNGVNDIKNHKW 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 23/56 (41%), Positives = 36/56 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
             GTP  L+PE++  + Y K VD WA GV++Y +  GYPPF+ +   ++Y +I +G
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  159 bits (404), Expect = 8e-46
 Identities = 66/260 (25%), Positives = 114/260 (43%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V+    K+T   +A K+++  ++  R    F   ER   I      P +V+L  +
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER--DIMAFANSPWVVQLFYA 137

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q++ Y Y+V + + GG+L   +   +   E  A     +++ +++  HS G +HRD+KP
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196

Query: 118 ENLLLASKAKGAAVKLADFGLAIEV--QGEQQAW-------------------------- 149
           +N+LL        +KLADFG  +++  +G  +                            
Sbjct: 197 DNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253

Query: 150 -----FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
                 GV LY +LVG  PF+ +     Y++I         P+ + ++ EAKNLI   LT
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT 313

Query: 205 VNPSKRIT---ASEALKHPW 221
            +   R+      E  +H +
Sbjct: 314 -DREVRLGRNGVEEIKRHLF 332

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 7/76 (9%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPP 297
            K N    ++  T     GTP Y+SPEVLK +     YG+  D W+ GV LY +LVG  P
Sbjct: 216 MKMNKEGMVRCDT---AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

Query: 298 FWDEDQHRLYAQIKAG 313
           F+ +     Y++I   
Sbjct: 273 FYADSLVGTYSKIMNH 288

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  157 bits (399), Expect = 4e-45
 Identities = 36/307 (11%), Positives = 76/307 (24%), Gaps = 79/307 (25%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT-KKLSARDFQKLEREARICRKLQ------------ 47
                      + TG  F   +    ++  +   ++++ E    R L+            
Sbjct: 89  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148

Query: 48  ----------HPNIVRLHDSIQEENYH-----YLVFDLVTG------GELFEDIVAREFY 86
                      P   ++     +E        + ++  +          L       +  
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208

Query: 87  SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE----- 141
                     Q++  +   H  G+VH  L+P +++L  +     V L  F   +      
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGFEHLVRDGASA 265

Query: 142 ------------------VQGEQQ----------AW-FGVILYILLVGYPPFWDEDQHRL 172
                             +   Q            W  G+ +Y +     P  D+     
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325

Query: 173 YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV 232
              I     + P           + L+   L      R+   +A++ P   Q     S  
Sbjct: 326 SEWIFRSCKNIP--------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 377

Query: 233 HRQETVD 239
                 D
Sbjct: 378 LPLYQTD 384

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.2 bits (166), Expect = 6e-13
 Identities = 9/62 (14%), Positives = 16/62 (25%), Gaps = 5/62 (8%)

Query: 260 GTPGYLSPEVLKKEP-----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 314
             P   +  +L              D W  G+ +Y +     P  D+        I    
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC 333

Query: 315 YD 316
            +
Sbjct: 334 KN 335

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  156 bits (397), Expect = 6e-45
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 42/256 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V    +  T   +A K +N +K   R+  + + +E +I + L+HP +V L  S Q
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +E   ++V DL+ GG+L   +     + E      I +++ ++++  +  ++HRD+KP+N
Sbjct: 86  DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-----------------------------W- 149
           +LL        V + DF +A  +  E Q                              W 
Sbjct: 146 ILLDEHGH---VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202

Query: 150 FGVILYILLVGYPPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            GV  Y LL G  P+          +    +     YPS      + E  +L+ ++L  N
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPN 258

Query: 207 PSKRITASEALK-HPW 221
           P +R +    ++  P+
Sbjct: 259 PDQRFSQLSDVQNFPY 274

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 6/62 (9%)

Query: 258 FAGTPGYLSPEVLKKEP---YGKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIK 311
            AGT  Y++PE+        Y   VD W+ GV  Y LL G  P+          +    +
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233

Query: 312 AG 313
             
Sbjct: 234 TT 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  154 bits (392), Expect = 7e-45
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 64/265 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ----KLEREARICRKLQHPNIVRLHD 56
           G+F  V     +  G  +A K++  K++  R  Q      ER   +   + HP I+R+  
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDER--LMLSIVTHPFIIRMWG 73

Query: 57  SIQEENYHYLVFDLVTGGELF----------EDIVAREFYSEADASHCIQQILESVNHCH 106
           + Q+    +++ D + GGELF             VA+ FY          ++  ++ + H
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAK-FY--------AAEVCLALEYLH 123

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA---------------------IEVQGE 145
           S  +++RDLKPEN+LL     G  +K+ DFG A                     +  +  
Sbjct: 124 SKDIIYRDLKPENILLD--KNGH-IKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY 180

Query: 146 QQA---W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
            ++   W FG+++Y +L GY PF+D +  + Y +I      +P         + K+L+++
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSR 236

Query: 202 MLTVNPSKRI-----TASEALKHPW 221
           ++T + S+R+        +   HPW
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPW 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.5 bits (210), Expect = 8e-19
 Identities = 22/56 (39%), Positives = 36/56 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
             GTP Y++PEV+  +PY K +D W+ G+++Y +L GY PF+D +  + Y +I   
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  153 bits (388), Expect = 1e-44
 Identities = 51/273 (18%), Positives = 92/273 (33%), Gaps = 52/273 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G F  V +CV++  G  +A K        + D Q   RE      L QH ++VR   +  
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81

Query: 60  EENYHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
           E+++  +  +   GG L + I        ++ EA+    + Q+   + + HS  +VH D+
Sbjct: 82  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 141

Query: 116 KPENLLL----------------ASKAKGAAVKLADFGLAI-----------------EV 142
           KP N+ +                   +     K+ D G                    EV
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEV 201

Query: 143 QGEQQA-------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 194
             E          +   + +       P          + +I+ G            + E
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGRLPRIPQVL---SQE 255

Query: 195 AKNLINQMLTVNPSKRITASEALKHPWICQRER 227
              L+  M+  +P +R +A   +KH  +    R
Sbjct: 256 FTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 57.7 bits (140), Expect = 8e-10
 Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 4/74 (5%)

Query: 251 KVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 309
           ++S+ Q   G   +L+ EVL+    +    DI+A  + +       P          + +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHE 239

Query: 310 IKAGAYDDEPKHKS 323
           I+ G     P+  S
Sbjct: 240 IRQGRLPRIPQVLS 253

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  153 bits (388), Expect = 5e-44
 Identities = 40/277 (14%), Positives = 81/277 (29%), Gaps = 63/277 (22%)

Query: 1   GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           GAF+ V    Q          +F  K+   K  +  +F    +     +       ++ +
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANPWEFYIGTQLMERLKPSMQHMFMKFY 133

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFY-----SEADASHCIQQILESVNHCHSNGV 110
            +   +N   LV +L + G L   I   +        +        ++L  +   H   +
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193

Query: 111 VHRDLKPENLLLASKA--------KGAAVKLADFGLAIEVQG------------------ 144
           +H D+KP+N +L +            A + L D G +I+++                   
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253

Query: 145 ----EQQAW--------FGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 191
                 + W            +Y +L G Y    +E        +           W   
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH--LDMW--- 308

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHP---WICQR 225
                   + ML +     + + + L+        Q 
Sbjct: 309 ----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 12/69 (17%), Positives = 24/69 (34%), Gaps = 1/69 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQ 309
           K +       T G+   E+L  +P+   +D +     +Y +L G Y    +E        
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

Query: 310 IKAGAYDDE 318
           +       +
Sbjct: 298 LFRRLPHLD 306

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  147 bits (373), Expect = 5e-41
 Identities = 65/263 (24%), Positives = 106/263 (40%), Gaps = 48/263 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDS 57
           GAF  V     K     FA KI+N  ++  R      + ER   +        I  LH +
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER--DVLVNGDSKWITTLHYA 142

Query: 58  IQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
            Q++N  YLV D   GG+L   +   E    E  A   + +++ +++  H    VHRD+K
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK 202

Query: 117 PENLLLASKAKGAAVKLADFGLAIEV--QGEQQAW------------------------- 149
           P+N+L+        ++LADFG  +++   G  Q+                          
Sbjct: 203 PDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259

Query: 150 -------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKNLINQ 201
                   GV +Y +L G  PF+ E     Y +I      +  P   T V+  AK+LI +
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR 319

Query: 202 MLTVNPSKRIT---ASEALKHPW 221
           ++  +   R+      +  KHP+
Sbjct: 320 LIC-SREHRLGQNGIEDFKKHPF 341

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 22/58 (37%), Positives = 30/58 (51%), Gaps = 5/58 (8%)

Query: 258 FAGTPGYLSPEVLKKEP-----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
             GTP Y+SPE+L+        YG   D W+ GV +Y +L G  PF+ E     Y +I
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  146 bits (370), Expect = 6e-41
 Identities = 68/266 (25%), Positives = 104/266 (39%), Gaps = 52/266 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDS 57
           GAFS V     K TG  +A KI+N   +  R      + ER   +        I +LH +
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER--DVLVNGDRRWITQLHFA 129

Query: 58  IQEENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            Q+ENY YLV +   GG+L   +            A   + +I+ +++  H  G VHRD+
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEMARFYLAEIVMAIDSVHRLGYVHRDI 188

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEV-------------------------QGEQQA-- 148
           KP+N+LL        ++LADFG  +++                          G      
Sbjct: 189 KPDNILLDRCGH---IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245

Query: 149 --------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKNL 198
                   W  GV  Y +  G  PF+ +     Y +I         P  D  V  EA++ 
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDF 305

Query: 199 INQMLTVNPSKRIT---ASEALKHPW 221
           I ++L   P  R+    A +   HP+
Sbjct: 306 IQRLLC-PPETRLGRGGAGDFRTHPF 330

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 24/76 (31%), Positives = 32/76 (42%), Gaps = 10/76 (13%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLK-------KEPYGKPVDIWACGVILYILLVG 294
            K  A   ++        GTP YLSPE+L+          YG   D WA GV  Y +  G
Sbjct: 210 LKLRADGTVRSLV---AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

Query: 295 YPPFWDEDQHRLYAQI 310
             PF+ +     Y +I
Sbjct: 267 QTPFYADSTAETYGKI 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  141 bits (358), Expect = 8e-40
 Identities = 71/253 (28%), Positives = 114/253 (45%), Gaps = 46/253 (18%)

Query: 6   VRRCVQKATGLEFAAKIINTKKLSARDFQ----KLEREARICRKLQHPNIVRLHDSIQEE 61
           VR+     TG  FA K++    +          K ER   I  +++HP IV L  + Q  
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER--NILEEVKHPFIVDLIYAFQTG 93

Query: 62  NYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLL 121
              YL+ + ++GGELF  +     + E  A   + +I  ++ H H  G+++RDLKPEN++
Sbjct: 94  GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM 153

Query: 122 LASKAKGAAVKLADFGL---------------------AIEV---QGEQQA---W-FGVI 153
           L  +     VKL DFGL                     A E+    G  +A   W  G +
Sbjct: 154 LNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-- 211
           +Y +L G PPF  E++ +   +I     + P      +T EA++L+ ++L  N + R+  
Sbjct: 211 MYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGA 266

Query: 212 ---TASEALKHPW 221
               A E   HP+
Sbjct: 267 GPGDAGEVQAHPF 279

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.7 bits (195), Expect = 9e-17
 Identities = 19/53 (35%), Positives = 33/53 (62%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PE+L +  + + VD W+ G ++Y +L G PPF  E++ +   +I
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  141 bits (357), Expect = 1e-39
 Identities = 69/249 (27%), Positives = 116/249 (46%), Gaps = 40/249 (16%)

Query: 6   VRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHY 65
           V++         +A K++    L  RD  + + E  I  ++ HP IV+LH + Q E   Y
Sbjct: 43  VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102

Query: 66  LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK 125
           L+ D + GG+LF  +     ++E D    + ++  +++H HS G+++RDLKPEN+LL  +
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162

Query: 126 AKGAAVKLADFGL---------------------AIEV---QGEQQA---W-FGVILYIL 157
                +KL DFGL                     A EV   +G  Q+   W FGV+++ +
Sbjct: 163 GH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219

Query: 158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----T 212
           L G  PF  +D+      I       P      ++PEA++L+  +   NP+ R+      
Sbjct: 220 LTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDG 275

Query: 213 ASEALKHPW 221
             E  +H +
Sbjct: 276 VEEIKRHSF 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 17/53 (32%), Positives = 30/53 (56%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++PEV+ +  + +  D W+ GV+++ +L G  PF  +D+      I
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (353), Expect = 5e-39
 Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 45/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R   K TG + A K +  +            E   C  L  P IV L+ +++E
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE 121

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             +  +  +L+ GG L + I       E  A + + Q LE + + H+  ++H D+K +N+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------------- 148
           LL+S   G+   L DFG A+ +Q +                                   
Sbjct: 182 LLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVTPEAKNLINQMLTVN 206
           W    ++  +L G  P+    +  L  +I   +   P  E   +  P     I + L   
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKI--ASEPPPIREIPPSCAPLTAQAIQEGLRKE 297

Query: 207 PSKRITASEALKHPWICQRE 226
           P  R +A E  +      +E
Sbjct: 298 PVHRASAMELRRKVGKALQE 317

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 16/58 (27%), Positives = 28/58 (48%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
            T     GT  +++PEV+  +P    VDIW+   ++  +L G  P+    +  L  +I
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (348), Expect = 9e-39
 Identities = 57/257 (22%), Positives = 107/257 (41%), Gaps = 36/257 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS--- 57
           G+F  V + +   T +E A   +  +KL+  + Q+ + EA + + LQHPNIVR +DS   
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96

Query: 58  -IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRD 114
            ++ +    LV +L+T G L   +   +           +QIL+ +   H+    ++HRD
Sbjct: 97  TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------W- 149
           LK +N+ +       +VK+ D GLA   +                             + 
Sbjct: 157 LKCDNIFI--TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYA 214

Query: 150 FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FG+ +  +     P+ +      +Y ++ +G    P+       PE K +I   +  N  
Sbjct: 215 FGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKD 272

Query: 209 KRITASEALKHPWICQR 225
           +R +  + L H +  + 
Sbjct: 273 ERYSIKDLLNHAFFQEE 289

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 15/71 (21%), Positives = 34/71 (47%), Gaps = 2/71 (2%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
                  + S  +   GTP +++PE+ + E Y + VD++A G+ +  +     P+ +   
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234

Query: 304 HR-LYAQIKAG 313
              +Y ++ +G
Sbjct: 235 AAQIYRRVTSG 245

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  137 bits (348), Expect = 1e-38
 Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 40/261 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + +V      +  +  A K I   +  +R  Q L  E  + + L+H NIV+   S  E
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             +  +  + V GG L   ++  ++     +E       +QILE + + H N +VHRD+K
Sbjct: 91  NGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------- 148
            +N+L+ +      +K++DFG +  + G                                
Sbjct: 150 GDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207

Query: 149 -W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            W  G  +  +  G PPF++       A  K G +       ++++ EAK  I +    +
Sbjct: 208 IWSLGCTIIEMATGKPPFYELG-EPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266

Query: 207 PSKRITASEALKHPWICQRER 227
           P KR  A++ L   ++    +
Sbjct: 267 PDKRACANDLLVDEFLKVSSK 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 19/53 (35%), Positives = 30/53 (56%), Gaps = 2/53 (3%)

Query: 253 STRQGFAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDEDQ 303
              + F GT  Y++PE++ K P  YGK  DIW+ G  +  +  G PPF++  +
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (346), Expect = 7e-38
 Identities = 64/252 (25%), Positives = 110/252 (43%), Gaps = 38/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARI-CRKLQHPNIVRLHDSI 58
           G+F  V     K T   FA K +    +   D  +    E R+     +HP +  +  + 
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q +   + V + + GG+L   I +   +  + A+    +I+  +   HS G+V+RDLK +
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147

Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W-F 150
           N+LL     G  +K+ADFG+  E + G+ +                           W F
Sbjct: 148 NILL--DKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L+G  PF  +D+  L+  I+     YP      +  EAK+L+ ++    P KR
Sbjct: 205 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKR 260

Query: 211 ITASEALK-HPW 221
           +     ++ HP 
Sbjct: 261 LGVRGDIRQHPL 272

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 23/53 (43%), Positives = 34/53 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP Y++PE+L  + Y   VD W+ GV+LY +L+G  PF  +D+  L+  I
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  141 bits (357), Expect = 9e-38
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER-EARI---CRKLQHPNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +  + L   E  +         P IV +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-- 149
           P N+LL        V+++D GLA +   ++                           W  
Sbjct: 320 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376

Query: 150 FGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
            G +L+ LL G+ PF      D+H +       A + P    D+ +PE ++L+  +L  +
Sbjct: 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRD 432

Query: 207 PSKRI-----TASEALKHPW 221
            ++R+      A E  + P+
Sbjct: 433 VNRRLGCLGRGAQEVKESPF 452

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 4/60 (6%)

Query: 256 QGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIK 311
               GT GY++PEVL K   Y    D ++ G +L+ LL G+ PF      D+H +     
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  135 bits (342), Expect = 2e-37
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 45/257 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRLHDS 57
           G F  V    +KATG  +A KI+  + + A+D       E   R+ +  +HP +  L  +
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES--RVLQNTRHPFLTALKYA 73

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            Q  +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133

Query: 118 ENLLLASKAKGAAVKLADFGL---------------------AIEV---QGEQQA---W- 149
           ENL+L        +K+ DFGL                     A EV       +A   W 
Sbjct: 134 ENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 190

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            GV++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQ 246

Query: 210 RI-----TASEALKHPW 221
           R+      A E ++H +
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 25/53 (47%), Positives = 36/53 (67%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  139 bits (351), Expect = 4e-37
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  +ATG  +A K +  K++  R  + +   E +I  K+    +V L  + +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254

Query: 60  EENYHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            ++   LV  L+ GG+L   I  + +  + EA A     +I   +   H   +V+RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W--F 150
           EN+LL        ++++D GLA+ V   Q                           W   
Sbjct: 315 ENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371

Query: 151 GVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
           G +LY ++ G  PF        +  +   +K    +Y     +  +P+A++L +Q+L  +
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKD 427

Query: 207 PSKRI-----TASEALKHPW 221
           P++R+     +A E  +HP 
Sbjct: 428 PAERLGCRGGSAREVKEHPL 447

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 21/67 (31%), Positives = 34/67 (50%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
           T +G  GT GY++PEV+K E Y    D WA G +LY ++ G  PF    +     +++  
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400

Query: 314 AYDDEPK 320
             +   +
Sbjct: 401 VKEVPEE 407

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  134 bits (340), Expect = 9e-37
 Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 45/257 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARI-CRKLQHPNIVRLHD 56
           G+F  V     KA  + +A K++  K +  +  +     ER   +  + ++HP +V LH 
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER--NVLLKNVKHPFLVGLHF 106

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           S Q  +  Y V D + GGELF  +     + E  A     +I  ++ + HS  +V+RDLK
Sbjct: 107 SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166

Query: 117 PENLLLASKAKGAAVKLADFGLA------------------------IEVQGEQQA---W 149
           PEN+LL S+     + L DFGL                         +  Q   +    W
Sbjct: 167 PENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             G +LY +L G PPF+  +   +Y  I              +T  A++L+  +L  + +
Sbjct: 224 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRT 279

Query: 209 KRI----TASEALKHPW 221
           KR+       E   H +
Sbjct: 280 KRLGAKDDFMEIKSHVF 296

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 26/53 (49%), Positives = 34/53 (64%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP YL+PEVL K+PY + VD W  G +LY +L G PPF+  +   +Y  I
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  133 bits (336), Expect = 2e-36
 Identities = 65/288 (22%), Positives = 107/288 (37%), Gaps = 81/288 (28%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-------REARICRKLQHPNIVR 53
           G++ +V +C  K TG   A K       S  D    +       RE ++ ++L+H N+V 
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKF---LESDDD----KMVKKIAMREIKLLKQLRHENLVN 88

Query: 54  LHDSIQEENYHYLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           L +  +++   YLVF+ V     +  E                + QI+  +  CHS+ ++
Sbjct: 89  LLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNII 146

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------WF------------- 150
           HRD+KPEN+L++       VKL DFG A  +    +         W+             
Sbjct: 147 HRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203

Query: 151 --------GVILYILLVGYPPF---WDEDQHRLY----------AQIKAGAYDYPS---- 185
                   G ++  + +G P F    D DQ  LY           + +      P     
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNPVFAGV 261

Query: 186 --PEWDTVTP----------EAKNLINQMLTVNPSKRITASEALKHPW 221
             PE     P             +L  + L ++P KR   +E L H +
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 15/36 (41%), Positives = 22/36 (61%), Gaps = 1/36 (2%)

Query: 264 YLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPF 298
           Y +PE+L     YGK VD+WA G ++  + +G P F
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  136 bits (343), Expect = 3e-36
 Identities = 67/264 (25%), Positives = 105/264 (39%), Gaps = 51/264 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQ 59
           G F  V  C  KATG  +A K +N K+L  R   +    E +I  K+    IV L  + +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255

Query: 60  EENYHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            +    LV  ++ GG++       D     F  E  A     QI+  + H H   +++RD
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFYTAQIVSGLEHLHQRNIIYRD 314

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------- 148
           LKPEN+LL        V+++D GLA+E++  Q                            
Sbjct: 315 LKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVD 371

Query: 149 W--FGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
           +   GV LY ++    PF    +      L  ++   A  YP    D  +P +K+    +
Sbjct: 372 YFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEAL 427

Query: 203 LTVNPSKRI-----TASEALKHPW 221
           L  +P KR+     +      HP 
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPL 451

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 20/58 (34%), Positives = 33/58 (56%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           +  +G+AGTPG+++PE+L  E Y   VD +A GV LY ++    PF    +     ++
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  132 bits (334), Expect = 4e-36
 Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 46/258 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARI-CRKLQHPNIVRLHD 56
           G+F  V    +K T   +A KI+    +   D      +E+  R+     + P + +LH 
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK--RVLALPGKPPFLTQLHS 88

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  Y V + V GG+L   I     + E  A     +I   +    S G+++RDLK
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148

Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W 149
            +N++L   ++G  +K+ADFG+  E +                                W
Sbjct: 149 LDNVML--DSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 205

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
            FGV+LY +L G  PF  ED+  L+  I      YP     +++ EA  +   ++T +P 
Sbjct: 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPG 261

Query: 209 KRI-----TASEALKHPW 221
           KR+        +  +H +
Sbjct: 262 KRLGCGPEGERDIKEHAF 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 27/53 (50%), Positives = 36/53 (67%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP Y++PE++  +PYGK VD WA GV+LY +L G  PF  ED+  L+  I
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  132 bits (334), Expect = 5e-36
 Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 54/261 (20%)

Query: 6   VRRCVQKATGLEFAAKIINTKKLSARDFQ----KLEREARI-CRKLQHPNIVRLHDSIQE 60
           VR+     TG  +A K++    +  +       + ER  ++     Q P +V LH + Q 
Sbjct: 73  VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER--QVLEHIRQSPFLVTLHYAFQT 130

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           E   +L+ D + GGELF  +  RE ++E +    + +I+ ++ H H  G+++RD+K EN+
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190

Query: 121 LLASKAKGAAVKLADFGLAIE-----------------------VQGEQQA-------W- 149
           LL S      V L DFGL+ E                       V+G           W 
Sbjct: 191 LLDSNGH---VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247

Query: 150 FGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
            GV++Y LL G  PF  + +      +  +I      YP      ++  AK+LI ++L  
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ----EMSALAKDLIQRLLMK 303

Query: 206 NPSKRI-----TASEALKHPW 221
           +P KR+      A E  +H +
Sbjct: 304 DPKKRLGCGPRDADEIKEHLF 324

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 2/55 (3%)

Query: 258 FAGTPGYLSPEVLKKEPYG--KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GT  Y++P++++    G  K VD W+ GV++Y LL G  PF  + +    A+I
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  133 bits (337), Expect = 8e-36
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 42/256 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E R+ +  +HP +  L  S Q
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
             +    V +   GGELF  +     +SE  A     +I+ ++++ HS   VV+RDLK E
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278

Query: 119 NLLLASKAKGAAVKLADFGL---------------------AIEV---QGEQQA---W-F 150
           NL+L        +K+ DFGL                     A EV       +A   W  
Sbjct: 279 NLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV++Y ++ G  PF+++D  +L+  I      +P     T+ PEAK+L++ +L  +P +R
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQR 391

Query: 211 I-----TASEALKHPW 221
           +      A E ++H +
Sbjct: 392 LGGGSEDAKEIMQHRF 407

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 24/53 (45%), Positives = 36/53 (67%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  +L+  I
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  130 bits (330), Expect = 2e-35
 Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 47/259 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQ---KLEREARI-CRKLQHPNIVRLHD 56
           G+F  V     K TG  +A K++    +   D       E+  RI      HP + +L  
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK--RILSLARNHPFLTQLFC 91

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             Q  +  + V + V GG+L   I     + EA A     +I+ ++   H  G+++RDLK
Sbjct: 92  CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLK 151

Query: 117 PENLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W 149
            +N+LL    +G   KLADFG+  E +                                W
Sbjct: 152 LDNVLL--DHEG-HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWW 208

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GV+LY +L G+ PF  E++  L+  I      YP+     +  +A  ++   +T NP+
Sbjct: 209 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPT 264

Query: 209 KRI-----TASEALK-HPW 221
            R+         A+  HP+
Sbjct: 265 MRLGSLTQGGEHAILRHPF 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 25/53 (47%), Positives = 36/53 (67%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP Y++PE+L++  YG  VD WA GV+LY +L G+ PF  E++  L+  I
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  132 bits (333), Expect = 1e-34
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 42/256 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARI-CRKLQHPNIVRLHDSI 58
           G+F  V    +K T   +A KI+    +   D  +    E R+     + P + +LH   
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q  +  Y V + V GG+L   I     + E  A     +I   +    S G+++RDLK +
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471

Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W-F 150
           N++L   ++G  +K+ADFG+  E +                                W F
Sbjct: 472 NVML--DSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L G  PF  ED+  L+  I      YP     +++ EA  +   ++T +P KR
Sbjct: 529 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKR 584

Query: 211 I-----TASEALKHPW 221
           +        +  +H +
Sbjct: 585 LGCGPEGERDIKEHAF 600

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 27/53 (50%), Positives = 36/53 (67%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           F GTP Y++PE++  +PYGK VD WA GV+LY +L G  PF  ED+  L+  I
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  125 bits (316), Expect = 1e-33
 Identities = 44/245 (17%), Positives = 84/245 (34%), Gaps = 51/245 (20%)

Query: 21  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI 80
           +  +    S         + R        N V        + Y Y+   L     L + +
Sbjct: 93  ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152

Query: 81  VAREFYSEADASHC---IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
             R    + +   C     QI E+V   HS G++HRDLKP N+          VK+ DFG
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFG 209

Query: 138 LAIEVQGEQQA---------------------------------------W-FGVILYIL 157
           L   +  +++                                        +  G+IL+ L
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
           L  Y      ++ R+   ++     +P   +    P+   ++  ML+ +P++R  A++ +
Sbjct: 270 L--YSFSTQMERVRIITDVRNL--KFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

Query: 218 KHPWI 222
           ++   
Sbjct: 325 ENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 53/349 (15%), Positives = 93/349 (26%), Gaps = 92/349 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV     K     +A K I          +K+ RE            V+    ++ 
Sbjct: 17  GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMRE------------VKALAKLEH 63

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
                 V       E   +    E              L S +   +  V  R + P + 
Sbjct: 64  PGI---VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDE--DQHRLYAQIKA 178
                                V   Q +   V LYI +        +   +  L   +  
Sbjct: 121 ------------------KNTVGQLQPSSPKVYLYIQM--------QLCRKENLKDWMNR 154

Query: 179 GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR---- 234
                             ++  Q+            EA++   +  +     ++HR    
Sbjct: 155 RCSLEDREH-----GVCLHIFIQIA-----------EAVEF--LHSK----GLMHRDLKP 192

Query: 235 --------------------QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP 274
                                   D  ++         +T  G  GT  Y+SPE +    
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252

Query: 275 YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKHKS 323
           Y   VDI++ G+IL+ LL  Y      ++ R+   ++   +      K 
Sbjct: 253 YSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKY 299

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  124 bits (313), Expect = 4e-33
 Identities = 54/266 (20%), Positives = 111/266 (41%), Gaps = 52/266 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRK-LQHPNIVRLHDSI 58
           G+++ V     K T   +A K++  + ++  +    ++ E  +  +   HP +V LH   
Sbjct: 20  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 80  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139

Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W-F 150
           N+LL   ++G  +KL D+G+  E ++                               W  
Sbjct: 140 NVLL--DSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196

Query: 151 GVILYILLVGYPPFW---------DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
           GV+++ ++ G  PF             +  L+  I       P     +++ +A +++  
Sbjct: 197 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKS 252

Query: 202 MLTVNPSKRI-----TASEALK-HPW 221
            L  +P +R+     T    ++ HP+
Sbjct: 253 FLNKDPKERLGCHPQTGFADIQGHPF 278

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 9/62 (14%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW---------DEDQHRLYA 308
           F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF             +  L+ 
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229

Query: 309 QI 310
            I
Sbjct: 230 VI 231

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  121 bits (306), Expect = 2e-32
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 41/263 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+  +V    +K +G + A K+++ +K   +  + L  E  I R  QH N+V ++ S   
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
               +++ + + GG L  DIV++   +E   +   + +L+++ + H+ GV+HRD+K +++
Sbjct: 114 GEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AW-FGV 152
           LL    +   VKL+DFG   ++  +                              W  G+
Sbjct: 173 LLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWDTVTPEAKNLINQMLTVNPSK 209
           ++  ++ G PP++ +   +   +++    D P P       V+P  ++ + +ML  +P +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285

Query: 210 RITASEALKHPWICQRERVASIV 232
           R TA E L HP++ Q      +V
Sbjct: 286 RATAQELLDHPFLLQTGLPECLV 308

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 52.0 bits (125), Expect = 8e-08
 Identities = 17/50 (34%), Positives = 32/50 (64%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           V  R+   GTP +++PEV+ +  Y   VDIW+ G+++  ++ G PP++ +
Sbjct: 195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  123 bits (310), Expect = 3e-32
 Identities = 53/266 (19%), Positives = 110/266 (41%), Gaps = 52/266 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRK-LQHPNIVRLHDSI 58
           G+++ V     K T   +A +++  + ++  +    ++ E  +  +   HP +V LH   
Sbjct: 63  GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q E+  + V + V GG+L   +  +    E  A     +I  ++N+ H  G+++RDLK +
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182

Query: 119 NLLLASKAKGAAVKLADFGLAIE-VQGEQQA--------------------------W-F 150
           N+LL S+     +KL D+G+  E ++                               W  
Sbjct: 183 NVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239

Query: 151 GVILYILLVGYPPFW---------DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
           GV+++ ++ G  PF             +  L+  I       P     +++ +A +++  
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKS 295

Query: 202 MLTVNPSKRI-----TASEALK-HPW 221
            L  +P +R+     T    ++ HP+
Sbjct: 296 FLNKDPKERLGCHPQTGFADIQGHPF 321

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 9/62 (14%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW---------DEDQHRLYA 308
           F GTP Y++PE+L+ E YG  VD WA GV+++ ++ G  PF             +  L+ 
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272

Query: 309 QI 310
            I
Sbjct: 273 VI 274

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (302), Expect = 6e-32
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 41/263 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++      + +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV 88

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQ---------------------------AW-FGV 152
           LL        VKL DFG   ++  EQ                             W  G+
Sbjct: 148 LLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWDTVTPEAKNLINQMLTVNPSK 209
           +   ++ G PP+ +E+  R    I        +P     + ++   ++ +N+ L ++  K
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIA----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260

Query: 210 RITASEALKHPWICQRERVASIV 232
           R +A E L+H ++   + ++S+ 
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLT 283

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 19/50 (38%), Positives = 32/50 (64%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
            S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  119 bits (301), Expect = 2e-31
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 83/290 (28%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           G +S V   +      +   KI+   K      +K++RE +I   L+  PNI+ L D ++
Sbjct: 47  GKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVK 101

Query: 60  --EENYHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHCHSNGVVHRD 114
                   LVF+ V   +       ++ Y           + +IL+++++CHS G++HRD
Sbjct: 102 DPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 155

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------WF---------------- 150
           +KP N+++  + +   ++L D+GLA E     Q         +F                
Sbjct: 156 VKPHNVMIDHEHR--KLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 212

Query: 151 -----GVILYILLVGYPPFW----DEDQHRLYAQI----------------KAGAYD--- 182
                G +L  ++    PF+    + DQ    A++                    ++   
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272

Query: 183 --YPSPEWDT---------VTPEAKNLINQMLTVNPSKRITASEALKHPW 221
             +    W+          V+PEA + ++++L  +   R+TA EA++HP+
Sbjct: 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  117 bits (296), Expect = 3e-31
 Identities = 37/222 (16%), Positives = 72/222 (32%), Gaps = 11/222 (4%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
                  + +  A   + A   ++ + +   D  Q+         ++  P + R+ D + 
Sbjct: 42  VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                 +V + + GG L E  VA    S   A   +Q +  + +  H  GV      P  
Sbjct: 102 TRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSR 159

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKA 178
           + ++       V LA      +   +      G  LY LLV   P  +       A  + 
Sbjct: 160 VRVSI---DGDVVLAYPATMPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216

Query: 179 GAYDY---PSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL 217
                   P+     +  +   +  + +  +   R +AS  L
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLL 257

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 40.1 bits (94), Expect = 5e-04
 Identities = 12/74 (16%), Positives = 16/74 (21%), Gaps = 19/74 (25%)

Query: 231 IVHRQETVDCLKKFNARRKLKVSTRQGFA--GTPGYLSPEVLKKEPYGKPVDIWACGVIL 288
           +               R      +  G      P  +              DI   G  L
Sbjct: 150 VALS-----IDHPSRVRV-----SIDGDVVLAYPATMPDA-------NPQDDIRGIGASL 192

Query: 289 YILLVGYPPFWDED 302
           Y LLV   P  +  
Sbjct: 193 YALLVNRWPLPEAG 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  119 bits (300), Expect = 8e-31
 Identities = 78/291 (26%), Positives = 109/291 (37%), Gaps = 86/291 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G+F VV +     +G   A K +       R   K  RE +I RKL H NIVRL      
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKV---LQDKRF--KN-RELQIMRKLDHCNIVRLRYFFYS 118

Query: 59  ----QEENYHYLVFDLVTGGELFEDI--VAREFYSEA---DASHC---IQQILESVNHCH 106
               ++E Y  LV D V      E +  VAR +          +    + Q+  S+ + H
Sbjct: 119 SGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA-IEVQGEQQA----------------- 148
           S G+ HRD+KP+NLLL      A +KL DFG A   V+GE                    
Sbjct: 174 SFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231

Query: 149 ---------W-FGVILYILLVGYPPFWDEDQ-HRLYAQIKA-GAYDYPSPE-WDTVTPEA 195
                    W  G +L  LL+G P F  +    +L   IK  G    P+ E    + P  
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT---PTREQIREMNPNY 288

Query: 196 KN-------------------------LINQMLTVNPSKRITASEALKHPW 221
                                      L +++L   P+ R+T  EA  H +
Sbjct: 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (294), Expect = 9e-31
 Identities = 63/278 (22%), Positives = 119/278 (42%), Gaps = 40/278 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T    A KII+ ++ +  + + +++E  +  +   P + + + S  +
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +   +++ + + GG    D++      E   +  +++IL+ +++ HS   +HRD+K  N+
Sbjct: 92  DTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150

Query: 121 LLASKAKGAAVKLADFG---------------------LAIEVQGEQQ------AW-FGV 152
           LL+   +   VKLADFG                     +A EV  +         W  G+
Sbjct: 151 LLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
               L  G PP  +    + L+   K      P+ E    +   K  +   L   PS R 
Sbjct: 208 TAIELARGEPPHSELHPMKVLFLIPKNNP---PTLE-GNYSKPLKEFVEACLNKEPSFRP 263

Query: 212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRK 249
           TA E LKH +I +  +  S +   E +D  K++ A + 
Sbjct: 264 TAKELLKHKFILRNAKKTSYL--TELIDRYKRWKAEQS 299

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 18/51 (35%), Positives = 26/51 (50%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED 302
              R  F GTP +++PEV+K+  Y    DIW+ G+    L  G PP  +  
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (291), Expect = 5e-30
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 39/285 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V            A K ++     + + +Q + +E R  +KL+HPN ++      
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            E+  +LV +   G       V ++   E + +      L+ + + HS+ ++HRD+K  N
Sbjct: 125 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 184

Query: 120 LLLASKAKGAAVKLADFG-----------------LAIEV-QGEQQA--------W-FGV 152
           +LL+       VKL DFG                 +A EV     +         W  G+
Sbjct: 185 ILLSEPGL---VKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
               L    PP ++ +    LY   +  +    S  W   +   +N ++  L   P  R 
Sbjct: 242 TCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRP 298

Query: 212 TASEALKHPWICQRERVAS----IVHRQETVDCLKKFNARRKLKV 252
           T+   LKH ++ +          I   ++ V  L     R+  K+
Sbjct: 299 TSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 15/55 (27%), Positives = 28/55 (50%), Gaps = 3/55 (5%)

Query: 251 KVSTRQGFAGTPGYLSPEV---LKKEPYGKPVDIWACGVILYILLVGYPPFWDED 302
            ++    F GTP +++PEV   + +  Y   VD+W+ G+    L    PP ++ +
Sbjct: 203 IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (285), Expect = 2e-29
 Identities = 61/269 (22%), Positives = 110/269 (40%), Gaps = 46/269 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K TG   AAK+I TK  S  + +    E  I     HP IV+L  +   
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87

Query: 61  ENYHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           +   +++ +   GG + + I+       +E       +Q+LE++N  HS  ++HRDLK  
Sbjct: 88  DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146

Query: 119 NLLLASKAKGAAVKLADFGLA------------------------IEVQGEQQA------ 148
           N+L+  +     ++LADFG++                        +  +  +        
Sbjct: 147 NVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203

Query: 149 --W-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPS-PEWDTVTPEAKNLINQML 203
             W  G+ L  +    PP  + +  R L    K+     P+       + E ++ +   L
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---PTLLTPSKWSVEFRDFLKIAL 260

Query: 204 TVNPSKRITASEALKHPWICQRERVASIV 232
             NP  R +A++ L+HP++       ++ 
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNKALR 289

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 5/52 (9%)

Query: 255 RQGFAGTPGYLSPEV-----LKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           R  F GTP +++PEV     +K  PY    DIW+ G+ L  +    PP  + 
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 3e-29
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 34/223 (15%)

Query: 19  AAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF 77
           A K I        +  ++ ERE     +L H NIV + D  +E++ +YLV + + G  L 
Sbjct: 40  AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLS 99

Query: 78  EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG 137
           E I +    S   A +   QIL+ + H H   +VHRD+KP+N+L+        +K+ DFG
Sbjct: 100 EYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFG 156

Query: 138 LAIEVQGEQ-----------------QAW------------FGVILYILLVGYPPFWDED 168
           +A  +                     QA              G++LY +LVG PPF  E 
Sbjct: 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216

Query: 169 QHRL-YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
              +    I+    +  +     +     N+I +    + + R
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 19/39 (48%), Positives = 25/39 (64%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           GT  Y SPE  K E   +  DI++ G++LY +LVG PPF
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  113 bits (284), Expect = 3e-29
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 21/148 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-------REARICRKLQHPNIVR 53
           G++ VV +C  + TG   A K       S  D            RE R+ ++L+HPN+V 
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKF---LESEDD----PVIKKIALREIRMLKQLKHPNLVN 66

Query: 54  LHDSIQEENYHYLVFDLVTG--GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
           L +  + +   +LVF+          +    +    E        Q L++VN CH +  +
Sbjct: 67  LLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCI 124

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLA 139
           HRD+KPEN+L+   +    +KL DFG A
Sbjct: 125 HRDVKPENILITKHSV---IKLCDFGFA 149

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 52.2 bits (126), Expect = 6e-08
 Identities = 9/32 (28%), Positives = 19/32 (59%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            ++  A  L+   L ++P++R+T  + L HP+
Sbjct: 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 17/36 (47%), Positives = 21/36 (58%), Gaps = 1/36 (2%)

Query: 264 YLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPF 298
           Y SPE+L     YG PVD+WA G +   LL G P +
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (282), Expect = 5e-29
 Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 54/283 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA +VV+         + A K IN +K       +L +E +   +  HPNIV  + S   
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNIVSYYTSFVV 84

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFY---------SEADASHCIQQILESVNHCHSNGVV 111
           ++  +LV  L++GG +  DI+               E+  +  ++++LE + + H NG +
Sbjct: 85  KDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI 143

Query: 112 HRDLKPENLLLASKAKGAAVKLADFG--------------------------LAIEVQGE 145
           HRD+K  N+LL        V++ADFG                          +A EV  +
Sbjct: 144 HRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200

Query: 146 QQA-------W-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTV----- 191
            +        W FG+    L  G  P+      + L   ++       +   D       
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY 260

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR 234
               + +I+  L  +P KR TA+E L+H +  + +    +  +
Sbjct: 261 GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDED 302
                  +   R+ F GTP +++PEV+++   Y    DIW+ G+    L  G  P+    
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  110 bits (277), Expect = 2e-28
 Identities = 51/155 (32%), Positives = 75/155 (48%), Gaps = 34/155 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G + VV +   K TG     +++  KK+      +L+           RE  + ++L HP
Sbjct: 14  GTYGVVYKARNKLTG-----EVVALKKI------RLDTETEGVPSTAIREISLLKELNHP 62

Query: 50  NIVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNH 104
           NIV+L D I  EN  YLVF     DL       +                + Q+L+ +  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGI-PLPLIKSYLFQLLQGLAF 118

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           CHS+ V+HRDLKP+NLL+ ++     +KLADFGLA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGA---IKLADFGLA 150

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 13/30 (43%), Positives = 22/30 (73%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
             + ++L++QML  +P+KRI+A  AL HP+
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (277), Expect = 2e-28
 Identities = 58/289 (20%), Positives = 119/289 (41%), Gaps = 46/289 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++  V + + K TG   A K +  +     D Q++ +E  I ++   P++V+ + S  +
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
               ++V +    G + + I  R    +E + +  +Q  L+ + + H    +HRD+K  N
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN 155

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------W-FG 151
           +LL ++      KLADFG+A ++                                 W  G
Sbjct: 156 ILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWDTVTPEAKNLINQMLTVNPS 208
           +    +  G PP+ D    R    I       P P   + +  +    + + Q L  +P 
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIP----TNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268

Query: 209 KRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQG 257
           +R TA++ L+HP++   + V+ +   ++ ++       +R+      +G
Sbjct: 269 QRATATQLLQHPFVRSAKGVSIL---RDLINEAMDVKLKRQESQQREEG 314

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 16/47 (34%), Positives = 26/47 (55%)

Query: 255 RQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE 301
           R    GTP +++PEV+++  Y    DIW+ G+    +  G PP+ D 
Sbjct: 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  109 bits (276), Expect = 8e-28
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 24/151 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-------REARICRKLQHPNIVR 53
           G F+ V +   K T    A K I   KL  R   K +       RE ++ ++L HPNI+ 
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKI---KLGHRSEAK-DGINRTALREIKLLQELSHPNIIG 76

Query: 54  LHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
           L D+   ++   LVF     DL     + +D       + +     +   L+ + + H +
Sbjct: 77  LLDAFGHKSNISLVFDFMETDL---EVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH 131

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            ++HRDLKP NLLL     G  +KLADFGLA
Sbjct: 132 WILHRDLKPNNLLLDE--NG-VLKLADFGLA 159

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 11/32 (34%), Positives = 17/32 (53%)

Query: 190 TVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
               +  +LI  +   NP  RITA++ALK  +
Sbjct: 263 AAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  109 bits (274), Expect = 8e-28
 Identities = 65/296 (21%), Positives = 107/296 (36%), Gaps = 82/296 (27%)

Query: 1   GAFSVVRRCVQKATGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G   +V   V        A K I+ T   S    +   RE +I R+L H NIV++ + + 
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKVFEILG 78

Query: 60  EENYHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ--------------QILESVNH 104
                  + D V        + + +E+  E D ++ ++              Q+L  + +
Sbjct: 79  PSGSQ--LTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRGLKY 135

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------WF--- 150
            HS  V+HRDLKP NL +    +   +K+ DFGLA  +                 W+   
Sbjct: 136 IHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193

Query: 151 ------------------GVILYILLVGYPPFWDED---QHRL------------YAQIK 177
                             G I   +L G   F       Q +L              ++ 
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253

Query: 178 AGAYDY-------PSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           +    Y       P      +    + EA + + Q+LT +P  R+TA EAL HP++
Sbjct: 254 SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  110 bits (276), Expect = 9e-28
 Identities = 74/287 (25%), Positives = 112/287 (39%), Gaps = 76/287 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+  V       TGL  A K +      +R FQ +       RE R+ + ++H N++ L
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93

Query: 55  HD------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            D      S++E N  YLV  L+ G +L   +  ++  ++      I QIL  + + HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILRGLKYIHSA 151

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------- 150
            ++HRDLKP NL +    +   +K+ DFGLA     E        W+             
Sbjct: 152 DIIHRDLKPSNLAVNEDCE---LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYN 208

Query: 151 --------GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAY--- 181
                   G I+  LL G   F   D       I                   A  Y   
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268

Query: 182 --DYPSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
               P   +  V     P A +L+ +ML ++  KRITA++AL H + 
Sbjct: 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  108 bits (273), Expect = 1e-27
 Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 29/154 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE----------REARICRKLQHPN 50
           G ++ V + + K TG+  A K +           KL+          RE  + ++L+H N
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEV-----------KLDSEEGTPSTAIREISLMKELKHEN 64

Query: 51  IVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHC 105
           IVRL+D I  EN   LVF     DL    +                 +   Q+L+ +  C
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           H N ++HRDLKP+NLL+  + +   +KL DFGLA
Sbjct: 125 HENKILHRDLKPQNLLINKRGQ---LKLGDFGLA 155

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 10/38 (26%), Positives = 20/38 (52%)

Query: 184 PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
                + +     + ++ +L +NP  R++A +AL HPW
Sbjct: 259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  108 bits (272), Expect = 1e-27
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 35/155 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G +  V +   + T      +I+  K++      +L+           RE  + ++L+H 
Sbjct: 13  GTYGTVFKAKNRETH-----EIVALKRV------RLDDDDEGVPSSALREICLLKELKHK 61

Query: 50  NIVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNH 104
           NIVRLHD +  +    LVF     DL    + F+                + Q+L+ +  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDL---KKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116

Query: 105 CHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           CHS  V+HRDLKP+NLL+    +   +KLA+FGLA
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGE---LKLANFGLA 148

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 53.3 bits (129), Expect = 2e-08
 Identities = 12/30 (40%), Positives = 20/30 (66%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
               ++L+  +L  NP +RI+A EAL+HP+
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (273), Expect = 1e-27
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 34/154 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE----------REARICRKLQHPN 50
           G ++ V +   K T       ++  K++      +LE          RE  + + L+H N
Sbjct: 13  GTYATVYKGKSKLTD-----NLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 51  IVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILESVNHC 105
           IV LHD I  E    LVF     DL    +  +D       +  +    + Q+L  + +C
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDC--GNIINMHNVKLFLFQLLRGLAYC 116

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           H   V+HRDLKP+NLL+  +     +KLADFGLA
Sbjct: 117 HRQKVLHRDLKPQNLLINER---GELKLADFGLA 147

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 9/30 (30%), Positives = 18/30 (60%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
             +  +L+ ++L      RI+A +A+KHP+
Sbjct: 255 DSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  108 bits (272), Expect = 4e-27
 Identities = 74/318 (23%), Positives = 123/318 (38%), Gaps = 86/318 (27%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+  V   V   TG + A      KKL  R FQ         RE R+ + ++H N++ L
Sbjct: 36  GAYGAVCSAVDGRTGAKVA-----IKKLY-RPFQSELFAKRAYRELRLLKHMRHENVIGL 89

Query: 55  HD------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            D      ++ +    YLV   + G +L   ++  E   E      + Q+L+ + + H+ 
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF------------- 150
           G++HRDLKP NL +    +   +K+ DFGLA +   E        W+             
Sbjct: 148 GIIHRDLKPGNLAVNEDCE---LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYT 204

Query: 151 --------GVILYILLVGYPPFWDEDQHRLYAQI------------------KAGAY--- 181
                   G I+  ++ G   F   D      +I                  +A  Y   
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264

Query: 182 --DYPSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ-----RERVA- 229
             +    ++ ++    +P A NL+ +ML ++  +R+TA EAL HP+         E    
Sbjct: 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 324

Query: 230 ----SIVHRQETVDCLKK 243
               S      T+D  K+
Sbjct: 325 KYDDSFDDVDRTLDEWKR 342

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  107 bits (270), Expect = 4e-27
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G +  V + +   T      + +  K++      +LE           RE  + ++LQH 
Sbjct: 45  GTYGEVYKAIDTVTN-----ETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 50  NIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           NI+ L   I   +  +L+F+     +L + +      S       + Q++  VN CHS  
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152

Query: 110 VVHRDLKPENLLL--ASKAKGAAVKLADFGLA 139
            +HRDLKP+NLLL  +  ++   +K+ DFGLA
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 13/42 (30%), Positives = 21/42 (50%)

Query: 180 AYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
                      +  E  +L+  ML ++P KRI+A  AL+HP+
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  108 bits (271), Expect = 4e-27
 Identities = 66/295 (22%), Positives = 103/295 (34%), Gaps = 80/295 (27%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN---TKKLSARDFQKLE------REARICRKLQHPNI 51
           G++  V   V    G+  A K +    +   +              RE R+     HPNI
Sbjct: 33  GSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91

Query: 52  VRLHDSI---QEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVN 103
           + L D     +E   H  YLV +L+   +L + I  +         H    +  IL  ++
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ--HIQYFMYHILLGLH 148

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------WF------ 150
             H  GVVHRDL P N+LLA       + + DF LA E   +          W+      
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

Query: 151 ---------------GVILYILLVGYPPF-------------------WDEDQHRLYAQ- 175
                          G ++  +      F                     ED     +  
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265

Query: 176 ----IKAGAYDYPSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
               ++    + P+  W  V     P A +LI +ML  NP +RI+  +AL+HP+ 
Sbjct: 266 ARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (271), Expect = 5e-27
 Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 84/293 (28%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+ +V         +  A      KK+S   F+         RE +I  + +H NI+ +
Sbjct: 38  GAYGMVCSAYDNLNKVRVA-----IKKISP--FEHQTYCQRTLREIKILLRFRHENIIGI 90

Query: 55  HDSI---QEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           +D I     E     Y+V DL+   +L++ +  +   S     + + QIL  + + HS  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHL-SNDHICYFLYQILRGLKYIHSAN 148

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------WF-------- 150
           V+HRDLKP NLLL +      +K+ DFGLA     +              W+        
Sbjct: 149 VLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

Query: 151 -------------GVILYILLVGYPPF-------------------WDEDQHRLYAQIKA 178
                        G IL  +L   P F                     ED + +    KA
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL-KA 264

Query: 179 GAY-----DYPSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWI 222
             Y           W+ +      +A +L+++MLT NP KRI   +AL HP++
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (267), Expect = 7e-27
 Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 37/208 (17%)

Query: 34  QKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASH 93
            +++REAR   +LQ P++V +HD  + +   Y+   L+ G +L   +  +   +   A  
Sbjct: 79  TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA 138

Query: 94  CIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ------- 146
            ++QI  +++  H+ G  HRD+KPEN+L+   +      L DFG+A     E+       
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNT 195

Query: 147 ----------QAW------------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 184
                     +                 +LY  L G PP+  +    + A I       P
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AIP 252

Query: 185 SP--EWDTVTPEAKNLINQMLTVNPSKR 210
            P      +      +I + +  NP  R
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAKNPEDR 280

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 14/39 (35%), Positives = 20/39 (51%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           GT  Y++PE   +       DI+A   +LY  L G PP+
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  107 bits (269), Expect = 8e-27
 Identities = 78/323 (24%), Positives = 125/323 (38%), Gaps = 96/323 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+  V   + K +G + A      KKLS R FQ         RE  + + +QH N++ L
Sbjct: 35  GAYGSVCSAIDKRSGEKVA-----IKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 55  HDSIQ----EENYH--YLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHC 105
            D         N++  YLV          +  + +    +         + Q+L+ + + 
Sbjct: 89  LDVFTPASSLRNFYDFYLVM------PFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----WF---------- 150
           HS GVVHRDLKP NL +    +   +K+ DFGLA     E        W+          
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCE---LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWM 199

Query: 151 -----------GVILYILLVGYPPF-------------------WDEDQHRLYAQIKAGA 180
                      G I+  +L G   F                     E   +L  +  A +
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK-AAKS 258

Query: 181 Y-----DYPSPEWDTV----TPEAKNLINQMLTVNPSKRITASEALKHPWICQ-----RE 226
           Y       P  ++  +    +P+A +L+ +ML ++  KR+TA++AL HP+         E
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318

Query: 227 RVA------SIVHRQETVDCLKK 243
             A      S+ H + TVD  K+
Sbjct: 319 TEAQQPFDDSLEHEKLTVDEWKQ 341

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  108 bits (271), Expect = 1e-26
 Identities = 64/313 (20%), Positives = 110/313 (35%), Gaps = 93/313 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH------PNIVRL 54
           G+F  V +          A K++  +K   R  ++   E RI   L+        N++ +
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVH 112
            ++    N+  + F+L+    L+E I   +F  +S          IL+ ++  H N ++H
Sbjct: 165 LENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ----QA-------------------- 148
            DLKPEN+LL  + + + +K+ DFG +           Q+                    
Sbjct: 224 CDLKPENILLKQQGR-SGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDM 282

Query: 149 W-FGVILYILLVGYPPFWDEDQHRLYAQI-----------------------KAGAYDY- 183
           W  G IL  LL GYP    ED+    A +                         G   Y 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYC 342

Query: 184 ---PSPEWDTVTPEAK----------------------------NLINQMLTVNPSKRIT 212
                 +   V    +                            + + Q L  +P+ R+T
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402

Query: 213 ASEALKHPWICQR 225
             +AL+HPW+ +R
Sbjct: 403 PGQALRHPWLRRR 415

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 20/47 (42%), Positives = 27/47 (57%)

Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           Y +PEV+    YG P+D+W+ G IL  LL GYP    ED+    A +
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  105 bits (264), Expect = 2e-26
 Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 13/107 (12%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADAS 92
           RE  I ++L+H NIV+L+D I  +    LVF     DL    +L +            A 
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL---KKLLDVC--EGGLESVTAK 103

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             + Q+L  + +CH   V+HRDLKP+NLL+  + +   +K+ADFGLA
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLA 147

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 53.7 bits (130), Expect = 2e-08
 Identities = 11/30 (36%), Positives = 22/30 (73%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
                +L+++ML ++P++RITA +AL+H +
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  105 bits (264), Expect = 2e-26
 Identities = 42/107 (39%), Positives = 60/107 (56%), Gaps = 13/107 (12%)

Query: 38  REARICRKLQHPNIVRLHDSIQEENYHYLVF-----DLVTGGELFEDIVAREFYSEADAS 92
           RE  + ++L HPNIV L D I  E    LVF     DL    ++ ++   +    ++   
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL---KKVLDEN--KTGLQDSQIK 122

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             + Q+L  V HCH + ++HRDLKP+NLL+ S     A+KLADFGLA
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLA 166

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 53.7 bits (130), Expect = 2e-08
 Identities = 12/30 (40%), Positives = 21/30 (70%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
             E  +L++ ML  +P+KRI+A +A+ HP+
Sbjct: 274 CQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (264), Expect = 7e-26
 Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 17/152 (11%)

Query: 1   GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G +  V +  +K      ++A K I    +S        RE  + R+L+HPN++ L    
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQKVF 87

Query: 59  QEENYH--YLVFD--------LVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
                   +L+FD        ++      +                + QIL+ +++ H+N
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147

Query: 109 GVVHRDLKPENLLLASKA-KGAAVKLADFGLA 139
            V+HRDLKP N+L+  +  +   VK+AD G A
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 13/61 (21%), Positives = 28/61 (45%), Gaps = 2/61 (3%)

Query: 161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP 220
           +     + +   Y         Y          +A +L+ ++LT++P KRIT+ +A++ P
Sbjct: 278 HSTLMKDFRRNTYT--NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335

Query: 221 W 221
           +
Sbjct: 336 Y 336

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (259), Expect = 9e-26
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 51/234 (21%)

Query: 19  AAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTG 73
           A K++         F  +  REA+    L HP IV ++D+ + E       Y+V + V G
Sbjct: 41  AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG 100

Query: 74  GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKL 133
             L + +      +   A   I    +++N  H NG++HRD+KP N+++   +   AVK+
Sbjct: 101 VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKV 157

Query: 134 ADFGLAIEVQGEQ-------------------QAW------------FGVILYILLVGYP 162
            DFG+A  +                       QA              G +LY +L G P
Sbjct: 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

Query: 163 PFWDED------QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           PF  +       QH +           PS   + ++ +   ++ + L  NP  R
Sbjct: 218 PFTGDSPVSVAYQH-VREDPIP-----PSARHEGLSADLDAVVLKALAKNPENR 265

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 16/39 (41%), Positives = 23/39 (58%)

Query: 260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           GT  YLSPE  + +      D+++ G +LY +L G PPF
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 2e-25
 Identities = 63/304 (20%), Positives = 122/304 (40%), Gaps = 56/304 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDS-- 57
           G +  V +     TG   A K+++   ++  + +++++E  + +K   H NI   + +  
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91

Query: 58  ----IQEENYHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
                  ++  +LV +    G   +L ++        E   ++  ++IL  ++H H + V
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-KEEWIAYICREILRGLSHLHQHKV 150

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA------------------------IEVQGEQ 146
           +HRD+K +N+LL   A+   VKL DFG++                        I      
Sbjct: 151 IHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207

Query: 147 QA--------W-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAK 196
            A        W  G+    +  G PP  D    R L+   +  A    S +W   + + +
Sbjct: 208 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQ 264

Query: 197 NLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQ 256
           + I   L  N S+R    + +KHP+I  +     +  R +  D + +   +R  K  T  
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV--RIQLKDHIDRTKKKRGEKDETEY 322

Query: 257 GFAG 260
            ++G
Sbjct: 323 EYSG 326

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 16/53 (30%), Positives = 25/53 (47%), Gaps = 5/53 (9%)

Query: 255 RQGFAGTPGYLSPEVLKKE-----PYGKPVDIWACGVILYILLVGYPPFWDED 302
           R  F GTP +++PEV+  +      Y    D+W+ G+    +  G PP  D  
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  104 bits (260), Expect = 2e-25
 Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 95/302 (31%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA  +V            A      KKLS R FQ         RE  + + + H NI+ L
Sbjct: 36  GAQGIVCAAYDAILERNVA-----IKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 55  HD------SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHC 105
            +      S++E    Y+V       EL +  + +    E D       + Q+L  + H 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVM------ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------WF-------- 150
           HS G++HRDLKP N+++ S      +K+ DFGLA                ++        
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200

Query: 151 ------------GVILYILLVGYPPFWDEDQHRLYAQI-----------------KAGAY 181
                       G I+  ++ G   F   D    + ++                     Y
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 182 -----DYPSPEWDTVTPEAKN----------------LINQMLTVNPSKRITASEALKHP 220
                 Y    ++ + P+                   L+++ML ++ SKRI+  EAL+HP
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320

Query: 221 WI 222
           +I
Sbjct: 321 YI 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  104 bits (261), Expect = 3e-25
 Identities = 64/299 (21%), Positives = 110/299 (36%), Gaps = 89/299 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA  +V            A      KKLS R FQ         RE  + + + H NI+ L
Sbjct: 73  GAQGIVCAAYDAVLDRNVA-----IKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 55  HDSIQ----EENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN 108
            +        E +   YLV +L+    L + I  +        S+ + Q+L  + H HS 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSA 183

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------WF----------- 150
           G++HRDLKP N+++ S      +K+ DFGLA                ++           
Sbjct: 184 GIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240

Query: 151 ---------GVILYILLVGYPPFWDED---QHRL------------YAQIKAGAYDY--- 183
                    G I+  ++     F   D   Q                 +++    +Y   
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300

Query: 184 ----PSPEWDTVTPEAK----------------NLINQMLTVNPSKRITASEALKHPWI 222
                   +  + P++                 +L+++ML ++P+KRI+  +AL+HP+I
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  102 bits (255), Expect = 3e-25
 Identities = 45/263 (17%), Positives = 96/263 (36%), Gaps = 42/263 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G    V +   + TG   A K +     +  + +++  +  +  K    P IV+   +  
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPE 118
                ++  +L+           +    E         I++++ +    +GV+HRD+KP 
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154

Query: 119 NLLLASKAKGAAVKLADFGLA-----------------------IEVQGEQQA------- 148
           N+LL  + +   +KL DFG++                       I+     +        
Sbjct: 155 NILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211

Query: 149 -W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--SPEWDTVTPEAKNLINQMLT 204
            W  G+ L  L  G  P+  ++    +  +     + P   P     + + ++ +   LT
Sbjct: 212 VWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT 269

Query: 205 VNPSKRITASEALKHPWICQRER 227
            +  KR   ++ L+H +I + E 
Sbjct: 270 KDHRKRPKYNKLLEHSFIKRYET 292

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 42.7 bits (101), Expect = 7e-05
 Identities = 14/68 (20%), Positives = 27/68 (39%), Gaps = 7/68 (10%)

Query: 258 FAGTPGYLSPEVLKKE-----PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
            AG   Y++PE +         Y    D+W+ G+ L  L  G  P+  ++    +  +  
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTK 241

Query: 313 GAYDDEPK 320
              ++ P 
Sbjct: 242 VLQEEPPL 249

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (250), Expect = 1e-24
 Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 57/279 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQ 59
           GA+ VV +     +G   A K I    +++++ ++L  +  I  R +  P  V  + ++ 
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFY-----SEADASHCIQQILESVNHCHSNG-VVHR 113
            E   ++  +L+      +    +         E         I++++ H HS   V+HR
Sbjct: 77  REGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134

Query: 114 DLKPENLLLASKAKGAAVKLADFG--------------------LAIEV-QGEQQA---- 148
           D+KP N+L+ +  +   VK+ DFG                    +A E    E       
Sbjct: 135 DVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191

Query: 149 -----W-FGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAKNLIN 200
                W  G+ +  L +   P+ D      +   Q+       P    D  + E  +  +
Sbjct: 192 VKSDIWSLGITMIELAILRFPY-DSWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTS 248

Query: 201 QMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD 239
           Q L  N  +R T  E ++HP+           H  +  D
Sbjct: 249 QCLKKNSKERPTYPELMQHPFFTL--------HESKGTD 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 13/45 (28%), Positives = 21/45 (46%), Gaps = 4/45 (8%)

Query: 258 FAGTPGYLSPEVLKKE----PYGKPVDIWACGVILYILLVGYPPF 298
            AG   Y++PE +  E     Y    DIW+ G+ +  L +   P+
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (252), Expect = 2e-24
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 28/153 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-- 58
           G+F VV +     +  E A K +       R   K  RE +I R ++HPN+V L      
Sbjct: 51  GSFGVVFQAKLVESD-EVAIKKV---LQDKRF--KN-RELQIMRIVKHPNVVDLKAFFYS 103

Query: 59  ----QEENYHYLVFDLVTGGELFEDI--VAREFYSEA---DASHC---IQQILESVNHCH 106
               ++E +  LV + V      E +   +R +               + Q+L S+ + H
Sbjct: 104 NGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G+ HRD+KP+NLLL        +KL DFG A
Sbjct: 159 SIGICHRDIKPQNLLL--DPPSGVLKLIDFGSA 189

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 49.3 bits (118), Expect = 7e-07
 Identities = 15/29 (51%), Positives = 22/29 (75%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPW 221
           P+A +LI+++L   PS R+TA EAL HP+
Sbjct: 296 PDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 47/158 (29%), Positives = 66/158 (41%), Gaps = 29/158 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQ---HPNI 51
           GA+  V +     +G   A K +   ++               RE  + R+L+   HPN+
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 52  VRLHDSIQEENYH-----YLVF-----DLVTGGELFEDIVAREFYSEADASHCIQQILES 101
           VRL D              LVF     DL      + D               ++Q L  
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDL----RTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 102 VNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ++  H+N +VHRDLKPEN+L+ S      VKLADFGLA
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLA 167

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.3 bits (129), Expect = 3e-08
 Identities = 13/30 (43%), Positives = 18/30 (60%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
                 L+ +MLT NP KRI+A  AL+H +
Sbjct: 270 EESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           Y +PEVL +  Y  PVD+W+ G I   +    P F
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 59/265 (22%), Positives = 103/265 (38%), Gaps = 51/265 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           GA+  V + V K +G   A K I +  +  ++ ++L  +  +  +    P IV+ + ++ 
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFY------SEADASHCIQQILESVNHCHSNG-VVH 112
            E   ++  +L++    F+      +        E          ++++NH   N  ++H
Sbjct: 92  REGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149

Query: 113 RDLKPENLLLASKAKGAAVKLADFG--------------------LAIEV-QGEQQA--- 148
           RD+KP N+LL        +KL DFG                    +A E           
Sbjct: 150 RDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206

Query: 149 ------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----SPEWDTVTPEAKN 197
                 W  G+ LY L  G  P+     + ++ Q+       P    + E    +P   N
Sbjct: 207 DVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264

Query: 198 LINQMLTVNPSKRITASEALKHPWI 222
            +N  LT + SKR    E LKHP+I
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFI 289

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 13/45 (28%), Positives = 21/45 (46%), Gaps = 4/45 (8%)

Query: 258 FAGTPGYLSPEVLKKEPYGKP----VDIWACGVILYILLVGYPPF 298
            AG   Y++PE +      +      D+W+ G+ LY L  G  P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 97.8 bits (244), Expect = 1e-23
 Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 44/251 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV +   +    + A K I ++    + F     E R   ++ HPNIV+L+ +   
Sbjct: 19  GAFGVVCKAKWR--AKDVAIKQIESESER-KAFI---VELRQLSRVNHPNIVKLYGACLN 72

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHS---NGVVHRD 114
                LV +   GG L+  +   E      A+H +    Q  + V + HS     ++HRD
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------AW------------------- 149
           LKP NLLL +   G  +K+ DFG A ++Q          AW                   
Sbjct: 131 LKPPNLLLVA--GGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFS 188

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KNLINQMLTVNPS 208
           +G+IL+ ++    PF  ++      +I    ++   P      P+  ++L+ +  + +PS
Sbjct: 189 WGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPS 246

Query: 209 KRITASEALKH 219
           +R +  E +K 
Sbjct: 247 QRPSMEEIVKI 257

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 20/86 (23%)

Query: 230 SIVHRQETVDCLKKFN-----ARRKLKVS----------TRQGFAGTPGYLSPEVLKKEP 274
           +++HR    D LK  N         LK+                 G+  +++PEV +   
Sbjct: 125 ALIHR----D-LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN 179

Query: 275 YGKPVDIWACGVILYILLVGYPPFWD 300
           Y +  D+++ G+IL+ ++    PF +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDE 205

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (251), Expect = 1e-23
 Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 50/205 (24%)

Query: 37  EREARICRKLQHPNIVRLHDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSEADA 91
             E +   ++ HP+IV++ + ++  + H     Y+V + V G  L +    ++    A+A
Sbjct: 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKL-PVAEA 184

Query: 92  SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV--------- 142
              + +IL ++++ HS G+V+ DLKPEN++L        +KL D G    +         
Sbjct: 185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGYLYGT 240

Query: 143 -------QGEQQAW-------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 188
                                 G  L  L +  P                G Y    PE 
Sbjct: 241 PGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTR-------------NGRYVDGLPED 287

Query: 189 D---TVTPEAKNLINQMLTVNPSKR 210
           D           L+ + +  +P +R
Sbjct: 288 DPVLKTYDSYGRLLRRAIDPDPRQR 312

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 13/42 (30%), Positives = 20/42 (47%), Gaps = 7/42 (16%)

Query: 260 GTPGYLSPEVLKKEPYGKPV---DIWACGVILYILLVGYPPF 298
           GTPG+ +PE+++      P    DI+  G  L  L +  P  
Sbjct: 239 GTPGFQAPEIVR----TGPTVATDIYTVGRTLAALTLDLPTR 276

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 43/163 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-----------REARICRKLQHP 49
           G F  V +   + TG     + +  KK+       +E           RE +I + L+H 
Sbjct: 28  GTFGEVFKARHRKTG-----QKVALKKV------LMENEKEGFPITALREIKILQLLKHE 76

Query: 50  NIVRLHDSIQEENYH--------YLVF-----DLVTGGELFEDIVAREFYSEADASHCIQ 96
           N+V L +  + +           YLVF     DL     L  ++     ++ ++    +Q
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNV--LVKFTLSEIKRVMQ 131

Query: 97  QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +L  + + H N ++HRD+K  N+L+        +KLADFGLA
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLA 171

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.6 bits (127), Expect = 5e-08
 Identities = 11/30 (36%), Positives = 22/30 (73%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
            P A +LI+++L ++P++RI + +AL H +
Sbjct: 285 DPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.1 bits (240), Expect = 6e-23
 Identities = 43/115 (37%), Positives = 56/115 (48%), Gaps = 20/115 (17%)

Query: 38  REARICRKLQ---HPNIVRLHD-----SIQEENYHYLVF-----DLVTGGELFEDIVARE 84
           RE  + R L+   HPN+VRL D         E    LVF     DL T    + D V   
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT----YLDKVPEP 115

Query: 85  FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                     + Q+L  ++  HS+ VVHRDLKP+N+L+ S      +KLADFGLA
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLA 167

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 14/30 (46%), Positives = 20/30 (66%)

Query: 192 TPEAKNLINQMLTVNPSKRITASEALKHPW 221
               K+L+ + LT NP+KRI+A  AL HP+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           Y +PEVL +  Y  PVD+W+ G I   +    P F
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 96.5 bits (240), Expect = 7e-23
 Identities = 51/295 (17%), Positives = 103/295 (34%), Gaps = 73/295 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G   VV +   K +GL  A K+I+ + +      ++ RE ++  +   P IV  + +   
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102

Query: 61  ENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNG-VVHRDLKPE 118
           +    +  + + GG L + ++ +     E         +++ + +      ++HRD+KP 
Sbjct: 103 DGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161

Query: 119 NLLLASKAKGAAVKLADFG-------------------LAIEV-QGEQ---QA--W-FGV 152
           N+L+ S+ +   +KL DFG                   ++ E  QG     Q+  W  G+
Sbjct: 162 NILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV--------------------- 191
            L  + VG  P    D   L            +                           
Sbjct: 219 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278

Query: 192 -------------------TPEAKNLINQMLTVNPSKRITASEALKHPWICQRER 227
                              + E ++ +N+ L  NP++R    + + H +I + + 
Sbjct: 279 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 54.5 bits (131), Expect = 1e-08
 Identities = 22/77 (28%), Positives = 29/77 (37%)

Query: 249 KLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 308
           +L  S    F GT  Y+SPE L+   Y    DIW+ G+ L  + VG  P    D   L  
Sbjct: 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

Query: 309 QIKAGAYDDEPKHKSAS 325
                   D  +     
Sbjct: 241 MFGCQVEGDAAETPPRP 257

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 96.2 bits (240), Expect = 7e-23
 Identities = 62/316 (19%), Positives = 100/316 (31%), Gaps = 96/316 (30%)

Query: 1   GAFSVVRRCVQKATGLEFAA-KII-NTKKLSARDFQKLEREARICRKLQHP------NIV 52
           G F  V  C+  A G    A KII N  K      +    E  + +K++          V
Sbjct: 30  GTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEKDKENKFLCV 85

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGV 110
            + D      +  + F+L+ G   FE +    F  Y      H   Q+  ++   H N +
Sbjct: 86  LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQL 144

Query: 111 VHRDLKPENLLLAS----------------KAKGAAVKLADFGLAIEVQGEQQA------ 148
            H DLKPEN+L  +                  K  ++++ADFG A               
Sbjct: 145 THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH 204

Query: 149 ------------------W-FGVILYILLVGYPPFWDEDQHRLYAQI------------- 176
                             W  G IL+    G+  F   +       +             
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264

Query: 177 ---KAGAYDYPSPEWDTVTPEAK------------------------NLINQMLTVNPSK 209
              K   +      WD  + + +                        +L+ +ML  +P++
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324

Query: 210 RITASEALKHPWICQR 225
           RIT +EAL HP+    
Sbjct: 325 RITLAEALLHPFFAGL 340

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 15/47 (31%), Positives = 24/47 (51%), Gaps = 7/47 (14%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           V+TR        Y  PEV+ +  + +P D+W+ G IL+    G+  F
Sbjct: 200 VATRH-------YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 44/245 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V R      G + A KI+  +   A    +  RE  I ++L+HPNIV    ++ +
Sbjct: 48  GSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNG--VVHRDL 115
                +V + ++ G L+  +       + D    +     + + +N+ H+    +VHR+L
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165

Query: 116 KPENLLLASKAKGAAVKLADFGLA-IEVQGEQQ--------AW----------------- 149
           K  NLL+  K     VK+ DFGL+ ++               W                 
Sbjct: 166 KSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222

Query: 150 --FGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEW-DTVTPEAKNLINQMLTV 205
             FGVIL+ L     P+ + +     AQ+ A   +     E    + P+   +I    T 
Sbjct: 223 YSFGVILWELATLQQPWGNLN----PAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278

Query: 206 NPSKR 210
            P KR
Sbjct: 279 EPWKR 283

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 22/85 (25%)

Query: 231 IVHRQETVDCLKKFN----ARRKLKVS-------------TRQGFAGTPGYLSPEVLKKE 273
           IVHR    + LK  N     +  +KV              + +  AGTP +++PEVL+ E
Sbjct: 160 IVHR----N-LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 274 PYGKPVDIWACGVILYILLVGYPPF 298
           P  +  D+++ GVIL+ L     P+
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPW 239

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 47/260 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-----FQKLEREARICRKLQHPNIVRLH 55
           G F +V +          A K +              FQ+ +RE  I   L HPNIV+L+
Sbjct: 30  GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNG--VVH 112
             +       +V + V  G+L+  ++ +      +     +  I   + +  +    +VH
Sbjct: 90  GLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVH 147

Query: 113 RDLKPENLLLASKAKGAA--VKLADFGLAIEVQGEQQA------W--------------- 149
           RDL+  N+ L S  + A    K+ADFGL+ +             W               
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207

Query: 150 ------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----PSPEWDTVTPEAKNLI 199
                 F +ILY +L G  PF  ++      +      +       PE     P  +N+I
Sbjct: 208 KADTYSFAMILYTILTGEGPF--DEYSYGKIKFINMIREEGLRPTIPE--DCPPRLRNVI 263

Query: 200 NQMLTVNPSKRITASEALKH 219
               + +P KR   S  +K 
Sbjct: 264 ELCWSGDPKKRPHFSYIVKE 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 48.9 bits (117), Expect = 8e-07
 Identities = 14/55 (25%), Positives = 30/55 (54%), Gaps = 4/55 (7%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVL--KKEPYGKPVDIWACGVILYILLVGYPPF 298
           +++ +   +  G  G   +++PE +  ++E Y +  D ++  +ILY +L G  PF
Sbjct: 176 SQQSVHSVS--GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 67/314 (21%), Positives = 103/314 (32%), Gaps = 98/314 (31%)

Query: 1   GAFSVVRRCVQKATGLEFAA-KII-NTKKLSARDFQKLEREARICRKLQHP------NIV 52
           GAF  V  C+    G    A KI+ N  +      +    E ++   L           V
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGV 110
           ++ +  +   +  +VF+L+ G   ++ I    F  +          QI +SVN  HSN +
Sbjct: 81  QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139

Query: 111 VHRDLKPENLLLASKA----------------KGAAVKLADFGLAIEVQGEQQA------ 148
            H DLKPEN+L                         +K+ DFG A     E  +      
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD-DEHHSTLVSTR 198

Query: 149 -------------------W-FGVILYILLVGYPPFWDEDQHRLYAQI------------ 176
                              W  G IL    +G+  F   D     A +            
Sbjct: 199 HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMI 258

Query: 177 ----KAGAYDYPSPEWDTVTPEAK------------------------NLINQMLTVNPS 208
               K   + +   +WD  +   +                        +LI +ML  +P+
Sbjct: 259 QKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318

Query: 209 KRITASEALKHPWI 222
           KRIT  EALKHP+ 
Sbjct: 319 KRITLREALKHPFF 332

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.6 bits (235), Expect = 4e-22
 Identities = 55/347 (15%), Positives = 106/347 (30%), Gaps = 81/347 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
                V     K TG     + IN +  S      L+ E  + +   HPNIV    +   
Sbjct: 38  EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +N  ++V   +  G    D++   F    +E   ++ +Q +L+++++ H  G VHR +K 
Sbjct: 98  DNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156

Query: 118 ENLLLASKAK------GAAVKLAD-------------------FGLAIEVQGEQQA---- 148
            ++L++   K       + + +                       L+ EV  +       
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216

Query: 149 ----W-FGVILYILLVGYPPFWDEDQHRLYAQI--------------------------- 176
               +  G+    L  G+ PF D    ++  +                            
Sbjct: 217 KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276

Query: 177 ---------------KAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
                           +       P   T +P   + + Q L  NP  R +AS  L H +
Sbjct: 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336

Query: 222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPE 268
             ++ +  +     E +  +         +     G  G    L   
Sbjct: 337 F-KQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEEL 382

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 49.5 bits (118), Expect = 7e-07
 Identities = 16/73 (21%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK--KEPYGKPVDIWACGVILYILLVGYPP 297
            +     R+++     +       +LSPEVL+   + Y    DI++ G+    L  G+ P
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

Query: 298 FWDEDQHRLYAQI 310
           F D    ++  + 
Sbjct: 237 FKDMPATQMLLEK 249

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 91.6 bits (228), Expect = 1e-21
 Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 41/246 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V R      G E A K          ++  + + +EA++   L+HPNI+ L    
Sbjct: 18  GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG---VVHRDL 115
            +E    LV +   GG L   +++ +        +   QI   +N+ H      ++HRDL
Sbjct: 76  LKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 116 KPENLLLASKAKGAA-----VKLADFGLAIEVQGEQQ-------AW-------------- 149
           K  N+L+  K +        +K+ DFGLA E     +       AW              
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194

Query: 150 -----FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
                +GV+L+ LL G  PF   D   +   +       P P   T       L+     
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS--TCPEPFAKLMEDCWN 252

Query: 205 VNPSKR 210
            +P  R
Sbjct: 253 PDPHSR 258

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 51.5 bits (124), Expect = 8e-08
 Identities = 18/51 (35%), Positives = 31/51 (60%)

Query: 248 RKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           R+   +T+   AG   +++PEV++   + K  D+W+ GV+L+ LL G  PF
Sbjct: 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 93.0 bits (231), Expect = 3e-21
 Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 27/153 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           G++  V     K      A K I       R F+ L       RE  I  +L H ++V++
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKIL------RVFEDLIDCKRILREIAILNRLNHDHVVKV 117

Query: 55  HDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESVNHCH 106
            D +  ++       Y+V ++    +  +      + +E    H    +  +L  V + H
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL---HIKTLLYNLLVGVKYVH 173

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S G++HRDLKP N L+        VK+ DFGLA
Sbjct: 174 SAGILHRDLKPANCLVNQDCS---VKVCDFGLA 203

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 14/31 (45%), Positives = 22/31 (70%)

Query: 191 VTPEAKNLINQMLTVNPSKRITASEALKHPW 221
            + +A +L+ +ML  NP+KRIT +E L HP+
Sbjct: 369 SSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 60/313 (19%), Positives = 104/313 (33%), Gaps = 96/313 (30%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----------HP 49
           G FS V            A KI+   K      +  E E ++ +++              
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 50  NIVRLHDS---IQEENYHY-LVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVN 103
           +I++L D          H  +VF+++ G  L   I   E             +Q+L  ++
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145

Query: 104 HCHSN-GVVHRDLKPENLLLA---SKAKGAAVKLADFGLAIEVQGEQQA----------- 148
           + H   G++H D+KPEN+L+    S      +K+AD G A                    
Sbjct: 146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPE 205

Query: 149 -------------W-FGVILYILLVGYPPF-------WDEDQHRLYAQI----------- 176
                        W    +++ L+ G   F       + +D   + AQI           
Sbjct: 206 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI-AQIIELLGELPSYL 264

Query: 177 -KAGAY-----------------------DYPSPEWDTVTPEAK---NLINQMLTVNPSK 209
            + G Y                       D  + ++     EAK   + ++ ML ++P K
Sbjct: 265 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324

Query: 210 RITASEALKHPWI 222
           R  A   + HPW+
Sbjct: 325 RADAGGLVNHPWL 337

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 42.8 bits (101), Expect = 8e-05
 Identities = 16/47 (34%), Positives = 24/47 (51%), Gaps = 7/47 (14%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF 298
           + TR+       Y SPEVL   P+G   DIW+   +++ L+ G   F
Sbjct: 196 IQTRE-------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 88.2 bits (219), Expect = 4e-20
 Identities = 42/256 (16%), Positives = 81/256 (31%), Gaps = 58/256 (22%)

Query: 1   GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 57
           G F  V        G    E A ++I+ ++ +    +  +RE    R+ +H N+V    +
Sbjct: 44  GRFGQVYH------GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 58  IQEENYHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
                +  ++  L  G  L+  +  A+            Q+I++ + + H+ G++H+DLK
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQ--------------AW------------- 149
            +N+   +      V + DFGL       Q                              
Sbjct: 158 SKNVFYDNG----KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213

Query: 150 ---------------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 194
                           G I Y L     PF  +    +  Q+  G       +      E
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-MKPNLSQIGM-GKE 271

Query: 195 AKNLINQMLTVNPSKR 210
             +++         +R
Sbjct: 272 ISDILLFCWAFEQEER 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 9/66 (13%)

Query: 257 GFAGTPGYLSPEVLK---------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY 307
              G   +L+PE+++         K P+ K  D++A G I Y L     PF  +    + 
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252

Query: 308 AQIKAG 313
            Q+  G
Sbjct: 253 WQMGTG 258

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 86.6 bits (215), Expect = 8e-20
 Identities = 49/248 (19%), Positives = 93/248 (37%), Gaps = 47/248 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +        + A K++N    + +  Q  + E  + RK +H NI+        
Sbjct: 35  GSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVNHCHSNGVVHRDLKP 117
                +V     G  L+  + A E  ++ +    I    Q    +++ H+  ++HRDLK 
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148

Query: 118 ENLLLASKAKGAAVKLADFGLA-IEVQGEQQ----------AW----------------- 149
            N+ L        VK+ DFGLA  + +               W                 
Sbjct: 149 NNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 150 -----FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KNLINQM 202
                FG++LY L+ G  P+ +  ++ ++   +  G+      +  +  P+  K L+ + 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265

Query: 203 LTVNPSKR 210
           L     +R
Sbjct: 266 LKKKRDER 273

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 14/51 (27%), Positives = 30/51 (58%), Gaps = 3/51 (5%)

Query: 253 STRQGFAGTPGYLSPEVLKKE---PYGKPVDIWACGVILYILLVGYPPFWD 300
              +  +G+  +++PEV++ +   PY    D++A G++LY L+ G  P+ +
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 21/150 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           G++  V     K T      K +  KK++ R F+ L       RE  I  +L+   I+RL
Sbjct: 37  GSYGYVYLAYDKNTE-----KNVAIKKVN-RMFEDLIDCKRILREITILNRLKSDYIIRL 90

Query: 55  HDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG 109
           +D I  ++       Y+V ++    +L +      F +E      +  +L   N  H +G
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG 149

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           ++HRDLKP N LL        VK+ DFGLA
Sbjct: 150 IIHRDLKPANCLLNQDCS---VKVCDFGLA 176

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 14/32 (43%), Positives = 22/32 (68%)

Query: 191 VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           ++ +  NL+  ML  NP+KRIT  +AL HP++
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 34/245 (13%), Positives = 78/245 (31%), Gaps = 45/245 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
                + +   +  G +   K++  +  S R  +    E    R   HPN++ +  + Q 
Sbjct: 21  NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78

Query: 61  --ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESVN--HCHSNGVVHR 113
               +  L+   +  G L+ +++        D S  ++    +   +   H     +   
Sbjct: 79  PPAPHPTLITHWMPYGSLY-NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH 137

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ----AW-------------------- 149
            L   ++++         +++   +    Q   +    AW                    
Sbjct: 138 ALNSRSVMIDEDMT---ARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194

Query: 150 --FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--PSPEWDTVTPEAKNLINQMLTV 205
             F V+L+ L+    PF   D   +   +K          P    ++P    L+   +  
Sbjct: 195 WSFAVLLWELVTREVPF--ADLSNMEIGMKVALEGLRPTIPPG--ISPHVSKLMKICMNE 250

Query: 206 NPSKR 210
           +P+KR
Sbjct: 251 DPAKR 255

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 49.2 bits (118), Expect = 5e-07
 Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 20/83 (24%)

Query: 231 IVHRQETVDCLKKFN----ARRKLKVS--------TRQGFAGTPGYLSPEVLKKEPYG-- 276
           I         L   +         ++S           G    P +++PE L+K+P    
Sbjct: 134 IPRH----A-LNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 277 -KPVDIWACGVILYILLVGYPPF 298
            +  D+W+  V+L+ L+    PF
Sbjct: 189 RRSADMWSFAVLLWELVTREVPF 211

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 29/157 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSI- 58
           G F  V+   +K+TG+  A K    K +    F+  E +  +    L HPNIV+L     
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIK----KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89

Query: 59  ------QEENYHYLVFDLVTGGELFEDI--VAREFYSEADA---SHC---IQQILESVN- 103
                 + + Y  +V + V      + +    R +Y    A         + Q++ S+  
Sbjct: 90  TLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144

Query: 104 -HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            H  S  V HRD+KP N+L+ ++A G  +KL DFG A
Sbjct: 145 LHLPSVNVCHRDIKPHNVLV-NEADG-TLKLCDFGSA 179

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 48.8 bits (117), Expect = 9e-07
 Identities = 11/29 (37%), Positives = 18/29 (62%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPW 221
            EA +L++ +L   P +R+   EAL HP+
Sbjct: 289 KEAYDLLSALLQYLPEERMKPYEALCHPY 317

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 48/162 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQ-HPNIVR 53
           GA+ +V + + + TG   A      KK+    FQ         RE  I  +L  H NIV 
Sbjct: 20  GAYGIVWKSIDRRTGEVVA-----VKKIF-DAFQNSTDAQRTFREIMILTELSGHENIVN 73

Query: 54  LHDSIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQ--------------Q 97
           L + ++ +N    YLVFD +                E D    I+              Q
Sbjct: 74  LLNVLRADNDRDVYLVFDYM----------------ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 98  ILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +++ + + HS G++HRD+KP N+LL ++     VK+ADFGL+
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFGLS 156

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 19/68 (27%), Positives = 34/68 (50%), Gaps = 1/68 (1%)

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS 214
            I  +       +   R             +P+ D    EA +L++++L  NP+KRI+A+
Sbjct: 266 MIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC-NEEALDLLDKLLQFNPNKRISAN 324

Query: 215 EALKHPWI 222
           +ALKHP++
Sbjct: 325 DALKHPFV 332

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 59/185 (31%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           G+F +V       +G  FA K +       +D +   RE  I + L H NI++L D    
Sbjct: 18  GSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYT 71

Query: 57  ----------------------------------SIQEENYHYLVFDLVTGGELFEDI-- 80
                                             +  +  Y  ++ + V      + +  
Sbjct: 72  TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTLHK 126

Query: 81  VAREFYSEADA---SHC---IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA 134
           V + F     +   +     I Q+  +V   HS G+ HRD+KP+NLL+   +K   +KL 
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLC 184

Query: 135 DFGLA 139
           DFG A
Sbjct: 185 DFGSA 189

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 11/29 (37%), Positives = 16/29 (55%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPW 221
             A +L+ Q+L   P  RI   EA+ HP+
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 43/164 (26%), Positives = 66/164 (40%), Gaps = 51/164 (31%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE------REARICRKLQHPNIVRL 54
           GA+ VV     K TG   A      KK+    F K        RE +I +  +H NI+ +
Sbjct: 22  GAYGVVCSATHKPTGEIVA-----IKKIEP--FDKPLFALRTLREIKILKHFKHENIITI 74

Query: 55  HDSIQEENYH-----YLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------- 96
            +  + +++      Y++ +L+                + D    I              
Sbjct: 75  FNIQRPDSFENFNEVYIIQELM----------------QTDLHRVISTQMLSDDHIQYFI 118

Query: 97  -QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            Q L +V   H + V+HRDLKP NLL+ S      +K+ DFGLA
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLA 159

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 16/32 (50%), Positives = 25/32 (78%)

Query: 191 VTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
           V P+  +L+ +ML  +P+KRITA EAL+HP++
Sbjct: 278 VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 81.6 bits (202), Expect = 7e-18
 Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 6/140 (4%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F    +   + TG      +    +      +   +E ++ R L+HPN+++    + +
Sbjct: 21  GCFGQAIKVTHRETGE--VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78

Query: 61  ENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +     + + + GG L   I + +  Y  +      + I   + + HS  ++HRDL   N
Sbjct: 79  DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138

Query: 120 LLLASKAKGAAVKLADFGLA 139
            L+        V +ADFGLA
Sbjct: 139 CLVRENKN---VVVADFGLA 155

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 11/64 (17%), Positives = 28/64 (43%)

Query: 235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG 294
            +     +   + +K     R    G P +++PE++    Y + VD+++ G++L  ++  
Sbjct: 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

Query: 295 YPPF 298
               
Sbjct: 219 VNAD 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 78.6 bits (194), Expect = 7e-17
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQ 59
           G+F  +      A G E A K    + +  +  Q L  E++I + +Q    I  +     
Sbjct: 20  GSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQ-LHIESKIYKMMQGGVGIPTIRWCGA 75

Query: 60  EENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           E +Y+ +V +L+  G   ED+    +R+F S         Q++  + + HS   +HRD+K
Sbjct: 76  EGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKNFIHRDVK 132

Query: 117 PENLLLASKAKGAAVKLADFGLA 139
           P+N L+    KG  V + DFGLA
Sbjct: 133 PDNFLMGLGKKGNLVYIIDFGLA 155

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 15/149 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP------NIVRL 54
           G+F  V +   +      A KII  KK       + + E R+   +          IV L
Sbjct: 65  GSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSN--GV 110
                  N+  LVF+++    L++ +    F   S        QQ+  ++    +    +
Sbjct: 122 KRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSI 180

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +H DLKPEN+LL +  + +A+K+ DFG +
Sbjct: 181 IHCDLKPENILLCNPKR-SAIKIVDFGSS 208

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 11/30 (36%), Positives = 17/30 (56%)

Query: 196 KNLINQMLTVNPSKRITASEALKHPWICQR 225
           K+LI +ML  +P  RI    AL+H +  + 
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKT 379

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 17/47 (36%), Positives = 24/47 (51%)

Query: 264 YLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           Y SPEVL   PY   +D+W+ G IL  +  G P F   ++     +I
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 11/143 (7%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           G+F  +       T  E A K+ N K        +L  E++I R LQ    I  +     
Sbjct: 18  GSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFGV 73

Query: 60  EENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           E +Y+ LV DL+  G   ED+    +R+  S         Q++  V   HS   +HRD+K
Sbjct: 74  EGDYNVLVMDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSFLHRDIK 130

Query: 117 PENLLLASKAKGAAVKLADFGLA 139
           P+N L+    +   V + DFGLA
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLA 153

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 39/219 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 287

Query: 61  ENYHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L  +     R+  S     +   QI  ++ +      +HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N L+        VK+ADFGL+  + G+                               W 
Sbjct: 348 NCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           FGV+L+ I   G  P+   D  ++Y  ++   Y    PE
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPE 442

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 54/247 (21%), Positives = 87/247 (35%), Gaps = 39/247 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V     +A     A K    + L      K  +EARI ++  HPNIVRL     +
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183

Query: 61  ENYHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +   Y+V +LV GG+    +               +      + +  S   +HRDL   N
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-----------W------------------- 149
            L+  K     +K++DFG++ E      A           W                   
Sbjct: 244 CLVTEK---NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FG++L+    +G  P+ +    +    ++ G    P PE          L+ Q     P 
Sbjct: 301 FGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPE--LCPDAVFRLMEQCWAYEPG 357

Query: 209 KRITASE 215
           +R + S 
Sbjct: 358 QRPSFST 364

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 39/219 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F K   EA + ++++HPN+V+L      
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTR 80

Query: 61  ENYHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L  +     R+  S     +   QI  ++ +      +HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N L+        VK+ADFGL+  + G+                               W 
Sbjct: 141 NCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           FGV+L+ I   G  P+   D  ++Y  ++   Y    PE
Sbjct: 198 FGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPE 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 17/147 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKI--INTKKLSARDFQKLEREARICRKLQH-PNIVRLHDS 57
           G+F V+          + A K     +         +L  E R  + L     I  ++  
Sbjct: 21  GSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 58  IQEENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
            QE  ++ LV DL+  G   ED+     R+F S    +   +Q+L  V   H   +V+RD
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKF-SVKTVAMAAKQMLARVQSIHEKSLVYRD 131

Query: 115 LKPENLLL--ASKAKGAAVKLADFGLA 139
           +KP+N L+   +      + + DFG+ 
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMV 158

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 35/167 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQH-----PNIVRL 54
           G F  V  C        +A K++ N KK      +  + EA I +K+Q+      NIV+ 
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVH 112
           H      ++  L+F+ + G  L+E I    +  +   D      +IL+++N+     + H
Sbjct: 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160

Query: 113 RDLKPENLLLAS----------------------KAKGAAVKLADFG 137
            DLKPEN+LL                        + K   +KL DFG
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 7/27 (25%), Positives = 17/27 (62%)

Query: 196 KNLINQMLTVNPSKRITASEALKHPWI 222
            + +  +L ++P+ R + +E LKH ++
Sbjct: 333 CDFLYSILQIDPTLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 15/55 (27%), Positives = 25/55 (45%), Gaps = 9/55 (16%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF--WDEDQH 304
           ++TRQ       Y +PEV+    +    D+W+ G +L  L  G   F   +  +H
Sbjct: 220 INTRQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 51/227 (22%)

Query: 1   GAFSVVRRCVQKATGLEF--AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V++   +   +    A KI+  +        +L  EA + ++L +P IVR+    
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------LESVNHCHSNGVVH 112
           + E+   LV ++   G L + +       + +    + Q+      LE  N       VH
Sbjct: 88  EAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN------FVH 140

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------ 148
           RDL   N+LL ++      K++DFGL+  ++ ++                          
Sbjct: 141 RDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 149 ------W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                 W FGV+++     G  P+       + A ++ G      P 
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPA 243

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.2 bits (180), Expect = 8e-15
 Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 17/147 (11%)

Query: 1   GAFSVVRRCVQKATGLEFAAKI--INTKKLSARDFQKLEREARICRKLQH-PNIVRLHDS 57
           G F  +R      T    A K+  + ++        +L  E R  ++L     I +++  
Sbjct: 20  GNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 58  IQEENYHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
                Y+ +V +L  G    +LF D+  R F S         Q++  + + HS  +++RD
Sbjct: 74  GPCGKYNAMVLEL-LGPSLEDLF-DLCDRTF-SLKTVLMIAIQLISRMEYVHSKNLIYRD 130

Query: 115 LKPENLLL--ASKAKGAAVKLADFGLA 139
           +KPEN L+          + + DF LA
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALA 157

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 72.3 bits (178), Expect = 8e-15
 Identities = 40/242 (16%), Positives = 77/242 (31%), Gaps = 66/242 (27%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 53
           G F+ + + V++  G            K++   K      +     A +  KL H ++V 
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVL 76

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQI------LE 100
            +      + + LV + V  G L        +  +              +Q+      LE
Sbjct: 77  NYGVCVCGDENILVQEFVKFGSL------DTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAA-----VKLADFGLAIEVQGEQQA-----W- 149
                    ++H ++  +N+LL  +          +KL+D G++I V  +        W 
Sbjct: 131 ENT------LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 150 -------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 189
                              FG  L+ I   G  P    D  R     +   +  P+P+  
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLPAPKAA 243

Query: 190 TV 191
            +
Sbjct: 244 EL 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 71.8 bits (177), Expect = 1e-14
 Identities = 45/224 (20%), Positives = 75/224 (33%), Gaps = 51/224 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F +V          + A K I    +S  DF     EA +  KL HP +V+L+    E
Sbjct: 19  GQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGVCLE 74

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSNGVVHR 113
           +    LV + +  G L       ++                   + E + +     V+HR
Sbjct: 75  QAPICLVTEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------- 148
           DL   N L+        +K++DFG+   V  +Q                           
Sbjct: 129 DLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 149 ---W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
              W FGV+++ +   G  P+ +     +   I  G +    P 
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPR 228

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 47/224 (20%), Positives = 82/224 (36%), Gaps = 51/224 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F     EA++   L H  +V+L+    +
Sbjct: 35  GQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGVCTK 90

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-SVNHCH------SNGVVHR 113
           +   +++ + +  G L        +  E       QQ+LE   + C       S   +HR
Sbjct: 91  QRPIFIITEYMANGCL------LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ----------------QA--------- 148
           DL   N L+  +     VK++DFGL+  V  ++                +          
Sbjct: 145 DLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201

Query: 149 ---W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
              W FGV+++ I  +G  P+           I  G      P 
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPH 244

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 35/151 (23%), Positives = 56/151 (37%), Gaps = 21/151 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL----HD 56
           G +  V R   +  G   A KI +++    + + + E E      L+H NI+        
Sbjct: 19  GRYGEVWRGSWQ--GENVAVKIFSSRDE--KSWFR-ETELYNTVMLRHENILGFIASDMT 73

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS--------N 108
           S       +L+      G L+ D +             +  I   + H H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLY-DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            + HRDLK +N+L+  K  G    +AD GLA
Sbjct: 133 AIAHRDLKSKNILV--KKNG-QCCIADLGLA 160

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 6/56 (10%)

Query: 257 GFAGTPGYLSPEVLKKEP------YGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
              GT  Y++PEVL +          K VDIWA G++L+ +          + ++ 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 38/147 (25%), Positives = 56/147 (38%), Gaps = 15/147 (10%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRL 54
           G F  V           TG   A K +  +        ++   +E  I R L H +I++ 
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK---QEIDILRTLYHEHIIKY 98

Query: 55  HD--SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
                        LV + V  G L + +        A      QQI E + + H+   +H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI-GLAQLLLFAQQICEGMAYLHAQHYIH 157

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLA 139
           RDL   N+LL +      VK+ DFGLA
Sbjct: 158 RDLAARNVLLDNDRL---VKIGDFGLA 181

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 70.5 bits (173), Expect = 6e-14
 Identities = 42/263 (15%), Positives = 74/263 (28%), Gaps = 74/263 (28%)

Query: 26  KKLSARDFQKLEREARIC--RKLQHPNIVRL----HDSIQEENYHYLVFDLVTGGELFED 79
           K     +     RE  I     ++H NI+                YL+ D    G L+ D
Sbjct: 66  KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY-D 124

Query: 80  IVAREFYSEADASHCIQQILESVNHCHS--------NGVVHRDLKPENLLLASKAKGAAV 131
            +                 +  + H H+          + HRDLK +N+L+         
Sbjct: 125 YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT---C 181

Query: 132 KLADFGLAIEVQGEQQA-------------W-------------------------FGVI 153
            +AD GLA++   +                +                         FG+I
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241

Query: 154 LYILLVGYPPFWDEDQHRL-YAQIKAGAYDY-----------------PSPEWDTVTPEA 195
           L+ +          ++++L Y  +      Y                      D    + 
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301

Query: 196 KNLINQMLTVNPSKRITASEALK 218
             L+ +    NP+ R+TA    K
Sbjct: 302 GKLMTECWAHNPASRLTALRVKK 324

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 32/115 (27%)

Query: 219 HPWICQRERVASIVHRQETVDCLKKFN----------------ARRKLKVSTRQ-----G 257
           H  I   +   +I HR    D LK  N                A + +  +         
Sbjct: 151 HTEIFSTQGKPAIAHR----D-LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 258 FAGTPGYLSPEVL------KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
             GT  Y+ PEVL               D+++ G+IL+ +          ++++L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 69.5 bits (171), Expect = 7e-14
 Identities = 44/224 (19%), Positives = 81/224 (36%), Gaps = 51/224 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    K    + A K+I    +S  +F +   EA+   KL HP +V+ +    +
Sbjct: 19  GQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVCSK 74

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSNGVVHR 113
           E   Y+V + ++ G L        +                   + E +    S+  +HR
Sbjct: 75  EYPIYIVTEYISNGCL------LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ----------------QA--------- 148
           DL   N L+        VK++DFG+   V  +Q                +          
Sbjct: 129 DLAARNCLVDRD---LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 149 ---W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
              W FG++++ +  +G  P+       +  ++  G +    P 
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYRPH 228

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 70.2 bits (172), Expect = 9e-14
 Identities = 45/286 (15%), Positives = 86/286 (30%), Gaps = 77/286 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V R   +  G E A KI ++++   R + + E E      L+H NI+    +  +
Sbjct: 53  GRFGEVWRGKWR--GEEVAVKIFSSREE--RSWFR-EAEIYQTVMLRHENILGFIAADNK 107

Query: 61  ENYHYLVFDLVT----GGELFEDIVAREFYSEADASHCIQQILESVNHCHSN-------- 108
           +N  +    LV+     G LF D + R   +              + H H          
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLF-DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------W------ 149
            + HRDLK +N+L+          +AD GLA+                     +      
Sbjct: 167 AIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 150 -------------------FGVILYILLVGYPPFWDEDQHRL-----------YAQIKAG 179
                               G++ + +          + ++L             +++  
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 180 AYDY-------PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK 218
             +           +          ++ +    N + R+TA    K
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 42.8 bits (101), Expect = 8e-05
 Identities = 13/56 (23%), Positives = 23/56 (41%), Gaps = 6/56 (10%)

Query: 257 GFAGTPGYLSPEVLKKE------PYGKPVDIWACGVILYILLVGYPPFWDEDQHRL 306
              GT  Y++PEVL            K  DI+A G++ + +          + ++L
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 41/219 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V       T    A K +    +S   F +   EA++ +KL+H  +V+L+  + E
Sbjct: 195 GCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVSE 250

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y+V + ++ G L + +      +           QI   + +      VHRDL+  
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N+L+         K+ADFGLA  ++  +                              W 
Sbjct: 310 NILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           FG++L  +   G  P+       +  Q++ G Y  P P 
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP 404

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 41/219 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V       T    A K +    +S   F +   EA++ +KL+H  +V+L+  + E
Sbjct: 278 GCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVSE 333

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y+V + ++ G L + +      +           QI   + +      VHRDL+  
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N+L+         K+ADFGLA  ++  +                              W 
Sbjct: 393 NILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           FG++L  +   G  P+       +  Q++ G Y  P P 
Sbjct: 450 FGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP 487

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 45/225 (20%)

Query: 1   GAFSVVRRCVQKATG---LEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G    V     +  G   +  A K +     +   RDF     EA I  +  HPNI+RL 
Sbjct: 60  GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL---SEASIMGQFDHPNIIRLE 116

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRD 114
             +       +V + +  G L   +   +  ++       ++ +   + +    G VHRD
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------- 148
           L   N+L+ S       K++DFGL+  ++ +  A                          
Sbjct: 177 LAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233

Query: 149 ----W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
               W FGV+++ +L  G  P+W+     + + ++ G Y  P+P 
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPM 277

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 27/130 (20%), Positives = 46/130 (35%), Gaps = 20/130 (15%)

Query: 26  KKLSARDFQKLEREARICR--KLQHPNIVRL-----HDSIQEENYHYLVFDLVTGGELFE 78
           K  S  + Q    E  I R   ++H NI R        +      + LV +    G L  
Sbjct: 42  KVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX- 100

Query: 79  DIVAREFYSEADASHCIQQILESVNHCHS---------NGVVHRDLKPENLLLASKAKGA 129
             ++        +      +   + + H+           + HRDL   N+L+  K  G 
Sbjct: 101 KYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KNDG- 157

Query: 130 AVKLADFGLA 139
              ++DFGL+
Sbjct: 158 TCVISDFGLS 167

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 57/231 (24%)

Query: 1   GAFSVVRRCVQKATG---LEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V     K      +  A K +     +   RDF     EA I  +  HPNI+RL 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL---GEASIMGQFDHPNIIRLE 112

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSN 108
             + +     +V + +  G L        F  + DA          ++ I   + +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 109 GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------W------- 149
           G VHRDL   N+L+ S       K++DFGL   ++ + +A            W       
Sbjct: 167 GYVHRDLAARNILINS---NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 150 ------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                       +G++L+ ++  G  P+W+     +   +  G Y  P P 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPPPM 273

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 27/163 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARIC--RKLQHPNIVRL---- 54
           G F  V +          A KI        +D Q  + E  +     ++H NI++     
Sbjct: 35  GRFGCVWKAQLL--NEYVAVKI-----FPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSN------ 108
                 +   +L+      G L  D +     S  +  H  + +   + + H +      
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLS-DFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146

Query: 109 ----GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ 147
                + HRD+K +N+LL  K       +ADFGLA++ +  + 
Sbjct: 147 GHKPAISHRDIKSKNVLL--KNNL-TACIADFGLALKFEAGKS 186

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 11/36 (30%), Positives = 20/36 (55%), Gaps = 5/36 (13%)

Query: 259 AGTPGYLSPEVL-----KKEPYGKPVDIWACGVILY 289
            GT  Y++PEVL      +      +D++A G++L+
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 67.3 bits (165), Expect = 6e-13
 Identities = 54/236 (22%), Positives = 83/236 (35%), Gaps = 69/236 (29%)

Query: 1   GAFSVVRRCVQKATGLEF--AAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F  VR+ V +    +   A K++   T+K    +     REA+I  +L +P IVRL  
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRLIG 77

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQI------LESVN 103
             Q E    LV ++  GG L       +F                + Q+      LE  N
Sbjct: 78  VCQAEA-LMLVMEMAGGGPL------HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------- 148
                  VHRDL   N+LL ++      K++DFGL+  +  +                  
Sbjct: 131 ------FVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181

Query: 149 ---------------W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                          W +GV ++  L  G  P+       + A I+ G      P 
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 67.3 bits (165), Expect = 6e-13
 Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 27/154 (17%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRL 54
           G F  V  C        TG + A K +   +      D +   +E  I R L H NIV+ 
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK---KEIEILRNLYHENIVKY 88

Query: 55  HDSIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHC 105
                E+  +   L+ + +  G L      +E+  +               QI + +++ 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSL------KEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            S   VHRDL   N+L+ S+ +   VK+ DFGL 
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQ---VKIGDFGLT 173

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 24/152 (15%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V  C     Q  TG   A K +  +  +    +  ERE  I + LQH NIV+   
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109

Query: 57  SIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHS 107
                      L+ + +  G L      R++  +               QI + + +  +
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
              +HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 164 KRYIHRDLATRNILVENENR---VKIGDFGLT 192

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 66.8 bits (164), Expect = 6e-13
 Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 39/216 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-Q 59
           G F  V        G + A K I     +A+ F     EA +  +L+H N+V+L   I +
Sbjct: 32  GEFGDVMLG--DYRGNKVAVKCIK-NDATAQAFLA---EASVMTQLRHSNLVQLLGVIVE 85

Query: 60  EENYHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           E+   Y+V + +  G L  +     R              + E++ +   N  VHRDL  
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA------W-------------------FGV 152
            N+L++        K++DFGL  E    Q        W                   FG+
Sbjct: 146 RNVLVSE---DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 202

Query: 153 ILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           +L+ I   G  P+       +  +++ G Y   +P+
Sbjct: 203 LLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 237

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 66.9 bits (164), Expect = 6e-13
 Identities = 39/153 (25%), Positives = 60/153 (39%), Gaps = 26/153 (16%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C     Q  TG   A K +        RDF+   RE  I + LQH NIV+  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE---REIEILKSLQHDNIVKYK 77

Query: 56  DSIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCH 106
                       L+ + +  G L      R++  +               QI + + +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +   +HRDL   N+L+ ++ +   VK+ DFGL 
Sbjct: 132 TKRYIHRDLATRNILVENENR---VKIGDFGLT 161

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 67.0 bits (164), Expect = 9e-13
 Identities = 45/153 (29%), Positives = 61/153 (39%), Gaps = 26/153 (16%)

Query: 1   GAFSVVRRCV----QKATGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V  C        TG   A K + ++     RDFQ   RE +I + L    IV+  
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ---REIQILKALHSDFIVKYR 90

Query: 56  DSIQEENYH--YLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCH 106
                       LV + +  G L      R+F     A            QI + + +  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEYLG 144

Query: 107 SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           S   VHRDL   N+L+ S+A    VK+ADFGLA
Sbjct: 145 SRRCVHRDLAARNILVESEAH---VKIADFGLA 174

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 45/235 (19%), Positives = 83/235 (35%), Gaps = 66/235 (28%)

Query: 1   GAFSVVRRCVQKATGLEF----AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + +    G +     A K +  +  S +  +++  EA +   + +P++ RL  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQI------LESVN 103
                    L+  L+  G L       ++  E   +       +   QI      LE   
Sbjct: 85  ICLTSTV-QLITQLMPFGCL------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------- 148
                 +VHRDL   N+L+ +      VK+ DFGLA  +  E++                
Sbjct: 138 ------LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 149 --------------W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                         W +GV ++ ++  G  P+       + + ++ G    P P 
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPP 242

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 41/157 (26%), Positives = 59/157 (37%), Gaps = 25/157 (15%)

Query: 1   GAFSVVRRC-----VQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           GAF  V            + L+ A K +  +  S +D      EA I  K  H NIVR  
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCI 140

Query: 56  DSIQEENYHYLVFDLVTGGELFE-------DIVAREFYSEADASHCIQQI------LESV 102
               +    +++ +L+ GG+L                 +  D  H  + I      LE  
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE- 199

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           NH      +HRD+   N LL     G   K+ DFG+A
Sbjct: 200 NHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 30/160 (18%), Positives = 61/160 (38%), Gaps = 28/160 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------------- 47
           G F ++          + A  ++   K+  ++   L  E +  +++              
Sbjct: 48  GGFGLIYLAFPTNKPEKDARHVV---KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 48  --HPNIVRLHDS----IQEENYHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQIL 99
             +  I   + S     +  +Y ++V + +  G   + I      F  ++       ++L
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF-KKSTVLQLGIRML 161

Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           + + + H N  VH D+K  NLLL        V LAD+GL+
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 41/239 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-Q 59
           G F  V     +  G + A K I     +A+ F     EA +  +L+H N+V+L   I +
Sbjct: 204 GEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLA---EASVMTQLRHSNLVQLLGVIVE 257

Query: 60  EENYHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           E+   Y+V + +  G L  +     R              + E++ +   N  VHRDL  
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQA------W-------------------FGV 152
            N+L++        K++DFGL  E    Q        W                   FG+
Sbjct: 318 RNVLVSED---NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374

Query: 153 ILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           +L+ I   G  P+       +  +++ G Y   +P+     P   +++     ++ + R
Sbjct: 375 LLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD--GCPPAVYDVMKNCWHLDAATR 430

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 41/157 (26%), Positives = 60/157 (38%), Gaps = 25/157 (15%)

Query: 1   GAFSVVRRCV-----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           GAF  V            + L+ A K +  +  S +D      EA I  K  H NIVR  
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCI 99

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQI------LESV 102
               +    +++ +L+ GG+L   +          +S       H  + I      LE  
Sbjct: 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE- 158

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           NH      +HRD+   N LL     G   K+ DFG+A
Sbjct: 159 NHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 33/161 (20%), Positives = 56/161 (34%), Gaps = 27/161 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---------- 50
           G F  +       +     +      K+   D   L  E +  ++   P           
Sbjct: 46  GGFGCIY-LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104

Query: 51  -----IVRLHDS----IQEENYHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQI 98
                + +   S       ++Y +++ D    G   + I    A+ F S         +I
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRF-SRKTVLQLSLRI 161

Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           L+ + + H +  VH D+K  NLLL  K     V L D+GLA
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLA 201

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 41/219 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V          + A K +    +S   F     EA + + LQH  +V+LH  + +
Sbjct: 199 GQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLVKLHAVVTK 254

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +  G L + + + E              QI E +        +HRDL+  
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N+L+++       K+ADFGLA  ++  +                              W 
Sbjct: 314 NILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           FG++L  I+  G  P+       +   ++ G Y  P PE
Sbjct: 371 FGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPE 408

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 64.7 bits (158), Expect = 5e-12
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 18/154 (11%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 54
           G F  VR    K     F   A K++    +++ D ++  REA   ++  HP++ +L   
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93

Query: 55  ---HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQILESVNHC 105
                +        ++   +  G+L   ++A                  +  I   + + 
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            S   +HRDL   N +LA       V +ADFGL+
Sbjct: 154 SSRNFIHRDLAARNCMLAE---DMTVCVADFGLS 184

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 64.2 bits (157), Expect = 6e-12
 Identities = 43/230 (18%), Positives = 71/230 (30%), Gaps = 60/230 (26%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL--- 54
           G F  V     K         A K +     S R+ ++   EA   +   HPN++RL   
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104

Query: 55  --HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQI------LE 100
               S Q      ++   +  G+L   ++     +             +  I      L 
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS 164

Query: 101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ------------- 147
           +  +      +HRDL   N +L        V +ADFGL+ ++                  
Sbjct: 165 N-RNF-----LHRDLAARNCMLRD---DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 148 ----------------AW-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAG 179
                            W FGV ++ I   G  P+     H +Y  +  G
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 53/210 (25%), Positives = 78/210 (37%), Gaps = 62/210 (29%)

Query: 23  INTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI 80
           I T K    D  + +  +EA   R+  HP+IV+L   I E    +++ +L T GEL    
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL---- 477

Query: 81  VAREFYSEADAS-------HCIQQI------LESVNHCHSNGVVHRDLKPENLLLASKAK 127
             R F      S           Q+      LES         VHRD+   N+L++S   
Sbjct: 478 --RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDC 529

Query: 128 GAAVKLADFGLAIEVQGEQ----------------------------QAW-FGVILY-IL 157
              VKL DFGL+  ++                                 W FGV ++ IL
Sbjct: 530 ---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

Query: 158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
           + G  PF     + +  +I+ G    P P 
Sbjct: 587 MHGVKPFQGVKNNDVIGRIENG-ERLPMPP 615

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 49/225 (21%), Positives = 79/225 (35%), Gaps = 43/225 (19%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 56
           G F  V          +    A K +N +     +  +   E  I +   HPN++ L   
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            ++ E    +V   +  G+L   I       +  D      Q+ + + +  S   VHRDL
Sbjct: 95  CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDL 154

Query: 116 KPENLLLASKAKGAAVKLADFGLA--IE------VQGEQQA-----W------------- 149
              N +L        VK+ADFGLA  +       V  +  A     W             
Sbjct: 155 AARNCMLDE---KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211

Query: 150 ------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                 FGV+L+ ++  G PP+ D +   +   +  G      PE
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPE 255

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 46/225 (20%), Positives = 80/225 (35%), Gaps = 53/225 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V          + A K +    +S   F     EA + ++LQH  +VRL+  + +
Sbjct: 24  GQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVVTQ 79

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASH--------CIQQILESVNHCHSNGVVH 112
           E   Y++ + +  G L       +F                   QI E +        +H
Sbjct: 80  EPI-YIITEYMENGSL------VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------ 148
           RDL+  N+L++      + K+ADFGLA  ++  +                          
Sbjct: 133 RDLRAANILVSDT---LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 149 ----W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
               W FG++L  I+  G  P+       +   ++ G Y    P+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPD 233

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 57/230 (24%)

Query: 1   GAFSVVRRCVQKATGLEF--AAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F  VR+ V +    +   A K++   T+K    +     REA+I  +L +P IVRL  
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM---REAQIMHQLDNPYIVRLIG 403

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQI------LESVNHCHSNG 109
             Q E    LV ++  GG L + +V +      ++ +  + Q+      LE  N      
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN------ 456

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------- 148
            VHR+L   N+LL ++      K++DFGL+  +  +                        
Sbjct: 457 FVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 149 ---------W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                    W +GV ++  L  G  P+       + A I+ G      P 
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP 562

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 46/223 (20%), Positives = 92/223 (41%), Gaps = 40/223 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKI-INTKKLSARDFQKLE--REARICRKLQHPNIVRLHDS 57
           G F  V + + K +  +    + I T K    + Q+++   EA I  +  H NI+RL   
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           I +     ++ + +  G L + +  ++  +S       ++ I   + +  +   VHRDL 
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------W--------------- 149
             N+L+ S       K++DFGL+  ++ + +A            W               
Sbjct: 175 ARNILVNSN---LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 231

Query: 150 ----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
               FG++++ ++  G  P+W+   H +   I  G +  P+P 
Sbjct: 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPM 273

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 45/164 (27%), Positives = 64/164 (39%), Gaps = 37/164 (22%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIIN--TKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G F  V   V      E    A K         +   F     EA I + L HP+IV+L 
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM---SEAVIMKNLDHPHIVKLI 79

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-------------LESV 102
             I+EE   +++ +L   GEL        +      S  +  +             LES+
Sbjct: 80  GIIEEEPT-WIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ 146
           N       VHRD+   N+L+AS      VKL DFGL+  ++ E 
Sbjct: 133 N------CVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDED 167

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 44/229 (19%), Positives = 85/229 (37%), Gaps = 54/229 (23%)

Query: 1   GAFSVVRRCVQKATGLEF----AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + +    G +     A K +  +  S +  +++  EA +   + +P++ RL  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSNG 109
                    L+  L+  G L       ++  E   +       +   QI + +N+     
Sbjct: 85  ICLTSTV-QLITQLMPFGCL------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------W--------- 149
           +VHRDL   N+L+ +      VK+ DFGLA  +  E++            W         
Sbjct: 138 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 150 ----------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                     +GV ++ ++  G  P+       + + ++ G    P P 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPP 242

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 42/150 (28%), Positives = 60/150 (40%), Gaps = 21/150 (14%)

Query: 1   GAFSVVRRCVQKATGLEF---AAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A   +    A K +    LS         RE      L H N++RL+ 
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQI------LESVNHCHSNG 109
            +       +V +L   G L + +   +  +     S    Q+      LES        
Sbjct: 89  VVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR------ 141

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            +HRDL   NLLLA++     VK+ DFGL 
Sbjct: 142 FIHRDLAARNLLLATRDL---VKIGDFGLM 168

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 23/156 (14%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 53
           G+F +V   V  A G+         A K +N +  S R+  +   EA + ++    ++VR
Sbjct: 36  GSFGMVYEGV--AKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 54  LHDSIQEENYHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESVN 103
           L   + +     ++ +L+T G+L            +       S +       +I + + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 104 HCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           + ++N  VHRDL   N ++A       VK+ DFG+ 
Sbjct: 153 YLNANKFVHRDLAARNCMVAE---DFTVKIGDFGMT 185

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 50/226 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSI 58
           G F  V + +  +      A  I T K    D  + +  +EA   R+  HP+IV+L   I
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSNGVV 111
            E    +++ +L T GEL      R F      S           Q+  ++ +  S   V
Sbjct: 86  TENPV-WIIMELCTLGEL------RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ----------------QA------- 148
           HRD+   N+L++S      VKL DFGL+  ++                   ++       
Sbjct: 139 HRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195

Query: 149 -----W-FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                W FGV ++ IL+ G  PF     + +  +I+ G    P P 
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPP 240

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 42/223 (18%)

Query: 1   GAFSVVRRCVQKATGLEF----AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V + V    G         K+I   K   + FQ +         L H +IVRL  
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDL 115
                +   LV   +  G L + +             +   QI + + +   +G+VHR+L
Sbjct: 83  LCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNL 141

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------W--------------- 149
              N+LL S ++   V++ADFG+A  +  + +            W               
Sbjct: 142 AARNVLLKSPSQ---VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198

Query: 150 ----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
               +GV ++ ++  G  P+       +   ++ G      P+
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQ 240

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 47/231 (20%), Positives = 76/231 (32%), Gaps = 55/231 (23%)

Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 56
           G F  V            +  A K +N +     +  +   E  I +   HPN++ L   
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESVNHCHSNG 109
            ++ E    +V   +  G+L      R F      +           Q+ + +    S  
Sbjct: 159 CLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA--IEVQGEQQA-----------W------- 149
            VHRDL   N +L        VK+ADFGLA  +  +                W       
Sbjct: 213 FVHRDLAARNCMLDE---KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 150 ------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 187
                       FGV+L+ ++  G PP+ D +   +   +  G      PE
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPE 319

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 61.5 bits (150), Expect = 5e-11
 Identities = 36/150 (24%), Positives = 59/150 (39%), Gaps = 21/150 (14%)

Query: 1   GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 56
           G F VV            ++ A K ++ +    +  +   RE  + R L HPN++ L   
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQI------LESVNHCHSNG 109
            +  E   +++   +  G+L + I + +   +  D      Q+      L          
Sbjct: 91  MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF----- 145

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            VHRDL   N +L        VK+ADFGLA
Sbjct: 146 -VHRDLAARNCMLDE---SFTVKVADFGLA 171

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 61.2 bits (149), Expect = 8e-11
 Identities = 41/167 (24%), Positives = 60/167 (35%), Gaps = 41/167 (24%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 53
           GAF  V     +   L         A K +  K+ S    Q  +REA +   LQH +IVR
Sbjct: 52  GAFGKVFLA--ECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVR 107

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS---------------HCIQQI 98
                 E     +VF+ +  G+L   + +    ++  A                    Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 99  ------LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                 L    H      VHRDL   N L+     G  VK+ DFG++
Sbjct: 168 AAGMVYLAG-LHF-----VHRDLATRNCLVGQ---GLVVKIGDFGMS 205

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 60.3 bits (147), Expect = 1e-10
 Identities = 39/168 (23%), Positives = 62/168 (36%), Gaps = 42/168 (25%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 53
           GAF  V     +   L         A K +  K  +    +  +REA +   LQH +IV+
Sbjct: 26  GAFGKVFLA--ECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADAS----------------HCIQQ 97
            +    + +   +VF+ +  G+L + + A    +                     H   Q
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 98  I------LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           I      L S  H      VHRDL   N L+ +      VK+ DFG++
Sbjct: 142 IASGMVYLAS-QHF-----VHRDLATRNCLVGA---NLLVKIGDFGMS 180

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 7/100 (7%)

Query: 44  RKLQHPNIVRLHDS-IQEENYHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQIL 99
                  I       + ++ Y +LV   + G       +        SE        ++L
Sbjct: 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL-SERSVLQVACRLL 169

Query: 100 ESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +++   H N  VH ++  EN+ +      + V LA +G A
Sbjct: 170 DALEFLHENEYVHGNVTAENIFV-DPEDQSQVTLAGYGFA 208

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 35/165 (21%), Positives = 59/165 (35%), Gaps = 35/165 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL----SARDFQKLEREARICRKLQHPNIVRLHD 56
             F  V +            + +  K L         ++   EA +  +LQHPN+V L  
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 79

Query: 57  SIQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQQI-- 98
            + ++    ++F   + G+L                 +D   +      D  H + QI  
Sbjct: 80  VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139

Query: 99  ----LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
               L S +H      VH+DL   N+L+        VK++D GL 
Sbjct: 140 GMEYLSS-HHV-----VHKDLATRNVLVYD---KLNVKISDLGLF 175

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 41/176 (23%), Positives = 62/176 (35%), Gaps = 49/176 (27%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 53
           GAF  V +   +A GL         A K++  ++ SA      +REA +  +  +PNIV+
Sbjct: 58  GAFGRVFQA--RAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVK 114

Query: 54  LHDSIQEENYHYLVFDLVTGGEL------------------------FEDIVAREFYSEA 89
           L           L+F+ +  G+L                                  S A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 90  DASHCIQQI------LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +     +Q+      L           VHRDL   N L+        VK+ADFGL+
Sbjct: 175 EQLCIARQVAAGMAYLSE-RKF-----VHRDLATRNCLVGE---NMVVKIADFGLS 221

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 41/158 (25%), Positives = 59/158 (37%), Gaps = 22/158 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL----SARDFQKLEREARICRKL-QHPNIVRLH 55
           GAF  V        G E A   +  K L     A + + L  E +I   L QH NIV L 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116

Query: 56  DSIQEENYHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQILES 101
            +        ++ +    G+L                  +A    S  D  H   Q+ + 
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176

Query: 102 VNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +    S   +HRD+   N+LL +   G   K+ DFGLA
Sbjct: 177 MAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLA 211

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 37/158 (23%), Positives = 55/158 (34%), Gaps = 23/158 (14%)

Query: 1   GAFSVVRRCVQKATGLEF--AAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDS 57
           G F  V +   K  GL    A K +  +  S  D +    E  +  KL  HPNI+ L  +
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94

Query: 58  IQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQQILES 101
            +   Y YL  +    G L                          S     H    +   
Sbjct: 95  CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154

Query: 102 VNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
           +++      +HRDL   N+L+         K+ADFGL+
Sbjct: 155 MDYLSQKQFIHRDLAARNILVGE---NYVAKIADFGLS 189

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 34/164 (20%), Positives = 61/164 (37%), Gaps = 31/164 (18%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKL-QHPNIV 52
           GAF  V      A G++        A K++  +  +  + + L  E +I   +  H N+V
Sbjct: 38  GAFGQVIEA--DAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 53  RLHD-SIQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCI 95
            L     +      ++ +    G L                  + + ++F +        
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            Q+ + +    S   +HRDL   N+LL+       VK+ DFGLA
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSE---KNVVKICDFGLA 195

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 42/170 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT----KKL----SARDFQKLEREARICRKL-QHPNI 51
           G F  V     +A G++            K L    + +D   L  E  + + + +H NI
Sbjct: 92  GCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149

Query: 52  VRLHDSIQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCI 95
           + L  +  ++   Y++ +  + G L                  + V  E  +  D   C 
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209

Query: 96  QQI------LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            Q+      L S   C     +HRDL   N+L+        +K+ADFGLA
Sbjct: 210 YQLARGMEYLAS-QKC-----IHRDLAARNVLVTE---NNVMKIADFGLA 250

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 53.4 bits (129), Expect = 2e-08
 Identities = 36/165 (21%), Positives = 53/165 (32%), Gaps = 32/165 (19%)

Query: 1   GAFSVVRRCVQKATGLEF-------AAKIINTKKLSARDFQKLEREARICRKL-QHPNIV 52
           GAF  V      A GL         A K++        + + L  E ++   L  H NIV
Sbjct: 34  GAFGKVVEA--TAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 53  RLHDSIQEENYHYLVFDLVTGGEL------------------FEDIVAREFYSEADASHC 94
            L  +        ++ +    G+L                               D    
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 95  IQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
             Q+ + +    S   +HRDL   N+LL     G   K+ DFGLA
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA 192

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 36/175 (20%), Positives = 61/175 (34%), Gaps = 47/175 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT--KKL----SARDFQKLEREARICRKLQHPNIVRL 54
           G F  V +    A  L+  A       K L    S  + + L  E  + +++ HP++++L
Sbjct: 34  GEFGKVVKA--TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91

Query: 55  HDSIQEENYHYLVFDLVTGGEL------------------------FEDIVAREFYSEAD 90
           + +  ++    L+ +    G L                          D       +  D
Sbjct: 92  YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151

Query: 91  ASHCIQQI------LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                 QI      L           VHRDL   N+L+A    G  +K++DFGL+
Sbjct: 152 LISFAWQISQGMQYLAE-MKL-----VHRDLAARNILVAE---GRKMKISDFGLS 197

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 30/164 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT----KKL----SARDFQKLEREARICRKL-QHPNI 51
           GAF  V      A GL+       T    K L    + +D   L  E  + + + +H NI
Sbjct: 80  GAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137

Query: 52  VRLHDSIQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCI 95
           + L  +  ++   Y++ +  + G L                       E  S  D   C 
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            Q+   + +  S   +HRDL   N+L+        +K+ADFGLA
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTE---DNVMKIADFGLA 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 30/164 (18%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT----KKL----SARDFQKLEREARICRKL-QHPNI 51
           GAF  V     +A G++            K L    + +D   L  E  + + + +H NI
Sbjct: 46  GAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103

Query: 52  VRLHDSIQEENYHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCI 95
           + L  +  ++   Y++ +  + G L                  + V  E  +  D   C 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163

Query: 96  QQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
            Q+   + +  S   +HRDL   N+L+        +K+ADFGLA
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTE---NNVMKIADFGLA 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 44/169 (26%), Positives = 65/169 (38%), Gaps = 35/169 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT--KKL----SARDFQKLEREARICRKL-QHPNIVR 53
           GAF  V      A G+      I    K L     + + + L  E ++  +L  H NIV 
Sbjct: 56  GAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113

Query: 54  LHDSIQEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCH------ 106
           L  +       YL+F+    G+L   + + RE +SE +  +  Q+ LE     +      
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173

Query: 107 ----------------SNGVVHRDLKPENLLLASKAKGAAVKLADFGLA 139
                               VHRDL   N+L+     G  VK+ DFGLA
Sbjct: 174 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLA 219

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 25/128 (19%), Positives = 33/128 (25%), Gaps = 10/128 (7%)

Query: 185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKF 244
             E       A+    Q     P      S A           +      +  V      
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 245 NARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPF------ 298
           NA    K         T  Y S EVL    Y  P DIW+   + + L  G   F      
Sbjct: 242 NACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299

Query: 299 --WDEDQH 304
               ++ H
Sbjct: 300 EYTRDEDH 307

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 34/140 (24%), Positives = 61/140 (43%), Gaps = 21/140 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----HPN---IV 52
           G FS V            A K++   K +    +    E R+ + ++      PN   +V
Sbjct: 48  GHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 53  RLHDS--IQEEN-YHY-LVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESVNHC 105
           +L D   I   N  H  +VF+++  G      + +  Y           IQQ+L+ +++ 
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 106 HS-NGVVHRDLKPENLLLAS 124
           H+   ++H D+KPEN+LL+ 
Sbjct: 163 HTKCRIIHTDIKPENILLSV 182

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 12/25 (48%), Positives = 17/25 (68%)

Query: 198 LINQMLTVNPSKRITASEALKHPWI 222
            +  ML + P KR TA+E L+HPW+
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWL 395

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.8 bits (110), Expect = 4e-06
 Identities = 32/196 (16%), Positives = 61/196 (31%), Gaps = 57/196 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSA------RDFQKLEREARICRKLQ------- 47
           G F  V + +   T    A KII  +          + F+++  E  I ++L        
Sbjct: 31  GVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88

Query: 48  --HPNIVRLHD------------------------------SIQEENYHYLVFDLVTGGE 75
                 + L+                                  +++  ++V +   GG 
Sbjct: 89  NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148

Query: 76  LFEDIVAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLL--------LASKA 126
             E +   +  S A A   + Q+  S+    ++    HRDL   N+L        L    
Sbjct: 149 DLEQMR-TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207

Query: 127 KGAAVKLADFGLAIEV 142
            G +  +   GL + +
Sbjct: 208 NGKSSTIPSCGLQVSI 223

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 4e-06
 Identities = 38/274 (13%), Positives = 86/274 (31%), Gaps = 75/274 (27%)

Query: 26  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFD-LVTGGE-----LFED 79
                +D Q + +      ++ H  I+   D     +    +F  L++  E       E+
Sbjct: 31  DNFDCKDVQDMPKSILSKEEIDH--IIMSKD---AVSGTLRLFWTLLSKQEEMVQKFVEE 85

Query: 80  IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKP----------------ENLL 121
           ++    +F      +   Q  + +  +      ++ D +                 + LL
Sbjct: 86  VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145

Query: 122 LASKAKGAAVK-LADFG---LAIEV----QGEQQAWFGVILYILLVGYPPFWDEDQHRLY 173
               AK   +  +   G   +A++V    + + +  F +           FW        
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI-----------FW-------- 186

Query: 174 AQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH 233
             +     + P    +TV    + L+ Q +  N + R   S  +K      +  +  ++ 
Sbjct: 187 --LNLKNCNSP----ETVLEMLQKLLYQ-IDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239

Query: 234 RQETVDCL------------KKFNARRKLKVSTR 255
            +   +CL              FN   K+ ++TR
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 29/130 (22%), Positives = 51/130 (39%), Gaps = 28/130 (21%)

Query: 26  KKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVA 82
           K+ +    Q +E    E       +HP++V L     E N   L++  +  G L   +  
Sbjct: 69  KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-- 126

Query: 83  REFYSEADASH---------CIQ--QILESVNHCHSNGVVHRDLKPENLLLASK--AKGA 129
             + S+              CI   + L    + H+  ++HRD+K  N+LL         
Sbjct: 127 --YGSDLPTMSMSWEQRLEICIGAARGLH---YLHTRAIIHRDVKSINILLDENFVP--- 178

Query: 130 AVKLADFGLA 139
             K+ DFG++
Sbjct: 179 --KITDFGIS 186

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 43.7 bits (104), Expect = 4e-05
 Identities = 27/137 (19%), Positives = 45/137 (32%), Gaps = 38/137 (27%)

Query: 26  KKLSARDFQKLER----EARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIV 81
           K+L     Q  E     E  +     H N++RL           LV+  +  G +     
Sbjct: 60  KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV----- 114

Query: 82  AREFYSEADASHCIQQILESVN------------------HCHSN-GVVHRDLKPENLLL 122
                  A       +    ++                  H H +  ++HRD+K  N+LL
Sbjct: 115 -------ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167

Query: 123 ASKAKGAAVKLADFGLA 139
             + +     + DFGLA
Sbjct: 168 DEEFE---AVVGDFGLA 181

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 16/36 (44%), Positives = 21/36 (58%), Gaps = 7/36 (19%)

Query: 106 HSNGVVHRDLKPENLLLASK--AKGAAVKLADFGLA 139
           H N  +HRD+K  N+LL     A     K++DFGLA
Sbjct: 150 HENHHIHRDIKSANILLDEAFTA-----KISDFGLA 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	328
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.4
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.39
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.28
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.21
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.21
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.18
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.17
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.12
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.1
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.1
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.09
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.08
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.06
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.03
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.03
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.02
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.01
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.01
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	98.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	98.88
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	98.87
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	98.87
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	98.82
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	98.82
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	98.82
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	98.81
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	98.81
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	98.8
3niz_A	311	Rhodanese family protein; structural genomics, str	98.78
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.77
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	98.77
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	98.76
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	98.76
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	98.76
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	98.76
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.75
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	98.74
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	98.73
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	98.72
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	98.72
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	98.72
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.72
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	98.72
3bhy_A	283	Death-associated protein kinase 3; death associate	98.7
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	98.7
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	98.69
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.69
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.68
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.68
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	98.68
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	98.68
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	98.66
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	98.66
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	98.65
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	98.65
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	98.65
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	98.65
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	98.64
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.64
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	98.64
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	98.64
3o0g_A	292	Cell division protein kinase 5; kinase activator c	98.63
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	98.62
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	98.62
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	98.6
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.6
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	98.6
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	98.59
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	98.59
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	98.58
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	98.57
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.57
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.57
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.57
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	98.56
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	98.56
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	98.55
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	98.55
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	98.55
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	98.54
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.54
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	98.54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	98.53
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	98.53
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	98.53
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	98.52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	98.52
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.52
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	98.52
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	98.51
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	98.51
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	98.51
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.51
3fme_A	290	Dual specificity mitogen-activated protein kinase;	98.51
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	98.51
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	98.5
2dyl_A	318	Dual specificity mitogen-activated protein kinase	98.5
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	98.5
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	98.48
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	98.48
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	98.47
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.46
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	98.45
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	98.45
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.45
4aoj_A	329	High affinity nerve growth factor receptor; transf	98.44
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	98.43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	98.43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	98.42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	98.42
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	98.42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	98.41
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	98.4
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.4
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	98.38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	98.38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	98.37
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	98.37
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	98.37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	98.37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.35
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	98.35
3rp9_A	458	Mitogen-activated protein kinase; structural genom	98.35
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	98.33
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	98.33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	98.32
3ork_A	311	Serine/threonine protein kinase; structural genomi	98.31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	98.29
3uqc_A	286	Probable conserved transmembrane protein; structur	98.29
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	98.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	98.17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	98.16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	98.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	98.11
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	98.06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.05
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	98.03
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	98.03
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	98.02
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	98.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	97.99
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	97.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	97.98
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	97.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	97.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	97.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	97.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	97.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	97.95
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	97.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	97.94
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	97.93
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	97.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	97.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	97.9
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	97.88
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	97.88
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	97.85
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	97.85
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	97.85
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	97.84
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	97.84
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	97.84
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	97.84
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	97.84
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	97.83
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	97.82
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	97.82
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	97.82
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	97.81
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	97.81
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	97.79
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	97.79
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	97.79
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	97.78
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	97.78
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	97.77
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	97.74
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	97.71
3pls_A	298	Macrophage-stimulating protein receptor; protein k	97.7
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	97.69
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	97.68
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	97.67
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	97.66
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	97.66
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	97.64
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	97.64
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	97.64
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	97.63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	97.62
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	97.62
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	97.61
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	97.61
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	97.61
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	97.61
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	97.61
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	97.6
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	97.58
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	97.58
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	97.56
3soc_A	322	Activin receptor type-2A; structural genomics cons	97.5
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	97.47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	97.47
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	97.44
3q4u_A	301	Activin receptor type-1; structural genomics conso	97.39

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-61  Score=431.15  Aligned_cols=212  Identities=31%  Similarity=0.548  Sum_probs=189.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++++.... ....+.+.+|+++|++++|||||+++++|++++.+|||||||+||+|.++
T Consensus        43 G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~  122 (311)
T 4aw0_A           43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY  122 (311)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHH
Confidence            89999999999999999999999865332 22356789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.++|.+++.++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+.....            
T Consensus       123 i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~---g~vKl~DFGla~~~~~~~~------------  187 (311)
T 4aw0_A          123 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESK------------  187 (311)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECCTTTT------------
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC---CCEEEEEcCCceecCCCCC------------
Confidence            9988999999999999999999999999999999999999999754   4699999999976532110            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       188 --------------------------------------------------------------------------------  187 (311)
T 4aw0_A          188 --------------------------------------------------------------------------------  187 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                  .....+++|||.|||||++.+.+|+.++|||||||+||||+||++||.+.+..+++.+|.++.+..|+
T Consensus       188 ------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~  255 (311)
T 4aw0_A          188 ------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE  255 (311)
T ss_dssp             ------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             ------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence                        00123468999999999999999999999999999999999999999999999999999999987654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-60  Score=430.88  Aligned_cols=214  Identities=31%  Similarity=0.560  Sum_probs=188.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.........+.+.+|+++|++|+|||||+++++|++.+.+|||||||+||+|.+++
T Consensus        35 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i  114 (350)
T 4b9d_A           35 GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI  114 (350)
T ss_dssp             ----CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence            89999999999999999999999988888888888999999999999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.+++.|+.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+...             
T Consensus       115 ~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~-------------  178 (350)
T 4b9d_A          115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNST-------------  178 (350)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT---CCEEECSTTEESCCCHH-------------
T ss_pred             HHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CCEEEcccccceeecCC-------------
Confidence            754  357999999999999999999999999999999999999754   46999999998643110             


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       179 --------------------------------------------------------------------------------  178 (350)
T 4b9d_A          179 --------------------------------------------------------------------------------  178 (350)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .....+.+|||.|||||++.+.+|+.++||||||||||||+||++||.+.+..+++.+|.++.+.+.
T Consensus       179 -------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~  245 (350)
T 4b9d_A          179 -------------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV  245 (350)
T ss_dssp             -------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             -------------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence                         0012235799999999999999999999999999999999999999999999999999999998666


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |.+.+
T Consensus       246 ~~~~s  250 (350)
T 4b9d_A          246 SLHYS  250 (350)
T ss_dssp             CTTSC
T ss_pred             CccCC
Confidence            65554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-58  Score=406.45  Aligned_cols=207  Identities=41%  Similarity=0.682  Sum_probs=173.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++++...... ...++.+|+++|++++|||||++++++++++.+|+||||| +|+|++.
T Consensus        24 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~  102 (275)
T 3hyh_A           24 GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDY  102 (275)
T ss_dssp             ---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHH
Confidence            8999999999999999999999987655433 3567899999999999999999999999999999999999 6799999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +..++.+++.+++.++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+......             
T Consensus       103 l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~~~-------------  166 (275)
T 3hyh_A          103 IVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGN-------------  166 (275)
T ss_dssp             HHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---CCEEECCSSCC--------------------
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC---CCEEEeecCCCeecCCCC-------------
Confidence            9999999999999999999999999999999999999999999754   469999999985421100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (275)
T 3hyh_A          167 --------------------------------------------------------------------------------  166 (275)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ...+.+|||.|||||++.+.+| +.++||||+||+||||+||++||.+.+...++++|..+.+..|
T Consensus       167 --------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p  232 (275)
T 3hyh_A          167 --------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP  232 (275)
T ss_dssp             ----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             --------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          0123569999999999999987 6899999999999999999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.8e-60  Score=419.76  Aligned_cols=209  Identities=31%  Similarity=0.554  Sum_probs=179.6

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|++.   .+++.||||+++.......+..++.+|+++|++++|||||+++++|++++.+|||||||+||+|.
T Consensus        35 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~  114 (304)
T 3ubd_A           35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF  114 (304)
T ss_dssp             GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEH
T ss_pred             CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHH
Confidence            899999999884   47889999999876544444456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+......           
T Consensus       115 ~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~~-----------  180 (304)
T 3ubd_A          115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHE-----------  180 (304)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---SCEEEESSEEEEC----------------
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC---CCEEecccccceeccCCC-----------
Confidence            999998999999999999999999999999999999999999999754   459999999986431110           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (304)
T 3ubd_A          181 --------------------------------------------------------------------------------  180 (304)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ....+.+|||.|||||++.+.+|+.++|||||||+||||+||++||.+.+..+++.+|.++.+..
T Consensus       181 ---------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~  245 (304)
T 3ubd_A          181 ---------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM  245 (304)
T ss_dssp             ---------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ---------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence                           01224579999999999999999999999999999999999999999999999999999998854


Q ss_pred             C
Q psy2131         318 E  318 (328)
Q Consensus       318 ~  318 (328)
                      |
T Consensus       246 p  246 (304)
T 3ubd_A          246 P  246 (304)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-58  Score=417.94  Aligned_cols=203  Identities=28%  Similarity=0.530  Sum_probs=180.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.....  ..+.+.+|+++|++++|||||+++++|.+.+.+|||||||+||+|.+++
T Consensus        85 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l  162 (346)
T 4fih_A           85 GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV  162 (346)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence            89999999999999999999999765433  2345789999999999999999999999999999999999999999877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. +.+++.+++.++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+.....             
T Consensus       163 ~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~~~-------------  225 (346)
T 4fih_A          163 TH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVP-------------  225 (346)
T ss_dssp             HH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSC-------------
T ss_pred             Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC---CCEEEecCcCceecCCCCC-------------
Confidence            64 679999999999999999999999999999999999999754   4699999999876532110             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       226 --------------------------------------------------------------------------------  225 (346)
T 4fih_A          226 --------------------------------------------------------------------------------  225 (346)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ...+.+|||.|||||++.+.+|+.++||||||||||||+||++||.+.++.+++..|..+..
T Consensus       226 -------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  287 (346)
T 4fih_A          226 -------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP  287 (346)
T ss_dssp             -------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred             -------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence                         12246799999999999999999999999999999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-58  Score=404.69  Aligned_cols=204  Identities=28%  Similarity=0.480  Sum_probs=180.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+++.||+|++..........+++.+|+++|++|+|||||+++++|.+    .+.+|||||||+||+|
T Consensus        37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L  116 (290)
T 3fpq_A           37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL  116 (290)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBH
T ss_pred             CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCH
Confidence            899999999999999999999998877777778889999999999999999999999975    3568999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+++...+.+++.++..++.||+.||+|||++|  ||||||||+|||++.  .++.+||+|||+|+....          
T Consensus       117 ~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~~~~~----------  184 (290)
T 3fpq_A          117 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRA----------  184 (290)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGGGCCT----------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCCEeCCC----------
Confidence            999998889999999999999999999999998  999999999999964  235699999999853211          


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (290)
T 3fpq_A          185 --------------------------------------------------------------------------------  184 (290)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~  313 (328)
                                        ....+.+|||.|||||++.+ +|+.++|||||||+||||+||++||.+. +...++..|..+
T Consensus       185 ------------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~  245 (290)
T 3fpq_A          185 ------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             ------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             ------------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence                              01123579999999999976 6999999999999999999999999875 577788888887


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       246 ~~  247 (290)
T 3fpq_A          246 VK  247 (290)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-58  Score=415.26  Aligned_cols=205  Identities=28%  Similarity=0.420  Sum_probs=179.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.+...       .+|+.+|++++|||||++|++|.+++.+|||||||+||+|.+++
T Consensus        69 G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l  141 (336)
T 4g3f_A           69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI  141 (336)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence            89999999999999999999999875432       36999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.||+.||+|||++|||||||||+|||++.++  ..+||+|||+|+.+......            
T Consensus       142 ~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~~vKl~DFGla~~~~~~~~~------------  207 (336)
T 4g3f_A          142 KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLG------------  207 (336)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--CCEEECCCTTCEEC------------------
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--CEEEEeeCCCCeEccCCCcc------------
Confidence            9888999999999999999999999999999999999999997543  25999999999765321100            


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       208 --------------------------------------------------------------------------------  207 (336)
T 4g3f_A          208 --------------------------------------------------------------------------------  207 (336)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                               ....+...++|||.|||||++.+.+|+.++|||||||+||||+||++||.+.+...++.+|.++..
T Consensus       208 ---------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~  273 (336)
T 4g3f_A          208 ---------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP  273 (336)
T ss_dssp             ---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC
T ss_pred             ---------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC
Confidence                     000112245799999999999999999999999999999999999999999999999999998865

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-57  Score=418.28  Aligned_cols=203  Identities=28%  Similarity=0.533  Sum_probs=180.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.....  ..+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||+||+|.+++
T Consensus       162 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i  239 (423)
T 4fie_A          162 GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV  239 (423)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred             CcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence            89999999999999999999999865433  2356789999999999999999999999999999999999999999877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . .+.+++.+++.++.||+.||+|||++|||||||||+||||+.+   +.+||+|||+|+.+.....             
T Consensus       240 ~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~---g~vKl~DFGla~~~~~~~~-------------  302 (423)
T 4fie_A          240 T-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVP-------------  302 (423)
T ss_dssp             H-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT---CCEEECCCTTCEECCSSCC-------------
T ss_pred             h-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEecCccceECCCCCc-------------
Confidence            5 4579999999999999999999999999999999999999754   4699999999876532110             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       303 --------------------------------------------------------------------------------  302 (423)
T 4fie_A          303 --------------------------------------------------------------------------------  302 (423)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ...+.+|||.|||||++.+.+|+.++|||||||+||||++|++||.+.++.+++..|..+..
T Consensus       303 -------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  364 (423)
T 4fie_A          303 -------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP  364 (423)
T ss_dssp             -------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             -------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence                         12246799999999999999999999999999999999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-56  Score=397.68  Aligned_cols=215  Identities=24%  Similarity=0.356  Sum_probs=184.8

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|++.     .+++.||||+++..  +....+.+.+|+++|++++|||||++++++.+.+.+|||||||+||+
T Consensus        24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~  101 (299)
T 4asz_A           24 GAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD  101 (299)
T ss_dssp             --CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             CCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCc
Confidence            899999999865     46889999999743  45566789999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          76 LFEDIVAR-------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        76 L~~~l~~~-------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      |.+++...             ..+++.++..++.|++.||.|||+++||||||||+|||++.+   +.+||+|||+|+..
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~---~~~Ki~DFGla~~~  178 (299)
T 4asz_A          102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMSRDV  178 (299)
T ss_dssp             HHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCSCHHHH
T ss_pred             HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC---CcEEECCcccceec
Confidence            99999754             369999999999999999999999999999999999999764   45999999998643


Q ss_pred             cCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         143 QGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       143 ~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .....                                                                           
T Consensus       179 ~~~~~---------------------------------------------------------------------------  183 (299)
T 4asz_A          179 YSTDY---------------------------------------------------------------------------  183 (299)
T ss_dssp             TGGGC---------------------------------------------------------------------------
T ss_pred             CCCCc---------------------------------------------------------------------------
Confidence            21100                                                                           


Q ss_pred             CCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCc
Q psy2131         223 CQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDE  301 (328)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~  301 (328)
                                                   ........||+.|||||++.+..|+.++|||||||+||||+| |++||.+.
T Consensus       184 -----------------------------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          184 -----------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             -----------------------------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             -----------------------------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                                         001123469999999999999999999999999999999999 99999999


Q ss_pred             cHHHHHHHHhcccCCCCCCcccc
Q psy2131         302 DQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       302 ~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      +..++...|.+|...+.|..++.
T Consensus       235 ~~~~~~~~i~~~~~~~~p~~~~~  257 (299)
T 4asz_A          235 SNNEVIECITQGRVLQRPRTCPQ  257 (299)
T ss_dssp             CHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             CHHHHHHHHHcCCCCCCCccchH
Confidence            99999999999998888887764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.6e-55  Score=393.67  Aligned_cols=215  Identities=22%  Similarity=0.321  Sum_probs=180.5

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+.+     .+++.||||+++..  +....+.+.+|+++|++++|||||++++++.+.+.+|||||||+||+
T Consensus        52 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~  129 (329)
T 4aoj_A           52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD  129 (329)
T ss_dssp             CSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             CCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence            899999999864     46889999999743  45566789999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccc
Q psy2131          76 LFEDIVAR---------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus        76 L~~~l~~~---------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~  140 (328)
                      |.+++...               ..+++.++..++.|++.||.|||+++||||||||+|||++.+   +.+||+|||+|+
T Consensus       130 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~---~~~Ki~DFGla~  206 (329)
T 4aoj_A          130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG---LVVKIGDFGMSR  206 (329)
T ss_dssp             HHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC---
T ss_pred             HHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC---CcEEEcccccce
Confidence            99998653               358999999999999999999999999999999999999754   569999999986


Q ss_pred             cccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         141 EVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       141 ~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      .......                                                                         
T Consensus       207 ~~~~~~~-------------------------------------------------------------------------  213 (329)
T 4aoj_A          207 DIYSTDY-------------------------------------------------------------------------  213 (329)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             eccCCCc-------------------------------------------------------------------------
Confidence            5422110                                                                         


Q ss_pred             ccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCC
Q psy2131         221 WICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFW  299 (328)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~  299 (328)
                                                     ........||+.|||||++.+..|+.++|||||||+||||+| |++||.
T Consensus       214 -------------------------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          214 -------------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             -------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             -------------------------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence                                           001123469999999999999999999999999999999999 999999


Q ss_pred             CccHHHHHHHHhcccCCCCCCcccc
Q psy2131         300 DEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       300 ~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      +.+..+++..|.+|.....|..++.
T Consensus       263 ~~~~~~~~~~i~~g~~~~~p~~~~~  287 (329)
T 4aoj_A          263 QLSNTEAIDCITQGRELERPRACPP  287 (329)
T ss_dssp             SSCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             CCCHHHHHHHHHcCCCCCCcccccH
Confidence            9999999999999987777777654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-55  Score=390.82  Aligned_cols=217  Identities=24%  Similarity=0.346  Sum_probs=184.8

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|..     ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+.+.+|||||||++|+
T Consensus        37 G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~  115 (308)
T 4gt4_A           37 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGD  115 (308)
T ss_dssp             CSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCB
T ss_pred             CCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCc
Confidence            89999999985     3577899999997543 33445778999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccc
Q psy2131          76 LFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLA  139 (328)
Q Consensus        76 L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla  139 (328)
                      |.++|..+                ..+++.++..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+|
T Consensus       116 L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~---~~~Ki~DFGla  192 (308)
T 4gt4_A          116 LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLF  192 (308)
T ss_dssp             HHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCSCCB
T ss_pred             HHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC---CCEEECCcccc
Confidence            99999653                358999999999999999999999999999999999999765   45999999998


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +........                                                                       
T Consensus       193 r~~~~~~~~-----------------------------------------------------------------------  201 (308)
T 4gt4_A          193 REVYAADYY-----------------------------------------------------------------------  201 (308)
T ss_dssp             CGGGGGGCB-----------------------------------------------------------------------
T ss_pred             eeccCCCce-----------------------------------------------------------------------
Confidence            754221100                                                                       


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf  298 (328)
                                                       .......||+.|||||++.+..|+.++|||||||+||||+| |++||
T Consensus       202 ---------------------------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf  248 (308)
T 4gt4_A          202 ---------------------------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  248 (308)
T ss_dssp             ---------------------------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ---------------------------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence                                             01123469999999999999999999999999999999999 99999


Q ss_pred             CCccHHHHHHHHhcccCCCCCCccccC
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKHKSAS  325 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~~~~~  325 (328)
                      .+.+..++...|..|...+.|..++..
T Consensus       249 ~~~~~~~~~~~i~~~~~~~~p~~~~~~  275 (308)
T 4gt4_A          249 CGYSNQDVVEMIRNRQVLPCPDDCPAW  275 (308)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCcccchHH
Confidence            999999999999999988888877653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=386.18  Aligned_cols=206  Identities=22%  Similarity=0.406  Sum_probs=169.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+.+.   .||||+++....+.+..+.+.+|+++|++++|||||++++++.+ +.+|||||||+||+|.+++
T Consensus        47 G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l  122 (307)
T 3omv_A           47 GSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHL  122 (307)
T ss_dssp             CSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHH
T ss_pred             CCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHH
Confidence            8999999997543   58999998777777778899999999999999999999998764 5689999999999999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||+++||||||||+|||++.+   +.+||+|||+|+.......            
T Consensus       123 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~~------------  187 (307)
T 3omv_A          123 HVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWSG------------  187 (307)
T ss_dssp             HTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC------------------
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC---CcEEEeeccCceecccCCc------------
Confidence            754 579999999999999999999999999999999999999754   5699999999864321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       188 --------------------------------------------------------------------------------  187 (307)
T 3omv_A          188 --------------------------------------------------------------------------------  187 (307)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCccH-HHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~  315 (328)
                                  .......+||+.|||||++.+   .+|+.++|||||||+||||+||++||.+.+. ..+...+.++..
T Consensus       188 ------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~  255 (307)
T 3omv_A          188 ------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA  255 (307)
T ss_dssp             ------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred             ------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence                        001123579999999999964   4689999999999999999999999998764 455555555554


Q ss_pred             CC
Q psy2131         316 DD  317 (328)
Q Consensus       316 ~~  317 (328)
                      .+
T Consensus       256 ~p  257 (307)
T 3omv_A          256 SP  257 (307)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-54  Score=400.60  Aligned_cols=213  Identities=25%  Similarity=0.384  Sum_probs=184.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE------ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~------~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|+++.+|+.||||+|+.........+++.+|+++|+.++|||||++++++..      .+.+|||||||+ |
T Consensus        65 G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g  143 (398)
T 4b99_A           65 GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-S  143 (398)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-E
T ss_pred             ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-C
Confidence            899999999999999999999998777667777888999999999999999999999864      367899999996 5


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|++.+...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.+......      
T Consensus       144 ~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~---~~~Ki~DFGla~~~~~~~~~------  214 (398)
T 4b99_A          144 DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAE------  214 (398)
T ss_dssp             EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTTCBCC------------
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC---CCEEEeecceeeecccCccc------
Confidence            799999888899999999999999999999999999999999999999754   46999999998754221000      


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       215 --------------------------------------------------------------------------------  214 (398)
T 4b99_A          215 --------------------------------------------------------------------------------  214 (398)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ......+.+||+.|||||++.+. .|+.++||||+|||+|||+||++||.+.+...++.+|...
T Consensus       215 ----------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          215 ----------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             -----------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             ----------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence                            00012246799999999999885 5699999999999999999999999999999999999988


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      ...+++
T Consensus       279 ~g~p~~  284 (398)
T 4b99_A          279 LGTPSP  284 (398)
T ss_dssp             HCCCCG
T ss_pred             cCCCCh
Confidence            776554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.9e-54  Score=382.91  Aligned_cols=214  Identities=31%  Similarity=0.485  Sum_probs=163.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------------EEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------------YHYLVF   68 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------------~~~lv~   68 (328)
                      |+||+||+|+++.+|+.||||+++... .....+.+.+|+++|++|+|||||+++++|.+.+            .+|+||
T Consensus        16 G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivm   94 (299)
T 4g31_A           16 GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQM   94 (299)
T ss_dssp             CC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEE
Confidence            899999999999999999999997654 3445577899999999999999999999997654            379999


Q ss_pred             EccCCCCcHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          69 DLVTGGELFEDIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        69 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |||+||+|.+++..+..   .++..+..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+...
T Consensus        95 E~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~---~~vKl~DFGla~~~~~~  171 (299)
T 4g31_A           95 QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQD  171 (299)
T ss_dssp             ECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCCCC------
T ss_pred             ecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---CcEEEccCccceecCCC
Confidence            99999999999987654   3456688999999999999999999999999999999754   46999999999765332


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .....                     .                              +                      
T Consensus       172 ~~~~~---------------------~------------------------------~----------------------  178 (299)
T 4g31_A          172 EEEQT---------------------V------------------------------L----------------------  178 (299)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             ccccc---------------------c------------------------------c----------------------
Confidence            11000                     0                              0                      


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED-QH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~  304 (328)
                                           ..........+.+|||.|||||++.+.+|+.++|||||||+||||++   ||.+.. ..
T Consensus       179 ---------------------~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          179 ---------------------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             ----------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             ---------------------cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence                                 00000011234679999999999999999999999999999999996   888764 45


Q ss_pred             HHHHHHhcccC
Q psy2131         305 RLYAQIKAGAY  315 (328)
Q Consensus       305 ~~~~~i~~~~~  315 (328)
                      ..+..+..+.+
T Consensus       235 ~~~~~~~~~~~  245 (299)
T 4g31_A          235 RTLTDVRNLKF  245 (299)
T ss_dssp             HHHHHHHTTCC
T ss_pred             HHHHHHhcCCC
Confidence            66677766655

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.1e-53  Score=407.23  Aligned_cols=208  Identities=28%  Similarity=0.462  Sum_probs=178.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS----ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||||+|++....    ........+++.+++.++|||||+++++|++.+.+|||||||+||+|
T Consensus       200 G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL  279 (689)
T 3v5w_A          200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL  279 (689)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcH
Confidence            89999999999999999999999754322    22222334457778888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+++...+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+   +.+||+|||+|+.+...           
T Consensus       280 ~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~---G~vKL~DFGlA~~~~~~-----------  345 (689)
T 3v5w_A          280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-----------  345 (689)
T ss_dssp             HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC-----------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC---CCEEecccceeeecCCC-----------
Confidence            9999998999999999999999999999999999999999999999754   45999999998654211           


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       346 --------------------------------------------------------------------------------  345 (689)
T 3v5w_A          346 --------------------------------------------------------------------------------  345 (689)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~  312 (328)
                                       ...+.+|||.|||||++. +.+|+.++|||||||+||||+||++||.+.   +...+...|..
T Consensus       346 -----------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~  408 (689)
T 3v5w_A          346 -----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT  408 (689)
T ss_dssp             -----------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH
T ss_pred             -----------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Confidence                             012357999999999996 568999999999999999999999999875   45678888888


Q ss_pred             ccCCCCC
Q psy2131         313 GAYDDEP  319 (328)
Q Consensus       313 ~~~~~~~  319 (328)
                      +.+..|+
T Consensus       409 ~~~~~p~  415 (689)
T 3v5w_A          409 MAVELPD  415 (689)
T ss_dssp             CCCCCCT
T ss_pred             CCCCCCc
Confidence            8875543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-52  Score=404.17  Aligned_cols=210  Identities=35%  Similarity=0.644  Sum_probs=187.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||++....  ..+.+.+.+|+++|+.++|||||+++++|++.+.+|||||||+||+|++++
T Consensus       168 G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i  245 (573)
T 3uto_A          168 GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV  245 (573)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHH
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHH
Confidence            899999999999999999999997643  445567889999999999999999999999999999999999999999998


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||+|+.+....             
T Consensus       246 ~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~~~~~-------------  311 (573)
T 3uto_A          246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQ-------------  311 (573)
T ss_dssp             TCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEECCTTS-------------
T ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEccCCC-------------
Confidence            64 46799999999999999999999999999999999999997642 3579999999987643211             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       312 --------------------------------------------------------------------------------  311 (573)
T 3uto_A          312 --------------------------------------------------------------------------------  311 (573)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                    .....+|||.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+++.+|.++.+..++
T Consensus       312 --------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~  377 (573)
T 3uto_A          312 --------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD  377 (573)
T ss_dssp             --------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS
T ss_pred             --------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc
Confidence                          112357999999999999999999999999999999999999999999999999999999987665


Q ss_pred             C
Q psy2131         320 K  320 (328)
Q Consensus       320 ~  320 (328)
                      .
T Consensus       378 ~  378 (573)
T 3uto_A          378 S  378 (573)
T ss_dssp             G
T ss_pred             c
Confidence            4

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.7e-52  Score=376.19  Aligned_cols=216  Identities=21%  Similarity=0.358  Sum_probs=180.5

Q ss_pred             CCceEEEEEEEccCC-----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceeEEEEEe-CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQE-ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~-~~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+..++     +.||||.++... ...+.+.+.+|+++|++++| ||||+++++|.+ .+.+|||||||+|
T Consensus        75 G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~  153 (353)
T 4ase_A           75 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  153 (353)
T ss_dssp             CSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTT
T ss_pred             CCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCC
Confidence            899999999876544     679999997543 44556779999999999965 899999999876 4678999999999


Q ss_pred             CCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecc
Q psy2131          74 GELFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG  137 (328)
Q Consensus        74 g~L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfG  137 (328)
                      |+|.++|...                ..+++.++..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||
T Consensus       154 G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~---~~vKi~DFG  230 (353)
T 4ase_A          154 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFG  230 (353)
T ss_dssp             EEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCG
T ss_pred             CCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC---CCEEECcch
Confidence            9999999653                348999999999999999999999999999999999999765   459999999


Q ss_pred             ccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         138 LAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       138 la~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      +|+.+......                                                                     
T Consensus       231 lar~~~~~~~~---------------------------------------------------------------------  241 (353)
T 4ase_A          231 LARDIYKDPDY---------------------------------------------------------------------  241 (353)
T ss_dssp             GGSCTTTCTTS---------------------------------------------------------------------
T ss_pred             hhhhcccCCCc---------------------------------------------------------------------
Confidence            99754221100                                                                     


Q ss_pred             cCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCC
Q psy2131         218 KHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYP  296 (328)
Q Consensus       218 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~  296 (328)
                                                         ....+..||+.|||||++.+..|+.++|||||||+||||+| |++
T Consensus       242 -----------------------------------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          242 -----------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             -----------------------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             -----------------------------------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence                                               01223569999999999999999999999999999999998 999


Q ss_pred             CCCCcc-HHHHHHHHhcccCCCCCCcccc
Q psy2131         297 PFWDED-QHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       297 Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      ||.+.+ ...+...+..|.....|..++.
T Consensus       287 Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~  315 (353)
T 4ase_A          287 PYPGVKIDEEFCRRLKEGTRMRAPDYTTP  315 (353)
T ss_dssp             SSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred             CCCCCCHHHHHHHHHHcCCCCCCCccCCH
Confidence            999876 5667788888887777766653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-51  Score=373.22  Aligned_cols=224  Identities=22%  Similarity=0.363  Sum_probs=167.5

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++   .+++.||||++....    ...++.+|+++|+.+ +|||||+++++|++.+.+|+|||||+||+|
T Consensus        32 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L  107 (361)
T 4f9c_A           32 GTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESF  107 (361)
T ss_dssp             CSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCH
T ss_pred             ccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccH
Confidence            899999999875   467899999987543    235678999999998 699999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+.+   +.+++.+++.++.||+.||+|||++|||||||||+|||++.+  .+.+||+|||+|+.............   
T Consensus       108 ~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~--~~~~kl~DFGla~~~~~~~~~~~~~~---  179 (361)
T 4f9c_A          108 LDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQGTHDTKIELLKFV---  179 (361)
T ss_dssp             HHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEECTTCSCGGGGGC---
T ss_pred             HHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC--CCeEEECcCCCCcccCCccccccccc---
Confidence            9887   359999999999999999999999999999999999999753  35799999999986543321100000   


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                               ...                                     ....+.+...                     
T Consensus       180 ---------~~~-------------------------------------~~~~~~~~~~---------------------  192 (361)
T 4f9c_A          180 ---------QSE-------------------------------------AQQERCSQNK---------------------  192 (361)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             ---------ccc-------------------------------------cccccccccc---------------------
Confidence                     000                                     0000000000                     


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCC-ccHHHHHHHHh
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIK  311 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~  311 (328)
                              ......+.....+.+|||.|+|||++.+. .|+.++||||+|||+|||+||++||.. .+....+..|.
T Consensus       193 --------~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~  261 (361)
T 4f9c_A          193 --------CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIM  261 (361)
T ss_dssp             ---------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred             --------ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence                    00000001122346899999999999886 489999999999999999999999964 45666666654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=363.86  Aligned_cols=262  Identities=82%  Similarity=1.258  Sum_probs=233.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.+|+|++........+.+.+.+|+++|+.++|||||++++++.+.+..|+|||||.||+|.+.+
T Consensus        22 G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i  101 (444)
T 3soa_A           22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI  101 (444)
T ss_dssp             C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHH
Confidence            89999999999999999999999988777777788999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC--------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------  146 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~--------------  146 (328)
                      ...+.+++.++..++.||+.||.|||++||+||||||+|||++.+.+++.+||+|||++.......              
T Consensus       102 ~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~A  181 (444)
T 3soa_A          102 VAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS  181 (444)
T ss_dssp             HHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCC
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCC
Confidence            999999999999999999999999999999999999999999876566789999999986543211              


Q ss_pred             -------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         147 -------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       147 -------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                   +.| +|+++|+|++|.+||.+.+.......+..+.+.++.+.|..+++++.+++.+||..||.+|||
T Consensus       182 PE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  261 (444)
T 3soa_A          182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT  261 (444)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC
Confidence                         122 799999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCC
Q psy2131         213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTP  262 (328)
Q Consensus       213 ~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  262 (328)
                      +.|+++|||+.......+...++...+.+++++..++++.........+.
T Consensus       262 a~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~~~~  311 (444)
T 3soa_A          262 AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATR  311 (444)
T ss_dssp             HHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEECCCC
T ss_pred             HHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence            99999999998776666666777888999999998888766654443333

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-49  Score=355.50  Aligned_cols=207  Identities=23%  Similarity=0.279  Sum_probs=160.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|++  +|+.||||+++...   ......++|+..+.+++|||||++++++.+++    .+|||||||+||+|
T Consensus        14 G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL   88 (303)
T 3hmm_A           14 GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             CCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence            89999999986  68999999997532   11222345777778899999999999998654    68999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSN--------GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~--------~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      .+++.. ..+++.++..++.|++.||.|||++        +||||||||+|||++.+   +.+||+|||+|+........
T Consensus        89 ~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~~~  164 (303)
T 3hmm_A           89 FDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDT  164 (303)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT---SCEEECCCTTCEEEETTTTE
T ss_pred             HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC---CCEEEEeCCCCccccCCCCc
Confidence            998865 4689999999999999999999987        99999999999999754   56999999998765332110


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      .                                                                               
T Consensus       165 ~-------------------------------------------------------------------------------  165 (303)
T 3hmm_A          165 I-------------------------------------------------------------------------------  165 (303)
T ss_dssp             E-------------------------------------------------------------------------------
T ss_pred             e-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC------CCCCCcchhhhhhHHHHHHhcCCCCCCc-
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE------PYGKPVDIWACGVILYILLVGYPPFWDE-  301 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~~DvwSlGvilyelltG~~Pf~~~-  301 (328)
                                             .....+.+||+.|||||++.+.      .|+.++|||||||+||||+||++||... 
T Consensus       166 -----------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~  222 (303)
T 3hmm_A          166 -----------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             -----------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             -----------------------eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence                                   0011234699999999999765      4678999999999999999998766422 


Q ss_pred             --------------cHHHHHHHHhcccCCCC
Q psy2131         302 --------------DQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       302 --------------~~~~~~~~i~~~~~~~~  318 (328)
                                    ....+...+..+.+.++
T Consensus       223 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~  253 (303)
T 3hmm_A          223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN  253 (303)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC
T ss_pred             cccccchhcccccchHHHHHHHHhcccCCCC
Confidence                          23556666666666544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8e-48  Score=352.83  Aligned_cols=254  Identities=88%  Similarity=1.364  Sum_probs=229.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.||+|++..........+.+.+|+.++++++|||||++++++.+.+..|+|||||.||+|.+.+
T Consensus        40 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l  119 (362)
T 2bdw_A           40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI  119 (362)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHH
Confidence            79999999999999999999999988777777888999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      .....+++.++..++.||+.||.|||++||+||||||+|||++.++++..+||+|||++......               
T Consensus       120 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP  199 (362)
T ss_dssp             TTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCH
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCH
Confidence            88889999999999999999999999999999999999999987766677999999998654321               


Q ss_pred             -----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         146 -----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       146 -----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                                 .+.| +|+++|+|++|.+||.+.+...+...+..+.+.++.+.|..+++++.+++.+||..||.+|||+
T Consensus       200 E~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  279 (362)
T 2bdw_A          200 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA  279 (362)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence                       1123 8999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhh
Q psy2131         214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVST  254 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (328)
                      .++++|||++......+...++...+.+++++..++.+...
T Consensus       280 ~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  320 (362)
T 2bdw_A          280 DQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAI  320 (362)
T ss_dssp             HHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHH
Confidence            99999999988766666667777888888888877766543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-48  Score=350.74  Aligned_cols=209  Identities=39%  Similarity=0.666  Sum_probs=188.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||||++..........+++.+|+++|+.++||||+++++++.+.+.+|+|||||+||+|.+++
T Consensus        26 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l  105 (328)
T 3fe3_A           26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL  105 (328)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHH
Confidence            89999999999999999999999887777777888999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......              
T Consensus       106 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~--------------  168 (328)
T 3fe3_A          106 VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTVGG--------------  168 (328)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTCCGGGSSSC--------------
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC---CCEEEeeccCceecCCCC--------------
Confidence            888899999999999999999999999999999999999999754   459999999985432110              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (328)
T 3fe3_A          169 --------------------------------------------------------------------------------  168 (328)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                   .....+||+.|+|||++.+..| +.++|||||||++|||+||++||.+.+...+...|.++.+..|.
T Consensus       169 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~  235 (328)
T 3fe3_A          169 -------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF  235 (328)
T ss_dssp             -------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             -------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                         0123469999999999999887 47999999999999999999999999999999999999986553

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.5e-48  Score=350.39  Aligned_cols=209  Identities=33%  Similarity=0.574  Sum_probs=184.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||+|+++.... .......+.+|+++|+.++||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus        16 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~   95 (337)
T 1o6l_A           16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH   95 (337)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            8999999999999999999999975422 122356688999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++......             
T Consensus        96 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~-------------  159 (337)
T 1o6l_A           96 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDG-------------  159 (337)
T ss_dssp             HHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTT-------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC---CCEEEeeccchhhcccCC-------------
Confidence            9888899999999999999999999999999999999999999754   469999999985421100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (337)
T 1o6l_A          160 --------------------------------------------------------------------------------  159 (337)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++..|..+.+..|
T Consensus       160 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p  225 (337)
T 1o6l_A          160 -------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP  225 (337)
T ss_dssp             -------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             -------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                         001235699999999999999999999999999999999999999999999999999999887554

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=354.98  Aligned_cols=210  Identities=32%  Similarity=0.531  Sum_probs=182.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+|+.||||+++.... .......+.+|+.+|+.+ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus        34 G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~  113 (353)
T 3txo_A           34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF  113 (353)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            8999999999999999999999976432 123456678999999988 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+......            
T Consensus       114 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---g~ikL~DFG~a~~~~~~~------------  178 (353)
T 3txo_A          114 HIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNG------------  178 (353)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCC--------------
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---CCEEEccccceeecccCC------------
Confidence            99888899999999999999999999999999999999999999754   459999999985421100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       179 --------------------------------------------------------------------------------  178 (353)
T 3txo_A          179 --------------------------------------------------------------------------------  178 (353)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++.+|..+.+..|
T Consensus       179 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  244 (353)
T 3txo_A          179 --------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  244 (353)
T ss_dssp             ---------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                          011234699999999999999999999999999999999999999999999999999999988665


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       245 ~  245 (353)
T 3txo_A          245 T  245 (353)
T ss_dssp             T
T ss_pred             C
Confidence            4

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-47  Score=343.45  Aligned_cols=207  Identities=29%  Similarity=0.592  Sum_probs=183.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||+|+++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        17 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~   96 (318)
T 1fot_A           17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL   96 (318)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHH
Confidence            89999999999999999999999754221 12345678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......              
T Consensus        97 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~Dfg~a~~~~~~--------------  159 (318)
T 1fot_A           97 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPDV--------------  159 (318)
T ss_dssp             HHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSSC--------------
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC---CCEEEeecCcceecCCc--------------
Confidence            9988899999999999999999999999999999999999999754   46999999998543110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (318)
T 1fot_A          160 --------------------------------------------------------------------------------  159 (318)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     ....+||+.|+|||++.+.+|+.++|||||||++|||++|++||.+.+...++.+|..+.+..|+
T Consensus       160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~  224 (318)
T 1fot_A          160 ---------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP  224 (318)
T ss_dssp             ---------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT
T ss_pred             ---------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                           11246999999999999999999999999999999999999999999999999999998876553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.6e-47  Score=346.99  Aligned_cols=209  Identities=29%  Similarity=0.505  Sum_probs=182.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|+++.+|+.||||+++..... ......+.+|..+++.+ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus        28 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~  107 (345)
T 1xjd_A           28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY  107 (345)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            89999999999999999999999754211 12345678899999876 99999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++......            
T Consensus       108 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~------------  172 (345)
T 1xjd_A          108 HIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGD------------  172 (345)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT------------
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC---CCEEEeEChhhhhcccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999985421100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (345)
T 1xjd_A          173 --------------------------------------------------------------------------------  172 (345)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++.+|..+....|
T Consensus       173 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p  238 (345)
T 1xjd_A          173 --------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP  238 (345)
T ss_dssp             --------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          001235699999999999999999999999999999999999999999999999999999876544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-47  Score=348.78  Aligned_cols=210  Identities=32%  Similarity=0.533  Sum_probs=184.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|+++.+|+.||||+++..... ....+.+.+|..+|..+ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus        31 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~  110 (353)
T 2i0e_A           31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY  110 (353)
T ss_dssp             ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence            79999999999999999999999764321 22346678899999988 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......            
T Consensus       111 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~------------  175 (353)
T 2i0e_A          111 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG------------  175 (353)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC---CcEEEEeCCcccccccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999985421100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (353)
T 2i0e_A          176 --------------------------------------------------------------------------------  175 (353)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+.+|+.++|||||||++|||++|++||.+.+..+++++|..+.+..|
T Consensus       176 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  241 (353)
T 2i0e_A          176 --------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  241 (353)
T ss_dssp             --------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          011235699999999999999999999999999999999999999999999999999999887654


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       242 ~  242 (353)
T 2i0e_A          242 K  242 (353)
T ss_dssp             T
T ss_pred             C
Confidence            3

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4e-47  Score=346.54  Aligned_cols=206  Identities=33%  Similarity=0.609  Sum_probs=183.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|+++..... ....+.+.+|+++|+.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        52 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~  131 (350)
T 1rdq_E           52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH  131 (350)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence            89999999999999999999999754321 12346788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......              
T Consensus       132 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFg~a~~~~~~--------------  194 (350)
T 1rdq_E          132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR--------------  194 (350)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC--------------
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC---CCEEEcccccceeccCC--------------
Confidence            9888889999999999999999999999999999999999999754   46999999998643110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       195 --------------------------------------------------------------------------------  194 (350)
T 1rdq_E          195 --------------------------------------------------------------------------------  194 (350)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++.+|..+.+..|
T Consensus       195 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p  258 (350)
T 1rdq_E          195 ---------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP  258 (350)
T ss_dssp             ---------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ---------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                           1124699999999999999999999999999999999999999999999999999999987554

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.1e-47  Score=347.97  Aligned_cols=210  Identities=36%  Similarity=0.634  Sum_probs=176.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARI-CRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+++.||||++++.... ......+.+|..+ ++.++||||+++++++.+.+.+|+|||||+||+|.+
T Consensus        49 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~  128 (373)
T 2r5t_A           49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY  128 (373)
T ss_dssp             CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            89999999999999999999999876543 2344566778877 577899999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++......            
T Consensus       129 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~ikL~DFG~a~~~~~~~------------  193 (373)
T 2r5t_A          129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHN------------  193 (373)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCBCGGGBCCC------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEeeCccccccccCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999986421110            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       194 --------------------------------------------------------------------------------  193 (373)
T 2r5t_A          194 --------------------------------------------------------------------------------  193 (373)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|..+.+..+
T Consensus       194 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~  259 (373)
T 2r5t_A          194 --------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK  259 (373)
T ss_dssp             --------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC
T ss_pred             --------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                          011235799999999999999999999999999999999999999999999999999999987665


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      |
T Consensus       260 ~  260 (373)
T 2r5t_A          260 P  260 (373)
T ss_dssp             S
T ss_pred             C
Confidence            4

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-46  Score=348.42  Aligned_cols=210  Identities=29%  Similarity=0.505  Sum_probs=180.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+++.||+|++++..... ...+.+.+|..+|.++ +|||||+++++|.+.+.+|+|||||+||+|.+
T Consensus        63 G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~  142 (396)
T 4dc2_A           63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF  142 (396)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHH
Confidence            899999999999999999999998765433 3345678899999887 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+......            
T Consensus       143 ~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~------------  207 (396)
T 4dc2_A          143 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPG------------  207 (396)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT------------
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---CCEEEeecceeeecccCC------------
Confidence            99888899999999999999999999999999999999999999754   459999999985421100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       208 --------------------------------------------------------------------------------  207 (396)
T 4dc2_A          208 --------------------------------------------------------------------------------  207 (396)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc---------cHHHHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE---------DQHRLYAQ  309 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---------~~~~~~~~  309 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.         ....+++.
T Consensus       208 --------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~  273 (396)
T 4dc2_A          208 --------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  273 (396)
T ss_dssp             --------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred             --------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence                          0112357999999999999999999999999999999999999999632         35668888


Q ss_pred             HhcccCCCCC
Q psy2131         310 IKAGAYDDEP  319 (328)
Q Consensus       310 i~~~~~~~~~  319 (328)
                      |..+.+..|+
T Consensus       274 i~~~~~~~p~  283 (396)
T 4dc2_A          274 ILEKQIRIPR  283 (396)
T ss_dssp             HHHCCCCCCT
T ss_pred             HhccccCCCC
Confidence            8888875543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-46  Score=340.83  Aligned_cols=209  Identities=30%  Similarity=0.515  Sum_probs=181.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|+++.+|+.||+|+++..... ....+.+.+|+.+++++ +||||+++++++.+.+.+|+|||||+||+|.+
T Consensus        20 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~   99 (345)
T 3a8x_A           20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF   99 (345)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence            89999999999999999999999876543 44567788999999988 89999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++......            
T Consensus       100 ~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFG~a~~~~~~~------------  164 (345)
T 3a8x_A          100 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPG------------  164 (345)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCGGGCBCSCCTT------------
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEEeccccccccCCC------------
Confidence            99888889999999999999999999999999999999999999754   469999999985421100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (345)
T 3a8x_A          165 --------------------------------------------------------------------------------  164 (345)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC---------ccHHHHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD---------EDQHRLYAQ  309 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---------~~~~~~~~~  309 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||++|||++|++||..         .+...+++.
T Consensus       165 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          165 --------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             --------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             --------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence                          001235699999999999999999999999999999999999999976         456678888


Q ss_pred             HhcccCCCC
Q psy2131         310 IKAGAYDDE  318 (328)
Q Consensus       310 i~~~~~~~~  318 (328)
                      |..+.+..|
T Consensus       231 i~~~~~~~p  239 (345)
T 3a8x_A          231 ILEKQIRIP  239 (345)
T ss_dssp             HHHCCCCCC
T ss_pred             HHcCCCCCC
Confidence            888877544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-47  Score=354.68  Aligned_cols=205  Identities=32%  Similarity=0.543  Sum_probs=176.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+++.||+|+++..... ....+.+.+|+.+++.++|||||+++++|.+.+.+|+|||||+||+|.++
T Consensus        80 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~  159 (410)
T 3v8s_A           80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL  159 (410)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            89999999999999999999999753211 11123467899999999999999999999999999999999999999988


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.......            
T Consensus       160 l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFG~a~~~~~~~~------------  223 (410)
T 3v8s_A          160 MSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGM------------  223 (410)
T ss_dssp             HHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSE------------
T ss_pred             HHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC---CCEEEeccceeEeeccCCc------------
Confidence            765 569999999999999999999999999999999999999754   4599999999865422110            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       224 --------------------------------------------------------------------------------  223 (410)
T 3v8s_A          224 --------------------------------------------------------------------------------  223 (410)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC----CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP----YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   ....+.+||+.|+|||++.+.+    |+.++|||||||+||||+||++||.+.+...++.+|..+.
T Consensus       224 -------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          224 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  289 (410)
T ss_dssp             -------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             -------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence                         0112357999999999998776    8899999999999999999999999999999999998875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9e-47  Score=353.23  Aligned_cols=206  Identities=30%  Similarity=0.510  Sum_probs=177.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+++.||+|+++...... .....+.+|+.++..++||||++++++|.+.+.+|+|||||+||+|.++
T Consensus        85 G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~  164 (437)
T 4aw2_A           85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL  164 (437)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHH
T ss_pred             CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHH
Confidence            899999999999999999999997532111 1123377899999999999999999999999999999999999999999


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. .+.+++..++.++.|++.||.|||++|||||||||+|||++.+   +.+||+|||+|+.......           
T Consensus       165 l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~-----------  230 (437)
T 4aw2_A          165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT-----------  230 (437)
T ss_dssp             HHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSC-----------
T ss_pred             HHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC---CCEEEcchhhhhhcccCCC-----------
Confidence            987 4689999999999999999999999999999999999999754   4699999999865422110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       231 --------------------------------------------------------------------------------  230 (437)
T 4aw2_A          231 --------------------------------------------------------------------------------  230 (437)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                    ......+||+.|+|||++.     +..|+.++|||||||+||||+||++||.+.+..+++.+|..+
T Consensus       231 --------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  296 (437)
T 4aw2_A          231 --------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  296 (437)
T ss_dssp             --------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             --------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence                          0011246999999999997     567899999999999999999999999999999999999865


Q ss_pred             c
Q psy2131         314 A  314 (328)
Q Consensus       314 ~  314 (328)
                      .
T Consensus       297 ~  297 (437)
T 4aw2_A          297 K  297 (437)
T ss_dssp             H
T ss_pred             c
Confidence            3

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-45  Score=335.19  Aligned_cols=226  Identities=41%  Similarity=0.707  Sum_probs=200.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH----HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||+|+++.......    ..+.+.+|+.+|++++||||+++++++.+.+.+|+|||||+||+|
T Consensus        23 G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L  102 (361)
T 2yab_A           23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL  102 (361)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcH
Confidence            7999999999999999999999987543321    346788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC-CCcEEEeeccccccccCC----------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLAIEVQGE----------  145 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~-~~~vkl~DfGla~~~~~~----------  145 (328)
                      .+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++......          
T Consensus       103 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  182 (361)
T 2yab_A          103 FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP  182 (361)
T ss_dssp             HHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCG
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCc
Confidence            999988889999999999999999999999999999999999999975432 226999999998654321          


Q ss_pred             ----------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         146 ----------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       146 ----------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                                      .+.| +|+++|+|++|.+||.+.+.......+..+.+.++...+..+++++++||.+||..||.
T Consensus       183 ~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  262 (361)
T 2yab_A          183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR  262 (361)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred             cEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChh
Confidence                            1123 79999999999999999999999999999988888777788999999999999999999


Q ss_pred             CCCCHHHHhcCcccCCcc
Q psy2131         209 KRITASEALKHPWICQRE  226 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~~  226 (328)
                      +|||+.++++|||+....
T Consensus       263 ~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          263 KRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             TSCCHHHHHTSTTTSCSS
T ss_pred             HCcCHHHHhcCcCcCCCc
Confidence            999999999999998543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-45  Score=334.18  Aligned_cols=210  Identities=31%  Similarity=0.569  Sum_probs=175.5

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|++.   .+|+.||+|+++.....  ......+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+
T Consensus        28 G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  107 (327)
T 3a62_A           28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE  107 (327)
T ss_dssp             ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEE
T ss_pred             CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCc
Confidence            799999999985   68999999999865432  2344567889999999999999999999999999999999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......         
T Consensus       108 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~---------  175 (327)
T 3a62_A          108 LFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFGLCKESIHDG---------  175 (327)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---SCEEECCCSCC----------------
T ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC---CcEEEEeCCcccccccCC---------
Confidence            99999888889999999999999999999999999999999999999754   469999999974321000         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (327)
T 3a62_A          176 --------------------------------------------------------------------------------  175 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                       .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++.+|..+.+
T Consensus       176 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  238 (327)
T 3a62_A          176 -----------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL  238 (327)
T ss_dssp             --------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             -----------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence                             001134699999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCC
Q psy2131         316 DDEP  319 (328)
Q Consensus       316 ~~~~  319 (328)
                      ..||
T Consensus       239 ~~p~  242 (327)
T 3a62_A          239 NLPP  242 (327)
T ss_dssp             CCCT
T ss_pred             CCCC
Confidence            6654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.9e-45  Score=323.37  Aligned_cols=238  Identities=89%  Similarity=1.376  Sum_probs=216.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.+.+
T Consensus        17 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~   96 (284)
T 3kk8_A           17 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI   96 (284)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHH
Confidence            79999999999999999999999888777777888999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+|||++.+++...+||+|||++......               
T Consensus        97 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aP  176 (284)
T 3kk8_A           97 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP  176 (284)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCH
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCc
Confidence            88889999999999999999999999999999999999999987766677999999998543221               


Q ss_pred             -----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         146 -----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       146 -----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                                 .+.| +|+++|+|++|..||.+.+.......+..+...++.+.+..+++++.+++.+||..||.+|||+
T Consensus       177 E~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  256 (284)
T 3kk8_A          177 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA  256 (284)
T ss_dssp             HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCH
Confidence                       1122 7999999999999999999999999999999999998889999999999999999999999999


Q ss_pred             HHHhcCcccCCcccchhhhhhhhhH
Q psy2131         214 SEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       214 ~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                      .++++|||+.+.....+..++++.+
T Consensus       257 ~~~l~h~~~~~~~~~~~~~~~~~~~  281 (284)
T 3kk8_A          257 DQALKVPWICNRERVASAIHRQDTV  281 (284)
T ss_dssp             HHHTTSHHHHSCCCGGGSCCCCCCC
T ss_pred             HHHhcCccccCChhHHhHhhcCCCc
Confidence            9999999999888777766666543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=349.83  Aligned_cols=206  Identities=33%  Similarity=0.541  Sum_probs=177.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++++.... ....+.+.+|+.++..++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        72 G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~  151 (412)
T 2vd5_A           72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL  151 (412)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHH
Confidence            89999999999999999999999753221 12234578899999999999999999999999999999999999999999


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +... ..+++..++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+++.......           
T Consensus       152 l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~---g~vkL~DFGla~~~~~~~~-----------  217 (412)
T 2vd5_A          152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRADGT-----------  217 (412)
T ss_dssp             HHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSC-----------
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC---CCEEEeechhheeccCCCc-----------
Confidence            9765 479999999999999999999999999999999999999754   4599999999865422110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       218 --------------------------------------------------------------------------------  217 (412)
T 2vd5_A          218 --------------------------------------------------------------------------------  217 (412)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-------cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                    ......+||+.|+|||++.       +..|+.++|||||||++|||+||++||.+.+..+++.+|.
T Consensus       218 --------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          218 --------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             --------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             --------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                          0011346999999999997       4678999999999999999999999999999999999998


Q ss_pred             ccc
Q psy2131         312 AGA  314 (328)
Q Consensus       312 ~~~  314 (328)
                      .+.
T Consensus       284 ~~~  286 (412)
T 2vd5_A          284 HYK  286 (412)
T ss_dssp             THH
T ss_pred             hcc
Confidence            754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=340.69  Aligned_cols=208  Identities=27%  Similarity=0.466  Sum_probs=178.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+++.||+|++...... ....+.+.+|+++|+.++|||||+++++|.+.+.+|+|||||.||+|.++
T Consensus        26 G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~  105 (384)
T 4fr4_A           26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH  105 (384)
T ss_dssp             CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHH
Confidence            89999999999999999999999754321 22356788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++..+..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||++.......             
T Consensus       106 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~-------------  169 (384)
T 4fr4_A          106 LQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRET-------------  169 (384)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTC-------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC---CCEEEeccceeeeccCCC-------------
Confidence            9888899999999999999999999999999999999999999754   469999999986532110             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (384)
T 4fr4_A          170 --------------------------------------------------------------------------------  169 (384)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCC---ccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~  313 (328)
                                    ...+.+||+.|+|||++.+   ..|+.++|||||||++|||+||++||.+   .+...+...+...
T Consensus       170 --------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~  235 (384)
T 4fr4_A          170 --------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT  235 (384)
T ss_dssp             --------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC
T ss_pred             --------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc
Confidence                          0123569999999999974   5689999999999999999999999984   3466777777776


Q ss_pred             cCCCC
Q psy2131         314 AYDDE  318 (328)
Q Consensus       314 ~~~~~  318 (328)
                      ....|
T Consensus       236 ~~~~p  240 (384)
T 4fr4_A          236 VVTYP  240 (384)
T ss_dssp             CCCCC
T ss_pred             ccCCC
Confidence            66443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-45  Score=325.99  Aligned_cols=207  Identities=31%  Similarity=0.474  Sum_probs=176.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..|+|||||+|++|.++
T Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~  101 (294)
T 4eqm_A           22 GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY  101 (294)
T ss_dssp             ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHH
Confidence            7999999999999999999999976543 344567889999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       102 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~------------  166 (294)
T 4eqm_A          102 IESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKALSETSL------------  166 (294)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCSSSTTC-----------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEEeCCCccccccccc------------
Confidence            9888889999999999999999999999999999999999999754   4699999999854311000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (294)
T 4eqm_A          167 --------------------------------------------------------------------------------  166 (294)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+......++..+..
T Consensus       167 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~  229 (294)
T 4eqm_A          167 -------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV  229 (294)
T ss_dssp             ---------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred             -------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence                         001124599999999999999999999999999999999999999999988777666666554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-45  Score=325.94  Aligned_cols=203  Identities=31%  Similarity=0.541  Sum_probs=176.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||+|++.......  .+.+.+|+.+++.++||||+++++++.+.+..|+|||||+||+|.+.+
T Consensus        31 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  108 (297)
T 3fxz_A           31 GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  108 (297)
T ss_dssp             ETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHH
Confidence            799999999999999999999997654332  356789999999999999999999999999999999999999999888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........             
T Consensus       109 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-------------  171 (297)
T 3fxz_A          109 TE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQS-------------  171 (297)
T ss_dssp             HH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSTTC-------------
T ss_pred             hh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---CCEEEeeCCCceecCCccc-------------
Confidence            65 469999999999999999999999999999999999999754   4599999999865422110             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (297)
T 3fxz_A          172 --------------------------------------------------------------------------------  171 (297)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.++......+.....
T Consensus       172 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  233 (297)
T 3fxz_A          172 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (297)
T ss_dssp             -------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             -------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence                         01124699999999999999999999999999999999999999999988777777665543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-45  Score=330.96  Aligned_cols=208  Identities=38%  Similarity=0.667  Sum_probs=163.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.++.+|+.||||++...     ....+.+|+.+++.+. ||||+++++++.+....|+|||||+||+|.+.
T Consensus        22 G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (325)
T 3kn6_A           22 GSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER   96 (325)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence            89999999999999999999999643     3456778999999997 99999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++........            
T Consensus        97 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~------------  164 (325)
T 3kn6_A           97 IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ------------  164 (325)
T ss_dssp             HHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC------------
Confidence            99888999999999999999999999999999999999999998766556799999999864321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (325)
T 3kn6_A          165 --------------------------------------------------------------------------------  164 (325)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-------HHHHHHHHhc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKA  312 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~  312 (328)
                                    ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+       ..+++..|..
T Consensus       165 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          165 --------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             ---------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             --------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence                          0112358999999999999999999999999999999999999998754       4688899999


Q ss_pred             ccCCCCC
Q psy2131         313 GAYDDEP  319 (328)
Q Consensus       313 ~~~~~~~  319 (328)
                      |.+..++
T Consensus       231 ~~~~~~~  237 (325)
T 3kn6_A          231 GDFSFEG  237 (325)
T ss_dssp             TCCCCCS
T ss_pred             CCCCCCc
Confidence            9886554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-45  Score=333.16  Aligned_cols=253  Identities=46%  Similarity=0.823  Sum_probs=206.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|+++.+|+.||||++.....   .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.
T Consensus        35 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~  114 (351)
T 3c0i_A           35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC  114 (351)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHH
Confidence            8999999999999999999999964321   1113467889999999999999999999999999999999999999998


Q ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------
Q psy2131          78 EDIVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------  146 (328)
Q Consensus        78 ~~l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------  146 (328)
                      +.+...    ..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++.......       
T Consensus       115 ~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  194 (351)
T 3c0i_A          115 FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV  194 (351)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCC
T ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCc
Confidence            877543    358999999999999999999999999999999999999877666679999999986542210       


Q ss_pred             --------------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhccc
Q psy2131         147 --------------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       147 --------------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  205 (328)
                                          +.| +|+++|+|++|.+||.+.. ......+..+.+..+...+..+++++.+++.+||..
T Consensus       195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  273 (351)
T 3c0i_A          195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML  273 (351)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred             CCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCC
Confidence                                112 7999999999999998754 456677777777776666778999999999999999


Q ss_pred             CCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhh
Q psy2131         206 NPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVST  254 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (328)
                      ||.+|||+.++++|||+................+.+++++..++.+...
T Consensus       274 dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  322 (351)
T 3c0i_A          274 DPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAV  322 (351)
T ss_dssp             STTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-----
T ss_pred             ChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999977554333333344556677777776665443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-45  Score=363.09  Aligned_cols=210  Identities=32%  Similarity=0.536  Sum_probs=184.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|+++.+++.||||+++.... .....+.+.+|..+|..+ +||||+++++++++.+.+|||||||+||+|.+
T Consensus       352 G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~  431 (674)
T 3pfq_A          352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY  431 (674)
T ss_dssp             TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHH
Confidence            8999999999999999999999975422 122345678899999987 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++...+.+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+......            
T Consensus       432 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~------------  496 (674)
T 3pfq_A          432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG------------  496 (674)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---SCEEECCCTTCEECCCTT------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---CcEEEeecceeeccccCC------------
Confidence            99988899999999999999999999999999999999999999755   459999999986431110            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       497 --------------------------------------------------------------------------------  496 (674)
T 3pfq_A          497 --------------------------------------------------------------------------------  496 (674)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+.+|+.++|||||||+||||+||++||.+.+..+++++|..+.+..|
T Consensus       497 --------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p  562 (674)
T 3pfq_A          497 --------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  562 (674)
T ss_dssp             --------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC
T ss_pred             --------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          011235799999999999999999999999999999999999999999999999999999988655


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       563 ~  563 (674)
T 3pfq_A          563 K  563 (674)
T ss_dssp             T
T ss_pred             c
Confidence            3

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-45  Score=347.28  Aligned_cols=209  Identities=33%  Similarity=0.572  Sum_probs=174.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus       159 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~  238 (446)
T 4ejn_A          159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH  238 (446)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHH
T ss_pred             CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHH
Confidence            8999999999999999999999975432 233456678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.....+++..+..++.|++.||.|||+ +|||||||||+|||++.+   +.+||+|||+|.......            
T Consensus       239 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~------------  303 (446)
T 4ejn_A          239 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDG------------  303 (446)
T ss_dssp             HHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---SCEEECCCCCCCTTCC--------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---CCEEEccCCCceeccCCC------------
Confidence            9888899999999999999999999998 999999999999999754   469999999985321100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       304 --------------------------------------------------------------------------------  303 (446)
T 4ejn_A          304 --------------------------------------------------------------------------------  303 (446)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+...++..|..+.+..|
T Consensus       304 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p  369 (446)
T 4ejn_A          304 --------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  369 (446)
T ss_dssp             -----------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          001235699999999999999999999999999999999999999999999999999998887544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-46  Score=338.22  Aligned_cols=208  Identities=36%  Similarity=0.632  Sum_probs=179.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||+|++........ ....+.+|+.+++.++||||+++++++.+.+..|+||||+ +|+|.+.
T Consensus        20 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~   98 (336)
T 3h4j_B           20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDY   98 (336)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHH
Confidence            8999999999999999999999975432211 2356889999999999999999999999999999999999 7899999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        99 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~DFG~s~~~~~~~-------------  162 (336)
T 3h4j_B           99 IVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN---LNVKIADFGLSNIMTDGN-------------  162 (336)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT---CCEEECCSSCTBTTTTSB-------------
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC---CCEEEEEeccceeccCCc-------------
Confidence            9888899999999999999999999999999999999999999754   469999999975432110             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (336)
T 3h4j_B          163 --------------------------------------------------------------------------------  162 (336)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+...++.++..+.+..|
T Consensus       163 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p  228 (336)
T 3h4j_B          163 --------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP  228 (336)
T ss_dssp             --------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC
T ss_pred             --------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc
Confidence                          0112459999999999999887 7899999999999999999999999988888888888877544


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       229 ~  229 (336)
T 3h4j_B          229 D  229 (336)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.8e-45  Score=348.99  Aligned_cols=209  Identities=33%  Similarity=0.545  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|+++...... ...+.+.+|+++|++++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus       196 G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~  275 (543)
T 3c4z_A          196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYH  275 (543)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHH
Confidence            899999999999999999999997543221 2346688999999999999999999999999999999999999999998


Q ss_pred             HHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +...    ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++........        
T Consensus       276 l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~---g~vkL~DFGla~~~~~~~~--------  344 (543)
T 3c4z_A          276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQT--------  344 (543)
T ss_dssp             HHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCTTCC--------
T ss_pred             HHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC---CCEEEeecceeeeccCCCc--------
Confidence            8763    369999999999999999999999999999999999999754   4699999999865422100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       345 --------------------------------------------------------------------------------  344 (543)
T 3c4z_A          345 --------------------------------------------------------------------------------  344 (543)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc----cHHHHHHHHh
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIK  311 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~i~  311 (328)
                                        .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.    +...+.+.|.
T Consensus       345 ------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~  406 (543)
T 3c4z_A          345 ------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL  406 (543)
T ss_dssp             ------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred             ------------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence                              011246999999999999999999999999999999999999999886    4578888888


Q ss_pred             cccCCCC
Q psy2131         312 AGAYDDE  318 (328)
Q Consensus       312 ~~~~~~~  318 (328)
                      .+....|
T Consensus       407 ~~~~~~p  413 (543)
T 3c4z_A          407 EQAVTYP  413 (543)
T ss_dssp             HCCCCCC
T ss_pred             hcccCCC
Confidence            8876544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-44  Score=342.89  Aligned_cols=225  Identities=42%  Similarity=0.796  Sum_probs=203.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.||||++............+.+|+++|++++|||||++++++.+.+.+|+|||||.||+|.+.+
T Consensus        33 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  112 (486)
T 3mwu_A           33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI  112 (486)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHH
Confidence            89999999999999999999999754333334567889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+|||++..+..+.+||+|||++......               
T Consensus       113 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP  192 (486)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCG
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCH
Confidence            88889999999999999999999999999999999999999987666678999999998643211               


Q ss_pred             ----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         146 ----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       146 ----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                                .+.| +|+++|+|++|.+||.+.+.......+..+.+.++.+.|..+|+++++|+.+||..||.+|||+.
T Consensus       193 E~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~  272 (486)
T 3mwu_A          193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT  272 (486)
T ss_dssp             GGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence                      1123 89999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             HHhcCcccCCc
Q psy2131         215 EALKHPWICQR  225 (328)
Q Consensus       215 ~~l~h~~~~~~  225 (328)
                      ++++|||+...
T Consensus       273 ~~l~hp~~~~~  283 (486)
T 3mwu_A          273 QCLEHPWIQKY  283 (486)
T ss_dssp             HHHHCHHHHHT
T ss_pred             HHhcCHhhccC
Confidence            99999999654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-45  Score=347.27  Aligned_cols=208  Identities=38%  Similarity=0.638  Sum_probs=183.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+|+.||||+++...... +....+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+|.++
T Consensus        27 G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~  106 (476)
T 2y94_A           27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDY  106 (476)
T ss_dssp             CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            899999999999999999999997543221 2346788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus       107 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~---~~vkL~DFG~a~~~~~~~-------------  170 (476)
T 2y94_A          107 ICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMMSDGE-------------  170 (476)
T ss_dssp             TTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT---CCEEECCCSSCEECCTTC-------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC---CCeEEEeccchhhccccc-------------
Confidence            9888889999999999999999999999999999999999999754   459999999986532110             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (476)
T 2y94_A          171 --------------------------------------------------------------------------------  170 (476)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    .....+||+.|+|||++.+..| +.++|||||||++|||++|++||.+.+...++.+|..+.+..|
T Consensus       171 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p  236 (476)
T 2y94_A          171 --------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP  236 (476)
T ss_dssp             --------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC
T ss_pred             --------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence                          0112469999999999999877 7899999999999999999999999999999999999988544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=332.71  Aligned_cols=209  Identities=36%  Similarity=0.623  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||+|+++...  ....+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+.+
T Consensus       100 G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l  177 (373)
T 2x4f_A          100 GRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI  177 (373)
T ss_dssp             ----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHH
T ss_pred             CcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence            899999999999999999999998643  345567899999999999999999999999999999999999999999888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||++||+||||||+|||+..+. .+.+||+|||++........            
T Consensus       178 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~~~~~~------------  244 (373)
T 2x4f_A          178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRYKPREK------------  244 (373)
T ss_dssp             HHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEECCTTCB------------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceecCCccc------------
Confidence            654 4699999999999999999999999999999999999996533 35799999999865422100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       245 --------------------------------------------------------------------------------  244 (373)
T 2x4f_A          245 --------------------------------------------------------------------------------  244 (373)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...++..|..+.+..++
T Consensus       245 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  309 (373)
T 2x4f_A          245 ---------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED  309 (373)
T ss_dssp             ---------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS
T ss_pred             ---------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh
Confidence                           01235899999999999999999999999999999999999999999999999999998876654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-44  Score=342.12  Aligned_cols=224  Identities=43%  Similarity=0.768  Sum_probs=199.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.++..||+|++............+.+|+.+|+.++|||||++++++.+....|+|||||.||+|.+.+
T Consensus        48 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~  127 (494)
T 3lij_A           48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI  127 (494)
T ss_dssp             C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence            89999999999999999999999876555445667889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      .....+++.++..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++......               
T Consensus       128 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aP  207 (494)
T 3lij_A          128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP  207 (494)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCH
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCH
Confidence            88889999999999999999999999999999999999999987666677999999998654221               


Q ss_pred             ----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         146 ----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       146 ----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                                .+.| +|+++|+|++|.+||.+.+.......+..+.+.++.+.|..+|+++++|+.+||..||.+|||+.
T Consensus       208 E~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~  287 (494)
T 3lij_A          208 EVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ  287 (494)
T ss_dssp             HHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHH
Confidence                      1123 79999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCcccCC
Q psy2131         215 EALKHPWICQ  224 (328)
Q Consensus       215 ~~l~h~~~~~  224 (328)
                      ++++|||+.+
T Consensus       288 e~l~hp~~~~  297 (494)
T 3lij_A          288 QALEHPWIKE  297 (494)
T ss_dssp             HHHTCHHHHH
T ss_pred             HHhcCccccc
Confidence            9999999965

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=334.21  Aligned_cols=219  Identities=24%  Similarity=0.369  Sum_probs=185.6

Q ss_pred             CCceEEEEEE-----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCV-----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~-----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.     +..+++.||||+++.. ........+.+|+.++++++|||||++++++.+....|+|||||+||+
T Consensus        82 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~  160 (367)
T 3l9p_A           82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD  160 (367)
T ss_dssp             CSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred             CCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCC
Confidence            8999999999     5567889999999743 344556678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          76 LFEDIVARE-------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        76 L~~~l~~~~-------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      |.+++....       .+++.++..++.|++.||.|||++||+||||||+|||++.++++..+||+|||+++....... 
T Consensus       161 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-  239 (367)
T 3l9p_A          161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-  239 (367)
T ss_dssp             HHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-
T ss_pred             HHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-
Confidence            999987643       489999999999999999999999999999999999998776667799999999753210000 


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       240 --------------------------------------------------------------------------------  239 (367)
T 3l9p_A          240 --------------------------------------------------------------------------------  239 (367)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~  307 (328)
                                             ........||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+...+.
T Consensus       240 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          240 -----------------------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             -----------------------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             -----------------------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                                   001112458999999999999999999999999999999998 99999999999999


Q ss_pred             HHHhcccCCCCCCcccc
Q psy2131         308 AQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       308 ~~i~~~~~~~~~~~~~~  324 (328)
                      ..+..+....+|..++.
T Consensus       297 ~~i~~~~~~~~~~~~~~  313 (367)
T 3l9p_A          297 EFVTSGGRMDPPKNCPG  313 (367)
T ss_dssp             HHHHTTCCCCCCTTCCH
T ss_pred             HHHHcCCCCCCCccCCH
Confidence            99999987777766553

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-44  Score=341.87  Aligned_cols=204  Identities=25%  Similarity=0.347  Sum_probs=172.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+|+.||||++..........+++.+|+.+|+.++|||||++++++...      ..+|+|||||+++
T Consensus        73 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~  152 (464)
T 3ttj_A           73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN  152 (464)
T ss_dssp             CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC
Confidence            8999999999999999999999987665666778889999999999999999999999654      4679999999874


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                       |.+.+.  ..+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+|+......        
T Consensus       153 -l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~--------  218 (464)
T 3ttj_A          153 -LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  218 (464)
T ss_dssp             -HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCCC-----CC--------
T ss_pred             -HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC---CCEEEEEEEeeeecCCCc--------
Confidence             666553  349999999999999999999999999999999999999754   469999999985421100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       219 --------------------------------------------------------------------------------  218 (464)
T 3ttj_A          219 --------------------------------------------------------------------------------  218 (464)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                         .....+||+.|+|||++.+.+|+.++|||||||+||||++|++||.+.+...++.+|.+..
T Consensus       219 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l  279 (464)
T 3ttj_A          219 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  279 (464)
T ss_dssp             -------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             -------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence                               0112469999999999999999999999999999999999999999999999999887755


Q ss_pred             CCC
Q psy2131         315 YDD  317 (328)
Q Consensus       315 ~~~  317 (328)
                      -.+
T Consensus       280 g~p  282 (464)
T 3ttj_A          280 GTP  282 (464)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-44  Score=334.68  Aligned_cols=205  Identities=38%  Similarity=0.608  Sum_probs=170.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHH-hCCCCCcceeEEEEEe----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~-~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+++.+|+.||||+++..       ..+.+|+.++. ..+||||++++++|..    ...+|+|||||+||+
T Consensus        73 G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~  145 (400)
T 1nxk_A           73 GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE  145 (400)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEE
T ss_pred             ccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCc
Confidence            79999999999999999999999632       34567888874 4589999999999876    667999999999999


Q ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          76 LFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        76 L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      |.+++....  .+++.++..++.||+.||.|||++|||||||||+|||++..+.++.+||+|||+++......       
T Consensus       146 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-------  218 (400)
T 1nxk_A          146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------  218 (400)
T ss_dssp             HHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----------
T ss_pred             HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-------
Confidence            999997653  59999999999999999999999999999999999999875556789999999986432100       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       219 --------------------------------------------------------------------------------  218 (400)
T 1nxk_A          219 --------------------------------------------------------------------------------  218 (400)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH----HHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQ  309 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~  309 (328)
                                          .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+...    ....
T Consensus       219 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  278 (400)
T 1nxk_A          219 --------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  278 (400)
T ss_dssp             ----------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred             --------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence                                0112458999999999999999999999999999999999999998876433    6677


Q ss_pred             HhcccCCCCC
Q psy2131         310 IKAGAYDDEP  319 (328)
Q Consensus       310 i~~~~~~~~~  319 (328)
                      |..+.+..+.
T Consensus       279 i~~~~~~~~~  288 (400)
T 1nxk_A          279 IRMGQYEFPN  288 (400)
T ss_dssp             HHHTCCCCCT
T ss_pred             HHcCcccCCC
Confidence            8888887654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=320.01  Aligned_cols=226  Identities=36%  Similarity=0.694  Sum_probs=199.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.++.+|+.||+|+++......    ...+.+.+|+.+|++++||||+++++++.+.+..|+|||||+||+|
T Consensus        22 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  101 (326)
T 2y0a_A           22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL  101 (326)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCH
Confidence            899999999999999999999998654322    1356788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC-CCCcEEEeeccccccccCC----------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLAIEVQGE----------  145 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~-~~~~vkl~DfGla~~~~~~----------  145 (328)
                      .+++.....+++.++..++.|++.||.|||++||+||||||+|||++.++ ....+||+|||++......          
T Consensus       102 ~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  181 (326)
T 2y0a_A          102 FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP  181 (326)
T ss_dssp             HHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCT
T ss_pred             HHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCc
Confidence            99998888899999999999999999999999999999999999997654 2236999999998654211          


Q ss_pred             ----------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         146 ----------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       146 ----------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                                      .+.| +|+++|+|++|.+||.+.+.......+......++...+...++.+.+++.+||..||.
T Consensus       182 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  261 (326)
T 2y0a_A          182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK  261 (326)
T ss_dssp             TTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGG
T ss_pred             CcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChh
Confidence                            1123 89999999999999999998888888888877777666678899999999999999999


Q ss_pred             CCCCHHHHhcCcccCCcc
Q psy2131         209 KRITASEALKHPWICQRE  226 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~~  226 (328)
                      +|||+.++++|||+....
T Consensus       262 ~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          262 KRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             GSCCHHHHHHSTTTSCCS
T ss_pred             hCCCHHHHhcCCCccCCc
Confidence            999999999999998654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-44  Score=334.40  Aligned_cols=212  Identities=22%  Similarity=0.300  Sum_probs=177.8

Q ss_pred             CceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHH
Q psy2131           2 AFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIV   81 (328)
Q Consensus         2 ~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~   81 (328)
                      +||+||+|+++.+|+.||||+++.........+.+.+|+.+++.++|||||++++++.+.+.+|+|||||+||+|.+++.
T Consensus        39 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (389)
T 3gni_B           39 DLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC  118 (389)
T ss_dssp             TTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred             CceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHh
Confidence            89999999999999999999998877777777888999999999999999999999999999999999999999999987


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          82 AR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        82 ~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ..  ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..........          
T Consensus       119 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~---~~~kl~dfg~~~~~~~~~~~~----------  185 (389)
T 3gni_B          119 THFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMISHGQRQ----------  185 (389)
T ss_dssp             HTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCGGGCEECEETTEEC----------
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccccceeeccccccc----------
Confidence            65  679999999999999999999999999999999999999754   469999999976542211000          


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (389)
T 3gni_B          186 --------------------------------------------------------------------------------  185 (389)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                               ...........||+.|+|||++.+  ..|+.++|||||||++|||++|++||.+.+.......+..+..
T Consensus       186 ---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          186 ---------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             ---------SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ---------cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence                     000000112368999999999988  6899999999999999999999999999887777776666554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.3e-44  Score=320.61  Aligned_cols=201  Identities=28%  Similarity=0.463  Sum_probs=170.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+  +|+.||+|++..........+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+++
T Consensus        48 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  125 (309)
T 3p86_A           48 GSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL  125 (309)
T ss_dssp             CSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHH
Confidence            89999999976  6889999999887777777788999999999999999999999999999999999999999999988


Q ss_pred             HhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          81 VAREF---YSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        81 ~~~~~---~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .....   +++..+..++.|++.||.|||++|  |+||||||+|||++.+   +.+||+|||++.......         
T Consensus       126 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~~~---------  193 (309)
T 3p86_A          126 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK---YTVKVCDFGLSRLKASTF---------  193 (309)
T ss_dssp             HSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT---CCEEECCCC------------------
T ss_pred             hhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC---CcEEECCCCCCccccccc---------
Confidence            76543   999999999999999999999999  9999999999999754   469999999974321000         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       194 --------------------------------------------------------------------------------  193 (309)
T 3p86_A          194 --------------------------------------------------------------------------------  193 (309)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+...+..
T Consensus       194 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  253 (309)
T 3p86_A          194 -----------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF  253 (309)
T ss_dssp             -------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred             -----------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence                             001124589999999999999999999999999999999999999999998888887753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-44  Score=330.52  Aligned_cols=216  Identities=23%  Similarity=0.415  Sum_probs=183.5

Q ss_pred             CCceEEEEEEEc-------cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQK-------ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~-------~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.+.       .++..||+|+++.. ......+.+.+|+.+|+++ +||||+++++++.+.+.+|+|||||+
T Consensus        92 G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  170 (370)
T 2psq_A           92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  170 (370)
T ss_dssp             CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             CCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            899999999875       35567999999764 3455667899999999999 89999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      ||+|.+++....                .+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DF  247 (370)
T 2psq_A          171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADF  247 (370)
T ss_dssp             TCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCC
T ss_pred             CCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC---CCEEEccc
Confidence            999999987643                47899999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       248 G~a~~~~~~~~~--------------------------------------------------------------------  259 (370)
T 2psq_A          248 GLARDINNIDYY--------------------------------------------------------------------  259 (370)
T ss_dssp             SSCEETTCCCTT--------------------------------------------------------------------
T ss_pred             cCCcccCcccce--------------------------------------------------------------------
Confidence            998654221100                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......||+.|+|||++.+..|+.++|||||||++|||+| |+
T Consensus       260 ------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          260 ------------------------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             ------------------------------------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ------------------------------------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence                                                00112347899999999999999999999999999999999 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCcccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      .||.+.+..+++..+..+.....|..++.
T Consensus       304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (370)
T 2psq_A          304 SPYPGIPVEELFKLLKEGHRMDKPANCTN  332 (370)
T ss_dssp             CSSTTCCGGGHHHHHHTTCCCCCCTTSCH
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            99999999999999999987666665543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.6e-44  Score=317.54  Aligned_cols=205  Identities=28%  Similarity=0.369  Sum_probs=173.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||+|+++...........+.+|+.++++++||||+++++++.+.+..|+|||||++ +|.+.+
T Consensus        13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~   91 (292)
T 3o0g_A           13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF   91 (292)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHH
T ss_pred             CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHH
Confidence            8999999999999999999999987766555667788999999999999999999999999999999999986 555555


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. .+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        92 ~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~------------  156 (292)
T 3o0g_A           92 DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVR------------  156 (292)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCSCCS------------
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecCCccc------------
Confidence            44 5789999999999999999999999999999999999999754   4599999999865421100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (292)
T 3o0g_A          157 --------------------------------------------------------------------------------  156 (292)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCC-CCCccHHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~P-f~~~~~~~~~~~i~~~~~  315 (328)
                                    ......||+.|+|||++.+.. |+.++|||||||++|||+||..| |.+.+....+..+.+...
T Consensus       157 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~  220 (292)
T 3o0g_A          157 --------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             --------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             --------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence                          011235899999999998766 79999999999999999988777 666677788888766443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-43  Score=337.50  Aligned_cols=224  Identities=43%  Similarity=0.789  Sum_probs=203.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+.+..|+|||||.||+|.+.
T Consensus        37 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (484)
T 3nyv_A           37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE  116 (484)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHH
Confidence            79999999999999999999999766543 33457789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC--------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE--------------  145 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~--------------  145 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++..+.++.+||+|||++......              
T Consensus       117 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a  196 (484)
T 3nyv_A          117 IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA  196 (484)
T ss_dssp             HHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCC
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccC
Confidence            998889999999999999999999999999999999999999976656678999999998654321              


Q ss_pred             -----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         146 -----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       146 -----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                                 .+.| +|+++|+|++|.+||.+.+.......+..+.+.++.+.|..+|+++++|+.+||..||.+|||+
T Consensus       197 PE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~  276 (484)
T 3nyv_A          197 PEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA  276 (484)
T ss_dssp             HHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence                       1223 7999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             HHHhcCcccCC
Q psy2131         214 SEALKHPWICQ  224 (328)
Q Consensus       214 ~~~l~h~~~~~  224 (328)
                      .++++|||+..
T Consensus       277 ~e~l~h~~~~~  287 (484)
T 3nyv_A          277 RDALDHEWIQT  287 (484)
T ss_dssp             HHHHTSHHHHH
T ss_pred             HHHhhChhhcc
Confidence            99999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-44  Score=347.21  Aligned_cols=208  Identities=31%  Similarity=0.493  Sum_probs=178.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|+++.+|+.||+|++...... ......+.+|+++|+.++|||||++++++.+.+.+|+|||||+||+|.++
T Consensus       195 G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~  274 (576)
T 2acx_A          195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH  274 (576)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHH
Confidence            89999999999999999999999754321 12345678999999999999999999999999999999999999999998


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...+  .+++..+..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||++.......           
T Consensus       275 l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~---g~vKL~DFGla~~~~~~~-----------  340 (576)
T 2acx_A          275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQ-----------  340 (576)
T ss_dssp             HHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCTTC-----------
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC---CCeEEEecccceecccCc-----------
Confidence            87654  39999999999999999999999999999999999999754   469999999986542110           


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       341 --------------------------------------------------------------------------------  340 (576)
T 2acx_A          341 --------------------------------------------------------------------------------  340 (576)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc----cHHHHHHHHhcc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIKAG  313 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~  313 (328)
                                      ...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.    +...+...|...
T Consensus       341 ----------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~  404 (576)
T 2acx_A          341 ----------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV  404 (576)
T ss_dssp             ----------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred             ----------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc
Confidence                            011246999999999999999999999999999999999999999986    357788888777


Q ss_pred             cCCCC
Q psy2131         314 AYDDE  318 (328)
Q Consensus       314 ~~~~~  318 (328)
                      ....+
T Consensus       405 ~~~~p  409 (576)
T 2acx_A          405 PEEYS  409 (576)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            65443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9e-45  Score=325.71  Aligned_cols=211  Identities=27%  Similarity=0.439  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~   75 (328)
                      |+||.||+|++..+++.||+|+++..... ......+.+|+.++++++||||+++++++....    ..|+|||||+|++
T Consensus        23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~  102 (311)
T 3ork_A           23 GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT  102 (311)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEE
T ss_pred             CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCC
Confidence            89999999999999999999999876443 344567899999999999999999999987654    3599999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       103 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~-------  172 (311)
T 3ork_A          103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNS-------  172 (311)
T ss_dssp             HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT---SCEEECCCSCC----------------
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC---CCEEEeeccCcccccccccc-------
Confidence            99999888889999999999999999999999999999999999999754   45999999998543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (311)
T 3ork_A          173 --------------------------------------------------------------------------------  172 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      ........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+...+..+..
T Consensus       173 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~  236 (311)
T 3ork_A          173 ----------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  236 (311)
T ss_dssp             -------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             ----------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence                            0011124599999999999999999999999999999999999999999998888777777665


Q ss_pred             CC
Q psy2131         316 DD  317 (328)
Q Consensus       316 ~~  317 (328)
                      .+
T Consensus       237 ~~  238 (311)
T 3ork_A          237 IP  238 (311)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=320.40  Aligned_cols=209  Identities=33%  Similarity=0.594  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH------------------------HHHHHHHHHHHHHHhCCCCCcceeEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA------------------------RDFQKLEREARICRKLQHPNIVRLHD   56 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~------------------------~~~~~~~~E~~il~~l~H~nIv~l~~   56 (328)
                      |+||.||+|++..+|+.||||++.......                        ...+.+.+|+++|++++||||+++++
T Consensus        24 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  103 (298)
T 2zv2_A           24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVE  103 (298)
T ss_dssp             --CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            899999999999999999999997654321                        12356889999999999999999999


Q ss_pred             EEEe--CCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEe
Q psy2131          57 SIQE--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA  134 (328)
Q Consensus        57 ~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~  134 (328)
                      ++.+  .+..|+|||||++++|.+.+ ....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+
T Consensus       104 ~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~  179 (298)
T 2zv2_A          104 VLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKIA  179 (298)
T ss_dssp             EEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEEC
T ss_pred             EEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CCEEEe
Confidence            9987  67899999999999997754 44679999999999999999999999999999999999999754   469999


Q ss_pred             eccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         135 DFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       135 DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                      |||++........                                                                   
T Consensus       180 Dfg~~~~~~~~~~-------------------------------------------------------------------  192 (298)
T 2zv2_A          180 DFGVSNEFKGSDA-------------------------------------------------------------------  192 (298)
T ss_dssp             CCTTCEECSSSSC-------------------------------------------------------------------
T ss_pred             cCCCccccccccc-------------------------------------------------------------------
Confidence            9999865422110                                                                   


Q ss_pred             HHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC---CCCCcchhhhhhHHHHH
Q psy2131         215 EALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP---YGKPVDIWACGVILYIL  291 (328)
Q Consensus       215 ~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DvwSlGvilyel  291 (328)
                                                             ......||+.|+|||++.+..   ++.++|||||||++|||
T Consensus       193 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l  233 (298)
T 2zv2_A          193 ---------------------------------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF  233 (298)
T ss_dssp             ---------------------------------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred             ---------------------------------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence                                                   011235899999999998765   37889999999999999


Q ss_pred             HhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         292 LVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       292 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ++|+.||.+.+...+...+..+....+.
T Consensus       234 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~  261 (298)
T 2zv2_A          234 VFGQCPFMDERIMCLHSKIKSQALEFPD  261 (298)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             HHCCCCCCCccHHHHHHHHhcccCCCCC
Confidence            9999999999999999999888776543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=319.79  Aligned_cols=222  Identities=28%  Similarity=0.598  Sum_probs=198.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+++.||+|++...   ......+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+|.+.+
T Consensus        16 G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l   92 (321)
T 1tki_A           16 GEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI   92 (321)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHH
Confidence            89999999999999999999999743   334566889999999999999999999999999999999999999999998


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------------
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------  146 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------------  146 (328)
                      .... .+++.++..++.|++.||.|||++||+||||||+|||++.+. ++.+||+|||++.......             
T Consensus        93 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a  171 (321)
T 1tki_A           93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA  171 (321)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCTTCEEEEEESCGGGSC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECCCCCccccccCChhhcC
Confidence            7654 699999999999999999999999999999999999997532 4679999999986543211             


Q ss_pred             -------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         147 -------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       147 -------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                   +.| +|+++|+|++|.+||.+.+.......+..+.+.++...+..+|+++.+++.+||..||.+|||
T Consensus       172 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt  251 (321)
T 1tki_A          172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             cHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC
Confidence                         122 799999999999999999999999999998888887777889999999999999999999999


Q ss_pred             HHHHhcCcccCCcc
Q psy2131         213 ASEALKHPWICQRE  226 (328)
Q Consensus       213 ~~~~l~h~~~~~~~  226 (328)
                      +.|+++|||+.+..
T Consensus       252 ~~e~l~hp~~~~~~  265 (321)
T 1tki_A          252 ASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHSHHHHSCG
T ss_pred             HHHHhcChhhccCc
Confidence            99999999997653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-44  Score=328.27  Aligned_cols=209  Identities=35%  Similarity=0.576  Sum_probs=171.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+.+|+|||||+||+|.+.+
T Consensus        31 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  107 (361)
T 3uc3_A           31 GNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI  107 (361)
T ss_dssp             STTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHH
Confidence            899999999999999999999997654322   45678999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++.....               
T Consensus       108 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~---------------  171 (361)
T 3uc3_A          108 CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH---------------  171 (361)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC---------------------
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCcccccccc---------------
Confidence            8888899999999999999999999999999999999999997543 245999999997421100               


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (361)
T 3uc3_A          172 --------------------------------------------------------------------------------  171 (361)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCC-cchhhhhhHHHHHHhcCCCCCCcc----HHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKP-VDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~  315 (328)
                                  .......||+.|+|||++.+..|+.+ +|||||||++|||++|++||.+.+    ...+.+.+....+
T Consensus       172 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          172 ------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             ---------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             ------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence                        00112359999999999999888655 999999999999999999999854    3566777777777


Q ss_pred             CCCCC
Q psy2131         316 DDEPK  320 (328)
Q Consensus       316 ~~~~~  320 (328)
                      ..|+.
T Consensus       240 ~~~~~  244 (361)
T 3uc3_A          240 SIPDD  244 (361)
T ss_dssp             CCCTT
T ss_pred             CCCCc
Confidence            66554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.4e-44  Score=323.78  Aligned_cols=208  Identities=27%  Similarity=0.342  Sum_probs=171.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||||+++...........+.+|++++++++||||+++++++.+.+..|+|||||+| +|.+++
T Consensus        45 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~  123 (329)
T 3gbz_A           45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM  123 (329)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHH
T ss_pred             cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHH
Confidence            8999999999999999999999987655554556678999999999999999999999999999999999985 999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .....+++.++..++.||+.||.|||++||+||||||+|||++.++  ....+||+|||++.......            
T Consensus       124 ~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~------------  191 (329)
T 3gbz_A          124 DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI------------  191 (329)
T ss_dssp             HHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---------------
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc------------
Confidence            8888899999999999999999999999999999999999996542  34569999999975431100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       192 --------------------------------------------------------------------------------  191 (329)
T 3gbz_A          192 --------------------------------------------------------------------------------  191 (329)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                    .......||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+....+..+....-
T Consensus       192 --------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          192 --------------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ----------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             --------------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence                          001123589999999999875 589999999999999999999999999998888888876544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-44  Score=330.22  Aligned_cols=222  Identities=30%  Similarity=0.466  Sum_probs=170.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--EEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEEN--YHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~--~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++...+  .+|+|||||++ +|.
T Consensus        20 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~   98 (388)
T 3oz6_A           20 GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLH   98 (388)
T ss_dssp             ----CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHH
Confidence            89999999999999999999999876666777788899999999997 999999999998554  79999999984 887


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+|+.........        
T Consensus        99 ~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~--------  166 (388)
T 3oz6_A           99 AVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVT--------  166 (388)
T ss_dssp             HHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEESSSCCCCC--------
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC---CCEEecCCccccccccccccc--------
Confidence            77765 579999999999999999999999999999999999999754   469999999997653321100        


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                        ...|..                         .+...                                          
T Consensus       167 --~~~~~~-------------------------~~~~~------------------------------------------  177 (388)
T 3oz6_A          167 --NNIPLS-------------------------INENT------------------------------------------  177 (388)
T ss_dssp             --CCGGGC-------------------------CC---------------------------------------------
T ss_pred             --cccccc-------------------------ccccc------------------------------------------
Confidence              000000                         00000                                          


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                       .   .+    ..........+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus       178 -~---~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          178 -E---NF----DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             --------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             -c---cc----ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence             0   00    000011234679999999999987 6789999999999999999999999999999999998874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-43  Score=335.93  Aligned_cols=225  Identities=38%  Similarity=0.695  Sum_probs=199.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-----------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-----------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFD   69 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-----------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E   69 (328)
                      |+||+||+|.++.+++.||+|++.......           ...+.+.+|+.+|++++|||||++++++.+...+|+|||
T Consensus        47 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  126 (504)
T 3q5i_A           47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE  126 (504)
T ss_dssp             --CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEe
Confidence            899999999999999999999998654332           234678899999999999999999999999999999999


Q ss_pred             ccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC----
Q psy2131          70 LVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE----  145 (328)
Q Consensus        70 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~----  145 (328)
                      ||+||+|.+.+.....+++.++..++.||+.||.|||++||+||||||+|||++.++....+||+|||++......    
T Consensus       127 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  206 (504)
T 3q5i_A          127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR  206 (504)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccc
Confidence            9999999999988889999999999999999999999999999999999999987665557999999998654321    


Q ss_pred             ---------------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         146 ---------------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       146 ---------------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                           .+.| +|+++|+|++|.+||.+.+.......+..+.+.++.+.|..+|+++++|+.+||
T Consensus       207 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  286 (504)
T 3q5i_A          207 DRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML  286 (504)
T ss_dssp             CCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHT
T ss_pred             cccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHc
Confidence                                 1123 899999999999999999999999999999988888888899999999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..||.+|||++++++|||+...
T Consensus       287 ~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          287 TYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CCChhHCCCHHHHhcCHhhhhc
Confidence            9999999999999999999654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.7e-44  Score=320.62  Aligned_cols=209  Identities=31%  Similarity=0.444  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++. +|+.||+|++............+.+|++++++++||||+++++++.+.+..|+|||||+| +|.+.+
T Consensus        32 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~  109 (311)
T 3niz_A           32 GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL  109 (311)
T ss_dssp             CSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHH
T ss_pred             CCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHH
Confidence            899999999985 589999999986654444556788999999999999999999999999999999999986 787777


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       110 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~------------  174 (311)
T 3niz_A          110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVR------------  174 (311)
T ss_dssp             HTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEETTSCCC------------
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---CCEEEccCcCceecCCCcc------------
Confidence            654 459999999999999999999999999999999999999754   4599999999865321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (311)
T 3niz_A          175 --------------------------------------------------------------------------------  174 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+.+..-.+.
T Consensus       175 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          175 --------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             -----------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             --------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence                          0112358999999999987 5689999999999999999999999999988888888776555444


Q ss_pred             CC
Q psy2131         319 PK  320 (328)
Q Consensus       319 ~~  320 (328)
                      |.
T Consensus       241 ~~  242 (311)
T 3niz_A          241 PR  242 (311)
T ss_dssp             TT
T ss_pred             hH
Confidence            43

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=318.15  Aligned_cols=250  Identities=43%  Similarity=0.746  Sum_probs=201.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+++.||||+++...    ..+.+.+|+.+|++++||||+++++++.+.+..|+|||||+||+|.+.+
T Consensus        64 G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  139 (349)
T 2w4o_A           64 GATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI  139 (349)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHH
Confidence            899999999999999999999997542    3356778999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      ...+.+++.++..++.|++.||.|||++||+||||||+|||++....++.+||+|||++......               
T Consensus       140 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          140 VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP  219 (349)
T ss_dssp             TTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCH
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCH
Confidence            88888999999999999999999999999999999999999986445677999999998643211               


Q ss_pred             -----------Ccch-HHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         146 -----------QQAW-FGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       146 -----------~~~~-~G~~~~~~~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                 .+.| +|+++|+|++|..||.+.... .....+......++.+.+..+++++.+++.+||..||.+|||
T Consensus       220 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (349)
T 2w4o_A          220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT  299 (349)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC
Confidence                       1123 899999999999999776544 466777787777777778889999999999999999999999


Q ss_pred             HHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhh
Q psy2131         213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQ  256 (328)
Q Consensus       213 ~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (328)
                      +.++++|||+.......  .........+++++..++.+.....
T Consensus       300 ~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  341 (349)
T 2w4o_A          300 TFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKA  341 (349)
T ss_dssp             HHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHH
Confidence            99999999998654322  2233445667777777777765544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.3e-44  Score=320.05  Aligned_cols=202  Identities=32%  Similarity=0.463  Sum_probs=169.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.||+|+++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||||+ |+|.+++
T Consensus        16 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l   93 (317)
T 2pmi_A           16 GTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM   93 (317)
T ss_dssp             ---CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHH
Confidence            8999999999999999999999976542 2233567889999999999999999999999999999999998 4898888


Q ss_pred             Hhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          81 VAR------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        81 ~~~------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ...      ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........       
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~-------  163 (317)
T 2pmi_A           94 DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARAFGIPVN-------  163 (317)
T ss_dssp             HHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCSSCEETTSCCC-------
T ss_pred             HhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---CCEEECcCccceecCCCcc-------
Confidence            654      358999999999999999999999999999999999999754   4699999999865321100       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (317)
T 2pmi_A          164 --------------------------------------------------------------------------------  163 (317)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                         ......||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+....+..|...
T Consensus       164 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  224 (317)
T 2pmi_A          164 -------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI  224 (317)
T ss_dssp             -------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             -------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence                               0112358999999999987 46899999999999999999999999999988888887654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.4e-44  Score=321.86  Aligned_cols=216  Identities=22%  Similarity=0.372  Sum_probs=182.5

Q ss_pred             CCceEEEEEEEccCCcE---EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLE---FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~---~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..+++.   ||||+++... .....+.+.+|+.++++++||||+++++++.+.+..|+|||||+||+|.
T Consensus        60 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  138 (325)
T 3kul_A           60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD  138 (325)
T ss_dssp             TTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHH
T ss_pred             CCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHH
Confidence            89999999999866654   9999997543 4555677899999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........        
T Consensus       139 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~--------  207 (325)
T 3kul_A          139 TFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN---LVCKVSDFGLSRVLEDDPDA--------  207 (325)
T ss_dssp             HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCSSCEECC----C--------
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC---CCEEECCCCcccccccCccc--------
Confidence            998654 579999999999999999999999999999999999999654   56999999998654221100        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       208 --------------------------------------------------------------------------------  207 (325)
T 3kul_A          208 --------------------------------------------------------------------------------  207 (325)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                     ........||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+...+...+..+..
T Consensus       208 ---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  272 (325)
T 3kul_A          208 ---------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR  272 (325)
T ss_dssp             ---------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ---------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC
Confidence                           000112347889999999999999999999999999999999 9999999999999999999877


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       273 ~~~~~~~~  280 (325)
T 3kul_A          273 LPAPMGCP  280 (325)
T ss_dssp             CCCCTTCC
T ss_pred             CCCCCCcC
Confidence            66665554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3e-43  Score=317.29  Aligned_cols=203  Identities=26%  Similarity=0.516  Sum_probs=176.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+|+.||||++.....  ...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+.+
T Consensus        56 G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  133 (321)
T 2c30_A           56 GSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV  133 (321)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHH
Confidence            7999999999999999999999976543  23456789999999999999999999999999999999999999998876


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........             
T Consensus       134 ~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~-------------  196 (321)
T 2c30_A          134 S-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP-------------  196 (321)
T ss_dssp             T-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSC-------------
T ss_pred             H-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CcEEEeeeeeeeecccCcc-------------
Confidence            5 4579999999999999999999999999999999999999754   4699999999865422100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       197 --------------------------------------------------------------------------------  196 (321)
T 2c30_A          197 --------------------------------------------------------------------------------  196 (321)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+..+..
T Consensus       197 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  258 (321)
T 2c30_A          197 -------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP  258 (321)
T ss_dssp             -------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred             -------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence                         01124699999999999999999999999999999999999999999999888888877643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-44  Score=326.49  Aligned_cols=201  Identities=29%  Similarity=0.451  Sum_probs=171.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+..+|+.||||++..........+++.+|+++|+.++||||+++++++....      .+|+||||+ |+
T Consensus        36 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~  114 (367)
T 1cm8_A           36 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GT  114 (367)
T ss_dssp             ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SE
T ss_pred             cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CC
Confidence            89999999999999999999999776666666778899999999999999999999998653      469999999 78


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++.....         
T Consensus       115 ~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~---------  181 (367)
T 1cm8_A          115 DLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQADSE---------  181 (367)
T ss_dssp             EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCSS---------
T ss_pred             CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC---CCEEEEeeecccccccc---------
Confidence            88877765 679999999999999999999999999999999999999754   46999999998643110         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       182 --------------------------------------------------------------------------------  181 (367)
T 1cm8_A          182 --------------------------------------------------------------------------------  181 (367)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          .....||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+....+..|...
T Consensus       182 --------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~  241 (367)
T 1cm8_A          182 --------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV  241 (367)
T ss_dssp             --------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             --------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                                112458999999999987 78999999999999999999999999999988888888765


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      .-
T Consensus       242 ~g  243 (367)
T 1cm8_A          242 TG  243 (367)
T ss_dssp             HC
T ss_pred             cC
Confidence            44

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-43  Score=315.34  Aligned_cols=202  Identities=30%  Similarity=0.409  Sum_probs=169.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++ .+|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+||||+++ +|.+.+
T Consensus        13 G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~   90 (288)
T 1ob3_A           13 GTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL   90 (288)
T ss_dssp             ETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHH
T ss_pred             CCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHH
Confidence            79999999998 6889999999976654333446778999999999999999999999999999999999986 888888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... +.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-------------  154 (288)
T 1ob3_A           91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPV-------------  154 (288)
T ss_dssp             HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---------------
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEeECccccccCccc-------------
Confidence            654 679999999999999999999999999999999999999754   469999999975421100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (288)
T 1ob3_A          155 --------------------------------------------------------------------------------  154 (288)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   .......||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+....+..+.+.
T Consensus       155 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  216 (288)
T 1ob3_A          155 -------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI  216 (288)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             -------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                         001123589999999999764 5899999999999999999999999999888887777654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.2e-43  Score=309.58  Aligned_cols=212  Identities=40%  Similarity=0.734  Sum_probs=184.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH----HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|++..+|+.||+|+++.......    ..+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|
T Consensus        16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   95 (283)
T 3bhy_A           16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL   95 (283)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcH
Confidence            8999999999999999999999986644321    356788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC-CCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA-KGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~-~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++.....+++.++..++.|++.||.|||++||+||||||+||+++.++ ....+||+|||++.......         
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---------  166 (283)
T 3bhy_A           96 FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---------  166 (283)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC------------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---------
Confidence            99998888899999999999999999999999999999999999997654 22369999999975432100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (283)
T 3bhy_A          167 --------------------------------------------------------------------------------  166 (283)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..+.+
T Consensus       167 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  228 (283)
T 3bhy_A          167 ------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY  228 (283)
T ss_dssp             -----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred             ------------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence                              00123589999999999999999999999999999999999999999999999999998887


Q ss_pred             CCCC
Q psy2131         316 DDEP  319 (328)
Q Consensus       316 ~~~~  319 (328)
                      ..++
T Consensus       229 ~~~~  232 (283)
T 3bhy_A          229 DFDE  232 (283)
T ss_dssp             CCCH
T ss_pred             CCcc
Confidence            6553

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=318.61  Aligned_cols=223  Identities=38%  Similarity=0.721  Sum_probs=198.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.++.+|+.||+|++....  ..+...+.+|+.+|+.++||||+++++++.+.+..|+|||||.||+|.+.+
T Consensus        62 G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l  139 (387)
T 1kob_A           62 GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI  139 (387)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHT
T ss_pred             CCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHH
Confidence            799999999999999999999997543  334567889999999999999999999999999999999999999999988


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------------
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------  146 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------------  146 (328)
                      .... .+++.++..++.|++.||.|||++||+||||||+|||++.++ .+.+||+|||++.......             
T Consensus       140 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~a  218 (387)
T 1kob_A          140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAA  218 (387)
T ss_dssp             TCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECCTTSCEEEECSSGGGCC
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-CCceEEEecccceecCCCcceeeeccCCCccC
Confidence            7654 699999999999999999999999999999999999997532 3569999999987543211             


Q ss_pred             -------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         147 -------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       147 -------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                   +.| +|+++|+|++|.+||.+.+.......+......++...+..+++++.+|+.+||..||.+|||
T Consensus       219 PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  298 (387)
T 1kob_A          219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT  298 (387)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             chhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC
Confidence                         122 899999999999999999988888889888888888788889999999999999999999999


Q ss_pred             HHHHhcCcccCCcc
Q psy2131         213 ASEALKHPWICQRE  226 (328)
Q Consensus       213 ~~~~l~h~~~~~~~  226 (328)
                      +.++++|||+....
T Consensus       299 ~~ell~hp~~~~~~  312 (387)
T 1kob_A          299 VHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHTSTTTSSCC
T ss_pred             HHHHhhCccccCCc
Confidence            99999999997643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.2e-43  Score=313.22  Aligned_cols=222  Identities=35%  Similarity=0.685  Sum_probs=191.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.||||++.....  ...+.+.+|+++++++ +||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus        24 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  101 (316)
T 2ac3_A           24 GAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH  101 (316)
T ss_dssp             CSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             CceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHH
Confidence            8999999999999999999999976532  2346788999999985 799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc----------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ----------------  143 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~----------------  143 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++....                
T Consensus       102 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  181 (316)
T 2ac3_A          102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP  181 (316)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccc
Confidence            9888889999999999999999999999999999999999999876655569999999875321                


Q ss_pred             -----------------------CCCcch-HHHHHHHHHhCCCCCCCCc---------------HHHHHHHHHhCCCCCC
Q psy2131         144 -----------------------GEQQAW-FGVILYILLVGYPPFWDED---------------QHRLYAQIKAGAYDYP  184 (328)
Q Consensus       144 -----------------------~~~~~~-~G~~~~~~~~g~~pf~~~~---------------~~~~~~~i~~~~~~~~  184 (328)
                                             ...+.| +|+++|+|++|.+||.+..               ...+...+..+...+|
T Consensus       182 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  261 (316)
T 2ac3_A          182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP  261 (316)
T ss_dssp             CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC
T ss_pred             cCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC
Confidence                                   011223 7999999999999997653               3456677778877777


Q ss_pred             CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         185 SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       185 ~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ...+..+++++.+++.+||..||.+|||++++++|||+..
T Consensus       262 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          262 DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence            6666789999999999999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=314.94  Aligned_cols=204  Identities=31%  Similarity=0.455  Sum_probs=174.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+|||||++++|.+.+
T Consensus        14 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   93 (311)
T 4agu_A           14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD   93 (311)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH
T ss_pred             cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHH
Confidence            89999999999999999999999877655555677889999999999999999999999999999999999999998888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........             
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-------------  157 (311)
T 4agu_A           94 RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH---SVIKLCDFGFARLLTGPSD-------------  157 (311)
T ss_dssp             HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC-----------------
T ss_pred             hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC---CCEEEeeCCCchhccCccc-------------
Confidence            878889999999999999999999999999999999999999754   4699999999865321100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (311)
T 4agu_A          158 --------------------------------------------------------------------------------  157 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                   ......||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+.......+...
T Consensus       158 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  218 (311)
T 4agu_A          158 -------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT  218 (311)
T ss_dssp             ---------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             -------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                         0112358999999999986 67899999999999999999999999999888777776654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-42  Score=314.95  Aligned_cols=218  Identities=40%  Similarity=0.804  Sum_probs=192.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.++.+|+.||+|+++.....      ..+|++++.++ +||||+++++++.+.+.+|+|||||+||+|.+.
T Consensus        33 G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~  106 (342)
T 2qr7_A           33 GSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK  106 (342)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence            89999999999999999999999865432      24688888887 799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCC------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQ------------  146 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~------------  146 (328)
                      +...+.+++.++..++.||+.||.|||++||+||||||+|||+... ++...+||+|||++.......            
T Consensus       107 i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  186 (342)
T 2qr7_A          107 ILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF  186 (342)
T ss_dssp             HHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSC
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccc
Confidence            9988899999999999999999999999999999999999998643 233469999999987543211            


Q ss_pred             ---------------cch-HHHHHHHHHhCCCCCCC---CcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCC
Q psy2131         147 ---------------QAW-FGVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP  207 (328)
Q Consensus       147 ---------------~~~-~G~~~~~~~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  207 (328)
                                     +.| +|+++|+|++|.+||.+   .+...+...+..+.+.++...|..+|+++++++.+||..||
T Consensus       187 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  266 (342)
T 2qr7_A          187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP  266 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSST
T ss_pred             cCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCCh
Confidence                           112 79999999999999976   45677888888888888888888999999999999999999


Q ss_pred             CCCCCHHHHhcCcccCC
Q psy2131         208 SKRITASEALKHPWICQ  224 (328)
Q Consensus       208 ~~R~t~~~~l~h~~~~~  224 (328)
                      .+|||+.++++|||+..
T Consensus       267 ~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          267 HQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TTSCCHHHHTTSHHHHT
T ss_pred             hHCcCHHHHhcCCeecC
Confidence            99999999999999954

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=324.90  Aligned_cols=192  Identities=19%  Similarity=0.292  Sum_probs=159.2

Q ss_pred             CCceEEEEE-----EEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRC-----VQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~-----~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||+||+|     .+..+++.||+|+++...     ...+.+|+++++.++   |+||+++++++...+..|+|||||+
T Consensus        76 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  150 (365)
T 3e7e_A           76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS  150 (365)
T ss_dssp             CSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCC
T ss_pred             cCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccC
Confidence            899999999     477899999999997542     345677888888886   9999999999999999999999999


Q ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEee--------CCCCCcEEEeecccc
Q psy2131          73 GGELFEDIVA-----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLAS--------KAKGAAVKLADFGLA  139 (328)
Q Consensus        73 gg~L~~~l~~-----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~--------~~~~~~vkl~DfGla  139 (328)
                      ||+|.+++..     ...+++.++..++.|++.||.|||++|||||||||+|||++.        +...+.+||+|||+|
T Consensus       151 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a  230 (365)
T 3e7e_A          151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS  230 (365)
T ss_dssp             SCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTC
T ss_pred             CCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchh
Confidence            9999999874     456999999999999999999999999999999999999976        122467999999998


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +.......                                                                        
T Consensus       231 ~~~~~~~~------------------------------------------------------------------------  238 (365)
T 3e7e_A          231 IDMKLFPK------------------------------------------------------------------------  238 (365)
T ss_dssp             EEGGGSCT------------------------------------------------------------------------
T ss_pred             hhhhccCC------------------------------------------------------------------------
Confidence            65321000                                                                        


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                                      ........||+.|+|||++.+.+|+.++|||||||++|||+||+.||.
T Consensus       239 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          239 --------------------------------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             --------------------------------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             --------------------------------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence                                            001123469999999999999999999999999999999999999987


Q ss_pred             Cc
Q psy2131         300 DE  301 (328)
Q Consensus       300 ~~  301 (328)
                      ..
T Consensus       287 ~~  288 (365)
T 3e7e_A          287 KN  288 (365)
T ss_dssp             EE
T ss_pred             cC
Confidence            54

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.6e-43  Score=321.72  Aligned_cols=204  Identities=25%  Similarity=0.359  Sum_probs=170.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++...+      ..|+|||||.+ 
T Consensus        36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-  114 (371)
T 2xrw_A           36 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-  114 (371)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-
T ss_pred             cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-
Confidence            89999999999999999999999876666666778899999999999999999999998665      78999999975 


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.  ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......        
T Consensus       115 ~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~--------  181 (371)
T 2xrw_A          115 NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  181 (371)
T ss_dssp             EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCC----------------
T ss_pred             CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEEEeeccccccccc--------
Confidence            7877775  458999999999999999999999999999999999999754   469999999974321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       182 --------------------------------------------------------------------------------  181 (371)
T 2xrw_A          182 --------------------------------------------------------------------------------  181 (371)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                         ......||+.|+|||++.+.+|+.++|||||||++|||+||++||.+.+....+.+|.+..
T Consensus       182 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  242 (371)
T 2xrw_A          182 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  242 (371)
T ss_dssp             ---------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred             -------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence                               0112458999999999999999999999999999999999999999999999999888765


Q ss_pred             CCC
Q psy2131         315 YDD  317 (328)
Q Consensus       315 ~~~  317 (328)
                      -.+
T Consensus       243 ~~~  245 (371)
T 2xrw_A          243 GTP  245 (371)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-43  Score=310.10  Aligned_cols=208  Identities=31%  Similarity=0.561  Sum_probs=180.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH-HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.||+|++........ ....+.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+.
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   99 (279)
T 3fdn_A           20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRE   99 (279)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHH
Confidence            8999999999999999999999965432221 235678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......              
T Consensus       100 l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~Dfg~~~~~~~~--------------  162 (279)
T 3fdn_A          100 LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS--------------  162 (279)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT---SCEEECSCCEESCC-----------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC---CCEEEEeccccccCCcc--------------
Confidence            9888889999999999999999999999999999999999999754   45999999987432110              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (279)
T 3fdn_A          163 --------------------------------------------------------------------------------  162 (279)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+..+....|+
T Consensus       163 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T 3fdn_A          163 --------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD  228 (279)
T ss_dssp             -------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT
T ss_pred             --------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC
Confidence                          011235899999999999999999999999999999999999999999999999999988775543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.4e-43  Score=319.32  Aligned_cols=203  Identities=27%  Similarity=0.387  Sum_probs=176.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-----CCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----HPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-----H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|++..+++.||||+++..   ......+.+|+.+++.+.     ||||+++++++...+..|+||||| |++
T Consensus        46 G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~  121 (360)
T 3llt_A           46 GTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPS  121 (360)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCB
T ss_pred             cCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCC
Confidence            89999999999999999999999742   344566788999999986     999999999999999999999999 899


Q ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC----------------------CCCCcE
Q psy2131          76 LFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK----------------------AKGAAV  131 (328)
Q Consensus        76 L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~----------------------~~~~~v  131 (328)
                      |.+++....  .+++.++..++.||+.||.|||++|||||||||+|||++..                      ...+.+
T Consensus       122 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (360)
T 3llt_A          122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI  201 (360)
T ss_dssp             HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCE
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCE
Confidence            999987654  49999999999999999999999999999999999999742                      124679


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||++......                                                                  
T Consensus       202 kl~DFG~a~~~~~~------------------------------------------------------------------  215 (360)
T 3llt_A          202 KLIDFGCATFKSDY------------------------------------------------------------------  215 (360)
T ss_dssp             EECCCTTCEETTSC------------------------------------------------------------------
T ss_pred             EEEeccCceecCCC------------------------------------------------------------------
Confidence            99999998542110                                                                  


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                                 .....||+.|+|||++.+.+|+.++|||||||++|||
T Consensus       216 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          216 -------------------------------------------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             -------------------------------------------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             -------------------------------------------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                                       0123589999999999999999999999999999999


Q ss_pred             HhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         292 LVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       292 ltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                      +||++||.+.+..+.+..+......
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~  277 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQP  277 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCC
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCC
Confidence            9999999999998888888776543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=313.84  Aligned_cols=207  Identities=30%  Similarity=0.390  Sum_probs=171.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH---HHHHHHHHHHHHHHhC---CCCCcceeEEEEEeCC-----EEEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA---RDFQKLEREARICRKL---QHPNIVRLHDSIQEEN-----YHYLVFD   69 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~---~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~-----~~~lv~E   69 (328)
                      |+||+||+|++..+|+.||+|++.......   .....+.+|+.+++.+   +||||+++++++.+..     ..++|||
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e   99 (308)
T 3g33_A           20 GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE   99 (308)
T ss_dssp             SSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEE
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEeh
Confidence            899999999999999999999997543211   1123456677777666   4999999999998765     5899999


Q ss_pred             ccCCCCcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCc
Q psy2131          70 LVTGGELFEDIVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus        70 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~  147 (328)
                      |+. |+|.+++.....  +++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++....... 
T Consensus       100 ~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~-  174 (308)
T 3g33_A          100 HVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQM-  174 (308)
T ss_dssp             CCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT---SCEEECSCSCTTTSTTCC-
T ss_pred             hhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEEeeCccccccCCCc-
Confidence            997 499998877654  9999999999999999999999999999999999999754   469999999975431100 


Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (308)
T 3g33_A          175 --------------------------------------------------------------------------------  174 (308)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             chhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHH
Q psy2131         228 VASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY  307 (328)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  307 (328)
                                                ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.....
T Consensus       175 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          175 --------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             --------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             --------------------------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                                      011246899999999999999999999999999999999999999999999998


Q ss_pred             HHHhcccCCCC
Q psy2131         308 AQIKAGAYDDE  318 (328)
Q Consensus       308 ~~i~~~~~~~~  318 (328)
                      .+|....-.++
T Consensus       229 ~~i~~~~~~~~  239 (308)
T 3g33_A          229 GKIFDLIGLPP  239 (308)
T ss_dssp             HHHHHHHCCCC
T ss_pred             HHHHHHhCCCC
Confidence            88876554333

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.9e-43  Score=315.69  Aligned_cols=209  Identities=33%  Similarity=0.545  Sum_probs=184.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||||+|++|.++
T Consensus        52 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  131 (335)
T 2owb_A           52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL  131 (335)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHH
Confidence            7999999999999999999999986543 345567789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~------------  196 (335)
T 2owb_A          132 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGE------------  196 (335)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCSTTC------------
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC---CCEEEeeccCceecccCcc------------
Confidence            8888889999999999999999999999999999999999999754   4599999999865321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       197 --------------------------------------------------------------------------------  196 (335)
T 2owb_A          197 --------------------------------------------------------------------------------  196 (335)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..+.+..+
T Consensus       197 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  261 (335)
T 2owb_A          197 --------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP  261 (335)
T ss_dssp             --------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             --------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC
Confidence                          01123589999999999999999999999999999999999999999998888888888877544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=319.76  Aligned_cols=215  Identities=24%  Similarity=0.352  Sum_probs=183.6

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .+++.||+|+++... .....+.+.+|+.++++++||||+++++++.+.+..|+|||||+||+
T Consensus        58 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  136 (343)
T 1luf_A           58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD  136 (343)
T ss_dssp             CSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCc
Confidence            899999999987     456899999997543 44556778999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          76 LFEDIVAR------------------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        76 L~~~l~~~------------------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      |.+++...                        ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+
T Consensus       137 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~  213 (343)
T 1luf_A          137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVV  213 (343)
T ss_dssp             HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCE
T ss_pred             HHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCC---CeE
Confidence            99998763                        568999999999999999999999999999999999999754   459


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||++........                                                                
T Consensus       214 kl~Dfg~~~~~~~~~~----------------------------------------------------------------  229 (343)
T 1luf_A          214 KIADFGLSRNIYSADY----------------------------------------------------------------  229 (343)
T ss_dssp             EECCCSCHHHHTGGGC----------------------------------------------------------------
T ss_pred             EEeecCCCcccccCcc----------------------------------------------------------------
Confidence            9999999754311000                                                                


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                              ........||+.|+|||++.+..|+.++|||||||++|||
T Consensus       230 ----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el  269 (343)
T 1luf_A          230 ----------------------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  269 (343)
T ss_dssp             ----------------------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence                                                    0001123589999999999999999999999999999999


Q ss_pred             Hh-cCCCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         292 LV-GYPPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       292 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      +| |+.||.+.+...+...+..+.....|..++
T Consensus       270 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (343)
T 1luf_A          270 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCP  302 (343)
T ss_dssp             HTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             HhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCC
Confidence            99 999999999999999999998876666554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-43  Score=320.81  Aligned_cols=214  Identities=21%  Similarity=0.263  Sum_probs=175.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||||++.....    .+.+.+|+++++++ +||||+++++++.+.+..|+||||| |++|.++
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~   94 (330)
T 2izr_A           20 GNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDL   94 (330)
T ss_dssp             -CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             cCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHH
Confidence            8999999999999999999999975432    23467899999999 9999999999999999999999999 9999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCC--CcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKG--AAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~--~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +.. ...+++.++..++.|++.||.|||++||+||||||+|||++.++..  ..+||+|||++..........       
T Consensus        95 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~-------  167 (330)
T 2izr_A           95 FDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK-------  167 (330)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC-------
T ss_pred             HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc-------
Confidence            876 4679999999999999999999999999999999999999765421  239999999987643221000       


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                          ..|                                                                         
T Consensus       168 ----~~~-------------------------------------------------------------------------  170 (330)
T 2izr_A          168 ----HIP-------------------------------------------------------------------------  170 (330)
T ss_dssp             ----BCC-------------------------------------------------------------------------
T ss_pred             ----ccc-------------------------------------------------------------------------
Confidence                000                                                                         


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC---ccHHHHHHHHhcc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIKAG  313 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~  313 (328)
                                     ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+   .+..+.+.+|..+
T Consensus       171 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          171 ---------------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             ---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             ---------------ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence                           0011235699999999999999999999999999999999999999998   4566667777666


Q ss_pred             cCCCC
Q psy2131         314 AYDDE  318 (328)
Q Consensus       314 ~~~~~  318 (328)
                      ....+
T Consensus       236 ~~~~~  240 (330)
T 2izr_A          236 KRATP  240 (330)
T ss_dssp             HHHSC
T ss_pred             hccCC
Confidence            55433

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.5e-43  Score=312.51  Aligned_cols=204  Identities=23%  Similarity=0.379  Sum_probs=168.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+++.||+|++..  ......+.+.+|++++++++||||+++++++.+.+..|+|||||+||+|.+++
T Consensus        21 G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (310)
T 3s95_A           21 GCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII   98 (310)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHH
Confidence            8999999999999999999999854  34566778999999999999999999999999999999999999999999999


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++...........+.       
T Consensus        99 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~-------  168 (310)
T 3s95_A           99 KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN---KNVVVADFGLARLMVDEKTQPEGL-------  168 (310)
T ss_dssp             HHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT---SCEEECCCTTCEECC----------------
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC---CCEEEeecccceeccccccccccc-------
Confidence            77 5679999999999999999999999999999999999999754   459999999987653221100000       


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (310)
T 3s95_A          169 --------------------------------------------------------------------------------  168 (310)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                           ...............||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus       169 -----~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          169 -----RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             -----ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence                 000000011122457999999999999999999999999999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.6e-43  Score=309.97  Aligned_cols=214  Identities=33%  Similarity=0.567  Sum_probs=183.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.  .....|+|||||+|++|.+
T Consensus        17 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~   96 (279)
T 2w5a_A           17 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS   96 (279)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHH
T ss_pred             CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHH
Confidence            89999999999999999999999987777777788999999999999999999999885  4678999999999999999


Q ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          79 DIVAR----EFYSEADASHCIQQILESVNHCHSNG-----VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        79 ~l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~-----ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      ++...    ..+++.++..++.|++.||.|||+++     |+||||||+|||++.+   +.+||+|||++.......   
T Consensus        97 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~---~~~kl~dfg~~~~~~~~~---  170 (279)
T 2w5a_A           97 VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDT---  170 (279)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS---SCEEECCCCHHHHC---C---
T ss_pred             HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC---CCEEEecCchheeecccc---
Confidence            88653    34999999999999999999999999     9999999999999754   459999999875421100   


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (279)
T 2w5a_A          171 --------------------------------------------------------------------------------  170 (279)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                             .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...+...
T Consensus       171 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  227 (279)
T 2w5a_A          171 -----------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK  227 (279)
T ss_dssp             -----------------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             -----------------------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH
Confidence                                   001123589999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCCCCCCccc
Q psy2131         310 IKAGAYDDEPKHKS  323 (328)
Q Consensus       310 i~~~~~~~~~~~~~  323 (328)
                      +..+.+...|...+
T Consensus       228 i~~~~~~~~~~~~~  241 (279)
T 2w5a_A          228 IREGKFRRIPYRYS  241 (279)
T ss_dssp             HHHTCCCCCCTTSC
T ss_pred             HhhcccccCCcccC
Confidence            99998866665544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-42  Score=308.02  Aligned_cols=209  Identities=33%  Similarity=0.545  Sum_probs=183.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||||+|++|.+.
T Consensus        26 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (294)
T 2rku_A           26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL  105 (294)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHH
Confidence            7999999999999999999999976543 344567789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       106 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~------------  170 (294)
T 2rku_A          106 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGE------------  170 (294)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCSTTC------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC---CCEEEEeccCceecccCcc------------
Confidence            8888889999999999999999999999999999999999999754   4599999999865321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (294)
T 2rku_A          171 --------------------------------------------------------------------------------  170 (294)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......||+.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+..+.+..+..+.+..|
T Consensus       171 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (294)
T 2rku_A          171 --------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP  235 (294)
T ss_dssp             --------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred             --------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc
Confidence                          01123589999999999999999999999999999999999999999998888888888877543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.8e-44  Score=328.13  Aligned_cols=216  Identities=24%  Similarity=0.342  Sum_probs=184.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.+++.||||+++.. ...+..+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+++
T Consensus       125 G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  203 (377)
T 3cbl_A          125 GNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL  203 (377)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             CCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHH
Confidence            79999999999999999999999754 34445567889999999999999999999999999999999999999999998


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+ .+++.++..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+++........           
T Consensus       204 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~---~~~kl~DfG~s~~~~~~~~~-----------  269 (377)
T 3cbl_A          204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSREEADGVYA-----------  269 (377)
T ss_dssp             HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCGGGCEECTTSEEE-----------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC---CcEEECcCCCceecCCCcee-----------
Confidence            7654 59999999999999999999999999999999999999654   46999999998643211000           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       270 --------------------------------------------------------------------------------  269 (377)
T 3cbl_A          270 --------------------------------------------------------------------------------  269 (377)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......+++.|+|||++.+..|+.++|||||||++|||+| |..||.+.+..++...+..+...+.
T Consensus       270 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          270 -------------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC  336 (377)
T ss_dssp             -------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred             -------------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                         00001235778999999999999999999999999999999 9999999999999999999887776


Q ss_pred             CCcccc
Q psy2131         319 PKHKSA  324 (328)
Q Consensus       319 ~~~~~~  324 (328)
                      |..++.
T Consensus       337 ~~~~~~  342 (377)
T 3cbl_A          337 PELCPD  342 (377)
T ss_dssp             CTTCCH
T ss_pred             CCCCCH
Confidence            766543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.9e-43  Score=318.40  Aligned_cols=201  Identities=25%  Similarity=0.426  Sum_probs=173.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||++...... ....+.+.+|+++|++++||||+++++++.+.+..|+|||||. |+|.+.
T Consensus        65 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~  143 (348)
T 1u5q_A           65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL  143 (348)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHH
T ss_pred             CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHH
Confidence            89999999999999999999999866443 3445678999999999999999999999999999999999998 577777


Q ss_pred             HH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~-~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +. ....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....              
T Consensus       144 l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~--------------  206 (348)
T 1u5q_A          144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP--------------  206 (348)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS--------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEeeccCceecCC--------------
Confidence            75 45679999999999999999999999999999999999999754   5699999999743211              


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       207 --------------------------------------------------------------------------------  206 (348)
T 1u5q_A          207 --------------------------------------------------------------------------------  206 (348)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .....||+.|+|||++.   +..|+.++|||||||++|||+||++||.+.+.......+.++..
T Consensus       207 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  270 (348)
T 1u5q_A          207 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  270 (348)
T ss_dssp             ----------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             ----------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence                            01235899999999985   56789999999999999999999999999988777777777654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=315.47  Aligned_cols=207  Identities=30%  Similarity=0.493  Sum_probs=172.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--YHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|++..+|+.||||+++.... ....+.+.+|+++|++++||||+++++++...+  ..|+|||||+|++|.+
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   98 (319)
T 4euu_A           20 GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT   98 (319)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHH
Confidence            8999999999999999999999975432 223466789999999999999999999998765  7899999999999999


Q ss_pred             HHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          79 DIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        79 ~l~~~~~---~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ++.....   +++.++..++.|++.||.|||++||+||||||+|||+... ...+.+||+|||++........       
T Consensus        99 ~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~-------  171 (319)
T 4euu_A           99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-------  171 (319)
T ss_dssp             HHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC-------
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc-------
Confidence            9876443   9999999999999999999999999999999999998332 2345699999999865422110       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (319)
T 4euu_A          172 --------------------------------------------------------------------------------  171 (319)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc--------cCCCCCCcchhhhhhHHHHHHhcCCCCCC----cc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK--------KEPYGKPVDIWACGVILYILLVGYPPFWD----ED  302 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~~~~~DvwSlGvilyelltG~~Pf~~----~~  302 (328)
                                          .....||+.|+|||++.        +..|+.++|||||||++|||+||+.||..    .+
T Consensus       172 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  231 (319)
T 4euu_A          172 --------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (319)
T ss_dssp             --------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred             --------------------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence                                11235899999999987        57889999999999999999999999973    34


Q ss_pred             HHHHHHHHhcccC
Q psy2131         303 QHRLYAQIKAGAY  315 (328)
Q Consensus       303 ~~~~~~~i~~~~~  315 (328)
                      ...++.++..+..
T Consensus       232 ~~~~~~~~~~~~p  244 (319)
T 4euu_A          232 NKEVMYKIITGKP  244 (319)
T ss_dssp             CHHHHHHHHHHCC
T ss_pred             hHHHHHHHhcCCC
Confidence            5667777777653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-43  Score=306.56  Aligned_cols=211  Identities=24%  Similarity=0.383  Sum_probs=180.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+. ++..||+|++.......   +.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        21 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (269)
T 4hcu_A           21 GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   96 (269)
T ss_dssp             CSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             CCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHH
Confidence            899999999986 57789999998665443   45789999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-------------  160 (269)
T 4hcu_A           97 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ-------------  160 (269)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECCTTGGGGBCCHH-------------
T ss_pred             HhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC---CCEEeccccccccccccc-------------
Confidence            654 468999999999999999999999999999999999999754   459999999985432100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (269)
T 4hcu_A          161 --------------------------------------------------------------------------------  160 (269)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                  ........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+...+...+..+.....
T Consensus       161 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (269)
T 4hcu_A          161 ------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  228 (269)
T ss_dssp             ------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             ------------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence                        001122357889999999999999999999999999999999 9999999999999999999866665


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |...+
T Consensus       229 ~~~~~  233 (269)
T 4hcu_A          229 PRLAS  233 (269)
T ss_dssp             CTTSC
T ss_pred             CCcCC
Confidence            65443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-43  Score=323.71  Aligned_cols=216  Identities=22%  Similarity=0.396  Sum_probs=173.7

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|+++   .++..||||+++... .....+.+.+|+.+|++++||||+++++++.+.+..|+|||||+||+|.
T Consensus        56 G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  134 (373)
T 2qol_A           56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD  134 (373)
T ss_dssp             CSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             CCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHH
Confidence            899999999887   567789999997543 4556678999999999999999999999999999999999999999999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........        
T Consensus       135 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~--------  203 (373)
T 2qol_A          135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLGRVLEDDPEA--------  203 (373)
T ss_dssp             HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC--------------------
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC---CCEEECcCccccccccCCcc--------
Confidence            9987654 69999999999999999999999999999999999999654   46999999997543211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       204 --------------------------------------------------------------------------------  203 (373)
T 2qol_A          204 --------------------------------------------------------------------------------  203 (373)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                     ........||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+...+...+..+..
T Consensus       204 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~  268 (373)
T 2qol_A          204 ---------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR  268 (373)
T ss_dssp             -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred             ---------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence                           000111236889999999999999999999999999999998 9999999999999999998877


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .++|..++
T Consensus       269 ~~~~~~~~  276 (373)
T 2qol_A          269 LPPPMDCP  276 (373)
T ss_dssp             CCCCTTCB
T ss_pred             CCCCcccc
Confidence            66665544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-43  Score=318.02  Aligned_cols=216  Identities=21%  Similarity=0.357  Sum_probs=169.7

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE------EEEEEcc
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH------YLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~------~lv~E~~   71 (328)
                      |+||+||+|.+..++.   .||+|+++.........+.+.+|++++++++||||+++++++.+....      |+|||||
T Consensus        34 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~  113 (323)
T 3qup_A           34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM  113 (323)
T ss_dssp             ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECC
T ss_pred             cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEec
Confidence            7999999999887775   899999987766666778899999999999999999999999877665      9999999


Q ss_pred             CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          72 TGGELFEDIVARE------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        72 ~gg~L~~~l~~~~------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      .+|+|.+++....      .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus       114 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~---~~~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLSRKIYSG  190 (323)
T ss_dssp             TTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC-------
T ss_pred             cCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC---CCEEEeecccccccccc
Confidence            9999999886543      58999999999999999999999999999999999999754   46999999998543211


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..                                                                              
T Consensus       191 ~~------------------------------------------------------------------------------  192 (323)
T 3qup_A          191 DY------------------------------------------------------------------------------  192 (323)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                ........||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..
T Consensus       193 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          193 --------------------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             ----------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             --------------------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence                                      000112347889999999999999999999999999999999 99999999999


Q ss_pred             HHHHHHhcccCCCCCCccc
Q psy2131         305 RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~~  323 (328)
                      .+...+..+.....|...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~  265 (323)
T 3qup_A          247 EIYNYLIGGNRLKQPPECM  265 (323)
T ss_dssp             GHHHHHHTTCCCCCCTTCC
T ss_pred             HHHHHHhcCCCCCCCCccC
Confidence            9999999888766665544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.4e-43  Score=343.51  Aligned_cols=217  Identities=21%  Similarity=0.338  Sum_probs=183.7

Q ss_pred             CCceEEEEEEE--ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQ--KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~--~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+  +.+++.||||+++.........+.+.+|+++|++++|||||++++++.++ ..|+|||||++|+|.+
T Consensus       380 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~  458 (635)
T 4fl3_A          380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNK  458 (635)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHH
T ss_pred             CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHH
Confidence            89999999954  56778999999987655555667899999999999999999999999754 5899999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+++.+......          
T Consensus       459 ~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~---~~~kL~DFGla~~~~~~~~~----------  525 (635)
T 4fl3_A          459 YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENY----------  525 (635)
T ss_dssp             HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCTTHHHHTTC--------------
T ss_pred             HHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---CCEEEEEcCCccccccCccc----------
Confidence            99888889999999999999999999999999999999999999865   46999999998654221100          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       526 --------------------------------------------------------------------------------  525 (635)
T 4fl3_A          526 --------------------------------------------------------------------------------  525 (635)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                   ........||+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..+....
T Consensus       526 -------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  592 (635)
T 4fl3_A          526 -------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG  592 (635)
T ss_dssp             ----------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             -------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                         000112347889999999999999999999999999999998 999999999999999999998877


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       593 ~p~~~~~  599 (635)
T 4fl3_A          593 CPAGCPR  599 (635)
T ss_dssp             CCTTCCH
T ss_pred             CCCCCCH
Confidence            7776653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-42  Score=306.47  Aligned_cols=210  Identities=25%  Similarity=0.374  Sum_probs=176.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+++.||+|+++...........+.+|+.++..+ +||||+++++++.+.+..|+|||||+|++|.++
T Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  101 (289)
T 1x8b_A           22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADA  101 (289)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHH
Confidence            7899999999999999999999987766666667788999999999 999999999999999999999999999999999


Q ss_pred             HHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC----------------CCCcEEEeecccc
Q psy2131          80 IVAR----EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA----------------KGAAVKLADFGLA  139 (328)
Q Consensus        80 l~~~----~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~----------------~~~~vkl~DfGla  139 (328)
                      +...    ..+++.++..++.|++.||.|||++||+||||||+|||++.++                ....+||+|||++
T Consensus       102 l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~  181 (289)
T 1x8b_A          102 ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV  181 (289)
T ss_dssp             HHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTC
T ss_pred             HHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccc
Confidence            8764    6799999999999999999999999999999999999998554                4456999999987


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      ......                                                                          
T Consensus       182 ~~~~~~--------------------------------------------------------------------------  187 (289)
T 1x8b_A          182 TRISSP--------------------------------------------------------------------------  187 (289)
T ss_dssp             EETTCS--------------------------------------------------------------------------
T ss_pred             cccCCc--------------------------------------------------------------------------
Confidence            543110                                                                          


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPF  298 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf  298 (328)
                                                          ....||+.|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus       188 ------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          188 ------------------------------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ------------------------------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ------------------------------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                                                012489999999999876 6678999999999999999999988


Q ss_pred             CCccHHHHHHHHhcccCCCCCCccc
Q psy2131         299 WDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       299 ~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      ...+.   +..+.++.....|...+
T Consensus       232 ~~~~~---~~~~~~~~~~~~~~~~~  253 (289)
T 1x8b_A          232 RNGDQ---WHEIRQGRLPRIPQVLS  253 (289)
T ss_dssp             SSSHH---HHHHHTTCCCCCSSCCC
T ss_pred             cchhH---HHHHHcCCCCCCCcccC
Confidence            76643   45566676655554443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.5e-43  Score=315.09  Aligned_cols=215  Identities=23%  Similarity=0.357  Sum_probs=183.4

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .++..||+|++... ......+.+.+|++++++++||||+++++++.+.+..|+|||||+||+
T Consensus        34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  112 (314)
T 2ivs_A           34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS  112 (314)
T ss_dssp             CSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCC
Confidence            899999999883     45689999999754 345667788999999999999999999999999999999999999999


Q ss_pred             cHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          76 LFEDIVAREF------------------------YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        76 L~~~l~~~~~------------------------~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      |.+++.....                        +++.++..++.|++.||.|||++||+||||||+|||++.+   +.+
T Consensus       113 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~---~~~  189 (314)
T 2ivs_A          113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG---RKM  189 (314)
T ss_dssp             HHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT---TEE
T ss_pred             HHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCC---CCE
Confidence            9999876543                        8999999999999999999999999999999999999754   469


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||++.........                                                               
T Consensus       190 kl~Dfg~~~~~~~~~~~---------------------------------------------------------------  206 (314)
T 2ivs_A          190 KISDFGLSRDVYEEDSY---------------------------------------------------------------  206 (314)
T ss_dssp             EECCCTTCEECTTTSCE---------------------------------------------------------------
T ss_pred             EEccccccccccccccc---------------------------------------------------------------
Confidence            99999998654221100                                                               


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                               .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       207 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  245 (314)
T 2ivs_A          207 -----------------------------------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI  245 (314)
T ss_dssp             -----------------------------------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             -----------------------------------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence                                                     001123478899999999999999999999999999999


Q ss_pred             Hh-cCCCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         292 LV-GYPPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       292 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      +| |+.||.+.+...+...+..+.....|..++
T Consensus       246 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (314)
T 2ivs_A          246 VTLGGNPYPGIPPERLFNLLKTGHRMERPDNCS  278 (314)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             HhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCC
Confidence            99 999999999999999999988766665544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.3e-43  Score=315.25  Aligned_cols=204  Identities=28%  Similarity=0.457  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.+.+
T Consensus        36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~  115 (331)
T 4aaa_A           36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE  115 (331)
T ss_dssp             GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH
T ss_pred             cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHH
Confidence            89999999999999999999999877666666677889999999999999999999999999999999999999888877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......              
T Consensus       116 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~--------------  178 (331)
T 4aaa_A          116 LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPG--------------  178 (331)
T ss_dssp             HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCTTC---------------------
T ss_pred             hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---CcEEEEeCCCceeecCCc--------------
Confidence            777889999999999999999999999999999999999999754   469999999975431100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       179 --------------------------------------------------------------------------------  178 (331)
T 4aaa_A          179 --------------------------------------------------------------------------------  178 (331)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                  .......||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+...
T Consensus       179 ------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  240 (331)
T 4aaa_A          179 ------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC  240 (331)
T ss_dssp             -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ------------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence                        001123589999999999876 7899999999999999999999999999887777776544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-43  Score=331.85  Aligned_cols=139  Identities=27%  Similarity=0.404  Sum_probs=120.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-----~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+++.+|+.||||++..........+++.+|+++|++++|||||++++++..     ...+|+||||+. |+
T Consensus        64 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~  142 (458)
T 3rp9_A           64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SD  142 (458)
T ss_dssp             ----CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EE
T ss_pred             cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cc
Confidence            899999999999999999999998766666677889999999999999999999999943     357999999985 68


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ  143 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~  143 (328)
                      |.+.+.....+++..+..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+...
T Consensus       143 L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          143 FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD---CSVKVCDFGLARTVD  207 (458)
T ss_dssp             HHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTTCBCTT
T ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC---CCEeecccccchhcc
Confidence            99988888889999999999999999999999999999999999999754   469999999997653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.8e-43  Score=322.80  Aligned_cols=207  Identities=26%  Similarity=0.414  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+.. ++.||||++..........+.+.+|+.+|++++  |||||++++++...+.+|+||| +.+++|.+
T Consensus        67 G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~  144 (390)
T 2zmd_A           67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS  144 (390)
T ss_dssp             CSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHH
T ss_pred             CCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHH
Confidence            8999999998865 899999999887777777788999999999996  5999999999999999999999 66889999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.||+.||.|||++||+||||||+|||++.    +.+||+|||++........           
T Consensus       145 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~~~-----------  209 (390)
T 2zmd_A          145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTT-----------  209 (390)
T ss_dssp             HHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC----------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCCCc-----------
Confidence            9998889999999999999999999999999999999999999942    4699999999865321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       210 --------------------------------------------------------------------------------  209 (390)
T 2zmd_A          210 --------------------------------------------------------------------------------  209 (390)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----------CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----------EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRL  306 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~  306 (328)
                                   .......+||+.|+|||++.+           ..|+.++|||||||+||||++|++||.+.. ....
T Consensus       210 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~  276 (390)
T 2zmd_A          210 -------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  276 (390)
T ss_dssp             -----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             -------------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence                         000123469999999999976           468999999999999999999999998763 4455


Q ss_pred             HHHHhcccCCC
Q psy2131         307 YAQIKAGAYDD  317 (328)
Q Consensus       307 ~~~i~~~~~~~  317 (328)
                      +..+..+....
T Consensus       277 ~~~~~~~~~~~  287 (390)
T 2zmd_A          277 LHAIIDPNHEI  287 (390)
T ss_dssp             HHHHHCTTSCC
T ss_pred             HHHHhCccccC
Confidence            66666655543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.4e-43  Score=308.31  Aligned_cols=208  Identities=30%  Similarity=0.572  Sum_probs=181.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+.
T Consensus        25 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  104 (284)
T 2vgo_A           25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKE  104 (284)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHH
Confidence            899999999999999999999997542211 1235688999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus       105 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~~~-------------  168 (284)
T 2vgo_A          105 LQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSLR-------------  168 (284)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---CCEEECCCTTCEECSSSC-------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---CCEEEecccccccCcccc-------------
Confidence            9888889999999999999999999999999999999999999754   459999999875431100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (284)
T 2vgo_A          169 --------------------------------------------------------------------------------  168 (284)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+..+....|+
T Consensus       169 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (284)
T 2vgo_A          169 ---------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP  233 (284)
T ss_dssp             ---------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred             ---------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC
Confidence                           11235899999999999999999999999999999999999999999999999999888775543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=319.63  Aligned_cols=215  Identities=25%  Similarity=0.420  Sum_probs=183.5

Q ss_pred             CCceEEEEEEEccC-------CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKAT-------GLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~-------~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||+||+|.+..+       +..||+|+++.. ......+.+.+|+++++++ +|||||++++++.+.+..|+|||||+
T Consensus        80 G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  158 (382)
T 3tt0_A           80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  158 (382)
T ss_dssp             CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             CCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecC
Confidence            89999999997543       357999999765 3455667889999999999 99999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      ||+|.+++....                .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DF  235 (382)
T 3tt0_A          159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADF  235 (382)
T ss_dssp             TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSC
T ss_pred             CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC---CcEEEccc
Confidence            999999997653                48999999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       236 G~a~~~~~~~~~--------------------------------------------------------------------  247 (382)
T 3tt0_A          236 GLARDIHHIDYY--------------------------------------------------------------------  247 (382)
T ss_dssp             SCCCCSSCCCTT--------------------------------------------------------------------
T ss_pred             Cccccccccccc--------------------------------------------------------------------
Confidence            998654221100                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus       248 ------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          248 ------------------------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             ------------------------------------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ------------------------------------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence                                                00112347889999999999999999999999999999999 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .||.+.+..++...+..+.....|..++
T Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (382)
T 3tt0_A          292 SPYPGVPVEELFKLLKEGHRMDKPSNCT  319 (382)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCSSCC
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence            9999999999999999998766666554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.8e-43  Score=321.11  Aligned_cols=199  Identities=31%  Similarity=0.465  Sum_probs=161.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..+|+.||||++..........+++.+|+++|+.++||||+++++++...      ...|+||||+ ++
T Consensus        40 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~  118 (367)
T 2fst_X           40 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA  118 (367)
T ss_dssp             ---CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CE
T ss_pred             cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CC
Confidence            8999999999999999999999987666666677889999999999999999999999754      5689999999 67


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++....          
T Consensus       119 ~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kL~DFG~a~~~~~----------  184 (367)
T 2fst_X          119 DLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTAD----------  184 (367)
T ss_dssp             ECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECC-------------------
T ss_pred             CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC---CCEEEeeccccccccc----------
Confidence            88877754 679999999999999999999999999999999999999754   4699999999743210          


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (367)
T 2fst_X          185 --------------------------------------------------------------------------------  184 (367)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                         ......||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..|.+.
T Consensus       185 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~  245 (367)
T 2fst_X          185 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  245 (367)
T ss_dssp             -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             -------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                               0112458999999999987 68899999999999999999999999999988888887764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-42  Score=303.89  Aligned_cols=211  Identities=24%  Similarity=0.364  Sum_probs=181.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+. ++..||+|+++......   +.+.+|++++++++||||+++++++.+.+..|+|||||+|++|.+++
T Consensus        19 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (268)
T 3sxs_A           19 GQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL   94 (268)
T ss_dssp             ETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             CCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHH
Confidence            799999999775 57789999998665443   45789999999999999999999999999999999999999999998


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus        95 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~------------  159 (268)
T 3sxs_A           95 RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD---LCVKVSDFGMTRYVLDDQY------------  159 (268)
T ss_dssp             HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT---CCEEECCTTCEEECCTTCE------------
T ss_pred             HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC---CCEEEccCccceecchhhh------------
Confidence            7654 59999999999999999999999999999999999999754   4699999999865422110            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (268)
T 3sxs_A          160 --------------------------------------------------------------------------------  159 (268)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   ....+..||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+.......+..+.....
T Consensus       160 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (268)
T 3sxs_A          160 -------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR  226 (268)
T ss_dssp             -------------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             -------------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC
Confidence                         00112347888999999999999999999999999999999 9999999999999999999887766


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |...+
T Consensus       227 ~~~~~  231 (268)
T 3sxs_A          227 PHLAS  231 (268)
T ss_dssp             CTTSC
T ss_pred             CCcCh
Confidence            65543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-42  Score=305.28  Aligned_cols=204  Identities=27%  Similarity=0.477  Sum_probs=176.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..++..||+|++..........+.+.+|+.++++++||||+++++++..    ...+|+|||||++|+|
T Consensus        37 G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L  116 (290)
T 1t4h_A           37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL  116 (290)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBH
T ss_pred             CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCH
Confidence            899999999999999999999999877777778889999999999999999999999875    4568999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+++.....+++..+..++.|++.||.|||+++  |+||||||+|||++.  .++.+||+|||++......         
T Consensus       117 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~~~~~~---------  185 (290)
T 1t4h_A          117 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRAS---------  185 (290)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGGCCTT---------
T ss_pred             HHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCccccccc---------
Confidence            999988888999999999999999999999999  999999999999963  2356999999997432110         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (290)
T 1t4h_A          186 --------------------------------------------------------------------------------  185 (290)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~  313 (328)
                                         ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+. +...+...+..+
T Consensus       186 -------------------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (290)
T 1t4h_A          186 -------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             -------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             -------------------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence                               0112358999999999875 5999999999999999999999999984 566667776666


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       246 ~~  247 (290)
T 1t4h_A          246 VK  247 (290)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.1e-43  Score=317.72  Aligned_cols=214  Identities=26%  Similarity=0.373  Sum_probs=177.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--------CCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--------ENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--------~~~~~lv~E~~~   72 (328)
                      |+||+||+|++..+|+.||+|++............+.+|+++++.++||||+++++++.+        .+.+|+|||||+
T Consensus        28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~  107 (351)
T 3mi9_A           28 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE  107 (351)
T ss_dssp             CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS
T ss_pred             CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC
Confidence            899999999999999999999997765544445567899999999999999999999987        456899999998


Q ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          73 GGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        73 gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      | +|.+.+... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........   
T Consensus       108 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~---  180 (351)
T 3mi9_A          108 H-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNS---  180 (351)
T ss_dssp             E-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCCCSSS---
T ss_pred             C-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CCEEEccchhcccccccccc---
Confidence            6 777776554 579999999999999999999999999999999999999754   46999999998654321100   


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (351)
T 3mi9_A          181 --------------------------------------------------------------------------------  180 (351)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                         .........||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+.......|
T Consensus       181 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  241 (351)
T 3mi9_A          181 -------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  241 (351)
T ss_dssp             -------------------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             -------------------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                               0000112468999999999986 56899999999999999999999999999999999988


Q ss_pred             hcccCCCCCC
Q psy2131         311 KAGAYDDEPK  320 (328)
Q Consensus       311 ~~~~~~~~~~  320 (328)
                      .+.....+|.
T Consensus       242 ~~~~~~~~~~  251 (351)
T 3mi9_A          242 SQLCGSITPE  251 (351)
T ss_dssp             HHHHCCCCTT
T ss_pred             HHHhCCCChh
Confidence            8766655544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.4e-43  Score=314.82  Aligned_cols=214  Identities=22%  Similarity=0.328  Sum_probs=172.5

Q ss_pred             CCceEEEEEEEccCCcEE----EEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEF----AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~----AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|++..+++.+    |+|.++... .....+.+.+|+.++++++||||+++++++.+.. .++|+||+.+|+|
T Consensus        26 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L  103 (327)
T 3poz_A           26 GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL  103 (327)
T ss_dssp             ETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBH
T ss_pred             CCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcH
Confidence            799999999998888765    677665332 2334567889999999999999999999998765 7899999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++........       
T Consensus       104 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~-------  173 (327)
T 3poz_A          104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKE-------  173 (327)
T ss_dssp             HHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTHHHHHTTTCC--------
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC---CEEEccCcceeEccCCccc-------
Confidence            999876 45799999999999999999999999999999999999998654   5999999998543211100       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (327)
T 3poz_A          174 --------------------------------------------------------------------------------  173 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+...+...+..+.
T Consensus       174 -----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  236 (327)
T 3poz_A          174 -----------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  236 (327)
T ss_dssp             -----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             -----------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence                             00112347889999999999999999999999999999999 999999999999999998888


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ..+.|..++
T Consensus       237 ~~~~~~~~~  245 (327)
T 3poz_A          237 RLPQPPICT  245 (327)
T ss_dssp             CCCCCTTBC
T ss_pred             CCCCCccCC
Confidence            766665554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-41  Score=300.24  Aligned_cols=222  Identities=32%  Similarity=0.572  Sum_probs=189.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..++..+|+|++..... ....+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+.+
T Consensus        33 G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  111 (285)
T 3is5_A           33 GAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI  111 (285)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHH
T ss_pred             CCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHH
Confidence            8999999999999999999999976542 223567889999999999999999999999999999999999999999888


Q ss_pred             Hh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-----------
Q psy2131          81 VA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-----------  145 (328)
Q Consensus        81 ~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-----------  145 (328)
                      ..    ...+++..+..++.|++.||.|||++||+||||||+|||++..+..+.+||+|||++......           
T Consensus       112 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~  191 (285)
T 3is5_A          112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL  191 (285)
T ss_dssp             HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGG
T ss_pred             HhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccC
Confidence            54    367999999999999999999999999999999999999976555677999999998643211           


Q ss_pred             --------------Ccc-hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCC
Q psy2131         146 --------------QQA-WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       146 --------------~~~-~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                                    .+. .+|+++|+|++|..||.+.+.......+......++. .....++++.+++.+||..||.+|
T Consensus       192 y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R  270 (285)
T 3is5_A          192 YMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERR  270 (285)
T ss_dssp             GCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTS
T ss_pred             cCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhC
Confidence                          112 3799999999999999998888777776665544433 223478999999999999999999


Q ss_pred             CCHHHHhcCcccCC
Q psy2131         211 ITASEALKHPWICQ  224 (328)
Q Consensus       211 ~t~~~~l~h~~~~~  224 (328)
                      ||+.|+++|||+.+
T Consensus       271 ps~~e~l~hp~f~~  284 (285)
T 3is5_A          271 PSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCHHHHHTSGGGGC
T ss_pred             cCHHHHhcCHHhhc
Confidence            99999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.8e-42  Score=300.59  Aligned_cols=222  Identities=39%  Similarity=0.752  Sum_probs=198.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..++..+|+|++......  ..+.+.+|++++++++||||+++++++.+.+..|+|||||+|++|.+.+
T Consensus        20 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   97 (277)
T 3f3z_A           20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV   97 (277)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             cCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHH
Confidence            79999999999999999999999765432  3567889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+|||+..++.++.+||+|||++......               
T Consensus        98 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aP  177 (277)
T 3f3z_A           98 VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP  177 (277)
T ss_dssp             HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCH
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccCh
Confidence            88888999999999999999999999999999999999999965555677999999998643211               


Q ss_pred             ----------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         146 ----------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       146 ----------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                                .+.| +|+++|+|++|..||...+.......+..+...++...+..+++++.+++.+||..||.+|||+.
T Consensus       178 E~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~  257 (277)
T 3f3z_A          178 QVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL  257 (277)
T ss_dssp             HHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHH
Confidence                      1123 89999999999999999999888889988888887777778999999999999999999999999


Q ss_pred             HHhcCcccCC
Q psy2131         215 EALKHPWICQ  224 (328)
Q Consensus       215 ~~l~h~~~~~  224 (328)
                      ++++|||+.+
T Consensus       258 ~~l~h~~~~~  267 (277)
T 3f3z_A          258 QALEHEWFEK  267 (277)
T ss_dssp             HHTTSHHHHH
T ss_pred             HHhcCHHHhc
Confidence            9999999853

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.5e-43  Score=319.35  Aligned_cols=215  Identities=22%  Similarity=0.355  Sum_probs=176.3

Q ss_pred             CCceEEEEEE-----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC-EEEEEEEccCC
Q psy2131           1 GAFSVVRRCV-----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEEN-YHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~-----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~-~~~lv~E~~~g   73 (328)
                      |+||.||+|.     +..+++.||||+++.. ......+.+.+|+++++++ +|||||++++++.+.+ .+|+|||||+|
T Consensus        33 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~  111 (359)
T 3vhe_A           33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  111 (359)
T ss_dssp             CSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTT
T ss_pred             CCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCC
Confidence            8999999998     5667799999999754 3445567789999999999 8999999999998755 48999999999


Q ss_pred             CCcHHHHHhcCC------------------------------------------------------------------CC
Q psy2131          74 GELFEDIVAREF------------------------------------------------------------------YS   87 (328)
Q Consensus        74 g~L~~~l~~~~~------------------------------------------------------------------~~   87 (328)
                      |+|.+++.....                                                                  ++
T Consensus       112 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  191 (359)
T 3vhe_A          112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT  191 (359)
T ss_dssp             EEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBC
T ss_pred             CcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccC
Confidence            999999876432                                                                  89


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCC
Q psy2131          88 EADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDE  167 (328)
Q Consensus        88 ~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~  167 (328)
                      +.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........                   
T Consensus       192 ~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~-------------------  249 (359)
T 3vhe_A          192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDY-------------------  249 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTSCTTC-------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CcEEEEeccceeeecccccc-------------------
Confidence            99999999999999999999999999999999999754   45999999998643211100                   


Q ss_pred             cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHh
Q psy2131         168 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNAR  247 (328)
Q Consensus       168 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (328)
                                                                                                      
T Consensus       250 --------------------------------------------------------------------------------  249 (359)
T 3vhe_A          250 --------------------------------------------------------------------------------  249 (359)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCcc-HHHHHHHHhcccCCCCCCccc
Q psy2131         248 RKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDED-QHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       248 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  323 (328)
                           .......||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+ ...+...+..+.....|...+
T Consensus       250 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (359)
T 3vhe_A          250 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT  322 (359)
T ss_dssp             -----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred             -----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence                 01112458999999999999999999999999999999999 999999886 556666666666555554443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.2e-42  Score=302.83  Aligned_cols=223  Identities=42%  Similarity=0.781  Sum_probs=201.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+||||+++++|.+.+
T Consensus        33 G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  112 (287)
T 2wei_A           33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI  112 (287)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHH
Confidence            78999999999999999999999866554555678899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC--------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ--------------  146 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~--------------  146 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++.......              
T Consensus       113 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aP  192 (287)
T 2wei_A          113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP  192 (287)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCH
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccCh
Confidence            888889999999999999999999999999999999999999876666679999999986543211              


Q ss_pred             -----------cc-hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         147 -----------QA-WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       147 -----------~~-~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                                 +. .+|+++++|++|..||.+.+.......+..+...++.+.+..+++++.+++.+||..||.+|||+.
T Consensus       193 E~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  272 (287)
T 2wei_A          193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT  272 (287)
T ss_dssp             HHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHH
Confidence                       22 389999999999999999998888888888888877777788999999999999999999999999


Q ss_pred             HHhcCcccC
Q psy2131         215 EALKHPWIC  223 (328)
Q Consensus       215 ~~l~h~~~~  223 (328)
                      ++++|||+.
T Consensus       273 ell~hp~~~  281 (287)
T 2wei_A          273 QCLEHPWIQ  281 (287)
T ss_dssp             HHHHSHHHH
T ss_pred             HHhcCHHHh
Confidence            999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-41  Score=306.34  Aligned_cols=227  Identities=39%  Similarity=0.691  Sum_probs=197.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|++..+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.+.+..|+|||||+|++|
T Consensus        23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  102 (321)
T 2a2a_A           23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL  102 (321)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcH
Confidence            899999999999999999999998654322    1356788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC-CCcEEEeeccccccccCC----------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLAIEVQGE----------  145 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~-~~~vkl~DfGla~~~~~~----------  145 (328)
                      .+++.....+++.++..++.|++.||.|||++||+||||||+|||++.++. ...+||+|||++......          
T Consensus       103 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~  182 (321)
T 2a2a_A          103 FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP  182 (321)
T ss_dssp             HHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCG
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCC
Confidence            999988888999999999999999999999999999999999999976432 126999999998654221          


Q ss_pred             ----------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         146 ----------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       146 ----------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                                      .+.| +|+++|+|++|..||.+.+.......+......++...+...++.+.+++.+||..||.
T Consensus       183 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  262 (321)
T 2a2a_A          183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETR  262 (321)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTT
T ss_pred             CccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChh
Confidence                            1122 79999999999999999998888888888777766555567899999999999999999


Q ss_pred             CCCCHHHHhcCcccCCccc
Q psy2131         209 KRITASEALKHPWICQRER  227 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~~~  227 (328)
                      +|||+.++++|||+.....
T Consensus       263 ~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          263 KRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             TSCCHHHHHHSTTTSCSSH
T ss_pred             hCcCHHHHhcCccccCCCc
Confidence            9999999999999976543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-42  Score=305.59  Aligned_cols=211  Identities=23%  Similarity=0.376  Sum_probs=179.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+. ++..||+|++.......   +.+.+|++++++++||||+++++++.+.+..|+|||||+|++|.+++
T Consensus        35 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (283)
T 3gen_A           35 GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL  110 (283)
T ss_dssp             --CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHH
T ss_pred             CCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHH
Confidence            899999999876 67789999998665443   45789999999999999999999999999999999999999999998


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus       111 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~-------------  174 (283)
T 3gen_A          111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDE-------------  174 (283)
T ss_dssp             HCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT---SCEEECSTTGGGGBCCHH-------------
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC---CCEEEccccccccccccc-------------
Confidence            76 4679999999999999999999999999999999999999754   469999999985432100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (283)
T 3gen_A          175 --------------------------------------------------------------------------------  174 (283)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                  ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.......+..+.....
T Consensus       175 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (283)
T 3gen_A          175 ------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR  242 (283)
T ss_dssp             ------------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             ------------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence                        001122347889999999999999999999999999999999 9999999999999999999877666


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |...+
T Consensus       243 ~~~~~  247 (283)
T 3gen_A          243 PHLAS  247 (283)
T ss_dssp             CTTCC
T ss_pred             CCcCC
Confidence            65543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-42  Score=308.52  Aligned_cols=216  Identities=21%  Similarity=0.349  Sum_probs=180.0

Q ss_pred             CCceEEEEEE--EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCV--QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~--~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.  +..+++.||+|+++.........+.+.+|+++++.++||||+++++++ ..+..|+||||+++++|.+
T Consensus        28 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~  106 (291)
T 1xbb_A           28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNK  106 (291)
T ss_dssp             CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHH
T ss_pred             ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHH
Confidence            8999999994  467789999999987655555567899999999999999999999999 5667899999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..........         
T Consensus       107 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~---------  174 (291)
T 1xbb_A          107 YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYY---------  174 (291)
T ss_dssp             HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCSEE---------
T ss_pred             HHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC---CcEEEccCCcceeeccCCCcc---------
Confidence            99888889999999999999999999999999999999999999865   469999999986542211000         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (291)
T 1xbb_A          175 --------------------------------------------------------------------------------  174 (291)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+...+..+....
T Consensus       175 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  240 (291)
T 1xbb_A          175 --------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG  240 (291)
T ss_dssp             --------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00111247889999999999999999999999999999999 999999999999999999887655


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       241 ~~~~~~  246 (291)
T 1xbb_A          241 CPAGCP  246 (291)
T ss_dssp             CCTTCC
T ss_pred             CCCCCC
Confidence            555443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-42  Score=313.36  Aligned_cols=218  Identities=24%  Similarity=0.371  Sum_probs=182.0

Q ss_pred             CCceEEEEEE-----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCV-----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~-----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.     +..+++.||+|++... ........+.+|+.++++++||||+++++++.+.+..|+|||||+||+
T Consensus        41 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  119 (327)
T 2yfx_A           41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD  119 (327)
T ss_dssp             -CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred             CCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCc
Confidence            8999999998     6678899999999743 344556678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          76 LFEDIVARE-------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        76 L~~~l~~~~-------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      |.+++....       .+++.++..++.|++.||.|||++||+||||||+|||++.+++...+||+|||++........ 
T Consensus       120 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-  198 (327)
T 2yfx_A          120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-  198 (327)
T ss_dssp             HHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC----
T ss_pred             HHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc-
Confidence            999997653       489999999999999999999999999999999999998766667799999998753211000 


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       199 --------------------------------------------------------------------------------  198 (327)
T 2yfx_A          199 --------------------------------------------------------------------------------  198 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHH
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLY  307 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~  307 (328)
                                             ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+.
T Consensus       199 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          199 -----------------------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             --------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             -----------------------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence                                   000112358999999999999999999999999999999998 99999999999999


Q ss_pred             HHHhcccCCCCCCccc
Q psy2131         308 AQIKAGAYDDEPKHKS  323 (328)
Q Consensus       308 ~~i~~~~~~~~~~~~~  323 (328)
                      ..+..+....+|..++
T Consensus       256 ~~~~~~~~~~~~~~~~  271 (327)
T 2yfx_A          256 EFVTSGGRMDPPKNCP  271 (327)
T ss_dssp             HHHHTTCCCCCCTTCC
T ss_pred             HHHhcCCCCCCCCCCC
Confidence            9999988766666554

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.5e-43  Score=315.53  Aligned_cols=216  Identities=22%  Similarity=0.315  Sum_probs=178.0

Q ss_pred             CCceEEEEEEEccCCcE----EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLE----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~----~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..+++.    +|+|++.... .......+.+|+.++++++||||+++++++.+ +..|+|||||.+|+|
T Consensus        24 G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L  101 (325)
T 3kex_A           24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSL  101 (325)
T ss_dssp             CSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBS
T ss_pred             cCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCH
Confidence            89999999999988887    6777765332 12223456789999999999999999999864 568999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... +.+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++........       
T Consensus       102 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~-------  171 (325)
T 3kex_A          102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP---SQVQVADFGVADLLPPDDKQ-------  171 (325)
T ss_dssp             HHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS---SCEEECSCSGGGGSCCCTTC-------
T ss_pred             HHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC---CeEEECCCCcccccCccccc-------
Confidence            9998764 579999999999999999999999999999999999999654   45999999998654221100       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (325)
T 3kex_A          172 --------------------------------------------------------------------------------  171 (325)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+...+...+..+.
T Consensus       172 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  234 (325)
T 3kex_A          172 -----------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE  234 (325)
T ss_dssp             -----------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred             -----------------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence                             00112347889999999999999999999999999999999 999999999999999999998


Q ss_pred             CCCCCCccccC
Q psy2131         315 YDDEPKHKSAS  325 (328)
Q Consensus       315 ~~~~~~~~~~~  325 (328)
                      ....|..++..
T Consensus       235 ~~~~~~~~~~~  245 (325)
T 3kex_A          235 RLAQPQICTID  245 (325)
T ss_dssp             BCCCCTTBCTT
T ss_pred             CCCCCCcCcHH
Confidence            77777665543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-42  Score=306.11  Aligned_cols=213  Identities=26%  Similarity=0.371  Sum_probs=171.4

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+   +..+|+|++.... .....+.+.+|+.++++++||||+++++++. .+..|+||||+++|+|.
T Consensus        26 G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~  103 (281)
T 1mp8_A           26 GQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELR  103 (281)
T ss_dssp             CSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHH
T ss_pred             cCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHH
Confidence            89999999998654   4569999987542 3445677899999999999999999999984 45689999999999999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........         
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~---------  171 (281)
T 1mp8_A          104 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTY---------  171 (281)
T ss_dssp             HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECC---------------------
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC---CCEEECccccccccCcccc---------
Confidence            9987654 69999999999999999999999999999999999999865   4699999999754311000         


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (281)
T 1mp8_A          172 --------------------------------------------------------------------------------  171 (281)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+...+...+..+..
T Consensus       172 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~  235 (281)
T 1mp8_A          172 ----------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  235 (281)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             ----------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence                            00011247889999999999999999999999999999997 9999999998899999998877


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       236 ~~~~~~~~  243 (281)
T 1mp8_A          236 LPMPPNCP  243 (281)
T ss_dssp             CCCCTTCC
T ss_pred             CCCCCCCC
Confidence            66665554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=315.47  Aligned_cols=208  Identities=29%  Similarity=0.389  Sum_probs=169.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+++.||+|+++..... .....+.+|+++|++++||||+++++++.+.+..|+|||||+| +|.+.+
T Consensus        13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~   90 (324)
T 3mtl_A           13 GTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL   90 (324)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHH
Confidence            89999999999999999999999754321 1112345799999999999999999999999999999999985 888888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~-------------  154 (324)
T 3mtl_A           91 DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT-------------  154 (324)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---CCEEECSSSEEECC-----------------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---CCEEEccCcccccccCCc-------------
Confidence            765 459999999999999999999999999999999999999754   459999999985421100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       155 --------------------------------------------------------------------------------  154 (324)
T 3mtl_A          155 --------------------------------------------------------------------------------  154 (324)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+.......|.+..-.++
T Consensus       155 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T 3mtl_A          155 -------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT  221 (324)
T ss_dssp             ---------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             -------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence                         00112358999999999987 6789999999999999999999999999999998888877554443


Q ss_pred             C
Q psy2131         319 P  319 (328)
Q Consensus       319 ~  319 (328)
                      +
T Consensus       222 ~  222 (324)
T 3mtl_A          222 E  222 (324)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=307.80  Aligned_cols=208  Identities=34%  Similarity=0.628  Sum_probs=154.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..|+|||||++++|.++
T Consensus        22 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  101 (278)
T 3cok_A           22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRY  101 (278)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHH
T ss_pred             CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHH
Confidence            899999999999999999999997542211 1246788999999999999999999999999999999999999999998


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus       102 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~~-----------  167 (278)
T 3cok_A          102 LKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPHE-----------  167 (278)
T ss_dssp             HHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT---CCEEECCCTTCEECC---------------
T ss_pred             HhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEEeecceeeccCCCC-----------
Confidence            8765 579999999999999999999999999999999999999754   4699999999754321000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (278)
T 3cok_A          168 --------------------------------------------------------------------------------  167 (278)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                     ......||+.|+|||++.+..++.++|+|||||++|||++|++||...+.......+....+..
T Consensus       168 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  231 (278)
T 3cok_A          168 ---------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM  231 (278)
T ss_dssp             ---------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC
T ss_pred             ---------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC
Confidence                           0012358999999999999999999999999999999999999999888777777776666543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.4e-42  Score=307.41  Aligned_cols=206  Identities=26%  Similarity=0.388  Sum_probs=170.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.++
T Consensus        45 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  124 (309)
T 2h34_A           45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAM  124 (309)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHH
T ss_pred             CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHH
Confidence            89999999999999999999999865433 33456789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       125 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~------------  189 (309)
T 2h34_A          125 LRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDEKL------------  189 (309)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSCCC---------------------
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---CCEEEecCccCcccccccc------------
Confidence            9888889999999999999999999999999999999999999754   4699999999743211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       190 --------------------------------------------------------------------------------  189 (309)
T 2h34_A          190 --------------------------------------------------------------------------------  189 (309)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                   .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+...+....
T Consensus       190 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (309)
T 2h34_A          190 -------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI  251 (309)
T ss_dssp             --------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC
T ss_pred             -------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC
Confidence                         00112358999999999999999999999999999999999999999998877777666544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-42  Score=324.03  Aligned_cols=139  Identities=30%  Similarity=0.456  Sum_probs=126.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+++.+|+.||||+++.........+++.+|+++|++++||||+++++++...     +.+|+|||||.+ +
T Consensus        37 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~  115 (432)
T 3n9x_A           37 GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-D  115 (432)
T ss_dssp             ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-E
T ss_pred             cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-C
Confidence            7999999999999999999999987666666778899999999999999999999999876     579999999974 9


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ  143 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~  143 (328)
                      |.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+...
T Consensus       116 L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          116 LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD---CSVKVCDFGLARTIN  180 (432)
T ss_dssp             HHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEEC-
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC---CCEEEccCCCccccc
Confidence            99999888889999999999999999999999999999999999999754   569999999997653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=312.28  Aligned_cols=202  Identities=27%  Similarity=0.446  Sum_probs=167.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+ .+++.||||++..........+.+.+|+.+|++++|  |||+++++++.+.+..|+||| +.+++|.+
T Consensus        20 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~   97 (343)
T 3dbq_A           20 GGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS   97 (343)
T ss_dssp             CSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHH
T ss_pred             CCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHH
Confidence            89999999987 468999999998877777777889999999999987  999999999999999999999 56789999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.|++.||.|||++||+||||||+|||++    ++.+||+|||++........           
T Consensus        98 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~-----------  162 (343)
T 3dbq_A           98 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT-----------  162 (343)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC----------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCcccc-----------
Confidence            999888999999999999999999999999999999999999995    24699999999865321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (343)
T 3dbq_A          163 --------------------------------------------------------------------------------  162 (343)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----------CCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----------EPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRL  306 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~  306 (328)
                                   ........||+.|+|||++.+           ..|+.++|||||||++|||++|++||.+. +....
T Consensus       163 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  229 (343)
T 3dbq_A          163 -------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  229 (343)
T ss_dssp             --------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             -------------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence                         000113469999999999975           67899999999999999999999999875 33344


Q ss_pred             HHHHhc
Q psy2131         307 YAQIKA  312 (328)
Q Consensus       307 ~~~i~~  312 (328)
                      +..+..
T Consensus       230 ~~~~~~  235 (343)
T 3dbq_A          230 LHAIID  235 (343)
T ss_dssp             HHHHHC
T ss_pred             HHHHhc
Confidence            444443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.9e-42  Score=303.67  Aligned_cols=208  Identities=39%  Similarity=0.664  Sum_probs=174.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++.+.+..|+|||||++++|.++
T Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  101 (276)
T 2h6d_A           22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDY  101 (276)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHH
Confidence            89999999999999999999999754221 12345788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......             
T Consensus       102 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~-------------  165 (276)
T 2h6d_A          102 ICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMMSDGE-------------  165 (276)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---SCEEECCCCGGGCCCC---------------
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---CCEEEeecccccccCCCc-------------
Confidence            9888889999999999999999999999999999999999999754   459999999975432100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (276)
T 2h6d_A          166 --------------------------------------------------------------------------------  165 (276)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                    ......||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||.+.+...+++.+..+.+..|
T Consensus       166 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  231 (276)
T 2h6d_A          166 --------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP  231 (276)
T ss_dssp             -------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc
Confidence                          0011348999999999998876 6899999999999999999999999999999999998877543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.4e-43  Score=317.04  Aligned_cols=192  Identities=31%  Similarity=0.524  Sum_probs=166.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH------HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|+++.+|+.||||+++.......      ....+.+|+.+|++++||||+++++++.+.+..|+||||+.+|
T Consensus        35 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g  114 (335)
T 3dls_A           35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG  114 (335)
T ss_dssp             SSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTS
T ss_pred             cCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCC
Confidence            8999999999999999999999987654322      3345678999999999999999999999999999999999776


Q ss_pred             -CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 -ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 -~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                       +|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......       
T Consensus       115 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~-------  184 (335)
T 3dls_A          115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED---FTIKLIDFGSAAYLERGK-------  184 (335)
T ss_dssp             CBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECCTTC-------
T ss_pred             ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC---CcEEEeecccceECCCCC-------
Confidence             999999888889999999999999999999999999999999999999754   469999999986542110       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (335)
T 3dls_A          185 --------------------------------------------------------------------------------  184 (335)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                          ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..
T Consensus       185 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  234 (335)
T 3dls_A          185 --------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE  234 (335)
T ss_dssp             --------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred             --------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence                                0112459999999999999887 889999999999999999999998643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=306.91  Aligned_cols=191  Identities=28%  Similarity=0.427  Sum_probs=160.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||++..............+|+..+.++ +||||+++++++.+.+.+|+||||| +++|.+.
T Consensus        68 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~  146 (311)
T 3p1a_A           68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH  146 (311)
T ss_dssp             ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHH
Confidence            7999999999999999999999987666666666666677666655 9999999999999999999999999 6688888


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +... ..+++.++..++.|++.||.|||++||+||||||+|||++.++   .+||+|||++.......            
T Consensus       147 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kl~DFG~a~~~~~~~------------  211 (311)
T 3p1a_A          147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG---RCKLGDFGLLVELGTAG------------  211 (311)
T ss_dssp             HHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG---CEEECCCTTCEECC---------------
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEccceeeeecccCC------------
Confidence            7654 4699999999999999999999999999999999999997654   59999999975432110            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       212 --------------------------------------------------------------------------------  211 (311)
T 3p1a_A          212 --------------------------------------------------------------------------------  211 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                     ......||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+.
T Consensus       212 ---------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~  260 (311)
T 3p1a_A          212 ---------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG  260 (311)
T ss_dssp             ------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH
T ss_pred             ---------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence                           0112358999999999987 799999999999999999999877776543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.5e-42  Score=324.16  Aligned_cols=206  Identities=24%  Similarity=0.380  Sum_probs=177.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-YHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+.  |+.||||+++...    ..+.+.+|+++|++++|||||++++++.+.+ .+|+|||||++|+|.++
T Consensus       204 G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~  277 (450)
T 1k9a_A          204 GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY  277 (450)
T ss_dssp             CSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHH
T ss_pred             cCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHH
Confidence            899999999874  7799999998653    3456889999999999999999999987665 79999999999999999


Q ss_pred             HHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~~--~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +...+.  +++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++.....            
T Consensus       278 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~------------  342 (450)
T 1k9a_A          278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST------------  342 (450)
T ss_dssp             HHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---SCEEECCCTTCEECC--------------
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC---CCEEEeeCCCccccccc------------
Confidence            976543  7999999999999999999999999999999999999754   46999999998542110            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       343 --------------------------------------------------------------------------------  342 (450)
T 1k9a_A          343 --------------------------------------------------------------------------------  342 (450)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                       .....+|+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.+|...
T Consensus       343 -----------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~  405 (450)
T 1k9a_A          343 -----------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  405 (450)
T ss_dssp             ---------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred             -----------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                             001236889999999999999999999999999999999 99999999999999999999776


Q ss_pred             CCCCcccc
Q psy2131         317 DEPKHKSA  324 (328)
Q Consensus       317 ~~~~~~~~  324 (328)
                      ..|..++.
T Consensus       406 ~~p~~~~~  413 (450)
T 1k9a_A          406 DAPDGCPP  413 (450)
T ss_dssp             CCCTTCCH
T ss_pred             CCCCcCCH
Confidence            66766553

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-42  Score=331.15  Aligned_cols=212  Identities=24%  Similarity=0.401  Sum_probs=183.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.++.++..||||+++....   ..+.+.+|+.+|++++|||||++++++.+.+.+|+|||||++|+|.+++
T Consensus       231 G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l  307 (495)
T 1opk_A          231 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  307 (495)
T ss_dssp             GTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHH
Confidence            8999999999999999999999986543   3467889999999999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||++|||||||||+|||++.+   +.+||+|||+++.......           
T Consensus       308 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~-----------  373 (495)
T 1opk_A          308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN---HLVKVADFGLSRLMTGDTY-----------  373 (495)
T ss_dssp             HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEECCTTCCE-----------
T ss_pred             HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC---CcEEEeecccceeccCCce-----------
Confidence            763  458999999999999999999999999999999999999754   4599999999865422110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       374 --------------------------------------------------------------------------------  373 (495)
T 1opk_A          374 --------------------------------------------------------------------------------  373 (495)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    ....+..+|+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+...+...+.++....
T Consensus       374 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  439 (495)
T 1opk_A          374 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  439 (495)
T ss_dssp             --------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             --------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00112346788999999999999999999999999999999 999999999999999998887766


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       440 ~~~~~~  445 (495)
T 1opk_A          440 RPEGCP  445 (495)
T ss_dssp             CCTTCC
T ss_pred             CCCCCC
Confidence            666554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-42  Score=326.04  Aligned_cols=211  Identities=21%  Similarity=0.386  Sum_probs=179.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+. ++..||||+++....   ..+.+.+|+++|++++|||||++++++. .+..|+|||||.+|+|.+++
T Consensus       199 G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l  273 (454)
T 1qcf_A          199 GQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFL  273 (454)
T ss_dssp             CSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHH
T ss_pred             CCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHH
Confidence            899999999885 467899999986543   3567889999999999999999999986 56789999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.|++.||.|||++|||||||||+|||++.+   +.+||+|||+++......            
T Consensus       274 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DFG~a~~~~~~~------------  338 (454)
T 1qcf_A          274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE------------  338 (454)
T ss_dssp             HSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT---CCEEECSTTGGGGBCCHH------------
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC---CcEEEeeCCCceEcCCCc------------
Confidence            754  368999999999999999999999999999999999999754   469999999986542100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       339 --------------------------------------------------------------------------------  338 (454)
T 1qcf_A          339 --------------------------------------------------------------------------------  338 (454)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                   ........+|+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.++...+
T Consensus       339 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~  405 (454)
T 1qcf_A          339 -------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP  405 (454)
T ss_dssp             -------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred             -------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                         001122346888999999999999999999999999999999 999999999999999999998777


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       406 ~~~~~~~  412 (454)
T 1qcf_A          406 RPENCPE  412 (454)
T ss_dssp             CCTTSCH
T ss_pred             CCCCCCH
Confidence            7766553

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-42  Score=311.31  Aligned_cols=213  Identities=30%  Similarity=0.452  Sum_probs=165.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------------------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------------------   62 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------------------   62 (328)
                      |+||.||+|+++.+|+.||||+++... .....+.+.+|+++|++++|||||++++++.+..                  
T Consensus        17 G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (332)
T 3qd2_B           17 GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST   95 (332)
T ss_dssp             C-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccc
Confidence            899999999999999999999998654 2334577899999999999999999999986543                  


Q ss_pred             ---------------------------------------EEEEEEEccCCCCcHHHHHhcCC---CCHHHHHHHHHHHHH
Q psy2131          63 ---------------------------------------YHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILE  100 (328)
Q Consensus        63 ---------------------------------------~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qll~  100 (328)
                                                             ..|+|||||+||+|.+++.....   .++..+..++.|++.
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~  175 (332)
T 3qd2_B           96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE  175 (332)
T ss_dssp             ------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred             cccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHH
Confidence                                                   38999999999999999876543   556678999999999


Q ss_pred             HHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC
Q psy2131         101 SVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGA  180 (328)
Q Consensus       101 ~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~  180 (328)
                      ||.|||++||+||||||+|||++.+   +.+||+|||++............                     .       
T Consensus       176 aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~---------------------~-------  224 (332)
T 3qd2_B          176 AVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTV---------------------L-------  224 (332)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECSCC-----------------------------------
T ss_pred             HHHHHHhCCeeecCCCcccEEEeCC---CCEEEeecCcccccccchhhccc---------------------c-------
Confidence            9999999999999999999999754   46999999998765432110000                     0       


Q ss_pred             CCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccC
Q psy2131         181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAG  260 (328)
Q Consensus       181 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G  260 (328)
                                                                                        .............|
T Consensus       225 ------------------------------------------------------------------~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          225 ------------------------------------------------------------------TPMPAYATHTGQVG  238 (332)
T ss_dssp             -------------------------------------------------------------------------CCCSCC-
T ss_pred             ------------------------------------------------------------------ccccccccccccCC
Confidence                                                                              00000011223569


Q ss_pred             CCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         261 TPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       261 t~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      |+.|+|||++.+..|+.++|||||||++|||++|..|+..  ...+...+..+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~  289 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL  289 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc
Confidence            9999999999999999999999999999999999888643  23344444444

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.3e-41  Score=300.62  Aligned_cols=224  Identities=44%  Similarity=0.730  Sum_probs=197.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+|+.||+|+++....  .....+.+|+.++++++||||+++++++.+.+..|+|||||+|++|.+.+
T Consensus        20 G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   97 (304)
T 2jam_A           20 GAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI   97 (304)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             CCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHH
Confidence            8999999999999999999999985432  22356789999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      ...+.+++.++..++.|++.||.|||++||+||||||+|||+...+.++.+||+|||++......               
T Consensus        98 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE  177 (304)
T 2jam_A           98 LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE  177 (304)
T ss_dssp             HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTT
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChH
Confidence            88888999999999999999999999999999999999999965445677999999987643211               


Q ss_pred             ----------Ccc-hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         146 ----------QQA-WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       146 ----------~~~-~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                                .+. .+|+++|+|++|..||...+.......+..+.+.++.+.+..+++++.+++.+||..||.+|||+.
T Consensus       178 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  257 (304)
T 2jam_A          178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCE  257 (304)
T ss_dssp             TBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence                      112 389999999999999999999889999999888888877888999999999999999999999999


Q ss_pred             HHhcCcccCCcc
Q psy2131         215 EALKHPWICQRE  226 (328)
Q Consensus       215 ~~l~h~~~~~~~  226 (328)
                      ++++|||+....
T Consensus       258 ~~l~h~~~~~~~  269 (304)
T 2jam_A          258 KALSHPWIDGNT  269 (304)
T ss_dssp             HHHTSHHHHSSC
T ss_pred             HHhcCccccCCC
Confidence            999999996543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-41  Score=306.12  Aligned_cols=225  Identities=34%  Similarity=0.592  Sum_probs=199.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||+|++............+.+|+.+++.+ +||||+++++++.+.+..|+|||||.||+|.+.
T Consensus        40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  119 (327)
T 3lm5_A           40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL  119 (327)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGG
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHH
Confidence            7999999999999999999999987665555567788999999999 569999999999999999999999999999988


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC------------
Q psy2131          80 IVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE------------  145 (328)
Q Consensus        80 l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~------------  145 (328)
                      +...  ..+++.++..++.|++.||.|||++||+||||||+|||++.....+.+||+|||++......            
T Consensus       120 ~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y  199 (327)
T 3lm5_A          120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY  199 (327)
T ss_dssp             GSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGG
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCc
Confidence            8543  67999999999999999999999999999999999999986444567999999998653211            


Q ss_pred             --------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCC
Q psy2131         146 --------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       146 --------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                                    .+.| +|+++|+|++|..||.+.+.......+......++...+..+++.+.+++.+||..||.+|
T Consensus       200 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  279 (327)
T 3lm5_A          200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR  279 (327)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             cCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhC
Confidence                          1123 7999999999999999999988888888888888888888999999999999999999999


Q ss_pred             CCHHHHhcCcccCCc
Q psy2131         211 ITASEALKHPWICQR  225 (328)
Q Consensus       211 ~t~~~~l~h~~~~~~  225 (328)
                      ||++++++|||+.+.
T Consensus       280 pt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          280 PTAEICLSHSWLQQW  294 (327)
T ss_dssp             CCHHHHTTCGGGCCC
T ss_pred             cCHHHHhCCHhhccc
Confidence            999999999999764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=335.44  Aligned_cols=216  Identities=25%  Similarity=0.420  Sum_probs=179.0

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.++  .++..||||+++... .....+.+.+|+++|++++|||||++++++.+ +.+|+|||||.||+|.+
T Consensus       347 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~  424 (613)
T 2ozo_A          347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK  424 (613)
T ss_dssp             CSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHH
T ss_pred             CCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHH
Confidence            899999999875  356679999997643 23356778999999999999999999999986 55999999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ++... ..+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+++........         
T Consensus       425 ~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkL~DFGla~~~~~~~~~---------  492 (613)
T 2ozo_A          425 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR---HYAKISDFGLSKALGADDSY---------  492 (613)
T ss_dssp             HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCSTTTTCC--------------
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC---CcEEEeeccCcccccCCCce---------
Confidence            88654 459999999999999999999999999999999999999865   46999999998654211100         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       493 --------------------------------------------------------------------------------  492 (613)
T 2ozo_A          493 --------------------------------------------------------------------------------  492 (613)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    ........||+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...|.+|...
T Consensus       493 --------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~  558 (613)
T 2ozo_A          493 --------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM  558 (613)
T ss_dssp             -----------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC
T ss_pred             --------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                          000111236789999999999999999999999999999998 99999999999999999999887


Q ss_pred             CCCCcccc
Q psy2131         317 DEPKHKSA  324 (328)
Q Consensus       317 ~~~~~~~~  324 (328)
                      ..|..++.
T Consensus       559 ~~p~~~~~  566 (613)
T 2ozo_A          559 ECPPECPP  566 (613)
T ss_dssp             CCCTTCCH
T ss_pred             CCCCcCCH
Confidence            77766653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8e-42  Score=312.55  Aligned_cols=198  Identities=26%  Similarity=0.403  Sum_probs=173.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..|+|||||+|++|.+++
T Consensus        44 G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  122 (360)
T 3eqc_A           44 GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL  122 (360)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHH
Confidence            899999999999999999999998653 4555677899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+   +.+||+|||++.....               
T Consensus       123 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~---------------  184 (360)
T 3eqc_A          123 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID---------------  184 (360)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHHH---------------
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC---CCEEEEECCCCccccc---------------
Confidence            8888899999999999999999999996 99999999999999754   4599999998743200               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (360)
T 3eqc_A          185 --------------------------------------------------------------------------------  184 (360)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                   .......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+...+...+
T Consensus       185 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  242 (360)
T 3eqc_A          185 -------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF  242 (360)
T ss_dssp             -------------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred             -------------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence                         0111246999999999999999999999999999999999999999998876665443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-42  Score=309.51  Aligned_cols=216  Identities=22%  Similarity=0.381  Sum_probs=176.8

Q ss_pred             CCceEEEEEEEccCC----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..++    ..||+|+++... .......+.+|++++++++||||+++++++.+.+..|+|||||+||+|
T Consensus        55 G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  133 (333)
T 1mqb_A           55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL  133 (333)
T ss_dssp             CSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred             CCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcH
Confidence            899999999887654    359999997543 445566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       134 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~-------  203 (333)
T 1mqb_A          134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEA-------  203 (333)
T ss_dssp             HHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC-----------------
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC---CcEEECCCCcchhhcccccc-------
Confidence            9988764 579999999999999999999999999999999999999753   46999999997543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       204 --------------------------------------------------------------------------------  203 (333)
T 1mqb_A          204 --------------------------------------------------------------------------------  203 (333)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+...+..+.
T Consensus       204 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  267 (333)
T 1mqb_A          204 ----------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF  267 (333)
T ss_dssp             -----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             ----------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC
Confidence                            000112347889999999999999999999999999999999 999999999999999999887


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ..+.|..++
T Consensus       268 ~~~~~~~~~  276 (333)
T 1mqb_A          268 RLPTPMDCP  276 (333)
T ss_dssp             CCCCCTTCB
T ss_pred             cCCCcccCC
Confidence            655555544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-42  Score=310.54  Aligned_cols=212  Identities=24%  Similarity=0.395  Sum_probs=177.3

Q ss_pred             CCceEEEEEEEccCCcEE--EEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEF--AAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~--AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|++..+|..+  |+|.+... ......+.+.+|+.+++++ +||||+++++++.+.+..|+|||||+||+|.
T Consensus        36 G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~  114 (327)
T 1fvr_A           36 GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL  114 (327)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred             CCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHH
Confidence            789999999999999866  99998743 2334456788999999999 9999999999999999999999999999999


Q ss_pred             HHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +++....                .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..
T Consensus       115 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kL~Dfg~~~~  191 (327)
T 1fvr_A          115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRG  191 (327)
T ss_dssp             HHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEES
T ss_pred             HHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC---CeEEEcccCcCcc
Confidence            9987654                69999999999999999999999999999999999999754   4599999999753


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .....                                                                           
T Consensus       192 ~~~~~---------------------------------------------------------------------------  196 (327)
T 1fvr_A          192 QEVYV---------------------------------------------------------------------------  196 (327)
T ss_dssp             SCEEC---------------------------------------------------------------------------
T ss_pred             ccccc---------------------------------------------------------------------------
Confidence            21000                                                                           


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~  300 (328)
                                                      ......+|+.|+|||++.+..++.++|||||||++|||+| |++||.+
T Consensus       197 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          197 --------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             --------------------------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             --------------------------------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence                                            0011237889999999999999999999999999999998 9999999


Q ss_pred             ccHHHHHHHHhcccCCCCCCccc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .+...+...+..+.....|..++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~  267 (327)
T 1fvr_A          245 MTCAELYEKLPQGYRLEKPLNCD  267 (327)
T ss_dssp             CCHHHHHHHGGGTCCCCCCTTBC
T ss_pred             CcHHHHHHHhhcCCCCCCCCCCC
Confidence            99999999999886655554443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-41  Score=302.49  Aligned_cols=210  Identities=25%  Similarity=0.451  Sum_probs=180.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        33 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  111 (303)
T 3a7i_A           33 GSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL  111 (303)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred             cCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHH
Confidence            8999999999999999999999976543 234677899999999999999999999999999999999999999998877


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      . .+.+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........             
T Consensus       112 ~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-------------  174 (303)
T 3a7i_A          112 E-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQI-------------  174 (303)
T ss_dssp             T-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECBTTBC-------------
T ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC---CCEEEeecccceecCcccc-------------
Confidence            5 4679999999999999999999999999999999999999754   4699999999865422100             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (303)
T 3a7i_A          175 --------------------------------------------------------------------------------  174 (303)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                                   ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...+...+..+.....|.
T Consensus       175 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T 3a7i_A          175 -------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG  241 (303)
T ss_dssp             -------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS
T ss_pred             -------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcc
Confidence                         0112458999999999999999999999999999999999999999999888888887776544443


Q ss_pred             c
Q psy2131         321 H  321 (328)
Q Consensus       321 ~  321 (328)
                      .
T Consensus       242 ~  242 (303)
T 3a7i_A          242 N  242 (303)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.4e-42  Score=310.14  Aligned_cols=215  Identities=24%  Similarity=0.422  Sum_probs=181.0

Q ss_pred             CCceEEEEEEEc-------cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQK-------ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~-------~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.+.       .++..||+|+++... .....+.+.+|+++++++ +||||+++++++.+.+..|+|||||+
T Consensus        46 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (334)
T 2pvf_A           46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  124 (334)
T ss_dssp             CSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCT
T ss_pred             cCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCC
Confidence            899999999976       467889999997543 455667889999999999 99999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      ||+|.+++....                .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Df  201 (334)
T 2pvf_A          125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADF  201 (334)
T ss_dssp             TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCC
T ss_pred             CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC---CCEEEccc
Confidence            999999987653                38999999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++.........                                                                    
T Consensus       202 g~~~~~~~~~~~--------------------------------------------------------------------  213 (334)
T 2pvf_A          202 GLARDINNIDYY--------------------------------------------------------------------  213 (334)
T ss_dssp             TTCEECTTTSSE--------------------------------------------------------------------
T ss_pred             cccccccccccc--------------------------------------------------------------------
Confidence            998654221100                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus       214 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          214 ------------------------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             ------------------------------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ------------------------------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence                                                00112347889999999999999999999999999999999 99


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                      .||.+.+..++...+..+.....|..++
T Consensus       258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (334)
T 2pvf_A          258 SPYPGIPVEELFKLLKEGHRMDKPANCT  285 (334)
T ss_dssp             CSSTTCCHHHHHHHHHHTCCCCCCTTCC
T ss_pred             CCcCcCCHHHHHHHHhcCCCCCCCccCC
Confidence            9999999999999999987666665544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.7e-42  Score=304.83  Aligned_cols=212  Identities=24%  Similarity=0.398  Sum_probs=182.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..++..||+|++....   ...+.+.+|++++++++||||+++++++.+.+..|+|||||+|++|.+++
T Consensus        24 G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  100 (288)
T 3kfa_A           24 GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  100 (288)
T ss_dssp             GTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             CCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence            799999999999999999999997543   34567889999999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus       101 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~-----------  166 (288)
T 3kfa_A          101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTY-----------  166 (288)
T ss_dssp             HHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG---GCEEECCCCGGGTSCSSSS-----------
T ss_pred             HhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC---CCEEEccCccceeccCCcc-----------
Confidence            764  459999999999999999999999999999999999999754   4599999999854321110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (288)
T 3kfa_A          167 --------------------------------------------------------------------------------  166 (288)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+...+...+..+....
T Consensus       167 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (288)
T 3kfa_A          167 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  232 (288)
T ss_dssp             --------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             --------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence                          01122457889999999999999999999999999999999 999999999988999888886655


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       233 ~~~~~~  238 (288)
T 3kfa_A          233 RPEGCP  238 (288)
T ss_dssp             CCTTCC
T ss_pred             CCCCCC
Confidence            555443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=315.46  Aligned_cols=207  Identities=31%  Similarity=0.538  Sum_probs=168.7

Q ss_pred             CCceEEEEEEEc---cCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK---ATGLEFAAKIINTKKLS--ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~---~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++.   .+|+.||||+++.....  ....+.+.+|+++|+++ +||||+++++++.+.+..|+|||||+||
T Consensus        65 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~  144 (355)
T 1vzo_A           65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG  144 (355)
T ss_dssp             TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCC
Confidence            899999999984   58999999999754321  12234466799999999 7999999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++......        
T Consensus       145 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~--------  213 (355)
T 1vzo_A          145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADE--------  213 (355)
T ss_dssp             BHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECCGGG--------
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CcEEEeeCCCCeecccCC--------
Confidence            999999888889999999999999999999999999999999999999754   469999999986431100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       214 --------------------------------------------------------------------------------  213 (355)
T 1vzo_A          214 --------------------------------------------------------------------------------  213 (355)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCc----cHHHHHH
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDE----DQHRLYA  308 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~  308 (328)
                                       ........||+.|+|||++.+  ..++.++|||||||+||||+||+.||...    ....+..
T Consensus       214 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  276 (355)
T 1vzo_A          214 -----------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  276 (355)
T ss_dssp             -----------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             -----------------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence                             001123469999999999986  45789999999999999999999999754    3455555


Q ss_pred             HHhcccC
Q psy2131         309 QIKAGAY  315 (328)
Q Consensus       309 ~i~~~~~  315 (328)
                      .+..+..
T Consensus       277 ~~~~~~~  283 (355)
T 1vzo_A          277 RILKSEP  283 (355)
T ss_dssp             HHHHCCC
T ss_pred             HHhccCC
Confidence            5555443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.1e-42  Score=304.73  Aligned_cols=215  Identities=23%  Similarity=0.354  Sum_probs=172.9

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|+    +..+++.||+|++...  .....+.+.+|++++++++||||+++++++..  ...+|+|||||++|
T Consensus        21 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   98 (295)
T 3ugc_A           21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG   98 (295)
T ss_dssp             CSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTC
T ss_pred             cCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCC
Confidence            8999999998    6779999999999743  45556788999999999999999999999864  45689999999999


Q ss_pred             CcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........     
T Consensus        99 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~-----  170 (295)
T 3ugc_A           99 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFGLTKVLPQDKEF-----  170 (295)
T ss_dssp             BHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCCSCC-------------
T ss_pred             CHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC---CeEEEccCcccccccCCcce-----
Confidence            9999997654 59999999999999999999999999999999999999865   45999999998543211000     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (295)
T 3ugc_A          171 --------------------------------------------------------------------------------  170 (295)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH---------
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH---------  304 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---------  304 (328)
                                        ........||+.|+|||++.+..|+.++|||||||++|||+||..||......         
T Consensus       171 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~  232 (295)
T 3ugc_A          171 ------------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK  232 (295)
T ss_dssp             -----------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred             ------------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence                              00011234778899999999999999999999999999999999998765432         


Q ss_pred             -------HHHHHHhcccCCCCCCccc
Q psy2131         305 -------RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 -------~~~~~i~~~~~~~~~~~~~  323 (328)
                             .+...+..+...+.|..++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (295)
T 3ugc_A          233 QGQMIVFHLIELLKNNGRLPRPDGCP  258 (295)
T ss_dssp             CTHHHHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccchhHHHHHHHHhccCcCCCCcCcC
Confidence                   4555566666555555554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-42  Score=299.06  Aligned_cols=211  Identities=24%  Similarity=0.369  Sum_probs=180.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+. ++..||+|++.......   +.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        19 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   94 (267)
T 3t9t_A           19 GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL   94 (267)
T ss_dssp             ETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHH
T ss_pred             CCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHH
Confidence            789999999986 67889999998665433   56789999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.......             
T Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~-------------  158 (267)
T 3t9t_A           95 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ-------------  158 (267)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG---GCEEECCTTGGGGBCCHH-------------
T ss_pred             hhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC---CCEEEccccccccccccc-------------
Confidence            765 568999999999999999999999999999999999999754   459999999975431100             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (267)
T 3t9t_A          159 --------------------------------------------------------------------------------  158 (267)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                  ........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+...+...+..+.....
T Consensus       159 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~  226 (267)
T 3t9t_A          159 ------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  226 (267)
T ss_dssp             ------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             ------------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence                        001112347889999999999999999999999999999999 9999999999999999999876665


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |...+
T Consensus       227 ~~~~~  231 (267)
T 3t9t_A          227 PRLAS  231 (267)
T ss_dssp             CTTSC
T ss_pred             CccCc
Confidence            55443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.4e-42  Score=319.66  Aligned_cols=196  Identities=31%  Similarity=0.443  Sum_probs=162.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~------~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+|+.||||++.....      ...+|+++|+.++|||||+++++|...      ..+++||||+++ 
T Consensus        65 G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-  137 (420)
T 1j1b_A           65 GSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-  137 (420)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-
T ss_pred             CCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-
Confidence            8999999999999999999999975431      124799999999999999999998532      247899999986 


Q ss_pred             CcHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~----~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      +|.+.+.    ....+++..+..++.||+.||.|||++||+||||||+|||++.+  .+.+||+|||+++......    
T Consensus       138 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~--~~~~kl~DFG~a~~~~~~~----  211 (420)
T 1j1b_A          138 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGE----  211 (420)
T ss_dssp             EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETT--TTEEEECCCTTCEECCTTC----
T ss_pred             cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCC--CCeEEeccchhhhhcccCC----
Confidence            5655543    34679999999999999999999999999999999999999743  3468999999986542110    


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       212 --------------------------------------------------------------------------------  211 (420)
T 1j1b_A          212 --------------------------------------------------------------------------------  211 (420)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                             ......||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+....+..
T Consensus       212 -----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~  268 (420)
T 1j1b_A          212 -----------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE  268 (420)
T ss_dssp             -----------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             -----------------------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                   01124689999999999775 799999999999999999999999999987777766


Q ss_pred             Hhc
Q psy2131         310 IKA  312 (328)
Q Consensus       310 i~~  312 (328)
                      |.+
T Consensus       269 i~~  271 (420)
T 1j1b_A          269 IIK  271 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.7e-42  Score=307.03  Aligned_cols=215  Identities=22%  Similarity=0.348  Sum_probs=182.5

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+.     .+++.||+|++.... .......+.+|+++++.++||||+++++++.+.+..|+|||||+||+
T Consensus        36 G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  114 (322)
T 1p4o_A           36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD  114 (322)
T ss_dssp             CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             CCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCc
Confidence            899999999877     467899999997543 34455678899999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          76 LFEDIVAR----------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        76 L~~~l~~~----------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |.+++...          ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus       115 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT---CCEEECCTTCCCGGGGG
T ss_pred             HHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC---CeEEECcCccccccccc
Confidence            99988653          356899999999999999999999999999999999999754   46999999997543111


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..                                                                              
T Consensus       192 ~~------------------------------------------------------------------------------  193 (322)
T 1p4o_A          192 DY------------------------------------------------------------------------------  193 (322)
T ss_dssp             GC------------------------------------------------------------------------------
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~  304 (328)
                                                ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus       194 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          194 --------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             --------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             --------------------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence                                      001112357899999999999999999999999999999999 99999999999


Q ss_pred             HHHHHHhcccCCCCCCccc
Q psy2131         305 RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~~  323 (328)
                      .+...+..+.....|..++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~  266 (322)
T 1p4o_A          248 QVLRFVMEGGLLDKPDNCP  266 (322)
T ss_dssp             HHHHHHHTTCCCCCCTTCC
T ss_pred             HHHHHHHcCCcCCCCCCCC
Confidence            9999999988766666554

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-41  Score=317.98  Aligned_cols=200  Identities=28%  Similarity=0.447  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC------CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL------QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l------~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+++.||||+++..   ......+.+|+++++.+      +|+||+++++++...+.+|+|||||. +
T Consensus       108 G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~  183 (429)
T 3kvw_A          108 GSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-M  183 (429)
T ss_dssp             SSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-C
T ss_pred             CccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-C
Confidence            89999999999999999999999753   33445677888888877      67799999999999999999999996 5


Q ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          75 ELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        75 ~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      +|.+.+....  .+++..+..++.||+.||.|||++|||||||||+|||++.++. ..+||+|||+|......       
T Consensus       184 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~DFG~a~~~~~~-------  255 (429)
T 3kvw_A          184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSCYEHQR-------  255 (429)
T ss_dssp             BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECCCTTCEETTCC-------
T ss_pred             CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEeecccceecCCc-------
Confidence            8988887654  4999999999999999999999999999999999999976542 33999999997542110       


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       256 --------------------------------------------------------------------------------  255 (429)
T 3kvw_A          256 --------------------------------------------------------------------------------  255 (429)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                            .....||+.|+|||++.+..|+.++|||||||+||||+||++||.+.+....+..|..
T Consensus       256 ----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~  313 (429)
T 3kvw_A          256 ----------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE  313 (429)
T ss_dssp             ----------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ----------------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                                  1124589999999999999999999999999999999999999999998888888776


Q ss_pred             cc
Q psy2131         313 GA  314 (328)
Q Consensus       313 ~~  314 (328)
                      ..
T Consensus       314 ~~  315 (429)
T 3kvw_A          314 LL  315 (429)
T ss_dssp             HH
T ss_pred             Hc
Confidence            53

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.3e-42  Score=314.87  Aligned_cols=197  Identities=28%  Similarity=0.436  Sum_probs=164.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--------------------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--------------------   60 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--------------------   60 (328)
                      |+||+||+|++..+|+.||||++..+...      ..+|+++|+.++|||||+++++|..                    
T Consensus        18 G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (383)
T 3eb0_A           18 GSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGG   91 (383)
T ss_dssp             C-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------
T ss_pred             ccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccc
Confidence            89999999999999999999999754321      2379999999999999999999844                    


Q ss_pred             ------------------CCEEEEEEEccCCCCcHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q psy2131          61 ------------------ENYHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE  118 (328)
Q Consensus        61 ------------------~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~  118 (328)
                                        ...+++|||||+| +|.+.+.    ....+++..+..++.|++.||.|||++||+||||||+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~  170 (383)
T 3eb0_A           92 KNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ  170 (383)
T ss_dssp             ------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGG
T ss_pred             cccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHH
Confidence                              3458999999985 7666554    3567999999999999999999999999999999999


Q ss_pred             cEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHH
Q psy2131         119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNL  198 (328)
Q Consensus       119 NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  198 (328)
                      |||++.  +++.+||+|||+|........                                                   
T Consensus       171 Nil~~~--~~~~~kl~Dfg~a~~~~~~~~---------------------------------------------------  197 (383)
T 3eb0_A          171 NLLVNS--KDNTLKLCDFGSAKKLIPSEP---------------------------------------------------  197 (383)
T ss_dssp             GEEEET--TTTEEEECCCTTCEECCTTSC---------------------------------------------------
T ss_pred             HEEEcC--CCCcEEEEECCCCcccCCCCC---------------------------------------------------
Confidence            999974  235799999999865422110                                                   


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCC
Q psy2131         199 INQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGK  277 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~  277 (328)
                                                                              .....||+.|+|||++.+. .|+.
T Consensus       198 --------------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~  221 (383)
T 3eb0_A          198 --------------------------------------------------------SVAYICSRFYRAPELMLGATEYTP  221 (383)
T ss_dssp             --------------------------------------------------------CCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred             --------------------------------------------------------CcCcccCCCccCHHHhcCCCCCCc
Confidence                                                                    1123589999999999875 4899


Q ss_pred             CcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         278 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       278 ~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                      ++||||+||++|||++|++||.+.+..+.+..|.+.
T Consensus       222 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  257 (383)
T 3eb0_A          222 SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI  257 (383)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999999999999999999999988888877653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.8e-42  Score=299.82  Aligned_cols=207  Identities=29%  Similarity=0.444  Sum_probs=166.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+.  |..+|+|+++.....  ....+.+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+
T Consensus        18 G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (271)
T 3dtc_A           18 GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNR   95 (271)
T ss_dssp             ETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHH
T ss_pred             CCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHH
Confidence            799999999874  889999998765332  2335678899999999999999999999999999999999999999977


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCcEEEeeCCC-----CCcEEEeeccccccccCCCcchH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNG---VVHRDLKPENLLLASKAK-----GAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~---ivHrDiKp~NiLl~~~~~-----~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      .+. ...+++..+..++.|++.||.|||++|   |+||||||+|||++...+     .+.+||+|||++......     
T Consensus        96 ~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----  169 (271)
T 3dtc_A           96 VLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-----  169 (271)
T ss_dssp             HHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------------
T ss_pred             Hhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc-----
Confidence            664 567999999999999999999999999   899999999999975322     456999999997432110     


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (271)
T 3dtc_A          170 --------------------------------------------------------------------------------  169 (271)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                             ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.......+
T Consensus       170 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  226 (271)
T 3dtc_A          170 -----------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV  226 (271)
T ss_dssp             -----------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             -----------------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence                                   001235899999999999999999999999999999999999999999988888887


Q ss_pred             hcccCCCC
Q psy2131         311 KAGAYDDE  318 (328)
Q Consensus       311 ~~~~~~~~  318 (328)
                      ..+....+
T Consensus       227 ~~~~~~~~  234 (271)
T 3dtc_A          227 AMNKLALP  234 (271)
T ss_dssp             HTSCCCCC
T ss_pred             hcCCCCCC
Confidence            77766544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=301.65  Aligned_cols=215  Identities=25%  Similarity=0.423  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+.  .++..||+|+++... .....+.+.+|++++++++||||+++++++ ..+..|+||||+++++|.+
T Consensus        21 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~   98 (287)
T 1u59_A           21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK   98 (287)
T ss_dssp             CTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHH
T ss_pred             cCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHH
Confidence            899999999854  578889999997653 455667889999999999999999999999 4556899999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........         
T Consensus        99 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~---------  166 (287)
T 1u59_A           99 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSY---------  166 (287)
T ss_dssp             HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEECTTCSCE---------
T ss_pred             HHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC---CCEEECcccceeeeccCcce---------
Confidence            88644 469999999999999999999999999999999999999864   46999999998654221100         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (287)
T 1u59_A          167 --------------------------------------------------------------------------------  166 (287)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+...+..+...
T Consensus       167 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~  232 (287)
T 1u59_A          167 --------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM  232 (287)
T ss_dssp             --------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred             --------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC
Confidence                          000112347899999999999999999999999999999999 99999999999999999998765


Q ss_pred             CCCCccc
Q psy2131         317 DEPKHKS  323 (328)
Q Consensus       317 ~~~~~~~  323 (328)
                      ..|..++
T Consensus       233 ~~~~~~~  239 (287)
T 1u59_A          233 ECPPECP  239 (287)
T ss_dssp             CCCTTCC
T ss_pred             CCCCCcC
Confidence            5555443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-40  Score=295.82  Aligned_cols=222  Identities=41%  Similarity=0.736  Sum_probs=196.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC---CH----HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL---SA----RDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~---~~----~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|.++.+|+.||+|+++....   ..    ...+.+.+|+++++++. ||||+++++++.+.+..|+||||++
T Consensus        28 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (298)
T 1phk_A           28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK  107 (298)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccC
Confidence            8999999999999999999999976542   22    22456789999999995 9999999999999999999999999


Q ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-------
Q psy2131          73 GGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-------  145 (328)
Q Consensus        73 gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-------  145 (328)
                      +++|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......       
T Consensus       108 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~  184 (298)
T 1phk_A          108 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVC  184 (298)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCCBCCCC
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC---CcEEEecccchhhcCCCccccccc
Confidence            99999999888889999999999999999999999999999999999999754   45999999988643210       


Q ss_pred             -------------------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHH
Q psy2131         146 -------------------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI  199 (328)
Q Consensus       146 -------------------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  199 (328)
                                               .+.| +|+++|+|++|..||...+.......+..+...++.+.+..+++++.+++
T Consensus       185 ~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  264 (298)
T 1phk_A          185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV  264 (298)
T ss_dssp             SCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHH
T ss_pred             CCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHH
Confidence                                     1223 89999999999999999988888888888888888888888999999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         200 NQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       200 ~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+||..||.+|||+.++++|||+.+.
T Consensus       265 ~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          265 SRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHccCCcccCCCHHHHHhChHhhhc
Confidence            99999999999999999999999753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.7e-42  Score=304.96  Aligned_cols=212  Identities=21%  Similarity=0.257  Sum_probs=174.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|.+..+|+.||+|++.....    .+.+.+|+.+++.+ +|+|++++++++.+....|+||||+ |++|.++
T Consensus        21 G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~   95 (298)
T 1csn_A           21 GSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDL   95 (298)
T ss_dssp             CSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             cCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHH
Confidence            8999999999999999999999975432    23467899999999 8999999999999999999999999 9999999


Q ss_pred             HHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +...+ .+++.++..++.|++.||.|||++||+||||||+|||++.++  ....+||+|||++..........       
T Consensus        96 l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~-------  168 (298)
T 1csn_A           96 LDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ-------  168 (298)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC-------
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc-------
Confidence            87654 599999999999999999999999999999999999997653  23459999999987653221100       


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                          ..                                                                          
T Consensus       169 ----~~--------------------------------------------------------------------------  170 (298)
T 1csn_A          169 ----HI--------------------------------------------------------------------------  170 (298)
T ss_dssp             ----BC--------------------------------------------------------------------------
T ss_pred             ----cc--------------------------------------------------------------------------
Confidence                00                                                                          


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhcc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAG  313 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~  313 (328)
                                    .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +....+..+..+
T Consensus       171 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          171 --------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             --------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             --------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence                          000112356999999999999999999999999999999999999999984   455666666655


Q ss_pred             cCC
Q psy2131         314 AYD  316 (328)
Q Consensus       314 ~~~  316 (328)
                      ...
T Consensus       237 ~~~  239 (298)
T 1csn_A          237 KQS  239 (298)
T ss_dssp             HHH
T ss_pred             ccC
Confidence            543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=309.22  Aligned_cols=214  Identities=22%  Similarity=0.322  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEccCCcEE----EEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEF----AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~----AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|++..+++.+    |+|.+.... .....+.+.+|+.++++++||||+++++++.+.. .++|+||+.+|+|
T Consensus        26 G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L  103 (327)
T 3lzb_A           26 GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL  103 (327)
T ss_dssp             CSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBH
T ss_pred             CCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcH
Confidence            899999999999888876    555554322 2334567889999999999999999999998765 7899999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||++........        
T Consensus       104 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~~~~~~~--------  172 (327)
T 3lzb_A          104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEK--------  172 (327)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC-----------------
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeEccCccc--------
Confidence            9998764 5699999999999999999999999999999999999997654   599999999854321100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       173 --------------------------------------------------------------------------------  172 (327)
T 3lzb_A          173 --------------------------------------------------------------------------------  172 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+...+...+..+.
T Consensus       173 ----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  236 (327)
T 3lzb_A          173 ----------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  236 (327)
T ss_dssp             -----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             ----------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence                            000112347889999999999999999999999999999999 999999999999999999888


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ..+.|..++
T Consensus       237 ~~~~~~~~~  245 (327)
T 3lzb_A          237 RLPQPPICT  245 (327)
T ss_dssp             CCCCCTTBC
T ss_pred             CCCCCccCC
Confidence            766666554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-43  Score=325.95  Aligned_cols=198  Identities=16%  Similarity=0.242  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHH---HHHHhCCCCCcceeE-------EEEEeCCE------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREA---RICRKLQHPNIVRLH-------DSIQEENY------   63 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~---~il~~l~H~nIv~l~-------~~~~~~~~------   63 (328)
                      |+||+||+|++..+|+.||||++..... .....+.+.+|+   ++|++++|||||+++       +++.+.+.      
T Consensus        84 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~  163 (377)
T 3byv_A           84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV  163 (377)
T ss_dssp             ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcccccc
Confidence            7999999999999999999999986533 334567788999   556666899999998       77776643      


Q ss_pred             -----------EEEEEEccCCCCcHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC
Q psy2131          64 -----------HYLVFDLVTGGELFEDIVAREFYSE-------ADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK  125 (328)
Q Consensus        64 -----------~~lv~E~~~gg~L~~~l~~~~~~~~-------~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~  125 (328)
                                 .|+||||| +|+|.+++...+.+++       ..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus       164 ~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~  242 (377)
T 3byv_A          164 RLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR  242 (377)
T ss_dssp             ------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred             ccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence                       89999999 6799999987655655       7777899999999999999999999999999999754


Q ss_pred             CCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhccc
Q psy2131         126 AKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       126 ~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  205 (328)
                         +.+||+|||+|+....                                                             
T Consensus       243 ---~~~kL~DFG~a~~~~~-------------------------------------------------------------  258 (377)
T 3byv_A          243 ---GGVFLTGFEHLVRDGA-------------------------------------------------------------  258 (377)
T ss_dssp             ---CCEEECCGGGCEETTC-------------------------------------------------------------
T ss_pred             ---CCEEEEechhheecCC-------------------------------------------------------------
Confidence               4699999999853211                                                             


Q ss_pred             CCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-----------C
Q psy2131         206 NPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-----------P  274 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----------~  274 (328)
                                                                      ......| +.|+|||++.+.           .
T Consensus       259 ------------------------------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  289 (377)
T 3byv_A          259 ------------------------------------------------RVVSSVS-RGFEPPELEARRATISYHRDRRTL  289 (377)
T ss_dssp             ------------------------------------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred             ------------------------------------------------cccCCCC-cCccChhhhccccccccccccccc
Confidence                                                            0112357 999999999988           8


Q ss_pred             CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         275 YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       275 ~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      |+.++|||||||+||||+||+.||.+.+.......+..
T Consensus       290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  327 (377)
T 3byv_A          290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR  327 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS
T ss_pred             CChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh
Confidence            99999999999999999999999988776555544443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-42  Score=310.56  Aligned_cols=224  Identities=34%  Similarity=0.624  Sum_probs=192.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..+++.||+|++....   ......+.+.+|++++++++||||+++++++.+.+..|+|||||+||+|.
T Consensus        37 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~  116 (345)
T 3hko_A           37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLL  116 (345)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred             cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHH
Confidence            899999999999999999999997542   23445678899999999999999999999999999999999999999999


Q ss_pred             HHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCC
Q psy2131          78 EDIVA----------------------------------------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKP  117 (328)
Q Consensus        78 ~~l~~----------------------------------------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp  117 (328)
                      +.+..                                        ...+++..+..++.|++.||.|||++||+||||||
T Consensus       117 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  196 (345)
T 3hko_A          117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP  196 (345)
T ss_dssp             HHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence            88742                                        11246778889999999999999999999999999


Q ss_pred             CcEEEeeCCCCCcEEEeeccccccccC---------------------------------CCcch-HHHHHHHHHhCCCC
Q psy2131         118 ENLLLASKAKGAAVKLADFGLAIEVQG---------------------------------EQQAW-FGVILYILLVGYPP  163 (328)
Q Consensus       118 ~NiLl~~~~~~~~vkl~DfGla~~~~~---------------------------------~~~~~-~G~~~~~~~~g~~p  163 (328)
                      +|||++.++ ...+||+|||++.....                                 ..+.| +|+++|+|++|..|
T Consensus       197 ~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p  275 (345)
T 3hko_A          197 ENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP  275 (345)
T ss_dssp             GGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999997543 23699999999864210                                 01123 89999999999999


Q ss_pred             CCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         164 FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       164 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      |.+.+.......+......++.+.+..+++++.+++.+||..||.+|||+.++++|||+.+.
T Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             SCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999888888888888888877777899999999999999999999999999999998653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-41  Score=317.09  Aligned_cols=224  Identities=36%  Similarity=0.679  Sum_probs=189.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC------HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+..+++.||+|++......      ......+.+|+.+|++++||||+++++++.. +..|+|||||+||
T Consensus       146 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  224 (419)
T 3i6u_A          146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGG  224 (419)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTC
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCC
Confidence            89999999999999999999999865322      1122357899999999999999999999854 5589999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------  145 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------  145 (328)
                      +|.+.+...+.+++.++..++.|++.||.|||++||+||||||+|||++..++...+||+|||+++.....         
T Consensus       225 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  304 (419)
T 3i6u_A          225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT  304 (419)
T ss_dssp             BGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------
T ss_pred             cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCC
Confidence            99999988888999999999999999999999999999999999999987666677999999998643210         


Q ss_pred             --------------------Ccch-HHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         146 --------------------QQAW-FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       146 --------------------~~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                          .+.| +|+++|+|++|.+||..... ..+...+..+.+.+++..+..+++++.+++.+||
T Consensus       305 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L  384 (419)
T 3i6u_A          305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL  384 (419)
T ss_dssp             CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             CCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHc
Confidence                                0123 89999999999999976543 3455667777777766667789999999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..||.+|||++++++|||+...
T Consensus       385 ~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          385 VVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cCChhHCcCHHHHhCCcccCCh
Confidence            9999999999999999999653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-41  Score=301.68  Aligned_cols=201  Identities=19%  Similarity=0.272  Sum_probs=167.4

Q ss_pred             CCceEEEEEEEccCC-------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATG-------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||+||+|++..++       ..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..|+|||||+|
T Consensus        19 G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   96 (289)
T 4fvq_A           19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKF   96 (289)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTT
T ss_pred             CCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCC
Confidence            799999999999887       469999996542  33456788999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCC-----CcEEEeeccccccccCCCc
Q psy2131          74 GELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKG-----AAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus        74 g~L~~~l~~~~~-~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~-----~~vkl~DfGla~~~~~~~~  147 (328)
                      |+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++..     ..+||+|||++.....   
T Consensus        97 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---  173 (289)
T 4fvq_A           97 GSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---  173 (289)
T ss_dssp             CBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---
Confidence            999999977654 9999999999999999999999999999999999999875431     1299999998743210   


Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (289)
T 4fvq_A          174 --------------------------------------------------------------------------------  173 (289)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             chhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhc-CCCCCCccHHH
Q psy2131         228 VASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVG-YPPFWDEDQHR  305 (328)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG-~~Pf~~~~~~~  305 (328)
                                                 .....||+.|+|||++.+ ..++.++|||||||++|||+|| .+||.+.+...
T Consensus       174 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          174 ---------------------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             ---------------------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             ---------------------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence                                       001237889999999988 7789999999999999999995 56666666666


Q ss_pred             HHHHHhcc
Q psy2131         306 LYAQIKAG  313 (328)
Q Consensus       306 ~~~~i~~~  313 (328)
                      ........
T Consensus       227 ~~~~~~~~  234 (289)
T 4fvq_A          227 KLQFYEDR  234 (289)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHhhcc
Confidence            55554443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3e-41  Score=304.55  Aligned_cols=219  Identities=31%  Similarity=0.522  Sum_probs=180.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||||+||+|.+.+
T Consensus        18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (323)
T 3tki_A           18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI   96 (323)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGS
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHH
Confidence            79999999999999999999999755432 23356789999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....                
T Consensus        97 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  173 (323)
T 3tki_A           97 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPY  173 (323)
T ss_dssp             BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEETTEECCBCSCCSCGGG
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---CCEEEEEeeccceeccCCcccccCCCccCcCc
Confidence            877789999999999999999999999999999999999999754   4599999999863210                


Q ss_pred             --------C------Ccch-HHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         145 --------E------QQAW-FGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       145 --------~------~~~~-~G~~~~~~~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                              .      .+.| +|+++|+|++|..||...+.. ............  ...+..+++++.+|+.+||..||.
T Consensus       174 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~  251 (323)
T 3tki_A          174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPS  251 (323)
T ss_dssp             SCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             cCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCHHHHHHHHHHccCChh
Confidence                    0      1122 799999999999999765543 222233322222  223567899999999999999999


Q ss_pred             CCCCHHHHhcCcccCCc
Q psy2131         209 KRITASEALKHPWICQR  225 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~  225 (328)
                      +|||+.|+++|||+.+.
T Consensus       252 ~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          252 ARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             TSCCHHHHTTCTTTTCC
T ss_pred             hCcCHHHHhhChhhccc
Confidence            99999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.1e-42  Score=306.14  Aligned_cols=216  Identities=22%  Similarity=0.343  Sum_probs=174.2

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN-----YHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-----~~~lv~E~~~   72 (328)
                      |+||.||+|.+..   +++.||+|+++.........+.+.+|+.++++++||||+++++++.+.+     ..|+||||++
T Consensus        45 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~  124 (313)
T 3brb_A           45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK  124 (313)
T ss_dssp             -CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCT
T ss_pred             cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEeccc
Confidence            8999999998765   5668999999877777777788999999999999999999999998755     3599999999


Q ss_pred             CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          73 GGELFEDIVA------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        73 gg~L~~~l~~------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      +|+|.+++..      ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~  201 (313)
T 3brb_A          125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLSKKIYSGD  201 (313)
T ss_dssp             TCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---SCEEECSCSCC-------
T ss_pred             CCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcEEEeecCcceeccccc
Confidence            9999998842      3569999999999999999999999999999999999999754   469999999975431110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       202 ~~------------------------------------------------------------------------------  203 (313)
T 3brb_A          202 YY------------------------------------------------------------------------------  203 (313)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~  305 (328)
                                                .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+...
T Consensus       204 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          204 --------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             ---------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             --------------------------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence                                      00111247889999999999999999999999999999999 999999999999


Q ss_pred             HHHHHhcccCCCCCCccc
Q psy2131         306 LYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       306 ~~~~i~~~~~~~~~~~~~  323 (328)
                      +...+..+.....|..++
T Consensus       258 ~~~~~~~~~~~~~~~~~~  275 (313)
T 3brb_A          258 MYDYLLHGHRLKQPEDCL  275 (313)
T ss_dssp             HHHHHHTTCCCCCBTTCC
T ss_pred             HHHHHHcCCCCCCCcccc
Confidence            999998887666665544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=311.73  Aligned_cols=212  Identities=25%  Similarity=0.417  Sum_probs=170.0

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+     ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++++.+.+..|+|||||+||
T Consensus        56 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g  134 (344)
T 1rjb_A           56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG  134 (344)
T ss_dssp             CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCC
Confidence            89999999997     3466789999997543 333456788999999999 9999999999999999999999999999


Q ss_pred             CcHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          75 ELFEDIVARE-----------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        75 ~L~~~l~~~~-----------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      +|.+++....                       .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+
T Consensus       135 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~  211 (344)
T 1rjb_A          135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVV  211 (344)
T ss_dssp             BHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT---TEE
T ss_pred             cHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCC---CcE
Confidence            9999987643                       37899999999999999999999999999999999999754   469


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||++........                                                                
T Consensus       212 kL~Dfg~~~~~~~~~~----------------------------------------------------------------  227 (344)
T 1rjb_A          212 KICDFGLARDIMSDSN----------------------------------------------------------------  227 (344)
T ss_dssp             EECCCGGGSCGGGCTT----------------------------------------------------------------
T ss_pred             EeCCCccCcccccCcc----------------------------------------------------------------
Confidence            9999999854321100                                                                


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                              ........||+.|+|||++.+..|+.++|||||||++|||
T Consensus       228 ----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el  267 (344)
T 1rjb_A          228 ----------------------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI  267 (344)
T ss_dssp             ----------------------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence                                                    0011234588999999999999999999999999999999


Q ss_pred             Hh-cCCCCCCccHHH-HHHHHhcccCCCCCC
Q psy2131         292 LV-GYPPFWDEDQHR-LYAQIKAGAYDDEPK  320 (328)
Q Consensus       292 lt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~  320 (328)
                      +| |..||.+.+... +...+..+.....|.
T Consensus       268 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (344)
T 1rjb_A          268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPF  298 (344)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT
T ss_pred             HcCCCCCcccCCcHHHHHHHHhcCCCCCCCC
Confidence            98 999999887444 444444443333333

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.6e-42  Score=299.12  Aligned_cols=200  Identities=16%  Similarity=0.304  Sum_probs=173.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+.  |+.+|+|++..........+.+.+|+.++++++||||+++++++.+.  +..|+|||||+||+|.+
T Consensus        21 G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   98 (271)
T 3kmu_A           21 NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN   98 (271)
T ss_dssp             ETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHH
T ss_pred             CCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHH
Confidence            799999999984  88999999998777777778899999999999999999999999887  78899999999999999


Q ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          79 DIVARE--FYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        79 ~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ++....  .+++.++..++.|++.||.|||++|  |+||||||+|||++.+   +.++|+|||++....           
T Consensus        99 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~---~~~~l~~~~~~~~~~-----------  164 (271)
T 3kmu_A           99 VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED---MTARISMADVKFSFQ-----------  164 (271)
T ss_dssp             HHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT---SCEEEEGGGSCCTTS-----------
T ss_pred             HHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC---cceeEEeccceeeec-----------
Confidence            998765  4899999999999999999999999  9999999999999754   458999988752210           


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (271)
T 3kmu_A          165 --------------------------------------------------------------------------------  164 (271)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCC---CcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~---~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                          .....||+.|+|||++.+..++.   ++|||||||++|||+||+.||.+.+.......+.
T Consensus       165 --------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  224 (271)
T 3kmu_A          165 --------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA  224 (271)
T ss_dssp             --------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH
T ss_pred             --------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH
Confidence                                01135899999999999876655   7999999999999999999999998888877776


Q ss_pred             cccCC
Q psy2131         312 AGAYD  316 (328)
Q Consensus       312 ~~~~~  316 (328)
                      .....
T Consensus       225 ~~~~~  229 (271)
T 3kmu_A          225 LEGLR  229 (271)
T ss_dssp             HSCCC
T ss_pred             hcCCC
Confidence            65543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-40  Score=304.95  Aligned_cols=220  Identities=43%  Similarity=0.797  Sum_probs=195.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC--CCHHH----HHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK--LSARD----FQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~--~~~~~----~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||.||+|+++.+|+.||||+++...  ....+    .+.+.+|+.+++++ +||||+++++++...+..|+|||||+|
T Consensus       105 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g  184 (365)
T 2y7j_A          105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK  184 (365)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTT
T ss_pred             CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCC
Confidence            899999999999999999999997654  22222    35678999999999 899999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC---------
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG---------  144 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~---------  144 (328)
                      ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+   +.+||+|||++..+..         
T Consensus       185 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~---~~ikl~DfG~~~~~~~~~~~~~~~g  261 (365)
T 2y7j_A          185 GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN---MQIRLSDFGFSCHLEPGEKLRELCG  261 (365)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCCBCCCCS
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEEecCcccccCCCcccccCCC
Confidence            9999999888889999999999999999999999999999999999999754   4699999998764321         


Q ss_pred             -----------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHH
Q psy2131         145 -----------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLIN  200 (328)
Q Consensus       145 -----------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  200 (328)
                                             ..+.| +|+++|+|++|..||...+.......+..+.+.++.+.+...++++.+++.
T Consensus       262 t~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  341 (365)
T 2y7j_A          262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS  341 (365)
T ss_dssp             CGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHH
T ss_pred             CCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHH
Confidence                                   11223 899999999999999998888888888888888877778889999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccC
Q psy2131         201 QMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      +||..||.+|||+.++++|||+.
T Consensus       342 ~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          342 RLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHcCCChhHCcCHHHHhcCcccC
Confidence            99999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.6e-41  Score=299.36  Aligned_cols=210  Identities=29%  Similarity=0.500  Sum_probs=169.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++||||+++++++.+.+..|+||||+++++|.++
T Consensus        43 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  122 (310)
T 2wqm_A           43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM  122 (310)
T ss_dssp             C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHH
T ss_pred             CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHH
Confidence            899999999999999999999998643 3455567789999999999999999999999999999999999999999888


Q ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          80 IVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        80 l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      +..    ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......         
T Consensus       123 l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~---~~~kl~Dfg~~~~~~~~~---------  190 (310)
T 2wqm_A          123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKT---------  190 (310)
T ss_dssp             HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCC-------------------
T ss_pred             HHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC---CCEEEEeccceeeecCCC---------
Confidence            864    4569999999999999999999999999999999999999754   469999999874321100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       191 --------------------------------------------------------------------------------  190 (310)
T 2wqm_A          191 --------------------------------------------------------------------------------  190 (310)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc--cHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~  313 (328)
                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.  +...+...+..+
T Consensus       191 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  253 (310)
T 2wqm_A          191 -----------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  253 (310)
T ss_dssp             -------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred             -----------------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence                             0011235899999999999999999999999999999999999999876  456777888887


Q ss_pred             cCCCCC
Q psy2131         314 AYDDEP  319 (328)
Q Consensus       314 ~~~~~~  319 (328)
                      .+...|
T Consensus       254 ~~~~~~  259 (310)
T 2wqm_A          254 DYPPLP  259 (310)
T ss_dssp             CSCCCC
T ss_pred             cCCCCc
Confidence            765444

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.3e-42  Score=321.47  Aligned_cols=211  Identities=23%  Similarity=0.358  Sum_probs=176.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+.. +..||||+++.....   .+.+.+|+++|++++||||+++++++.+ +..|+|||||++|+|.+++
T Consensus       195 G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l  269 (452)
T 1fmk_A          195 GCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL  269 (452)
T ss_dssp             CSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred             CCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHH
Confidence            8999999999875 467999999865543   3567899999999999999999999876 6789999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++.......           
T Consensus       270 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~-----------  335 (452)
T 1fmk_A          270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEY-----------  335 (452)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC------------------
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC---CCEEECCCccceecCCCce-----------
Confidence            643  469999999999999999999999999999999999999754   4599999999854311000           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       336 --------------------------------------------------------------------------------  335 (452)
T 1fmk_A          336 --------------------------------------------------------------------------------  335 (452)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.+|...+
T Consensus       336 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~  401 (452)
T 1fmk_A          336 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP  401 (452)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                          00112347888999999999999999999999999999999 999999999999999999998766


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       402 ~~~~~~~  408 (452)
T 1fmk_A          402 CPPECPE  408 (452)
T ss_dssp             CCTTSCH
T ss_pred             CCCCCCH
Confidence            6766553

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-41  Score=311.69  Aligned_cols=197  Identities=31%  Similarity=0.453  Sum_probs=169.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE------EEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH------YLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~------~lv~E~~~gg   74 (328)
                      |+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++...+..      |+||||+. +
T Consensus        53 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~  131 (371)
T 4exu_A           53 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-T  131 (371)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-E
T ss_pred             CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-c
Confidence            8999999999999999999999987766666677889999999999999999999999877655      99999997 5


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+  ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....          
T Consensus       132 ~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~----------  196 (371)
T 4exu_A          132 DLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADA----------  196 (371)
T ss_dssp             EHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSTTCC---------------
T ss_pred             cHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC---CCEEEEecCccccccc----------
Confidence            777666  3459999999999999999999999999999999999999754   4599999999743210          


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       197 --------------------------------------------------------------------------------  196 (371)
T 4exu_A          197 --------------------------------------------------------------------------------  196 (371)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                         ......||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+....+..+.+
T Consensus       197 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  256 (371)
T 4exu_A          197 -------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  256 (371)
T ss_dssp             ----------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             -------------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                               0112458999999999987 7899999999999999999999999999998888877765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=319.18  Aligned_cols=206  Identities=30%  Similarity=0.498  Sum_probs=170.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--YHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|++..+|+.||||+++.... ....+.+.+|+++|++++||||+++++++.+.+  ..|+|||||+||+|.+
T Consensus        20 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~   98 (396)
T 4eut_A           20 GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT   98 (396)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHH
Confidence            8999999999999999999999975432 223466789999999999999999999998765  7899999999999999


Q ss_pred             HHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          79 DIVAREF---YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        79 ~l~~~~~---~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ++.....   +++.++..++.|++.||.|||++||+||||||+|||+... ...+.+||+|||++.......        
T Consensus        99 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--------  170 (396)
T 4eut_A           99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--------  170 (396)
T ss_dssp             HTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--------
T ss_pred             HHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--------
Confidence            8865432   9999999999999999999999999999999999998332 234569999999986542110        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (396)
T 4eut_A          171 --------------------------------------------------------------------------------  170 (396)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--------CCCCCCcchhhhhhHHHHHHhcCCCCCC----cc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--------EPYGKPVDIWACGVILYILLVGYPPFWD----ED  302 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~----~~  302 (328)
                                         ......||+.|+|||++.+        ..|+.++|||||||++|||+||+.||..    .+
T Consensus       171 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          171 -------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             -------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             -------------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence                               0112459999999999875        5778899999999999999999999974    34


Q ss_pred             HHHHHHHHhccc
Q psy2131         303 QHRLYAQIKAGA  314 (328)
Q Consensus       303 ~~~~~~~i~~~~  314 (328)
                      ..+++.++..+.
T Consensus       232 ~~~~~~~~~~~~  243 (396)
T 4eut_A          232 NKEVMYKIITGK  243 (396)
T ss_dssp             CHHHHHHHHHSC
T ss_pred             hHHHHHHHhcCC
Confidence            556677777664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.1e-41  Score=299.60  Aligned_cols=219  Identities=40%  Similarity=0.726  Sum_probs=180.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHH-HhCCCCCcceeEEEEEe----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il-~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..+|+.||+|+++..       ..+.+|+.++ +.++||||+++++++.+    ....|+|||||+||+
T Consensus        29 G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~  101 (299)
T 3m2w_A           29 GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE  101 (299)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCB
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCc
Confidence            79999999999999999999999642       3456788887 56699999999999987    778999999999999


Q ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-----cc
Q psy2131          76 LFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-----QA  148 (328)
Q Consensus        76 L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-----~~  148 (328)
                      |.+++....  .+++.++..++.|++.||.|||++||+||||||+|||++..+.++.+||+|||++....+..     +.
T Consensus       102 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~Di  181 (299)
T 3m2w_A          102 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDM  181 (299)
T ss_dssp             HHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCGGGGHHHH
T ss_pred             HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccccCCchhhH
Confidence            999998754  69999999999999999999999999999999999999875556789999999998765432     23


Q ss_pred             h-HHHHHHHHHhCCCCCCCCcHHHHHH----HHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         149 W-FGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       149 ~-~G~~~~~~~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      | +|+++|+|++|.+||.+.+......    .+......++.+.+..+++++.+++.+||..||.+|||++++++|||+.
T Consensus       182 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          182 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             HHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            3 8999999999999997765443321    1122223333334467899999999999999999999999999999997


Q ss_pred             Ccc
Q psy2131         224 QRE  226 (328)
Q Consensus       224 ~~~  226 (328)
                      +..
T Consensus       262 ~~~  264 (299)
T 3m2w_A          262 QST  264 (299)
T ss_dssp             TGG
T ss_pred             ccc
Confidence            654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-41  Score=299.39  Aligned_cols=204  Identities=30%  Similarity=0.509  Sum_probs=170.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.+|+|++....  ....+.+.+|+++++.++||||+++++++.+.+..|+|||||++++|.+++
T Consensus        30 G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~  107 (302)
T 2j7t_A           30 GAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM  107 (302)
T ss_dssp             STTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHH
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHH
Confidence            899999999999999999999997543  334567889999999999999999999999999999999999999998887


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....               
T Consensus       108 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~---------------  169 (302)
T 2j7t_A          108 LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKNLK---------------  169 (302)
T ss_dssp             HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---SCEEECCCHHHHHHHH---------------
T ss_pred             HhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---CCEEEEECCCCccccc---------------
Confidence            65 4679999999999999999999999999999999999999754   4599999998632100               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (302)
T 2j7t_A          170 --------------------------------------------------------------------------------  169 (302)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccc-----ccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-----~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                 .........||+.|+|||++     .+..++.++|||||||++|+|++|++||.+.+.......+..+.
T Consensus       170 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (302)
T 2j7t_A          170 -----------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD  238 (302)
T ss_dssp             -----------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             -----------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence                       00011224589999999998     46788999999999999999999999999999888888887765


Q ss_pred             C
Q psy2131         315 Y  315 (328)
Q Consensus       315 ~  315 (328)
                      .
T Consensus       239 ~  239 (302)
T 2j7t_A          239 P  239 (302)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-41  Score=299.59  Aligned_cols=209  Identities=23%  Similarity=0.433  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+..   .+|+|+++.........+.+.+|+.++++++||||++++++. .....++|||||+|++|.+.+
T Consensus        35 G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l  110 (289)
T 3og7_A           35 GSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL  110 (289)
T ss_dssp             CSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHH
T ss_pred             CCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHH
Confidence            8999999997543   599999988777777788899999999999999999999954 556689999999999999888


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       111 ~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~------------  175 (289)
T 3og7_A          111 HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED---NTVKIGDFGLATEKSRWSG------------  175 (289)
T ss_dssp             TTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC----------------------
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEEccceeccccccccc------------
Confidence            54 3569999999999999999999999999999999999999754   4699999999753211000            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       176 --------------------------------------------------------------------------------  175 (289)
T 3og7_A          176 --------------------------------------------------------------------------------  175 (289)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~  315 (328)
                                  ........||+.|+|||++.   +.+++.++|||||||++|||++|+.||.+.+ ...+...+.++.+
T Consensus       176 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  243 (289)
T 3og7_A          176 ------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL  243 (289)
T ss_dssp             --------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred             ------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence                        00011235899999999997   6778899999999999999999999998864 6667777777776


Q ss_pred             CCCCC
Q psy2131         316 DDEPK  320 (328)
Q Consensus       316 ~~~~~  320 (328)
                      .+++.
T Consensus       244 ~~~~~  248 (289)
T 3og7_A          244 SPDLS  248 (289)
T ss_dssp             CCCTT
T ss_pred             Ccchh
Confidence            55443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-41  Score=307.15  Aligned_cols=188  Identities=24%  Similarity=0.347  Sum_probs=156.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|++.  ++.||||++...   ........+|+.++++++|||||++++++.+..    .+|+|||||++|+|
T Consensus        35 G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L  109 (322)
T 3soc_A           35 GRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL  109 (322)
T ss_dssp             STTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             cCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence            899999999875  789999999653   233445667999999999999999999998744    47999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSN----------GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~----------~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      .+++.. ..+++.++..++.|++.||.|||+.          ||+||||||+|||++.+   +.+||+|||+++......
T Consensus       110 ~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~---~~~kL~DFg~a~~~~~~~  185 (322)
T 3soc_A          110 SDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN---LTACIADFGLALKFEAGK  185 (322)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT---CCEEECCCTTCEEECTTS
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC---CeEEEccCCccccccccc
Confidence            998865 4599999999999999999999999          99999999999999754   469999999986543211


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       186 ~~------------------------------------------------------------------------------  187 (322)
T 3soc_A          186 SA------------------------------------------------------------------------------  187 (322)
T ss_dssp             CC------------------------------------------------------------------------------
T ss_pred             Cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                                .......||+.|+|||++.+     ..++.++|||||||++|||+||+.||.+.
T Consensus       188 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          188 --------------------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             --------------------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             --------------------------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence                                      00112459999999999987     35567899999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-41  Score=298.51  Aligned_cols=213  Identities=25%  Similarity=0.350  Sum_probs=175.8

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..   ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+. ..|+||||+++++|.
T Consensus        23 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~  100 (281)
T 3cc6_A           23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELG  100 (281)
T ss_dssp             CSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHH
T ss_pred             cCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHH
Confidence            8999999998654   34569999997653 445567889999999999999999999998755 468999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........         
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~---------  168 (281)
T 3cc6_A          101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP---ECVKLGDFGLSRYIEDEDY---------  168 (281)
T ss_dssp             HHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET---TEEEECCCCGGGCC--------------
T ss_pred             HHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC---CcEEeCccCCCcccccccc---------
Confidence            998764 459999999999999999999999999999999999999865   4699999999854321100         


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (281)
T 3cc6_A          169 --------------------------------------------------------------------------------  168 (281)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+...+..+..
T Consensus       169 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~  232 (281)
T 3cc6_A          169 ----------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR  232 (281)
T ss_dssp             --------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC
T ss_pred             ----------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC
Confidence                            00112347889999999999999999999999999999998 9999998888888888888876


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|..++
T Consensus       233 ~~~~~~~~  240 (281)
T 3cc6_A          233 LPKPDLCP  240 (281)
T ss_dssp             CCCCTTCC
T ss_pred             CCCCCCCC
Confidence            65555443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=314.20  Aligned_cols=195  Identities=29%  Similarity=0.452  Sum_probs=151.7

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++  .+++.||||++......    ..+.+|+.+|++++|||||++++++..  ...+|+|||||.| +|
T Consensus        32 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l  106 (405)
T 3rgf_A           32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL  106 (405)
T ss_dssp             ----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EH
T ss_pred             cCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CH
Confidence            899999999976  57899999999865443    346789999999999999999999954  6789999999975 78


Q ss_pred             HHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC-CCCCcEEEeeccccccccCCC
Q psy2131          77 FEDIVAR---------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK-AKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        77 ~~~l~~~---------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~-~~~~~vkl~DfGla~~~~~~~  146 (328)
                      .+.+...         ..+++.++..++.||+.||.|||++||+||||||+|||+... ...+.+||+|||+|.......
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~  186 (405)
T 3rgf_A          107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL  186 (405)
T ss_dssp             HHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC------
T ss_pred             HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCC
Confidence            7777532         249999999999999999999999999999999999999543 244679999999986432110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .                                                                               
T Consensus       187 ~-------------------------------------------------------------------------------  187 (405)
T 3rgf_A          187 K-------------------------------------------------------------------------------  187 (405)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             c-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                              .........||+.|+|||++.+. .|+.++|||||||+||||+||++||.+.+.
T Consensus       188 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          188 ------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             ---------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             ------------------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence                                    00011234699999999999884 589999999999999999999999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-41  Score=297.95  Aligned_cols=207  Identities=23%  Similarity=0.327  Sum_probs=157.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||+|+++.........+.+.+|...++.++||||+++++++.+.+..|+|||||+| +|.+.+
T Consensus        18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l   96 (290)
T 3fme_A           18 GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFY   96 (290)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHH
T ss_pred             CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHH
Confidence            8999999999999999999999986654444444555666668889999999999999999999999999985 776665


Q ss_pred             Hh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          81 VA----REFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        81 ~~----~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      ..    ...+++.++..++.|++.||.|||++ ||+||||||+|||++.+   +.+||+|||++.......         
T Consensus        97 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~---------  164 (290)
T 3fme_A           97 KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDV---------  164 (290)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT---CCEEBCCC-------------------
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeecCCcccccccc---------
Confidence            43    46799999999999999999999998 99999999999999754   469999999975421100         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (290)
T 3fme_A          165 --------------------------------------------------------------------------------  164 (290)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc----ccCCCCCCcchhhhhhHHHHHHhcCCCCCC-cc-HHHHHHH
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL----KKEPYGKPVDIWACGVILYILLVGYPPFWD-ED-QHRLYAQ  309 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~-~~~~~~~  309 (328)
                                        ......||+.|+|||++    .+..++.++|||||||++|||+||+.||.+ .. ...+...
T Consensus       165 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  226 (290)
T 3fme_A          165 ------------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV  226 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred             ------------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence                              01112589999999996    567889999999999999999999999985 23 4444444


Q ss_pred             HhcccCCCC
Q psy2131         310 IKAGAYDDE  318 (328)
Q Consensus       310 i~~~~~~~~  318 (328)
                      +.......+
T Consensus       227 ~~~~~~~~~  235 (290)
T 3fme_A          227 VEEPSPQLP  235 (290)
T ss_dssp             HHSCCCCCC
T ss_pred             hccCCCCcc
Confidence            444444333

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-41  Score=301.85  Aligned_cols=216  Identities=25%  Similarity=0.362  Sum_probs=174.2

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lv~E~~~gg   74 (328)
                      |+||.||+|+    +..+++.||+|++.... .....+.+.+|+++++.++||||+++++++.+.  +.+|+|||||++|
T Consensus        32 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~  110 (302)
T 4e5w_A           32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG  110 (302)
T ss_dssp             CSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTC
T ss_pred             CCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCC
Confidence            8999999998    67899999999997653 233456788999999999999999999999876  6789999999999


Q ss_pred             CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........     
T Consensus       111 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~-----  182 (302)
T 4e5w_A          111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEY-----  182 (302)
T ss_dssp             BHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCCE-----
T ss_pred             cHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC---CCEEECcccccccccCCCcc-----
Confidence            99999844 4579999999999999999999999999999999999999865   46999999998654321110     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       183 --------------------------------------------------------------------------------  182 (302)
T 4e5w_A          183 --------------------------------------------------------------------------------  182 (302)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc------------
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE------------  301 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~------------  301 (328)
                                        ........||+.|+|||++.+..++.++|||||||++|||+||+.||...            
T Consensus       183 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  244 (302)
T 4e5w_A          183 ------------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH  244 (302)
T ss_dssp             ------------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred             ------------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence                              00011234888999999999999999999999999999999999876432            


Q ss_pred             ---cHHHHHHHHhcccCCCCCCccc
Q psy2131         302 ---DQHRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       302 ---~~~~~~~~i~~~~~~~~~~~~~  323 (328)
                         ....+...+..+...+.|...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~  269 (302)
T 4e5w_A          245 GQMTVTRLVNTLKEGKRLPCPPNCP  269 (302)
T ss_dssp             GGGHHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCHHHHHHHHhccCCCCCCCCCC
Confidence               3456666777776666665544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-41  Score=297.96  Aligned_cols=204  Identities=25%  Similarity=0.433  Sum_probs=166.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHH-----HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-----FQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|++..+++.||+|++.........     .+.+.+|+.++++++||||+++++++.+..  ++||||+++|+
T Consensus        30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~  107 (287)
T 4f0f_A           30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGD  107 (287)
T ss_dssp             CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCB
T ss_pred             CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCC
Confidence            89999999999999999999999765433221     167889999999999999999999997776  69999999999


Q ss_pred             cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCC--CCcEEEeeccccccccCCCcchH
Q psy2131          76 LFEDIVAR-EFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAK--GAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        76 L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~--~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      |.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.  ...+||+|||++......     
T Consensus       108 L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----  182 (287)
T 4f0f_A          108 LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----  182 (287)
T ss_dssp             HHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----
T ss_pred             HHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----
Confidence            98888654 46999999999999999999999999  999999999999975432  224899999997532110     


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       183 --------------------------------------------------------------------------------  182 (287)
T 4f0f_A          183 --------------------------------------------------------------------------------  182 (287)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc--ccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc--HHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL--KKEPYGKPVDIWACGVILYILLVGYPPFWDED--QHRL  306 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l--~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~  306 (328)
                                              .....||+.|+|||++  .+..|+.++|||||||++|||++|+.||.+.+  ....
T Consensus       183 ------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  238 (287)
T 4f0f_A          183 ------------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF  238 (287)
T ss_dssp             ------------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred             ------------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence                                    1124589999999999  45567899999999999999999999998765  3333


Q ss_pred             HHHHhcccC
Q psy2131         307 YAQIKAGAY  315 (328)
Q Consensus       307 ~~~i~~~~~  315 (328)
                      ...+.....
T Consensus       239 ~~~~~~~~~  247 (287)
T 4f0f_A          239 INMIREEGL  247 (287)
T ss_dssp             HHHHHHSCC
T ss_pred             HHHHhccCC
Confidence            444444433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=298.68  Aligned_cols=201  Identities=26%  Similarity=0.449  Sum_probs=171.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||+|++....    ..+.+.+|+.+++.++||||+++++++.+.+..|+|||||++++|.+++
T Consensus        40 G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  115 (314)
T 3com_A           40 GSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII  115 (314)
T ss_dssp             ---CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHH
Confidence            799999999999999999999997643    2356788999999999999999999999999999999999999999988


Q ss_pred             H-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 V-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~-~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      . ....+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........            
T Consensus       116 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~------------  180 (314)
T 3com_A          116 RLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDTMA------------  180 (314)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECBTTBS------------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---CCEEEeecccchhhhhhcc------------
Confidence            6 45679999999999999999999999999999999999999754   4599999999855321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (314)
T 3com_A          181 --------------------------------------------------------------------------------  180 (314)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus       181 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  241 (314)
T 3com_A          181 --------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP  241 (314)
T ss_dssp             --------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             --------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence                          0112358999999999999999999999999999999999999999988777666655543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-41  Score=302.87  Aligned_cols=212  Identities=22%  Similarity=0.356  Sum_probs=174.0

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+     ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++.+.+..|+|||||++|
T Consensus        34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  112 (313)
T 1t46_A           34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG  112 (313)
T ss_dssp             CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             cCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCC
Confidence            89999999985     4678899999997543 344567789999999999 9999999999999999999999999999


Q ss_pred             CcHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          75 ELFEDIVARE------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        75 ~L~~~l~~~~------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|.+++....                  .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus       113 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Df  189 (313)
T 1t46_A          113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDF  189 (313)
T ss_dssp             EHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT---TEEEECCC
T ss_pred             CHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC---CCEEEccc
Confidence            9999987654                  48999999999999999999999999999999999999754   56999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |++........                                                                     
T Consensus       190 g~~~~~~~~~~---------------------------------------------------------------------  200 (313)
T 1t46_A          190 GLARDIKNDSN---------------------------------------------------------------------  200 (313)
T ss_dssp             GGGSCTTSCTT---------------------------------------------------------------------
T ss_pred             ccccccccccc---------------------------------------------------------------------
Confidence            99854322100                                                                     


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                         ........||+.|+|||++.+..++.++|||||||++|||+| |+
T Consensus       201 -----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  245 (313)
T 1t46_A          201 -----------------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (313)
T ss_dssp             -----------------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             -----------------------------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence                                               000112347899999999999999999999999999999999 99


Q ss_pred             CCCCCccH-HHHHHHHhcccCCCCCC
Q psy2131         296 PPFWDEDQ-HRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       296 ~Pf~~~~~-~~~~~~i~~~~~~~~~~  320 (328)
                      .||.+.+. ..+...+..+.....|.
T Consensus       246 ~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (313)
T 1t46_A          246 SPYPGMPVDSKFYKMIKEGFRMLSPE  271 (313)
T ss_dssp             CSSTTCCSSHHHHHHHHHTCCCCCCT
T ss_pred             CCCCcccchhHHHHHhccCCCCCCcc
Confidence            99998764 44444444444333333

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8e-41  Score=301.33  Aligned_cols=224  Identities=37%  Similarity=0.691  Sum_probs=186.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC------HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|++..+++.||||++......      ......+.+|+++|++++||||+++++++...+ .|+|||||+|+
T Consensus        21 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~   99 (322)
T 2ycf_A           21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG   99 (322)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTE
T ss_pred             CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCC
Confidence            89999999999999999999999765432      122345789999999999999999999998766 89999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------  145 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------  145 (328)
                      +|.+.+.....+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++......         
T Consensus       100 ~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt  179 (322)
T 2ycf_A          100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT  179 (322)
T ss_dssp             ETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSC
T ss_pred             cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCC
Confidence            99999988888999999999999999999999999999999999999987666667999999998643211         


Q ss_pred             --------------------Ccch-HHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         146 --------------------QQAW-FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       146 --------------------~~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                          .+.| +|+++|+|++|..||..... ..+...+..+...+.+..+..+++++.+++.+||
T Consensus       180 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (322)
T 2ycf_A          180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL  259 (322)
T ss_dssp             CTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             cCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHc
Confidence                                1223 89999999999999976543 2445556666665554455678999999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..||.+|||++++++|||+...
T Consensus       260 ~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          260 VVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ccCHhhCCCHHHHhhCcCcCCH
Confidence            9999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-42  Score=313.61  Aligned_cols=218  Identities=24%  Similarity=0.350  Sum_probs=172.2

Q ss_pred             CCceEEEEEEEccCC---cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~---~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..++   ..+|+|.++... .....+.+.+|+.++++++||||+++++++. ..+..|+|||||++|+|
T Consensus       100 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L  178 (373)
T 3c1x_A          100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL  178 (373)
T ss_dssp             CSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBH
T ss_pred             CCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCH
Confidence            899999999875433   468999987532 3445678899999999999999999999865 45678999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++........       
T Consensus       179 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DFG~a~~~~~~~~~-------  248 (373)
T 3c1x_A          179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEFD-------  248 (373)
T ss_dssp             HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC-------------------
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC---CCEEEeeccccccccccccc-------
Confidence            9998764 458999999999999999999999999999999999999754   46999999998543211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       249 --------------------------------------------------------------------------------  248 (373)
T 3c1x_A          249 --------------------------------------------------------------------------------  248 (373)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                     .........||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+.++.
T Consensus       249 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~  313 (373)
T 3c1x_A          249 ---------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  313 (373)
T ss_dssp             ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred             ---------------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence                           0001112357899999999999999999999999999999999 799999988888888899998


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ....|..++.
T Consensus       314 ~~~~p~~~~~  323 (373)
T 3c1x_A          314 RLLQPEYCPD  323 (373)
T ss_dssp             CCCCCTTCCH
T ss_pred             CCCCCCCCCH
Confidence            7777765543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=299.12  Aligned_cols=217  Identities=24%  Similarity=0.323  Sum_probs=178.9

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE-EEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH-YLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~-~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..++.   .+|+|++... ......+.+.+|+.++++++||||+++++++.+.+.. |+||||+.+|+|
T Consensus        32 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L  110 (298)
T 3pls_A           32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL  110 (298)
T ss_dssp             ETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBH
T ss_pred             CCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCH
Confidence            8999999999766555   7999999753 3445567889999999999999999999999876655 999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+.. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       111 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~-------  180 (298)
T 3pls_A          111 LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLARDILDREYY-------  180 (298)
T ss_dssp             HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECCTTSSCTTTTGGGG-------
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcEEeCcCCCcccccCCccc-------
Confidence            999876 4568999999999999999999999999999999999999644   46999999998643211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (298)
T 3pls_A          181 --------------------------------------------------------------------------------  180 (298)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                     .........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+...+...+..+.
T Consensus       181 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 3pls_A          181 ---------------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR  245 (298)
T ss_dssp             ---------------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred             ---------------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence                           0000112357899999999999999999999999999999999 677777778889999999888


Q ss_pred             CCCCCCccc
Q psy2131         315 YDDEPKHKS  323 (328)
Q Consensus       315 ~~~~~~~~~  323 (328)
                      ....|...+
T Consensus       246 ~~~~~~~~~  254 (298)
T 3pls_A          246 RLPQPEYCP  254 (298)
T ss_dssp             CCCCCTTCC
T ss_pred             CCCCCccch
Confidence            766666554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-41  Score=308.58  Aligned_cols=204  Identities=29%  Similarity=0.447  Sum_probs=170.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|++..+++.||||++.... .....+.+.+|+++|++++||||+++++++...     ...|+||||+.| +
T Consensus        38 G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~  115 (364)
T 3qyz_A           38 GAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-D  115 (364)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-E
T ss_pred             CCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-C
Confidence            899999999999999999999997533 344557788999999999999999999999765     468999999975 8


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.. ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       116 L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~-------  184 (364)
T 3qyz_A          116 LYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDH-------  184 (364)
T ss_dssp             HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCGGGCB-------
T ss_pred             HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC---CCEEEEeCcceEecCCCCCc-------
Confidence            8887754 569999999999999999999999999999999999999754   45999999998653211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (364)
T 3qyz_A          185 --------------------------------------------------------------------------------  184 (364)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                      ........||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+....+..|...
T Consensus       185 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  247 (364)
T 3qyz_A          185 ----------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  247 (364)
T ss_dssp             ----------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred             ----------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence                            000123469999999998754 55899999999999999999999999999888888877643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-41  Score=311.86  Aligned_cols=200  Identities=21%  Similarity=0.250  Sum_probs=158.8

Q ss_pred             CCceEEEEEEEccC-----CcEEEEEEeccCCCCHH-HH--------HHHHHHHHHHHhCCCCCcceeEEEEEeC----C
Q psy2131           1 GAFSVVRRCVQKAT-----GLEFAAKIINTKKLSAR-DF--------QKLEREARICRKLQHPNIVRLHDSIQEE----N   62 (328)
Q Consensus         1 G~fg~V~~~~~~~~-----~~~~AiK~i~~~~~~~~-~~--------~~~~~E~~il~~l~H~nIv~l~~~~~~~----~   62 (328)
                      |+||+||+|.+..+     ++.||||++........ +.        ....+|+..++.++||||+++++++...    .
T Consensus        46 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~  125 (364)
T 3op5_A           46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS  125 (364)
T ss_dssp             C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEE
T ss_pred             CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcc
Confidence            89999999998765     58899999976531110 00        1234566778888999999999998764    5


Q ss_pred             EEEEEEEccCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          63 YHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        63 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      ..|+||||| |++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++.
T Consensus       126 ~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~~~kl~DFG~a~~  203 (364)
T 3op5_A          126 YRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYR  203 (364)
T ss_dssp             EEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-CTTCEEECCCTTCEE
T ss_pred             eEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-CCCeEEEEECCccee
Confidence            689999999 99999988765 679999999999999999999999999999999999999843 235699999999876


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .......                                ..                                       
T Consensus       204 ~~~~~~~--------------------------------~~---------------------------------------  212 (364)
T 3op5_A          204 YCPEGVH--------------------------------KA---------------------------------------  212 (364)
T ss_dssp             SSGGGCC--------------------------------CC---------------------------------------
T ss_pred             cccCCcc--------------------------------cc---------------------------------------
Confidence            4321100                                00                                       


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                                  ..........||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.
T Consensus       213 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          213 ----------------------------YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             ----------------------------SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             ----------------------------cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence                                        0000112346999999999999999999999999999999999999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-41  Score=306.46  Aligned_cols=193  Identities=23%  Similarity=0.350  Sum_probs=164.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+ .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..|+|||||+||+|.+++
T Consensus        50 G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  126 (321)
T 2qkw_B           50 GVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL  126 (321)
T ss_dssp             CSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGS
T ss_pred             CCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHH
Confidence            89999999986 478999999987653  334567899999999999999999999999999999999999999999888


Q ss_pred             HhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          81 VARE----FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        81 ~~~~----~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      ....    .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........        
T Consensus       127 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~--------  195 (321)
T 2qkw_B          127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN---FVPKITDFGISKKGTELDQT--------  195 (321)
T ss_dssp             SSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT---CCEEECCCTTCEECSSSSCC--------
T ss_pred             hccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC---CCEEEeeccccccccccccc--------
Confidence            6543    58999999999999999999999999999999999999643   56999999998643211000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       196 --------------------------------------------------------------------------------  195 (321)
T 2qkw_B          196 --------------------------------------------------------------------------------  195 (321)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                      .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+..+
T Consensus       196 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          196 ----------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             ----------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             ----------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence                            001123589999999999999999999999999999999999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-41  Score=302.78  Aligned_cols=202  Identities=28%  Similarity=0.432  Sum_probs=171.9

Q ss_pred             CCceEEEEEEE-ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC------cceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQ-KATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN------IVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~-~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~n------Iv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+ ..+|+.||+|+++..   ....+.+.+|+++++.++|+|      |+++++++.+.+..|+||||| +
T Consensus        25 G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  100 (339)
T 1z57_A           25 GAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-G  100 (339)
T ss_dssp             ETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             CCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-C
Confidence            79999999998 568899999999643   344567889999999887665      999999999999999999999 8


Q ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC----------------CCcEEEee
Q psy2131          74 GELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK----------------GAAVKLAD  135 (328)
Q Consensus        74 g~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~----------------~~~vkl~D  135 (328)
                      ++|.+.+...+  .+++.++..++.|++.||.|||++||+||||||+|||++..+.                ++.+||+|
T Consensus       101 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  180 (339)
T 1z57_A          101 LSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD  180 (339)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECC
T ss_pred             CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEee
Confidence            89999987765  6899999999999999999999999999999999999975321                45699999


Q ss_pred             ccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy2131         136 FGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE  215 (328)
Q Consensus       136 fGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~  215 (328)
                      ||++......                                                                      
T Consensus       181 fg~~~~~~~~----------------------------------------------------------------------  190 (339)
T 1z57_A          181 FGSATYDDEH----------------------------------------------------------------------  190 (339)
T ss_dssp             CSSCEETTSC----------------------------------------------------------------------
T ss_pred             CcccccCccc----------------------------------------------------------------------
Confidence            9997542110                                                                      


Q ss_pred             HhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcC
Q psy2131         216 ALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY  295 (328)
Q Consensus       216 ~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~  295 (328)
                                                             .....||+.|+|||++.+..|+.++|||||||++|||+||+
T Consensus       191 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          191 ---------------------------------------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             ---------------------------------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ---------------------------------------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                                                   01235899999999999999999999999999999999999


Q ss_pred             CCCCCccHHHHHHHHhcccC
Q psy2131         296 PPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~  315 (328)
                      +||.+.+.......+.+..-
T Consensus       232 ~pf~~~~~~~~~~~~~~~~~  251 (339)
T 1z57_A          232 TVFPTHDSKEHLAMMERILG  251 (339)
T ss_dssp             CSCCCSCHHHHHHHHHHHHC
T ss_pred             CCCCCCChHHHHHHHHHHhC
Confidence            99999988777776655443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.8e-41  Score=295.96  Aligned_cols=210  Identities=21%  Similarity=0.359  Sum_probs=176.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+. ++..||+|++......   .+.+.+|++++++++||||+++++++.+ +..|+||||++|++|.+++
T Consensus        24 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l   98 (279)
T 1qpc_A           24 GQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL   98 (279)
T ss_dssp             ETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHT
T ss_pred             CCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHH
Confidence            799999999875 5678999999765433   3567899999999999999999999874 4589999999999999988


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ....  .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........           
T Consensus        99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-----------  164 (279)
T 1qpc_A           99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLARLIEDNEY-----------  164 (279)
T ss_dssp             TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECSSSCE-----------
T ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC---CCEEECCCcccccccCccc-----------
Confidence            6543  69999999999999999999999999999999999999743   4699999999865422110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (279)
T 1qpc_A          165 --------------------------------------------------------------------------------  164 (279)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+.++....
T Consensus       165 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (279)
T 1qpc_A          165 --------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV  230 (279)
T ss_dssp             --------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC
Confidence                          00112347889999999999999999999999999999999 999999999999999999887655


Q ss_pred             CCCccc
Q psy2131         318 EPKHKS  323 (328)
Q Consensus       318 ~~~~~~  323 (328)
                      .|..++
T Consensus       231 ~~~~~~  236 (279)
T 1qpc_A          231 RPDNCP  236 (279)
T ss_dssp             CCTTCC
T ss_pred             Cccccc
Confidence            555443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-41  Score=306.15  Aligned_cols=207  Identities=23%  Similarity=0.375  Sum_probs=171.7

Q ss_pred             CCceEEEEEEEccCCc-----EEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGL-----EFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~-----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+..++.     .||+|++.... .....+.+.+|+.+++++ +||||+++++++.+.+..|+|||||++|
T Consensus        57 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g  135 (333)
T 2i1m_A           57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG  135 (333)
T ss_dssp             CSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             CCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCC
Confidence            8999999999987765     79999997543 345567789999999999 8999999999999999999999999999


Q ss_pred             CcHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccc
Q psy2131          75 ELFEDIVAR--------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus        75 ~L~~~l~~~--------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~  140 (328)
                      +|.+++...              ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus       136 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~  212 (333)
T 2i1m_A          136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLAR  212 (333)
T ss_dssp             EHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG---GEEEBCCCGGGC
T ss_pred             cHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC---CeEEECcccccc
Confidence            999988653              357999999999999999999999999999999999999754   469999999985


Q ss_pred             cccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         141 EVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       141 ~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      .......                                                                         
T Consensus       213 ~~~~~~~-------------------------------------------------------------------------  219 (333)
T 2i1m_A          213 DIMNDSN-------------------------------------------------------------------------  219 (333)
T ss_dssp             CGGGCTT-------------------------------------------------------------------------
T ss_pred             ccccccc-------------------------------------------------------------------------
Confidence            4321100                                                                         


Q ss_pred             ccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCC
Q psy2131         221 WICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFW  299 (328)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~  299 (328)
                                                     ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.
T Consensus       220 -------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          220 -------------------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             -------------------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             -------------------------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence                                           000112347889999999999999999999999999999999 999999


Q ss_pred             CccHHHHHHHHhcccC
Q psy2131         300 DEDQHRLYAQIKAGAY  315 (328)
Q Consensus       300 ~~~~~~~~~~i~~~~~  315 (328)
                      +......+..+....+
T Consensus       269 ~~~~~~~~~~~~~~~~  284 (333)
T 2i1m_A          269 GILVNSKFYKLVKDGY  284 (333)
T ss_dssp             TCCSSHHHHHHHHHTC
T ss_pred             ccchhHHHHHHHhcCC
Confidence            8865444444444443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=306.60  Aligned_cols=197  Identities=31%  Similarity=0.458  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE------EEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY------HYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~------~~lv~E~~~gg   74 (328)
                      |+||.||+|+++.+|+.||||++............+.+|+.+++.++||||+++++++...+.      .|+||||+. +
T Consensus        35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~  113 (353)
T 3coi_A           35 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-T  113 (353)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-E
T ss_pred             CCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-C
Confidence            899999999999999999999998766666667788999999999999999999999987654      499999998 4


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+.  ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......         
T Consensus       114 ~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~---------  179 (353)
T 3coi_A          114 DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADAE---------  179 (353)
T ss_dssp             EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---CCEEECSTTCTTC-------------
T ss_pred             CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC---CcEEEeecccccCCCCC---------
Confidence            8877653  359999999999999999999999999999999999999754   46999999997432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (353)
T 3coi_A          180 --------------------------------------------------------------------------------  179 (353)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                          .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..|.+
T Consensus       180 --------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~  238 (353)
T 3coi_A          180 --------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  238 (353)
T ss_dssp             ------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred             --------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                                012358999999999987 7889999999999999999999999999998877777655

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.1e-41  Score=299.08  Aligned_cols=218  Identities=24%  Similarity=0.346  Sum_probs=177.6

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..+   +..+|+|.++.. ......+.+.+|+.++++++||||+++++++ ...+..|+|||||+||+|
T Consensus        36 G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L  114 (298)
T 3f66_A           36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL  114 (298)
T ss_dssp             ETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBH
T ss_pred             cCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCH
Confidence            89999999986543   346899998753 2445567789999999999999999999985 456688999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       115 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~-------  184 (298)
T 3f66_A          115 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEYY-------  184 (298)
T ss_dssp             HHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECSCGGGCCCSCGGGC-------
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC---CCEEECcccccccccccchh-------
Confidence            9998753 458999999999999999999999999999999999999643   46999999998654221100       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (298)
T 3f66_A          185 --------------------------------------------------------------------------------  184 (298)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                     .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+...+...+.++.
T Consensus       185 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 3f66_A          185 ---------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  249 (298)
T ss_dssp             ---------------BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred             ---------------ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence                           0001123458999999999999999999999999999999999 788888888888889999988


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ....|..++.
T Consensus       250 ~~~~~~~~~~  259 (298)
T 3f66_A          250 RLLQPEYCPD  259 (298)
T ss_dssp             CCCCCTTCCH
T ss_pred             CCCCCccCCH
Confidence            8777765543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-41  Score=302.56  Aligned_cols=214  Identities=22%  Similarity=0.355  Sum_probs=175.3

Q ss_pred             CCceEEEEEEE-----ccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC-EEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQ-----KATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEEN-YHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~-----~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~-~~~lv~E~~~g   73 (328)
                      |+||+||+|.+     ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++...+ .+|+|||||+|
T Consensus        38 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~  116 (316)
T 2xir_A           38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  116 (316)
T ss_dssp             CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTT
T ss_pred             CCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCC
Confidence            89999999985     4577899999997543 445567789999999999 7999999999988754 58999999999


Q ss_pred             CCcHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecc
Q psy2131          74 GELFEDIVAREF----------------YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG  137 (328)
Q Consensus        74 g~L~~~l~~~~~----------------~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfG  137 (328)
                      |+|.+++.....                +++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg  193 (316)
T 2xir_A          117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFG  193 (316)
T ss_dssp             EEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCG
T ss_pred             CcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEECCCc
Confidence            999999876543                8999999999999999999999999999999999999754   459999999


Q ss_pred             ccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         138 LAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       138 la~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      ++........                                                                      
T Consensus       194 ~~~~~~~~~~----------------------------------------------------------------------  203 (316)
T 2xir_A          194 LARDIYKDPD----------------------------------------------------------------------  203 (316)
T ss_dssp             GGSCTTTCTT----------------------------------------------------------------------
T ss_pred             cccccccCcc----------------------------------------------------------------------
Confidence            9854321100                                                                      


Q ss_pred             cCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCC
Q psy2131         218 KHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYP  296 (328)
Q Consensus       218 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~  296 (328)
                                                        ........||+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus       204 ----------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          204 ----------------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             ----------------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ----------------------------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence                                              001123458999999999999999999999999999999998 999


Q ss_pred             CCCCcc-HHHHHHHHhcccCCCCCCcc
Q psy2131         297 PFWDED-QHRLYAQIKAGAYDDEPKHK  322 (328)
Q Consensus       297 Pf~~~~-~~~~~~~i~~~~~~~~~~~~  322 (328)
                      ||.+.+ ...+...+..+.....|...
T Consensus       250 p~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (316)
T 2xir_A          250 PYPGVKIDEEFCRRLKEGTRMRAPDYT  276 (316)
T ss_dssp             SSTTCCCSHHHHHHHHHTCCCCCCTTC
T ss_pred             CCcccchhHHHHHHhccCccCCCCCCC
Confidence            998876 45566666666654444443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=300.40  Aligned_cols=210  Identities=28%  Similarity=0.507  Sum_probs=172.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQ--EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+..+++.+|+|+++.....  ......+.+|++++++++||||+++++++.  +.+..|+|||||.++ |
T Consensus        16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l   94 (305)
T 2wtk_C           16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-M   94 (305)
T ss_dssp             CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-H
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-H
Confidence            89999999999999999999999754321  234567889999999999999999999984  556889999999986 6


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+.+..  ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........       
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~dfg~~~~~~~~~~-------  164 (305)
T 2wtk_C           95 QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAA-------  164 (305)
T ss_dssp             HHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCS-------
T ss_pred             HHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---CcEEeeccccccccCcccc-------
Confidence            666654  3569999999999999999999999999999999999999754   4699999999865321100       


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (305)
T 2wtk_C          165 --------------------------------------------------------------------------------  164 (305)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC--CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY--GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~--~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                       ........||+.|+|||++.+...  +.++|||||||++|||++|+.||.+.+...++..+..
T Consensus       165 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~  227 (305)
T 2wtk_C          165 -----------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK  227 (305)
T ss_dssp             -----------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             -----------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence                             000112358999999999987544  7899999999999999999999999999999999999


Q ss_pred             ccCCCC
Q psy2131         313 GAYDDE  318 (328)
Q Consensus       313 ~~~~~~  318 (328)
                      +.+..+
T Consensus       228 ~~~~~~  233 (305)
T 2wtk_C          228 GSYAIP  233 (305)
T ss_dssp             CCCCCC
T ss_pred             CCCCCC
Confidence            887544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=310.02  Aligned_cols=199  Identities=20%  Similarity=0.233  Sum_probs=160.9

Q ss_pred             CCceEEEEEEEcc---CCcEEEEEEeccCCCCHH---------HHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEE
Q psy2131           1 GAFSVVRRCVQKA---TGLEFAAKIINTKKLSAR---------DFQKLEREARICRKLQHPNIVRLHDSIQE----ENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~---~~~~~AiK~i~~~~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~   64 (328)
                      |+||+||+|.+..   ++..+|+|++........         ....+.+|+.+++.++||||+++++++.+    ....
T Consensus        48 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  127 (345)
T 2v62_A           48 GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYR  127 (345)
T ss_dssp             ----CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEE
T ss_pred             cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEE
Confidence            8999999999987   889999999986542111         11235678999999999999999999988    7889


Q ss_pred             EEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC
Q psy2131          65 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG  144 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~  144 (328)
                      |+||||| |++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++. +.+||+|||+++.+..
T Consensus       128 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~kL~Dfg~a~~~~~  205 (345)
T 2v62_A          128 FMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-DQVYLADYGLSYRYCP  205 (345)
T ss_dssp             EEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST-TSEEECCCTTCEESSG
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC-CcEEEEeCCCceeccc
Confidence            9999999 9999999887778999999999999999999999999999999999999986542 3699999999876432


Q ss_pred             CCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         145 EQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       145 ~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ....             .+                                                             
T Consensus       206 ~~~~-------------~~-------------------------------------------------------------  211 (345)
T 2v62_A          206 NGNH-------------KQ-------------------------------------------------------------  211 (345)
T ss_dssp             GGCC-------------CC-------------------------------------------------------------
T ss_pred             cccc-------------cc-------------------------------------------------------------
Confidence            1100             00                                                             


Q ss_pred             cccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         225 RERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                                               ..........||+.|+|||++.+..|+.++|||||||++|||+||+.||.+
T Consensus       212 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          212 -------------------------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             -------------------------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             -------------------------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence                                     000012235699999999999999999999999999999999999999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=299.59  Aligned_cols=203  Identities=26%  Similarity=0.451  Sum_probs=167.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe------CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE------ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~------~~~~~lv~E~~~g   73 (328)
                      |+||.||+|.+..+|+.||+|++.....   ....+.+|+.+++++ +||||+++++++..      .+.+|+|||||++
T Consensus        35 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  111 (326)
T 2x7f_A           35 GTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA  111 (326)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTT
T ss_pred             CCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCC
Confidence            7899999999999999999999976533   235678899999999 89999999999987      5689999999999


Q ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          74 GELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        74 g~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      |+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......     
T Consensus       112 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~-----  183 (326)
T 2x7f_A          112 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTV-----  183 (326)
T ss_dssp             EEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCCTTTC-----------
T ss_pred             CcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC---CCEEEeeCcCceecCcCc-----
Confidence            9999988764  579999999999999999999999999999999999999754   469999999875421100     


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       184 --------------------------------------------------------------------------------  183 (326)
T 2x7f_A          184 --------------------------------------------------------------------------------  183 (326)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                           .......||+.|+|||++.     +..++.++|||||||++|+|+||+.||.+.+....
T Consensus       184 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  242 (326)
T 2x7f_A          184 ---------------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  242 (326)
T ss_dssp             ----------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             ---------------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence                                 0011235899999999997     56789999999999999999999999999988877


Q ss_pred             HHHHhcccC
Q psy2131         307 YAQIKAGAY  315 (328)
Q Consensus       307 ~~~i~~~~~  315 (328)
                      ...+.++..
T Consensus       243 ~~~~~~~~~  251 (326)
T 2x7f_A          243 LFLIPRNPA  251 (326)
T ss_dssp             HHHHHHSCC
T ss_pred             HHHhhcCcc
Confidence            777766544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.3e-41  Score=302.24  Aligned_cols=215  Identities=25%  Similarity=0.339  Sum_probs=177.0

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~~~~lv~E~~~gg   74 (328)
                      |+||.||+|+    +..+++.||+|++...  .....+.+.+|++++++++||||+++++++.  +....|+|||||+|+
T Consensus        34 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~  111 (327)
T 3lxl_A           34 GNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG  111 (327)
T ss_dssp             ETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTC
T ss_pred             CCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCC
Confidence            7999999998    5778999999999754  3455677899999999999999999999987  566799999999999


Q ss_pred             CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........     
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~-----  183 (327)
T 3lxl_A          112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDY-----  183 (327)
T ss_dssp             BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCGGGCEECCTTCSE-----
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC---CCEEEcccccceecccCCcc-----
Confidence            99999876 4569999999999999999999999999999999999999865   45999999998654221100     


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       184 --------------------------------------------------------------------------------  183 (327)
T 3lxl_A          184 --------------------------------------------------------------------------------  183 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH----------
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ----------  303 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----------  303 (328)
                                        ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....          
T Consensus       184 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  245 (327)
T 3lxl_A          184 ------------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER  245 (327)
T ss_dssp             ------------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred             ------------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence                              0001123488999999999999999999999999999999999999987654          


Q ss_pred             -----HHHHHHHhcccCCCCCCccc
Q psy2131         304 -----HRLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       304 -----~~~~~~i~~~~~~~~~~~~~  323 (328)
                           ..+...+..+.....|..++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~  270 (327)
T 3lxl_A          246 DVPALSRLLELLEEGQRLPAPPACP  270 (327)
T ss_dssp             -CCHHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccHHHHHHHhhcccCCCCCCccc
Confidence                 35556666666555555444

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-40  Score=307.60  Aligned_cols=201  Identities=26%  Similarity=0.363  Sum_probs=172.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CC-----CcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HP-----NIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~-----nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+++.||||+++..   ......+.+|+++++.++ |+     +|+++++++...+..|+|||||.+ 
T Consensus        65 G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-  140 (382)
T 2vx3_A           65 GSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-  140 (382)
T ss_dssp             ETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-
T ss_pred             cCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-
Confidence            79999999999999999999999743   334566788999998885 55     499999999999999999999965 


Q ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIVAR--EFYSEADASHCIQQILESVNHCH--SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH--~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      +|.+.+...  ..+++..+..++.|++.||.|||  +.|||||||||+|||++.+. .+.+||+|||++......     
T Consensus       141 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~-~~~~kL~DFG~a~~~~~~-----  214 (382)
T 2vx3_A          141 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQLGQR-----  214 (382)
T ss_dssp             BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-SCCEEECCCTTCEETTCC-----
T ss_pred             CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-CCcEEEEeccCceecccc-----
Confidence            999988765  45999999999999999999999  57999999999999996432 356999999998543110     


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       215 --------------------------------------------------------------------------------  214 (382)
T 2vx3_A          215 --------------------------------------------------------------------------------  214 (382)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                              .....||+.|+|||++.+.+|+.++|||||||++|||+||++||.+.+...++..|
T Consensus       215 ------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          215 ------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             ------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ------------------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                    01235899999999999999999999999999999999999999999999999988


Q ss_pred             hcccC
Q psy2131         311 KAGAY  315 (328)
Q Consensus       311 ~~~~~  315 (328)
                      .+..-
T Consensus       271 ~~~~~  275 (382)
T 2vx3_A          271 VEVLG  275 (382)
T ss_dssp             HHHHC
T ss_pred             HHHhC
Confidence            87643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.7e-41  Score=323.57  Aligned_cols=211  Identities=23%  Similarity=0.359  Sum_probs=178.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+.. +..||||+++.....   .+.+.+|+++|++++|||||++++++.+ +..|||||||.+|+|.+++
T Consensus       278 G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l  352 (535)
T 2h8h_A          278 GCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL  352 (535)
T ss_dssp             CSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHH
T ss_pred             CCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHH
Confidence            8999999999865 467999999865543   3567899999999999999999999876 6789999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+++......            
T Consensus       353 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~------------  417 (535)
T 2h8h_A          353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNE------------  417 (535)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCTTSTTTCCCHH------------
T ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC---CcEEEcccccceecCCCc------------
Confidence            643  469999999999999999999999999999999999999754   459999999985431100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       418 --------------------------------------------------------------------------------  417 (535)
T 2h8h_A          418 --------------------------------------------------------------------------------  417 (535)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                   ........||+.|+|||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.+|...+
T Consensus       418 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~  484 (535)
T 2h8h_A          418 -------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP  484 (535)
T ss_dssp             -------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             -------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                         001122347888999999999999999999999999999999 999999999999999999998766


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       485 ~~~~~~~  491 (535)
T 2h8h_A          485 CPPECPE  491 (535)
T ss_dssp             CCTTCCH
T ss_pred             CCCCCCH
Confidence            6666553

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.1e-41  Score=309.50  Aligned_cols=189  Identities=26%  Similarity=0.366  Sum_probs=160.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--------CCCcceeEEEEE----eCCEEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--------HPNIVRLHDSIQ----EENYHYLVF   68 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~--------H~nIv~l~~~~~----~~~~~~lv~   68 (328)
                      |+||+||+|++..+++.||||+++..   ....+.+.+|+.+|+.++        |+||+++++++.    +...+|+||
T Consensus        48 G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~  124 (397)
T 1wak_A           48 GHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF  124 (397)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEE
Confidence            89999999999999999999999743   344567889999999985        788999999998    566899999


Q ss_pred             EccCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCC-------------------
Q psy2131          69 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKA-------------------  126 (328)
Q Consensus        69 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~-------------------  126 (328)
                      ||| +++|.+.+...  ..+++.++..++.||+.||.|||++ |||||||||+|||++.++                   
T Consensus       125 e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~  203 (397)
T 1wak_A          125 EVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP  203 (397)
T ss_dssp             CCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC--------
T ss_pred             ecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC
Confidence            999 66777777654  4699999999999999999999998 999999999999997543                   


Q ss_pred             ---------------------------CCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC
Q psy2131         127 ---------------------------KGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAG  179 (328)
Q Consensus       127 ---------------------------~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~  179 (328)
                                                 ....+||+|||++......                                  
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------------------------------  249 (397)
T 1wak_A          204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------------------------------  249 (397)
T ss_dssp             -------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------------------------------
T ss_pred             CCCCCccccCCcccccccccccccccccccceEecccccccccccc----------------------------------
Confidence                                       1136999999987543110                                  


Q ss_pred             CCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhcc
Q psy2131         180 AYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFA  259 (328)
Q Consensus       180 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (328)
                                                                                                 .....
T Consensus       250 ---------------------------------------------------------------------------~~~~~  254 (397)
T 1wak_A          250 ---------------------------------------------------------------------------FTEDI  254 (397)
T ss_dssp             ---------------------------------------------------------------------------SCSCC
T ss_pred             ---------------------------------------------------------------------------CccCC
Confidence                                                                                       11235


Q ss_pred             CCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         260 GTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       260 Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ||+.|+|||++.+..|+.++|||||||+||||+||++||.+.+
T Consensus       255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            8999999999999999999999999999999999999998654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6e-41  Score=310.60  Aligned_cols=196  Identities=28%  Similarity=0.403  Sum_probs=159.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+++ +|+|.+......      ..+|+++|+.++||||+++++++....      .+|+|||||+++
T Consensus        51 G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~  123 (394)
T 4e7w_A           51 GSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET  123 (394)
T ss_dssp             ETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE
T ss_pred             CCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc
Confidence            7999999999987776 888877643321      236999999999999999999996543      389999999875


Q ss_pred             CcHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          75 ELFEDIV----AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        75 ~L~~~l~----~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                       +.+.+.    ....+++..+..++.|++.||.|||++||+||||||+|||++.  .++.+||+|||+|+.......   
T Consensus       124 -l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~kL~DFG~a~~~~~~~~---  197 (394)
T 4e7w_A          124 -VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEP---  197 (394)
T ss_dssp             -HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCEECCTTCC---
T ss_pred             -HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcEEEeeCCCcccccCCCC---
Confidence             434332    3567999999999999999999999999999999999999973  235799999999865421110   


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       198 --------------------------------------------------------------------------------  197 (394)
T 4e7w_A          198 --------------------------------------------------------------------------------  197 (394)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                              .....||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+....+..
T Consensus       198 ------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~  253 (394)
T 4e7w_A          198 ------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE  253 (394)
T ss_dssp             ------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                    1124589999999999775 589999999999999999999999999998877777


Q ss_pred             Hhcc
Q psy2131         310 IKAG  313 (328)
Q Consensus       310 i~~~  313 (328)
                      |.+.
T Consensus       254 i~~~  257 (394)
T 4e7w_A          254 IIKV  257 (394)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4e-40  Score=297.48  Aligned_cols=184  Identities=26%  Similarity=0.482  Sum_probs=158.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEe--CCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE--ENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|++..+++.||+|+++..     ..+.+.+|+.++++++ ||||+++++++.+  ....++||||+.+++|.
T Consensus        47 G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~  121 (330)
T 3nsz_A           47 GKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK  121 (330)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHH
T ss_pred             cCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHH
Confidence            89999999999999999999999743     2356789999999997 9999999999998  67899999999999998


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.+.   .+++.++..++.|++.||.|||++||+||||||+|||++.++  ..+||+|||++........          
T Consensus       122 ~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~~~~~----------  186 (330)
T 3nsz_A          122 QLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQE----------  186 (330)
T ss_dssp             HHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECCTTCC----------
T ss_pred             HHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcCCCCc----------
Confidence            8764   389999999999999999999999999999999999997543  3699999999864321100          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       187 --------------------------------------------------------------------------------  186 (330)
T 3nsz_A          187 --------------------------------------------------------------------------------  186 (330)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                       .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus       187 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          187 -----------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             -----------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             -----------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence                             112358999999999987 67899999999999999999999999644

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-40  Score=300.26  Aligned_cols=202  Identities=31%  Similarity=0.401  Sum_probs=168.2

Q ss_pred             CCceEEEEEEEc-cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC---CCCCcceeEEEEE-----eCCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQK-ATGLEFAAKIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHDSIQ-----EENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~-~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~-----~~~~~~lv~E~~   71 (328)
                      |+||.||+|++. .+|+.||+|+++...........+.+|+.+++.+   +||||+++++++.     .....|+||||+
T Consensus        22 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  101 (326)
T 1blx_A           22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV  101 (326)
T ss_dssp             ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECC
T ss_pred             cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecC
Confidence            799999999995 7889999999976543332223455677777666   8999999999987     567789999999


Q ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          72 TGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        72 ~gg~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      . |+|.+++....  .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......    
T Consensus       102 ~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~----  173 (326)
T 1blx_A          102 D-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ----  173 (326)
T ss_dssp             S-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCCSCCCCCGG----
T ss_pred             C-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC---CCEEEecCcccccccCC----
Confidence            8 59998887643  49999999999999999999999999999999999999754   46999999997432110    


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (326)
T 1blx_A          174 --------------------------------------------------------------------------------  173 (326)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                             .......||+.|+|||++.+..++.++|||||||++|||+||++||.+.+....+..
T Consensus       174 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  230 (326)
T 1blx_A          174 -----------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  230 (326)
T ss_dssp             -----------------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             -----------------------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence                                   011224689999999999999999999999999999999999999999998888888


Q ss_pred             Hhcc
Q psy2131         310 IKAG  313 (328)
Q Consensus       310 i~~~  313 (328)
                      |...
T Consensus       231 i~~~  234 (326)
T 1blx_A          231 ILDV  234 (326)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-41  Score=300.50  Aligned_cols=209  Identities=27%  Similarity=0.467  Sum_probs=154.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++
T Consensus        26 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  104 (303)
T 2vwi_A           26 GATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDII  104 (303)
T ss_dssp             --CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHH
T ss_pred             ccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHH
Confidence            7999999999999999999999875432 234566789999999999999999999999999999999999999999988


Q ss_pred             Hh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          81 VA--------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        81 ~~--------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      ..        ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........    
T Consensus       105 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~----  177 (303)
T 2vwi_A          105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDI----  177 (303)
T ss_dssp             HHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCCHHHHHCC---------
T ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC---CCEEEEeccchheeccCCCc----
Confidence            63        3568999999999999999999999999999999999999754   46999999997543211000    


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       178 --------------------------------------------------------------------------------  177 (303)
T 2vwi_A          178 --------------------------------------------------------------------------------  177 (303)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                       ..........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+.........
T Consensus       178 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  240 (303)
T 2vwi_A          178 -----------------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL  240 (303)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             -----------------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence                             00001123469999999999976 678999999999999999999999999887666655555


Q ss_pred             ccc
Q psy2131         312 AGA  314 (328)
Q Consensus       312 ~~~  314 (328)
                      .+.
T Consensus       241 ~~~  243 (303)
T 2vwi_A          241 QND  243 (303)
T ss_dssp             TSS
T ss_pred             ccC
Confidence            443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=298.29  Aligned_cols=198  Identities=26%  Similarity=0.420  Sum_probs=160.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE----eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ----EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~----~~~~~~lv~E~~~gg~L   76 (328)
                      |+||.||+|.+..+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.    .....|+|||||.+|+|
T Consensus        40 G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L  117 (317)
T 2buj_A           40 GGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL  117 (317)
T ss_dssp             --CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBH
T ss_pred             CCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcH
Confidence            89999999999999999999998653  3455677899999999999999999999987    34578999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          77 FEDIVA----REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        77 ~~~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      .+.+..    ...+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..........   
T Consensus       118 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~dfg~~~~~~~~~~~~---  191 (317)
T 2buj_A          118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGSMNQACIHVEGS---  191 (317)
T ss_dssp             HHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCSSCEESCEEEESH---
T ss_pred             HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC---CCEEEEecCcchhcccccccc---
Confidence            988875    4679999999999999999999999999999999999999654   459999999875432110000   


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       192 --------------------------------------------------------------------------------  191 (317)
T 2buj_A          192 --------------------------------------------------------------------------------  191 (317)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC---CCCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP---YGKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                         .           ............||+.|+|||++.+..   ++.++|||||||++|||++|+.||..
T Consensus       192 ---~-----------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          192 ---R-----------QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             ---H-----------HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ---c-----------ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence               0           000000112245899999999998654   68999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-41  Score=297.20  Aligned_cols=211  Identities=23%  Similarity=0.306  Sum_probs=168.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEE-EEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~-~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+|+.||+|++......    +.+.+|+.+++.++|++++..+.. +.+.+..|+||||+ +++|.++
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~   94 (296)
T 3uzp_A           20 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDL   94 (296)
T ss_dssp             ETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             CCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHH
Confidence            78999999999999999999998765432    347789999999998886655554 46788899999999 8999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.|++.||.|||++||+||||||+|||++....++.+||+|||++..........         
T Consensus        95 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~---------  165 (296)
T 3uzp_A           95 FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---------  165 (296)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC---------
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc---------
Confidence            873 4579999999999999999999999999999999999999643345679999999987653321100         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                        ..|                                                                           
T Consensus       166 --~~~---------------------------------------------------------------------------  168 (296)
T 3uzp_A          166 --HIP---------------------------------------------------------------------------  168 (296)
T ss_dssp             --BCC---------------------------------------------------------------------------
T ss_pred             --ccc---------------------------------------------------------------------------
Confidence              000                                                                           


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc---cHHHHHHHHhcccC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAY  315 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~  315 (328)
                                   ........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.   +....+..+..+..
T Consensus       169 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          169 -------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             -------------CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             -------------cccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence                         00112346999999999999999999999999999999999999999874   33344555554444

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=296.32  Aligned_cols=205  Identities=28%  Similarity=0.385  Sum_probs=167.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEE--------------eCCEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--------------EENYHYL   66 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--------------~~~~~~l   66 (328)
                      |+||.||+|.+..+|+.||+|++...  .....+.+.+|++++++++||||+++++++.              +.+..|+
T Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~l   99 (320)
T 2i6l_A           22 GGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI   99 (320)
T ss_dssp             ----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEE
T ss_pred             CCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeE
Confidence            79999999999999999999999754  3455678899999999999999999999873              4478899


Q ss_pred             EEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          67 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        67 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      ||||+. |+|.+.+. .+.+++.++..++.|++.||.|||++||+||||||+|||++.+  ++.+||+|||++.......
T Consensus       100 v~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--~~~~kl~Dfg~~~~~~~~~  175 (320)
T 2i6l_A          100 VQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--DLVLKIGDFGLARIMDPHY  175 (320)
T ss_dssp             EEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT--TTEEEECCCTTCBCC----
T ss_pred             EeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC--CCeEEEccCccccccCCCc
Confidence            999998 58887775 4679999999999999999999999999999999999999743  3579999999986432110


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .                                                                               
T Consensus       176 ~-------------------------------------------------------------------------------  176 (320)
T 2i6l_A          176 S-------------------------------------------------------------------------------  176 (320)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             c-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                              .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+...
T Consensus       177 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  232 (320)
T 2i6l_A          177 ------------------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE  232 (320)
T ss_dssp             ---------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ------------------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence                                    0000112358999999999876 778999999999999999999999999999888


Q ss_pred             HHHHHhccc
Q psy2131         306 LYAQIKAGA  314 (328)
Q Consensus       306 ~~~~i~~~~  314 (328)
                      ....+..+.
T Consensus       233 ~~~~~~~~~  241 (320)
T 2i6l_A          233 QMQLILESI  241 (320)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHhc
Confidence            888877653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.1e-41  Score=294.63  Aligned_cols=205  Identities=24%  Similarity=0.376  Sum_probs=168.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-NYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+  +|+.||+|+++...    ..+.+.+|++++++++||||+++++++.+. +..|+||||+++++|.++
T Consensus        32 G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (278)
T 1byg_A           32 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY  105 (278)
T ss_dssp             CSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred             CCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence            89999999987  48899999997543    346688999999999999999999997554 578999999999999999


Q ss_pred             HHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVAREF--YSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~~--~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +.....  +++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......            
T Consensus       106 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~------------  170 (278)
T 1byg_A          106 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST------------  170 (278)
T ss_dssp             HHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC-------------------
T ss_pred             HHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC---CcEEEeecccccccccc------------
Confidence            876543  8999999999999999999999999999999999999754   46999999987432100            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (278)
T 1byg_A          171 --------------------------------------------------------------------------------  170 (278)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                       .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+...+...+..+...
T Consensus       171 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  233 (278)
T 1byg_A          171 -----------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  233 (278)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred             -----------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence                             001247889999999999999999999999999999998 99999999988899998888654


Q ss_pred             CCCCccc
Q psy2131         317 DEPKHKS  323 (328)
Q Consensus       317 ~~~~~~~  323 (328)
                      ..|..++
T Consensus       234 ~~~~~~~  240 (278)
T 1byg_A          234 DAPDGCP  240 (278)
T ss_dssp             CCCTTCC
T ss_pred             CCcccCC
Confidence            4454433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.8e-41  Score=309.44  Aligned_cols=189  Identities=18%  Similarity=0.259  Sum_probs=144.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhC--CCCCcceeE-------EEEEeC---------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKL--QHPNIVRLH-------DSIQEE---------   61 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l--~H~nIv~l~-------~~~~~~---------   61 (328)
                      |+||+||+|.+..+|+.||||++...... ....+.+.+|+.+++.|  +||||++++       +++...         
T Consensus        73 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~  152 (371)
T 3q60_A           73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS  152 (371)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCS
T ss_pred             CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeecc
Confidence            89999999999999999999999987653 34456677885544444  699988765       555543         


Q ss_pred             --------CEEEEEEEccCCCCcHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC
Q psy2131          62 --------NYHYLVFDLVTGGELFEDIVARE-FYSEADA------SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA  126 (328)
Q Consensus        62 --------~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~------~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~  126 (328)
                              ..+|+|||||+ |+|.+++...+ .+++...      ..++.||+.||+|||++|||||||||+|||++.+ 
T Consensus       153 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-  230 (371)
T 3q60_A          153 PGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-  230 (371)
T ss_dssp             CC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT-
T ss_pred             CCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC-
Confidence                    34899999999 79999987643 3443333      4566999999999999999999999999999754 


Q ss_pred             CCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccC
Q psy2131         127 KGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN  206 (328)
Q Consensus       127 ~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~  206 (328)
                        +.+||+|||+|+.....                                                             
T Consensus       231 --~~~kL~DFG~a~~~~~~-------------------------------------------------------------  247 (371)
T 3q60_A          231 --GRLMLGDVSALWKVGTR-------------------------------------------------------------  247 (371)
T ss_dssp             --SCEEECCGGGEEETTCE-------------------------------------------------------------
T ss_pred             --CCEEEEecceeeecCCC-------------------------------------------------------------
Confidence              46999999998643110                                                             


Q ss_pred             CCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhh
Q psy2131         207 PSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWAC  284 (328)
Q Consensus       207 p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSl  284 (328)
                                                                      .....||+.|+|||++.+  ..|+.++|||||
T Consensus       248 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          248 ------------------------------------------------GPASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             ------------------------------------------------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             ------------------------------------------------ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence                                                            002347799999999988  789999999999


Q ss_pred             hhHHHHHHhcCCCCCCcc
Q psy2131         285 GVILYILLVGYPPFWDED  302 (328)
Q Consensus       285 GvilyelltG~~Pf~~~~  302 (328)
                      ||+||||+||++||.+.+
T Consensus       280 G~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          280 GLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             HHHHHHHHHSSCSTTBCC
T ss_pred             HHHHHHHHhCCCCCCCcC
Confidence            999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-40  Score=299.17  Aligned_cols=215  Identities=26%  Similarity=0.340  Sum_probs=173.1

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.    +..+|+.||+|+++.. ......+.+.+|+++|++++||||+++++++.+  ...+|+|||||++|
T Consensus        42 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~  120 (318)
T 3lxp_A           42 GHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG  120 (318)
T ss_dssp             CSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTC
T ss_pred             CCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCC
Confidence            8999997774    4568899999999865 345566788999999999999999999999987  46899999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+++... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........      
T Consensus       121 ~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~------  190 (318)
T 3lxp_A          121 SLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEY------  190 (318)
T ss_dssp             BHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCGGGCEECCTTCSE------
T ss_pred             cHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC---CCEEECCccccccccccccc------
Confidence            999888654 59999999999999999999999999999999999999754   46999999998654321100      


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       191 --------------------------------------------------------------------------------  190 (318)
T 3lxp_A          191 --------------------------------------------------------------------------------  190 (318)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH----------
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH----------  304 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------  304 (328)
                                       ........||+.|+|||++.+..++.++|||||||++|||+||+.||......          
T Consensus       191 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          191 -----------------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             -----------------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             -----------------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence                             00011235888999999999999999999999999999999999999865432          


Q ss_pred             -----HHHHHHhcccCCCCCCccc
Q psy2131         305 -----RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       305 -----~~~~~i~~~~~~~~~~~~~  323 (328)
                           .+...+.++...+.|..++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~  277 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDKCP  277 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCC
T ss_pred             chhHHHHHHHHhcccCCCCCcccc
Confidence                 4555666666555555444

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.1e-40  Score=300.92  Aligned_cols=210  Identities=30%  Similarity=0.441  Sum_probs=168.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||.||+|.+..+|+.||||++.... .......+.+|++++++++||||+++++++...     ...|+||||+. |+
T Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~   99 (353)
T 2b9h_A           22 GAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TD   99 (353)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EE
T ss_pred             CCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-cc
Confidence            899999999999999999999996432 344556788999999999999999999988754     67899999997 48


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+.. ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++...........     
T Consensus       100 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~-----  170 (353)
T 2b9h_A          100 LHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNS-----  170 (353)
T ss_dssp             HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECC------------
T ss_pred             HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC---CcEEEEeccccccccccccccc-----
Confidence            8877765 579999999999999999999999999999999999999754   4699999999876432110000     


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (353)
T 2b9h_A          171 --------------------------------------------------------------------------------  170 (353)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                 .............||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.+
T Consensus       171 -----------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          171 -----------EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             --------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             -----------CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence                       00000011223569999999999865 7789999999999999999999999999987766665543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=294.82  Aligned_cols=203  Identities=29%  Similarity=0.487  Sum_probs=163.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|.+.  ++.||+|++...    ...+.+.+|++++++++||||+++++++.+  ..|+|||||+||+|.+++
T Consensus        19 G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l   90 (307)
T 2eva_A           19 GAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL   90 (307)
T ss_dssp             CSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHH
T ss_pred             CCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHH
Confidence            899999999874  788999998643    345678899999999999999999998874  379999999999999998


Q ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          81 VARE---FYSEADASHCIQQILESVNHCHS---NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        81 ~~~~---~~~~~~~~~~~~qll~~L~ylH~---~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      ....   .+++.++..++.|++.||.|||+   +||+||||||+|||++.++  ..+||+|||++......         
T Consensus        91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~~kl~Dfg~~~~~~~~---------  159 (307)
T 2eva_A           91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACDIQTH---------  159 (307)
T ss_dssp             HCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT--TEEEECCCCC----------------
T ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC--CEEEEcccccccccccc---------
Confidence            7654   47899999999999999999999   8999999999999997543  34899999997432100         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (307)
T 2eva_A          160 --------------------------------------------------------------------------------  159 (307)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc--cHHHHHHHHhc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKA  312 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~  312 (328)
                                          .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.  ....+...+..
T Consensus       160 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  219 (307)
T 2eva_A          160 --------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN  219 (307)
T ss_dssp             -------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT
T ss_pred             --------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc
Confidence                                00124899999999999999999999999999999999999999854  35556666666


Q ss_pred             ccCCCCCCcc
Q psy2131         313 GAYDDEPKHK  322 (328)
Q Consensus       313 ~~~~~~~~~~  322 (328)
                      +.....|..+
T Consensus       220 ~~~~~~~~~~  229 (307)
T 2eva_A          220 GTRPPLIKNL  229 (307)
T ss_dssp             TCCCCCBTTC
T ss_pred             CCCCCccccc
Confidence            6554444433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.5e-40  Score=299.51  Aligned_cols=201  Identities=25%  Similarity=0.445  Sum_probs=169.4

Q ss_pred             CCceEEEEEEEccCC-cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC------cceeEEEEEeCCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATG-LEFAAKIINTKKLSARDFQKLEREARICRKLQHPN------IVRLHDSIQEENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~n------Iv~l~~~~~~~~~~~lv~E~~~g   73 (328)
                      |+||+||+|++..++ +.||+|+++..   ....+.+.+|+.+++.++|+|      ++.+++++...+..|+||||| +
T Consensus        30 G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~  105 (355)
T 2eu9_A           30 GTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-G  105 (355)
T ss_dssp             ETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             cCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-C
Confidence            799999999998877 78999999743   344567788999999998766      999999999999999999999 6


Q ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC----------------CCCCcEEEee
Q psy2131          74 GELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK----------------AKGAAVKLAD  135 (328)
Q Consensus        74 g~L~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~----------------~~~~~vkl~D  135 (328)
                      ++|.+.+....  .+++.++..++.||+.||.|||++||+||||||+|||+...                ...+.+||+|
T Consensus       106 ~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  185 (355)
T 2eu9_A          106 KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD  185 (355)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECC
T ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEee
Confidence            67878776653  69999999999999999999999999999999999999432                1346799999


Q ss_pred             ccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy2131         136 FGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE  215 (328)
Q Consensus       136 fGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~  215 (328)
                      ||++......                                                                      
T Consensus       186 fg~~~~~~~~----------------------------------------------------------------------  195 (355)
T 2eu9_A          186 FGSATFDHEH----------------------------------------------------------------------  195 (355)
T ss_dssp             CTTCEETTSC----------------------------------------------------------------------
T ss_pred             cCcccccccc----------------------------------------------------------------------
Confidence            9997532110                                                                      


Q ss_pred             HhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcC
Q psy2131         216 ALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY  295 (328)
Q Consensus       216 ~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~  295 (328)
                                                             .....||+.|+|||++.+..|+.++|||||||++|||+||+
T Consensus       196 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          196 ---------------------------------------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             ---------------------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ---------------------------------------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                                                   01235899999999999999999999999999999999999


Q ss_pred             CCCCCccHHHHHHHHhccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~  314 (328)
                      +||.+.+.......+....
T Consensus       237 ~pf~~~~~~~~~~~~~~~~  255 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEKIL  255 (355)
T ss_dssp             CSCCCSSHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHc
Confidence            9999988777666655543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-40  Score=290.52  Aligned_cols=196  Identities=30%  Similarity=0.502  Sum_probs=165.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----------------CCEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----------------~~~~   64 (328)
                      |+||.||+|.+..+|+.||+|+++...      ..+.+|++++++++||||+++++++..                ...+
T Consensus        22 G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (284)
T 2a19_B           22 GGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCL   95 (284)
T ss_dssp             SSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceE
Confidence            899999999999999999999997543      245689999999999999999999865                4568


Q ss_pred             EEEEEccCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          65 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      |+|||||++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~  172 (284)
T 2a19_B           96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT---KQVKIGDFGLVTSL  172 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEES
T ss_pred             EEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC---CCEEECcchhheec
Confidence            9999999999999998654  579999999999999999999999999999999999999865   45999999998654


Q ss_pred             cCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         143 QGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       143 ~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .....                                                                           
T Consensus       173 ~~~~~---------------------------------------------------------------------------  177 (284)
T 2a19_B          173 KNDGK---------------------------------------------------------------------------  177 (284)
T ss_dssp             SCCSC---------------------------------------------------------------------------
T ss_pred             ccccc---------------------------------------------------------------------------
Confidence            22100                                                                           


Q ss_pred             CCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         223 CQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                                      .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       178 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  225 (284)
T 2a19_B          178 --------------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS  225 (284)
T ss_dssp             --------------------------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH
T ss_pred             --------------------------------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH
Confidence                                            011348999999999999999999999999999999999999986543


Q ss_pred             HHHHHHHHhccc
Q psy2131         303 QHRLYAQIKAGA  314 (328)
Q Consensus       303 ~~~~~~~i~~~~  314 (328)
                        .....+..+.
T Consensus       226 --~~~~~~~~~~  235 (284)
T 2a19_B          226 --KFFTDLRDGI  235 (284)
T ss_dssp             --HHHHHHHTTC
T ss_pred             --HHHHHhhccc
Confidence              3444555444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=304.83  Aligned_cols=194  Identities=18%  Similarity=0.276  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEccC--------CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcce---------------eEEE
Q psy2131           1 GAFSVVRRCVQKAT--------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR---------------LHDS   57 (328)
Q Consensus         1 G~fg~V~~~~~~~~--------~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~---------------l~~~   57 (328)
                      |+||.||+|++..+        ++.||+|++...       ..+.+|++++++++||||++               ++++
T Consensus        53 G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~  125 (352)
T 2jii_A           53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF  125 (352)
T ss_dssp             ETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEE
T ss_pred             CCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhc
Confidence            79999999999884        889999999754       35678999999999999998               6777


Q ss_pred             EEe-CCEEEEEEEccCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEe
Q psy2131          58 IQE-ENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLA  134 (328)
Q Consensus        58 ~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~  134 (328)
                      +.. .+..|+||||| |++|.+++...  ..+++.++..++.|++.||.|||++||+||||||+|||++.++. ..+||+
T Consensus       126 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~-~~~kl~  203 (352)
T 2jii_A          126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLA  203 (352)
T ss_dssp             EEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEE-EEEEEC
T ss_pred             cccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCC-ceEEEe
Confidence            776 78899999999 99999999876  78999999999999999999999999999999999999975421 269999


Q ss_pred             eccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy2131         135 DFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS  214 (328)
Q Consensus       135 DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~  214 (328)
                      |||++.........                                ..                                
T Consensus       204 Dfg~a~~~~~~~~~--------------------------------~~--------------------------------  219 (352)
T 2jii_A          204 GYGFAFRYCPSGKH--------------------------------VA--------------------------------  219 (352)
T ss_dssp             CGGGCBCSSGGGCC--------------------------------CC--------------------------------
T ss_pred             cCcceeeccCCCcc--------------------------------cc--------------------------------
Confidence            99998654321100                                00                                


Q ss_pred             HHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhc
Q psy2131         215 EALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG  294 (328)
Q Consensus       215 ~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG  294 (328)
                                                         ..........||+.|+|||++.+..|+.++|||||||+||||+||
T Consensus       220 -----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          220 -----------------------------------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             -----------------------------------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             -----------------------------------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence                                               000011234699999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q psy2131         295 YPPFWDED  302 (328)
Q Consensus       295 ~~Pf~~~~  302 (328)
                      +.||.+.+
T Consensus       265 ~~pf~~~~  272 (352)
T 2jii_A          265 FLPWTNCL  272 (352)
T ss_dssp             CCTTGGGT
T ss_pred             CCCcccCC
Confidence            99999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-40  Score=301.95  Aligned_cols=201  Identities=25%  Similarity=0.353  Sum_probs=160.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-------EEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY-------HYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~-------~~lv~E~~~g   73 (328)
                      |+||+||+|.+..+|+.||||++......   .....+|++.++.++||||+++++++...+.       +|+|||||.+
T Consensus        34 G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~  110 (360)
T 3e3p_A           34 GTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD  110 (360)
T ss_dssp             -----CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc
Confidence            89999999999999999999998654322   2345678888899999999999999976433       8999999987


Q ss_pred             CCcHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCc
Q psy2131          74 GELFEDIV----AREFYSEADASHCIQQILESVNHCH--SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQ  147 (328)
Q Consensus        74 g~L~~~l~----~~~~~~~~~~~~~~~qll~~L~ylH--~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~  147 (328)
                       +|.+.+.    ....+++..+..++.|++.||.|||  ++||+||||||+|||++..  ++.+||+|||++....... 
T Consensus       111 -~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~kl~Dfg~a~~~~~~~-  186 (360)
T 3e3p_A          111 -TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSE-  186 (360)
T ss_dssp             -BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEEECCCTTCBCCCTTS-
T ss_pred             -cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEEEeeCCCceecCCCC-
Confidence             4444433    4567899999999999999999999  9999999999999999742  3579999999986532110 


Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                                                                                                      
T Consensus       187 --------------------------------------------------------------------------------  186 (360)
T 3e3p_A          187 --------------------------------------------------------------------------------  186 (360)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             chhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCCCCccHHHH
Q psy2131         228 VASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRL  306 (328)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~  306 (328)
                                                ......||+.|+|||++.+.. |+.++|||||||++|||+||++||.+.+....
T Consensus       187 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  240 (360)
T 3e3p_A          187 --------------------------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ  240 (360)
T ss_dssp             --------------------------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             --------------------------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence                                      011235899999999997654 89999999999999999999999999998888


Q ss_pred             HHHHhccc
Q psy2131         307 YAQIKAGA  314 (328)
Q Consensus       307 ~~~i~~~~  314 (328)
                      +..+.+..
T Consensus       241 ~~~~~~~~  248 (360)
T 3e3p_A          241 LHEIVRVL  248 (360)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHc
Confidence            88887643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-40  Score=304.45  Aligned_cols=201  Identities=26%  Similarity=0.400  Sum_probs=162.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC---------HHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS---------ARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ENYHYL   66 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~---------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-----~~~~~l   66 (328)
                      |+||.||+|.+.. |+.||||++......         ....+.+.+|++++++++||||+++++++..     ...+|+
T Consensus        33 G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (362)
T 3pg1_A           33 GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL  111 (362)
T ss_dssp             ETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEE
T ss_pred             CCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEE
Confidence            7999999998865 999999999654322         2234678999999999999999999999854     347899


Q ss_pred             EEEccCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          67 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        67 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |||||. |+|.+.+... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          112 VTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---NDITICDFNLAREDTAD  187 (362)
T ss_dssp             EEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCTTC-------
T ss_pred             EEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC---CCEEEEecCcccccccc
Confidence            999998 5888877654 369999999999999999999999999999999999999754   45999999997432110


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .                                                                               
T Consensus       188 ~-------------------------------------------------------------------------------  188 (362)
T 3pg1_A          188 A-------------------------------------------------------------------------------  188 (362)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             c-------------------------------------------------------------------------------
Confidence            0                                                                               


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~  304 (328)
                                                  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus       189 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          189 ----------------------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             -----------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ----------------------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence                                        0112358999999999987 77899999999999999999999999999988


Q ss_pred             HHHHHHhcc
Q psy2131         305 RLYAQIKAG  313 (328)
Q Consensus       305 ~~~~~i~~~  313 (328)
                      ..+..+...
T Consensus       241 ~~~~~i~~~  249 (362)
T 3pg1_A          241 NQLNKIVEV  249 (362)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            888887654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-40  Score=296.94  Aligned_cols=194  Identities=26%  Similarity=0.379  Sum_probs=162.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+  +++.||+|++.....  .....+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.+
T Consensus        42 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  119 (307)
T 2nru_A           42 GGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD  119 (307)
T ss_dssp             CSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             CCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHH
Confidence            89999999975  688999999975432  23345778999999999999999999999999999999999999999999


Q ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          79 DIVA---REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        79 ~l~~---~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+..   ...+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       120 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~-------  189 (307)
T 2nru_A          120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLARASEKFAQT-------  189 (307)
T ss_dssp             HHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCSCSSC-------
T ss_pred             HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---CcEEEeeccccccccccccc-------
Confidence            8863   3469999999999999999999999999999999999999643   46999999998643211000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       190 --------------------------------------------------------------------------------  189 (307)
T 2nru_A          190 --------------------------------------------------------------------------------  189 (307)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH  304 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~  304 (328)
                                       .......||+.|+|||++.+ .++.++|||||||++|+|+||++||.+.+..
T Consensus       190 -----------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          190 -----------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             -----------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             -----------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence                             00112458999999999876 4899999999999999999999999876543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.7e-40  Score=321.38  Aligned_cols=213  Identities=25%  Similarity=0.367  Sum_probs=178.0

Q ss_pred             CCceEEEEEEEccC---CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~---~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|.+..+   +..+|+|+++.. ......+.+.+|+.++++++||||+++++++. ++..|+|||||++|+|.
T Consensus       401 G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~  478 (656)
T 2j0j_A          401 GQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELR  478 (656)
T ss_dssp             CSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred             CCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHH
Confidence            89999999998654   457999998653 23445577899999999999999999999985 45689999999999999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++........         
T Consensus       479 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~---~~vkL~DFG~a~~~~~~~~---------  546 (656)
T 2j0j_A          479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTY---------  546 (656)
T ss_dssp             HHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCCCCCSCCC------------
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC---CCEEEEecCCCeecCCCcc---------
Confidence            9987654 68999999999999999999999999999999999999865   4699999999865421100         


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       547 --------------------------------------------------------------------------------  546 (656)
T 2j0j_A          547 --------------------------------------------------------------------------------  546 (656)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+...+...|..+..
T Consensus       547 ----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~  610 (656)
T 2j0j_A          547 ----------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  610 (656)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred             ----------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence                            00011247889999999999999999999999999999997 9999999999999999999887


Q ss_pred             CCCCCccc
Q psy2131         316 DDEPKHKS  323 (328)
Q Consensus       316 ~~~~~~~~  323 (328)
                      .+.|+.++
T Consensus       611 ~~~~~~~~  618 (656)
T 2j0j_A          611 LPMPPNCP  618 (656)
T ss_dssp             CCCCTTCC
T ss_pred             CCCCcccc
Confidence            66666654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=295.82  Aligned_cols=221  Identities=29%  Similarity=0.404  Sum_probs=178.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH---HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||.||+|.+..+|+.||+|+++.......   ..+.+.+|+++++.++||||+++++++.+.+..|+|||||++ +|.
T Consensus        21 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~   99 (346)
T 1ua2_A           21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLE   99 (346)
T ss_dssp             ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHH
T ss_pred             cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHH
Confidence            7999999999999999999999976433221   124678999999999999999999999999999999999987 787


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-----------
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-----------  145 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-----------  145 (328)
                      +.+... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++......           
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~t~  176 (346)
T 1ua2_A          100 VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAYTHQVVTR  176 (346)
T ss_dssp             HHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCCCCCCSCCCC
T ss_pred             HHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC---CCEEEEecccceeccCCcccCCcccccc
Confidence            777654 368999999999999999999999999999999999999754   46999999998653210           


Q ss_pred             -----------C------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC--------------------
Q psy2131         146 -----------Q------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------------------  187 (328)
Q Consensus       146 -----------~------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------  187 (328)
                                 .      +.| +|+++|+|++|.+||.+.+.......+.......+...                    
T Consensus       177 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (346)
T 1ua2_A          177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP  256 (346)
T ss_dssp             TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCC
T ss_pred             cccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCC
Confidence                       0      112 89999999999999999888777666544221111111                    


Q ss_pred             ----cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         188 ----WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       188 ----~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                          +...++++.+|+.+||..||.+|||++|+++|||+...
T Consensus       257 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                14567899999999999999999999999999999754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-41  Score=301.85  Aligned_cols=189  Identities=22%  Similarity=0.321  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+ .+|+.||+|++...... .....+.+|+++++.++||||+++++++.+.+..|+|||||.||+|.+.+
T Consensus        41 G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  118 (326)
T 3uim_A           41 GGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL  118 (326)
T ss_dssp             CSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHH
T ss_pred             CCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHH
Confidence            89999999975 47899999999765322 12235789999999999999999999999999999999999999999988


Q ss_pred             HhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          81 VARE----FYSEADASHCIQQILESVNHCHSN---GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        81 ~~~~----~~~~~~~~~~~~qll~~L~ylH~~---~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.+   +.+||+|||++........      
T Consensus       119 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~------  189 (326)
T 3uim_A          119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDT------  189 (326)
T ss_dssp             HCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT---CCEEECCCSSCEECCSSSS------
T ss_pred             HhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC---CCEEeccCccccccCcccc------
Confidence            7643    489999999999999999999999   99999999999999754   4699999999865421110      


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       190 --------------------------------------------------------------------------------  189 (326)
T 3uim_A          190 --------------------------------------------------------------------------------  189 (326)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                         .......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       190 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          190 -------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             -------------------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             -------------------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence                               00112358999999999999999999999999999999999999995

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=296.81  Aligned_cols=208  Identities=31%  Similarity=0.479  Sum_probs=146.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEE--------eCCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--------EENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~--------~~~~~~lv~E~~   71 (328)
                      |+||.||+|++..+|+.||+|++...  .....+.+.+|+.+++++. ||||+++++++.        ....+|+|||||
T Consensus        39 G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~  116 (337)
T 3ll6_A           39 GGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC  116 (337)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC
T ss_pred             CCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec
Confidence            89999999999999999999998654  3445567889999999996 999999999994        445689999999


Q ss_pred             CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          72 TGGELFEDIVA---REFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        72 ~gg~L~~~l~~---~~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      . |+|.+++..   .+.+++.++..++.|++.||.|||++|  |+||||||+|||++.+   +.+||+|||++.......
T Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~  192 (337)
T 3ll6_A          117 K-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYP  192 (337)
T ss_dssp             S-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT---SCEEBCCCTTCBCCSSCC
T ss_pred             C-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC---CCEEEecCccceeccccC
Confidence            6 688887754   457999999999999999999999999  9999999999999754   469999999987653321


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .....                                                                           
T Consensus       193 ~~~~~---------------------------------------------------------------------------  197 (337)
T 3ll6_A          193 DYSWS---------------------------------------------------------------------------  197 (337)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             ccccc---------------------------------------------------------------------------
Confidence            10000                                                                           


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc---ccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                         ..+...........||+.|+|||++   .+..++.++|||||||++|||+||+.||.+.+.
T Consensus       198 -------------------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          198 -------------------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             ---------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             -------------------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence                               0000000011234589999999999   577889999999999999999999999988766


Q ss_pred             HHHHH
Q psy2131         304 HRLYA  308 (328)
Q Consensus       304 ~~~~~  308 (328)
                      ..+..
T Consensus       259 ~~~~~  263 (337)
T 3ll6_A          259 LRIVN  263 (337)
T ss_dssp             -----
T ss_pred             HHhhc
Confidence            55433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.2e-40  Score=291.90  Aligned_cols=197  Identities=24%  Similarity=0.306  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEE-EEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~-~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+++.||+|++......    ..+.+|+.+++.++|+|++..+.. +.+.+..|+||||+ +++|.+.
T Consensus        20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~   94 (296)
T 4hgt_A           20 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDL   94 (296)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             CCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHH
Confidence            89999999999999999999997654322    346789999999998887766555 47788899999999 9999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.|++.||.|||++||+||||||+|||++....++.+||+|||++..........         
T Consensus        95 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~---------  165 (296)
T 4hgt_A           95 FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---------  165 (296)
T ss_dssp             HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC---------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc---------
Confidence            874 4579999999999999999999999999999999999999544445679999999987653321100         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                        ..|                                                                           
T Consensus       166 --~~~---------------------------------------------------------------------------  168 (296)
T 4hgt_A          166 --HIP---------------------------------------------------------------------------  168 (296)
T ss_dssp             --BCC---------------------------------------------------------------------------
T ss_pred             --cCC---------------------------------------------------------------------------
Confidence              000                                                                           


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       169 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 4hgt_A          169 -------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             -------------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             -------------CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence                         00112346999999999999999999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-40  Score=293.08  Aligned_cols=210  Identities=26%  Similarity=0.401  Sum_probs=166.8

Q ss_pred             CCceEEEEEEEcc-CCc--EEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKA-TGL--EFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~--~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+.. ++.  .||+|+++..... ....+.+.+|++++++++||||+++++++.+.+ .++||||+++++|
T Consensus        29 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L  107 (291)
T 1u46_A           29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL  107 (291)
T ss_dssp             ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBH
T ss_pred             CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCH
Confidence            7999999998643 333  6899999865443 345677899999999999999999999998766 8999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.........       
T Consensus       108 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~-------  177 (291)
T 1u46_A          108 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDH-------  177 (291)
T ss_dssp             HHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECCC-CCE-------
T ss_pred             HHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC---CCEEEccccccccccccccc-------
Confidence            9988764 569999999999999999999999999999999999999865   45999999998654221100       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       178 --------------------------------------------------------------------------------  177 (291)
T 1u46_A          178 --------------------------------------------------------------------------------  177 (291)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+....
T Consensus       178 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  241 (291)
T 1u46_A          178 ----------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  241 (291)
T ss_dssp             ----------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             ----------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence                            000112347889999999999999999999999999999999 999999999999999887765


Q ss_pred             CCC
Q psy2131         315 YDD  317 (328)
Q Consensus       315 ~~~  317 (328)
                      ...
T Consensus       242 ~~~  244 (291)
T 1u46_A          242 ERL  244 (291)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            533

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.4e-39  Score=282.14  Aligned_cols=219  Identities=30%  Similarity=0.495  Sum_probs=183.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+.+
T Consensus        18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (276)
T 2yex_A           18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI   96 (276)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS
T ss_pred             CCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHH
Confidence            89999999999999999999999765432 34567889999999999999999999999999999999999999999988


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------------  144 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------------  144 (328)
                      .....+++.++..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.....                
T Consensus        97 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  173 (276)
T 2yex_A           97 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPY  173 (276)
T ss_dssp             BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEETTEECCBCCCCSCGGG
T ss_pred             hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC---CCEEEeeCCCccccCCCcchhcccCCccccCc
Confidence            777789999999999999999999999999999999999999754   4599999998853210                


Q ss_pred             --------C------Ccc-hHHHHHHHHHhCCCCCCCCcHH-HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         145 --------E------QQA-WFGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       145 --------~------~~~-~~G~~~~~~~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                              .      .+. .+|+++|+|++|..||...+.. .....+......  ...+..+++.+.+++.+||..||.
T Consensus       174 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~  251 (276)
T 2yex_A          174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPS  251 (276)
T ss_dssp             CCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             cChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCHHHHHHHHHHCCCCch
Confidence                    0      011 2799999999999999775542 223333332222  223457899999999999999999


Q ss_pred             CCCCHHHHhcCcccCCc
Q psy2131         209 KRITASEALKHPWICQR  225 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~~  225 (328)
                      +|||++++++|||+.+.
T Consensus       252 ~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          252 ARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             TSCCHHHHTTCTTTTCC
T ss_pred             hCCCHHHHhcCccccCh
Confidence            99999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-39  Score=294.17  Aligned_cols=219  Identities=34%  Similarity=0.660  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||+|++...   ....   ......++.++||||+++++++..    ...+|+|||||+||+|
T Consensus        40 G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L  113 (336)
T 3fhr_A           40 GVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL  113 (336)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCH
Confidence            79999999999999999999999653   2221   222334567799999999999986    5568999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------
Q psy2131          77 FEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------  145 (328)
Q Consensus        77 ~~~l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------  145 (328)
                      .+++....  .+++.++..++.|++.||.|||++||+||||||+|||++.++..+.+||+|||++......         
T Consensus       114 ~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~  193 (336)
T 3fhr_A          114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP  193 (336)
T ss_dssp             HHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCc
Confidence            99997654  6999999999999999999999999999999999999987666677999999998643211         


Q ss_pred             ----------------Ccc-hHHHHHHHHHhCCCCCCCCcHHHH----HHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcc
Q psy2131         146 ----------------QQA-WFGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       146 ----------------~~~-~~G~~~~~~~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~  204 (328)
                                      .+. .+|+++|+|++|..||........    ...+......++.+.+..+++++.+++.+||.
T Consensus       194 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  273 (336)
T 3fhr_A          194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLK  273 (336)
T ss_dssp             ----------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSC
T ss_pred             CccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCC
Confidence                            012 289999999999999977655433    33445566667777888899999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCc
Q psy2131         205 VNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .||.+|||++++++|||+.+.
T Consensus       274 ~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          274 TDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             SSGGGSCCHHHHHHSHHHHTG
T ss_pred             CChhHCcCHHHHhcCcccccc
Confidence            999999999999999999764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=289.96  Aligned_cols=208  Identities=21%  Similarity=0.334  Sum_probs=158.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+|+.||||++..........+.+..+..+++.++||||+++++++.+.+..|+||||+ ++.+....
T Consensus        36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~  114 (318)
T 2dyl_A           36 GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK  114 (318)
T ss_dssp             ----CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHH
T ss_pred             cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHH
Confidence            79999999999999999999999876544444444555666788899999999999999999999999999 44443333


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      .. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+   +.+||+|||++.......            
T Consensus       115 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~------------  179 (318)
T 2dyl_A          115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDK------------  179 (318)
T ss_dssp             HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT---SCEEECCCTTC-------------------
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC---CCEEEEECCCchhccCCc------------
Confidence            32 46799999999999999999999995 99999999999999754   469999999874321100            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (318)
T 2dyl_A          180 --------------------------------------------------------------------------------  179 (318)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-----cCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-----KEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKA  312 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~  312 (328)
                                     ......||+.|+|||++.     +..++.++|||||||++|||++|+.||.+. +...++..+.+
T Consensus       180 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (318)
T 2dyl_A          180 ---------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ  244 (318)
T ss_dssp             ----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred             ---------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence                           001134899999999994     567899999999999999999999999974 56677777777


Q ss_pred             ccCCCCC
Q psy2131         313 GAYDDEP  319 (328)
Q Consensus       313 ~~~~~~~  319 (328)
                      +.....|
T Consensus       245 ~~~~~~~  251 (318)
T 2dyl_A          245 EEPPLLP  251 (318)
T ss_dssp             SCCCCCC
T ss_pred             cCCCCCC
Confidence            6654433

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-39  Score=291.57  Aligned_cols=204  Identities=27%  Similarity=0.429  Sum_probs=167.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||.||+|.+. +++.||+|++..........+.+.+|++++++++  ||||+++++++.+.+..|+||| +.+++|.+
T Consensus        39 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~  116 (313)
T 3cek_A           39 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS  116 (313)
T ss_dssp             CSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHH
T ss_pred             CCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHH
Confidence            899999999885 5899999999887777777788999999999997  5999999999999999999999 56789999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.|++.||.|||++||+||||||+|||++.    +.+||+|||++........           
T Consensus       117 ~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~~~~~~~~-----------  181 (313)
T 3cek_A          117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTT-----------  181 (313)
T ss_dssp             HHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCC-----------------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccccccCccc-----------
Confidence            9998889999999999999999999999999999999999999952    5699999999854321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       182 --------------------------------------------------------------------------------  181 (313)
T 3cek_A          182 --------------------------------------------------------------------------------  181 (313)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-----------CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-----------EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRL  306 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~  306 (328)
                                   ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.+.. ....
T Consensus       182 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (313)
T 3cek_A          182 -------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  248 (313)
T ss_dssp             ---------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             -------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence                         000112358999999999976           478899999999999999999999998753 3344


Q ss_pred             HHHHhccc
Q psy2131         307 YAQIKAGA  314 (328)
Q Consensus       307 ~~~i~~~~  314 (328)
                      +..+....
T Consensus       249 ~~~~~~~~  256 (313)
T 3cek_A          249 LHAIIDPN  256 (313)
T ss_dssp             HHHHHCTT
T ss_pred             HHHHHhcc
Confidence            44444433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-39  Score=290.82  Aligned_cols=131  Identities=25%  Similarity=0.378  Sum_probs=111.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh--CCCCCcceeEEEEEe----CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK--LQHPNIVRLHDSIQE----ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+  +|+.||||++...     ....+.+|.+++..  ++||||+++++++.+    ...+|+|||||++|
T Consensus        19 G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g   91 (301)
T 3q4u_A           19 GRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG   91 (301)
T ss_dssp             CSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTC
T ss_pred             CCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCC
Confidence            89999999987  6899999998643     23445566666666  899999999998654    35689999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCH--------SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH--------~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +|.+++. ...+++..+..++.|++.||.|||        ++||+||||||+|||++.+   +.+||+|||++...
T Consensus        92 ~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           92 SLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---GQCCIADLGLAVMH  163 (301)
T ss_dssp             BHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT---SCEEECCCTTCEEE
T ss_pred             CHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC---CCEEEeeCCCeeec
Confidence            9998884 457999999999999999999999        9999999999999999754   46999999998654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-39  Score=307.76  Aligned_cols=208  Identities=26%  Similarity=0.327  Sum_probs=167.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.+..+++.||||++......    ..+.+|+++++.++| ++|+.+..++.+.+..||||||| |++|.++
T Consensus        18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~l   92 (483)
T 3sv0_A           18 GSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL   92 (483)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             CCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHH
Confidence            89999999999999999999998765432    246789999999987 55666677778889999999999 8999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +.. ...+++.++..++.||+.||.|||++|||||||||+|||++.....+.+||+|||+++.........         
T Consensus        93 l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~---------  163 (483)
T 3sv0_A           93 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ---------  163 (483)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC---------
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc---------
Confidence            875 4579999999999999999999999999999999999999643345679999999987653321100         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                        ..|                                                                           
T Consensus       164 --~~~---------------------------------------------------------------------------  166 (483)
T 3sv0_A          164 --HIP---------------------------------------------------------------------------  166 (483)
T ss_dssp             --BCC---------------------------------------------------------------------------
T ss_pred             --ccc---------------------------------------------------------------------------
Confidence              000                                                                           


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc---HHHHHHHHhc
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKA  312 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~  312 (328)
                                   ........||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+   ....+.++..
T Consensus       167 -------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          167 -------------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             -------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             -------------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence                         001113569999999999999999999999999999999999999998743   3444444433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-39  Score=299.14  Aligned_cols=189  Identities=25%  Similarity=0.384  Sum_probs=159.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-----------CCCcceeEEEEEeCC----EEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----------HPNIVRLHDSIQEEN----YHY   65 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-----------H~nIv~l~~~~~~~~----~~~   65 (328)
                      |+||+||+|.+..+++.||||++...   ......+.+|+.++++++           ||||+++++++...+    .++
T Consensus        30 G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  106 (373)
T 1q8y_A           30 GHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV  106 (373)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEE
Confidence            89999999999999999999999743   334566788999999886           899999999998654    789


Q ss_pred             EEEEccCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCC---CCCcEEEeecccc
Q psy2131          66 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKA---KGAAVKLADFGLA  139 (328)
Q Consensus        66 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~---~~~~vkl~DfGla  139 (328)
                      +||||+ |++|.+.+...  ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++   ....+||+|||++
T Consensus       107 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a  185 (373)
T 1q8y_A          107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA  185 (373)
T ss_dssp             EEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred             EEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccc
Confidence            999999 88999988763  4599999999999999999999998 999999999999997543   2346999999998


Q ss_pred             ccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         140 IEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       140 ~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      ......                                                                          
T Consensus       186 ~~~~~~--------------------------------------------------------------------------  191 (373)
T 1q8y_A          186 CWYDEH--------------------------------------------------------------------------  191 (373)
T ss_dssp             EETTBC--------------------------------------------------------------------------
T ss_pred             cccCCC--------------------------------------------------------------------------
Confidence            543110                                                                          


Q ss_pred             cccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         220 PWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                                         .....||+.|+|||++.+..|+.++|||||||++|||+||++||.
T Consensus       192 -----------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          192 -----------------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             -----------------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             -----------------------------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence                                               011358999999999999999999999999999999999999998


Q ss_pred             Ccc
Q psy2131         300 DED  302 (328)
Q Consensus       300 ~~~  302 (328)
                      +.+
T Consensus       237 ~~~  239 (373)
T 1q8y_A          237 PDE  239 (373)
T ss_dssp             ---
T ss_pred             CCc
Confidence            764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-39  Score=304.15  Aligned_cols=208  Identities=25%  Similarity=0.432  Sum_probs=158.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||.+ ...+|+.||||++..+     ..+.+.+|+++|+++ +|||||++++++.+.+.+|+|||||. |+|.++
T Consensus        26 G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~   98 (434)
T 2rio_A           26 GSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDL   98 (434)
T ss_dssp             CSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHH
T ss_pred             CCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence            899999865 4568999999998653     234567899999876 89999999999999999999999996 599998


Q ss_pred             HHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC----------CCCcEEEeeccccccc
Q psy2131          80 IVAREFY-------SEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA----------KGAAVKLADFGLAIEV  142 (328)
Q Consensus        80 l~~~~~~-------~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~----------~~~~vkl~DfGla~~~  142 (328)
                      +......       ++.++..++.|++.||.|||++|||||||||+|||++..+          ....+||+|||++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~  178 (434)
T 2rio_A           99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL  178 (434)
T ss_dssp             HHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEEC
T ss_pred             HhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceec
Confidence            8765433       2334567999999999999999999999999999997642          3457999999998764


Q ss_pred             cCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         143 QGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       143 ~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .......                                                                         
T Consensus       179 ~~~~~~~-------------------------------------------------------------------------  185 (434)
T 2rio_A          179 DSGQSSF-------------------------------------------------------------------------  185 (434)
T ss_dssp             CC------------------------------------------------------------------------------
T ss_pred             CCCCccc-------------------------------------------------------------------------
Confidence            3211000                                                                         


Q ss_pred             CCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-------CCCCCCcchhhhhhHHHHHHh-c
Q psy2131         223 CQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-------EPYGKPVDIWACGVILYILLV-G  294 (328)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~~DvwSlGvilyellt-G  294 (328)
                                                   ........||+.|+|||++.+       ..++.++|||||||++|||+| |
T Consensus       186 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g  236 (434)
T 2rio_A          186 -----------------------------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG  236 (434)
T ss_dssp             --------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             -----------------------------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence                                         000112469999999999976       678999999999999999999 9


Q ss_pred             CCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         295 YPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       295 ~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      +.||.+.....  ..+..+.+..++
T Consensus       237 ~~Pf~~~~~~~--~~i~~~~~~~~~  259 (434)
T 2rio_A          237 KHPFGDKYSRE--SNIIRGIFSLDE  259 (434)
T ss_dssp             CCTTCSTTTHH--HHHHHTCCCCCC
T ss_pred             CCCCCCchhhH--HHHhcCCCCccc
Confidence            99998775443  455566665443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.5e-41  Score=303.34  Aligned_cols=196  Identities=20%  Similarity=0.236  Sum_probs=158.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC------CHHHHHHHHHHHHHHHhCC---------CCCcceeEEEE-------
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL------SARDFQKLEREARICRKLQ---------HPNIVRLHDSI-------   58 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~------~~~~~~~~~~E~~il~~l~---------H~nIv~l~~~~-------   58 (328)
                      |+||+||+|++  +|+.||||++.....      .....+.+.+|+.+|+.++         |||||++.+++       
T Consensus        31 G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~h  108 (336)
T 2vuw_A           31 GVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYP  108 (336)
T ss_dssp             ETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCC
T ss_pred             cCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCc
Confidence            79999999988  789999999987643      2233467889999999886         66666666654       


Q ss_pred             ----------Ee-------------CCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeec
Q psy2131          59 ----------QE-------------ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCH-SNGVVHRD  114 (328)
Q Consensus        59 ----------~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH-~~~ivHrD  114 (328)
                                .+             .+.+|+|||||++|++++.+.. ..+++.++..++.||+.||.||| ++||||||
T Consensus       109 p~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrD  187 (336)
T 2vuw_A          109 PLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRD  187 (336)
T ss_dssp             HHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSC
T ss_pred             HHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECC
Confidence                      32             6889999999999988887754 67899999999999999999999 99999999


Q ss_pred             CCCCcEEEeeCCC-----------------CCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q psy2131         115 LKPENLLLASKAK-----------------GAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIK  177 (328)
Q Consensus       115 iKp~NiLl~~~~~-----------------~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~  177 (328)
                      |||+|||++.++.                 ...+||+|||+|+....                                 
T Consensus       188 lKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------------------------------  234 (336)
T 2vuw_A          188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------------------------------  234 (336)
T ss_dssp             CCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------------------------------
T ss_pred             CCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------------------------------
Confidence            9999999987641                 12699999999864311                                 


Q ss_pred             hCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhh
Q psy2131         178 AGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQG  257 (328)
Q Consensus       178 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (328)
                                                                                                    ..
T Consensus       235 ------------------------------------------------------------------------------~~  236 (336)
T 2vuw_A          235 ------------------------------------------------------------------------------GI  236 (336)
T ss_dssp             ------------------------------------------------------------------------------TE
T ss_pred             ------------------------------------------------------------------------------Cc
Confidence                                                                                          01


Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhH-HHHHHhcCCCCCCcc-HHHHHHHHh
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVI-LYILLVGYPPFWDED-QHRLYAQIK  311 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvi-lyelltG~~Pf~~~~-~~~~~~~i~  311 (328)
                      ..||+.|+|||++.+.. +.++||||++++ .+++++|..||.+.. ...+...+.
T Consensus       237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~  291 (336)
T 2vuw_A          237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML  291 (336)
T ss_dssp             EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH
T ss_pred             EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh
Confidence            36999999999999877 889999998877 889999999997643 233444444

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-39  Score=292.54  Aligned_cols=201  Identities=24%  Similarity=0.434  Sum_probs=146.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|.++.+|+.||||+++... .......+.+|+. +++.++||||+++++++.+.+..|+||||+.| +|.+.
T Consensus        33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~  110 (327)
T 3aln_A           33 GAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKF  110 (327)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHH
T ss_pred             CCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHH
Confidence            899999999999999999999998654 3334445556665 77788999999999999999999999999986 77776


Q ss_pred             HHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          80 IVA-----REFYSEADASHCIQQILESVNHCHSN-GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        80 l~~-----~~~~~~~~~~~~~~qll~~L~ylH~~-~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+   +.+||+|||++.......       
T Consensus       111 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~-------  180 (327)
T 3aln_A          111 YKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSI-------  180 (327)
T ss_dssp             HHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT---TEEEECCCSSSCC------------
T ss_pred             HHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC---CCEEEccCCCceeccccc-------
Confidence            653     56799999999999999999999999 99999999999999754   469999999975431100       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (327)
T 3aln_A          181 --------------------------------------------------------------------------------  180 (327)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc----ccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL----KKEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYA  308 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~  308 (328)
                                          ......||+.|+|||++    .+..|+.++|||||||++|||++|+.||.+.+ ......
T Consensus       181 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  240 (327)
T 3aln_A          181 --------------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT  240 (327)
T ss_dssp             ---------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C
T ss_pred             --------------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence                                00112489999999999    56779999999999999999999999998754 233344


Q ss_pred             HHhcc
Q psy2131         309 QIKAG  313 (328)
Q Consensus       309 ~i~~~  313 (328)
                      .+..+
T Consensus       241 ~~~~~  245 (327)
T 3aln_A          241 QVVKG  245 (327)
T ss_dssp             CCCCS
T ss_pred             HHhcC
Confidence            44444

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=293.01  Aligned_cols=193  Identities=24%  Similarity=0.394  Sum_probs=162.2

Q ss_pred             CCceEEEEEE----EccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCV----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN--YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~----~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--~~~lv~E~~~gg   74 (328)
                      |+||.||+|+    +..+|+.||+|++...  .....+.+.+|++++++++||||+++++++...+  ..|+||||++++
T Consensus        52 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~  129 (326)
T 2w1i_A           52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG  129 (326)
T ss_dssp             CSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTC
T ss_pred             CCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCC
Confidence            8999999998    4678999999999754  3455677899999999999999999999987544  789999999999


Q ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          75 ELFEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        75 ~L~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..........    
T Consensus       130 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~kL~Dfg~~~~~~~~~~~~----  202 (326)
T 2w1i_A          130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFGLTKVLPQDKEYY----  202 (326)
T ss_dssp             BHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECCSSCSEE----
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC---CcEEEecCcchhhcccccccc----
Confidence            999998765 459999999999999999999999999999999999999865   469999999986542211000    


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       203 --------------------------------------------------------------------------------  202 (326)
T 2w1i_A          203 --------------------------------------------------------------------------------  202 (326)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                         .......||+.|+|||++.+..++.++|||||||++|||+||..||...
T Consensus       203 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  251 (326)
T 2w1i_A          203 -------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  251 (326)
T ss_dssp             -------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred             -------------------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence                               0011134788899999999999999999999999999999999998754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=298.40  Aligned_cols=209  Identities=22%  Similarity=0.340  Sum_probs=171.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..   .+|+|+++.........+.+.+|+.++++++||||+++++++.+.+..|+|||||+|++|.+++
T Consensus        44 G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l  120 (319)
T 2y4i_B           44 GRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV  120 (319)
T ss_dssp             SSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHT
T ss_pred             CCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHH
Confidence            8999999998754   4999999876554444556778999999999999999999999999999999999999999988


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ...+ .+++.++..++.|++.||.|||++||+||||||+|||++    ++.+||+|||++.........           
T Consensus       121 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~-----------  185 (319)
T 2y4i_B          121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAG-----------  185 (319)
T ss_dssp             TSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-------------------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccccccccc-----------
Confidence            7654 699999999999999999999999999999999999996    246999999997532110000           


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       186 --------------------------------------------------------------------------------  185 (319)
T 2y4i_B          186 --------------------------------------------------------------------------------  185 (319)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---------CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---------EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                ..........||+.|+|||++.+         ..|+.++|||||||++|||+||+.||.+.+...+...+
T Consensus       186 ----------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          186 ----------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ----------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence                      00000112348999999999975         45789999999999999999999999999999999988


Q ss_pred             hcccCCC
Q psy2131         311 KAGAYDD  317 (328)
Q Consensus       311 ~~~~~~~  317 (328)
                      ..+....
T Consensus       256 ~~~~~~~  262 (319)
T 2y4i_B          256 GTGMKPN  262 (319)
T ss_dssp             HTTCCCC
T ss_pred             ccCCCCC
Confidence            8886543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-40  Score=296.57  Aligned_cols=192  Identities=29%  Similarity=0.520  Sum_probs=164.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----HHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEEccCC-
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQ--HPNIVRLHDSIQEENYHYLVFDLVTG-   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv~E~~~g-   73 (328)
                      |+||.||+|++..+|+.||||++.......    .....+.+|+.++++++  ||||+++++++.+.+..++|||++.+ 
T Consensus        54 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  133 (320)
T 3a99_A           54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV  133 (320)
T ss_dssp             SSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSE
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCC
Confidence            899999999999999999999998654332    12244668999999996  59999999999999999999999986 


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.  +.+.+||+|||++.......       
T Consensus       134 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~Dfg~~~~~~~~~-------  204 (320)
T 3a99_A          134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTV-------  204 (320)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECCSSC-------
T ss_pred             ccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEeeCcccccccccc-------
Confidence            899999988888999999999999999999999999999999999999973  23569999999986532110       


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       205 --------------------------------------------------------------------------------  204 (320)
T 3a99_A          205 --------------------------------------------------------------------------------  204 (320)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                                           .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.+
T Consensus       205 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  253 (320)
T 3a99_A          205 ---------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE  253 (320)
T ss_dssp             ---------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             ---------------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence                                 012358999999999988776 788999999999999999999998754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=302.64  Aligned_cols=203  Identities=27%  Similarity=0.445  Sum_probs=157.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+|+. ....+|+.||||++..+..     ..+.+|+++|+.+ +|||||++++++.+.+..|+|||||. |+|.++
T Consensus        35 G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~  107 (432)
T 3p23_A           35 GAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY  107 (432)
T ss_dssp             CGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHH
T ss_pred             CcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHH
Confidence            89998763 4557899999999975432     2246799999999 89999999999999999999999997 499888


Q ss_pred             HHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC--CCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK--GAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~--~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +.... .+.+.++..++.|++.||.|||++|||||||||+|||++..+.  ...+||+|||+|.........        
T Consensus       108 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~--------  179 (432)
T 3p23_A          108 VEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS--------  179 (432)
T ss_dssp             HHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------------
T ss_pred             HHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc--------
Confidence            87654 4566677899999999999999999999999999999964332  235789999998654221000        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       180 --------------------------------------------------------------------------------  179 (432)
T 3p23_A          180 --------------------------------------------------------------------------------  179 (432)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~  312 (328)
                                     ........||+.|+|||++.   +..++.++|||||||++|||+| |.+||.+.........+..
T Consensus       180 ---------------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~  244 (432)
T 3p23_A          180 ---------------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA  244 (432)
T ss_dssp             ---------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC
T ss_pred             ---------------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc
Confidence                           00112356999999999998   4677889999999999999999 9999987766555544433


Q ss_pred             c
Q psy2131         313 G  313 (328)
Q Consensus       313 ~  313 (328)
                      .
T Consensus       245 ~  245 (432)
T 3p23_A          245 C  245 (432)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-38  Score=281.27  Aligned_cols=216  Identities=24%  Similarity=0.438  Sum_probs=180.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-------------CCEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-------------ENYHYLV   67 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-------------~~~~~lv   67 (328)
                      |+||.||+|++..+|+.||||++...   ....+.+.+|+.++++++||||+++++++.+             .+..|+|
T Consensus        17 G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv   93 (303)
T 1zy4_A           17 GAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ   93 (303)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEE
T ss_pred             CCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEE
Confidence            89999999999999999999999642   4456778899999999999999999999865             4578999


Q ss_pred             EEccCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC--
Q psy2131          68 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG--  144 (328)
Q Consensus        68 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~--  144 (328)
                      ||||+||+|.+++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~  170 (303)
T 1zy4_A           94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES---RNVKIGDFGLAKNVHRSL  170 (303)
T ss_dssp             EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCCCSCTTC--
T ss_pred             EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC---CCEEEeeCcchhhccccc
Confidence            99999999999987543 58889999999999999999999999999999999999654   4699999998864320  


Q ss_pred             ----------------------------------C------Ccch-HHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCC
Q psy2131         145 ----------------------------------E------QQAW-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYD  182 (328)
Q Consensus       145 ----------------------------------~------~~~~-~G~~~~~~~~g~~pf~~-~~~~~~~~~i~~~~~~  182 (328)
                                                        .      .+.| +|+++|+|++   ||.. .+.......+......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~  247 (303)
T 1zy4_A          171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE  247 (303)
T ss_dssp             -----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCC
T ss_pred             chhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccc
Confidence                                              0      0122 7999999998   5543 3344556667666666


Q ss_pred             CCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         183 YPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       183 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +|.......++.+.+++.+||..||.+|||+.++++|||+...
T Consensus       248 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            6666566778899999999999999999999999999999754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-39  Score=292.62  Aligned_cols=220  Identities=23%  Similarity=0.456  Sum_probs=185.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH---------------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA---------------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHY   65 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~---------------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~   65 (328)
                      |+||.||+|.+  +|+.||+|++.......               ...+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        42 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  119 (348)
T 2pml_X           42 GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY  119 (348)
T ss_dssp             CSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEE
T ss_pred             CCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            89999999998  89999999997542211               11267889999999999999999999999999999


Q ss_pred             EEEEccCCCCcHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          66 LVFDLVTGGELFED------IVA--REFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        66 lv~E~~~gg~L~~~------l~~--~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|||||+||+|.++      +..  ...+++.++..++.|++.||.|||+ +||+||||||+|||++.+   +.+||+||
T Consensus       120 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~---~~~kl~df  196 (348)
T 2pml_X          120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN---GRVKLSDF  196 (348)
T ss_dssp             EEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT---SCEEECCC
T ss_pred             EEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC---CcEEEecc
Confidence            99999999999887      555  5679999999999999999999999 999999999999999754   46999999


Q ss_pred             cccccccC---------------------------CCcch-HHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCC
Q psy2131         137 GLAIEVQG---------------------------EQQAW-FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPE  187 (328)
Q Consensus       137 Gla~~~~~---------------------------~~~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  187 (328)
                      |++.....                           ..+.| +|+++|+|++|..||...+. ......+..+...+|...
T Consensus       197 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~  276 (348)
T 2pml_X          197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR  276 (348)
T ss_dssp             TTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS
T ss_pred             ccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch
Confidence            99864211                           11123 89999999999999988776 777777777766655321


Q ss_pred             ---------------cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         188 ---------------WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       188 ---------------~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                                     ...+++++.+++.+||..||.+|||+.++++|||+.+.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                           15689999999999999999999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.4e-38  Score=277.99  Aligned_cols=219  Identities=25%  Similarity=0.410  Sum_probs=176.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++
T Consensus        33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (295)
T 2clq_A           33 GTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL  110 (295)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHH
T ss_pred             cCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHH
Confidence            899999999999999999999997653  234567889999999999999999999999999999999999999999988


Q ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC------------
Q psy2131          81 VARE---FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE------------  145 (328)
Q Consensus        81 ~~~~---~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~------------  145 (328)
                      ....   .+++..+..++.|++.||.|||++||+||||||+|||++..  ++.+||+|||++......            
T Consensus       111 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  188 (295)
T 2clq_A          111 RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQ  188 (295)
T ss_dssp             HHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC-----CCCCCCGG
T ss_pred             HhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCCCcccccCCCcc
Confidence            7642   46789999999999999999999999999999999999752  346999999998643210            


Q ss_pred             -----------------Ccch-HHHHHHHHHhCCCCCCCCcHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccC
Q psy2131         146 -----------------QQAW-FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN  206 (328)
Q Consensus       146 -----------------~~~~-~G~~~~~~~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~  206 (328)
                                       .+.| +|+++|+|++|..||....... ........  .........+++++.+++.+||..|
T Consensus       189 y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~d  266 (295)
T 2clq_A          189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAKAFILKCFEPD  266 (295)
T ss_dssp             GCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred             ccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHHHHHHHHHccCC
Confidence                             0112 7999999999999997543322 11111111  1112223468999999999999999


Q ss_pred             CCCCCCHHHHhcCcccCCc
Q psy2131         207 PSKRITASEALKHPWICQR  225 (328)
Q Consensus       207 p~~R~t~~~~l~h~~~~~~  225 (328)
                      |.+|||+.+++.|||+...
T Consensus       267 p~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          267 PDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             TTTSCCHHHHHTSGGGCC-
T ss_pred             hhhCCCHHHHhcChhhhhc
Confidence            9999999999999999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-39  Score=315.85  Aligned_cols=196  Identities=30%  Similarity=0.500  Sum_probs=170.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE------ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~------~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|.+..+|+.||||+++.. ......+.+.+|++++++++||||+++++++..      .+..|+|||||+||
T Consensus        25 G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~gg  103 (676)
T 3qa8_A           25 GGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG  103 (676)
T ss_dssp             CSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSC
T ss_pred             CCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCC
Confidence            89999999999999999999999764 355667788999999999999999999999765      67789999999999


Q ss_pred             CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHH
Q psy2131          75 ELFEDIVARE---FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFG  151 (328)
Q Consensus        75 ~L~~~l~~~~---~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G  151 (328)
                      +|.+++....   .+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++.......     
T Consensus       104 sL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-----  178 (676)
T 3qa8_A          104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-----  178 (676)
T ss_dssp             BHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-----
T ss_pred             CHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc-----
Confidence            9999987654   58999999999999999999999999999999999999877666679999999985432110     


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhh
Q psy2131         152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASI  231 (328)
Q Consensus       152 ~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~  231 (328)
                                                                                                      
T Consensus       179 --------------------------------------------------------------------------------  178 (676)
T 3qa8_A          179 --------------------------------------------------------------------------------  178 (676)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH
Q psy2131         232 VHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH  304 (328)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~  304 (328)
                                            ......||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+..
T Consensus       179 ----------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~  229 (676)
T 3qa8_A          179 ----------------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP  229 (676)
T ss_dssp             ----------------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred             ----------------------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence                                  011245899999999999999999999999999999999999999876433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-38  Score=284.21  Aligned_cols=188  Identities=23%  Similarity=0.373  Sum_probs=151.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeC----CEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK--LQHPNIVRLHDSIQEE----NYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~~~----~~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+.  |+.||+|++...     ......+|.+++..  ++||||+++++++.+.    ...|+|||||+||
T Consensus        48 G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g  120 (337)
T 3mdy_A           48 GRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG  120 (337)
T ss_dssp             ETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTC
T ss_pred             CCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCC
Confidence            799999999874  899999998643     22334455555554  4999999999999887    7899999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSN--------GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~--------~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      +|.+++.. ..+++.++..++.|++.||.|||++        ||+||||||+|||++.+   +.+||+|||++.......
T Consensus       121 ~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~  196 (337)
T 3mdy_A          121 SLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVKFISDT  196 (337)
T ss_dssp             BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT---SCEEECCCTTCEECC---
T ss_pred             cHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC---CCEEEEeCCCceeecccc
Confidence            99998865 4699999999999999999999999        99999999999999754   469999999986542211


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ..                                                                              
T Consensus       197 ~~------------------------------------------------------------------------------  198 (337)
T 3mdy_A          197 NE------------------------------------------------------------------------------  198 (337)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             cc------------------------------------------------------------------------------
Confidence            00                                                                              


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCC------cchhhhhhHHHHHHhc------
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKP------VDIWACGVILYILLVG------  294 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~------~DvwSlGvilyelltG------  294 (328)
                                              .........||+.|+|||++.+..++.+      +|||||||++|||+||      
T Consensus       199 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          199 ------------------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ----------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ------------------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence                                    0000113469999999999998887776      9999999999999999      


Q ss_pred             ----CCCCCCc
Q psy2131         295 ----YPPFWDE  301 (328)
Q Consensus       295 ----~~Pf~~~  301 (328)
                          +.||.+.
T Consensus       255 ~~~~~~p~~~~  265 (337)
T 3mdy_A          255 VEEYQLPYHDL  265 (337)
T ss_dssp             CCCCCCTTTTT
T ss_pred             cccccccHhhh
Confidence                7888653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.3e-39  Score=284.45  Aligned_cols=212  Identities=17%  Similarity=0.163  Sum_probs=172.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||.||+|++..+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..|+|||||+|++|.++
T Consensus        42 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~  121 (286)
T 3uqc_A           42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV  121 (286)
T ss_dssp             STTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHH
T ss_pred             cCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHH
Confidence            89999999999999999999999876544 45567789999999999999999999999999999999999999999988


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch-HHHHHHHHH
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-FGVILYILL  158 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~-~G~~~~~~~  158 (328)
                      +.. + ....++..++.|++.||.|||++||+||||||+|||++.+   +.+||+++|.........+.| +|+++|+|+
T Consensus       122 l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~---g~~kl~~~~~~~~~~~~~Di~slG~il~ell  196 (286)
T 3uqc_A          122 ADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPATMPDANPQDDIRGIGASLYALL  196 (286)
T ss_dssp             HTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT---SCEEECSCCCCTTCCHHHHHHHHHHHHHHHH
T ss_pred             Hhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC---CCEEEEeccccCCCCchhHHHHHHHHHHHHH
Confidence            843 3 4666788999999999999999999999999999999854   459999888765554445555 899999999


Q ss_pred             hCCCCCCCCcHHHHHH---HHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         159 VGYPPFWDEDQHRLYA---QIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +|..||.+.+..+...   ....+....+......+++++.+++.+||..||.+| |+.++++
T Consensus       197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          197 VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            9999998754322110   000111111111234689999999999999999999 9999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=290.37  Aligned_cols=191  Identities=21%  Similarity=0.332  Sum_probs=147.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHH--HHHHHHHhCCCCCcceeEEEEEe-----CCEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE--REARICRKLQHPNIVRLHDSIQE-----ENYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~--~E~~il~~l~H~nIv~l~~~~~~-----~~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+  +++.||||+++...     ...+.  .|+..+..++||||+++++.+..     ...+|+|||||+|
T Consensus        24 G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~   96 (336)
T 3g2f_A           24 GRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN   96 (336)
T ss_dssp             CSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred             CCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence            89999999966  78999999997432     22333  44444556899999999986542     3367999999999


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSN---------GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG  144 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~---------~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~  144 (328)
                      |+|.+++... ..++.++..++.|++.||.|||+.         ||+||||||+|||++.+   +.+||+|||++.....
T Consensus        97 g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~---~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A           97 GSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND---GTCVISDFGLSMRLTG  172 (336)
T ss_dssp             CBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT---SCEEECCCTTCEECSS
T ss_pred             CcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC---CcEEEeeccceeeccc
Confidence            9999988654 458899999999999999999999         99999999999999754   4699999999876533


Q ss_pred             CCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         145 EQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       145 ~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ......+                                                                         
T Consensus       173 ~~~~~~~-------------------------------------------------------------------------  179 (336)
T 3g2f_A          173 NRLVRPG-------------------------------------------------------------------------  179 (336)
T ss_dssp             SSCC----------------------------------------------------------------------------
T ss_pred             ccccCcc-------------------------------------------------------------------------
Confidence            2110000                                                                         


Q ss_pred             cccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-------CCCCCCcchhhhhhHHHHHHhcCCC
Q psy2131         225 RERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-------EPYGKPVDIWACGVILYILLVGYPP  297 (328)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~~DvwSlGvilyelltG~~P  297 (328)
                                               ..........||+.|+|||++.+       ..++.++|||||||++|||+||..|
T Consensus       180 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          180 -------------------------EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             -------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             -------------------------ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence                                     00001123469999999999987       4667899999999999999999777


Q ss_pred             CCC
Q psy2131         298 FWD  300 (328)
Q Consensus       298 f~~  300 (328)
                      |..
T Consensus       235 ~~~  237 (336)
T 3g2f_A          235 LFP  237 (336)
T ss_dssp             GST
T ss_pred             CCC
Confidence            654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4e-38  Score=285.65  Aligned_cols=205  Identities=25%  Similarity=0.364  Sum_probs=165.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC----EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK--LQHPNIVRLHDSIQEEN----YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg   74 (328)
                      |+||.||+|.+  +|+.||||+++..     ....+.+|++++..  ++||||+++++++...+    ..|+||||+++|
T Consensus        53 G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g  125 (342)
T 1b6c_B           53 GRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG  125 (342)
T ss_dssp             ETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTC
T ss_pred             CCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCC
Confidence            78999999987  5899999999643     34567788998887  79999999999998876    899999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCH--------SNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ  146 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH--------~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~  146 (328)
                      +|.+++.. ..+++.++..++.|++.||.|||        +.||+||||||+|||++.+   +.+||+|||++.......
T Consensus       126 ~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          126 SLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSAT  201 (342)
T ss_dssp             BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT---SCEEECCCTTCEEEETTT
T ss_pred             cHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC---CCEEEEECCCceeccccc
Confidence            99998865 46899999999999999999999        8999999999999999754   469999999986543211


Q ss_pred             cchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         147 QAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       147 ~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ...                                                                             
T Consensus       202 ~~~-----------------------------------------------------------------------------  204 (342)
T 1b6c_B          202 DTI-----------------------------------------------------------------------------  204 (342)
T ss_dssp             TEE-----------------------------------------------------------------------------
T ss_pred             ccc-----------------------------------------------------------------------------
Confidence            000                                                                             


Q ss_pred             cchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC------CCCCcchhhhhhHHHHHHhc------
Q psy2131         227 RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP------YGKPVDIWACGVILYILLVG------  294 (328)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~~~~~DvwSlGvilyelltG------  294 (328)
                                               ........||+.|+|||++.+..      ++.++|||||||++|||+||      
T Consensus       205 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          205 -------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             -------------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             -------------------------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence                                     00011245999999999998763      34689999999999999999      


Q ss_pred             ----CCCCCCc-----cHHHHHHHHhcccCCCC
Q psy2131         295 ----YPPFWDE-----DQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       295 ----~~Pf~~~-----~~~~~~~~i~~~~~~~~  318 (328)
                          +.||.+.     ....+...+..+...+.
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN  292 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHHhCCC
Confidence                8899875     34566666665555443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-38  Score=313.84  Aligned_cols=183  Identities=25%  Similarity=0.399  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEcc-CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-----EEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKA-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENY-----HYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~-~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~-----~~lv~E~~~gg   74 (328)
                      |+||+||+|.+.. +|+.||||++.... .......+.+|+++|++++|||||++++++.+.+.     .|||||||+|+
T Consensus        91 G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~  169 (681)
T 2pzi_A           91 GGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ  169 (681)
T ss_dssp             ETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCE
T ss_pred             CCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCC
Confidence            7999999999976 78999999987532 34455678899999999999999999999987665     79999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+.+..  .+++.++..++.||+.||.|||++|||||||||+|||++.+    .+||+|||++......         
T Consensus       170 ~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG~a~~~~~~---------  234 (681)
T 2pzi_A          170 SLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRINSF---------  234 (681)
T ss_dssp             ECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCTTCEETTCC---------
T ss_pred             cHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecccchhcccC---------
Confidence            99876644  79999999999999999999999999999999999999742    5999999998543110         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       235 --------------------------------------------------------------------------------  234 (681)
T 2pzi_A          235 --------------------------------------------------------------------------------  234 (681)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE  301 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  301 (328)
                                           ....||+.|+|||++.+.. +.++|||||||+||||++|.+||.+.
T Consensus       235 ---------------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          235 ---------------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             ---------------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             ---------------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence                                 1235999999999998754 88999999999999999999998754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4e-39  Score=310.69  Aligned_cols=136  Identities=18%  Similarity=0.264  Sum_probs=114.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC----C----HHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL----S----ARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~----~----~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~   71 (328)
                      |++|.+..++..-+|+.||+|++..+..    .    +...+++.+|+++|+++ +|+||+++++++++++.+|||||||
T Consensus       245 ~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv  324 (569)
T 4azs_A          245 GAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKL  324 (569)
T ss_dssp             -------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECC
T ss_pred             CCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecC
Confidence            4567777788888999999999986532    1    23346789999999999 7999999999999999999999999


Q ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          72 TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        72 ~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +|++|.+.+...+.+++.   .|+.||+.||+|+|++|||||||||+|||++.+   +.+||+|||+|+..
T Consensus       325 ~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---g~vKL~DFGlAr~~  389 (569)
T 4azs_A          325 PGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---QHARLIDFGSIVTT  389 (569)
T ss_dssp             CSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---SCEEECCCTTEESC
T ss_pred             CCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC---CCEEEeecccCeeC
Confidence            999999999988888765   478999999999999999999999999999754   46999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-37  Score=275.13  Aligned_cols=214  Identities=29%  Similarity=0.509  Sum_probs=172.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----HHHHHHHHHHHHHHhC----CCCCcceeEEEEEeCCEEEEEEEc-c
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKL----QHPNIVRLHDSIQEENYHYLVFDL-V   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----~~~~~~~~E~~il~~l----~H~nIv~l~~~~~~~~~~~lv~E~-~   71 (328)
                      |+||.||+|++..+|+.||+|++.......    .....+.+|+.+++++    +||||+++++++.+.+..++|||| +
T Consensus        42 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~  121 (312)
T 2iwi_A           42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL  121 (312)
T ss_dssp             ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCS
T ss_pred             CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecC
Confidence            799999999999999999999997654332    1223456799999998    899999999999999999999999 7


Q ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC------
Q psy2131          72 TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE------  145 (328)
Q Consensus        72 ~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~------  145 (328)
                      .+++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.  .++.+||+|||++......      
T Consensus       122 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~dfg~~~~~~~~~~~~~~  199 (312)
T 2iwi_A          122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLIDFGSGALLHDEPYTDFD  199 (312)
T ss_dssp             SEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEECCCSSCEECCSSCBCCCC
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEEEcchhhhcccCcccccC
Confidence            89999999988888999999999999999999999999999999999999973  2356999999998643211      


Q ss_pred             --------------------Ccc-hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcc
Q psy2131         146 --------------------QQA-WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       146 --------------------~~~-~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~  204 (328)
                                          .+. .+|+++|+|++|..||.....      +......++    ..+++++.+++.+||.
T Consensus       200 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~----~~~~~~~~~li~~~l~  269 (312)
T 2iwi_A          200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP----AHVSPDCCALIRRCLA  269 (312)
T ss_dssp             SCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCCC----TTSCHHHHHHHHHHTC
T ss_pred             CcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCCc----ccCCHHHHHHHHHHcc
Confidence                                112 279999999999999975432      223333333    4678999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCcc
Q psy2131         205 VNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .||.+|||++++++|||+....
T Consensus       270 ~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          270 PKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             SSTTTSCCHHHHHHSTTTCC--
T ss_pred             CChhhCcCHHHHhcChhhcCch
Confidence            9999999999999999997643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.6e-38  Score=290.79  Aligned_cols=198  Identities=15%  Similarity=0.184  Sum_probs=149.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCC-CCcce---------------------eEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQH-PNIVR---------------------LHDS   57 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H-~nIv~---------------------l~~~   57 (328)
                      |+||+||+|.+..+|+.||||+++.... .....+.+.+|+.+++.++| +|...                     +..+
T Consensus        89 G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (413)
T 3dzo_A           89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV  168 (413)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-------
T ss_pred             CCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccc
Confidence            8999999999999999999999984432 23345778999999999987 32211                     1111


Q ss_pred             EEe-----CCEEEEEEEccCCCCcHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeC
Q psy2131          58 IQE-----ENYHYLVFDLVTGGELFEDIVA-------REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASK  125 (328)
Q Consensus        58 ~~~-----~~~~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~  125 (328)
                      +..     ....+++|+++ +++|.+++..       ...+++..+..++.|++.||.|||++|||||||||+|||++.+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~  247 (413)
T 3dzo_A          169 RLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR  247 (413)
T ss_dssp             --------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred             cCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecC
Confidence            121     22467788876 5688887741       2347777888899999999999999999999999999999755


Q ss_pred             CCCCcEEEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhccc
Q psy2131         126 AKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       126 ~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  205 (328)
                      +   .+||+|||+++.....                                                            
T Consensus       248 ~---~~kL~DFG~a~~~~~~------------------------------------------------------------  264 (413)
T 3dzo_A          248 G---GVFLTGFEHLVRDGAS------------------------------------------------------------  264 (413)
T ss_dssp             C---CEEECCGGGCEETTEE------------------------------------------------------------
T ss_pred             C---eEEEEeccceeecCCc------------------------------------------------------------
Confidence            4   4999999997542110                                                            


Q ss_pred             CCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccc----------ccCCC
Q psy2131         206 NPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVL----------KKEPY  275 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----------~~~~~  275 (328)
                                                                       .....| +.|+|||++          .+..|
T Consensus       265 -------------------------------------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          265 -------------------------------------------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             -------------------------------------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             -------------------------------------------------cccCCC-CceeCchhhhccccccccccCcCC
Confidence                                                             112357 999999999          56668


Q ss_pred             CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         276 GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       276 ~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      +.++|||||||++|||+||+.||.+.+...+...+..
T Consensus       295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~  331 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR  331 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh
Confidence            8999999999999999999999998876655555544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=1.9e-31  Score=255.76  Aligned_cols=185  Identities=19%  Similarity=0.180  Sum_probs=146.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH------HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|  ...+..+|+|+.........      ..+++.+|+++|++++||||+++..++.+.+..|||||||+|+
T Consensus       347 G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~gg  424 (540)
T 3en9_A          347 GAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGK  424 (540)
T ss_dssp             -CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSE
T ss_pred             CCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCC
Confidence            899999999  45678899998765443322      1345789999999999999995555555677789999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.+++..        +..++.|++.||.|||++||+||||||+|||++.     .+||+|||+|+........      
T Consensus       425 sL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~~~~------  485 (540)
T 3en9_A          425 LAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLDEDK------  485 (540)
T ss_dssp             EHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCHHHH------
T ss_pred             CHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCcccc------
Confidence            99988765        5689999999999999999999999999999974     5999999998764221000      


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       486 --------------------------------------------------------------------------------  485 (540)
T 3en9_A          486 --------------------------------------------------------------------------------  485 (540)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                        ..+           ......+..||+.|||||++.+  ..|+..+|+||..+-..+...++.+|.
T Consensus       486 --~~~-----------~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 --AVD-----------LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             --HHH-----------HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             --ccc-----------hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence              000           0001224569999999999987  778899999999999999999988875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=4.8e-27  Score=207.41  Aligned_cols=126  Identities=24%  Similarity=0.325  Sum_probs=101.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----------------HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----------------RDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----------------~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||.||+|.+ .+|+.||+|+++......                .....+.+|+.+|++++  | +++++++.. +..
T Consensus       101 G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~  175 (282)
T 1zar_A          101 GKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGN  175 (282)
T ss_dssp             CSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETT
T ss_pred             CCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cce
Confidence            89999999999 889999999997543211                13456889999999999  4 666665544 446


Q ss_pred             EEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131          65 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      |+|||||+||+|.+ +.      ..+...++.|++.||.|||++||+||||||+|||++ +   +.+||+|||+|+..
T Consensus       176 ~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~---~~vkl~DFG~a~~~  242 (282)
T 1zar_A          176 AVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E---EGIWIIDFPQSVEV  242 (282)
T ss_dssp             EEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T---TEEEECCCTTCEET
T ss_pred             EEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C---CcEEEEECCCCeEC
Confidence            99999999999987 42      234567999999999999999999999999999998 3   46999999998643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=7.2e-23  Score=178.38  Aligned_cols=132  Identities=20%  Similarity=0.207  Sum_probs=100.8

Q ss_pred             CCceEEEEEEEccCCcE--EEEEEeccCCCCH----------------------HHHHHHHHHHHHHHhCCCCCc--cee
Q psy2131           1 GAFSVVRRCVQKATGLE--FAAKIINTKKLSA----------------------RDFQKLEREARICRKLQHPNI--VRL   54 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~--~AiK~i~~~~~~~----------------------~~~~~~~~E~~il~~l~H~nI--v~l   54 (328)
                      |+||.||+|.+..+|+.  ||||+++......                      .....+.+|+.+|+++.|+++  +.+
T Consensus        58 G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  137 (258)
T 1zth_A           58 GKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQP  137 (258)
T ss_dssp             CSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCE
T ss_pred             cceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeE
Confidence            89999999999888999  9999986542111                      112357899999999988864  444


Q ss_pred             EEEEEeCCEEEEEEEccCC-C----CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCcEEEeeCCCC
Q psy2131          55 HDSIQEENYHYLVFDLVTG-G----ELFEDIVAREFYSEADASHCIQQILESVNHCH-SNGVVHRDLKPENLLLASKAKG  128 (328)
Q Consensus        55 ~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH-~~~ivHrDiKp~NiLl~~~~~~  128 (328)
                      ++.    +..+||||||.+ |    +|.+....   .++.++..++.|++.||.||| +.|||||||||+|||++.    
T Consensus       138 ~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----  206 (258)
T 1zth_A          138 YTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----  206 (258)
T ss_dssp             EEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----
T ss_pred             EEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----
Confidence            442    246899999942 4    55544322   235577889999999999999 999999999999999964    


Q ss_pred             CcEEEeeccccccccC
Q psy2131         129 AAVKLADFGLAIEVQG  144 (328)
Q Consensus       129 ~~vkl~DfGla~~~~~  144 (328)
                       .++|+|||+|.....
T Consensus       207 -~~~liDFG~a~~~~~  221 (258)
T 1zth_A          207 -KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             -SEEECCCTTCEETTS
T ss_pred             -cEEEEECcccccCCC
Confidence             599999999977643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.2e-18  Score=158.53  Aligned_cols=136  Identities=15%  Similarity=0.185  Sum_probs=95.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC---------------HHH---H--HHHHHHHHHHHhCCCCCcceeEEEEEe
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS---------------ARD---F--QKLEREARICRKLQHPNIVRLHDSIQE   60 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~---------------~~~---~--~~~~~E~~il~~l~H~nIv~l~~~~~~   60 (328)
                      |+||.||+|.+. +|+.||||+++....+               ...   .  ....+|...|.++.+.++.-..-+...
T Consensus       106 Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~  184 (397)
T 4gyi_A          106 GKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS  184 (397)
T ss_dssp             CSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE
T ss_pred             CCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc
Confidence            899999999874 7999999998643110               000   1  112467777777755544322212222


Q ss_pred             CCEEEEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCC-------CcEEE
Q psy2131          61 ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKG-------AAVKL  133 (328)
Q Consensus        61 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~-------~~vkl  133 (328)
                      .  .+|||||++|++|.+..      ...++..++.|++.+|.|||++|||||||||.|||++.+++.       ..+.|
T Consensus       185 ~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~i  256 (397)
T 4gyi_A          185 R--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPII  256 (397)
T ss_dssp             T--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEE
T ss_pred             C--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEE
Confidence            2  37999999998875432      223566788999999999999999999999999999876531       13789


Q ss_pred             eeccccccccCC
Q psy2131         134 ADFGLAIEVQGE  145 (328)
Q Consensus       134 ~DfGla~~~~~~  145 (328)
                      +||+-+......
T Consensus       257 ID~~Q~V~~~hp  268 (397)
T 4gyi_A          257 IXFPQMVSMDHP  268 (397)
T ss_dssp             CCCTTCEETTST
T ss_pred             EEeCCcccCCCC
Confidence            999987665443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=5e-13  Score=115.98  Aligned_cols=129  Identities=17%  Similarity=0.184  Sum_probs=99.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+++.||++..  .+..+++|+.......  ....+.+|+.+|+.+. +.++.++++++.+.+..|+||||++|.+|.+.
T Consensus        25 ~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~  100 (263)
T 3tm0_A           25 MSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence            45678999864  3678999998753211  1234788999999884 67888999999999999999999999988654


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHS----------------------------------------------------  107 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~----------------------------------------------------  107 (328)
                      +     .+..+...++.++..+|..||+                                                    
T Consensus       101 ~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  175 (263)
T 3tm0_A          101 Y-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             C-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred             c-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence            2     1223345678899999999998                                                    


Q ss_pred             -------CCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131         108 -------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus       108 -------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                             ..++|+|++|.|||++.   +..+.|+||+.+..
T Consensus       176 ~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          176 TEKPEEELVFSHGDLGDSNIFVKD---GKVSGFIDLGRSGR  213 (263)
T ss_dssp             HCCCCCCEEEECSSCCTTSEEEET---TEEEEECCCTTCEE
T ss_pred             hcCCCCCceEECCCCCcCcEEEEC---CcEEEEEEchhccc
Confidence                   45899999999999963   23457999998743

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.40  E-value=1.4e-13  Score=125.39  Aligned_cols=64  Identities=91%  Similarity=1.615  Sum_probs=59.9

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+.+|+.++|||||||++|||++|++||.+.+...++..|..+.+..+++
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  252 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP  252 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            4679999999999999999999999999999999999999999999999999999999876654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.39  E-value=1.3e-13  Score=125.58  Aligned_cols=63  Identities=40%  Similarity=0.777  Sum_probs=59.5

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+.+|+.++|||||||++|+|++|.+||.+.+...++..|..+.+..++
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            457999999999999999999999999999999999999999999999999999999987765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.39  E-value=1.6e-13  Score=128.43  Aligned_cols=65  Identities=86%  Similarity=1.593  Sum_probs=60.7

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCCc
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPKH  321 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  321 (328)
                      +..||+.|+|||++.+.+|+.++|||||||++|+|++|.+||.+.+...++..|..+.+..+++.
T Consensus       172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  236 (444)
T 3soa_A          172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE  236 (444)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence            46799999999999999999999999999999999999999999999999999999999776643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=2.3e-12  Score=111.28  Aligned_cols=125  Identities=17%  Similarity=0.176  Sum_probs=92.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC--cceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+.+.||++. ..+|..+++|+.....     ...+.+|+.+++.+.+.+  +.+++.+..+.+..|+||||++|.+|. 
T Consensus        31 g~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           31 CSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             TSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             CCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            4458999985 3567789999976531     234678999999886544  567999988888899999999998873 


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------------
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNG-------------------------------------------------  109 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~-------------------------------------------------  109 (328)
                       .   ...+   ...++.++...|..||+..                                                 
T Consensus       104 -~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  176 (264)
T 1nd4_A          104 -S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  176 (264)
T ss_dssp             -T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             -c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence             1   1122   2246677777788887643                                                 


Q ss_pred             ---------CeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131         110 ---------VVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus       110 ---------ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                               ++|+|++|.|||++.   +..+.|+|||.+...
T Consensus       177 ~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          177 RMPDGEDLVVTHGDACLPNIMVEN---GRFSGFIDCGRLGVA  215 (264)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEET---TEEEEECCCTTCEEE
T ss_pred             hcCCCCCeEEECCCCCCCcEEEEC---CcEEEEEcchhcccC
Confidence                     999999999999963   234579999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.29  E-value=6e-13  Score=119.16  Aligned_cols=63  Identities=27%  Similarity=0.597  Sum_probs=58.8

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...|||.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...++..|..+.+..++
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  224 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE  224 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh
Confidence            356999999999999999999999999999999999999999999999999999999987664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.28  E-value=1.5e-12  Score=116.80  Aligned_cols=63  Identities=38%  Similarity=0.758  Sum_probs=58.1

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+...++..+..+.+..++
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            456999999999999999999999999999999999999999999999999999988876654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.28  E-value=1.3e-12  Score=120.00  Aligned_cols=64  Identities=31%  Similarity=0.597  Sum_probs=59.1

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+...++..+..+.+..++.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  272 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED  272 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            3569999999999999999999999999999999999999999999999999999998876654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.27  E-value=1e-11  Score=111.64  Aligned_cols=79  Identities=25%  Similarity=0.577  Sum_probs=67.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+..+.+..+..... .....+..+|+++++||.+||+.||.+|||++|+++|||+.+.
T Consensus       252 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            345 89999999999999999998888888876532 2334567899999999999999999999999999999999764


Q ss_pred             c
Q psy2131         226 E  226 (328)
Q Consensus       226 ~  226 (328)
                      .
T Consensus       331 ~  331 (346)
T 4fih_A          331 G  331 (346)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.26  E-value=8.5e-13  Score=119.28  Aligned_cols=63  Identities=33%  Similarity=0.712  Sum_probs=57.3

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC---ccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~~~  319 (328)
                      ..+||+.|+|||++.+.+|+.++|||||||++|||++|++||.+   .+..+++..|.++.+..++
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  244 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG  244 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS
T ss_pred             ccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc
Confidence            45799999999999998999999999999999999999999986   5688999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.26  E-value=1.8e-12  Score=117.47  Aligned_cols=63  Identities=54%  Similarity=1.154  Sum_probs=56.1

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+ ..++..|..+.+..+|.
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence            4579999999999999999999999999999999999999999865 57788888888876653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.25  E-value=2.9e-12  Score=112.23  Aligned_cols=64  Identities=91%  Similarity=1.615  Sum_probs=59.4

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+.+++.++|||||||++|+|++|+.||.+.+...+...+..+.+..+++
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP  229 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch
Confidence            3579999999999999999999999999999999999999999999999999999998876654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.24  E-value=4e-12  Score=112.63  Aligned_cols=62  Identities=55%  Similarity=1.125  Sum_probs=57.8

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ..||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+...++..|.++.+..++
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES  228 (304)
T ss_dssp             HHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT
T ss_pred             ccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            46999999999999999999999999999999999999999999999999999999886554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=2.3e-11  Score=110.48  Aligned_cols=135  Identities=18%  Similarity=0.314  Sum_probs=98.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEec--cCCCCHHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeC---CEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIIN--TKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEE---NYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~--~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~---~~~~lv~E~~~g   73 (328)
                      |.++.||++...  +..+++|+..  ..... .....+.+|+.+++.+.  +..+++++.++.+.   +..|+||||++|
T Consensus        49 G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G  125 (359)
T 3dxp_A           49 GQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSG  125 (359)
T ss_dssp             -CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCC
T ss_pred             cccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCC
Confidence            667889988653  4678888775  32211 12345778999999997  45688999988776   447999999999


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHS----------------------------------------------  107 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~----------------------------------------------  107 (328)
                      ..+.+..  ...++..+...++.++...|..||+                                              
T Consensus       126 ~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (359)
T 3dxp_A          126 RVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDW  203 (359)
T ss_dssp             BCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHH
T ss_pred             eecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHH
Confidence            8774321  2246788888899999999999997                                              


Q ss_pred             ------------CCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131         108 ------------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus       108 ------------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                                  ..++|+|++|.|||++.++. ..+.|+||+.+..
T Consensus       204 l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~  248 (359)
T 3dxp_A          204 LPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL  248 (359)
T ss_dssp             GGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred             HHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence                        35899999999999975432 3468999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.24  E-value=2.8e-12  Score=121.23  Aligned_cols=63  Identities=40%  Similarity=0.759  Sum_probs=57.6

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+...++..|..+.+..+.+
T Consensus       187 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred             cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            3569999999999987 69999999999999999999999999999999999999999876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.24  E-value=3.4e-12  Score=114.04  Aligned_cols=63  Identities=38%  Similarity=0.770  Sum_probs=58.3

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...++..+..+.+..++
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            456999999999999999999999999999999999999999999999999999998886654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.22  E-value=4.2e-12  Score=115.02  Aligned_cols=63  Identities=41%  Similarity=0.858  Sum_probs=52.7

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+ ...++..|..+.+..++
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS  272 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC
Confidence            3569999999999999999999999999999999999999998876 45588888888776544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.22  E-value=4.4e-12  Score=120.00  Aligned_cols=63  Identities=38%  Similarity=0.814  Sum_probs=57.2

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+...++..|..+.+..+.+
T Consensus       182 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP  244 (486)
T ss_dssp             CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred             CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            3569999999999987 59999999999999999999999999999999999999999865543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.21  E-value=6e-12  Score=119.33  Aligned_cols=63  Identities=38%  Similarity=0.825  Sum_probs=57.6

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+...++.+|..+.+..+++
T Consensus       197 ~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  259 (494)
T 3lij_A          197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP  259 (494)
T ss_dssp             CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG
T ss_pred             ccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence            457999999999987 469999999999999999999999999999999999999999876654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.21  E-value=6.8e-12  Score=112.46  Aligned_cols=64  Identities=36%  Similarity=0.692  Sum_probs=57.2

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+.+|+.++|||||||++|||+||+.||.+.+.......+.......++.
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  255 (327)
T 3lm5_A          192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE  255 (327)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence            3579999999999999999999999999999999999999999999999999988887765544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.21  E-value=3.6e-11  Score=110.87  Aligned_cols=79  Identities=25%  Similarity=0.577  Sum_probs=67.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+....+..|..... .....+..+|+++++||.+||+.||.+|+|++|+|+|||+.+.
T Consensus       329 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            445 89999999999999999999888888876532 2334566899999999999999999999999999999999764


Q ss_pred             c
Q psy2131         226 E  226 (328)
Q Consensus       226 ~  226 (328)
                      .
T Consensus       408 ~  408 (423)
T 4fie_A          408 G  408 (423)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.19  E-value=2e-11  Score=106.58  Aligned_cols=73  Identities=40%  Similarity=0.750  Sum_probs=66.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      +.| +||++|+|++|.+||.+.+...+...+..+.+.+|    ..+|+++++|+.+||+.||.+|||++|+++|||+.
T Consensus       194 DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          194 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence            344 89999999999999999999999999998877765    35899999999999999999999999999999984

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.19  E-value=9.6e-12  Score=112.03  Aligned_cols=64  Identities=36%  Similarity=0.573  Sum_probs=55.4

Q ss_pred             hccCCCCCCCcccccc--CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKK--EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+  ..|+.++|||||||++|||++|+.||.+.+.......+..+....+++
T Consensus       233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (345)
T 3hko_A          233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP  298 (345)
T ss_dssp             --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG
T ss_pred             ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc
Confidence            4569999999999976  688999999999999999999999999999888888888887755543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.18  E-value=1e-11  Score=108.35  Aligned_cols=63  Identities=40%  Similarity=0.802  Sum_probs=57.0

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+. ++.++|||||||++|||+||+.||.+.+...+...+..+.+..++.
T Consensus       167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK  229 (277)
T ss_dssp             CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence            45699999999999765 9999999999999999999999999999999999999998866653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.17  E-value=3.3e-11  Score=106.82  Aligned_cols=74  Identities=31%  Similarity=0.737  Sum_probs=66.2

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASE------ALKH  219 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~------~l~h  219 (328)
                      +.| +||++|+|++|.+||.+.+...++..|..+.+.+|.    .+|+++++||.+||+.||.+|+|++|      +++|
T Consensus       216 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H  291 (311)
T 4aw0_A          216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH  291 (311)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence            344 899999999999999999999999999998887763    68999999999999999999999998      4789


Q ss_pred             cccCC
Q psy2131         220 PWICQ  224 (328)
Q Consensus       220 ~~~~~  224 (328)
                      |||..
T Consensus       292 p~F~~  296 (311)
T 4aw0_A          292 PFFES  296 (311)
T ss_dssp             GGGTT
T ss_pred             CCcCC
Confidence            99864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.17  E-value=1e-11  Score=118.02  Aligned_cols=62  Identities=44%  Similarity=0.904  Sum_probs=56.9

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+...++..|..+.+..++
T Consensus       207 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          207 DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             cccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            4579999999999875 6999999999999999999999999999999999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.17  E-value=8.4e-12  Score=113.70  Aligned_cols=63  Identities=52%  Similarity=1.037  Sum_probs=56.1

Q ss_pred             hccCCCCCCCcccccc------CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKK------EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+      ..|+.++|||||||++|||+||+.||.+.+...+...|..+.+..++
T Consensus       258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            4579999999999964      36899999999999999999999999999999999999999886553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.15  E-value=3.9e-11  Score=108.06  Aligned_cols=76  Identities=24%  Similarity=0.435  Sum_probs=66.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+...+...+..+.+.   +.+..+|+++++||.+||+.||.+|||++|+++|||+.++
T Consensus       207 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            345 899999999999999999999998888877653   2345789999999999999999999999999999999653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.14  E-value=5.8e-11  Score=114.37  Aligned_cols=76  Identities=29%  Similarity=0.666  Sum_probs=72.5

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||++|+|++|.+||.+.+....+..|....+.++...+..+|+++++||.+||+.||.+|||++|+|+|||+...
T Consensus       342 lGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            8999999999999999999999999999999998888889999999999999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.12  E-value=1.2e-11  Score=109.95  Aligned_cols=63  Identities=43%  Similarity=0.832  Sum_probs=53.2

Q ss_pred             hccCCCCCCCcccccc-----CCCCCCcchhhhhhHHHHHHhcCCCCCCcc---------------HHHHHHHHhcccCC
Q psy2131         257 GFAGTPGYLSPEVLKK-----EPYGKPVDIWACGVILYILLVGYPPFWDED---------------QHRLYAQIKAGAYD  316 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~~---------------~~~~~~~i~~~~~~  316 (328)
                      ...||+.|+|||++.+     ..|+.++|||||||++|||+||++||.+.+               ...++..|..+.+.
T Consensus       180 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  259 (316)
T 2ac3_A          180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE  259 (316)
T ss_dssp             --CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC
T ss_pred             cccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc
Confidence            3569999999999976     568999999999999999999999998764               45688888888886


Q ss_pred             CCC
Q psy2131         317 DEP  319 (328)
Q Consensus       317 ~~~  319 (328)
                      .|+
T Consensus       260 ~~~  262 (316)
T 2ac3_A          260 FPD  262 (316)
T ss_dssp             CCH
T ss_pred             cCc
Confidence            654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.10  E-value=1.5e-10  Score=102.47  Aligned_cols=74  Identities=28%  Similarity=0.618  Sum_probs=66.1

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA-----SEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~-----~~~l~h~  220 (328)
                      +.| +||++|+|++|.+||.+.+..++...+..+.+.+|    ..+|+++++||.+||+.||.+|+|+     +|+++||
T Consensus       208 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp  283 (304)
T 3ubd_A          208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS  283 (304)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred             cccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence            344 89999999999999999999999999988877665    3689999999999999999999984     7999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       284 ~f~~  287 (304)
T 3ubd_A          284 FFST  287 (304)
T ss_dssp             GGTT
T ss_pred             cccC
Confidence            9965

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.10  E-value=3.4e-11  Score=108.74  Aligned_cols=60  Identities=30%  Similarity=0.339  Sum_probs=52.4

Q ss_pred             hccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         257 GFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                      ...||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+....+..|..+...
T Consensus       171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~  231 (346)
T 1ua2_A          171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  231 (346)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence            45799999999999764 5899999999999999999999999999988888888765443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.09  E-value=1.1e-10  Score=102.70  Aligned_cols=76  Identities=18%  Similarity=0.417  Sum_probs=59.7

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +.| +||++|+|++|.+||.+.+ ...+...+..+..  |.......++++++||.+||..||.+|||++|+++|||+.+
T Consensus       211 DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            344 8999999999999997654 4455555554432  22334567899999999999999999999999999999965

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.08  E-value=1.4e-10  Score=106.55  Aligned_cols=79  Identities=24%  Similarity=0.358  Sum_probs=63.6

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC---------------------------CcCCCCHHHHHH
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------------------------EWDTVTPEAKNL  198 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~s~~~~~l  198 (328)
                      +.| +||++|+|++|.+||.+.+....+..|......++..                           .+..+|+++.+|
T Consensus       245 DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  324 (398)
T 4b99_A          245 DLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSL  324 (398)
T ss_dssp             HHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHH
T ss_pred             heehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHH
Confidence            344 8999999999999999999888877775433322211                           123578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         199 INQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      |.+||+.||.+|+|++|+|+|||+.+.
T Consensus       325 l~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          325 LGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.06  E-value=7e-11  Score=104.06  Aligned_cols=64  Identities=44%  Similarity=0.922  Sum_probs=56.9

Q ss_pred             hccCCCCCCCccccc------cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLK------KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.      ...++.++|||||||++|||++|+.||.+.+...+...+..+.+..+++
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            356999999999985      4578999999999999999999999999999999999999998876543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=1.6e-10  Score=102.53  Aligned_cols=129  Identities=16%  Similarity=0.230  Sum_probs=91.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCC--cceeEEEEEeCC---EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN--IVRLHDSIQEEN---YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~n--Iv~l~~~~~~~~---~~~lv~E~~~gg   74 (328)
                      |..+.||++.     ..+++|+....    .....+.+|+.+|+.+. +..  +.+++......+   ..|+|||+++|.
T Consensus        31 G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           31 GNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             CSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             CCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            5666777652     46888886432    34567889999998883 333  445555543333   348999999998


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHS-----------------------------------------------  107 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~-----------------------------------------------  107 (328)
                      +|.+...  ..++..+...++.|+...|..||+                                               
T Consensus       102 ~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          102 PLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             ECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             ECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            8865433  346777788888888888888886                                               


Q ss_pred             -----------CCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131         108 -----------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus       108 -----------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                                 ..++|+|++|.|||++.+. ...+.|+||+.+..
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAI  223 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEE
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCcc
Confidence                       1369999999999997531 34578999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.06  E-value=2.4e-11  Score=112.77  Aligned_cols=64  Identities=48%  Similarity=0.884  Sum_probs=49.7

Q ss_pred             hccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+   ..|+.++|||||||++|||+||++||.+.. ...+...+..+.+..+|.
T Consensus       300 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~  367 (419)
T 3i6u_A          300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  367 (419)
T ss_dssp             -----CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred             ccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence            4579999999999864   678899999999999999999999998764 556777888888876553

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.06  E-value=4.9e-11  Score=104.66  Aligned_cols=61  Identities=39%  Similarity=0.842  Sum_probs=54.9

Q ss_pred             ccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ..||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+...+...+..+.+..+.
T Consensus       183 ~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T 2wei_A          183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL  243 (287)
T ss_dssp             HHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             ccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            3588999999999764 899999999999999999999999999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.03  E-value=9.7e-11  Score=102.73  Aligned_cols=60  Identities=32%  Similarity=0.535  Sum_probs=51.2

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                      ...||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+...+...+..+....
T Consensus       185 ~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          185 NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             --CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             CcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            456999999999986 468999999999999999999999999999888888877665443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.03  E-value=3e-11  Score=108.16  Aligned_cols=58  Identities=33%  Similarity=0.751  Sum_probs=46.6

Q ss_pred             hccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHH-HHHHHHhccc
Q psy2131         257 GFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGA  314 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~  314 (328)
                      ...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.+.. ..+..+....
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  225 (323)
T 3tki_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  225 (323)
T ss_dssp             SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred             CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence            4679999999999988876 78999999999999999999999876543 3333333333

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.02  E-value=5.1e-10  Score=101.67  Aligned_cols=38  Identities=45%  Similarity=0.825  Sum_probs=34.7

Q ss_pred             CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         187 EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       187 ~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .|..+|+++.||+.+||+.||.+|+|++|+|+||||.+
T Consensus       321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            35678999999999999999999999999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.01  E-value=6.5e-11  Score=105.67  Aligned_cols=62  Identities=50%  Similarity=0.912  Sum_probs=51.7

Q ss_pred             ccCCCCCCCccccc---cCCCCCCcchhhhhhHHHHHHhcCCCCCCcc-HHHHHHHHhcccCCCCC
Q psy2131         258 FAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       258 ~~Gt~~y~aPE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~  319 (328)
                      ..||+.|+|||++.   +..|+.++|||||||++|+|++|+.||.+.+ ...+...+..+.+...|
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             HHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             ccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            46999999999974   5678999999999999999999999998765 34666777778776554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.01  E-value=2e-11  Score=109.93  Aligned_cols=64  Identities=42%  Similarity=0.805  Sum_probs=27.4

Q ss_pred             hhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHH----HHHHhcccCCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDDEP  319 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~~~  319 (328)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+    ...+..+.+..++
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            345689999999999999999999999999999999999999988775554    4445555554443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.00  E-value=1.1e-10  Score=105.19  Aligned_cols=63  Identities=29%  Similarity=0.587  Sum_probs=55.7

Q ss_pred             hhccCCCCCCCccccccC-CCCC-CcchhhhhhHHHHHHhcCCCCCCccH-HHHHHHHhcccCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKKE-PYGK-PVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDDE  318 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~-~~~~-~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~~  318 (328)
                      ....||+.|+|||++.+. .|+. ++|||||||++|||++|+.||.+.+. ..++..+..+....|
T Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~  273 (348)
T 2pml_X          208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP  273 (348)
T ss_dssp             CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCC
T ss_pred             cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCc
Confidence            345799999999999987 6766 99999999999999999999999887 899999999877655

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=98.96  E-value=1.3e-10  Score=101.02  Aligned_cols=58  Identities=33%  Similarity=0.751  Sum_probs=46.5

Q ss_pred             hccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHH-HHHHHHhccc
Q psy2131         257 GFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGA  314 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~  314 (328)
                      ...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.+.. ..+..+....
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (276)
T 2yex_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  225 (276)
T ss_dssp             CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred             CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence            4569999999999998776 78999999999999999999999876532 3344444433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=98.88  E-value=4.8e-09  Score=93.97  Aligned_cols=72  Identities=33%  Similarity=0.597  Sum_probs=65.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|.+||.+.+...+...+..+.+..|.    ..|+++.+++.+||..||.+|||++++++|||+..
T Consensus       199 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          199 SLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence            3899999999999999999999999999888776664    57999999999999999999999999999999965

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=98.87  E-value=1.1e-09  Score=98.23  Aligned_cols=78  Identities=22%  Similarity=0.299  Sum_probs=63.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH---------
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA---------  216 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~---------  216 (328)
                      +.| +||++|+|++|.+||.+.+...+...+..+....+ ..+..+|++++++|.+||+.||.+|||+.|+         
T Consensus       238 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          238 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            445 89999999999999988877777777776654321 2345789999999999999999999999997         


Q ss_pred             ----hcCcccCCc
Q psy2131         217 ----LKHPWICQR  225 (328)
Q Consensus       217 ----l~h~~~~~~  225 (328)
                          ++|||+.+.
T Consensus       317 ~~~~l~hPw~~~~  329 (336)
T 4g3f_A          317 EVGGLKSPWKGEY  329 (336)
T ss_dssp             HTTSSCSCSSSSC
T ss_pred             hhhhccCCCcCCC
Confidence                579998654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=98.87  E-value=1.8e-09  Score=98.49  Aligned_cols=77  Identities=39%  Similarity=0.679  Sum_probs=70.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||.+.+.......+......++...+..+++++.+|+.+||..||.+|||+.++++|||+.+.
T Consensus       273 slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          273 SVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            38999999999999999999988888888888887777778899999999999999999999999999999999654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=98.84  E-value=6e-10  Score=97.78  Aligned_cols=46  Identities=41%  Similarity=0.941  Sum_probs=41.0

Q ss_pred             hccCCCCCCCccccccCC--CCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         257 GFAGTPGYLSPEVLKKEP--YGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~--~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ...||+.|+|||++.+..  ++.++|||||||++|||+||+.||.+.+
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            456999999999997754  8999999999999999999999998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=98.82  E-value=5.1e-09  Score=92.61  Aligned_cols=77  Identities=25%  Similarity=0.316  Sum_probs=59.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC-----------------------cCCCCHHHHHHHHHhccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-----------------------WDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~s~~~~~li~~~l~~  205 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+...                       ...+++++.+|+.+||+.
T Consensus       204 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  283 (308)
T 3g33_A          204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF  283 (308)
T ss_dssp             HHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence            389999999999999999888777766644222221111                       135788999999999999


Q ss_pred             CCCCCCCHHHHhcCcccCCc
Q psy2131         206 NPSKRITASEALKHPWICQR  225 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ||.+|||+.|+++|||+.+.
T Consensus       284 dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          284 NPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             STTTSCCHHHHHTSTTC---
T ss_pred             CCccCCCHHHHhcCccccCC
Confidence            99999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=98.82  E-value=8.3e-09  Score=90.40  Aligned_cols=76  Identities=24%  Similarity=0.301  Sum_probs=58.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-------------------------CCcCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+.                         .....+++++.+++.+||
T Consensus       186 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  265 (288)
T 1ob3_A          186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML  265 (288)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHc
Confidence            3899999999999999988776665554321111000                         012357899999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCC
Q psy2131         204 TVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ..||.+|||++++++|||+.+
T Consensus       266 ~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          266 KLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCCcccCCCHHHHhcCcchhh
Confidence            999999999999999999964

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=98.81  E-value=7.7e-09  Score=90.99  Aligned_cols=73  Identities=37%  Similarity=0.654  Sum_probs=63.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      .+|+++|+|++|..||.+.+.......+......++.  ...+++++.+++.+||..||.+|||+.|+++|||+.
T Consensus       225 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          225 AMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            3899999999999999998888887777776655543  457899999999999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=98.81  E-value=3.2e-09  Score=94.95  Aligned_cols=79  Identities=35%  Similarity=0.678  Sum_probs=66.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCc-------HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         149 WFGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .+|+++|+|++|.+||.+.+       .......+..+.+.++...+..+++++++|+.+||..||.+|||++++++|||
T Consensus       194 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             HHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             HHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence            38999999999999997643       35667778888877777777889999999999999999999999999999999


Q ss_pred             cCCccc
Q psy2131         222 ICQRER  227 (328)
Q Consensus       222 ~~~~~~  227 (328)
                      +.....
T Consensus       274 ~~~~~~  279 (325)
T 3kn6_A          274 LQDGSQ  279 (325)
T ss_dssp             GCTTCC
T ss_pred             hccCcc
Confidence            976543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=98.80  E-value=2.3e-09  Score=94.24  Aligned_cols=61  Identities=21%  Similarity=0.514  Sum_probs=46.5

Q ss_pred             hccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCC-CccHHHHHHHHhcccCCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ...||+.|+|||++.+. .++.++|||||||++|||++   ||. +.+...+...+..+....||.
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 1zy4_A          189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD  251 (303)
T ss_dssp             -----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTT
T ss_pred             cCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcc
Confidence            45699999999999875 68999999999999999998   665 446777888888877755543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=98.78  E-value=8e-09  Score=91.68  Aligned_cols=76  Identities=25%  Similarity=0.364  Sum_probs=57.2

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC--------------------------cCCCCHHHHHHHHHhc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------------------------WDTVTPEAKNLINQML  203 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~l  203 (328)
                      +|+++|+|++|.+||.+.+.......+.......+...                          ....++++.+|+.+||
T Consensus       206 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  285 (311)
T 3niz_A          206 IGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNML  285 (311)
T ss_dssp             HHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHc
Confidence            89999999999999987766555444432111111111                          1246789999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.||.+|||++|+++|||+.+.
T Consensus       286 ~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          286 CFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTS
T ss_pred             CCChhHCCCHHHHhcCcccccC
Confidence            9999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.77  E-value=4.7e-09  Score=96.68  Aligned_cols=78  Identities=44%  Similarity=0.957  Sum_probs=67.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH----HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|.+||.+.+..    .....+..+.+.++.+.+..+++++.+||.+||..||.+|||+.++++|||+.+
T Consensus       248 slG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             HHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            3899999999999999776532    245667788888888888999999999999999999999999999999999975


Q ss_pred             cc
Q psy2131         225 RE  226 (328)
Q Consensus       225 ~~  226 (328)
                      ..
T Consensus       328 ~~  329 (400)
T 1nxk_A          328 ST  329 (400)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=98.77  E-value=9e-09  Score=91.86  Aligned_cols=77  Identities=21%  Similarity=0.287  Sum_probs=60.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCC--------------------------cCCCCHHHHHHHHHh
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------------------------WDTVTPEAKNLINQM  202 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~  202 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+...                          ...+++++.+|+.+|
T Consensus       186 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  265 (324)
T 3mtl_A          186 GVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKL  265 (324)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHH
Confidence            389999999999999999887776665543222111111                          124688999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCCc
Q psy2131         203 LTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      |+.||.+|||++|+++|||+.+.
T Consensus       266 L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          266 LQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             SCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cCcCcccCCCHHHHhcChhhhhc
Confidence            99999999999999999999754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=98.76  E-value=9.6e-09  Score=92.62  Aligned_cols=76  Identities=22%  Similarity=0.387  Sum_probs=61.5

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCC----------------------------CCHHHHHHHHH
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT----------------------------VTPEAKNLINQ  201 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------~s~~~~~li~~  201 (328)
                      +|+++|+|++|.+||.+.+.......+.......+...+..                            .++++.+|+.+
T Consensus       215 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  294 (351)
T 3mi9_A          215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK  294 (351)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHH
Confidence            89999999999999999888777776655433333332222                            27789999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCCc
Q psy2131         202 MLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ||+.||.+|||++|+++|||+...
T Consensus       295 ~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          295 LLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             HhcCChhhCCCHHHHhCCCCcCCC
Confidence            999999999999999999999754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=98.76  E-value=1.1e-08  Score=99.03  Aligned_cols=74  Identities=27%  Similarity=0.540  Sum_probs=61.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHh
Q psy2131         147 QAW-FGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEAL  217 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l  217 (328)
                      ++| +||++|+|++|.+||.+.   +...+...+......+|    ..+|+++++||.+||+.||.+|++     ++|++
T Consensus       373 DiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            445 899999999999999764   34456666766666655    468999999999999999999998     79999


Q ss_pred             cCcccCC
Q psy2131         218 KHPWICQ  224 (328)
Q Consensus       218 ~h~~~~~  224 (328)
                      +||||..
T Consensus       449 ~HpfF~~  455 (689)
T 3v5w_A          449 ESPFFRS  455 (689)
T ss_dssp             TSGGGTT
T ss_pred             cCccccC
Confidence            9999964

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=98.76  E-value=1.3e-08  Score=91.05  Aligned_cols=77  Identities=25%  Similarity=0.359  Sum_probs=59.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCc--------------------------CCCCHHHHHHHHHh
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--------------------------DTVTPEAKNLINQM  202 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------------------------~~~s~~~~~li~~~  202 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+...+                          ..+++++.+|+.+|
T Consensus       223 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  302 (329)
T 3gbz_A          223 SIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAM  302 (329)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHH
Confidence            3899999999999999988877666655432111111111                          11678999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCCc
Q psy2131         203 LTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      |..||.+|||++|+++|||+.+.
T Consensus       303 L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          303 LEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             ccCChhhCCCHHHHhCCcccCCC
Confidence            99999999999999999999754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.75  E-value=2.1e-07  Score=82.46  Aligned_cols=131  Identities=18%  Similarity=0.208  Sum_probs=86.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCC---CcceeEEEEE-eCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP---NIVRLHDSIQ-EENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~---nIv~l~~~~~-~~~~~~lv~E~~~gg~L   76 (328)
                      |....||+.     |..+++|+-.    .......+.+|+.+|+.+.+.   .+.+.+.+.. ..+..|+|||+++|.++
T Consensus        30 G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           30 GFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             CSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             CcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            445577776     5678888853    223456788999999999753   3567776664 44567899999999888


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------------
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSN------------------------------------------------  108 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~------------------------------------------------  108 (328)
                      .+...  ..++..+...+..++...|..||+.                                                
T Consensus       101 ~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  178 (306)
T 3tdw_A          101 GEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS  178 (306)
T ss_dssp             HHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred             chhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence            65321  1234444445555555555555532                                                


Q ss_pred             ------------CCeeecCCCCcEEEeeCCCCCc-EEEeeccccccc
Q psy2131         109 ------------GVVHRDLKPENLLLASKAKGAA-VKLADFGLAIEV  142 (328)
Q Consensus       109 ------------~ivHrDiKp~NiLl~~~~~~~~-vkl~DfGla~~~  142 (328)
                                  .++|+|++|.|||++.++.++. +.|+||+.+..-
T Consensus       179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                        3599999999999975222233 589999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=98.74  E-value=3e-08  Score=87.36  Aligned_cols=80  Identities=19%  Similarity=0.342  Sum_probs=62.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                      .+|+++|+|++|..||.+.+.......+...... .......+++.+.+++.+||..||.+|||++++++|||+......
T Consensus       201 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence            3899999999999999888776655544433221 122335689999999999999999999999999999999765443


Q ss_pred             h
Q psy2131         229 A  229 (328)
Q Consensus       229 ~  229 (328)
                      .
T Consensus       280 ~  280 (297)
T 3fxz_A          280 S  280 (297)
T ss_dssp             G
T ss_pred             c
Confidence            3

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=98.73  E-value=1.4e-08  Score=90.30  Aligned_cols=77  Identities=22%  Similarity=0.361  Sum_probs=59.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC------------------------------CCcCCCCHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------------------------PEWDTVTPEAKNL  198 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~s~~~~~l  198 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+.                              ......++++.+|
T Consensus       194 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  273 (317)
T 2pmi_A          194 SCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDF  273 (317)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHH
Confidence            3899999999999999988877766655431111000                              0112578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         199 INQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.+||+.||.+|||++|+++|||+.+.
T Consensus       274 i~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          274 LHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHCCCCcccCCCHHHHhCChhhhcc
Confidence            999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=98.72  E-value=3.2e-08  Score=88.93  Aligned_cols=75  Identities=32%  Similarity=0.733  Sum_probs=66.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~  220 (328)
                      +.| +|+++|+|++|.+||.+.+...+...+......+|.    .+++++.+++.+||..||.+|+     +++++++||
T Consensus       187 DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             hcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence            344 899999999999999999988888888887776653    6899999999999999999999     999999999


Q ss_pred             ccCCc
Q psy2131         221 WICQR  225 (328)
Q Consensus       221 ~~~~~  225 (328)
                      |+...
T Consensus       263 ~f~~~  267 (337)
T 1o6l_A          263 FFLSI  267 (337)
T ss_dssp             GGTTC
T ss_pred             CcCCC
Confidence            99653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=98.72  E-value=1.9e-08  Score=90.96  Aligned_cols=75  Identities=29%  Similarity=0.631  Sum_probs=67.3

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA------SEALKH  219 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~------~~~l~h  219 (328)
                      +.| +|+++|+|++|.+||.+.+...+...+..+...+|.    .+++++.+++.+||..||.+|+++      +++++|
T Consensus       206 DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            444 899999999999999999999999999988777763    589999999999999999999998      899999


Q ss_pred             cccCCc
Q psy2131         220 PWICQR  225 (328)
Q Consensus       220 ~~~~~~  225 (328)
                      ||+...
T Consensus       282 p~f~~~  287 (353)
T 3txo_A          282 PFFKEI  287 (353)
T ss_dssp             GGGTTC
T ss_pred             CcccCC
Confidence            999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=98.72  E-value=1.1e-08  Score=89.10  Aligned_cols=73  Identities=40%  Similarity=0.722  Sum_probs=64.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||...+.......+......+|    ...++++.+++.+||..||.+|||+.++++|||+...
T Consensus       192 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          192 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence            489999999999999999988888888877766555    3578999999999999999999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.72  E-value=2.1e-09  Score=95.23  Aligned_cols=47  Identities=32%  Similarity=0.730  Sum_probs=40.9

Q ss_pred             hhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         256 QGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..
T Consensus       196 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  243 (312)
T 2iwi_A          196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ  243 (312)
T ss_dssp             CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence            34569999999999988777 458999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=98.72  E-value=6.7e-09  Score=95.10  Aligned_cols=74  Identities=35%  Similarity=0.559  Sum_probs=59.0

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-------------------------------------------
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------------------------------------  186 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------------------------  186 (328)
                      +|+++|+|++|.+||.+.+.......+.... ..|..                                           
T Consensus       217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (388)
T 3oz6_A          217 LGCILGEILCGKPIFPGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI  295 (388)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccc
Confidence            8999999999999999988777666654211 11110                                           


Q ss_pred             -CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         187 -EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       187 -~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                       .....++++.+|+.+||+.||.+|||++|+++|||+..
T Consensus       296 ~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             CTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred             cccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence             11267899999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.70  E-value=9.6e-09  Score=89.53  Aligned_cols=76  Identities=34%  Similarity=0.646  Sum_probs=67.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||.+.+.......+......++...+...++.+.+++.+||..||.+|||+.++++|||+..
T Consensus       196 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          196 SIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            3899999999999999999888888888877776665556678999999999999999999999999999999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=98.70  E-value=4e-08  Score=87.52  Aligned_cols=74  Identities=28%  Similarity=0.774  Sum_probs=66.1

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~  220 (328)
                      +.| +|+++|+|++|.+||.+.+.......+......+|.    .+++++.+++.+||..||.+|+     +++++++||
T Consensus       185 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp  260 (318)
T 1fot_A          185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  260 (318)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence            444 899999999999999999988888888887776653    5799999999999999999999     999999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       261 ~f~~  264 (318)
T 1fot_A          261 WFKE  264 (318)
T ss_dssp             GGSS
T ss_pred             cccC
Confidence            9975

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=98.69  E-value=4e-08  Score=86.29  Aligned_cols=77  Identities=23%  Similarity=0.321  Sum_probs=59.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----------------CCC---------cCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----------------SPE---------WDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~----------------~~~---------~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|..||.+.+..+....+.......+                .+.         ...+++++.+++.+||
T Consensus       189 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  268 (299)
T 2r3i_A          189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML  268 (299)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCchhhhhHhhcCcccchhhhcccchhhHhhCCCCCHHHHHHHHHhc
Confidence            389999999999999998887666555443211110                011         1347899999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..||.+|||+.++++|||+.+.
T Consensus       269 ~~dP~~Rpt~~~~l~hp~~~~~  290 (299)
T 2r3i_A          269 HYDPNKRISAKAALAHPFFQDV  290 (299)
T ss_dssp             CSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CcCcccCCCHHHHhcChhhhcC
Confidence            9999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.69  E-value=1.3e-08  Score=92.98  Aligned_cols=76  Identities=26%  Similarity=0.288  Sum_probs=55.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC-----------------------------------CCCcCC---
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-----------------------------------SPEWDT---  190 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------------------~~~~~~---  190 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+                                   .+....   
T Consensus       243 SlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  322 (382)
T 2vx3_A          243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHN  322 (382)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHH
Confidence            389999999999999998887766655543211100                                   000000   


Q ss_pred             ----------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         191 ----------------------VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       191 ----------------------~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                                            .++++.+|+.+||+.||.+|||++|+++|||+.+
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~  378 (382)
T 2vx3_A          323 ILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK  378 (382)
T ss_dssp             HHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC
T ss_pred             HhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccccc
Confidence                                  0137899999999999999999999999999965

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.68  E-value=1.2e-08  Score=94.83  Aligned_cols=77  Identities=32%  Similarity=0.454  Sum_probs=56.3

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC--------------------CC------------------------
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--------------------PS------------------------  185 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~--------------------~~------------------------  185 (328)
                      +|+++|+|++|.+||.+.+.......+.......                    |.                        
T Consensus       285 lG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (429)
T 3kvw_A          285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL  364 (429)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCE
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhc
Confidence            8999999999999999888766655443210000                    00                        


Q ss_pred             ------CC-----cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         186 ------PE-----WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       186 ------~~-----~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                            ..     ....++++.+|+.+||+.||.+|||++|+++|||+.+..
T Consensus       365 ~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             ECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             cCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                  00     012378899999999999999999999999999997653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.68  E-value=2.5e-08  Score=86.48  Aligned_cols=72  Identities=38%  Similarity=0.640  Sum_probs=63.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++++|++|..||...+.......+..+....|    ..+++++.+++.+||..||.+|||+.++++|||+.+
T Consensus       196 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          196 SCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence            489999999999999999888888888877765544    357899999999999999999999999999999854

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=98.68  E-value=4.4e-08  Score=87.13  Aligned_cols=76  Identities=22%  Similarity=0.330  Sum_probs=62.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+|+++|+|++|..||.+.+.......+.....  +......+++.+.+++.+||..||.+|||+.++++|||+.+..
T Consensus       219 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          219 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            389999999999999988877766665554432  2223456899999999999999999999999999999997643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=98.68  E-value=1.8e-08  Score=93.03  Aligned_cols=79  Identities=30%  Similarity=0.491  Sum_probs=67.3

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK--RITASEALKHPWIC  223 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~t~~~~l~h~~~~  223 (328)
                      ++| +|+++|+|++|.+||.+.+....+..+.........+.+..+|+++++||.+||..+|.+  |++++|+++|||+.
T Consensus       255 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          255 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             eEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            344 899999999999999999998888888765444444555679999999999999999988  99999999999997


Q ss_pred             Cc
Q psy2131         224 QR  225 (328)
Q Consensus       224 ~~  225 (328)
                      ..
T Consensus       335 ~~  336 (410)
T 3v8s_A          335 ND  336 (410)
T ss_dssp             CS
T ss_pred             CC
Confidence            53

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=98.66  E-value=5.7e-08  Score=87.74  Aligned_cols=71  Identities=30%  Similarity=0.754  Sum_probs=65.0

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l~h~~~~~  224 (328)
                      +|+++|+|++|.+||.+.+.......+..+...+|.    .+++++.+++.+||..||.+|++     ++++++|||+..
T Consensus       224 lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             ccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            899999999999999999999999999888776653    58999999999999999999998     999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=98.66  E-value=7.6e-08  Score=85.73  Aligned_cols=77  Identities=22%  Similarity=0.486  Sum_probs=63.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+|+++|+|++|..||...+.......+....... ......+++++.+++.+||..||.+|||+.++++|||+.+..
T Consensus       226 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            38999999999999999888877777666543221 123346789999999999999999999999999999997643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=98.65  E-value=6.4e-08  Score=90.32  Aligned_cols=73  Identities=30%  Similarity=0.668  Sum_probs=65.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHPWIC  223 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~~~~  223 (328)
                      .+|+++|+|++|.+||.+.+.......+......+|.    .+++++.+|+.+||..||.+||     +++++++|||+.
T Consensus       334 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             hhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence            3899999999999999999999998888888776653    5799999999999999999999     999999999997


Q ss_pred             Cc
Q psy2131         224 QR  225 (328)
Q Consensus       224 ~~  225 (328)
                      ..
T Consensus       410 ~~  411 (446)
T 4ejn_A          410 GI  411 (446)
T ss_dssp             TC
T ss_pred             CC
Confidence            53

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=98.65  E-value=2.9e-08  Score=89.49  Aligned_cols=72  Identities=32%  Similarity=0.635  Sum_probs=65.1

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCCc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS-EALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~-~~l~h~~~~~~  225 (328)
                      +|+++|+|++|.+||.+.+...+...+......+|    ..+++++++++.+||..||.+||++. ++++|||+..-
T Consensus       204 lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          204 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            89999999999999999999999988888776655    35899999999999999999999998 99999999753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=98.65  E-value=4.6e-08  Score=86.13  Aligned_cols=73  Identities=29%  Similarity=0.593  Sum_probs=64.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||.+.+.......+..+....+    ...++++.+++.+||..||.+|||++++++|||+...
T Consensus       198 slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          198 SAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            389999999999999999988888888887766544    3678999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=98.65  E-value=2.4e-08  Score=92.01  Aligned_cols=77  Identities=25%  Similarity=0.396  Sum_probs=54.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH---------HHHHHHHhCCCCCCCCCcC------------------------------
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH---------RLYAQIKAGAYDYPSPEWD------------------------------  189 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~------------------------------  189 (328)
                      .+|+++|+|++|.+||.+.+..         .....+.......+...|.                              
T Consensus       221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (405)
T 3rgf_A          221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME  300 (405)
T ss_dssp             HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence            3899999999999999765431         2233332211111111121                              


Q ss_pred             ----CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         190 ----TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       190 ----~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                          ..++++.+||.+||..||.+|||++|+++|||+.+.
T Consensus       301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence                127789999999999999999999999999999764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=98.64  E-value=1.7e-08  Score=94.80  Aligned_cols=78  Identities=23%  Similarity=0.413  Sum_probs=57.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC----------------------CCCCcC--------------
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----------------------PSPEWD--------------  189 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~----------------------~~~~~~--------------  189 (328)
                      +.| +|+++|+|++|.+||.+.+.......+.......                      ....+.              
T Consensus       245 DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (464)
T 3ttj_A          245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH  324 (464)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccc
Confidence            444 8999999999999999988766665553321110                      000000              


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         190 --TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       190 --~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                        ..++++.+|+.+||..||.+|||++|+++|||+..
T Consensus       325 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             ccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence              01567899999999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.64  E-value=3.8e-08  Score=89.44  Aligned_cols=76  Identities=26%  Similarity=0.365  Sum_probs=59.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC-----------------------CC----CCcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-----------------------PS----PEWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~----~~~~~~s~~~~~li~~  201 (328)
                      .+|+++++|++|.+||.+.+.......+.......                       +.    ..+...++++.+|+.+
T Consensus       211 slG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  290 (367)
T 1cm8_A          211 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK  290 (367)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence            38999999999999999888766655543321111                       11    1124578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCC
Q psy2131         202 MLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ||..||.+|||+.++++|||+.+
T Consensus       291 mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          291 MLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HccCChhHCCCHHHHhcChHHHh
Confidence            99999999999999999999965

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=98.64  E-value=6.4e-08  Score=87.55  Aligned_cols=74  Identities=31%  Similarity=0.632  Sum_probs=65.9

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l~h~  220 (328)
                      +.| +|+++|+|++|.+||.+.+...+...+......+|.    .+++++.+++.+||..||.+|++     +.++++||
T Consensus       203 DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~  278 (353)
T 2i0e_A          203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  278 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred             cccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence            344 899999999999999999999999999888777663    68999999999999999999994     69999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       279 ~f~~  282 (353)
T 2i0e_A          279 FFRY  282 (353)
T ss_dssp             GGTT
T ss_pred             cccC
Confidence            9964

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=98.64  E-value=4.1e-08  Score=92.38  Aligned_cols=72  Identities=38%  Similarity=0.630  Sum_probs=64.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|.+||.+.+...+...+..+.+..|    ..+++++.+++.+||..||.+|||+.++++|||+.+
T Consensus       201 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             hhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            389999999999999999888888888888766554    357899999999999999999999999999999865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=98.63  E-value=4.2e-08  Score=85.99  Aligned_cols=76  Identities=25%  Similarity=0.319  Sum_probs=55.2

Q ss_pred             hHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhCCCCCCC-------------------------CCcCCCCHHHHHHHHHh
Q psy2131         149 WFGVILYILLVGYPP-FWDEDQHRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKNLINQM  202 (328)
Q Consensus       149 ~~G~~~~~~~~g~~p-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~  202 (328)
                      .+|+++|+|++|..| |.+.+.......+.......+.                         ......++++++|+.+|
T Consensus       187 slG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  266 (292)
T 3o0g_A          187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL  266 (292)
T ss_dssp             HHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHH
Confidence            389999999987776 5555555555554331111110                         11235789999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCC
Q psy2131         203 LTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      |+.||.+|||++|+++|||+.+
T Consensus       267 L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          267 LKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccChhhCCCHHHHhcCccccc
Confidence            9999999999999999999964

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=98.62  E-value=6e-08  Score=86.23  Aligned_cols=78  Identities=27%  Similarity=0.301  Sum_probs=60.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC-----C------------------CCCcCCCCHHHHHHHHHhccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-----P------------------SPEWDTVTPEAKNLINQMLTV  205 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~-----~------------------~~~~~~~s~~~~~li~~~l~~  205 (328)
                      .+|+++|+|++|.+||.+.+.......+.......     +                  ......+++.+.+++.+||..
T Consensus       204 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  283 (326)
T 1blx_A          204 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF  283 (326)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCC
Confidence            38999999999999999888776665554311000     0                  011245789999999999999


Q ss_pred             CCCCCCCHHHHhcCcccCCcc
Q psy2131         206 NPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       206 ~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ||.+|||+.++++|||+.+..
T Consensus       284 dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          284 NPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             STTTSCCHHHHHTSGGGTTCC
T ss_pred             CcccCCCHHHHhcCccccccc
Confidence            999999999999999997654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=98.62  E-value=5.4e-08  Score=84.85  Aligned_cols=72  Identities=28%  Similarity=0.586  Sum_probs=63.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||...+.......+......+|    ..+++++.+++.+||..||.+|||++++++|||+..
T Consensus       197 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence            389999999999999998888888777777665554    357899999999999999999999999999999854

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=98.60  E-value=2.5e-08  Score=90.44  Aligned_cols=77  Identities=30%  Similarity=0.393  Sum_probs=58.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC--------------------CCCC-------CcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------------------YPSP-------EWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~--------------------~~~~-------~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|.+||.+.+.......+......                    .+..       .....++++.+|+.+
T Consensus       217 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  296 (364)
T 3qyz_A          217 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK  296 (364)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH
Confidence            3899999999999999887765555444321110                    0100       113578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCCc
Q psy2131         202 MLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ||..||.+|||+.|+++|||+.+.
T Consensus       297 ~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          297 MLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HcCCChhhCCCHHHHhcCcchhhc
Confidence            999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.60  E-value=3.7e-08  Score=90.41  Aligned_cols=77  Identities=30%  Similarity=0.394  Sum_probs=59.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-----------------CCCCCC--------CcCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGA-----------------YDYPSP--------EWDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~-----------------~~~~~~--------~~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|.+||.+.+.......+....                 ..++..        .....++++.+|+.+||
T Consensus       227 SlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (394)
T 4e7w_A          227 STGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLL  306 (394)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHh
Confidence            38999999999999999888766555443210                 111110        12247899999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.||.+|||+.+++.|||+.+.
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          307 EYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSTT
T ss_pred             CCChhhCCCHHHHhcChhhhhh
Confidence            9999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=98.60  E-value=9e-08  Score=85.51  Aligned_cols=72  Identities=29%  Similarity=0.582  Sum_probs=64.3

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~~~~~  224 (328)
                      +|+++|+|++|.+||.+.+.......+......+|    ..+++++++++.+||..||.+||     ++.++++|||+..
T Consensus       207 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          207 LGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            89999999999999999988888888887766655    35799999999999999999999     8899999999965


Q ss_pred             c
Q psy2131         225 R  225 (328)
Q Consensus       225 ~  225 (328)
                      .
T Consensus       283 ~  283 (327)
T 3a62_A          283 I  283 (327)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=98.59  E-value=1.8e-07  Score=82.64  Aligned_cols=78  Identities=22%  Similarity=0.403  Sum_probs=59.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------------CCCCCC--------CcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------------------YDYPSP--------EWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~-------------------~~~~~~--------~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|.+||.+.+.......+....                   ...+.+        ....+++++.+++.+
T Consensus       188 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  267 (311)
T 4agu_A          188 AIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKG  267 (311)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHH
Confidence            38999999999999998887766554443211                   111111        124678899999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         202 MLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      ||..||.+|||++++++|||+.+..
T Consensus       268 ~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          268 CLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             HCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HccCChhhcCCHHHHhcChHHHhcc
Confidence            9999999999999999999997654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=98.59  E-value=3.4e-08  Score=90.39  Aligned_cols=76  Identities=26%  Similarity=0.354  Sum_probs=53.1

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC------------------------------------------CCCCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------------------------------------------YPSPE  187 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~  187 (328)
                      +|+++|+|++|.+||.+.+.......+..+...                                          ...+.
T Consensus       223 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (389)
T 3gni_B          223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY  302 (389)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence            899999999999999876543333222111100                                          01112


Q ss_pred             cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         188 WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       188 ~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...+++++.+|+.+||+.||.+|||++|+++|||+.+.
T Consensus       303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence            34578999999999999999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=98.58  E-value=1.1e-07  Score=86.20  Aligned_cols=74  Identities=31%  Similarity=0.605  Sum_probs=57.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH----HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|.+||.+.+.    ......+....+.+|  ....+++++.+|+.+||..||.+|||+.++++|||+..
T Consensus       203 slG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          203 SCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             hhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            389999999999999977543    344455555544443  34468999999999999999999999999999999854

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=98.57  E-value=3.5e-08  Score=85.74  Aligned_cols=74  Identities=32%  Similarity=0.644  Sum_probs=55.1

Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.+|+++|+|++|.+||...+.......+....+..|    ..+++++.+++.+||..||.+|||++++++|||+.+.
T Consensus       196 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            3489999999999999987655444433333322222    3578999999999999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.57  E-value=1.7e-07  Score=82.32  Aligned_cols=77  Identities=19%  Similarity=0.274  Sum_probs=62.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+|+++|+|++|.+||...+.......+....... ......++.++.+++.+||..||.+|||+.++++|||+....
T Consensus       207 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          207 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            38999999999999999888777766665543321 122356789999999999999999999999999999997644

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=98.57  E-value=8.1e-08  Score=84.00  Aligned_cols=74  Identities=19%  Similarity=0.394  Sum_probs=57.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||..... ......+..+..  +.......++++.+++.+||..||.+|||++++++|||+.+
T Consensus       214 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          214 AFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            389999999999999987544 344444443322  22233456789999999999999999999999999999965

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.57  E-value=3.9e-08  Score=89.43  Aligned_cols=76  Identities=30%  Similarity=0.371  Sum_probs=58.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-----------------------CCCCC----CcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-----------------------DYPSP----EWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~~----~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|.+||.+.+.......+.....                       ..+..    .+...++++.+|+.+
T Consensus       215 slG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~  294 (367)
T 2fst_X          215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK  294 (367)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence            389999999999999998887665555432111                       11111    123568999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCC
Q psy2131         202 MLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ||..||.+|||+.+++.|||+.+
T Consensus       295 mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          295 MLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hCCCCcccCcCHHHHhcChhhhh
Confidence            99999999999999999999965

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.56  E-value=5.7e-08  Score=88.38  Aligned_cols=76  Identities=29%  Similarity=0.411  Sum_probs=58.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCC-----------------------CCCC----CcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----------------------YPSP----EWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~-----------------------~~~~----~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|.+||.+.+.......+......                       .+..    .+...++++.+|+.+
T Consensus       227 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  306 (371)
T 4exu_A          227 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK  306 (371)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHH
Confidence            3899999999999999988776665554321110                       0111    123578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCC
Q psy2131         202 MLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ||+.||.+|||++|+++|||+..
T Consensus       307 ~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          307 MLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             HSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HCCCChhhcCCHHHHhcCccccc
Confidence            99999999999999999999964

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=1.2e-06  Score=75.65  Aligned_cols=126  Identities=16%  Similarity=0.156  Sum_probs=87.8

Q ss_pred             EEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHHHHHhc
Q psy2131           5 VVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFEDIVAR   83 (328)
Q Consensus         5 ~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~   83 (328)
                      .||+......+..+.+|+-...     ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|.++.+.....
T Consensus        40 ~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~  114 (272)
T 4gkh_A           40 TIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY  114 (272)
T ss_dssp             EEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC
T ss_pred             eEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC
Confidence            6898877777788999986532     3456788999998884 334678899999999999999999998775543221


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------C----
Q psy2131          84 EFYSEADASHCIQQILESVNHCHS---------------------------------------------------N----  108 (328)
Q Consensus        84 ~~~~~~~~~~~~~qll~~L~ylH~---------------------------------------------------~----  108 (328)
                          ..+...+..++...|.-||+                                                   .    
T Consensus       115 ----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  190 (272)
T 4gkh_A          115 ----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFS  190 (272)
T ss_dssp             ----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCC
T ss_pred             ----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccccc
Confidence                11222334444444444442                                                   1    


Q ss_pred             ---CCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131         109 ---GVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus       109 ---~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                         .++|+|+.|.|||++.   ++.+-|+||+.+..-
T Consensus       191 ~~~~l~HGDl~~~Nil~~~---~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          191 PDSVVTHGDFSLDNLIFDE---GKLIGCIDVGRVGIA  224 (272)
T ss_dssp             CCEEEECSCCCTTSEEEET---TEEEEECCCTTCEEE
T ss_pred             CCcEEEcCCCCCCeEEEEC---CeEEEEEECcccccC
Confidence               2799999999999963   234569999987543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=98.56  E-value=2.6e-08  Score=90.01  Aligned_cols=75  Identities=21%  Similarity=0.337  Sum_probs=57.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC---------------------Cc-------------------
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------------------EW-------------------  188 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~-------------------  188 (328)
                      .+|+++|+|++|.+||...+.......+.......|..                     .|                   
T Consensus       244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  323 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL  323 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence            38999999999999999888777666555433322210                     00                   


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         189 --DTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       189 --~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                        ...++.+.+|+.+||+.||.+|||++|+++|||+.
T Consensus       324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence              01247788999999999999999999999999983

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=98.56  E-value=1.3e-07  Score=87.44  Aligned_cols=76  Identities=26%  Similarity=0.410  Sum_probs=58.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHh-----------------CCCCCCCCC--------cCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKA-----------------GAYDYPSPE--------WDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~-----------------~~~~~~~~~--------~~~~s~~~~~li~~~l  203 (328)
                      .+||++|+|++|.+||.+.+.......+..                 ..+.+|...        ....++++.+|+.+||
T Consensus       242 SlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L  321 (420)
T 1j1b_A          242 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL  321 (420)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhc
Confidence            389999999999999998876655544332                 111222110        1346899999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCC
Q psy2131         204 TVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ..||.+|||+.|+++|||+..
T Consensus       322 ~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          322 EYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             CSSGGGSCCHHHHHTSGGGGG
T ss_pred             cCChhHCCCHHHHhCCHhhcc
Confidence            999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=98.55  E-value=1.4e-07  Score=86.49  Aligned_cols=75  Identities=25%  Similarity=0.396  Sum_probs=58.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|.+||.... .......+.......+.+  ...++++.+++.+||..||.+|||+.++++|||+...
T Consensus       252 SlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            38999999999999997753 334445555444433333  2357899999999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=98.55  E-value=7.4e-08  Score=86.92  Aligned_cols=77  Identities=23%  Similarity=0.266  Sum_probs=58.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC----------------------------CCCcCCCCHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----------------------------SPEWDTVTPEAKNLIN  200 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~s~~~~~li~  200 (328)
                      .+|+++|+|++|.+||.+.+.......+.......+                            .......++++.+|+.
T Consensus       217 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  296 (360)
T 3e3p_A          217 SVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS  296 (360)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHH
Confidence            389999999999999999887766655543111000                            0011225678999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||+.||.+|||+.|+++|||+.+.
T Consensus       297 ~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          297 ALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHhccCccccCCHHHHhcCcccccc
Confidence            9999999999999999999999754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=98.55  E-value=1e-08  Score=92.16  Aligned_cols=72  Identities=36%  Similarity=0.697  Sum_probs=56.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||.+.....+...+..+.+..|    ..+|+++.+++.+||..||.+|||++|+++|||+..
T Consensus       193 slG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            389999999999999977654443333333333222    357999999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=98.54  E-value=1.4e-07  Score=92.48  Aligned_cols=71  Identities=31%  Similarity=0.607  Sum_probs=66.0

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA-----SEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~-----~~~l~h~~~~~  224 (328)
                      +|+++|+|++|.+||.+.+...++..|......+|.    .+++++.+||.+||+.||.+|+++     +++++||||..
T Consensus       528 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          528 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             hHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            899999999999999999999999999988877764    689999999999999999999997     99999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.54  E-value=2.8e-07  Score=83.06  Aligned_cols=76  Identities=29%  Similarity=0.441  Sum_probs=58.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-----------------------CCCC----CCCcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGA-----------------------YDYP----SPEWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~-----------------------~~~~----~~~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|..||.+.+.......+....                       ...+    .......++++.+++.+
T Consensus       209 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  288 (353)
T 3coi_A          209 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK  288 (353)
T ss_dssp             HHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH
Confidence            38999999999999998887665554443210                       0001    11234678999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCC
Q psy2131         202 MLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ||..||.+|||++++++|||+..
T Consensus       289 ~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          289 MLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             HSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HcCCCcccCCCHHHHhcCcchhh
Confidence            99999999999999999999964

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=98.54  E-value=1.5e-07  Score=83.25  Aligned_cols=71  Identities=18%  Similarity=0.303  Sum_probs=54.5

Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC--CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--SPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+||++|+|++|.+||.+.+.......+.......|  ...+..+++++.+++.+||+.||.+|||+++++.
T Consensus       221 wS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          221 YSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            3489999999999999988765544444443333333  2334578999999999999999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=98.53  E-value=1.9e-07  Score=84.17  Aligned_cols=71  Identities=20%  Similarity=0.486  Sum_probs=58.8

Q ss_pred             HHHHHHHHHhCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH------H
Q psy2131         150 FGVILYILLVGYPPFWD---------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA------S  214 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~------~  214 (328)
                      +|+++|+|++|.+||..         .....+...+......+|    ..+++++++++.+||..||.+|+++      +
T Consensus       196 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~  271 (345)
T 3a8x_A          196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFA  271 (345)
T ss_dssp             HHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHH
T ss_pred             HHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHH
Confidence            89999999999999965         233455666777666655    3589999999999999999999996      8


Q ss_pred             HHhcCcccCC
Q psy2131         215 EALKHPWICQ  224 (328)
Q Consensus       215 ~~l~h~~~~~  224 (328)
                      ++++|||+..
T Consensus       272 ~i~~hp~f~~  281 (345)
T 3a8x_A          272 DIQGHPFFRN  281 (345)
T ss_dssp             HHHTSGGGTT
T ss_pred             HHhcCCccCC
Confidence            9999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=98.53  E-value=2.5e-07  Score=83.44  Aligned_cols=76  Identities=18%  Similarity=0.280  Sum_probs=61.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+|+++|+|++|.+||.+.+.......+.....  +......+++.+.+++.+||..||.+|||++++++|||+....
T Consensus       238 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          238 SLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            389999999999999998887666655554432  2223356899999999999999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=98.53  E-value=1.9e-07  Score=82.13  Aligned_cols=76  Identities=24%  Similarity=0.278  Sum_probs=62.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                      .+|+++|+|++|.+||...+.......+.....   ......+++.+.+++.+||..||.+|||+.++++|||+.....
T Consensus       204 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          204 SLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            389999999999999998887777666655432   2223468999999999999999999999999999999965443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=98.52  E-value=4.3e-08  Score=89.16  Aligned_cols=78  Identities=27%  Similarity=0.473  Sum_probs=57.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-----------------CCcC-------------------
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-----------------PEWD-------------------  189 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------------~~~~-------------------  189 (328)
                      +.| +|+++|+|++|.+||.+.+.......+.........                 +...                   
T Consensus       208 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (371)
T 2xrw_A          208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH  287 (371)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccc
Confidence            444 899999999999999998877766665443221100                 0000                   


Q ss_pred             --CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         190 --TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       190 --~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                        ..++++++|+.+||..||.+|||++++++|||+..
T Consensus       288 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence              01567899999999999999999999999999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=98.52  E-value=2.4e-07  Score=80.37  Aligned_cols=75  Identities=27%  Similarity=0.384  Sum_probs=63.8

Q ss_pred             chHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         148 AWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.+|+++|+|++|..||...+.......+..+....   ....+++++.+++.+||..||.+|||+.++++|+|+.+.
T Consensus       200 ~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          200 WSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             HHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            348999999999999999988888887777765432   123678999999999999999999999999999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.52  E-value=1.5e-07  Score=84.69  Aligned_cols=76  Identities=34%  Similarity=0.492  Sum_probs=57.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC------------------------CCCCC----CcCCCCHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------------------------DYPSP----EWDTVTPEAKNLIN  200 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~------------------------~~~~~----~~~~~s~~~~~li~  200 (328)
                      .+|+++|+|++|.+||.+.+.......+.....                        .++..    .+..+++++.+++.
T Consensus       208 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  287 (353)
T 2b9h_A          208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ  287 (353)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHH
Confidence            389999999999999998876555444322100                        01111    12467899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCC
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +||..||.+|||++++++|||+..
T Consensus       288 ~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          288 RMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HhcCcCcccCCCHHHHhcCccccc
Confidence            999999999999999999999965

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=98.52  E-value=6.9e-08  Score=86.72  Aligned_cols=77  Identities=26%  Similarity=0.433  Sum_probs=56.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC----------------Cc------------------------
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----------------EW------------------------  188 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------------~~------------------------  188 (328)
                      .+|+++|+|++|.+||...+.......+.......|..                .|                        
T Consensus       224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (355)
T 2eu9_A          224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD  303 (355)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence            38999999999999998887665554443322111110                00                        


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         189 DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       189 ~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...++++.+|+.+||..||.+|||+.++++|||+...
T Consensus       304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             chhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence            1123578899999999999999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=98.51  E-value=1.8e-07  Score=85.21  Aligned_cols=71  Identities=27%  Similarity=0.557  Sum_probs=64.2

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA----SEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~----~~~l~h~~~~~  224 (328)
                      +|+++|+|++|.+||.+.+...++..+......++    ..+++++++++.+||+.||.+|+++    .++++|||+..
T Consensus       225 lG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            89999999999999999999999999888776655    3689999999999999999999987    69999999965

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=98.51  E-value=1.2e-07  Score=83.12  Aligned_cols=72  Identities=36%  Similarity=0.628  Sum_probs=63.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||...........+.......|    ..+++.+.+++.+||..||.+|||++++++|||+.+
T Consensus       200 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence            389999999999999999888887777777665544    367899999999999999999999999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=98.51  E-value=2.1e-07  Score=85.44  Aligned_cols=74  Identities=20%  Similarity=0.506  Sum_probs=60.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCC---------cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH---
Q psy2131         147 QAW-FGVILYILLVGYPPFWDE---------DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA---  213 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~---  213 (328)
                      ++| +|+++|+|++|.+||...         ....+...+......+|.    .+|+++++|+.+||+.||.+|+++   
T Consensus       235 DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~  310 (396)
T 4dc2_A          235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQ  310 (396)
T ss_dssp             HHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTT
T ss_pred             HHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCC
Confidence            344 899999999999999532         234466677777666653    589999999999999999999985   


Q ss_pred             ---HHHhcCcccCC
Q psy2131         214 ---SEALKHPWICQ  224 (328)
Q Consensus       214 ---~~~l~h~~~~~  224 (328)
                         +++++|||+..
T Consensus       311 ~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          311 TGFADIQGHPFFRN  324 (396)
T ss_dssp             THHHHHHHSTTTTT
T ss_pred             CCHHHHhcCccccC
Confidence               79999999965

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.51  E-value=2.2e-07  Score=84.86  Aligned_cols=76  Identities=25%  Similarity=0.363  Sum_probs=58.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-----------------CCCCCCC--------CcCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAG-----------------AYDYPSP--------EWDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~-----------------~~~~~~~--------~~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|.+||.+.+..+....+...                 ...+|..        .....++++.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            3899999999999999988876665554321                 1111111        11247889999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCC
Q psy2131         204 TVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ..||.+|||+.|+++|||+.+
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CSSGGGSCCHHHHHTSGGGHH
T ss_pred             cCChhhCCCHHHHhcCHHHHH
Confidence            999999999999999999953

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=98.51  E-value=1.4e-07  Score=82.36  Aligned_cols=73  Identities=21%  Similarity=0.275  Sum_probs=56.3

Q ss_pred             hHHHHHHHHHhCCCCCCCC-cHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDE-DQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~-~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||... .... ....+.......+   ...+++++.+++.+||..||.+|||+.++++|||+..
T Consensus       198 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            3899999999999999753 3333 3333333332222   3468999999999999999999999999999999964

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=98.51  E-value=3.2e-08  Score=88.45  Aligned_cols=77  Identities=18%  Similarity=0.295  Sum_probs=58.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC-------------------CCCCCC--------CcCCCCHHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------------------YDYPSP--------EWDTVTPEAKNLINQ  201 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~-------------------~~~~~~--------~~~~~s~~~~~li~~  201 (328)
                      .+|+++|+|++|.+||.+.+.......+....                   ...+..        ....+++++.+|+.+
T Consensus       210 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  289 (331)
T 4aaa_A          210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK  289 (331)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHH
Confidence            38999999999999998887765554433211                   111110        123578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCCc
Q psy2131         202 MLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ||..||.+|||++|+++|||+...
T Consensus       290 ~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          290 CLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HhccCcccCCCHHHHhcCchhccC
Confidence            999999999999999999999654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=98.50  E-value=8.4e-08  Score=89.28  Aligned_cols=78  Identities=26%  Similarity=0.510  Sum_probs=63.7

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC-CcCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-EWDTVTPEAKNLINQMLTVNPSK--RITASEALKHPWI  222 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~--R~t~~~~l~h~~~  222 (328)
                      +.| +|+++|+|++|.+||.+.+..+.+..+......++.+ ....+|+++++||.+||..+|.+  |++++|+++|||+
T Consensus       263 DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          263 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             eeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            344 8999999999999999999888888776543222222 23568999999999999988888  9999999999999


Q ss_pred             CC
Q psy2131         223 CQ  224 (328)
Q Consensus       223 ~~  224 (328)
                      ..
T Consensus       343 ~~  344 (437)
T 4aw2_A          343 SG  344 (437)
T ss_dssp             TT
T ss_pred             CC
Confidence            64

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=98.50  E-value=1.8e-07  Score=82.70  Aligned_cols=75  Identities=17%  Similarity=0.253  Sum_probs=58.7

Q ss_pred             hHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||... ........+....... .+....+++++.+++.+||..||.+||+++++++|||+.+
T Consensus       214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          214 SLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            3899999999999999773 4445555554443221 2233468999999999999999999999999999999854

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=98.50  E-value=1.3e-07  Score=84.69  Aligned_cols=73  Identities=36%  Similarity=0.615  Sum_probs=63.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||...........+.......+    ..+++++.+++.+||..||.+|||++++++|+|+.+.
T Consensus       226 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            389999999999999998888887777777766554    3578999999999999999999999999999998653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=98.48  E-value=2.4e-07  Score=81.31  Aligned_cols=77  Identities=19%  Similarity=0.270  Sum_probs=56.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCC-----CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-DYP-----SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-~~~-----~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .+|+++|+|++|..||...+............. ..+     .......++++.+++.+||..||.+|||+.++++|||+
T Consensus       212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          212 SFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            389999999999999987765544443333221 111     12234678999999999999999999999999999999


Q ss_pred             CCc
Q psy2131         223 CQR  225 (328)
Q Consensus       223 ~~~  225 (328)
                      .+.
T Consensus       292 ~~~  294 (303)
T 2vwi_A          292 QKA  294 (303)
T ss_dssp             ---
T ss_pred             hcC
Confidence            653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=98.48  E-value=7.6e-08  Score=85.13  Aligned_cols=76  Identities=28%  Similarity=0.368  Sum_probs=59.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC----------------------CCC----CcCCCCHHHHHHHHHh
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----------------------PSP----EWDTVTPEAKNLINQM  202 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~----------------------~~~----~~~~~s~~~~~li~~~  202 (328)
                      .+|+++|+|++|..||.+.+.......+.......                      +..    ....+++++.+++.+|
T Consensus       210 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (320)
T 2i6l_A          210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI  289 (320)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTT
T ss_pred             hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHH
Confidence            38999999999999999888766655544322110                      110    1235799999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCC
Q psy2131         203 LTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      |..||.+|||++++++|||+..
T Consensus       290 L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          290 LTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             SCSSGGGSCCHHHHHTSHHHHT
T ss_pred             cCCCccccCCHHHHhCCccccc
Confidence            9999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=98.47  E-value=3.8e-08  Score=89.48  Aligned_cols=75  Identities=19%  Similarity=0.255  Sum_probs=55.6

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHH--HHH---HHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRL--YAQ---IKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +|+++|+|++|.+||.+......  ...   ..........+.+..+++++.+++.+||..||.+|||+.++++|||+.+
T Consensus       279 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            89999999999999976632110  000   1111122333445678999999999999999999999999999999854

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.46  E-value=1.6e-07  Score=83.64  Aligned_cols=76  Identities=33%  Similarity=0.489  Sum_probs=55.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----------------CCc------------------------
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------------PEW------------------------  188 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------  188 (328)
                      .+|+++|+|++|.+||...+.......+.......|.                ..|                        
T Consensus       219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
T 1z57_A          219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ  298 (339)
T ss_dssp             HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence            3899999999999999887766555443322111110                001                        


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         189 DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       189 ~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ...++++.+++.+||..||.+|||+.|+++|||+..
T Consensus       299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             hhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            112467889999999999999999999999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=98.45  E-value=1.7e-07  Score=83.48  Aligned_cols=77  Identities=23%  Similarity=0.413  Sum_probs=54.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCc-HHHHH-------------HHHHhCCCCCC--------------------CCCcCCCCHH
Q psy2131         149 WFGVILYILLVGYPPFWDED-QHRLY-------------AQIKAGAYDYP--------------------SPEWDTVTPE  194 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~-~~~~~-------------~~i~~~~~~~~--------------------~~~~~~~s~~  194 (328)
                      .+|+++|+|++|..||.... .....             ..+.......+                    ......++++
T Consensus       216 slG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (330)
T 3nsz_A          216 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE  295 (330)
T ss_dssp             HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHH
T ss_pred             HHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHH
Confidence            38999999999999995432 21111             11222221111                    1122337999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         195 AKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       195 ~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.+|+.+||..||.+|||++|+++|||+.+.
T Consensus       296 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          296 ALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            9999999999999999999999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=98.45  E-value=4e-07  Score=80.43  Aligned_cols=77  Identities=21%  Similarity=0.321  Sum_probs=60.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+|+++|+|++|..||...+.......+...... .......+++++.+++.+||..||.+|||+.++++|||+....
T Consensus       210 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          210 SLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            3899999999999999887776655555443221 1122345789999999999999999999999999999997654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.45  E-value=1.3e-07  Score=85.56  Aligned_cols=77  Identities=25%  Similarity=0.353  Sum_probs=58.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC------------------------CCCCCCC----cCCCCHHHHHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGA------------------------YDYPSPE----WDTVTPEAKNLIN  200 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~------------------------~~~~~~~----~~~~s~~~~~li~  200 (328)
                      .+|+++|+|++|.+||.+.+.......+....                        ...+...    ....++.+.+|+.
T Consensus       219 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  298 (362)
T 3pg1_A          219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA  298 (362)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHH
Confidence            38999999999999999887766655543211                        1111111    2346889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         201 QMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       201 ~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||..||.+|||+.++++|||+.+.
T Consensus       299 ~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          299 KMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhcCChhhCCCHHHHHcCchhhhc
Confidence            9999999999999999999999753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=98.44  E-value=4.2e-07  Score=81.23  Aligned_cols=68  Identities=18%  Similarity=0.316  Sum_probs=57.0

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+||++|+|++ |.+||.+.+..+....+..+.. .+  ....+++++.+++.+||+.||++|||++|++.
T Consensus       244 wS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-~~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          244 WSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE-LE--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-CC--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             cchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CC--CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            348999999998 8999999988888888776532 12  22468999999999999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=98.43  E-value=4.6e-07  Score=81.36  Aligned_cols=75  Identities=23%  Similarity=0.327  Sum_probs=56.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|.+||..... ......+........  .....++++.+++.+||..||.+|||+.++++|||+...
T Consensus       205 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            389999999999999976433 333334433322222  123467899999999999999999999999999999654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=98.43  E-value=1.7e-07  Score=86.46  Aligned_cols=76  Identities=26%  Similarity=0.511  Sum_probs=60.6

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCC--CCCCCCCcCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKNLINQMLTVNPSKR---ITASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~p~~R---~t~~~~l~h~  220 (328)
                      ++| +|+++|+|++|.+||.+.+....+..+....  ..+|. ....+|+++++||.+||. +|.+|   ++++++++||
T Consensus       252 DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          252 DWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             hhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            344 8999999999999999998888887776532  22322 234689999999999999 99998   5999999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       330 ff~~  333 (412)
T 2vd5_A          330 FFFG  333 (412)
T ss_dssp             GGTT
T ss_pred             CcCC
Confidence            9965

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=98.42  E-value=4.7e-07  Score=80.04  Aligned_cols=75  Identities=24%  Similarity=0.340  Sum_probs=56.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||.... .......+.......+.  ....++++.+++.+||..||.+|||+.++++|||+...
T Consensus       224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          224 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            38999999999999997653 33333344333322222  23458899999999999999999999999999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=98.42  E-value=2.6e-07  Score=83.41  Aligned_cols=74  Identities=22%  Similarity=0.281  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHH------------------------------------------HhCCCCCCCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQI------------------------------------------KAGAYDYPSP  186 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i------------------------------------------~~~~~~~~~~  186 (328)
                      .+|+++|+|++|..||...+.......+                                          ....  .+..
T Consensus       215 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  292 (360)
T 3eqc_A          215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKL  292 (360)
T ss_dssp             HHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC--CCCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC--CCCC
Confidence            3899999999999999876654432221                                          1111  1111


Q ss_pred             CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         187 EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       187 ~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ....+++++.+|+.+||..||.+|||++++++|||+..
T Consensus       293 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence            22347889999999999999999999999999999964

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=98.42  E-value=4.7e-08  Score=89.10  Aligned_cols=68  Identities=15%  Similarity=0.207  Sum_probs=51.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||.+.+.......+.        ..+..+++++.+++.+||..||.+|||+.++++|||+.+
T Consensus       298 SlG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          298 ALGLVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            38999999999999997655433222221        123578999999999999999999999999999999853

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=98.41  E-value=1.7e-07  Score=82.95  Aligned_cols=71  Identities=20%  Similarity=0.256  Sum_probs=54.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++++|++|..|+.+.+..   ..+..+.  .+......+++++.+++.+||..||.+|||++++++|||+.+
T Consensus       240 slG~il~el~~g~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          240 SLGLTILEVACNMELPHGGEGW---QQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHHTCCCCSSHHHH---HHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHhCCCCCCCccHH---HHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            3899999999998777654332   2222221  122233468999999999999999999999999999999964

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=98.41  E-value=5.2e-07  Score=79.56  Aligned_cols=66  Identities=18%  Similarity=0.249  Sum_probs=56.6

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      .+||++|+|++ |.+||.+.+..++...+..+....   ....+++++.+++.+||+.||++|||++++.
T Consensus       215 S~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          215 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            48999999998 899999999988888887765321   2246899999999999999999999999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=98.40  E-value=1.2e-07  Score=86.61  Aligned_cols=32  Identities=38%  Similarity=0.723  Sum_probs=29.6

Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         192 TPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       192 s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      ++++.+|+.+||..||.+|||++|+++|||+.
T Consensus       365 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence            45688999999999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.40  E-value=1.6e-07  Score=85.13  Aligned_cols=35  Identities=29%  Similarity=0.642  Sum_probs=31.6

Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         191 VTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       191 ~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .++++.+|+.+||+.||.+|||++++++|||+.+.
T Consensus       306 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             HHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             hHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence            35678899999999999999999999999999754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=98.38  E-value=7.2e-07  Score=81.55  Aligned_cols=74  Identities=24%  Similarity=0.524  Sum_probs=60.9

Q ss_pred             cch-HHHHHHHHHhCCCCCCC---CcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcc
Q psy2131         147 QAW-FGVILYILLVGYPPFWD---EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-ASEALKHPW  221 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-~~~~l~h~~  221 (328)
                      +.| +|+++|+|++|.+||..   .........+......+|    ..+++++.+++.+||..||.+||+ ++++++|||
T Consensus       199 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~  274 (384)
T 4fr4_A          199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY  274 (384)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred             eeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence            344 89999999999999974   344556666666666555    358999999999999999999998 899999999


Q ss_pred             cCC
Q psy2131         222 ICQ  224 (328)
Q Consensus       222 ~~~  224 (328)
                      +..
T Consensus       275 f~~  277 (384)
T 4fr4_A          275 MND  277 (384)
T ss_dssp             GTT
T ss_pred             hhc
Confidence            965

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=98.38  E-value=5.2e-07  Score=80.81  Aligned_cols=69  Identities=26%  Similarity=0.421  Sum_probs=54.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRER  227 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~  227 (328)
                      .+|+++|+|++|..||.....      ......    .....+++++.+++.+||..||.+|||+.++++|||+.+...
T Consensus       215 slG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          215 SLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             hHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            389999999999999976432      111111    122357999999999999999999999999999999976543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=98.37  E-value=5.1e-07  Score=86.61  Aligned_cols=74  Identities=27%  Similarity=0.616  Sum_probs=61.2

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCc----HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHH
Q psy2131         147 QAW-FGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEA  216 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~  216 (328)
                      ++| +|+++|+|++|.+||.+.+    ...+...+......++    ..+|+++++|+.+||..||.+|+     +++|+
T Consensus       367 DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei  442 (576)
T 2acx_A          367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREV  442 (576)
T ss_dssp             HHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH
Confidence            344 8999999999999998753    3556666666655554    46899999999999999999999     89999


Q ss_pred             hcCcccCC
Q psy2131         217 LKHPWICQ  224 (328)
Q Consensus       217 l~h~~~~~  224 (328)
                      ++|||+..
T Consensus       443 l~HpfF~~  450 (576)
T 2acx_A          443 KEHPLFKK  450 (576)
T ss_dssp             HTSGGGTT
T ss_pred             HhChhhcc
Confidence            99999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=98.37  E-value=5.8e-07  Score=79.60  Aligned_cols=67  Identities=18%  Similarity=0.251  Sum_probs=57.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+||++|+|++ |.+||.+.+..++...+..+... |  ....+++++.+++.+|+..||.+|||++|++.
T Consensus       232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~  299 (308)
T 4gt4_A          232 SYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHS  299 (308)
T ss_dssp             HHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            38999999998 89999999998888888765432 2  23468999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=98.37  E-value=5.3e-07  Score=78.27  Aligned_cols=71  Identities=18%  Similarity=0.223  Sum_probs=53.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|.+|+...+..   ..+..+...   .....+++++.+++.+||..||.+|||+.++++|||+.+.
T Consensus       216 slG~il~~l~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          216 ALALTVVCAAGAEPLPRNGDQW---HEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHHHHHTTCCCCCSSSHHH---HHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHHHHHhcCCCCCcchhHH---HHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            3899999999999887655432   233333221   1224689999999999999999999999999999999754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.35  E-value=1.6e-07  Score=83.62  Aligned_cols=77  Identities=29%  Similarity=0.347  Sum_probs=55.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH-HHHHHHHh-CCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH-RLYAQIKA-GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||.+.+.. .....+.. ....++.......++++.+++.+||..||.+|||+.++++|||+...
T Consensus       214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             HHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            4899999999999999764421 11111111 11222333345689999999999999999999999999999999643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=98.35  E-value=1.5e-07  Score=84.99  Aligned_cols=72  Identities=32%  Similarity=0.546  Sum_probs=57.5

Q ss_pred             hHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcC
Q psy2131         149 WFGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h  219 (328)
                      .+|+++|+|++|..||...    ....+...+......++    ..+++.+.+++.+||..||.+||     +++++++|
T Consensus       247 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          247 SLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            3899999999999999643    23444445544443333    46889999999999999999999     99999999


Q ss_pred             cccCC
Q psy2131         220 PWICQ  224 (328)
Q Consensus       220 ~~~~~  224 (328)
                      ||+..
T Consensus       323 ~~f~~  327 (355)
T 1vzo_A          323 LFFQK  327 (355)
T ss_dssp             GGGTT
T ss_pred             cchhc
Confidence            99965

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=98.35  E-value=3.5e-07  Score=85.55  Aligned_cols=37  Identities=38%  Similarity=0.649  Sum_probs=34.1

Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         189 DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       189 ~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ...++++.+|+.+||..||.+|||++|+++|||+.+.
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            4569999999999999999999999999999999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=98.33  E-value=7.3e-07  Score=85.10  Aligned_cols=71  Identities=27%  Similarity=0.550  Sum_probs=60.3

Q ss_pred             HHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q psy2131         150 FGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEALKHP  220 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l~h~  220 (328)
                      +|+++|+|++|.+||.+.    ....+...+......+|    ..+++++.+++.+||..||.+||+     ++++++||
T Consensus       375 lGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp  450 (543)
T 3c4z_A          375 LGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP  450 (543)
T ss_dssp             HHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred             chHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence            899999999999999775    34566777777666655    468999999999999999999995     58999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       451 ff~~  454 (543)
T 3c4z_A          451 LFRD  454 (543)
T ss_dssp             GGTT
T ss_pred             cccC
Confidence            9965

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=98.33  E-value=1.1e-06  Score=81.46  Aligned_cols=37  Identities=38%  Similarity=0.699  Sum_probs=34.3

Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         189 DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       189 ~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..+++++.+|+.+||..||.+|||++|+++|||+.+.
T Consensus       332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            4689999999999999999999999999999999753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=98.33  E-value=2e-07  Score=82.27  Aligned_cols=73  Identities=22%  Similarity=0.415  Sum_probs=52.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +.| +||++|+|++   ||.+..+ ......+....  +| +.+...++...+|+.+||+.||.+|||+.|+++|||+.+
T Consensus       212 DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          212 DIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            344 8999999995   8865433 23333343332  22 233456778899999999999999999999999999975


Q ss_pred             c
Q psy2131         225 R  225 (328)
Q Consensus       225 ~  225 (328)
                      -
T Consensus       286 ~  286 (299)
T 4g31_A          286 L  286 (299)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=1.5e-06  Score=79.72  Aligned_cols=74  Identities=11%  Similarity=0.082  Sum_probs=45.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCC--CH---HHHHHHHHHHHHHHhCCC--C-CcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKL--SA---RDFQKLEREARICRKLQH--P-NIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~--~~---~~~~~~~~E~~il~~l~H--~-nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |.++.||++....+++.+++|.......  ..   ....++.+|+++|+.+..  + .+.+++.+  +.+..++|||+++
T Consensus        41 G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~  118 (397)
T 2olc_A           41 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS  118 (397)
T ss_dssp             SSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT
T ss_pred             CceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCC
Confidence            6788999997666678899998754221  01   112456778888887742  3 45566654  3445689999998


Q ss_pred             CCCc
Q psy2131          73 GGEL   76 (328)
Q Consensus        73 gg~L   76 (328)
                      |...
T Consensus       119 g~~~  122 (397)
T 2olc_A          119 HLKI  122 (397)
T ss_dssp             TSEE
T ss_pred             Ccch
Confidence            7543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=98.32  E-value=3.8e-07  Score=82.34  Aligned_cols=68  Identities=28%  Similarity=0.406  Sum_probs=53.3

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+||++|+|++ |.+||.+.+. ..+...+..+. ..+.  ...+++++.+++.+||..||.+|||++++++|
T Consensus       272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~-~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCC-CCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            38999999998 9999988654 44445555443 2222  24689999999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=98.31  E-value=2.6e-07  Score=81.72  Aligned_cols=75  Identities=20%  Similarity=0.338  Sum_probs=63.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      .+|+++|+|++|..||.+.+.......+.......+......+++++.+++.+||..||.+||++.+++.|+|+.
T Consensus       204 slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          204 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            389999999999999999888777766666655544444567899999999999999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=98.29  E-value=1e-06  Score=81.77  Aligned_cols=75  Identities=31%  Similarity=0.518  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCC---cCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPE---WDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++ |.+||.+.....  ..+..+....+...   ...+++++.+++.+||..||.+|||+.++++|||+..
T Consensus       224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            38999999998 999997654333  23444444433221   1234688999999999999999999999999999975


Q ss_pred             c
Q psy2131         225 R  225 (328)
Q Consensus       225 ~  225 (328)
                      .
T Consensus       302 ~  302 (434)
T 2rio_A          302 K  302 (434)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=98.29  E-value=1.3e-07  Score=82.81  Aligned_cols=39  Identities=26%  Similarity=0.296  Sum_probs=33.9

Q ss_pred             cCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH
Q psy2131         259 AGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH  304 (328)
Q Consensus       259 ~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~  304 (328)
                      .++++|++|       ++.++|||||||++|||+||+.||.+.+..
T Consensus       170 l~~~~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          170 LAYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             ECSCCCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             EEeccccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence            457888875       889999999999999999999999987643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.26  E-value=1.2e-06  Score=77.70  Aligned_cols=67  Identities=31%  Similarity=0.569  Sum_probs=54.1

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .+|+++|+|++|..||...+.      +......+    ...+++++.+++.+||..||.+|||++++++|||+.+.
T Consensus       234 slG~il~el~~g~~pf~~~~~------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          234 SLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             HHHHHHHHHHHSSCSCCSHHH------HHHCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             hHHHHHHHHHHCCCCCCChhh------hhcccccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            389999999999999976432      22222222    24689999999999999999999999999999999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=98.26  E-value=5.7e-07  Score=83.52  Aligned_cols=75  Identities=27%  Similarity=0.409  Sum_probs=53.6

Q ss_pred             HHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         150 FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +|+++|+|++ |.+||...........+........ ......+..+.+++.+||..||.+|||+.++++|||+...
T Consensus       215 lG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          215 AGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             HHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            8999999999 9999966554443322222221111 1112345668999999999999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=98.17  E-value=3.6e-06  Score=72.50  Aligned_cols=69  Identities=22%  Similarity=0.313  Sum_probs=57.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++|..||.+.+.......+.......+.  ....++++.+++.+||..||.+|||+.+++++
T Consensus       199 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          199 SYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            3899999999999999998887777776666544433  34688999999999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=98.16  E-value=2.8e-06  Score=75.32  Aligned_cols=74  Identities=19%  Similarity=0.327  Sum_probs=56.0

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-------ASEALKHP  220 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-------~~~~l~h~  220 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+...   .....+++++.+++.+||..||.+|||       .++++.|+
T Consensus       224 slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          224 AFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            48999999999 99999988887777776655422   223468899999999999999999999       67777899


Q ss_pred             ccCCc
Q psy2131         221 WICQR  225 (328)
Q Consensus       221 ~~~~~  225 (328)
                      |+...
T Consensus       301 ~~~~~  305 (323)
T 3qup_A          301 SVLST  305 (323)
T ss_dssp             -----
T ss_pred             hhcCC
Confidence            98654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=98.15  E-value=1.4e-06  Score=80.44  Aligned_cols=68  Identities=16%  Similarity=0.191  Sum_probs=54.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+|+++|+|++|..||...+.......+        ...+..+++++.+++.+||..||.+||++.++++|||+.+
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            3899999999999999876543322222        2223467899999999999999999999999999999854

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=4.8e-05  Score=67.70  Aligned_cols=68  Identities=13%  Similarity=0.163  Sum_probs=39.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceeEE------EEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHD------SIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~------~~~~~~~~~lv~E~~~   72 (328)
                      |..+.||++... + ..+++|+....   .   ..+..|+.+++.|.  .-.+.+++.      +....+..|++|||++
T Consensus        43 G~~n~~~~v~~~-~-~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           43 NQMALVWKVHTD-S-GAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ---CEEEEEEET-T-EEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             cccCcEEEEEeC-C-CCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            456789988653 3 35899998752   2   23334555555442  112334433      1235677899999999


Q ss_pred             CCCc
Q psy2131          73 GGEL   76 (328)
Q Consensus        73 gg~L   76 (328)
                      |.++
T Consensus       115 G~~~  118 (346)
T 2q83_A          115 GRPF  118 (346)
T ss_dssp             CBCC
T ss_pred             CccC
Confidence            8654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=98.11  E-value=6.6e-06  Score=70.63  Aligned_cols=68  Identities=18%  Similarity=0.245  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.+.......+.......+  ....+++++.+++.+||..||.+|||++++++
T Consensus       196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            489999999999999998888777666665544332  23468999999999999999999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.06  E-value=7e-06  Score=70.68  Aligned_cols=68  Identities=19%  Similarity=0.348  Sum_probs=56.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||...+.......+..+....   .....++++.+++.+||..||.+|||+.+++++
T Consensus       192 slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            48999999999 999999988888888777653222   224578999999999999999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.05  E-value=7.8e-07  Score=78.15  Aligned_cols=41  Identities=41%  Similarity=0.888  Sum_probs=30.0

Q ss_pred             ccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHH
Q psy2131         267 PEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY  307 (328)
Q Consensus       267 PE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  307 (328)
                      .+.+.+..|+.++|||||||++|||+||++||.+.+...+.
T Consensus       167 a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  207 (299)
T 3m2w_A          167 AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  207 (299)
T ss_dssp             CEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred             ccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence            34455678899999999999999999999999887655543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=4e-06  Score=75.57  Aligned_cols=77  Identities=12%  Similarity=0.066  Sum_probs=48.2

Q ss_pred             CCceEEEEEEEcc------CCcEEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCC---CCcceeEEEEEeC---CEEEEE
Q psy2131           1 GAFSVVRRCVQKA------TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQH---PNIVRLHDSIQEE---NYHYLV   67 (328)
Q Consensus         1 G~fg~V~~~~~~~------~~~~~AiK~i~~~~~-~~~~~~~~~~E~~il~~l~H---~nIv~l~~~~~~~---~~~~lv   67 (328)
                      |..+.+|++....      ++..+++|+...... .......+.+|+.+|+.+..   -.+.+++.+..+.   +..|+|
T Consensus        32 G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v  111 (357)
T 3ats_A           32 GMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFL  111 (357)
T ss_dssp             SSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEE
T ss_pred             CccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEE
Confidence            4456788775430      256788887654220 00001345678888888742   3577888887665   346899


Q ss_pred             EEccCCCCcH
Q psy2131          68 FDLVTGGELF   77 (328)
Q Consensus        68 ~E~~~gg~L~   77 (328)
                      |||++|..+.
T Consensus       112 ~e~l~G~~l~  121 (357)
T 3ats_A          112 MDYVEGVVPP  121 (357)
T ss_dssp             EECCCCBCCC
T ss_pred             EEecCCCChh
Confidence            9999986653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=98.03  E-value=1.1e-05  Score=71.29  Aligned_cols=70  Identities=20%  Similarity=0.284  Sum_probs=57.2

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.| +|+++|+|++|..||.+.+.......+.......+.  ...+++++.+++.+||..||.+|||++++++
T Consensus       221 DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            344 899999999999999998888777766544433322  2468999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=98.03  E-value=4.6e-06  Score=72.54  Aligned_cols=68  Identities=25%  Similarity=0.340  Sum_probs=51.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH--HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||...+..  .....+.......  .....+++++.+++.+||..||.+|||++++++
T Consensus       213 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          213 SFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3899999999999999765433  3344444433322  233568999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=98.02  E-value=1e-05  Score=70.39  Aligned_cols=68  Identities=19%  Similarity=0.302  Sum_probs=58.2

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+.......+.  ...+++++.+++.+||..||.+|||+.++++
T Consensus       209 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          209 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            38999999999 99999998888888877766544433  3468999999999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=98.00  E-value=1.7e-06  Score=76.79  Aligned_cols=70  Identities=19%  Similarity=0.446  Sum_probs=50.8

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +|+++|+|++|..|+..  .......+.....  + ..+...++++.+++.+||..||.+|||+.++++|||+.+
T Consensus       262 lG~il~el~~~~~~~~~--~~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          262 LGLILFELLYSFSTQME--RVRIITDVRNLKF--P-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC--C-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHHHHHHHHHcCCChhH--HHHHHHHhhccCC--C-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            89999999998877522  2222233333211  1 122345788899999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=97.99  E-value=1.1e-05  Score=69.25  Aligned_cols=68  Identities=16%  Similarity=0.225  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||...+.......+..+.....   ....++++.+++.+||..||.+|||+.+++++
T Consensus       190 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            38999999998 9999998888877777766543322   23578999999999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=97.98  E-value=9.1e-06  Score=72.16  Aligned_cols=71  Identities=18%  Similarity=0.296  Sum_probs=59.2

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .+|+++|+|++ |..||...+.......+..+....+   ...+++.+.+++.+||..||.+||++.+++++.|.
T Consensus       230 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            48999999998 9999998888877777766543222   24678999999999999999999999999988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=97.98  E-value=1.2e-05  Score=69.04  Aligned_cols=68  Identities=19%  Similarity=0.324  Sum_probs=56.3

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+|+++|+|++ |.+||...+.......+..+....   .....++.+.+++.+||..||.+|||+.++++
T Consensus       189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          189 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            348999999999 899999988888877776653322   22357899999999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=97.98  E-value=9.2e-06  Score=73.58  Aligned_cols=71  Identities=18%  Similarity=0.296  Sum_probs=59.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      .+|+++|+|++ |.+||...+.......+..+....+   ...+++.+.+++.+||..||.+|||+.+++++.+.
T Consensus       271 slG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          271 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            38999999998 9999999998888888776653222   24678999999999999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=97.98  E-value=8.9e-06  Score=72.24  Aligned_cols=68  Identities=21%  Similarity=0.312  Sum_probs=56.1

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+..   ......+++++.+++.+||..||.+|||+++++.+
T Consensus       226 slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          226 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            38999999998 9999999888887777665422   12234678999999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=97.97  E-value=9.4e-06  Score=70.62  Aligned_cols=70  Identities=17%  Similarity=0.139  Sum_probs=57.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .+|+++|+|++ |..||...+.......+..+...   .....+++++.+++.+||..||.+||++.+++++.+
T Consensus       198 slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          198 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            38999999998 99999988877777777665321   122468999999999999999999999999987543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=97.97  E-value=2.2e-05  Score=68.44  Aligned_cols=67  Identities=18%  Similarity=0.183  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+...   .....+++++.+++.+||..||.+||++.++++
T Consensus       205 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          205 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            48999999999 99999998888777777665321   122468999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=97.95  E-value=1.5e-05  Score=69.10  Aligned_cols=68  Identities=16%  Similarity=0.192  Sum_probs=56.8

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||...+.......+..+.....   ....++.+.+++.+||..||.+|||+.+++.|
T Consensus       206 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            48999999998 9999999888888777776543222   24578999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=97.95  E-value=3.2e-06  Score=74.89  Aligned_cols=73  Identities=15%  Similarity=0.158  Sum_probs=50.7

Q ss_pred             hHHHHHHHHHhCCCCCCCC----cHHHHHHHHHhCCCC-------------------CCC--CCcCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYD-------------------YPS--PEWDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~----~~~~~~~~i~~~~~~-------------------~~~--~~~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|..||...    ........+..+...                   ++.  .....+++.+.+++.+||
T Consensus       208 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L  287 (319)
T 4euu_A          208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL  287 (319)
T ss_dssp             HHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhc
Confidence            3899999999999999642    223444444433221                   111  111224567889999999


Q ss_pred             ccCCCCCCCHHHHhcCcc
Q psy2131         204 TVNPSKRITASEALKHPW  221 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~  221 (328)
                      +.||.+|||++|+++||-
T Consensus       288 ~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          288 EADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCCTTTSCCHHHHHHHHH
T ss_pred             cCChhhhccHHHhhhccH
Confidence            999999999999999873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=97.95  E-value=1.7e-05  Score=70.43  Aligned_cols=67  Identities=18%  Similarity=0.360  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+..   .+....+++++.+++.+||..||.+|||+.+++.
T Consensus       239 slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          239 SFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            38999999998 9999999988888877766522   2223468999999999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=97.94  E-value=1e-05  Score=71.19  Aligned_cols=68  Identities=26%  Similarity=0.365  Sum_probs=55.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+.+.......+..+...   .....+++++.+++.+||..||.+|||+.+++++
T Consensus       237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            38999999999 99999888877777766655321   2234689999999999999999999999999753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=97.93  E-value=2.1e-05  Score=69.32  Aligned_cols=68  Identities=18%  Similarity=0.187  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||...+.......+..+..  +......+++++.+++.+||..||.+|||+.++++
T Consensus       228 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          228 ALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            389999999999999998888877777765533  22223467899999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=97.92  E-value=1.4e-05  Score=70.44  Aligned_cols=72  Identities=22%  Similarity=0.351  Sum_probs=54.6

Q ss_pred             Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q psy2131         146 QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-TASEALK  218 (328)
Q Consensus       146 ~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-t~~~~l~  218 (328)
                      .+.| +|+++|+|++|..||...+.......+.. ....+......+++++.+++.+||..||.+|| ++++++.
T Consensus       216 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            3444 89999999999999988776654444433 33333334567899999999999999999999 7877763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=97.92  E-value=1.3e-05  Score=69.50  Aligned_cols=68  Identities=22%  Similarity=0.354  Sum_probs=54.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||...+.......+..+...   +....+++.+.+++.+||..||.+|||+.+++++
T Consensus       199 slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            48999999998 99999877766666666554321   2224578999999999999999999999999853

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=97.90  E-value=1.4e-05  Score=69.22  Aligned_cols=67  Identities=24%  Similarity=0.405  Sum_probs=54.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+...   +....+++++.+++.+||..||.+|||+.+++.
T Consensus       202 slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          202 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            38999999996 99999888777777776654321   223468999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=97.88  E-value=2.7e-05  Score=67.25  Aligned_cols=67  Identities=18%  Similarity=0.206  Sum_probs=55.2

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+..   ......+++++.+++.+||..||.+|||++++++
T Consensus       195 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            38999999999 9999998888777777765432   1223468899999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=97.88  E-value=2.3e-05  Score=69.22  Aligned_cols=68  Identities=18%  Similarity=0.225  Sum_probs=56.8

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+.+.......+..+....   ....+++.+.+++.+||..||.+|||+.+++++
T Consensus       225 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          225 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            48999999999 899999988888777776654322   224688999999999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=97.85  E-value=1.6e-05  Score=69.88  Aligned_cols=69  Identities=23%  Similarity=0.388  Sum_probs=51.5

Q ss_pred             chHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+|+++|+|++|..||.+..  .......+....  ++......+++++.+++.+||..||.+|||+.++++
T Consensus       220 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            348999999999999997643  334444554443  333334578999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=97.85  E-value=1.1e-05  Score=72.37  Aligned_cols=68  Identities=28%  Similarity=0.393  Sum_probs=51.6

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHH-HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||.+.... .....+..+.. .+  .....++++.+++.+||..||.+|||+.++++|
T Consensus       280 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          280 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            38999999998 99999876543 33334433322 11  224588999999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=97.85  E-value=3.3e-05  Score=68.87  Aligned_cols=67  Identities=18%  Similarity=0.404  Sum_probs=55.6

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+.. .  +....+++++.+++.+||..||.+||++.++++
T Consensus       235 slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          235 SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-L--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-C--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            38999999998 9999998888887777765522 2  223468899999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=97.84  E-value=1.9e-05  Score=69.47  Aligned_cols=67  Identities=19%  Similarity=0.275  Sum_probs=55.1

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+..   ......+++++.+++.+||..||.+|||+.+++.
T Consensus       234 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            38999999999 9999988877777766655432   2223468899999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=97.84  E-value=2.8e-05  Score=69.27  Aligned_cols=67  Identities=16%  Similarity=0.286  Sum_probs=56.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+....   ....+++++.+++.+||..||.+|||+.++++
T Consensus       261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            48999999998 999999988888887777664422   22468899999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=97.84  E-value=2.6e-05  Score=67.90  Aligned_cols=70  Identities=19%  Similarity=0.328  Sum_probs=53.9

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH-HHHHHHHHhCCCCCCC-CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPS-PEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~-~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.+. ......+..+....+. .....+++++.+++.+||..||.+|||+.+++.
T Consensus       210 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          210 AFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            389999999999999987554 3444455554443332 234568899999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=97.84  E-value=2.6e-05  Score=70.93  Aligned_cols=68  Identities=22%  Similarity=0.308  Sum_probs=57.0

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++++|++ |..||.+.+.......+..+....   ....+++++.+++.+||..||.+|||+.+++++
T Consensus       278 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          278 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            38999999999 999999988888887776654322   224689999999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=97.84  E-value=1.6e-05  Score=71.06  Aligned_cols=70  Identities=11%  Similarity=0.179  Sum_probs=53.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      .+|+++|+|++ |..||.+.........+.......+  .....++++.+++.+||..||.+|||+.+++.+-
T Consensus       259 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            38999999998 9999987765444444333333322  2245799999999999999999999999998754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=97.83  E-value=2.5e-05  Score=67.55  Aligned_cols=67  Identities=13%  Similarity=0.245  Sum_probs=54.2

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||...+.......+..+.   ........++++.+++.+||..||.+|||+.++++
T Consensus       199 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          199 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            48999999998 999998887766666665442   12223468999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=97.82  E-value=2.4e-05  Score=69.55  Aligned_cols=67  Identities=15%  Similarity=0.247  Sum_probs=55.2

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+...   +.....++++.+++.+||..||.+|||+.+++.
T Consensus       204 slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          204 SYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            38999999999 99999988877777666654322   223458899999999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=97.82  E-value=3e-05  Score=69.06  Aligned_cols=67  Identities=21%  Similarity=0.307  Sum_probs=56.1

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+...+...+..+...   .....+++++.+++.+||..||.+|||+.++++
T Consensus       244 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          244 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            38999999999 99999998888877777665422   122468899999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=97.82  E-value=3.3e-05  Score=72.03  Aligned_cols=68  Identities=18%  Similarity=0.257  Sum_probs=56.3

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+|+++|+|++ |.+||.+.+..+....+..+. ..+  ....+++++.+++.+||..||.+|||+++++.
T Consensus       369 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            348999999999 999999988888877776652 222  23468999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=97.81  E-value=1.9e-05  Score=69.39  Aligned_cols=68  Identities=15%  Similarity=0.292  Sum_probs=51.3

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.................+  .....++++.+++.+||..||.+|||+.++++
T Consensus       232 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            38999999998 9999987664433333332222222  23467899999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=97.81  E-value=2.3e-05  Score=71.11  Aligned_cols=67  Identities=21%  Similarity=0.307  Sum_probs=55.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+...+...+..+...   .....+++++.+++.+||..||.+|||+.++++
T Consensus       290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            38999999998 99999988877777766655321   122468899999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=97.79  E-value=2.4e-05  Score=69.50  Aligned_cols=68  Identities=15%  Similarity=0.233  Sum_probs=55.3

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+.+.......+..+...   +.....+.++.+++.+||..||.+|||+.+++.+
T Consensus       204 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          204 SYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            38999999999 99999888777776666554322   2234578999999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=97.79  E-value=2e-05  Score=69.99  Aligned_cols=68  Identities=15%  Similarity=0.156  Sum_probs=54.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+.........+..+.....   ....++++.+++.+||..||.+|||+.+++++
T Consensus       202 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          202 SYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            38999999999 9999998877777766665432221   23478889999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=97.79  E-value=2.1e-05  Score=69.16  Aligned_cols=68  Identities=28%  Similarity=0.393  Sum_probs=51.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcH-HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+... ......+..+.. .  ......++++.+++.+||..||.+|||+.++++|
T Consensus       235 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-M--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            38999999998 9999977653 334444444322 1  1224578999999999999999999999999865

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=97.78  E-value=3.5e-05  Score=66.80  Aligned_cols=67  Identities=21%  Similarity=0.316  Sum_probs=54.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+.....   ......+++++.+++.+||..||.+|||+.++++
T Consensus       197 slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          197 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            38999999999 9999988877766666655422   2223568999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=97.78  E-value=1.1e-05  Score=70.30  Aligned_cols=70  Identities=11%  Similarity=0.067  Sum_probs=50.1

Q ss_pred             hHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCCCCCCC-CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPS-PEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.   ........+.......+. .....+++++.+++.+||..||.+||+++++++
T Consensus       203 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          203 ALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            3899999999999999773   333333333322211111 112367899999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=97.77  E-value=4.7e-05  Score=69.10  Aligned_cols=67  Identities=18%  Similarity=0.303  Sum_probs=54.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+.. .+  ....+++++.+++.+||..||.+|||+++++.
T Consensus       300 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          300 SFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LP--CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            38999999998 9999998888777766655432 22  22457899999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=97.74  E-value=5.5e-05  Score=70.48  Aligned_cols=67  Identities=21%  Similarity=0.242  Sum_probs=55.6

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+..+....+..+. ..+  ....+++.+.+++.+||..||.+|||+++++.
T Consensus       366 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            48999999999 999999988888877776543 222  22468999999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=97.71  E-value=3.1e-05  Score=67.17  Aligned_cols=66  Identities=23%  Similarity=0.331  Sum_probs=47.7

Q ss_pred             hHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++| .+||...+....... .......+    ...++++.+++.+||..||.+|||+.+++++
T Consensus       203 slG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          203 SFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccccchHHHHHH-hhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            489999999995 555555544443333 33333333    2457889999999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=97.70  E-value=5.8e-05  Score=65.72  Aligned_cols=67  Identities=25%  Similarity=0.364  Sum_probs=51.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ +.+||...+.......+......   +.....++++.+++.+||..||.+|||+.++++
T Consensus       213 slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          213 SFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            38999999999 56666666666666655554322   223467899999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=97.69  E-value=1.1e-05  Score=70.25  Aligned_cols=70  Identities=14%  Similarity=0.133  Sum_probs=48.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhCCCCCCC-CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDYPS-PEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.+.   ......+.......+. .....+++++.+++.+||..||.+|||++++++
T Consensus       200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            389999999999999976321   1222222221111111 112357899999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=97.68  E-value=3.1e-05  Score=68.75  Aligned_cols=68  Identities=12%  Similarity=0.267  Sum_probs=51.3

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.........+.......+  .....++++.+++.+||..||.+|||+.++++
T Consensus       251 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            38999999998 9999987655444433333332222  22457899999999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=97.67  E-value=2.7e-05  Score=68.12  Aligned_cols=73  Identities=19%  Similarity=0.317  Sum_probs=54.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC-CCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .+|+++|+|++|.+||.+.+............. ..+......+++.+.+++.+||..||.+||+..+.+.+.|
T Consensus       197 slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          197 SIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            389999999999999998887665544443322 2222234568999999999999999999996666665554

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=97.66  E-value=5.7e-05  Score=68.51  Aligned_cols=67  Identities=13%  Similarity=0.334  Sum_probs=54.0

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|++++ |..||...+.......+..+.. .+  ....++.++.+++.+||..||.+||++.+++.
T Consensus       235 SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          235 SYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-LP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-CC--CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            48999999997 9999999888887777765422 12  22467899999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=97.66  E-value=5.6e-05  Score=70.40  Aligned_cols=67  Identities=15%  Similarity=0.276  Sum_probs=54.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+. ..+  ....+++++.+++.+||..||.+|||+.+++.
T Consensus       371 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMD--APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            48999999998 999998887777766666542 222  23468999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=97.64  E-value=6.8e-05  Score=65.39  Aligned_cols=67  Identities=19%  Similarity=0.260  Sum_probs=52.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ +.+||.+.+.......+..+.....   ....++.+.+++.+||..||.+|||+.++++
T Consensus       217 slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            38999999999 7778877766666666655443322   2457899999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=97.64  E-value=1.3e-05  Score=69.79  Aligned_cols=70  Identities=14%  Similarity=0.140  Sum_probs=48.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcH---HHHHHHHHhCCCCCCCC-CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDYPSP-EWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.+.   ......+.......+.. ....+++++.+++.+||..||.+|||++++++
T Consensus       200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            389999999999999976432   11122221111111111 12357899999999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=97.64  E-value=6.3e-05  Score=67.47  Aligned_cols=70  Identities=9%  Similarity=0.152  Sum_probs=50.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCc--HHHHHHH---HHhCCCCCC--CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDED--QHRLYAQ---IKAGAYDYP--SPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~--~~~~~~~---i~~~~~~~~--~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||....  .......   .......++  ...+..+++++.+++.+||..||.+|||++++++
T Consensus       253 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          253 SLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            38999999999999997653  3222222   222222222  2234567999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=97.63  E-value=2.7e-05  Score=69.21  Aligned_cols=70  Identities=14%  Similarity=0.109  Sum_probs=49.1

Q ss_pred             hHHHHHHHHHhCCCCCCCC---cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.   +....+..+.......+........+++.+++.+|+..||.+||+++++.+
T Consensus       202 slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          202 ALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            3899999999999999874   333444444332222222222223449999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=97.62  E-value=0.00013  Score=64.10  Aligned_cols=67  Identities=21%  Similarity=0.402  Sum_probs=50.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCc--HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||....  .......+..+.   ..+....+++.+.+++.+||..||.+|||++++++
T Consensus       188 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          188 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            38999999999999997543  233333333322   22234568999999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=97.62  E-value=2.5e-05  Score=69.92  Aligned_cols=70  Identities=11%  Similarity=0.077  Sum_probs=47.4

Q ss_pred             hHHHHHHHHHhCCCCCCCC--cHHHHHHHHHhCCCCCCC-----CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPS-----PEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~--~~~~~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..||.+.  +...............+.     ......++++.+++.+||..||.+|||++++++
T Consensus       245 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          245 ILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            3899999999999999552  222222111111111111     011268899999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=97.61  E-value=0.00014  Score=70.82  Aligned_cols=67  Identities=18%  Similarity=0.183  Sum_probs=56.3

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+.......+..+...   .....+++++.+++.+||..||.+||++++++.
T Consensus       557 SlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          557 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            38999999998 99999999888888877765432   122468999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=97.61  E-value=5.2e-05  Score=68.84  Aligned_cols=67  Identities=19%  Similarity=0.269  Sum_probs=52.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+....   ....+++.+.+++.+||..||.+|||+.++++
T Consensus       281 SlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          281 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             HHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            38999999999 788887776655555555543322   22467899999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=97.61  E-value=7.7e-05  Score=65.68  Aligned_cols=71  Identities=10%  Similarity=0.006  Sum_probs=46.9

Q ss_pred             chHHHHHHHHHhCCCCCCCC---------------cHHHHHHHHHhCCCCCCCCCcC---CCCHHHHHHHHHhcccCCCC
Q psy2131         148 AWFGVILYILLVGYPPFWDE---------------DQHRLYAQIKAGAYDYPSPEWD---TVTPEAKNLINQMLTVNPSK  209 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~---------------~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~~l~~~p~~  209 (328)
                      +.+||++|+|++|.+||...               ....+...+.......+.+...   ..+..+.+++.+||..||.+
T Consensus       202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~  281 (303)
T 3hmm_A          202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA  281 (303)
T ss_dssp             HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred             hhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence            34899999999998765321               1233344444444433322211   12346789999999999999


Q ss_pred             CCCHHHHhc
Q psy2131         210 RITASEALK  218 (328)
Q Consensus       210 R~t~~~~l~  218 (328)
                      |||+.++++
T Consensus       282 RPt~~ei~~  290 (303)
T 3hmm_A          282 RLTALRIKK  290 (303)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=97.61  E-value=1.8e-05  Score=76.98  Aligned_cols=76  Identities=18%  Similarity=0.274  Sum_probs=49.5

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHH---------HHH-----HhCCCCC------CCCCcCCCCHHHHHHHHHhcccCCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLY---------AQI-----KAGAYDY------PSPEWDTVTPEAKNLINQMLTVNPS  208 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~---------~~i-----~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~p~  208 (328)
                      .+|+++|+|++|..||.........         ..+     ..+...+      |......+++.+.+++.+||..||.
T Consensus       208 SLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~  287 (676)
T 3qa8_A          208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR  287 (676)
T ss_dssp             HHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred             HHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence            3899999999999999765332110         000     0111111      1112223568899999999999999


Q ss_pred             CCCCHHHHhcCcccCC
Q psy2131         209 KRITASEALKHPWICQ  224 (328)
Q Consensus       209 ~R~t~~~~l~h~~~~~  224 (328)
                      +|||+.++++|||+..
T Consensus       288 kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          288 QRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             ---CCTTCCCCTTHHH
T ss_pred             hCcCHHHHhcCHHHHH
Confidence            9999999999999854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=97.61  E-value=3.9e-05  Score=67.98  Aligned_cols=66  Identities=35%  Similarity=0.552  Sum_probs=45.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      .+|+++|+|++|..||.+.......    .....  .+.....++.+.+++.+||..||.+|||+.+++++-
T Consensus       238 slG~il~el~~g~~p~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          238 ALGCILYLLCFRQHPFEDGAKLRIV----NGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             HHHHHHHHHHHSSCCC----------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcchhHHHhh----cCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            3899999999999999765543322    22222  223356778899999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=97.60  E-value=1.6e-05  Score=70.03  Aligned_cols=70  Identities=23%  Similarity=0.413  Sum_probs=49.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcH--HHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +.| +|+++|+|++|..||.....  ......+.. ...  .+.....++++.+++.+||..||.+|||+.+++++
T Consensus       228 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            344 89999999999999953211  111222222 222  23345689999999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=97.58  E-value=0.00014  Score=70.46  Aligned_cols=67  Identities=18%  Similarity=0.162  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+.+..+....+..+...   .....+++++.+++.+||..||.+||++.+++.
T Consensus       524 SlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          524 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            38999999998 99999998888888777665421   122468999999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=97.58  E-value=9.1e-05  Score=69.87  Aligned_cols=67  Identities=21%  Similarity=0.330  Sum_probs=54.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+. ..  .....+++++.+++.+||..||.+|||+.++++
T Consensus       404 SlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            38999999998 999998887776666665432 22  223468999999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=97.56  E-value=0.00012  Score=69.83  Aligned_cols=67  Identities=21%  Similarity=0.242  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |..||.+....+....+..+. ..+  ....+++++.++|.+||..||.+|||+++++.
T Consensus       449 SlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            48999999999 999999988888877776543 222  22468999999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=97.50  E-value=8.4e-05  Score=65.79  Aligned_cols=70  Identities=10%  Similarity=0.053  Sum_probs=46.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCc----------------HHHHHHHHHhCCCCCCCCC-c--CCCCHHHHHHHHHhcccCCCC
Q psy2131         149 WFGVILYILLVGYPPFWDED----------------QHRLYAQIKAGAYDYPSPE-W--DTVTPEAKNLINQMLTVNPSK  209 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~----------------~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~l~~~p~~  209 (328)
                      .+|+++|+|++|..||.+..                .......+.........+. +  ...++++.+++.+||..||.+
T Consensus       223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  302 (322)
T 3soc_A          223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA  302 (322)
T ss_dssp             HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred             HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence            38999999999999996542                1222222222222211111 1  112356899999999999999


Q ss_pred             CCCHHHHhc
Q psy2131         210 RITASEALK  218 (328)
Q Consensus       210 R~t~~~~l~  218 (328)
                      |||+.++++
T Consensus       303 Rps~~ell~  311 (322)
T 3soc_A          303 RLSAGCVGE  311 (322)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00035  Score=64.37  Aligned_cols=33  Identities=12%  Similarity=0.323  Sum_probs=26.4

Q ss_pred             HHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccc
Q psy2131         106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  142 (328)
Q Consensus       106 H~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~  142 (328)
                      +...++|+|++|.|||++.+   + ++++||+.+..-
T Consensus       230 ~~~~liHGDl~~~Nil~~~~---~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQD---S-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSS---C-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCC---C-CEEEeCcccccC
Confidence            34679999999999999643   2 899999987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=97.47  E-value=0.0002  Score=69.87  Aligned_cols=67  Identities=24%  Similarity=0.405  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||.+.+.......+..+...   +....+++.+.+++.+||..||.+|||+.+++.
T Consensus       577 SlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          577 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            38999999997 99999998888887777665422   122468899999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=97.47  E-value=8.2e-05  Score=65.91  Aligned_cols=68  Identities=22%  Similarity=0.270  Sum_probs=49.7

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH---------------HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH---------------RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      .+|+++|+|++|..||......               .....+..+ .  ..+....+++++.+++.+||..||.+|||+
T Consensus       215 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  291 (327)
T 3lxl_A          215 SFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG-Q--RLPAPPACPAEVHELMKLCWAPSPQDRPSF  291 (327)
T ss_dssp             HHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc-c--CCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence            3899999999999998654432               122222222 1  222335789999999999999999999999


Q ss_pred             HHHhcC
Q psy2131         214 SEALKH  219 (328)
Q Consensus       214 ~~~l~h  219 (328)
                      .+++++
T Consensus       292 ~ell~~  297 (327)
T 3lxl_A          292 SALGPQ  297 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=97.44  E-value=0.00012  Score=64.71  Aligned_cols=67  Identities=25%  Similarity=0.269  Sum_probs=48.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHH---------------HHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQH---------------RLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA  213 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~  213 (328)
                      .+|+++|+|++|..||......               .....+..+ .  ..+....+++++.+++.+||..||.+|||+
T Consensus       222 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  298 (318)
T 3lxp_A          222 SFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-E--RLPRPDKCPAEVYHLMKNCWETEASFRPTF  298 (318)
T ss_dssp             HHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-c--CCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence            3899999999999999754321               111222222 1  222335689999999999999999999999


Q ss_pred             HHHhc
Q psy2131         214 SEALK  218 (328)
Q Consensus       214 ~~~l~  218 (328)
                      .+++.
T Consensus       299 ~ell~  303 (318)
T 3lxp_A          299 ENLIP  303 (318)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=97.39  E-value=0.00016  Score=62.98  Aligned_cols=70  Identities=24%  Similarity=0.323  Sum_probs=46.3

Q ss_pred             hHHHHHHHHHhC----------CCCCCCCc-----HHHHHHHHHhCCCCCCCCC---cCCCCHHHHHHHHHhcccCCCCC
Q psy2131         149 WFGVILYILLVG----------YPPFWDED-----QHRLYAQIKAGAYDYPSPE---WDTVTPEAKNLINQMLTVNPSKR  210 (328)
Q Consensus       149 ~~G~~~~~~~~g----------~~pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R  210 (328)
                      .+|+++|+|++|          .+||....     .......+.........+.   ....++++.+++.+||..||.+|
T Consensus       208 slG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  287 (301)
T 3q4u_A          208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR  287 (301)
T ss_dssp             HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence            389999999999          88885532     1222222222222111111   12245789999999999999999


Q ss_pred             CCHHHHhc
Q psy2131         211 ITASEALK  218 (328)
Q Consensus       211 ~t~~~~l~  218 (328)
                      ||+.++++
T Consensus       288 ps~~~i~~  295 (301)
T 3q4u_A          288 LTALRIKK  295 (301)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHHH
Confidence            99999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	328
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-71
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-15
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-70
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-13
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-13
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-13
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-11
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-65
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-16
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-65
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-12
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-64
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-14
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-12
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-62
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-10
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-61
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-15
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-61
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-14
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-11
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-16
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-14
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-13
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-57
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-08
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-56
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-12
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-56
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-13
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-14
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-52
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-10
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-14
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-08
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-51
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-11
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-50
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-12
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-12
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-49
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-09
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-48
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-10
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-48
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-08
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-09
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-47
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-06
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-47
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-47
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-09
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-08
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-12
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-13
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-07
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-12
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-44
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-07
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-13
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-12
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-11
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-43
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-09
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-08
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-11
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-09
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-41
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-08
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-11
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-10
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-09
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-04
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-11
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-10
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-10
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-11
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-09
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-05
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-05
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (564), Expect = 3e-71
 Identities = 103/278 (37%), Positives = 146/278 (52%), Gaps = 29/278 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAFS V     K T    A K I  K L  ++   +E E  +  K++HPNIV L D  + 
Sbjct: 20  GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDDIYES 78

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
             + YL+  LV+GGELF+ IV + FY+E DAS  I Q+L++V + H  G+VHRDLKPENL
Sbjct: 79  GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGVI 153
           L  S  + + + ++DFGL+                                      GVI
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            YILL GYPPF+DE+  +L+ QI    Y++ SP WD ++  AK+ I  ++  +P KR T 
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258

Query: 214 SEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLK 251
            +AL+HPWI     +   +H Q   + +KK  A+ K K
Sbjct: 259 EQALQHPWIAGDTALDKNIH-QSVSEQIKKNFAKSKWK 295

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 73.9 bits (181), Expect = 1e-15
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 22/138 (15%)

Query: 200 NQMLTVNPSKRITAS--EALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKV----- 252
               T   + R+     +A+K+           IVHR    + L  ++     K+     
Sbjct: 101 KGFYTERDASRLIFQVLDAVKYLHDLG------IVHRDLKPENLLYYSLDEDSKIMISDF 154

Query: 253 ---------STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
                    S      GTPGY++PEVL ++PY K VD W+ GVI YILL GYPPF+DE+ 
Sbjct: 155 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214

Query: 304 HRLYAQIKAGAYDDEPKH 321
            +L+ QI    Y+ +  +
Sbjct: 215 AKLFEQILKAEYEFDSPY 232

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  219 bits (558), Expect = 8e-70
 Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 31/250 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV RCV+KATG  F AK INT     +    ++ E  I  +L HP ++ LHD+ ++
Sbjct: 40  GAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKLINLHDAFED 97

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    L+ + ++GGELF+ I A ++  SEA+  + ++Q  E + H H + +VH D+KPEN
Sbjct: 98  KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           ++  +K   + VK+ DFGLA ++  ++                               GV
Sbjct: 158 IMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 216

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + Y+LL G  PF  ED       +K   +++    + +V+PEAK+ I  +L   P KR+T
Sbjct: 217 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276

Query: 213 ASEALKHPWI 222
             +AL+HPW+
Sbjct: 277 VHDALEHPWL 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 68.2 bits (166), Expect = 1e-13
 Identities = 21/71 (29%), Positives = 34/71 (47%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
              +    T  + +PE++ +EP G   D+WA GV+ Y+LL G  PF  ED       +K 
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242

Query: 313 GAYDDEPKHKS 323
             ++ +    S
Sbjct: 243 CDWEFDEDAFS 253

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 5e-69
 Identities = 70/280 (25%), Positives = 133/280 (47%), Gaps = 38/280 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F +V RCV+ ++   + AK +   K+   D   +++E  I    +H NI+ LH+S + 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                ++F+ ++G ++FE I    F  +E +    + Q+ E++   HS+ + H D++PEN
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           ++  ++ + + +K+ +FG A +++                                  G 
Sbjct: 133 IIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           ++Y+LL G  PF  E   ++   I    Y +    +  ++ EA + ++++L      R+T
Sbjct: 192 LVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251

Query: 213 ASEALKHPWICQR-ERVASIVHRQETVDCLKKFNARRKLK 251
           ASEAL+HPW+ Q+ ERV++ V R      LK       L 
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRT-----LKHRRYYHTLI 286

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.8 bits (165), Expect = 2e-13
 Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 1/81 (1%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
           AR+       +     P Y +PEV + +      D+W+ G ++Y+LL G  PF  E   +
Sbjct: 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210

Query: 306 LYAQIKAGAYD-DEPKHKSAS 325
           +   I    Y  DE   K  S
Sbjct: 211 IIENIMNAEYTFDEEAFKEIS 231

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  216 bits (552), Expect = 6e-69
 Identities = 75/250 (30%), Positives = 127/250 (50%), Gaps = 31/250 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF VV R  ++ATG  FAAK + T   S +  + + +E +    L+HP +V LHD+ ++
Sbjct: 37  GAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFED 94

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +N   ++++ ++GGELFE +       SE +A   ++Q+ + + H H N  VH DLKPEN
Sbjct: 95  DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------FGV 152
           ++  +K     +KL DFGL   +  +Q                               GV
Sbjct: 155 IMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 213

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
           + YILL G  PF  E+       +K+  ++     +  ++ + K+ I ++L  +P+ R+T
Sbjct: 214 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273

Query: 213 ASEALKHPWI 222
             +AL+HPW+
Sbjct: 274 IHQALEHPWL 283

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 67.8 bits (165), Expect = 2e-13
 Identities = 20/76 (26%), Positives = 35/76 (46%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
                   + +   GT  + +PEV + +P G   D+W+ GV+ YILL G  PF  E+   
Sbjct: 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232

Query: 306 LYAQIKAGAYDDEPKH 321
               +K+  ++ +   
Sbjct: 233 TLRNVKSCDWNMDDSA 248

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (536), Expect = 5e-67
 Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 38/283 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V            A K ++ + K S   +Q + +E R  +KL+HPN ++      
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
            E+  +LV +   G       V ++   E + +      L+ + + HS+ ++HRD+K  N
Sbjct: 86  REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------W-FGV 152
           +LL+       VKL DFG A  +                                W  G+
Sbjct: 146 ILLSEPGL---VKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Query: 153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT 212
               L    PP ++ +       I     + P+ +    +   +N ++  L   P  R T
Sbjct: 203 TCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260

Query: 213 ASEALKHPWICQRERVASIVHR--QETVDCLKKFN--ARRKLK 251
           +   LKH ++  RER  +++    Q T D +++ +    RK+K
Sbjct: 261 SEVLLKHRFV-LRERPPTVIMDLIQRTKDAVRELDNLQYRKMK 302

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 3/71 (4%)

Query: 252 VSTRQGFAGTPGYLSPEVL---KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 308
           ++    F GTP +++PEV+    +  Y   VD+W+ G+    L    PP ++ +      
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224

Query: 309 QIKAGAYDDEP 319
            I         
Sbjct: 225 HIAQNESPALQ 235

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 2e-65
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 34/249 (13%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +K +    A K++   +L     +  L RE  I   L+HPNI+RL+    
Sbjct: 17  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    YL+ +    G ++ ++     + E   +  I ++  ++++CHS  V+HRD+KPEN
Sbjct: 77  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW--------------------------FGVI 153
           LLL S  +   +K+ADFG ++     ++                             GV+
Sbjct: 137 LLLGSAGE---LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITA 213
            Y  LVG PPF        Y +I    + +P    D VT  A++LI+++L  NPS+R   
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPML 249

Query: 214 SEALKHPWI 222
            E L+HPWI
Sbjct: 250 REVLEHPWI 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.4 bits (185), Expect = 2e-16
 Identities = 23/73 (31%), Positives = 33/73 (45%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F        S R    GT  YL PE+++   + + VD+W+ GV+ Y  LVG PPF     
Sbjct: 150 FGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209

Query: 304 HRLYAQIKAGAYD 316
              Y +I    + 
Sbjct: 210 QETYKRISRVEFT 222

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  204 bits (519), Expect = 7e-65
 Identities = 88/263 (33%), Positives = 131/263 (49%), Gaps = 44/263 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLE-------REARICRKLQ-HPNIV 52
           G  SVVRRC+ K T  E+A KII+     +   ++++       +E  I RK+  HPNI+
Sbjct: 14  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L D+ +   + +LVFDL+  GELF+ +  +   SE +    ++ +LE +   H   +VH
Sbjct: 74  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVH 133

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW----------------------- 149
           RDLKPEN+LL        +KL DFG + ++   ++                         
Sbjct: 134 RDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190

Query: 150 ----------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI 199
                      GVI+Y LL G PPFW   Q  +   I +G Y + SPEWD  +   K+L+
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250

Query: 200 NQMLTVNPSKRITASEALKHPWI 222
           ++ L V P KR TA EAL HP+ 
Sbjct: 251 SRFLVVQPQKRYTAEEALAHPFF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 63.9 bits (155), Expect = 3e-12
 Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 16/132 (12%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS-IVHRQETVDCLKKFNARRKLK 251
            E + ++  +L            AL    I  R+     I+   +    L  F    +L 
Sbjct: 110 KETRKIMRALLE--------VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161

Query: 252 VSTR-QGFAGTPGYLSPEVL------KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH 304
              + +   GTP YL+PE++          YGK VD+W+ GVI+Y LL G PPFW   Q 
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221

Query: 305 RLYAQIKAGAYD 316
            +   I +G Y 
Sbjct: 222 LMLRMIMSGNYQ 233

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-64
 Identities = 65/261 (24%), Positives = 120/261 (45%), Gaps = 37/261 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA   V   +  ATG E A + +N ++   ++   +  E  + R+ ++PNIV   DS   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLV 88

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            +  ++V + + GG L  D+V      E   +   ++ L+++   HSN V+HRD+K +N+
Sbjct: 89  GDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------W-FGV 152
           LL        VKL DFG   ++  EQ                             W  G+
Sbjct: 148 LLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 153 ILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +   ++ G PP+ +E+  R LY     G  +  +PE   ++   ++ +N+ L ++  KR 
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK--LSAIFRDFLNRCLDMDVEKRG 262

Query: 212 TASEALKHPWICQRERVASIV 232
           +A E L+H ++   + ++S+ 
Sbjct: 263 SAKELLQHQFLKIAKPLSSLT 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (171), Expect = 3e-14
 Identities = 22/73 (30%), Positives = 38/73 (52%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           S R    GTP +++PEV+ ++ YG  VDIW+ G++   ++ G PP+ +E+  R    I  
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 313 GAYDDEPKHKSAS 325
               +    +  S
Sbjct: 231 NGTPELQNPEKLS 243

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 4e-63
 Identities = 62/256 (24%), Positives = 106/256 (41%), Gaps = 40/256 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GAF  V +   K T +  AAK+I+TK  S  + +    E  I     HPNIV+L D+   
Sbjct: 23  GAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 80

Query: 61  ENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  +++ +   GG +   ++  E   +E+      +Q L+++N+ H N ++HRDLK  N
Sbjct: 81  ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN 140

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------------ 149
           +L         +KLADFG++ +     Q                                
Sbjct: 141 ILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197

Query: 150 ---FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
               G+ L  +    PP  + +  R+  +I          +    +   K+ + + L  N
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKN 256

Query: 207 PSKRITASEALKHPWI 222
              R T S+ L+HP++
Sbjct: 257 VDARWTTSQLLQHPFV 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.9 bits (155), Expect = 2e-12
 Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 5/78 (6%)

Query: 253 STRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY 307
             R  F GTP +++PEV+     K  PY    D+W+ G+ L  +    PP  + +  R+ 
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224

Query: 308 AQIKAGAYDDEPKHKSAS 325
            +I         +    S
Sbjct: 225 LKIAKSEPPTLAQPSRWS 242

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 6e-62
 Identities = 90/287 (31%), Positives = 133/287 (46%), Gaps = 47/287 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ 59
           G    V +   K T  +FA K++       +D  K  RE  +  +  Q P+IVR+ D  +
Sbjct: 23  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 60  ----EENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHR 113
                     +V + + GGELF  I  R  + ++E +AS  ++ I E++ + HS  + HR
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 135

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------ 149
           D+KPENLL  SK   A +KL DFG A E                                
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 195

Query: 150 ---FGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
               GVI+YILL GYPPF+          +  +I+ G Y++P+PEW  V+ E K LI  +
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255

Query: 203 LTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRK 249
           L   P++R+T +E + HPWI Q  +V        T   LK+   R +
Sbjct: 256 LKTEPTQRMTITEFMNHPWIMQSTKVPQT--PLHTSRVLKEDKERWE 300

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 26/76 (34%), Positives = 38/76 (50%)

Query: 237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYP 296
            +       A+     ++      TP Y++PEVL  E Y K  D+W+ GVI+YILL GYP
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211

Query: 297 PFWDEDQHRLYAQIKA 312
           PF+      +   +K 
Sbjct: 212 PFYSNHGLAISPGMKT 227

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-61
 Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 38/255 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G+FS V    + AT  E+A KI+  + +   +    + RE  +  +L HP  V+L+ + Q
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           ++   Y        GEL + I     + E        +I+ ++ + H  G++HRDLKPEN
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------------ 149
           +LL        +++ DFG A  +  E +                                
Sbjct: 139 ILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 195

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G I+Y L+ G PPF   +++ ++ +I    YD+P    +   P+A++L+ ++L ++ +K
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 251

Query: 210 RITASEALKHPWICQ 224
           R+   E   +  +  
Sbjct: 252 RLGCEEMEGYGPLKA 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.4 bits (177), Expect = 3e-15
 Identities = 32/129 (24%), Positives = 60/129 (46%), Gaps = 13/129 (10%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQRE-RVASIVHRQETVDCLKKFNARRKLK 251
              +    ++++        A E L    I  R+ +  +I+  ++    +  F   + L 
Sbjct: 108 TCTRFYTAEIVS--------ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159

Query: 252 VSTRQG----FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLY 307
             ++Q     F GT  Y+SPE+L ++   K  D+WA G I+Y L+ G PPF   +++ ++
Sbjct: 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219

Query: 308 AQIKAGAYD 316
            +I    YD
Sbjct: 220 QKIIKLEYD 228

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-61
 Identities = 80/254 (31%), Positives = 134/254 (52%), Gaps = 32/254 (12%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL----SARDFQKLEREARICRKLQHPNIVRLHD 56
           G F+VV++C +K+TGL++AAK I  ++          + +ERE  I +++QHPN++ LH+
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
             + +    L+ +LV GGELF+ +  +E  +E +A+  ++QIL  V + HS  + H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140

Query: 117 PENLLLASK-AKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
           PEN++L  +      +K+ DFGLA ++    +                            
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 200

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
             GVI YILL G  PF  + +    A + A  Y++    +   +  AK+ I ++L  +P 
Sbjct: 201 SIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 260

Query: 209 KRITASEALKHPWI 222
           KR+T  ++L+HPWI
Sbjct: 261 KRMTIQDSLQHPWI 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.8 bits (170), Expect = 3e-14
 Identities = 25/76 (32%), Positives = 41/76 (53%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
           A +    +  +   GTP +++PE++  EP G   D+W+ GVI YILL G  PF  + +  
Sbjct: 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

Query: 306 LYAQIKAGAYDDEPKH 321
             A + A  Y+ E ++
Sbjct: 224 TLANVSAVNYEFEDEY 239

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-59
 Identities = 67/253 (26%), Positives = 107/253 (42%), Gaps = 36/253 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V+  V + T    A KI++  K +    + +++E  I + L H N+V+ +   +E
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
            N  YL  +  +GGELF+ I       E DA     Q++  V + H  G+ HRD+KPENL
Sbjct: 75  GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQA------------------------------W- 149
           LL  +     +K++DFGLA   +   +                               W 
Sbjct: 135 LLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G++L  +L G  P+                  Y +P W  +      L++++L  NPS 
Sbjct: 192 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-WKKIDSAPLALLHKILVENPSA 250

Query: 210 RITASEALKHPWI 222
           RIT  +  K  W 
Sbjct: 251 RITIPDIKKDRWY 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 1/74 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
                  GT  Y++PE+LK+  +  +PVD+W+CG++L  +L G  P+             
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219

Query: 312 AGAYDDEPKHKSAS 325
                     K   
Sbjct: 220 KEKKTYLNPWKKID 233

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-59
 Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 45/261 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G++   ++  +K+ G     K ++   ++  + Q L  E  + R+L+HPNIVR +D I +
Sbjct: 15  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74

Query: 61  E--NYHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESVNHCH-----SNG 109
                 Y+V +   GG+L   I      R++  E      + Q+  ++  CH      + 
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------- 148
           V+HRDLKP N+ L  K     VKL DFGLA  +  +                        
Sbjct: 135 VLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 191

Query: 149 ------W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQ 201
                 W  G +LY L    PPF    Q  L  +I+ G +      +     E   +I +
Sbjct: 192 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS---DELNEIITR 248

Query: 202 MLTVNPSKRITASEALKHPWI 222
           ML +    R +  E L++P I
Sbjct: 249 MLNLKDYHRPSVEEILENPLI 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.3 bits (182), Expect = 7e-16
 Identities = 26/76 (34%), Positives = 38/76 (50%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           S  + F GTP Y+SPE + +  Y +  DIW+ G +LY L    PPF    Q  L  +I+ 
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

Query: 313 GAYDDEPKHKSASVVK 328
           G +   P   S  + +
Sbjct: 229 GKFRRIPYRYSDELNE 244

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-58
 Identities = 57/254 (22%), Positives = 107/254 (42%), Gaps = 36/254 (14%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V + +   T +E A   +  +KL+  + Q+ + EA + + LQHPNIVR +DS + 
Sbjct: 20  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79

Query: 61  ----ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRD 114
               +    LV +L+T G L   +   +           +QIL+ +   H+    ++HRD
Sbjct: 80  TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 139

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------W- 149
           LK +N+ +       +VK+ D GLA   +                             + 
Sbjct: 140 LKCDNIFITG--PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYA 197

Query: 150 FGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FG+ +  +     P+ +  +  ++Y ++ +G    P+       PE K +I   +  N  
Sbjct: 198 FGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKD 255

Query: 209 KRITASEALKHPWI 222
           +R +  + L H + 
Sbjct: 256 ERYSIKDLLNHAFF 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 17/86 (19%), Positives = 39/86 (45%), Gaps = 2/86 (2%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-D 302
                  + S  +   GTP +++PE+ + E Y + VD++A G+ +  +     P+ +  +
Sbjct: 159 LGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 217

Query: 303 QHRLYAQIKAGAYDDEPKHKSASVVK 328
             ++Y ++ +G         +   VK
Sbjct: 218 AAQIYRRVTSGVKPASFDKVAIPEVK 243

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-57
 Identities = 48/293 (16%), Positives = 99/293 (33%), Gaps = 71/293 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G   VV +   K +GL  A K+I+  ++      ++ RE ++  +   P IV  + +   
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPEN 119
           +    +  + + GG L + +       E         +++ + +    + ++HRD+KP N
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA-------------------------W-FGVI 153
           +L+ S+ +   +KL DFG++ ++                               W  G+ 
Sbjct: 136 ILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 192

Query: 154 LYILLVGYPPFWDEDQHRLYAQIKAGAY-------------------------------- 181
           L  + VG  P    D   L                                         
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252

Query: 182 --------DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE 226
                     P       + E ++ +N+ L  NP++R    + + H +I + +
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 1e-13
 Identities = 23/76 (30%), Positives = 29/76 (38%)

Query: 244 FNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ 303
           F    +L  S    F GT  Y+SPE L+   Y    DIW+ G+ L  + VG  P    D 
Sbjct: 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

Query: 304 HRLYAQIKAGAYDDEP 319
             L          D  
Sbjct: 209 KELELMFGCQVEGDAA 224

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  186 bits (474), Expect = 4e-57
 Identities = 56/258 (21%), Positives = 101/258 (39%), Gaps = 40/258 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHD 56
           G F  V  C +  TG  +A K ++ K++  +              +      P IV +  
Sbjct: 15  GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
           +    +    + DL+ GG+L   +     +SEAD      +I+  + H H+  VV+RDLK
Sbjct: 75  AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 134

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQAW--------------------------- 149
           P N+LL        V+++D GLA +   ++                              
Sbjct: 135 PANILLDEHGH---VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 191

Query: 150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
            G +L+ LL G+ PF        + +I            D+ +PE ++L+  +L  + ++
Sbjct: 192 LGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250

Query: 210 RIT-----ASEALKHPWI 222
           R+      A E  + P+ 
Sbjct: 251 RLGCLGRGAQEVKESPFF 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 51.7 bits (123), Expect = 5e-08
 Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 1/86 (1%)

Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPFW 299
           +                  GT GY++PEVL K   Y    D ++ G +L+ LL G+ PF 
Sbjct: 148 ISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

Query: 300 DEDQHRLYAQIKAGAYDDEPKHKSAS 325
                  +   +           S S
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFS 233

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-56
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 41/256 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 59
           G F  V    +KATG  +A KI+  + + A+D       E+R+ +  +HP +  L  + Q
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
             +    V +   GGELF  +     ++E  A     +I+ ++ + HS  VV+RD+K EN
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQ----------------------------AWFG 151
           L+L        +K+ DFGL  E   +                                 G
Sbjct: 136 LMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           V++Y ++ G  PF+++D  RL+  I      +P     T++PEAK+L+  +L  +P +R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 248

Query: 212 -----TASEALKHPWI 222
                 A E ++H + 
Sbjct: 249 GGGPSDAKEVMEHRFF 264

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (155), Expect = 3e-12
 Identities = 26/64 (40%), Positives = 39/64 (60%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 312
           +T + F GTP YL+PEVL+   YG+ VD W  GV++Y ++ G  PF+++D  RL+  I  
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

Query: 313 GAYD 316
               
Sbjct: 220 EEIR 223

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  182 bits (462), Expect = 6e-56
 Identities = 56/253 (22%), Positives = 109/253 (43%), Gaps = 38/253 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     +  G  +A K++  + +   +  +    E  +   + HP I+R+  + Q
Sbjct: 15  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    +++ D + GGELF  +   + +    A     ++  ++ + HS  +++RDLKPEN
Sbjct: 75  DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------FGVIL 154
           +LL        +K+ DFG A  V                                FG+++
Sbjct: 135 ILLDKNGH---IKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 191

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +L GY PF+D +  + Y +I      +P         + K+L+++++T + S+R+   
Sbjct: 192 YEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNL 247

Query: 212 --TASEALKHPWI 222
                +   HPW 
Sbjct: 248 QNGTEDVKNHPWF 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.8 bits (165), Expect = 2e-13
 Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 11/100 (11%)

Query: 231 IVHR----------QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVD 280
           I++R          +     +  F   + +         GTP Y++PEV+  +PY K +D
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEVVSTKPYNKSID 183

Query: 281 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK 320
            W+ G+++Y +L GY PF+D +  + Y +I        P 
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 7e-54
 Identities = 62/253 (24%), Positives = 104/253 (41%), Gaps = 38/253 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKK-LSARDFQKLEREARI-CRKLQHPNIVRLHDSI 58
           G+F  V     K T   FA K +     L   D +    E R+     +HP +  +  + 
Sbjct: 13  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           Q +   + V + + GG+L   I +   +  + A+    +I+  +   HS G+V+RDLK +
Sbjct: 73  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 132

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAW----------------------------F 150
           N+LL        +K+ADFG+  E                                    F
Sbjct: 133 NILLDKDGH---IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKR 210
           GV+LY +L+G  PF  +D+  L+  I+     YP      +  EAK+L+ ++    P KR
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKR 245

Query: 211 ITA-SEALKHPWI 222
           +    +  +HP  
Sbjct: 246 LGVRGDIRQHPLF 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (169), Expect = 5e-14
 Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 3/109 (2%)

Query: 211 ITASEALKHPWICQRERVAS-IVHRQETVDCLKKFNARRKLKVSTRQ--GFAGTPGYLSP 267
           I   + L    I  R+     I+  ++    +  F   ++  +   +   F GTP Y++P
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172

Query: 268 EVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 316
           E+L  + Y   VD W+ GV+LY +L+G  PF  +D+  L+  I+     
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 63/281 (22%), Positives = 97/281 (34%), Gaps = 59/281 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDS 57
           G F+ V +   K T    A K I     S       +   RE ++ ++L HPNI+ L D+
Sbjct: 9   GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68

Query: 58  IQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
              ++   LVFD +               + +     +   L+ + + H + ++HRDLKP
Sbjct: 69  FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 128

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------- 149
            NLLL        +KLADFGLA       +A+                            
Sbjct: 129 NNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD------------------- 189
             G IL  LL+  P    +       +I          +W                    
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245

Query: 190 -----TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR 225
                    +  +LI  +   NP  RITA++ALK  +   R
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.5 bits (143), Expect = 1e-10
 Identities = 18/70 (25%), Positives = 25/70 (35%), Gaps = 1/70 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
                   T  Y +PE+L     YG  VD+WA G IL  LL+  P    +       +I 
Sbjct: 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214

Query: 312 AGAYDDEPKH 321
                   + 
Sbjct: 215 ETLGTPTEEQ 224

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (430), Expect = 1e-51
 Identities = 54/258 (20%), Positives = 97/258 (37%), Gaps = 39/258 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ 59
           G  S V          + A K++         F     REA+    L HP IV ++D+ +
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77

Query: 60  EEN----YHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            E       Y+V + V G  L + +      +   A   I    +++N  H NG++HRD+
Sbjct: 78  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 137

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
           KP N+++++      VK+ DFG+A  +     +                           
Sbjct: 138 KPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 194

Query: 150 -----FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLT 204
                 G +LY +L G PPF  +    +  Q        PS   + ++ +   ++ + L 
Sbjct: 195 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA 254

Query: 205 VNPSKRITASEALKHPWI 222
            NP  R   +  ++   +
Sbjct: 255 KNPENRYQTAAEMRADLV 272

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 70.5 bits (172), Expect = 1e-14
 Identities = 22/111 (19%), Positives = 39/111 (35%), Gaps = 6/111 (5%)

Query: 211 ITASEALKHPWICQRE------RVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGY 264
             A        I  R+       +++    +     + +  A     V+      GT  Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 265 LSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 315
           LSPE  + +      D+++ G +LY +L G PPF  +    +  Q      
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  169 bits (428), Expect = 3e-51
 Identities = 67/276 (24%), Positives = 106/276 (38%), Gaps = 58/276 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +      G  FA K I  +K          RE  I ++L+H NIV+L+D I  
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +    LVF+ +         V         A   + Q+L  + +CH   V+HRDLKP+NL
Sbjct: 72  KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAW-----------------------------FG 151
           L+  + +   +K+ADFGLA       + +                              G
Sbjct: 132 LINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT------------------- 192
            I   ++ G P F    +     +I        S  W  VT                   
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 193 ------PEAKNLINQMLTVNPSKRITASEALKHPWI 222
                     +L+++ML ++P++RITA +AL+H + 
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 52.2 bits (124), Expect = 2e-08
 Identities = 17/72 (23%), Positives = 27/72 (37%), Gaps = 1/72 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 309
            V        T  Y +P+VL   + Y   +DIW+ G I   ++ G P F    +     +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212

Query: 310 IKAGAYDDEPKH 321
           I         K+
Sbjct: 213 IFRILGTPNSKN 224

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 4e-51
 Identities = 56/291 (19%), Positives = 98/291 (33%), Gaps = 72/291 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V +   + TG + A K +  +           RE +I + L+H N+V L +  + 
Sbjct: 21  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80

Query: 61  --------ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
                   +   YLVFD                ++ ++    +Q +L  + + H N ++H
Sbjct: 81  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 140

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW----------------------- 149
           RD+K  N+L+        +KLADFGLA      + +                        
Sbjct: 141 RDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197

Query: 150 ----------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT------- 192
                      G I+  +    P      +    A I           W  V        
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257

Query: 193 ---------------------PEAKNLINQMLTVNPSKRITASEALKHPWI 222
                                P A +LI+++L ++P++RI + +AL H + 
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.1 bits (147), Expect = 3e-11
 Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 1/80 (1%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWD 300
           + F+  +  + +       T  Y  PE+L  E  YG P+D+W  G I+  +    P    
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224

Query: 301 EDQHRLYAQIKAGAYDDEPK 320
             +    A I        P+
Sbjct: 225 NTEQHQLALISQLCGSITPE 244

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-50
 Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 52/273 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQ--HPNIVRL 54
           G F  V   ++ +  L  A K +   ++S      +  ++  E  + +K+      ++RL
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74

Query: 55  HDSIQEENYHYLVFDLVTGG-ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHR 113
            D  +  +   L+ +      +LF+ I  R    E  A     Q+LE+V HCH+ GV+HR
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 134

Query: 114 DLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF----------------------- 150
           D+K EN+L+        +KL DFG    ++      F                       
Sbjct: 135 DIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 192

Query: 151 ----GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
               G++LY ++ G  PF  +++      I  G   +       V+ E ++LI   L + 
Sbjct: 193 VWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSECQHLIRWCLALR 242

Query: 207 PSKRITASEALKHPWICQRERVASIVHRQETVD 239
           PS R T  E   HPW+        ++  QET +
Sbjct: 243 PSDRPTFEEIQNHPWM------QDVLLPQETAE 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (153), Expect = 5e-12
 Identities = 25/114 (21%), Positives = 46/114 (40%), Gaps = 11/114 (9%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLK--KFNARRKL 250
             A++   Q+L         A     +  +  R+     +        LK   F +   L
Sbjct: 110 ELARSFFWQVLE--------AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ 303
           K +    F GT  Y  PE ++   Y G+   +W+ G++LY ++ G  PF  +++
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 9e-50
 Identities = 48/262 (18%), Positives = 86/262 (32%), Gaps = 43/262 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F  V +          A K++N    + +  Q  + E  + RK +H NI+        
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YST 74

Query: 61  ENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
                +V     G  L+  +   E  +         +Q  + +++ H+  ++HRDLK  N
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------------- 148
           + L        VK+ DFGLA        +                               
Sbjct: 135 IFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191

Query: 149 -W-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--WDTVTPEAKNLINQMLT 204
            + FG++LY L+ G  P+ + +       +    Y  P             K L+ + L 
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251

Query: 205 VNPSKRITASEALKHPWICQRE 226
               +R    + L    +  R 
Sbjct: 252 KKRDERPLFPQILASIELLARS 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 3/70 (4%)

Query: 253 STRQGFAGTPGYLSPEVLK---KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 309
              +  +G+  +++PEV++   K PY    D++A G++LY L+ G  P+ + +       
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

Query: 310 IKAGAYDDEP 319
           +    Y    
Sbjct: 221 MVGRGYLSPD 230

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-49
 Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 45/264 (17%)

Query: 1   GAFSVV---RRCVQKATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQH-PNIVRL 54
           GA+  V   R+     TG  +A K++    +   A+  +    E ++   ++  P +V L
Sbjct: 35  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
           H + Q E   +L+ D + GGELF  +  RE ++E +    + +I+ ++ H H  G+++RD
Sbjct: 95  HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRD 154

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------- 149
           +K EN+LL S      V L DFGL+ E   ++                            
Sbjct: 155 IKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211

Query: 150 ------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
                  GV++Y LL G  PF  + +    A+I         P    ++  AK+LI ++L
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271

Query: 204 TVNPSKRI-----TASEALKHPWI 222
             +P KR+      A E  +H + 
Sbjct: 272 MKDPKKRLGCGPRDADEIKEHLFF 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.1 bits (129), Expect = 7e-09
 Identities = 20/63 (31%), Positives = 32/63 (50%), Gaps = 2/63 (3%)

Query: 260 GTPGYLSPEVL--KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDD 317
           GT  Y++P+++      + K VD W+ GV++Y LL G  PF  + +    A+I       
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251

Query: 318 EPK 320
           EP 
Sbjct: 252 EPP 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 66/253 (26%), Positives = 118/253 (46%), Gaps = 38/253 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 59
           G+F  V     K +G  +A KI++ +K+   +  +    E RI + +  P +V+L  S +
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           + +  Y+V + V GGE+F  +     +SE  A     QI+ +  + HS  +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------FGVIL 154
           LL+  +     +++ DFG A  V+G                               GV++
Sbjct: 172 LLIDQQGY---IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

Query: 155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI--- 211
           Y +  GYPPF+ +   ++Y +I +G   +PS      + + K+L+  +L V+ +KR    
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVDLTKRFGNL 284

Query: 212 --TASEALKHPWI 222
               ++   H W 
Sbjct: 285 KNGVNDIKNHKWF 297

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 59.0 bits (142), Expect = 2e-10
 Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 11/100 (11%)

Query: 231 IVHR----------QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVD 280
           +++R          Q+    +  F    K          GTP  L+PE++  + Y K VD
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF-GFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 281 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK 320
            WA GV++Y +  GYPPF+ +   ++Y +I +G       
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 68/284 (23%), Positives = 100/284 (35%), Gaps = 70/284 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G+F VV +     +G   A K +   K      +   RE +I RKL H NIVRL      
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYS 84

Query: 61  ------ENYHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVV 111
                 E Y  LV D V             A++          + Q+  S+ + HS G+ 
Sbjct: 85  SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144

Query: 112 HRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------- 149
           HRD+KP+NLLL      A +KL DFG A ++   +                         
Sbjct: 145 HRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202

Query: 150 ------FGVILYILLVGYPPFWDEDQHRLYAQI-------------------------KA 178
                  G +L  LL+G P F  +       +I                         + 
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262

Query: 179 GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
            A+ +         PEA  L +++L   P+ R+T  EA  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.1 bits (124), Expect = 3e-08
 Identities = 14/66 (21%), Positives = 29/66 (43%), Gaps = 1/66 (1%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSP-EVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH 304
           A++ ++      +  +  Y +P  +     Y   +D+W+ G +L  LL+G P F  +   
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229

Query: 305 RLYAQI 310
               +I
Sbjct: 230 DQLVEI 235

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-48
 Identities = 65/288 (22%), Positives = 102/288 (35%), Gaps = 70/288 (24%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+ +V         +  A K I+         Q+  RE +I  + +H NI+ ++D I+ 
Sbjct: 19  GAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77

Query: 61  ENYH-----YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
                    YLV  L+  G     ++  +  S     + + QIL  + + HS  V+HRDL
Sbjct: 78  PTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
           KP NLLL +      +K+ DFGLA     +                              
Sbjct: 136 KPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192

Query: 150 ------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-------------- 189
                  G IL  +L   P F  +        I          + +              
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252

Query: 190 -------------TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
                            +A +L+++MLT NP KRI   +AL HP++ Q
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (134), Expect = 2e-09
 Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 1/82 (1%)

Query: 240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVGYPPF 298
            L +              +  T  Y +PE++   + Y K +DIW+ G IL  +L   P F
Sbjct: 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213

Query: 299 WDEDQHRLYAQIKAGAYDDEPK 320
             +        I         +
Sbjct: 214 PGKHYLDQLNHILGILGSPSQE 235

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-47
 Identities = 62/277 (22%), Positives = 97/277 (35%), Gaps = 58/277 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V +   + T    A K +              RE  + ++L+H NIVRLHD +  
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENL 120
           +    LVF+                         + Q+L+ +  CHS  V+HRDLKP+NL
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132

Query: 121 LLASKAKGAAVKLADFGLAIEVQGEQQAW-----------------------------FG 151
           L+    +   +KLA+FGLA       + +                              G
Sbjct: 133 LINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

Query: 152 VILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT------------------ 192
            I   L     P F   D      +I          +W ++T                  
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249

Query: 193 -------PEAKNLINQMLTVNPSKRITASEALKHPWI 222
                     ++L+  +L  NP +RI+A EAL+HP+ 
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (103), Expect = 9e-06
 Identities = 15/63 (23%), Positives = 22/63 (34%), Gaps = 2/63 (3%)

Query: 261 TPGYLSPEVL-KKEPYGKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDDE 318
           T  Y  P+VL   + Y   +D+W+ G I   L     P F   D      +I        
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223

Query: 319 PKH 321
            + 
Sbjct: 224 EEQ 226

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-47
 Identities = 62/281 (22%), Positives = 104/281 (37%), Gaps = 64/281 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           GA+  V   V   TG + A K +     S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88

Query: 61  EN------YHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
           +         YLV   +  G     ++  E   E      + Q+L+ + + H+ G++HRD
Sbjct: 89  DETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------- 149
           LKP NL +    +   +K+ DFGLA +   E   +                         
Sbjct: 147 LKPGNLAVNEDCE---LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 203

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD------------------- 189
             G I+  ++ G   F   D      +I       P+                       
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263

Query: 190 --------TVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                     +P A NL+ +ML ++  +R+TA EAL HP+ 
Sbjct: 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 2e-09
 Identities = 26/129 (20%), Positives = 42/129 (32%), Gaps = 9/129 (6%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKV 252
              + L+ QML             +    I  R+     +   E  +         +   
Sbjct: 121 DRIQFLVYQMLK--------GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172

Query: 253 STRQGFAGTPGYLSPEV-LKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 311
           S   G+  T  Y +PEV L    Y + VDIW+ G I+  ++ G   F   D      +I 
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 312 AGAYDDEPK 320
                   +
Sbjct: 233 KVTGTPPAE 241

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 68/283 (24%), Positives = 102/283 (36%), Gaps = 64/283 (22%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ- 59
           GA+  V       TGL  A K ++    S    ++  RE R+ + ++H N++ L D    
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88

Query: 60  -----EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
                E N  YLV  L+  G    +IV  +  ++      I QIL  + + HS  ++HRD
Sbjct: 89  ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------- 149
           LKP NL      +   +K+ DFGLA     E   +                         
Sbjct: 147 LKPSNLA---VNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

Query: 150 -FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT------------------ 190
             G I+  LL G   F   D       I        +                       
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263

Query: 191 ---------VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ 224
                      P A +L+ +ML ++  KRITA++AL H +  Q
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.3 bits (132), Expect = 3e-09
 Identities = 29/170 (17%), Positives = 50/170 (29%), Gaps = 9/170 (5%)

Query: 152 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           + L  +        + +   L   +     +             + LI Q+L        
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR------- 132

Query: 212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEV-L 270
              + +    I  R+   S +   E  +         +       G+  T  Y +PE+ L
Sbjct: 133 -GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 191

Query: 271 KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK 320
               Y + VDIW+ G I+  LL G   F   D       I         +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-46
 Identities = 70/277 (25%), Positives = 108/277 (38%), Gaps = 58/277 (20%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G + VV +   K TG   A K I     +        RE  + ++L HPNIV+L D I  
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72

Query: 61  ENYHYLVFDLV-TGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           EN  YLVF+ +    + F D  A            + Q+L+ +  CHS+ V+HRDLKP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-----------------------------F 150
           LL+ ++     +KLADFGLA       + +                              
Sbjct: 133 LLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189

Query: 151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD--------------------- 189
           G I   ++     F  + +     +I           W                      
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249

Query: 190 ----TVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                +  + ++L++QML  +P+KRI+A  AL HP+ 
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (127), Expect = 1e-08
 Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 309
            V T      T  Y +PE+L    Y    VDIW+ G I   ++     F  + +     +
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

Query: 310 I 310
           I
Sbjct: 215 I 215

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-46
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 46/273 (16%)

Query: 1   GAFSVVRRCVQKAT--GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  VR+ V +     ++ A K++  +     D +++ REA+I  +L +P IVRL    
Sbjct: 20  GNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 78

Query: 59  QEENYHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           Q E    LV ++  GG L + +V  RE    ++ +  + Q+   + +      VHRDL  
Sbjct: 79  QAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 137

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------- 149
            N+LL ++      K++DFGL+  +  +   +                            
Sbjct: 138 RNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194

Query: 150 ---FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
              +GV ++  L  G  P+       + A I+ G             PE   L++     
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPECPPELYALMSDCWIY 251

Query: 206 NPSKRITASE---ALKHPWICQRERVASIVHRQ 235
               R         ++  +     +V    H  
Sbjct: 252 KWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 7e-12
 Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 1/89 (1%)

Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFW 299
           L K         + R        + +PE +    +    D+W+ GV ++  L  G  P+ 
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214

Query: 300 DEDQHRLYAQIKAGAYDDEPKHKSASVVK 328
                 + A I+ G   + P      +  
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYA 243

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-45
 Identities = 47/258 (18%), Positives = 96/258 (37%), Gaps = 44/258 (17%)

Query: 1   GAFSVVRRCV--QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V++     K      A KI+  +        +L  EA + ++L +P IVR+    
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 77

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           + E++  LV ++   G L + +       + +    + Q+   + +   +  VHRDL   
Sbjct: 78  EAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 136

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAW----------------------------- 149
           N+LL ++      K++DFGL+  ++ ++  +                             
Sbjct: 137 NVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193

Query: 150 --FGVILYILL-VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVN 206
             FGV+++     G  P+       + A ++ G              E  +L+N   T +
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMNLCWTYD 250

Query: 207 PSKRITASE---ALKHPW 221
              R   +     L++ +
Sbjct: 251 VENRPGFAAVELRLRNYY 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.1 bits (163), Expect = 2e-13
 Identities = 13/90 (14%), Positives = 29/90 (32%), Gaps = 1/90 (1%)

Query: 240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILL-VGYPPF 298
            L K     +     +        + +PE +    +    D+W+ GV+++     G  P+
Sbjct: 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

Query: 299 WDEDQHRLYAQIKAGAYDDEPKHKSASVVK 328
                  + A ++ G     P      +  
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPREMYD 241

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (389), Expect = 2e-45
 Identities = 55/250 (22%), Positives = 97/250 (38%), Gaps = 41/250 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G +  V   V K   L  A K +    +   +F    +EA + ++++HPN+V+L      
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHPNLVQLLGVCTR 84

Query: 61  ENYHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +T G L + +    R+  S     +   QI  ++ +      +HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA-----------------------------W 149
           N L+        VK+ADFGL+  + G+                                 
Sbjct: 145 NCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201

Query: 150 FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FGV+L+ I   G  P+   D  ++Y  ++    DY     +    +   L+      NPS
Sbjct: 202 FGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPS 258

Query: 209 KRITASEALK 218
            R + +E  +
Sbjct: 259 DRPSFAEIHQ 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 49.7 bits (118), Expect = 1e-07
 Identities = 17/79 (21%), Positives = 32/79 (40%), Gaps = 1/79 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQ 309
             +   G      + +PE L    +    D+WA GV+L+ I   G  P+   D  ++Y  
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228

Query: 310 IKAGAYDDEPKHKSASVVK 328
           ++     + P+     V +
Sbjct: 229 LEKDYRMERPEGCPEKVYE 247

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-44
 Identities = 70/288 (24%), Positives = 100/288 (34%), Gaps = 63/288 (21%)

Query: 1   GAFSVVRRCVQKATGLEFAA-KIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHD 56
           GA+  V +      G  F A K +  +           RE  + R L   +HPN+VRL D
Sbjct: 18  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77

Query: 57  -----SIQEENYHYLVFDLVTGGEL-FEDIVAREFYSEADASHCIQQILESVNHCHSNGV 110
                    E    LVF+ V      + D V             + Q+L  ++  HS+ V
Sbjct: 78  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 137

Query: 111 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW--------------------- 149
           VHRDLKP+N+L+ S  +   +KLADFGLA     +                         
Sbjct: 138 VHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194

Query: 150 ------FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--------------- 188
                  G I   +    P F          +I          +W               
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254

Query: 189 --------DTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV 228
                     +    K+L+ + LT NP+KRI+A  AL HP+    ER 
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 5e-12
 Identities = 21/91 (23%), Positives = 29/91 (31%), Gaps = 11/91 (12%)

Query: 231 IVHR-----------QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPV 279
           +VHR              +       AR             T  Y +PEVL +  Y  PV
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 196

Query: 280 DIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
           D+W+ G I   +    P F          +I
Sbjct: 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-44
 Identities = 44/250 (17%), Positives = 88/250 (35%), Gaps = 41/250 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F VV+    +    + A K+I    +S  +F     EA++   L H  +V+L+    +
Sbjct: 15  GQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGVCTK 70

Query: 61  ENYHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +   +++ + +  G L   +   R  +         + + E++ +  S   +HRDL   N
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-----------------------------F 150
            L+  +     VK++DFGL+  V  ++                                F
Sbjct: 131 CLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187

Query: 151 GVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           GV+++ I  +G  P+           I  G            + +   ++         +
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADE 244

Query: 210 RITASEALKH 219
           R T    L +
Sbjct: 245 RPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 6e-12
 Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 1/79 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQ 309
           + ++  G      +  PEVL    +    DIWA GV+++ I  +G  P+           
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213

Query: 310 IKAGAYDDEPKHKSASVVK 328
           I  G     P   S  V  
Sbjct: 214 IAQGLRLYRPHLASEKVYT 232

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  151 bits (383), Expect = 4e-44
 Identities = 60/286 (20%), Positives = 115/286 (40%), Gaps = 75/286 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 59
           G +S V   +      +   KI+   K      +K++RE +I   L+  PNI+ L D ++
Sbjct: 46  GKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVK 100

Query: 60  E--ENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           +       LVF+ V   +  +     +  ++ D    + +IL+++++CHS G++HRD+KP
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 157

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------- 149
            N+++    +   ++L D+GLA      Q+                              
Sbjct: 158 HNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 215

Query: 150 FGVILYILLVGYPPFW----DEDQHRLYAQIKAGAYDY---------------------- 183
            G +L  ++    PF+    + DQ    A++      Y                      
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 275

Query: 184 --------PSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW 221
                    S     V+PEA + ++++L  +   R+TA EA++HP+
Sbjct: 276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 48.3 bits (114), Expect = 5e-07
 Identities = 15/117 (12%), Positives = 39/117 (33%), Gaps = 12/117 (10%)

Query: 193 PEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS--IVHRQETVDCLKKFN-ARRK 249
            + +  + ++L         A +      I  R+      ++  +     L  +  A   
Sbjct: 129 YDIRFYMYEILK--------ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 250 LKVSTRQGFAGTPGYLSPEV-LKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
                      +  +  PE+ +  + Y   +D+W+ G +L  ++    PF+    + 
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 8e-44
 Identities = 47/248 (18%), Positives = 90/248 (36%), Gaps = 41/248 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQ 59
           G F  V     +  G + A K I     +    Q    EA +  +L+H N+V+L    ++
Sbjct: 18  GEFGDVMLGDYR--GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
           E+   Y+V + +  G L + + +R                + E++ +   N  VHRDL  
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------FGV 152
            N+L++        K++DFGL  E    Q                            FG+
Sbjct: 132 RNVLVSEDNV---AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 188

Query: 153 ILYILL-VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI 211
           +L+ +   G  P+       +  +++ G   Y     D   P    ++     ++ + R 
Sbjct: 189 LLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245

Query: 212 TASEALKH 219
           +  +  + 
Sbjct: 246 SFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 1/117 (0%)

Query: 213 ASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK 272
           A E L+      R+  A  V   E            K   ST+        + +PE L++
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 174

Query: 273 EPYGKPVDIWACGVILYILL-VGYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK 328
           + +    D+W+ G++L+ +   G  P+       +  +++ G   D P     +V +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-43
 Identities = 49/250 (19%), Positives = 87/250 (34%), Gaps = 41/250 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F +V          + A K I    +S  DF     EA +  KL HP +V+L+    E
Sbjct: 16  GQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGVCLE 71

Query: 61  ENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           +    LVF+ +  G L + +  +   ++          + E + +     V+HRDL   N
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQAW-----------------------------F 150
            L+        +K++DFG+   V  +Q                                F
Sbjct: 132 CLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188

Query: 151 GVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSK 209
           GV+++ +   G  P+ +     +   I  G   +   +    +     ++N      P  
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWKERPED 245

Query: 210 RITASEALKH 219
           R   S  L+ 
Sbjct: 246 RPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 7e-12
 Identities = 17/79 (21%), Positives = 33/79 (41%), Gaps = 1/79 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQ 309
           + ++  G      + SPEV     Y    D+W+ GV+++ +   G  P+ +     +   
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214

Query: 310 IKAGAYDDEPKHKSASVVK 328
           I  G    +P+  S  V +
Sbjct: 215 ISTGFRLYKPRLASTHVYQ 233

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-43
 Identities = 52/265 (19%), Positives = 91/265 (34%), Gaps = 52/265 (19%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD-FQKLEREARICRKL-QHPNIVRLHDSI 58
           G F  V +   K  GL   A I   K+ +++D  +    E  +  KL  HPNI+ L  + 
Sbjct: 21  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREFY----------------SEADASHCIQQILESV 102
           +   Y YL  +    G L + +                      S     H    +   +
Sbjct: 81  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140

Query: 103 NHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------- 149
           ++      +HRDL   N+L+         K+ADFGL+   +   +               
Sbjct: 141 DYLSQKQFIHRDLAARNILVGENYV---AKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 197

Query: 150 --------------FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 194
                         +GV+L+ ++  G  P+       LY ++  G   Y   +      E
Sbjct: 198 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDE 254

Query: 195 AKNLINQMLTVNPSKRITASEALKH 219
             +L+ Q     P +R + ++ L  
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVS 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 6e-11
 Identities = 26/160 (16%), Positives = 52/160 (32%), Gaps = 3/160 (1%)

Query: 172 LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS- 230
           L   ++        P +      A  L +Q L    +      + L       R+  A  
Sbjct: 98  LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157

Query: 231 -IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY 289
            +V             +R +     +        +++ E L    Y    D+W+ GV+L+
Sbjct: 158 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217

Query: 290 ILLV-GYPPFWDEDQHRLYAQIKAGAYDDEPKHKSASVVK 328
            ++  G  P+       LY ++  G   ++P +    V  
Sbjct: 218 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-43
 Identities = 48/250 (19%), Positives = 84/250 (33%), Gaps = 43/250 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V          + A K +    +S   F     EA + ++LQH  +VRL+  + +
Sbjct: 24  GQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQRLVRLYAVVTQ 79

Query: 61  ENYHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y++ + +  G L + +        +         QI E +        +HRDL+  
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQAW----------------------------- 149
           N+L++        K+ADFGLA  ++  +                                
Sbjct: 139 NILVSDTLS---CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 150 FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FG++L  ++  G  P+       +   ++ G   Y     D    E   L+       P 
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPE 252

Query: 209 KRITASEALK 218
            R T      
Sbjct: 253 DRPTFDYLRS 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 12/76 (15%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKA 312
            R+G      + +PE +    +    D+W+ G++L  ++  G  P+       +   ++ 
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

Query: 313 GAYDDEPKHKSASVVK 328
           G     P +    + +
Sbjct: 226 GYRMVRPDNCPEELYQ 241

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 45/278 (16%), Positives = 85/278 (30%), Gaps = 64/278 (23%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKL-QHPNIVRLH 55
           GAF  V             +  +  K L  +    + + L  E ++  +L  H NIV L 
Sbjct: 48  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVARE-----------------------FYSEADAS 92
            +       YL+F+    G+L   + ++                          +  D  
Sbjct: 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167

Query: 93  HCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW--- 149
               Q+ + +        VHRDL   N+L+        VK+ DFGLA ++  +       
Sbjct: 168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARDIMSDSNYVVRG 224

Query: 150 ---------------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAY 181
                                      +G++L+ I  +G  P+        + ++    +
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284

Query: 182 DYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
               P +   T E   ++      +  KR +       
Sbjct: 285 KMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.9 bits (126), Expect = 2e-08
 Identities = 14/78 (17%), Positives = 33/78 (42%), Gaps = 2/78 (2%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIK 311
             R        +++PE L +  Y    D+W+ G++L+ I  +G  P+        + ++ 
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 312 AGAYD-DEPKHKSASVVK 328
              +  D+P + +  +  
Sbjct: 281 QNGFKMDQPFYATEEIYI 298

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (370), Expect = 2e-42
 Identities = 41/256 (16%), Positives = 84/256 (32%), Gaps = 43/256 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINT--KKLSARDFQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V     K  G       I T     + +  +    EA I  +  HPN++ L   +
Sbjct: 37  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96

Query: 59  QEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
            +     ++ + +  G L   +   +  ++       ++ I   + +      VHRDL  
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------- 149
            N+L+ S       K++DFGL+  ++ +                                
Sbjct: 157 RNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213

Query: 150 -----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
                +G++++ ++  G  P+WD     +   I+    DY  P           L+    
Sbjct: 214 SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCW 270

Query: 204 TVNPSKRITASEALKH 219
             + + R    + +  
Sbjct: 271 QKDRNHRPKFGQIVNT 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 59.8 bits (144), Expect = 7e-11
 Identities = 12/78 (15%), Positives = 34/78 (43%), Gaps = 1/78 (1%)

Query: 252 VSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQI 310
            ++  G      + +PE ++   +    D+W+ G++++ ++  G  P+WD     +   I
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246

Query: 311 KAGAYDDEPKHKSASVVK 328
           +       P    +++ +
Sbjct: 247 EQDYRLPPPMDCPSALHQ 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-41
 Identities = 56/256 (21%), Positives = 89/256 (34%), Gaps = 43/256 (16%)

Query: 1   GAFSVVRRCVQKAT---GLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHD 56
           G+F VVRR    A     +  A K +    LS  +      RE      L H N++RL+ 
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            +       +V +L   G L + +   +  +     S    Q+ E + +  S   +HRDL
Sbjct: 79  VVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
              NLLLA++     VK+ DFGL   +      +                          
Sbjct: 138 AARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194

Query: 150 -----FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
                FGV L+ +   G  P+   +  ++  +I       P PE      +  N++ Q  
Sbjct: 195 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCW 252

Query: 204 TVNPSKRITASEALKH 219
              P  R T       
Sbjct: 253 AHKPEDRPTFVALRDF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (135), Expect = 1e-09
 Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 2/90 (2%)

Query: 241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFW 299
           L +   +       ++       + +PE LK   +    D W  GV L+ +   G  P+ 
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 300 DEDQHRLYAQIKAGAYD-DEPKHKSASVVK 328
             +  ++  +I         P+     +  
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYN 246

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 4e-41
 Identities = 54/260 (20%), Positives = 91/260 (35%), Gaps = 45/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V       T    A K +    +S   F    +EA++ +KL+H  +V+L+  + E
Sbjct: 28  GCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFL---QEAQVMKKLRHEKLVQLYAVVSE 83

Query: 61  ENYHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPE 118
           E   Y+V + ++ G L + +      +           QI   + +      VHRDL+  
Sbjct: 84  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142

Query: 119 NLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------------------W- 149
           N+L+         K+ADFGLA  ++  +                              W 
Sbjct: 143 NILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199

Query: 150 FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPS 208
           FG++L  L   G  P+       +  Q++ G   Y  P          +L+ Q     P 
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPE 256

Query: 209 KRITASEALK--HPWICQRE 226
           +R T          +    E
Sbjct: 257 ERPTFEYLQAFLEDYFTSTE 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (153), Expect = 4e-12
 Identities = 16/79 (20%), Positives = 30/79 (37%), Gaps = 1/79 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQ 309
           + + RQG      + +PE      +    D+W+ G++L  L   G  P+       +  Q
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226

Query: 310 IKAGAYDDEPKHKSASVVK 328
           ++ G     P     S+  
Sbjct: 227 VERGYRMPCPPECPESLHD 245

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-41
 Identities = 56/293 (19%), Positives = 103/293 (35%), Gaps = 77/293 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---- 56
           GA  +V            A K ++    +    ++  RE  + + + H NI+ L +    
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87

Query: 57  --SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRD 114
             +++E    YLV +L+         V +        S+ + Q+L  + H HS G++HRD
Sbjct: 88  QKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144

Query: 115 LKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------------------------- 149
           LKP N+++ S      +K+ DFGLA                                   
Sbjct: 145 LKPSNIVVKSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 150 --FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----------------------- 184
              G I+  ++     F   D    + ++                               
Sbjct: 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 261

Query: 185 ---------------SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI 222
                          S        +A++L+++ML ++P+KRI+  +AL+HP+I
Sbjct: 262 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 2e-08
 Identities = 17/76 (22%), Positives = 29/76 (38%)

Query: 246 ARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR 305
           AR          +  T  Y +PEV+    Y + VDIW+ G I+  ++     F   D   
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Query: 306 LYAQIKAGAYDDEPKH 321
            + ++        P+ 
Sbjct: 226 QWNKVIEQLGTPCPEF 241

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 7e-41
 Identities = 43/261 (16%), Positives = 92/261 (35%), Gaps = 42/261 (16%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKL----SARDFQKLEREARICRKLQHPNIVRLHD 56
           GAF  V + +    G +    +   K+L    S +  +++  EA +   + +P++ RL  
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAI-KELREATSPKANKEILDEAYVMASVDNPHVCRLLG 78

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLK 116
                    +   +  G  L      ++        +   QI + +N+     +VHRDL 
Sbjct: 79  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 138

Query: 117 PENLLLASKAKGAAVKLADFGLAIEVQGEQQA---------------------------- 148
             N+L+ +      VK+ DFGLA  +  E++                             
Sbjct: 139 ARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195

Query: 149 --WFGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTV 205
              +GV ++ ++  G  P+       + + ++ G      P+    T +   ++ +   +
Sbjct: 196 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMVKCWMI 252

Query: 206 NPSKRITASEALKHPWICQRE 226
           +   R    E +       R+
Sbjct: 253 DADSRPKFRELIIEFSKMARD 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (148), Expect = 3e-11
 Identities = 13/79 (16%), Positives = 31/79 (39%), Gaps = 1/79 (1%)

Query: 251 KVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQ 309
           K    +G      +++ E +    Y    D+W+ GV ++ ++  G  P+       + + 
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225

Query: 310 IKAGAYDDEPKHKSASVVK 328
           ++ G    +P   +  V  
Sbjct: 226 LEKGERLPQPPICTIDVYM 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (355), Expect = 2e-40
 Identities = 46/265 (17%), Positives = 87/265 (32%), Gaps = 47/265 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN-IVRLHDSIQ 59
           G+F  +      A G E A K+   K        +L  E++I + +Q    I  +     
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           E +Y+ +V +L+              +S         Q++  + + HS   +HRD+KP+N
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133

Query: 120 LLLASKAKGAAVKLADFGLAIEVQGEQQA------------------------------- 148
            L+    KG  V + DFGLA + +  +                                 
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193

Query: 149 ---W-FGVILYILLVGYPPF---WDEDQHRLYAQIKAGAYDYPSPE-WDTVTPEAKNLIN 200
                 G +L    +G  P+       + + Y +I       P          E    +N
Sbjct: 194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 253

Query: 201 QMLTVNPSKRITAS---EALKHPWI 222
              ++    +   S   +  ++ + 
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 56.8 bits (136), Expect = 7e-10
 Identities = 9/66 (13%), Positives = 19/66 (28%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 313
             +   GT  Y S          +  D+ + G +L    +G  P+          + +  
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 314 AYDDEP 319
           +     
Sbjct: 229 SEKKMS 234

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-40
 Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 40/252 (15%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRLHDSI 58
           G F  V + +  +      A  I T K    D   +K  +EA   R+  HP+IV+L   I
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77

Query: 59  QEENYHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESVNHCHSNGVVHRDLKP 117
             EN  +++ +L T GEL   +  R++    A       Q+  ++ +  S   VHRD+  
Sbjct: 78  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 136

Query: 118 ENLLLASKAKGAAVKLADFGLAIEVQGEQQAW---------------------------- 149
            N+L++S      VKL DFGL+  ++                                  
Sbjct: 137 RNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 193

Query: 150 -FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNP 207
            FGV ++ IL+ G  PF     + +  +I+ G      P      P   +L+ +    +P
Sbjct: 194 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPPTLYSLMTKCWAYDP 250

Query: 208 SKRITASEALKH 219
           S+R   +E    
Sbjct: 251 SRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 6e-09
 Identities = 14/76 (18%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIKA 312
                     +++PE +    +    D+W  GV ++ IL+ G  PF     + +  +I+ 
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224

Query: 313 GAYDDEPKHKSASVVK 328
           G     P +   ++  
Sbjct: 225 GERLPMPPNCPPTLYS 240

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-39
 Identities = 45/273 (16%), Positives = 86/273 (31%), Gaps = 61/273 (22%)

Query: 1   GAFSVVRRC-----VQKATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRL 54
           GAF  V        ++    +  A K++        + + L  E ++   L  H NIV L
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNIVNL 92

Query: 55  HDSIQEENYHYLVFDLVTGGELFEDI------------------VAREFYSEADASHCIQ 96
             +        ++ +    G+L   +                           D      
Sbjct: 93  LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152

Query: 97  QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA-------- 148
           Q+ + +    S   +HRDL   N+LL         K+ DFGLA +++ +           
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRI---TKICDFGLARDIKNDSNYVVKGNARL 209

Query: 149 ----------------------WFGVILYILL-VGYPPFWDEDQHRLYAQIKAGAYDYPS 185
                                  +G+ L+ L  +G  P+        + ++    +   S
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269

Query: 186 PEWDTVTPEAKNLINQMLTVNPSKRITASEALK 218
           PE      E  +++      +P KR T  + ++
Sbjct: 270 PEH--APAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 2/93 (2%)

Query: 238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
            D     + +       +        +++PE +    Y    D+W+ G+ L+ L      
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 298 FWD--EDQHRLYAQIKAGAYDDEPKHKSASVVK 328
            +       + Y  IK G     P+H  A +  
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-38
 Identities = 45/255 (17%), Positives = 94/255 (36%), Gaps = 44/255 (17%)

Query: 1   GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 56
           G F  V + + K +     +  A K +     + +       EA I  +  H NI+RL  
Sbjct: 18  GEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76

Query: 57  SIQEENYHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            I +     ++ + +  G L + +  ++  +S       ++ I   + +  +   VHRDL
Sbjct: 77  VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------------- 149
              N+L+ S       K++DFGL+  ++ + +A                           
Sbjct: 137 AARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 193

Query: 150 -----FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML 203
                FG++++ ++  G  P+W+   H +   I  G   +  P           L+ Q  
Sbjct: 194 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCW 250

Query: 204 TVNPSKRITASEALK 218
               ++R   ++ + 
Sbjct: 251 QQERARRPKFADIVS 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (150), Expect = 1e-11
 Identities = 15/90 (16%), Positives = 35/90 (38%), Gaps = 1/90 (1%)

Query: 240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPF 298
            L +          T  G      + +PE +    +    D+W+ G++++ ++  G  P+
Sbjct: 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214

Query: 299 WDEDQHRLYAQIKAGAYDDEPKHKSASVVK 328
           W+   H +   I  G     P    +++ +
Sbjct: 215 WELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (327), Expect = 3e-36
 Identities = 50/278 (17%), Positives = 90/278 (32%), Gaps = 67/278 (24%)

Query: 1   GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           GAF  V +               A K++  ++ SA      +REA +  +  +PNIV+L 
Sbjct: 24  GAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLL 82

Query: 56  DSIQEENYHYLVFDLVTGGELFEDIVAREFY------------------------SEADA 91
                     L+F+ +  G+L E + +   +                        S A+ 
Sbjct: 83  GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 142

Query: 92  SHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-- 149
               +Q+   + +      VHRDL   N L+        VK+ADFGL+  +         
Sbjct: 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLSRNIYSADYYKAD 199

Query: 150 ----------------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA 180
                                       +GV+L+ I   G  P++      +   ++ G 
Sbjct: 200 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG- 258

Query: 181 YDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK 218
                   +    E  NL+    +  P+ R +     +
Sbjct: 259 --NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 56.8 bits (136), Expect = 6e-10
 Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 1/77 (1%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIK 311
                 A    ++ PE +    Y    D+WA GV+L+ I   G  P++      +   ++
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256

Query: 312 AGAYDDEPKHKSASVVK 328
            G     P++    +  
Sbjct: 257 DGNILACPENCPLELYN 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 8e-36
 Identities = 52/274 (18%), Positives = 94/274 (34%), Gaps = 62/274 (22%)

Query: 1   GAFSVVRRCVQKAT-------GLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIV 52
           GAF  V                 + A K++     + +D   L  E  + + + +H NI+
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNII 82

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDI----------------VAREFYSEADASHCIQ 96
            L  +  ++   Y++ +  + G L E +                   E  S  D   C  
Sbjct: 83  NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142

Query: 97  QILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW------- 149
           Q+   + +  S   +HRDL   N+L+        +K+ADFGLA ++              
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHIDYYKKTTNGRL 199

Query: 150 -----------------------FGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 185
                                  FGV+L+ I  +G  P+       L+  +K G   +  
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG---HRM 256

Query: 186 PEWDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
            +    T E   ++       PS+R T  + ++ 
Sbjct: 257 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (141), Expect = 2e-10
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 1/76 (1%)

Query: 254 TRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIKA 312
                     +++PE L    Y    D+W+ GV+L+ I  +G  P+       L+  +K 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 313 GAYDDEPKHKSASVVK 328
           G   D+P + +  +  
Sbjct: 253 GHRMDKPSNCTNELYM 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-35
 Identities = 49/257 (19%), Positives = 86/257 (33%), Gaps = 45/257 (17%)

Query: 1   GAFSVVRRCV---QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 56
           G F  V            +  A K +N +     +  +   E  I +   HPN++ L   
Sbjct: 38  GHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 96

Query: 57  SIQEENYHYLVFDLVTGGELFE-DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDL 115
            ++ E    +V   +  G+L           +  D      Q+ + +    S   VHRDL
Sbjct: 97  CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 156

Query: 116 KPENLLLASKAKGAAVKLADFGLAIEVQGEQQA--------------------------- 148
              N +L  K     VK+ADFGLA ++  ++                             
Sbjct: 157 AARNCMLDEKFT---VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213

Query: 149 ----W-FGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQM 202
               W FGV+L+ L+  G PP+ D +   +   +  G       + +        ++ + 
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDPLYEVMLKC 270

Query: 203 LTVNPSKRITASEALKH 219
                  R + SE +  
Sbjct: 271 WHPKAEMRPSFSELVSR 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (149), Expect = 2e-11
 Identities = 16/88 (18%), Positives = 39/88 (44%), Gaps = 1/88 (1%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWD 300
           +    +    V  + G      +++ E L+ + +    D+W+ GV+L+ L+  G PP+ D
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237

Query: 301 EDQHRLYAQIKAGAYDDEPKHKSASVVK 328
            +   +   +  G    +P++    + +
Sbjct: 238 VNTFDITVYLLQGRRLLQPEYCPDPLYE 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 8e-35
 Identities = 48/276 (17%), Positives = 92/276 (33%), Gaps = 59/276 (21%)

Query: 1   GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           G+F +V   V K           A K +N +  S R+  +   EA + ++    ++VRL 
Sbjct: 31  GSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVRLL 89

Query: 56  DSIQEENYHYLVFDLVTGGELF----------EDIVAREFYSEADASHCIQQILESVNHC 105
             + +     ++ +L+T G+L            +       S +       +I + + + 
Sbjct: 90  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149

Query: 106 HSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA----------------- 148
           ++N  VHRDL   N ++A       VK+ DFG+  ++                       
Sbjct: 150 NANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206

Query: 149 -------------WFGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 194
                         FGV+L+ I  +   P+      ++   +  G       + D     
Sbjct: 207 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL---DKPDNCPDM 263

Query: 195 AKNLINQMLTVNPSKRITASEALK------HPWICQ 224
              L+      NP  R +  E +        P   +
Sbjct: 264 LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (127), Expect = 9e-09
 Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 1/72 (1%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIKAGAYD 316
                 ++SPE LK   +    D+W+ GV+L+ I  +   P+      ++   +  G   
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 317 DEPKHKSASVVK 328
           D+P +    + +
Sbjct: 255 DKPDNCPDMLFE 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-33
 Identities = 48/272 (17%), Positives = 88/272 (32%), Gaps = 58/272 (21%)

Query: 1   GAFSVVRRCV-----QKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 55
           GAF  V         + AT    A K++      +     +     +     H N+V L 
Sbjct: 24  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83

Query: 56  DSIQEE-NYHYLVFDLVTGGELFEDI----------------VAREFYSEADASHCIQQI 98
            +  +      ++ +    G L   +                + ++F +         Q+
Sbjct: 84  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143

Query: 99  LESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA---------- 148
            + +    S   +HRDL   N+LL+ K     VK+ DFGLA ++  +             
Sbjct: 144 AKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDYVRKGDARLPL 200

Query: 149 --------------------WFGVILYILLVGY-PPFWDEDQHRLYAQIKAGAYDYPSPE 187
                                FGV+L+ +      P+        + +         +P+
Sbjct: 201 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 260

Query: 188 WDTVTPEAKNLINQMLTVNPSKRITASEALKH 219
           +   TPE    +       PS+R T SE ++H
Sbjct: 261 Y--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 11/78 (14%), Positives = 29/78 (37%), Gaps = 2/78 (2%)

Query: 253 STRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQI 310
             +        +++PE +    Y    D+W+ GV+L+ +       +   +       ++
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 311 KAGAYDDEPKHKSASVVK 328
           K G     P + +  + +
Sbjct: 251 KEGTRMRAPDYTTPEMYQ 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 44/285 (15%), Positives = 79/285 (27%), Gaps = 75/285 (26%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 60
           G F  V R      G E A KI ++++  +      E E      L+H NI+    +  +
Sbjct: 14  GRFGEVWRGKW--RGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHENILGFIAADNK 68

Query: 61  ENYH----YLVFDLVTGGELFEDIVAREFYSEADASHCIQ-------QILESVNHCHSNG 109
           +N      +LV D    G LF+ +       E      +          +E V       
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 110 VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW-------------------- 149
           + HRDLK +N+L+          +AD GLA+                             
Sbjct: 129 IAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 150 ------------------FGVILYILLVGYPPFWDEDQHR---------------LYAQI 176
                              G++ + +          + ++               +   +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 177 KAGAYDYPSPEW---DTVTPEAKNLINQMLTVNPSKRITASEALK 218
                    P              ++ +    N + R+TA    K
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (103), Expect = 1e-05
 Identities = 13/70 (18%), Positives = 26/70 (37%), Gaps = 6/70 (8%)

Query: 242 KKFNARRKLKVSTRQGFAGTPGYLSPEVL------KKEPYGKPVDIWACGVILYILLVGY 295
            + ++             GT  Y++PEVL      K     K  DI+A G++ + +    
Sbjct: 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215

Query: 296 PPFWDEDQHR 305
                 + ++
Sbjct: 216 SIGGIHEDYQ 225

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  113 bits (284), Expect = 4e-30
 Identities = 42/260 (16%), Positives = 76/260 (29%), Gaps = 46/260 (17%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQ 59
           G+F V+          + A K    +     D  +L  E R  + L     I  ++   Q
Sbjct: 16  GSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 60  EENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPEN 119
           E  ++ LV DL+         +    +S    +   +Q+L  V   H   +V+RD+KP+N
Sbjct: 72  EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 131

Query: 120 LLLASK--AKGAAVKLADFGL----------------------------AIEVQGEQQA- 148
            L+          + + DFG+                            +I     ++  
Sbjct: 132 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191

Query: 149 -----W-FGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPSPE-WDTVTPEAKNL 198
                   G +    L G  P+         + Y +I       P  E       E    
Sbjct: 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKY 251

Query: 199 INQMLTVNPSKRITASEALK 218
           ++    +             
Sbjct: 252 MHYARNLAFDATPDYDYLQG 271

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 62.1 bits (150), Expect = 1e-11
 Identities = 11/82 (13%), Positives = 26/82 (31%)

Query: 238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPP 297
           V   +    ++ +    ++  +GT  Y+S          +  D+ A G +    L G  P
Sbjct: 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212

Query: 298 FWDEDQHRLYAQIKAGAYDDEP 319
           +          + +      + 
Sbjct: 213 WQGLKAATNKQKYERIGEKKQS 234

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (286), Expect = 8e-30
 Identities = 49/311 (15%), Positives = 89/311 (28%), Gaps = 92/311 (29%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---------- 50
           G FS V            A KI+   K+        E E ++ +++   +          
Sbjct: 24  GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---EDEIKLLQRVNDADNTKEDSMGAN 80

Query: 51  -IVRLHDSIQEENYHYLVFDLVT-----GGELFEDIVAREFYSEADASHCIQQILESVNH 104
            I++L D    +  + +   +V                             +Q+L  +++
Sbjct: 81  HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140

Query: 105 CHSN-GVVHRDLKPENLLLASK---AKGAAVKLADFGLAIEVQGEQQAW----------- 149
            H   G++H D+KPEN+L+           +K+AD G A                     
Sbjct: 141 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV 200

Query: 150 --------------FGVILYILLVGYPPFWDEDQHRLY------AQIKAGAYDYPSPEW- 188
                            +++ L+ G   F  ++ H         AQI     + PS    
Sbjct: 201 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 260

Query: 189 -------------------------------------DTVTPEAKNLINQMLTVNPSKRI 211
                                                     E  + ++ ML ++P KR 
Sbjct: 261 NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320

Query: 212 TASEALKHPWI 222
            A   + HPW+
Sbjct: 321 DAGGLVNHPWL 331

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 52.0 bits (123), Expect = 4e-08
 Identities = 16/53 (30%), Positives = 24/53 (45%)

Query: 258 FAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 310
              T  Y SPEVL   P+G   DIW+   +++ L+ G   F  ++ H      
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.1 bits (189), Expect = 2e-17
 Identities = 27/158 (17%), Positives = 51/158 (32%), Gaps = 16/158 (10%)

Query: 1   GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQK--------LEREARICRKLQHPNIV 52
           G  S V  C  +    E   K       S +  ++            A    + +   + 
Sbjct: 11  GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 53  RLHDSIQEENYHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVH 112
           +L      + Y +    ++       D          +    +  ILE V   +  G+VH
Sbjct: 70  KLQGLAVPKVYAWEGNAVLME---LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVH 126

Query: 113 RDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF 150
            DL   N+L++ +     + + DF  ++EV  E     
Sbjct: 127 GDLSQYNVLVSEE----GIWIIDFPQSVEVGEEGWREI 160

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	328
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.5
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.41
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.37
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.28
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.26
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.25
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.2
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.19
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.16
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.14
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.14
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.1
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.08
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.07
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.05
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.04
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.04
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.01
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	98.99
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	98.99
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	98.99
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	98.98
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	98.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	98.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	98.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	98.95
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	98.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	98.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	98.9
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	98.87
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	98.87
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	98.82
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	98.75
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	98.7
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.69
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	98.66
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	98.5
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	98.46
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	98.46
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	98.46
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	98.45
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	98.44
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	98.37
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	98.37
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	98.36
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.31
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	98.3
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	98.29
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	98.29
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	98.28
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	98.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.26
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	98.23
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	98.18
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	98.17
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	98.16
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	98.13
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	98.11
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	98.11
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.85
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	97.28
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	96.66
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.33

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-57  Score=392.73  Aligned_cols=208  Identities=31%  Similarity=0.561  Sum_probs=185.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||+|++.+..... ...+.+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+.
T Consensus        17 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~   96 (263)
T d2j4za1          17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRE   96 (263)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHH
Confidence            899999999999999999999997543322 2345688999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.++..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|.......             
T Consensus        97 l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~~kl~DFG~a~~~~~~~-------------  160 (263)
T d2j4za1          97 LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSR-------------  160 (263)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCSCSCCCCCC-------------
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---CCEeecccceeeecCCCc-------------
Confidence            9988899999999999999999999999999999999999999754   459999999985432110             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       161 --------------------------------------------------------------------------------  160 (263)
T d2j4za1         161 --------------------------------------------------------------------------------  160 (263)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     .....||+.|+|||++.+.+|+.++|||||||+||||+||++||.+.++.+++.+|.++.+..|+
T Consensus       161 ---------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~  225 (263)
T d2j4za1         161 ---------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD  225 (263)
T ss_dssp             ---------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred             ---------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence                           11245999999999999999999999999999999999999999999999999999999986543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-57  Score=397.38  Aligned_cols=211  Identities=31%  Similarity=0.546  Sum_probs=185.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||+++..... ....+.+.+|+++|++++|||||+++++|.+.+.+|+|||||+||+|.++
T Consensus        19 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~   98 (288)
T d1uu3a_          19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY   98 (288)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHh
Confidence            89999999999999999999999754322 22346789999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.+++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+.....            
T Consensus        99 ~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~~------------  163 (288)
T d1uu3a_          99 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESK------------  163 (288)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECC----------------
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC---ceEEecccccceecccCCc------------
Confidence            9988999999999999999999999999999999999999999754   4599999999875432110            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (288)
T d1uu3a_         164 --------------------------------------------------------------------------------  163 (288)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                  .....+.+||+.|+|||++.+.+|+.++|||||||+||||+||++||.+.++..++++|.++.+..|
T Consensus       164 ------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p  230 (288)
T d1uu3a_         164 ------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP  230 (288)
T ss_dssp             ------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             ------------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence                        0011235699999999999999999999999999999999999999999999999999999998654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-56  Score=397.70  Aligned_cols=212  Identities=44%  Similarity=0.728  Sum_probs=176.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|||||||+||+|.+++
T Consensus        20 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l   98 (307)
T d1a06a_          20 GAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI   98 (307)
T ss_dssp             GGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhh
Confidence            899999999999999999999998765432 2356789999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.||+.||.|||++|||||||||+|||+....+++.+||+|||+|+......              
T Consensus        99 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--------------  164 (307)
T d1a06a_          99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--------------  164 (307)
T ss_dssp             HTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------------
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--------------
Confidence            988899999999999999999999999999999999999999876566789999999985321100              


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (307)
T d1a06a_         165 --------------------------------------------------------------------------------  164 (307)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                                   ...+.+||+.|||||++.+.+|+.++|||||||+||||+||++||.+.+..++...|.++.+..+++
T Consensus       165 -------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         165 -------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             -------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence                         0123469999999999999999999999999999999999999999999999999999999876653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=390.40  Aligned_cols=215  Identities=33%  Similarity=0.579  Sum_probs=181.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+|+.||||+++....++...+.+.+|+++|++++|||||++++++.+  .+.+|+|||||+||+|.+
T Consensus        15 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~   94 (269)
T d2java1          15 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS   94 (269)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHH
Confidence            899999999999999999999999887777778889999999999999999999999964  456899999999999999


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcch
Q psy2131          79 DIVA----REFYSEADASHCIQQILESVNHCHSNG-----VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAW  149 (328)
Q Consensus        79 ~l~~----~~~~~~~~~~~~~~qll~~L~ylH~~~-----ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~  149 (328)
                      ++..    ...+++.++..++.|++.||+|||++|     ||||||||+|||++.+   +.+||+|||+|+.+....   
T Consensus        95 ~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~---  168 (269)
T d2java1          95 VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDT---  168 (269)
T ss_dssp             HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEECCHHHHHHC-------
T ss_pred             HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEEeeccceeecccCC---
Confidence            8753    457999999999999999999999976     9999999999999754   469999999986532110   


Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccch
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVA  229 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~  229 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (269)
T d2java1         169 --------------------------------------------------------------------------------  168 (269)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHH
Q psy2131         230 SIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  309 (328)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  309 (328)
                                             ....+..|||.|||||++.+.+|+.++|||||||++|||+||++||.+.+..++..+
T Consensus       169 -----------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~  225 (269)
T d2java1         169 -----------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK  225 (269)
T ss_dssp             ------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             -----------------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH
Confidence                                   001235699999999999999999999999999999999999999999999999999


Q ss_pred             HhcccCCCCCCcccc
Q psy2131         310 IKAGAYDDEPKHKSA  324 (328)
Q Consensus       310 i~~~~~~~~~~~~~~  324 (328)
                      |..+.+...|..++.
T Consensus       226 i~~~~~~~~~~~~s~  240 (269)
T d2java1         226 IREGKFRRIPYRYSD  240 (269)
T ss_dssp             HHHTCCCCCCTTSCH
T ss_pred             HHcCCCCCCCcccCH
Confidence            999998777766654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-56  Score=400.24  Aligned_cols=213  Identities=32%  Similarity=0.562  Sum_probs=188.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|++++|||||+++++|++.+.+|+|||||+||+|.+.
T Consensus        16 G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~   95 (337)
T d1o6la_          16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH   95 (337)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhh
Confidence            89999999999999999999999865322 22456788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+......             
T Consensus        96 ~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---g~vkl~DFG~a~~~~~~~-------------  159 (337)
T d1o6la_          96 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDG-------------  159 (337)
T ss_dssp             HHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTT-------------
T ss_pred             hhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---CCEEEeecccccccccCC-------------
Confidence            9999999999999999999999999999999999999999999754   469999999986542210             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (337)
T d1o6la_         160 --------------------------------------------------------------------------------  159 (337)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                   ......+|||.|+|||++.+.+|+.++|||||||+||||+||++||.+.+..+++++|..+.+..| 
T Consensus       160 -------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p-  225 (337)
T d1o6la_         160 -------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-  225 (337)
T ss_dssp             -------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             -------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC-
Confidence                         011235799999999999999999999999999999999999999999999999999999998554 


Q ss_pred             Cccc
Q psy2131         320 KHKS  323 (328)
Q Consensus       320 ~~~~  323 (328)
                      +..|
T Consensus       226 ~~~s  229 (337)
T d1o6la_         226 RTLS  229 (337)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            4443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-55  Score=385.55  Aligned_cols=203  Identities=31%  Similarity=0.542  Sum_probs=177.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.....  ..+.+.+|+++|++++|||||+++++|.+.+.+|+|||||+||+|.+++
T Consensus        31 G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~  108 (293)
T d1yhwa1          31 GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  108 (293)
T ss_dssp             SSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred             CcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHh
Confidence            89999999999999999999999865433  3466889999999999999999999999999999999999999998766


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      .. +.+++.+++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.+.....             
T Consensus       109 ~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~~~-------------  171 (293)
T d1yhwa1         109 TE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQS-------------  171 (293)
T ss_dssp             HH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSTTC-------------
T ss_pred             hc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---CcEeeccchhheeeccccc-------------
Confidence            54 579999999999999999999999999999999999999754   4699999999876432110             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (293)
T d1yhwa1         172 --------------------------------------------------------------------------------  171 (293)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .....+||+.|+|||++.+.+|+.++|||||||+||||+||++||.+.+....+..+.++..
T Consensus       172 -------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~  233 (293)
T d1yhwa1         172 -------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (293)
T ss_dssp             -------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             -------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence                         01224699999999999999999999999999999999999999999998777777766543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-55  Score=391.58  Aligned_cols=207  Identities=29%  Similarity=0.592  Sum_probs=185.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|...
T Consensus        15 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~   94 (316)
T d1fota_          15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL   94 (316)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccc
Confidence            89999999999999999999999754322 22356788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +.....+++.+++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.....              
T Consensus        95 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~---g~vkL~DFG~a~~~~~~--------------  157 (316)
T d1fota_          95 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPDV--------------  157 (316)
T ss_dssp             HHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSSC--------------
T ss_pred             ccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC---CCEEEecCccceEeccc--------------
Confidence            9999999999999999999999999999999999999999999754   46999999998653210              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (316)
T d1fota_         158 --------------------------------------------------------------------------------  157 (316)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                     ..+.+||+.|||||++.+.+|+.++|||||||+||||+||++||.+.+..+++.+|.++.+..||
T Consensus       158 ---------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~  222 (316)
T d1fota_         158 ---------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP  222 (316)
T ss_dssp             ---------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT
T ss_pred             ---------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence                           11246999999999999999999999999999999999999999999999999999999986554

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=386.60  Aligned_cols=207  Identities=32%  Similarity=0.573  Sum_probs=172.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++..... +..+.+.+|+++|++++|||||++++++.+++.+|||||||+||+|.+.+
T Consensus        16 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l   94 (271)
T d1nvra_          16 GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI   94 (271)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHH
Confidence            89999999999999999999999865432 23456889999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHhC
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLVG  160 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~g  160 (328)
                      ...+.+++.++..++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|+.......             
T Consensus        95 ~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---~~~KL~DFG~a~~~~~~~~-------------  158 (271)
T d1nvra_          95 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNR-------------  158 (271)
T ss_dssp             BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECEETTE-------------
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---CCEEEccchhheeeccCCc-------------
Confidence            888889999999999999999999999999999999999999754   4599999999875422110             


Q ss_pred             CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHHH
Q psy2131         161 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVDC  240 (328)
Q Consensus       161 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~  240 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (271)
T d1nvra_         159 --------------------------------------------------------------------------------  158 (271)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccH-HHHHHHHhcccC
Q psy2131         241 LKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAY  315 (328)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~  315 (328)
                                 .....+.+|||.|||||++.+.+| +.++|||||||+||||+||++||.+.+. ...+..+.....
T Consensus       159 -----------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~  224 (271)
T d1nvra_         159 -----------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT  224 (271)
T ss_dssp             -----------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT
T ss_pred             -----------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence                       001223579999999999999887 6789999999999999999999987653 344444444443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=380.15  Aligned_cols=204  Identities=27%  Similarity=0.477  Sum_probs=179.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+++.||+|++..........+.+.+|+++|++++|||||++++++.+    ...+|+|||||+||+|
T Consensus        20 G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L   99 (270)
T d1t4ha_          20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL   99 (270)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBH
T ss_pred             CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcH
Confidence            899999999999999999999998877777778889999999999999999999999975    4568999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNG--VVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~--ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      .+++.....+++.++..++.||+.||+|||+++  ||||||||+|||++.  +++.+||+|||+|+.....         
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~~~~~~---------  168 (270)
T d1t4ha_         100 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRAS---------  168 (270)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGGCCTT---------
T ss_pred             HHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCcceeccCC---------
Confidence            999988889999999999999999999999999  999999999999963  2356999999998532110         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (270)
T d1t4ha_         169 --------------------------------------------------------------------------------  168 (270)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCc-cHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~  313 (328)
                                         ...+.+|||.|||||++.+ +|+.++|||||||++|||+||++||.+. +...++.+|.++
T Consensus       169 -------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~  228 (270)
T d1t4ha_         169 -------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  228 (270)
T ss_dssp             -------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             -------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence                               1123569999999999976 5999999999999999999999999865 577788888887


Q ss_pred             cC
Q psy2131         314 AY  315 (328)
Q Consensus       314 ~~  315 (328)
                      ..
T Consensus       229 ~~  230 (270)
T d1t4ha_         229 VK  230 (270)
T ss_dssp             CC
T ss_pred             CC
Confidence            55

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-55  Score=384.48  Aligned_cols=205  Identities=31%  Similarity=0.527  Sum_probs=179.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++...  ....+.+.+|+++|++++|||||++++++.+.+.+|+|||||+||+|.+++
T Consensus        23 G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~  100 (288)
T d2jfla1          23 GAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM  100 (288)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred             CCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHH
Confidence            899999999999999999999997653  344567889999999999999999999999999999999999999999887


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. .+.+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|......              
T Consensus       101 ~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---~~~Kl~DFG~a~~~~~~--------------  163 (288)
T d2jfla1         101 LELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRT--------------  163 (288)
T ss_dssp             HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECHHH--------------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---CCEEEEechhhhccCCC--------------
Confidence            65 4579999999999999999999999999999999999999754   45999999998542100              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (288)
T d2jfla1         164 --------------------------------------------------------------------------------  163 (288)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccc-----ccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVL-----KKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l-----~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                  .....+..||+.|+|||++     .+.+|+.++|||||||+||||+||++||.+.++.+++.+|.++.
T Consensus       164 ------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~  231 (288)
T d2jfla1         164 ------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE  231 (288)
T ss_dssp             ------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred             ------------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence                        0012245799999999998     45678999999999999999999999999999999999999886


Q ss_pred             CC
Q psy2131         315 YD  316 (328)
Q Consensus       315 ~~  316 (328)
                      ..
T Consensus       232 ~~  233 (288)
T d2jfla1         232 PP  233 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=383.53  Aligned_cols=212  Identities=37%  Similarity=0.683  Sum_probs=188.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA----RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~----~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||||++++.....    ...+.+.+|+++|++++|||||+++++|.+.+.+|||||||+||+|
T Consensus        21 G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L  100 (293)
T d1jksa_          21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL  100 (293)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccc
Confidence            899999999999999999999998654432    2356789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCC-CCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAK-GAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~-~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++...+.+++.++..++.|++.||+|||++|||||||||+|||++.++. ...+||+|||+|.......         
T Consensus       101 ~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---------  171 (293)
T d1jksa_         101 FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---------  171 (293)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---------
T ss_pred             cchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc---------
Confidence            999988889999999999999999999999999999999999999986542 2359999999986542211         


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       172 --------------------------------------------------------------------------------  171 (293)
T d1jksa_         172 --------------------------------------------------------------------------------  171 (293)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                        ...+..||+.|+|||++.+..|+.++|||||||+||||+||++||.+.+..+++.+|.++.+
T Consensus       172 ------------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~  233 (293)
T d1jksa_         172 ------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  233 (293)
T ss_dssp             ------------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred             ------------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence                              01124689999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCC
Q psy2131         316 DDEP  319 (328)
Q Consensus       316 ~~~~  319 (328)
                      ..++
T Consensus       234 ~~~~  237 (293)
T d1jksa_         234 EFED  237 (293)
T ss_dssp             CCCH
T ss_pred             CCCc
Confidence            7664

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-54  Score=392.16  Aligned_cols=210  Identities=35%  Similarity=0.644  Sum_probs=187.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||++....  ..+.+.+.+|+++|++++|||||++++++.+.+.+|||||||+||+|.+.+
T Consensus        37 G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l  114 (350)
T d1koaa2          37 GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV  114 (350)
T ss_dssp             ETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHH
Confidence            899999999999999999999997543  345577899999999999999999999999999999999999999999988


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. .+.+++.++..++.||+.||.|||++|||||||||+|||++.+. ++.+||+|||+|+.+....             
T Consensus       115 ~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~~~-------------  180 (350)
T d1koaa2         115 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQ-------------  180 (350)
T ss_dssp             TCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCTTS-------------
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheeccccc-------------
Confidence            54 45799999999999999999999999999999999999997543 3579999999986543211             


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       181 --------------------------------------------------------------------------------  180 (350)
T d1koaa2         181 --------------------------------------------------------------------------------  180 (350)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                                    ...+..||+.|||||++.+.+|+.++|||||||++|||+||++||.+.+..+++.+|.++.+..++
T Consensus       181 --------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  246 (350)
T d1koaa2         181 --------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD  246 (350)
T ss_dssp             --------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC
T ss_pred             --------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence                          012356999999999999999999999999999999999999999999999999999999987765


Q ss_pred             C
Q psy2131         320 K  320 (328)
Q Consensus       320 ~  320 (328)
                      .
T Consensus       247 ~  247 (350)
T d1koaa2         247 S  247 (350)
T ss_dssp             G
T ss_pred             c
Confidence            4

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-54  Score=384.75  Aligned_cols=205  Identities=25%  Similarity=0.398  Sum_probs=181.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||+++...... ...+.+.+|+++|++++|||||++++++.+.+.+|+|||||.||+|...
T Consensus        26 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~  105 (309)
T d1u5ra_          26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL  105 (309)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHH
Confidence            899999999999999999999998765543 4456789999999999999999999999999999999999999999877


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +..++.+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|.....               
T Consensus       106 ~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~~Kl~DFG~a~~~~~---------------  167 (309)
T d1u5ra_         106 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP---------------  167 (309)
T ss_dssp             HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS---------------
T ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---CCEEEeecccccccCC---------------
Confidence            7778889999999999999999999999999999999999999754   5699999999854211               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (309)
T d1u5ra_         168 --------------------------------------------------------------------------------  167 (309)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                     .....|||.|||||++.+   .+|+.++|||||||++|||++|++||.+.+....+.+|.++...
T Consensus       168 ---------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~  232 (309)
T d1u5ra_         168 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP  232 (309)
T ss_dssp             ---------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             ---------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence                           012459999999999964   46899999999999999999999999999998888888887764


Q ss_pred             CC
Q psy2131         317 DE  318 (328)
Q Consensus       317 ~~  318 (328)
                      .+
T Consensus       233 ~~  234 (309)
T d1u5ra_         233 AL  234 (309)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-54  Score=389.93  Aligned_cols=206  Identities=33%  Similarity=0.609  Sum_probs=185.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+++.+|+.||||++++.... ....+.+.+|+++|+.++|||||++++++.+....|+|||||.||+|.+.
T Consensus        52 G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~  131 (350)
T d1rdqe_          52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH  131 (350)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred             CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhh
Confidence            89999999999999999999999754322 23356788999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          80 IVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        80 l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      +...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.+...              
T Consensus       132 l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~---g~ikL~DFG~a~~~~~~--------------  194 (350)
T d1rdqe_         132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR--------------  194 (350)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC--------------
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC---CCEEeeeceeeeecccc--------------
Confidence            9988899999999999999999999999999999999999999754   46999999998654211              


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       195 --------------------------------------------------------------------------------  194 (350)
T d1rdqe_         195 --------------------------------------------------------------------------------  194 (350)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ..+..||+.|||||++.+.+|+.++|||||||+||||+||++||.+.++..++.+|..+.+..|
T Consensus       195 ---------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p  258 (350)
T d1rdqe_         195 ---------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP  258 (350)
T ss_dssp             ---------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ---------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence                           1124699999999999999999999999999999999999999999999999999999987554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=386.64  Aligned_cols=191  Identities=26%  Similarity=0.416  Sum_probs=169.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||+|+++.+. .....+++.+|+.+|++++|||||+++++|.+.+.+|+|||||+||+|.+++
T Consensus        17 G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l   95 (322)
T d1s9ja_          17 GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL   95 (322)
T ss_dssp             CSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence            899999999999999999999998653 3344567899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .+.+.+++.+++.++.|++.||.|||+ +|||||||||+|||++.+   +.+||+|||+|+....               
T Consensus        96 ~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~---------------  157 (322)
T d1s9ja_          96 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID---------------  157 (322)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHHH---------------
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC---CCEEEeeCCCccccCC---------------
Confidence            888899999999999999999999997 599999999999999754   4699999999853210               


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       158 --------------------------------------------------------------------------------  157 (322)
T d1s9ja_         158 --------------------------------------------------------------------------------  157 (322)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccH
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQ  303 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  303 (328)
                                   ....+.+||+.|+|||++.+.+|+.++||||+||++|||+||+.||.+.+.
T Consensus       158 -------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         158 -------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             -------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             -------------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence                         011235799999999999999999999999999999999999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=373.75  Aligned_cols=217  Identities=20%  Similarity=0.336  Sum_probs=183.4

Q ss_pred             CCceEEEEEEEc--cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQK--ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~--~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.+.  .+++.||||+++.+..+....+.+.+|+++|++++|||||++++++.++ ..|||||||+||+|.+
T Consensus        18 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~   96 (277)
T d1xbba_          18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNK   96 (277)
T ss_dssp             CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHH
T ss_pred             CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHH
Confidence            899999999754  4567899999987655555667899999999999999999999999754 5789999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+......          
T Consensus        97 ~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~---~~~kl~DFGla~~~~~~~~~----------  163 (277)
T d1xbba_          97 YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENY----------  163 (277)
T ss_dssp             HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCSE----------
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---Ccccccchhhhhhccccccc----------
Confidence            99988899999999999999999999999999999999999999865   45999999998764322110          


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (277)
T d1xbba_         164 --------------------------------------------------------------------------------  163 (277)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                   ........||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..++...|.+|...+
T Consensus       164 -------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~  230 (277)
T d1xbba_         164 -------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG  230 (277)
T ss_dssp             -------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             -------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence                         001112458999999999999999999999999999999998 999999999999999999998877


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       231 ~p~~~~~  237 (277)
T d1xbba_         231 CPAGCPR  237 (277)
T ss_dssp             CCTTCCH
T ss_pred             CCcccCH
Confidence            7777654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=377.96  Aligned_cols=209  Identities=29%  Similarity=0.506  Sum_probs=182.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICR-KLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~-~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|+++.+|+.||||++++.... ....+.+.+|+.++. .++|||||++++++.+++.+|+|||||+||+|.+
T Consensus        13 G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~   92 (320)
T d1xjda_          13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY   92 (320)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred             CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHH
Confidence            89999999999999999999999754321 223456677777765 6899999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          79 DIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        79 ~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ++.....+++.++..++.||+.||+|||++|||||||||+|||++..   +.+||+|||+|+.......           
T Consensus        93 ~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~---~~~kl~DFG~a~~~~~~~~-----------  158 (320)
T d1xjda_          93 HIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGDA-----------  158 (320)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTTC-----------
T ss_pred             HhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC---Cceeccccchhhhcccccc-----------
Confidence            99988899999999999999999999999999999999999999754   4599999999864321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       159 --------------------------------------------------------------------------------  158 (320)
T d1xjda_         159 --------------------------------------------------------------------------------  158 (320)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                     ......||+.|+|||++.+.+|+.++|||||||++|||+||++||.+.++.+++.+|..+.+..|
T Consensus       159 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p  223 (320)
T d1xjda_         159 ---------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP  223 (320)
T ss_dssp             ---------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ---------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                           01124699999999999999999999999999999999999999999999999999999987543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=371.60  Aligned_cols=219  Identities=19%  Similarity=0.351  Sum_probs=176.1

Q ss_pred             CCceEEEEEEEccCCc---EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~---~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|+++.+|+   .||||.+... ......+.+.+|+++|++++|||||++++++.+.+.+|+|||||+||+|.
T Consensus        37 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~  115 (299)
T d1jpaa_          37 GEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD  115 (299)
T ss_dssp             CSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHH
T ss_pred             CCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcce
Confidence            8999999999987765   5888888653 34556678999999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++... +.+++.++..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+|+.+......        
T Consensus       116 ~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFGla~~~~~~~~~--------  184 (299)
T d1jpaa_         116 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSD--------  184 (299)
T ss_dssp             HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC--------------------
T ss_pred             eeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC---CcEEECCcccceEccCCCCc--------
Confidence            888764 469999999999999999999999999999999999999754   56999999998654321100        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       185 --------------------------------------------------------------------------------  184 (299)
T d1jpaa_         185 --------------------------------------------------------------------------------  184 (299)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                   .......+..||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..++...|.++..
T Consensus       185 -------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~  251 (299)
T d1jpaa_         185 -------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR  251 (299)
T ss_dssp             ------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             -------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence                         00001122458999999999999999999999999999999998 8999999999999999999988


Q ss_pred             CCCCCcccc
Q psy2131         316 DDEPKHKSA  324 (328)
Q Consensus       316 ~~~~~~~~~  324 (328)
                      .++|..++.
T Consensus       252 ~~~~~~~~~  260 (299)
T d1jpaa_         252 LPPPMDCPS  260 (299)
T ss_dssp             CCCCTTCCH
T ss_pred             CCCCccchH
Confidence            777776654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-52  Score=366.72  Aligned_cols=211  Identities=27%  Similarity=0.436  Sum_probs=176.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~   75 (328)
                      |+||+||+|++..+|+.||||+++..... ....+++.+|+++|+.++|||||++++++.+.+    .+|+|||||+||+
T Consensus        18 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~   97 (277)
T d1o6ya_          18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT   97 (277)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCE
Confidence            89999999999999999999999876554 445567899999999999999999999998654    4899999999999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      |.+.+...+.+++.++..++.||+.||.|||++|||||||||+|||++.++   .++|+|||++........        
T Consensus        98 L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~~~~~~~~~--------  166 (277)
T d1o6ya_          98 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGN--------  166 (277)
T ss_dssp             HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTCEECC------------
T ss_pred             ehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhhhhhccccc--------
Confidence            999998888999999999999999999999999999999999999997654   589999998754321100        


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (277)
T d1o6ya_         167 --------------------------------------------------------------------------------  166 (277)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                     ......+.+||+.|+|||++.+.+|+.++|||||||++|||+||++||.+.++.+++.++.++..
T Consensus       167 ---------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~  231 (277)
T d1o6ya_         167 ---------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  231 (277)
T ss_dssp             ---------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             ---------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC
Confidence                           00011235699999999999999999999999999999999999999999999988888887766


Q ss_pred             CC
Q psy2131         316 DD  317 (328)
Q Consensus       316 ~~  317 (328)
                      .+
T Consensus       232 ~~  233 (277)
T d1o6ya_         232 IP  233 (277)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=378.55  Aligned_cols=206  Identities=37%  Similarity=0.611  Sum_probs=174.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHh-CCCCCcceeEEEEEe----CCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRK-LQHPNIVRLHDSIQE----ENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~~----~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+++.+|+.||||+++..       ..+.+|+.++.+ ++|||||+++++|++    ...+|+|||||+||+
T Consensus        23 G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~   95 (335)
T d2ozaa1          23 GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE   95 (335)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEE
T ss_pred             ccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCc
Confidence            89999999999999999999999642       356789998765 589999999999976    467899999999999


Q ss_pred             cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          76 LFEDIVAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        76 L~~~l~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      |.+++..+  ..+++.+++.++.||+.||+|||++||+||||||+|||++..++.+.+||+|||+|+.......      
T Consensus        96 L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~------  169 (335)
T d2ozaa1          96 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS------  169 (335)
T ss_dssp             HHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC------
T ss_pred             HHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc------
Confidence            99999765  3699999999999999999999999999999999999998776677899999999865422110      


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (335)
T d2ozaa1         170 --------------------------------------------------------------------------------  169 (335)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHH----HHHHH
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ  309 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~  309 (328)
                                           .....|||.|+|||++.+.+|+.++|||||||+||||+||++||.+.+..    .+..+
T Consensus       170 ---------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~  228 (335)
T d2ozaa1         170 ---------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  228 (335)
T ss_dssp             ---------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred             ---------------------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence                                 11245999999999999999999999999999999999999999987644    34556


Q ss_pred             HhcccCCCCCC
Q psy2131         310 IKAGAYDDEPK  320 (328)
Q Consensus       310 i~~~~~~~~~~  320 (328)
                      |..+.+..|.+
T Consensus       229 i~~~~~~~~~~  239 (335)
T d2ozaa1         229 IRMGQYEFPNP  239 (335)
T ss_dssp             CCSCSSSCCTT
T ss_pred             HhcCCCCCCCc
Confidence            67777766543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-51  Score=368.97  Aligned_cols=222  Identities=39%  Similarity=0.729  Sum_probs=199.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++...  ..+...+.+|+.+|++++|||||+++++|.+++.+|||||||+||+|.+.+
T Consensus        40 G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~  117 (352)
T d1koba_          40 GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI  117 (352)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHT
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHH
Confidence            899999999999999999999998653  344567889999999999999999999999999999999999999999887


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------------
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------  146 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------------  146 (328)
                      ...+ .+++.++..++.||+.||+|||++|||||||||+|||++.. ..+.+||+|||+|..+....             
T Consensus       118 ~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~a  196 (352)
T d1koba_         118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAA  196 (352)
T ss_dssp             TCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCTTSCEEEECSSGGGCC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCCCCceeeccCcccccC
Confidence            6654 69999999999999999999999999999999999999753 24679999999997653221             


Q ss_pred             -------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         147 -------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       147 -------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                   +.| +||++|+|++|.+||.+.+.......+..+.+.++...+..+|+++++||.+||+.||.+|||
T Consensus       197 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  276 (352)
T d1koba_         197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT  276 (352)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence                         123 899999999999999999999999999999988888888899999999999999999999999


Q ss_pred             HHHHhcCcccCCc
Q psy2131         213 ASEALKHPWICQR  225 (328)
Q Consensus       213 ~~~~l~h~~~~~~  225 (328)
                      ++|+++|||+...
T Consensus       277 ~~eil~Hp~~~~~  289 (352)
T d1koba_         277 VHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHTSTTTSSC
T ss_pred             HHHHhcCHhhCCC
Confidence            9999999999753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=365.74  Aligned_cols=216  Identities=26%  Similarity=0.428  Sum_probs=183.8

Q ss_pred             CCceEEEEEEEcc--CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           1 GAFSVVRRCVQKA--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         1 G~fg~V~~~~~~~--~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      |+||+||+|.++.  ++..||||+++.. ......+.+.+|+++|++++|||||++++++.++ .+|+|||||+||+|.+
T Consensus        20 G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~   97 (285)
T d1u59a_          20 GNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHK   97 (285)
T ss_dssp             CTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHH
T ss_pred             ccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHH
Confidence            8999999998764  4557999999754 3455677899999999999999999999998754 5899999999999998


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          79 DIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        79 ~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ++.. +..+++.++..++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|+.+......         
T Consensus        98 ~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~~~---------  165 (285)
T d1u59a_          98 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSY---------  165 (285)
T ss_dssp             HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEECTTCSCE---------
T ss_pred             HhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC---Cceeeccchhhhcccccccc---------
Confidence            8765 4579999999999999999999999999999999999999865   46999999999765322110         


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (285)
T d1u59a_         166 --------------------------------------------------------------------------------  165 (285)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    ........||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..++...|.+|...
T Consensus       166 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~  231 (285)
T d1u59a_         166 --------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM  231 (285)
T ss_dssp             --------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred             --------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                          000112358999999999999999999999999999999998 99999999999999999999987


Q ss_pred             CCCCcccc
Q psy2131         317 DEPKHKSA  324 (328)
Q Consensus       317 ~~~~~~~~  324 (328)
                      ..|++++.
T Consensus       232 ~~p~~~~~  239 (285)
T d1u59a_         232 ECPPECPP  239 (285)
T ss_dssp             CCCTTCCH
T ss_pred             CCCCcCCH
Confidence            77777764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-52  Score=367.38  Aligned_cols=213  Identities=23%  Similarity=0.380  Sum_probs=181.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++.+..   ..+++.+|+++|++++|||||++++++.+.+.+|+|||||++|+|.+++
T Consensus        28 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l  104 (287)
T d1opja_          28 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  104 (287)
T ss_dssp             TTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHh
Confidence            8999999999999999999999976543   3456889999999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++..+..++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|+.......           
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFG~a~~~~~~~~-----------  170 (287)
T d1opja_         105 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTY-----------  170 (287)
T ss_dssp             HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCCTTTCCSSSS-----------
T ss_pred             hhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC---CcEEEccccceeecCCCCc-----------
Confidence            654  568999999999999999999999999999999999999765   4599999999865422110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       171 --------------------------------------------------------------------------------  170 (287)
T d1opja_         171 --------------------------------------------------------------------------------  170 (287)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcC-CCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGY-PPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~-~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    ....+..||+.|+|||++.+..|+.++|||||||++|||+||. +||.+.+...+++.+..+....
T Consensus       171 --------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~  236 (287)
T d1opja_         171 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  236 (287)
T ss_dssp             --------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence                          0112345899999999999999999999999999999999965 5566678888888888887666


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       237 ~~~~~~~  243 (287)
T d1opja_         237 RPEGCPE  243 (287)
T ss_dssp             CCTTCCH
T ss_pred             CCccchH
Confidence            6665543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.9e-51  Score=356.98  Aligned_cols=221  Identities=41%  Similarity=0.737  Sum_probs=198.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCH---H----HHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSA---R----DFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~---~----~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||+||+|+++.+|+.||||+++......   .    ..+.+.+|+.+|++++ |||||++++++.+.+.+|||||||+
T Consensus        14 G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~   93 (277)
T d1phka_          14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK   93 (277)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCC
Confidence            899999999999999999999998765432   1    2345789999999997 9999999999999999999999999


Q ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC-------
Q psy2131          73 GGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE-------  145 (328)
Q Consensus        73 gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~-------  145 (328)
                      ||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.   ++.+||+|||+++.+...       
T Consensus        94 ~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a~~~~~~~~~~~~~  170 (277)
T d1phka_          94 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGFSCQLDPGEKLREVC  170 (277)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCEECCTTCCBCCCC
T ss_pred             CchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC---CCCeEEccchheeEccCCCceeeee
Confidence            9999999998889999999999999999999999999999999999999964   356999999998654221       


Q ss_pred             -------------------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHH
Q psy2131         146 -------------------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLI  199 (328)
Q Consensus       146 -------------------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  199 (328)
                                               .+.| +|+++|+|++|.+||.+.+.......+..+...++.+.+..+|+++++|+
T Consensus       171 gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  250 (277)
T d1phka_         171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV  250 (277)
T ss_dssp             SCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHH
T ss_pred             ccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHH
Confidence                                     1123 79999999999999999999998999999988888888889999999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         200 NQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       200 ~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .+||+.||++|||++|+++|||+.+
T Consensus       251 ~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         251 SRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHccCChhHCcCHHHHHcCHHHHH
Confidence            9999999999999999999999954

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=367.12  Aligned_cols=221  Identities=28%  Similarity=0.603  Sum_probs=199.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++...   .+...+.+|+++|++++|||||+++++|++++.+|+|||||+||+|.+++
T Consensus        16 G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i   92 (321)
T d1tkia_          16 GEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI   92 (321)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence            899999999999999999999997643   33456789999999999999999999999999999999999999999999


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-------------
Q psy2131          81 VARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-------------  146 (328)
Q Consensus        81 ~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-------------  146 (328)
                      ...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++.......             
T Consensus        93 ~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~a  171 (321)
T d1tkia_          93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA  171 (321)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCTTCEEEEEESCGGGSC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccccCCccccccccccccc
Confidence            7665 699999999999999999999999999999999999997643 3579999999987543221             


Q ss_pred             -------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC
Q psy2131         147 -------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT  212 (328)
Q Consensus       147 -------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t  212 (328)
                                   +.| +||++|+|++|.+||.+.+.......|..+.+.++...+..+|+++++|+.+||..||.+|||
T Consensus       172 pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  251 (321)
T d1tkia_         172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC
Confidence                         223 899999999999999999999999999999888888778889999999999999999999999


Q ss_pred             HHHHhcCcccCCc
Q psy2131         213 ASEALKHPWICQR  225 (328)
Q Consensus       213 ~~~~l~h~~~~~~  225 (328)
                      ++|+++|||+.+.
T Consensus       252 ~~eil~hp~~~~~  264 (321)
T d1tkia_         252 ASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHSHHHHSC
T ss_pred             HHHHhcCHhhccC
Confidence            9999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=371.88  Aligned_cols=209  Identities=29%  Similarity=0.352  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH---HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|+++.+|+.||||+++.......   ..+.+.+|+++|++++|||||++++++.+++.+|+|||||.|+++.
T Consensus         9 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~   88 (299)
T d1ua2a_           9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV   88 (299)
T ss_dssp             ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHH
T ss_pred             CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHh
Confidence            8999999999999999999999976543322   1346889999999999999999999999999999999999998877


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      ........+++.++..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.......          
T Consensus        89 ~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~---~~~KL~DFG~a~~~~~~~~----------  155 (299)
T d1ua2a_          89 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNR----------  155 (299)
T ss_dssp             HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCC----------
T ss_pred             hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---CccccccCccccccCCCcc----------
Confidence            666667789999999999999999999999999999999999999754   4699999999865322110          


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (299)
T d1ua2a_         156 --------------------------------------------------------------------------------  155 (299)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                      ...+.+||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+..+++.+|.+....
T Consensus       156 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~  219 (299)
T d1ua2a_         156 ----------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  219 (299)
T ss_dssp             ----------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ----------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence                            1123469999999999875 56899999999999999999999999999999999998876554


Q ss_pred             CC
Q psy2131         317 DE  318 (328)
Q Consensus       317 ~~  318 (328)
                      +.
T Consensus       220 ~~  221 (299)
T d1ua2a_         220 PT  221 (299)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=363.12  Aligned_cols=206  Identities=23%  Similarity=0.400  Sum_probs=168.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+.+   ..||||+++....+....+.+.+|+.+|++++|||||++++++.+ +.+|+|||||+||+|.+++
T Consensus        19 G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l   94 (276)
T d1uwha_          19 GSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL   94 (276)
T ss_dssp             CSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHH
T ss_pred             CCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHH
Confidence            899999999643   359999998877777778889999999999999999999998654 5689999999999999998


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++.++..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.......            
T Consensus        95 ~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~---~~~Kl~DFGla~~~~~~~~------------  159 (276)
T d1uwha_          95 HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSG------------  159 (276)
T ss_dssp             HTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---SSEEECCCCCSCC------------------
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC---CCEEEccccceeeccccCC------------
Confidence            654 569999999999999999999999999999999999999754   4699999999854321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       160 --------------------------------------------------------------------------------  159 (276)
T d1uwha_         160 --------------------------------------------------------------------------------  159 (276)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCcccccc---CCCCCCcchhhhhhHHHHHHhcCCCCCCccH-HHHHHHHhcccC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKK---EPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAY  315 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~  315 (328)
                                  .....+..||+.|||||++.+   .+|+.++|||||||+||||+||+.||.+.+. ..+...+.++..
T Consensus       160 ------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  227 (276)
T d1uwha_         160 ------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL  227 (276)
T ss_dssp             ------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred             ------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence                        001123469999999999964   3589999999999999999999999998764 455566666654


Q ss_pred             CC
Q psy2131         316 DD  317 (328)
Q Consensus       316 ~~  317 (328)
                      .+
T Consensus       228 ~p  229 (276)
T d1uwha_         228 SP  229 (276)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=358.37  Aligned_cols=212  Identities=24%  Similarity=0.381  Sum_probs=176.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++ +++.||||+++......   +.+.+|++++++++|||||++++++.+.+..|+|||||++|+|.+++
T Consensus        16 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l   91 (263)
T d1sm2a_          16 GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   91 (263)
T ss_dssp             CSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             CCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHh
Confidence            899999999986 56789999998655443   46789999999999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      ... ..+++..+..++.|++.||+|||+++|+||||||+|||++.+   +.+||+|||+|+.......            
T Consensus        92 ~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~~------------  156 (263)
T d1sm2a_          92 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQY------------  156 (263)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---GCEEECSCC----------------------
T ss_pred             hccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---CCeEecccchheeccCCCc------------
Confidence            654 568999999999999999999999999999999999999865   4599999999854321100            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (263)
T d1sm2a_         157 --------------------------------------------------------------------------------  156 (263)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...|..|.....
T Consensus       157 -------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~  223 (263)
T d1sm2a_         157 -------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  223 (263)
T ss_dssp             ---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC
T ss_pred             -------------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence                         01122458999999999999999999999999999999999 6888888899999999999988888


Q ss_pred             CCcccc
Q psy2131         319 PKHKSA  324 (328)
Q Consensus       319 ~~~~~~  324 (328)
                      |..++.
T Consensus       224 p~~~~~  229 (263)
T d1sm2a_         224 PRLAST  229 (263)
T ss_dssp             CTTSCH
T ss_pred             ccccCH
Confidence            877654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-51  Score=373.83  Aligned_cols=205  Identities=28%  Similarity=0.476  Sum_probs=171.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH----HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||||++........    ...+..+|+++++.++|||||+++++|.+.+.+|+|||||+||+|
T Consensus        15 G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L   94 (364)
T d1omwa3          15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL   94 (364)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcH
Confidence            8999999999999999999999975432221    122334557788888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+++.....+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+......          
T Consensus        95 ~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~---g~iKl~DFGla~~~~~~~----------  161 (364)
T d1omwa3          95 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK----------  161 (364)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---SCEEECCCTTCEECSSSC----------
T ss_pred             HHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC---CcEEEeeeceeeecCCCc----------
Confidence            9999988899999999999999999999999999999999999999754   459999999986542210          


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       162 --------------------------------------------------------------------------------  161 (364)
T d1omwa3         162 --------------------------------------------------------------------------------  161 (364)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCcc---HHHHHHHHhc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKA  312 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~  312 (328)
                                        .....||+.|+|||++. +..|+.++|||||||+||||+||++||.+.+   ...+...+..
T Consensus       162 ------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~  223 (364)
T d1omwa3         162 ------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT  223 (364)
T ss_dssp             ------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS
T ss_pred             ------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence                              11246999999999996 5679999999999999999999999998765   3445555555


Q ss_pred             ccCC
Q psy2131         313 GAYD  316 (328)
Q Consensus       313 ~~~~  316 (328)
                      ..+.
T Consensus       224 ~~~~  227 (364)
T d1omwa3         224 MAVE  227 (364)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            5443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=355.39  Aligned_cols=211  Identities=21%  Similarity=0.352  Sum_probs=178.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++ +++.||||+++.....   .+.+.+|+++|++++|||||++++++.+ +.+|+|||||++|+|.+.+
T Consensus        24 G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~   98 (272)
T d1qpca_          24 GQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL   98 (272)
T ss_dssp             ETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHT
T ss_pred             CCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHH
Confidence            899999999975 6788999999865443   3568899999999999999999998755 5579999999999998876


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VAR--EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~~--~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ...  ..+++.++..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+|+.......           
T Consensus        99 ~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~---~~~Kl~DFGla~~~~~~~~-----------  164 (272)
T d1qpca_          99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLARLIEDNEY-----------  164 (272)
T ss_dssp             TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECSSSCE-----------
T ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc---cceeeccccceEEccCCcc-----------
Confidence            543  359999999999999999999999999999999999999754   5699999999876432110           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (272)
T d1qpca_         165 --------------------------------------------------------------------------------  164 (272)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    ....+..||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..++++.|..|...+
T Consensus       165 --------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~  230 (272)
T d1qpca_         165 --------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV  230 (272)
T ss_dssp             --------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence                          01123468999999999999999999999999999999999 567778888999999999998777


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|..++.
T Consensus       231 ~p~~~~~  237 (272)
T d1qpca_         231 RPDNCPE  237 (272)
T ss_dssp             CCTTCCH
T ss_pred             CcccChH
Confidence            7776654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=366.48  Aligned_cols=215  Identities=23%  Similarity=0.386  Sum_probs=172.9

Q ss_pred             CCceEEEEEEEccCCc-----EEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGL-----EFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~-----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++..+++     .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.+.+|+|||||+||
T Consensus        48 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g  126 (325)
T d1rjba_          48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG  126 (325)
T ss_dssp             CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCC
Confidence            8999999999876654     69999987543 233446788999999998 8999999999999999999999999999


Q ss_pred             CcHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          75 ELFEDIVARE-----------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        75 ~L~~~l~~~~-----------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      +|.+++....                       .+++.++..++.|++.||+|||++|||||||||+|||++.+   +.+
T Consensus       127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~---~~~  203 (325)
T d1rjba_         127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVV  203 (325)
T ss_dssp             BHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT---TEE
T ss_pred             cHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccC---CeE
Confidence            9999986542                       48899999999999999999999999999999999999754   569


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||+|+.......                                                                
T Consensus       204 Kl~DFGla~~~~~~~~----------------------------------------------------------------  219 (325)
T d1rjba_         204 KICDFGLARDIMSDSN----------------------------------------------------------------  219 (325)
T ss_dssp             EECCCGGGSCGGGCTT----------------------------------------------------------------
T ss_pred             EEeeccccccccCCCc----------------------------------------------------------------
Confidence            9999999865321110                                                                


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                              .....+..||+.|||||++.+..|+.++|||||||+||||
T Consensus       220 ----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~em  259 (325)
T d1rjba_         220 ----------------------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI  259 (325)
T ss_dssp             ----------------------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHH
Confidence                                                    0112235689999999999999999999999999999999


Q ss_pred             Hh-cCCCCCCccHHHHHHHH-hcccCCCCCCccc
Q psy2131         292 LV-GYPPFWDEDQHRLYAQI-KAGAYDDEPKHKS  323 (328)
Q Consensus       292 lt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~  323 (328)
                      +| |++||.+.+....+.++ ..+...+.|.+++
T Consensus       260 lt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~  293 (325)
T d1rjba_         260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYAT  293 (325)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCC
Confidence            98 89999987655544444 4444444455554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=349.07  Aligned_cols=211  Identities=23%  Similarity=0.375  Sum_probs=183.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++ +++.||||+++.+....   +.+.+|++++++++|||||++++++.+++.+|+|||||++|+|.+++
T Consensus        15 G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~   90 (258)
T d1k2pa_          15 GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL   90 (258)
T ss_dssp             ETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHH
T ss_pred             CCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhh
Confidence            899999999985 78899999998766544   46789999999999999999999999999999999999999998886


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHHh
Q psy2131          81 VA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILLV  159 (328)
Q Consensus        81 ~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~~  159 (328)
                      .. ...+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+||+|||+|+.+.....            
T Consensus        91 ~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~---~~~kl~DfG~a~~~~~~~~------------  155 (258)
T d1k2pa_          91 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEY------------  155 (258)
T ss_dssp             HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT---CCEEECCCSSCCBCSSSSC------------
T ss_pred             hccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC---CcEEECcchhheeccCCCc------------
Confidence            54 4579999999999999999999999999999999999999753   5699999999865432110            


Q ss_pred             CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhHH
Q psy2131         160 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETVD  239 (328)
Q Consensus       160 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~  239 (328)
                                                                                                      
T Consensus       156 --------------------------------------------------------------------------------  155 (258)
T d1k2pa_         156 --------------------------------------------------------------------------------  155 (258)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         240 CLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                                   .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++..+|.+|...++
T Consensus       156 -------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~  222 (258)
T d1k2pa_         156 -------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR  222 (258)
T ss_dssp             -------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             -------------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                         00112358999999999999999999999999999999998 8999999999999999999988777


Q ss_pred             CCccc
Q psy2131         319 PKHKS  323 (328)
Q Consensus       319 ~~~~~  323 (328)
                      |..++
T Consensus       223 p~~~~  227 (258)
T d1k2pa_         223 PHLAS  227 (258)
T ss_dssp             CTTCC
T ss_pred             ccccc
Confidence            76655

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=356.63  Aligned_cols=206  Identities=32%  Similarity=0.399  Sum_probs=171.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|++..+|+.||||+++.........+++.+|+++|++++|||||++++++.+.+.+|+|||||.++.+ +.+
T Consensus        13 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~-~~~   91 (298)
T d1gz8a_          13 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFM   91 (298)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH-HHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh-hhh
Confidence            8999999999999999999999987655544567889999999999999999999999999999999999987544 444


Q ss_pred             H-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 V-A-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~-~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      . . ...+++.+++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|+......            
T Consensus        92 ~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~---~~~kl~DFG~a~~~~~~~------------  156 (298)
T d1gz8a_          92 DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPV------------  156 (298)
T ss_dssp             HHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTHHHHHCCCS------------
T ss_pred             hhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc---CcceeccCCcceeccCCc------------
Confidence            3 2 3569999999999999999999999999999999999999754   469999999985432110            


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (298)
T d1gz8a_         157 --------------------------------------------------------------------------------  156 (298)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                    .......||+.|+|||++....+ +.++|+||+||++|+|++|++||.+.+....+.+|.+....
T Consensus       157 --------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         157 --------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             --------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             --------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence                          01123469999999999888775 88999999999999999999999999988888888765443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=350.47  Aligned_cols=217  Identities=22%  Similarity=0.385  Sum_probs=176.9

Q ss_pred             CCceEEEEEEEccCC----cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~----~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|..+.++    ..||||+++.. ........+.+|+++|++++|||||++++++.+.+.+|+|||||.+|++
T Consensus        18 G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l   96 (283)
T d1mqba_          18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL   96 (283)
T ss_dssp             CSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred             CCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcc
Confidence            899999999887655    46999999754 3455566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... ..+++.++..++.|++.||+|||+++||||||||+|||++.+   +.+||+|||+|+........       
T Consensus        97 ~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~---~~~Kl~DFGla~~~~~~~~~-------  166 (283)
T d1mqba_          97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEA-------  166 (283)
T ss_dssp             HHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC-----------------
T ss_pred             hhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC---CeEEEcccchhhcccCCCcc-------
Confidence            8877654 579999999999999999999999999999999999999754   56999999998654221000       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       167 --------------------------------------------------------------------------------  166 (283)
T d1mqba_         167 --------------------------------------------------------------------------------  166 (283)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      .....+..||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+++..|..|.
T Consensus       167 ----------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~  230 (283)
T d1mqba_         167 ----------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF  230 (283)
T ss_dssp             -----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             ----------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC
Confidence                            001123458999999999999999999999999999999999 466677778999999999998


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ..+.|..++.
T Consensus       231 ~~~~~~~~~~  240 (283)
T d1mqba_         231 RLPTPMDCPS  240 (283)
T ss_dssp             CCCCCTTCBH
T ss_pred             CCCCchhhHH
Confidence            7777766654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=348.93  Aligned_cols=214  Identities=25%  Similarity=0.358  Sum_probs=173.8

Q ss_pred             CCceEEEEEEEccCC---cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~---~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|++..++   ..||||.++... .....+.+.+|+++|++++|||||++++++. .+.+|+|||||++|+|.
T Consensus        18 G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~   95 (273)
T d1mp8a_          18 GQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELR   95 (273)
T ss_dssp             CSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHH
T ss_pred             CCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHH
Confidence            899999999987544   568899886432 4455677899999999999999999999996 46789999999999998


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          78 EDIVA-REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        78 ~~l~~-~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +++.. ...+++.++..++.||+.||.|||+++||||||||+|||++.++   .+||+|||+|+.......         
T Consensus        96 ~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~~~~~~~---------  163 (273)
T d1mp8a_          96 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTY---------  163 (273)
T ss_dssp             HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC---------------------
T ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC---cEEEccchhheeccCCcc---------
Confidence            87765 45699999999999999999999999999999999999998654   599999999864321100         


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (273)
T d1mp8a_         164 --------------------------------------------------------------------------------  163 (273)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccC
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                                      .......||+.|+|||++.+.+|+.++|||||||+||||+| |.+||.+.+..++..+|..|..
T Consensus       164 ----------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~  227 (273)
T d1mp8a_         164 ----------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  227 (273)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             ----------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence                            00112358999999999999999999999999999999998 9999999999999999999998


Q ss_pred             CCCCCcccc
Q psy2131         316 DDEPKHKSA  324 (328)
Q Consensus       316 ~~~~~~~~~  324 (328)
                      .+.|+.++.
T Consensus       228 ~~~~~~~~~  236 (273)
T d1mp8a_         228 LPMPPNCPP  236 (273)
T ss_dssp             CCCCTTCCH
T ss_pred             CCCCCCCCH
Confidence            777777664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=352.42  Aligned_cols=203  Identities=28%  Similarity=0.492  Sum_probs=170.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHH----HHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEEEEccCC-
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQ--HPNIVRLHDSIQEENYHYLVFDLVTG-   73 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~----~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv~E~~~g-   73 (328)
                      |+||+||+|++..+|+.||||+++.......    ...++.+|+.+|++++  |||||++++++.+.+..|+||||+.+ 
T Consensus        15 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~   94 (273)
T d1xwsa_          15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV   94 (273)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCc
Confidence            8999999999999999999999986554321    1234678999999996  89999999999999999999999986 


Q ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHH
Q psy2131          74 GELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVI  153 (328)
Q Consensus        74 g~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~  153 (328)
                      +++.+.+.....+++.+++.++.||+.||+|||++|||||||||+|||++.+  .+.+||+|||+|......        
T Consensus        95 ~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~--~~~vkl~DFG~a~~~~~~--------  164 (273)
T d1xwsa_          95 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKDT--------  164 (273)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEECCSS--------
T ss_pred             chHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC--CCeEEECccccceecccc--------
Confidence            5777888888899999999999999999999999999999999999999743  357999999998543111        


Q ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhh
Q psy2131         154 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVH  233 (328)
Q Consensus       154 ~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~  233 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (273)
T d1xwsa_         165 --------------------------------------------------------------------------------  164 (273)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCC-CCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         234 RQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPY-GKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                                          ...+..||+.|+|||++.+..| +.++|||||||++|||+||++||.+.+      .|.+
T Consensus       165 --------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~  218 (273)
T d1xwsa_         165 --------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR  218 (273)
T ss_dssp             --------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred             --------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh
Confidence                                0113469999999999998776 678999999999999999999998754      3556


Q ss_pred             ccCCCCC
Q psy2131         313 GAYDDEP  319 (328)
Q Consensus       313 ~~~~~~~  319 (328)
                      +.+..++
T Consensus       219 ~~~~~~~  225 (273)
T d1xwsa_         219 GQVFFRQ  225 (273)
T ss_dssp             CCCCCSS
T ss_pred             cccCCCC
Confidence            6654443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=351.81  Aligned_cols=215  Identities=22%  Similarity=0.316  Sum_probs=176.3

Q ss_pred             CCceEEEEEEEccCCc----EEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~----~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|.+..+|+    .||+|.++... +.+..+.+.+|+++|++++|||||++++++.++ ..+++||||.+|+|
T Consensus        20 G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l   97 (317)
T d1xkka_          20 GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL   97 (317)
T ss_dssp             CSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBH
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcc
Confidence            8999999999988887    47888776432 333456789999999999999999999999875 46888999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+... ..+++..+..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+........       
T Consensus        98 ~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~---~~~kl~DFGla~~~~~~~~~-------  167 (317)
T d1xkka_          98 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKE-------  167 (317)
T ss_dssp             HHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCCSHHHHTTTTCC--------
T ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC---CCeEeeccccceeccccccc-------
Confidence            8887664 579999999999999999999999999999999999999865   46999999998654221100       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (317)
T d1xkka_         168 --------------------------------------------------------------------------------  167 (317)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                       .......||+.|+|||++.+..|+.++|||||||+||||+| |++||.+.+..++...+.+|.
T Consensus       168 -----------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~  230 (317)
T d1xkka_         168 -----------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  230 (317)
T ss_dssp             ------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred             -----------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence                             00112358999999999999999999999999999999999 899999999999999999998


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ..+.|..++.
T Consensus       231 ~~~~p~~~~~  240 (317)
T d1xkka_         231 RLPQPPICTI  240 (317)
T ss_dssp             CCCCCTTBCH
T ss_pred             CCCCCcccCH
Confidence            8777777654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-49  Score=347.84  Aligned_cols=216  Identities=24%  Similarity=0.332  Sum_probs=183.4

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+.+     .+++.||||+++.. ......+.+.+|+++|++++||||+++++++.+.+..+++||||++|+
T Consensus        24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~  102 (301)
T d1lufa_          24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD  102 (301)
T ss_dssp             CSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             CCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCc
Confidence            899999999875     35688999999754 345556789999999999999999999999999999999999999999


Q ss_pred             cHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcE
Q psy2131          76 LFEDIVARE------------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAV  131 (328)
Q Consensus        76 L~~~l~~~~------------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~v  131 (328)
                      |.+++....                        .+++.++..++.|++.||+|||+++||||||||+|||++.+   +.+
T Consensus       103 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~---~~~  179 (301)
T d1lufa_         103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVV  179 (301)
T ss_dssp             HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCE
T ss_pred             HHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCC---CcE
Confidence            999886432                        37889999999999999999999999999999999999764   459


Q ss_pred             EEeeccccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC
Q psy2131         132 KLADFGLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI  211 (328)
Q Consensus       132 kl~DfGla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~  211 (328)
                      ||+|||+|+.......                                                                
T Consensus       180 Kl~DFGls~~~~~~~~----------------------------------------------------------------  195 (301)
T d1lufa_         180 KIADFGLSRNIYSADY----------------------------------------------------------------  195 (301)
T ss_dssp             EECCCSCHHHHTGGGC----------------------------------------------------------------
T ss_pred             EEccchhheeccCCcc----------------------------------------------------------------
Confidence            9999999854321100                                                                


Q ss_pred             CHHHHhcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHH
Q psy2131         212 TASEALKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYIL  291 (328)
Q Consensus       212 t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyel  291 (328)
                                                              .....+..||+.|+|||++.+..|+.++|||||||+||||
T Consensus       196 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el  235 (301)
T d1lufa_         196 ----------------------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  235 (301)
T ss_dssp             ----------------------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence                                                    0011234689999999999999999999999999999999


Q ss_pred             Hhc-CCCCCCccHHHHHHHHhcccCCCCCCcccc
Q psy2131         292 LVG-YPPFWDEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       292 ltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      ++| .+||.+.++.++...|..|.+...|.+++.
T Consensus       236 l~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~  269 (301)
T d1lufa_         236 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCPL  269 (301)
T ss_dssp             HTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             HccCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            999 578999999999999999998777776654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=350.07  Aligned_cols=205  Identities=30%  Similarity=0.359  Sum_probs=167.9

Q ss_pred             CCceEEEEEEEccC-CcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC---CCCCcceeEEEEEe-----CCEEEEEEEcc
Q psy2131           1 GAFSVVRRCVQKAT-GLEFAAKIINTKKLSARDFQKLEREARICRKL---QHPNIVRLHDSIQE-----ENYHYLVFDLV   71 (328)
Q Consensus         1 G~fg~V~~~~~~~~-~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~-----~~~~~lv~E~~   71 (328)
                      |+||+||+|++..+ ++.||||+++.+.........+.+|+.+|+.|   +|||||+++++|..     ...+|++||||
T Consensus        18 G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~   97 (305)
T d1blxa_          18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV   97 (305)
T ss_dssp             ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECC
T ss_pred             ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEec
Confidence            89999999999765 67799999986554433334456777777665   89999999999863     35789999999


Q ss_pred             CCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchH
Q psy2131          72 TGGELFEDIV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWF  150 (328)
Q Consensus        72 ~gg~L~~~l~-~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~  150 (328)
                      .++++..... ....+++..++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||++......     
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~---~~~kl~dfg~~~~~~~~-----  169 (305)
T d1blxa_          98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ-----  169 (305)
T ss_dssp             SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCCSCCCCCGG-----
T ss_pred             cCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC---CCeeecchhhhhhhccc-----
Confidence            9887644433 34569999999999999999999999999999999999999754   45999999987432110     


Q ss_pred             HHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchh
Q psy2131         151 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVAS  230 (328)
Q Consensus       151 G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~  230 (328)
                                                                                                      
T Consensus       170 --------------------------------------------------------------------------------  169 (305)
T d1blxa_         170 --------------------------------------------------------------------------------  169 (305)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHH
Q psy2131         231 IVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  310 (328)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  310 (328)
                                            .......||+.|+|||++.+.+|+.++||||+||++|||+||++||.+.+...++.+|
T Consensus       170 ----------------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  227 (305)
T d1blxa_         170 ----------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  227 (305)
T ss_dssp             ----------------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ----------------------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence                                  0112356999999999999999999999999999999999999999999999998888


Q ss_pred             hcccC
Q psy2131         311 KAGAY  315 (328)
Q Consensus       311 ~~~~~  315 (328)
                      .+...
T Consensus       228 ~~~~~  232 (305)
T d1blxa_         228 LDVIG  232 (305)
T ss_dssp             HHHHC
T ss_pred             HHhhC
Confidence            76543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=343.93  Aligned_cols=211  Identities=24%  Similarity=0.368  Sum_probs=174.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+ +.||||+++......   +.+.+|+.+|++++|||||++++++.+ +.+|+|||||++|+|...+
T Consensus        28 G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~  102 (285)
T d1fmka3          28 GCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL  102 (285)
T ss_dssp             CSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred             CCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhh
Confidence            89999999998755 569999998665433   568899999999999999999999855 5579999999999998887


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          81 VA--REFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        81 ~~--~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      ..  ...+++.++..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|+.......           
T Consensus       103 ~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~---~~~kl~DfGla~~~~~~~~-----------  168 (285)
T d1fmka3         103 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEY-----------  168 (285)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC------------------
T ss_pred             hhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC---CcEEEcccchhhhccCCCc-----------
Confidence            54  3569999999999999999999999999999999999999764   4599999999864321100           


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       169 --------------------------------------------------------------------------------  168 (285)
T d1fmka3         169 --------------------------------------------------------------------------------  168 (285)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCCC
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDD  317 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~  317 (328)
                                    .......||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+++..|.++...+
T Consensus       169 --------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~  234 (285)
T d1fmka3         169 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP  234 (285)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             --------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence                          01112358999999999999999999999999999999999 567777888999999999998777


Q ss_pred             CCCcccc
Q psy2131         318 EPKHKSA  324 (328)
Q Consensus       318 ~~~~~~~  324 (328)
                      .|+.++.
T Consensus       235 ~~~~~~~  241 (285)
T d1fmka3         235 CPPECPE  241 (285)
T ss_dssp             CCTTSCH
T ss_pred             CCcccCH
Confidence            7776654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=346.01  Aligned_cols=216  Identities=25%  Similarity=0.339  Sum_probs=177.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--------CCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--------ENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--------~~~~~lv~E~~~   72 (328)
                      |+||+||+|+++.+|+.||||++............+.+|+++|++++||||+++++++..        .+.+|+|||||.
T Consensus        21 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~  100 (318)
T d3blha1          21 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE  100 (318)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCC
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccC
Confidence            899999999999999999999998766555556778899999999999999999999865        346899999999


Q ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHH
Q psy2131          73 GGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGV  152 (328)
Q Consensus        73 gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~  152 (328)
                      ++.+.........+++.+++.++.|++.||.|||++|||||||||+|||++.+   +.+||+|||++..+......    
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~---~~~kl~dfg~~~~~~~~~~~----  173 (318)
T d3blha1         101 HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNS----  173 (318)
T ss_dssp             EEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCC--------
T ss_pred             CCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC---CcEEeeecceeeeccccccc----
Confidence            87766555566789999999999999999999999999999999999999754   46999999998654321110    


Q ss_pred             HHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhh
Q psy2131         153 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIV  232 (328)
Q Consensus       153 ~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~  232 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (318)
T d3blha1         174 --------------------------------------------------------------------------------  173 (318)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHh
Q psy2131         233 HRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  311 (328)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  311 (328)
                                        ......+.+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+....+..|.
T Consensus       174 ------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         174 ------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             -------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ------------------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence                              00011234699999999999765 78999999999999999999999999999999999988


Q ss_pred             cccCCCCCCc
Q psy2131         312 AGAYDDEPKH  321 (328)
Q Consensus       312 ~~~~~~~~~~  321 (328)
                      +....++|..
T Consensus       236 ~~~~~~~~~~  245 (318)
T d3blha1         236 QLCGSITPEV  245 (318)
T ss_dssp             HHHCCCCTTT
T ss_pred             HhcCCCChhh
Confidence            8777665544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=337.53  Aligned_cols=206  Identities=24%  Similarity=0.376  Sum_probs=172.1

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|+.  +|..||||+++.+.    ..+.+.+|+++|++++|||||++++++.+ .+.+|+|||||++|+|.++
T Consensus        18 G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~   91 (262)
T d1byga_          18 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY   91 (262)
T ss_dssp             CSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred             CCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHH
Confidence            89999999987  47789999997543    34568899999999999999999999854 5668999999999999999


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHH
Q psy2131          80 IVARE--FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYIL  157 (328)
Q Consensus        80 l~~~~--~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~  157 (328)
                      +..+.  .+++..+..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+++.....            
T Consensus        92 l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~---~~~kl~dfg~s~~~~~~------------  156 (262)
T d1byga_          92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST------------  156 (262)
T ss_dssp             HHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC-------------------
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC---CCEeecccccceecCCC------------
Confidence            86543  58999999999999999999999999999999999999754   46999999997542110            


Q ss_pred             HhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhh
Q psy2131         158 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQET  237 (328)
Q Consensus       158 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~  237 (328)
                                                                                                      
T Consensus       157 --------------------------------------------------------------------------------  156 (262)
T d1byga_         157 --------------------------------------------------------------------------------  156 (262)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhcccCC
Q psy2131         238 VDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD  316 (328)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  316 (328)
                                       .....||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..++...|..|...
T Consensus       157 -----------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~  219 (262)
T d1byga_         157 -----------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  219 (262)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred             -----------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                             111347899999999999999999999999999999998 79999999999999999999887


Q ss_pred             CCCCcccc
Q psy2131         317 DEPKHKSA  324 (328)
Q Consensus       317 ~~~~~~~~  324 (328)
                      +.|..++.
T Consensus       220 ~~~~~~~~  227 (262)
T d1byga_         220 DAPDGCPP  227 (262)
T ss_dssp             CCCTTCCH
T ss_pred             CCCccCCH
Confidence            77766543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=343.77  Aligned_cols=213  Identities=23%  Similarity=0.369  Sum_probs=177.3

Q ss_pred             CCceEEEEEEEccCCcE--EEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLE--FAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~--~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|+++.+|..  ||||.++.. ...+..+.+.+|+++|+++ +|||||++++++.+.+.+|+|||||+||+|.
T Consensus        21 G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~   99 (309)
T d1fvra_          21 GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL   99 (309)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred             CCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHH
Confidence            89999999999988875  566776532 2334556789999999999 7999999999999999999999999999999


Q ss_pred             HHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccc
Q psy2131          78 EDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIE  141 (328)
Q Consensus        78 ~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~  141 (328)
                      +++...                ..+++.++..++.||+.||.|||+++||||||||+|||++.+   +.+||+|||+|+.
T Consensus       100 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~---~~~kl~DfG~a~~  176 (309)
T d1fvra_         100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRG  176 (309)
T ss_dssp             HHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEES
T ss_pred             HHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC---CceEEcccccccc
Confidence            998653                568999999999999999999999999999999999999765   4599999999854


Q ss_pred             ccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         142 VQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       142 ~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .....                                                                           
T Consensus       177 ~~~~~---------------------------------------------------------------------------  181 (309)
T d1fvra_         177 QEVYV---------------------------------------------------------------------------  181 (309)
T ss_dssp             SCEEC---------------------------------------------------------------------------
T ss_pred             ccccc---------------------------------------------------------------------------
Confidence            31100                                                                           


Q ss_pred             cCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhc-CCCCCC
Q psy2131         222 ICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG-YPPFWD  300 (328)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG-~~Pf~~  300 (328)
                                                      ......||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+
T Consensus       182 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         182 --------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             --------------------------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             --------------------------------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence                                            01123589999999999999999999999999999999996 578999


Q ss_pred             ccHHHHHHHHhcccCCCCCCcccc
Q psy2131         301 EDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       301 ~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      .+..++...|.+|.....|..++.
T Consensus       230 ~~~~~~~~~i~~~~~~~~~~~~~~  253 (309)
T d1fvra_         230 MTCAELYEKLPQGYRLEKPLNCDD  253 (309)
T ss_dssp             CCHHHHHHHGGGTCCCCCCTTBCH
T ss_pred             CCHHHHHHHHHhcCCCCCCccCCH
Confidence            999999999999977666666543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=348.27  Aligned_cols=203  Identities=29%  Similarity=0.456  Sum_probs=171.5

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------EEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN------YHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~------~~~lv~E~~~gg   74 (328)
                      |+||+||+|+++.+|+.||||+++....+....+.+.+|+++|++++|||||+++++|...+      .+|+||||| |+
T Consensus        29 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~  107 (346)
T d1cm8a_          29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GT  107 (346)
T ss_dssp             ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cc
Confidence            89999999999999999999999877777777788999999999999999999999998655      579999999 44


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                      +|.. +.....+++..++.++.||+.||.|||++|||||||||+|||++.+   +.+|++|||+|+.....         
T Consensus       108 ~l~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~---~~~kl~Dfg~a~~~~~~---------  174 (346)
T d1cm8a_         108 DLGK-LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQADSE---------  174 (346)
T ss_dssp             EHHH-HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCSS---------
T ss_pred             cHHH-HHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc---cccccccccceeccCCc---------
Confidence            5544 5556789999999999999999999999999999999999999754   46999999998653211         


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       175 --------------------------------------------------------------------------------  174 (346)
T d1cm8a_         175 --------------------------------------------------------------------------------  174 (346)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                          .....||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+....+..+.+.
T Consensus       175 --------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~  234 (346)
T d1cm8a_         175 --------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV  234 (346)
T ss_dssp             --------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             --------------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence                                1124589999999999875 5699999999999999999999999999988888887776


Q ss_pred             cCCC
Q psy2131         314 AYDD  317 (328)
Q Consensus       314 ~~~~  317 (328)
                      ...+
T Consensus       235 ~~~~  238 (346)
T d1cm8a_         235 TGTP  238 (346)
T ss_dssp             HCCC
T ss_pred             cCCC
Confidence            5543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-47  Score=336.66  Aligned_cols=220  Identities=30%  Similarity=0.400  Sum_probs=183.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++ +|+.||||+++.........+++.+|+.+|++++|||||++++++.+.+..|++|||+.++.+....
T Consensus        13 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~   91 (286)
T d1ob3a_          13 GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD   91 (286)
T ss_dssp             ETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH
T ss_pred             CCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH
Confidence            899999999985 8899999999876554444678899999999999999999999999999999999999988776666


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      ...+.+++.++..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|......               
T Consensus        92 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~  168 (286)
T d1ob3a_          92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWYRA  168 (286)
T ss_dssp             TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---------CCCTTCC
T ss_pred             hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---CCEEecccccceecccCccccceecccchhhh
Confidence            667889999999999999999999999999999999999999754   45999999998543211               


Q ss_pred             -------------Ccch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC-------------------------C
Q psy2131         146 -------------QQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------------------------P  186 (328)
Q Consensus       146 -------------~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~  186 (328)
                                   .+.| +|+++|+|++|.+||.+.+..+...++.......+.                         .
T Consensus       169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (286)
T d1ob3a_         169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES  248 (286)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred             HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhh
Confidence                         1123 899999999999999988877766655432111110                         0


Q ss_pred             CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         187 EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       187 ~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ....+|+++.+|+.+||+.||++|||++|+++|||+.+
T Consensus       249 ~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            12346889999999999999999999999999999853

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=341.09  Aligned_cols=216  Identities=25%  Similarity=0.426  Sum_probs=180.7

Q ss_pred             CCceEEEEEEEccCC-------cEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATG-------LEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~-------~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |+||.||+|++..++       ..||||+++.+. .......+.+|+..++++ +|||||++++++.+++.+|+|||||+
T Consensus        24 G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~  102 (299)
T d1fgka_          24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS  102 (299)
T ss_dssp             ----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             cCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccC
Confidence            899999999976655       479999997643 455667788999999888 89999999999999999999999999


Q ss_pred             CCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          73 GGELFEDIVARE----------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        73 gg~L~~~l~~~~----------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|+|.+++..+.                .+++.++..++.|++.||+|||+++||||||||+|||++.+   +.+||+||
T Consensus       103 ~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~---~~~kl~df  179 (299)
T d1fgka_         103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADF  179 (299)
T ss_dssp             TCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECST
T ss_pred             CCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC---CCeEeccc
Confidence            999999986543                48999999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |+++.......                                                                     
T Consensus       180 g~~~~~~~~~~---------------------------------------------------------------------  190 (299)
T d1fgka_         180 GLARDIHHIDY---------------------------------------------------------------------  190 (299)
T ss_dssp             TCCCCGGGCCT---------------------------------------------------------------------
T ss_pred             hhhcccccccc---------------------------------------------------------------------
Confidence            99865422110                                                                     


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                         ........||+.|+|||++.+.+|+.++||||||||+|||+| |.
T Consensus       191 -----------------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~  235 (299)
T d1fgka_         191 -----------------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  235 (299)
T ss_dssp             -----------------------------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             -----------------------------------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCC
Confidence                                               001122458999999999999999999999999999999998 79


Q ss_pred             CCCCCccHHHHHHHHhcccCCCCCCcccc
Q psy2131         296 PPFWDEDQHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       296 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      +||.+.+..+++..|..|.....|.+++.
T Consensus       236 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~  264 (299)
T d1fgka_         236 SPYPGVPVEELFKLLKEGHRMDKPSNCTN  264 (299)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCSSCCH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            99999999999999999988777777654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=339.60  Aligned_cols=216  Identities=25%  Similarity=0.400  Sum_probs=168.7

Q ss_pred             CCceEEEEEEEc-cCC--cEEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQK-ATG--LEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~-~~~--~~~AiK~i~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+.. .++  ..||||+++...... +..+.+.+|+++|++++|||||++++++.+. .+++|||||++|++
T Consensus        19 G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l   97 (273)
T d1u46a_          19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSL   97 (273)
T ss_dssp             ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBH
T ss_pred             CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcch
Confidence            899999999864 333  368999998765433 3456789999999999999999999999764 67899999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+.+..+ +.+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++........       
T Consensus        98 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~~~~~~-------  167 (273)
T d1u46a_          98 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH-------  167 (273)
T ss_dssp             HHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECCC-CCE-------
T ss_pred             hhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc---ceeeccchhhhhcccCCCc-------
Confidence            8877654 5699999999999999999999999999999999999998754   6999999998765332110       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       168 --------------------------------------------------------------------------------  167 (273)
T d1u46a_         168 --------------------------------------------------------------------------------  167 (273)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cCCCCCCccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                      ........||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..++..+|.++.
T Consensus       168 ----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~  231 (273)
T d1u46a_         168 ----------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  231 (273)
T ss_dssp             ----------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             ----------------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence                            001112347889999999999999999999999999999998 899999999999999987776


Q ss_pred             CCC-CCCccc
Q psy2131         315 YDD-EPKHKS  323 (328)
Q Consensus       315 ~~~-~~~~~~  323 (328)
                      +.+ .|.+++
T Consensus       232 ~~~~~~~~~~  241 (273)
T d1u46a_         232 ERLPRPEDCP  241 (273)
T ss_dssp             CCCCCCTTCC
T ss_pred             CCCCCccccc
Confidence            543 334443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=337.16  Aligned_cols=216  Identities=21%  Similarity=0.348  Sum_probs=166.3

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC-CEEEEEEEccCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE-NYHYLVFDLVTG   73 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~-~~~~lv~E~~~g   73 (328)
                      |+||+||+|.+..     +++.||||+++... .....+.+.+|+.++.++ +|+|||++++++.+. +.+|+|||||+|
T Consensus        24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~  102 (299)
T d1ywna1          24 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF  102 (299)
T ss_dssp             CSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTT
T ss_pred             cCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCC
Confidence            8999999999754     44689999997543 344556777888888776 689999999988654 568999999999


Q ss_pred             CCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecc
Q psy2131          74 GELFEDIVAR----------------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFG  137 (328)
Q Consensus        74 g~L~~~l~~~----------------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfG  137 (328)
                      |+|.+++...                ..+++.++..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||
T Consensus       103 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~---~~~Kl~DFG  179 (299)
T d1ywna1         103 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFG  179 (299)
T ss_dssp             CBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECC--
T ss_pred             CcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC---CcEEEccCc
Confidence            9999998653                248899999999999999999999999999999999999754   459999999


Q ss_pred             ccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         138 LAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       138 la~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      +|+.......                                                                      
T Consensus       180 la~~~~~~~~----------------------------------------------------------------------  189 (299)
T d1ywna1         180 LARDIYKDPD----------------------------------------------------------------------  189 (299)
T ss_dssp             ----CCSCTT----------------------------------------------------------------------
T ss_pred             chhhcccccc----------------------------------------------------------------------
Confidence            9865322110                                                                      


Q ss_pred             cCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhc-CC
Q psy2131         218 KHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG-YP  296 (328)
Q Consensus       218 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG-~~  296 (328)
                                                        ........||+.|+|||++.+..|+.++|||||||++|||+|| .+
T Consensus       190 ----------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~  235 (299)
T d1ywna1         190 ----------------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  235 (299)
T ss_dssp             ----------------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ----------------------------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence                                              0011234699999999999999999999999999999999997 67


Q ss_pred             CCCCcc-HHHHHHHHhcccCCCCCCcccc
Q psy2131         297 PFWDED-QHRLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       297 Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  324 (328)
                      ||.+.+ ...+...+..|.....|..++.
T Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (299)
T d1ywna1         236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTP  264 (299)
T ss_dssp             SSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            888775 5566677777776666655543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-47  Score=336.21  Aligned_cols=216  Identities=22%  Similarity=0.339  Sum_probs=184.2

Q ss_pred             CCceEEEEEEEcc-----CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKA-----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~-----~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|.++.     +++.||||+++... ...+...+.+|++++++++|||||++++++...+..++|||||++|+
T Consensus        31 G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  109 (308)
T d1p4oa_          31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD  109 (308)
T ss_dssp             CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             CCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCC
Confidence            8999999998753     46789999997543 45556678999999999999999999999999999999999999999


Q ss_pred             cHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC
Q psy2131          76 LFEDIVAR----------EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE  145 (328)
Q Consensus        76 L~~~l~~~----------~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~  145 (328)
                      |.+++...          ..+++..+..++.|++.||.|||+++||||||||+|||++.+   +.+||+|||+|+.....
T Consensus       110 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~---~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT---CCEEECCTTCCCGGGGG
T ss_pred             HHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC---ceEEEeecccceeccCC
Confidence            99887542          246889999999999999999999999999999999999754   56999999998654221


Q ss_pred             CcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         146 QQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       146 ~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      ..                                                                              
T Consensus       187 ~~------------------------------------------------------------------------------  188 (308)
T d1p4oa_         187 DY------------------------------------------------------------------------------  188 (308)
T ss_dssp             GC------------------------------------------------------------------------------
T ss_pred             cc------------------------------------------------------------------------------
Confidence            10                                                                              


Q ss_pred             ccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhc-CCCCCCccHH
Q psy2131         226 ERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVG-YPPFWDEDQH  304 (328)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG-~~Pf~~~~~~  304 (328)
                                                ........||+.|+|||.+.+..|+.++|||||||+||||+|| ++||.+.+..
T Consensus       189 --------------------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         189 --------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             --------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             --------------------------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence                                      0011224589999999999999999999999999999999999 6999999999


Q ss_pred             HHHHHHhcccCCCCCCcccc
Q psy2131         305 RLYAQIKAGAYDDEPKHKSA  324 (328)
Q Consensus       305 ~~~~~i~~~~~~~~~~~~~~  324 (328)
                      +++..|.+|...+.|..++.
T Consensus       243 ~~~~~i~~~~~~~~p~~~~~  262 (308)
T d1p4oa_         243 QVLRFVMEGGLLDKPDNCPD  262 (308)
T ss_dssp             HHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHHHhCCCCCCcccchH
Confidence            99999999998777877664

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=340.79  Aligned_cols=205  Identities=27%  Similarity=0.429  Sum_probs=166.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+++.+|+.||||+++... .....+++.+|+.+|++++|||||++++++....    ..++++||+.||+|
T Consensus        19 G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L   97 (345)
T d1pmea_          19 GAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL   97 (345)
T ss_dssp             --CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEH
T ss_pred             ccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCch
Confidence            899999999999999999999997644 3445667899999999999999999999997653    23445566679999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      .+++.. ..+++.+++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||+|.........        
T Consensus        98 ~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~---~~~kl~DfG~a~~~~~~~~~--------  165 (345)
T d1pmea_          98 YKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDH--------  165 (345)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCGGGCB--------
T ss_pred             hhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC---CCEEEcccCceeeccCCCcc--------
Confidence            988865 469999999999999999999999999999999999999754   46999999998654221100        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       166 --------------------------------------------------------------------------------  165 (345)
T d1pmea_         166 --------------------------------------------------------------------------------  165 (345)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccc-cCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLK-KEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  313 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  313 (328)
                                     .......+||+.|+|||++. +..|+.++||||+||++|||++|++||.+.+.......+...
T Consensus       166 ---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~  228 (345)
T d1pmea_         166 ---------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  228 (345)
T ss_dssp             ---------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ---------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence                           00112346999999999985 456799999999999999999999999999887777766544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=341.23  Aligned_cols=206  Identities=26%  Similarity=0.347  Sum_probs=170.7

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE------ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~------~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|+++.+|+.||||+++....+.....++.+|+.+|++++|||||+++++|..      ...+|+|||||.|+
T Consensus        28 G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~  107 (355)
T d2b1pa1          28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN  107 (355)
T ss_dssp             C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH
Confidence            899999999999999999999999877777777889999999999999999999999963      47899999999765


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHH
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVIL  154 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~  154 (328)
                       +++.+  ...+++.+++.++.||+.||.|||++||+||||||+|||++.+   +.+|++|||+++......        
T Consensus       108 -l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---~~~kl~df~~~~~~~~~~--------  173 (355)
T d2b1pa1         108 -LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSF--------  173 (355)
T ss_dssp             -HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC----------------
T ss_pred             -HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---cceeeechhhhhcccccc--------
Confidence             44544  3568999999999999999999999999999999999999754   459999999864321100        


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhh
Q psy2131         155 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHR  234 (328)
Q Consensus       155 ~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~  234 (328)
                                                                                                      
T Consensus       174 --------------------------------------------------------------------------------  173 (355)
T d2b1pa1         174 --------------------------------------------------------------------------------  173 (355)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhccc
Q psy2131         235 QETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  314 (328)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  314 (328)
                                         ......||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+......+|....
T Consensus       174 -------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~  234 (355)
T d2b1pa1         174 -------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_dssp             --------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             -------------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence                               0112458999999999999999999999999999999999999999999999888887766


Q ss_pred             CCCCC
Q psy2131         315 YDDEP  319 (328)
Q Consensus       315 ~~~~~  319 (328)
                      ..++|
T Consensus       235 ~~~~~  239 (355)
T d2b1pa1         235 GTPCP  239 (355)
T ss_dssp             CCCCH
T ss_pred             cCCCH
Confidence            55444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=325.35  Aligned_cols=221  Identities=27%  Similarity=0.370  Sum_probs=185.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEEccCCCCcHHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEENYHYLVFDLVTGGELFEDI   80 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l   80 (328)
                      |+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++|||||++++++.+....++|||++.|++|...+
T Consensus        13 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~   92 (292)
T d1unla_          13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD   92 (292)
T ss_dssp             CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH
T ss_pred             CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccc
Confidence            89999999999999999999999877666666788999999999999999999999999999999999999999998888


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCC---------------
Q psy2131          81 VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGE---------------  145 (328)
Q Consensus        81 ~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~---------------  145 (328)
                      ...+.+++.+++.++.|++.||+|||++|||||||||+|||++.+   +.+||+|||.|......               
T Consensus        93 ~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  169 (292)
T d1unla_          93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRP  169 (292)
T ss_dssp             HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSCCSCCCSCCSCGGGCC
T ss_pred             ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---CceeeeecchhhcccCCCccceeeccccchhh
Confidence            888899999999999999999999999999999999999999754   45999999998754211               


Q ss_pred             -------------Ccch-HHHHHHHHHhCCCCCCC-CcHHHHHHHHHhCCCCC-------------------------CC
Q psy2131         146 -------------QQAW-FGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDY-------------------------PS  185 (328)
Q Consensus       146 -------------~~~~-~G~~~~~~~~g~~pf~~-~~~~~~~~~i~~~~~~~-------------------------~~  185 (328)
                                   .+.| +||++|+|++|..||.. .+.......+.......                         ..
T Consensus       170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (292)
T d1unla_         170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV  249 (292)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCT
T ss_pred             hhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhh
Confidence                         1123 89999999999988644 44444444433211110                         01


Q ss_pred             CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         186 PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       186 ~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ......|+.+.+|+.+||+.||.+|||++|+|+|||+.+
T Consensus       250 ~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            122356889999999999999999999999999999964

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=334.18  Aligned_cols=215  Identities=22%  Similarity=0.356  Sum_probs=177.1

Q ss_pred             CCceEEEEEEEc-----cCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQK-----ATGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~-----~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|...     .+++.||||+++... .......+.+|+.+++++ +|||||++++++.+.+.+|+|||||+||
T Consensus        34 G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g  112 (311)
T d1t46a_          34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG  112 (311)
T ss_dssp             CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTE
T ss_pred             cCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCC
Confidence            899999999863     566789999998654 345566789999999999 6999999999999999999999999999


Q ss_pred             CcHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeec
Q psy2131          75 ELFEDIVARE------------------FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADF  136 (328)
Q Consensus        75 ~L~~~l~~~~------------------~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~Df  136 (328)
                      +|.+++....                  .+++.++..++.||+.||+|||+++||||||||+|||++.+   +.+|++||
T Consensus       113 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~---~~~ki~Df  189 (311)
T d1t46a_         113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDF  189 (311)
T ss_dssp             EHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT---TEEEECCC
T ss_pred             CHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc---Cccccccc
Confidence            9999986543                  58999999999999999999999999999999999999754   46999999


Q ss_pred             cccccccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         137 GLAIEVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       137 Gla~~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      |+++........                                                                    
T Consensus       190 G~~~~~~~~~~~--------------------------------------------------------------------  201 (311)
T d1t46a_         190 GLARDIKNDSNY--------------------------------------------------------------------  201 (311)
T ss_dssp             GGGSCTTSCTTS--------------------------------------------------------------------
T ss_pred             chheeccCCCcc--------------------------------------------------------------------
Confidence            998654221100                                                                    


Q ss_pred             hcCcccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHh-cC
Q psy2131         217 LKHPWICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLV-GY  295 (328)
Q Consensus       217 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyellt-G~  295 (328)
                                                          .......||+.|+|||++.+..|+.++|||||||++|||+| |.
T Consensus       202 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~  245 (311)
T d1t46a_         202 ------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (311)
T ss_dssp             ------------------------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ------------------------------------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence                                                01123468999999999999999999999999999999998 77


Q ss_pred             CCCCCccHH-HHHHHHhcccCCCCCCccc
Q psy2131         296 PPFWDEDQH-RLYAQIKAGAYDDEPKHKS  323 (328)
Q Consensus       296 ~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~  323 (328)
                      +||.+.+.. .+...+.++.....|.+++
T Consensus       246 p~~~~~~~~~~~~~~i~~~~~~~~~~~~~  274 (311)
T d1t46a_         246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAP  274 (311)
T ss_dssp             CSSTTCCSSHHHHHHHHHTCCCCCCTTSC
T ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCccccc
Confidence            778777654 4555666666655565554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=331.23  Aligned_cols=218  Identities=22%  Similarity=0.314  Sum_probs=175.0

Q ss_pred             CCceEEEEEEEccCC---cEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ENYHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~---~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|++..++   ..||||+++.. .+....+++.+|+++|++++|||||++++++.+ ++..|+|||||++|+|
T Consensus        38 G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l  116 (311)
T d1r0pa_          38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL  116 (311)
T ss_dssp             ETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBH
T ss_pred             cCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCch
Confidence            899999999986543   36899999743 345667889999999999999999999999765 5689999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHH
Q psy2131          77 FEDIVARE-FYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILY  155 (328)
Q Consensus        77 ~~~l~~~~-~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~  155 (328)
                      .+++.... .+++.++..++.|++.||.|||+.+|+||||||+|||++++   +.+||+|||+++........       
T Consensus       117 ~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~---~~~kL~DFG~~~~~~~~~~~-------  186 (311)
T d1r0pa_         117 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEFD-------  186 (311)
T ss_dssp             HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECSSGGGCCTTTTTCC-------
T ss_pred             hhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC---CCEEEecccchhhccccccc-------
Confidence            98887543 57788899999999999999999999999999999999754   56999999998765322110       


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhh
Q psy2131         156 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQ  235 (328)
Q Consensus       156 ~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~  235 (328)
                                                                                                      
T Consensus       187 --------------------------------------------------------------------------------  186 (311)
T d1r0pa_         187 --------------------------------------------------------------------------------  186 (311)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC-ccHHHHHHHHhccc
Q psy2131         236 ETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGA  314 (328)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~  314 (328)
                                     .........||+.|+|||++.+..|+.++|||||||+||||+||..||.. .+..++...+.+|.
T Consensus       187 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~  251 (311)
T d1r0pa_         187 ---------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  251 (311)
T ss_dssp             ---------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred             ---------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence                           00011124589999999999999999999999999999999997666664 46778888999998


Q ss_pred             CCCCCCcccc
Q psy2131         315 YDDEPKHKSA  324 (328)
Q Consensus       315 ~~~~~~~~~~  324 (328)
                      ....|.+++.
T Consensus       252 ~~~~p~~~~~  261 (311)
T d1r0pa_         252 RLLQPEYCPD  261 (311)
T ss_dssp             CCCCCTTCCH
T ss_pred             CCCCcccCcH
Confidence            8777776653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.3e-46  Score=330.21  Aligned_cols=210  Identities=21%  Similarity=0.285  Sum_probs=169.8

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||+++....    ...+.+|+++++.++| +|++.+++++.+....|+||||| |++|.+.
T Consensus        16 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~   90 (293)
T d1csna_          16 GSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDL   90 (293)
T ss_dssp             CSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHH
Confidence            8999999999999999999999875432    2345678999999965 89999999999999999999999 6799888


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCC--CCCcEEEeeccccccccCCCcchHHHHHHH
Q psy2131          80 IVAR-EFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKA--KGAAVKLADFGLAIEVQGEQQAWFGVILYI  156 (328)
Q Consensus        80 l~~~-~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~--~~~~vkl~DfGla~~~~~~~~~~~G~~~~~  156 (328)
                      +... ..+++.++..++.|++.||.|||++|||||||||+|||++...  ..+.+||+|||+|+........        
T Consensus        91 ~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~--------  162 (293)
T d1csna_          91 LDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--------  162 (293)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC--------
T ss_pred             HHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc--------
Confidence            8665 4699999999999999999999999999999999999997532  2457999999999765332110        


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhh
Q psy2131         157 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQE  236 (328)
Q Consensus       157 ~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~  236 (328)
                                                                                                      
T Consensus       163 --------------------------------------------------------------------------------  162 (293)
T d1csna_         163 --------------------------------------------------------------------------------  162 (293)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCcc---HHHHHHHHhcc
Q psy2131         237 TVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAG  313 (328)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~  313 (328)
                                 .........+..|||.|||||++.+.+|+.++|||||||++|||+||++||.+.+   .......|...
T Consensus       163 -----------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~  231 (293)
T d1csna_         163 -----------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  231 (293)
T ss_dssp             -----------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             -----------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence                       0000011234579999999999999999999999999999999999999998543   44444444443


Q ss_pred             c
Q psy2131         314 A  314 (328)
Q Consensus       314 ~  314 (328)
                      .
T Consensus       232 ~  232 (293)
T d1csna_         232 K  232 (293)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-46  Score=330.00  Aligned_cols=201  Identities=22%  Similarity=0.292  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEEccCCCCcHHH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-VRLHDSIQEENYHYLVFDLVTGGELFED   79 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv~E~~~gg~L~~~   79 (328)
                      |+||+||+|++..+|+.||||++......    .++.+|+++++.++|+|+ +.++.++.+.+..|+|||||.+ +|.+.
T Consensus        18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~   92 (299)
T d1ckia_          18 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDL   92 (299)
T ss_dssp             CSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHH
T ss_pred             CCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhh
Confidence            89999999999999999999998765322    346789999999987765 5556667888999999999954 56555


Q ss_pred             HH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcchHHHHHHHHH
Q psy2131          80 IV-AREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQAWFGVILYILL  158 (328)
Q Consensus        80 l~-~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~~~G~~~~~~~  158 (328)
                      +. ....+++.++..++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+.......         
T Consensus        93 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~---------  163 (299)
T d1ckia_          93 FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---------  163 (299)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC---------
T ss_pred             hhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc---------
Confidence            54 45679999999999999999999999999999999999999776666789999999997654321100         


Q ss_pred             hCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccchhhhhhhhhH
Q psy2131         159 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERVASIVHRQETV  238 (328)
Q Consensus       159 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~  238 (328)
                                                                                                      
T Consensus       164 --------------------------------------------------------------------------------  163 (299)
T d1ckia_         164 --------------------------------------------------------------------------------  163 (299)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHH
Q psy2131         239 DCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHR  305 (328)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~  305 (328)
                                ...........||+.|+|||++.+.+|+.++|||||||++|||+||++||.+.....
T Consensus       164 ----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~  220 (299)
T d1ckia_         164 ----------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT  220 (299)
T ss_dssp             ----------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred             ----------ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence                      000001223569999999999999999999999999999999999999998765443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=329.80  Aligned_cols=215  Identities=32%  Similarity=0.434  Sum_probs=173.2

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE------ENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~------~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|+++.+|+.||||+++.+...      ..+|+++|++++|||||+++++|..      ..++|||||||+++
T Consensus        31 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~  104 (350)
T d1q5ka_          31 GSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET  104 (350)
T ss_dssp             ETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE
T ss_pred             CcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc
Confidence            89999999999999999999999765422      2479999999999999999999853      34589999999876


Q ss_pred             CcHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC----
Q psy2131          75 ELFEDI----VAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ----  146 (328)
Q Consensus        75 ~L~~~l----~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~----  146 (328)
                      .+ +.+    .....+++.+++.++.||+.||+|||++|||||||||+|||++.++  ..+||+|||++.......    
T Consensus       105 ~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~DFG~a~~~~~~~~~~~  181 (350)
T d1q5ka_         105 VY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS  181 (350)
T ss_dssp             HH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECCCTTCEECCTTSCCCS
T ss_pred             cH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEecccchhhccCCccccc
Confidence            43 333    3455799999999999999999999999999999999999997543  469999999986542211    


Q ss_pred             -----------------------cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhC-----------------CCCCCC
Q psy2131         147 -----------------------QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAG-----------------AYDYPS  185 (328)
Q Consensus       147 -----------------------~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~-----------------~~~~~~  185 (328)
                                             +.| +||++|+|++|.+||...+....+..+...                 ...++.
T Consensus       182 ~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  261 (350)
T d1q5ka_         182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ  261 (350)
T ss_dssp             CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCC
T ss_pred             ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccc
Confidence                                   123 899999999999999888776665554321                 111111


Q ss_pred             --------CCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         186 --------PEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       186 --------~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                              ......++++.+|+.+||..||.+|||++|+++|||+.+
T Consensus       262 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                    122357899999999999999999999999999999965

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=330.79  Aligned_cols=220  Identities=28%  Similarity=0.393  Sum_probs=180.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEEEEEEEccCCCC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----NYHYLVFDLVTGGE   75 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~gg~   75 (328)
                      |+||+||+|+++.+|+.||||+++....+....+++.+|+++|++++|||||++++++...     ...+++||||.||+
T Consensus        29 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~  108 (348)
T d2gfsa1          29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD  108 (348)
T ss_dssp             GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCc
Confidence            8999999999999999999999998777777778899999999999999999999999643     34466778888999


Q ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC-----------
Q psy2131          76 LFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG-----------  144 (328)
Q Consensus        76 L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~-----------  144 (328)
                      |.+++. .+.+++.+++.++.||+.||+|||++|||||||||+|||++.+   +.+|++|||+|.....           
T Consensus       109 L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~---~~~kl~dfg~a~~~~~~~~~~~g~~~y  184 (348)
T d2gfsa1         109 LNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEMTGYVATRWY  184 (348)
T ss_dssp             HHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCC----CCTGGGSSSCHHHHT
T ss_pred             hhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc---ccccccccchhcccCcccccccccccc
Confidence            988774 4579999999999999999999999999999999999999754   4599999999754311           


Q ss_pred             --------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC-----------------------CC
Q psy2131         145 --------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-----------------------SP  186 (328)
Q Consensus       145 --------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~~  186 (328)
                                    ..+.| +|+++|+|++|.+||.+.+.......+.......+                       ..
T Consensus       185 ~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (348)
T d2gfsa1         185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM  264 (348)
T ss_dssp             SCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC
T ss_pred             cCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc
Confidence                          11234 89999999999999998887766665543322211                       11


Q ss_pred             ----CcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         187 ----EWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       187 ----~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                          .+...|+++++||.+||..||.+|||++|+|+|||+.+
T Consensus       265 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                12357899999999999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=329.61  Aligned_cols=221  Identities=30%  Similarity=0.515  Sum_probs=182.1

Q ss_pred             CCceEEEEEEE---ccCCcEEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEEccCCC
Q psy2131           1 GAFSVVRRCVQ---KATGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQH-PNIVRLHDSIQEENYHYLVFDLVTGG   74 (328)
Q Consensus         1 G~fg~V~~~~~---~~~~~~~AiK~i~~~~~~--~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv~E~~~gg   74 (328)
                      |+||+||+|++   +.+|+.||||+++.....  ....+.+.+|+++|++++| |||+++++++.+...+|++||||.||
T Consensus        35 G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~  114 (322)
T d1vzoa_          35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG  114 (322)
T ss_dssp             TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeeccccc
Confidence            89999999987   457999999999765432  1234567889999999976 89999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccC----------
Q psy2131          75 ELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQG----------  144 (328)
Q Consensus        75 ~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~----------  144 (328)
                      +|.+.+...+.+++..+..++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+....          
T Consensus       115 ~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~vkL~DFG~a~~~~~~~~~~~~~~~  191 (322)
T d1vzoa_         115 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFC  191 (322)
T ss_dssp             BHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECCGGGGGGGCGGG
T ss_pred             HHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---CCEEEeeccchhhhcccccccccccc
Confidence            999999998999999999999999999999999999999999999999754   4699999999864311          


Q ss_pred             --------------------CCcch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhc
Q psy2131         145 --------------------EQQAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQML  203 (328)
Q Consensus       145 --------------------~~~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  203 (328)
                                          ..+.| +||++|+|++|..||.+.+.......+.......+.+.....|+++.+|+.+||
T Consensus       192 g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l  271 (322)
T d1vzoa_         192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL  271 (322)
T ss_dssp             SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHc
Confidence                                01223 899999999999999776544333333332222223333478999999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCcccCC
Q psy2131         204 TVNPSKRI-----TASEALKHPWICQ  224 (328)
Q Consensus       204 ~~~p~~R~-----t~~~~l~h~~~~~  224 (328)
                      ..||.+|+     |++|+++|||+.+
T Consensus       272 ~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         272 MKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            99999999     5899999999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.4e-44  Score=320.99  Aligned_cols=214  Identities=27%  Similarity=0.498  Sum_probs=172.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEEEEccCCCCcH
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE--NYHYLVFDLVTGGELF   77 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~--~~~~lv~E~~~gg~L~   77 (328)
                      |+||+||+|+++.+|+.||||+++...     .+++.+|+++|+.++ ||||++++++|...  ..+|+|||||.+++|.
T Consensus        46 G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~  120 (328)
T d3bqca1          46 GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK  120 (328)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGG
T ss_pred             CcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHH
Confidence            899999999999999999999997532     456789999999995 99999999999854  5699999999999986


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCC-----------
Q psy2131          78 EDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQ-----------  146 (328)
Q Consensus        78 ~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~-----------  146 (328)
                      ..   .+.+++.+++.++.||+.||.|||++|||||||||+|||++.++  ..+||+|||+|.......           
T Consensus       121 ~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~~~~~~~~~~t~~y  195 (328)
T d3bqca1         121 QL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYF  195 (328)
T ss_dssp             GT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCTTCCCCSCCSCGGG
T ss_pred             HH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccCCCcccccccCccc
Confidence            64   34699999999999999999999999999999999999997543  469999999986542211           


Q ss_pred             ----------------cch-HHHHHHHHHhCCCCCCCCcH-HHHHHHH-------------HhCCCC-------------
Q psy2131         147 ----------------QAW-FGVILYILLVGYPPFWDEDQ-HRLYAQI-------------KAGAYD-------------  182 (328)
Q Consensus       147 ----------------~~~-~G~~~~~~~~g~~pf~~~~~-~~~~~~i-------------~~~~~~-------------  182 (328)
                                      +.| +|+++|+|++|..||..... ......+             ......             
T Consensus       196 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (328)
T d3bqca1         196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS  275 (328)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCC
T ss_pred             cCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccccc
Confidence                            123 89999999999999976542 2111111             111110             


Q ss_pred             -------CCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         183 -------YPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       183 -------~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                             .+......+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus       276 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             ccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                   111233457899999999999999999999999999999964

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=318.45  Aligned_cols=188  Identities=26%  Similarity=0.311  Sum_probs=150.3

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EEEEEEEccCCCCc
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEEN----YHYLVFDLVTGGEL   76 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~----~~~lv~E~~~gg~L   76 (328)
                      |+||+||+|+.  +|+.||||+++...   ......++|+..+++++|||||++++++.+.+    .+|+|||||++|+|
T Consensus        14 G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L   88 (303)
T d1vjya_          14 GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             CCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence            89999999985  68899999996432   12222345666667889999999999997654    68999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeecCCCCcEEEeeCCCCCcEEEeeccccccccCCCcc
Q psy2131          77 FEDIVAREFYSEADASHCIQQILESVNHCHS--------NGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQGEQQA  148 (328)
Q Consensus        77 ~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~--------~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~~~~~~  148 (328)
                      .+++.+. .+++.+...++.|++.||.|+|+        +|||||||||+|||++.+   +.+||+|||++.........
T Consensus        89 ~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~---~~~Kl~DFGl~~~~~~~~~~  164 (303)
T d1vjya_          89 FDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDT  164 (303)
T ss_dssp             HHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT---SCEEECCCTTCEEEETTTTE
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC---CCeEEEecCccccccCCCcc
Confidence            9988754 68999999999999999999996        599999999999999754   56999999998765332110


Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRERV  228 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~~~  228 (328)
                                                                                                      
T Consensus       165 --------------------------------------------------------------------------------  164 (303)
T d1vjya_         165 --------------------------------------------------------------------------------  164 (303)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             hhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCC------CCCCcchhhhhhHHHHHHhcCCCCC
Q psy2131         229 ASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEP------YGKPVDIWACGVILYILLVGYPPFW  299 (328)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~~~~~DvwSlGvilyelltG~~Pf~  299 (328)
                                            .........||+.|+|||++.+..      |+.++|||||||+||||+||.+||.
T Consensus       165 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         165 ----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             ----------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ----------------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence                                  000112346999999999997653      5778999999999999999998874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-38  Score=284.99  Aligned_cols=190  Identities=25%  Similarity=0.356  Sum_probs=152.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-----------CCCcceeEEEEE--eCCEEEEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----------HPNIVRLHDSIQ--EENYHYLV   67 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-----------H~nIv~l~~~~~--~~~~~~lv   67 (328)
                      |+||+||+|+++.+|+.||||+++.+.   ...+.+.+|+++++.++           |+|||++++++.  .....+++
T Consensus        24 G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  100 (362)
T d1q8ya_          24 GHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV  100 (362)
T ss_dssp             CSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeee
Confidence            899999999999999999999997542   23456778999988875           578999999876  44677888


Q ss_pred             EEccCCCCcHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCcEEEeeCCCC---CcEEEeeccccc
Q psy2131          68 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESVNHCHS-NGVVHRDLKPENLLLASKAKG---AAVKLADFGLAI  140 (328)
Q Consensus        68 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qll~~L~ylH~-~~ivHrDiKp~NiLl~~~~~~---~~vkl~DfGla~  140 (328)
                      |+++..+.......   ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++..   ..+|++|||.|.
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~  180 (362)
T d1q8ya_         101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC  180 (362)
T ss_dssp             EEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred             eeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccc
Confidence            88877665433332   33568999999999999999999998 899999999999999865432   248999999975


Q ss_pred             cccCCCcchHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q psy2131         141 EVQGEQQAWFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHP  220 (328)
Q Consensus       141 ~~~~~~~~~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~  220 (328)
                      .....                                                                           
T Consensus       181 ~~~~~---------------------------------------------------------------------------  185 (362)
T d1q8ya_         181 WYDEH---------------------------------------------------------------------------  185 (362)
T ss_dssp             ETTBC---------------------------------------------------------------------------
T ss_pred             ccccc---------------------------------------------------------------------------
Confidence            43110                                                                           


Q ss_pred             ccCCcccchhhhhhhhhHHHHHhHHHhhhhhhhhhhhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCC
Q psy2131         221 WICQRERVASIVHRQETVDCLKKFNARRKLKVSTRQGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWD  300 (328)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  300 (328)
                                                        ....+||+.|+|||++.+..|+.++|+||+||+++||++|+.||.+
T Consensus       186 ----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         186 ----------------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             ----------------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ----------------------------------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence                                              1124599999999999999999999999999999999999999986


Q ss_pred             cc
Q psy2131         301 ED  302 (328)
Q Consensus       301 ~~  302 (328)
                      .+
T Consensus       232 ~~  233 (362)
T d1q8ya_         232 DE  233 (362)
T ss_dssp             --
T ss_pred             Cc
Confidence            54

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.2e-25  Score=182.59  Aligned_cols=127  Identities=24%  Similarity=0.320  Sum_probs=100.4

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccCCCC----------------HHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTKKLS----------------ARDFQKLEREARICRKLQHPNIVRLHDSIQEENYH   64 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~~~~----------------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~   64 (328)
                      |+||+||+|.+. +|+.||||+++....+                ........+|...+.++.|.+++..+++..    .
T Consensus        11 G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~   85 (191)
T d1zara2          11 GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----N   85 (191)
T ss_dssp             CSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----T
T ss_pred             CcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----C
Confidence            899999999885 7899999998643211                011233567899999999999999886632    2


Q ss_pred             EEEEEccCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCcEEEeeCCCCCcEEEeecccccccc
Q psy2131          65 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESVNHCHSNGVVHRDLKPENLLLASKAKGAAVKLADFGLAIEVQ  143 (328)
Q Consensus        65 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qll~~L~ylH~~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~~~~  143 (328)
                      +++|||++++.+.+       +++..+..++.|++.+|.|||++||+||||||+|||++.+    .++|+|||+|....
T Consensus        86 ~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~liDFG~a~~~~  153 (191)
T d1zara2          86 AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWIIDFPQSVEVG  153 (191)
T ss_dssp             EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEECCCTTCEETT
T ss_pred             EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEEECCCcccCC
Confidence            79999999865532       4556677899999999999999999999999999999742    48999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.50  E-value=2.6e-15  Score=133.98  Aligned_cols=65  Identities=31%  Similarity=0.596  Sum_probs=60.2

Q ss_pred             hhccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ....||+.|+|||++.+.+|+.++|||||||+||||+||++||.+.+..+++..|.++.+.+++.
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  250 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED  250 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            34679999999999999999999999999999999999999999999999999999999876653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=2.1e-14  Score=126.57  Aligned_cols=63  Identities=27%  Similarity=0.597  Sum_probs=59.1

Q ss_pred             hccCCCCCCCccccccCCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.++.+.+++
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~  224 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE  224 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh
Confidence            456999999999999999999999999999999999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.37  E-value=9.5e-14  Score=119.66  Aligned_cols=65  Identities=43%  Similarity=0.898  Sum_probs=57.4

Q ss_pred             hhccCCCCCCCcccccc------CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKK------EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEPK  320 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  320 (328)
                      ....||+.|+|||++.+      ..|+.++||||+||+||||+||++||.+.++..+.+.|.++.+.++++
T Consensus       167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            34679999999999863      457889999999999999999999999999999999999999875544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.28  E-value=3e-12  Score=111.73  Aligned_cols=80  Identities=45%  Similarity=1.015  Sum_probs=73.9

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+...+...+..+...++.+.+..+|+++++|+.+||..||.+|||++|+++|||+.+.
T Consensus       191 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            344 8999999999999999999999999999999988888888999999999999999999999999999999999764


Q ss_pred             c
Q psy2131         226 E  226 (328)
Q Consensus       226 ~  226 (328)
                      .
T Consensus       271 ~  271 (307)
T d1a06a_         271 T  271 (307)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.26  E-value=1.3e-12  Score=112.94  Aligned_cols=63  Identities=24%  Similarity=0.292  Sum_probs=52.4

Q ss_pred             hhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  318 (328)
                      ....||+.|+|||++.+. .++.++|+||+||+||||++|++||.+.+..+++.+|......++
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            345699999999999764 569999999999999999999999999999999998877655443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=4.1e-13  Score=118.16  Aligned_cols=61  Identities=31%  Similarity=0.589  Sum_probs=48.9

Q ss_pred             hhhccCCCCCCCccccccC--CCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccC
Q psy2131         255 RQGFAGTPGYLSPEVLKKE--PYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  315 (328)
Q Consensus       255 ~~~~~Gt~~y~aPE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  315 (328)
                      ..+..||+.|+|||.+.+.  .|+.++|||||||+||||+||+.||.+.+...+...|.++..
T Consensus       187 ~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            3446799999999999765  468899999999999999999999998876666666655544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=6.2e-12  Score=109.00  Aligned_cols=76  Identities=34%  Similarity=0.705  Sum_probs=70.3

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||++|+|++|.+||.+.+..+....+......++...+..+|+++++||.+||..||.+|||++|+++|||+...
T Consensus       202 lGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             hhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            8999999999999999999999999999988888776777899999999999999999999999999999999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.19  E-value=1.2e-11  Score=109.76  Aligned_cols=78  Identities=28%  Similarity=0.639  Sum_probs=72.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQRE  226 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~~  226 (328)
                      .+||++|+|++|.+||.+.+..+....+....+.++...+..+|+++++||.+||..||.+|||++|+++|||+.+..
T Consensus       210 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             hhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            389999999999999999999999999999988888877888999999999999999999999999999999997643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=5.7e-12  Score=112.04  Aligned_cols=58  Identities=24%  Similarity=0.469  Sum_probs=50.9

Q ss_pred             hhhccCCCCCCCcccccc-CCCCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhc
Q psy2131         255 RQGFAGTPGYLSPEVLKK-EPYGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  312 (328)
Q Consensus       255 ~~~~~Gt~~y~aPE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  312 (328)
                      ..+..||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+....+..|.+
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~  237 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  237 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence            334679999999999875 5789999999999999999999999999988888877764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=4.6e-12  Score=112.48  Aligned_cols=64  Identities=28%  Similarity=0.395  Sum_probs=55.9

Q ss_pred             hhccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCCCCccHHHHHHHHhcccCCCCC
Q psy2131         256 QGFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDDEP  319 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  319 (328)
                      .+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......|.+....+++
T Consensus       176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            3467999999999987765 589999999999999999999999999999999999888765543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=3e-11  Score=102.92  Aligned_cols=73  Identities=41%  Similarity=0.800  Sum_probs=65.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      +.| +||++|+|++|.+||.+.+.......+....+.+|    ..+|+++++|+.+||+.||.+|||++|+++|||+.
T Consensus       186 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             hhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            444 89999999999999999999999998888777665    35899999999999999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=8.3e-11  Score=101.65  Aligned_cols=78  Identities=22%  Similarity=0.465  Sum_probs=62.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHh-CCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKA-GAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +.| +||++|+|++|.+||.+.+.......+.. .....  ..+..+|+++++||.+||..||.+|||++|+++|||+..
T Consensus       198 DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            344 89999999999999998887666555443 33322  334678999999999999999999999999999999964


Q ss_pred             cc
Q psy2131         225 RE  226 (328)
Q Consensus       225 ~~  226 (328)
                      ..
T Consensus       276 ~~  277 (293)
T d1yhwa1         276 AK  277 (293)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=1.1e-10  Score=99.61  Aligned_cols=73  Identities=29%  Similarity=0.488  Sum_probs=63.9

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWI  222 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~  222 (328)
                      +.| +|+++|+|++|.+||.+.+..++...+..+.....   ...+|+++++|+.+||+.||.+|||++|+++|||+
T Consensus       196 DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         196 DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            344 89999999999999999999888888887765422   24689999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=1e-10  Score=100.78  Aligned_cols=78  Identities=21%  Similarity=0.344  Sum_probs=64.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+..+....+..+.... ......+|+++++|+.+||+.||.+|||++|+++|||++..
T Consensus       197 DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         197 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             hHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            444 8999999999999999988877777776654322 22345789999999999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=1.6e-10  Score=100.14  Aligned_cols=77  Identities=25%  Similarity=0.295  Sum_probs=60.6

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCC------------------------CcCCCCHHHHHHHHHhcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------------------EWDTVTPEAKNLINQMLT  204 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~l~  204 (328)
                      .+||++|+|++|.+||.+.+..+....|.......+..                        .....|+++.+|+.+||+
T Consensus       186 SlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~  265 (299)
T d1ua2a_         186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL  265 (299)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHC
T ss_pred             hcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHcc
Confidence            38999999999999999988887776665321111100                        013568899999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCc
Q psy2131         205 VNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       205 ~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      .||++|||++|+|+|||+.+.
T Consensus       266 ~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         266 FNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             SSTTTSCCHHHHHTSGGGTSS
T ss_pred             CChhhCcCHHHHhCCHhhCCC
Confidence            999999999999999999754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=1.4e-10  Score=99.07  Aligned_cols=73  Identities=25%  Similarity=0.438  Sum_probs=57.2

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      +||++|+|++|.+||...+... ....+.....  ....+..+|+++.+|+.+||+.||.+|||++|+++|||+.+
T Consensus       192 lGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         192 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             hHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            8999999999999997655432 2333333222  22335678999999999999999999999999999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=1.5e-10  Score=100.47  Aligned_cols=76  Identities=25%  Similarity=0.268  Sum_probs=59.9

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCC-----------------------CCCcCCCCHHHHHHHHHhcccC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-----------------------SPEWDTVTPEAKNLINQMLTVN  206 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~l~~~  206 (328)
                      +||++|+|++|.+||.+.+.......+.......+                       ......+|+++.+|+.+||+.|
T Consensus       201 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d  280 (305)
T d1blxa_         201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN  280 (305)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred             hHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC
Confidence            89999999999999999888777666543111000                       0112457899999999999999


Q ss_pred             CCCCCCHHHHhcCcccCCc
Q psy2131         207 PSKRITASEALKHPWICQR  225 (328)
Q Consensus       207 p~~R~t~~~~l~h~~~~~~  225 (328)
                      |.+|||++|+++|||+.+-
T Consensus       281 P~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         281 PAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TTTSCCHHHHHTSGGGTTC
T ss_pred             hhHCcCHHHHhcChhhcCc
Confidence            9999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.01  E-value=2.1e-10  Score=98.87  Aligned_cols=72  Identities=29%  Similarity=0.663  Sum_probs=64.2

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHH------hcCccc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEA------LKHPWI  222 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~------l~h~~~  222 (328)
                      .+||++|+|++|.+||.+.+...+...+..+.+.+|.    .+|+++++||.+||+.||.+|||++|+      ++|||+
T Consensus       195 SlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff  270 (288)
T d1uu3a_         195 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF  270 (288)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred             hhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCcc
Confidence            3899999999999999999999999999888777663    689999999999999999999999984      778888


Q ss_pred             CC
Q psy2131         223 CQ  224 (328)
Q Consensus       223 ~~  224 (328)
                      ..
T Consensus       271 ~~  272 (288)
T d1uu3a_         271 ES  272 (288)
T ss_dssp             TT
T ss_pred             CC
Confidence            54

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=3e-11  Score=106.59  Aligned_cols=77  Identities=44%  Similarity=0.985  Sum_probs=62.9

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHH----HHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||++|+|++|.+||.+.+....    ...+..+.+.+|.+.+..+|+++++||.+||+.||++|||+.|+++|||+.+.
T Consensus       199 lGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         199 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             hchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            89999999999999977654333    33445566677777777899999999999999999999999999999999654


Q ss_pred             c
Q psy2131         226 E  226 (328)
Q Consensus       226 ~  226 (328)
                      .
T Consensus       279 ~  279 (335)
T d2ozaa1         279 T  279 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=2.7e-10  Score=97.23  Aligned_cols=75  Identities=19%  Similarity=0.415  Sum_probs=59.3

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCc-HHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q psy2131         147 QAW-FGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWIC  223 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~  223 (328)
                      +.| +||++|+|++|.+||.+.. ...+...+..+..  |.......++++++++.+||..||++|||++|+++|||+.
T Consensus       194 DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             chhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            344 8999999999999997654 4455556654432  2223356789999999999999999999999999999983

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=5.4e-10  Score=98.34  Aligned_cols=74  Identities=32%  Similarity=0.749  Sum_probs=66.8

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l~h~  220 (328)
                      +.| +||++|+|++|.+||.+.+...+...+..+...+|.    .+|+++++||.+||++||.+|++     ++|+++||
T Consensus       187 DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp  262 (337)
T d1o6la_         187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             cccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence            444 899999999999999999999999999988877764    68999999999999999999994     89999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       263 ~f~~  266 (337)
T d1o6la_         263 FFLS  266 (337)
T ss_dssp             GGTT
T ss_pred             cccc
Confidence            9965

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.98  E-value=5e-10  Score=97.42  Aligned_cols=78  Identities=18%  Similarity=0.302  Sum_probs=64.5

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.| +||++|+|++|.+||.+.+.......+..+....  .....+|+++++|+.+||+.||.+|||++|+++|||+.+.
T Consensus       196 DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            344 8999999999999999988877777666554322  2335689999999999999999999999999999999654


Q ss_pred             c
Q psy2131         226 E  226 (328)
Q Consensus       226 ~  226 (328)
                      .
T Consensus       274 ~  274 (309)
T d1u5ra_         274 R  274 (309)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=2.6e-10  Score=99.74  Aligned_cols=71  Identities=32%  Similarity=0.655  Sum_probs=64.8

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccCC
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITAS-EALKHPWICQ  224 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~-~~l~h~~~~~  224 (328)
                      +||++|+|++|.+||.+.+...+...+..+.+.+|.    .+|+++.+|+.+||+.||.+|||+. ++++|||+.+
T Consensus       189 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         189 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             hhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            899999999999999999999999999888776653    6899999999999999999999995 8999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.96  E-value=5.6e-10  Score=97.42  Aligned_cols=75  Identities=23%  Similarity=0.391  Sum_probs=59.0

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcC----------------------------CCCHHHHHHHHH
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD----------------------------TVTPEAKNLINQ  201 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~s~~~~~li~~  201 (328)
                      +|+++|+|++|.+||.+.+.......+......++...+.                            ..++++.+|+.+
T Consensus       208 lGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~  287 (318)
T d3blha1         208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK  287 (318)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHH
Confidence            8999999999999999888777666654433332221111                            136788999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccCC
Q psy2131         202 MLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       202 ~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ||+.||++|+|++|+++||||..
T Consensus       288 mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         288 LLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             HCcCChhHCcCHHHHHcChhhcc
Confidence            99999999999999999999964

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.96  E-value=8e-10  Score=96.39  Aligned_cols=75  Identities=28%  Similarity=0.755  Sum_probs=66.7

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~  220 (328)
                      +.| +||++|+|++|.+||.+.+.......+..+...+|.    .+|+++++++.+||..||.+|+     |++++++||
T Consensus       183 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             hccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence            344 899999999999999999999999999888776653    6899999999999999999996     999999999


Q ss_pred             ccCCc
Q psy2131         221 WICQR  225 (328)
Q Consensus       221 ~~~~~  225 (328)
                      |+.+-
T Consensus       259 ~f~~i  263 (316)
T d1fota_         259 WFKEV  263 (316)
T ss_dssp             GGSSC
T ss_pred             ccccC
Confidence            99753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=6.7e-10  Score=96.09  Aligned_cols=77  Identities=23%  Similarity=0.320  Sum_probs=58.8

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCC----------------C---------CcCCCCHHHHHHHHHhc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------------P---------EWDTVTPEAKNLINQML  203 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------~---------~~~~~s~~~~~li~~~l  203 (328)
                      .+|+++|+|++|.+||.+.+.......+.........                +         ....+|+++.+|+.+||
T Consensus       188 SlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL  267 (298)
T d1gz8a_         188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML  267 (298)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHT
T ss_pred             ccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHc
Confidence            3899999999999999988876665554321111100                0         01256889999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccCCc
Q psy2131         204 TVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       204 ~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +.||.+|||++|+++|||+.+-
T Consensus       268 ~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         268 HYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cCChhHCcCHHHHhCCHhhccC
Confidence            9999999999999999999654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.95  E-value=8.7e-10  Score=97.53  Aligned_cols=75  Identities=28%  Similarity=0.757  Sum_probs=66.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRI-----TASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----t~~~~l~h~  220 (328)
                      +.| +||++|+|++|.+||.+.+.......+..+...+|    ..+|+++.+|+.+||..||.+|+     |++++++||
T Consensus       220 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp  295 (350)
T d1rdqe_         220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             cccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence            344 89999999999999999999999999988876665    36899999999999999999995     999999999


Q ss_pred             ccCCc
Q psy2131         221 WICQR  225 (328)
Q Consensus       221 ~~~~~  225 (328)
                      ||...
T Consensus       296 ~f~~~  300 (350)
T d1rdqe_         296 WFATT  300 (350)
T ss_dssp             GGTTC
T ss_pred             cccCC
Confidence            99653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=1.7e-10  Score=99.40  Aligned_cols=62  Identities=23%  Similarity=0.244  Sum_probs=50.6

Q ss_pred             hccCCCCCCCccccccCC-CCCCcchhhhhhHHHHHHhcCCCC-CCccHHHHHHHHhcccCCCC
Q psy2131         257 GFAGTPGYLSPEVLKKEP-YGKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDDE  318 (328)
Q Consensus       257 ~~~Gt~~y~aPE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~~  318 (328)
                      ...+++.|+|||++.+.. ++.++||||+||++|||++|+.|| .+.+..+++.++......+.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            345889999999998765 599999999999999999999885 56678888888776655443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=7.2e-10  Score=94.68  Aligned_cols=66  Identities=32%  Similarity=0.597  Sum_probs=55.4

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCc
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      +||++|+|++|.+||.+.+      .+..+...++    ..+|+++++|+.+||+.||.+|||++|+++|||+.+.
T Consensus       196 lGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         196 LGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            8999999999999997643      2344444443    4689999999999999999999999999999999653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=98.87  E-value=3.6e-10  Score=99.13  Aligned_cols=47  Identities=21%  Similarity=0.454  Sum_probs=41.6

Q ss_pred             hhccCCCCCCCccccccC-CCCCCcchhhhhhHHHHHHhcCCCCCCcc
Q psy2131         256 QGFAGTPGYLSPEVLKKE-PYGKPVDIWACGVILYILLVGYPPFWDED  302 (328)
Q Consensus       256 ~~~~Gt~~y~aPE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~  302 (328)
                      ....||+.|+|||++.+. .|+.++|+||+||++|||++|+.||...+
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            345799999999998875 57999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.87  E-value=1.1e-09  Score=97.30  Aligned_cols=77  Identities=21%  Similarity=0.352  Sum_probs=58.1

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRIT-----ASEALKHP  220 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t-----~~~~l~h~  220 (328)
                      +.| +||++|+|++|.+||.+.+........ ......+...+..+|+++++||.+||..||.+|||     ++|+++||
T Consensus       188 DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp  266 (364)
T d1omwa3         188 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  266 (364)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred             chhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence            344 899999999999999775433222211 22222333344578999999999999999999999     79999999


Q ss_pred             ccCC
Q psy2131         221 WICQ  224 (328)
Q Consensus       221 ~~~~  224 (328)
                      |+..
T Consensus       267 ~f~~  270 (364)
T d1omwa3         267 FFRS  270 (364)
T ss_dssp             GGTT
T ss_pred             cccC
Confidence            9975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.82  E-value=2e-09  Score=95.07  Aligned_cols=78  Identities=27%  Similarity=0.431  Sum_probs=59.4

Q ss_pred             cch-HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCC-----------------------CC----CCcCCCCHHHHHH
Q psy2131         147 QAW-FGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-----------------------PS----PEWDTVTPEAKNL  198 (328)
Q Consensus       147 ~~~-~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~----~~~~~~s~~~~~l  198 (328)
                      +.| +||++|+|++|.+||.+.+.......+.......                       ..    ......|+++.+|
T Consensus       201 DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  280 (346)
T d1cm8a_         201 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL  280 (346)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHH
T ss_pred             hhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHH
Confidence            344 8999999999999999887665554433211111                       11    1224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         199 INQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       199 i~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      |.+||..||.+|||++|+|+|||+.+
T Consensus       281 i~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         281 LEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHHCcCChhHCcCHHHHhcChhhCc
Confidence            99999999999999999999999965

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.75  E-value=4.1e-09  Score=92.06  Aligned_cols=35  Identities=23%  Similarity=0.441  Sum_probs=32.6

Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         190 TVTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       190 ~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      ..|+++.+|+.+||+.||.+|||++|+|+|||+.+
T Consensus       269 ~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         269 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            46899999999999999999999999999999854

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.70  E-value=8.4e-09  Score=90.90  Aligned_cols=76  Identities=30%  Similarity=0.412  Sum_probs=57.0

Q ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC--------------------CCCC-------CCcCCCCHHHHHHHHHh
Q psy2131         150 FGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--------------------DYPS-------PEWDTVTPEAKNLINQM  202 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~--------------------~~~~-------~~~~~~s~~~~~li~~~  202 (328)
                      +|+++|+|++|.+||.+.+.............                    ..+.       ..+..+|+++.+|+.+|
T Consensus       199 lG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  278 (345)
T d1pmea_         199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM  278 (345)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred             cCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHH
Confidence            89999999999999988776544433211000                    0010       11346789999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccCCc
Q psy2131         203 LTVNPSKRITASEALKHPWICQR  225 (328)
Q Consensus       203 l~~~p~~R~t~~~~l~h~~~~~~  225 (328)
                      |+.||.+|||++|+|+|||+.+.
T Consensus       279 L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         279 LTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             ccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=6.3e-09  Score=92.11  Aligned_cols=76  Identities=24%  Similarity=0.371  Sum_probs=56.3

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCC----------------------CCCCCC----------------cCC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAY----------------------DYPSPE----------------WDT  190 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~----------------------~~~~~~----------------~~~  190 (328)
                      .+||++++|++|.+||.+.+.......+.....                      ......                ...
T Consensus       203 SlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (355)
T d2b1pa1         203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL  282 (355)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred             cccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccccccccccc
Confidence            389999999999999988876665544432111                      000000                112


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         191 VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       191 ~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .|+++.+|+.+||..||++|||++|+|+|||+..
T Consensus       283 ~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         283 KASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            3678899999999999999999999999999965

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=98.66  E-value=9.3e-09  Score=87.73  Aligned_cols=73  Identities=21%  Similarity=0.343  Sum_probs=61.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKHPW  221 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~  221 (328)
                      .+|+++|+|++|.+||.+.+..+....+.......+...+..+|+++.++|.+||+.||.+||+..+.+.|+|
T Consensus       199 SlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l  271 (277)
T d1o6ya_         199 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  271 (277)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             cchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence            3899999999999999999888888877777777676677889999999999999999999995444444444

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=1.1e-07  Score=80.78  Aligned_cols=67  Identities=19%  Similarity=0.304  Sum_probs=58.5

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      .+|+++|+|++ |.+||.+.+..+....+......++.  ...+++++.+++.+||..||++|||+++++
T Consensus       199 S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         199 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            48999999997 89999999999988888777655443  357899999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=8.6e-08  Score=81.35  Aligned_cols=68  Identities=24%  Similarity=0.405  Sum_probs=57.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||.+.+..++...+..+...   +.+..+|+++.+|+.+||..||.+|||++|++++
T Consensus       194 SlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         194 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            48999999987 89999998888888887765432   2345789999999999999999999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=6.6e-08  Score=84.30  Aligned_cols=69  Identities=12%  Similarity=0.186  Sum_probs=55.0

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+||++|+|++ |.+||.+.+.......+.......+.  ...+|+++++|+.+||+.||++|||++|+++|
T Consensus       251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            38999999997 89999887665555555554444333  34689999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=1.4e-07  Score=79.43  Aligned_cols=68  Identities=15%  Similarity=0.145  Sum_probs=57.7

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |..||.+.+..++...+..+... +  .....++++.+|+.+||+.||++|||++++++|
T Consensus       186 S~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-Y--RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-C--CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            38999999998 89999999988888888765432 2  224688999999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=1.5e-07  Score=80.06  Aligned_cols=66  Identities=18%  Similarity=0.211  Sum_probs=55.1

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      .+|+++|+|++ |.+||.+.+..++...+..+.. .  +....+++++.+++.+||..||.+|||+++++
T Consensus       195 S~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~--~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~  261 (277)
T d1xbba_         195 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-M--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE  261 (277)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            48999999997 8999999888888877776532 1  22246899999999999999999999999984

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=8.5e-08  Score=81.57  Aligned_cols=71  Identities=20%  Similarity=0.280  Sum_probs=54.0

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHH-HHHHHhCCCCCC-CCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDYP-SPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~-~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++|..||.+.+.... ...+..+..... ......+++++.+++.+||..||.+|||+++++.+
T Consensus       194 S~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            489999999999999988665444 344444332221 22345688999999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.37  E-value=4.4e-07  Score=77.91  Aligned_cols=68  Identities=13%  Similarity=0.306  Sum_probs=56.8

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+||++|+|++ |.+||.+.+..++...+..+.. .+  ....+++++.+++.+||..||.+|||++++++
T Consensus       217 wS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~  285 (299)
T d1jpaa_         217 WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN  285 (299)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            348999999997 8999999988888887766532 22  23468999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.37  E-value=1.3e-07  Score=80.80  Aligned_cols=66  Identities=18%  Similarity=0.157  Sum_probs=54.9

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      .+|+++|+|++ |.+||.+.+..++...+..+...   +....+++++.+++.+||..||.+|||+.++.
T Consensus       197 S~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~  263 (285)
T d1u59a_         197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVE  263 (285)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             cchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            38999999997 99999988888888777765432   12246899999999999999999999999884

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=1.8e-07  Score=79.34  Aligned_cols=72  Identities=17%  Similarity=0.195  Sum_probs=56.1

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Cccc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK--HPWI  222 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~--h~~~  222 (328)
                      +.+|+++|+|++ |.+||...+.......+..+..   .+....+++++.+++.+||+.||.+|||++++++  ++|+
T Consensus       194 wS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            348999999998 5666777777777777765432   2223568999999999999999999999999986  4554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.31  E-value=1.6e-07  Score=82.79  Aligned_cols=34  Identities=29%  Similarity=0.663  Sum_probs=31.4

Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q psy2131         191 VTPEAKNLINQMLTVNPSKRITASEALKHPWICQ  224 (328)
Q Consensus       191 ~s~~~~~li~~~l~~~p~~R~t~~~~l~h~~~~~  224 (328)
                      .++++.+|+.+||..||.+|||++|+|+|||+.+
T Consensus       300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~  333 (362)
T d1q8ya_         300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD  333 (362)
T ss_dssp             HHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred             cCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence            4678899999999999999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=6.1e-07  Score=77.01  Aligned_cols=68  Identities=22%  Similarity=0.320  Sum_probs=56.2

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+|+++|+|++ |.+||.+.+...+...+..+. ..+  ....+++++.+++.+||+.||.+|||+.|+++
T Consensus       221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-CCC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            348999999997 799999888888887776542 222  23468999999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=5.3e-07  Score=75.89  Aligned_cols=69  Identities=19%  Similarity=0.327  Sum_probs=55.8

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      +.+|+++|+|++ |.+||...+..++...+..+....   .....++++.+++.+||+.||++|||++++++|
T Consensus       186 wS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            348999999998 677888778878888777653322   224678999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=4e-07  Score=78.55  Aligned_cols=68  Identities=19%  Similarity=0.258  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++| .+||.+.+..++...+..+..   .+.+..+++++.+|+.+||..||++|||+++++++
T Consensus       211 SfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         211 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            489999999996 567888888888887765422   22335689999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=6.7e-07  Score=76.22  Aligned_cols=74  Identities=19%  Similarity=0.211  Sum_probs=58.4

Q ss_pred             chHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CcccCC
Q psy2131         148 AWFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK--HPWICQ  224 (328)
Q Consensus       148 ~~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~--h~~~~~  224 (328)
                      +.+|+++|+|++ |.+|+.+....++...+..+..   .+....+++++++++.+||+.||++|||+++++.  ++|+..
T Consensus       198 ~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         198 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            348999999998 4666677777777777765432   2234578999999999999999999999999987  777754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=3.8e-07  Score=76.82  Aligned_cols=67  Identities=13%  Similarity=0.257  Sum_probs=55.0

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||...+...+...+..+. ..+  .....++++.+++.+||..||.+|||+.++++
T Consensus       185 SfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMD--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             HHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC--CCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            48999999997 799998888888877776542 222  23468899999999999999999999999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.26  E-value=2.5e-06  Score=71.21  Aligned_cols=72  Identities=14%  Similarity=0.127  Sum_probs=50.6

Q ss_pred             ceEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCcHH
Q psy2131           3 FSVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGELFE   78 (328)
Q Consensus         3 fg~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L~~   78 (328)
                      .+.||+..  ..+..+.+|+.......  ....+.+|+..+..+. +--+.+++.+..+.+..|+|||+++|.++.+
T Consensus        27 ~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          27 PAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             SSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             CCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            35788874  45667788887643221  1223567888887774 3346788888889999999999999977644

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=5.6e-07  Score=77.92  Aligned_cols=68  Identities=15%  Similarity=0.233  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++ |.+||.+.+...+...+..+...   +....+++++.+++.+|+..||.+|||+.+++.|
T Consensus       198 S~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         198 SYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            48999999998 89999888877777777665321   2224689999999999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.18  E-value=1.5e-06  Score=74.46  Aligned_cols=67  Identities=15%  Similarity=0.246  Sum_probs=56.3

Q ss_pred             hHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++| .+||.+.+..++...+..+...   +....+++++.+++.+||+.||++|||+.|+++
T Consensus       227 S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            489999999988 5789999988888888776532   223468999999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.17  E-value=7.8e-07  Score=76.23  Aligned_cols=68  Identities=26%  Similarity=0.346  Sum_probs=50.9

Q ss_pred             hHHHHHHHHHhC-CCCCCCCcHHH-HHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVG-YPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g-~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++| .+||.+.+... +...+..+. ..+  ....+++++.+++.+||+.||.+|||++|+++|
T Consensus       221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            489999999986 56887665433 344444432 222  234689999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.16  E-value=1.9e-06  Score=73.44  Aligned_cols=67  Identities=19%  Similarity=0.258  Sum_probs=51.1

Q ss_pred             hHHHHHHHHHhCCCC-CCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVGYPP-FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++|..| |.+.+...+...+..+ ...  +....+++++.+|+.+||..||.+|||++++++
T Consensus       201 S~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         201 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            489999999996555 5555666666555543 222  233568999999999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.13  E-value=1.9e-06  Score=74.16  Aligned_cols=68  Identities=18%  Similarity=0.184  Sum_probs=56.7

Q ss_pred             chHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         148 AWFGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       148 ~~~G~~~~~~~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      +.+|+++|+|++| .+||.+.+..+.+..+..+....   ....+++.+.+++.+|++.||.+|||+.++++
T Consensus       219 ~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3489999999998 58898888888888877654321   22468899999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.11  E-value=1.5e-06  Score=74.97  Aligned_cols=68  Identities=15%  Similarity=0.292  Sum_probs=51.4

Q ss_pred             hHHHHHHHHHh-CCCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|++ |.+||...+.......+.......+  .....++++.+|+.+||+.||.+|||+++++.
T Consensus       232 S~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            48999999998 6777767666555444443333332  22467999999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.11  E-value=3.6e-06  Score=71.42  Aligned_cols=67  Identities=16%  Similarity=0.352  Sum_probs=52.9

Q ss_pred             hHHHHHHHHHhC-CCCCCCCcHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy2131         149 WFGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALK  218 (328)
Q Consensus       149 ~~G~~~~~~~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~  218 (328)
                      .+|+++|+|+++ .+|+...+..++...+..+.. .+  ....+++++.+++.+||..||++|||+.+++.
T Consensus       198 S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         198 SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CC--CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            489999999985 666666777777777765532 22  23468899999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=4.2e-06  Score=72.01  Aligned_cols=68  Identities=15%  Similarity=0.192  Sum_probs=48.7

Q ss_pred             hHHHHHHHHHhCCCCCCCC-cHHHHHHHHHhCCCCCCCCCcCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy2131         149 WFGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKNLINQMLTVNPSKRITASEALKH  219 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l~h  219 (328)
                      .+|+++|+|++|..||... +.......+..+.. .+  ....+++++.+++.+||..||.+||++.|+++|
T Consensus       219 SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~--~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         219 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4899999999976666543 44445555555432 22  224678999999999999999999999999864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.90  E-value=1.5e-05  Score=70.67  Aligned_cols=74  Identities=12%  Similarity=0.097  Sum_probs=44.6

Q ss_pred             CCceEEEEEEEccCCcEEEEEEeccC-CCC----HHHHHHHHHHHHHHHhCC-C--CCcceeEEEEEeCCEEEEEEEccC
Q psy2131           1 GAFSVVRRCVQKATGLEFAAKIINTK-KLS----ARDFQKLEREARICRKLQ-H--PNIVRLHDSIQEENYHYLVFDLVT   72 (328)
Q Consensus         1 G~fg~V~~~~~~~~~~~~AiK~i~~~-~~~----~~~~~~~~~E~~il~~l~-H--~nIv~l~~~~~~~~~~~lv~E~~~   72 (328)
                      |....||++.+..+++.+.+|.-... +..    .....+..+|...|+.+. +  ..+++++.+  +.+..++|||++.
T Consensus        37 G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~  114 (392)
T d2pula1          37 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS  114 (392)
T ss_dssp             SSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT
T ss_pred             CceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccC
Confidence            45678999988777888999975421 110    112334567888887662 2  356677755  3445578999998


Q ss_pred             CCCc
Q psy2131          73 GGEL   76 (328)
Q Consensus        73 gg~L   76 (328)
                      +..+
T Consensus       115 ~~~~  118 (392)
T d2pula1         115 HLKI  118 (392)
T ss_dssp             TSEE
T ss_pred             Cccc
Confidence            7654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.85  E-value=3.2e-05  Score=63.89  Aligned_cols=67  Identities=21%  Similarity=0.177  Sum_probs=48.0

Q ss_pred             eEEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           4 SVVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         4 g~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      +.||+... ..+..+.+|.-.....     ..+.+|+..|+.+..  -.+.+++.+..+.+..|+|||+++|.++
T Consensus        25 ~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          25 AAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            57888754 4566788887654322     235678887776643  3467888888888899999999998665

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.59  E-value=1.1e-05  Score=68.74  Aligned_cols=68  Identities=13%  Similarity=0.084  Sum_probs=45.4

Q ss_pred             hHHHHHHHHHhCCCCCCCCcHHHHHHH---HHhCCCCCCCC-CcCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy2131         149 WFGVILYILLVGYPPFWDEDQHRLYAQ---IKAGAYDYPSP-EWDTVTPEAKNLINQMLTVNPSKRITASEA  216 (328)
Q Consensus       149 ~~G~~~~~~~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~t~~~~  216 (328)
                      .+|+++|+|++|.+||...........   ........+.+ ....+|+++.+++.+|+..||++||+++++
T Consensus       198 SlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             HHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             ecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            389999999999999977554332221   11111111111 234688999999999999999999998865

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00045  Score=59.19  Aligned_cols=67  Identities=16%  Similarity=0.319  Sum_probs=44.1

Q ss_pred             EEEEEEEccCCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-----cee--EEEEEeCCEEEEEEEccCCCC
Q psy2131           5 VVRRCVQKATGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRL--HDSIQEENYHYLVFDLVTGGE   75 (328)
Q Consensus         5 ~V~~~~~~~~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~l--~~~~~~~~~~~lv~E~~~gg~   75 (328)
                      .||++.. .+|..|++|+.+....+.   +++..|...+..|....|     +..  -..+......+.+++++.|..
T Consensus        37 ~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          37 RVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             EEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            6888854 578889999987665443   445668887777642222     111  123455677899999998753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.28  E-value=0.00012  Score=62.36  Aligned_cols=71  Identities=10%  Similarity=0.006  Sum_probs=45.7

Q ss_pred             chHHHHHHHHHhCCCCCCCC---------------cHHHHHHHHHhCCCCCCCCCcC---CCCHHHHHHHHHhcccCCCC
Q psy2131         148 AWFGVILYILLVGYPPFWDE---------------DQHRLYAQIKAGAYDYPSPEWD---TVTPEAKNLINQMLTVNPSK  209 (328)
Q Consensus       148 ~~~G~~~~~~~~g~~pf~~~---------------~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~~l~~~p~~  209 (328)
                      +.+|+++|+|++|.+||...               ................+.+...   .....+.+++.+||+.||.+
T Consensus       202 ~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~  281 (303)
T d1vjya_         202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA  281 (303)
T ss_dssp             HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred             hhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhH
Confidence            34899999999998876331               1222333333333322222111   12245889999999999999


Q ss_pred             CCCHHHHhc
Q psy2131         210 RITASEALK  218 (328)
Q Consensus       210 R~t~~~~l~  218 (328)
                      |||+.|++.
T Consensus       282 Rps~~ei~~  290 (303)
T d1vjya_         282 RLTALRIKK  290 (303)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.66  E-value=0.00047  Score=58.16  Aligned_cols=68  Identities=12%  Similarity=0.092  Sum_probs=46.3

Q ss_pred             HHHHHHHHHhCCCCCCCCc---HHHHHHHHHhCCCCCCCC-CcCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy2131         150 FGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSP-EWDTVTPEAKNLINQMLTVNPSKRITASEAL  217 (328)
Q Consensus       150 ~G~~~~~~~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~t~~~~l  217 (328)
                      +|+++|+|++|..||.+.+   .......+.......+.. ....+++++.+++..|+..+|++||+.+.+.
T Consensus       199 lG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             hhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            8999999999999997543   222333332211111111 1235789999999999999999999877653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.47  E-value=0.0052  Score=53.74  Aligned_cols=64  Identities=11%  Similarity=0.028  Sum_probs=40.6

Q ss_pred             EEEEEEEcc-------CCcEEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEEccCCCCc
Q psy2131           5 VVRRCVQKA-------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEENYHYLVFDLVTGGEL   76 (328)
Q Consensus         5 ~V~~~~~~~-------~~~~~AiK~i~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~E~~~gg~L   76 (328)
                      .+|++....       .++.+.+++..... .   .....+|..+++.+. +.-..+++.++.+    .+||||++|.++
T Consensus        57 ~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          57 MLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             ceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            677776542       34567777765221 1   123457888888874 4334588887753    689999988654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.33  E-value=0.031  Score=46.73  Aligned_cols=30  Identities=33%  Similarity=0.515  Sum_probs=24.4

Q ss_pred             CCCeeecCCCCcEEEeeCCCCCcEEEeeccccc
Q psy2131         108 NGVVHRDLKPENLLLASKAKGAAVKLADFGLAI  140 (328)
Q Consensus       108 ~~ivHrDiKp~NiLl~~~~~~~~vkl~DfGla~  140 (328)
                      .|+||+|+.+.||+++.+   ...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~---~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGD---ELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETT---EEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccc---cceeEecccccc
Confidence            479999999999999743   335799999874